PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bando, S; Soeki, T; Matsuura, T; Tobiume, T; Ise, T; Kusunose, K; Yamaguchi, K; Yagi, S; Fukuda, D; Iwase, T; Yamada, H; Wakatsuki, T; Shimabukuro, M; Muguruma, N; Takayama, T; Kishimoto, I; Kangawa, K; Sata, M				Bando, Sachiko; Soeki, Takeshi; Matsuura, Tomomi; Tobiume, Takeshi; Ise, Takayuki; Kusunose, Kenya; Yamaguchi, Koji; Yagi, Shusuke; Fukuda, Daiju; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Shimabukuro, Michio; Muguruma, Naoki; Takayama, Tetsuji; Kishimoto, Ichiro; Kangawa, Kenji; Sata, Masataka			Plasma brain natriuretic peptide levels are elevated in patients with cancer	PLOS ONE			English	Article							HEART-FAILURE; INNATE IMMUNITY; CELL-LINES; INFLAMMATION; CYTOKINES; HORMONES; DISEASE; GENE; IL-6; BNP	Background Natriuretic peptides have been proposed as biomarkers of cardiovascular disease, especially heart failure. Brain natriuretic peptide (BNP) has also been shown to be upregulated at the transcriptional and translational levels by pro-inflammatory cytokines in cardiac myocytes. Although we often measure plasma BNP levels in cancer patients, it remains unknown whether cancer-related inflammation affects the plasma BNP levels. We investigated the relationship between the BNP and human cancers. Methods We retrospectively studied 2,923 patients in whom the plasma BNP levels and serum Creactive protein (CRP) were measured and echocardiography was performed. Patients with clinically evident heart failure (NYHA II or higher), heart disease requiring medical treatment or surgery, renal dysfunction, and inflammatory disease were excluded. There were 234 patients in the final analysis. Blood sampling was performed before surgery and chemotherapy. In addition, we evaluated the relationship between the inflammation and plasma BNP levels in mouse models of colon cancer. Results Of the 234 patients, 80 were diagnosed with cancer. Both the plasma BNP and serum CRP levels were significantly higher in cancer patients than those without. There were no significant differences in the echocardiographic parameters. There was a significant positive correlation between the plasma BNP and serum CRP levels in cancer patients (r = 0.360, P < 0.01) but not in those without. In cancer patients, only the CRP correlated with the BNP independent of the age, creatinine level, hypertension, and body mass index. In addition, in nude mice with subcutaneous colon cancer, the plasma BNP level was elevated compared with that in non-cancer mice, and there was a significant relationship between the plasma BNP and serum levels of the inflammatory markers. Conclusions In cancer patients, as well as colon cancer model mice, the plasma BNP levels were elevated, possibly due to cancer-related inflammation. The effect of cancer on the BNP levels should be considered when using BNP as an indicator of heart failure in cancer patients.	[Bando, Sachiko; Soeki, Takeshi; Matsuura, Tomomi; Tobiume, Takeshi; Ise, Takayuki; Kusunose, Kenya; Yamaguchi, Koji; Yagi, Shusuke; Fukuda, Daiju; Iwase, Takashi; Yamada, Hirotsugu; Wakatsuki, Tetsuzo; Sata, Masataka] Tokushima Univ, Inst Biomed Sci, Dept Cardiovasc Med, Grad Sch, Tokushima, Japan; [Shimabukuro, Michio] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima, Japan; [Muguruma, Naoki; Takayama, Tetsuji] Tokushima Univ, Grad Sch, Dept Gastroenterol & Oncol, Inst Biomed Sci, Tokushima, Japan; [Kishimoto, Ichiro; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Suita, Osaka, Japan	Tokushima University; Tokushima University; Tokushima University; National Cerebral & Cardiovascular Center - Japan	Soeki, T (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Cardiovasc Med, Grad Sch, Tokushima, Japan.	soeki@tokushima-u.ac.jp	Kusunose, Kenya/AAC-9978-2021; Fukuda, Daiju/AAO-6752-2021	Kusunose, Kenya/0000-0002-4909-754X; Muguruma, Naoki/0000-0002-4740-4809	Grants-in-Aid for Scientific Research [16K09517] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abudiab MM, 2013, EUR J HEART FAIL, V15, P776, DOI 10.1093/eurjhf/hft026; Andreu Aileen, 2012, Congest Heart Fail, V18, P333, DOI 10.1111/j.1751-7133.2011.00258.x; BLISS DP, 1990, J NATL CANCER I, V82, P305, DOI 10.1093/jnci/82.4.305; Burjonroppa SC, 2007, AM J CLIN ONCOL-CANC, V30, P287, DOI 10.1097/01.coc.0000256101.04404.b0; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Hildebrandt P, 2004, EUR J HEART FAIL, V6, P313, DOI 10.1016/j.ejheart.2004.01.001; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kishimoto I, 2011, FEBS J, V278, P1830, DOI 10.1111/j.1742-4658.2011.08116.x; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ma KK, 2004, J MOL CELL CARDIOL, V36, P505, DOI 10.1016/j.yjmcc.2004.01.001; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; McCullough PA, 2003, HEART FAIL REV, V8, P355, DOI 10.1023/A:1026195332025; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Saba SR, 2006, HISTOL HISTOPATHOL, V21, P775, DOI 10.14670/HH-21.775; Shor R, 2006, EUR J INTERN MED, V17, P536, DOI 10.1016/j.ejim.2006.07.013; Solus J, 2008, ARTHRITIS RHEUM-US, V58, P2662, DOI 10.1002/art.23796; St Peter JV, 2006, CLIN CHEM, V52, P680, DOI 10.1373/clinchem.2005.062562; Vesely DL, 2009, J INVEST MED, V57, P22, DOI 10.2310/JIM.0b013e3181948b25; Vesely DL, 2006, CLIN EXP PHARMACOL P, V33, P169, DOI 10.1111/j.1440-1681.2006.04344.x; Vila G, 2008, J APPL PHYSIOL, V105, P1741, DOI 10.1152/japplphysiol.90442.2008; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wang XQ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-56; WIGLE DA, 1995, AM J PHYSIOL-HEART C, V268, pH1869, DOI 10.1152/ajpheart.1995.268.5.H1869	34	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178607	10.1371/journal.pone.0178607	http://dx.doi.org/10.1371/journal.pone.0178607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570595	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800086
J	Chang, LC; Mahmood, R; Qureshi, S; Breder, CD				Chang, Lin-Chau; Mahmood, Riaz; Qureshi, Samina; Breder, Christopher D.			Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications	PLOS ONE			English	Article							RETRIEVAL; TERMS	Purpose Standardised MedDRA Queries (SMQs) have been developed since the early 2000's and used by academia, industry, public health, and government sectors for detecting safety signals in adverse event safety databases. The purpose of the present study is to characterize how SMQs are used and the impact in safety analyses for New Drug Application (NDA) and Biologics License Application (BLA) submissions to the United States Food and Drug Administration (USFDA). Methods We used the PharmaPendium database to capture SMQ use in Summary Basis of Approvals (SBoAs) of drugs and biologics approved by the USFDA. Characteristics of the drugs and the SMQ use were employed to evaluate the role of SMQ safety analyses in regulatory decisions and the veracity of signals they revealed. Results A comprehensive search of the SBoAs yielded 184 regulatory submissions approved from 2006 to 2015. Search strategies more frequently utilized restrictive searches with "narrow terms" to enhance specificity over strategies using "broad terms" to increase sensitivity, while some involved modification of search terms. A majority (59%) of 1290 searches used descriptive statistics, however inferential statistics were utilized in 35% of them. Commentary from reviewers and supervisory staff suggested that a small, yet notable percentage (18%) of 1290 searches supported regulatory decisions. The searches with regulatory impact were found in 73 submissions (40% of the submissions investigated). Most searches (75% of 227 searches) with regulatory implications described how the searches were confirmed, indicating prudence in the decision-making process. Conclusions SMQs have an increasing role in the presentation and review of safety analysis for NDAs/BLAs and their regulatory reviews. This study suggests that SMQs are best used for screening process, with descriptive statistics, description of SMQ modifications, and systematic verification of cases which is crucial for drawing regulatory conclusions.	[Chang, Lin-Chau; Mahmood, Riaz; Qureshi, Samina; Breder, Christopher D.] Johns Hopkins Univ, Master Sci Regulatory Sci Program, Adv Acad Programs, Krieger Sch Arts & Sci, Rockville, MD 20850 USA; [Mahmood, Riaz] Campbell Univ, Sch Osteopath Med, Lillington, NC USA; [Qureshi, Samina] PSI Int Inc, Healthcare Pharma, Fairfax, VA USA; [Breder, Christopher D.] US FDA, DNP, ODE1, OND,CDER, Silver Spring, MD 20993 USA	Johns Hopkins University; Campbell University; US Food & Drug Administration (FDA)	Breder, CD (corresponding author), Johns Hopkins Univ, Master Sci Regulatory Sci Program, Adv Acad Programs, Krieger Sch Arts & Sci, Rockville, MD 20850 USA.; Breder, CD (corresponding author), US FDA, DNP, ODE1, OND,CDER, Silver Spring, MD 20993 USA.	cbreder1@jhu.edu		Breder, Christopher/0000-0002-1902-1595; Chang, Lin-Chau/0000-0001-7441-9355	PSI International, INC.	PSI International, INC.	SQ received support in the form of salary from PSI International, INC. However, no external sources of funding were obtained specifically for this study. PSI International, INC. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill Robert W, 2012, AMIA Annu Symp Proc, V2012, P43; Botsis T, 2013, DRUG SAFETY, V36, P573, DOI 10.1007/s40264-013-0064-4; Breder CD, 2016, PHARM MED, V30, P103, DOI 10.1007/s40290-016-0136-8; Council for International Organizations of Medical Sciences (CIOMS), 2004, SMQS DEV RAT US STAN; Dupuch M, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-18; Geniaux H, 2014, DRUG SAFETY, V37, P537, DOI 10.1007/s40264-014-0187-2; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2013, UND MEDDRA MED DICT; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2015, MEDDRA DAT RETR PRES; Li X, 2013, COMP SCI S; Maund E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3555; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; MOZZICATO P, 2009, PHARM MED, V23, P65; Pearson RK, 2009, INT J MED INFORM, V78, pE97, DOI 10.1016/j.ijmedinf.2009.01.001; Sacks L.V., 2000, JAMA-J AM MED ASSOC, V311, P378, DOI DOI 10.1001/JAMA.2013.282542; Schroll JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041174; Souvignet Julien, 2012, AMIA Annu Symp Proc, V2012, P882; WHO Collaborating Centre for Drug Statistics Methodology, 2016, GUID ATC CLASS DDD A	17	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178104	10.1371/journal.pone.0178104	http://dx.doi.org/10.1371/journal.pone.0178104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570569	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800029
J	Lee, SSY; Black, AA; Wood, JM				Lee, Samantha Sze-Yee; Black, Alex A.; Wood, Joanne M.			Effect of glaucoma on eye movement patterns and laboratory-based hazard detection ability	PLOS ONE			English	Article							VISUAL-FIELD LOSS; MOTOR-VEHICLE COLLISIONS; OLDER DRIVERS; MOTION PERCEPTION; PERFORMANCE; SAFETY; IMPAIRMENT; MODERATE; CRASHES; RISK	Purpose The mechanisms underlying the elevated crash rates of older drivers with glaucoma are poorly understood. A key driving skill is timely detection of hazards; however, the hazard detection ability of drivers with glaucoma has been largely unexplored. This study assessed the eye movement patterns and visual predictors of performance on a laboratory-based hazard detection task in older drivers with glaucoma. Methods Participants included 30 older drivers with glaucoma (71 +/- 7 years; average better-eye mean deviation (MD) = -3.1 +/- 3.2 dB; average worse-eye MD = -11.9 +/- 6.2 dB) and 25 age-matched controls (72 +/- 7 years). Visual acuity, contrast sensitivity, visual fields, useful field of view (UFoV; processing speeds), and motion sensitivity were assessed. Participants completed a computerised Hazard Perception Test (HPT) while their eye movements were recorded using a desk-mounted Tobii TX300 eye-tracking system. The HPT comprises a series of real-world traffic videos recorded from the driver's perspective; participants responded to road hazards appearing in the videos, and hazard response times were determined. Results Participants with glaucoma exhibited an average of 0.42 seconds delay in hazard response time (p = 0.001), smaller saccades (p = 0.010), and delayed first fixation on hazards (p<0.001) compared to controls. Importantly, larger saccades were associated with faster hazard responses in the glaucoma group (p = 0.004), but not in the control group (p = 0.19). Across both groups, significant visual predictors of hazard response times included motion sensitivity, UFoV, and worse-eye MD (p<0.05). Conclusions Older drivers with glaucoma had delayed hazard response times compared to controls, with associated changes in eye movement patterns. The association between larger saccades and faster hazard response time in the glaucoma group may represent a compensatory behaviour to facilitate improved performance.	[Lee, Samantha Sze-Yee; Black, Alex A.; Wood, Joanne M.] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia; [Lee, Samantha Sze-Yee; Black, Alex A.; Wood, Joanne M.] Queensland Univ Technol, Inst Biomed & Hlth Innovat, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Black, AA; Wood, JM (corresponding author), Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia.; Black, AA; Wood, JM (corresponding author), Queensland Univ Technol, Inst Biomed & Hlth Innovat, Brisbane, Qld, Australia.	aa.black@qut.edu.au; j.wood@qut.edu.au	Lee, Samantha/AAB-1799-2019; Black, Alex/I-9727-2012	Black, Alex/0000-0002-8671-5167; Lee, Sze-Yee/0000-0001-6635-1098	QUT School of Optometry and Vision Science Scholarship; QUT HDR Tuition Fees Sponsorship; QUT Write-up Scholarship	QUT School of Optometry and Vision Science Scholarship; QUT HDR Tuition Fees Sponsorship; QUT Write-up Scholarship	This work was supported by QUT School of Optometry and Vision Science Scholarship; QUT HDR Tuition Fees Sponsorship; QUT Write-up Scholarship.	[Anonymous], 2010, TOB TX300 SPEC GAZ P; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Bhorade AM, 2016, AM J OPHTHALMOL, V166, P43, DOI 10.1016/j.ajo.2016.02.031; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Burton R, 2014, GRAEF ARCH CLIN EXP, V252, P1621, DOI 10.1007/s00417-014-2752-x; Cerulli A, 2014, EUR J OPHTHALMOL, V24, P358, DOI 10.5301/ejo.5000397; Cheong AMY, 2008, OPTOMETRY VISION SCI, V85, P26, DOI 10.1097/OPX.0b013e31815ed6fd; Cornelissen FW, 2005, OPTOMETRY VISION SCI, V82, P27; Crabb DP, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00312; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; ELLIOTT DB, 1991, CLIN VISION SCI, V6, P471; ESTERMAN B, 1982, OPHTHALMOLOGY, V89, P1226; Field A, 2013, DISCOVERING STAT USI; Frezzotti P, 2016, HUM BRAIN MAPP, V37, P4581, DOI 10.1002/hbm.23330; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Glen FC, 2016, CLIN EXP OPTOM, V99, P469, DOI 10.1111/cxo.12435; Glen FC, 2015, BRIT J OPHTHALMOL, V99, P613, DOI 10.1136/bjophthalmol-2014-305932; Glen FC, 2013, VISION RES, V82, P42, DOI 10.1016/j.visres.2013.02.010; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Heun R, 1998, INT J GERIATR PSYCH, V13, P368, DOI 10.1002/(SICI)1099-1166(199806)13:6<368::AID-GPS775>3.3.CO;2-0; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Kasneci E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087470; Kubler TC, 2015, OPTOMETRY VISION SCI, V92, P1037, DOI 10.1097/OPX.0000000000000702; Kunimatsu-Sanuki S, 2016, BRIT J OPHTHALMOLOGY; Kunimatsu-Sanuki S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006379; Kwon M, 2016, OPHTHALMOLOGY, V123, P109, DOI 10.1016/j.ophtha.2015.08.043; Lacherez P, 2014, ACTA OPHTHALMOL, V92, P88, DOI 10.1111/j.1755-3768.2012.02575.x; Lamirel C, 2014, J GLAUCOMA, V23, P23, DOI 10.1097/IJG.0b013e31825c10dc; Lee SSY, 2016, OPTOMETRY VISION SCI, V93, P1137, DOI 10.1097/OPX.0000000000000903; Lee SSY, 2015, OPHTHAL PHYSL OPT, V35, P522, DOI 10.1111/opo.12230; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2015, J GLAUCOMA, V24, P138, DOI 10.1097/IJG.0b013e3182a0761c; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; Milea D, 2016, INVEST OPHTH VIS SCI, V57; Noe G, 2003, CLIN EXP OPHTHALMOL, V31, P482, DOI 10.1046/j.1442-9071.2003.00712.x; Ono T, 2014, OPTOMETRY VISION SCI, V92, P357; Ono T, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/497067; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ramulu PY, 2014, OPTOMETRY VISION SCI, V91, P187, DOI 10.1097/OPX.0000000000000139; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Sagberg F, 2006, ACCIDENT ANAL PREV, V38, P407, DOI 10.1016/j.aap.2005.10.014; Sippel K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106089; Smith ND, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-45; Smith ND, 2012, SEEING PERCEIVING, V25, P471, DOI 10.1163/187847612X634454; Underwood G, 2005, OPHTHAL PHYSL OPT, V25, P346, DOI 10.1111/j.1475-1313.2005.00290.x; Vargas-Martin F, 2006, INVEST OPHTH VIS SCI, V47, P5295, DOI 10.1167/iovs.05-1043; Vega RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077294; Wetton MA, 2011, ACCIDENT ANAL PREV, V43, P1759, DOI 10.1016/j.aap.2011.04.007; Wiecek E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00472; Wilkins L, 2013, INVEST OPHTH VIS SCI, V54, P8364, DOI 10.1167/iovs.13-12774; Wood JM, 2008, J AM GERIATR SOC, V56, P986, DOI 10.1111/j.1532-5415.2008.01709.x; Wood JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158318; Wood JM, 2014, GERONTOLOGY, V60, P315, DOI 10.1159/000356753; Wood JM, 2013, ACCIDENT ANAL PREV, V50, P1161, DOI 10.1016/j.aap.2012.09.009	60	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178876	10.1371/journal.pone.0178876	http://dx.doi.org/10.1371/journal.pone.0178876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570621	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800130
J	Wang, XY; Hu, Q; Fang, MY; He, Y; Wei, HM; Chen, XX; Zhang, B				Wang, Xiao-Yan; Hu, Qiao; Fang, Meng-Yuan; He, Yan; Wei, Hai-Ming; Chen, Xue-Xue; Zhang, Bing			The correlation between HER-2 expression and the CEUS and ARFI characteristics of breast cancer	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; ULTRASOUND; ELASTOGRAPHY; MAMMOGRAPHY; SONOGRAPHY; LESIONS	Objective The purpose of the present study was to explore the correlation between the contrast-enhanced ultrasound (CEUS) and acoustic radiation force impulse (ARFI) characteristics of breast cancers and the expression of human epidermal growth factor receptor 2 (HER-2). Methods HER-2 expression levels in the tumor masses of 167 clearly diagnosed cases of breast cancer were measured and analyzed. The enhancement features and time intensity curve (TIC) of CEUS and virtual touch tissue imaging (VTI) and virtual touch tissue quantification (VTQ) technology of ARFI were employed to analyze the relationship between HER-2 expression and the CEUS and ARFI characteristics of breast cancer. Results (1) Statistically significant differences in the distribution of the contrast agent, perforator blood flow, the overranging phenomenon and perfusion defects between the study groups with different HER-2 expression levels (P < 0.05) were observed on CEUS. In addition, statistically significant differences in the TIC peak time (PT), slope of the ascending branch (K) and area under the curve (AUC) were found in the groups expressing different levels of HER-2 (P < 0.05). In contrast, the degree of contrast agent enhancement and TIC peak intensity (PI) were found to be independent of the expression status of HER-2, as they were not statistically significant (P > 0.05). (2) Statistically significant differences in the VTQ results between the groups with different HER-2 expression levels were found (P < 0.05). However, no statistically significant differences in VTI image characteristics were detected between the groups expressing different levels of HER-2 (P > 0.05). Conclusion A correlation was found between the CEUS and ARFI characteristics of breast cancer and HER-2 expression levels. This correlation was principally reflected in perfusion defects, perforator blood flow, PI, PT, K and VTQ.	[Wang, Xiao-Yan; Hu, Qiao; Fang, Meng-Yuan; He, Yan; Chen, Xue-Xue; Zhang, Bing] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Ultrasound, Nanning, Guangxi, Peoples R China; [Wei, Hai-Ming] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Pathol, Nanning, Guangxi, Peoples R China		Wang, XY (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Ultrasound, Nanning, Guangxi, Peoples R China.	ultrasoundwang@sina.com			Key Scientific Research Project of Medicine and Healthcare of Guangxi Province [Zhong 200813]; National Natural Science Foundation of China [81660292]; Guangxi Scientific Research and Technology Development Project [059207-2C, GuiKegong 14124004-1-13]	Key Scientific Research Project of Medicine and Healthcare of Guangxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Scientific Research and Technology Development Project	The present study was supported by the Key Scientific Research Project of Medicine and Healthcare of Guangxi Province (No: Zhong 200813), The National Natural Science Foundation of China (81660292), Guangxi Scientific Research and Technology Development Project (No: 059207-2C) and Guangxi Scientific Research and Technology Development Project (No: GuiKegong 14124004-1-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell KL, 2004, CLIN CANCER RES, V10, P4083, DOI 10.1158/1078-0432.CCR-03-0695; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Cooke T, 2001, EUR J CANCER, V37, pS3, DOI 10.1016/S0959-8049(00)00402-0; Itoh A, 2004, 7 C AS FED SOC ULTR; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jeong Kwon H, 2003, BIOCHEM BIOPH RES CO, V300, P241; Jung EM, 2005, CLIN HEMORHEOL MICRO, V33, P109; Kumm TR, 2010, CANCER CONTROL, V17, P156, DOI 10.1177/107327481001700303; Li ZZ, 2012, J ULTRASOUND CLIN ME, V14, P585; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Ozdemir A, 2004, J ULTRAS MED, V23, P183; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Rim Alice, 2008, Cleve Clin J Med, V75 Suppl 1, pS2; Rubaltelli L, 2009, ULTRASCHALL MED, V30, P175, DOI 10.1055/s-2008-1027442; Schroeder RJ, 2003, EUR RADIOL, V13, P68, DOI 10.1007/s00330-002-1413-3; Tozaki M, 2011, JPN J RADIOL, V29, P452, DOI 10.1007/s11604-011-0561-2; Zeng Xuan, 2005, Zhonghua Bing Li Xue Za Zhi, V34, P701; Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807	19	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178692	10.1371/journal.pone.0178692	http://dx.doi.org/10.1371/journal.pone.0178692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570680	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800104
J	Jin, YP; Wang, YB; Zhang, DC; Shen, XL; Liu, W; Chen, FJ				Jin, Yupei; Wang, Yubing; Zhang, Dechun; Shen, Xiangling; Liu, Wen; Chen, Faju			Floral organ MADS-box genes in Cercidiphyllum japonicum (Cercidiphyllaceae): Implications for systematic evolution and bracts definition	PLOS ONE			English	Article							AGAMOUS SUBFAMILY; FLOWER; DIVERSIFICATION; DUPLICATION; DIVERGENCE; IDENTIFICATION; CONSERVATION; PHYLOGENY; DIVERSITY; APETALA3	The dioecious relic Cercidiphyllum japonicum is one of two species of the sole genus Cercidiphyllum, with a tight inflorescence lacking an apparent perianth structure. In addition, its systematic place has been much debated and, so far researches have mainly focused on its morphology and chloroplast genes. In our investigation, we identified 10 floral organ identity genes, including four A-class, three B-class, two C-class and one D-class. Phylogenetic analyses showed that all ten genes are grouped with Saxifragales plants, which confirmed the phylogenetic place of C. japonicum. Expression patterns of those genes were examined by quantitative reverse transcriptase PCR, with some variations that did not completely coincide with the ABCDE model, suggesting some subfunctionalization. As well, our research supported the idea that thebract actually is perianth according to our morphological and molecular analyses in Cercidiphyllum japonicum.	[Jin, Yupei; Wang, Yubing; Zhang, Dechun; Shen, Xiangling; Liu, Wen; Chen, Faju] China Three Gorges Univ, Biotechnol Res Ctr, Yichang, Hubei Province, Peoples R China	China Three Gorges University	Chen, FJ (corresponding author), China Three Gorges Univ, Biotechnol Res Ctr, Yichang, Hubei Province, Peoples R China.	chenfj616@163.com			Natural Science Foundation of China [31570651, 31170625]; Excellent Graduate Funds of Three Gorges University of China [2016PY079]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Graduate Funds of Three Gorges University of China	This research was supported by grants from the Natural Science Foundation of China (Grant No. 31570651 and No. 31170625) and Excellent Graduate Funds of Three Gorges University of China (Grant No. 2016PY079). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Guoke Chen from Institute of Botany, the Chinese Academy of Sciences for providing us the plant materials. This research was supported by grants from the Natural Science Foundation of China (Grant No. 31570651 and No. 31170625) and Excellent Graduate Funds of Three Gorges University of China (Grant No. 2016PY079).	Aoki S, 2004, J PLANT RES, V117, P229, DOI 10.1007/s10265-004-0153-7; BAILEY IW, 1951, AM J BOT, V38, P373, DOI 10.2307/2437826; Baillon H., 1871, ADANSONIA, V10, P120; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; CRANE PR, 1984, BOT J LINN SOC, V89, P199, DOI 10.1111/j.1095-8339.1984.tb02196.x; DAHLGREN RMT, 1980, BOT J LINN SOC, V80, P91, DOI 10.1111/j.1095-8339.1980.tb01661.x; Ding BZ, 1981, FLORA OF HENAN, P409; ENDRESS PK, 1986, ANN MO BOT GARD, V73, P297, DOI 10.2307/2399115; Feng XY, 1998, J SYST EVOL, V36, P411; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Gu Q, 1998, DEVELOPMENT, V125, P1509; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Harms H., 1916, BER DEUT BOT GES, V34, P272; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heijmans K, 2012, PLANT CELL, V24, P2305, DOI 10.1105/tpc.112.097030; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kyozuka J, 1997, PLANT MOL BIOL, V35, P573, DOI 10.1023/A:1005885808652; Litt A, 2003, GENETICS, V165, P821; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; Matsunaga S, 2003, MOL BIOL EVOL, V20, P1062, DOI 10.1093/molbev/msg114; Melzer R, 2010, SEMIN CELL DEV BIOL, V21, P118, DOI 10.1016/j.semcdb.2009.11.015; Oliver D., 1899, TETRACENTRON SINENSE, P1892; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; [吕山花 Shanhua Lu], 2007, [植物学通报, Chinese Bulletin of Botany], V24, P60; Siebold PF, 1846, ABH BAYER AKAD WISS, P111; Solereder H., 1899, BER DEUT BOT GES, V17, P387; Takhtajan A., 1996, DIVERSITY CLASSIFICA, P128; Tanai T, 1992, B MIZUNAMI FOSSIL MU, V19, P125; The Angiosperm Phylogeny Group II, 2003, BOT J LINN SOC, V141, P399, DOI [DOI 10.1046/J.1095-8339.2003.T01-1-00158.X, 10.1046/j.1095-8339.2003.t01-1-00158.x]; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; THORNE R F, 1983, Nordic Journal of Botany, V3, P85; Tieghem PV, 1900, J BOT MOROT, V14, P259; Tieghem PV, 1900, J BOT MOROT, V14, p[259, 330]; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; VANHEEL WA, 1986, BLUMEA, V31, P273; von Siebold P.F., 1845, ABHANDLUNGEN MATH PH, V4, P109, DOI [10.5962/bhl.title.10718, DOI 10.5962/BHL.TITLE.10718]; Wang PP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.188, 10.1038/nplants.2015.188]; Winter KU, 1999, P NATL ACAD SCI USA, V96, P7342, DOI 10.1073/pnas.96.13.7342; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wroblewska M, 2016, PLANT BIOLOGY, V18, P230, DOI 10.1111/plb.12392; Wu HC, 2007, INT J PLANT SCI, V168, P775, DOI 10.1086/518274; Yan XL, 2007, J INTEGR PLANT BIOL, V49, P1400, DOI 10.1111/j.1744-7909.2007.00526.x; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Zahn LM, 2006, EVOL DEV, V8, P30, DOI 10.1111/j.1525-142X.2006.05073.x; Zahn LM, 2005, J HERED, V96, P225, DOI 10.1093/jhered/esi033; Zhang B, 2015, PLANT SCI, V241, P277, DOI 10.1016/j.plantsci.2015.10.017; [Zhang Qun 章群], 2003, [生态科学, Ecologic Science], V22, P113	54	0	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178382	10.1371/journal.pone.0178382	http://dx.doi.org/10.1371/journal.pone.0178382			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562649	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700056
J	Weigand, WJ; Messmore, A; Tu, J; Morales-Sanz, A; Blair, DL; Deheyn, DD; Urbach, JS; Robertson-Anderson, RM				Weigand, W. J.; Messmore, A.; Tu, J.; Morales-Sanz, A.; Blair, D. L.; Deheyn, D. D.; Urbach, J. S.; Robertson-Anderson, R. M.			Active microrheology determines scale-dependent material properties of Chaetopterus mucus	PLOS ONE			English	Article							MULTIPLE-PARTICLE TRACKING; HUMAN CERVICOVAGINAL MUCUS; HUMAN CERVICAL-MUCUS; TRACHEOBRONCHIAL MUCUS; RHEOLOGIC PROPERTIES; GASTRIC MUCIN; NASAL MUCUS; TRANSPORT; MICROHETEROGENEITY; VISCOELASTICITY	We characterize the lengthscale-dependent rheological properties of mucus from the ubiquitous Chaetopterus marine worm. We use optically trapped probes (2-10 mu m) to induce microscopic strains and measure the stress response as a function of oscillation amplitude. Our results show that viscoelastic properties are highly dependent on strain scale (l), indicating three distinct lengthscale-dependent regimes at l(1)<= 4 mu m, l(2)approximate to 4-10 mu m, and l(3)>= 10 mu m. While mucus response is similar to water for l(1), suggesting that probes rarely contact the mucus mesh, the response for l(2) is distinctly more viscous and independent of probe size, indicative of continuum mechanics. Only for l(3) does the response match the macroscopic elasticity, likely due to additional stiffer constraints that strongly resist probe displacement. Our results suggest that, rather than a single lengthscale governing crossover from viscous to elastic, mucus responds as a hierarchical network with a loose biopolymer mesh coupled to a larger scaffold responsible for macroscopic gel-like mechanics.	[Weigand, W. J.; Messmore, A.; Robertson-Anderson, R. M.] Univ San Diego, Dept Phys & Biophys, San Diego, CA 92110 USA; [Tu, J.; Deheyn, D. D.] Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA USA; [Morales-Sanz, A.; Blair, D. L.; Urbach, J. S.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Morales-Sanz, A.; Blair, D. L.; Urbach, J. S.] Georgetown Univ, Inst Soft Matter Synth & Metrol, Washington, DC USA	University of San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Georgetown University; Georgetown University	Robertson-Anderson, RM (corresponding author), Univ San Diego, Dept Phys & Biophys, San Diego, CA 92110 USA.	randerson@sandiego.edu		Urbach, Jeffrey/0000-0002-1593-520X; Robertson-Anderson, Rae/0000-0003-4475-4667	Air Force Office of Scientific Research Young Investigator Program [FA95550-12-1-0315, FA9550-14-1-0008, FA9550-14-1-0171]; Burroughs Wellcome Fund [1012729]	Air Force Office of Scientific Research Young Investigator Program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Air Force Office of Scientific Research Young Investigator Program, Grant No. FA95550-12-1-0315 (RMRA), as well as Grant No. FA9550-14-1-0008 (DDD) and FA9550-14-1-0171 (JSU and DLB). It was also the subject of a travel grant from the Burroughs Wellcome Fund (Grant No. 1012729) for DDD to perform analyses at Georgetown University.	Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; APP EM, 1993, EUR RESPIR J, V6, P67; Bansil R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00310; BARNES RD, 1965, BIOL BULL, V129, P217, DOI 10.2307/1539840; BELL AE, 1985, GASTROENTEROLOGY, V88, P269, DOI 10.1016/S0016-5085(85)80180-3; BELL AE, 1984, INT J BIOL MACROMOL, V6, P309, DOI 10.1016/0141-8130(84)90015-1; Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9; Cai LH, 2011, MACROMOLECULES, V44, P7853, DOI 10.1021/ma201583q; Carlstedt I, 1989, Symp Soc Exp Biol, V43, P289; Celli JP, 2007, BIOMACROMOLECULES, V8, P1580, DOI 10.1021/bm0609691; Celli JP, 2009, P NATL ACAD SCI USA, V106, P14321, DOI 10.1073/pnas.0903438106; Chapman CD, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.098303; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Colin Nicol JA, 1952, J MAR BIOL ASSOC UK, V31, P113; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Deheyn DD, 2016, RHEOLOGICAL PH UNPUB; Deheyn DD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P702, DOI 10.1086/673869; Enders HE, 1909, J MORPHOL, V20, P479, DOI 10.1002/jmor.1050200306; Falzone TT, 2015, SOFT MATTER, V11, P4418, DOI 10.1039/c5sm00155b; FLOOD PR, 1982, MAR BIOL, V72, P27, DOI 10.1007/BF00393944; Flood PR, MARINE BIOL, V72, P27; FLOREY H, 1955, PROC R SOC SER B-BIO, V143, P147, DOI 10.1098/rspb.1955.0001; Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372; Gerber V, 2000, EQUINE VET J, V32, P411, DOI 10.2746/042516400777591183; GIROD S, 1992, EUR RESPIR J, V5, P477; Goodman A, 2002, J MOL BIOL, V323, P199, DOI 10.1016/S0022-2836(02)00893-8; Hong ZN, 2005, BIOMACROMOLECULES, V6, P3458, DOI 10.1021/bm0505843; JEANNERETGROSJEAN A, 1988, AM REV RESPIR DIS, V137, P707, DOI 10.1164/ajrccm/137.3.707; JORGENSEN CB, 1984, MAR ECOL PROG SER, V15, P283, DOI 10.3354/meps015283; KING M, 1979, J APPL PHYSIOL, V47, P26, DOI 10.1152/jappl.1979.47.1.26; Kirch J, 2012, P NATL ACAD SCI USA, V109, P18355, DOI 10.1073/pnas.1214066109; Knowles MR, J CLIN INVESTIGATION, V109, P571; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LEIKAUF GD, 1984, J APPL PHYSIOL, V56, P426, DOI 10.1152/jappl.1984.56.2.426; LORENZI G, 1992, BIORHEOLOGY, V29, P433; MACCHIONE M, 1995, RESP PHYSIOL, V99, P165, DOI 10.1016/0034-5687(94)00080-J; MACGINITIE GE, 1945, BIOL BULL, V88, P107, DOI 10.2307/1538038; Macginitie GE, 1939, BIOL BULL-US, V77, P115, DOI 10.2307/1537850; Mackie A. R., 2012, Food Digestion, V3, P8; Majima Y, 1999, AM J RESP CRIT CARE, V160, P421, DOI 10.1164/ajrccm.160.2.9805117; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Ou-Yang Hd, 1999, 15 DESIGN APPL OSCIL; Rutllant J, 2001, ANAT HISTOL EMBRYOL, V30, P159, DOI 10.1046/j.1439-0264.2001.00275.x; SALTZMAN WM, 1994, BIOPHYS J, V66, P508, DOI 10.1016/S0006-3495(94)80802-1; Sellers L A, 1989, Symp Soc Exp Biol, V43, P65; SELLERS LA, 1988, CARBOHYD RES, V178, P93, DOI 10.1016/0008-6215(88)80104-6; SELLERS LA, 1987, BIORHEOLOGY, V24, P615; Shen H, 2006, BIOPHYS J, V91, P639, DOI 10.1529/biophysj.105.077404; Suk JS, 2009, BIOMATERIALS, V30, P2591, DOI 10.1016/j.biomaterials.2008.12.076; TAM PY, 1980, BIORHEOLOGY, V17, P465; Taormina MJ, 2016, ACTIVE MICRORHEOLOGY; Tassieri M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115032; Tassieri M, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026308; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; TOMKIEWICZ RP, 1995, CAN J PHYSIOL PHARM, V73, P165, DOI 10.1139/y95-025; Tomkiewicz RP, 1995, PULM PHARMACOL, V8, P259, DOI 10.1006/pulp.1995.1035; Wang YY, 2013, BIOMACROMOLECULES, V14, P4429, DOI 10.1021/bm401356q; Willits RK, 2001, BIOMATERIALS, V22, P445, DOI 10.1016/S0142-9612(00)00197-6; Xu JY, 2007, FOOD CHEM, V103, P1192, DOI 10.1016/j.foodchem.2006.10.024; Xu JY, 2002, BIOMACROMOLECULES, V3, P92, DOI 10.1021/bm015586b; Yeates D, 1997, LUNG SCI FDN, P487; ZIEMANN F, 1994, BIOPHYS J, V66, P2210, DOI 10.1016/S0006-3495(94)81017-3; ZINNER K, 1988, ARQ BIOL TECNOL, V31, P281	68	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0176732	10.1371/journal.pone.0176732	http://dx.doi.org/10.1371/journal.pone.0176732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562662	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700004
J	Wu, W; Xiong, WH; Zhang, P; Chen, LF; Fang, JQ; Shields, C; Xu, XM; Jin, XM				Wu, Wei; Xiong, Wenhui; Zhang, Ping; Chen, Lifang; Fang, Jianqiao; Shields, Christopher; Xu, Xiao-Ming; Jin, Xiaoming			Increased threshold of short-latency motor evoked potentials in transgenic mice expressing Channelrhodopsin-2	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INJURED EPILEPTOGENIC NEOCORTEX; SPINAL-CORD-INJURY; RETICULOSPINAL NEURONS; SYNAPTIC CONNECTIVITY; NEURAL CIRCUITRY; RAT; MOUSE; LOCOMOTION; HINDBRAIN	Transgenic mice that express channelrhodopsin-2 or its variants provide a powerful tool for optogenetic study of the nervous system. Previous studies have established that introducing such exogenous genes usually does not alter anatomical, electrophysiological, and behavioral properties of neurons in these mice. However, in a line of Thy1-ChR2-YFP transgenic mice (line 9, Jackson lab), we found that short-latency motor evoked potentials (MEPs) induced by transcranial magnetic stimulation had a longer latency and much lower amplitude than that of wild type mice. MEPs evoked by transcranial electrical stimulation also had a much higher threshold in ChR2 mice, although similar amplitudes could be evoked in both wild and ChR2 mice at maximal stimulation. In contrast, long-latency MEPs evoked by electrically stimulating the motor cortex were similar in amplitude and latency between wild type and ChR2 mice. Whole-cell patch clamp recordings from layer V pyramidal neurons of the motor cortex in ChR2 mice revealed no significant differences in intrinsic membrane properties and action potential firing in response to current injection. These data suggest that corticospinal tract is not accountable for the observed abnormality. Motor behavioral assessments including BMS score, rotarod, and grid-walking test showed no significant differences between the two groups. Because short-latency MEPs are known to involve brainstem reticulospinal tract, while long-latency MEPs mainly involve primary motor cortex and dorsal corticospinal tract, we conclude that this line of ChR2 transgenic mice has normal function of motor cortex and dorsal corticospinal tract, but reduced excitability and responsiveness of reticulospinal tracts. This abnormality needs to be taken into account when using these mice for related optogenetic study.	[Wu, Wei; Xu, Xiao-Ming; Jin, Xiaoming] Indiana Univ, Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Wu, Wei; Xiong, Wenhui; Xu, Xiao-Ming; Jin, Xiaoming] Indiana Univ, Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Xiong, Wenhui; Chen, Lifang; Xu, Xiao-Ming; Jin, Xiaoming] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Zhang, Ping; Shields, Christopher] Norton Healthcare, Norton Neurosci Inst, Louisville, KY USA; [Chen, Lifang; Fang, Jianqiao] Zhejiang Chinese Med Univ, Affiliated Hosp 3, Dept Acupuncture, Hangzhou, Zhejiang, Peoples R China; [Fang, Jianqiao] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Xu, XM; Jin, XM (corresponding author), Indiana Univ, Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Xu, XM; Jin, XM (corresponding author), Indiana Univ, Sch Med, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Xu, XM; Jin, XM (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	xu26@iupui.edu; xijin@iupui.edu	Jin, Xiaoming/AAH-3555-2020; Jin, Xiaoming/N-8545-2016; Wu, Wei/M-9220-2014	Jin, Xiaoming/0000-0002-8671-8640; Wu, Wei/0000-0002-7835-4963; Fang, Jianqiao/0000-0002-5155-8544	NIH [NS059622, NS073636]; U.S.Department of Veterans Affairs [I01BX002356]; Craig H Neilsen Foundation [296749]; Indiana Spinal Cord and BrainInjury Research Foundation; Mari Hulman George Endow ment Funds; Program of Introducing Talents of Discipline to Universities [B14036]; NIHDA [039530]; CURE Epilepsy Foundation; DOD CDMRP [W81XWH1 2-1-0562]; Indiana State Department of Health [A70-1-079438, A70-30 79971, A70-4-079956]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA039530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S.Department of Veterans Affairs(US Department of Veterans Affairs); Craig H Neilsen Foundation; Indiana Spinal Cord and BrainInjury Research Foundation; Mari Hulman George Endow ment Funds; Program of Introducing Talents of Discipline to Universities; NIHDA; CURE Epilepsy Foundation; DOD CDMRP(United States Department of Defense); Indiana State Department of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by NIH NS059622, NS073636, DOD CDMRP W81XWH1 2-1-0562, Merit Review Award I01BX002356 from the U.S.Department of Veterans Affairs, Craig H Neilsen Foundation 296749, Indiana Spinal Cord and Brain Injury Research Foundation, Mari Hulman George Endow ment Funds, and Program of Introducing Talents of Discipline to Universities (B14036) to Jinan University, PRChina (XMX), the Norton Health care, Louisville, KY (CBS) to XMX, and supported by the NIHDA 039530, CURE Epilepsy Foundation, and the Indiana Spinal Cord and BrainInjury Research Fund from the Indiana State Department of Health(A70-1-079438,A70-30 79971,and A70-4-079956) to XMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip T.T	ADAMSON J, 1989, ELECTROEN CLIN NEURO, V74, P469, DOI 10.1016/0168-5597(89)90038-5; Agrawal G, 2009, IEEE ENG MED BIO, P2086, DOI 10.1109/IEMBS.2009.5333953; Akemann W, 2004, J COMP NEUROL, V480, P72, DOI 10.1002/cne.20338; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Auclair F, 1999, J COMP NEUROL, V411, P288, DOI 10.1002/(SICI)1096-9861(19990823)411:2<288::AID-CNE9>3.0.CO;2-U; Barnes WL, 2014, IEEE ENG MED BIO, P6129, DOI 10.1109/EMBC.2014.6945028; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bretzner F, 2013, J NEUROSCI, V33, P14681, DOI 10.1523/JNEUROSCI.5231-12.2013; Cepeda-Nieto AC, 2005, MOL CELL NEUROSCI, V28, P30, DOI 10.1016/j.mcn.2004.06.016; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Funke K, 2010, RESTOR NEUROL NEUROS, V28, P399, DOI 10.3233/RNN-2010-0566; GLASSMAN SD, 1993, SPINE, V18, P1083, DOI 10.1097/00007632-199306150-00020; Grubb MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013761; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jordan LM, 1998, ANN NY ACAD SCI, V860, P83, DOI 10.1111/j.1749-6632.1998.tb09040.x; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Loy DN, 2002, J NEUROSCI, V22, P315, DOI 10.1523/JNEUROSCI.22-01-00315.2002; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Metzger F, 2002, EUR J NEUROSCI, V15, P40, DOI 10.1046/j.0953-816x.2001.01837.x; Miyashita T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00008; Mori S, 1998, ANN NY ACAD SCI, V860, P94, DOI 10.1111/j.1749-6632.1998.tb09041.x; Murase N, 2015, BRAIN STIMUL, V8, P105, DOI 10.1016/j.brs.2014.09.010; Nashmi R, 1997, J NEUROTRAUM, V14, P151, DOI 10.1089/neu.1997.14.151; Nielsen JB, 2007, EUR J NEUROSCI, V25, P805, DOI 10.1111/j.1460-9568.2007.05326.x; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Redondo-Castro E, 2016, J NEUROTRAUM, V33, P907, DOI 10.1089/neu.2015.4140; Salvador R, 2009, IEEE ENG MED BIO, P674, DOI 10.1109/IEMBS.2009.5334070; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; Winter SM, 2007, RESP PHYSIOL NEUROBI, V159, P108, DOI 10.1016/j.resp.2007.05.009; Zhang YP, 2008, J NEUROTRAUM, V25, P1227, DOI 10.1089/neu.2007.0388; Zhang YP, 2007, J NEUROSCI METH, V165, P9, DOI 10.1016/j.jneumeth.2007.05.021; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178803	10.1371/journal.pone.0178803	http://dx.doi.org/10.1371/journal.pone.0178803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562670	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700089
J	Li, XM; Wang, XH; Wei, HL; Zhu, XG; Peng, YL; Li, M; Li, T; Huang, H				Li, Xumeng; Wang, Xiaohui; Wei, Hailin; Zhu, Xinguang; Peng, Yulin; Li, Ming; Li, Tao; Huang, Huang			A technique system for the measurement, reconstruction and character extraction of rice plant architecture	PLOS ONE			English	Article							CANOPY STRUCTURE; MODELS; CROPS; YIELD	This study developed a technique system for the measurement, reconstruction, and trait extraction of rice canopy architectures, which have challenged functional structural plant modeling for decades and have become the foundation of the design of ideo-plant architectures. The system uses the location-separation-measurement method (LSMM) for the collection of data on the canopy architecture and the analytic geometry method for the reconstruction and visualization of the three-dimensional (3D) digital architecture of the rice plant. It also uses the virtual clipping method for extracting the key traits of the canopy architecture such as the leaf area, inclination, and azimuth distribution in spatial coordinates. To establish the technique system, we developed (i) simple tools to measure the spatial position of the stem axis and azimuth of the leaf midrib and to capture images of tillers and leaves; (ii) computer software programs for extracting data on stem diameter, leaf nodes, and leaf midrib curves from the tiller images and data on leaf length, width, and shape from the leaf images; (iii) a database of digital architectures that stores the measured data and facilitates the reconstruction of the 3D visual architecture and the extraction of architectural traits; and (iv) computation algorithms for virtual clipping to stratify the rice canopy, to extend the stratified surface from the horizontal plane to a general curved surface (including a cylindrical surface), and to implement in silico. Each component of the technique system was quantitatively validated and visually compared to images, and the sensitivity of the virtual clipping algorithms was analyzed. This technique is inexpensive and accurate and provides high throughput for the measurement, reconstruction, and trait extraction of rice canopy architectures. The technique provides a more practical method of data collection to serve functional structural plant models of rice and for the optimization of rice canopy types. Moreover, the technique can be easily adapted for other cereal crops such as wheat, which has numerous stems and leaves sheltering each other.	[Li, Xumeng] Hunan Agr Univ, Agr Math Modeling & Data Proc Ctr, Changsha, Hunan, Peoples R China; [Li, Xumeng; Li, Tao] Int Rice Res Inst, Manila, Philippines; [Li, Xumeng; Zhu, Xinguang; Peng, Yulin] State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Wang, Xiaohui; Wei, Hailin; Li, Ming; Huang, Huang] Hunan Agr Univ, Changsha, Hunan, Peoples R China	Hunan Agricultural University; CGIAR; International Rice Research Institute (IRRI); Hunan Agricultural University	Li, T (corresponding author), Int Rice Res Inst, Manila, Philippines.; Huang, H (corresponding author), Hunan Agr Univ, Changsha, Hunan, Peoples R China.	t.li@irri.org; hh863@126.com	Li, Tao/N-2730-2019	Li, Tao/0000-0002-1360-1396	National Natural Science Foundation of China [31301231]; Hunan Provincial Natural Science Foundation of China [14JJ4037]; Hunan province colleges and universities scientific research projects [15C0657]; State Scholarship Fund [201408430018]; Open Project Program of State Key Laboratory of Hybrid Rice [2016KF04]; National Science and Technology Projects for Rice Fertility [2013BAD07B11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan province colleges and universities scientific research projects; State Scholarship Fund; Open Project Program of State Key Laboratory of Hybrid Rice; National Science and Technology Projects for Rice Fertility	National Natural Science Foundation of China (CN) 31301231 Xumeng Li The Hunan Provincial Natural Science Foundation of China 14JJ4037 Xumeng Li Hunan province colleges and universities scientific research projects 15C0657 Xiaohui Wang The State Scholarship Fund 201408430018 Xumeng Li The Open Project Program of State Key Laboratory of Hybrid Rice 2016KF04 Xumeng Li National Science and Technology Projects for Rice Fertility 2013BAD07B11 Huang Huang	Ariyaratna M., 2011, Journal of Plant Breeding and Crop Science, V3, P114; Baret F, 2010, AGR FOREST METEOROL, V150, P1393, DOI 10.1016/j.agrformet.2010.04.011; Chen H.F., 2014, J PLANT NUTR FERTIL, V20, P1319, DOI DOI 10.11674/ZWYF.2014.0601; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Dornbusch T, 2007, ECOL MODEL, V200, P119, DOI 10.1016/j.ecolmodel.2006.07.028; Gladstone E A, 2015, VITIS J GRAPEVINE RE, V42, P123; Kempthorne DM, 2014, ANZIAM J, V55, pC138, DOI DOI 10.0000/ANZIAMJ.V55I0.7850; LINDENMAYER A, 1968, J THEOR BIOL, V18, P280, DOI 10.1016/0022-5193(68)90079-9; Louarn G, 2008, ANN BOT-LONDON, V101, P1167, DOI 10.1093/aob/mcm170; Lu CG, 2010, RICE SCI, V17, P235, DOI 10.1016/S1672-6308(09)60022-6; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; NILSON T, 1997, FOR SCI, V50, P23; Paulus S, 2014, SENSORS-BASEL, V14, P3001, DOI 10.3390/s140203001; Reinhardt D, 2002, EMBO REP, V3, P846, DOI 10.1093/embo-reports/kvf177; TANAKA T, 1969, P CROP SCI SOC JPN, V38, P287; Vos J, 2007, WAG UR FRON, V22, P1; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Vos J., 2009, J EXP BOT; Watanabe T, 2005, ANN BOT-LONDON, V95, P1131, DOI 10.1093/aob/mci136; Yang WN, 2013, CURR OPIN PLANT BIOL, V16, P180, DOI 10.1016/j.pbi.2013.03.005; [袁隆平 Yuan Longping], 2012, [杂交水稻, Hybrid Rice], V27, P1; Zheng BangYou, 2009, Scientia Agricultura Sinica, V42, P1181	22	5	5	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177205	10.1371/journal.pone.0177205	http://dx.doi.org/10.1371/journal.pone.0177205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558045	gold, Green Submitted, Green Published			2022-12-26	WOS:000402607000009
J	Naik, AS; Owsianka, A; Palmer, BA; O'Halloran, CJ; Walsh, N; Crosbie, O; Kenny-Walsh, E; Patel, AH; Fanning, LJ				Naik, Amruta S.; Owsianka, Ania; Palmer, Brendan A.; O'Halloran, Ciaran J.; Walsh, Nicole; Crosbie, Orla; Kenny-Walsh, Elizabeth; Patel, Arvind H.; Fanning, Liam J.			Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; HYPERVARIABLE REGION; PROTEIN; IMMUNIZATION; INFECTION; RESPONSES; DISEASE; ESCAPE	The humoral immune system responds to chronic hepatitis C virus (HCV) infection by producing neutralising antibodies (nAb). In this study we generated three HCV pseudoparticles in which E1E2 glycoprotein sequence was targeted by the host humoral immune system. We used patient derived virus free Fabs (VF-Fabs) obtained from HCV genotype 1a (n = 3), genotype 1b (n = 7) and genotype 3a (n = 1) for neutralisation of HCVpp produced in this study both individually and in combination. Based on the available anti-HCV monoclonal nAb mapping information we selected amino acid region 384-619 for conformational epitope mapping. Amongst our notable findings, we observed significant reduction in HCVpp infectivity (p< 0.05) when challenged with a combination of inter genotype and subtype VFFabs. We also identified five binding motifs targeted by patient derived VF-Fab upon peptide mapping, of which two shared the residues with previously reported epitopes. One epitope lies within an immunodominant HVR1 and two were novel. In summary, we used a reverse epitope mapping strategy to identify preferred epitopes by the host humoral immune system. Additionally, we have combined different VF-Fabs to further reduce the HCVpp infectivity. Our data indicates that combining the antigen specificity of antibodies may be a useful strategy to reduce (in-vitro) infectivity.	[Naik, Amruta S.; Palmer, Brendan A.; O'Halloran, Ciaran J.; Walsh, Nicole; Fanning, Liam J.] Univ Coll Cork, Dept Med, Cork, Ireland; [Owsianka, Ania; Patel, Arvind H.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland; [Crosbie, Orla; Kenny-Walsh, Elizabeth] Cork Univ Hosp, Dept Hepatol, Cork, Ireland; [Fanning, Liam J.] Univ Coll Cork, Microbiome Inst, APC, Cork, Ireland	University College Cork; University of Glasgow; University College Cork; University College Cork	Fanning, LJ (corresponding author), Univ Coll Cork, Dept Med, Cork, Ireland.; Fanning, LJ (corresponding author), Univ Coll Cork, Microbiome Inst, APC, Cork, Ireland.	l.fanning@ucc.ie	FANNING, LIAM J/F-5281-2015; Crosbie Dr, Orla M/AAA-7264-2022; Naik, Amruta/AAT-6044-2020	FANNING, LIAM J/0000-0001-6629-8418; Naik, Amruta/0000-0003-0673-2643; Palmer, Brendan/0000-0001-6637-0723; O'Halloran, Ciaran/0000-0002-8869-9826	Molecular Medicine Ireland-Clinical & transnational research scholars programme; Medical Research Council [MC_U130184144, MC_UU_12014/2] Funding Source: researchfish; MRC [MC_UU_12014/2, MC_U130184144] Funding Source: UKRI	Molecular Medicine Ireland-Clinical & transnational research scholars programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AN received a PhD scholarship from Molecular Medicine Ireland-Clinical & transnational research scholars programme (http:// www.molecularmedicineireland.ie/research/ctrsp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2014, J VIROL, V88, P14278, DOI 10.1128/JVI.01911-14; Alhammad Y, 2015, J VIROL, V89, P12245, DOI 10.1128/JVI.02070-15; Ball JK, 2014, ANTIVIR RES, V105, P100, DOI 10.1016/j.antiviral.2014.02.013; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bukh J, 2015, J VIROL, V89, P9128, DOI 10.1128/JVI.01194-15; Cashman SB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00550; Caskey M, 2015, NATURE; Deng K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138756; Drummer HE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00329; Flego M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-4; Helle F, 2011, VIRUSES-BASEL, V3, P1909, DOI 10.3390/v3101909; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Khan AG, 2014, NATURE, V509, P381, DOI 10.1038/nature13117; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Langedijk JPM, 1997, J CLIN MICROBIOL, V35, P1656, DOI 10.1128/JCM.35.7.1656-1660.1997; Moreau I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-103; Naik AS, 2016, J GEN VIROL; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Hara M, 2010, J VIROL, V84, P4252, DOI 10.1128/JVI.02442-09; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Palmer BA, 2016, J VIROL, V90, P3318, DOI 10.1128/JVI.02995-15; Palmer BA, 2012, J GEN VIROL, V93, P2614, DOI 10.1099/vir.0.045344-0; Perez-Berna AJ, 2006, BIOCHEMISTRY-US, V45, P3755, DOI 10.1021/bi0523963; Petit MA, 2003, J BIOL CHEM, V278, P44385, DOI 10.1074/jbc.M304047200; POSTHUMUS WPA, 1991, VIROLOGY, V182, P371, DOI 10.1016/0042-6822(91)90684-4; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Ritchie GRS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0087-1; Sabahi A, 2014, J VIROL, V88, P10280, DOI 10.1128/JVI.00874-14; Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11; Sautto G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/450963; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Stamataki Z, 2011, J INFECT DIS, V204, P811, DOI 10.1093/infdis/jir399; Sun J, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S4-S6; Swann RE, 2016, J VIROL, V90, P4530, DOI 10.1128/JVI.02669-15; Tarr AW, 2015, VIRUSES-BASEL, V7, P3995, DOI 10.3390/v7072809; Tarr Alexander W, 2007, Methods Mol Biol, V379, P177; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; Urbanowicz RA, 2015, J VIROLOGY; Urbanowicz RA, 2016, J GEN VIROL; Verstrepen BE, 2015, WORLD J HEPATOL, V7, P32, DOI 10.4254/wjh.v7.i1.53; Vieyres G, 2011, J GEN VIROL, V92, P494, DOI 10.1099/vir.0.028092-0; Wasilewski L, 2016, J GEN VIROL	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0175349	10.1371/journal.pone.0175349	http://dx.doi.org/10.1371/journal.pone.0175349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558001	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000402607000002
J	Grooteman, KV; Matheeuwsen, M; van Geenen, EJM; Drenth, JPH				Grooteman, Karina V.; Matheeuwsen, Mijntje; van Geenen, Erwin J. M.; Drenth, Joost P. H.			Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort	PLOS ONE			English	Article							GENERAL-POPULATION; FATIGUE; ANEMIA; DISEASE; SF-36	Gastrointestinal angiodysplasias may cause anemia. Quality of life (QoL) is a valid patient reported outcome and improvement of QoL represents an important treatment goal. There is a paucity of data on the effect of angiodysplasias on QoL. Therefore, we aim to evaluate QoL and fatigue in angiodysplasia patients. We performed a cross-sectional patient-reported outcome study. We included patients with endoscopy proven angiodysplasias and measured QoL with Short Form-36 and level of fatigue using Multi Fatigue Inventory-20. We distinguished three subgroups of patients according to disease severity: 1) with treatment for angiodysplasias, 2) without treatment for angiodysplasias and 3) without recent hospital visits. The primary outcome was the physical component summary (PCS) score on the SF-36. Multivariate regression analysis were performed to correct for differences at baseline. A total of 144 patients completed the questionnaires (response rate = 62%; mean age 68 years; 65% men). Angiodysplasia patients have a significant lower PCS compared to the age-matched general population (respectively 41.0 vs. 43.3, p = 0.01). Disease severity is independently associated with a negative outcome on QoL (beta -4.6, 95% CI -7.8--1.3). Similarly patients score lower on multiple QoL subdomains, i.e. role limitations due to physical health problems (40.8 vs. 44.0, p<0.01), general health (39.7 vs. 47.3, p<0.01). Angiodysplasia patients are more fatigued compared to the general population (male 56.1 vs. 48.5, p<0.01, female 59.2 vs. 51.5, p = 0.01). In conclusion, angiodysplasias are independently associated with clinically significant impairments in multiple domains of health-related QoL, especially in measures of functional limitation.	[Grooteman, Karina V.; Matheeuwsen, Mijntje; van Geenen, Erwin J. M.; Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands	Radboud University Nijmegen	Grooteman, KV (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands.	karina.grooteman@radboudumc.nl	Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019					Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; Diggs NG, 2011, CLIN GASTROENTEROL H, V9, P415, DOI 10.1016/j.cgh.2011.02.003; Ge ZZ, 2011, GASTROENTEROLOGY, V141, P1629, DOI 10.1053/j.gastro.2011.07.018; Gentile S, 2003, EUR J CANCER CARE, V12, P58, DOI 10.1046/j.1365-2354.2003.00295.x; Hansen RA, 2009, RES SOC ADMIN PHARM, V5, P143, DOI 10.1016/j.sapharm.2008.06.004; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; Hinz A, 2011, GEN HOSP PSYCHIAT, V33, P462, DOI 10.1016/j.genhosppsych.2011.05.009; Holleran G, 2013, SCAND J GASTROENTERO, V48, P433, DOI 10.3109/00365521.2012.763178; KANTZ ME, 1992, MED CARE, V30, pMS240, DOI 10.1097/00005650-199205001-00024; Kosiinski M. WJe, 2005, QUALITY LIFE RES; KROUSELWOOD MA, 1994, AM J MED SCI, V308, P211; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Lee AJ, 2005, CURR MED RES OPIN, V21, P1777, DOI 10.1185/030079905X65277; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mingardi G, 1999, NEPHROL DIAL TRANSPL, V14, P1503, DOI 10.1093/ndt/14.6.1503; Molsted S, 2004, SCAND J UROL NEPHROL, V38, P174, DOI 10.1080/00365590310020015; Nissenson AR, 2003, ARCH INTERN MED, V163, P1400, DOI 10.1001/archinte.163.12.1400; Pennazio M, 2004, GASTROENTEROLOGY, V126, P643, DOI 10.1053/j.gastro.2003.11.057; Roger SD, 2014, INT UROL NEPHROL, V46, P469, DOI 10.1007/s11255-013-0512-1; Sami SS, 2014, ALIMENT PHARM THER, V39, P15, DOI 10.1111/apt.12527; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Thein M, 2009, MEDICINE, V88, P107, DOI 10.1097/MD.0b013e31819d89d5	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177522	10.1371/journal.pone.0177522	http://dx.doi.org/10.1371/journal.pone.0177522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VT	28552982	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000008
J	Torres, AU; Chu, A; Read, R; MacDonald, J; Gregson, D; Louie, T; Delongchamp, J; Ward, L; McClure, J; Zhang, KY; Conly, J				Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; MacDonald, Judy; Gregson, Daniel; Louie, Thomas; Delongchamp, Johanna; Ward, Linda; McClure, Joann; Zhang, Kunyan; Conly, John			The epidemiology of Staphylococcus aureus carriage in patients attending inner city sexually transmitted infections and community clinics in Calgary, Canada	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; RISK-FACTORS; UNITED-STATES; NASAL COLONIZATION; CLONE USA300; PREVALENCE; VANCOMYCIN; POPULATION	Background Although the nares represent the most common carriage site for traditional hospital-associated strains of Staphylococcus aureus (SA), the predominant site of carriage of SA in the community is less certain. Methods We conducted a cross-sectional study in 285 patients attending sexually transmitted diseases and inner-city clinics to evaluate the prevalence, body site colonisation and risk factors associated with carriage of methicillin susceptible SA (MSSA). All isolates were characterized by pulsed field gel electrophoresis, staphylococcal cassette chromosome mec, staphylococcal protein A and multilocus sequence typing. Results The prevalence of colonisation with SA was 57.5% (164/285); 162 (56.8%) participants were colonized with MSSA, and 4 (1.4%) with methicillin-resistant SA (MRSA), 2 of them were co-colonised with both MRSA and MSSA. The most common sites of colonisation were the throat (73.1%), nares (65.2%) and interdigital web spaces of the hand (21.3%). Three out of 4 MRSA isolates were USA300-MRSA strains. Twelve MSSA isolates were closely related to the USA300 CA-MRSA. We identified sexual behaviours such as having more than 6 heterosexual sexual partners in the last 6 months and trimming pubic hair to be independently associated with MSSA colonisation, and more specifically practicing oral sex as a risk factor for throat colonisation. Conclusion There is a high prevalence of MSSA carriage in this population, with a low prevalence of MRSA. The throat was the most common site of carriage and sexual behaviours were found to be risk factors for MSSA colonisation. Close strain relatedness of MSSA and USA300-MRSA isolates suggests either gain or loss of the SCCmec element, respectively.	[Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada; [Torres, Alejandra Ugarte; Chu, Angel; Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Calgary, AB, Canada; [Chu, Angel; Read, Ron] Alberta Hlth Serv, Sexually Transmitted Infect Clin, Calgary, AB, Canada; [Read, Ron; Louie, Thomas; Zhang, Kunyan; Conly, John] Cumming Sch Med, Dept Microbiol Infect Dis & Immunol, Calgary, AB, Canada; [Read, Ron; Gregson, Daniel; Louie, Thomas; Zhang, Kunyan; Conly, John] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [MacDonald, Judy] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [MacDonald, Judy; Louie, Thomas; Ward, Linda] Alberta Hlth Serv, Infect Prevent & Control, Calgary, AB, Canada; [Gregson, Daniel; Zhang, Kunyan; Conly, John] Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada; [Gregson, Daniel; Conly, John] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Ctr Antimicrobial Resistance, Calgary, AB, Canada; [Delongchamp, Johanna; McClure, Joann; Zhang, Kunyan; Conly, John] Univ Calgary, Calgary, AB, Canada; [Zhang, Kunyan; Conly, John] Alberta Hlth Serv, Calgary Lab Serv, Calgary, AB, Canada	University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Conly, J (corresponding author), Univ Calgary, Dept Med, Div Infect Dis, Calgary, AB, Canada.; Conly, J (corresponding author), Alberta Hlth Serv, Calgary, AB, Canada.; Conly, J (corresponding author), Cumming Sch Med, Dept Microbiol Infect Dis & Immunol, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.; Conly, J (corresponding author), Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Alberta Hlth Serv, Calgary, AB, Canada.; Conly, J (corresponding author), Univ Calgary, Calgary, AB, Canada.; Conly, J (corresponding author), Alberta Hlth Serv, Calgary Lab Serv, Calgary, AB, Canada.	john.conly@albertahealthservices.ca		MacDonald, Judy/0000-0001-9774-7220; Zhang, Kunyan/0000-0003-1078-6011; McClure, JoAnn/0000-0003-4165-744X	University of Calgary Multipurpose Research and Education Fund [753315]	University of Calgary Multipurpose Research and Education Fund	This work received support from the University of Calgary Multipurpose Research and Education Fund, Grant number 753315. The recipient of the grant is JC.	Adhikari RP, 2004, J ANTIMICROB CHEMOTH, V54, P360, DOI 10.1093/jac/dkh350; Akmatov MK, 2014, INT J INFECT DIS, V25, P4, DOI 10.1016/j.ijid.2014.01.021; Bland JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3166; Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Chan Edward L, 2013, Clin Lab Sci, V26, P175; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; Crum-Cianflone NF, 2011, MEDICINE, V90, P379, DOI 10.1097/MD.0b013e318238dc2c; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garcia Stephen A, 2012, Clin Lab Sci, V25, P156; Gardam M, 2001, INFECT CONT HOSP EP, V22, P152, DOI 10.1086/501882; Gilbert M, 2007, CAN J INFECT DIS MED, V18, P357, DOI 10.1155/2007/597123; Gilbert M, 2006, CAN MED ASSOC J, V175, P149, DOI 10.1503/cmaj.051565; Giuliani M, 2010, EPIDEMIOL INFECT, V138, P738, DOI 10.1017/S0950268810000130; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Lee NE, 2005, CLIN INFECT DIS, V40, P1529, DOI 10.1086/429827; Maree CL, 2010, CLIN INFECT DIS, V51, P1248, DOI 10.1086/657067; Markley JD, 2012, AM J INFECT CONTROL, V40, P1008, DOI 10.1016/j.ajic.2012.01.015; Mermel LA, 2011, J CLIN MICROBIOL, V49, P1119, DOI 10.1128/JCM.02601-10; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Miko BA, 2012, MICROBES INFECT, V14, P1040, DOI 10.1016/j.micinf.2012.06.004; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Nguyen D, 2005, EMERG INFECT DIS, V27, P54; NOBLE WC, 1968, BRIT MED J, V1, P417, DOI 10.1136/bmj.1.5589.417; Noto MJ, 2008, ANTIMICROB AGENTS CH, V52, P1221, DOI 10.1128/AAC.01164-07; Pan ES, 2005, J INFECT DIS, V192, P811, DOI 10.1086/432072; Pan ES, 2003, CLIN INFECT DIS, V37, P1384, DOI 10.1086/379019; Peters PJ, 2013, EMERG INFECT DIS, V19, P623, DOI 10.3201/eid1904.121353; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Simor AE, 2015, INFECT CONT HOSP EP, V31, P348; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zhang K, 2008, J CLIN MICROBIOL, V46, P1118, DOI 10.1128/JCM.01309-07; Zhang KY, 2012, MOL CELL PROBE, V26, P218, DOI 10.1016/j.mcp.2012.04.002; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178557	10.1371/journal.pone.0178557	http://dx.doi.org/10.1371/journal.pone.0178557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542601	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800102
J	Bermudez-Tamayo, C; Besancon, S; Johri, M; Assa, S; Brown, JB; Ramaiya, K				Bermudez-Tamayo, Clara; Besancon, Stephane; Johri, Mira; Assa, Sidibe; Brown, Jonathan Betz; Ramaiya, Kaushik			Direct and indirect costs of diabetes mellitus in Mali: A case-control study	PLOS ONE			English	Article							ECONOMIC BURDEN; AFRICA; CARE	Background Diabetes mellitus (DM) is one of the most burdensome chronic diseases and is associated with shorter lifetime, diminished quality of life and economic burdens on the patient and society as a result of healthcare, medication, and reduced labor market participation. We aimed to estimate the direct (medical and non-medical) and indirect costs of DM and compare them with those of people without DM (ND), as well as the cost predictors. Methods and findings Observational retrospective case-control study performed in Mali. Participants were identified and randomly selected from diabetes registries. We recruited 500 subjects with DM and 500 subjects without DM, matched by sex and age. We conducted structured, personal interviews. Costs were expressed for a 90-day period. Direct medical costs comprised: inpatient stays, ICU, laboratory tests and other hospital visits, specialist and primary care doctor visits, others, traditional practitioners, and medication. Direct non-medical costs comprised travel for treatment and paid caregivers. The indirect costs include the productivity losses by patients and caregivers, and absenteeism. We estimate a two-part model by type of service and a linear multiple regression model for the total cost. We found that total costs of persons with DM were almost 4 times higher than total cost of people without DM. Total costs were $77.08 and $281.92 for ND and DM, respectively, with a difference of $204.84. Conclusions Healthcare use and costs were dramatically higher for people with DM than for people with normal glucose tolerance and, in relative terms, much higher than in developed countries.	[Bermudez-Tamayo, Clara] Andalusian Sch Publ Hlth, Granada, Spain; [Bermudez-Tamayo, Clara] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Besancon, Stephane] NGO Sante Diabete, Bamako, Mali; [Johri, Mira] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada; [Johri, Mira] Univ Montreal, Ecole Sante Publ, Dept Adm Sante, Montreal, PQ, Canada; [Assa, Sidibe] Mali Natl Hosp, Endocrinol Dept, Bamako, Mali; [Brown, Jonathan Betz] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Ramaiya, Kaushik] Shree Hindu Mandal Hosp, Dar Es Salaam, Tanzania	Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universite de Montreal; Universite de Montreal; Kaiser Permanente	Bermudez-Tamayo, C (corresponding author), Andalusian Sch Publ Hlth, Granada, Spain.; Bermudez-Tamayo, C (corresponding author), Inst Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	clara.bermudez.easp@juntadeandalucia.es	Bermudez-Tamayo, Clara/AAB-7321-2019; Johri, Mira/D-5104-2013	Bermudez-Tamayo, Clara/0000-0002-2964-6361; Johri, Mira/0000-0001-5642-787X; Besancon, Stephane/0000-0002-3779-3441	International Diabetes Federation (IDF); Economic Studies Fund; Merck and Co.; Novo Nordisk; Eli Lilly and Co.; Takeda Pharmaceuticals North America; GSK, Inc.	International Diabetes Federation (IDF); Economic Studies Fund; Merck and Co.(Merck & Company); Novo Nordisk(Novo Nordisk); Eli Lilly and Co.(Eli Lilly); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); GSK, Inc.	The research on which this paper is based was organized and funded by International Diabetes Federation (IDF) as part of a program to measure the impact of diabetes in low- and middle-income countries. To fund this program, IDF solicited and combined unrestricted research grants from several commercial pharmaceutical organizations into an Economic Studies Fund. The contributors to this fund were Merck and Co., Novo Nordisk, Eli Lilly and Co., Takeda Pharmaceuticals North America, and GSK, Inc. These contributors did not select the African countries to be studied and had no role in the design, conduct and reporting of the study in any country, including Mali.	Akossou-Zinsou SY, 2001, DIABETES METAB, V27, P709; American Diabetes Association, 2008, DIABETES, V31; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Azevedo M, 2008, INT J DIABETES DEV C, V28, P101, DOI 10.4103/0973-3930.45268; Bahia LR, 2011, VALUE HEALTH, V14, pS137, DOI 10.1016/j.jval.2011.05.009; Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Besancon S, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0042-9; Briggs AH, 1999, HEALTH TECHNOL ASSES, V3, P1134; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; Brown JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106716; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Cai L, 2013, INT J CARDIOL, V165, P273, DOI 10.1016/j.ijcard.2011.08.039; Cavanaugh Kerri L, 2011, Diabetes Manag (Lond), V1, P191; CHALE SS, 1992, BRIT MED J, V304, P1215, DOI 10.1136/bmj.304.6836.1215; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Elgart JF, 2014, INT J PUBLIC HEALTH, V59, P851, DOI 10.1007/s00038-014-0604-4; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; Imam T, 2012, INT J ADV RES TECHNO, V1, P95; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GEN EV; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jaffiol C, 2011, B ACAD NAT MED PARIS, V195, P1239, DOI 10.1016/S0001-4079(19)31983-1; Jha R., 2004, INT J DIABETES DEV C, V24, P29; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Nkegoum AV, 2012, THESIS; Osterweis M., 1987, PAIN DISABILITY CLIN; Ringborg A, 2009, INT J CLIN PRACT, V63, P997, DOI 10.1111/j.1742-1241.2009.02098.x; Segel J., COST OF ILLNESS STUD; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2005, WHOEIPHSFPB0502; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yang W., 2012, ARCH CONSTRUCTION, V2012, P9, DOI DOI 10.1371/J0URNAL.P0NE.0039513; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	37	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176128	10.1371/journal.pone.0176128	http://dx.doi.org/10.1371/journal.pone.0176128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545129	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400003
J	Mabrouk, R; Strafella, AP; Knezevic, D; Ghadery, C; Mizrahi, R; Gharehgazlou, A; Koshimori, Y; Houle, S; Rusjan, P				Mabrouk, Rostom; Strafella, Antonio P.; Knezevic, Dunja; Ghadery, Christine; Mizrahi, Romina; Gharehgazlou, Avideh; Koshimori, Yuko; Houle, Sylvain; Rusjan, Pablo			Feasibility study of TSPO quantification with [F-18] FEPPA using population-based input function	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VENOUS-BLOOD SAMPLE; TRANSLOCATOR PROTEIN; PET RADIOLIGAND; GLUCOSE-METABOLISM; BINDING-AFFINITY; REFERENCE REGION; HUMAN BRAIN; NEUROINFLAMMATION; NEURORECEPTOR	Purpose The input function (IF) is a core element in the quantification of Translocator protein 18 kDa with positron emission tomography (PET), as no suitable reference region with negligible binding has been identified. Arterial blood sampling is indeed needed to create the IF (ASIF). In the present manuscript we study individualization of a population based input function (PBIF) with a single arterial manual sample to estimate total distribution volume (V-T) for [F-18] FEPPA and to replicate previously published clinical studies in which the ASIF was used. Methods The data of 3 previous [F-18] FEPPA studies (39 of healthy controls (HC), 16 patients with Parkinson's disease (PD) and 18 with Alzheimer's disease (AD)) was reanalyzed with the new approach. PBIF was used with the Logan graphical analysis (GA) neglecting the vascular contribution to estimate VT. Time of linearization of the GA was determined with the maximum error criteria. The optimal calibration of the PBIF was determined based on the area under the curve (AUC) of the IF and the agreement range of VT between methods. The shape of the IF between groups was studied while taking into account genotyping of the polymorphism (rs6971). Results PBIF scaled with a single value of activity due to unmetabolized radioligand in arterial plasma, calculated as the average of a sample taken at 60 min and a sample taken at 90 min post-injection, yielded a good interval of agreement between methods and optimized the area under the curve of IF. In HC, gray matter V(T)s estimated by PBIF highly correlated with those using the standard method ( r(2) = 0.82, p = 0.0001). Bland-Altman plots revealed PBIF slightly underestimates (similar to 1 mL/cm(3)) V-T calculated by ASIF (including a vascular contribution). It was verified that the AUC of the ASIF were independent of genotype and disease (HC, PD, and AD). Previous clinical results were replicated using PBIF but with lower statistical power. Conclusion A single arterial blood sample taken 75 minute post-injection contains enough information to individualize the IF in the groups of subjects studied; however, the higher variability produced requires an increase in sample size to reach the same effect size.	[Mabrouk, Rostom; Strafella, Antonio P.; Knezevic, Dunja; Ghadery, Christine; Mizrahi, Romina; Gharehgazlou, Avideh; Koshimori, Yuko; Houle, Sylvain; Rusjan, Pablo] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Strafella, Antonio P.] Univ Toronto, Morton & Gloria Shulman Movement Disorder Unit, EJ Safra Parkinson Dis Program, Toronto Western Hosp,UHN, Toronto, ON, Canada; [Strafella, Antonio P.; Ghadery, Christine; Koshimori, Yuko] Univ Toronto, UHN, Div Brain Imaging & Behav Syst Neurosci, Krembil Res Inst, Toronto, ON, Canada; [Strafella, Antonio P.; Mizrahi, Romina; Rusjan, Pablo] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Rusjan, P (corresponding author), Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada.; Rusjan, P (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.	pablo.rusjan@camhpet.ca	Mabrouk, Rostom/M-1674-2019	Rusjan, Pablo/0000-0003-0075-2918; Houle, Sylvain/0000-0002-4231-6316; Mizrahi, Romina/0000-0001-6667-7928	Canadian Institutes of Health Research [INE - 117891]; Canada Research Chair program; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100043] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Canadian Institutes of Health Research (INE - 117891) to APS. APS is supported by the Canada Research Chair program.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brock CS, 2005, INT J ONCOL, V26, P1377; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Contractor KB, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-11; Eberl S, 1997, EUR J NUCL MED, V24, P299, DOI 10.1007/s002590050056; FENG D, 1993, INT J BIOMED COMPUT, V32, P95, DOI 10.1016/0020-7101(93)90049-C; Hilton J, 2000, NUCL MED BIOL, V27, P627, DOI 10.1016/S0969-8051(00)00125-6; Hong IK, 2007, IEEE T MED IMAGING, V26, P789, DOI 10.1109/TMI.2007.892644; Ichise M, 2002, J CEREBR BLOOD F MET, V22, P1271, DOI 10.1097/01.WCB.0000038000.34930.4E; Koshimori Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138721; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Lyoo CH, 2015, J NUCL MED, V56, P701, DOI 10.2967/jnumed.114.146027; Mabrouk R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115768; Mabrouk R, 2013, IEEE T BIO-MED ENG, V60, P63, DOI 10.1109/TBME.2012.2221463; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Rissanen E, 2015, J CEREBR BLOOD F MET, V35, P157, DOI 10.1038/jcbfm.2014.194; Rusjan P, 2006, PSYCHIAT RES-NEUROIM, V147, P79, DOI 10.1016/j.pscychresns.2006.01.011; Rusjan PM, 2011, J CEREBR BLOOD F MET, V31, P1807, DOI 10.1038/jcbfm.2011.55; Slifstein M, 2000, J NUCL MED, V41, P2083; Suridjan I, 2015, MOL PSYCHIATR, V20, P1579, DOI 10.1038/mp.2015.1; Takagi S, 2004, ANN NUCL MED, V18, P297, DOI 10.1007/BF02984467; Turkheimer FE, 2007, J NUCL MED, V48, P158; van der Weerdt AP, 2001, J NUCL MED, V42, P1622; Varga J, 2002, J CEREBR BLOOD F MET, V22, P240, DOI 10.1097/00004647-200202000-00012; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Zanotti-Fregonara P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060231; Zanotti-Fregonara P, 2012, NEUROIMAGE, V63, P1532, DOI 10.1016/j.neuroimage.2012.08.007; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177785	10.1371/journal.pone.0177785	http://dx.doi.org/10.1371/journal.pone.0177785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545084	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700076
J	Kramer, N; Schmollerl, J; Unger, C; Nivarthi, H; Rudisch, A; Unterleuthner, D; Scherzer, M; Riedl, A; Artaker, M; Crncec, I; Lenhardt, D; Schwarz, T; Prieler, B; Han, X; Hengstschalger, M; Schuler, J; Eferl, R; Moriggl, R; Sommergruber, W; Dolznig, H				Kramer, N.; Schmoellerl, J.; Unger, C.; Nivarthi, H.; Rudisch, A.; Unterleuthner, D.; Scherzer, M.; Riedl, A.; Artaker, M.; Crncec, I.; Lenhardt, D.; Schwarz, T.; Prieler, B.; Han, X.; Hengstschaelger, M.; Schueler, J.; Eferl, R.; Moriggl, R.; Sommergruber, W.; Dolznig, H.			Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression	ONCOGENE			English	Article							GENE-EXPRESSION; UP-REGULATION; BETA-CATENIN; ACTIVATION PROTEIN; TUMOR PROGRESSION; COLON-CANCER; STEM-CELLS; IN-VITRO; CARCINOMA; ESOPHAGEAL	The canonical WNT signaling pathway is crucial for intestinal stem cell renewal and aberrant WNT signaling is an early event in colorectal cancer (CRC) development. Here, we show for the first time that WNT2 is one of the most significantly induced genes in CRC stroma as compared to normal stroma. The impact of stromal WNT2 on carcinoma formation or progression was not addressed so far. Canonical WNT/beta-catenin signaling was assessed using a 7TGP-reporter construct. Furthermore, effects of WNT2 on fibroblast migration and invasion were determined using siRNA-mediated gene silencing. Tumor cell invasion was studied using organotypic raft cultures and in vivo significance was assessed via a xenograft mouse model. We identified cancer-associated fibroblasts (CAFs) as the main source of WNT2. CAF-derived WNT2 activated canonical signaling in adenomatous polyposis coli/beta-catenin wild-type colon cancer cells in a paracrine fashion, whereas no hyperactivation was detectable in cell lines harboring mutations in the adenomatous polyposis coli/beta-catenin pathway. Furthermore, WNT2 activated autocrine canonical WNT signaling in primary fibroblasts, which was associated with a pro-migratory and pro-invasive phenotype. We identified FZD8 as the putative WNT2 receptor in CAFs. Three-dimensional organotypic co-culture assays revealed that WNT2-mediated fibroblast motility and extracellular matrix remodeling enhanced cancer cell invasion of cell lines even harboring mutations in the adenomatous polyposis coli/beta-catenin pathway. Thus, suggesting a tumor-promoting influence on a broad range of CRC. In line, WNT2 also promotes tumor growth, invasion and metastasis in vivo. Moreover, high WNT2 expression is associated with poor prognosis in human CRC. The identification of the pro-malignant function of stromal derived WNT2 in CRC classifies WNT2 and its receptor as promising stromal targets to confine cancer progression in combination with conventional or targeted therapies.	[Kramer, N.; Schmoellerl, J.; Unger, C.; Unterleuthner, D.; Scherzer, M.; Riedl, A.; Schwarz, T.; Prieler, B.; Hengstschaelger, M.; Dolznig, H.] Med Univ Vienna, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria; [Schmoellerl, J.; Nivarthi, H.; Moriggl, R.] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Rudisch, A.; Sommergruber, W.] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Artaker, M.] Med Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Crncec, I.; Eferl, R.] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Lenhardt, D.; Schueler, J.] Oncotest GmbH, Freiburg, Germany; [Han, X.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Moriggl, R.] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Nivarthi, H.] Austrian Acad Sci, Res Ctr Mol Med, CeMM, Lazarettgasse 14, A-1090 Vienna, Austria; [Scherzer, M.] Karolinska Inst, Solnavagen 1, S-17177 Solna, Sweden	Medical University of Vienna; Ludwig Boltzmann Institute; Boehringer Ingelheim; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Oncotest GmbH; Cincinnati Children's Hospital Medical Center; University of Veterinary Medicine Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Karolinska Institutet	Dolznig, H (corresponding author), Med Univ Vienna, Inst Med Genet, Wahringer Str 10, A-1090 Vienna, Austria.	helmut.dolznig@meduniwien.ac.at	Dolznig, Helmut/L-7005-2015; Moriggl, Richard/H-8118-2019	Dolznig, Helmut/0000-0002-6063-3585; Moriggl, Richard/0000-0003-0918-9463; Kramer, Nina/0000-0002-9058-8076; Eferl, Robert/0000-0002-6074-7144; Schmoellerl, Johannes/0000-0002-8461-8881; Han, Xiaonan/0000-0001-5368-6489; Schwarz, Thomas/0000-0002-1951-9676	Herzfelder Family Foundation; Niederosterreichische Forschungs-und Bildungsges.m.b.H; DOC Fellowship of the Austrian Academy of Sciences [24032]; Austrian Science Fund (FWF) [SFB F28, SFB F47, P25925-B20, 0P26908-B20]; Comprehensive Cancer Center (CCC) Vienna Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103388] Funding Source: NIH RePORTER	Herzfelder Family Foundation; Niederosterreichische Forschungs-und Bildungsges.m.b.H; DOC Fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Comprehensive Cancer Center (CCC) Vienna Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HD was supported by the Herzfelder Family Foundation and the Niederosterreichische Forschungs-und Bildungsges.m.b.H. AW was a recipient of a DOC Fellowship (24032) of the Austrian Academy of Sciences. RM was supported by the Austrian Science Fund (FWF, SFB F28 & F47). RE was supported by FWF (P25925-B20, 0P26908-B20, DK Inflammation and Immunity) and the Comprehensive Cancer Center (CCC) Vienna Research Grant.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bayle J, 2008, J INVEST DERMATOL, V128, P871, DOI 10.1038/sj.jid.5701101; BLASBAND A, 1992, ONCOGENE, V7, P153; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Bravo DT, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-316; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dale TC, 1996, CANCER RES, V56, P4320; de Castro J, 2000, VIRCHOWS ARCH, V437, P599, DOI 10.1007/s004280000266; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; HUGUET EL, 1994, CANCER RES, V54, P2615; Humphreys RC, 1997, CELL GROWTH DIFFER, V8, P839; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jiang H, 2014, AM J CANCER RES, V4, P537; Katoh M, 2001, INT J ONCOL, V19, P1003; Katoh M, 2003, INT J MOL MED, V12, P811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Miller MF, 2012, P NATL ACAD SCI USA, V109, P15348, DOI 10.1073/pnas.1201583109; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; OGASAWARA S, 1994, VIRCHOWS ARCH, V424, P607, DOI 10.1007/BF01069740; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JK, 2009, NEOPLASMA, V56, P119, DOI 10.4149/neo_2009_02_119; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rosner M, 2010, NAT PROTOC, V5, P1081, DOI 10.1038/nprot.2010.74; Ru MX, 2008, TROP BIOMED, V25, P46; Rupp C, 2006, DIAGN MOL PATHOL, V15, P35, DOI 10.1097/00019606-200603000-00006; Rupp C, 2015, ONCOGENE, V34, P815, DOI 10.1038/onc.2014.18; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Suraweera N, 2006, INT J CANCER, V119, P1837, DOI 10.1002/ijc.22046; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Timpson P, 2011, JOVE-J VIS EXP, DOI 10.3791/3089; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vider BZ, 1996, ONCOGENE, V12, P153; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352	52	66	68	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5460	5472		10.1038/onc.2017.144	http://dx.doi.org/10.1038/onc.2017.144			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28553956				2022-12-26	WOS:000411960500003
J	Sun, JH; Gao, ZY; Zhang, XC; Zou, XX; Cao, LL; Wang, JB				Sun, Jinhua; Gao, Zhaoyin; Zhang, Xinchun; Zou, Xiaoxiao; Cao, Lulu; Wang, Jiabao			Transcriptome analysis of Phytophthora litchii reveals pathogenicity arsenals and confirms taxonomic status	PLOS ONE			English	Article							DOWNY MILDEWS; PERONOPHYTHORA-LITCHII; PHYLOGENETIC ANALYSIS; EFFECTOR PROTEINS; DNA-SEQUENCES; GENOME; INFESTANS; BLIGHT; PERONOSPORALES; RECOGNITION	Litchi downy blight, caused by Peronophythora litchii, is one of the major diseases of litchi and has caused severe economic losses. P. litchii has the unique ability to produce downy mildew like sporangiophores under artificial culture. The pathogen had been placed in a new family Peronophytophthoraceae by some authors. In this study, the whole transcriptome of P. litchii from mycelia, sporangia, and zoospores was sequenced for the first time. A set of 23637 transcripts with an average length of 1284 bp was assembled. Using six open reading frame (ORF) predictors, 19267 representative ORFs were identified and were annotated by searching against several public databases. There were 4666 conserved gene families and various sets of lineage-specific genes among P. litchii and other four closely related oomycetes. In silico analyses revealed 490 pathogen-related proteins including 128 RXLR and 22 CRN effector candidates. Based on the phylogenetic analysis of 164 single copy orthologs from 22 species, it is validated that P. litchii is in the genus Phytophthora. Our work provides valuable data to elucidate the pathogenicity basis and ascertain the taxonomic status of P. litchii.	[Sun, Jinhua; Gao, Zhaoyin; Zhang, Xinchun; Cao, Lulu; Wang, Jiabao] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China; [Zou, Xiaoxiao] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Wang, JB (corresponding author), Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Peoples R China.	fdabo@163.com	SUN, JIN/GPX-9641-2022		National Natural Science Foundation [31301766]; Modern Agricultural Industry Technology System of China [CARS-33-02]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Modern Agricultural Industry Technology System of China	Funded by the National Natural Science Foundation (31301766) JHS the Special Funds of the Modern Agricultural Industry Technology System of China (CARS-33-02) JBW.; This study was supported by the National Natural Science Foundation (31301766) and the Special Funds of the Modern Agricultural Industry Technology System of China (CARS-33-02).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ann P. J., 1984, Plant Disease, V68, P826, DOI 10.1094/PD-69-826d; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; CHEN C. -C., 1961, SPEC PUBL COLL AGRIC NATL TAIWAN UNIV, V10, P1; Chen XR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-980; Chen XR, 2013, PLOS ONE, V8; Chi P. K., 1984, Acta Phytopathologica Sinica, V14, P113; Chi PK, 1982, P ANN M CHIN PHYT SO, P72; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn R. D., 2016, NUCL ACIDS RES, V44; Gijzen M, 2006, PHYTOCHEMISTRY, V37; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Huang H., 1983, Acta Mycologica Sinica, V2, P201; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; KAO CW, 1980, MYCOLOGIA, V72, P737, DOI 10.2307/3759766; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; KO WH, 1978, MYCOLOGIA, V70, P380, DOI 10.2307/3759036; Krajaejun T, 2014, FUNGAL BIOL-UK, V118, P640, DOI 10.1016/j.funbio.2014.01.009; Kunjeti SG, 2012, MOL PLANT PATHOL, V13, P454, DOI 10.1111/j.1364-3703.2011.00761.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Moriya Y, 2007, NUCL ACIDS RES, V35; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Retief J D, 2000, Methods Mol Biol, V132, P243; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1904-7; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stassen JHM, 2011, CURR OPIN PLANT BIOL, V14, P407, DOI 10.1016/j.pbi.2011.05.002; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; Thines M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004790; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Van Poppel PMJA, 2009, MOL PLANT PATHOL, V10, P611, DOI [10.1111/j.1364-3703.2009.00556.x, 10.1111/J.1364-3703.2009.00556.X]; Voglmayr H, 2003, MYCOL RES, V107, P1132, DOI 10.1017/S0953756203008438; Wang HC, 2009, PLANT PATHOL, V58, P571, DOI 10.1111/j.1365-3059.2008.01990.x; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Ye WW, 2016, MOL PLANT MICROBE IN, V29, P573, DOI 10.1094/MPMI-03-16-0056-R; Zhang ZG, 2007, BOT STUD, V48, P79	52	15	16	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178245	10.1371/journal.pone.0178245	http://dx.doi.org/10.1371/journal.pone.0178245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570700	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800036
J	Xiang, JS; Tang, S; Zhi, H; Jia, GQ; Wang, HJ; Diao, XM				Xiang, Jishan; Tang, Sha; Zhi, Hui; Jia, Guanqing; Wang, Huajun; Diao, Xianmin			Loose Panicle1 encoding a novel WRKY transcription factor, regulates panicle development, stem elongation, and seed size in foxtail millet [Setaria italica (L.) P. Beauv.]	PLOS ONE			English	Article							AXILLARY MERISTEMS; GENOME SEQUENCE; RICE; GENE; ARABIDOPSIS; SUPERFAMILY; YIELD; PROTEIN; MODEL	Panicle development is an important agronomic trait that aids in determining crop productivity. Foxtail millet and its wild ancestor green foxtail have recently been used as model systems to dissect gene functions. Here, we characterized a recessive mutant of foxtail millet, loose-panicle 1 (lp1), which showed pleiotropic phenotypes, such as a lax primary branching pattern, aberrant branch morphology, semi-dwarfism, and enlarged seed size. The loose panicle phenotype was attributed to increased panicle lengths and decreased primary branch numbers. Map-based cloning, combined with high-throughput sequencing, revealed that LP1, which encodes a novel WRKY transcription factor, is responsible for the mutant phenotype. A phylogenetic analysis revealed that LP1 belongs to the Group I WRKY subfamily, which possesses two WRKY domains (WRKY I and II). A single G-to-A transition in the fifth intron of LP1 resulted in three disorganized splicing events in mutant plants. For each of these aberrant splice variants, the normal C2H2 motif in the WRKY II domain was completely disrupted, resulting in a loss-of-function mutation. LP1 mRNA was expressed in all of the tissues examined, with higher expression levels observed in inflorescences, roots, and seeds at the grain-filling stage. A subcellular localization analysis showed that LP1 predominantly accumulated in the nucleus, which confirmed its role as a transcriptional regulator. This study provides novel insights into the roles of WRKY proteins in regulating reproductive organ development in plants and may help to develop molecular markers associated with crop yields.	[Xiang, Jishan; Wang, Huajun] Gansu Agr Univ, Gansu Key Lab Crop Improvement & Germplasm Enhanc, Coll Agron, Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Peoples R China; [Xiang, Jishan; Tang, Sha; Zhi, Hui; Jia, Guanqing; Diao, Xianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Xiang, Jishan] Chifeng Univ, Chifeng, Peoples R China	Gansu Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chifeng University	Wang, HJ (corresponding author), Gansu Agr Univ, Gansu Key Lab Crop Improvement & Germplasm Enhanc, Coll Agron, Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Peoples R China.; Diao, XM (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	whuajun@yahoo.com; diaoxianmin@caas.cn		, Sha/0000-0002-5825-9598	National High Technology Research and Development Program of China (863 Program) [2013AA102603]; National Natural Science Foundation of China [31660423, 31501324]; China Agricultural Research System [CARS0713.5-A02]; Chinese Academy of Agricultural Sciences	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agricultural Research System; Chinese Academy of Agricultural Sciences	This work was supported by the National High Technology Research and Development Program of China (863 Program) (2013AA102603), the National Natural Science Foundation of China (31660423 and 31501324), China Agricultural Research System (CARS0713.5-A02), and the Agricultural Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Diao XM, 2014, FRONT AGRIC SCI ENG, V1, P16, DOI 10.15302/J-FASE-2014011; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fornara F, 2003, PLANT BIOLOGY, V5, P16, DOI 10.1055/s-2003-37975; Grunewald W, 2013, EMBO REP, V14, P1136, DOI 10.1038/embor.2013.169; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Komatsu M, 2003, DEVELOPMENT, V130, P3841, DOI 10.1242/dev.00564; Li P, 2011, J EXPT BOT; Li SB, 2009, PLANT J, V58, P592, DOI 10.1111/j.1365-313X.2009.03799.x; Li W, 2016, PHYSIOL PLANTARUM, V157, P24, DOI 10.1111/ppl.12405; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu X., 2016, HYDROL EARTH SYST SC, V2016, P1; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Luo X, 2013, J EXPT BOT; Muthamilarasan M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00910; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Randall RS, 2015, BIOL OPEN, V4, P1229, DOI 10.1242/bio.013128; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tabuchi H, 2011, PLANT CELL, V23, P3276, DOI 10.1105/tpc.111.088765; Tanaka W, 2012, PLANT CELL, V24, P80, DOI 10.1105/tpc.111.094797; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wu Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006386; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xue CX, 2016, CROP SCI, V56, P95, DOI 10.2135/cropsci2015.05.0331; Yoshida A, 2012, PLANT J, V70, P327, DOI 10.1111/j.1365-313X.2011.04872.x; Zhang CQ, 2011, PLANTA, V234, P541, DOI 10.1007/s00425-011-1423-y; Zhang DB, 2014, ANNU REV PLANT BIOL, V65, P553, DOI 10.1146/annurev-arplant-050213-040104; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou X, 2011, MOL CELLS, V31, P303, DOI 10.1007/s10059-011-0047-1	39	30	35	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178730	10.1371/journal.pone.0178730	http://dx.doi.org/10.1371/journal.pone.0178730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570666	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800113
J	Busquets-Vass, G; Newsome, SD; Calambokidis, J; Serra-Valente, G; Jacobsen, JK; Aguiniga-Garcia, S; Gendron, D				Busquets-Vass, Geraldine; Newsome, Seth D.; Calambokidis, John; Serra-Valente, Gabriela; Jacobsen, Jeff K.; Aguiniga-Garcia, Sergio; Gendron, Diane			Estimating blue whale skin isotopic incorporation rates and baleen growth rates: Implications for assessing diet and movement patterns in mysticetes	PLOS ONE			English	Article							EASTERN NORTH PACIFIC; SEA-SURFACE TEMPERATURE; NITROGEN STABLE-ISOTOPES; SOUTHERN CALIFORNIA; CARBON ISOTOPES; TURNOVER RATES; ESCHRICHTIUS-ROBUSTUS; BALAENA-MYSTICETUS; LIPID EXTRACTION; HUMPBACK WHALE	Stable isotope analysis in mysticete skin and baleen plates has been repeatedly used to assess diet and movement patterns. Accurate interpretation of isotope data depends on understanding isotopic incorporation rates for metabolically active tissues and growth rates for metabolically inert tissues. The aim of this research was to estimate isotopic incorporation rates in blue whale skin and baleen growth rates by using natural gradients in baseline isotope values between oceanic regions. Nitrogen (delta N-15) and carbon (delta C-13) isotope values of blue whale skin and potential prey were analyzed from three foraging zones (Gulf of California, California Current System, and Costa Rica Dome) in the northeast Pacific from 1996-2015. We also measured delta N-15 and delta C-13 values along the lengths of baleen plates collected from six blue whales stranded in the 1980s and 2000s. Skin was separated into three strata: basale, externum, and sloughed skin. A mean (+/- SD) skin isotopic incorporation rate of 163 +/- 91 days was estimated by fitting a generalized additive model of the seasonal trend in delta N-15 values of skin strata collected in the Gulf of California and the California Current System. A mean (+/- SD) baleen growth rate of 15.5 +/- 2.2 cm y(-1) was estimated by using seasonal oscillations in delta N-15 values from three whales. These oscillations also showed that individual whales have a high fidelity to distinct foraging zones in the northeast Pacific across years. The absence of oscillations in delta N-15 values of baleen sub -samples from three male whales suggests these individuals remained within a specific zone for several years prior to death. delta C-13 values of both whale tissues (skin and baleen) and potential prey were not distinct among foraging zones. Our results highlight the importance of considering tissue isotopic incorporation and growth rates when studying migratory mysticetes and provide new insights into the individual movement strategies of blue whales.	[Busquets-Vass, Geraldine; Aguiniga-Garcia, Sergio; Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz, Baja Calif Sur, Mexico; [Newsome, Seth D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Calambokidis, John] Cascadia Res Collect, Olympia, WA USA; [Serra-Valente, Gabriela] Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Marine Mammal & Turtle Div, Natl Marine Fisheries Serv, La Jolla, CA USA; [Jacobsen, Jeff K.] Humboldt State Univ, Dept Biol Sci, Vertebrate Museum, Arcata, CA 95521 USA	Instituto Politecnico Nacional - Mexico; University of New Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; California State Polytechnic University, Humboldt	Gendron, D (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz, Baja Calif Sur, Mexico.	dianegendroncicimar@gmail.com	Busquets-Vass, Geraldine/AAR-8847-2021	Busquets-Vass, Geraldine/0000-0003-2867-7614	Instituto Politecnico Nacional:SIP [20130223, 20140495, 20150115, 20160496]; University of New Mexico Center for Stable Isotopes (Albuquerque); Consejo Nacional de Ciencia y Tecnologia (CONAGyT); Cetacean Society International; American Cetacean Society - Monterey Bay; John H. Prescott Marine Mammal Rescue Assistance Grant Program	Instituto Politecnico Nacional:SIP; University of New Mexico Center for Stable Isotopes (Albuquerque); Consejo Nacional de Ciencia y Tecnologia (CONAGyT); Cetacean Society International; American Cetacean Society - Monterey Bay; John H. Prescott Marine Mammal Rescue Assistance Grant Program	The authors received financial support from Instituto Politecnico Nacional:SIP: 20130223; 20140495; 20150115; 20160496 (http://www.ipn.mx/Paginas/inicio.aspx) and the University of New Mexico Center for Stable Isotopes (Albuquerque, NM; http://csi.unm.edu/). GBV received a PhD grant from the Consejo Nacional de Ciencia y Tecnologia (CONAGyT; http://www.conacyt.mx/), a research grant from Cetacean Society International (http://www.csiwhalesalive.org/index.php) specifically for processing the baleen plates, and a grant from American Cetacean Society - Monterey Bay (http://acsonline.org/) to process skin samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the institutions that facilitated the use of tissues samples and issued the permits to collect and process these samples: NOAA-SWFSC, CRC, CICIMAR-IPN, HSU-Vertebrate Museum, Museo de la Ballena y Ciencias del Mar (La Paz, BCS), the California Department of Parks and Recreation-Prairie Creek Redwoods State Park, NOAA/NMFS and SEMARNAT. We are also very grateful to all the personnel from the former institutions, the Stranding Network of California, and the Center for Stable Isotopes of the University of New Mexico who participated in the collection and processing of the tissue samples. We would also like to thank the John H. Prescott Marine Mammal Rescue Assistance Grant Program that has provided grants to the stranding networks. J. Rice, J. Loomis, T. Holmes, and F.J. Gomez-Diaz collaborated during the process of locating potential baleen plates for this study and we are very beholden for their support. We would also like to give special recognition to K. Robertson who helped with the logistics of sample selection and the sex identification of an important baleen sample at the genetics lab in SWFSC. M.A. Pardo, H. Villalobos-Ortiz, C. Arnold, and two anonymous reviewers made some valuable comments to improve the manuscript.	Aguilar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092288; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Aurioles-Gamboa D, 2013, MAR ECOL PROG SER, V488, P275, DOI 10.3354/meps10369; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; BARAFF LS, 1991, MAR MAMMAL SCI, V7, P197, DOI 10.1111/j.1748-7692.1991.tb00567.x; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Barrow LM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P688, DOI 10.1086/588172; Becker BH, 2007, MAR ECOL PROG SER, V329, P267, DOI 10.3354/meps329267; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; BERTA A, 2006, MARINE MAMMALS EVOLU; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; BOILY P, 1995, J THEOR BIOL, V172, P235, DOI 10.1006/jtbi.1995.0020; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Brinton E., 2000, EUPHAUSIIDS WORLD OC; Browning NE, 2014, J EXP BIOL, V217, P214, DOI 10.1242/jeb.093963; Burrows DG, 2014, MAR MAMMAL SCI, V30, P747, DOI 10.1111/mms.12076; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 1997, STILLWATER MINNESOTA; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Caraveo-Patino J, 2005, HYDROBIOLOGIA, V539, P99, DOI 10.1007/s10750-004-3370-0; Carle R.D, 2014, SEASONAL SEX SPECIFI, DOI [10.31979/etd.mq72-vbhn, DOI 10.31979/ETD.MQ72-VBHN]; Chelton DB, 2007, J PHYS OCEANOGR, V37, P495, DOI 10.1175/JPO3025.1; Chuang YH, 2012, ATMOS POLLUT RES, V3, P148, DOI 10.5094/APR.2012.019; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Cosgrove, 2000, DISTRIBUTION ABUNDAN; Costa-Urrutia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058315; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DELANGELRODRIGU.J, 1997, THESIS CTR INTERDISC; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Durban JW, 2012, BIOL LETTERS, V8, P274, DOI 10.1098/rsbl.2011.0875; Escalante F, 2013, CIENC MAR, V39, P203, DOI [10.7773/cm.v39i2.2233, 10.7773/cm.v3912.2233]; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Etnoyer Peter, 2004, Oceanography, V17, P90; Fiedler PC, 1998, DEEP-SEA RES PT II, V45, P1781, DOI 10.1016/S0967-0645(98)80017-9; Fleming AH, 2016, GLOBAL CHANGE BIOL, V22, P1214, DOI 10.1111/gcb.13171; Forney KA, 1998, MAR MAMMAL SCI, V14, P460, DOI 10.1111/j.1748-7692.1998.tb00737.x; Fry B., 2006, STABLE ISOTOPE ECOLO; Fudge Douglas S., 2009, Aquatic Mammals, V35, P226, DOI 10.1578/AM.35.2.2009.226; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Gendron D., 2001, Journal of Cetacean Research and Management, V3, P41; GENDRON D, 2002, THESIS CTR INVESTIGA; Gendron Diane, 2001, Journal of Cetacean Research and Management, V3, P77; Geraci J.R., 1986, P3; Gimenez J, 2016, J EXP MAR BIOL ECOL, V475, P54, DOI 10.1016/j.jembe.2015.11.001; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Harrison R.J., 1974, P45; Hazen EL, 2016, J APPL ECOL; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hipfner JM, 2010, OECOLOGIA, V163, P351, DOI 10.1007/s00442-010-1618-0; Hoyt E., 2009, REP WDC, P1; Ingram T, 2007, LIMNOL OCEANOGR-METH, V5, P338, DOI 10.4319/lom.2007.5.338; IRVING LAURENCE, 1957, CANADIAN JOUR ZOOL, V35, P497, DOI 10.1139/z57-041; Jaume-Schinkel S, 2004, THESIS CTR INTERDISC; Jimenez-Pinedo N.C, 2010, HABITOS ALIMENTARIOS; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Lee SH, 2005, MAR ECOL PROG SER, V285, P271, DOI 10.3354/meps285271; Lesage V, 2010, MAR ECOL PROG SER, V419, P249, DOI 10.3354/meps08825; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Mangiafico SS, 2016, R RUTGERS COOPERATIV; Mate BR, 1999, MAR MAMMAL SCI, V15, P1246, DOI 10.1111/j.1748-7692.1999.tb00888.x; Matteson R. S., 2009, THESIS OREGON STATE; Matthews CJD, 2015, MAR ECOL PROG SER, V522, P269, DOI 10.3354/meps11145; Matthews CJD, 2014, J MAR BIOL ASSOC UK, V94, P1343, DOI 10.1017/S0025315413001379; Mauchline J., 1980, ADV MAR BIOL, V18, P373; McClatchie S, 2009, CAL COOP OCEAN FISH, V50, P43; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMahon KW, 2015, LIMNOL OCEANOGR, V60, P1076, DOI 10.1002/lno.10081; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Miller TW, 2008, LIMNOL OCEANOGR, V53, P1493, DOI 10.4319/lo.2008.53.4.1493; MILLER TW, 2006, THESIS OREGON STATE; Mitani Y, 2006, FISHERIES SCI, V72, P69, DOI 10.1111/j.1444-2906.2006.01118.x; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; Morin PA, 2006, MAR MAMMAL SCI, V22, P897, DOI 10.1111/j.1748-7692.2006.00070.x; Nemoto T, 1977, INT WHALING COMMISSI, V1, P80; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oleson EM, 2007, MAR MAMMAL SCI, V23, P574, DOI 10.1111/j.1748-7692.2007.02303.x; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; OLIVER JS, 1983, FISH B-NOAA, V81, P513; Pardo MA, 2013, MAR ECOL PROG SER, V487, P245, DOI 10.3354/meps10217; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Popp BN, 2007, TERR ECOL SER, V1, P173; R Development Core T, 2011, R LANG ENV STAT COMP; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Reilly S. B., 2008, IUCN RED LIST THREAT, DOI [10. 2305/iucn. uk. 2008. rlts. t2477a9447146. en, DOI 10.2305/IUCN.UK.2008.RLTS.T2477A9447146.EN]; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Ryan C, 2012, RAPID COMMUN MASS SP, V26, P2745, DOI 10.1002/rcm.6394; Sampson L, 2010, J MAR BIOL ASSOC UK, V90, P969, DOI 10.1017/S0025315410000548; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Schell D.M., 1989, Ecological Studies, V68, P260; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Schneider N, 2005, J PHYS OCEANOGR, V35, P1421, DOI 10.1175/JPO2759.1; Sears R, 2013, ENDANGER SPECIES RES, V22, P23, DOI 10.3354/esr00532; Sheehan D.C., 1980, THEORY PRACTICE HIST; Silva R. G., 2004, Braz. J. Biol., V64, P719, DOI 10.1590/S1519-69842004000400021; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; STAUBIN DJ, 1990, CAN J ZOOL, V68, P359, DOI 10.1139/z90-051; Sydeman WJ, 1997, CONDOR, V99, P327, DOI 10.2307/1369938; Tershy BR, 1990, REPORTS INT WHALING, V12, P369; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Todd Sean, 1997, Journal of Northwest Atlantic Fishery Science, V22, P71; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Voigt CC, 2003, J EXP BIOL, V206, P1419, DOI 10.1242/jeb.00274; Williams R., 2013, THESIS U RHODE ISLAN; Williams RL, 2014, DEEP-SEA RES PT I, V90, P36, DOI 10.1016/j.dsr.2014.04.008; Wisner R. L., 1974, TAXONOMY DISTRIBUTIO; Witteveen BH, 2012, MAR MAMMAL SCI, V28, pE233, DOI 10.1111/j.1748-7692.2011.00508.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xiang D., 2001, FITTING GEN ADDITIVE, P256; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	118	54	54	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177880	10.1371/journal.pone.0177880	http://dx.doi.org/10.1371/journal.pone.0177880			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562625	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700032
J	Kepchia, D; Moliver, S; Chohan, K; Phillips, C; Luetje, CW				Kepchia, Devin; Moliver, Scott; Chohan, Kunal; Phillips, Cameron; Luetje, Charles W.			Inhibition of insect olfactory behavior by an airborne antagonist of the insect odorant receptor co-receptor subunit	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; IONOTROPIC GLUTAMATE RECEPTORS; SOUTHERN HOUSE MOSQUITO; DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; ION CHANNELS; DEET; SYSTEM; CONSERVATION; ARCHITECTURE	Response to volatile environmental chemosensory cues is essential for insect survival. The odorant receptor (OR) family is an important class of receptors that detects volatile molecules; guiding insects towards food, mates, and oviposition sites. ORs are odorant-gated ion channels, consisting of a variable odorant specificity subunit and a conserved odorant receptor co-receptor (Orco) subunit, in an unknown stoichiometry. The Orco subunit possesses an allosteric site to which modulators can bind and noncompetitively inhibit odorant activation of ORs. In this study, we characterized several halogen-substituted versions of a phenylthiophenecarboxamide Orco antagonist structure. Orco antagonist activity was assessed on ORs from Drosophila melanogaster flies and Culex quinquefasciatus mosquitoes, expressed in Xenopus laevis oocytes and assayed by two-electrode voltage clamp electrophysiology. One compound, OX1w, was also shown to inhibit odorant activation of a panel of Anopheles gambiae mosquito ORs activated by diverse odorants. Next, we asked whether Orco antagonist OX1w could affect insect olfactory behavior. A Drosophila melanogaster larval chemotaxis assay was utilized to address this question. Larvae were robustly attracted to highly diluted ethyl acetate in a closed experimental chamber. Attraction to ethyl acetate was Orco dependent and also required the odorant specificity subunit Or42b. The addition of the airborne Orco antagonist OX1w to the experimental chamber abolished larval chemotaxis towards ethyl acetate. The Orco antagonist was not a general inhibitor of sensory behavior, as behavioral repulsion from a light source was unaffected. This is the first demonstration that an airborne Orco antagonist can alter olfactory behavior in an insect. These results suggest a new approach to insect control and emphasize the need to develop more potent Orco antagonists.	[Kepchia, Devin; Moliver, Scott; Chohan, Kunal; Phillips, Cameron; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Luetje, CW (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu			National Institutes of Health [RO1 DC011091]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a grant from the National Institutes of Health (RO1 DC011091 to CWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Andersson MN, 2017, FRONT ECOL EVOL, V5; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084575; Chen Sisi, 2014, F1000Res, V3, P84, DOI 10.12688/f1000research.3825.1; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; DeGennaro M, 2015, FLY, V9, P45, DOI 10.1080/19336934.2015.1079360; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dweck HKM, 2015, CURR BIOL, V25, P455, DOI 10.1016/j.cub.2014.11.062; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Franco TA, 2016, INSECT BIOCHEM MOLEC, V69, P82, DOI 10.1016/j.ibmb.2015.02.012; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007; Leal WS, 2013, P NATL ACAD SCI USA, V110, P18704, DOI 10.1073/pnas.1316059110; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Li Y, 2016, INSECT BIOCHEM MOLEC, V79, P27, DOI 10.1016/j.ibmb.2016.10.003; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Ramdya P, 2010, TRENDS GENET, V26, P307, DOI 10.1016/j.tig.2010.04.004; Rinker DC, 2012, PHYSIOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-3032.2011.00821.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Smallegange RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063602; Sparks JT, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1367-y; Stanczyk NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054438; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Sutherland WJ, 2015, TRENDS ECOL EVOL, V30, P17, DOI 10.1016/j.tree.2014.11.002; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Tsitoura P, 2015, J BIOL CHEM, V290, P7961, DOI 10.1074/jbc.M114.632299; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111	61	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177454	10.1371/journal.pone.0177454	http://dx.doi.org/10.1371/journal.pone.0177454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562598	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700016
J	Bae, JS; Kim, JH; Yu, MH; Lee, DH; Kim, HC; Chung, JW; Han, JK				Bae, Jae Seok; Kim, Jung Hoon; Yu, Mi Hye; Lee, Dong Ho; Kim, Hyo-Cheol; Chung, Jin Wook; Han, Joon Koo			Diagnostic accuracy of gadoxetic acid enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS)	PLOS ONE			English	Article							C-ARM CT; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; OBSERVER PERFORMANCE; SENSITIVITY	Background & aims To assess diagnostic accuracy of gadoxetic acid enhanced MR for small hypervascular hepatocellular carcinoma (HCC) detected by C-arm CT and concordance rate of Liver Imaging Reporting and Data System (LI-RADS). Methods In this retrospective study, we recruited 4,544 patients suspected of having HCC underwent C arm CT from November 2008 to May 2013. Among these patients, gadoxetic acid enhanced MR was performed in 167 patients with HCC (n = 379; 257 > 1 cm, 122 <= 1 cm). HCC was confirmed by MR, CT, or follow-up images. Two radiologists graded likelihood of HCC and assessed MR features. Jackknife alternative free-response receiver operating characteristic (JAFROC) analysis was performed. All HCCs were evaluated concordance rate of LI-RADS. Results Mean JAFROC figure of merit for large (> 1-cm) HCC was 0.948, while that for small HCC was 0.787 with fair agreement (K = 0.409). Mean sensitivity and positive predictive value (PPV) were 91% and 90% for large HCC versus 63.0% and 79% for small HCC, respectively. Seventeen of 122 small HCCs (13.9%) were not visible on MR. Among 379 HCCs, 99 met LR-5, and 259 met LR-4. Common features for small HCC included arterial enhancement (81.9%), hepatobiliary phase hypointensity (80.3%), and delayed washout (72.9%). Conclusion Diagnostic accuracy of gadoxetic acid enhanced MR imaging for small, hypervascular HCCs (Mean figure of merit = 0.787) was still low compared with large HCC (Mean figure of merit = 0.948). LR-5 and LR-4 covered 94% (358/379) of the HCCs.	[Bae, Jae Seok; Kim, Jung Hoon; Yu, Mi Hye; Lee, Dong Ho; Kim, Hyo-Cheol; Chung, Jin Wook; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Chung, Jin Wook; Han, Joon Koo] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea; [Yu, Mi Hye] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Konkuk University; Konkuk University Medical Center	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea.	jhkim2008@gmail.com	Bae, Jaeseok/T-9071-2019	Bae, Jaeseok/0000-0003-2768-7917; Yu, Mi Hye/0000-0003-0519-7853; Kim, Hyo-Cheol/0000-0002-6016-247X				Bashir MR, 2013, J MAGN RESON IMAGING, V37, P398, DOI 10.1002/jmri.23818; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cartier V, 2013, Diagn Interv Imaging, V94, P697, DOI 10.1016/j.diii.2013.03.007; Chakraborty DP, 2006, ACAD RADIOL, V13, P1187, DOI 10.1016/j.acra.2006.06.016; CHEN N, 2015, MAGNETIC RESONANCE M; Higashihara H, 2012, EUR RADIOL, V22, P872, DOI 10.1007/s00330-011-2324-y; Hwang J, 2014, BRIT J RADIOLOGY; Iwazawa J, 2010, AM J ROENTGENOL, V195, P882, DOI 10.2214/AJR.10.4417; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joo I, 2015, EUR RADIOL, P1; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Kim D, 2014, BRIT J RADIOLOGY; Kim HC, 2011, CARDIOVASC INTER RAD, V34, P87, DOI 10.1007/s00270-010-9883-1; Kim JE, 2011, AM J ROENTGENOL, V196, pW758, DOI 10.2214/AJR.10.4394; Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Le Moigne F, 2012, MAGN RESON IMAGING, V30, P656, DOI 10.1016/j.mri.2012.01.002; Lee YJ, 2015, RADIOLOGY; Li JJ, 2015, WORLD J GASTROENTERO, V21, P3035, DOI 10.3748/wjg.v21.i10.3035; Loffroy R, 2012, CARDIOVASC INTER RAD, V35, P97, DOI 10.1007/s00270-011-0118-x; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Meyer BC, 2009, EUR RADIOL, V19, P2302, DOI 10.1007/s00330-009-1410-x; Mitchell DG, 2014, HEPATOLOGY; Miyayama S, 2013, J VASC INTERV RADIOL, V24, P501, DOI 10.1016/j.jvir.2012.12.022; Mortele KJ, 2001, EUR RADIOL, V11, P1631, DOI 10.1007/s003300100834; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Park MS, 2012, HEPATOLOGY, V56, P140, DOI 10.1002/hep.25681; Park MJ, 2012, RADIOLOGY, V264, P761, DOI 10.1148/radiol.12112517; Radiology ACo, 2013, LIV IM REP DAT SYST; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Yu MH, 2014, RADIOLOGY, V271, P748, DOI 10.1148/radiol.14131996; Yu MH, 2013, AM J ROENTGENOL, V201, P675, DOI 10.2214/AJR.12.10445; Zhao XT, 2014, J DIGEST DIS, V15, P137, DOI 10.1111/1751-2980.12119; Zheng B, 2005, MED PHYS, V32, P1031, DOI 10.1118/1.1884766	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178495	10.1371/journal.pone.0178495	http://dx.doi.org/10.1371/journal.pone.0178495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558068	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000053
J	Funk, P; Motyka, K; Soural, M; Malon, M; Koshino, H; Kusz, J; Hlavac, J				Funk, Petr; Motyka, Kamil; Soural, Miroslav; Malon, Michal; Koshino, Hiroyuki; Kusz, Joachim; Hlavac, Jan			Study of 2-aminoquinolin-4(1H)-one under Mannich and retro-Mannich reaction	PLOS ONE			English	Article							DERIVATIVES; CHEMISTRY	2-Aminoquinolin-4(1H)-one was reacted with various primary/secondary amines and paraformaldehyde under Mannich reaction conditions. In the case of secondary amines, the reaction in N,N-dimethylformamide yielded expected Mannich products accompanied with 3,3'-methylenebis(2-aminoquinolin-4(1H)-one). Except these main products, the pyrimido [4,5-b]quinolin-5-one derivative was also identified as co-product. The reaction with primary amines led to the formation of pyrimido[4,5-b]quinolin-5-ones. The Mannich reaction products were thermally unstable and afforded a mixture of bis-(2-aminoquinolin-4(1H)-one) and tris-(2-aminoquinolin-4(1H)-one) derivative, probably via reactive methylene species. This retro-Mannich reaction was tested in reaction with indole and thiophenole as nucleophilles, and appropriate conjugates were formed. The mechanism of above discussed reactions in which 2-aminoquinolinone displays the nucleophilicity on C3 carbon as well as N2 nitrogen is discussed.	[Funk, Petr; Motyka, Kamil] Palacky Univ, Fac Sci, Inst Mol & Translat Med, Dept Organ Chem, Olomouc, Czech Republic; [Soural, Miroslav; Hlavac, Jan] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Malon, Michal] JEOL RESONANCE Inc, Akishima, Tokyo, Japan; [Koshino, Hiroyuki] RIKEN Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Kusz, Joachim] Univ Silesian, Inst Phys, Katowice, Poland	Palacky University Olomouc; Palacky University Olomouc; Jeol Ltd; JEOL Japan; RIKEN	Hlavac, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.	jan.hlavac@upol.cz	Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021	Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Hlavac, Jan/0000-0002-4652-7751; Kusz, Joachim/0000-0001-8156-936X	National Program of Sustainability [L01304]; JEOL RESONANCE Inc.	National Program of Sustainability; JEOL RESONANCE Inc.	This study was funded by the National Program of Sustainability, L01304, and by JEOL RESONANCE Inc., which provided support in the form of salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACTOR P, 1974, ARZNEIMITTELFORSCH, V24, P8; BANY T, 1974, ROCZ CHEM, V48, P1443; Di Antonio M, 2012, ANGEW CHEM INT EDIT, V51, P11073, DOI 10.1002/anie.201206281; Farhanullah, 2009, J MED CHEM, V44, P239; Goulet M.T., 2007089634 WO, Patent No. WO2007089634; HAAS G, 1981, J HETEROCYCLIC CHEM, V18, P607, DOI 10.1002/jhet.5570180334; Hamma T, 2003, BIOCONJUGATE CHEM, V14, P320, DOI 10.1021/bc025638+; Haughan A. F., 2003035066 WO, Patent No. WO 2003035066; Heravi MM, 2014, CURR ORG CHEM, V18, P2857, DOI 10.2174/1385272819666141014212254; Kang DH, 2009, J MED CHEM, V52, P3093, DOI 10.1021/jm8014734; Muller S, 2012, ORG BIOMOL CHEM, V10, P6537, DOI 10.1039/c2ob25830g; Quintal S, 2013, J ORGANOMET CHEM, V745, P299, DOI 10.1016/j.jorganchem.2013.07.044; Rivkin A, 2006, TETRAHEDRON LETT, V47, P2395, DOI 10.1016/j.tetlet.2006.01.148; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Roman G, 2015, EUR J MED CHEM, V89, P743, DOI 10.1016/j.ejmech.2014.10.076; Styskala J, 2002, J HETEROCYCLIC CHEM, V39, P1305, DOI 10.1002/jhet.5570390630; Wang LX, 2015, TETRAHEDRON, V71, P4982, DOI 10.1016/j.tet.2015.05.081; Zubkov V. A., 2005, ORG FARM KHIM, V3, P23; Zubkov VO, 2003, VISNIK FARM, V4, P3	19	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0175364	10.1371/journal.pone.0175364	http://dx.doi.org/10.1371/journal.pone.0175364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557987	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000003
J	Jiang, RX; Lee, I; Lee, TA; Pickard, AS				Jiang, Ruixuan; Lee, Inyoung; Lee, Todd A.; Pickard, A. Simon			The societal cost of heroin use disorder in the United States	PLOS ONE			English	Article							C VIRUS-INFECTION; CHRONIC HEPATITIS-B; LATENT TUBERCULOSIS; PHARMACOLOGICAL-TREATMENT; HUMAN IMMUNODEFICIENCY; MAINTENANCE THERAPY; INJECT DRUGS; HIV; PREVALENCE; PREVENTION	Objective Heroin use in the United States has reached epidemic proportions. The objective of this paper is to estimate the annual societal cost of heroin use disorder in the United States in 2015 US dollars. Methods An analytic model was created that included incarceration and crime; treatment for heroin use disorder; chronic infectious diseases (HIV, Hepatitis B, Hepatitis C, and Tuberculosis) and their treatments; treatment of neonatal abstinence syndrome; lost productivity; and death by heroin overdose. Results Using literature-based estimates to populate the model, the cost of heroin use disorder was estimated to be $51.2 billion in 2015 US dollars ($50,799 per heroin user). One-way sensitivity analyses showed that overall cost estimates were sensitive to the number of heroin users, cost of HCV treatment, and cost of incarcerating heroin users. Conclusion The annual cost of heroin use disorder to society in the United States emphasizes the need for sustained investment in healthcare and non-healthca rerelated strategies that reduce the likelihood of abuse and provide care and support for users to overcome the disorder.	[Jiang, Ruixuan; Lee, Inyoung; Lee, Todd A.; Pickard, A. Simon] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA; [Jiang, Ruixuan; Lee, Inyoung; Lee, Todd A.; Pickard, A. Simon] Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA; [Pickard, A. Simon] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Pickard, AS (corresponding author), Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA.; Pickard, AS (corresponding author), Univ Illinois, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA.; Pickard, AS (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	pickard1@uic.edu		Lee, Inyoung/0000-0001-5436-2013; Pickard, A. Simon/0000-0001-5645-7091; Jiang, Ruixuan/0000-0003-1737-2989	Takeda Development Center Americas, Inc.	Takeda Development Center Americas, Inc.(Takeda Pharmaceutical Company Ltd)	Ruixuan Jiang was supported by a fellowship through Takeda Development Center Americas, Inc. The authors also would like to thank Tyler Reinsch and Amy Si Leng Lam for their contributions to the model development and inputs. The authors have no financial conflicts of interest to declare.	Ahamad K, 2015, LANCET HIV, V2, pE445, DOI 10.1016/S2352-3018(15)00129-0; Ahrnsbrak R KL, NATL SURVEY DRUG USE; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Apa ZL, 2012, PUBLIC HEALTH NURS, V29, P467, DOI 10.1111/j.1525-1446.2012.01027.x; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Boutwell Amy E, 2007, J Opioid Manag, V3, P328; Center for Behavioral Health Statistics and Quality, RES 2015 NAT SURV DR; Center for Behavioral Health Statistics and Quality, 2016, HHS PUBL; Center for Disease Control, 2014, HIV VIRAL HEPATITIS; Center for Disease Control and Prevention, TB RISK FACT; Centers for Disease Control and Prevention, DIV HEART DIS STROK; Centers for Disease Control and Prevention, TOD HER EP INF; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Cohen J, 2013, SCIENCE, V342, P1302, DOI 10.1126/science.342.6164.1302; Davidson J, 2016, OBAMA ANTIHEROIN STR; Deiss RG, 2009, CLIN INFECT DIS, V48, P72, DOI 10.1086/594126; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Elliott JC, 2015, AIDS BEHAV; Evans E, 2015, ADDICTION, V110, P996, DOI 10.1111/add.12863; Factor SH, 2011, SUBST USE MISUSE, V46, P1711, DOI 10.3109/10826084.2011.615562; Ford ES, 2015, CHEST, V147, P31, DOI 10.1378/chest.14-0972; Fox RK, 2005, CLIN INFECT DIS, V41, P177, DOI 10.1086/430913; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Genberg BL, 2015, ADDICTION, V110, P1152, DOI 10.1111/add.12938; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hauck FR, 2009, AM FAM PHYSICIAN, V79, P879; Hennessey KA, 2009, J URBAN HEALTH, V86, P93, DOI 10.1007/s11524-008-9305-8; Henrichson Christian., 2012, PRICE PRISONS WHAT I; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Inocencio TJ, 2013, PAIN MED, V14, P1534, DOI 10.1111/pme.12183; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Kilmer B ES, WHAT AM USERS SPEND; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Mumola C. J, 2006, DRUG USE DEPENDENCE; National Institute on Drug Abuse, DOES HER US AFF PREG; National Institute on Drug Abuse, DRUGFACTS NAT TRENDS; National Institute on Drug Abuse, WHY DOES HER US CREA; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Ogbuagu O, 2014, CURR HIV-AIDS REP, V11, P505, DOI 10.1007/s11904-014-0238-4; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Patrick SW, 2015, J PERINATOL, V35, P650, DOI 10.1038/jp.2015.36; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Saag MS, 2015, CLIN INFECT DIS, V61, P169, DOI 10.1093/cid/civ221; Samuels J, 2015, CE ANN DETERMINATION; Sarkar M, 2014, DIGEST DIS SCI, V59, P2100, DOI 10.1007/s10620-014-3142-2; Social Security Administration, MEAS CENTR TEND WAG; Solomon M, 2011, DIGEST DIS SCI, V56, P3024, DOI 10.1007/s10620-011-1802-z; Spiller MW, 2015, MMWR-MORBID MORTAL W, V64, P270; Substance Abuse and Mental Health Services Administration, 2009, RES 2009 NAT SURV DR, VI; Teesson M, 2015, ADDICTION, V110, P986, DOI 10.1111/add.12860; Tetrault JM, 2012, DRUGS, V72, P217, DOI 10.2165/11597520-000000000-00000; The White House, 2016, FACT SHEET OBAMA ADM; Thiagarajan P, 2015, CURR OPIN INFECT DIS, V28, P563, DOI 10.1097/QCO.0000000000000205; United States Department of Justice National Drug Intelligence Center, 2011, EC IMP ILL DRUG US A; Wakeman Sarah E., 2010, HIV Therapy, V4, P505, DOI 10.2217/HIV.10.35; Weaver T, 2014, LANCET, V384, P153, DOI 10.1016/S0140-6736(14)60196-3; Weinbaum CA, 2005, AIDS, V19, pS41, DOI 10.1097/01.aids.0000192069.95819.aa; Westergaard RP, 2013, AIDS, V27, P2559, DOI 10.1097/QAD.0b013e328363bff2; Younossi ZMP, 2016, REAL WORLD OUTCOMES	69	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177323	10.1371/journal.Pone.0177323	http://dx.doi.org/10.1371/journal.Pone.0177323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GJ	28557994	Green Submitted, gold, Green Published			2022-12-26	WOS:000402607000010
J	Sebastjan, A; Skrzek, A; Ignasiak, Z; Slawinska, T				Sebastjan, Anna; Skrzek, Anna; Ignasiak, Zofia; Slawinska, Teresa			Age-related changes in hand dominance and functional asymmetry in older adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEX-DIFFERENCES; PERFORMANCE; HANDEDNESS; HYPOTHESIS; PREFERENCE; REDUCTION; BRAIN; LIFE; MAGNITUDE	The aim of the study was to investigate fine motor performance and ascertain age-related changes in laterality between the dominant and non-dominant hand. A representative sample of 635 adults (144 males and 491 females) aged 50 years and over completed a test battery MLS (Motor Performance Series) to assess a broad range of hand functions. Functional asymmetry was observed in all four motor tests (postural tremor, aiming, tapping, and inserting long pins). Significant differences between the dominant and non-dominant hand were obtained in both sexes across all age groups, except in the oldest female group (age >70) for the aiming (number of hits and errors) and postural tremor (number of errors) tasks. These differences in age-related changes may be attributed to hemispheric asymmetry, environmental factors, or use-dependent plasticity. Conflicting evidence in the literature warrants additional research to better explain age-related alterations of hand dominance and manual performance in old age.	[Sebastjan, Anna; Ignasiak, Zofia; Slawinska, Teresa] Univ Sch Phys Educ Wroclaw, Fac Phys Educ, Wroclaw, Poland; [Skrzek, Anna] Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Wroclaw, Poland		Sebastjan, A (corresponding author), Univ Sch Phys Educ Wroclaw, Fac Phys Educ, Wroclaw, Poland.	Anna.sebastjan@awf.wroc.pl		Ignasiak, Zofia/0000-0001-8656-9107; Sebastjan, Anna/0000-0001-6395-6147; Skrzek, Anna/0000-0003-1533-0291; Slawinska-Ochla, Teresa/0000-0002-7217-5868				Albert M. S., 1988, GERIATRIC NEUROPSYCH; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Bernard JA, 2012, PLOS ONE, V7, P1; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Bowden JL, 2013, EXP GERONTOL, V48, P756, DOI 10.1016/j.exger.2013.03.011; BROWN JW, 1975, NEUROPSYCHOLOGIA, V13, P107, DOI 10.1016/0028-3932(75)90054-8; Brown SG, 2006, LATERALITY, V11, P1, DOI 10.1080/1357650054200000440; Bryden PJ, 2006, DEV PSYCHOBIOL, V48, P121, DOI 10.1002/dev.20120; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; CABEZA R, 2001, HDB FUNCTIONAL NEURO, P331; Cai LY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00031; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Chapman J.A., 1999, PERSPECTIVES HUMAN B, V4, P211; COLE KJ, 1991, J MOTOR BEHAV, V23, P251, DOI 10.1080/00222895.1991.9942036; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; de Bruin N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00007; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; Gonzalez CLR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00285; Hausmann M, 2003, LATERALITY, V8, P277, DOI 10.1080/13576500244000201; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; Hyder F, 2012, NEUROIMAGE, V62, P985, DOI 10.1016/j.neuroimage.2012.04.027; Ittyerah M., 2013, HAND PREFERENCE HAND; Kalisch T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000090; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Lin AL, 2014, FUTUR NEUROL, V9, P341, DOI 10.2217/FNL.14.13; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; MEUDELL PR, 1987, CORTEX, V23, P431; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Paizis C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00049; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Przybyla A, 2011, NEUROSCI LETT, V489, P99, DOI 10.1016/j.neulet.2010.11.074; Raczek J., 2001, J HUM KINET, V6, P113; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rodrigues P, 2013, BIAS HUMAN BEHAV, P111; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; SAND PL, 1973, PERCEPT MOTOR SKILL, V36, P1343, DOI 10.2466/pms.1973.36.3c.1343; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; SEIDLER RD, 1995, QUEST, V47, P386, DOI 10.1080/00336297.1995.10484165; Sherback M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000708; Sivagnanasunderam M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01556; Skrzek A, 2015, AGING CLIN EXP RES, V27, P491, DOI 10.1007/s40520-014-0299-7; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Stone KD, 2014, EXP BRAIN RES, V232, P385, DOI 10.1007/s00221-013-3746-3; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Triggs WJ, 2000, CORTEX, V36, P679, DOI 10.1016/S0010-9452(08)70545-8; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; WARABI T, 1986, EXP NEUROL, V92, P686, DOI 10.1016/0014-4886(86)90309-2; WELLER MPI, 1985, PSYCHOL MED, V15, P867, DOI 10.1017/S0033291700005109; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Woytowicz E, 2016, CURR GERI REP; Zverev YP, 2006, BRAIN COGNITION, V60, P259	66	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177845	10.1371/journal.pone.0177845	http://dx.doi.org/10.1371/journal.pone.0177845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GJ	28558047	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000015
J	Heymann, PW; Nguyen, HT; Steinke, JW; Turner, RB; Woodfolk, JA; Platts-Mills, TAE; Martin, L; He, H; Myers, JB; Lindsey, M; Sivaprasad, U; Medvedovic, M; Mahi, N; Carper, H; Murphy, DD; Patrie, J; Hershey, GKK				Heymann, Peter W.; Huyen-Tran Nguyen; Steinke, John W.; Turner, Ronald B.; Woodfolk, Judith A.; Platts-Mills, Thomas A. E.; Martin, Lisa; He, Hua; Myers, Jocelyn Biagini; Lindsey, Mark; Sivaprasad, Umasundari; Medvedovic, Mario; Mahi, Naim; Carper, Holliday; Murphy, Deborah D.; Patrie, James; Hershey, Gurjit K. Khurana			Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescence	PLOS ONE			English	Article							INTERLEUKIN-10 PROMOTER POLYMORPHISMS; BRONCHIAL EPITHELIAL-CELLS; SERINE-PROTEASE INHIBITOR; GENE-EXPRESSION PROFILES; EXACERBATIONS IN-VIVO; CHRONIC RHINOSINUSITIS; CHILDHOOD ASTHMA; ATOPIC ASTHMA; SPINK5; CHILDREN	Background Rhinovirus (HRV) is associated with the large majority of virus-induced asthma exacerbations in children and young adults, but the mechanisms remain poorly defined. Methods Asthmatics and non-asthmatic controls were inoculated with HRV-A16, and nasal epithelial samples were obtained 7 days before, 36 hours after, and 7 days after viral inoculation. RNA was extracted and subjected to RNA-seq analysis. Results At baseline, 57 genes were differentially expressed between asthmatics and controls, and the asthmatics had decreased expression of viral replication inhibitors and increased expression of genes involved in inflammation. At 36 hours (before the emergence of peak symptoms), 1329 genes were significantly altered from baseline in the asthmatics compared to 62 genes in the controls. At this time point, asthmatics lacked an increase in IL-10 signaling observed in the controls. At 7 days following HRV inoculation, 222 genes were significantly dysregulated in the asthmatics, whereas only 4 genes were dysregulated among controls. At this time point, the controls but not asthmatics demonstrated upregulation of SPINK5. Conclusions As judged by the magnitude and persistence of dysregulated genes, asthmatics have a substantially different host response to HRV-A16 infection compared with non-asthmatic controls. Gene expression differences illuminate biologically plausible mechanisms that contribute to a better understanding of the pathogenesis of HRV-induced asthma exacerbations.	[Heymann, Peter W.; Carper, Holliday; Murphy, Deborah D.] Univ Virginia, Dept Pediat, Div Allergy Immunol & Resp Med, Charlottesville, VA USA; [Heymann, Peter W.; Steinke, John W.; Woodfolk, Judith A.; Platts-Mills, Thomas A. E.] Univ Virginia, Dept Internal Med, Asthma & Allerg Dis Ctr, Charlottesville, VA USA; [Huyen-Tran Nguyen; Myers, Jocelyn Biagini; Lindsey, Mark; Sivaprasad, Umasundari; Hershey, Gurjit K. Khurana] Univ Cincinnati, Dept Pediat, Div Asthma Res, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45267 USA; [Huyen-Tran Nguyen] Univ Cincinnati, Div Allergy & Immunol, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Turner, Ronald B.] Univ Virginia, Dept Pediat, Div Infect Dis, Charlottesville, VA USA; [Martin, Lisa; He, Hua] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; [Medvedovic, Mario; Mahi, Naim] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Patrie, James] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA	University of Virginia; University of Virginia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Virginia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Virginia	Hershey, GKK (corresponding author), Univ Cincinnati, Dept Pediat, Div Asthma Res, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45267 USA.	Gurjit.Hershey@cchmc.org	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946; Mahi, Naim/0000-0003-4660-5809; Platts-Mills, Thomas/0000-0002-1263-329X	National Institutes of Health [2U19A170235, U01-AI100799, R01-AI020565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100799, U19AI070235, T32AI060515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institutes of Health grants 2U19A170235 (GKKH, JBM, LJM); U01-AI100799 (PWH, TPM, JWS, RBT, JAW) and R01-AI020565 (TPM, PWH, JAW).	Adura PT, 2014, EUR RESPIR J, V43, P1186, DOI 10.1183/09031936.00141713; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Birben E, 2012, RESP MED, V106, P349, DOI 10.1016/j.rmed.2011.11.007; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Chatterjee R, 2005, CLIN EXP ALLERGY, V35, P914, DOI 10.1111/j.1365-2222.2005.02273.x; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Durrani SR, 2012, J ALLERGY CLIN IMMUN, V130, P489, DOI 10.1016/j.jaci.2012.05.023; Fruth K, 2012, LARYNGOSCOPE, V122, P1198, DOI 10.1002/lary.23300; Gern JE, 2015, CLIN EXP ALLERGY, V45, P32, DOI 10.1111/cea.12428; Guajardo JR, 2005, J ALLERGY CLIN IMMUN, V115, P243, DOI 10.1016/j.jaci.2004.10.032; Heymann PW, 2012, J ALLERGY CLIN IMMUN, V130, P1315, DOI 10.1016/j.jaci.2012.10.024; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958, DOI 10.1164/ajrccm.158.6.9804011; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hyun MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053758; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Jongepier H, 2005, J ALLERGY CLIN IMMUN, V115, P486, DOI 10.1016/j.jaci.2004.12.013; Kabesch M, 2004, CLIN EXP ALLERGY, V34, P340, DOI 10.1111/j.1365-2222.2004.01860.x; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; Khetsuriani N, 2007, J ALLERGY CLIN IMMUN, V119, P314, DOI 10.1016/j.jaci.2006.08.041; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Martinez-Aguilar NE, 2015, J ASTHMA, V52, P232, DOI 10.3109/02770903.2014.966913; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Myers JMB, 2014, J ALLERGY CLIN IMMUN, V134, P891, DOI 10.1016/j.jaci.2014.03.037; Nie W, 2012, CYTOKINE, V60, P849, DOI 10.1016/j.cyto.2012.08.023; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Richer SL, 2008, AM J RHINOL, V22, P228, DOI 10.2500/ajr.2008.22.3162; Soto-Quiros M, 2012, J ALLERGY CLIN IMMUN, V129, P1499, DOI 10.1016/j.jaci.2012.03.040; Stanic B, 2015, J ALLERGY CLIN IMMUN, V135, P771, DOI 10.1016/j.jaci.2014.07.041; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Zambrano JC, 2003, J ALLERGY CLIN IMMUN, V111, P1008, DOI 10.1067/mai.2003.1396; Zheng XY, 2014, LUNG, V192, P65, DOI 10.1007/s00408-013-9519-8	39	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178096	10.1371/journal.pone.0178096	http://dx.doi.org/10.1371/journal.pone.0178096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552993	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000020
J	Stanik, J; Kratzsch, J; Landgraf, K; Scheuermann, K; Spielau, U; Gausche, R; Gasperikova, D; Kiess, W; Korner, A				Stanik, Juraj; Kratzsch, Juergen; Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Gausche, Ruth; Gasperikova, Daniela; Kiess, Wieland; Koerner, Antje			Concordance of bioactive vs. total immunoreactive serum leptin levels in children with severe early onset obesity	PLOS ONE			English	Article							ORAL DISPOSITION INDEX; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; DEFICIENCY; HUMANS; RESISTANCE; ADIPOSITY; GENE	Context Leptin secreted from adipose tissue signals peripheral energy status to the brain. Monogenic leptin deficiency results in severe early onset obesity with hyperphagia. Recently, a similar phenotype of inactivating leptin mutations but with preserved immunoreactivity and hence normal circulating immunoreactive leptin has been reported. Objective We aimed to evaluate the proportion of bioactive leptin serum levels (compared to immunoreactive leptin) as a biomarker for the screening of leptin gene mutations causing monogenic obesity. Furthermore, we aimed to compare the immunoreactive and bioactive leptin levels associations with parameters of insulin resistance and insulin secretion in obese children and adolescents. Patients and methods We measured bioactive and immunoreactive leptin levels by enzyme-linked immunosorbent assays in fasting serum samples of 70 children with severe (BMI SDS > 3) non-syndromic obesity with onset <3 years of life from our Leipzig childhood obesity cohort (n = 1204). Sanger sequencing of the leptin gene was performed in probands with proportion of bioactive/immunoreactive leptin <90%. Results The mean levels of bioactive and immunoreactive leptin were almost identical (41.1 +/- 25.2 vs. 41.1 +/- 25.4ng/mL). In three probands with the lowest bioactive leptin proportion (<90%) we did not identify mutations in the leptin gene. Compared to immunoreactive leptin, bioactive leptin showed similar and slightly better statistical associations with indices of insulin resistance in correlation and multivariate analyses. Conclusion In our sample selected for severe early onset childhood obesity, we did not identify leptin gene mutations leading to decreased proportion of bioactive leptin. Nevertheless, the bioactive leptin levels were stronger associated with selected insulin secretion/resistance indices than the immunoreactive leptin levels.	[Stanik, Juraj; Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany; [Stanik, Juraj] Comenius Univ, Med Fac, Dept Pediat 1, Bratislava, Slovakia; [Stanik, Juraj; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, Biomed Res Ctr, DIABGENE Lab, Bratislava, Slovakia; [Kratzsch, Juergen] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Landgraf, Kathrin; Scheuermann, Kathrin; Spielau, Ulrike; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Leipzig, Germany; [Gausche, Ruth] Univ Leipzig, CrescNet, Leipzig, Germany	Leipzig University; Comenius University Bratislava; Slovak Academy of Sciences; Leipzig University; Leipzig University; Leipzig University	Korner, A (corresponding author), Univ Leipzig, Univ Hosp Children & Adolescents, Ctr Pediat Res Leipzig, Leipzig, Germany.; Korner, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Leipzig, Germany.	antje.koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Landgraf, Kathrin/J-4937-2016; Gasperikova, Daniela/E-7824-2018; Stanik, Juraj/AAQ-6217-2021	Körner, Antje/0000-0001-6001-0356; Landgraf, Kathrin/0000-0002-6878-6033; Gasperikova, Daniela/0000-0002-5725-6424; Stanik, Juraj/0000-0002-0538-1274	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01001]; German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" [CRC1052/1 C05]; LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), - European Union; European Regional Development Fund (ERFD); ESPE (European Society for Pediatric Endocrinology) Research Fellowship;  [FP7-HEALTH.2011.2.4.3-2]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms"(German Research Foundation (DFG)); LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), - European Union; European Regional Development Fund (ERFD)(European Commission); ESPE (European Society for Pediatric Endocrinology) Research Fellowship; 	This work was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01E01001 (IFB Adiposity Diseases), the German Research Council (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05, and is a collaborative project of the European FP7-HEALTH.2011.2.4.3-2 program (betaJuDOBeta-JUDO). and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative. J.S. was supported by ESPE (European Society for Pediatric Endocrinology) Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore F, 1998, MOL GENET METAB, V63, P134, DOI 10.1006/mgme.1997.2658; Farooqi IS, 2014, J ENDOCRINOL, V223, pT63, DOI 10.1530/JOE-14-0480; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; Haffner SM, 1996, INT J OBESITY, V20, P904; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Landgraf K, 2012, J CLIN ENDOCR METAB, V97, pE556, DOI 10.1210/jc.2011-2937; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meier JJ, 2009, DIABETES, V58, P1595, DOI 10.2337/db08-1611; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; Paolini B, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038718; Paz G, 2015, METABOLISM, V64, P146, DOI 10.1016/j.metabol.2014.07.014; REAVEN GM, 1993, J CLIN ENDOCR METAB, V76, P44, DOI 10.1210/jc.76.1.44; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wabitsch M, 2017, EUR J ENDOCRINOL, V176, P315, DOI 10.1530/EJE-16-0821; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178107	10.1371/journal.pone.0178107	http://dx.doi.org/10.1371/journal.pone.0178107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542631	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800040
J	Petersen, G; Cuenca, A; Zervas, A; Ross, GT; Graham, SW; Barrett, CF; Davis, JI; Seberg, O				Petersen, Gitte; Cuenca, Argelia; Zervas, Athanasios; Ross, Gregory T.; Graham, Sean W.; Barrett, Craig F.; Davis, Jerrold I.; Seberg, Ole			Mitochondrial genome evolution in Alismatales: Size reduction and extensive loss of ribosomal protein genes	PLOS ONE			English	Article							TRANSFER-RNAS; GENERATION; SEQUENCES; RATES; RECOMBINATION; ALIGNMENT; PROVIDES; ORIGINS; LINEAGE; NUCLEAR	The order Alismatales is a hotspot for evolution of plant mitochondrial genomes characterized by remarkable differences in genome size, substitution rates, RNA editing, retrotranscription, gene loss and intron loss. Here we have sequenced the complete mitogenomes of Zostera marina and Stratiotes aloides, which together with previously sequenced mitogenomes from Butomus and Spirodela, provide new evolutionary evidence of genome size reduction, gene loss and transfer to the nucleus. The Zostera mitogenome includes a large portion of DNA transferred from the plastome, yet it is the smallest known mitogenome from a non-parasitic plant. Using a broad sample of the Alismatales, the evolutionary history of ribosomal protein gene loss is analyzed. In Zostera almost all ribosomal protein genes are lost from the mitogenome, but only some can be found in the nucleus.	[Petersen, Gitte; Cuenca, Argelia; Zervas, Athanasios; Seberg, Ole] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, UBC Bot Garden, Vancouver, BC, Canada; [Ross, Gregory T.; Graham, Sean W.] Univ British Columbia, Ctr Plant Res, Vancouver, BC, Canada; [Barrett, Craig F.; Davis, Jerrold I.] Cornell Univ, LH Bailey Hortorium & Plant Biol Sect, Ithaca, NY USA; [Cuenca, Argelia] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Barrett, Craig F.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	University of Copenhagen; University of British Columbia; University of British Columbia; University of British Columbia; Cornell University; Technical University of Denmark; West Virginia University	Petersen, G (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.	gittep@snm.ku.dk	Zervas, Athanasios/ABF-7511-2020; Petersen, Gitte/H-1903-2011; Cuenca, Argelia/AAK-9053-2021; Graham, Sean W/L-3944-2014	Zervas, Athanasios/0000-0002-4706-4023; Petersen, Gitte/0000-0002-2325-0059; Cuenca, Argelia/0000-0001-8596-1086; Graham, Sean W/0000-0001-8209-5231	Danish Council for Independent Research \ Natural Sciences [12-126713]; NSERC (Natural Sciences and Engineering Research Council of Canada); US National Science Foundation [DEB 0830036, DEB 0830020]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF))	This work was funded by the Danish Council for Independent Research vertical bar Natural Sciences (grant no. 12-126713 to OS and GP), NSERC (Natural Sciences and Engineering Research Council of Canada) Discovery Grant to SWG, and US National Science Foundation (grants DEB 0830036 to SWG and DEB 0830020 to JID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, MOL BIOL EVOL, V18, P2289, DOI 10.1093/oxfordjournals.molbev.a003775; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Christensen AC, 2014, GENOME BIOL EVOL, V6, P1448, DOI 10.1093/gbe/evu115; Christensen AC, 2013, GENOME BIOL EVOL, V5, P1079, DOI 10.1093/gbe/evt069; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cuenca A, 2016, GENOME BIOL EVOL, V8, P2176, DOI 10.1093/gbe/evw148; Cuenca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061552; Cuenca A, 2012, J MOL EVOL, V74, P158, DOI 10.1007/s00239-012-9496-1; Cuenca A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-349; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Grewe F, 2014, MITOCHONDRION, V19, P135, DOI 10.1016/j.mito.2014.05.008; Guo WH, 2016, MOL BIOL EVOL, V33, P1448, DOI 10.1093/molbev/msw024; Guo WH, 2013, J MOL EVOL, V77, P43, DOI 10.1007/s00239-013-9579-7; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; Iorizzo M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-61; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Knoop V, 2012, GENOMICS CHLOROPLAST, V35, P175, DOI DOI 10.1007/978-94-007-2920-9_; Kubo N, 2010, DNA RES, V17, P1, DOI 10.1093/dnares/dsp024; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Liu SL, 2009, MOL BIOL EVOL, V26, P875, DOI 10.1093/molbev/msp011; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; MARECHALDROUARD L, 1988, NUCLEIC ACIDS RES, V16, P4777, DOI 10.1093/nar/16.11.4777; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Olsen JL, 2016, NATURE, V530, P331, DOI 10.1038/nature16548; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Park S, 2015, NEW PHYTOL, V208, P570, DOI 10.1111/nph.13467; Park S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-405; Petersen G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17588; Petersen G, 2006, TAXON, V55, P871, DOI 10.2307/25065682; Petersen G, 2016, CLADISTICS, V32, P141, DOI 10.1111/cla.12120; Qiu YL, 2004, J MOL EVOL, V59, P722, DOI 10.1007/s00239-004-5951-y; Rice DW, 2013, SCIENCE, V342, P1468, DOI 10.1126/science.1246275; Richardson AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-29; Ross TG, 2016, CLADISTICS, V32, P160, DOI 10.1111/cla.12133; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Skippington E, 2015, P NATL ACAD SCI USA, V112, pE3515, DOI 10.1073/pnas.1504491112; Sloan DB, 2014, GENOME BIOL EVOL, V6, P3210, DOI 10.1093/gbe/evu253; Sloan DB, 2013, NEW PHYTOL, V200, P978, DOI 10.1111/nph.12395; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046747; Wang Z, 2015, BMC GENOMICS, V16, DOI [10.1186/s12864-015-1988-0, 10.1186/s12864-015-1216-y]; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zhang T, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0029774; Zhu AD, 2014, MOL BIOL EVOL, V31, P1228, DOI 10.1093/molbev/msu079	59	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177606	10.1371/journal.pone.0177606	http://dx.doi.org/10.1371/journal.pone.0177606			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545148	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700057
J	Sudan, M; Arah, OA; Becker, T; Levy, Y; Sigsgaard, T; Olsen, J; Vergara, X; Kheifets, L				Sudan, Madhuri; Arah, Onyebuchi A.; Becker, Thomas; Levy, Yael; Sigsgaard, Torben; Olsen, Jorn; Vergara, Ximena; Kheifets, Leeka			Re-examining the association between residential exposure to magnetic fields from power lines and childhood asthma in the Danish National Birth Cohort	PLOS ONE			English	Article							LEUKEMIA; RISK; CHILDREN; PREGNANCY; REGISTRY; METAANALYSIS; ADOLESCENTS; PREVALENCE; DENMARK; CANCER	Background A study reported an increased risk of asthma in children whose mothers were exposed to magnetic field (MF) levels above 0.2 mu T during pregnancy. We re-examined this association using data from mothers and children in the Danish National Birth Cohort (DNBC). Methods This study included 92,676 singleton-born children and their mothers from the DNBC. MF exposure from power lines was estimated for all residences where the mothers lived during pregnancy and for all children from birth until the end of follow up. Exposure was categorized into 0 mu T, 0.1 mu T, and >= 0.2 mu T for analysis. Definitive and possible asthma cases were identified using data from three independent data sources: 1) mothers' reports, 2) a national hospitalization register, 3) a national prescription drug register. We calculated hazard ratios (HR) and 95% confidence intervals (CI) for the association between the highest level of exposure during pregnancy and asthma in children, adjusting for several potential confounding factors. We also examined the sensitivity of the risk estimates to changes in exposure and outcome definitions. Results No differences or trends in the risk of asthma development were detected between children with different levels of MF exposure regardless of the asthma case definition or outcome data source. For definitive cases, the HR (95% CI) for those with any exposure was 0.72 (0.27-1.92), and it was 0.41 (0.06-2.92) for those exposed to >= 0.2 mu T. Adjustments for confounding and variations in the exposure definition did not appreciably alter the results. Conclusion We did not find evidence that residential exposure to MF during pregnancy or early childhood increased the risk of childhood asthma. This interpretation is in line with the lack of an established biological mechanism directly linking MF exposure to asthma, but high exposure was very rare in this cohort.	[Sudan, Madhuri; Arah, Onyebuchi A.; Kheifets, Leeka] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Sudan, Madhuri; Olsen, Jorn] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark; [Sudan, Madhuri] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Becker, Thomas; Olsen, Jorn] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark; [Levy, Yael] Schneider Childrens Med Ctr Israel, Kipper Inst Immunol & Allergy, Petah Tiqwa, Israel; [Sigsgaard, Torben] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Vergara, Ximena] Elect Power Res Inst, Environm Sect, Palo Alto, CA USA	University of California System; University of California Los Angeles; Aarhus University; Western University of Health Sciences; Aarhus University; Aarhus University; Electric Power Research Institute (EPRI)	Sudan, M (corresponding author), Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA.; Sudan, M (corresponding author), Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark.; Sudan, M (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA.	msudan@ucla.edu	Kheifets, Leeka/AAI-5614-2020; Sigsgaard, Torben/AAC-1292-2020	Sigsgaard, Torben/0000-0002-2043-7571; Arah, Onyebuchi/0000-0002-9067-1697; VERGARA, XIMENA/0000-0002-7719-8399; Sudan, Madhuri/0000-0002-9160-9203	Electric Power Research Institute (EPRI) [EP-P44562]	Electric Power Research Institute (EPRI)	This Study is funded by the Electric Power Research Institute (EPRI) (grant EP-P44562). XV is employed by EPRI and is an Adjunct Assistant Professor of Epidemiology at the UCLA Fielding School of Public Health. The funder provided support in the form of partial salaries for some of the authors (MS, LK and TB). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MS, OA, TB, YL, TS, JO, XV, LK collaborated on the preparation of the manuscript.	Bacharier LB, 2015, ANN ALLERG ASTHMA IM, V115, P463, DOI 10.1016/j.anai.2015.09.019; Beale I, 2001, J AUSTR COLL NUTR EN, V20, P9; Beale I, 2001, J AUSTR COLL NUTR EN, V20, P30; Beale I, 2001, J AUSTR COLL NUTR EN, V20, P15; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Hansen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036328; Harb H, 2016, CURR OPIN PEDIATR, V28, P754, DOI 10.1097/MOP.0000000000000424; Hermann C, 2006, ACTA PAEDIATR, V95, P1182, DOI 10.1080/08035250600582814; Kheifets L, 2008, RADIAT PROT DOSIM, V132, P139, DOI 10.1093/rpd/ncn260; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kinlen LJ, 2012, BRIT J CANCER, V107, P1163, DOI 10.1038/bjc.2012.402; Li DK, 2011, ARCH PEDIAT ADOL MED, V165, P945, DOI 10.1001/archpediatrics.2011.135; Li DK, 2002, EPIDEMIOLOGY, V13, P9, DOI 10.1097/00001648-200201000-00004; Linabery AM, 2010, AM J EPIDEMIOL, V171, P749, DOI 10.1093/aje/kwq004; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Moth G, 2007, ACTA PAEDIATR, V96, P1470, DOI 10.1111/j.1651-2227.2007.00460.x; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; OLSEN JH, 1993, BRIT MED J, V307, P891, DOI 10.1136/bmj.307.6909.891; Pedersen C, 2015, BRIT J CANCER, V113, P1370, DOI 10.1038/bjc.2015.365; Pedersen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107096; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Raaschou-Nielsen O, 2008, EPIDEMIOLOGY, V19, P536, DOI 10.1097/EDE.0b013e318176bfcd; Savitz DA, 2006, EPIDEMIOLOGY, V17, P222, DOI 10.1097/01.ede.0000197294.05564.08; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sly PD, 2011, CURR OPIN ALLERGY CL, V11, P24, DOI 10.1097/ACI.0b013e328342309d; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Sudan M, 2016, EUR J EPIDEMIOL, V31, P593, DOI 10.1007/s10654-016-0126-x; Thomsen SF, 2004, ANN ALLERG ASTHMA IM, V92, P506, DOI 10.1016/S1081-1206(10)61757-7; Zar HJ, 2014, PEDIATR PULM, V49, P430, DOI 10.1002/ppul.23030	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177651	10.1371/journal.pone.0177651	http://dx.doi.org/10.1371/journal.pone.0177651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545137	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700061
J	Malaina, I; Martinez, L; Matorras, R; Bringas, C; Aranburu, L; Fernandez-Llebrez, L; Gonzalez, L; Arana, I; Perez, MB; de la Fuente, IM				Malaina, Iker; Martinez, Luis; Matorras, Roberto; Bringas, Carlos; Aranburu, Larraitz; Fernandez-Llebrez, Luis; Gonzalez, Leire; Arana, Itziar; Perez, Martin-Blas; Martinez de la Fuente, Ildefonso			Estimation of preterm labor immediacy by nonlinear methods	PLOS ONE			English	Article							APPROXIMATE ENTROPY; RISK; PREDICTION; REGULARITY; BIRTH; HEART; UTERUS	Preterm delivery affects about one tenth of human births and is associated with an increased perinatal morbimortality as well as with remarkable costs. Even if there are a number of predictors and markers of preterm delivery, none of them has a high accuracy. In order to find quantitative indicators of the immediacy of labor, 142 cardiotocographies (CTG) recorded from women consulting because of suspected threatened premature delivery with gestational ages comprehended between 24 and 35 weeks were collected and analyzed. These 142 samples were divided into two groups: the delayed labor group (n = 75), formed by the women who delivered more than seven days after the tocography was performed, and the anticipated labor group (n = 67), which corresponded to the women whose labor took place during the seven days following the recording. As a means of finding significant differences between the two groups, some key informational properties were analyzed by applying nonlinear techniques on the tocography recordings. Both the regularity and the persistence levels of the delayed labor group, which were measured by Approximate Entropy (ApEn) and Generalized Hurst Exponent (GHE) respectively, were found to be significantly different from the anticipated labor group. As delivery approached, the values of ApEn tended to increase while the values of GHE tended to decrease, suggesting that these two methods are sensitive to labor immediacy. On this paper, for the first time, we have been able to estimate childbirth immediacy by applying nonlinear methods on tocographies. We propose the use of the techniques herein described as new quantitative diagnosis tools for premature birth that significantly improve the current protocols for preterm labor prediction worldwide.	[Malaina, Iker; Martinez, Luis; Perez, Martin-Blas; Martinez de la Fuente, Ildefonso] Univ Basque Country, Dept Math, UPV EHU, Leioa, Spain; [Matorras, Roberto; Fernandez-Llebrez, Luis; Gonzalez, Leire; Arana, Itziar] Cruces Univ Hosp, Obstet & Gynecol Dept, Baracaldo, Spain; [Matorras, Roberto] Univ Basque Country, Dept Med Surg Specialties, UPV EHU, Leioa, Spain; [Bringas, Carlos] Univ Basque Country, Dept Cell Biol & Histol, UPV EHU, Leioa, Spain; [Aranburu, Larraitz] Univ Basque Country, Dept Appl Math Stat & Operat Res, UPV EHU, Leioa, Spain; [Martinez de la Fuente, Ildefonso] CEBAS CSIC Inst, Dept Nutr, Espinardo Univ Campus, Murcia, Spain	University of Basque Country; Hospital Universitario Cruces; University of Basque Country; University of Basque Country; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Malaina, I (corresponding author), Univ Basque Country, Dept Math, UPV EHU, Leioa, Spain.	iker.malaina@ehu.eus	Blanco, Leire/O-5114-2017; Matorras, Roberto/E-1664-2012; Martínez, Luis/G-6266-2012; Malaina, Iker/AAQ-1997-2020	Martínez, Luis/0000-0002-6297-1449; Malaina, Iker/0000-0002-1305-6623; De la Fuente, Ildefonso/0000-0001-6548-7583	Basque Government [PRE-2015-1-194, IT974-16]; FERRING laboratories Madrid, Spain	Basque Government(Basque Government); FERRING laboratories Madrid, Spain(Ferring Pharmaceuticals)	Work by the first author was supported by the Basque Government grant PRE-2015-1-194,and work by the first and second authors by the Basque Government grant IT974-16. This work was also supported in part by FERRING laboratories Madrid, Spain (RM), https://www.ferring.com/en/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ H, 1954, Gynaecologia, V138, P190; BARABASI AL, 1991, PHYS REV A, V44, P2730, DOI 10.1103/PhysRevA.44.2730; Berghella V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007235.pub3; Caldeyro-Barcia R, 1957, OBSTET GYNECOLOGICAL, V12, P652; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; DAWES GS, 1992, OBSTET GYNECOL, V80, P763; Di Matteo T, 2007, QUANT FINANC, V7, P21, DOI 10.1080/14697680600969727; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Esplin MS, 2008, OBSTET GYNECOL, V112, P516, DOI 10.1097/AOG.0b013e318184181a; Esposti F, 2006, ENG MED BIOL SOC IEE, P6157; Ferrario M, 2006, IEEE T BIO-MED ENG, V53, P119, DOI 10.1109/TBME.2005.859809; FLANDRIN P, 1989, IEEE T INFORM THEORY, V35, P197, DOI 10.1109/18.42195; Georgiou HM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/435014; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 2002, NEW ENGL J MED, V346, P250, DOI 10.1056/NEJMoa002868; Ivancevic Tijana, 2008, Recent Patents on Biomedical Engineering, V1, P160, DOI 10.2174/1874764710801030160; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Leitich H, 1999, AM J OBSTET GYNECOL, V180, P1169, DOI 10.1016/S0002-9378(99)70612-5; LUSTED LB, 1971, NEW ENGL J MED, V284, P416, DOI 10.1056/NEJM197102252840805; Malaina I, 2016, ITISE P, V2016, P799; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Newman RB, 2008, OBSTET GYNECOL, V112, P508, DOI 10.1097/AOG.0b013e3181842087; Paternoster DM, 2007, ACTA OBSTET GYN SCAN, V86, P151, DOI 10.1080/00016340600935730; Pincus S, 1991, P 1991 IEEE 17 ANN N; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Revah A., 1997, American Journal of Obstetrics and Gynecology, V176, pS53, DOI 10.1016/S0002-9378(97)80223-2; Roura L C, 2006, MED PANAMERICANA, P125; Smith R, 2015, AM J OBSTET GYNECOL, V213, P181, DOI 10.1016/j.ajog.2015.06.040; Sotiriadis A, 2010, ULTRASOUND OBST GYN, V35, P54, DOI 10.1002/uog.7457; Spilka J, 2014, COMPUT CARDIOL CONF, V41, P777; Stout MJ, 2011, CLIN PERINATOL, V38, P127, DOI 10.1016/j.clp.2010.12.002; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Zhang MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152421	42	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178257	10.1371/journal.pone.0178257	http://dx.doi.org/10.1371/journal.pone.0178257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570658	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800037
J	Shim, SH; Lee, SJ; Dong, M; Suh, JH; Kim, SY; Lee, JH; Kim, SN; Kang, SB; Kim, J				Shim, Seung-Hyuk; Lee, Sun Joo; Dong, Meari; Suh, Jung Hwa; Kim, Seo Yeon; Lee, Ji Hye; Kim, Soo-Nyung; Kang, Soon-Beom; Kim, Jayoun			Prediction model for 30-day morbidity after gynecological malignancy surgery	PLOS ONE			English	Article							OVARIAN-CANCER; RISK-FACTORS; POSTOPERATIVE COMPLICATIONS; APGAR SCORE; QUALITY; CHEMOTHERAPY; IMPROVEMENT; ONCOLOGY; NSQIP; ENDOMETRIAL	Objective The potential risk of postoperative morbidity is important for gynecologic cancer patients because it leads to delays in adjunctive therapy and additional costs. We aimed to develop a preoperative nomogram to predict 30-day morbidity after gynecological cancer surgery. Methods Between 2005 and 2015, 533 consecutive patients with elective gynecological cancer surgery in our center were reviewed. Of those patients, 373 and 160 patients were assigned to the model development or validation cohort, respectively. To investigate independent predictors of 30-day morbidity, a multivariate Cox regression model with backward stepwise elimination was utilized. A nomogram based on this Cox model was developed and externally validated. Its performance was assessed using the concordance index and a calibration curve. Results Ninety-seven (18.2%) patients had at least one postoperative complication within 30 days after surgery. After bootstrap resampling, the final model indicated age, operating time, and serum albumin level as statistically significant predictors of postoperative morbidity. The bootstrap-corrected concordance index of the nomogram incorporating these three predictors was 0.656 (95% CI, 0.608-0.723). In the validation cohort, the nomogram showed fair discrimination [ concordance index: 0.674 (95% CI = 0.619-0.732] and good calibration (P = 0.614; Hosmer-Lemeshow test). Conclusion The 30-day morbidity after gynecologic cancer surgery could be predicted according to age, operation time, and serum albumin level. After further validation using an independent dataset, the constructed nomogram could be valuable for predicting operative risk in individual patients.	[Shim, Seung-Hyuk; Lee, Sun Joo; Dong, Meari; Suh, Jung Hwa; Kim, Seo Yeon; Lee, Ji Hye; Kim, Soo-Nyung; Kang, Soon-Beom] Konkuk Univ, Sch Med, Dept Obstet & Gynecol, 120 Neungdong Ro, Seoul, South Korea; [Kim, Jayoun] Konkuk Univ, Res Coordinating Ctr, Med Ctr, 120 Neungdong Ro, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center	Lee, SJ (corresponding author), Konkuk Univ, Sch Med, Dept Obstet & Gynecol, 120 Neungdong Ro, Seoul, South Korea.	20050073@kuh.ac		Shim, Seung-Hyuk/0000-0001-8043-2257	Konkuk University	Konkuk University	This paper was supported by Konkuk University.	Aletti GD, 2007, GYNECOL ONCOL, V107, P99, DOI 10.1016/j.ygyno.2007.05.032; Berek JS, 2005, GYNECOL ONCOL, V99, P153, DOI 10.1016/j.ygyno.2005.05.034; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark RM, 2015, GYNECOL ONCOL, V136, P516, DOI 10.1016/j.ygyno.2014.11.016; Copeland G P, 1991, Br J Surg, V78, P355, DOI 10.1002/bjs.1800780327; Das N, 2006, EJSO-EUR J SURG ONC, V32, P1135, DOI 10.1016/j.ejso.2006.06.010; Davenport DL, 2006, ANN SURG, V243, P636, DOI 10.1097/01.sla.0000216508.95556.cc; Dimick JB, 2004, J AM COLL SURGEONS, V199, P531, DOI 10.1016/j.jamcollsurg.2004.05.276; Erekson EA, 2012, FEMALE PELVIC MED RE, V18, P274, DOI 10.1097/SPV.0b013e318263a210; Eskander RN, 2014, J CLIN ONCOL, V32, P4113, DOI 10.1200/JCO.2014.56.7743; Gawande AA, 2007, J AM COLL SURGEONS, V204, P201, DOI 10.1016/j.jamcollsurg.2006.11.011; Gerestein CG, 2010, EUR J CANCER, V46, P102, DOI 10.1016/j.ejca.2009.10.017; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; GRAF W, 1994, EUR J CANCER, V30A, P453, DOI 10.1016/0959-8049(94)90417-0; Hofstetter G, 2013, GYNECOL ONCOL, V131, P15, DOI 10.1016/j.ygyno.2013.07.086; Huhmann MB, 2009, NUTR CLIN PRACT, V24, P520, DOI 10.1177/0884533609335375; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; Kondalsamy-Chennakesavan S, 2012, EUR J CANCER, V48, P2155, DOI 10.1016/j.ejca.2012.03.013; Kondalsamy-Chennakesavan S, 2009, GYNECOL ONCOL, V115, P329, DOI 10.1016/j.ygyno.2009.08.004; Lim MC, 2013, J GYNECOL ONCOL, V24, P298, DOI 10.3802/jgo.2013.24.4.298; Mandi H, 2015, J MINIM INVAS GYN, V22, P94, DOI 10.1016/j.jmig.2014.07.014; Ra J, 2008, ANN SURG ONCOL, V15, P1577, DOI 10.1245/s10434-008-9867-4; Rivadeneira DE, 2001, SURGERY, V129, P617, DOI 10.1067/msy.2001.112963; Rivard C, 2016, GYNECOL ONCOL, V141, P281, DOI 10.1016/j.ygyno.2016.02.015; Sanders J, 2012, J CLIN EPIDEMIOL, V65, P423, DOI 10.1016/j.jclinepi.2011.11.004; Shim SH, 2015, GYNECOL ONCOL, V136, P30, DOI 10.1016/j.ygyno.2014.11.004; Shimada M, 1998, BRIT J SURG, V85, P195; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Ueno M, 2009, DIGEST SURG, V26, P392, DOI 10.1159/000229973; Uppal S, 2013, GYNECOL ONCOL, V131, P416, DOI 10.1016/j.ygyno.2013.08.011; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Weimann A, 2006, CLIN NUTR, V25, P224, DOI 10.1016/j.clnu.2006.01.015; Whiteley MS, 1996, BRIT J SURG, V83, P812, DOI 10.1002/bjs.1800830628	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178610	10.1371/journal.pone.0178610	http://dx.doi.org/10.1371/journal.pone.0178610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570652	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800087
J	Tan, KF; Zheng, K; Li, DY; Lu, HY; Wang, SQ; Sun, X				Tan, Kefang; Zheng, Ke; Li, Daiye; Lu, Haiyuan; Wang, Siqi; Sun, Xuan			Impact of adipose tissue or umbilical cord derived mesenchymal stem cells on the immunogenicity of human cord blood derived endothelial progenitor cells	PLOS ONE			English	Article							STROMAL CELLS; TRANSPLANTATION	The application of autologous endothelial progenitor cell (EPC) transplantation is a promising approach in therapeutic cardiovascular diseases and ischemic diseases. In this study, we compared the immunogenicity of EPCs, adipose tissue (AD)-derived mesenchymal stem cells (MSCs) and umbilical cord (UC)-derived MSCs by flow cytometry and the mixed lymphocyte reaction. The impact of AD-MSCs and UC-MSCs on the immunogenicity of EPCs was analyzed by the mixed lymphocyte reaction and cytokine secretion in vitro and was further tested by allogenic peripheral blood mononuclear cell (PBMC) induced immunorejection on a cell/matrigel graft in an SCID mouse model. EPCs and AD-MSCs express higher levels of MHC class I than UC-MSCs. All three kinds of cells are negative for MHC class II. UC-MSCs also express lower levels of IFN-y receptor mRNA when compared with EPCs and AD-MSCs. EPCs can stimulate higher rates of proliferation of lymphocytes than AD-MSCs and UC-MSCs. Furthermore, AD-MSCs and UC-MSCs can modulate immune response and inhibit lymphocyte proliferation induced by EPCs, mainly through inhibition of the proliferation of CD8+ T cells. Compared with UC-MSCs, AD-MSCs can significantly improve vessel formation and maintain the integrity of neovascular structure in an EPC +MSC/matrigel graft in SCID mice, especially under allo-PBMC induced immuno-rejection. In conclusion, our study shows that AD-MSC is a powerful candidate to minimize immunological rejection and improve vessel formation in EPC transplantation treatment.	[Tan, Kefang; Zheng, Ke; Li, Daiye; Lu, Haiyuan; Wang, Siqi; Sun, Xuan] Cent S Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Tan, Kefang; Zheng, Ke; Li, Daiye; Wang, Siqi; Sun, Xuan] Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China; [Lu, Haiyuan] Cent S Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University	Sun, X (corresponding author), Cent S Univ, Sch Basic Med Sci, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.; Sun, X (corresponding author), Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China.	almasun97184@hotmail.com			Science and technology project of Hunan Provincial Department of Finance; National Natural Science Foundation of China [31100941]	Science and technology project of Hunan Provincial Department of Finance; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by funding by the grants from the Science and technology project of Hunan Provincial Department of Finance and National Natural Science Foundation of China (31100941).	Amato Bruno, 2016, BMC Surg, V16, P24; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Balaji S, 2013, ADV WOUND CARE, V2, P283, DOI 10.1089/wound.2012.0398; Bruneau S, 2016, PEDIATR NEPHROL, V31, P41, DOI 10.1007/s00467-015-3094-6; Chong MSK, 2016, STEM CELL TRANSL MED, V5, P530, DOI 10.5966/sctm.2015-0227; Gazdic M, 2015, STEM CELL REV REP, V11, P280, DOI 10.1007/s12015-014-9583-3; Gharibi T, 2015, CELL IMMUNOL, V293, P113, DOI 10.1016/j.cellimm.2015.01.002; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Goligorsky MS, 2014, SEMIN NEPHROL, V34, P365, DOI 10.1016/j.semnephrol.2014.06.003; Hong Y, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0810-3; Hoogduijn MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0596-3; Jia SJ, 2014, DISCOV MED, V18, P237; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Liao JY, 2015, AUTOIMMUN REV, V14, P43, DOI 10.1016/j.autrev.2014.10.001; Lin CP, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/845037; Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111; Lu QJ, 2013, J AUTOIMMUN, V41, P1, DOI 10.1016/j.jaut.2013.01.010; Ming YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127861; Qin ZQ, 2013, HUM IMMUNOL, V74, P1445, DOI 10.1016/j.humimm.2013.05.002; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Souidi N, 2017, STEM CELLS; Suarez Y, 2007, J IMMUNOL, V179, P7488, DOI 10.4049/jimmunol.179.11.7488; Sun X, 2012, MICROVASC RES, V84, P149, DOI 10.1016/j.mvr.2012.06.003; Tan Kefang, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P1211, DOI 10.11817/j.issn.1672-7347.2014.11.018; Vrijsen KR, 2016, ADV HEALTHC MATER, V5, P2555, DOI 10.1002/adhm.201600308; Xia J, 2016, CELL BIOL INT, V40, P407, DOI 10.1002/cbin.10579; Xiao N, 2013, CYTOTHERAPY, V15, P1374, DOI 10.1016/j.jcyt.2013.06.013; Zhang M, 2014, CURR OPIN HEMATOL, V21, P224, DOI 10.1097/MOH.0000000000000041	28	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178624	10.1371/journal.pone.0178624	http://dx.doi.org/10.1371/journal.pone.0178624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562647	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700079
J	Matrka, MC; Watanabe, M; Muraleedharan, R; Lambert, PF; Lane, AN; Romick-Rosendale, LE; Wells, SI				Matrka, Marie C.; Watanabe, Miki; Muraleedharan, Ranjithmenon; Lambert, Paul F.; Lane, Andrew N.; Romick-Rosendale, Lindsey E.; Wells, Susanne I.			Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis	PLOS ONE			English	Article							CANCER METABOLISM; ENERGY-METABOLISM; PYRUVATE-KINASE; POOR-PROGNOSIS; UP-REGULATION; HEAD; PROTEIN; CARCINOMA; EXPRESSION; ONCOPROTEIN	The DEK oncogene is overexpressed in many human malignancies including at early tumor stages. Our reported in vitro and in vivo models of squamous cell carcinoma have demonstrated that DEK contributes functionally to cellular and tumor survival and to proliferation. However, the underlying molecular mechanisms remain poorly understood. Based on recent RNA sequencing experiments, DEK expression was necessary for the transcription of several metabolic enzymes involved in anabolic pathways. This identified a possible mechanism whereby DEK may drive cellular metabolism to enable cell proliferation. Functional metabolic Seahorse analysis demonstrated increased baseline and maximum extra cellular acidification rates, a readout of glycolysis, in DEK-overexpressing keratinocytes and squamous cell carcinoma cells. DEK overexpression also increased the maximum rate of oxygen consumption and therefore increased the potential for oxidative phosphorylation (OxPhos). To detect small metabolites that participate in glycolysis and the tricarboxylic acid cycle (TCA) that supplies substrate for OxPhos, we carried out NMR-based metabolomics studies. We found that high levels of DEK significantly reprogrammed cellular metabolism and altered the abundances of amino acids, TCA cycle intermediates and the glycolytic end products lactate, alanine and NAD+. Taken together, these data support a scenario whereby overexpression of the human DEK oncogene reprograms keratinocyte metabolism to fulfill energy and macromolecule demands required to enable and sustain cancer cell growth.	[Matrka, Marie C.; Muraleedharan, Ranjithmenon; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Matrka, Marie C.; Muraleedharan, Ranjithmenon; Wells, Susanne I.] Univ Cincinnati, Cincinnati, OH 45220 USA; [Watanabe, Miki; Romick-Rosendale, Lindsey E.] Cincinnati Childrens Hosp Med Ctr, NMR Based Metabol Core Facil, Div Pathol & Lab Med, Cincinnati, OH 45229 USA; [Lambert, Paul F.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI USA; [Lane, Andrew N.] Ctr Environm Syst Biochem, Dept Toxicol & Canc Biol, Lexington, KY USA; [Lane, Andrew N.] Markey Canc Ctr, Lexington, KY USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Wisconsin System; University of Wisconsin Madison	Wells, SI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA.; Wells, SI (corresponding author), Univ Cincinnati, Cincinnati, OH 45220 USA.; Romick-Rosendale, LE (corresponding author), Cincinnati Childrens Hosp Med Ctr, NMR Based Metabol Core Facil, Div Pathol & Lab Med, Cincinnati, OH 45229 USA.	Lindsey.Romick-Rosendale@cchmc.org; Susanne.Wells@cchmc.org	muraleedharan, ranjithmenon/AAW-6386-2021	Romick-Rosendale, Lindsey/0000-0002-7252-1193	National Institutes of Health [R01-CM 16316, 1U24DK097215-01A1, R01-CA116316]; University of Cincinnati Cancer Institute Head AMP; Neck Comprehensive Center Pilot Grant Program; Carmen L. Buck endowment; Digestive Health Center NIDDK [P30 DK078392]; NATIONAL CANCER INSTITUTE [R01CA116316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Cancer Institute Head AMP; Neck Comprehensive Center Pilot Grant Program; Carmen L. Buck endowment; Digestive Health Center NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by the National Institutes of Health R01-CM 16316 to SIW; the University of Cincinnati Cancer Institute Head & Neck Comprehensive Center Pilot Grant Program 2014 to SIW; Carmen L. Buck endowment to ANL; National Institutes of Health 1U24DK097215-01A1 to ANL.r This work was supported by the National Institutes of Health R01-CA116316 to S.I. W.; the University of Cincinnati Cancer Institute Head & Neck Comprehensive Center Pilot Grant Program 2014; Carmen L. Buck endowment (to ANL) and National Institutes of Health 1U24DK097215-01A1 to ANL. All flow cytometric data were acquired using the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center and supported in part by the Digestive Health Center NIDDK P30 DK078392. All NMR-based metabolomics data was acquired and analyzed within the NMR-Based Metabolomics Core, a Cincinnati Children's Research Foundation Shared Facility, in the Division of Pathology and Laboratory Medicine at CCHMC. We thank Dr. James Lessard for the monoclonal actin antibody, and Eric Smith, Lisa Privette-Vinnedge, Allie Adams, and Elizabeth Hoskins for proofreading and editing.	Adams AK, 2015, ONCOGENE, V34, P868, DOI 10.1038/onc.2014.15; Adams AK, 2015, ONCOTARGET, V6, P43395, DOI 10.18632/oncotarget.6028; Agostini M, 2004, ORAL ONCOL, V40, P728, DOI 10.1016/j.oraloncology.2004.01.011; Alexiadis V, 2000, GENE DEV, V14, P1308; Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; Bag S, 2015, BIOCHEM BIOPH RES CO, V459, P574, DOI 10.1016/j.bbrc.2015.02.149; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm F, 2005, NUCLEIC ACIDS RES, V33, P1101, DOI 10.1093/nar/gki258; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P1571, DOI 10.1093/nar/gkg247; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cleary J, 2005, J BIOL CHEM, V280, P31760, DOI 10.1074/jbc.M500884200; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; Curry JM, 2013, CELL CYCLE, V12, P1371, DOI 10.4161/cc.24092; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Fan TWM, 2016, PROG NUCL MAG RES SP, V92-93, P18, DOI 10.1016/j.pnmrs.2016.01.005; Fan TWM, 2012, PHARMACOL THERAPEUT, V133, P366, DOI 10.1016/j.pharmthera.2011.12.007; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Goodwin Matthew L, 2014, Front Nutr, V1, P27, DOI 10.3389/fnut.2014.00027; Gottschalk M, 2008, NMR BIOMED, V21, P809, DOI 10.1002/nbm.1258; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hu HG, 2007, BIOCHEM BIOPH RES CO, V358, P1008, DOI 10.1016/j.bbrc.2007.05.019; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Iurlaro R, 2014, METHOD ENZYMOL, V542, P59, DOI 10.1016/B978-0-12-416618-9.00003-0; Kappes F, 2001, J BIOL CHEM, V276, P26317, DOI 10.1074/jbc.M100162200; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kondoh N, 1999, CANCER RES, V59, P4990; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Krupar R, 2014, VIRCHOWS ARCH, V465, P299, DOI 10.1007/s00428-014-1630-6; Lee DG, 2011, CURR CANCER DRUG TAR, V11, P966; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Matrka MC, 2015, CELL CYCLE, V14, P3939, DOI 10.1080/15384101.2015.1044177; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Mims J, 2015, RADIAT RES, V183, P291, DOI 10.1667/RR13828.1; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nagarajan A, 2016, TRENDS CANCER, V2, P365, DOI 10.1016/j.trecan.2016.06.002; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Privette Vinnedge LM, 2011, ONCOGENE; Sanden C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-215; Sanden C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-440; Schock TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059521; Schock TB, 2012, FOOD CHEM, V133, P90, DOI 10.1016/j.foodchem.2011.12.077; Secchiero P, 2010, CLIN CANCER RES, V16, P1824, DOI 10.1158/1078-0432.CCR-09-3031; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Sobhakumari A, 2016, ONCOL RES, V24, P55, DOI 10.3727/096504016X14586627440192; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tripathi P, 2012, INT J BIOCHEM CELL B, V44, P1852, DOI 10.1016/j.biocel.2012.06.025; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; von Lindern M, 1992, MOL CELL BIOL, P12; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Wang JY, 2013, J HISTOCHEM CYTOCHEM, V61, P510, DOI 10.1369/0022155413488120; Wang L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-25; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WEINHOUSE S, 1976, Z KREBSFORSCH KLIN O, V87, P115; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Wilson GD, 2014, INT J RADIAT ONCOL, V90, P620, DOI 10.1016/j.ijrobp.2014.06.062; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu QY, 2008, PATHOL INT, V58, P378, DOI 10.1111/j.1440-1827.2008.02239.x; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Yang ZL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0337-5; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181	79	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177952	10.1371/journal.pone.0177952	http://dx.doi.org/10.1371/journal.pone.0177952			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558019	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000017
J	Tang, KT; Hsieh, TY; Chao, YH; Lin, MX; Chen, YH; Chen, DY; Lin, CC				Tang, Kuo-Tung; Hsieh, Tsu-Yi; Chao, Ya-Hsuan; Lin, Meng-Xian; Chen, Yi-Hsing; Chen, Der-Yuan; Lin, Chi-Chen			Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; SYNDROME PAPS; HMGB1; DISEASE; PATHOGENESIS; PROTEIN; MECHANISMS; SERUM	Introduction Many studies have demonstrated elevated circulating levels of high-mobility group box 1 (HMGB1) and decreased circulating levels of soluble receptor for advanced glycation end products (sRAGE) in patients with autoimmune diseases. In the present study, we investigated plasma levels of both HMGB1 and sRAGE in primary antiphospholipid syndrome (pAPS) patients. Methods We prospectively recruited 11 pAPS patients, 17 antiphospholipid antibody (APA)-positive SLE patients without APS manifestations (APA(+)SLE) and 12 SLE patients with secondary APS (APS(+)SLE). We also recruited 10 healthy controls (HCs). Plasma levels of HMGB1 and sRAGE were determined using sandwich ELISA kits. In addition, plasma levels of HMGB1 were also determined using Western blot in 6 pAPS patients and 6 HCs. Results There was no significant difference in plasma levels of HMGB1 measured by ELISA among subgroups of the enrolled subjects. In addition, there was no significant difference in plasma levels of HMGB1 measured by Western blot between pAPS patients and HCs. On the other hand, we observed a trend toward lower plasma levels of sRAGE in APA(+)SLE or APS(+)SLE patients when compared with HCs. However, there was no significant difference in plasma levels of sRAGE between pAPS patients and HCs, or between APA(+)SLE patients and APS(+)SLE patients. Conclusion There was no significant difference in plasma levels of sRAGE or HMGB1 between pAPS patients and HCs. Plasma levels of sRAGE/HMGB1 could not be utilized to differentiate between APA(+)SLE and APS(+)SLE patients.	[Tang, Kuo-Tung; Hsieh, Tsu-Yi; Chen, Yi-Hsing; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Tang, Kuo-Tung] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Chao, Ya-Hsuan; Lin, Meng-Xian; Chen, Der-Yuan; Lin, Chi-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chao, Ya-Hsuan; Lin, Meng-Xian; Chen, Der-Yuan; Lin, Chi-Chen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Yi-Hsing; Chen, Der-Yuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY; Lin, CC (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, DY; Lin, CC (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, DY (corresponding author), Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan.	dychen@vghtc.gov.tw; lincc@dragon.nchu.edu.tw	Chao, Ya-Hsuan/AAW-3470-2020	Chao, Ya-Hsuan/0000-0001-8283-6589; Lin, Chi-Chien/0000-0002-1464-0231; Hsieh, Tsu-Yi/0000-0001-9897-6957; Tang, Kuo-Tung/0000-0002-5468-1329	National Chung Hsing University, Taichung, Taiwan, Republic of China [TCVGH-NCHU1047611]; Taichung Veterans General Hospital	National Chung Hsing University, Taichung, Taiwan, Republic of China; Taichung Veterans General Hospital	This work was supported by grants from the Taichung Veterans General Hospital and National Chung Hsing University (TCVGH-NCHU1047611), Taichung, Taiwan, Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3332; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Andrade D, 2015, LUPUS; Artenjak A, 2012, AUTOIMMUN REV, V11, P873, DOI 10.1016/j.autrev.2012.03.002; Bertero MT, 2012, LUPUS, V21, P751, DOI 10.1177/0961203312445229; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Ceribelli A, 2011, AUTOIMMUNITY, V44, P90, DOI 10.3109/08916934.2010.499886; Chen DY, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0569-3; EHRENSTEIN MR, 1993, BRIT J RHEUMATOL, V32, P362; Espinosa G, 2015, NAT REV RHEUMATOL, V11, P586, DOI 10.1038/nrrheum.2015.88; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giannakopoulos B, 2009, BLOOD, V114, P2020, DOI 10.1182/blood-2009-05-220756; Gualtierotti R, 2013, CLIN REV ALLERG IMMU, V44, P51, DOI 10.1007/s12016-011-8268-9; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Kim HS, 2013, NEPHROLOGY, V18, P777, DOI 10.1111/nep.12166; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; Ma CY, 2012, SCAND J IMMUNOL, V75, P614, DOI 10.1111/j.1365-3083.2012.02691.x; Maillard-Lefebvre H, 2009, RHEUMATOLOGY, V48, P1190, DOI 10.1093/rheumatology/kep199; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meroni PL, 2012, LUPUS, V21, P708, DOI 10.1177/0961203312438116; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Pullerits R, 2005, ARTHRITIS RES THER, V7, pR817, DOI 10.1186/ar1749; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tang KT, 2014, LUPUS, V23, P926, DOI 10.1177/0961203314530791; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; Wirestam L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0856-2; Yu SL, 2015, LUPUS, V24, P675, DOI 10.1177/0961203314559631; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178404	10.1371/journal.pone.0178404	http://dx.doi.org/10.1371/journal.pone.0178404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558055	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000041
J	Yang, J; Li, YL; Feng, JF; Hu, JH; Liu, A				Yang, Jian; Li, Yongli; Feng, Jinfu; Hu, Junhua; Liu, An			Simulation and experimental research on trans-media vehicle water-entry motion characteristics at low speed	PLOS ONE			English	Article								The motion characteristics of trans-media vehicles during the water-entry process were explored in this study in an effort to obtain the optimal water-entry condition of the vehicle for developing a novel, single control strategy integrating underwater non-control and in-air control. A water-entry dynamics model is established by combining the water-entry motion characteristics of the vehicle in uncontrolled conditions at low speed with time-varying parameters (e.g. buoyancy, added mass). A water-entry experiment is designed to confirm the effectiveness of the established model. After that, by comparing the experimental results with the simulated results, the model is further modified to more accurately reflect water entry motion. The change laws of the vehicle's attitude and position during the water-entry process are also obtained by analyzing the simulation of the modified model under different velocity, angle, and angle of attack conditions. The results presented here have guiding significance for the future realization of reaching the stable underwater navigation state of the vehicle after water-entry process.	[Yang, Jian; Feng, Jinfu; Hu, Junhua; Liu, An] Air Force Engn Univ, Sch Aeronaut & Astronaut Engn, Xian, Shaanxi, Peoples R China; [Li, Yongli] Engn Univ CAPF, Xian, Shaanxi, Peoples R China	Air Force Engineering University	Li, YL (corresponding author), Engn Univ CAPF, Xian, Shaanxi, Peoples R China.	819111743@qq.com			National Natural Science Foundation of China [51541905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (51541905), http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their thanks for the support from the National Natural Science Foundation of China (No. 51541905).	Birkhoff G, 1957, JET WAKES CAVITIES, V6; Crouse GL, 2010, AIAA; GEERS TL, 1983, J ACOUST SOC AM, V73, P1152, DOI 10.1121/1.389286; Gekle S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.034502; Gordillo JM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.194501; He CT, 2012, ACTA PHYS SIN-CH ED, V61, DOI 10.7498/aps.61.134701; Korobkin AA, 2000, P ROY SOC A-MATH PHY, V456, P2489, DOI 10.1098/rspa.2000.0622; Luo Hanbing, 2012, J SHIP MECH, V16, P907; [马庆鹏 Ma Qingpeng], 2014, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V46, P24; Marks P., 2010, NEW SCI, V7, pw32; May A., 1968, 6799051968 AD; Park MS, 2003, COMPUT FLUIDS, V32, P939, DOI 10.1016/S0045-7930(02)00087-7; Qi D, 2016, P 2016 IEEE 2 INT C; Scolan YM, 2015, J FLUIDS STRUCTURES, V01, P1; Tian-ging You, 2010, Journal of Solid Mechanics and Materials Engineering, V4, P1360, DOI 10.1299/jmmp.4.1360; Truscott TT, 2014, ANNU REV FLUID MECH, V46, P355, DOI 10.1146/annurev-fluid-011212-140753; Truscott TT, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3272264; Waugh JG, 1975, A007529 AD; Worthington AM, 1909, STUDY SPLASHES SCI, V29, P464, DOI [DOI 10.1126/SCIENCE.29.742.464, 10.1126/science.29.742.464]; Xu BW, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3614-2; Xu JJ, 2015, ACTA MATER, V90, P431, DOI 10.1016/j.actamat.2015.03.005; [闫发锁 Yan Fasuo], 2015, [振动与冲击, Journal of Vibration and Shock], V34, P214; Yan WS, 2005, TORPEDO SAILING MECH; [严忠汉 Yan Zhonghan], 2002, [中国造船, Shipbuilding of China], V43, P88; Yang XB, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS (ROBIO), P1138, DOI 10.1109/ROBIO.2013.6739617	25	2	3	10	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178461	10.1371/journal.pone.0178461	http://dx.doi.org/10.1371/journal.pone.0178461			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558012	Green Submitted, gold, Green Published			2022-12-26	WOS:000402607000048
J	Acevedo, GR; Longhi, SA; Bunying, A; Sabri, N; Atienza, A; Zago, MP; Santos, R; Judkowski, VA; Pinilla, C; Gomez, KA				Acevedo, Gonzalo R.; Longhi, Silvia A.; Bunying, Alcinette; Sabri, Nazila; Atienza, Augusto; Zago, Maria P.; Santos, Radleigh; Judkowski, Valeria A.; Pinilla, Clemencia; Gomez, Karina A.			Methodological approach to the ex vivo expansion and detection of T-cruzi-specific T cells from chronic Chagas disease patients	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; TRYPANOSOMA-CRUZI; CARDIOMYOPATHY PATIENTS; RECOMBINANT ANTIGENS; IMMUNE-RESPONSES; GENE-EXPRESSION; HUMAN NAIVE; IN-VITRO; MEMORY; INFECTION	The discovery of T cell epitopes is essential not only for gaining knowledge about host response to infectious disease but also for the development of immune-intervention strategies. In Chagas disease, given the size and complexity of the Trypanosoma cruzi proteome and its interaction with the host's immune system, the fine specificity of T cells has not been extensively studied yet, and this is particularly true for the CD4(+) T cell compartment. The aim of the present work was to optimize a protocol for the generation of parasite-specific memory T cell lines, representative of their in vivo precursor populations and capable of responding to parasite antigens after long-term culture. Accordingly, peripheral blood mononuclear cells (PBMC) from both chronic asymptomatic and cardiac patients, and from noninfected individuals, underwent different in vitro culture and stimulation conditions. Subsequently, cells were tested for their capacity to respond against T. cruzi lysate by measuring [H-3]-thymidine incorporation and interferon-. and GM-CSF secretion. Results allowed us to adjust initial T. cruzi lysate incubation time as well as the number of expansions with phytohemagglutinin (PHA) and irradiated allogeneic PBMC prior to specificity evaluation. Moreover, our data demonstrated that parasite specific T cells displayed a clear and strong activation by using T. cruzi lysate pulsed, Epstein-Barr virus (EBV)-transformed human B lymphocytes (B-LCL), as autologous antigen presenting cells. Under these culture conditions, we generated a clone from an asymptomatic patient's memory CD4(+) T cells which responded against epimastigote and trypomastigote protein lysate. Our results describe a culture method for isolating T. cruzi specific T cell clones from patients with Chagas disease, which enable the acquisition of information on functionality and specificity of individual T cells.	[Acevedo, Gonzalo R.; Longhi, Silvia A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Hector N Torres, Buenos Aires, DF, Argentina; [Bunying, Alcinette; Sabri, Nazila; Judkowski, Valeria A.; Pinilla, Clemencia; Gomez, Karina A.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Atienza, Augusto] Hosp Gen Agudos JM Ramos Mejia, Buenos Aires, DF, Argentina; [Zago, Maria P.] Inst Patol Expt IPE UNSA, Salta, Argentina; [Santos, Radleigh] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Torrey Pines Institute for Molecular Studies, California; Hospital Ramos Mejia; Torrey Pines Institute for Molecular Studies, Florida	Gomez, KA (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA.	gomez@dna.uba.ar	da Penha Zago-Gomes, Maria/I-6608-2015	Gomez, Karina Andrea/0000-0001-8115-667X; Acevedo, Gonzalo/0000-0002-8330-2500	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [112200801-02915]; Agencia Nacional de Promoci6n Cientifica y Tecnologica (ANPCyT) [2014-1026]; National Institute of Allergy and Infectious Diseases (NIH-NIAID) [5R21A1109439-02]; Fulbright Program; Bunge y Born Foundation	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promoci6n Cientifica y Tecnologica (ANPCyT)(ANPCyT); National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fulbright Program; Bunge y Born Foundation	This work was financially supported by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET; Grant number 112200801-02915) and by the Agencia Nacional de Promoci6n Cientifica y Tecnologica (ANPCyT; Grant number 2014-1026) to KAG and in part by National Institute of Allergy and Infectious Diseases (NIH-NIAID, Grant number 5R21A1109439-02) to CP. GRA performed part of the experimental work in this article during a stay at TPIMS supported by the Fulbright Program and the Bunge y Born Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; ARNHOLDT ACV, 1993, J IMMUNOL, V151, P3171; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Cerny N, 2016, HUM VACC IMMUNOTHER, V12, P438, DOI 10.1080/21645515.2015.1078044; Cuellar A, 2008, IMMUNOL CELL BIOL, V86, P255, DOI 10.1038/sj.icb.7100146; de Melo AS, 2012, CYTOKINE, V58, P207, DOI 10.1016/j.cyto.2012.01.008; Duarte RF, 2002, GENE THER, V9, P1359, DOI 10.1038/sj.gt.3301807; Dutra WO, 1997, SCAND J IMMUNOL, V45, P74, DOI 10.1046/j.1365-3083.1997.d01-362.x; Eickhoff CS, 2015, HUM VACC IMMUNOTHER, V11, P2322, DOI 10.1080/21645515.2015.1061160; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fiuza JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000512; Garg N, 2002, INFECT IMMUN, V70, P5547, DOI 10.1128/IAI.70.10.5547-5555.2002; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gupta S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004828; Hondowicz BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029949; Kim M, 2006, INT IMMUNOL, V18, P435, DOI 10.1093/intimm/dxh383; Lasso P, 2016, PEPTIDES, V78, P68, DOI 10.1016/j.peptides.2016.02.002; Leggatt GR, 2004, J LEUKOCYTE BIOL, V76, P787, DOI 10.1189/jlb.0104026; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2000, J IMMUNOL, V165, P925, DOI 10.4049/jimmunol.165.2.925; Longhi SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002906; Lorena VMB, 2008, J CLIN LAB ANAL, V22, P91, DOI 10.1002/jcla.20209; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Martinez-Campos V, 2015, VACCINE, V33, P4505, DOI 10.1016/j.vaccine.2015.07.017; Mazzatti DJ, 2007, AGING CELL, V6, P155, DOI 10.1111/j.1474-9726.2007.00269.x; Michailowsky V, 2003, INFECT IMMUN, V71, P3165, DOI 10.1128/IAI.71.6.3165-3171.2003; Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006; PIUVEZAM MR, 1993, J IMMUNOL, V150, P916; Quijano-Hernandez I, 2011, HUM VACCINES, V7, P1184, DOI 10.4161/hv.7.11.17016; Rampazo EV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117778; Ribeirao M, 2000, PARASITE IMMUNOL, V22, P49, DOI 10.1046/j.1365-3024.2000.00260.x; Scharfstein J, 2009, MEM I OSWALDO CRUZ, V104, P187, DOI 10.1590/S0074-02762009000900025; Serna C, 2014, VACCINE, V32, P3525, DOI 10.1016/j.vaccine.2014.04.026; Souza PEA, 2004, INFECT IMMUN, V72, P5283, DOI 10.1128/IAI.72.9.5283-5291.2004; Sun Q, 2000, J IMMUNOL, V165, P4105, DOI 10.4049/jimmunol.165.7.4105; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Tumeh PC, 2010, J IMMUNOTHER, V33, P759, DOI 10.1097/CJI.0b013e3181f1d644; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737	43	10	11	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178380	10.1371/journal.pone.0178380	http://dx.doi.org/10.1371/journal.pone.0178380			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552984	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000041
J	Malik, A; Pal, R; Gupta, SK				Malik, Ankita; Pal, Rahul; Gupta, Satish Kumar			Interdependence of JAK-STAT and MAPK signaling pathways during EGF-mediated HTR-8/SVneo cell invasion	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; SERINE PHOSPHORYLATION; HUMAN TROPHOBLAST; MATRIX METALLOPROTEINASES; EXPRESSION; PREECLAMPSIA; PROLIFERATION; RECEPTOR; TRANSCRIPTION	Invasion of trophoblast cells is spatio-temporally regulated by various cytokines and growth factors. In pregnancy, complications like preeclampsia, shallow invasion of trophoblast cells and low amounts of epidermal growth factor (EGF) have been reported. In the present study, regulatory mechanisms associated with EGF-mediated invasion in HTR-8/SVneo trophoblastic cells have been delineated. Treatment of HTR-8/SVneo cells with EGF (10 ng/ml) led to eight fold increase (p < 0.05) in invasion. Increased invasion of HTR-8/SVneo cells by EGF was associated with an increase in phosphorylation of ERK1/2. In addition, significant phosphorylation of STAT1 (ser 727) and STAT3 (both tyr 705 and ser 727 residues) was also observed, accompanied by a decrease in total STAT1. Inhibition of ERK1/2 phosphorylation by U0126 (10 mu M) led to a significant decrease in EGF-mediated invasion with simultaneous decrease in the phosphorylated forms of STAT3 and STAT1. Decrease in total STAT1 was also reversed on inhibition of ERK1/2. Interestingly, inhibition of STAT3 by siRNA led to a significant decrease in EGF-mediated invasion of HTR-8/SVneo cells and phosphorylation of STAT1, but it did not have any effect on the activation of ERK1/2. On the other hand, inhibition of STAT1 by siRNA, also led to a significant decrease in the EGF-mediated invasion of HTR-8/SVneo cells, showed concomitant decrease in ERK1/2 phosphorylation and STAT3 phosphorylation at ser 727 residue. These results suggest cross-communication between ERK1/2 and JAK-STAT pathways during EGF-mediated increase in invasion of trophoblast cells; phosphorylation at ser 727 residue of both STAT3 and STAT1 appears to be critical.	[Malik, Ankita; Gupta, Satish Kumar] Natl Inst Immunol, Reprod Cell Biol Lab, Delhi, India; [Pal, Rahul] Natl Inst Immunol, Immunoendocrinol Lab, Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, SK (corresponding author), Natl Inst Immunol, Reprod Cell Biol Lab, Delhi, India.	skgupta@nii.ac.in			J. C. Bose Fellowship - Science and Engineering Research Board, Department of Science and Technology [SB/S2/JCB-040/2015]; Department of Biotechnology, Government of India [BT/PR12312/MED/30/1424/2014]; National Institute of Immunology, NewDelhi, India	J. C. Bose Fellowship - Science and Engineering Research Board, Department of Science and Technology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Immunology, NewDelhi, India	This research is funded by J. C. Bose Fellowship (SB/S2/JCB-040/2015) granted to SKG by Science and Engineering Research Board, Department of Science and Technology and Department of Biotechnology project number-BT/PR12312/MED/30/1424/2014, Government of India. SKG would also like to acknowledge National Institute of Immunology, NewDelhi, India for financial support. These funding sources have no role in data collection, experimental design and manuscript preparation role in data collection, experimental design and manuscript preparation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Anteby EY, 2004, MOL HUM REPROD, V10, P229, DOI 10.1093/molehr/gah031; Armant DR, 2015, PLACENTA, V36, P270, DOI 10.1016/j.placenta.2014.12.006; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Biadasiewicz K, 2011, ENDOCRINOLOGY, V152, P1458, DOI 10.1210/en.2010-0936; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Chenthuran T, 2014, J OBSTET GYNAECOL RE, V40, P1235, DOI 10.1111/jog.12362; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Delgoffe Greg M, 2013, JAKSTAT, V2, pe23060, DOI 10.4161/jkst.23060; Faxen M, 1998, AM J PERINAT, V15, P9, DOI 10.1055/s-2007-993890; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Fitzgerald JS, 2010, AM J REPROD IMMUNOL, V63, P492, DOI 10.1111/j.1600-0897.2010.00824.x; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gugneja S, 1997, J BIOL CHEM, V272, P18732, DOI 10.1074/jbc.272.30.18732; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jia RZ, 2014, PLACENTA, V35, P450, DOI 10.1016/j.placenta.2014.04.011; Jia RZ, 2014, CELL PHYSIOL BIOCHEM, V34, P628, DOI 10.1159/000363028; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Lindqvist P, 1999, EARLY HUM DEV, V56, P143, DOI 10.1016/S0378-3782(99)00037-7; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu LY, 2016, J APPL TOXICOL, V36, P946, DOI 10.1002/jat.3227; Marca HL, 2008, HUM REPROD, V23, P1733; Maruo T, 1995, REPROD FERT DEVELOP, V7, P1465, DOI 10.1071/RD9951465; MATSUO H, 1993, ACTA ENDOCRINOL-COP, V128, P225, DOI 10.1530/acta.0.1280225; Morales-Prieto DM, 2013, SCI WORLD J, DOI 10.1155/2013/259845; Ospina-Prieto S, 2015, REPROD SCI, V22, P1358, DOI 10.1177/1933719115578923; Ospina-Prieto S, 2014, PLACENTA, V35, pA104, DOI 10.1016/j.placenta.2014.06.340; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Qiu Q, 2004, REPRODUCTION, V128, P355, DOI 10.1530/rep.1.00234; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Sonderegger S, 2011, HUM REPROD, V26, P2841, DOI 10.1093/humrep/der259; Sousa F L P, 2012, Pregnancy Hypertens, V2, P243, DOI 10.1016/j.preghy.2012.04.118; Staun-Ram E, 2009, PLACENTA, V30, P1029, DOI 10.1016/j.placenta.2009.09.010; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Suman P., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.25155; Suman P, 2013, FERTIL STERIL, V99, P533, DOI 10.1016/j.fertnstert.2012.10.004; Suman P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029745; Uchikura Y, 2017, REPROD SCI, V1; Uckun FM, 2012, P NATL ACAD SCI USA, V109, P18072, DOI 10.1073/pnas.1209828109; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wortman AC, 2013, OBSTET GYN CLIN N AM, V40, P137, DOI 10.1016/j.ogc.2012.12.002; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhang Z, 2015, J MOL HISTOL, V46, P205, DOI 10.1007/s10735-015-9613-8	51	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178269	10.1371/journal.pone.0178269	http://dx.doi.org/10.1371/journal.pone.0178269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542650	gold, Green Submitted, Green Published			2022-12-26	WOS:000402062800062
J	Banno, T; Omura, T; Masaki, N; Arima, H; Xu, D; Okamoto, A; Costigan, M; Latremoliere, A; Matsuyama, Y; Setou, M				Banno, Tomohiro; Omura, Takao; Masaki, Noritaka; Arima, Hideyuki; Xu, Dongmin; Okamoto, Ayako; Costigan, Michael; Latremoliere, Alban; Matsuyama, Yukihiro; Setou, Mitsutoshi			Arachidonic acid containing phosphatidylcholine increases due to microglial activation in ipsilateral spinal dorsal horn following spared sciatic nerve injury	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; NEUROPATHIC PAIN; RAT MODEL; SIGNALING PATHWAYS; CORD-INJURY; MINOCYCLINE; MECHANISMS; NEURONS; LIPIDS; GLIA	Peripheral nerve injury induces substantial molecular changes in the somatosensory system that leads to maladaptive plasticity and cause neuropathic pain. Understanding the molecular pathways responsible for the development of neuropathic pain is essential to the development of novel rationally designed therapeutics. Although lipids make up to half of the dry weight of the spinal cord, their relation with the development of neuropathic pain is poorly understood. We aimed to elucidate the regulation of spinal lipids in response to neuropathic peripheral nerve injury in mice by utilizing matrix-assisted laser desorption/ionization imaging mass spectrometry, which allows visualization of lipid distribution within the cord. We found that arachidonic acid (AA) containing [PC(diacyl-16:0/20:4)+K](+) was increased temporarily at superficial ipsilateral dorsal horn seven days after spared nerve injury (SNI). The spatiotemporal changes in lipid concentration resembled microglia activation as defined by ionized calcium binding adaptor molecule 1 (Iba1) immunohistochemistry. Suppression of microglial function through minocycline administration resulted in attenuation of hypersensitivity and reduces [PC(diacyl-16:0/20:4)+K](+) elevation in the spinal dorsal horn. These data suggested that AA containing [PC(diacyl-16:0/20:4)+K](+) is related to hypersensitivity evoked by SNI and implicate microglial cell activation in this lipid production.	[Banno, Tomohiro; Omura, Takao; Arima, Hideyuki; Xu, Dongmin; Okamoto, Ayako; Matsuyama, Yukihiro] Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Hamamatsu, Shizuoka, Japan; [Banno, Tomohiro; Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan; [Banno, Tomohiro; Masaki, Noritaka; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan; [Costigan, Michael; Latremoliere, Alban] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA USA; [Costigan, Michael; Latremoliere, Alban] Harvard Med Sch, Boston, MA USA; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Inst Med Photon Res, Dept Syst Mol Anat, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Setou, Mitsutoshi] Natl Inst Physiol Sci, Div Neural Systemat, Okazaki, Aichi, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hamamatsu University School of Medicine; University of Hong Kong; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Setou, M (corresponding author), Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ Sch Med, Inst Med Photon Res, Dept Syst Mol Anat, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China.; Setou, M (corresponding author), Natl Inst Physiol Sci, Div Neural Systemat, Okazaki, Aichi, Japan.	setou@hama-med.ac.jp		Latremoliere, Alban/0000-0002-9212-1007	Japan Agency for Medical Research and Development [921910520]; Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure [25801]; JSPS KAKENHI [24592192]; NIH [NS074430]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074430] Funding Source: NIH RePORTER	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Japan Agency for Medical Research and Development (grant no. 921910520) and Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure (grant no. 25801) for M. Setou, JSPS KAKENHI (grant no. 24592192) for Y. Matsuyama and NIH (NS074430) for M. Costigan.; This work was supported by Japan Agency for Medical Research and Development (grant No.921910520) and Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure (grant No.25801) for M. Setou, JSPS KAKENHI (grant No. 24592192) for Y. Matsuyama and NIH (NS074430) for M. Costigan.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arima H, 2014, NEUROSCIENCE, V269, P1, DOI 10.1016/j.neuroscience.2014.03.012; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Buczynski MW, 2010, J NEUROCHEM, V114, P981, DOI 10.1111/j.1471-4159.2010.06815.x; Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Costigan M, 2010, BRAIN, V133, P2519, DOI 10.1093/brain/awq195; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Gangadharan V, 2013, PAIN, V154, P2801, DOI 10.1016/j.pain.2013.08.019; Hanada M, 2012, ANAL BIOANAL CHEM, V403, P1873, DOI 10.1007/s00216-012-5900-3; Hanrieder J, 2013, ANAL CHEM, V85, P8741, DOI 10.1021/ac401830m; Jackson SN, 2009, J CHROMATOGR B, V877, P2822, DOI 10.1016/j.jchromb.2008.11.033; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Latremoliere A, 2015, NEURON, V86, P1393, DOI 10.1016/j.neuron.2015.05.033; Ma MT, 2012, EUR J PAIN, V16, P38, DOI 10.1016/j.ejpain.2011.06.013; Meirer K, 2014, BASIC CLIN PHARMACOL, V114, P83, DOI 10.1111/bcpt.12134; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nalamachu S, 2013, AM J MANAG CARE, V19, pS261; O'Rielly DD, 2007, ANESTHESIOLOGY, V106, P795, DOI 10.1097/01.anes.0000264777.94662.d6; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Papa M, 2014, NEUROSCI BIOBEHAV R, V42, P35, DOI 10.1016/j.neubiorev.2014.01.010; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Piomelli D, 2012, PAIN, V153, P3, DOI 10.1016/j.pain.2011.09.026; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Scholz J, 2008, PAIN, V138, P130, DOI 10.1016/j.pain.2007.11.019; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sui P, 2014, J PROTEOME RES, V13, P3957, DOI 10.1021/pr500241q; Sung B, 2007, PAIN, V131, P121, DOI 10.1016/j.pain.2006.12.020; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Walker JM, 2005, PROSTAG OTH LIPID M, V77, P35, DOI 10.1016/j.prostaglandins.2004.09.017; Wang HY, 2013, PHARMACOL BIOCHEM BE, V106, P47, DOI 10.1016/j.pbb.2013.03.002; Xu DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26427; Yaksh Tony L, 2015, F1000Prime Rep, V7, P56, DOI 10.12703/P7-56; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177595	10.1371/journal.pone.0177595	http://dx.doi.org/10.1371/journal.pone.0177595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542572	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500033
J	Seok, JM; Choi, M; Bin Cho, E; Lee, HL; Kim, BJ; Lee, KH; Song, P; Joo, EY; Min, JH				Seok, Jin Myoung; Choi, Misong; Bin Cho, Eun; Lee, Hye Lim; Kim, Byoung Joon; Lee, Kwang Ho; Song, Pamela; Joo, Eun Yeon; Min, Ju-Hong			Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of lifef	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OF-LIFE; DIAGNOSTIC-CRITERIA; SLEEP DISTURBANCES; BASAL GANGLIA; DEPRESSION; PAIN; DISABILITY; ATROPHY; AXIS	Fatigue is a prevalent symptom and major burden in neuroimmunological diseases. In neuromyelitis optica spectrum disorder (NMOSD), a severe autoimmune central nervous system (CNS) inflammatory disease with autoantibodies reactive to aquaporin-4, there are few reports about fatigue and quality of life (QOL). We aimed to evaluate the severity of fatigue and its relationship with QOL in patients with NMOSD. We prospectively studied patients with NMOSD who were in remission and seropositive for anti-aquaporin-4 antibody, and they were divided into 2 groups based on the presence of fatigue assessed using the Functional Assessment of Chronic Illness Therapy-fatigue score. Sleep quality, depression, pain, and QOL were also evaluated. A total of 35 patients were enrolled (mean age, 46.5 +/- 14.1 years; female: male = 29: 6), and the median Expanded Disability Status Scale (EDSS) score was 2.0 (range, 0 to 8.0). The patients with fatigue (N = 25, 71.4%) had poorer sleep quality and more severe depression than those without fatigue (p = 0.009 and p = 0.001). Both the physical and mental QOL scores were lower in patients with fatigue than in those without fatigue (p = 0.033 and p = 0.004). Multiple linear regression analyses showed that the degree of fatigue with EDSS score and pain were independent predictors of physical aspects of QOL (B = 0.382, p = 0.001), whereas depression was the only predictor of the mental components of QOL (B = -0.845, p = <0.001). Fatigue is a common symptom and an important predictor of QOL in patients with NMOSD.	[Seok, Jin Myoung; Choi, Misong; Kim, Byoung Joon; Lee, Kwang Ho; Joo, Eun Yeon; Min, Ju-Hong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Seok, Jin Myoung; Choi, Misong; Kim, Byoung Joon; Lee, Kwang Ho; Joo, Eun Yeon; Min, Ju-Hong] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Seok, Jin Myoung] Soonchunhyang Univ, Cheonan Hosp, Dept Neurol, Coll Med, Cheonan, South Korea; [Bin Cho, Eun] Gyeongsang Natl Univ, Sch Med, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Lee, Hye Lim] Korea Univ, Guro Hosp, Dept Neurol, Seoul, South Korea; [Lee, Hye Lim] Korea Univ, Coll Med, Seoul, South Korea; [Song, Pamela] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Neurol, Goyang, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University; Gyeongsang National University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Inje University	Min, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Min, JH (corresponding author), Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.	juhongm@gmail.com		Seok, Jin Myoung/0000-0002-1484-2968				Akaishi T, 2015, J NEUROIMMUNOL, V283, P70, DOI 10.1016/j.jneuroim.2015.05.007; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Attarian HP, 2004, ARCH NEUROL-CHICAGO, V61, P525, DOI 10.1001/archneur.61.4.525; Baba T, 2009, J NEUROL, V256, P287, DOI 10.1007/s00415-009-0139-4; Barat M., 2006, Annales de Readaptation et de Medecine Physique, V49, P365, DOI 10.1016/j.annrmp.2006.04.014; Bisecco A, 2016, MULTIPLE SCLEROSIS; Blechingberg J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046251; Bomholt SF, 2004, STRESS, V7, P1, DOI 10.1080/10253890310001650268; Calabrese M, 2012, NEUROLOGY, V79, P1671, DOI 10.1212/WNL.0b013e31826e9a96; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Chanson JB, 2011, EUR J NEUROL, V18, P836, DOI 10.1111/j.1468-1331.2010.03252.x; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chavarro VS, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000286; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Giovannoni G, 2006, J NEUROL NEUROSUR PS, V77, P2, DOI 10.1136/jnnp.2005.074948; Greim B, 2007, J NEUROL, V254, P102, DOI 10.1007/s00415-007-2025-2; Guo Y, 2014, JAMA NEUROL, V71, P1025, DOI 10.1001/jamaneurol.2014.775; Haldorsen K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3487; Kanamori Y, 2011, NEUROLOGY, V77, P652, DOI 10.1212/WNL.0b013e318229e694; Kanbayashi T, 2009, ARCH NEUROL-CHICAGO, V66, P1563, DOI 10.1001/archneurol.2009.264; Kaneko K, 2016, J NEUROLOGY; Kang ES, 2012, ANN LAB MED, V32, P331, DOI 10.3343/alm.2012.32.5.331; Kong YZ, 2016, J NEUROL SCI, V368, P84, DOI 10.1016/j.jns.2016.06.041; Kroencke DC, 2000, MULT SCLER, V6, P131, DOI 10.1177/135245850000600213; Krupp L, 2006, MULT SCLER J, V12, P367, DOI 10.1191/135248506ms1373ed; Lai JS, 2011, J RHEUMATOL, V38, P672, DOI 10.3899/jrheum.100799; Malik R, 2014, MUSCLE NERVE, V50, P859, DOI 10.1002/mus.24298; Pan J, 2015, CNS NEUROSCI THER, V21, P599, DOI 10.1111/cns.12411; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Shi ZY, 2016, J NEUROIMMUNOL, V293, P54, DOI 10.1016/j.jneuroim.2016.02.011; Song YJ, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000094; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Trebst C, 2014, J NEUROL, V261, P1, DOI 10.1007/s00415-013-7169-7; Veauthier C, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0073-3; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wingerchuk DM, 2007, NEUROLOGY, V68, P603, DOI 10.1212/01.wnl.0000254502.87233.9a; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6; Zamvil SS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000062; Zekeridou A, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000110; Zhao SZ, 2014, MULT SCLER J, V20, P1658, DOI 10.1177/1352458514522103	43	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177230	10.1371/journal.pone.0177230	http://dx.doi.org/10.1371/journal.pone.0177230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542592	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800011
J	Biswas, RK; Kabir, E				Biswas, Raaj Kishore; Kabir, Enamul			Influence of distance between residence and health facilities on non-communicable diseases: An assessment over hypertension and diabetes in Bangladesh	PLOS ONE			English	Article							RISK-FACTORS; PHYSICAL-ACTIVITY; DEPRESSION; PREVALENCE; POPULATION; BURDEN; STROKE; ADULTS	Objective This paper reflected on the prevalence of hypertension and diabetes in Bangladesh, which is spreading rapidly in low-income countries. The rationale of constructing more health centers for addressing NCDs was assessed in this paper by determining the relationship between prevalence of NCDs, particularly hypertension and diabetes, and distance to health facilities. Methods From BDHS (Bangladesh Health and Demographic Survey) 2011 data set, 7544 samples were analyzed to demonstrate association between Non-communicable diseases (NCD) and distance from respondents' home to health facilities like hospitals, community clinics, pharmacies or doctors' chambers, and community facilities like market, post office or cinema hall. Bivariate analysis was conducted between accessibility to health facilities and prevalence of the diseases. The causal relationship between the spatial effects and the prevalence of the diseases were analyzed by applying Generalized Linear Mixed Model (GLMM) was fitted. Results Fitting linear mixed effect models, we found that hypertension and diabetes react differently with various spatial effects. Distance from home to hospital had significant effect (P < 0.001) on hypertension showing people living further from the facilities or town centers seemed to be less hypertensive, whereas diabetes showed no such affiliation. Conclusion Higher prevalence of diabetes (40.9%) over hypertension (26.5%) in people aging 35 or higher, have appeared to have caused the difference, which concluded that each non-communicable disease should be dealt to its own merit for policy making instead considering as a group of diseases.	[Biswas, Raaj Kishore; Kabir, Enamul] Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia	University of Southern Queensland	Biswas, RK (corresponding author), Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia.	RaajKishore.Biswas@usq.edu.au	Biswas, Raaj Kishore/K-4256-2018	Biswas, Raaj Kishore/0000-0003-4294-6323; Kabir, Enamul/0000-0002-6157-2753				AbuSayeed M, 1997, DIABETES CARE, V20, P551, DOI 10.2337/diacare.20.4.551; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Alam DS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004983; Alam GM, 2009, AFR J AGR RES, V4, P1334; [Anonymous], 2010, HLTH NUTR POPUL SER; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhowmik B, 2012, DIABETES METAB J, V36, P422, DOI 10.4093/dmj.2012.36.6.422; BRONSTEIN JM, 1990, MED CARE, V28, P853, DOI 10.1097/00005650-199009000-00013; Choukem SP, 2007, DIABETES RES CLIN PR, V77, P293, DOI 10.1016/j.diabres.2006.11.007; Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495; DHS, 2011, DHS WEBS BANGL STAND; GESLER WM, 1992, SOC SCI MED, V34, P735, DOI 10.1016/0277-9536(92)90360-3; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Gupta I, 2006, EC IMPACT CARDIOVASC; Habib SH, 2010, DIABETES METAB SYND, V4, P41, DOI 10.1016/j.dsx.2008.04.005; Hirai M, 2015, DHS OCCASIONAL PAPER, V10; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; Islam A K M Monwarul, 2012, Indian Heart J, V64, P319, DOI 10.1016/S0019-4832(12)60096-0; Jordan H., 2004, INT J HEALTH GEOGR, V3, P1; Killewo J, 2006, J HEALTH POPUL NUTR, V24, P403; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leeder S, 2004, RACE TIME CHALLENGE; Lloyd-Sherlock P, 2010, DEV POLICY REV, V28, P693, DOI 10.1111/j.1467-7679.2010.00505.x; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; Measure DHS. Bangladesh Demographic and Health Survey, 2011, BANGL DEM HLTH SURV; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; Oladiji JO, 2009, AFR J PSYCHIATRY, V12, P47; Paripovic D, 2010, PEDIATR NEPHROL, V25, P1719, DOI 10.1007/s00467-010-1552-8; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rahman MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118365; Rutstein S. O., 2004, DHS WEALTH INDEX; Saftlas AF, 2004, AM J EPIDEMIOL, V160, P758, DOI 10.1093/aje/kwh277; Schoeps A, 2011, AM J EPIDEMIOL, V173, P492, DOI 10.1093/aje/kwq386; Shannon G, 1979, J Community Health, V5, P113, DOI 10.1007/BF01324013; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; STOCK R, 1983, SOC SCI MED, V17, P563, DOI 10.1016/0277-9536(83)90298-8; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Timyan J, 1993, ACCESS CARE MORE PRO; WHO. World Health Organization, 2002, WORLD HLTH REP 2002, P81	41	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177027	10.1371/journal.pone.0177027	http://dx.doi.org/10.1371/journal.pone.0177027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545074	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000401672400019
J	Liu, X; Guo, KL; Huang, L; Ji, ZY; Jiang, HM; Li, H; Zhang, JF				Liu, Xiao; Guo, Kangli; Huang, Lin; Ji, Zhengyu; Jiang, Huimin; Li, Hu; Zhang, Jianfeng			Responses of absolute and specific enzyme activity to consecutive application of composted sewage sludge in a Fluventic Ustochrept	PLOS ONE			English	Article							SOLID-WASTE COMPOST; SOIL MICROBIAL BIOMASS; AMENDMENTS; MANAGEMENT; METALS; IMPACT	Composted sewage sludge (CS) is considered a rich source of soil nutrients and significantly affects the physical, chemical, and biological characteristics of soil, but its effect on specific enzyme activity in soil is disregarded. The present experiment examined the absolute and specific enzyme activity of the enzymes involved in carbon, nitrogen, and phosphorus cycles, the diversity of soil microbial functions, and soil community composition in a Fluventic Ustochrept under a maize-wheat rotation system in North China during 2012- 2015. Application of CS led to increase in MBC and in its ratio to both total organic carbon (TOC) and microbial biomass nitrogen (MBN). Absolute enzyme activity, except that of phosphatase, increased in CS-treated soils, whereas specific activity of all the enzymes declined, especially at the highest dose of CS (45 t ha(-1)). The diversity of soil microbial community also increased in CS-treated soils, whereas its functional diversity declined at higher doses of CS owing to the lowered specific enzyme activity. These changes indicate that CS application induced the domination of microorganisms that are not metabolically active and those that use resources more efficiently, namely fungi. Redundancy analysis showed that fundamental alterations in soil enzyme activity depend on soil pH. Soil specific enzyme activity is affected more than absolute enzyme activity by changes in soil properties, especially soil microbial activity and composition of soil microflora (as judged by the following ratios: MBC/TOC, MBC/MBN, and TOC/LOC, that is labile organic carbon) through the Pearson Correlation Coefficient. Specific enzyme activity is thus a more accurate parameter than absolute enzyme activity for monitoring the effect of adding CS on the activities and structure of soil microbial community.	[Liu, Xiao; Guo, Kangli; Ji, Zhengyu; Jiang, Huimin; Li, Hu; Zhang, Jianfeng] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Huang, Lin] Sewage Purificat Co Ltd, Zhengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Li, H; Zhang, JF (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.	lihu@caas.cn; zhangjianfeng@caas.cn	Liu, Xiao/ABD-8066-2021	Liu, Xiao/0000-0002-5363-6331	joint laboratory with Chinese Academy of Agriculture Sciences and University of New Hampshire; National Natural Science Foundation of China [21577172, 41501322]; International Scientific and Technological Cooperation Projects of China [2015DFA20790]; National Basic Research Program (973 program) of China [2013CB127406]; project of central public welfare scientific research institute [161032016043]; National Key Research and Development Program [2016YFE0101100]	joint laboratory with Chinese Academy of Agriculture Sciences and University of New Hampshire; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific and Technological Cooperation Projects of China; National Basic Research Program (973 program) of China(National Basic Research Program of China); project of central public welfare scientific research institute; National Key Research and Development Program	The research was financially supported by joint laboratory with Chinese Academy of Agriculture Sciences and University of New Hampshire. This research was also funded by National Natural Science Foundation of China, 21577172, 41501322 (http://program.most.gov.cn/), the International Scientific and Technological Cooperation Projects of China 2015DFA20790 (http;//www.istcp.org.cri/), the National Basic Research Program (973 program) of China, 2013CB127406 (http://program.most.gov.cn/), the project of central public welfare scientific research institute, 161032016043 (http://program.most.gov cn/) and National Key Research and Development Program, 2016YFE0101100 (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial affiliation (Sewage Purification Co., Ltd) provided support in the form of salaries for author (HL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta-Martinez V, 2007, APPL SOIL ECOL, V35, P35, DOI 10.1016/j.apsoil.2006.05.012; Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Anderson TH, 2010, SOIL BIOL BIOCHEM, V42, P2039, DOI 10.1016/j.soilbio.2010.06.026; Asensio V, 2013, SCI TOTAL ENVIRON, V456, P82, DOI 10.1016/j.scitotenv.2013.03.061; Baker LR, 2011, APPL SOIL ECOL, V48, P1, DOI 10.1016/j.apsoil.2011.02.007; Banerjee MR, 1997, AGR ECOSYST ENVIRON, V66, P241, DOI 10.1016/S0167-8809(97)00129-1; Barcenas-Moreno G, 2011, SOIL BIOL BIOCHEM, V43, P1023, DOI 10.1016/j.soilbio.2011.01.019; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; BROOKES PC, 1995, BIOL FERT SOILS, V19, P269, DOI 10.1007/BF00336094; Carbonell G, 2011, CHEMOSPHERE, V85, P1614, DOI 10.1016/j.chemosphere.2011.08.025; Chuang YL, 1984, J BIOMEDICAL MAT R A, V28, P463; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Degens BP, 2000, SOIL BIOL BIOCHEM, V32, P189, DOI 10.1016/S0038-0717(99)00141-8; Enowashu E, 2009, APPL SOIL ECOL, V43, P11, DOI 10.1016/j.apsoil.2009.05.003; Fernandez JM, 2009, APPL SOIL ECOL, V42, P18, DOI 10.1016/j.apsoil.2009.01.006; Filip Z, 2002, BIOL FERT SOILS, V36, P426, DOI 10.1007/s00374-002-0559-0; Franco-Otero VG, 2012, BIOL FERT SOILS, V48, P205, DOI 10.1007/s00374-011-0620-y; Garcia-Gil JC, 2000, SOIL BIOL BIOCHEM, V32, P1907, DOI 10.1016/S0038-0717(00)00165-6; Gonzalez-Ubierna S, 2012, J SOIL SEDIMENT, V12, P1257, DOI 10.1007/s11368-012-0516-y; Harris D, 1997, CAN J SOIL SCI, V77, P507, DOI 10.4141/S96-064; JOHNSON JOHN L., 1964, SOIL SCI SOC AMER PROC, V28, P207; Jorge-Mardomingo I, 2013, GEODERMA, V206, P40, DOI 10.1016/j.geoderma.2013.04.025; Lagomarsino A, 2011, BIOL FERT SOILS, V47, P283, DOI 10.1007/s00374-010-0530-4; Lloret E, 2016, APPL SOIL ECOL, V101, P37, DOI 10.1016/j.apsoil.2016.01.002; Medeiros EV, SOIL TILLAGE RES, V145, P208; Mukherjee S, 2016, EUR J SOIL BIOL, V73, P93, DOI 10.1016/j.ejsobi.2016.01.009; Nadal M, 2011, ENVIRON POLLUT, V159, P1769, DOI 10.1016/j.envpol.2011.04.007; NANNIPIERI P, 1979, SOIL SCI, V127, P26, DOI 10.1097/00010694-197901000-00004; Nannipieri P, 2002, BOOK SOIL P, P1; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Paz-Ferreiro J, 2007, NEW ZEAL J AGR RES, V50, P537, DOI 10.1080/00288230709510321; Paz-Ferreiro J, 2012, BIOL FERT SOILS, V48, P511, DOI 10.1007/s00374-011-0644-3; Pedra F, 2007, SOIL BIOL BIOCHEM, V39, P1375, DOI 10.1016/j.soilbio.2006.12.014; Raiesi F, 2014, APPL SOIL ECOL, V75, P63, DOI 10.1016/j.apsoil.2013.10.012; Ramdani N, 2015, ENVIRON SCI TECHNOL, V13, P1; RODRIGUEZKABANA R, 1982, PLANT SOIL, V69, P97, DOI 10.1007/BF02185708; Roig N, 2012, SCI TOTAL ENVIRON, V425, P99, DOI 10.1016/j.scitotenv.2012.03.018; Sciubba L, 2014, GEODERMA, V221, P40, DOI 10.1016/j.geoderma.2014.01.018; Sinsabaugh RL, 2014, BIOGEOCHEMISTRY, V121, P287, DOI 10.1007/s10533-014-0030-y; Sinsabaugh RL, 2010, MICROB ECOL, V60, P885, DOI 10.1007/s00248-010-9696-4; Smith MTE, 2006, BIOL FERT SOILS, V42, P186, DOI 10.1007/s00374-005-0014-0; Song YY, 2012, ENVIRON MANAGE, V50, P418, DOI 10.1007/s00267-012-9890-x; Tate RL, 1987, SOIL ORGANIC MATTER, P98; Tejada M, 2013, ECOL ENG, V50, P31, DOI 10.1016/j.ecoleng.2012.07.006; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Weber J, 2007, SOIL BIOL BIOCHEM, V39, P1294, DOI 10.1016/j.soilbio.2006.12.005; Zhang XY, SCI TOTAL ENV, V536, P59; Zhou XB, 2012, SOIL BIOL BIOCHEM, V47, P67, DOI 10.1016/j.soilbio.2011.05.012	51	17	20	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177796	10.1371/journal.pone.0177796	http://dx.doi.org/10.1371/journal.pone.0177796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545130	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700080
J	Nuvolone, M; Paolucci, M; Sorce, S; Kana, V; Moos, R; Matozaki, T; Aguzzi, A				Nuvolone, Mario; Paolucci, Marta; Sorce, Silvia; Kana, Veronika; Moos, Rita; Matozaki, Takashi; Aguzzi, Adriano			Prion pathogenesis is unaltered in the absence of SIRP alpha-mediated "don't-eat-me" signaling	PLOS ONE			English	Article							REGULATORY PROTEIN-ALPHA; MICROGLIAL ACTIVATION; APOPTOTIC CELLS; NEGATIVE REGULATION; THERAPEUTIC TARGET; POLYMORPHIC SIRPA; STEM-CELLS; PHAGOCYTOSIS; CD47; MOUSE	Prion diseases are neurodegenerative conditions caused by misfolding of the prion protein, leading to conspicuous neuronal loss and intense microgliosis. Recent experimental evidence point towards a protective role of microglia against prion-induced neurodegeneration, possibly through elimination of prion-containing apoptotic bodies. The molecular mechanisms by which microglia recognize and eliminate apoptotic cells in the context of prion diseases are poorly defined. Here we investigated the possible involvement of signal regulatory protein a (SIRP alpha), a key modulator of host cell phagocytosis; SIRPa is encoded by the Sirpa gene that is genetically linked to the prion gene Prnp. We found that Sirpa transcripts are highly enriched in microglia cells within the brain. However, Sirpa mRNA levels were essentially unaltered during the course of experimental prion disease despite upregulation of other microglia-enriched transcripts. To study the involvement of SIRPa in prion pathogenesis in vivo, mice expressing a truncated SIRPa protein unable to inhibit phagocytosis were inoculated with rodent-adapted scrapie prions of the 22L strain. Homozygous and heterozygous Sirpa mutants and wild-type mice experienced similar incubation times after inoculation with either of two doses of 22L prions. Moreover, the extent of neuronal loss, microgliosis and abnormal prion protein accumulation was not significantly affected by Sirpa genotypes. Collectively, these data indicate that SIRPa-mediated phagocytosis is not a major determinant in prion disease pathogenesis. It will be important to search for additional candidates mediating prion phagocytosis, as this mechanism may represent an important target of antiprion therapies.	[Nuvolone, Mario; Paolucci, Marta; Sorce, Silvia; Kana, Veronika; Moos, Rita; Aguzzi, Adriano] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland; [Nuvolone, Mario] Univ Pavia, Dept Mol Med, Fdn Sci Inst Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo, Japan	University of Zurich; University Zurich Hospital; University of Pavia; Kobe University	Nuvolone, M; Aguzzi, A (corresponding author), Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland.; Nuvolone, M (corresponding author), Univ Pavia, Dept Mol Med, Fdn Sci Inst Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy.	mario.nuvolone@unipv.it; adriano.aguzzi@usz.ch	Nuvolone, Mario/K-4763-2018	Nuvolone, Mario/0000-0001-8334-1684; Kana, Veronika/0000-0002-9362-3156; Sorce, Silvia/0000-0002-3843-8644; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council (ERC) [250356]; European Union (DEMTEST, NEURINOX); Swiss National Foundation; Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Klinische Forschungsschwerpunkte (KFSPs)	European Research Council (ERC)(European Research Council (ERC)); European Union (DEMTEST, NEURINOX); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX); Klinische Forschungsschwerpunkte (KFSPs)	AA is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the European Union (DEMTEST, NEURINOX), the Swiss National Foundation, the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX) and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2013, NAT REV IMMUNOL, V13, P888, DOI 10.1038/nri3553; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Andreoletti O, 2002, J HISTOCHEM CYTOCHEM, V50, P1357, DOI 10.1177/002215540205001009; Baker CA, 1999, J VIROL, V73, P5089, DOI 10.1128/JVI.73.6.5089-5097.1999; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; BUELER H, 1994, MOL MED, V1, P19; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; Carroll JA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005551; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Floden AM, 2011, J ALZHEIMERS DIS, V25, P279, DOI 10.3233/JAD-2011-101014; Gehlenborg N, 2009, DATABASE, V2009, DOI DOI 10.1093/DATABASE/BAP011; Gitik M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-24; Horrigan SK, 2017, ELIFE, V6; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Iwamoto C, 2014, EXP HEMATOL, V42, P163, DOI 10.1016/j.exphem.2013.11.005; Karki S, 2014, BIOCHEM BIOPH RES CO, V454, P239, DOI 10.1016/j.bbrc.2014.10.081; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lv ZY, 2015, J IMMUNOL, V195, P661, DOI 10.4049/jimmunol.1401719; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Murata Y, 2014, J BIOCHEM, V155, P335, DOI 10.1093/jb/mvu017; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Nuvolone M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171923; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Sorce S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004531; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Szabo R, 2016, J THROMB HAEMOST, V14, P1618, DOI 10.1111/jth.13338; Tada K, 2003, J IMMUNOL, V171, P5718, DOI 10.4049/jimmunol.171.11.5718; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Washio K, 2015, GENES CELLS, V20, P451, DOI 10.1111/gtc.12238; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Williams A, 1997, EXP NEUROL, V144, P433, DOI 10.1006/exnr.1997.6424; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yamao T, 2002, J BIOL CHEM, V277, P39833, DOI 10.1074/jbc.M203287200; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354; Yanagita T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89140; Zhang HY, 2015, BRAIN RES, V1623, P74, DOI 10.1016/j.brainres.2015.03.012; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhu CH, 2016, J EXP MED, V213, P1047, DOI 10.1084/jem.20151000	56	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177876	10.1371/journal.pone.0177876	http://dx.doi.org/10.1371/journal.pone.0177876			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545141	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700092
J	Kato, T; Sato, T; Yokoi, K; Sekido, Y				Kato, T.; Sato, T.; Yokoi, K.; Sekido, Y.			E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells	ONCOGENE			English	Article							NF2 TUMOR-SUPPRESSOR; PLEURAL MESOTHELIOMA; OVARIAN-CANCER; SIGNALING PATHWAYS; GROWTH-FACTOR; LUNG-CANCER; GENE NF2; PROLIFERATION; FAK; PROMOTES	Malignant mesothelioma (MM) is an aggressive tumor commonly caused by asbestos exposure after a long latency. Focal adhesion kinase (FAK) inhibitors inhibit the cell growth of Merlin-deficient MM cells; however, their clinical efficacy has not been clearly determined. The aim of this study was to evaluate the growth inhibitory effect of the FAK inhibitor VS-4718 on MM cell lines and identify biomarkers for its efficacy. Although most Merlin-deficient cell lines were sensitive to VS-4718 compared with control MeT-5A cells, a subset of these cell lines exhibited resistance to this drug. Microarray and qRT-PCR analyses using RNA isolated from Merlin-deficient MM cell lines revealed a significant correlation between E-cadherin mRNA levels and VS-4718 resistance. Merlin-and E-cadherin-negative Y-MESO-22 cells underwent apoptosis upon treatment with a low concentration of VS-4718, whereas Merlin-negative, E-cadherin-positive Y-MESO-9 cells did not undergo VS-4718-induced apoptosis. Furthermore, E-cadherin knockdown in Merlin-negative MM cells significantly sensitized cells to VS-4718 and induced apoptotic cell death upon VS-4718 treatment. Together, our results suggest that E-cadherin serves as a predictive biomarker for molecular target therapy with FAK inhibitors for patients with mesothelioma and that its expression endows MM cells with resistance to FAK inhibitors.	[Kato, T.; Sato, T.; Sekido, Y.] Aichi Canc Ctr, Div Mol Oncol, Res Inst, Nagoya, Aichi, Japan; [Kato, T.; Yokoi, K.] Nagoya Univ, Dept Thorac Surg, Grad Sch Med, Nagoya, Aichi, Japan; [Sekido, Y.] Dept Canc Genet, Program Funct Construct Med, Nagoya, Aichi, Japan	Aichi Cancer Center; Nagoya University	Sekido, Y (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	ysekido@aichi-cc.jp		Kato, Taketo/0000-0003-2568-6603; Sekido, Yoshitaka/0000-0002-2428-3848	JSPS KAKENHI [JP25290053, JP16H04706]; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund [14-24617]; Project Mirai Cancer Research Grants; P-DIRECT; Grants-in-Aid for Scientific Research [16H04706] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Princess Takamatsu Cancer Research Fund; Project Mirai Cancer Research Grants; P-DIRECT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Numbers JP25290053 and JP16H04706), the Takeda Science Foundation, a Research Grant from the Princess Takamatsu Cancer Research Fund (14-24617), Project Mirai Cancer Research Grants, and P-DIRECT. We thank Dr Adi F Gazdar for the cell lines, Dr Hideki Murakami for his technical support during gene expression profiling, and Miwako Nishizawa for her excellent technical assistance. We gratefully thank Dr Hirotaka Osada for the study design and his careful supervision of the data (Dr Osada was a member of our lab and passed away on 23 August 2016).	Addis B, 2009, HISTOPATHOLOGY, V54, P55, DOI 10.1111/j.1365-2559.2008.03178.x; Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Dong LL, 2012, ACTA PHARMACOL SIN, V33, P817, DOI 10.1038/aps.2012.30; Frank AL, 2014, ANN GLOB HEALTH, V80, P257, DOI 10.1016/j.aogh.2014.09.016; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Ishiguro F, 2012, J THORAC ONCOL, V7, P890, DOI 10.1097/JTO.0b013e31824af2db; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Japan Ministry of Health, 2015, TRENDS DEATHS DUE MA; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kakiuchi T, 2016, CARCINOGENESIS, V37, P1098, DOI 10.1093/carcin/bgw084; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lallemand D, 2009, J CELL SCI, V122, P4141, DOI 10.1242/jcs.045914; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Lim STS, 2013, MOL CELLS, V36, P1, DOI 10.1007/s10059-013-0139-1; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marlowe TA, 2016, MOL CANCER THER, V15, P3028, DOI 10.1158/1535-7163.MCT-16-0366; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Muller AM, 2002, VIRCHOWS ARCH, V441, P41, DOI 10.1007/s00428-001-0563-z; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; SEKIDO Y, 1995, CANCER RES, V55, P1227; Sekido Y, 2010, CANCER SCI, V101, P1, DOI 10.1111/j.1349-7006.2009.01336.x; Shah NR, 2014, GYNECOL ONCOL, V134, P104, DOI 10.1016/j.ygyno.2014.04.044; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tanaka I, 2015, ONCOGENE, V34, P73, DOI 10.1038/onc.2013.528; Tang KJ, 2016, CLIN CANCER RES, V22, P5851, DOI 10.1158/1078-0432.CCR-15-2603; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Tanjoni I, 2010, CANCER BIOL THER, V9, P764, DOI 10.4161/cbt.9.10.11434; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738	55	17	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5522	5531		10.1038/onc.2017.147	http://dx.doi.org/10.1038/onc.2017.147			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28553954				2022-12-26	WOS:000411960500008
J	Kumar, S; Bharti, D; Shazib, SUA; Shin, MK				Kumar, Santosh; Bharti, Daizy; Shazib, Shahed Uddin Ahmed; Shin, Mann Kyoon			Discovery of a new hypotrich ciliate from petroleum contaminated soil	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CILIOPHORA; MORPHOGENESIS; OXYTRICHIDAE; MORPHOLOGY; PROTOZOA; KAHL; N.	Pollution after oil spill represents extreme habitat for survival and is a major concern for loss of species diversity in the affected area. In this study, we investigated soil samples collected from a petrochemical industry, Ulsan, South Korea. The soil was in the phase of recovery from the contamination of crude oil spill. Detailed investigation, based on morphology, ontogenesis, and molecular phylogenetic methods, resulted in discovery of a novel hypotrich ciliate, i.e., Metasterkiella koreana n. gen., n. sp., which is morphologically characterized by a semirigid body, undulating membranes in Oxytricha pattern, 18 frontal-ventral-transverse cirri with cirrus V/3 placed posteriorly, one right and one left row of marginal cirri, four dorsal kineties, two dorsomarginal rows, and caudal cirri at the end of dorsal kineties 1, 2, and 4. Interestingly, during ontogenesis, formation of three common anlagen for the proter and the opisthe and involvement of cirrus V/3 in anlagen formation was observed. The dorsal ontogenesis was typical of oxytrichids, i.e., simple fragmentation of dorsal kinety 3 and formation of dorsomarginal rows close to the right marginal row. The new species was found to be similar with Sterkiella subtropica, except for some minor differences in morphometry, and at gene level with only one base pair difference. In phylogenetic analyses, based on SSU rRNA gene sequence, M. koreana cluster in a clade away from Sterkiella species, which could be explained by the differences in the morphogenetic pattern between these two genera. It is proposed that S. subtropica probably belongs to Metasterkiella; however, we do not perform changes and wait for the reinvestigation of its morphogenetic pattern.	[Kumar, Santosh; Bharti, Daizy; Shazib, Shahed Uddin Ahmed; Shin, Mann Kyoon] Univ Ulsan, Dept Biol Sci, Coll Nat Sci, Ulsan, South Korea; [Kumar, Santosh] Prani Vigyan Bhawan, Zool Survey India, Kolkata, India	University of Ulsan; Zoological survey of India	Shin, MK (corresponding author), Univ Ulsan, Dept Biol Sci, Coll Nat Sci, Ulsan, South Korea.	mkshin@ulsan.ac.kr	SHAZIB, SHAHED UDDIN AHMED/AAT-2802-2021; Shin, Mann Kyoon/M-7043-2013	SHAZIB, SHAHED UDDIN AHMED/0000-0001-9470-8568; Shin, Mann Kyoon/0000-0001-6592-1204	National Research Foundation of Korea (NRF) from the Ministry of Education, Ministry of Science, ICT and Future Planning; National Institute of Biological Resources (NIBR) from the Ministry of Education, Ministry of Science, ICT and Future Planning; Ministry of Environment of Korean government [2015R1D1A09058911, 2015H1D3A1062066, NIBR201701201]	National Research Foundation of Korea (NRF) from the Ministry of Education, Ministry of Science, ICT and Future Planning(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); National Institute of Biological Resources (NIBR) from the Ministry of Education, Ministry of Science, ICT and Future Planning; Ministry of Environment of Korean government(Ministry of Environment (ME), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) and National Institute of Biological Resources (NIBR) from the Ministry of Education, Ministry of Science, ICT and Future Planning, and Ministry of Environment of Korean government (2015R1D1A09058911, 2015H1D3A1062066 and NIBR201701201).	Berger H, 1997, ARCH PROTISTENKD, V148, P125; BERGER H, 1985, PROTISTOLOGICA, V21, P295; Berger H., 1999, MONOGRAPHIAE BIOL, V78, P1, DOI DOI 10.1007/978-94-011-4637-1; Blatterer H., 2003, Linzer Biologische Beitraege, V35, P831; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen XM, 2015, INT J SYST EVOL MICR, V65, P2292, DOI 10.1099/ijs.0.000253; Chen XM, 2013, INT J SYST EVOL MICR, V63, P1912, DOI 10.1099/ijs.0.048611-0; Foissner W., 1987, Progress in Protistology, V2, P69; Foissner W, 1999, ACTA PROTOZOOL, V38, P215; Foissner Wilhelm, 2006, V81, P1; Foissner Wilhelm, 2016, Denisia, V35, P1; Foissner W, 2014, ACTA PROTOZOOL, V53, P159, DOI 10.4467/16890027AP.14.015.1596; Foissner Wilhelm, 2002, Denisia, V5, P1; Gong J, 2007, J EUKARYOT MICROBIOL, V54, P468, DOI 10.1111/j.1550-7408.2007.00288.x; KAMRA K, 1990, EUR J PROTISTOL, V25, P264, DOI 10.1016/S0932-4739(11)80179-3; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, EUR J PROTISTOL, V56, P200, DOI 10.1016/j.ejop.2016.09.006; Kumar S, 2016, EUR J PROTISTOL, V53, P61, DOI 10.1016/j.ejop.2015.10.001; Kumar S, 2015, EUR J PROTISTOL, V51, P86, DOI 10.1016/j.ejop.2014.12.002; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miller M.A., 2010, P GAT COMP ENV WORKS; Pan HB, 2013, J EUKARYOT MICROBIOL, V60, P44, DOI 10.1111/jeu.12005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; ROGERSON A, 1982, T AM MICROSC SOC, V101, P27, DOI 10.2307/3225568; ROGERSON A, 1981, J GEN MICROBIOL, V124, P53; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santoferrara LF, 2013, PROTIST, V164, P24, DOI 10.1016/j.protis.2011.12.002; Shazib SUA, 2016, MOL PHYLOGENET EVOL, V102, P128, DOI 10.1016/j.ympev.2016.05.041; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wallengren H, 1900, BIH K SVENSK VET, V26, P1	32	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178657	10.1371/journal.pone.0178657	http://dx.doi.org/10.1371/journal.pone.0178657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570607	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800095
J	Shai, N; Sikweyiya, Y; van der Heijden, I; Abrahams, N; Jewkes, R				Shai, Nwabisa; Sikweyiya, Yandisa; van der Heijden, Ingrid; Abrahams, Naeemah; Jewkes, Rachel			"I was in the darkness but the group brought me light": Development, relevance and feasibility of the Sondela HIV adjustment and coping intervention	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; CRITICAL CONSCIOUSNESS; CAPE-TOWN; CARE; PREVENTION; PEOPLE; HIV/AIDS	Developing interventions that address psychosocial wellbeing of people living with HIV is critical to ensure strong linkages to and retention in HIV care. This paper describes the development of Sondela, an HIV adjustment and coping intervention for heterosexual men and women living with HIV, and its relevance and feasibility in the South African context. Sondela is a six three-hour, small group-based, participatory workshop series. We followed an iterative, multi-phased process of curriculum development that involved research, theoretical frameworks and piloting. A systematic review highlighted the absence of psychosocial interventions targeting heterosexual HIV positive populations living in high HIV prevalence and resource-poor settings. Formative studies demonstrated risk and social factors associated with adjustment and coping with HIV, emphasising the need for interventions that acknowledge gendered experiences. Our pilot of Sondela demonstrated high levels of relevance and feasibility. Men appreciated the workshop "space" to openly talk about their HIV positive status and what is means for their role as partners and fathers and friends. Women valued the skills and approaches because they were relevant to "real life" situations and not just about HIV. Sondela promises to be valuable in supporting health system initiatives and psychosocial support to strengthen linkages to and retention in HIV care, and this suggests a need for rigorous evaluation of Sondela to establish evidence for its effectiveness in a general population.	[Shai, Nwabisa; Sikweyiya, Yandisa; van der Heijden, Ingrid; Abrahams, Naeemah; Jewkes, Rachel] MRC, Gender & Hlth Res Unit, Pretoria, South Africa; [Shai, Nwabisa; Sikweyiya, Yandisa; Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [van der Heijden, Ingrid] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Abrahams, Naeemah] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa; [Abrahams, Naeemah] Univ Cape Town, Sch Hlth & Rehabil Sci, Fac Hlth, Cape Town, South Africa	University of Witwatersrand; University of Cape Town; University of the Western Cape; University of Cape Town	Shai, N (corresponding author), MRC, Gender & Hlth Res Unit, Pretoria, South Africa.; Shai, N (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	Nwabisa.Shai@mrc.ac.za	Abrahams, Naeemah/AAF-1144-2020	Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267; Abrahams, Naeemah/0000-0002-6138-6256	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001137-4]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This paper was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention, under the terms of Cooperative Agreement Number 5U2GPS001137-4. The South African Medical Research Council is a member of the said Cooperative Agreement and also provided funding support for the production of this paper.; This paper was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention, under the terms of Cooperative Agreement Number 5U2GPS001137-4.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Abrahams N, 2015, DEV TESTING GENDER B; Angelino Andrew F., 2002, Top HIV Med, V10, P31; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Basavaraj K H, 2010, Indian J Sex Transm Dis AIDS, V31, P75, DOI 10.4103/0253-7184.74971; Campbell C, 2002, SOC SCI MED, V55, P331, DOI 10.1016/S0277-9536(01)00289-1; Campbell C, 2000, SOC SCI MED, V50, P479, DOI 10.1016/S0277-9536(99)00317-2; Carrico AW, 2009, AIDS BEHAV, V13, P555, DOI 10.1007/s10461-008-9429-6; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MH, 2004, AM J PUBLIC HEALTH, V94, P1147, DOI 10.2105/AJPH.94.7.1147; Colbert AM, 2010, J ASSOC NURSE AIDS C, V21, P302, DOI 10.1016/j.jana.2009.11.004; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; Dageid W, 2012, CULT HEALTH SEX, V14, P925, DOI 10.1080/13691058.2012.710337; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Department of Health, 2014, NAT CON GUID PREV MO; du Toit E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096867; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Fomundam H, 2015, 7 SA AIDS C 2015 10; Freire Paolo, 1972, PEDAGOGY OPPRESSED; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gordillo V, 2009, J BEHAV MED, V32, P523, DOI 10.1007/s10865-009-9222-7; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Handwerker P. W., 2001, QUICK ETHNOGRAPHY GU; Hatcher AM, 2016, SOC SCI MED, V168, P130, DOI 10.1016/j.socscimed.2016.09.013; Hatcher A, 2011, HEALTH EDUC RES, V26, P542, DOI 10.1093/her/cyq057; Hatcher AM, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19233; Hatcher AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049821; Hudson A L, 2001, J Assoc Nurses AIDS Care, V12, P68, DOI 10.1016/S1055-3290(06)60218-5; JEWKES R, 2002, STEPPING STONES S AF; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jones AS, 2010, WOMEN HEALTH ISS, V20, P335, DOI 10.1016/j.whi.2010.03.005; Kalichman S C, 2001, J Assoc Nurses AIDS Care, V12, P58, DOI 10.1016/S1055-3290(06)60217-3; Katz MH, 2001, ANN INTERN MED, V135, P557, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00006; Kenyon C, 2010, SAHARA J-J SOC ASP H, V7, P35, DOI 10.1080/17290376.2010.9724967; Khan R.A., 2013, THESIS; Kirby D., 2011, REDUCING ADOLESCENT; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Lawless S, 1996, SOC SCI MED, V43, P1371, DOI 10.1016/0277-9536(96)00017-2; Lazarus R.S., 1984, EMOTION ADAPTATION; Leventhal H, 1989, STRESS REDUCTION PRE, P5; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Misselhorn A, 2014, SEX EDUC-SEX SOC LEA, V14, P543, DOI 10.1080/14681811.2014.905463; Mkhize L., 2009, THESIS; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; National Institute of Communicable Diseases, 2014, UNPUB; Nezu AM, 2001, BEHAV THER, V32, P537, DOI 10.1016/S0005-7894(01)80035-6; Nichols JE, 2002, HIV RELATED STRESSOR, P113; Pakenham KI, 2001, J BEHAV MED, V24, P259, DOI 10.1023/A:1010718823753; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Reihling H, 2013, SOC DYNAMICS, V39, P92, DOI 10.1080/02533952.2013.772738; Reilly T, 2004, HEALTH SOC WORK, V29, P97, DOI 10.1093/hsw/29.2.97; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Sikweyiya YM, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24631; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sowell RL, 2003, HEALTH EDUC RES, V18, P32, DOI 10.1093/her/18.1.32; Treisman G, 2007, CLIN INFECT DIS, V45, pS313, DOI 10.1086/522556; UNAIDS, 2016, PREV GAP REP; van der Heijden I, 2013, COCHRANE DB SYST REV; van der Heijden I, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010806.pub2; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Welbourn A., 1995, PACKAGE FACILITATORS	73	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178135	10.1371/journal.pone.0178135	http://dx.doi.org/10.1371/journal.pone.0178135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6HZ	28570597	Green Submitted, gold, Green Published			2022-12-26	WOS:000402611800030
J	Vorkapic, E; Folkesson, M; Magnell, K; Bohlooly-Y, M; Lanne, T; Wagsater, D				Vorkapic, Emina; Folkesson, Maggie; Magnell, Kerstin; Bohlooly-Y, Mohammad; Lanne, Toste; Wagsater, Dick			ADAMTS-1 in abdominal aortic aneurysm	PLOS ONE			English	Article							MATRIX; INFLAMMATION; EXPRESSION	Introduction Extracellular matrix degradation is a hallmark of abdominal aortic aneurysm (AAA). Among proteases that are capable of degrading extracellular matrix are a disintegrin and metalloproteases with thrombospondin motifs (ADAMTS). Pathogenesis of these proteases in AAA has not been investigated until date. Methods and results Human aneurysmal and control aortas were collected and analyzed with RT-PCR measuring the ADAMTS-1, 4,5,6,8,9,10,13,17 and ADAMTSL-1. Expression of a majority of the investigated ADAMTS members on mRNA level was decreased in aneurysm compared to control aorta. ADAMTS-1 was one of the members that was reduced most. Protein analysis using immunohistochemistry and western blot for localization and expression of ADAMTS-1 revealed that ADAMTS-1 was present predominantly in areas of SMCs and macrophages in aneurysmal aorta and higher expressed in AAA compared to control aortas. The role of ADAMTS-1 in AAA disease was further examined using ADAMTS-1 transgenic/apoE(-/-) mice with the experimental angiotensin II induced aneurysmal model. Transgenic mice overexpressing ADAMTS-1 showed to be similar to ADAMTS-1 wild type mice pertaining collagen, elastin content and aortic diameter. Conclusion Several of the ADAMTS members, and especially ADAMTS-1, are down regulated at mRNA level in AAA, due to unknown mechanisms, at the same time ADAMTS-1 protein is induced. The cleavage of its substrates, don't seem to be crucial for the pathogenesis of AAA but rather more important in the development of thoracic aortic aneurysm and atherosclerosis as shown in previous studies.	[Vorkapic, Emina; Folkesson, Maggie; Wagsater, Dick] Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Magnell, Kerstin; Bohlooly-Y, Mohammad] AstraZeneca R&D, Div Discovery Sci, Innovat Med, Molndal, Sweden; [Lanne, Toste] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Lanne, Toste] Cty Council Ostergotland, Dept Cardiovasc Surg, Linkoping, Sweden	Linkoping University; AstraZeneca; Linkoping University; City Council Ostergotland	Wagsater, D (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden.	dick.wagsater@liu.se		, Dick/0000-0002-3655-2419	Swedish Research Council [2016-02626]; Swedish Heart-Lung Foundation [20160779, 2013-0650]; Ake Wibergs stiftelse [M16-0070]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Ake Wibergs stiftelse	This work was supported by Swedish Research Council (vr.se, Grant #2016-02626, DW), the Swedish Heart-Lung Foundation (iungfonden.se, Grant#20160779, DW and #2013-0650, TL) and Ake Wibergs stiftelse (ake.wiberg.se, Grant#M16-0070, DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandler S, 1996, BIOCHEM BIOPH RES CO, V228, P421, DOI 10.1006/bbrc.1996.1677; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Folkesson M, 2015, THROMB HAEMOSTASIS, V114, P1165, DOI 10.1160/TH14-10-0899; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kazi M, 2005, ARTERIOSCL THROM VAS, V25, P1341, DOI 10.1161/01.ATV.0000166601.49954.21; Lipp C, 2012, J VASC RES, V49, P198, DOI 10.1159/000332959; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Ren PP, 2013, ANN THORAC SURG, V95, P570, DOI 10.1016/j.athoracsur.2012.10.084; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Vorkapic E, 2016, ATHEROSCLEROSIS, V249, P101, DOI 10.1016/j.atherosclerosis.2016.04.006; Vorkapic E, 2015, ATHEROSCLEROSIS, V241, P561, DOI 10.1016/j.atherosclerosis.2015.06.014; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Wagsater D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31414	15	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178729	10.1371/journal.pone.0178729	http://dx.doi.org/10.1371/journal.pone.0178729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570682	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800112
J	Xu, HL; Su, WC; Zhang, D; Sun, LL; Wang, HL; Xue, F; Zhai, SG; Zou, ZG; Wu, RH				Xu, Hongle; Su, Wangcang; Zhang, Di; Sun, Lanlan; Wang, Hengliang; Xue, Fei; Zhai, Shunguo; Zou, Zeguo; Wu, Renhai			Influence of environmental factors on Cucumis melo L. var. agrestis Naud. seed germination and seedling emergence	PLOS ONE			English	Article							BURIED WEED SEEDS; HERBICIDES; MANAGEMENT; SALINITY; DORMANCY; ECOLOGY; GROWTH	Cucumis melo L. var. agrestis Naud. (field muskmelon) is an annual invasive weed in many parts of Asia. However, there is very little available information about the germination and emergence of this species. Therefore, laboratory experiments were conducted to evaluate the effects of light, temperature, salt stress, osmotic stress, pH, and depth of planting on field muskmelon germination and seedling emergence. Light had no effect on seed germination, and the seeds germinated at a wide range of temperatures. More than 90% of the seeds germinated at constant temperatures between 20 degrees C and 35 degrees C, and fluctuating day/night temperatures between 15/25 and 30/40 degrees C. The seeds were tolerant to salinity as germination occurred up to the 200 mM NaCl treatment. However, the seeds were sensitive to osmotic stress as seed germination was completely inhibited at -0.6 MPa. The seeds germinated over a pH range of 4 to 10, which suggested that pH was not a limiting factor for germination. Seedling emergence was greatest (97.86%) when the seeds were planted on the soil surface, but emergence declined as the burial depth increased. Information from this study can be used to predict future infestations in China and help develop strategies to manage this species.	[Xu, Hongle; Su, Wangcang; Zhang, Di; Sun, Lanlan; Wang, Hengliang; Xue, Fei; Wu, Renhai] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China; [Xu, Hongle; Su, Wangcang; Zhang, Di; Sun, Lanlan; Wang, Hengliang; Xue, Fei; Wu, Renhai] Henan Key Lab Crop Pest Control, Zhengzhou, Peoples R China; [Xu, Hongle; Su, Wangcang; Zhang, Di; Sun, Lanlan; Wang, Hengliang; Xue, Fei; Wu, Renhai] Key Lab Integrated Pest Management Crops Southern, Zhengzhou, Peoples R China; [Zhai, Shunguo; Zou, Zeguo] Luoshan Inst Agr Sci, Xinyang, Peoples R China	Henan Academy of Agricultural Sciences	Wu, RH (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Peoples R China.; Wu, RH (corresponding author), Henan Key Lab Crop Pest Control, Zhengzhou, Peoples R China.; Wu, RH (corresponding author), Key Lab Integrated Pest Management Crops Southern, Zhengzhou, Peoples R China.	renhai.wu@163.com	Wang, Hengliang/AAL-5340-2021	Wang, Hengliang/0000-0001-8476-4320	Special Fund for Agro-scientific Research in the Public Interest [201203098]; Special fund for independent innovation of Henan Academy of Agricultural Sciences [2017ZC41]	Special Fund for Agro-scientific Research in the Public Interest; Special fund for independent innovation of Henan Academy of Agricultural Sciences	The present study has been supported by the Special Fund for Agro-scientific Research in the Public Interest (201203098) and Special fund for independent innovation of Henan Academy of Agricultural Sciences (2017ZC41).	Asgarpour R, 2015, WEED SCI, V63, P502, DOI 10.1614/WS-D-14-00162.1; Asif Tanveer, 2012, Pakistan Journal of Weed Science Research, V18, P445; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO, P705; BASKIN JM, 1985, BIOSCIENCE, V35, P492, DOI 10.2307/1309817; Benvenuti S, 2003, AGRON J, V95, P191, DOI 10.2134/agronj2003.0191; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bewley JD, 1994, SEEDS PHYSL DEV GERM, V3rd, P445, DOI 10.1007/978-1-4899-1002-8; Bhowmik PC, 1997, WEED SCI, V45, P349, DOI 10.1017/S0043174500092973; Bolfrey-Arku GEK, 2011, WEED SCI, V59, P182, DOI 10.1614/WS-D-10-00095.1; BRECKE BJ, 1995, WEED SCI, V43, P103, DOI 10.1017/S0043174500080899; Chachalis D, 2000, WEED SCI, V48, P212, DOI 10.1614/0043-1745(2000)048[0212:FACRSG]2.0.CO;2; Chauhan BS, 2008, WEED SCI, V56, P383, DOI 10.1614/WS-07-154.1; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Dai WanHong, 2009, Acta Pedologica Sinica, V46, P851; Edelstein M, 2001, SEED SCI RES, V11, P265; Grichar WJ, 2007, WEED TECHNOL, V21, P777, DOI 10.1614/WT-06-173.1; Grichar WJ, 2007, WEED TECHNOL, V21, P688, DOI 10.1614/WT-06-166.1; *ISTA, 1985, SEED SCI TECHNOL, V13, P307; KERJE T, 2000, ACTA HORTIC, V510, P37; Koger CH, 2004, WEED SCI, V52, P989, DOI 10.1614/WS-03-139R2; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Motsa MM, 2015, S AFR J BOT, V99, P29, DOI 10.1016/j.sajb.2015.03.185; Norsworthy JK, 2006, WEED SCI, V54, P903, DOI 10.1614/WS-06-070R2.1; Oliveira MJ, 2006, WEED SCI, V54, P910, DOI 10.1614/WS-06-068R.1.1; Ramirez AHM, 2014, WEED SCI, V62, P45, DOI 10.1614/WS-D-13-00041.1; REDDY KN, 1992, WEED SCI, V40, P195, DOI 10.1017/S0043174500057210; SMITH CA, 1992, WEED RES, V32, P103, DOI 10.1111/j.1365-3180.1992.tb01867.x; Sohrabi S, 2016, S AFR J BOT, V105, P1, DOI 10.1016/j.sajb.2016.03.002; Sohrabikertabad S, 2013, PLANTA DANINHA, V31, P833, DOI 10.1590/S0100-83582013000400009; Sposito G., 2008, CHEM SOILS, V2nd; Susko DJ, 1999, WEED SCI, V47, P585, DOI 10.1017/S0043174500092304; Tingle CH, 2003, WEED SCI, V51, P56, DOI 10.1614/0043-1745(2003)051[0056:IOEFOS]2.0.CO;2; Wang H.W., 2009, P 3 NAT AC C ENV CHE, VIV, P138; Zapata PJ, 2004, PLANT SCI, V167, P781, DOI 10.1016/j.plantsci.2004.05.014; [张哲 Zhang Zhe], 2016, [植物保护, Plant Protection], V42, P254; Zhang ZZ, 1961, J ANHUI AGR SCI, V01, P57	38	10	12	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178638	10.1371/journal.pone.0178638	http://dx.doi.org/10.1371/journal.pone.0178638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570590	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800093
J	Im, JJ; Kim, B; Hwang, J; Kim, JE; Kim, JY; Rhie, SJ; Namgung, E; Kang, I; Moon, S; Lyoo, IK; Park, CH; Yoon, S				Im, Jooyeon Jamie; Kim, Binna; Hwang, Jaeuk; Kim, Jieun E.; Kim, Jung Yoon; Rhie, Sandy Jeong; Namgung, Eun; Kang, Ilhyang; Moon, Sohyeon; Lyoo, In Kyoon; Park, Chang-Hyun; Yoon, Sujung			Diagnostic potential of multimodal neuroimaging in posttraumatic stress disorder	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; 3-YEAR FOLLOW-UP; QUALITY-OF-LIFE; NEURONAL CIRCUITS; FUNCTIONAL MRI; FEAR CIRCUIT; PTSD; AMYGDALA; SCHIZOPHRENIA	Despite accumulating evidence of physiological abnormalities related to posttraumatic stress disorder (PTSD), the current diagnostic criteria for PTSD still rely on clinical interviews. In this study, we investigated the diagnostic potential of multimodal neuroimaging for identifying posttraumatic symptom trajectory after trauma exposure. Thirty trauma-exposed individuals and 29 trauma-unexposed healthy individuals were followed up over a 5-year period. Three waves of assessments using multimodal neuroimaging, including structural magnetic resonance imaging (MRI) and diffusion-weighted MRI, were performed. Based on previous findings that the structural features of the fear circuitry-related brain regions may dynamically change during recovery from the trauma, we employed a machine learning approach to determine whether local, connectivity, and network features of brain regions of the fear circuitry including the amygdala, orbitofrontal and ventromedial prefrontal cortex (OMPFC), hippocampus, insula, and thalamus could distinguish trauma-exposed individuals from trauma-unexposed individuals at each recovery stage. Significant improvement in PTSD symptoms was observed in 23%, 52%, and 88% of trauma-exposed individuals at 1.43, 2.68, and 3.91 years after the trauma, respectively. The structural features of the amygdala were found as major classifiers for discriminating trauma-exposed individuals from trauma-unexposed individuals at 1.43 years after the trauma, but these features were nearly normalized at later phases when most of the trauma-exposed individuals showed clinical improvement in PTSD symptoms. Additionally, the structural features of the OMPFC showed consistent predictive values throughout the recovery period. In conclusion, the current study provides a promising step forward in the development of a clinically applicable predictive model for diagnosing PTSD and predicting recovery from PTSD.	[Im, Jooyeon Jamie; Kim, Binna; Kim, Jieun E.; Kim, Jung Yoon; Namgung, Eun; Kang, Ilhyang; Moon, Sohyeon; Lyoo, In Kyoon; Park, Chang-Hyun; Yoon, Sujung] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Im, Jooyeon Jamie; Kim, Binna] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul, South Korea; [Hwang, Jaeuk] Soonchunhyang Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Kim, Jieun E.; Kim, Jung Yoon; Namgung, Eun; Kang, Ilhyang; Lyoo, In Kyoon; Yoon, Sujung] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Rhie, Sandy Jeong] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Rhie, Sandy Jeong] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Moon, Sohyeon; Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	Ewha Womans University; Seoul National University (SNU); Soonchunhyang University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Park, CH; Yoon, S (corresponding author), Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea.; Yoon, S (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea.	chang-hyun.park@ewha.ac.kr; sujungjyoon@ewha.ac.kr	Kim, Jung Yoon/AAC-5343-2020	Kim, Jung Yoon/0000-0002-2396-9514; Hwang, Jaeuk/0000-0003-0528-3305	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3C7A1028373, 2015M3C7A1028376]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015M3C7A1028373 and 2015M3C7A1028376 to JEK and IKL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Breslau N, 2001, J CLIN PSYCHIAT, V62, P55; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Dejean C, 2015, BIOL PSYCHIAT, V78, P298, DOI 10.1016/j.biopsych.2015.03.017; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fan Y, 2007, NEUROIMAGE, V36, P1189, DOI 10.1016/j.neuroimage.2007.04.009; First M. D., 1996, USERS GUIDE STRUCTUR; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Galatzer-Levy IR, 2014, J PSYCHIATR RES, V59, P68, DOI 10.1016/j.jpsychires.2014.08.017; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Li HH, 2013, NAT NEUROSCI, V16, P332, DOI 10.1038/nn.3322; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; North CS, 2002, J URBAN HEALTH, V79, P383, DOI 10.1093/jurban/79.3.383; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Sripada RK, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00672; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Ulas A, 2011, INT J IMAG SYST TECH, V21, P179, DOI 10.1002/ima.20279; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Wu HC, 2006, AUST NZ J PSYCHIAT, V40, P355, DOI 10.1111/j.1440-1614.2006.01802.x; Yang HH, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00192; Yoon S, 2017, NEUROPSYCHOPHARMACOL, V42, P454, DOI 10.1038/npp.2016.136	44	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177847	10.1371/journal.pone.0177847	http://dx.doi.org/10.1371/journal.pone.0177847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558004	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000016
J	Sala, S; Catillon, M; Hadzic, E; Schaffner-Reckinger, E; Van Troys, M; Ampe, C				Sala, Stefano; Catillon, Marie; Hadzic, Ermin; Schaffner-Reckinger, Elisabeth; Van Troys, Marleen; Ampe, Christophe			The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactions	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; TUMOR-SUPPRESSOR; ACTIN; VINCULIN; ZYXIN; BREAST; EVL	The focal adhesion protein testin is a modular scaffold and tumour suppressor that consists of an N-terminal cysteine rich (CR) domain, a PET domain of unknown function and three C-terminal LIM domains. Testin has been proposed to have an open and a closed conformation based on the observation that its N-terminal half and C-terminal half directly interact. Here we extend the testin conformational model by demonstrating that testin can also form an antiparallel homodimer. In support of this extended model we determined that the testin region (amino acids 52-233) harbouring the PET domain interacts with the C-terminal LIM1-2 domains in vitro and in cells, and assign a critical role to tyrosine 288 in this interaction.	[Sala, Stefano; Van Troys, Marleen; Ampe, Christophe] Univ Ghent, Dept Biochem, Ghent, Belgium; [Catillon, Marie; Hadzic, Ermin; Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSTC, Luxembourg, Luxembourg	Ghent University; University of Luxembourg	Ampe, C (corresponding author), Univ Ghent, Dept Biochem, Ghent, Belgium.	christophe.ampe@ugent.be		Sala, Stefano/0000-0003-3675-6849; Van Troys, Marleen/0000-0003-4283-8103; Christophe, Ampe/0000-0002-8554-3594	PhD scholarship [FWO-Inter UGent-UL G.0353.11N, FWO-Inter UGent-UL INTER/FWO/10/01]	PhD scholarship	This work was supported by PhD scholarship to SS - Fonds Wetenschappelijk Onderzoek Vlaanderen (http://www.fwo.be/); Grant FWO-Inter UGent-UL G.0353.11N to CA (http:// www.fwo.be/); PhD scholarship to EH - Fonds National de la Recherche, Luxembourg (http://fnr.lu/); and FWO-Inter UGent-UL INTER/FWO/10/01 to Evelyne Friederich, taken over by ESR (http://fnr.lu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Boeda B, 2011, J BIOL CHEM, V286, P11543, DOI 10.1074/jbc.M110.171264; Chinthalapudi K, 2015, BIOCHEMISTRY-US, V54, P2758, DOI 10.1021/acs.biochem.5b00015; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Eyckerman S, 2016, J PROTEOME RES, V15, P3929, DOI 10.1021/acs.jproteome.6b00517; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Garvalov BK, 2003, J CELL BIOL, V161, P33, DOI 10.1083/jcb.200211015; Golji J, 2014, BIOPHYS J, V107, P1802, DOI 10.1016/j.bpj.2014.08.038; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Griffith E, 2004, CELL MOTIL CYTOSKEL, V57, P133, DOI 10.1002/cm.10162; Gronenborn AM, 2009, CURR OPIN STRUC BIOL, V19, P39, DOI 10.1016/j.sbi.2008.12.002; Gu ZP, 2014, MED SCI MONITOR, V20, P980, DOI 10.12659/MSM.890544; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Hadzic E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140511; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Leyman S, 2009, MOL BIOL CELL, V20, P4509, DOI 10.1091/mbc.E09-02-0121; Li H, 2014, ONCOTARGET, V7, P45819; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Oldenburg J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17225; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Sala S, 2017, J PROTEOME RES; Sarti M, 2005, CLIN CANCER RES, V11, P806; Sweede M, 2008, BIOCHEMISTRY-US, V47, P13524, DOI 10.1021/bi801037h; Thompson PM, 2013, FEBS LETT, V587, P1220, DOI 10.1016/j.febslet.2013.02.042; Weeks RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151341; Weeks RJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-163; Wodak SJ, 2015, BIOPHYS J ELSERVIER, V109, P1067; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126; Zhong YL, 2009, MOL CELL BIOCHEM, V320, P85, DOI 10.1007/s11010-008-9901-7; Zhu J, 2012, CANCER SCI, V103, P2092, DOI 10.1111/cas.12020	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177879	10.1371/journal.pone.0177879	http://dx.doi.org/10.1371/journal.pone.0177879			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542564	Green Published, gold			2022-12-26	WOS:000401672400106
J	Fang, YX; Jonas, JB; Yokoi, T; Cao, KJ; Shinohara, K; Ohno-Matsui, K				Fang, Yuxin; Jonas, Jost B.; Yokoi, Tae; Cao, Kejia; Shinohara, Kosei; Ohno-Matsui, Kyoko			Macular Bruch's membrane defect and dome-shaped macula in high myopia	PLOS ONE			English	Article							CHOROIDAL NEOVASCULARIZATION; EYE GROWTH; ATROPHY; ZONE	Purpose To examine an association between macular Bruch's membrane defects (MBMD) and a dome-shaped appearance of the macula (DSM). Design Retrospective, observational case series study. Methods The study included highly myopic individuals who were consecutively examined between May 2014 and December 2015. The patients underwent swept-source optical coherence tomography (OCT) for visualization of DSM and MBMDs defined as Bruch's membrane defects located at a distance of maximal 1500 mu m from the foveola. Results Out of 1983 highly myopic eyes (1057 patients), 166 eyes (8.4%; 95% confidence interval (CI): 7.2%, 9.6%)) showed a DSM and 534 eyes showed a MBMD. In multivariate binary regression analysis, higher prevalence of DSM was associated with a higher prevalence of a MBMD (P<0.001; OR: 1.96; 95% CI: 1.40, 2.75) after adjusting for longer axial length (P<0.001; odds ratio (OR): 1.27; 95% CI: 1.16, 1.38). In eyes with a DSM partially surrounded by a MBMD, the retina, retinal pigment epithelium (RPE) and choroid appeared relatively unchanged in the central region with Bruch's membrane (BM) preserved. In the ring-like BM-free region surrounding the central prominent island of the DSM, the RPE, the outer and middle retinal layers, the choriocapillaris and the middle-sized choroidal vessel layer were absent. In association with a DSM, three MBMD types were differentiated: MBMDs in patchy chorioretinal atrophy, MBMDs in choroidal neovascularization-related macular atrophy, and MBMDs as temporally extending large parapapillary gamma zone. Conclusions Presence of a DSM was significantly associated with the presence of MBMDs. The morphology of the DSM in association with MBMDs may be associated with a focal relaxation of the posterior sclera, no longer pushed outward by an expanding BM but allowed to partially bulge inward, leading to the formation of a DSM.	[Fang, Yuxin; Yokoi, Tae; Cao, Kejia; Shinohara, Kosei; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Tokyo Medical & Dental University (TMDU); Ruprecht Karls University Heidelberg	Ohno-Matsui, K (corresponding author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan.	k.ohno.oph@tmd.ac.jp			Japanese Society for Promotion of Science [15H04993, 15K15629]; Grants-in-Aid for Scientific Research [15H04993] Funding Source: KAKEN	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Society for Promotion of Science (number; 15H04993, 15K15629). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ACTA OPHTHALMOL; [Anonymous], INVEST OPHTHALMOL VI; Bird AC, 2014, JAMA OPHTHALMOL, V132, P338, DOI 10.1001/jamaophthalmol.2013.5799; Caillaux V, 2013, AM J OPHTHALMOL, V156, P958, DOI 10.1016/j.ajo.2013.06.032; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Ellabban AA, 2014, AM J OPHTHALMOL; Ellabban AA, 2013, AM J OPHTHALMOL, V155, P320, DOI 10.1016/j.ajo.2012.08.007; Gaucher D, 2008, AM J OPHTHALMOL, V145, P909, DOI 10.1016/j.ajo.2008.01.012; GOTTLIEB MD, 1987, INVEST OPHTH VIS SCI, V28, P1225; Groen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019985; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; Hogan MJ, 1971, HISTOLOGY HUMAN EYE, P320; Imamura Y, 2011, AM J OPHTHALMOL, V151, P297, DOI 10.1016/j.ajo.2010.08.014; Ito-Ohara M, 1998, OPHTHALMOLOGICA, V212, P23, DOI 10.1159/000027254; Jonas JB, 2016, ACTA OPHTHALMOL; Jonas JB, 2017, BRUCH MEMBRANE MECH; Jonas JB, 2016, INVEST OPHTH VIS SCI, V57, P1791, DOI 10.1167/iovs.15-18529; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Ohno-Matsui K, 2016, AM J OPHTHALMOL, V166, P22, DOI 10.1016/j.ajo.2016.03.019; Ohno-Matsui K, 2016, AM J OPHTHALMOL, V162, P133, DOI 10.1016/j.ajo.2015.11.014; Ohno-Matsui K, 2015, AM J OPHTHALMOL, V159, P877, DOI 10.1016/j.ajo.2015.01.022; Smith EL, 2009, INVEST OPHTH VIS SCI, V50, P5057, DOI 10.1167/iovs.08-3232; Viola F, 2014, AM J OPHTHALMOL; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5	27	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178998	10.1371/journal.pone.0178998	http://dx.doi.org/10.1371/journal.pone.0178998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570624	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800135
J	Jraissati, Y; Douven, I				Jraissati, Yasmina; Douven, Igor			Does optimal partitioning of color space account for universal color categorization?	PLOS ONE			English	Article							LANGUAGE; APPEARANCE; EVOLUTION; COGNITION; YELLOW	A 2007 study by Regier, Kay, and Khetarpal purports to show that universal categories emerge as a result of optimal partitioning of color space. Regier, Kay, and Khetarpal only consider color categorizations of up to six categories. However, in most industrialized societies eleven color categories are observed. This paper shows that when applied to the case of eleven categories, Regier, Kay, and Khetarpal's optimality criterion yields unsatisfactory results. Applications of the criterion to the intermediate cases of seven, eight, nine, and ten color categories are also briefly considered and are shown to yield mixed results. We consider a number of possible explanations of the failure of the criterion in the case of eleven categories, and suggest that, as color categorizations get more complex, further criteria come to play a role, alongside Regier, Kay, and Khetarpal's optimality criterion.	[Jraissati, Yasmina] Amer Univ Beirut, Dept Philosophy, Beirut, Lebanon; [Douven, Igor] Paris Sorbonne Univ, Sci, Normes, Decis CNRS, Paris, France	American University of Beirut; UDICE-French Research Universities; Sorbonne Universite	Jraissati, Y (corresponding author), Amer Univ Beirut, Dept Philosophy, Beirut, Lebanon.	yasmina.jraissati@gmail.com			Centre for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC [AH/L007053/1]; Center for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC (Art and Humanities Research Council) [AH/L007053/1]; Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish; AHRC [AH/L007053/1] Funding Source: UKRI	Centre for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC; Center for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC (Art and Humanities Research Council); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	We are greatly indebted to Terry Regier, who provided extensive and very valuable comments on two previous versions of this paper. For further comments, we are grateful to Alejandro Parraga, Steven Verheyen, and an anonymous referee. Henrik Singmann gave useful advice on the hydroPSO optimization procedure, for which we thank him. The first author's research for this project was supported by a fellowship from the Centre for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC grant "Rethinking the Senses" (AH/L007053/1). This support is also gratefully acknowledged.; The first author's research project was supported by a fellowship from the Center for the Study of the Senses, Institute of Philosophy, School of Advanced Study, University of London, in the context of AHRC (Art and Humanities Research Council) grant "Rethinking the Senses" (AH/L007053/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J., 2012, P ANN M COGNITIVE SC, V34, P60; Abbott JT, 2016, P NATL ACAD SCI USA, V113, P11178, DOI 10.1073/pnas.1513298113; ABRAMOV I, 1994, ANNU REV PSYCHOL, V45, P451, DOI 10.1146/annurev.ps.45.020194.002315; Al-rasheed AS, 2014, PSYCHOLOGY, V5, P1714, DOI DOI 10.4236/PSYCH.2014.515179; [Anonymous], 1997, COLOR CATEGORIES THO; [Anonymous], VISION RES; Berlin B., 1969, BASIC COLOR TERMS TH; Bimler D, 2007, J COGN CULT, V7, P173, DOI 10.1163/156853707X208477; Boas Franz, 1938, MIND PRIMITIVE MAN; Churchland P, 2007, PHILOS SCI, V74, P119, DOI 10.1086/519027; Claidiere N, 2008, J COGN CULT, V8, P211, DOI 10.1163/156853708X358155; Cook R.S., 2005, HDB CATEGORIZATION C, P223; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; Davidoff J, 2001, TRENDS COGN SCI, V5, P382, DOI 10.1016/S1364-6613(00)01726-5; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P512, DOI 10.1073/pnas.97.1.512; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; Fairchild M.D., 2013, COLOUR APPEARANCE MO, DOI DOI 10.1002/9781118653128; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Garner W. R., 1974, PROCESSING INFORM ST; Hering E., 1964, OUTLINES THEORY LIGH; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jakobson Roman, 1972, CHILD LANGUAGE APHAS, P14; Jameson K., 1997, COLOR CATEGORIES THO, P295, DOI DOI 10.1017/CBO9780511519819.014; Jameson KA, 2005, J COGN CULT, V5, P293, DOI 10.1163/156853705774648527; Kamieniecki K, 2016, CEC CROSS ENTROPY CL; KAY P, 1978, LANGUAGE, V54, P610, DOI 10.2307/412789; Kay P, 1999, AM ANTHROPOL, V101, P743, DOI 10.1525/aa.1999.101.4.743; Kay P., 1991, J LINGUIST ANTHROPOL, V1, P12, DOI [10.1525/jlin.1991.1.1.12, DOI 10.1525/JLIN.1991.1.1.12]; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Khetarpal N., 2009, P 31 ANN C COGN SCI, P2396; Lenneberg EH, 1956, INDIANA U PUBLICATIO, V13, P1; LILJENCRANTS J, 1972, LANGUAGE, V48, P839, DOI 10.2307/411991; MacAdam DL, 1942, J OPT SOC AM, V32, P247, DOI 10.1364/JOSA.32.000247; MACLAURY RE, 1987, AM ANTHROPOL, V89, P107, DOI 10.1525/aa.1987.89.1.02a00060; Maechler M., 2016, CLUSTER CLUSTERANALY; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Molinier Ch, 2006, CAHIERS GRAMMAIRE, V30, P259; Munsell A. H., 1941, COLOR NOTATION ILLUS; Newhall SM, 1943, J OPT SOC AM, V33, P385, DOI 10.1364/JOSA.33.000385; PAGE EB, 1963, J AM STAT ASSOC, V58, P216, DOI 10.2307/2282965; Parraga CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149538; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Regier T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151138; Regier T, 2015, BLACKW HBK LINGUIST, P237; Regier T, 2009, LANGUAGE, V85, P884; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2005, CROSS-CULT RES, V39, P56, DOI 10.1177/1069397104267890; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Sharma G., 2012, P SPIE COLOR IMAGING, V8292, P1; Shepard R.N., 1992, ADAPTED MIND EVOLUTI, P495; Stanlaw James, 1997, COLOR CATEGORIES THO, P240; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; van Dongen S., 2000, INSR0012 NAT RES I M; Whorf B.L., 1940, TECHNOL REV, V44, P229; Whorf B. L., 1940, TECHNOL REV, V42, P247; Witzel C, 2013, J VISION, V13, DOI 10.1167/13.7.1; Xu J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3073; Yendrikhovskij SN, 2001, COLOR RES APPL, V26, pS235, DOI 10.1002/1520-6378(2001)26:1+<::AID-COL50>3.0.CO;2-O; Zambrano-Bigiarini M., 2014, HYDROPSO PARTICLE SW	62	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178083	10.1371/journal.pone.0178083	http://dx.doi.org/10.1371/journal.pone.0178083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EW6HZ	28570598	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800026
J	Pagnotta, MA; Fernandez, JA; Sonnante, G; Egea-Gilabert, C				Pagnotta, Mario A.; Fernandez, Juan A.; Sonnante, Gabriella; Egea-Gilabert, Catalina			Genetic diversity and accession structure in European Cynara cardunculus collections	PLOS ONE			English	Article							POPULATION-STRUCTURE; WILD CARDOON; MICROSATELLITE LOCI; CULTIVATED CARDOON; RAPD VARIATION; SSR MARKERS; ARTICHOKE; L.; AFLP; SOFTWARE	Understanding the distribution of genetic variations and accession structures is an important factor for managing genetic resources, but also for using proper germplasm in association map analyses and breeding programs. The globe artichoke is the fourth most important horticultural crop in Europe. Here, we report the results of a molecular analysis of a collection including globe artichoke and leafy cardoon germplasm present in the Italian, French and Spanish gene banks. The aims of this study were to: (i) assess the diversity present in European collections, (ii) determine the population structure, (iii) measure the genetic distance between accessions; (iv) cluster the accessions; (v) properly distinguish accessions present in the different national collections carrying the same name; and (vi) understand the diversity distribution in relation to the gene bank and the geographic origin of the germplasm. A total of 556 individuals grouped into 174 accessions of distinct typologies were analyzed by different types of molecular markers, i.e. dominant (ISSR and AFLP) and co-dominant (SSR). The data of the two crops (globe artichoke and leafy cardoon) were analyzed jointly and separately to compute, among other aims, the gene diversity, heterozygosity (He, Ho), fixation indexes, AMOVA, genetic distance and structure. The findings underline the huge diversity present in the analyzed material, and the existence of alleles that are able to discriminate among accessions. The accessions were clustered not only on the basis of their typology, but also on the basis of the gene bank they come from. Probably, the environmental conditions of the different field gene banks affected germplasm conservation. These outcomes will be useful in plant breeding to select accessions and to fingerprint varieties. Moreover, the results highlight the particular attention that should be paid to the method used to conserve the Cynara cardunculus germplasm and suggest to the preference of using accessions from different gene banks to run an association map.	[Pagnotta, Mario A.] Tuscia Univ, Dipartimento Sci Agr & Forestali DAFNE, Viterbo, Italy; [Pagnotta, Mario A.; Egea-Gilabert, Catalina] Univ Politecn Cartagena, ETS Ingn Agronoma, Ciencia & Tecnol Agr, Cartagena, Murcia, Spain; [Fernandez, Juan A.] Univ Politecn Cartagena, ETS Ingn Agronoma, Prod Vegetal, Cartagena, Murcia, Spain; [Fernandez, Juan A.; Egea-Gilabert, Catalina] Univ Politecn Cartagena, IBV, Cartagena, Murcia, Spain; [Sonnante, Gabriella] CNR, Inst Biosci & Bioresources, Natl Res Council, Bari, Italy	Tuscia University; Universidad Politecnica de Cartagena; Universidad Politecnica de Cartagena; Universidad Politecnica de Cartagena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Pagnotta, MA (corresponding author), Tuscia Univ, Dipartimento Sci Agr & Forestali DAFNE, Viterbo, Italy.; Pagnotta, MA (corresponding author), Univ Politecn Cartagena, ETS Ingn Agronoma, Ciencia & Tecnol Agr, Cartagena, Murcia, Spain.	pagnotta@unitus.it	Pagnotta, Mario/H-7872-2019; Fernández, Juan A./K-6611-2014	Pagnotta, Mario/0000-0002-5436-3478; Fernández, Juan A./0000-0001-7959-7118	Seneca Foundation; AGRI GEN RES Community Programme (European Commission, Directorate-General for Agriculture and Rural Development, under Council Regulation (EC) [870/2004]	Seneca Foundation(Fundacion Seneca); AGRI GEN RES Community Programme (European Commission, Directorate-General for Agriculture and Rural Development, under Council Regulation (EC)	The authors acknowledge the financial support from the CYNARES project, sponsored by the AGRI GEN RES Community Programme (European Commission, Directorate-General for Agriculture and Rural Development, under Council Regulation (EC) No 870/2004), and the Seneca Foundation for its program "Estancias de Investigadores Visitantes", for mobility, cooperation and internationalization 2015; with the aims to encourage researcher mobility, scientific exchange and attracting research talent and knowledge to the province of Murcia.; AGRI GEN RES Community Programme (European Commission, Directorate-General for Agriculture and Rural Development, under Council Regulation (EC) No 870/2004) financially supported the project. Financial support was also provided by The Seneca Foundation for its program "Estancias de Investigadores Visitantes", for mobility, cooperation and internationalization.	Acquadro A, 2010, PLANT CELL TISS ORG, V100, P329, DOI 10.1007/s11240-009-9654-3; Acquadro A, 2003, MOL ECOL NOTES, V3, P37, DOI 10.1046/j.1471-8286.2003.00343.x; Acquadro A, 2005, MOL ECOL NOTES, V5, P272, DOI 10.1111/j.1471-8286.2005.00897.x; Acquadro A, 2005, GENOME, V48, P217, DOI [10.1139/G04-111, 10.1139/g04-111]; [Anonymous], 2013, CPVO TP 184 2 GLOBE; Ben Ammar I, 2015, SCI HORTIC-AMSTERDAM, V185, P76, DOI 10.1016/j.scienta.2015.01.017; Bianco V.V., 1990, ORTICOLTURA, P209; Boury S, 2012, ACTA HORTIC, V942, P81, DOI 10.17660/ActaHortic.2012.942.8; Brown A. H. D., 1989, The use of plant genetic resources., P136; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Ciancolini A, 2012, EUPHYTICA, V186, P433, DOI 10.1007/s10681-012-0634-z; Cravero V, 2007, J AM SOC HORTIC SCI, V132, P208, DOI 10.21273/JASHS.132.2.208; Cravero V, 2010, SCI HORTIC-AMSTERDAM, V126, P73, DOI 10.1016/j.scienta.2010.07.012; Crino P, 2008, GENET RESOUR CROP EV, V55, P823, DOI 10.1007/s10722-007-9287-5; Crino P, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010014; Curci PL, 2016, MOL ECOL RESOUR, V16, P562, DOI 10.1111/1755-0998.12457; De Felice B, 2015, GENET RESOUR CROP EV, P1; Engelman L, 1985, BMDP STATISTICAL SOF, P464; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAOSTAT, 2016, PROD 2014; Foury C., 1989, ACTA HORTIC, V242, P155; Frankel O. H., 1984, Genetic manipulation: impact on man and society., P161; Gatto A, 2013, ANN BOT-LONDON, V112, P855, DOI 10.1093/aob/mct150; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; HEDRICK PW, 1987, GENETICS, V117, P331; Lahoz I, 2011, SCI HORTIC-AMSTERDAM, V127, P188, DOI 10.1016/j.scienta.2010.10.002; Lanteri S, 2004, J HORTIC SCI BIOTECH, V79, P863, DOI 10.1080/14620316.2004.11511858; Lanteri S, 2001, PLANT BREEDING, V120, P243, DOI 10.1046/j.1439-0523.2001.00605.x; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lo Bianco C, 2011, MOL BREEDING, V27, P157, DOI 10.1007/s11032-010-9418-0; Mauro R, 2009, CONSERV GENET, V10, P431, DOI 10.1007/s10592-008-9621-2; Messmer M., 2002, Journal of Herbs, Spices & Medicinal Plants, V9, P177, DOI 10.1300/J044v09n02_25; Mondini L., 2009, Diversity, V1, P19; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Noorani A, 2013, ACTA HORTIC, V983, P47, DOI 10.17660/ActaHortic.2013.983.4; Noorani A, 2012, ACTA HORTIC, V942, P49, DOI 10.17660/ActaHortic.2012.942.3; Pagnotta M.A., 2014, GENOMICS PLANT GENET, P559, DOI [10.1007/978-94-007-7572-5_23, DOI 10.1007/978-94-007-7572-5_23]; Pagnotta MA, 2004, ACTA HORTIC, P99, DOI 10.17660/ActaHortic.2004.660.11; Pagnotta MA, 1995, ISRAEL J PLANT SCI, V43, P347, DOI 10.1080/07929978.1995.10676621; Pandino G, 2012, SCI HORTIC-AMSTERDAM, V138, P259, DOI 10.1016/j.scienta.2012.02.032; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pignone D, 2004, GENET RESOUR CROP EV, V51, P577, DOI 10.1023/B:GRES.0000024786.01004.71; Porceddu E, 1976, ATT 2 C INT STUD CAR, P1105; Portis E, 2005, PLANT SCI, V168, P1591, DOI 10.1016/j.plantsci.2005.02.009; Portis E, 2005, PLANT BREEDING, V124, P299, DOI 10.1111/j.1439-0523.2005.01098.x; Portis E, 2005, PLANT SCI, V169, P199, DOI 10.1016/j.plantsci.2005.03.014; Pritchard JK, 2000, GENETICS, V155, P945; Raccuia SA, 2004, PLANT BREEDING, V123, P280, DOI 10.1111/j.1439-0523.2004.00983.x; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Snyder M.J., 1979, P 3 C INT STUD CARC; Sonnante G., 2003, Plant Genetic Resources: Characterization and Utilization, V1, P125, DOI 10.1079/PGR200319; Sonnante G, 2004, ACTA HORTIC, P61, DOI 10.17660/ActaHortic.2004.660.6; Sonnante G, 2002, GENET RESOUR CROP EV, V49, P247, DOI 10.1023/A:1015574627621; Sonnante G, 2008, GENET RESOUR CROP EV, V55, P1029, DOI 10.1007/s10722-008-9310-5; Sonnante G, 2007, ANN BOT-LONDON, V100, P1095, DOI 10.1093/aob/mcm127; Sonnante G, 2011, THEOR APPL GENET, V123, P1215, DOI 10.1007/s00122-011-1661-1; Tivang J, 1996, J AM SOC HORTIC SCI, V121, P783, DOI 10.21273/JASHS.121.5.783; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	63	14	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178770	10.1371/journal.pone.0178770	http://dx.doi.org/10.1371/journal.pone.0178770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570688	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800120
J	Vieira, MC; McCowan, LME; Gillett, A; Poston, L; Fyfe, E; Dekker, GA; Baker, PN; Walker, JJ; Kenny, LC; Pasupathy, D				Vieira, Matias C.; McCowan, Lesley M. E.; Gillett, Alexandra; Poston, Lucilla; Fyfe, Elaine; Dekker, Gustaaf A.; Baker, Philip N.; Walker, James J.; Kenny, Louise C.; Pasupathy, Dharmintra		SCOPE Consortium	Clinical, ultrasound and molecular biomarkers for early prediction of large for gestational age infants in nulliparous women: An international prospective cohort study	PLOS ONE			English	Article							EXPECTANT MANAGEMENT; FETAL MACROSOMIA; RISK; PREGNANCY; OBESITY; PREECLAMPSIA; INDUCTION; CENTILES; WEIGHT; MODEL	Objective To develop a prediction model for term infants born large for gestational age (LGA) by customised birthweight centiles. Methods International prospective cohort of nulliparous women with singleton pregnancy recruited to the Screening for Pregnancy Endpoints (SCOPE) study. LGA was defined as birthweight above the 90(th) customised centile, including adjustment for parity, ethnicity, maternal height and weight, fetal gender and gestational age. Clinical risk factors, ultrasound parameters and biomarkers at 14-16 or 19-21 weeks were combined into a prediction model for LGA infants at term using stepwise logistic regression in a training dataset. Prediction performance was assessed in a validation dataset using area under the Receiver Operating Characteristics curve (AUC) and detection rate at fixed false positive rates. Results The prevalence of LGA at term was 8.8% (n = 491/5628). Clinical and ultrasound factors selected in the prediction model for LGA infants were maternal birthweight, gestational weight gain between 14-16 and 19-21 weeks, and fetal abdominal circumference, head circumference and uterine artery Doppler resistance index at 19-21 weeks (AUC 0.67; 95%CI 0.63-0.71). Sensitivity of this model was 24% and 49% for a fixed false positive rate of 10% and 25%, respectively. The addition of biomarkers resulted in selection of random glucose, LDL-cholesterol, vascular endothelial growth factor receptor-1 (VEGFR1) and neutrophil gelatinase-associated lipocalin (NGAL), but with minimal improvement in model performance (AUC 0.69; 95%CI 0.65-0.73). Sensitivity of the full model was 26% and 50% for a fixed false positive rate of 10% and 25%, respectively. Conclusion Prediction of LGA infants at term has limited diagnostic performance before 22 weeks but may have a role in contingency screening in later pregnancy.	[Vieira, Matias C.; Gillett, Alexandra; Poston, Lucilla; Pasupathy, Dharmintra] Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England; [Vieira, Matias C.; Gillett, Alexandra; Poston, Lucilla; Pasupathy, Dharmintra] Kings Hlth Partners, London, England; [Vieira, Matias C.] Pontificia Univ Catolica Rio Grande do Sul, Escola Med, Nucleo Formacao Especifica Ginecol & Obstet, Porto Alegre, RS, Brazil; [McCowan, Lesley M. E.; Fyfe, Elaine] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland, New Zealand; [Poston, Lucilla; Pasupathy, Dharmintra] Guys & St Thomas NH Fdn Trust, NIHR Biomed Res Ctr, London, England; [Poston, Lucilla; Pasupathy, Dharmintra] Kings Coll London, London, England; [Dekker, Gustaaf A.] Univ Adelaide, Lyell McEwin Hosp, Womens & Childrens Div, Adelaide, SA, Australia; [Baker, Philip N.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Walker, James J.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Dept Obstet & Gynaecol, Leeds, W Yorkshire, England; [Kenny, Louise C.] Cork Univ, Matern Hosp, Irish Ctr Fetal & Neonatal Translat Res INFANT, Dept Obstet & Gynaecol,Univ Coll Cork, Cork, Ireland	University of London; King's College London; University of London; King's College London; Pontificia Universidade Catolica Do Rio Grande Do Sul; University of Auckland; University of London; King's College London; Lyell McEwin Hospital; University of Adelaide; University of Leicester; University of Leeds; University College Cork	Pasupathy, D (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, Div Womens Hlth, London, England.; Pasupathy, D (corresponding author), Guys & St Thomas NH Fdn Trust, NIHR Biomed Res Ctr, London, England.	dharmintra.pasupathy@kcl.ac.uk	Kenny, Louise/X-6329-2019; Pasupathy, Dharmintra/N-9586-2019; Kenny, Louise C/G-1112-2011	Kenny, Louise/0000-0002-9011-759X; Pasupathy, Dharmintra/0000-0002-6722-1006; Kenny, Louise C/0000-0002-9011-759X; Poston, Lucilla/0000-0003-1100-2821; /0000-0002-8076-4275; Gillett, Alexandra/0000-0002-5069-3197	South Australian Government; NHM RC [GNT519225]; Foundation for Research Science and Technology; Health Research Council [04/198]; Auckland District Health Board Charitable Trust; Health Research Board of Ireland [CSA/2007/2]; National Health Service NEAT [FSD025]; Biotechnology and Biological Sciences Research council [GT084]; University of Manchester; Guy's and St. Thomas' Charity (King's College London) and Tommy's Charity (King's College London and University of Manchester); Cerebra UK (University of Leeds); Alere Inc, San Diego, CA; CAPES [BEX: 9571/13-2]; Science Foundation Ireland [12/RC/2272]; Tommy's Charity, UK; King's College London; National Institute for Health Research [CL-2010-17-007] Funding Source: researchfish	South Australian Government; NHM RC(National Health and Medical Research Council (NHMRC) of Australia); Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Health Research Council; Auckland District Health Board Charitable Trust; Health Research Board of Ireland; National Health Service NEAT; Biotechnology and Biological Sciences Research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester; Guy's and St. Thomas' Charity (King's College London) and Tommy's Charity (King's College London and University of Manchester); Cerebra UK (University of Leeds); Alere Inc, San Diego, CA; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Tommy's Charity, UK; King's College London(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	The Australian SCOPE study was supported by the Premier's Science and Research Fund, South Australian Government, and a NHM RC project grant (GNT519225). The New Zealand SCOPE study was funded by the New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council [04/198]; Evelyn Bond Fund, Auckland District Health Board Charitable Trust. The Irish SCOPE study was funded by the Health Research Board of Ireland [CSA/2007/2]. The UK SCOPE study was funded by National Health Service NEAT Grant [Neat Grant FSD025], Biotechnology and Biological Sciences Research council [GT084] and University of Manchester Proof of Concept Funding (University of Manchester); Guy's and St. Thomas' Charity (King's College London) and Tommy's Charity (King's College London and University of Manchester); and Cerebra UK (University of Leeds). Biomarker measurement was funded by an unrestricted research grant from Alere Inc, San Diego, CA. MCV is supported by a Science Without Borders Fellowship from CAPES (BEX: 9571/13-2). LCK is supported by a Science Foundation Ireland Program Grant for INFANT (12/RC/2272). DP and LP are supported by Tommy's Charity, UK. Open access for this article was funded by King's College London (Open Scholarship Fund). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert PS, 2012, STAT MED, V31, P143, DOI 10.1002/sim.4405; Berntorp K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0722-x; Boulvain M, 2015, LANCET, V385, P2600, DOI 10.1016/S0140-6736(14)61904-8; Campbell S, 2014, ULTRASOUND OBST GYN, V43, P3, DOI 10.1002/uog.13268; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Frick AP, 2015, ULTRASOUND OBSTET GY; Gardosi J, 2009, BJOG-INT J OBSTET GY, V116, P1356, DOI 10.1111/j.1471-0528.2009.02245.x; Goetzinger KR, 2013, J PERINATOL, V33, P352, DOI 10.1038/jp.2012.130; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Heywood RE, 2009, AM J PERINAT, V26, P165, DOI 10.1055/s-0028-1095187; Irion O, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000938.; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Lindell G, 2013, ULTRASOUND OBST GYN, V41, P398, DOI 10.1002/uog.11218; Mossayebi E, 2014, PEDIATR NEONATOL, V55, P28, DOI 10.1016/j.pedneo.2013.05.006; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Pasupathy D, 2012, PAEDIATR PERINAT EP, V26, P543, DOI 10.1111/ppe.12002; Poston L, 2015, LANCET DIABETES ENDO; Sanchez-Ramos L, 2002, OBSTET GYNECOL, V100, P997, DOI 10.1016/S0029-7844(02)02321-9; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Sparks TN, 2011, J MATERN-FETAL NEO M, V24, P708, DOI 10.3109/14767058.2010.516285; Tarca AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164161; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Tyrrell J, 2016, JAMA-J AM MED ASSOC, V315, P1129, DOI 10.1001/jama.2016.1975; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	25	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178484	10.1371/journal.pone.0178484	http://dx.doi.org/10.1371/journal.pone.0178484			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570613	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800060
J	Ariff, MI; Yahya, A; Zaki, R; Sarimin, R; Ghazali, IMM; Gill, BS; Suli, Z; Yusof, MAM; Lutfi, NA; Thye, SL; Ismail, F; Mahmud, M; Bakri, R				Ariff, Mohd Izhar; Yahya, Abqariyah; Zaki, Rafdzah; Sarimin, Roza; Ghazali, Izzuna Mudla Mohamed; Gill, Balvinder Singh; Suli, Zailiza; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Thye, Sin Lian; Ismail, Fatanah; Mahmud, Maimunah; Bakri, Rugayah			Evaluation of awareness & utilisation of clinical practise guideline for management of adult Dengue infection among Malaysia doctors	PLOS ONE			English	Article							CARE	Clinical Practice Guideline (CPG) provides evidence-based guidance for the management of Dengue Infection in adult patients. A cross sectional study was conducted to evaluate awareness and utilization of CPG among doctors in public or private hospitals and clinics in Malaysia. Doctors practicing only at hospital Medical and Emergency Departments were included, while private specialist clinics were excluded in this study. A multistage proportionate random sampling according to region (Central, Northern, Southern, Eastern, Sabah and Sarawak) was performed to select study participants. The overall response rate was 74% (84% for public hospitals, 82% for private hospitals, 70% for public clinics, and 64% for private clinics). The CPG Awareness and Utilization Feedback Form were used to determine the percentage in the study. The total numbers of respondent were 634 with response rate of 74%. The mean lengths of service of the respondent were 13.98 (11.55).A higher percentages of doctors from public facilities (99%) were aware of the CPG compared to those in private facilities (84%). The percentage of doctors utilising the CPG were also higher (98%) in public facilities compared to private facilities (86%). The percentage of Medical Officer in private facilities that utilizing the CPG were 84% compares to Medical Officer in public facilities 98%. The high percentage of doctors using the CPG in both public (97%) and private (94%) hospitals were also observed. However, only 69% of doctors in private clinics utilised the CPG compared to doctors in public clinics (98%). Doctors in both public and private facilities were aware of the dengue CPG. However, most doctors in private clinic were less likely to utilise the CPG. Therefore, there is a need to increase the level of CPG utilisation especially in private clinics.	[Ariff, Mohd Izhar] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Yahya, Abqariyah; Zaki, Rafdzah] Univ Malaya, Fac Med, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Sarimin, Roza; Ghazali, Izzuna Mudla Mohamed; Suli, Zailiza; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Thye, Sin Lian; Bakri, Rugayah] Minist Hlth, Med Dev Div, Hlth Technol Assessment Sect, Putrajaya, Malaysia; [Gill, Balvinder Singh] Minist Hlth, Dis Control Div, Informat & Documentat Surveillance Sect, Putrajaya, Malaysia; [Ismail, Fatanah] Minist Hlth, Family Hlth Div, Putrajaya, Malaysia; [Ismail, Fatanah] Minist Hlth, Inst Hlth Management, Putrajaya, Malaysia; [Mahmud, Maimunah] Minist Hlth, Jinjang Hlth Clin, Putrajaya, Malaysia; [Bakri, Rugayah] Minist Hlth, Med Dev Div, Hlth Technol Assessment Sect, Putrajaya, Malaysia	Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Yahya, A (corresponding author), Univ Malaya, Fac Med, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	abqariyah.yahya@ummc.edu.my	Suli, Zailiza/AAG-4045-2019; Yahya, Abqariyah/B-5638-2017; ZAKI, RAFDZAH AHMAD/B-9520-2010	Yahya, Abqariyah/0000-0001-9158-415X; ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198	University Malaya Research Fund Assistance (BKP) [BK029-2014]; University of Malaya research Grant [RP034C-15HTM]; Director General of Health, Ministry of Health, Malaysia; UM BKP Grant [BK029-2014]; UMRG Grant [RP034C-15HTM]	University Malaya Research Fund Assistance (BKP); University of Malaya research Grant; Director General of Health, Ministry of Health, Malaysia; UM BKP Grant; UMRG Grant	This study was supported and funded by University Malaya Research Fund Assistance (BKP) Grant: BK029-2014 and University of Malaya research Grant: RP034C-15HTM, URLs:https://www.um.edu.my/research-and-community/information-for-researchers/research-funding/university-imalaya grant.; The authors would like to thank the Director General of Health, Ministry of Health, Malaysia for supporting the work described in this paper and permission to publish this paper. We are indebted to patients and controls for their kind participation. The authors also thank Nurul Syafika Amir Hamzah, Nor Samsuhada Ahmad, Zulaikha Abd Halim, Farid Aspar, Fahmi Zawawi and Zulhelmi Mansor for the collection of data, Rosnah Siran and Mohd Tholib for practical help and assistance. This study was supported and funded by UM BKP Grant: BK029-2014 and UMRG Grant: RP034C-15HTM.	Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Grimshaw J M, 1994, Qual Health Care, V3, P45, DOI 10.1136/qshc.3.1.45; Guzman Maria, 2004, Expert Rev Vaccines, V3, P511, DOI 10.1586/14760584.3.5.511; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15; Hameed L. M., 2014, C MAN MUAM 2014 U IS; Heneghan C, 2007, BRIT J GEN PRACT, V57, P948, DOI 10.3399/096016407782604965; Kularatne S. A. M., 2015, BMC RES NOTES, V8; Kumarasamy V, 2006, Med J Malaysia, V61, P1; Lee LK, 2011, ANN ACAD MED SINGAP, V40, P533; McKinlay JB, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-006-0075-2; Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Plumb B, 2015, POSTGRAD MED J, V91, P3, DOI 10.1136/postgradmedj-2013-132181; Santamaria R, 2009, INT HEALTH, V1, P133, DOI 10.1016/j.inhe.2009.08.006; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x	16	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178137	10.1371/journal.pone.0178137	http://dx.doi.org/10.1371/journal.pone.0178137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562626	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700044
J	Lee, AJ; Bhattacharya, R; Scheuermann, RH; Pickett, BE				Lee, Alexandra J.; Bhattacharya, Roshni; Scheuermann, Richard H.; Pickett, Brett E.			Identification of diagnostic peptide regions that distinguish Zika virus from related mosquito-borne Flaviviruses	PLOS ONE			English	Article							DENGUE VIRUS; SWISS-MODEL; ENVELOPE GLYCOPROTEIN; CROSS-REACTIVITY; ANTIBODIES; SEROPREVALENCE; EPITOPES; DATABASE; CHIKUNGUNYA; ENVIRONMENT	Zika virus (ZIKV) is a member of the Flavivirus genus of positive-sense single-stranded RNA viruses, which includes Dengue, West Nile, Yellow Fever, and other mosquito-borne arboviruses. Infection by ZIKV can be difficult to distinguish from infection by other mosquito -borne Flaviviruses due to high sequence similarity, serum antibody cross-reactivity, and virus co-circulation in endemic areas. Indeed, existing serological methods are not able to consistently differentiate ZIKV from other Flaviviruses, which makes it extremely difficult to accurately calculate the incidence rate of Zika-associated Guillain-Barre in adults, microcephaly in newborns, or asymptomatic infections within a geographical area. In order to identify Zika-specific peptide regions that could be used as serology reagents, we have applied comparative genomics and protein structure analyses to identify amino acid residues that distinguish each of 10 Flavivirus species and subtypes from each other by calculating the specificity, sensitivity, and surface exposure of each residue in relevant target proteins. For ZIKV we identified 104 and 116 15-mer peptides in the E glycoprotein and NS1 non-structural protein, respectively, that contain multiple diagnostic sites and are located in surface-exposed regions in the tertiary protein structure. These sensitive, specific, and surface -exposed peptide regions should serve as useful reagents for seroprevalence studies to better distinguish between prior infections with any of these mosquito-borne Flaviviruses. The development of better detection methods and diagnostic tools will enable clinicians and public health workers to more accurately estimate the true incidence rate of asymptomatic infections, neurological syndromes, and birth defects associated with ZIKV infection.	[Lee, Alexandra J.; Bhattacharya, Roshni; Scheuermann, Richard H.; Pickett, Brett E.] J Craig Venter Inst, La Jolla, CA 92037 USA; [Bhattacharya, Roshni] San Diego State Univ, Biol & Med Informat, San Diego, CA 92182 USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Scheuermann, Richard H.] La Jolla Inst Allergy & Immunol, La Jolla, CA USA	J. Craig Venter Institute; California State University System; San Diego State University; University of California System; University of California San Diego; La Jolla Institute for Immunology	Pickett, BE (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.	bpickett@jcvi.org	Pickett, Brett/AAE-3582-2020	Pickett, Brett/0000-0001-7930-8160; Lee, Alexandra/0000-0002-0208-3730	United States National Institute of Allergy and Infectious Diseases from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Department of Health and Human Services [HHSN272201400028C, U19A1110819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110819] Funding Source: NIH RePORTER	United States National Institute of Allergy and Infectious Diseases from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) under contract number HHSN272201400028C, U19A1110819 (Genomic Centers for Infectious Diseases) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartley LM, 2002, EPIDEMIOL INFECT, V128, P213, DOI 10.1017/S0950268801006495; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Conlan JV, 2015, AM J TROP MED HYG, V93, P1010, DOI 10.4269/ajtmh.15-0072; CRASKE J, 1990, VOX SANG, V59, P160, DOI 10.1111/j.1423-0410.1990.tb00851.x; Crill WD, 2007, J GEN VIROL, V88, P1169, DOI 10.1099/vir.0.82640-0; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Ergunay K, 2010, VECTOR-BORNE ZOONOT, V10, P771, DOI 10.1089/vbz.2009.0130; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; FONG TL, 1991, HEPATOLOGY, V14, P64, DOI 10.1002/hep.1840140111; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329; Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Organization WH, 2016, ZIK SIT REP; Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saqi MAS, 1998, PROTEIN ENG, V11, P627, DOI 10.1093/protein/11.8.627; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stave JW, 2013, J IMMUNOL, V191, P1428, DOI 10.4049/jimmunol.1203198; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463	54	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178199	10.1371/journal.pone.0178199	http://dx.doi.org/10.1371/journal.pone.0178199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562637	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700046
J	Connolly, C; Madden, SF; Buggy, DJ; Gallagher, HC				Connolly, C.; Madden, S. F.; Buggy, D. J.; Gallagher, H. C.			Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasis	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; CANCER SURGERY; INHIBITION; MECHANISMS; ACTIVATION; PROPOFOL; KETAMINE; SURVIVAL; INVASION; MORPHINE	Background Retrospective analyses suggest anaesthetic-analgesics technique during cancer surgery may affect recurrence/metastasis. This could involve direct effects of anaesthetic-analgesic drugs on cancer cells. While mu-opioid receptor over-expression in lung tumours is associated with greater metastasis, other anaesthetic-analgesic receptor targets in cancer recurrence/metastasis remain unexplored. Therefore, we evaluated the association between genetic expression of anaesthetic-analgesic receptor targets and recurrence/metastasis, using a repository of breast cancer gene expression and matching clinical data. Methods A list of 23 genes encoding for the most prominent anaesthetic-analgesic receptor targets was compiled. This was processed through BreastMark- an algorithm integrating gene expression data from-17,000 samples and clinical data from >4,500 breast cancer samples. Gene expression data was dichotomized using disease-free survival (survival without recurrence) and distant disease-free survival (survival without metastasis) as end points. Hazard ratios were calculated by Cox-regression analysis. Enrichment for prognostic markers was determined by randomly choosing 23-member gene lists from all available genes, calculating how often >5 significant markers were observed and adjusting p-values for multiple testing. This was repeated 10,000 times and an empirical p-value calculated. Results Of 23 selected genes, 9 were significantly associated with altered rates of metastasis and 4 with recurrence on univariate analysis. Adjusting for multiple testing, 5 of these 9 genes remained significantly associated with metastasis, non with recurrence. This ratio of genes (5/23) was not significantly enriched for markers of metastasis (p = 0.07). Conclusion Several anaesthetic-analgesic receptor genes were associated with metastatic spread in breast cancer. Overall there was no significant enrichment in prognostic markers of metastasis, although a trend was observed.	[Connolly, C.; Buggy, D. J.; Gallagher, H. C.] Mater Misericordiae Univ Hosp, Dept Anaesthesia, Dublin, Ireland; [Connolly, C.; Buggy, D. J.; Gallagher, H. C.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Madden, S. F.] Royal Coll Surg, Dept Psychol, RCSI Populat Hlth Sci, Dublin, Ireland; [Buggy, D. J.; Gallagher, H. C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Buggy, D. J.] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA	Mater Misericordiae University Hospital; University College Dublin; University College Dublin; Royal College of Surgeons - Ireland; University College Dublin; University College Dublin; Cleveland Clinic Foundation	Connolly, C; Buggy, DJ (corresponding author), Mater Misericordiae Univ Hosp, Dept Anaesthesia, Dublin, Ireland.; Connolly, C; Buggy, DJ (corresponding author), Univ Coll Dublin, Sch Med, Dublin, Ireland.	caraconnolly83@gmail.com; donal.buggy@ucd.ie		Buggy, Donal/0000-0003-3922-4397; Madden, Stephen/0000-0002-0489-4588; Gallagher, Helen C./0000-0003-0297-838X				Alexander SPH, 2013, BRIT J PHARMACOL, V70, P1449; Ash SA, 2013, BEST PRAC RES-CL ANA, V27, P441, DOI 10.1016/j.bpa.2013.10.005; Baptista-Hon DT, 2014, BRIT J ANAESTH, V113, P39, DOI 10.1093/bja/aeu104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bortsov AV, 2012, ANESTHESIOLOGY, V116, P896, DOI 10.1097/ALN.0b013e31824b96a1; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cieslinska A, 2015, TUMOR BIOL, V36, P4655, DOI 10.1007/s13277-015-3113-z; Dai X, 2005, PLOS ONE, V10; Downie DL, 1996, BRIT J PHARMACOL, V118, P493, DOI 10.1111/j.1476-5381.1996.tb15430.x; Ecimovic P, 2011, BRIT J ANAESTH, V107, P916, DOI 10.1093/bja/aer259; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Fleischmann Edith, 2009, BMC Anesthesiol, V9, P1, DOI 10.1186/1471-2253-9-1; Forget P, 2010, EUR J ANAESTH, V27, P233, DOI 10.1097/EJA.0b013e32832d540e; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Gupta K, 2002, CANCER RES, V62, P4491; Hahnenkamp K, 2006, BRIT J ANAESTH, V96, P77, DOI 10.1093/bja/aei271; Hara K, 2000, ANESTHESIOLOGY, V93, P1329, DOI 10.1097/00000542-200011000-00028; Heaney A, 2012, BRIT J ANAESTH, V109, pI17, DOI 10.1093/bja/aes421; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Kawaraguchi Y, 2011, ANESTHESIOLOGY, V115, P499, DOI 10.1097/ALN.0b013e3182276d42; Kharmate G, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-93; Lennon FE, 2012, ANESTHESIOLOGY, V116, P857, DOI 10.1097/ALN.0b013e31824babe2; Lu Jing, 2009, Cancer Res, V69, P4951, DOI 10.1158/0008-5472.CAN-09-0099; Lucchinetti E, 2012, ANESTHESIOLOGY, V116, P841, DOI 10.1097/ALN.0b013e31824babfe; Lugli AK, 2009, EUR J ANAESTH, V26, P807, DOI 10.1097/EJA.0b013e32832d6b0f; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; Mathew B, 2011, ANESTH ANALG, V112, P558, DOI 10.1213/ANE.0b013e31820568af; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; O'Shea SM, 2009, MOL PHARMACOL, V76, P641, DOI 10.1124/mol.109.055111; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Piegeler T, 2012, ANESTHESIOLOGY, V117, P548, DOI 10.1097/ALN.0b013e3182661977; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Sessler DI, 2008, CONTEMP CLIN TRIALS, V29, P517, DOI 10.1016/j.cct.2008.01.002; Singleton PA, 2014, BRIT J ANAESTH, V113, pi103; Smothers CT, 2007, J PHARMACOL EXP THER, V322, P739, DOI 10.1124/jpet.107.123836; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weir CJ, 2006, CONTIN ED ANAESTH CR, V6, P49, DOI DOI 10.1093/BJACEACCP/MKI068; Yevenes GE, 2011, BRIT J PHARMACOL, V164, P224, DOI 10.1111/j.1476-5381.2011.01471.x	43	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177105	10.1371/journal.pone.0177105	http://dx.doi.org/10.1371/journal.pone.0177105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558008	gold, Green Published, Green Submitted			2022-12-26	WOS:000402607000008
J	Jeong, HS; Kim, JY; Lee, SH; Hwang, J; Shin, JW; Song, KS; Lee, S; Kim, J				Jeong, Hye Seon; Kim, Jee-Yeon; Lee, Seo Hyun; Hwang, Junha; Shin, Jong Wook; Song, Kyu Sang; Lee, Sukhoon; Kim, Jei			Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; TOTAL HOMOCYSTEINE; HEMOGLOBIN A1C; PREDICTION; EXPRESSION; SCORE; LIPOPROTEIN(A); INDIVIDUALS; MICRORNAS	Synergy of specific microRNAs (miRNAs) with cardiovascular risk factors to estimate atherosclerosis presence in ischemic stroke patients has not been investigated. The present study aimed to identify atherosclerosis-related circulating miRNAs and to evaluate interaction with other cardiovascular markers to improve the estimation of atherosclerosis presence. We performed a miRNA profiling study using serum of 15 patients with acute ischemic stroke who were classified by the presence of no (n = 8) or severe (n = 7) stenosis on intracranial and extracranial vessels, which identified miR-212, -372, -454, and -744 as miRNAs related with atherosclerosis presence. Of the 4 miRNAs, only miR-212 showed a significant increase in expression in atherosclerosis patients in a validation study (atherosclerotic patients, n = 32, non-atherosclerotic patients, n = 33). Hemoglobin Al c, a high-density lipoprotein cholesterol, and lipoprotein(a), both established risk markers, were independently related with atherosclerosis presence in the validation population. miR-212 enhanced the accuracy of atherosclerosis presence by the three existing markers (three markers, 78.5%; three markers+miR-212, 84.6%, P<0.05) and significantly added to the area under the receiver operating characteristic curve (three markers, 0.8258; three markers+miR-212, 0.8646, P<0.05). The inclusion of miR-212 increased the reclassification index calculated using net reclassification improvement (0.4527, P<0.05) and integrated discrimination improvement (0.0737, P<0.05). We identified circulating miR-212 as a novel marker of atherosclerosis. miR-212 enhanced the estimation of atherosclerosis presence in combination with hemoglobin Al c, high-density lipoprotein cholesterol, and lipoprotein(a). Thus, miR-212 is expected to improve the estimation of atherosclerosis using peripheral blood of patients.	[Jeong, Hye Seon; Kim, Jee-Yeon; Hwang, Junha; Shin, Jong Wook; Kim, Jei] Chungnam Natl Univ, Sch Med & Hosp, Neuroepigenet Lab, Daejeon, South Korea; [Jeong, Hye Seon; Kim, Jee-Yeon; Hwang, Junha; Shin, Jong Wook; Kim, Jei] Chungnam Natl Univ, Sch Med & Hosp, Dept Neurol, Daejeon, South Korea; [Jeong, Hye Seon; Shin, Jong Wook; Kim, Jei] Chungnam Natl Univ Hosp, Reg Cerebrovasc Ctr, Daejeon, South Korea; [Lee, Seo Hyun; Lee, Sukhoon] Chungnam Natl Univ, Dept Informat & Stat, Coll Nat Sci, Daejeon, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Sch Med & Hosp, Dept Pathol, Daejeon, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Sch Med & Hosp, Hunan Bioresource Bank, Daejeon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University; Chungnam National University Hospital; Chungnam National University; Chungnam National University; Chungnam National University	Kim, J (corresponding author), Chungnam Natl Univ, Sch Med & Hosp, Neuroepigenet Lab, Daejeon, South Korea.; Kim, J (corresponding author), Chungnam Natl Univ, Sch Med & Hosp, Dept Neurol, Daejeon, South Korea.; Kim, J (corresponding author), Chungnam Natl Univ Hosp, Reg Cerebrovasc Ctr, Daejeon, South Korea.	jeikim@cnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2013R1A1A2010072]; Chungnam National University; Ministry of Health and Welfare	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Chungnam National University; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2013R1A1A2010072) and a Research Fund of Chungnam National University 2016.; Serum from ischemic stroke patients used for the present study were provided by the Human Bio-Resource Bank of Chungnam National University Hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health and Welfare.	Allen LM, 2012, RADIOGRAPHICS, V32, P1285, DOI 10.1148/rg.325115760; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Eskildsen TV, 2013, INT J MOL SCI, V14, P11190, DOI 10.3390/ijms140611190; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Greco S, 2015, J MOL CELL CARDIOL, V83, P142, DOI DOI 10.1016/j.yjmcc.2015.01.011; Han HS, 2014, ONCOL LETT, V8, P1889, DOI 10.3892/ol.2014.2404; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Henkelman S, 2009, MAT SCI ENG C-BIO S, V29, P1650, DOI 10.1016/j.msec.2009.01.002; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Jarmul JA, 2015, CIRC-CARDIOVASC QUAL, V8, P501, DOI 10.1161/CIRCOUTCOMES.115.001639; Jovanovic I, 2014, MED HYPOTHESES, V83, P11, DOI 10.1016/j.mehy.2014.04.019; Kim HK, 2013, DIABETES CARE, V36, P328, DOI 10.2337/dc12-0587; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Li W, 2001, METHODS MICROARRAY D, P137; Li ZG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-609; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Nakahama T, 2013, P NATL ACAD SCI USA, V110, P11964, DOI 10.1073/pnas.1311087110; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Puska P., 2011, WHO GLOBAL ATLAS CAR, P3; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; RAMIREZ LC, 1992, ANN INTERN MED, V117, P42, DOI 10.7326/0003-4819-117-1-42; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rijlaarsdam MA, 2015, ANDROLOGY-US, V3, P85, DOI 10.1111/andr.298; Rivera JJ, 2010, CORONARY ARTERY DIS, V21, P157, DOI 10.1097/MCA.0b013e328337ff9b; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sherlock G, 2000, CURR OPIN IMMUNOL, V12, P201, DOI 10.1016/S0952-7915(99)00074-6; Soni MS, 2014, DIABETES, V63, P3805, DOI 10.2337/db13-1677; Stevens J, 1998, AM J EPIDEMIOL, V147, P563; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; World Health Organization, 2007, PREV CARD DIS GUID A; 2004, CANC RES, V64, P5245	50	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177809	10.1371/journal.pone.0177809	http://dx.doi.org/10.1371/journal.pone.0177809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557988	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000014
J	Tartaglione, L; Pasquali, M; Rotondi, S; Muci, ML; Leonangeli, C; Farcomeni, A; Fassino, V; Mazzaferro, S				Tartaglione, Lida; Pasquali, Marzia; Rotondi, Silverio; Muci, Maria Luisa; Leonangeli, Cristiana; Farcomeni, Alessio; Fassino, Valeria; Mazzaferro, Sandro			Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation	PLOS ONE			English	Article							GROWTH-FACTOR 23; BONE-MINERAL DENSITY; SERUM SCLEROSTIN; CALCIFICATION; MAINTENANCE; CORRELATE; HORMONE; GENE	Relationships of Sclerostin, a bone anti-anabolic protein, with biomarkers of mineral bone disorders in chronic kidney disease are still unsettled, in particular in kidney transplant (KTR). In 80 KTR patients (31F/49M, 54.7 +/- 10.3 years) we studied the relationships of serum Sclerostin with eGFR, Calcium, Phosphate, Alkaline Phosphatase (AP), intact Parathyroid hormone (iPTH), soluble alpha-Klotho (sKlotho), intact Fibroblast Growth Factor 23 (iFGF23), 25-hydroxyvitamin D(25D) and 1,25-dihydroxyvitamin D (1,25D). Thirty healthy subjects (35.0 +/- 12.4 years, eGFR 109.1 +/- 14.1 ml/min/1,73m(2)) served as control for Sclerostin, iFGF23 and sKlotho. With a median eGFR of 46.3 mUmin/1.73m(2) (IQR, 36.2-58.3) our KTR had median Sclerostin levels of 23.7 pmol/L (IQR: 20.8-32.8), not different from controls (26.6 pmol/L, IQR: 22.0-32.2; p = n.s). Sclerostin correlated negatively with AP (r = -.251; p = 0.023) and positively with iFGF23 (r =.227; p = 0.017) and 25D (r =.214; p = 0.025). Age -adjusted multiple regression analysis identified AP and 1,25D as negative and 25D and sKlotho as positive best predictors of Sclerostin. No correlation was evident with eGFR. The negative correlation with AP confirms the direct anti -anabolic role of Sclerostin. The associations either negative or positive with iFGF23, sKlotho, and vitamin D metabolites suggest also a modulatory role in mineral homeostasis. In particular, the associations with iFGF23 (positive) and 1,25D (negative) underline the relevant inhibitory action of Sclerostin on vitamin D activation. In conclusion, Sclerostin levels in KTR are normal and influenced more by bone turnover than by eGFR. Its involvement with other hormones of mineral homeostasis (FGF23/Klotho and Vitamin D) is part of the sophisticated cross -talk between bone and the kidney.	[Tartaglione, Lida; Rotondi, Silverio; Muci, Maria Luisa; Leonangeli, Cristiana; Mazzaferro, Sandro] Sapienza Univ Rome, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Rome, Italy; [Pasquali, Marzia] Policlin Umberto 1, Univ Hosp Co, Dept Nephrol & Dialysis, Rome, Italy; [Farcomeni, Alessio] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Fassino, Valeria] Policlin Umberto 1, Univ Hosp Co, Dept Internal Med & Med Specialties, Rome, Italy	Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome	Mazzaferro, S (corresponding author), Sapienza Univ Rome, Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat, Rome, Italy.	sandro.mazzaferro@uniroma1.it	Rotondi, Silverio/Y-8662-2019; Tartaglione, Lida/AAA-9895-2019; Rotondi, silverio/AAM-5845-2020; Mazzaferro, Sandro/E-9321-2012	Tartaglione, Lida/0000-0003-4537-0876; Rotondi, Silverio/0000-0003-4553-1756; Mazzaferro, Sandro/0000-0003-3071-1893				Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; BEIGHTON P, 1984, CLIN GENET, V25, P175; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bonani M, 2014, KIDNEY BLOOD PRESS R, V39, P230, DOI 10.1159/000355781; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Carrillo-Lopez N, 2016, KIDNEY INT, V90, P77, DOI 10.1016/j.kint.2016.01.024; Cejka D, 2014, J CLIN ENDOCR METAB, V99, P248, DOI 10.1210/jc.2013-2786; Cejka D, 2012, NEPHROL DIAL TRANSPL, V27, P226, DOI 10.1093/ndt/gfr270; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Cozzolino M, 2010, CURR VASC PHARMACOL, V8, P404, DOI 10.2174/157016110791112313; Desjardins L, 2014, NEPHROL THER, V10, P463, DOI 10.1016/j.nephro.2014.04.002; Drechsler C, 2015, NEPHROL DIAL TRANSPL, V30, P288, DOI 10.1093/ndt/gfu301; Evenepoel P, 2015, J CLIN ENDOCR METAB, V100, P4669, DOI 10.1210/jc.2015-3056; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Heijboer AC, 2013, NEPHROL DIAL TRANSPL, V28, P2283, DOI 10.1093/ndt/gft236; Il Modder U, 2011, J BONE MINER RES, V26, P27, DOI 10.1002/jbmr.128; Ishimura E, 2014, J CLIN ENDOCR METAB, V99, P4315, DOI 10.1210/jc.2014-2372; Kanbay M, 2014, J CLIN ENDOCR METAB, V99, pE1854, DOI 10.1210/jc.2014-2042; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Mazzaferro S, 2010, ARCH BIOCHEM BIOPHYS, V503, P95, DOI 10.1016/j.abb.2010.06.028; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Pelletier S, 2013, CLIN J AM SOC NEPHRO, V8, P819, DOI 10.2215/CJN.07670712; Perez-Padilla R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121832; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rotondi S, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/872193; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sankaralingam A, 2014, J OSTEOPOROS, V2014, DOI 10.1155/2014/682763; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Tomei P, 2014, TRANSPL P, V46, P2241, DOI 10.1016/j.transproceed.2014.07.024	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178637	10.1371/journal.pone.0178637	http://dx.doi.org/10.1371/journal.pone.0178637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558021	gold, Green Published, Green Submitted			2022-12-26	WOS:000402607000059
J	Foged, MT; Lindberg, U; Vakamudi, K; Larsson, HBW; Pinborg, LH; Kjaer, TW; Fabricius, M; Svarer, C; Ozenne, B; Thomsen, C; Beniczky, S; Paulson, OB; Posse, S				Foged, Mette Thrane; Lindberg, Ulrich; Vakamudi, Kishore; Larsson, Henrik B. W.; Pinborg, Lars H.; Kjaer, Troels W.; Fabricius, Martin; Svarer, Claus; Ozenne, Brice; Thomsen, Carsten; Beniczky, Sandor; Paulson, Olaf B.; Posse, Stefan			Safety and EEG data quality of concurrent high-density EEG and high-speed fMRI at 3 Tesla	PLOS ONE			English	Article							FUNCTIONAL MRI; SIMULTANEOUS ELECTROENCEPHALOGRAPHY; EPILEPTIC ACTIVITY; LOCALIZATION; ARTIFACT; SURGERY; SCANS; CAP	Purpose Concurrent EEG and fMRI is increasingly used to characterize the spatial-temporal dynamics of brain activity. However, most studies to date have been limited to conventional echoplanar imaging (EPI). There is considerable interest in integrating recently developed highspeed fMRI methods with high-density EEG to increase temporal resolution and sensitivity for task-based and resting state fMRI, and for detecting interictal spikes in epilepsy. In the present study using concurrent high-density EEG and recently developed high-speed fMRI methods, we investigate safety of radiofrequency (RF) related heating, the effect of EEG on cortical signal-to-noise ratio (SNR) in fMRI, and assess EEG data quality. Materials and methods The study compared EPI, multi-echo EPI, multi-band EPI and multi-slab echo-volumar imaging pulse sequences, using clinical 3 Tesla MR scanners from two different vendors that were equipped with 64- and 256-channel MR-compatible EEG systems, respectively, and receive only array head coils. Data were collected in 11 healthy controls (3 males, age range 18-70 years) and 13 patients with epilepsy (8 males, age range 21-67 years). Three of the healthy controls were scanned with the 256-channel EEG system, the other subjects were scanned with the 64-channel EEG system. Scalp surface temperature, SNR in occipital cortex and head movement were measured with and without the EEG cap. The degree of artifacts and the ability to identify background activity was assessed by visual analysis by a trained expert in the 64 channel EEG data (7 healthy controls, 13 patients). Results RF induced heating at the surface of the EEG electrodes during a 30-minute scan period with stable temperature prior to scanning did not exceed 1.0 degrees C with either EEG system and any of the pulse sequences used in this study. There was no significant decrease in cortical SNR due to the presence of the EEG cap (p > 0.05). No significant differences in the visually analyzed EEG data quality were found between EEG recorded during high-speed fMRI and during conventional EPI (p = 0.78). Residual ballistocardiographic artifacts resulted in 58% of EEG data being rated as poor quality. Conclusion This study demonstrates that high-density EEG can be safely implemented in conjunction with high-speed fMRI and that high-speed fMRI does not adversely affect EEG data quality. However, the deterioration of the EEG quality due to residual ballistocardiographic artifacts remains a significant constraint for routine clinical applications of concurrent EEG-fMRI.	[Foged, Mette Thrane; Lindberg, Ulrich; Pinborg, Lars H.; Svarer, Claus; Paulson, Olaf B.] Rigshosp, Neurobiol Res Unit, Dept Neurol, Copenhagen, Denmark; [Foged, Mette Thrane; Larsson, Henrik B. W.; Pinborg, Lars H.; Kjaer, Troels W.; Thomsen, Carsten; Paulson, Olaf B.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Lindberg, Ulrich; Larsson, Henrik B. W.] Rigshosp, Funct Imaging Unit, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Vakamudi, Kishore; Posse, Stefan] Univ New Mexico, Dept Neurol, Albuquerque, NM USA; [Vakamudi, Kishore; Posse, Stefan] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Kjaer, Troels W.; Fabricius, Martin; Beniczky, Sandor] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Ozenne, Brice] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Thomsen, Carsten] Rigshosp, Dept Radiol, Copenhagen, Denmark; [Beniczky, Sandor] Danish Epilepsy Ctr, Dept Clin Neurophysiol, Dianalund, Denmark; [Beniczky, Sandor] Aarhus Univ, Dept Clin Neurophysiol, Aarhus, Denmark; [Posse, Stefan] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of New Mexico; University of New Mexico; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of New Mexico	Foged, MT; Paulson, OB (corresponding author), Rigshosp, Neurobiol Res Unit, Dept Neurol, Copenhagen, Denmark.; Foged, MT; Paulson, OB (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.	mette.thrane.foged@nru.dk; olaf.paulson@nru.dk	Foged, Mette/G-9668-2018; Lindberg, Ulrich/AAL-6538-2020; Paulson, Olaf B./N-6924-2016	Foged, Mette/0000-0001-7964-5669; Lindberg, Ulrich/0000-0002-0004-6354; Paulson, Olaf B./0000-0001-7712-8596; Pinborg, Lars Hageman/0000-0001-9024-7936; Beniczky, Sandor/0000-0002-6035-6581; Svarer, Claus/0000-0001-7811-1825	Lundbeck Foundation; Lundbeck Foundation [R118-2012-11263, R143-2013-12894] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	All funding (see Funding Information) for the study was obtained for Denmark by Olaf B. Paulson. No funding was obtained from the US. The Lundbeck Foundation provides salary for MTF during her PhD study. The Lundbeck Foundation provided funding, including salary, allowing SP to be visiting professor in Copenhagen for 6 months.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bagshaw AP, 2005, NEUROIMAGE, V24, P1099, DOI 10.1016/j.neuroimage.2004.10.010; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Carmichael DW, 2012, NEUROIMAGE, V63, P301, DOI 10.1016/j.neuroimage.2012.05.056; Carmichael DW, 2010, NEUROIMAGE, V49, P379, DOI 10.1016/j.neuroimage.2009.07.062; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Grouiller F, 2007, NEUROIMAGE, V38, P124, DOI 10.1016/j.neuroimage.2007.07.025; Grouiller F, 2011, BRAIN, V134, P2867, DOI 10.1093/brain/awr156; Jacobs J, 2014, NEUROIMAGE, V88, P282, DOI 10.1016/j.neuroimage.2013.10.018; Jayakar P, 2008, EPILEPSIA, V49, P758, DOI 10.1111/j.1528-1167.2007.01428.x; Klein C, 2015, NEUROIMAGE, V106, P189, DOI 10.1016/j.neuroimage.2014.11.053; Lazeyras F, 2001, J MAGN RESON IMAGING, V13, P943, DOI 10.1002/jmri.1135; Lodder SS, 2013, CLIN NEUROPHYSIOL, V124, P228, DOI 10.1016/j.clinph.2012.07.007; Luo QF, 2012, MAGN RESON MED, V68, P807, DOI 10.1002/mrm.23299; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mullinger K., 2010, SIMULTANEOUS EEG FMR, P95; Noth U, 2012, J MAGN RESON IMAGING, V35, P561, DOI 10.1002/jmri.22843; Pittau F, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00218; Pittau F, 2013, BRAIN TOPOGR, V26, P627, DOI 10.1007/s10548-013-0302-1; Posse S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00479; Posse S, 2012, NEUROIMAGE, V61, P115, DOI 10.1016/j.neuroimage.2012.02.059; R Core Team, 2013, R LANG ENV STAT COMP; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Sherg Michael, 2014, BRAIN ELECT SOURCE A; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Song J, 2015, J NEUROSCI METH, V256, P9, DOI 10.1016/j.jneumeth.2015.08.015; Stoermer R, 2015, NEUROIMAGE, V105, P132; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yamazaki M, 2012, ISRN NEUROL, V2012	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178409	10.1371/journal.pone.0178409	http://dx.doi.org/10.1371/journal.pone.0178409			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552957	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000044
J	Mei, Y; Bi, WYLD; Greenwald, NF; Agar, NY; Beroukhim, R; Dunn, GP; Dunn, IF				Mei, Yu; Bi, Wenya Linda; Greenwald, Noah F.; Agar, Nathalie Y.; Beroukhim, Rameen; Dunn, Gavin P.; Dunn, Ian F.			Genomic profile of human meningioma cell lines	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; DNA-SEQUENCING DATA; PROSTATE-CANCER; MUTATIONS; BRAIN; AKT1; SMO; PROGRESSION; FRAMEWORK; SYSTEM	Meningiomas, derived from arachnoid cap cells, are the most common intracranial tumor. High-grade meningiomas, as well as those located at the skull base or near venous sinuses, frequently recur and are challenging to manage. Next-generation sequencing is identifying novel pharmacologic targets in meningiomas to complement surgery and radiation. However, due to the lack of in vitro models, the importance and implications of these genetic variants in meningioma pathogenesis and therapy remain unclear. We performed whole exome sequencing to assess single nucleotide variants and somatic copy number variants in four human meningioma cell lines, including two benign lines (HBL-52 and Ben-Men-1) and two malignant lines (IOMM-Lee and CH157-MN). The two malignant cell lines harbored an elevated rate of mutations and copy number alterations compared to the benign lines, consistent with the genetic profiles of high-grade meningiomas. In addition, these cell lines also harbored known meningioma driver mutations in neurofibromin 2 (NF2) and TNF receptor associated factor 7 (TRAF7). These findings demonstrate the relevance of meningioma cell lines as a model system, especially as tools to investigate the signaling pathways of, and subsequent resistance to, therapeutics currently in clinical trials.	[Mei, Yu; Bi, Wenya Linda; Greenwald, Noah F.; Agar, Nathalie Y.; Dunn, Ian F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Ctr Skull Base & Pituitary Surg, Boston, MA 02115 USA; [Bi, Wenya Linda; Greenwald, Noah F.; Agar, Nathalie Y.; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bi, Wenya Linda; Greenwald, Noah F.; Beroukhim, Rameen] Broad Inst MIT & Harvard, Cambridge, MA USA; [Beroukhim, Rameen; Dunn, Ian F.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dunn, Gavin P.] Washington Univ, Sch Med, Dept Neurosurg Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL)	Dunn, IF (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Ctr Skull Base & Pituitary Surg, Boston, MA 02115 USA.; Dunn, IF (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	idunn@partners.org	Greenwald, Noah/GNH-3982-2022	Greenwald, Noah/0000-0002-7836-4379				Abedalthagafi M, 2016, NEURO-ONCOLOGY, V18, P649, DOI 10.1093/neuonc/nov316; Aizer AA, 2016, NEURO-ONCOLOGY, V18, P269, DOI 10.1093/neuonc/nov177; Akat K, 2008, CELL TISSUE RES, V331, P401, DOI 10.1007/s00441-007-0512-5; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bi WL, 2016, J NEUROSURG, V125, P525, DOI 10.3171/2015.6.JNS15591; Bi WL, 2016, CLIN CANC RES; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Goutagny S, 2014, BRAIN PATHOL, V24, P184, DOI 10.1111/bpa.12110; Horiguchi A, 2008, PROSTATE, V68, P975, DOI 10.1002/pros.20760; Rodriguez MI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003531; Johanns TM, 2016, BRAIN TUMOR PATHOL, V33, P222, DOI 10.1007/s10014-016-0257-5; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LEE WH, 1990, NEUROSURGERY, V27, P389, DOI 10.1227/00006123-199009000-00008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Puttmann S, 2005, LAB INVEST, V85, P1163, DOI 10.1038/labinvest.3700307; Schiewer MJ, 2012, CANCER DISCOV, V2, P1134, DOI 10.1158/2159-8290.CD-12-0120; Shankar GM, 2016, NEUROONCOLO IN PRESS; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Talukder AH, 2006, ONCOGENE, V25, P1311, DOI 10.1038/sj.onc.1209172; TSAI JC, 1995, J NEUROSURG, V82, P864, DOI 10.3171/jns.1995.82.5.0864; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702	32	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178322	10.1371/journal.pone.0178322	http://dx.doi.org/10.1371/journal.pone.0178322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552950	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000035
J	Choi, JM; Kim, SG; Kim, J; Han, SJ; Park, JY; Oh, S; Im, JP; Kim, JS; Kim, WH; Jung, HC				Choi, Ji Min; Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Kim, Woo Ho; Jung, Hyun Chae			Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers	PLOS ONE			English	Article							HELICOBACTER-PYLORI; MOLECULAR-BIOLOGY; EPIDEMIOLOGY; CARCINOMA; CARCINOGENESIS; PREDICTORS; RISK	Background Although gastric adenoma is widely accepted as a precursor of gastric cancer, pre-existing adenoma is not always detected in gastric cancer patients. Objective To investigate the clinical characteristics of early gastric cancer (EGC) arising from adenoma, compared with those of EGC without pre-existing adenoma. Methods Patients who underwent endoscopic resection for EGC at a single tertiary hospital were divided into two groups based on the presence (ex-adenoma group) or absence (de novo group) of pre-existing adenoma on pathologic specimens. Clinicopathologic characteristics, endoscopic features and long-term outcomes were analyzed. Results Of 1,509 patients, 236 (15.6%) were included in the ex-adenoma group. Mean age (P = 0.003) and Helicobacter pylori infection rate (P = 0.040) were significantly higher in the ex-adenoma than in the de novo group. Mean endoscopic size was significantly larger, elevated lesions were more prevalent (both P < 0.001), and carcinomas were more differentiated in the ex-adenoma group than in the de novo group (P = 0.037). The degree of atrophy (P = 0.025) or intestinal metaplasia (P < 0.001) was more advanced in the ex-adenoma group. Synchronous gastric neoplasia was significantly more prevalent in the ex-adenoma group (P < 0.001), whereas metachronous cancer recurrence rate was not significantly different between the two groups. Conclusions EGCs with pre-existing adenoma show a greater association with H. pylori-related chronic inflammation than those without, which could explain the differences in the characteristics between groups. Potential differences in carcinogenic mechanisms between the groups were explored.	[Choi, Ji Min] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Healthcare Res Inst, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Sang Gyun; Kim, Jung; Han, Seung Jun; Park, Jae Yong; Oh, Sooyeon; Im, Jong Pil; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, SG (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	harley1333@hanmail.net		Kim, Sang Gyun/0000-0003-1799-9028	Promising-Pioneering Researcher Program through Seoul National University	Promising-Pioneering Researcher Program through Seoul National University	This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Promising-Pioneering Researcher Program through Seoul National University in 2015.	[Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Chen YC, 2016, PATHOL ONCOL RES, V22, P197, DOI 10.1007/s12253-015-9996-6; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Choi JM, 2016, SURG ENDOSC, V30, P89, DOI 10.1007/s00464-015-4165-2; CORREA P, 1992, CANCER RES, V52, P6735; de Vries AC, GASTROENTEROLOGY; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Jahng J, 2012, WORLD J GASTROENTERO, V18, P3571, DOI 10.3748/wjg.v18.i27.3571; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jung SJ, 2013, SURG ENDOSC, V27, P1211, DOI 10.1007/s00464-012-2577-9; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kanno T, 2015, J GASTROEN HEPATOL, V30, P842, DOI 10.1111/jgh.12876; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kudo M, 2001, J GASTROENTEROL, V36, P65, DOI 10.1007/s005350170157; Kushima Ryoji, 2006, Gastric Cancer, V9, P177, DOI 10.1007/s10120-006-0381-8; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee S, 2006, ONCOL REP, V16, P747; Mueller JD, 2002, VIRCHOWS ARCH, V440, P453, DOI 10.1007/s00428-002-0623-z; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PRICE AB, 1991, J GASTROEN HEPATOL, V6, P209, DOI 10.1111/j.1440-1746.1991.tb01468.x; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; TAHARA E, 1995, WORLD J SURG, V19, P484, DOI 10.1007/BF00294705; Tahara Eiichi, 2004, IARC Sci Publ, P327; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yamamoto S, 2011, DIGEST DIS SCI, V56, P2354, DOI 10.1007/s10620-011-1681-3; Yang HJ, 2015, SURG ENDOSC, V29, P1145, DOI 10.1007/s00464-014-3780-7	28	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178419	10.1371/journal.pone.0178419	http://dx.doi.org/10.1371/journal.pone.0178419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542582	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800087
J	Hwang, AR; Han, JH; Lim, JH; Kang, YJ; Woo, CH				Hwang, Ae-Rang; Han, Jung-Hwa; Lim, Jae Hyang; Kang, Young Jin; Woo, Chang-Hoon			Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; HEME OXYGENASE-1; NEOINTIMAL FORMATION; SIGNALING PATHWAY; ARTERIAL INJURY; CYCLE ARREST; CANCER CELLS; IN-VITRO	Advanced glycation endproduct (AGE)-induced vascular smooth muscle cell (VSMC) proliferation and reactive oxygen species (ROS) production are emerging as important mechanisms of diabetic vasculopathy, but little is known about the molecular mechanism responsible for the antioxidative effects of statins on AGEs. It has been reported that statins exert pleiotropic effects on the cardiovascular system due to decreases in AGE-induced cell proliferation, migration, and vascular inflammation. Thus, in the present study, the authors investigated the molecular mechanism by which statins decrease AGE-induced cell proliferation and VSMC migration. In cultured VSMCs, statins upregulated Nrf2-related antioxidant gene, NQO1 and HO-1, via an ERK5-dependent Nrf2 pathway. Inhibition of ERK5 by siRNA or BIX02189 (a specific ERK5 inhibitor) reduced the statin-induced upregulations of Nrf2, NQO1, and HO-1. Furthermore, fluvastatin was found to significantly increase ARE promoter activity through ERK5 signaling, and to inhibit AGE-induced VSMC proliferation and migration as determined by MTT assay, cell counting, FACS analysis, a wound scratch assay, and a migration chamber assay. In addition, AGE-induced proliferation was diminished in the presence of Ad-CA-MEK5a encoding a constitutively active mutant form of MEK5a (an upstream kinase of ERK5), whereas depletion of Nrf2 restored statin-mediated reduction of AGE-induced cell proliferation. Moreover, fluvastatin suppressed the protein expressions of cyclin D1 and Cdk4, but induced p27, and blocked VSMC proliferation by regulating cell cycle. These results suggest statin-induced activation of an ERK5-dependent Nrf2 pathway reduces VSMC proliferation and migration induced by AGEs, and that the ERK5-Nrf2 signal module be viewed as a potential therapeutic target of vasculopathy in patients with diabetes and complications of the disease.	[Hwang, Ae-Rang; Han, Jung-Hwa; Kang, Young Jin; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea; [Han, Jung-Hwa; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea; [Lim, Jae Hyang] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea	Yeungnam University; Yeungnam University; Ewha Womans University	Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Dept Pharmacol, Daegu, South Korea.; Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea.	changhoon_woo@yu.ac.kr		Lim, Jae Hyang/0000-0003-0972-9271	Medical Research Center Program [2015R1A5A2009124]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2015R1D1A1A01059398]	Medical Research Center Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This research was supported by the Medical Research Center Program (2015R1A5A2009124) and Basic Science Research Program (NRF-2015R1D1A1A01059398) through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning.	Adams PD, 2001, BIOCHIM BIOPHYS ACTA, V21, pM123; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Alegret M, 2007, TIMELY TOP MED CARDI, V18; Antonopoulos AS, 2012, CURR PHARM DESIGN, V18, P1519; Bierhaus A, 1997, DIABETES, V46, P1481, DOI 10.2337/diabetes.46.9.1481; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Choi HC, 2009, KOREAN J PHYSIOL PHA, V13, P309, DOI 10.4196/kjpp.2009.13.4.309; De Rosa S, 2010, CURR VASC PHARMACOL, V8, P259; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Forman HJ, 2004, FREE RADICAL BIO MED, V36, P1197, DOI 10.1016/j.freeradbiomed.2004.03.004; Fouty BW, 2003, CIRC RES, V92, P501, DOI 10.1161/01.RES.0000061180.03813.0F; Goncalves DO, 2011, BRAZ J MED BIOL RES, V44, P173, DOI 10.1590/S0100-879X2011007500001; Haendeler J, 2004, CIRCULATION, V110, P856, DOI 10.1161/01.CIR.0000138743.09012.93; Hall C, 2001, MOL CELL BIOL, V21, P1854, DOI 10.1128/MCB.21.5.1854-1865.2001; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kim M, 2012, J BIOL CHEM, V287, P40722, DOI 10.1074/jbc.M112.381509; Kim SE, 2009, EXP MOL MED, V41, P277, DOI 10.3858/emm.2009.41.4.031; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Makabe S, 2010, ATHEROSCLEROSIS, V213, P377, DOI 10.1016/j.atherosclerosis.2010.07.059; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Maron DJ, 2000, AM J CARDIOL, V86, p11L; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Oh CJ, 2014, REDOX BIOL, V2, P855, DOI 10.1016/j.redox.2014.06.003; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; Rao S, 1999, EXP CELL RES, V252, P211, DOI 10.1006/excr.1999.4620; Sakaguchi T, 2003, J CLIN INVEST, V111, P959, DOI 10.1172/JCI200317115; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Stephenson K, 2003, ARTERIOSCL THROM VAS, V23, P2027, DOI 10.1161/01.ATV.0000096394.32433.E9; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tatake RJ, 2008, BIOCHEM BIOPH RES CO, V377, P120, DOI 10.1016/j.bbrc.2008.09.087; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Yoon SJ, 2009, EXP MOL MED, V41, P802, DOI 10.3858/emm.2009.41.11.086; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23; Zhu P, 2010, ACTA PHARMACOL SIN, V31, P1329, DOI 10.1038/aps.2010.145	48	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178278	10.1371/journal.pone.0178278	http://dx.doi.org/10.1371/journal.pone.0178278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542559	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400076
J	Choi, SR; Britigan, BE; Moran, DM; Narayanasamy, P				Choi, Seoung-ryoung; Britigan, Bradley E.; Moran, David M.; Narayanasamy, Prabagaran			Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages	PLOS ONE			English	Article							IRON ACQUISITION; ARREST; 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL; METABOLISM; GALECTIN-3; INFECTION; TARGET; CELLS; RAB5	New treatments and novel drugs are required to counter the growing problem of drug-resistant strains of Mycobacterium tuberculosis (M.tb). Our approach against drug resistant M.tb, as well as other intracellular pathogens, is by targeted drug delivery using nanoformulations of drugs already in use, as well as drugs in development. Among the latter are gallium (III) (Ga)-basedcompounds. In the current work, six different types of Ga and rifampin nanoparticles were prepared in such a way as to enhance targeting of M.tb infected-macrophages. They were then tested for their ability to inhibit growth of a fully pathogenic strain (H37Rv) or a non-pathogenic strain (H37Ra) of M.tb. Encapsulating Ga in folate-or mannose-conjugated block copolymers provided sustained Ga release for 15 days and significantly inhibited M.tb growth in human monocyte-derived macrophages. Nanoformulations with dendrimers encapsulating Ga or rifampin also showed promising anti-tuberculous activity. The nanoparticles co-localized with M.tb containing phagosomes, as measured by detection of mature cathepsin D (34 kDa, lysosomal hydrogenase). They also promoted maturation of the phagosome, which would be expected to increase macrophage-mediated killing of the organism. Delivery of Ga or rifampin in the form of nanoparticles to macrophages offers a promising approach for the development of new therapeutic anti-tuberculous drugs.	[Choi, Seoung-ryoung; Britigan, Bradley E.; Moran, David M.; Narayanasamy, Prabagaran] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68182 USA; [Britigan, Bradley E.] Univ Nebraska, Med Ctr, Dept Internal Med, Coll Med, Omaha, NE USA; [Britigan, Bradley E.] Vet Affairs Med Ctr Nebraska Western Iowa, Res Serv, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Narayanasamy, P (corresponding author), Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68182 USA.	p.narayanasamy@unmc.edu	choi, seoung/AAD-6139-2019	Narayanasamy, Prabagaran/0000-0002-9617-5555	Nebraska Research Initiative; Veterans Affairs Merit Review grant; Veterans Affairs [I01BX002504, I01CX000102] Funding Source: NIH RePORTER	Nebraska Research Initiative; Veterans Affairs Merit Review grant(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Nebraska Research Initiative to PN and a Veterans Affairs Merit Review grant to BEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Nebraska Research Initiative to PN and a Veterans Affairs Merit Review grant to BEB.	Ahmed H, 2015, CLIN MED INSIGHTS-ON, V9, P113, DOI 10.4137/CMO.S29462; Alexander PE, 2007, CAN J INFECT DIS MED, V18, P289, DOI 10.1155/2007/986794; [Anonymous], 2012, NANOMEDICINE-UK, V7, P1294; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Britigan BE, 2000, INFECT IMMUN, V68, P1271, DOI 10.1128/IAI.68.3.1271-1275.2000; BROWN CA, 1969, NATURE, V221, P658, DOI 10.1038/221658a0; Choi SR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02505-16, 10.1128/aac.02505-16]; Choi SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40077; Choi SR, 2016, BIOORG MED CHEM LETT, V26, P1997, DOI 10.1016/j.bmcl.2016.02.087; Choi SR, 2016, FUTURE MED CHEM, V8, P11, DOI 10.4155/fmc.15.168; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; de Faria TJ, 2012, ANTIMICROB AGENTS CH, V56, P2259, DOI 10.1128/AAC.05993-11; Deretic V, 1997, ELECTROPHORESIS, V18, P2542, DOI 10.1002/elps.1150181409; Dietz AB, 2000, BIOCHEM BIOPH RES CO, V275, P731, DOI 10.1006/bbrc.2000.3372; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Edagwa BJ, 2014, FASEB J, V28, P5071, DOI 10.1096/fj.14-255786; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Kalluru R, 2013, J CELL SCI, V126, P3043, DOI 10.1242/jcs.121814; Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783; Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; LIU FT, 1995, AM J PATHOL, V147, P1016; Narayanasamy P., 2014, CHEM SCI J, V5; Narayanasamy P., 2015, CHEMICAL SCIENCES JO, P6; Narayanasamy P, 2008, HETEROCYCLES, V76, P243, DOI 10.3987/COM-08-S(N)72; Narayanasamy P, 2008, TETRAHEDRON LETT, V49, P4461, DOI 10.1016/j.tetlet.2008.05.074; Narayanasamy P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08824; Narayanasamy P, 2010, CHEM BIOL, V17, P117, DOI 10.1016/j.chembiol.2010.01.013; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Olakanmi O, 2004, INFECT IMMUN, V72, P2022, DOI 10.1128/IAI.72.4.2022-2028.2004; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; Olakanmi O, 2013, ANTIMICROB AGENTS CH, V57, P6074, DOI 10.1128/AAC.01543-13; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Olakanmi Y, 2005, J INVEST MED, V53, P143, DOI 10.2310/6650.2005.00310; Parat A, 2015, NANOMEDICINE-UK, V10, P977, DOI [10.2217/NNM.14.196, 10.2217/nnm.14.196]; Puligujja P, 2013, NANOMED-NANOTECHNOL, V9, P1263, DOI 10.1016/j.nano.2013.05.003; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	47	34	34	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177987	10.1371/journal.pone.0177987	http://dx.doi.org/10.1371/journal.pone.0177987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542623	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400127
J	Chini, A; Ben-Romdhane, W; Hassairi, A; Aboul-Soud, MAM				Chini, Andrea; Ben-Romdhane, Walid; Hassairi, Afif; Aboul-Soud, Mourad A. M.			Identification of TIFY/JAZ family genes in Solanum lycopersicum and their regulation in response to abiotic stresses	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; JAZ REPRESSION; LEAF GROWTH; JASMONATE; COMPLEX; PROTEIN; MOTIF; EXPRESSION; ACID; BIOSYNTHESIS	Plant phenotypic plasticity determines plant adaptation to changing environments and agricultural productivity. Phytohormones are essential plant signalling molecules regulating this plasticity through complex signalling networks. Jasmonates (JAs) are key phytohormones regulating many aspects of growth, development and defence responses. An important role of JAs in tolerance to abiotic stresses is also emerging. The expression of JAZ (JASMONATE-ZIM-DOMAIN PROTEIN) genes, encoding for the key repressors in the JA-pathway, is regulated by multiple abiotic stresses, suggesting a role for the JAZ proteins in response to these stresses. The JAZ proteins belong to the TIFY family, well described in many plant species. However, only the role of few tomato JAZ proteins in response to microbial infection has been analysed so far. Here, we identify the members of the tomato TIFY family, and characterize them phylogenetically. In addition, we analyse the transcriptional regulation of several SlJAZ in response to abiotic stresses and hormone treatments both in root and leaves to assess their specific expression in response to stresses. Most SlJAZ are JA-induced and responsive to one or more abiotic stresses, providing clues for functional analysis of JAZ genes in abiotic responses in tomato.	[Chini, Andrea] CNB CSIC, Plant Mol Genet Dept, Madrid, Spain; [Ben-Romdhane, Walid; Hassairi, Afif] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Ben-Romdhane, Walid; Hassairi, Afif] Univ Sfax, LPAP, CBS, Sfax, Tunisia; [Aboul-Soud, Mourad A. M.] King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Aboul-Soud, Mourad A. M.] Cairo Univ, Cairo Univ Res Pk, Biochem & Mol Biol Dept, Giza, Egypt	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); King Saud University; Centre de Biotechnologie de Sfax; Universite de Sfax; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University	Chini, A (corresponding author), CNB CSIC, Plant Mol Genet Dept, Madrid, Spain.; Aboul-Soud, MAM (corresponding author), King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.; Aboul-Soud, MAM (corresponding author), Cairo Univ, Cairo Univ Res Pk, Biochem & Mol Biol Dept, Giza, Egypt.	achini@cnb.csic.es; maboulsoud@KSU.EDU.SA	Ben Romdhane, Walid Ben/ABB-6543-2020; HASSAIRI, AFIF/AAX-9584-2021; Chini, Andrea/D-1336-2009; Aboul-Soud, Mourad/F-8111-2010	HASSAIRI, AFIF/0000-0001-6292-9753; Aboul-Soud, Mourad/0000-0001-9395-0563; Chini, Andrea/0000-0001-5841-0254; Ben Romdhane, Walid/0000-0002-7797-5813	National Plan for Science, Technology and Innovation (MAARIFAH); King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11-BI02119-02]	National Plan for Science, Technology and Innovation (MAARIFAH); King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This Project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (11-BIO2119-02).; We would like to thank Roberto Solano and Sandra Fonseca for her critical reading of the manuscript. This Project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (11-BIO2119-02).	Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Chen Xiaodong, 2016, Plant Diversity, V38, P118, DOI 10.1016/j.pld.2016.06.001; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Clauw P, 2016, PLANT CELL, V28, P2417, DOI 10.1105/tpc.16.00483; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Ge LF, 2016, P NATL ACAD SCI USA, V113, P12414, DOI 10.1073/pnas.1611763113; Gimenez-Ibanez S, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5010009; Gimenez-Ibanez S, 2015, ESSAYS BIOCHEM, V58, P83, DOI [10.1042/BSE0580083, 10.1042/bse0580083]; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Gonzalez-Guzman M, 2014, J EXP BOT, V65, P4451, DOI 10.1093/jxb/eru219; Goossens J, 2015, NEW PHYTOL, V206, P1229, DOI 10.1111/nph.13398; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Ke JY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500107; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Pauwels L, 2015, PLANT PHYSIOL, V169, P1405, DOI 10.1104/pp.15.00479; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Pazos F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00363; Perez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084891; Pietrosemoli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055524; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003; Shaikhali J, 2012, PLANT CELL, V24, P3009, DOI 10.1105/tpc.112.100099; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008; Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056; Thatcher LF, 2016, J EXP BOT, V67, P2367, DOI 10.1093/jxb/erw040; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thireault C, 2015, PLANT J, V82, P669, DOI 10.1111/tpj.12841; Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wu H, 2015, PLANT SCI, V232, P1, DOI 10.1016/j.plantsci.2014.12.010; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang F, 2017, P NATL ACAD SCI USA, V114, P1720, DOI 10.1073/pnas.1616938114; Zhang F, 2015, NATURE, V525, P269, DOI 10.1038/nature14661; Zhang LH, 2015, J PLANT RES, V128, P995, DOI 10.1007/s10265-015-0755-2; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593; Zhang ZB, 2015, MOL GENET GENOMICS, V290, P1849, DOI 10.1007/s00438-015-1042-6	55	54	56	9	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177381	10.1371/journal.pone.0177381	http://dx.doi.org/10.1371/journal.pone.0177381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570564	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800008
J	Kang, YY; Liu, Y; Wang, ML; Guo, M; Wang, Y; Cheng, ZF				Kang, Ying-ying; Liu, Yang; Wang, Ming-Li; Guo, Min; Wang, Yan; Cheng, Zhi-Feng			Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma	PLOS ONE			English	Article							CELL-PROLIFERATION; INDUCED APOPTOSIS; EXPRESSION; CANCER; PREDICTION; INVASION; PATTERN	Thyroid-carcinoma (THCA) is the most common malignancy with an increasing incidence. Recent evidence has emphasized the role of microRNA (miRNA) in THCA. However, knowledge concerning the roles of miRNAs in THCA is still limited. We therefore use a miRNA-target gene differential regulatory network (MGDRN) to identify key miRNAs and characterize their synergistic regulation in THCA. Both miRNA-target gene interactions from multiple databases and negative expression correlations between miRNA-target genes were used to characterize the interactions. Then, two regulatory networks involving normal and tumor conditions were constructed, respectively. The MGDRN was finally constructed using different interactions between the above two regulatory networks. By analyzing topological features of the MGDRN, four miRNAs (hsa-mir-152-3p, hsa-mir-148a, hsa-mir-130b and hsa-mir-15b) are identified as key miRNAs in THCA. Over-expression of mir-152-3p inhibited proliferation and colony formation of TPC-1 cells. Furthermore, mir-152-3p negatively regulated ERBB3 by binding to the 3'-UTR of ERBB3, and down-regulation of ERBB3 by small interfering (si) RNAs inhibited proliferation and colony formation of TPC-1 cells, indicating that mir-152-3p acted as an anti-tumor miRNA by negatively regulating ERBB3. Finally, two synergistically dysregulated modules were identified which may contribute to the initiation and progression of THCA. Overall, the results provided a better understanding of the molecular basis of THCA, and suggested novel treatment strategies for this cancer.	[Kang, Ying-ying; Wang, Ming-Li; Guo, Min; Wang, Yan; Cheng, Zhi-Feng] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China; [Liu, Yang] Harbin Med Univ, Affiliated Hosp 4, Clin Lab, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Cheng, ZF (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China.	zxc13694519706@126.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Falcone G, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0148-3; Hesselink ENK, 2013, J CLIN ONCOL, V31, P4046, DOI 10.1200/JCO.2013.49.1043; Hong S, 2016, THYROID OFFICIAL J A; Huang C, 2015, J CLIN ENDOCR METAB, V100, pE204, DOI 10.1210/jc.2014-2883; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang N, 2012, FEBS LETT, V586, P884, DOI 10.1016/j.febslet.2012.02.017; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu GP, 2016, ONCOL REP, V36, P3005, DOI 10.3892/or.2016.5064; Liu XX, 2016, ONCOL LETT, V11, P3911, DOI 10.3892/ol.2016.4509; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Qi RL, 2016, CELL PHYSIOL BIOCHEM, V40, P668, DOI 10.1159/000452579; Qu FJ, 2013, MOL CELL BIOCHEM, V377, P121, DOI 10.1007/s11010-013-1576-z; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saiselet M, 2016, ONCOTARGET; Stokowy T, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1427042; Tian XY, 2015, INT J CLIN EXP PATHO, V8, P4933; Viola D, 2016, ENDOCR-RELAT CANCER, V23, pR185, DOI 10.1530/ERC-15-0555; Wang RF, 2016, ANN HEPATOL, V15, P190, DOI 10.5604/16652681.1193709; Wang T, 2015, CANCER BIOMARK, V15, P543, DOI 10.3233/CBM-150493; Widodo, 2016, ANN MED SURG, V7, P9, DOI 10.1016/j.amsu.2016.01.091; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yan X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-220; Yu G, 2014, J UROLOGY, V192, P1229, DOI 10.1016/j.juro.2014.05.094; Yu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30923; Zhang HR, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/2832980	32	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178331	10.1371/journal.pone.0178331	http://dx.doi.org/10.1371/journal.pone.0178331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570571	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800039
J	Nyoka, R; Omony, J; Mwalili, SM; Achia, TNO; Gichangi, A; Mwambi, H				Nyoka, Raymond; Omony, Jimmy; Mwalili, Samuel M.; Achia, Thomas N. O.; Gichangi, Anthony; Mwambi, Henry			Effect of climate on incidence of respiratory syncytial virus infections in a refugee camp in Kenya: A non-Gaussian time-series analysis	PLOS ONE			English	Article							SURVEILLANCE; SEASONALITY; INFLUENZA; CHILDREN; PACKAGE; DISEASE; MODELS	Respiratory syncytial virus (RSV) is one of the major causes of acute lower respiratory tract infections (ALRTI) in children. Children younger than 1 year are the most susceptible to RSV infection. RSV infections occur seasonally in temperate climate regions. Based on RSV surveillance and climatic data, we developed statistical models that were assessed and compared to predict the relationship between weather and RSV incidence among refugee children younger than 5 years in Dadaab refugee camp in Kenya. Most time-series analyses rely on the assumption of Gaussian-distributed data. However, surveillance data often do not have a Gaussian distribution. We used a generalized linear model (GLM) with a sinusoidal component over time to account for seasonal variation and extended it to a generalized additive model (GAM) with smoothing cubic splines. Climatic factors were included as covariates in the models before and after timescale decompositions, and the results were compared. Models with decomposed covariates fit RSV incidence data better than those without. The Poisson GAM with decomposed covariates of climatic factors fit the data well and had a higher explanatory and predictive power than GLM. The best model predicted the relationship between atmospheric conditions and RSV infection incidence among children younger than 5 years. This knowledge helps public health officials to prepare for, and respond more effectively to increasing RSV incidence in low-resource regions or communities.	[Nyoka, Raymond; Achia, Thomas N. O.; Mwambi, Henry] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Scottsville, South Africa; [Omony, Jimmy] Univ Groningen, Mol Genet Dept, Groningen, Netherlands; [Mwalili, Samuel M.] Jomo Kenyatta Univ Agr & Technol, Stat Dept, Nairobi, Kenya; [Gichangi, Anthony] Johns Hopkins Univ, Jhpiego, Nairobi, Kenya	University of Kwazulu Natal; University of Groningen; Jomo Kenyatta University of Agriculture & Technology; Jhpiego	Nyoka, R (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Scottsville, South Africa.	nyomus@gmail.com	Achia, Thomas N. O./I-3674-2013; Mwalili, Samuel/AAV-6758-2020	Achia, Thomas N. O./0000-0002-0700-9468; Mwalili, Samuel/0000-0002-9703-6514				Agoti CN, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-178; Aintablian N, 1998, INFECT CONT HOSP EP, V19, P918; Ampofo K, 2008, PEDIATRICS, V122, P229, DOI 10.1542/peds.2007-3192; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Brandt Patrick T, 2007, MULTIPLE TIME SERIES, V148; Calcagno V, 2010, J STAT SOFTW, V34, P1; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Development Core Team R, 2011, R LANG ENV STAT COMP; DeVincenzo JP, 2008, PEDIATR INFECT DIS J, pS1; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Donaldson GC, 2006, CLIN INFECT DIS, V42, P677, DOI 10.1086/500208; Gasparrini A., 2014, DISTRIBUTED LAG LINE, P1; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; Hall CB, 2000, CLIN INFECT DIS, V31, P590, DOI 10.1086/313960; Hastie T., 1986, STAT SCI, V1, P297; Haynes AK, 2013, J INFECT DIS S3, V208; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jonsson G., 2010, 21 INT MIGR I, P1; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kim C, 2012, J IMMIGR MINOR HEALT, V14, P140, DOI 10.1007/s10903-011-9494-1; Leecaster M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-105; Loeffelholz M, 2010, INT J MICROBIOLOGY; Mangtani P, 2006, CLIN INFECT DIS, V42, P640, DOI 10.1086/499810; Mwambi H, 2011, STAT METHODS MED RES, V20, P573; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noyola DE, 2008, EPIDEMIOL INFECT, V136, P1328, DOI 10.1017/S0950268807000143; PATRICK TB, 2001, POLITICAL ANAL, V0009; Peng RD, 2008, STAT METHODS ENV EPI, P1; Piedimonte G, 2014, PEDIATR REV, V35, P519, DOI 10.1542/pir.35-12-519; Simoes EAF, 2015, J INFECT DIS, V211, pS1, DOI 10.1093/infdis/jiu828; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Vandini S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-1; Vitor P, 2012, VIRUS REV RES, P23; Wolff C, 2014, LIMNOL OCEANOGR, V59, P1621, DOI 10.4319/lo.2014.59.5.1621; Wood S.N., 2006, TEXTS STAT SCI, Vxvii, P392, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X	36	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178323	10.1371/journal.pone.0178323	http://dx.doi.org/10.1371/journal.pone.0178323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570627	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800038
J	Planchon, M; Leger, T; Spalla, O; Huber, G; Ferrari, R				Planchon, Mariane; Leger, Thibaut; Spalla, Olivier; Huber, Gaspard; Ferrari, Roselyne			Metabolomic and proteomic investigations of impacts of titanium dioxide nanoparticles on Escherichia coli	PLOS ONE			English	Article							ELONGATION-FACTOR TU; TIO2 NANOPARTICLES; OXIDATIVE STRESS; SUCCINATE-DEHYDROGENASE; TOXICITY; NMR; ECOTOXICITY; PROTEINS; BINDING; CONTRIBUTES	In a previous study, it was demonstrated that the toxic impact of titanium dioxide nanoparticles on Escherichia coli starts at 10 ppm and is closely related to the presence of little aggregates. It was also assumed that only a part of the bacterial population is able to adapt to this stress and attempts to survive. Proteomic analyses, supported by results from metabolomics, reveal that exposure of E. coli to nano-TiO2 induces two main effects on bacterial metabolism: firstly, the up-regulation of proteins and the increase of metabolites related to energy and growth metabolism; secondly, the down-regulation of other proteins resulting in an increase of metabolites, particularly amino acids. Some proteins, e.g. chaperonin 1 or isocitrate dehydrogenase, and some metabolites, e.g. phenylalanine or valine, might be used as biomarkers of nanoparticles stress. Astonishingly, the ATP content gradually rises in relation with the nano-TiO2 concentration in the medium, indicating a dramatic release of ATP by the damaged cells. These apparently contradictory results accredit the thesis of a heterogeneity of the bacterial population. This heterogeneity is also confirmed by SEM images which show that while some bacteria are fully covered by nano-TiO2, the major part of the bacterial population remains free from nanoparticles, resulting in a difference of proteome and metabolome. The use of combined-omics has allowed to better understand the heterogeneous bacterial response to nano-TiO2 stress due to heterogeneous contacts between the protagonists under environmental conditions.	[Planchon, Mariane; Spalla, Olivier; Huber, Gaspard] Univ Paris Saclay, CEA Saclay, CNRS, NIMBE,CEA, F-91191 Gif Sur Yvette, France; [Planchon, Mariane; Ferrari, Roselyne] Univ Paris Diderot, Sorbonne Paris Cite, IPGP, UMR 7154, Paris 13, France; [Planchon, Mariane; Spalla, Olivier] iCEINT, Int Consortium Environm Implicat Nanotechnol, Paris, France; [Leger, Thibaut] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Mass Spectrometry Lab,Inst Jacques Monod,UMR 7592, Paris, France; [Ferrari, Roselyne] Univ Paris Diderot, Sorbonne Paris Cite, LIED, UMR 8236, Paris, France; [Planchon, Mariane] Deloitte, Neuilly, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Deloitte Touche Tohmatsu Limited	Huber, G (corresponding author), Univ Paris Saclay, CEA Saclay, CNRS, NIMBE,CEA, F-91191 Gif Sur Yvette, France.; Ferrari, R (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, IPGP, UMR 7154, Paris 13, France.; Ferrari, R (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, LIED, UMR 8236, Paris, France.	gaspard.huber@cea.fr; roselyne.ferrari@univ-paris-diderot.fr	Léger, Thibaut/GPP-5828-2022; HUBER, Gaspard/E-5486-2015	HUBER, Gaspard/0000-0001-5766-1916; Leger, Thibaut/0000-0002-6304-3433	Region Ile-de-France; nanoscience competence center of Paris Region; iCEINT, International Consortium for the Environmental Implications of Nano Technology	Region Ile-de-France(Region Ile-de-France); nanoscience competence center of Paris Region(Region Ile-de-France); iCEINT, International Consortium for the Environmental Implications of Nano Technology	Dr Sam Dukan is acknowledged for the gift of E. coli wild type strain MG1655. Laure Cordier is acknowledged for ICP-AES analysis of dissolved Ti (IV). Pr Philippe Silar and Francois van Essen are acknowledged for their careful reading of the text. This work was supported by the Region Ile-de-France in the framework of C'NanoIdF, the nanoscience competence center of Paris Region and by the iCEINT, International Consortium for the Environmental Implications of Nano Technology.; This work was supported by the Region Ile-de-France in the framework of C'NanoIdF, the nanoscience competence center of Paris Region and by the iCEINT, International Consortium for the Environmental Implications of Nano Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dominguez-Martin MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103380; Armand L, 2016, NANOTOXICOLOGY, V10, P913, DOI 10.3109/17435390.2016.1141338; Barrena R, 2009, CHEMOSPHERE, V75, P850, DOI 10.1016/j.chemosphere.2009.01.078; Botelho D, 2010, J PROTEOME RES, V9, P2863, DOI 10.1021/pr900949p; Bour A, 2015, J HAZARD MATER, V283, P764, DOI 10.1016/j.jhazmat.2014.10.021; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Canesi L, 2010, AQUAT TOXICOL, V96, P151, DOI 10.1016/j.aquatox.2009.10.017; Carlson RP, 2007, BIOINFORMATICS, V23, P1258, DOI 10.1093/bioinformatics/btm082; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Carre G, 2014, APPL ENVIRON MICROB, V80, P2573, DOI 10.1128/AEM.03995-13; Chapman SJ, 2012, J BIOL CHEM, V287, P1229, DOI 10.1074/jbc.M111.294850; Clemente Z, 2014, AQUAT TOXICOL, V147, P129, DOI 10.1016/j.aquatox.2013.12.024; Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057; Dimkpa CO, 2011, J HAZARD MATER, V188, P428, DOI 10.1016/j.jhazmat.2011.01.118; Enjalbert B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021318; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fraser ME, 2000, J MOL BIOL, V299, P1325, DOI 10.1006/jmbi.2000.3807; Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Grivet JP, 2003, BIOCHIMIE, V85, P823, DOI 10.1016/j.biochi.2003.08.004; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; Han MJ, 2006, MICROBIOL MOL BIOL R, V70, P362, DOI 10.1128/MMBR.00036-05; Hasan N, 2013, TALANTA, V103, P38, DOI 10.1016/j.talanta.2012.10.003; Hoerr V, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0696-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Isarankura-Na-Ayudhya P., 2009, EUR J SCI RES, V25, P679; Johnston BD, 2010, ENVIRON SCI TECHNOL, V44, P1144, DOI 10.1021/es901971a; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Kremling A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-42; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Lindon J C., 2010, BIOFLUIDS STUDIED NM, P128; Liu WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108474; Liu YF, 2012, INFECT IMMUN, V80, P1815, DOI 10.1128/IAI.06395-11; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Luders S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-36; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mallevre F, 2014, ENVIRON POLLUT, V195, P218, DOI 10.1016/j.envpol.2014.09.002; Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Michta E, 2012, ENVIRON MICROBIOL, V14, P3203, DOI 10.1111/1462-2920.12006; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Mu L, 2010, PHARM RES-DORDR, V27, P1746, DOI 10.1007/s11095-010-0139-1; Nuidate T, 2015, APPL BIOCHEM BIOTECH, V175, P243, DOI 10.1007/s12010-014-1263-x; Ojima Y, 2008, BIOTECHNOL LETT, V30, P1107, DOI 10.1007/s10529-008-9655-z; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Planchon M, 2013, COLLOID SURFACE B, V102, P158, DOI 10.1016/j.colsurfb.2012.08.034; Plesa M, 2006, RES MICROBIOL, V157, P582, DOI 10.1016/j.resmic.2005.11.015; Pottier AS, 2003, J MATER CHEM, V13, P877, DOI 10.1039/b211271j; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Richarme G, 1997, J BIOL CHEM, V272, P15607, DOI 10.1074/jbc.272.25.15607; Rosenfeldt RR, 2014, ENVIRON SCI TECHNOL, V48, P6965, DOI 10.1021/es405396a; Schaumann GE, 2015, SCI TOTAL ENVIRON, V535, P3, DOI 10.1016/j.scitotenv.2014.10.035; Schneider BL, 2013, MOL MICROBIOL, V88, P537, DOI 10.1111/mmi.12207; Schrand AM, 2010, WIRES NANOMED NANOBI, V2, P544, DOI 10.1002/wnan.103; Schug H, 2014, ENVIRON SCI TECHNOL, V48, P11620, DOI 10.1021/es502620e; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049; Sohm B, 2015, PROTEOMICS, V15, P98, DOI 10.1002/pmic.201400101; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027; Han TH, 2011, RES MICROBIOL, V162, P108, DOI 10.1016/j.resmic.2010.11.005; Tkachenko A, 2001, ARCH MICROBIOL, V176, P155, DOI 10.1007/s002030100301; Tsugawa H, 2014, J BIOSCI BIOENG, V117, P122, DOI 10.1016/j.jbiosc.2013.06.009; Tweeddale H, 1998, J BACTERIOL, V180, P5109, DOI 10.1128/JB.180.19.5109-5116.1998; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Ye YF, 2012, J PROTEOME RES, V11, P2559, DOI 10.1021/pr3000128; Yikilmaz E, 2014, BIOCHEMISTRY-US, V53, P5710, DOI 10.1021/bi500533x; Zheng H, 2000, J PHOTOCH PHOTOBIO A, V130, P163, DOI 10.1016/S1010-6030(99)00205-1	80	35	36	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178437	10.1371/journal.pone.0178437	http://dx.doi.org/10.1371/journal.pone.0178437			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570583	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800054
J	Zahiri, R; Lafontaine, JD; Schmidt, BC; deWaard, JR; Zakharov, EV; Hebert, PDN				Zahiri, Reza; Lafontaine, J. Donald; Schmidt, B. Christian; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.			Probing planetary biodiversity with DNA barcodes: The Noctuoidea of North America	PLOS ONE			English	Article							MALE-KILLING WOLBACHIA; MITOCHONDRIAL-DNA; REFERENCE LIBRARY; NATURAL-HISTORY; GENE TREES; LEPIDOPTERA; POPULATION; BUTTERFLIES; TAXONOMY; MOTHS	This study reports the assembly of a DNA barcode reference library for species in the lepidopteran superfamily Noctuoidea from Canada and the USA. Based on the analysis of 69,378 specimens, the library provides coverage for 97.3% of the noctuoid fauna (3565 of 3664 species). In addition to verifying the strong performance of DNA barcodes in the discrimination of these species, the results indicate close congruence between the number of species analyzed (3565) and the number of sequence clusters (3816) recognized by the Barcode Index Number (BIN) system. Distributional patterns across 12 North American ecoregions are examined for the 3251 species that have GPS data while BIN analysis is used to quantify overlap between the noctuoid faunas of North America and other zoogeo-graphic regions. This analysis reveals that 90% of North American noctuoids are endemic and that just 7.5% and 1.8% of BINs are shared with the Neotropics and with the Palearctic, respectively. One third (29) of the latter species are recent introductions and, as expected, they possess low intraspecific divergences.	[Zahiri, Reza] Canadian Food Inspect Agcy, Ottawa Plant Lab, Entomol Unit, Ottawa, ON, Canada; [Zahiri, Reza; deWaard, Jeremy R.; Zakharov, Evgeny V.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada; [Lafontaine, J. Donald; Schmidt, B. Christian] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Biodivers Program, Ottawa, ON, Canada	Canadian Food Inspection Agency; University of Guelph; Agriculture & Agri Food Canada	Zahiri, R (corresponding author), Canadian Food Inspect Agcy, Ottawa Plant Lab, Entomol Unit, Ottawa, ON, Canada.; Zahiri, R (corresponding author), Univ Guelph, Biodivers Inst Ontario, Ctr Biodivers Genom, Guelph, ON, Canada.	reza.zahiri@inspection.gc.ca	Schmidt, Christian/AAE-3069-2019; Zahiri, Reza/G-5797-2018	Zahiri, Reza/0000-0001-6274-6973; Schmidt, Christian/0000-0003-4160-7629	Natural Sciences and Engineering Research Council of Canada (NSERC); government of Canada through Genome Canada; Ontario Genomics; Canada First Research Excellence Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics; Canada First Research Excellence Fund	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to PDNH and by funding from the government of Canada through Genome Canada and Ontario Genomics in support of the International Barcode of Life project. This is a contribution from the Food For Though Research program supported by the Canada First Research Excellence Fund.	Butcher BA, 2012, ZOOTAXA, P7; CEC, 1997, EC REG N AM COMM PER, P71; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; DeWaard Jeremy R., 2008, V410, P275; deWaard JR, 2010, PLOS ONE, V5; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Foottit RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101385; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Grimaldi David, 2005, pi; Gwiazdowski RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125635; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, GENOME, V49, P851, DOI 10.1139/G06-025; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hausmann A, 2011, SPIXIANA, V34, P47; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heppner J. B., 1998, Holarctic Lepidoptera, V5, P1; Heraty John, 2009, P445, DOI 10.1002/9781444308211.ch19; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Institute EESR, 1999, ARCGIS DESKT; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jiggins FM, 2003, GENETICS, V164, P5; Jiggins FM, 2001, HEREDITY, V86, P161, DOI 10.1046/j.1365-2540.2001.00804.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kerr KCR, 2007, MOL ECOL NOTES; Knebelsberger T, 2014, MOL ECOL RESOUR, V14, P1060, DOI 10.1111/1755-0998.12238; Lafontaine JD, 2015, ZOOKEYS, P127, DOI 10.3897/zookeys.527.6151; Lafontaine JD, 2013, ZOOKEYS, P227, DOI 10.3897/zookeys.264.4443; Lafontaine JD, 2011, ZOOKEYS, P145, DOI 10.3897/zookeys.149.1805; Lafontaine JD, 2010, ZOOKEYS, P225, DOI 10.3897/zookeys.39.438; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Miller SE, 2013, P ENTOMOL SOC WASH, V115, P107, DOI 10.4289/0013-8797.115.1.107; Mutanen M, 2016, SYST BIOL; NHEERL) USEOoRDO-NHaEERL, 2010, EC N AM CORV; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Rota J, 2016, SYST ENTOMOL, V41, P416, DOI 10.1111/syen.12162; Rougerie R, 2010, ANN SOC ENTOMOL FR, V46, P477, DOI 10.1080/00379271.2010.10697684; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; Xiao JH, 2012, EVOLUTION, V66, P1907, DOI 10.1111/j.1558-5646.2011.01561.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x	58	40	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178548	10.1371/journal.pone.0178548	http://dx.doi.org/10.1371/journal.pone.0178548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570635	Green Published, gold			2022-12-26	WOS:000402611800074
J	Martin-Brevet, S; Jarrasse, N; Burdet, E; Roby-Brami, A				Martin-Brevet, Sandra; Jarrasse, Nathanael; Burdet, Etienne; Roby-Brami, Agnes			Taxonomy based analysis of force exchanges during object grasping and manipulation	PLOS ONE			English	Article							GRIP FORCE; MULTIFINGER PREHENSION; SENSORIMOTOR MEMORY; LOAD FORCE; MOVEMENTS; CLASSIFICATION; INFORMATION; STRATEGIES; HANDEDNESS; SYNERGIES	The flexibility of the human hand in object manipulation is essential for daily life activities, but remains relatively little explored with quantitative methods. On the one hand, recent taxonomies describe qualitatively the classes of hand postures for object grasping and manipulation. On the other hand, the quantitative analysis of hand function has been generally restricted to precision grip (with thumb and index opposition) during lifting tasks. The aim of the present study is to fill the gap between these two kinds of descriptions, by investigating quantitatively the forces exerted by the hand on an instrumented object in a set of representative manipulation tasks. The object was a parallelepiped object able to measure the force exerted on the six faces and its acceleration. The grasping force was estimated from the lateral force and the unloading force from the bottom force. The protocol included eleven tasks with complementary constraints inspired by recent taxonomies: four tasks corresponding to lifting and holding the object with different grasp configurations, and seven to manipulating the object (rotation around each of its axis and translation). The grasping and unloading forces and object rotations were measured during the five phases of the actions: unloading, lifting, holding or manipulation, preparation to deposit, and deposit. The results confirm the tight regulation between grasping and unloading forces during lifting, and extend this to the deposit phase. In addition, they provide a precise description of the regulation of force exchanges during various manipulation tasks spanning representative actions of daily life. The timing of manipulation showed both sequential and overlapping organization of the different sub-actions, and micro-errors could be detected. This phenomenological study confirms the feasibility of using an instrumented object to investigate complex manipulative behavior in humans. This protocol will be used in the future to investigate upper-limb dexterity in patients with sensory-motor impairments.	[Martin-Brevet, Sandra; Jarrasse, Nathanael; Roby-Brami, Agnes] Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, Paris, France; [Martin-Brevet, Sandra; Jarrasse, Nathanael; Roby-Brami, Agnes] Inst Syst Intelligents & Robot, CNRS, UMR 7222, Paris, France; [Martin-Brevet, Sandra; Jarrasse, Nathanael; Roby-Brami, Agnes] Agathe Inst Syst Intelligents & Robot, INSERM, U1150, Paris, France; [Burdet, Etienne] Imperial Coll Sci Technol & Med, London, England; [Burdet, Etienne] Nanyang Technol Univ, Singapore, Singapore	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Roby-Brami, A (corresponding author), Univ Pierre & Marie Curie Paris 06, Sorbonne Univ, Paris, France.; Roby-Brami, A (corresponding author), Inst Syst Intelligents & Robot, CNRS, UMR 7222, Paris, France.; Roby-Brami, A (corresponding author), Agathe Inst Syst Intelligents & Robot, INSERM, U1150, Paris, France.	roby-brami@isir.upmc.fr	Roby-Brami, Agnes/K-5759-2017	Roby-Brami, Agnes/0000-0002-6196-7229; Jarrasse, Nathanael/0000-0002-5680-1566; Burdet, Etienne/0000-0002-2123-0185	COST Action European Network on Robotics [TD1006]; French state funds [ANR-11-LABX-65, ANR-11-IDEX-0004-02]; EU-FP7 [PEOPLE-ITN-317488-CONTEST]; FP7 HUMOUR [ICT 231554]; EU-H [ICT-644727 COGIMON]	COST Action European Network on Robotics; French state funds; EU-FP7(European Commission); FP7 HUMOUR; EU-H	This work was supported in part by the COST Action TD1006 European Network on Robotics for NeuroRehabilitation, http://www.rehabilitationrobotics.eui. This work was performed within the Labex SMART (ANR-11-LABX-65) supported by French state funds managed by the ANR within the lnvestissements d'Avenir programme under reference ANR-11-IDEX-0004-02, http://www.smart-labex.fr/.EB is in part supported by the EU-FP7 PEOPLE-ITN 317488-CONTEST, http.//cordis.europa.euiproiect/m/1/104707 fr.html, FP7 HUMOUR (ICT 231554) and EU-H2020 ICT-644727 COGIMON, http://cordis europa .eu/project/rcn/1/194239_en html, grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensmail D, 2010, NEUROREHAB NEURAL RE, V24, P141, DOI 10.1177/1545968309347683; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Bullock IM, 2013, IEEE T HAPTICS, V6, P296, DOI 10.1109/TOH.2013.6; Bullock IM, 2013, IEEE T HAPTICS, V6, P129, DOI [10.1109/TOH.2012.53, 10.1109/ToH.2012.53]; Bullock Ian M, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975408, DOI 10.1109/ICORR.2011.5975408; Cochet H, 2013, ANIM COGN, V16, P531, DOI 10.1007/s10071-013-0626-y; ELLIOTT JM, 1984, DEV MED CHILD NEUROL, V26, P283, DOI 10.1111/j.1469-8749.1984.tb04445.x; Fagard J, 2005, INFANT BEHAV DEV, V28, P305, DOI 10.1016/j.infbeh.2005.05.005; Feix T., 2015, P IEEE T HUMAN MACHI, P1; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; FLANAGAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P944, DOI 10.1037/0096-1523.20.5.944; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; Flanagan JR, 2009, SENSORIMOTOR CONTROL, P161; Fu QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108222; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Goodwin AW, 1998, J NEUROSCI, V18, P10724; GORDON AM, 1991, EXP BRAIN RES, V83, P477; Han HY, 1996, IEEE INT CONF ROBOT, P3061, DOI 10.1109/ROBOT.1996.509177; Hermsdorfer J, 2004, HUM MOVEMENT SCI, V23, P643, DOI 10.1016/j.humov.2004.10.005; Hermsdorfer J, 2003, CLIN NEUROPHYSIOL, V114, P915, DOI 10.1016/S1388-2457(03)00042-7; Hirose N., 2007, STUDIES PERCEPTION A, V9, P91; Hussain A, 2015, INT C REHAB ROBOT, P247, DOI 10.1109/ICORR.2015.7281207; Iberall T., 1986, EXP BRAIN RES, V15, P158, DOI DOI 10.1007/978-3-642-71476-4_12; Jarrasse N, 2013, IEEE INT C REH ROB, V2013; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson R., 2009, SENSORIMOTOR CONTROL; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; Johansson RS, 1999, EXP BRAIN RES, V128, P20, DOI 10.1007/s002210050813; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; LANDSMEER JMF, 1962, ANN RHEUM DIS, V21, P164, DOI 10.1136/ard.21.2.164; Latash M.L., 1996, DEXTERITY ITS DEV; Marneweck M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138258; Naceri A, 2014, HAPT S HAPTICS 2014; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Nowak D. A., 2009, SENSORIMOTOR CONTROL; Nowak DA, 2003, EUR J NEUROSCI, V18, P2883, DOI 10.1111/j.1460-9568.2003.03011.x; Nowak DA, 2002, SOMATOSENS MOT RES, V19, P49, DOI 10.1080/08990220120113048; Nowak DA, 2006, BRAIN RES REV, V51, P108, DOI 10.1016/j.brainresrev.2005.10.003; Obhi SS, 2004, MOTOR CONTROL, V8, P111, DOI 10.1123/mcj.8.2.111; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Roach N, 2012, IEEE PULSE, V3, P51, DOI 10.1109/MPUL.2012.2216719; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Rosenbaum DA, 2012, PSYCHOL BULL, V138, P924, DOI 10.1037/a0027839; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Santello M, 1998, J NEUROSCI, V18, P10105; Seligman SC, 2014, CLIN NEUROPSYCHOL, V28, P97, DOI 10.1080/13854046.2013.852624; Steele J, 2012, PHILOS T R SOC B, V367, P4, DOI 10.1098/rstb.2011.0295; Tomlinson SE, 2007, P I MECH ENG J-J ENG, V221, P841, DOI 10.1243/13506501JET313; WESTLING G, 1984, EXP BRAIN RES, V53, P277; White O, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00007; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zatsiorsky VM, 2003, EXP BRAIN RES, V148, P77, DOI 10.1007/s00221-002-1278-3; Zatsiorsky VM, 2002, BIOL CYBERN, V87, P50, DOI 10.1007/s00422-002-0321-6	57	6	6	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178185	10.1371/journal.pone.0178185	http://dx.doi.org/10.1371/journal.pone.0178185			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562617	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700045
J	Pillet, F; Passot, FM; Pasta, F; Leberre, VA; Bouet, JY				Pillet, Flavien; Passot, Fanny Marie; Pasta, Franck; Leberre, Veronique Anton; Bouet, Jean-Yves			Analysis of ParB-centromere interactions by multiplex SPR imaging reveals specific patterns for binding ParB in six centromeres of Burkholderiales chromosomes and plasmids	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); ESCHERICHIA-COLI; BACILLUS-SUBTILIS; REPLICATION INITIATION; LINEAR CHROMOSOME; PARTITION COMPLEX; CYSTIC-FIBROSIS; DNA SEGREGATION; PROTEIN; ORIGIN	Bacterial centromeres also called parS, are cis-acting DNA sequences which, together with the proteins ParA and ParB, are involved in the segregation of chromosomes and plasmids. The specific binding of ParB to parS nucleates the assembly of a large ParB/DNA complex from which ParA the motor protein, segregates the sister replicons. Closely related families of partition systems, called Bsr, were identified on the chromosomes and large plasmids of the multi-chromosomal bacterium Burkholderia cenocepacia and other species from the order Burkholeriales. The centromeres of the Bsr partition families are 16 by palindromes, displaying similar base compositions, notably a central CG dinucleotide. Despite centromeres bind the cognate ParB with a narrow specificity, weak ParB-parS non cognate interactions were nevertheless detected between few Bsr partition systems of replicons not belonging to the same genome. These observations suggested that Bsr partition systems could have a common ancestry but that evolution mostly erased the possibilities of cross reactions between them, in particular to prevent replicon incompatibility. To detect novel similarities between Bsr partition systems, we have analyzed the binding of six Bsr parS sequences and a wide collection of modified derivatives, to their cognate ParB. The study was carried out by Surface Plasmon Resonance imaging (SPRi) mulitplex analysis enabling a systematic survey of each nucleotide position within the centromere. We found that in each parS some positions could be changed while maintaining binding to ParB. Each centromere displays its own pattern of changes, but some positions are shared more or less widely. In addition from these changes we could speculate evolutionary links between these centromeres.	[Pillet, Flavien; Leberre, Veronique Anton] Inst Natl Sci Appl, Inst Natl Rech Agron, Ingn Syst Biol & Proc INRA UMR792, Toulouse, France; [Pillet, Flavien; Leberre, Veronique Anton] Univ Toulouse, Inst Natl Sci Appl, CNRS, Lab Ingn Syst Biol & Proc CNRS UMR5504, Toulouse, France; [Passot, Fanny Marie; Pasta, Franck; Bouet, Jean-Yves] Univ Paul Sabatier, CNRS, Ctr Biol Integrat, Lab Microbiol & Genet Mol, Toulouse, France; [Pillet, Flavien] Univ Paul Sabatier, CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Passot, Fanny Marie] Lund Univ, Dept Biol, Mol Cell Biol Unit, Lund, Sweden	INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Lund University	Pasta, F (corresponding author), Univ Paul Sabatier, CNRS, Ctr Biol Integrat, Lab Microbiol & Genet Mol, Toulouse, France.	pasta@ibcg.biotoul.fr	Anton Leberre, veronique/U-9208-2018; Bouet, Jean-Yves/H-8469-2019	Bouet, Jean-Yves/0000-0003-1488-5455; Anton-Leberre, Veronique/0000-0002-8022-4295; Passot, Fanny/0000-0002-0257-816X	Agence Nationale pour la Recherche [10 BLAN 1316 01]	Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale pour la Recherche, 10 BLAN 1316 01.	Baek JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004184; Bartosik AA, 2005, ACTA BIOCHIM POL, V52, P1; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Du WL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006172; Dubarry N, 2006, J BACTERIOL, V188, P1489, DOI 10.1128/JB.188.4.1489-1496.2006; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Godfrin-Estevenon AM, 2002, MOL MICROBIOL, V43, P39, DOI 10.1046/j.1365-2958.2002.02735.x; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jensen J, 2005, PHILOS T R SOC LON B, V360, P523; Kadoya R, 2011, J BACTERIOL, V193, P1504, DOI 10.1128/JB.01067-10; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Koper P, 2016, MOL MICROBIOL, V102, P446, DOI 10.1111/mmi.13472; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lemonnier M, 2000, MOL MICROBIOL, V38, P493, DOI 10.1046/j.1365-2958.2000.02101.x; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Passot FM, 2012, J BACTERIOL, V194, P3426, DOI 10.1128/JB.00041-12; Pillet F, 2011, NUCLEIC ACIDS RES, V39, P7477, DOI 10.1093/nar/gkr457; Pillet F, 2010, SENSOR ACTUAT B-CHEM, V147, P87, DOI 10.1016/j.snb.2010.03.015; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Sanchez A, 2015, CELL SYST, V1, P163, DOI 10.1016/j.cels.2015.07.013; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Yamaichi Y, 2007, J BACTERIOL, V189, P5314, DOI 10.1128/JB.00416-07	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177056	10.1371/journal.pone.0177056	http://dx.doi.org/10.1371/journal.pone.0177056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562673	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700009
J	Tickler, DM; Letessier, TB; Koldewey, HJ; Meeuwig, JJ				Tickler, David M.; Letessier, Tom B.; Koldewey, Heather J.; Meeuwig, Jessica J.			Drivers of abundance and spatial distribution of reef-associated sharks in an isolated atoll reef system	PLOS ONE			English	Article							MARINE PROTECTED AREAS; SPECIES COMPOSITION; CONSERVATION; MOVEMENTS; REPRODUCTION; PREDATORS; DIVERSITY; FIDELITY; OCEAN; DIET	We investigated drivers of reef shark demography across a large and isolated marine protected area, the British Indian Ocean Territory Marine Reserve, using stereo baited remote underwater video systems. We modelled shark abundance against biotic and abiotic variables at 35 sites across the reserve and found that the biomass of low trophic order fish (specifically planktivores) had the greatest effect on shark abundance, although models also included habitat variables (depth, coral cover and site type). There was significant variation in the composition of the shark assemblage at different atolls within the reserve. In particular, the deepest habitat sampled (a seamount at 70-80m visited for the first time in this study) recorded large numbers of scalloped hammerhead sharks (Sphyrna lewini) not observed elsewhere. Size structure of the most abundant and common species, grey reef sharks (Carcharhinus amblyrhynchos), varied with location. Individuals at an isolated bank were 30% smaller than those at the main atolls, with size structure significantly biased towards the size range for young of year (YOY). The 18 individuals judged to be YOY represented the offspring of between four and six females, so, whilst inconclusive, these data suggest the possible use of a common pupping site by grey reef sharks. The importance of low trophic order fish biomass (i.e. potential prey) in predicting spatial variation in shark abundance is consistent with other studies both in marine and terrestrial systems which suggest that prey availability may be a more important predictor of predator distribution than habitat suitability. This result supports the need for ecosystem level rather than species-specific conservation measures to support shark recovery. The observed spatial partitioning amongst sites for species and life-stages also implies the need to include a diversity of habitats and reef types within a protected area for adequate protection of reef-associated shark assemblages.	[Tickler, David M.; Letessier, Tom B.; Meeuwig, Jessica J.] Univ Western Australia, Oceans Inst, Ctr Marine Futures, 35 Stirling Highway, Perth, WA, Australia; [Letessier, Tom B.; Koldewey, Heather J.] Zool Soc London, Regents Pk, London, England; [Koldewey, Heather J.] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Exeter, Devon, England	University of Western Australia; Zoological Society of London; University of Exeter	Tickler, DM (corresponding author), Univ Western Australia, Oceans Inst, Ctr Marine Futures, 35 Stirling Highway, Perth, WA, Australia.	david.tickler@research.uwa.edu.au	Letessier, Tom Bech/AAV-2759-2020	Letessier, Tom Bech/0000-0003-4011-0207; Meeuwig, Jessica/0000-0003-1169-8785; Tickler, David/0000-0001-7722-0771	UK Government's Department for Environment, Food Rural Affairs [El DCF006]; Bertarelli Foundation; Darwin Foundation	UK Government's Department for Environment, Food Rural Affairs; Bertarelli Foundation; Darwin Foundation	HJK received a Darwin Initiative grant (El DCF006) from the UK Government's Department for Environment, Food & Rural Affairs (http://mw.danwininitiative.org.A/project/ EIDCF006/). DT received a maintenance scholarship from the Bertarelli Foundation (www. fondation-bertareilLorg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The data collection for this project would not have been possible without the support and hard work of Captain Neil Sandes and the crew of the British Indian Ocean Territory patrol vessel Pacific Marlin and support from the UK FCO. Fieldwork was supported by funding from the Darwin Foundation. DT was supported by a scholarship from the Bertarelli Foundation.	Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Barley SC, 2017, MAR ECOL PROG SER, V565, P163, DOI 10.3354/meps11981; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bearzi G, 2006, BIOL CONSERV, V127, P373, DOI 10.1016/j.biocon.2005.08.017; Benoit-Bird KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053348; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Boistol L., 2011, FISHERIES CTR RES RE, V19, P39; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Ceccarelli DM, 2014, REV FISH BIOL FISHER, V24, P169, DOI 10.1007/s11160-013-9324-8; Chin A, 2013, AQUAT CONSERV, V23, P468, DOI 10.1002/aqc.2349; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; D'agata S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12000; Dale JJ, 2011, PLOS ONE, P6; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Espinoza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106885; Estes J.A., 2010, TROPHIC CASCADES; Farmer NA, 2011, MAR ECOL PROG SER, V433, P169, DOI 10.3354/meps09198; Frisch AJ, 2016, CORAL REEFS, V35, P1, DOI [10.1007/s00338-016-1410-7, DOI 10.1007/S00338-016-1410-7]; Froese R., 2017, FISHBASE GLOBAL INFO; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrell FE, 2001, REGRESSION MODELING; Hay Mark E, 2010, F1000 Biol Rep, V2, P71, DOI 10.3410/B2-71; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Keim JL, 2011, ECOL APPL, V21, P1011, DOI 10.1890/10-0949.1; Knip DM, 2012, BIOL CONSERV, V148, P200, DOI 10.1016/j.biocon.2012.01.008; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kulbicki M, 2005, AQUAT LIVING RESOUR, V18, P231, DOI 10.1051/alr:2005029; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Martin S., 2013, CATCH BYCATCH COMPOS; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Meekan M. M., 2006, SURVEYS SHARK FIN FI; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Olds AD, 2014, GLOBAL CHANGE BIOL; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Papastamatiou YP, 2006, MAR ECOL PROG SER; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Rassweiler A, 2012, P NATL ACAD SCI USA, V109, P11884, DOI 10.1073/pnas.1116193109; Rife AN, 2013, CONSERV LETT, V6, P200, DOI 10.1111/j.1755-263X.2012.00303.x; Robbins WD, 2006, THESIS J COOK U; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Speed CW, 2016, REG STUD MAR SCI, V3, P58, DOI 10.1016/j.rsma.2015.05.002; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Vianna G, 2013, PLOS ONE; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Walsh SM, 2012, J FISH BIOL, V80, P519, DOI 10.1111/j.1095-8649.2011.03209.x; Ward-Paige CA, 2015, THESIS DALHOUSIE U; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Wetherbee BM, 1997, MAR ECOL PROG SER, V151, P181, DOI 10.3354/meps151181; Wilkinson C, 2008, STATUS CORAL REEFS W; Wirsing AJ, 2007, OECOLOGIA, V153, P563, DOI 10.1007/s00442-007-0769-0; Wirsing AJ, 2011, FRONT ECOL ENVIRON, V9, P335, DOI 10.1890/090226; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004; Zeller DC, 1997, MAR ECOL PROG SER, V154, P65, DOI 10.3354/meps154065; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	78	19	19	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5								10.1371/journal.pone.0177374	http://dx.doi.org/10.1371/journal.pone.0177374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562602	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700012
J	Wei, W; Chai, ZZ; Xie, YG; Gao, K; Cui, MY; Jiang, Y; Feng, JY				Wei, Wei; Chai, Zhuangzhuang; Xie, Yinge; Gao, Kuan; Cui, Mengyuan; Jiang, Ying; Feng, Jiayue			Bioinformatics identification and transcript profile analysis of the mitogen-activated protein kinase gene family in the diploid woodland strawberry Fragaria vesca	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABIOTIC STRESS; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; DISEASE RESISTANCE; INNATE IMMUNITY; MAPK CASCADES; SALT STRESS; ARABIDOPSIS; PLANTS	Mitogen-activated protein kinases (MAPKs) play essential roles in mediating biotic and abiotic stress responses in plants. However, the MAPKgene family in strawberry has not been systematically characterized. Here, we performed a genome-wide survey and identified 12 MAPK genes in the Fragaria vesca genome. Protein domain analysis indicated that all FvMAPKs have typical protein kinase domains. Sequence alignments and phylogenetic analysis classified the FvMAPKgenes into four different groups. Conserved motif and exon-intron organization supported the evolutionary relationships inferred from the phylogenetic analysis. Analysis of the stress-related cis-regulatory element in the promoters and subcellular localization predictions of FvMAPKs were also performed. Gene transcript profile analysis showed that the majority of the FvMAPKgenes were ubiquitously transcribed in strawberry leaves after Podosphaera aphanis inoculation and after treatment with cold, heat, drought, salt and the exogenous hormones abscisic acid, ethephon, methyl jasmonate, and salicylic acid. RT-qPCR showed that six selected FvMAPKgenes comprehensively responded to various stimuli. Additionally, interaction networks revealed that the crucial signaling transduction controlled by FvMAPKs may be involved in the biotic and abiotic stress responses. Our results may provide useful information for future research on the function of the MAPKgene family and the genetic improvement of strawberry resistance to environmental stresses.	[Wei, Wei; Chai, Zhuangzhuang; Xie, Yinge; Gao, Kuan; Cui, Mengyuan; Jiang, Ying; Feng, Jiayue] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wei, Wei; Chai, Zhuangzhuang; Xie, Yinge; Gao, Kuan; Cui, Mengyuan; Jiang, Ying; Feng, Jiayue] Minist Agr, Key Lab Protected Hort Engn Northwest China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Feng, JY (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Feng, JY (corresponding author), Minist Agr, Key Lab Protected Hort Engn Northwest China, Yangling, Shaanxi, Peoples R China.	fengjy19151@nwsuaf.edu.cn			National Natural Science Foundation of China [31201657]; Yangling Agricultural Hi-tech Industry Demo Zone synergy innovation for cooperation in production, study, and research [2016CXY-11]; project for Agriculture Sci-Tech demonstration and extension of Yangling Agricultural Hi-tech Industry Demo Zone [TS-2016-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yangling Agricultural Hi-tech Industry Demo Zone synergy innovation for cooperation in production, study, and research; project for Agriculture Sci-Tech demonstration and extension of Yangling Agricultural Hi-tech Industry Demo Zone	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31201657), the major program of Yangling Agricultural Hi-tech Industry Demo Zone synergy innovation for cooperation in production, study, and research (2016CXY-11), and the project for Agriculture Sci-Tech demonstration and extension of Yangling Agricultural Hi-tech Industry Demo Zone (TS-2016-18). The study was performed in State Key Laboratory of Crop Stress Biology for Arid Areas, Northwest A&F University and Key Laboratory of Protected Horticulture Engineering in Northwest China, Ministry of Agriculture, the People's Republic of China.	Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Amsalem L, 2006, EUR J PLANT PATHOL, V114, P283, DOI 10.1007/s10658-005-5804-6; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Berriri S, 2012, PLANT CELL, V24, P4281, DOI 10.1105/tpc.112.101253; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Cakir B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00556; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Darwish O, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1221-1; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Droillard MJ, 2002, FEBS LETT, V527, P43, DOI 10.1016/S0014-5793(02)03162-9; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Husaini AM, 2012, PLANT MOL BIOL REP, V30, P1055, DOI 10.1007/s11105-011-0394-2; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jammes F, 2009, P NATL ACAD SCI USA, V106, P20520, DOI 10.1073/pnas.0907205106; Janitza P, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00271; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jung S, 2004, BMC BIOINFORMATICS, V36, pD1034; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Lee SK, 2011, J BIOSCIENCES, V36, P139, DOI 10.1007/s12038-011-9002-8; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mohanta TK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1244-7; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rohila JS, 2007, J INTEGR PLANT BIOL, V49, P751, DOI 10.1111/j.1744-7909.2007.00501.x; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Song CK, 2015, PLANT PHYSIOL, V169, P1656, DOI 10.1104/pp.15.00794; Song QM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0681-4; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Tohge T, 2010, NAT PROTOC, V5, P1210, DOI 10.1038/nprot.2010.82; Wang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1621-2; Wei W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01937; Wei W, 2016, PLANT PHYSIOL BIOCH, V105, P129, DOI 10.1016/j.plaphy.2016.04.014; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu J, 2015, TRENDS PLANT SCI, V20, P56, DOI 10.1016/j.tplants.2014.10.001; Yamada K, 2016, EMBO J, V35, P2468, DOI 10.15252/embj.201694248; Yan Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01294; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang SZ, 2013, GENE, V531, P377, DOI 10.1016/j.gene.2013.07.107; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	55	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178596	10.1371/journal.pone.0178596	http://dx.doi.org/10.1371/journal.pone.0178596			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562633	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700077
J	Al-Kindi, KM; Kwan, P; Andrew, N; Welch, M				Al-Kindi, Khalifa M.; Kwan, Paul; Andrew, Nigel; Welch, Mitchell			Impact of environmental variables on Dubas bug infestation rate: A case study from the Sultanate of Oman	PLOS ONE			English	Article							OMMATISSUS-LYBICUS; DATE PALM; SPATIOTEMPORAL PATTERNS; POPULATIONS	Date palm cultivation is economically important in the Sultanate of Oman, with significant financial investment coming from both the government and from private individuals. However, a global infestation of Dubas bug (Ommatissus lybicus Bergevin) has impacted the Middle East region, and infestations of date palms have been widespread. In this study, spatial analysis and geostatistical techniques were used to model the spatial distribution of Dubas bug infestations to (a) identify correlations between Dubas bug densities and different environmental variables, and (b) predict the locations of future Dubas bug infestations in Oman. Firstly, we considered individual environmental variables and their correlations with infestation locations. Then, we applied more complex predictive models and regression analysis techniques to investigate the combinations of environmental factors most conducive to the survival and spread of the Dubas bug. Environmental variables including elevation, geology, and distance to drainage pathways were found to significantly affect Dubas bug infestations. In contrast, aspect and hillshade did not significantly impact on Dubas bug infestations. Understanding their distribution and therefore applying targeted controls on their spread is important for effective mapping, control and management (e.g., resource allocation) of Dubas bug infestations.	[Al-Kindi, Khalifa M.; Kwan, Paul; Welch, Mitchell] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Andrew, Nigel] Univ New England, Ctr Behav & Physiol Ecol, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England; University of New England	Kwan, P (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	paul.kwan@une.edu.au	Alkindi, Khalifa/AAK-4998-2020; Andrew, Nigel/B-7162-2008	Andrew, Nigel/0000-0002-2850-2307; Welch, Mitchell/0000-0003-4220-8734; Kwan, Paul Wing Hing/0000-0002-4959-5274				ABDULLAH S.K, 2010, BASRAH J DATE PALM R, V9, P40; AI-Khatri S. A., 2004, P DAT PALM REG WORKS, P84; Al Harthi S, 2015, J TAIBAH U MED SCI; Al-Busaidi MA, 2015, FOOD CONTROL, V51, P55, DOI 10.1016/j.foodcont.2014.10.039; Al-Khatri SAH, 2011, BIOL ECOLOGICAL PSYL; Al-Kindi KM, 2017, CROP PROT, V93, P113, DOI 10.1016/j.cropro.2016.11.033; Al-Kindi KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171103; Al-Samarrie AI, 2011, AGRIC BIOL JN AM, V12, P1416; Al-Wahaibi A, 2013, FIGHT UNDERSTAND DUB, P4; Al-Yahyai R., 2015, DATE PALM GENETIC RE, P207, DOI [10.1007/978-94-017-9707-8_6, DOI 10.1007/978-94-017-9707-8_6]; Al-Zadjali T. S., 2006, Egyptian Journal of Agricultural Research, V84, P51; Aldryhim Y, 2004, ENCY ENTOMOLOGY, P727; Ali HG, 2010, DEV DATE PALM CULTIV, P29; Anselin L, 2010, ADV SPAT SCI, P35, DOI 10.1007/978-3-642-01976-0_3; Bagheri A, 2016, J AGR SCI TECH-IRAN, V18, P1605; Bagheri A, ANN ENTOMOLOGICAL SO; Beckler A. A., 2005, Transactions in GIS, V9, P109, DOI 10.1111/j.1467-9671.2005.00209.x; Bedford GO, 2015, SUST PLANT CROP PRO, P73, DOI 10.1007/978-3-319-24397-9_5; Belwal R, 2014, TRENDS GLOBAL CONSID, V159; Blumberg D, 2008, PHYTOPARASITICA, V36, P411, DOI 10.1007/BF03020290; El-Juhany L.I., 2010, AUST J BASIC APPL SC, V4, P3998, DOI DOI 10.1016/J.RADPHYSCHEM.2006.10.004; El-Shafie H. A. F., 2012, Agriculture and Biology Journal of North America, V3, P516; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Griffith DA, 1999, GEOGRAPHIC INFORM SC, V5, P97; Hassan N, 2014, INT PEST CONTROL, V56, P92; Heward AP, 2014, GEOL SOC SPEC PUBL, V392, P279, DOI 10.1144/SP392.15; Howard F. W., 2001, Pesticide Outlook, V12, P240, DOI 10.1039/b110547g; HUSSAIN A. A., 1963, Bulletin of Entomological Research, V53, P737, DOI 10.1017/S0007485300048458; Jasim H, 2010, EGGS DISTRIBUTION OL, P465; Kamel A, 2007, FOOD CHEM, V100, P1590, DOI 10.1016/j.foodchem.2006.01.002; Khan A, 2001, CITESEER, P211; KLEIN M, 1985, PHYTOPARASITICA, V13, P95, DOI 10.1007/BF02980886; Kounatidis I, 2008, J APPL ENTOMOL, V132, P722, DOI 10.1111/j.1439-0418.2008.01349.x; Mahmoudi M, 2015, J AGR SCI TECH-IRAN, V17, P263; Mokhtar A, 1999, AGR SCI, V4, P1, DOI DOI 10.24200/JAMS.V0L4ISS1PP1-4; Mokhtar AM, 2010, EUR J ENTOMOL, V107, P681, DOI 10.14411/eje.2010.076; Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49; Payandeh Arezoo, 2010, Munis Entomology & Zoology, V5, P726; Pinault LL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-236; Pohl C, 1998, INT J REMOTE SENS, V19, P823, DOI 10.1080/014311698215748; Richardson A. J., 1977, DISTINGUISHING VEGET; Rivera D, 2015, DATE PALM STATUS PER, P489; Schools E.H., 2012, UTILIZING NEXRAD WEA; Scott, 2011, SPATIAL STAT BEST PR; Shah A, 2012, PAKISTAN J ZOOLOGY, V44; Shah A, 2013, J INSECT BEHAV, V26, P371, DOI 10.1007/s10905-012-9354-4; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x	47	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178109	10.1371/journal.pone.0178109	http://dx.doi.org/10.1371/journal.pone.0178109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558069	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000028
J	Takeuchi, M; Sato, T; Sakurai, Y; Taguchi, M; Harimoto, K; Karasawa, Y; Ito, M				Takeuchi, Masaru; Sato, Tomohito; Sakurai, Yutaka; Taguchi, Manzo; Harimoto, Kozo; Karasawa, Yoko; Ito, Masataka			Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy	PLOS ONE			English	Article							T-CELLS; IL-17; INFLAMMATION; IDENTIFICATION; ANGIOGENESIS; PATHOGENESIS; RECEPTOR	Inflammation is known to be involved in the progression of diabetic retinopathy. We have recently reported that vitreous levels of IL-4, IL-17A, IL-22, IL-31, and TNFa are higher than the respective serum levels in proliferative diabetic retinopathy (PDR) patients, and that vitreous levels of these cytokines are higher in PDR than in other non-inflammatory vitreoretinal diseases or uveitis associated with sarcoidosis. In the present study, we investigated inflammatory cytokines including Th17 cell-related cytokines in aqueous humor samples obtained from eyes with PDR, and analyzed the association between the aqueous humor and vitreous fluid levels of individual cytokines. The study group consisted of 31 consecutive type 2 diabetic patients with PDR who underwent cataract surgery and vitrectomy for vitreous hemorrhage and/or tractional retinal detachment. Undiluted aqueous humor was collected during cataract surgery, and then vitreous fluid was obtained using a 25G vitreous cutter inserted into the mid-vitreous cavity at the beginning of vitrectomy. IL-113, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, IFN-y, soluble CD40 ligand (sCD4OL), and TNFa levels in the aqueous humor and vitreous fluid were measured using a beads-array system. Although IL-17A was detected in the aqueous humor of eyes with PDR and the level correlated with IL-17A level in the vitreous fluid, both percent detectable and level of IL-17A in the aqueous humor were significantly lower than those in the vitreous fluid. Vitreous IL-17A level was related significantly to IL-10, IL-22, and TNFa levels in aqueous humor as well as in vitreous fluid, On the other hand, aqueous IL-17A level was not related significantly to aqueous or vitreous levels of IL-10, IL-22 or TNFa level. The present study demonstrated that IL-17A level and detectable rate in the aqueous humor of patients with PDR are markedly lower than those in the vitreous fluid and aqueous IL-17A does not correlate with vitreous levels of other cytokines, and hence should not be used as a surrogate for IL-17A in the vitreous fluid.	[Takeuchi, Masaru; Sato, Tomohito; Sakurai, Yutaka; Taguchi, Manzo; Harimoto, Kozo; Karasawa, Yoko] Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Saitama, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Takeuchi, M (corresponding author), Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan.	masatake@ndmc.ac.jp			Japan Society for the Promotion of Science [16K11337]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid 16K11337 for Scientific Research from the Japan Society for the Promotion of Science, URL:http://www-shinsei.isps.go.jp/kaken/index.html.	Abu El-Asrar AM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/539658; Bromberg-White JL, 2013, INVEST OPHTH VIS SCI, V54, P6472, DOI 10.1167/iovs.13-12518; Chen H, 2016, J INT MED RES; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; Cheung CMG, 2012, MOL VIS, V18, P830; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Demircan N, 2006, EYE, P20; Dong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125329; Dong N, 2013, MOL VIS, V19, P1734; ELASRAR AM, 1992, AM J OPHTHALMOL, V114, P731, DOI 10.1016/S0002-9394(14)74052-8; Evans JR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011234.pub2; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; Gologorsky D, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/629452; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kawasaki R, 2011, DIABETOLOGIA, V54, P2288, DOI 10.1007/s00125-011-2199-0; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kuiper J, 2015, ACTA OPHTHALMOL, V93, pE680, DOI 10.1111/aos.12733; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Liu SL, 2016, EXP THER MED, V11, P257, DOI 10.3892/etm.2015.2877; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Meleth AD, 2005, INVEST OPHTH VIS SCI, V46, P4295, DOI 10.1167/iovs.04-1057; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Qu N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/968549; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shin JI, 2013, NAT REV IMMUNOL, V13, DOI 10.1038/nri3459-c1; Sumarac-Dumanovic M, 2013, IMMUNOBIOLOGY, V218, P1113, DOI 10.1016/j.imbio.2013.03.002; Suryawanshi A, 2012, J IMMUNOL, V188, P3434, DOI 10.4049/jimmunol.1102602; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Takeuchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137358; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Wolf LA, 2003, OPHTHALMOLOGY, V110, P1671, DOI 10.1016/S0161-6420(03)00811-X; Xu HY, 2015, GRAEF ARCH CLIN EXP, V253, P1485, DOI 10.1007/s00417-014-2842-9; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	43	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178230	10.1371/journal.pone.0178230	http://dx.doi.org/10.1371/journal.pone.0178230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558009	gold, Green Submitted, Green Published			2022-12-26	WOS:000402607000034
J	Brown, SL; Whiting, D; Fielden, HG; Saini, P; Beesley, H; Holcombe, C; Holcombe, S; Greenhalgh, L; Fairburn, L; Salmon, P				Brown, Stephen L.; Whiting, Demian; Fielden, Hannah G.; Saini, Pooja; Beesley, Helen; Holcombe, Christopher; Holcombe, Susan; Greenhalgh, Lyn; Fairburn, Louise; Salmon, Peter			Qualitative analysis of how patients decide that they want risk-reducing mastectomy, and the implications for surgeons in responding to emotionally-motivated patient requests	PLOS ONE			English	Article							CONTRALATERAL PROPHYLACTIC MASTECTOMY; DECISION-MAKING; FAMILY-HISTORY; WOMEN; CONSOLIDATION; DELIBERATION; EFFICACY; MODEL	Objective Contemporary approaches to medical decision-making advise that clinicians should respect patients' decisions. However, patients' decisions are often shaped by heuristics, such as being guided by emotion, rather than by objective risk and benefit. Risk-reducing mastectomy (RRM) decisions focus this dilemma sharply. RRM reduces breast cancer (BC) risk, but is invasive and can have iatrogenic consequences. Previous evidence suggests that emotion guides patients' decision-making about RRM. We interviewed patients to better understand how they made decisions about RRM, using findings to consider how clinicians could ethically respond to their decisions. Methods Qualitative face-to-face interviews with 34 patients listed for RRM surgery and two who had decided against RRM. Results Patients generally did not use objective risk estimates or, indeed, consider risks and benefits of RRM. Instead emotions guided their decisions: they chose RRM because they feared BC and wanted to do 'all they could' to prevent it. Most therefore perceived RRM to be the 'obvious' option and made the decision easily. However, many recounted extensive post-decisional deliberation, generally directed towards justifying the original decision. A few patients deliberated before the decision because fears of surgery counterbalanced those of BC. Conclusion Patients seeking RRM were motivated by fear of BC, and the need to avoid potential regret for not doing all they could to prevent it. We suggest that choices such as that for RRM, which are made emotionally, can be respected as autonomous decisions, provided patients have considered risks and benefits. Drawing on psychological theory about how people do make decisions, as well as normative views of how they should, we propose that practitioners can guide consideration of risks and benefits even, where necessary, after patients have opted for surgery. This model of practice could be extended to other medical decisions that are influenced by patients' emotions.	[Brown, Stephen L.; Fielden, Hannah G.; Saini, Pooja; Beesley, Helen; Fairburn, Louise; Salmon, Peter] Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England; [Whiting, Demian] Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Holcombe, Christopher; Holcombe, Susan] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Greenhalgh, Lyn] Royal Liverpool Womens Hosp NHS Trust, Liverpool, Merseyside, England	University of Liverpool; University of Hull; University of York - UK; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Brown, SL (corresponding author), Univ Liverpool, Dept Psychol Sci, Liverpool, Merseyside, England.	slbrown@liverpool.ac.uk	; Salmon, Peter/H-5289-2018	Saini, Pooja/0000-0002-4981-7914; Brown, Stephen/0000-0002-6142-0995; Salmon, Peter/0000-0001-6450-5209	Economic and Social Research Council (UK) [ES/J008184/1]; ESRC [ES/J008184/1] Funding Source: UKRI; Economic and Social Research Council [ES/J008184/1] Funding Source: researchfish	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was entirely funded by the Economic and Social Research Council (UK) Grant ES/J008184/1. ESRC did not seek to influence the conduct of the investigation or this report.	[Anonymous], 1999, EVID-BASED MENT HEAL, DOI DOI 10.1136/EBMH.2.4.99; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Beesley H, 2013, BREAST, V22, P179, DOI 10.1016/j.breast.2012.06.005; De Roubaix JAM, 2011, J PLAST RECONSTR AES, V64, P11, DOI 10.1016/j.bjps.2010.03.034; de Vries M, 2013, PATIENT EDUC COUNS, V91, P154, DOI 10.1016/j.pec.2012.11.016; Dijksterhuis A, 1996, J EXP SOC PSYCHOL, V32, P254, DOI 10.1006/jesp.1996.0012; Elwyn G, 2014, PATIENT EDUC COUNS, V97, P158, DOI 10.1016/j.pec.2014.07.027; Elwyn G, 2010, HEALTH EXPECT, V13, P139, DOI 10.1111/j.1369-7625.2009.00572.x; Evans DG, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0650-8; Frost MH, 2005, J CLIN ONCOL, V23, P7849, DOI 10.1200/JCO.2005.09.233; Geiger AM, 2006, J CLIN ONCOL, V24, P1350, DOI 10.1200/JCO.2005.01.9901; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Heiniger L, 2015, J BEHAV MED, V38, P727, DOI 10.1007/s10865-015-9632-7; Kleinman A, 1999, DAEDALUS-US, V128, P69; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Labroo AA, 2009, PSYCHOL SCI, V20, P127, DOI 10.1111/j.1467-9280.2008.02264.x; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lostumbo L, 2004, COCHRANE DB SYST REV, V4; Luce MF, 2005, HEALTH PSYCHOL, V24, pS23, DOI 10.1037/0278-6133.24.4.S23; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; McDonnell SK, 2001, J CLIN ONCOL, V19, P3938, DOI 10.1200/JCO.2001.19.19.3938; Mendick N, 2010, SOC SCI MED, V70, P1904, DOI 10.1016/j.socscimed.2009.12.039; National Collaborating Centre for Cancer, 2013, FAM BREAST CANC CLAS; Neuburger J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003179; Persson K, 2014, HEALTH CARE ANAL, V22, P305, DOI 10.1007/s10728-012-0216-1; Seale C., 1999, QUALITY QUALITATIVE; Simard S, 2013, J CANCER SURVIV, V7, P300, DOI 10.1007/s11764-013-0272-z; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; Svenson O, 2009, JUDGM DECIS MAK, V4, P397; Swindell JS, 2010, ANN FAM MED, V8, P260, DOI 10.1370/afm.1118; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; van Dijk S, 2004, AM J MED GENET A, V131A, P42, DOI 10.1002/ajmg.a.30322; Wong SM, 2017, ANN SURG, V265, P581, DOI 10.1097/SLA.0000000000001698; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	36	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178392	10.1371/journal.pone.0178392	http://dx.doi.org/10.1371/journal.pone.0178392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VT	28552971	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000042
J	Qu, B; Sillanpaa, M; Li, CL; Kang, SC; Stubbins, A; Yan, FP; Aho, KS; Zhou, F; Raymond, PA				Qu, Bin; Sillanpaa, Mika; Li, Chaoliu; Kang, Shichang; Stubbins, Aron; Yan, Fangping; Aho, Kelly Sue; Zhou, Feng; Raymond, Peter A.			Aged dissolved organic carbon exported from rivers of the Tibetan Plateau	PLOS ONE			English	Article							PERMAFROST CARBON; SOIL CARBON; CLIMATE; BIOLABILITY; TEMPERATURE; VEGETATION; NITROGEN; STORAGE; MATTER; POOLS	The role played by river networks in regional and global carbon cycle is receiving increasing attention. Despite the potential of radiocarbon measurements (C-14) to elucidate sources and cycling of different riverine carbon pools, there remain large regions such as the climate- sensitive Tibetan Plateau for which no data are available. Here we provide new C-14 data on dissolved organic carbon (DOC) from three large Asian rivers (the Yellow, Yangtze and Yarlung Tsangpo Rivers) running on the Tibetan Plateau and present the carbon transportation pattern in rivers of the plateau versus other river system in the world. Despite higher discharge rates during the high flow season, the DOC yield of Tibetan Plateau rivers (0.41 gC m(-2) yr(-1)) was lower than most other rivers due to lower concentrations. Radiocarbon ages of the DOC were older/more depleted (511 +/- 294 years before present, yr BP) in the Tibetan rivers than those in Arctic and tropical rivers. A positive correlation between radiocarbon age and permafrost watershed coverage was observed, indicating that C-14-deplted/ old carbon is exported from permafrost regions of the Tibetan Plateau during periods of high flow. This is in sharp contrast to permafrost regions of the Arctic which export C-14-enriched carbon during high discharge periods.	[Qu, Bin; Sillanpaa, Mika; Yan, Fangping] Lappeenranta Univ Technol, Lab Green Chem, Mikkeli, Finland; [Sillanpaa, Mika] Florida Int Univ, Dept Civil & Environm Engn, Miami, FL 33199 USA; [Li, Chaoliu] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China; [Kang, Shichang] Chinese Acad Sci, Norwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Gansu, Peoples R China; [Kang, Shichang] Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Stubbins, Aron] Univ Georgia, Dept Marine Sci, Skidaway Inst Oceanog, Savannah, GA USA; [Aho, Kelly Sue; Raymond, Peter A.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA; [Zhou, Feng] Peking Univ, Sino France Inst Earth Syst Sci, Coll Urban & Environm Sci, Lab Earth Surface Proc, Beijing, Peoples R China	Lappeenranta University of Technology; State University System of Florida; Florida International University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Yale University; Peking University	Li, CL (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China.	lichaoliu@itpcas.ac.cn	Sillanpää, Mika E T/G-1366-2011; Zhou, Feng/C-9377-2011; Stubbins, Aron/M-8801-2014; Aho, Kelly/AAW-8790-2021; Raymond, Peter A/C-4087-2009; Kang, Shichang/I-6830-2018	Sillanpää, Mika E T/0000-0003-3247-5337; Zhou, Feng/0000-0001-6122-0611; Stubbins, Aron/0000-0002-3994-1946; Raymond, Peter A/0000-0002-8564-7860; Kang, Shichang/0000-0003-2115-9005; Qu, Bin/0000-0003-3582-4977; li, chao liu/0000-0003-2092-2435	National Nature Science Foundation of China [41271015, 41225002, 41421061]; State Key Laboratory of Cryospheric Science [SKLCS-ZZ-2015]; Academy of Finland [268170]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cryospheric Science; Academy of Finland(Academy of Finland)	This work was supported by the National Nature Science Foundation of China (41271015 and 41225002, 41421061), State Key Laboratory of Cryospheric Science (SKLCS-ZZ-2015), the Academy of Finland (decision number 268170).; This work was funded by the National Nature Science Foundation of China (41171398, 41225002 and 41271015), State Key Laboratory of Cryospheric Science (SKLCS-ZZ-2015), the Academy of Finland (decision number 268170). Wenjun Song and Brad Erkkila are thanked for their assistance on trapping CO<INF>2</INF> of samples. Pengfei Chen and Xiaofei Li are thanked for their collecting samples. Tanguang Gao and Zhiguo Li are thanked for providing and processing data of area data. Qinglong You is thanked for providing the Figure B in S1 bile.	Aitchison JC, 2002, J ASIAN EARTH SCI, V21, P251, DOI 10.1016/S1367-9120(02)00037-8; Aitkenhead JA, 1999, HYDROL PROCESS, V13, P1289, DOI 10.1002/(SICI)1099-1085(19990615)13:8&lt;1289::AID-HYP766&gt;3.0.CO;2-M; Alexander E, 1989, P WAT 89 C STEW SOIL; ARNOLD JR, 1949, SCIENCE, V110, P678, DOI 10.1126/science.110.2869.678; ARNOLD JR, 1957, TELLUS, V9, P28, DOI 10.1111/j.2153-3490.1957.tb01850.x; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; BOUTTON T W, 1991, P173; Butman DE, 2015, NAT GEOSCI, V8, P112, DOI [10.1038/ngeo2322, 10.1038/NGEO2322]; Chen Fa-jin, 2010, Bulletin of Mineralogy, Petrology and Geochemistry, V29, P83; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Cheng S., 2000, J NAT RESOUR, V15, P297; Coleman D., 2012, CARBON ISOTOPE TECHN; Cory RM, 2013, P NATL ACAD SCI USA, V110, P3429, DOI 10.1073/pnas.1214104110; Dahlback A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007700; Fellman JB, 2014, ECOLOGY, V95, P2622, DOI 10.1890/13-1360.1; Feng XJ, 2013, P NATL ACAD SCI USA, V110, P14168, DOI 10.1073/pnas.1307031110; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Frey KE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022025; Galy V, 2011, NAT GEOSCI, V4, P843, DOI [10.1038/ngeo1293, 10.1038/NGEO1293]; Iimura H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012733; Kimble J, 1990, T 14 INT C SOIL SCI, VV; Lapierre JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3972; Li S., 1996, MAP FROZEN GROUND QI; [廖顺宝 Liao shunbao], 2003, [地理学报, Acta Geographica Sinica], V58, P25; Lu HY, 2004, BIOGEOCHEMISTRY, V70, P273; Mann PJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001798; Marwick TR, 2015, GLOBAL BIOGEOCHEM CY, V29, P122, DOI 10.1002/2014GB004911; Masiello CA, 2001, GLOBAL BIOGEOCHEM CY, V15, P407, DOI 10.1029/2000GB001290; McCallister SL, 2012, P NATL ACAD SCI USA, V109, P16963, DOI 10.1073/pnas.1207305109; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Olsson I. U., 1970, RADIOCARBON VARIATIO, P17; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2001, ORG GEOCHEM, V32, P469, DOI 10.1016/S0146-6380(00)00190-X; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Reimer P, 2004, GEOPHYS RES LETT; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Sillanpaa M, 2015, NATURAL ORGANIC MATTER IN WATER: CHARACTERIZATION AND TREATMENT METHODS, P1; Spencer RGM, 2015, GEOPHYS RES LETT, V42, P2830, DOI 10.1002/2015GL063498; Spencer RGM, 2014, GEOCHIM COSMOCHIM AC, V142, P64, DOI 10.1016/j.gca.2014.08.006; Stubbins A, 2012, LIMNOL OCEANOGR-METH, V10, P347, DOI 10.4319/lom.2012.10.347; Thurman E.M., 1985, ORG GEOCHEM, V2, P7, DOI [10.1007/978-94-009-5095-5_2., DOI 10.1007/978-94-009-5095-5_2, 10.1007/978-94-009-5095-5_2]; Vonk JE, 2013, GEOPHYS RES LETT, V40, P2689, DOI 10.1002/grl.50348; Wang GX, 2008, GEODERMA, V143, P143, DOI 10.1016/j.geoderma.2007.10.023; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wiegner TN, 2006, AQUAT MICROB ECOL, V43, P277, DOI 10.3354/ame043277; WOLF A., 1999, INT J WATER RESOUR D, V15, P387, DOI [DOI 10.1080/07900629948682, 10.1080/07900629948682]; Xu WX, 2007, CHINESE GEOGR SCI, V17, P151, DOI 10.1007/s11769-007-0151-5; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yang MX, 2010, EARTH-SCI REV, V103, P31, DOI 10.1016/j.earscirev.2010.07.002; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; [杨志刚 Yang Zhigang], 2014, [冰川冻土, Journal of Glaciology and Geocryology], V36, P166; Zhang T, 2005, J GEOPHYS RES ATMOSP, V110; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003	56	22	24	9	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178166	10.1371/journal.pone.0178166	http://dx.doi.org/10.1371/journal.pone.0178166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552976	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000023
J	Qu, SS; Du, Y; Chang, SH; Guo, LY; Fang, KC; Li, YZ; Zhang, FC; Zhang, KL; Wang, J				Qu, Susu; Du, Yang; Chang, Suhua; Guo, Liyuan; Fang, Kechi; Li, Yongzhe; Zhang, Fengchun; Zhang, Kunlin; Wang, Jing			Common variants near IKZF1 are associated with primary Sjogren's syndrome in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; SUSCEPTIBILITY LOCI; COMPLEX TRAITS; DISEASE GENES; IKAROS GENE; VISUALIZATION; DISORDERS; CONSENSUS	Primary Sjogren's syndrome (pSS) is a systematic autoimmune disease with evidence of genetic predisposition. The IKZF1 (IKAROS family zinc finger 1 (Ikaros)) gene is located at 7p12.2, encodes a transcription factor related to chromatin remodeling, regulates lymphocyte differentiation, and has been reported to be associated with some autoimmune diseases. However, there have been no reports of an association between IKZF1 and pSS. To investigate the possibility of an association between the IKZF1 locus and pSS, we selected two single nucleotide polymorphisms (SNPs) in the IKZF1 locus, rs4917129 and rs4917014, based on a detailed analysis of genome-wide association study (GWAS) data and performed genotyping in 665 Han Chinese pSS patients and 863 healthy controls. The results of an association test showed significant association signals (rs4917129: P-value = 5.5e-4, OR (odds ratio) = 0.72, 95% CI (confidence interval) = 0.60-0.87; rs4917014: P-value = 1.2e-3, OR = 0.76, 95% CI = 0.64-0.89). A meta-analysis that combined the above results with data from previous GWAS, further confirmed these associations (rs4917129: P-meta = 4.24e-8, ORmeta = 0.70, 95% CI = 0.61-0.79; rs4917014: P-meta = 6.0e-8, ORmeta = 0.72, 95% CI = 0.64-0.81). A bioinformatics analysis indicated that both SNPs were located in a putative enhancer area in immune-related cell lines and tissues. A protein-protein interaction analysis found that IKZF1, together with GTF2I (an SS susceptibility gene newly identified through GWAS), could interact with histone deacetylase family proteins. In summary, this is the first study to report an association between IKZF1 and SS in Han Chinese.	[Qu, Susu; Du, Yang; Chang, Suhua; Guo, Liyuan; Fang, Kechi; Zhang, Kunlin; Wang, Jing] Chinese Acad Sci, Key Lab Mental Hlth, Inst Psychol, Beijing, Peoples R China; [Qu, Susu; Du, Yang; Chang, Suhua; Guo, Liyuan; Fang, Kechi; Zhang, Kunlin; Wang, Jing] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Li, Yongzhe; Zhang, Fengchun] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol & Clin Immunol, Beijing, Peoples R China; [Li, Yongzhe; Zhang, Fengchun] Chinese Acad Med Sci, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhang, KL; Wang, J (corresponding author), Chinese Acad Sci, Key Lab Mental Hlth, Inst Psychol, Beijing, Peoples R China.; Zhang, KL; Wang, J (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.	zhangkl@psych.ac.cn; wangjing@psych.ac.cn	Chang, Suhua/AGZ-1921-2022		Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA) International Partnership Program for Creative Research Teams [Y2CX131003]; National Natural Science Foundation of China [81101545]	Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA) International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs (CAS/SAFEA) International Partnership Program for Creative Research Teams (Y2CX131003 to J.W.) and the National Natural Science Foundation of China (81101545 to K.Z.). URLs:Y2CX131003 to J.W., http://www.cas.ac.cn/, http://www.safea.gov.cn/index.shtml; 81101545 to K.Z., http://www.nsfc.gov.cn/.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burbelo PD, 2014, AUTOIMMUN REV, V13, P756, DOI 10.1016/j.autrev.2014.02.002; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Guo J, 2013, ABSTRACTS OF THE 201; Guo LY, 2016, NUCLEIC ACIDS RES, V44, pD888, DOI 10.1093/nar/gkv1107; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hu SJ, 2013, MOD RHEUMATOL, V23, P205, DOI 10.1007/s10165-012-0706-x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Merkenschlager M, 2010, FEBS LETT, V584, P4910, DOI 10.1016/j.febslet.2010.09.042; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Ueta M, 2015, J ALLERGY CLIN IMMUN, V135, P1538, DOI 10.1016/j.jaci.2014.12.1916; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177320	10.1371/journal.pone.0177320	http://dx.doi.org/10.1371/journal.pone.0177320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552951	Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000004
J	Luti, S; Martellini, F; Bemporad, F; Mazzoli, L; Paoli, P; Pazzagli, L				Luti, Simone; Martellini, Federica; Bemporad, Francesco; Mazzoli, Lorenzo; Paoli, Paolo; Pazzagli, Luigia			A single amino acid mutation affects elicitor and expansins-like activities of ceratoplatanin, a non-catalytic fungal protein	PLOS ONE			English	Article							CERATO-PLATANIN; BACTERIAL EXPANSIN; ESCHERICHIA-COLI; PHYTOTOXIC PROTEIN; INCLUSION-BODIES; STRUCTURAL BASIS; PICHIA-PASTORIS; 1ST MEMBER; EXPRESSION; TRICHODERMA	Cerato-platanin (CP) is a non-catalytic, cysteine-rich protein, the first member of the ceratoplatanin family. It is a single-domain protein with a double psi/beta barrel domain resembling the D1 domain of plant and bacterial expansins. Similarly to expansins, CP shows a cell wallloosening activity on cellulose and can be defined as an expanisin-like protein, in spite of the missing D2 domain, normally present in plant expansins. The weakening activity shown on cellulose may facilitate the CP-host interaction, corroborating the role of CP in eliciting plant defence response. Indeed, CP is an elicitor of primary defences acting as a PathogenAssociated Molecular Patterns (PAMP). So far, structure-function relationship study has been mainly performed on the bacterial BsEXLX1 expansin, probably due to difficulties in expressing plant expansins in heterologous systems. Here, we report a subcloning and purification method of CP in the engineered E. coli SHuffle cells, which proved to be suitable to obtain the properly folded and biologically active protein. The method also enabled the production of the mutant D77A, rationally designed to be inactive. The wild-type and the mutated CP were characterized for cellulose weakening activity and for PAMP activity (i.e. induction of Reactive Oxygen Species synthesis and phytoalexins production). Our analysis reveals that the carboxyl group of D77 is crucial for expansin-like and PAMP activities, thus permitting to establish a correlation between the ability to weaken cellulose and the capacity to induce defence responses in plants. Our results enable the structural and functional characterization of a mono-domain eukaryotic expansin and identify the essential role of a specific aspartic residue in cellulose weakening.	[Luti, Simone; Martellini, Federica; Bemporad, Francesco; Mazzoli, Lorenzo; Paoli, Paolo; Pazzagli, Luigia] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy	University of Florence	Luti, S (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	simone.luti@unifi.it	Paoli, Paolo/A-2040-2014	Paoli, Paolo/0000-0001-6448-7266; Luti, Simone/0000-0001-7050-6590; Bemporad, Francesco/0000-0002-0643-6249	MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno); University of Florence	MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno)(Ministry of Education, Universities and Research (MIUR)); University of Florence	This work was supported by MIUR (Mlnistero Universita e Ricerca scientifica, Universita degli Studi di Firenze anno 2015) that is shown by the acronym: LUIGIAPZZAGLIRICATEN15. The funding is released by University of Florence to researchers that require financial support for their research.	Baccelli I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100959; Baccelli I, 2014, APPL MICROBIOL BIOT, V98, P175, DOI 10.1007/s00253-013-4822-0; Baccelli I, 2012, FEMS MICROBIOL LETT, V327, P155, DOI 10.1111/j.1574-6968.2011.02475.x; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Carresi L, 2006, PROTEIN EXPRES PURIF, V49, P159, DOI 10.1016/j.pep.2006.07.006; Chung WJ, 2015, PROTEIN EXPRES PURIF, V110, P79, DOI 10.1016/j.pep.2015.02.012; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2014, CURR OPIN PLANT BIOL, V22, P122, DOI 10.1016/j.pbi.2014.11.001; Crutcher FK, 2015, FUNGAL BIOL-UK, V119, P476, DOI 10.1016/j.funbio.2015.01.004; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Tovar-Herrera OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122296; Frias M, 2013, MOL PLANT PATHOL, V14, P191, DOI 10.1111/j.1364-3703.2012.00842.x; Frischmann A, 2013, J BIOL CHEM, V288, P4278, DOI 10.1074/jbc.M112.427633; Gaderer R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-014-0333-0; Georgelis N, 2015, APPL MICROBIOL BIOT, V99, P3807, DOI 10.1007/s00253-015-6534-0; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Ke N, 2014, CURR PROTOC MOL BIOL, V108, P16; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Lee SB, 2014, APPL MICROBIOL BIOT, V98, P10041, DOI 10.1007/s00253-014-6139-z; Liu XW, 2015, BIOTECHNOL LETT, V37, P1541, DOI 10.1007/s10529-015-1842-0; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Lombardi L, 2013, PHYSIOL PLANTARUM, V149, P408, DOI 10.1111/ppl.12041; Luti S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060866; Marowa P, 2016, PLANT CELL REP; Martellini F, 2013, MOL BIOTECHNOL, V55, P27, DOI 10.1007/s12033-012-9618-4; OBoyle NM, 2012, J CHEMINFORMATICS, V3, P33; Olarte-Lozano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095638; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2006, CELL BIOCHEM BIOPHYS, V44, P512, DOI 10.1385/CBB:44:3:512; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Vallet A, 2015, FEMS MICROBIOL REV, V39, P171, DOI 10.1093/femsre/fuu003; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Silveira RL, 2016, PHYS CHEM CHEM PHYS, V18, P3510, DOI 10.1039/c5cp06674c; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Suzuki H, 2014, FUNGAL GENET BIOL, V72, P115, DOI 10.1016/j.fgb.2014.05.008; Wang WC, 2014, BIOCHEM ENG J, V84, P16, DOI 10.1016/j.bej.2013.12.018; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	44	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178337	10.1371/journal.pone.0178337	http://dx.doi.org/10.1371/journal.pone.0178337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542638	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800076
J	Jin, SL; Su, HR; Tran, NT; Song, J; Lu, SS; Li, Y; Huang, SM; Abdel-Wahab, O; Liu, YY; Zhao, XY				Jin, Shuiling; Su, Hairui; Ngoc-Tung Tran; Song, Jing; Lu, Sydney S.; Li, Ying; Huang, Suming; Abdel-Wahab, Omar; Liu, Yanyan; Zhao, Xinyang			Splicing factor SF3B1(K700E) mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1	PLOS ONE			English	Article							PRE-MESSENGER-RNA; ARGININE METHYLATION; SF3B1 MUTATIONS; SCL; METHYLTRANSFERASE; MYELODYSPLASIA; SPLICEOSOME; EXPRESSION; GENES; CELLS	More than 60% of myeloid dysplasia syndrome (MDS) contains mutations in genes encoding for splicing factors such as SF3B1, U2AF, SRSF2 and ZRSR2. Mutations in SF3B1 are associated with 80% cases of refractory anemia with ring sideroblast (RARS), a subtype of MDS. SF3B1(K700E) is the most frequently mutated site among mutations on SF3B1. Yet the molecular mechanisms on how mutations of splicing factors lead to defective erythropoiesis are not clear. SF3B1(K700E) mutant binds to an RNA binding protein, RBM15, stronger than the wild type SF3B1 protein in co-immunoprecipitation assays. In addition, K700E mutant alters the RNA splicing of transcription factors TAL1 and GATA1. Via alternative RNA splicing, a novel short TAL1 transcript variant (TAL1s) is generated. Enhanced interaction between SF3B1 and RBM15 promotes the production of full-length TAL1 (TAL1fl) mRNA, while reduction of RBM15 protein level via PRMT1-mediated degradation pathway changes TAL1s/TAL1fl ratio in favor of TAL1s. TAL1s contains the helix-loop-helix DNA binding domain but not the N terminal region upstream of the DNA binding domain. The TAL1s protein loses its interaction with ETO2, which represses early erythropoiesis. In this vein, overexpression of TAL1s stimulates the transcription of beta-hemoglobin in human leukemia K562 cells and promotes erythroid differentiation of human cord blood CD34(+) cells cultured in erythropoietin-containing medium. Therefore, mutations of SF3B1 may block erythropoiesis via dysregulation of alternative RNA splicing of transcription factor TAL1, and targeting PRMT1 may alleviate the anemic symptoms in MDS patients.	[Jin, Shuiling; Liu, Yanyan] Zhengzhou Univ, Dept Internal Med, Henan Canc Hosp, Zhengzhou, Peoples R China; [Jin, Shuiling; Liu, Yanyan] Zhengzhou Univ, Dept Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Jin, Shuiling; Su, Hairui; Ngoc-Tung Tran; Zhao, Xinyang] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Song, Jing] Zhengzhou Univ, Dept Internal Med, Affiliated Hosp 2, Zhengzhou, Peoples R China; [Lu, Sydney S.; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Li, Ying] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Ave Wai Long, Taipa, Macau, Peoples R China; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem Mol Biol, Gainesville, FL 32610 USA	Zhengzhou University; Zhengzhou University; University of Alabama System; University of Alabama Birmingham; Zhengzhou University; Memorial Sloan Kettering Cancer Center; Macau University of Science & Technology; State University System of Florida; University of Florida	Liu, YY (corresponding author), Zhengzhou Univ, Dept Internal Med, Henan Canc Hosp, Zhengzhou, Peoples R China.; Liu, YY (corresponding author), Zhengzhou Univ, Dept Internal Med, Affiliated Canc Hosp, Zhengzhou, Peoples R China.; Zhao, XY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	yyliu@zzu.edu.cn; zhaox88@uab.edu	Li, Ying/L-7292-2019	Lu, Sydney/0000-0002-2217-1674; Tran, Ngoc-Tung/0000-0003-0896-8641	NCI [1R21CA202390-01A1]; Leukemia Research Foundation; China Scholarship Council; Nature Science Foundation of China (NSFC) [81270570, 81470365]; NIDDK [R01DK11018]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; China Scholarship Council(China Scholarship Council); Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by NCI grant (https://www.cancer.gov/) 1R21CA202390-01A1 and the Leukemia Research Foundation (http://www.allbloodcancers.org/) to XZ, a fellowship from China Scholarship Council (http://en.csc.edu.cn/) to SJ, and Nature Science Foundation (http://www.nsfc.gov.cn/) of China (NSFC) grants no. 81270570 and no. 81470365 to YL. SH is supported by NIDDK grant (R01DK11018).	Abdel-Wahab O, 2011, CANCER CELL, V20, P420, DOI 10.1016/j.ccr.2011.10.004; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Fujiwara T, 2013, EXP HEMATOL, V41, P303, DOI 10.1016/j.exphem.2012.10.015; Inoue D, 2016, CANCER CELL, V30, P371, DOI 10.1016/j.ccell.2016.08.013; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Komeno Y, 2014, BLOOD; Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Obeng EA, 2016, CANCER CELL, V30, P404, DOI 10.1016/j.ccell.2016.08.006; Palii CG, 2011, EMBO J, V30, P494, DOI 10.1038/emboj.2010.342; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Patel B, 2014, LEUKEMIA, V28, P349, DOI 10.1038/leu.2013.158; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schutte J, 2016, ELIFE, V5, DOI 10.7554/eLife.11469; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Stadhouders R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9893; Wang L, 2013, NUCLEIC ACIDS RES, V41, P6870, DOI 10.1093/nar/gkt415; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072; Zhang LP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804603; Zhao X., 2015, CANC TRANSLATIONAL M, V1, P21, DOI [10.4103/2395-3977.151483, DOI 10.4103/2395-3977.151483]; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	39	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0175523	10.1371/journal.pone.0175523	http://dx.doi.org/10.1371/journal.pone.0175523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545085	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400001
J	Tamura, M; Kageyama, D; Honda, N; Fujimoto, H; Kato, A				Tamura, Masaru; Kageyama, Daisuke; Honda, Naoko; Fujimoto, Hirofumi; Kato, Atsushi			Enzymatic activity necessary to restore the lethality due to Escherichia coli RNase E deficiency is distributed among bacteria lacking RNase E homologues	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; MESSENGER-RNA; BACILLUS-SUBTILIS; E ESSENTIALITY; EUREMA-HECABE; HFQ BINDING; IN-VIVO; PROTEIN; GENE; MATURATION	Escherichia coli RNase E (Eco-RNase E), encoded by rne (Eco-rne), is considered the global RNA decay initiator. Although Eco-RNase E is an essential gene product in E. coli, some bacterial species, such as Bacillus subtilis, do not possess Eco-RNase E sequence homologues. B. subtilis instead possesses RNase J1/J2 (Bsu-RNase J1/J2) and RNase Y (Bsu-RNase Y) to execute RNA decay. Here we found that E. coli lacking the Eco-rne gene (Delta rne E. coli) was viable conditional on M9 minimal media by introducing Bsu-RNase J1/J2 or Bsu-RNase Y. We also cloned an extremely short Eco-RNase E homologue (Wpi-RNase E) and a canonical sized Bsu-RNase J1/J2 homologue (Wpi-RNase J) from Wolbachia pipientis, an alpha-proteobacterial endosymbiont of arthropods. We found that Wpi-RNase J restored the colony-forming ability (CFA) of Delta rne E. coli, whereas Wpi-RNase E did not. Unexpectedly, Wpi-RNase E restored defective CFA due to lack of Eco-RNase G, a paralogue of Eco-RNase E. Our results indicate that bacterial species that lack Eco-RNase E homologues or bacterial species that possess Eco-RNase E homologues which lack Eco-RNase E-like activities have a modest Eco-RNase E-like function using RNase J and/or RNase Y. These results suggest that Eco-RNase E-like activities might distribute among a wide array of bacteria and that functions of RNases may have changed dynamically during evolutionary divergence of bacterial lineages.	[Tamura, Masaru; Honda, Naoko; Fujimoto, Hirofumi; Kato, Atsushi] Natl Inst Infect Dis, Dept Qual Assurance & Radiol Protect, Shinjuku Ku, Tokyo, Japan; [Kageyama, Daisuke] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan	National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan	Tamura, M (corresponding author), Natl Inst Infect Dis, Dept Qual Assurance & Radiol Protect, Shinjuku Ku, Tokyo, Japan.	mtamura@niid.go.jp	Kageyama, Daisuke/B-4460-2010	Kageyama, Daisuke/0000-0002-9026-9825	Japan Agency for Medical Research and Development (AMED) [48650201]; Ministry of Health, Labour and Welfare (MHLW) [10201500];  [16K08106]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); 	This study was supported by a 'Japan Agency for Medical Research and Development (AMED)' grant 48650201 and 'Ministry of Health, Labour and Welfare (MHLW)' grant 10201500 to AK, and by 'Grants-in-Aid for Scientific Research (KAKEN-HI)' 16K08106 to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Bara S, 2015, MOL MICROBIOL, V97, P1021, DOI 10.1111/mmi.13095; ALIFANO P, 1994, GENE DEV, V8, P3021, DOI 10.1101/gad.8.24.3021; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apirion D, 1980, PROCESSING RRNA TRNA; Baginsky S, 2001, RNA, V7, P1464; Baumgardt K, 2017, MICROBIOL-SGM, V163, P570, DOI 10.1099/mic.0.000442; Baumgardt K, 2014, J BACTERIOL, V196, P1435, DOI 10.1128/JB.01471-13; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chung DH, 2010, RNA, V16, P1371, DOI 10.1261/rna.2104810; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P1293, DOI 10.1073/pnas.70.5.1293; COHEN SN, 1977, J BACTERIOL, V132, P734, DOI 10.1128/JB.132.2.734-737.1977; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Condon C, 1997, J MOL BIOL, V268, P235, DOI 10.1006/jmbi.1997.0971; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; Deana A, 2004, MOL MICROBIOL, V51, P1205, DOI 10.1046/j.1365-2958.2003.03905.x; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003181; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Figaro S, 2013, J BACTERIOL, V195, P2340, DOI 10.1128/JB.00164-13; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0; Hardwick SW, 2011, NUCLEIC ACIDS RES, V39, P1449, DOI 10.1093/nar/gkq928; Hiroki M, 2004, P ROY SOC B-BIOL SCI, V271, P1751, DOI 10.1098/rspb.2004.2769; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaberdin VR, 1998, P NATL ACAD SCI USA, V95, P11637, DOI 10.1073/pnas.95.20.11637; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Khemici V, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005577, 10.1371/journal.pgen.1006320]; Lee K, 2003, MOL MICROBIOL, V48, P349, DOI 10.1046/j.1365-2958.2003.03435.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Lehnik-Habrink M, 2011, J BACTERIOL, V193, P5431, DOI 10.1128/JB.05500-11; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; LUNDBERG U, 1995, RNA, V1, P327; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Madhugiri R, 2009, FEBS LETT, V583, P2339, DOI 10.1016/j.febslet.2009.06.026; Maeda S., 1989, INVERTEBRATE CELL SY, P167; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mohanty BK, 2016, NUCLEIC ACIDS RES, V44, P6350, DOI 10.1093/nar/gkw517; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Narita S, 2007, FEMS MICROBIOL ECOL, V61, P235, DOI 10.1111/j.1574-6941.2007.00333.x; Narita S, 2011, ECOL ENTOMOL, V36, P309, DOI 10.1111/j.1365-2311.2011.01274.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Richards J, 2016, J BIOL CHEM, V291, P5038, DOI 10.1074/jbc.M115.702555; Rische T, 2012, RNA BIOL, V9, P343, DOI 10.4161/rna.19433; Rische-Grahl T, 2014, RNA BIOL, V11, P855, DOI 10.4161/rna.29440; Sakai T, 2007, APPL MICROBIOL BIOT, V76, P183, DOI 10.1007/s00253-007-1006-9; Sambrook J., 2001, MOL CLONING LAB MANU; Schein A, 2008, RNA, V14, P1057, DOI 10.1261/rna.907608; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh D, 2009, P NATL ACAD SCI USA, V106, P864, DOI 10.1073/pnas.0810205106; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stead MB, 2011, NUCLEIC ACIDS RES, V39, P3188, DOI 10.1093/nar/gkq1242; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Tamura M, 2016, ARCH MICROBIOL, V198, P409, DOI 10.1007/s00203-016-1201-0; Tamura M, 2013, J BACTERIOL, V195, P1133, DOI 10.1128/JB.01558-12; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; Taverniti V, 2011, MOL MICROBIOL, V82, P1260, DOI 10.1111/j.1365-2958.2011.07888.x; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vanderpool CK, 2005, NAT STRUCT MOL BIOL, V12, P285, DOI 10.1038/nsmb0405-285; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Wachi M, 1997, MOL GEN GENET, V253, P515, DOI 10.1007/s004380050352; WANG M, 1994, P NATL ACAD SCI USA, V91, P10591, DOI 10.1073/pnas.91.22.10591; Woolfit M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118595; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019	83	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177915	10.1371/journal.pone.0177915	http://dx.doi.org/10.1371/journal.pone.0177915			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542621	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400113
J	Li, XM; Wang, XH; Peng, YL; Wei, HL; Zhu, XG; Chang, SQ; Li, M; Li, T; Huang, H				Li, Xumeng; Wang, Xiaohui; Peng, Yulin; Wei, Hailin; Zhu, Xinguang; Chang, Shuoqi; Li, Ming; Li, Tao; Huang, Huang			Quantitative descriptions of rice plant architecture and their application	PLOS ONE			English	Article							ORYZA-SATIVA L.; GREEN-REVOLUTION; USE EFFICIENCY; DWARF; YIELD; GENE	Plant architecture is an important agronomic trait, and improving plant architecture has attracted the attention of scientists for decades, particularly studies to create desirable plant architecture for high grain yields through breeding and culture practices. However, many important structural phenotypic traits still lack quantitative description and modeling on structural-functional relativity. This study defined new architecture indices (AIs) derived from the digitalized plant architecture using the virtual blade method. The influences of varieties and crop management on these indices and the influences of these indices on biomass accumulation were analyzed using field experiment data at two crop growth stages: early and late panicle initiation. The results indicated that the vertical architecture indices (LAI, PH, 90%-DRI, MDI, 90%-LI) were significantly influenced by variety, water, nitrogen management and the interaction of water and nitrogen, and compact architecture indices (H-CI, Q-CI, 90%-LI, 50%-LI) were significantly influenced by nitrogen management and the interaction of variety and water. Furthermore, there were certain trends in the influence of variety, water, and nitrogen management on AIs. Biomass accumulation has a positive linear correlation with vertical architecture indices and has a quadratic correlation with compact architecture indices, respectively. Furthermore, the combination of vertical and compact architecture indices is the indicator for evaluating the effects of plant architecture on biomass accumulation.	[Li, Xumeng] Hunan Agr Univ, Agr Math Modeling & Data Proc Ctr, Changsha, Hunan, Peoples R China; [Li, Xumeng; Li, Tao] Int Rice Res Inst, Manila, Philippines; [Li, Xumeng; Peng, Yulin; Zhu, Xinguang; Chang, Shuoqi] State Key Lab Hybrid Rice, Changsha, Hunan, Peoples R China; [Li, Xumeng; Wang, Xiaohui; Wei, Hailin; Li, Ming; Huang, Huang] Hunan Agr Univ, Changsha, Hunan, Peoples R China	Hunan Agricultural University; CGIAR; International Rice Research Institute (IRRI); Hunan Agricultural University	Li, T (corresponding author), Int Rice Res Inst, Manila, Philippines.; Huang, H (corresponding author), Hunan Agr Univ, Changsha, Hunan, Peoples R China.	t.li@irri.org; hh863@126.com	Li, Tao/N-2730-2019	Li, Tao/0000-0002-1360-1396	National Natural Science Foundation of China [31301231]; Hunan Provincial Natural Science Foundation of China [14JJ4037]; Hunan province colleges and universities scientific research projects [15C0657]; State Scholarship Fund [201408430018]; State Key Laboratory of Hybrid Rice [2016KF04]; National Science and Technology Projects for Rice Fertility [2013BAD07B11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Hunan province colleges and universities scientific research projects; State Scholarship Fund; State Key Laboratory of Hybrid Rice; National Science and Technology Projects for Rice Fertility	This work was supported by the National Natural Science Foundation of China (31301231); the Hunan Provincial Natural Science Foundation of China (14JJ4037); Hunan province colleges and universities scientific research projects (15C0657); the State Scholarship Fund (201408430018); the Open Project Program of State Key Laboratory of Hybrid Rice (2016KF04); and National Science and Technology Projects for Rice Fertility (2013BAD07B11).	Bouman BAM, 1996, AGR SYST, V52, P171, DOI 10.1016/0308-521X(96)00011-X; Chen YT, 2015, FIELD CROP RES, V184, P50, DOI 10.1016/j.fcr.2015.09.006; Dobermann A, 2000, AGRON J, V92, P633, DOI 10.2134/agronj2000.924633x; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jiang Hu, 2010, PLANT MOL BIOL, V73, P283, DOI DOI 10.1007/S11103-010-9614-7; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Li Xumeng, 2017, PLOS ONE FORTHCOMING; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Li YH, 2011, THEOR APPL GENET, V123, P973, DOI 10.1007/s00122-011-1640-6; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Lu CG, 2010, RICE SCI, V17, P235, DOI 10.1016/S1672-6308(09)60022-6; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Ross J., 2012, RAD REGIME ARCHITECT; Sangoi L., 1997, Ciencia Rural, V27, P1, DOI 10.1590/S0103-84781997000100001; Sheehy JE, 1998, FIELD CROP RES, V59, P31, DOI 10.1016/S0378-4290(98)00105-1; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; SMART RE, 1982, AM J ENOL VITICULT, V33, P99; Tuong TP, 1999, AGR WATER MANAGE, V40, P117, DOI 10.1016/S0378-3774(98)00091-2; van Ittersum K, 2003, J BUS RES, V56, P215, DOI 10.1016/S0148-2963(01)00223-5; Vos J, 2007, WAG UR FRON, V22, P1; Wang YK, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0865-6; Wang YH, 2006, CURR OPIN BIOTECH, V17, P123, DOI 10.1016/j.copbio.2006.02.004; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Zhang Yu-zhu, 2010, Zhongguo Shuidao Kexue, V24, P487, DOI 10.3969/j.issn.1001-7216.2010.05.007; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878; Zou JH, 2005, PLANTA, V222, P604, DOI 10.1007/s00425-005-0007-0	28	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177669	10.1371/journal.pone.0177669	http://dx.doi.org/10.1371/journal.pone.0177669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545144	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700063
J	Linck, H; Kruger, E; Reineke, A				Linck, Holger; Krueger, Erika; Reineke, Annette			A multiplex TaqMan qPCR assay for sensitive and rapid detection of phytoplasmas infecting Rubus species	PLOS ONE			English	Article							REAL-TIME PCR; APPLE PROLIFERATION; YELLOWS PHYTOPLASMA; ELM YELLOWS; IDENTIFICATION; AMPLIFICATION; UNIVERSAL; VECTORS; PLANTS; GENES	Rubus stunt is an economically important disease in the production of raspberries, blackberries, and loganberries. A fast, sensitive, and reliable diagnosis of phytoplasmas, the causal agent of the disease, is of prime importance to stop its spread by vegetative propagation and by insect vectors. Therefore, multiplex qPCR assays using TaqMan probes with different kinds of fluorophores in one reaction were developed, allowing the detection of phytoplasmas in general as well as a more specific detection of phytoplasmas belonging to group 16SrV and host DNA (either plant or insect). This assay now provides a practical tool for the screening of motherplants and monitoring the presence and distribution of phytoplasmas in Rubus plants of different geographic origins, cultivars, and cultivation systems, as well as in putative insect vectors like leafhoppers.	[Linck, Holger; Reineke, Annette] Hsch Geisenheim Univ, Dept Phytomed, Geisenheim, Germany; [Krueger, Erika] Hsch Geisenheim Univ, Dept Pomiculture, Geisenheim, Germany		Linck, H (corresponding author), Hsch Geisenheim Univ, Dept Phytomed, Geisenheim, Germany.	holger.linck@hs-gm.de			Federal Ministry of Food, Agriculture and Consumer Protection (BMELV);  [2814703611]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV); 	The project was supported by funds of the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE) under the innovation support programme (Grant number: 2814703611; URL: http://www.ble.ed/EN/00_Home/homepage_node. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini E, 2007, J MICROBIOL METH, V68, P613, DOI 10.1016/j.mimet.2006.11.015; Baric S, 2006, PLANT MOL BIOL REP, V24, P169, DOI 10.1007/BF02914056; Baric S, 2004, J MICROBIOL METH, V57, P135, DOI 10.1016/j.mimet.2003.12.009; Bertaccini A., 1995, Acta Horticulturae, P126; Borroto Fernandez EG, 2007, B INSECTOL, V60, P391; Christensen NM, 2004, MOL PLANT MICROBE IN, V17, P1175, DOI 10.1094/MPMI.2004.17.11.1175; Christensen Nynne Meyn, 2013, Methods Mol Biol, V938, P245, DOI 10.1007/978-1-62703-089-2_21; Cieslinska M, 2011, J PLANT PATHOL, V93, P51; D'Amelio R, 2008, B INSECTOL, V61, P349; Daire X, 1997, EUR J PLANT PATHOL, V103, P507, DOI 10.1023/A:1008641411025; Danet J. L., 2010, Julius-Kuhn-Archiv, P35; Davies DL, 2000, PLANT PATHOL, V49, P86, DOI 10.1046/j.1365-3059.2000.00418.x; de FLUTTER H. J., 1953, TIJDSCHR PLANTENZIEKTEN, V59, P195, DOI 10.1007/BF01988195; Delic D., 2012, POLYMERASE CHAIN REA, P91; DENG SJ, 1991, J MICROBIOL METH, V14, P53, DOI 10.1016/0167-7012(91)90007-D; Fahmeed F, 2009, J PHYTOPATHOL, V157, P639, DOI 10.1111/j.1439-0434.2009.01549.x; Galetto L, 2005, ANN APPL BIOL, V147, P191, DOI 10.1111/j.1744-7348.2005.00030.x; Herath P, 2010, PLANT DIS, V94, P1355, DOI 10.1094/PDIS-12-09-0783; Hodgetts J, 2009, APPL ENVIRON MICROB, V75, P2945, DOI 10.1128/AEM.02610-08; Hoshi A, 2007, B INSECTOL, V60, P105; Jarausch W, 2001, EUR J PLANT PATHOL, V107, P209, DOI 10.1023/A:1011234921833; Lee I. M., 1995, Phytopathologia Mediterranea, V34, P174; LORENZ KH, 1995, PHYTOPATHOLOGY, V85, P771, DOI 10.1094/Phyto-85-771; Malandraki I, 2015, J VIROL METHODS, V213, P12, DOI 10.1016/j.jviromet.2014.11.010; Malembic-Maher S, 2011, INT J SYST EVOL MICR, V61, P2129, DOI 10.1099/ijs.0.025411-0; Marcone C, 1997, EUR J FOREST PATHOL, V27, P45; Marzachi C, 2005, MOL BIOTECHNOL, V30, P117, DOI 10.1385/MB:30:2:117; Marzachi C, 1998, ANN APPL BIOL, V133, P45, DOI 10.1111/j.1744-7348.1998.tb05801.x; MAURER R, 1995, PLANT PATHOL, V44, P244, DOI 10.1111/j.1365-3059.1995.tb02775.x; Minguzzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146515; Monti M, 2013, MOL CELL PROBE, V27, P129, DOI 10.1016/j.mcp.2013.02.001; Nikolic P, 2010, MOL CELL PROBE, V24, P303, DOI 10.1016/j.mcp.2010.06.005; Oberhansli T, 2011, B INSECTOL, V64, pS37; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Pelletier C, 2009, VITIS, V48, P87; Rashidi M, 2014, ANN APPL BIOL, V165, P404, DOI 10.1111/aab.12146; Reeder R, 2010, PLANT PATHOL, V59, P394, DOI 10.1111/j.1365-3059.2009.02195.x; Smart CD, 1996, APPL ENVIRON MICROB, V62, P2988, DOI 10.1128/AEM.62.8.2988-2993.1996; van dersMeer F. A., 1987, VIRUS DIS SMALL FRUI, V631, P203; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039	40	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177808	10.1371/journal.pone.0177808	http://dx.doi.org/10.1371/journal.pone.0177808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545043	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700083
J	Tanui, CK; Shyntum, DY; Priem, SL; Theron, J; Moleleki, LN				Tanui, Collins Kipngetich; Shyntum, Divine Yutefar; Priem, Stefan Louis; Theron, Jacques; Moleleki, Lucy Novungayo			Influence of the ferric uptake regulator (Fur) protein on pathogenicity in Pectobacterium carotovorum subsp brasiliense	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR ENZYMES; IRON ACQUISITION; OXIDATIVE STRESS; SECRETION SYSTEM; GENES; MOTILITY; PATHOGENESIS; METALLOREGULATION	Iron is an important nutrient for the survival and growth of many organisms. In order to survive, iron uptake from the environment must be strictly regulated and maintained to avoid iron toxicity. The ferric uptake regulator protein (Fur) regulates genes involved in iron homeostasis in many bacteria, including phytopathogens. However, to date, the role played by Fur in the biology of Pectobacterium carotovorum subsp. brasiliense (Pcb1692), an important pathogen of potatoes, has not yet been studied. To this end, we used the lambda recombineering method to generate a fur mutant strain of Pcb1692 and assessed the virulence and fitness of the mutant strain. The results showed that production of siderophores in Pcb1692 Delta fur increased compared to the Pcb1692 wild-type and the complemented strain Pcb1692 Delta fur-pfur. However, production of N-acyl homoserine lactone (AHLs), biofilm formation, exopolysaccharide (EPS) production, virulence on potato tubers and swimming motility, were all significantly decreased in Pcb1692 Delta fur compared to the wild-type and complemented Pcb1692 Delta fur-pfur strains. The Pcb1692 Delta fur mutant also demonstrated significant sensitivity to oxidative stress when exposed to H2O2. Consistent with phenotypic results, qRT-PCR results demonstrated that Fur down-regulates genes which encode proteins associated with: iron uptake (HasA-extracellular heme-binding protein and FerrodoxinAED- 0004132), stress response (SodC-superoxide dismutase), plant cell wall degrading enzymes (PrtA and CelV) and motility (FlhC and MotA). We conclude that the ferric uptake regulator protein (Fur) of Pcb1692 regulates traits that are important to host-pathogens interactions.	[Tanui, Collins Kipngetich; Shyntum, Divine Yutefar; Priem, Stefan Louis; Moleleki, Lucy Novungayo] Univ Pretoria, Forestry Agr & Biotechnol Inst, Pretoria, South Africa; [Theron, Jacques; Moleleki, Lucy Novungayo] Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa	University of Pretoria; University of Pretoria	Moleleki, LN (corresponding author), Univ Pretoria, Forestry Agr & Biotechnol Inst, Pretoria, South Africa.; Moleleki, LN (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, Pretoria, South Africa.	lucy.moleleki@up.ac.za	Theron, Jacques/E-4755-2010; Moleleki, Lucy/E-8951-2010	Moleleki, Lucy/0000-0002-1003-4621; shyntum, divine/0000-0002-4884-6983; Theron, Jacques/0000-0001-9091-3898; Tanui, Collins/0000-0002-0421-1708	National Research Foundation (NRF), South Africa [98993]; NRF Bioinformatics and Functional Genomics [BFG 93685]; NRF Research Technology and Transfer Fund (RTF) [98654]; University of Pretoria Bursary; NRF Grant Holder Linked Bursary; Potatoes South Africa Transformation Bursary	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); NRF Bioinformatics and Functional Genomics; NRF Research Technology and Transfer Fund (RTF); University of Pretoria Bursary; NRF Grant Holder Linked Bursary; Potatoes South Africa Transformation Bursary	This research study was funded by the National Research Foundation (NRF), South Africa through Competitive Funding for Rated Researchers (CFRR) 98993; NRF Bioinformatics and Functional Genomics (BFG 93685) and NRF Research Technology and Transfer Fund (RTF) 98654. CKT was funded by University of Pretoria Bursary and SLP funded by the NRF Grant Holder Linked Bursary. SLP was also funded by Potatoes South Africa Transformation Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039; BAGG A, 1987, MICROBIOL REV, V51, P509, DOI 10.1128/MMBR.51.4.509-518.1987; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Burbank L, 2015, APPL ENVIRON MICROB, V81, P139, DOI 10.1128/AEM.02503-14; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Charkowski AO, 2007, THE SOFT ROT ERWINIA, P423; Chatterjee A, 2009, J BACTERIOL, V191, P4582, DOI 10.1128/JB.00154-09; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; Collmer A, 2009, PLANT PHYSIOL, V150, P1623, DOI 10.1104/pp.109.140327; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duarte V, 2004, J APPL MICROBIOL, V96, P535, DOI 10.1111/j.1365-2672.2004.02173.x; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Escolar L, 1997, MOL MICROBIOL, V26, P799, DOI 10.1046/j.1365-2958.1997.6211987.x; Fones H, 2013, FEMS MICROBIOL REV, V37, P495, DOI 10.1111/1574-6976.12004; Fones H, 2012, FEMS MICROBIOL LETT, V327, P1, DOI 10.1111/j.1574-6968.2011.02449.x; Franza T, 1999, MOL PLANT MICROBE IN, V12, P119, DOI 10.1094/MPMI.1999.12.2.119; Franza T, 2010, IRON UPTAKE AND HOMEOSTASIS IN MICROORGANISMS, P101; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; Hossain MM, 2005, PHYSIOL MOL PLANT P, V66, P134, DOI 10.1016/j.pmpp.2005.06.001; Kubheka GC, 2013, PHYTOPATHOLOGY; Lamont I, 2009, BIOMETALS, V22, P53, DOI 10.1007/s10534-008-9197-9; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Liu HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149280; Louden BC, 2011, J MICROBIOL BIOL EDU, V12, P51, DOI 10.1128/jmbe.v12i1.249; Marcotte L, 2007, ANAL BIOCHEM, V361, P7, DOI 10.1016/j.ab.2006.11.009; Marquez-Villavicencio MD, 2011, PLANT DIS, V95, P232, DOI 10.1094/PDIS-07-10-0526; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Moleleki L, 2016, MOLECULAR PLANT PATH; Onkendi E, 2017, PLANT DIS, V101, P279; OToole R, 1996, MOL MICROBIOL, V19, P625, DOI 10.1046/j.1365-2958.1996.412927.x; Panda P., 2012, New Disease Reports, V26, P15, DOI 10.5197/j.2044-0588.2012.026.015; Perez-Mendoza D, 2011, MICROBIOL-SGM, V157, P3340, DOI 10.1099/mic.0.050450-0; Sambrook J, 1989, MOL CLONING; Sauvage C, 1996, J BACTERIOL, V178, P1227, DOI 10.1128/jb.178.4.1227-1231.1996; Shyntum DY, 2015, MOL PLANT MICROBE IN, V28, P420, DOI 10.1094/MPMI-07-14-0219-R; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; van der Merwe JJ, 2010, EUR J PLANT PATHOL, V126, P175, DOI 10.1007/s10658-009-9531-2; Velkov T, 2005, PROTEIN EXPRES PURIF, V44, P23, DOI 10.1016/j.pep.2005.04.006	44	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177647	10.1371/journal.pone.0177647	http://dx.doi.org/10.1371/journal.pone.0177647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545065	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700060
J	Joy, M; Gau, D; Castellucci, N; Prywes, R; Roy, P				Joy, Marion; Gau, David; Castellucci, Nevin; Prywes, Ron; Roy, Partha			The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell migration; cytoskeleton; profilin; serum-response factor (SRF); MKL; SAP-domain	SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; ACTIN DYNAMICS; PROTEIN PROFILIN; MRTF-A; MIGRATION; DISTINCT; EXPRESSION; MOTILITY; ACTIVATION	Megakaryoblastic leukemia (MKL)/serum-response factor (SRF)-mediated gene transcription is a highly conserved mechanism that connects dynamic reorganization of the actin cytoskeleton to regulation of expression of a wide range of genes, including SRF itself and many important structural and regulatory components of the actin cytoskeleton. In this study, we examined the possible role of MKL/SRF in the context of regulation of profilin (Pfn), a major controller of actin dynamics and actin cytoskeletal remodeling in cells. We demonstrated that despite being located on different genomic loci, two major isoforms of Pfn (Pfn1 and Pfn2) are co-regulated by a common mechanism involving the action of MKL that is independent of its SRF-related activity. We found that MKL co-regulates the expression of Pfn isoforms indirectly by modulating signal transducer and activator of transcription 1 (STAT1) and utilizing its SAP-domain function. Unexpectedly, our studies revealed that cellular externalization, rather than transcription of Pfn1, is affected by the perturbations of MKL. We further demonstrated that MKL can influence cell migration by modulating Pfn1 expression, indicating a functional connection between MKL and Pfn1 in actin-dependent cellular processes. Finally, we provide initial evidence supporting the ability of Pfn to influence MKL and SRF expression. Collectively, these findings suggest that Pfn may play a role in a possible feedback loop of the actin/MKL/SRF signaling circuit.	[Joy, Marion; Gau, David; Castellucci, Nevin; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA; [Prywes, Ron] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Roy, P (corresponding author), Univ Pittsburgh, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.	par19@pitt.edu	Gau, David M/G-8375-2011	Gau, David M/0000-0002-3079-3692; Roy, Partha/0000-0002-4946-8531	National Institutes of Health [2R01CA108607, 2T32HL076124]; National Science Foundation [2012139050]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant 2R01CA108607 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Pre-doctoral Fellowship 2012139050 and National Institutes of Health Cardiovascular Bioengineering Pre-doctoral Training Grant 2T32HL076124.	Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Coumans JVF, 2014, OMICS, V18, P778, DOI 10.1089/omi.2014.0075; Cui XB, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0884-y; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI 10.4161/cam.21832; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jella KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165763; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Karamchandani JR, 2015, HUM PATHOL, V46, P673, DOI 10.1016/j.humpath.2014.11.007; Leitner L, 2011, J CELL SCI, V124, P4318, DOI 10.1242/jcs.092791; Lewis TC, 2013, BBA-GENE REGUL MECH, V1829, P1147, DOI 10.1016/j.bbagrm.2013.08.002; Liao XH, 2014, CELL SIGNAL, V26, P2370, DOI 10.1016/j.cellsig.2014.07.023; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Qi YF, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-41; Romeo G, 2004, FASEB J, V18, P725, DOI 10.1096/fj.03-0841fje; Romeo GR, 2008, J BIOL CHEM, V283, P9595, DOI 10.1074/jbc.M710092200; Shields AR, 2014, DEVELOPMENT, V141, P73, DOI 10.1242/dev.101931; Smith EC, 2012, BLOOD, V120, P2317, DOI 10.1182/blood-2012-04-420828; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Zaromytidou AI, 2006, MOL CELL BIOL, V26, P4134, DOI 10.1128/MCB.01902-05; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	45	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11777	11791		10.1074/jbc.M117.781104	http://dx.doi.org/10.1074/jbc.M117.781104			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28546428	Green Published, hybrid			2022-12-26	WOS:000405485600016
J	Loiseau, L; Fyfe, C; Aussel, L; Chehade, MH; Hernandez, SB; Faivre, B; Hamdane, D; Mellot-Draznieks, C; Rascalou, B; Pelosi, L; Velours, C; Cornu, D; Lombard, M; Casadesus, J; Pierrel, F; Fontecave, M; Barras, F				Loiseau, Laurent; Fyfe, Cameron; Aussel, Laurent; Chehade, Mahmoud Hajj; Hernandez, Sara B.; Faivre, Bruno; Hamdane, Djemel; Mellot-Draznieks, Caroline; Rascalou, Berengere; Pelosi, Ludovic; Velours, Christophe; Cornu, David; Lombard, Murielle; Casadesus, Josep; Pierrel, Fabien; Fontecave, Marc; Barras, Frederic			The UbiK protein is an accessory factor necessary for bacterial ubiquinone (UQ) biosynthesis and forms a complex with the UQ biogenesis factor UbiJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL CARRIER PROTEIN-2; COENZYME-Q BIOSYNTHESIS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; WAVE COMPLEX; SALMONELLA; YEAST; MENAQUINONE	Ubiquinone (UQ), also referred to as coenzyme Q, is a widespread lipophilic molecule in both prokaryotes and eukaryotes in which it primarily acts as an electron carrier. Eleven proteins are known to participate in UQ biosynthesis in Escherichia coli, and we recently demonstrated that UQ biosynthesis requires additional, nonenzymatic factors, some of which are still unknown. Here, we report on the identification of a bacterial gene, yqiC, which is required for efficient UQ biosynthesis, and which we have renamed ubiK. Using several methods, we demonstrated that the UbiK protein forms a complex with the C-terminal part of UbiJ, another UQ biogenesis factor we previously identified. We found that both proteins are likely to contribute to global UQ biosynthesis rather than to a specific biosynthetic step, because both ubiK and ubiJ mutants accumulated octaprenylphenol, an early intermediate of the UQ biosynthetic pathway. Interestingly, we found that both proteins are dispensable for UQ biosynthesis under anaerobiosis, even though they were expressed in the absence of oxygen. We also provide evidence that the UbiK-UbiJ complex interacts with palmitoleic acid, a major lipid in E. coli. Last, in Salmonella enterica, ubiK was required for proliferation in macrophages and virulence in mice. We conclude that although the role of the UbiK-UbiJ complex remains unknown, our results support the hypothesis that UbiK is an accessory factor of Ubi enzymes and facilitates UQ biosynthesis by acting as an assembly factor, a targeting factor, or both.	[Loiseau, Laurent; Aussel, Laurent; Barras, Frederic] Aix Marseille Univ, CNRS, IMM, LCB,UMR 7283, F-13402 Marseille, France; [Fyfe, Cameron; Faivre, Bruno; Hamdane, Djemel; Mellot-Draznieks, Caroline; Lombard, Murielle; Fontecave, Marc] Univ Paris 06, Coll France, Lab Chim Proc Biol, UMR8229,CNRS, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France; [Chehade, Mahmoud Hajj; Rascalou, Berengere; Pelosi, Ludovic; Pierrel, Fabien] Univ Grenoble Alpes, TIMC IMAG, Lab Technol Ingn Med & Complexite Informat Math &, UMR 5525, F-38000 Grenoble, France; [Chehade, Mahmoud Hajj; Rascalou, Berengere; Pelosi, Ludovic; Pierrel, Fabien] TIMC IMAG, CNRS, F-38000 Grenoble, France; [Hernandez, Sara B.; Casadesus, Josep] Univ Seville, Dept Genet, E-41012 Seville, Spain; [Velours, Christophe] CNRS, UMR9198, Inst Biol Integrat Cellule, Plateforme Interact Macromol,I2BC, Bat 430F, F-91405 Orsay, France; [Cornu, David] CNRS, Inst Biol Integrat Cellule, Plateforme SICaPS, I2BC,Ctr Rech Gif,SICaPS, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Fontecave, M (corresponding author), Univ Paris 06, Coll France, Lab Chim Proc Biol, UMR8229,CNRS, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.; Pierrel, F (corresponding author), Lab TIMC IMAG, F-38700 La Tronche, France.; Barras, F (corresponding author), LCB CNRS, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	fabien.pierrel@univ-grenoble-alpes.fr; mfontecave@cea.fr; barras@imm.cnrs.fr	PIERREL, Fabien/M-6016-2014; Lombard, Murielle/E-4974-2019; Hernandez, Sara B./M-2986-2019; Pelosi, Ludovic/AAB-9832-2020; Hernandez, Sara/L-2220-2017	PIERREL, Fabien/0000-0003-2083-3002; Lombard, Murielle/0000-0002-4775-3494; Hernandez, Sara B./0000-0002-8349-360X; Pelosi, Ludovic/0000-0002-4198-5681; Hernandez, Sara/0000-0002-8349-360X; Barras, Frederic/0000-0003-3458-2574; Aussel, Laurent/0000-0001-5239-4556; Fyfe, Cameron/0000-0001-7604-8009	FRISBI [UMR 9198]	FRISBI	We thank the FB group for discussions and suggestions. This work has benefited from the facilities and expertise of the Macromolecular Interaction Platform of I2BC (UMR 9198) supported by FRISBI.	ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4750, DOI 10.1021/bi00615a024; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Aussel L, 2014, J BACTERIOL, V196, P70, DOI 10.1128/JB.01065-13; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bouveret E, 2012, METHODS MOL BIOL, V804, P15, DOI 10.1007/978-1-61779-361-5_2; Carrica MC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-95; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Garcia FL, 2000, J MOL BIOL, V295, P595, DOI 10.1006/jmbi.1999.3355; Golemis E. A., 1994, 2 HYBRID SYSTEMS INT; Gonzalez-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243; Haapalainen AM, 2001, J MOL BIOL, V313, P1127, DOI 10.1006/jmbi.2001.5084; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; Pelosi L, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00091-16; Perez De Berti Federico, 2013, Journal of Structural and Functional Genomics, V14, P145, DOI 10.1007/s10969-013-9166-6; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Ravcheev DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00128; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stolowich NJ, 2002, CELL MOL LIFE SCI, V59, P193, DOI 10.1007/s00018-002-8416-8; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Wang KC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01614; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	40	28	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11937	11950		10.1074/jbc.M117.789164	http://dx.doi.org/10.1074/jbc.M117.789164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559279	Green Published, hybrid			2022-12-26	WOS:000405485600029
J	Alber, M; Zimmert, J; Dogan, U; Kloft, M				Alber, Maximilian; Zimmert, Julian; Dogan, Urun; Kloft, Marius			Distributed optimization of multi-class SVMs	PLOS ONE			English	Article							VECTOR; IMPLEMENTATION; BINARY	Training of one-vs.-rest SVMs can be parallelized over the number of classes in a straight forward way. Given enough computational resources, one-vs.-rest SVMs can thus be trained on data involving a large number of classes. The same cannot be stated, however, for the so-called all-in-one SVMs, which require solving a quadratic program of size quadratically in the number of classes. We develop distributed algorithms for two all-in-one SVM formulations (Lee et al. and Weston and Watkins) that parallelize the computation evenly over the number of classes. This allows us to compare these models to one-vs.-rest SVMs on unprecedented scale. The results indicate superior accuracy on text classification data.	[Alber, Maximilian] Berlin Inst Technol, Berlin Big Data Ctr, Berlin, Germany; [Zimmert, Julian; Kloft, Marius] Humboldt Univ, Dept Comp Sci, Berlin, Germany; [Dogan, Urun] Microsoft Res, Cambridge, England	Technical University of Berlin; Humboldt University of Berlin; Microsoft	Kloft, M (corresponding author), Humboldt Univ, Dept Comp Sci, Berlin, Germany.	kloft@hu-berlin.de			German Research Foundation (DFG) [KL 2698/2-1]; Federal Ministry of Education and Research (BMBF) [031L0023A, 031B0187B, 01I514013A]	German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Some authors were supported by academic funding: MK acknowledges support by the German Research Foundation (DFG) under KL 2698/2-1 and by the Federal Ministry of Education and Research (BMBF) under 031L0023A and 031B0187B. MA acknowledges support by the Federal Ministry of Education and Research (BMBF) under 01I514013A. Besides support in form of salaries or scholarships, the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Microsoft Research provided support in the form of salaries for author UD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Agarwal A., 2011, CORR; Allwein EL, 2001, J MACH LEARN RES, V1, P113, DOI 10.1162/15324430152733133; Asuncion A, 2007, UCI MACHINE LEARNING; Babbar R., 2016, P 2016 SIAM INT C DA, P234; Bengio Samy, 2010, ADV NEURAL INFORM PR, V1, P163, DOI [DOI 10.5555/2997189.2997208, 10.5555/2997189.2997208]; BERTSEKAS D, 1995, NONLINEAR PROGRAMMIN; Bondy J.A., 1976, GRAPH THEORY APPL, V290; Boyd Stephen, 2010, Foundations and Trends in Machine Learning, V3, P1, DOI 10.1561/2200000016; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Chiang WL, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1485, DOI 10.1145/2939672.2939826; Choromanska A. E., 2015, ADV NEURAL INFORM PR, P55; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Crammer K, 2002, MACH LEARN, V47, P201, DOI 10.1023/A:1013637720281; Dagum L, 1998, IEEE COMPUT SCI ENG, V5, P46, DOI 10.1109/99.660313; Dalcin LD, 2011, ADV WATER RESOUR, V34, P1124, DOI 10.1016/j.advwatres.2011.04.013; Deng J., 2011, ADV NEURAL INFORM PR, P567, DOI DOI 10.5555/2986459.2986523; Do T., 2014, VIETNAM J COMPUTER S, V1, P107, DOI DOI 10.1007/S40595-013-0013-2; Dogan U, 2016, J MACH LEARN RES, V17; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Gao TS, 2011, IEEE I CONF COMP VIS, P2072, DOI 10.1109/ICCV.2011.6126481; Gopal S., 2013, INT C MACHINE LEARNI, P289; Gopal S, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P257; Govada A, 2015, ARXIV1512019932015; Govada A, 2015, PROCEEDING OF THE THIRD INTERNATIONAL SYMPOSIUM ON WOMEN IN COMPUTING AND INFORMATICS (WCI-2015), P54, DOI 10.1145/2791405.2791534; Gropp W, 1996, PARALLEL COMPUT, V22, P789, DOI 10.1016/0167-8191(96)00024-5; Gupta MR, 2014, J MACH LEARN RES, V15, P1461; Han XF, 2012, PROC CVPR IEEE, P3554, DOI 10.1109/CVPR.2012.6248099; Hill SI, 2007, J ARTIF INTELL RES, V30, P525, DOI 10.1613/jair.2251; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Igel C, 2008, J MACH LEARN RES, V9, P993; Jenssen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042947; Keerthi SS, 2008, P 14 ACM SIGKDD INT, P408, DOI DOI 10.1145/1401890.1401942; Lee YK, 2004, J AM STAT ASSOC, V99, P67, DOI 10.1198/016214504000000098; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu Y, 2005, IEEE IJCNN, P849; Liu Y., 2007, 11 INT C ART INT STA, V2, P289; Liu YF, 2011, J COMPUT GRAPH STAT, V20, P901, DOI 10.1198/jcgs.2010.09206; Lodi S, 2010, METHODS, V14, P2; Madzarov G, 2009, INFORM-J COMPUT INFO, V33, P225; Partalas I., 2015, CORR; Rifkin R, 2004, J MACH LEARN RES, V5, P101; Szedmak S, 2006, LEARNING VIA LINEAR; Tseng P, 2001, J OPTIMIZ THEORY APP, V109, P475, DOI 10.1023/A:1017501703105; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vapnik V., 1998, STAT LEARNING THEORY; Weston J., 1999, 7th European Symposium on Artificial Neural Networks. ESANN'99. Proceedings, P219; Xiao L., 2011, ICML, P801	53	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178161	10.1371/journal.pone.0178161	http://dx.doi.org/10.1371/journal.pone.0178161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570703	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800032
J	Guduru, A; Fleischman, D; Shin, S; Zeng, DL; Baldwin, JB; Houghton, OM; Say, EA				Guduru, Abhilash; Fleischman, David; Shin, Sunyoung; Zeng, Donglin; Baldwin, James B.; Houghton, Odette M.; Say, Emil A.			Ultra-widefield fundus autofluorescence in age-related macular degeneration	PLOS ONE			English	Article							PERIPHERAL AUTOFLUORESCENCE; GEOGRAPHIC ATROPHY; LIPOFUSCIN; CLASSIFICATION; FLUOROPHORE; PREVALENCE; AGREEMENT; PATTERNS; A2E	Background Establish accuracy and reproducibility of subjective grading in ultra-widefield fundus auto-fluorescence (FAF) imaging in patients with age-related macular degeneration (AMD), and determine if an association exists between peripheral FAF abnormalities and AMD. Methods This was a prospective, single-blinded case-control study. Patients were consecutively recruited for the study. Patients were excluded if there was a history of prior or active ocular pathology other than AMD or image quality was insufficient for analysis as determined by two independent graders. Control patients were those without any evidence of AMD or other ophthalmic disease apart from cataract. Using the Optos 200Tx (Optos, Marlborough, MA, USA), a ResMax central macula and an ultra-widefield peripheral retina image was taken for each eye in both normal color and short wavelength FAF. Ultra-widefield photographs were modified to mask the macula. Each ResMax and ultra-widefield image was independently graded by two blinded investigators. Results There were 28 AMD patients and 11 controls. There was a significant difference in the average age between AMD patients and control groups (80 versus 64, respectively P<0.001). There was moderate, statistically significant agreement between observers regarding image interpretation (78.4%, K = 0.524, P<0.001), and 69.0% (K = 0.49, P<0.001) agreement between graders for FAF abnormality patterns. Patients with AMD were at greater risk for peripheral FAF abnormalities (OR: 3.43, P = 0.019) and patients with FAF abnormalities on central macular ResMax images were at greater risk of peripheral FAF findings (OR: 5.19, P = 0.017). Conclusion Subjective interpretation of FAF images has moderate reproducibility and validity in assessment of peripheral FAF abnormalities. Peripheral FAF abnormalities are seen in both AMD and control patients. Those with AMD, poor visual acuity, and macular FAF abnormalities are at greater risk.	[Guduru, Abhilash] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Fleischman, David; Zeng, Donglin; Baldwin, James B.; Houghton, Odette M.] Univ N Carolina, Dept Ophthalmol, Kittner Eye Ctr, Chapel Hill, NC 27599 USA; [Shin, Sunyoung] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Shin, Sunyoung] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Say, Emil A.] Med Univ South Carolina, Storm Eye Inst, Dept Ophthalmol, Charleston, SC 29425 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical University of South Carolina	Fleischman, D (corresponding author), Univ N Carolina, Dept Ophthalmol, Kittner Eye Ctr, Chapel Hill, NC 27599 USA.	david8fleischman@gmail.com		Guduru, Abhilash/0000-0003-2138-3576	Research to Prevent Blindness, Inc (New York, NY)	Research to Prevent Blindness, Inc (New York, NY)(Research to Prevent Blindness (RPB))	University of North Carolina is a recipient of an unrestricted grant from Research to Prevent Blindness, Inc (New York, NY). The funders had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review or approval of the manuscript.	Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bindewald A, 2005, INVEST OPHTH VIS SCI, V46, P3309, DOI 10.1167/iovs.04-0430; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Domalpally A, 2014, INVEST OPHTH VIS SCI, V55; Domalpally A, 2017, OPHTHALMOLOGY, V124, P479, DOI 10.1016/j.ophtha.2016.12.004; Friberg TR, 2014, INVEST OPHTH VIS SCI, V55; Friberg TR, 2015, INVEST OPHTH VIS SCI, V56; Hardin JW, 2012, GEN ESTIMATING EQUAT; Heussen FM, 2012, INVEST OPHTH VIS SCI, V53, P6526, DOI 10.1167/iovs.12-9909; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kernt Marcus, 2013, Oman J Ophthalmol, V6, pS32, DOI 10.4103/0974-620X.122292; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lengyel I, 2015, OPHTHALMOLOGY, V122, P1340, DOI 10.1016/j.ophtha.2015.03.005; Nomura Y, 2015, CLIN OPHTHALMOL, V9, P297, DOI 10.2147/OPTH.S78210; Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976; Reznicek L, 2012, INVEST OPHTH VIS SCI, V53, P2193, DOI 10.1167/iovs.11-8483; Sadatsafavi M, 2008, J CLIN EPIDEMIOL, V61, P722, DOI 10.1016/j.jclinepi.2007.10.023; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Tan CS, 2013, OPHTHALMOLOGY, V120, P1271, DOI 10.1016/j.ophtha.2012.12.002; Witmer MT, 2012, ACTA OPHTHALMOL, V90, pe428, DOI 10.1111/j.1755-3768.2012.02434.x; Wu ZC, 2015, INVEST OPHTH VIS SCI, V56, P1546, DOI 10.1167/iovs.14-16211	25	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177207	10.1371/journal.pone.0177207	http://dx.doi.org/10.1371/journal.pone.0177207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570556	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800007
J	McGregor, R; Shan, L; Wu, MF; Siegel, JM				McGregor, Ronald; Shan, Ling; Wu, Ming-Fung; Siegel, Jerome M.			Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss	PLOS ONE			English	Article							CONCENTRATING HORMONE NEURONS; BASAL FOREBRAIN NEURONS; OREXIN-A LEVELS; OREXIN/HYPOCRETIN NEURONS; FOS EXPRESSION; RAT; SYSTEM; ACTIVATION; NARCOLEPSY; BRAIN	The loss of specific neuronal phenotypes, as determined by immunohistochemistry, has become a powerful tool for identifying the nature and cause of neurological diseases. Here we show that the number of neurons identified and quantified using this method misses a substantial percentage of extant neurons in a phenotype specific manner. In mice, 24% more hypocretin/orexin (Hcrt) neurons are seen in the night compared to the day, and an additional 17% are seen after inhibiting microtubule polymerization with colchicine. We see no such difference between the number of MCH (melanin concentrating hormone) neurons in dark, light or colchicine conditions, despite MCH and Hcrt both being hypothalamic peptide transmitters. Although the size of Hcrt neurons did not differ between light and dark, the size of MCH neurons was increased by 15% in the light phase. The number of neurons containing histidine decarboxylase (HDC), the histamine synthesizing enzyme, was 34% greater in the dark than in the light, but, like Hcrt, cell size did not differ. We did not find a significant difference in the number or the size of neurons expressing choline acetyltransferase (ChAT), the acetylcholine synthesizing enzyme, in the horizontal diagonal band (HBD) during the dark and light conditions. As expected, colchicine treatment did not increase the number of these neurons. Understanding the function and dynamics of transmitter production within "non-visible" phenotypically defined cells has fundamental implications for our understanding of brain plasticity.	[McGregor, Ronald; Shan, Ling; Wu, Ming-Fung; Siegel, Jerome M.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [McGregor, Ronald; Shan, Ling; Wu, Ming-Fung; Siegel, Jerome M.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [McGregor, Ronald; Shan, Ling; Wu, Ming-Fung; Siegel, Jerome M.] Vet Adm Greater Los Angeles Healthcare Syst, Neurobiol Res, North Hills, CA 91343 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Siegel, JM (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.; Siegel, JM (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.; Siegel, JM (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Neurobiol Res, North Hills, CA 91343 USA.	JSiegel@ucla.edu	Shan, Ling/N-7075-2019; Shan, Ling/E-4281-2012	Shan, Ling/0000-0002-4765-2474; Shan, Ling/0000-0002-4765-2474	National Institutes of Health [DA034748, MH064109]; Medical Research Service of the Department of Veteran Affairs; Brain & Behavior Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034748] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veteran Affairs; Brain & Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	Support was provided by the National Institutes of Health DA034748 and MH064109, the Medical Research Service of the Department of Veteran Affairs (JMS) and the 2014 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (LS).	Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Deats SP, 2014, NEUROSCIENCE, V272, P252, DOI 10.1016/j.neuroscience.2014.04.069; Detari L, 1999, PROG NEUROBIOL, V58, P249, DOI 10.1016/S0301-0082(98)00084-7; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fujiki N, 2001, NEUROREPORT, V12, P993, DOI 10.1097/00001756-200104170-00026; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Ichikawa T, 1997, J CHEM NEUROANAT, V13, P23, DOI 10.1016/S0891-0618(97)00021-5; Jalewa J, 2014, BEHAV BRAIN RES, V272, P196, DOI 10.1016/j.bbr.2014.05.030; John J., 2013, ANN NEUROL; Kodama T, 2005, PEPTIDES, V26, P631, DOI 10.1016/j.peptides.2004.11.016; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luppi PH, 2013, CURR OPIN NEUROBIOL, V23, P786, DOI 10.1016/j.conb.2013.02.006; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Martinez GS, 2002, BRAIN RES, V955, P1, DOI 10.1016/S0006-8993(02)03264-X; McGregor R, 2011, J NEUROSCI, V31, P15455, DOI 10.1523/JNEUROSCI.4017-11.2011; Mikrouli E, 2011, NEUROPEPTIDES, V45, P401, DOI 10.1016/j.npep.2011.07.010; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; MIZUNO T, 1991, NEUROSCIENCE, V44, P607, DOI 10.1016/0306-4522(91)90081-X; MOCHIZUKI T, 1992, PHYSIOL BEHAV, V51, P391, DOI 10.1016/0031-9384(92)90157-W; Muschamp JW, 2007, J NEUROSCI, V27, P2837, DOI 10.1523/JNEUROSCI.4121-06.2007; NITZ D, 1995, NEUROREPORT, V6, P1521, DOI 10.1097/00001756-199507310-00014; Obukuro K, 2013, J NEUROSCI, V33, P12557, DOI 10.1523/JNEUROSCI.0595-13.2013; Palomba M, 2015, NEUROSCIENCE, V290, P185, DOI 10.1016/j.neuroscience.2014.12.066; Parmentier R, 2002, J NEUROSCI, V22, P7695; Passani MB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00064; Pelluru D, 2013, SLEEP, V36, P1779, DOI 10.5665/sleep.3196; Perekrest SV, 2008, MED SCI MONITOR, V14, pBR127; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Rozov SV, 2014, EUR J NEUROSCI, V39, P218, DOI 10.1111/ejn.12397; Santollo J, 2013, J NEUROENDOCRINOL, V25, P570, DOI 10.1111/jne.12032; Shan L, 2012, NEUROBIOL AGING, V33, P2585, DOI 10.1016/j.neurobiolaging.2011.12.026; Shan L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.016; Shan L, 2012, SLEEP, V35, P713, DOI 10.5665/sleep.1838; Tafti M, 1997, J COMP NEUROL, V379, P185, DOI 10.1002/(SICI)1096-9861(19970310)379:2<185::AID-CNE2>3.0.CO;2-#; Taheri S, 2000, NEUROSCI LETT, V279, P109, DOI 10.1016/S0304-3940(99)00955-6; Takahashi K, 2006, J NEUROSCI, V26, P10292, DOI 10.1523/JNEUROSCI.2341-06.2006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993; Valko P. O., 2013, ANN NEUROL; Yamaguchi K, 2015, RESP PHYSIOL NEUROBI, V206, P11, DOI 10.1016/j.resp.2014.11.003; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Yu X, 2014, CURR BIOL, V24, P2838, DOI 10.1016/j.cub.2014.10.019	50	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178573	10.1371/journal.pone.0178573	http://dx.doi.org/10.1371/journal.pone.0178573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570646	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800081
J	Safronov, O; Kreuzwieser, J; Haberer, G; Alyousif, MS; Schulze, W; Al-Harbi, N; Arab, L; Ache, P; Stempfl, T; Kruse, J; Mayer, KX; Hedrich, R; Rennenberg, H; Salojarvi, J; Kangasjarvi, J				Safronov, Omid; Kreuzwieser, Juergen; Haberer, Georg; Alyousif, Mohamed S.; Schulze, Waltraud; Al-Harbi, Naif; Arab, Leila; Ache, Peter; Stempfl, Thomas; Kruse, Joerg; Mayer, Klaus X.; Hedrich, Rainer; Rennenberg, Heinz; Salojarvi, Jarkko; Kangasjarvi, Jaakko			Detecting early signs of heat and drought stress in Phoenix dactylifera (date palm)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; CELL-DEATH; PLANTS; PROLINE; GENOME; DEFENSE; IDENTIFICATION; COMBINATIONS; ACCLIMATION	Plants adapt to the environment by either long-term genome evolution or by acclimatization processes where the cellular processes and metabolism of the plant are adjusted within the existing potential in the genome. Here we studied the adaptation strategies in date palm, Phoenix dactylifera, under mild heat, drought and combined heat and drought by transcriptomic and metabolomic profiling. In transcriptomics data, combined heat and drought resembled heat response, whereas in metabolomics data it was more similar to drought. In both conditions, soluble carbohydrates, such as fucose, and glucose derivatives, were increased, suggesting a switch to carbohydrate metabolism and cell wall biogenesis. This result is consistent with the evidence from transcriptomics and cis-motif analysis. In addition, transcriptomics data showed transcriptional activation of genes related to reactive oxygen species in all three conditions (drought, heat, and combined heat and drought), suggesting increased activity of enzymatic antioxidant systems in cytosol, chloroplast and peroxisome. Finally, the genes that were differentially expressed in heat and combined heat and drought stresses were significantly enriched for circadian and diurnal rhythm motifs, suggesting new stress avoidance strategies.	[Safronov, Omid; Salojarvi, Jarkko; Kangasjarvi, Jaakko] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Kreuzwieser, Juergen; Arab, Leila; Kruse, Joerg; Rennenberg, Heinz] Univ Freiburg, Inst Forest Sci, Freiburg, Germany; [Haberer, Georg; Mayer, Klaus X.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Plant Genome & Syst Biol, Neuherberg, Germany; [Alyousif, Mohamed S.; Al-Harbi, Naif; Mayer, Klaus X.; Hedrich, Rainer; Kangasjarvi, Jaakko] King Saud Univ, Coll Sci, Riyadh, Saudi Arabia; [Schulze, Waltraud] Univ Hohenheim, Inst Physiol & Biotechnol Plants, Plant Syst Biol, Stuttgart, Germany; [Ache, Peter] Univ Wurzburg, Inst Mol Plant Physiol & Biophys, Wurzburg, Germany; [Stempfl, Thomas] Univ Regensburg, Ctr Excellence Fluorescent Bioanalyt KFB, Regensburg, Germany	University of Helsinki; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; King Saud University; University Hohenheim; University of Wurzburg; University of Regensburg	Kangasjarvi, J (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.; Kangasjarvi, J (corresponding author), King Saud Univ, Coll Sci, Riyadh, Saudi Arabia.	jaakko.kangasjarvi@helsinki.fi	Hedrich, Rainer/G-8771-2011; Kangasjärvi, Jaakko/A-3024-2015; Kangasjärvi, Jaakko/AAP-8639-2021; Mayer, Klaus FX/M-7941-2015; Ache, Peter/AAS-7651-2021; Schulze, Waltraud X/E-9800-2011; Salojärvi, Jarkko/E-9103-2016; Alharbi, Naiyf S/B-9402-2019	Hedrich, Rainer/0000-0003-3224-1362; Kangasjärvi, Jaakko/0000-0002-8959-1809; Kangasjärvi, Jaakko/0000-0002-8959-1809; Mayer, Klaus FX/0000-0001-6484-1077; Ache, Peter/0000-0002-2902-7552; Schulze, Waltraud X/0000-0001-9957-7245; Salojärvi, Jarkko/0000-0002-4096-6278; Alharbi, Naiyf S/0000-0001-5820-9649; Haberer, Georg/0000-0002-6612-6939; Safronov, Omid/0000-0003-2044-3258	KSU DSFP (Distinguished Scientist Fellowship Program); Academy of Finland Centre of Excellence program	KSU DSFP (Distinguished Scientist Fellowship Program); Academy of Finland Centre of Excellence program(Academy of Finland)	The work was supported by the KSU DSFP (Distinguished Scientist Fellowship Program) and Academy of Finland Centre of Excellence program 2014-2019.; The work was supported by the KSU DSFP (Distinguished Scientist Fellowship Program) and Academy of Finland Centre of Excellence program 2014 - 2019. Irina Safronova is acknowledged for her contribution in Figure 4, and Cezary M Waszczak for productive discussions.	Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Arab L, 2016, ENVIRON EXP BOT, V125, P20, DOI 10.1016/j.envexpbot.2016.01.003; Bemm F, 2016, GENOME RES, V26, P812, DOI 10.1101/gr.202200.115; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Cordoba E, 2015, J EXP BOT, V66, P147, DOI 10.1093/jxb/eru394; Cosgrove D. J, 2016, F1000 RES, DOI [10.12688/ f1000research.7180.1, DOI 10.12688/F1000RESEARCH.7180.1]; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Echevarria-Zomeno S, 2016, PLANT CELL ENVIRON, V39, P1264, DOI 10.1111/pce.12664; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; FARAGO ME, 1979, INORG CHIM ACTA, V32, pL93, DOI 10.1016/S0020-1693(00)91627-X; Feller U, 2016, J PLANT PHYSIOL, V203, P69, DOI 10.1016/j.jplph.2016.04.002; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Jacob P, 2017, PLANT BIOTECHNOL J, V15, P405, DOI 10.1111/pbi.12659; Jaeger C, 2009, J EXP BOT, V60, P4335, DOI 10.1093/jxb/erp268; Khelil R, 2016, SCI HORTIC-AMSTERDAM, V201, P238, DOI 10.1016/j.scienta.2016.02.012; Kruse JR, 2017, TREES-STRUCT FUNCT, V31, P623, DOI 10.1007/s00468-016-1496-0; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Li X, 2016, PLANT CELL, V28, P2755, DOI 10.1105/tpc.16.00354; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liu HL, 2007, J PLANT PHYSIOL, V164, P1384, DOI 10.1016/j.jplph.2007.03.005; Lytovchenko A, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-4; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Michael S, 2008, BIOINFORMATICS, V24, P453, DOI 10.1093/bioinformatics/btm624; Ming R, 2015, NAT GENET, V47, P1435, DOI 10.1038/ng.3435; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Nankishore A, 2016, J PLANT PHYSIOL, V202, P75, DOI 10.1016/j.jplph.2016.07.006; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Osakabe Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00086; Pandey P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00723; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saidi Y, 2011, NEW PHYTOL, V190, P556, DOI 10.1111/j.1469-8137.2010.03571.x; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tang H, 2015, GOATOOLS TOOLS GENE; Tremblay A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37797; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Willems P, 2016, PLANT PHYSIOL, V171, P1720, DOI 10.1104/pp.16.00420; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	55	27	26	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177883	10.1371/journal.pone.0177883	http://dx.doi.org/10.1371/journal.pone.0177883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570677	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800019
J	Yang, D; Wang, CJ; Luo, YW; Li, X; Song, QB; Zhang, J; Xin, SJ				Yang, Dong; Wang, Chuanjiang; Luo, Yingwei; Li, Xuan; Song, Qingbin; Zhang, Jian; Xin, Shijie			Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling	PLOS ONE			English	Article							BETA-CATENIN; CANCER; LIMITATIONS; PATHWAY; LINES	Disruption of Wnt signaling often happens in tumorigenesis, but whether Wnt signaling affects the early stages of thyroid tumor, such as papillary thyroid carcinoma, is still a question, especially in the papillary thyroid carcinoma without genomic RET/PTC mutation. In this study, we demonstrated the important function of Wnt signaling in papillary thyroid carcinoma K1 cells, which have no RET/PTC mutation. We found that K1 cells have enhanced Wnt signaling in comparison to normal thyroid cells. We further demonstrated that K1 cells require the enhanced Wnt signaling for growth and survival. Interestingly, we identified that enhancing E2F activity by either knockdown of Rb or overexpression of Cyclin D1 induces cell death in K1 cells. And we further revealed that the cell death is caused by enhanced oxidative stress. Our studies present a novel cell model to support the key roles of Wnt signaling in early stage of thyroid tumor, and also provide an alternative way to limit thyroid cancer.	[Yang, Dong; Wang, Chuanjiang; Luo, Yingwei; Li, Xuan; Song, Qingbin; Zhang, Jian; Xin, Shijie] China Med Univ, Hosp 1, Dept Thyroid Surg, Shenyang, Liaoning, Peoples R China	China Medical University	Yang, D (corresponding author), China Med Univ, Hosp 1, Dept Thyroid Surg, Shenyang, Liaoning, Peoples R China.	ydzf001@gmail.com		Xin, Shijie/0000-0001-6278-8794	National Natural Science Foundation of China [81000136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China, Grant number: 81000136 (DY received the funding) [http://www.nsfc.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Cassinelli G, 2009, NEOPLASIA, V11, P10, DOI 10.1593/neo.08916; Castellone MD, 2009, CANCER RES, V69, P1867, DOI 10.1158/0008-5472.CAN-08-1982; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Imai Y, 2014, CELL REP, V7, P194, DOI 10.1016/j.celrep.2014.03.006; Kurihara T, 2004, THYROID, V14, P1020, DOI 10.1089/thy.2004.14.1020; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Macleod KF, 2008, NAT REV CANCER, V8, P769, DOI 10.1038/nrc2504; Meireles AM, 2007, THYROID, V17, P707, DOI 10.1089/thy.2007.0097; Nicolay BN, 2013, GENE DEV, V27, P182, DOI 10.1101/gad.206227.112; Omur O, 2014, CRIT REV ONCOL HEMAT, V90, P233, DOI 10.1016/j.critrevonc.2013.12.007; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tartari CJ, 2011, AM J CANCER RES, V1, P716; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Zhang TY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004357; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhu ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102582	21	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178908	10.1371/journal.pone.0178908	http://dx.doi.org/10.1371/journal.pone.0178908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570681	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800134
J	Bautista-Rodriguez, C; Launes, C; Jordan, I; Andres, M; Arias, MT; Lozano, F; Garcia-Garcia, JJ; Munoz-Almagro, C				Bautista-Rodriguez, Carles; Launes, Cristian; Jordan, Iolanda; Andres, Maria; Teresa Arias, Maria; Lozano, Francisco; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen			Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; SEROTYPES; DISEASE; CHILDREN; IDENTIFICATION; FREQUENCY; CARRIAGE; DURATION; VARIANT; INNATE	Objectives The objective of this study was to evaluate to evaluate the role of mannose-binding-lectin deficient genotypes in pneumococcal meningitis (PM) in children. Methods We performed a 16-year retrospective study (January 2001 to March 2016) including patients <= 18 years with PM. Variables including attack rate of pneumococcal serotype (high or low invasive capacity) and MBL2 genotypes associated with low serum MBL levels were recorded. Results Forty-eight patients were included in the study. Median age was 18.5 months and 17/48 episodes (35.4%) occurred in children <= 12 months old. Serotypes with high-invasive disease potential were identified in 15/48 episodes (31.2%). MBL2 deficient genotypes accounted for 18.8% (9/48). Children <= 12 months old had a 7-fold risk (95% CI: 1.6-29.9; p < 0.01) of having a MBL2 deficient genotype in comparison to those > 12 months old. A sub-analysis of patients by age group revealed significant proportions of carriers of MBL2 deficient genotypes among those < 12 months old with PM caused by opportunistic serotypes (54.5%), admitted to the PICU (Pediatric Intensive Care Unit) (46.7%) and of White ethnicity (35.7%). These proportions were significantly higher than in older children (all p<0.05). Conclusions Our results suggest that differences in MBL2 genotype in children <= 12 months old affects susceptibility to PM, and it may have an important role in the episodes caused by non-high invasive disease potential serotypes.	[Bautista-Rodriguez, Carles; Launes, Cristian; Jose Garcia-Garcia, Juan] Univ Hosp St Joan de Deu, Pediat Dept, Barcelona, Spain; [Launes, Cristian; Jordan, Iolanda; Andres, Maria; Jose Garcia-Garcia, Juan; Munoz-Almagro, Carmen] Inst Salud Carlos III, CIBERESP, Madrid, Spain; [Jordan, Iolanda] Univ Hosp St Joan de Deu, Pediat Intens Care Dept, Barcelona, Spain; [Jordan, Iolanda; Lozano, Francisco; Jose Garcia-Garcia, Juan] Univ Barcelona, Sch Med, Barcelona, Spain; [Andres, Maria; Munoz-Almagro, Carmen] Univ Hosp St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain; [Teresa Arias, Maria; Lozano, Francisco] Hosp Clin Barcelona, Ctr Diagnost Biomed, Dept Immunol, Barcelona, Spain; [Lozano, Francisco] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Immunoreceptors Innate & Adapt Syst, Barcelona, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Sch Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Internacional de Catalunya (UIC)	Munoz-Almagro, C (corresponding author), Inst Salud Carlos III, CIBERESP, Madrid, Spain.; Munoz-Almagro, C (corresponding author), Univ Hosp St Joan de Deu, Mol Microbiol Dept, Barcelona, Spain.; Munoz-Almagro, C (corresponding author), Univ Int Catalunya, Sch Med, Barcelona, Spain.	cma@sjdhospitalbarcelona.org	Muñoz-Almagro, Carmen/N-7248-2015; LOZANO, FRANCISCO/AAB-7888-2019; Launes, Cristian/ABD-8312-2020; Garcia-Garcia, Juan José/J-5295-2014	Muñoz-Almagro, Carmen/0000-0001-5586-404X; LOZANO, FRANCISCO/0000-0003-1119-4368; Launes, Cristian/0000-0002-0913-9303; Garcia-Garcia, Juan José/0000-0002-3483-528X	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D+i) [SAF2013-46151-R]; Spanish Network for Research in Infectious Diseases (REIPI) [RD12/0015/0018]; Institut de Salud Carlos III (ISCIII) - European Development Regional Fund "A way to achieve Europe" ERDF [PI13/01729]	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D+i); Spanish Network for Research in Infectious Diseases (REIPI); Institut de Salud Carlos III (ISCIII) - European Development Regional Fund "A way to achieve Europe" ERDF	This work was supported by the Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D+i, SAF2013-46151-R) (http://www.mineco.gob.esi); Institut de Salud Carlos III (ISCIII) - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF - (Grant PI13/01729) (http://www.isciii.es/) (http://ec.europa.eu/regional_policy/en/funding/erdf/)) and the Spanish Network for Research in Infectious Diseases (REIPI, RD12/0015/0018) (http//reipi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Brouwer MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065151; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cervera C, 2009, LIVER TRANSPLANT, V15, P1217, DOI 10.1002/lt.21834; Darton T C, 2014, Clin Microbiol Infect, V20, P1337, DOI 10.1111/1469-0691.12745; del Amo E, 2015, EUR J CLIN MICROBIOL, V34, P705, DOI 10.1007/s10096-014-2280-y; del Amo E, 2014, CLIN MICROBIOL INFEC, V20, P684, DOI 10.1111/1469-0691.12422; Dommett R, 2013, J PEDIAT HEMATOL ONC, V35, P69, DOI 10.1097/MPH.0b013e31827076e5; Eisen DP, 2008, CLIN INFECT DIS, V47, P510, DOI 10.1086/590006; GARRED P, 1992, CLIN EXP IMMUNOL, V90, P517; Goenka A, 2015, J INFECTION, V71, pS112, DOI 10.1016/j.jinf.2015.04.027; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Garcia-Laorden MI, 2013, EUR RESPIR J, V41, P131, DOI 10.1183/09031936.00174111; Knoll MD, 2014, PEDIATR INFECT DIS J, V33, pS119, DOI 10.1097/INF.0000000000000079; Kronborg G, 2002, J INFECT DIS, V185, P1517, DOI 10.1086/340216; Launes C, 2014, CLIN MICROBIOL INFEC, V20, pO1088, DOI 10.1111/1469-0691.12744; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Munoz-Almagro C, 2014, CLIN MICROBIOL INFEC, V20, pO745, DOI 10.1111/1469-0691.12615; Munoz-Almagro C, 2011, J INFECTION, V63, P151, DOI 10.1016/j.jinf.2011.06.002; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Opal Steven M, 2005, Pediatr Crit Care Med, V6, pS55, DOI 10.1097/01.PCC.0000161580.79526.4C; Palaniyar N, 2010, INNATE IMMUN-LONDON, V16, P131, DOI 10.1177/1753425910370498; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Smithson A, 2010, CLIN VACCINE IMMUNOL, V17, P447, DOI 10.1128/CVI.00375-09; Speletas M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/478412; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Turner M W, 2000, Rev Immunogenet, V2, P305; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178377	10.1371/journal.pone.0178377	http://dx.doi.org/10.1371/journal.pone.0178377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562692	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700055
J	Bett, B; Said, MY; Sang, R; Bukachi, S; Wanyoike, S; Kifugo, SC; Otieno, F; Ontiri, E; Njeru, I; Lindahl, J; Grace, D				Bett, Bernard; Said, Mohammed Y.; Sang, Rosemary; Bukachi, Salome; Wanyoike, Salome; Kifugo, Shem C.; Otieno, Fredrick; Ontiri, Enoch; Njeru, Ian; Lindahl, Johanna; Grace, Delia			Effects of flood irrigation on the risk of selected zoonotic pathogens in an arid and semi-arid area in the eastern Kenya	PLOS ONE			English	Article							RIFT-VALLEY FEVER; WEST-NILE-VIRUS; DIVERSITY; IMPACT; POPULATION; PREVALENCE; WILDLIFE; DYNAMICS; CLIMATE; MALARIA	To investigate the effects of irrigation on land cover changes and the risk of selected zoonotic pathogens, we carried out a study in irrigated, pastoral and riverine areas in the eastern Kenya. Activities implemented included secondary data analyses to determine land use and land cover (LULC) changes as well as human, livestock and wildlife population trends; entomological surveys to characterize mosquitoes population densities and species distribution by habitat and season; and serological surveys in people to determine the risk of Rift Valley fever virus (RVFV), West Nile fever virus (WNV), dengue fever virus (DFV), Leptospira spp. and Brucella spp. Results demonstrate a drastic decline in vegetation cover over R approximate to 25 years particularly in the irrigated areas where cropland increased by about 1,400% and non-farm land (under closed trees, open to closed herbaceous vegetation, bushlands and open trees) reduced by 30-100%. The irrigated areas had high densities of Aedes mcintoshi, Culexspp. and Mansonia spp. (important vectors for multiple arboviruses) during the wet and dry season while pastoral areas had high densities of Ae. tricholabis specifically in the wet season. The seroprevalences of RVFV, WNV and DFV were higher in the irrigated compared to the pastoral areas while those for Leptospira spp and Brucella spp. were higher in the pastoral compared to the irrigated areas. It is likely that people in the pastoral areas get exposed to Leptospira spp by using water fetched from reservoirs that are shared with livestock and wildlife, and to Brucella spp. by consuming raw or partially cooked animal source foods such as milk and meat. This study suggests that irrigation increases the risk of mosquito-borne infections while at the same time providing a protective effect against zoonotic pathogens that thrive in areas with high livestock population densities.	[Bett, Bernard; Said, Mohammed Y.; Kifugo, Shem C.; Otieno, Fredrick; Ontiri, Enoch; Lindahl, Johanna; Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya; [Sang, Rosemary] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Bukachi, Salome] Univ Nairobi, Inst Anthropol Gender & African Studies, Nairobi, Kenya; [Wanyoike, Salome] Minist Agr, Dept Vet Serv, Nairobi, Kenya; [Njeru, Ian] Kenyatta Natl Hosp, Minist Publ Hlth & Sanitat, Div Dis Surveillance & Response, Nairobi, Kenya; [Lindahl, Johanna] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Lindahl, Johanna] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden	CGIAR; International Livestock Research Institute (ILRI); Kenya Medical Research Institute; University of Nairobi; Kenyatta National Hospital; Swedish University of Agricultural Sciences; Uppsala University	Bett, B (corresponding author), Int Livestock Res Inst, Nairobi, Kenya.	b.bett@cgiar.org	said, mohammed/E-4932-2019; Lindahl, Johanna/AFJ-4911-2022	said, mohammed/0000-0001-9278-3193; Lindahl, Johanna/0000-0002-1175-0398; Grace, Delia/0000-0002-0195-9489; Njeru, Ian/0000-0003-0610-3492	Ecosystem Services for Poverty Alleviation Programme (ESPA) [NE-J001570-1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); CGIAR Research Program Agriculture for Nutrition and Health (A4NH); Swedish Research Council; CGIAR Research Program Agriculture for Nutrition and Health [NE-J001570-1]; NERC [NE/J001570/1, NE/J001422/1] Funding Source: UKRI; Natural Environment Research Council [NE/J001570/1, NE/J001422/1] Funding Source: researchfish	Ecosystem Services for Poverty Alleviation Programme (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CGIAR Research Program Agriculture for Nutrition and Health (A4NH)(CGIAR); Swedish Research Council(Swedish Research CouncilEuropean Commission); CGIAR Research Program Agriculture for Nutrition and Health(CGIAR); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was part of the project: Dynamic Drivers of Disease in Africa:Ecosystems, livestock/wildlife, health and wellbeing NE-J001570-1 that was jointly funded by the Ecosystem Services for Poverty Alleviation Programme (ESPA). The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). Other funding was provided by the CGIAR Research Program Agriculture for Nutrition and Health (A4NH) led by IFPRI. The contribution of JL was supported by the Swedish Research Council.; We acknowledge all the participants of the study as well as the technicians that screened the samples. The technicians included Samson Limbaso Konongoi and Martin Wainaina. Serosurveillance data were collected by John Muriuki and Damaris Mwololo. This study was part of a project entitled Dynamic Drivers of Disease in Africa:Ecosystems, livestock/wildlife, health and wellbeing NE-J001570-1 that was jointly funded by the Ecosystem Services for Poverty Alleviation Programme (ESPA) and the CGIAR Research Program Agriculture for Nutrition and Health. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). The contribution of JL was supported by the Swedish Research Council.	Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; Antipa RS, 2007, IJARA LAMU DISTRICTS; Bett B, 2009, PREV VET MED, V90, P194, DOI 10.1016/j.prevetmed.2009.05.001; Britch SC, 2013, PLOS ONE, P8; Butynski TM, 1994, CONSERVATION STATUS; Corvalan C, 2005, ECOSYSTEMS HUMAN WEL; De Jong Y. A., 2012, AFRICAN PRIMATES, V7, P135, DOI [10.1896/052.029.0107, DOI 10.1896/052.029.0107]; Dohoo I, 2003, PRINCE EDWARD ISLAND; Edwards FW, 1941, CULICINE ADULTS PUPA; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; FAO, 2000, AFR MULT LAND COV DA; Gillies MT, 1987, PUBL S AFRICAN I MED; Gillies MT, 1968, ANOPHELINES AFRICA S; Halliday JEB, 2013, AM J TROP MED HYG, V89, P1095, DOI 10.4269/ajtmh.13-0415; Harbach R.E., 1988, Contributions of the American Entomological Institute, V24, P1; Hightower A, 2012, AM J TROP MED HYG, V86, P373, DOI 10.4269/ajtmh.2012.11-0450; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; Jaleta KT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-350; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Jost CC, 2010, AM J TROP MED HYG, V83, P65, DOI 10.4269/ajtmh.2010.09-0290; Jupp P. G., 1986, MOSQUITOES SO AFRICA, P156; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keiser J, 2005, EFFECT IRRIGATION LA; Klinkenberg Eveline, 2003, 68 INT WAT MAN I; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; Muturi EJ, 2007, AM J TROP MED HYG, V76, P95, DOI 10.4269/ajtmh.2007.76.95; Nanyingi Mark O., 2015, Infection Ecology & Epidemiology, V5, P28024, DOI 10.3402/iee.v5.28024; Norton-Griffithms M, 1978, COUNTING ANIMALS; Nyamwaya D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2019-8; Ogutu Joseph O., 2014, Open Ecology Journal, V7, P9; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sang R, 2017, J MED ENTOMOL, V54, P460, DOI 10.1093/jme/tjw206; Team QGD, 2014, OP SOURC GEOSP FDN	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0172626	10.1371/journal.pone.0172626	http://dx.doi.org/10.1371/journal.pone.0172626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562600	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700001
J	Konigorski, S; Yilmaz, YE; Pischon, T				Konigorski, Stefan; Yilmaz, Yildiz E.; Pischon, Tobias			Comparison of single-marker and multi-marker tests in rare variant association studies of quantitative traits	PLOS ONE			English	Article							INFLUENCING BLOOD-PRESSURE; COMMON DISEASES; POWERFUL; DESIGNS; GENES	In genetic association studies of rare variants, low statistical power and potential violations of established estimator properties are among the main challenges of association tests. Multi-marker tests (MMTs) have been proposed to target these challenges, but any comparison with single-marker tests (SMTs) has to consider that their aim is to identify causal genomic regions instead of variants. Valid power comparisons have been performed for the analysis of binary traits indicating that MMTs have higher power, but there is a lack of conclusive studies for quantitative traits. The aim of our study was therefore to fairly compare SMTs and MMTs in their empirical power to identify the same causal loci associated with a quantitative trait. The results of extensive simulation studies indicate that previous results for binary traits cannot be generalized. First, we show that for the analysis of quantitative traits, conventional estimation methods and test statistics of single-marker approaches have valid properties yielding association tests with valid type I error, even when investigating singletons or doubletons. Furthermore, SMTs lead to more powerful association tests for identifying causal genes than MMTs when the effect sizes of causal variants are large, and less powerful tests when causal variants have small effect sizes. For moderate effect sizes, whether SMTs or MMTs have higher power depends on the sample size and percentage of causal SNVs. For a more complete picture, we also compare the power in studies of quantitative and binary traits, and the power to identify causal genes with the power to identify causal rare variants. In a genetic association analysis of systolic blood pressure in the Genetic Analysis Workshop 19 data, SMTs yielded smaller p-values compared to MMTs for most of the investigated blood pressure genes, and were least influenced by the definition of gene regions.	[Konigorski, Stefan; Pischon, Tobias] Helmholtz Assoc, Max Delbruck Ctr MDC Mol Med, Mol Epidemiol Res Grp, Berlin, Germany; [Yilmaz, Yildiz E.] Mem Univ Newfoundland, Dept Math & Stat, St John, NF, Canada; [Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Yilmaz, Yildiz E.] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Pischon, Tobias] Charite, Berlin, Germany; [Pischon, Tobias] DZHK German Ctr Cardiovasc Res, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Konigorski, S (corresponding author), Helmholtz Assoc, Max Delbruck Ctr MDC Mol Med, Mol Epidemiol Res Grp, Berlin, Germany.	stefan.konigorski@mdc-berlin.de	Pischon, Tobias/HGE-8577-2022	Pischon, Tobias/0000-0003-1568-767X	Natural Sciences and Engineering Research Council of Canada [RGPIN2014-04904]; Research &Development Corporation of New found land and Labrador [5404.1723.101]; Faculty of Medicine of Memorial University of New found land [209666]; Helmholtz Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102830, R01HL113323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073541, U01DK085501, U01DK085526, R01DK053889, U01DK085545, U01DK057295, U01DK085584, U01DK085524, R01DK047482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research &Development Corporation of New found land and Labrador; Faculty of Medicine of Memorial University of New found land; Helmholtz Association(Helmholtz Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Natural Sciences and Engineering Research Council of Canada[RGPIN2014-04904toYEY], the Research &Development Corporation of New found land and Labrador[5404.1723.101toYEY]and the Faculty of Medicine of Memorial University of New found land[209666toYEY]. SK is partly supported by funds granted by the Helmholtz Association as part of the port folio topic "Metabolic Dysfunction".The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero John, 2016, BMC Proc, V10, P71; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Chun HH, 2011, GENET EPIDEMIOL, V35, P479, DOI 10.1002/gepi.20596; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Gorlov IP, 2011, CLIN GENET, V79, P199, DOI 10.1111/j.1399-0004.2010.01535.x; Huang JF, 2016, GENETICS, V202, P919, DOI 10.1534/genetics.115.185009; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kinnamon DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030238; Knight K., 1999, MATH STAT; Konigorski Stefan, 2016, BMC Proc, V10, P289; Konigorski Stefan, 2014, BMC Proc, V8, pS72, DOI 10.1186/1753-6561-8-S1-S72; Ladouceur M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002496; Laird N.M., 2011, FUNDAMENTALS MODERN; Lee S, 2016, SKAT SNP SET SEQUENC; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Lohmueller KE, 2013, AM J HUM GENET, V93, P1072, DOI 10.1016/j.ajhg.2013.11.005; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pan W, 2014, GENETICS, V197, P1081, DOI 10.1534/genetics.114.165035; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Saad Mohamad, 2011, BMC Proc, V5 Suppl 9, pS33, DOI 10.1186/1753-6561-5-S9-S33; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Sun L, 2011, HUM GENET, V129, P545, DOI 10.1007/s00439-011-0948-2; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Wang SR, 2014, AM J HUM GENET, V94, P710, DOI 10.1016/j.ajhg.2014.03.019; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052977; Wang XF, 2012, GENET EPIDEMIOL, V36, P480, DOI 10.1002/gepi.21642; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Xu CJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00011	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178504	10.1371/journal.pone.0178504	http://dx.doi.org/10.1371/journal.pone.0178504			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562689	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000402608700066
J	Li, JW; Li, YM; Liu, H; Liu, YL; Cui, BB				Li, Jingwen; Li, Yongmin; Liu, He; Liu, Yanlong; Cui, Binbin			The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MEDIATED CELL-MIGRATION; OCCULT BLOOD-TEST; GROWTH-FACTOR; COPY NUMBER; MESENCHYMAL TRANSITION; GENE AMPLIFICATION; OVEREXPRESSION; METASTASIS; CARCINOMA	The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) have been shown to be involved in tumorigenesis of various cancers. However, their roles in colorectal cancer (CRC) remain unclear. In this study, we explored the expressions of MAL2 and TPD52 in tumor specimens resected from 123 CRC patients and the prognostic values of the two proteins in CRC. Immunohistochemical analyses showed that MAL2 (P < 0.001) and TPD52 (P < 0.001) were significantly highly expressed in primary carcinoma tissues compared with adjacent non-cancerous mucosa tissues. And TPD52 exhibited frequent overexpression in liver metastasis tissues relative to primary carcinoma tissues (P = 0.042), while MAL2 in lymphnode and liver metastasis tissues showed no significant elevation. Real-time quantitative PCR (RT-qPCR) showed the identical results. Correlation analyses by Pearson's chisquare test demonstrated that MAL2 in tumors was positively correlated with tumor status (pathological assessment of regional lymph nodes (pN, P = 0.024)), and clinic stage (P = 0.017). Additionally, the expression of TPD52 was detected under the same condition and was shown to be positively correlated withtumor status (pathological assessment of the primary tumor (pT, P = 0.035), distant metastasis (pM, P = 0.001)) and CRC clinicopathology (P = 0.024). Kaplan-Meier survival curves indicated that positive MAL2 (P < 0.001) and TPD52 (P < 0.001) expressions were associated with poor overall survival (OS) in CRC patients. Multivariate analysis showed that MAL2 and TPD52 expression was an independent prognostic factor for reduced OS of CRC patients. Moreover, overexpression of TPD52 in CRC SW480 cells showed an increased cell migration (P = 0.023) and invasion (P = 0.012) through inducing occurrence of epithelial-mesenchymal transition (EMT) and activating focal adhesion kinase (FAK)-mediated integrin signalling and PI3K/Akt signalling. Whereas TPD52-depleted cells showed the reverse effect. These data suggested that MAL2 and TPD52 might be potential biomarkers for clinical prognosis and might be a promising therapeutic target for CRC.	[Li, Jingwen; Li, Yongmin; Liu, He; Liu, Yanlong; Cui, Binbin] Harbin Med Univ, Canc Hosp, Dept Colorectal Surg, Harbin, Peoples R China	Harbin Medical University	Liu, YL; Cui, BB (corresponding author), Harbin Med Univ, Canc Hosp, Dept Colorectal Surg, Harbin, Peoples R China.	lyanlong77@163.com; cuibb328@163.com	Liu, Yanlong/AAL-3503-2021		National Natural Science Foundation of China (NSFC) [1272704, 81402367]; ScienceAMP;Technology Bureau of Harbin [2014RFQGJ, 2015RAXYJ063]; Research Fund for the Doctoral Program of Higher Education (SRFDP) [20132307120012]; Heilongjiang postdoctoral fund [LBH-Z12155]; Harbin Municipal Science and Technology Committee Harbin [2015RAXYJ063]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); ScienceAMP;Technology Bureau of Harbin; Research Fund for the Doctoral Program of Higher Education (SRFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Heilongjiang postdoctoral fund; Harbin Municipal Science and Technology Committee Harbin	This project was supported by the National Natural Science Foundation of China (NSFC, GrantNo.1272704 and 81402367), the Science&Technology Bureau of Harbin(No. 2014 RFQGJ and 2015RAXYJ063) and Research Fund for the Doctoral Program of Higher Education (SRFDP, No.20132307120012), Heilongjiang postdoctoral fund(No.LBH-Z12155) and Harbin Municipal Science and Technology Committee Harbin outstanding academic leaders plan(No. 2015RAXYJ063).The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.of	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Boutros R, 2004, BIOCHEM BIOPH RES CO, V325, P1115, DOI 10.1016/j.bbrc.2004.10.112; Boutros R, 2003, J MOL BIOL, V332, P675, DOI 10.1016/S0022-2836(03)00944-6; Byrne JA, 2005, INT J CANCER, V117, P1049, DOI 10.1002/ijc.21250; Byrne JA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-497; Dasgupta S, 2006, ORAL ONCOL, V42, P306, DOI 10.1016/j.oraloncology.2005.08.007; Eguchi D, 2013, SURGERY, V154, P573, DOI 10.1016/j.surg.2013.03.010; Fanayan S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-7; Gu YC, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1841; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Hauck CR, 2001, CANCER RES, V61, P7079; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hoang CD, 2004, CHEST, V125, P1843, DOI 10.1378/chest.125.5.1843; Zhang H, 2007, CANCER RES, V67, P8906, DOI 10.1158/0008-5472.CAN-06-4214; Hullinger TG, 1998, PROSTATE, V36, P14, DOI 10.1002/(SICI)1097-0045(19980615)36:1<14::AID-PROS3>3.0.CO;2-B; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kronborg O, 2004, SCAND J GASTROENTERO, V39, P846, DOI 10.1080/00365520410003182; Kumamoto T, 2016, INT J ONCOL, V49, P1870, DOI 10.3892/ijo.2016.3690; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lewis JD, 2007, MOL CANCER RES, V5, P133, DOI 10.1158/1541-7786.MCR-06-0245; Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Marazuela M, 2004, HISTOL HISTOPATHOL, V19, P925, DOI 10.14670/HH-19.925; O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Petrova DT, 2008, CLIN BIOCHEM, V41, P1224, DOI 10.1016/j.clinbiochem.2008.07.012; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Rohan S, 2006, CLIN CANCER RES, V12, P6937, DOI 10.1158/1078-0432.CCR-06-1268; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Schaner ME, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-26; Shehata M, 2008, CLIN CANCER RES, V14, P5050, DOI 10.1158/1078-0432.CCR-07-4994; Shehata Mona, 2008, Critical Reviews in Oncogenesis, V14, P33; Shridhar V, 2001, CANCER RES, V61, P5895; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Thomas DDH, 2001, J BIOL CHEM, V276, P28866, DOI 10.1074/jbc.M102214200; Ummanni R, 2008, FEBS J, V275, P5703, DOI 10.1111/j.1742-4658.2008.06697.x; Wang RX, 2007, CLIN CANCER RES, V13, P6040, DOI 10.1158/1078-0432.CCR-07-0640; Wang RX, 2004, CANCER RES, V64, P1589, DOI 10.1158/0008-5472.CAN-03-3331; Wang Y, 2016, ONCOTARGET, V7, P6323, DOI 10.18632/oncotarget.6319; Wilson SHD, 2001, GENOMICS, V76, P81, DOI 10.1006/geno.2001.6610; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Zhang L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-60; Zhao ZH, 2017, ONCOL RES, V25, P773, DOI 10.3727/096504016X14774889687280; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	59	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178515	10.1371/journal.pone.0178515	http://dx.doi.org/10.1371/journal.pone.0178515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562687	Green Submitted, gold, Green Published			2022-12-26	WOS:000402608700067
J	Raina, R; Chauvin, AM; Bunchman, T; Askenazi, D; Deep, A; Ensley, MJ; Krishnappa, V; Sethi, SK				Raina, Rupesh; Chauvin, Abigail M.; Bunchman, Timothy; Askenazi, David; Deep, Akash; Ensley, Michael J.; Krishnappa, Vinod; Sethi, Sidharth Kumar			Treatment of AKI in developing and developed countries: An international survey of pediatric dialysis modalities	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; CHILDREN; ULTRAFILTRATION; EPIDEMIOLOGY; HEMODIALYSIS; METAANALYSIS; MANAGEMENT; FAILURE	Hypothesis Acute kidney injury (AKI) is a common cause of morbidity and mortality worldwide, with a pediatric incidence ranging from 19.3% to 24.1%. Treatment of pediatric AKI is a source of debate in varying geographical regions. Currently CRRT is the treatment for pediatric AKI, but limitations due to cost and accessibility force use of adult equipment and other therapeutic options such as peritoneal dialysis (PD) and hemodialysis (HD). It was hypothesized that more cost-effective measures would likely be used in developing countries due to lesser resource availability. Methods A 26-question internet-based survey was distributed to 650 pediatric Nephrologists. There was a response rate of 34.3% (223 responses). The survey was distributed via pedneph and perrt email servers, inquiring about demographics, technology, resources, pediatric-specific supplies, and preference in renal replacement therapy (RRT) in pediatric AKI. The main method of analysis was to compare responses about treatments between nephrologists in developed countries and nephrologists in developing countries using difference-of-proportions tests. Results PD was available in all centers surveyed, while HD was available in 85.1% and 54.1% (p = 0.00), CRRT was available in 60% and 33.3% (p = 0.001), and SLED was available in 20% and 25% (p = 0.45) centers of developed and developing world respectively. In developing countries, 68.5% (p = 0.000) of physicians preferred PD to costlier therapies, while in developed countries it was found that physicians favored HD (72%, p = 0.00) or CRRT (24%, p = 0.041) in infants. Conclusions Lack of availability of resources, trained physicians and funds often preclude standards of care in developing countries, and there is much development needed in terms of meeting higher global standards for treating pediatric AKI patients. PD remains the main modality of choice for treatment of AKI in infants in developing world.	[Raina, Rupesh] Akron Childrens Hosp, Dept Pediat Nephrol, Akron, OH 44308 USA; [Raina, Rupesh; Krishnappa, Vinod] Cleveland Clin Akron Gen, Dept Nephrol, Akron, OH 44307 USA; [Chauvin, Abigail M.] Northeast Ohio Med Univ, Rootstown, OH USA; [Bunchman, Timothy] VCU Sch Med, Childrens Hosp Richmond, Richmond, VA USA; [Askenazi, David] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Deep, Akash] Kings Coll Hosp London, Denmark Hill, London, England; [Ensley, Michael J.] Kent State Univ, Dept Polit Sci, Kent, OH 44242 USA; [Sethi, Sidharth Kumar] Medanta, Kidney Inst, Gurgaon, Haryana, India	Akron Children's Hospital; Northeast Ohio Medical University (NEOMED); Virginia Commonwealth University; University of Alabama System; University of Alabama Birmingham; King's College Hospital NHS Foundation Trust; King's College Hospital; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Raina, R (corresponding author), Akron Childrens Hosp, Dept Pediat Nephrol, Akron, OH 44308 USA.; Raina, R (corresponding author), Cleveland Clin Akron Gen, Dept Nephrol, Akron, OH 44307 USA.	rraina@chmca.org	Krishnappa, Vinod/Y-8213-2018; raina, rupesh/AAE-6660-2020	Krishnappa, Vinod/0000-0002-1697-4526; 				Askenazi D, 2016, PEDIATR NEPHROL, V31, P853, DOI 10.1007/s00467-015-3259-3; Basu RK, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0016-6; BELSHA CW, 1995, PEDIATR NEPHROL, V9, P361, DOI 10.1007/BF02254215; Bunchman TE, 2008, SEMIN NEPHROL, V28, P488, DOI 10.1016/j.semnephrol.2008.05.009; Cerda J, 2008, NAT CLIN PRACT NEPHR, V4, P138, DOI 10.1038/ncpneph0722; Coulthard MG, 2014, PEDIATR NEPHROL, V29, P1873, DOI 10.1007/s00467-014-2923-3; COULTHARD MG, 1995, ARCH DIS CHILD-FETAL, V73, pF162, DOI 10.1136/fn.73.3.F162; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kidney Disease: Improving Global Outcomes (KDIGO) Group, 2012, KIDNEY INT S; McCulloch M SH, 2016, PEDIAT NEPHROLOGY, P2613; Momtaz HE, 2014, J CLIN NEONATOL, V3, P99, DOI 10.4103/2249-4847.134691; Peruzzi L, 2014, CASE REP NEPHROL DIA, V4, P113, DOI 10.1159/000363691; Ronco C, 2015, AM J KIDNEY DIS, V66, P206, DOI 10.1053/j.ajkd.2015.03.029; Ronco C, 2014, LANCET, V383, P1807, DOI 10.1016/S0140-6736(14)60799-6; Ronco C, 2012, PEDIATR NEPHROL, V27, P1203, DOI 10.1007/s00467-012-2179-8; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Sutherland SM, 2013, CLIN J AM SOC NEPHRO, V8, P1661, DOI 10.2215/CJN.00270113; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Vasudevan A, 2012, Indian J Nephrol, V22, P121, DOI 10.4103/0971-4065.97130; Warady BA, 2000, PEDIATR NEPHROL, V15, P11, DOI 10.1007/s004670000420	20	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178233	10.1371/journal.pone.0178233	http://dx.doi.org/10.1371/journal.pone.0178233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557999	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000035
J	Yuan, XY; Li, C; Sui, JY; Zhao, QQ; Zhang, X; Mou, NN; Zhao, HF; Samuel, OC; Zheng, N; Han, SH; Yu, SB; Sui, HJ				Yuan, Xiao-Ying; Li, Chan; Sui, Jia-Ying; Zhao, Qi-Qi; Zhang, Xiao; Mou, Na-Na; Zhao Huang-Fu; Samuel, Okoye Chukwuemeka; Zheng, Nan; Han, Seung-Ho; Yu, Sheng-Bo; Sui, Hong-Jin			The second terminations of the suboccipital muscles: An assistant pivot for the To Be Named Ligament	PLOS ONE			English	Article							SPINAL DURA-MATER; CONNECTIVE-TISSUE; MYODURAL BRIDGE; MINOR MUSCLE; HEADACHE; NUCHAE	In the last two decades, many studies have focused on the muscles and dense connective tissues located in the suboccipital region. Our study investigated the existence of the second terminations originating from the suboccipital muscles, and the relationship between the variable types of the To Be Named Ligament (TBNL). Anatomical dissection was performed on 35 head-neck specimens. The existence of the second terminations of the suboccipital muscles was confirmed and various types of the TBNL were observed in this study. The second terminations originated from multiple suboccipital muscles including the rectus capitis posterior minor (RCPmi), rectus capitis posterior major (RCPma) and obliquus capitis inferior (OCI) muscles, merged and terminated at the TBNL. The overall incidence of the second terminations of the suboccipital muscles was 34.29% and it varied among the various suboccipital muscle origins. 28.57% of the second terminations originated from the RCPma; 11.43% was from the RCPmi and 8.57% was from the OCI. Furthermore, there was a significant relationship between the existence of second terminations and the particular type of the TBNL. 95% of the arcuate type of the TBNL was accompanied with the second terminations which attached to their turning part, whereas only 10% of all the radiate type of the TBNL was accompanied with the second terminations. This study for the first time described the second terminations originating from multiple suboccipital muscles and demonstrated the relationship with the various types of the TBNL. We speculated that the second terminations maintain the arcuate TBNL and transfer tensile forces to the Myodural Bridge (MDB), thereby modulating the physiological functions of the MDB.	[Yuan, Xiao-Ying; Li, Chan; Samuel, Okoye Chukwuemeka; Zheng, Nan; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China; [Sui, Jia-Ying; Zhao, Qi-Qi; Mou, Na-Na; Zhao Huang-Fu] Dalian Med Univ, Clin Coll 2, Dalian, Peoples R China; [Zhao, Qi-Qi] Dalian Med Univ, Clin Coll 1, Dalian, Peoples R China; [Han, Seung-Ho] Chung Ang Univ, Coll Med, Dept Anat, Seoul, South Korea	Dalian Medical University; Dalian Medical University; Dalian Medical University; Chung Ang University; Chung Ang University Hospital	Yu, SB; Sui, HJ (corresponding author), Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China.	ysbdmu@hotmail.com; suihj@hotmail.com			Natural Science Foundation of China [NSFC31571234, NSFC31600972]; Liaoning Province Department of Education Funds [L2015156, L2016012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province Department of Education Funds	This work was supported by Natural Science Foundation of China (NSFC31571234 and NSFC31600972) and Liaoning Province Department of Education Funds (L2015156 and L2016012). URL: http://www.nsfc.gov.cn/, http://www.lnen.cn/.	Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; Fernandez-De-Las-Penas C, 2008, AM J PHYS MED REHAB, V87, P197, DOI 10.1097/PHM.0b013e3181619766; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; Kahkeshani K, 2012, CLIN ANAT, V25, P415, DOI 10.1002/ca.21261; Kontautas Egidijus, 2005, Medicina (Kaunas), V41, P802; Liu P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173630; McPartland J.M., 1999, J BODYW MOV THER, V3, P30, DOI [10.1016/S1360-8592(99)80040-0, DOI 10.1016/S1360-8592(99)80040-0]; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Tagil SM, 2005, CLIN ANAT, V18, P373, DOI 10.1002/ca.20106; Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31787; Yuan XY, 2016, CEPHALALGIA, V17; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451	18	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177120	10.1371/journal.pone.0177120	http://dx.doi.org/10.1371/journal.pone.0177120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28545087	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800009
J	Ooga, M; Wakayama, T				Ooga, Masatoshi; Wakayama, Teruhiko			FRAP analysis of chromatin looseness in mouse zygotes that allows full-term development	PLOS ONE			English	Article							PREIMPLANTATION DEVELOPMENT; TRANSCRIPTION; PLURIPOTENCY; INVOLVEMENT; EMBRYOS	Chromatin looseness, which can be analyzed by fluorescence recovery after photobleaching (FRAP) using eGFP-tagged core histone proteins, is an important index of the differentiation potential of blastomere cells and embryonic stem cells. Whether chromatin looseness is a reliable index of the developmental potential of embryos during ontogenesis is not known. As a necessary first step toward answering this question, we investigated whether FRAP-analyzed embryos are capable of normal preimplantation and full-term development. All tested concentrations (50, 100, and 250 ng/mu L) of microinjected eGFP-H2B mRNA were sufficient for detecting differences in chromatin looseness between male and female pronuclei. After FRAP analysis, most of the zygotes developed into blastocysts. Importantly, a considerable number of offspring developed from the FRAP analyzed zygotes (32/78; 41.0%) and grew into healthy adults. The offspring of zygotes injected with 250 ng/mu L of eGFP-H2B mRNA and bleached using 110 mu W laser power for 5 s were not genetically modified. Interestingly, bleaching using a 3-fold stronger laser intensity for a 6-fold longer time did not cause toxicity during preimplantation development, indicating that bleaching did not critically affect preimplantation development. Finally, we confirmed that similar results were obtained using two different types of confocal laser-scanning microscopes. This FRAP protocol would be useful for investigating the association between chromatin looseness and development.	[Ooga, Masatoshi; Wakayama, Teruhiko] Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan; [Ooga, Masatoshi; Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Ooga, M (corresponding author), Univ Yamanashi, Adv Biotechnol Ctr, Kofu, Yamanashi, Japan.; Ooga, M (corresponding author), Univ Yamanashi, Fac Life & Environm Sci, Kofu, Yamanashi, Japan.	mohga@yamanashi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities; Japan Society for the Promotion of Science [16H02593]; Asada Science Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H02593] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asada Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially funded by Ministry of Education, Culture, Sports, Science and Technology program for promoting the reform of national universities to M.O.; the Japan Society for the Promotion of Science (16H02593), Asada Science Foundation, and the Takeda Science Foundation to T.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Akiyama T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002279; Boskovic A, 2014, GENE DEV, V28, P1042, DOI 10.1101/gad.238881.114; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Burton A, 2010, BRIEF FUNCT GENOMICS, V9, P444, DOI 10.1093/bfgp/elq027; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Ooga M, 2016, EPIGENETICS-US, V11, P85, DOI 10.1080/15592294.2015.1136774; Ooga M, 2015, J REPROD DEVELOP, V61, P179, DOI 10.1262/jrd.2014-137; Ooga M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113258; QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147; Terashita Y, 2011, J REPROD DEVELOP, V57, P564, DOI 10.1262/jrd.11-015H; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	20	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178255	10.1371/journal.pone.0178255	http://dx.doi.org/10.1371/journal.pone.0178255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542635	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400074
J	Barbaret, C; Brosse, C; Rhondali, W; Ruer, M; Monsarrat, L; Michaud, P; Schott, AM; Delgado-Guay, M; Bruera, E; Sanchez, S; Filbet, M				Barbaret, Cecile; Brosse, Christelle; Rhondali, Wadih; Ruer, Murielle; Monsarrat, Lea; Michaud, Patrick; Schott, Anne Marie; Delgado-Guay, Marvin; Bruera, Eduardo; Sanchez, Stephane; Filbet, Marilene			Financial distress in patients with advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; CELL LUNG-CANCER; HEALTH-CARE; FACT-G; DEPRESSION; ASSOCIATIONS; SURVIVAL; TOXICITY; BURDEN; STRAIN	Purpose We examined the frequency and severity of financial distress (FD) and its association with quality of life (QOL) and symptoms among patients with advanced cancer in France. Design In this cross-sectional study, 143 patients with advanced cancer were enrolled. QOL was assessed using the Functional Assessment of Cancer General (FACT-G) and symptoms assessed using Edmonton Assessment System (ESAS) and Hospital Anxiety and Depression Scale (HADS). FD was assessed using a self-rated numeric scale from 0 to 10. Results Seventy-three (51%) patients reported having FD. Patients reported having FD were most likely to be younger (53.8 (16,7SD) versus 62 (10.5SD), p<0.001), single (33 (62%) versus 40 (44%), p = 0.03) and had a breast cancer (26 (36%), p = 0.024). Patients with FD had a lower FACT-G score (59 versus 70, p = 0.005). FD decreased physical (14 versus 18, p = 0.008), emotional (14 versus 16, p = 0.008), social wellbeing (17 versus 19, p = 0.04). Patients with FD had higher HADS-D (8 versus 6 p = 0.007) and HADS-A (9 versus 7, p = 0.009) scores. FD was linked to increased ESAS score (59 (18SD) versus 67 (18SD), p = 0.005) and spiritual suffering (22(29SD) versus 13(23SD), p = 0.045). Conclusion The high rate of patient-reported FD was unexpected in our studied population, as the French National Health Insurance covers specific cancer treatments. The FD was associated with a poorer quality of life. Having a systematic assessment, with a simple tool, should lead to future research on interventions that will increase patients' QOL.	[Barbaret, Cecile] CHU Grenoble, Dept Support & Palliat Care, Grenoble, France; [Brosse, Christelle] Inst Cancerol Loire, Dept Palliat Care, St Etienne, France; [Rhondali, Wadih; Michaud, Patrick; Filbet, Marilene] Ctr Hosp Lyon Sud, Dept Support & Palliat Care, Lyon, France; [Ruer, Murielle; Monsarrat, Lea; Schott, Anne Marie] Hosp Civils Lyon, Pole IMER, Lyon, France; [Delgado-Guay, Marvin; Bruera, Eduardo] MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX USA; [Sanchez, Stephane] Hop Champagne Sud, Dept Med Informat Evaluat & Performance, Troyes, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Cancerologie de la Loire; CHU Lyon; CHU Lyon; University of Texas System; UTMD Anderson Cancer Center	Filbet, M (corresponding author), Ctr Hosp Lyon Sud, Dept Support & Palliat Care, Lyon, France.	marilene.filbet@chu-lyon.fr	Sanchez, Stephane/ABD-3014-2020; Bruera, Eduardo/AAA-1550-2022; Schott, Anne-Marie/V-7580-2018	Sanchez, Stephane/0000-0002-0925-6948; Schott, Anne-Marie/0000-0003-3337-4474; Barbaret, Cecile/0000-0001-7144-7115				Arndt V, 2004, EUR J CANCER, V40, P673, DOI 10.1016/j.ejca.2003.12.007; Bailey W., 1998, PERSONAL FINANCES 2, V2, P198; Banthin JS, 2008, HEALTH AFFAIR, V27, P188, DOI 10.1377/hlthaff.27.1.188; Bernard DSM, 2011, J CLIN ONCOL, V29, P2821, DOI 10.1200/JCO.2010.33.0522; Bernard DM, 2006, MED CARE, V44, P210, DOI 10.1097/01.mlr.0000199729.25503.60; Bradshaw M, 2010, SOC SCI MED, V71, P196, DOI 10.1016/j.socscimed.2010.03.015; Bruera E, 1991, J Palliat Care, V7, P6; Conroy T, 2004, EUR J CANCER, V40, P2243, DOI 10.1016/j.ejca.2004.06.010; Costet N, 2005, QUAL LIFE RES, V14, P1427, DOI 10.1007/s11136-004-5531-z; Cunningham PJ, 2010, HEALTH AFFAIR, V29, P1037, DOI 10.1377/hlthaff.2009.0493; de Souza JA, 2014, CANCER-AM CANCER SOC, V120, P3245, DOI 10.1002/cncr.28814; Delgado-Guay M, 2015, ONCOLOGIST, V20, P1092, DOI 10.1634/theoncologist.2015-0026; Emanuel EJ, 2000, ANN INTERN MED, V21, P132; Gupta D, 2007, SUPPORT CARE CANCER, V15, P1051, DOI 10.1007/s00520-007-0214-2; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Joo S., 1998, PERSONAL FINANCES WO, V2, P162; Joo S, 2004, J FAM ECON ISS, V25, P162, DOI [10.1023/B:JEEI.0000016722.37994.9f, DOI 10.1023/B:JEEI.0000016722.37994.9F]; Kendall J, 2011, PSYCHO-ONCOLOGY, V20, P594, DOI 10.1002/pon.1907; Markman M, 2010, J ONCOL PRACT, V6, P69, DOI 10.1200/JOP.091074; Nekolaichuk C, 2008, PALLIATIVE MED, V22, P111, DOI 10.1177/0269216307087659; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pautex S., 2010, VERS VERSION FRANCOP; Perrone F, 2016, ANN ONCOL, V27, P2224, DOI 10.1093/annonc/mdw433; Pirl WF, 2008, PSYCHOSOMATICS, V49, P218, DOI 10.1176/appi.psy.49.3.218; Pirl WF, 2012, J CLIN ONCOL, V30, P1310, DOI 10.1200/JCO.2011.38.3166; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Selenko E, 2011, SOC SCI MED, V73, P1725, DOI 10.1016/j.socscimed.2011.09.022; Sharp L, 2013, PSYCHO-ONCOLOGY, V22, P745, DOI 10.1002/pon.3055; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Walson C, 1993, J FAM ECON ISS, V14, P193, DOI DOI 10.1007/BF01022177; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	34	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176470	10.1371/journal.pone.0176470	http://dx.doi.org/10.1371/journal.pone.0176470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545063	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400007
J	Kouba, M; Bartos, L; Tomasek, V; Popelkova, A; Stastny, K; Zarybnicka, M				Kouba, Marek; Bartos, Ludek; Tomasek, Vaclav; Popelkova, Alena; Stastny, Karel; Zarybnicka, Marketa			Home range size of Tengmalm's owl during breeding in Central Europe is determined by prey abundance	PLOS ONE			English	Article							NORTHERN SPOTTED OWLS; HABITAT-USE; REPRODUCTIVE SUCCESS; AEGOLIUS-FUNEREUS; TERRITORY SIZE; SEASONAL-VARIATION; FOOD ABUNDANCE; ESTIMATORS; DENSITY; AUTOCORRELATION	Animal home ranges typically characterized by their size, shape and a given time interval can be affected by many different biotic and abiotic factors. However, despite the fact that many studies have addressed home ranges, our knowledge of the factors influencing the size of area occupied by different animals is, in many cases, still quite poor, especially among raptors. Using radio-telemetry (VHF; 2.1 g tail-mounted tags) we studied movements of 20 Tengmalm's owl (Aegolius funereus) males during the breeding season in a mountain area of Central Europe (the Czech Republic, the Ore Mountains: 50 degrees 40' N, 13 degrees 35 degrees) between years 2006-2010, determined their average hunting home range size and explored what factors affected the size of home range utilised. The mean breeding home range size calculated according to 95% fixed kernel density estimator was 190.7-65.7 ha (+/- SD) with a median value of 187.1 ha. Home range size was affected by prey abundance, presence or absence of polygyny, the number of fledglings, and weather conditions. Home range size increased with decreasing prey abundance. Polygynously mated males had overall larger home range than those mated monogamously, and individuals with more fledged young possessed larger home range compared to those with fewer raised fledglings. Finally, we found that home ranges recorded during harsh weather (nights with strong wind speed and/or heavy rain) were smaller in size than those registered during better weather. Overall, the results provide novel insights into what factors may influence home range size and emphasize the prey abundance as a key factor for breeding dynamics in Tengmalm's owl.	[Kouba, Marek; Bartos, Ludek; Tomasek, Vaclav; Popelkova, Alena] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic; [Kouba, Marek; Tomasek, Vaclav; Popelkova, Alena; Stastny, Karel] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Tomasek, Vaclav] Nat Conservat Agcy Czech Republ, Prague, Czech Republic; [Zarybnicka, Marketa] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Appl Geoinformat & Spatial Planning, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic.; Kouba, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	marekkouba8@gmail.com	Kouba, Marek/A-1350-2019; Riegert, Jan/D-9070-2016; Riegert, Jan/AAQ-5136-2021; ZÃrybnickÃ, MarkÃ©ta/AAM-3181-2020	Kouba, Marek/0000-0003-2262-5733; Riegert, Jan/0000-0003-4195-1278; Riegert, Jan/0000-0003-4195-1278; Zarybnicka, Marketa/0000-0001-5883-0988	Czech University of Life Sciences Prague [CIGA CZU 20104201, IGA FZP 3116, IGA FZP 3127, IGA FZP 3138]; Ministry of Education, Youth and Sports of the Czech Republic [MSMT 1321/213205]; Ministry of Agriculture of the Czech Republic [MZERO 0716]; Ministry of Environment of the Czech Republic [GS LCR 5/2006]	Czech University of Life Sciences Prague; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Ministry of Environment of the Czech Republic	This work has been supported by grants from the Czech University of Life Sciences Prague (CIGA CZU 20104201 [VT], IGA FZP 3116, 3127, and 3138 [VT]), the Ministry of Education, Youth and Sports of the Czech Republic (MSMT 1321/213205 [LB]), the Ministry of Agriculture of the Czech Republic (MZERO 0716 [LB]), and the Ministry of Environment of the Czech Republic (GS LCR 5/2006 [KS]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; ANDERSSON M, 1981, THEOR POPUL BIOL, V19, P58, DOI 10.1016/0040-5809(81)90035-6; [Anonymous], 1861, ORIGIN SPECIES MEANS; BELTHOFF JR, 1993, J RAPTOR RES, V27, P8; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Breinnger DR, 2011, J HERPETOL, V45, P484; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; BYE FN, 1992, BEHAV ECOL, V3, P266, DOI 10.1093/beheco/3.3.266; CRAMP S, 1985, BIRDS W PALAEARCTIC, V4; Cushman SA, 2005, OIKOS, V109, P331, DOI 10.1111/j.0030-1299.2005.13538.x; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Eldegard K, 2012, J ORNITHOL, V153, P385, DOI 10.1007/s10336-011-0753-7; Eldegard K, 2010, BEHAV ECOL SOCIOBIOL, V64, P815, DOI 10.1007/s00265-009-0898-z; Eldegard K, 2009, P ROY SOC B-BIOL SCI, V276, P1713, DOI 10.1098/rspb.2008.1775; Ferguson-Lees J, 2001, RAPTORS WORLD; Forsman ED, 2005, J RAPTOR RES, V39, P365; Grzywaczewski G, 2009, ARDEA, V97, P541, DOI 10.5253/078.097.0420; Hakkarainen H, 2003, OIKOS, V100, P162, DOI 10.1034/j.1600-0706.2003.11906.x; Hansteen TL, 1997, J WILDLIFE MANAGE, V61, P280, DOI 10.2307/3802583; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; HAYNE DW, 1949, J MAMMAL, V30, P1, DOI 10.2307/1375189; Hinam HL, 2008, BIOL CONSERV, V141, P524, DOI 10.1016/j.biocon.2007.11.011; HIXON MA, 1980, AM NAT, V115, P510, DOI 10.1086/283577; HORNFELDT B, 1988, AUK, V105, P783; Hubbs AH, 1998, CAN J ZOOL, V76, P592, DOI 10.1139/cjz-76-3-592; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jacobsen BV, 1987, USDA SERV GEN TECH R, V142, P189; Jerina K, 2012, J MAMMAL, V93, P1139, DOI 10.1644/11-MAMM-A-136.1; Kenward RE., 2000, MANUAL WILDLIFE RADI; Klaus S., 1975, Zoologische Jb (Syst), V102, P485; Konig C, 2008, WLS OF THE WORLD; Korpimaki E, 2012, BOREAL OWL: ECOLOGY, BEHAVIOUR AND CONSERVATION OF A FOREST-DWELLING PREDATOR, P1, DOI 10.1017/CBO9780511844164; Korpimaki E, 1981, ACTA U OULUENSIS 118, V13, P1; Kouba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121641; Kouba M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095594; Kouba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067034; KRUUK H, 1982, J ZOOL, V196, P31; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Leary AW, 1998, WILSON BULL, V110, P198; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mace G. M., 1984, ECOLOGY ANIMAL MOVEM, P32; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Newton I., 1986, SPARROWHAWK; NORBERG R A, 1970, Ornis Scandinavica, V1, P51, DOI 10.2307/3676334; Pfeiffer T, 2015, J ORNITHOL, V156, P963, DOI 10.1007/s10336-015-1230-5; Powell R.A., 1997, ECOLOGY BEHAV N AM B; Powell RA, 2000, METH C CONS, P65; REDPATH SM, 1995, J ANIM ECOL, V64, P652, DOI 10.2307/5807; Rivers JW, 2014, BIRD CONSERV INT, V24, P492, DOI 10.1017/S0959270913000592; Rodgers A.R., 2011, HRT HOME RANGE TOOLS; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Ross S, 2012, J MAMMAL, V93, P1292, DOI 10.1644/11-MAMM-A-060.1; Santangeli A, 2012, ANIM BEHAV, V83, P1115, DOI 10.1016/j.anbehav.2012.02.002; Schilling JW, 2013, J RAPTOR RES, V47, P1, DOI 10.3356/JRR-11-76.1; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Scillitani L, 2012, HYSTRIX, V23, P19, DOI 10.4404/hystrix-23.2-4622; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Silverman B.W., 1986, DENSITY ESTIMATION S; Sokolov V, 2014, POLAR BIOL, V37, P1621, DOI 10.1007/s00300-014-1548-0; SONERUD G A, 1986, Fauna Norvegica Series C Cinclus, V9, P100; Sorbi Serge, 2003, Alauda, V71, P215; TAITT MJ, 1982, J ANIM ECOL, V51, P681, DOI 10.2307/3991; Tao J., 2002, MIXED MODEL ANAL USI; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; TURNER FB, 1969, ECOLOGY, V50, P1076, DOI 10.2307/1936898; Welsch R, 1980, REGRESSION DIAGNOSTI; White G.C., 1990, ANAL WILDLIFE RADIO; Wiktander U, 2001, BIOL CONSERV, V100, P387, DOI 10.1016/S0006-3207(01)00045-3; Withey John C., 2001, P43, DOI 10.1016/B978-012497781-5/50004-9; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; ZABEL CJ, 1995, CAN J ZOOL, V73, P433, DOI 10.1139/z95-049; Zarybnicka M, 2015, J ORNITHOL, V156, P457, DOI 10.1007/s10336-014-1145-6; Zarybnicka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036932; Zarybnicka M, 2009, ACTA ORNITHOL, V44, P81, DOI 10.3161/000164509X464911	81	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177314	10.1371/journal.pone.0177314	http://dx.doi.org/10.1371/journal.pone.0177314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545112	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400036
J	Tomillo, PS; Fonseca, L; Paladino, FV; Spotila, JR; Oro, D				Tomillo, Pilar Santidrian; Fonseca, Luis; Paladino, Frank V.; Spotila, James R.; Oro, Daniel			Are thermal barriers "higher" in deep sea turtle nests?	PLOS ONE			English	Article							LEATHERBACK TURTLES; CHELONIA-MYDAS; PLAYA-GRANDE; GREEN TURTLE; COSTA-RICA; LEPIDOCHELYS-OLIVACEA; CLIMATE-CHANGE; TEMPERATURE; TOLERANCE; ECOLOGY	Thermal tolerances are affected by the range of temperatures that species encounter in their habitat. Daniel Janzen hypothesized in his "Why mountain passes are higher in the tropics" that temperature gradients were effective barriers to animal movements where climatic uniformity was high. Sea turtles bury their eggs providing some thermal stability that varies with depth. We assessed the relationship between thermal uniformity and thermal tolerance in nests of three species of sea turtles. We considered that barriers were "high" when small thermal changes had comparatively large effects and "low" when the effects were small. Mean temperature was lower and fluctuated less in species that dig deeper nests. Thermal barriers were comparatively "higher" in leatherback turtle (Dermochelys coriacea) nests, which were the deepest, as embryo mortality increased at lower "high" temperatures than in olive ridley (Lepidochelys olivacea) and green turtle (Chelonia mydas) nests. Sea turtles have temperature-dependent sex determination (TSD) and embryo mortality increased as temperature approached the upper end of the transitional range of temperatures (TRT) that produces both sexes (temperature producing 100% female offspring) in leatherback and olive ridley turtles. As thermal barriers are "higher" in some species than in others, the effects of climate warming on embryo mortality is likely to vary among sea turtles. Population resilience to climate warming may also depend on the balance between temperatures that produce female offspring and those that reduce embryo survival.	[Tomillo, Pilar Santidrian; Oro, Daniel] UIB, CSIC, IMEDEA, Inst Mediterrani Estudis Avancats,Populat Ecol Gr, Miquel Marques 21, Mallorca, Spain; [Tomillo, Pilar Santidrian; Paladino, Frank V.; Spotila, James R.] Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Costa Rica; [Fonseca, Luis] Biocenosis Marina, San Jose, Costa Rica; [Paladino, Frank V.] Indiana Purdue Univ, Dept Biol, Ft Wayne, IN USA; [Spotila, James R.] Drexel Univ, Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Purdue University System; Indiana University Purdue University Fort Wayne; Drexel University	Tomillo, PS (corresponding author), UIB, CSIC, IMEDEA, Inst Mediterrani Estudis Avancats,Populat Ecol Gr, Miquel Marques 21, Mallorca, Spain.; Tomillo, PS (corresponding author), Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Costa Rica.	bibi@leatherback.org	Oro, Daniel/H-4208-2012; Santidrián Tomillo, Pilar/N-5406-2014	Oro, Daniel/0000-0003-4782-3007; Santidrián Tomillo, Pilar/0000-0002-6895-7218	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme [PIIF-GA-2012-329798]; Leatherback Trust; Earthwatch Institute; Betz Chair Endowment of Environmental Science at Drexel University; Schrey Chair of Biology at Indiana UniversityPurdue University Fort Wayne	Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme(European Commission); Leatherback Trust; Earthwatch Institute; Betz Chair Endowment of Environmental Science at Drexel University; Schrey Chair of Biology at Indiana UniversityPurdue University Fort Wayne	Funding was provided by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (grant number PIIF-GA-2012-329798), the Leatherback Trust (www.leatherback.org), the Earthwatch Institute (www.earthwatch.org), the Betz Chair Endowment of Environmental Science at Drexel University and the Schrey Chair of Biology at Indiana UniversityPurdue University Fort Wayne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank field assistants and volunteers that have participated on the data collection at Nancite, Cabuyal and Playa Grande. Funding was provided by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme (grant number PIIF-GA-2012-329798), the Leatherback Trust (www.leatherback.org), the Earthwatch Institute (www.earthwatch.org), the Betz Chair Endowment of Environmental Science at Drexel University and the Schrey Chair of Biology at Indiana UniversityPurdue University Fort Wayne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Roldan Valverde for facilitating the use of dataloggers at Nancite and the Goldring-Gund Marine Station for accommodation during the seasons at Playa Grande. We thank Nathan Robinson for reading early versions of this manuscript. We especially thank the Guanacaste and Tempisque Conservation Areas for providing scientific permits and in particular, Roger Blanco and Roberto Zuniga for facilitating the process. We acknowledge use of the MAPTOOL program for the graphics in this paper. MAPTOOL is a product of seaturtle.org (information is available at www.seaturtle.org). We thank Lucy Hawkes, Claire Tanner, Jacques-Olivier Laloe and anonymous reviewers for insightful comments that have helped improved our manuscript.	Ackerman R.A., 2004, P15; Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Bell BA, 2004, BIOL CONSERV, V115, P131, DOI 10.1016/S0006-3207(03)00102-2; Binckley CA, 1998, COPEIA, P291; Binckley Christopher A., 2015, P84; Birchard G.F., 2004, P103; BJORNDAL KA, 1985, BIOL CONSERV, V34, P353, DOI 10.1016/0006-3207(85)90040-0; Broderick AC, 2006, GLOBAL ECOL BIOGEOGR, V15, P21, DOI 10.1111/j.1466-822x.2006.00195.x; Broderick Annette C., 1996, Zoology in the Middle East, V13, P27; CHEN TH, 1995, MAR BIOL, V124, P9, DOI 10.1007/BF00349141; Chevalier J, 1999, ANN SCI NAT ZOOL, V20, P147, DOI 10.1016/S0003-4339(00)88882-6; Clusella Trullas S, 2007, J ZOOL, V272, P367, DOI 10.1111/j.1469-7998.2006.00277.x; CORNELIUS S E, 1976, Brenesia, V8, P1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dornfeld TC, 2015, MAR BIOL, V162, P123, DOI 10.1007/s00227-014-2583-7; Drake DL, 2002, J THERM BIOL, V27, P71, DOI 10.1016/S0306-4565(01)00017-1; Eckert Karen L., 2015, P63; Fernandez-Chacon A, 2011, GLOBAL CHANGE BIOL, V17, P3075, DOI 10.1111/j.1365-2486.2011.02469.x; Fish MR, 2005, CONSERV BIOL, V19, P482, DOI 10.1111/j.1523-1739.2005.00146.x; Fonseca LG, 2009, CHELONIAN CONSERV BI, V8, P19, DOI 10.2744/CCB-0739.1; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Girondot M, 1999, EVOL ECOL RES, V1, P479; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2007, P ROY SOC LOND B BIO, V284; Heppell SS, 2002, BIOL SEA TURTLES, VII, P275; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; Howard R, 2015, J EXP BIOL, V218, P3330, DOI 10.1242/jeb.118778; Howard R, 2014, ENDANGER SPECIES RES, V26, P75, DOI 10.3354/esr00636; Hulin V, 2009, OECOLOGIA, V160, P493, DOI 10.1007/s00442-009-1313-1; IBM Corp. Released, 2015, IBM SPSS STAT WINDOW; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; Madeira D, 2012, J SEA RES, V70, P32, DOI 10.1016/j.seares.2012.03.002; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; MCCOY CJ, 1983, J HERPETOL, V17, P404, DOI 10.2307/1563594; Miller Jeffrey D., 1997, P51; Mitchell Nicola J, 2006, Front Zool, V3, P9, DOI 10.1186/1742-9994-3-9; Nordmoe ED, 2004, ANIM BEHAV, V68, P387, DOI 10.1016/j.anbehav.2003.07.015; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Perez TM, 2016, SCIENCE, V351, P1392, DOI 10.1126/science.aaf3343; Poloczanska ES, 2009, ADV MAR BIOL, V56, P151, DOI 10.1016/S0065-2881(09)56002-6; Price ER, 2004, ENDANGER SPECIES RES, V1, P41; Pritchard P. C. H, 1997, BIOL SEA TURTLES, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Saba VS, 2012, NATURE CLIMATE CHANG; Santidrian Tomillo P, 2015, BIOL CONSERVATION LE, P74; Santidrian Tomillo P, 2015, GLOBAL CHANGE BIOL, V21, P2980; Tomillo PS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16789; Tomillo PS, 2015, MAR ECOL-EVOL PERSP, V36, P506, DOI 10.1111/maec.12159; Tomillo PS, 2014, BIOL CONSERV, V176, P71, DOI 10.1016/j.biocon.2014.05.011; SPOTILA JR, 1987, HERPETOLOGICA, V43, P74; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Stocker T.F., 2013, PHYS SCI BASIS; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Weber SB, 2012, P ROY SOC B-BIOL SCI, V279, P1077, DOI 10.1098/rspb.2011.1238; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	63	18	18	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177256	10.1371/journal.pone.0177256	http://dx.doi.org/10.1371/journal.pone.0177256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545092	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400032
J	Jia, LM; Parker, CN; Parker, TJ; Kinnear, EM; Derhy, PH; Alvarado, AM; Huygens, F; Lazzarini, PA				Jia, Limin; Parker, Christina N.; Parker, Tony J.; Kinnear, Ewan M.; Derhy, Patrick H.; Alvarado, Ann M.; Huygens, Flavia; Lazzarini, Peter A.		Diabetic Foot Working Grp; Queensland Statewide Diabet Clinic	Incidence and risk factors for developing infection in patients presenting with uninfected diabetic foot ulcers	PLOS ONE			English	Article							LOWER-EXTREMITY AMPUTATION; DISEASES SOCIETY; MANAGEMENT; PREVALENCE; INDIVIDUALS; ASSOCIATION; VALIDATION; DIAGNOSIS; ISCHEMIA; DURATION	Objective There is a paucity of research on patients presenting with uninfected diabetic foot ulcers (DFU) that go on to develop infection. We aimed to investigate the incidence and risk factors for developing infection in a large regional cohort of patients presenting with uninfected DFUs. Methods We performed a secondary analysis of data collected from a validated prospective state-wide clinical diabetic foot database in Queensland (Australia). Patients presenting for their first visit with an uninfected DFU to a Diabetic Foot Service in one of thirteen Queensland regions between January 2012 and December 2013 were included. Socio-demographic, medical history, foot disease history, DFU characteristics and treatment variables were captured at the first visit. Patients were followed until their DFU healed, or if their DFU did not heal for 12-months, to determine if they developed a foot infection in that period. Results Overall, 853 patients were included; mean(standard deviation) age 62.9(12.8) years, 68.0% male, 90.9% type 2 diabetes, 13.6% indigenous Australians. Foot infection developed in 342 patients for an overall incidence of 40.1%; 32.4% incidence in DFUs healed <3 months, 55.9% in DFUs healed between 3-12 months (p<0.05). Independent risk factors (Odds Ratio (95% confidence interval)) for developing infection were: DFUs healed between 3-12 months (2.3 (1.6-3.3)), deep DFUs (2.2 (1.2-3.9)), peripheral neuropathy (1.8 (1.1-2.9)), previous DFU history (1.7 (1.2-2.4)), foot deformity (1.4 (1.0-2.0)), female gender (1.5 (1.1-2.1)) and years of age (0.98 (0.97-0.99)) (all p<0.05). Conclusions A considerable proportion of patients presenting with an uninfected DFU will develop an infection prior to healing. To prevent infection clinicians treating patients with uninfected DFUs should be particularly vigilant with those presenting with deep DFUs, previous DFU history, peripheral neuropathy, foot deformity, younger age, female gender and DFUs that have not healed by 3 months after presentation.	[Jia, Limin; Parker, Christina N.; Parker, Tony J.; Alvarado, Ann M.; Huygens, Flavia; Lazzarini, Peter A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Jia, Limin] Ningxia Peoples Hosp, Dept Endocrinol, Yinchuan, Ningxia Hui Aut, Peoples R China; [Parker, Christina N.] Queensland Univ Technol, Sch Nursing, Brisbane, Qld, Australia; [Parker, Tony J.; Alvarado, Ann M.; Huygens, Flavia] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Kinnear, Ewan M.; Lazzarini, Peter A.] Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia; [Derhy, Patrick H.] Queensland Hlth, Clin Access & Redesign Unit, Brisbane, Qld, Australia; [Lazzarini, Peter A.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland Health; Queensland University of Technology (QUT)	Lazzarini, PA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia.	Peter.Lazzarini@health.qld.gov.au	Parker, Christina Narelle/V-3844-2019	Parker, Christina/0000-0003-3834-205X; Lazzarini, Peter/0000-0002-8235-7964; Huygens, Flavia/0000-0002-2737-2264				Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; Australian Bureau of Statistics, 2014, ALL STAT; Australian Bureau of Statistics (ABS), 2010, AUSTR STAND GEOGR CL; Australian Bureau of Statistics (ABS), 2006, INF PAP INTR SOC IND; Baba M, 2015, J DIABETES COMPLICAT, V29, P356, DOI 10.1016/j.jdiacomp.2015.01.008; Bakker K, 2012, DIABETES-METAB RES, V28, P225, DOI 10.1002/dmrr.2253; Commons RJ, 2015, DIABETES RES CLIN PR, V110, P147, DOI 10.1016/j.diabres.2015.09.016; Earl BJ, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/s13047-014-0041-x; Gershater MA, 2009, DIABETOLOGIA, V52, P398, DOI 10.1007/s00125-008-1226-2; Hobizal KB, 2012, DIABET FOOT ANKLE, V3, DOI 10.3402/dfa.v3i0.18409; Holman N, 2015, DIABETIC MED, V32, P78, DOI 10.1111/dme.12564; Holman N, 2012, DIABETOLOGIA, V55, P1919, DOI 10.1007/s00125-012-2468-6; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ince P, 2007, DIABETIC MED, V24, P977, DOI 10.1111/j.1464-5491.2007.02189.x; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Lavery LA, 2007, CLIN INFECT DIS, V44, P562, DOI 10.1086/511036; Lavery LA, 2006, DIABETES CARE, V29, P1288, DOI 10.2337/dc05-2425; Lavery LA, 2009, DIABETES RES CLIN PR, V83, P347, DOI 10.1016/j.diabres.2008.11.030; Lazzarini PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008544; Lazzarini PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130609; Lazzarini PA, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-7; Lazzarini PA, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-1; Lazzarini PA, 2012, AUST HEALTH REV, V36, P8, DOI 10.1071/AH10978; Lipsky Benjamin A, 2007, Int Wound J, V4, P30, DOI 10.1111/j.1742-481X.2006.00274.x; Lipsky BA, 2016, DIABETES-METAB RES, V32, P45, DOI 10.1002/dmrr.2699; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis460, 10.1093/cid/cis346]; Lipsky BA, 2011, DIABETES CARE, V34, P1695, DOI 10.2337/dc11-0331; Malone M, 2016, DIABETES ME IN PRESS; Margolis DJ, 2011, DIABETES CARE, V34, P2363, DOI 10.2337/dc11-0807; Margolis DJ, 2002, DIABETES CARE, V25, P1835, DOI 10.2337/diacare.25.10.1835; National Health & Medical Research Council (NHMRC) Guidelines, 2011, NAT EV BAS GUID PREV; Oyibo SO, 2001, DIABETIC MED, V18, P133, DOI 10.1046/j.1464-5491.2001.00422.x; Pallant J., 2010, SPSS SURVIVAL MANUAL, DOI DOI 10.1108/jacpr.2011.55003baa.002; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Peters EJG, 2005, J DIABETES COMPLICAT, V19, P107, DOI 10.1016/j.jdiacomp.2004.06.002; Pickwell K, 2015, DIABETES CARE, V38, P852, DOI 10.2337/dc14-1598; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Skrepnek GH, 2017, DIABETES CA IN PRESS; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Yotsu RR, 2014, J DIABETES COMPLICAT, V28, P528, DOI 10.1016/j.jdiacomp.2014.03.013	42	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177916	10.1371/journal.pone.0177916	http://dx.doi.org/10.1371/journal.pone.0177916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545120	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700095
J	Kitano, T; Miyagawa, M; Nishio, S; Moteki, H; Oda, K; Ohyama, K; Miyazaki, H; Hidaka, H; Nakamura, K; Murata, T; Matsuoka, R; Ohta, Y; Nishiyama, N; Kumakawa, K; Furutate, S; Iwasaki, S; Yamada, T; Ohta, Y; Uehara, N; Noguchi, Y; Usami, S				Kitano, Tomohiro; Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Oda, Kiyoshi; Ohyama, Kenji; Miyazaki, Hiromitsu; Hidaka, Hiroshi; Nakamura, Ken-ichi; Murata, Takaaki; Matsuoka, Rina; Ohta, Yoko; Nishiyama, Nobuhiro; Kumakawa, Kozo; Furutate, Sakiko; Iwasaki, Satoshi; Yamada, Takechiyo; Ohta, Yumi; Uehara, Natsumi; Noguchi, Yoshihiro; Usami, Shin-ichi			POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss	PLOS ONE			English	Article							DEAFNESS; FAMILY; DFNA15; LOCALIZATION; IMPAIRMENT; EXPRESSION; ETIOLOGY; DISEASE; BRN-3C	A variant in a transcription factor gene, POU4F3, is responsible for autosomal dominant nonsyndromic hereditary hearing loss, DFNA15. To date, 14 variants, including a whole deletion of POU4F3, have been reported to cause HL in various ethnic groups. In the present study, genetic screening for POU4F3 variants was carried out for a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA15 in the Japanese population. Massively parallel DNA sequencing of 68 target candidate genes was utilized in 2,549 unrelated Japanese HL patients (probands) to identify genomic variations responsible for HL. The detailed clinical features in patients with POU4F3 variants were collected from medical charts and analyzed. Novel 12 POU4F3 likely pathogenic variants (six missense variants, three frameshift variants, and three nonsense variants) were successfully identified in 15 probands (2.5%) among 602 families exhibiting autosomal dominant HL, whereas no variants were detected in the other 1,947 probands with autosomal recessive or inheritance pattern unknown HL. To obtain the audiovestibular configuration of the patients harboring POU4F3 variants, we collected audiograms and vestibular symptoms of the probands and their affected family members. Audiovestibular phenotypes in a total of 24 individuals from the 15 families possessing variants were characterized by progressive HL, with a large variation in the onset age and severity with or without vestibular symptoms observed. Pure-tone audiograms indicated the most prevalent configuration as mid-frequency HL type followed by high-frequency HL type, with asymmetry observed in approximately 20% of affected individuals. Analysis of the relationship between age and pure-tone average suggested that individuals with truncating variants showed earlier onset and slower progression of HL than did those with non-truncating variants. The present study showed that variants in POU4F3 were a common cause of autosomal dominant HL.	[Kitano, Tomohiro; Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Usami, Shin-ichi] Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan; [Miyagawa, Maiko; Nishio, Shin-ya; Moteki, Hideaki; Noguchi, Yoshihiro; Usami, Shin-ichi] Shinshu Univ, Dept Hearing Implant Sci, Sch Med, Matsumoto, Nagano, Japan; [Oda, Kiyoshi; Ohyama, Kenji] Tohoku Rosai Hosp, Dept Otorhinolaryngol, Sendai, Miyagi, Japan; [Miyazaki, Hiromitsu; Hidaka, Hiroshi] Tohoku Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Sendai, Miyagi, Japan; [Nakamura, Ken-ichi] Jichi Med Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shimotsuke, Japan; [Murata, Takaaki] Gunma Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Maebashi, Gunma, Japan; [Matsuoka, Rina] Juntendo Univ, Dept Otorhinolaryngol, Fac Med, Tokyo, Japan; [Ohta, Yoko; Nishiyama, Nobuhiro] Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan; [Kumakawa, Kozo] Toranomon Gen Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Furutate, Sakiko; Iwasaki, Satoshi] Int Univ Hlth & Welf, Mita Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Yamada, Takechiyo] Univ Fukui, Dept Otorhinolaryngol Head & Neck Surg, Fukui, Japan; [Ohta, Yumi] Osaka Univ, Dept Otorhinolaryngol Head & Neck Surg, Grad Sch Med, Osaka, Japan; [Uehara, Natsumi] Kobe Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Kobe, Hyogo, Japan	Shinshu University; Shinshu University; Tohoku University; Jichi Medical University; Gunma University; Juntendo University; Tokyo Medical University; Toranomon Hospital; International University of Health & Welfare; University of Fukui; Osaka University; Kobe University	Usami, S (corresponding author), Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan.; Usami, S (corresponding author), Shinshu Univ, Dept Hearing Implant Sci, Sch Med, Matsumoto, Nagano, Japan.	usami@shinshu-u.ac.jp	Hidala, Hiroshi/N-2957-2016	Hidala, Hiroshi/0000-0001-5214-3159; Nishio, Shin-ya/0000-0001-6640-2297; Kitano, Tomohiro/0000-0003-2317-8672	Ministry of Health, Labour and Welfare of Japan [H26-Nanchito (Nan)-Ippan-032]; Japan Agency for Medical Research and Development (AMED) [16ek0109114h0002]; Ministry of Education, Science and Culture of Japan [15H02565]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labour Sciences Research Grant for Research on rare and intractable diseases (H26-Nanchito (Nan)-Ippan-032) from the Ministry of Health, Labour and Welfare of Japan (S.U.), Practical Research Project for Rare / Intractable Disease from Japan Agency for Medical Research and Development (AMED) (S.U.) (16ek0109114h0002), and by a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan (S.U.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Cai XZ, 2017, J HUM GENET, V62, P317, DOI 10.1038/jhg.2016.102; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Freitas EL, 2014, EUR J MED GENET, V57, P125, DOI 10.1016/j.ejmg.2014.02.006; Frejo L, 2016, J NEUROL, V263, pS45, DOI 10.1007/s00415-015-7988-9; Frydman M, 2000, ARCH OTOLARYNGOL, V126, P633, DOI 10.1001/archotol.126.5.633; HE L, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/9890827; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kim H.-S., 2013, J NANOMATER, V2013, P4, DOI [10.1155/2013/679758, DOI 10.12826/18333575.2013.0016.KIM]; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee HK, 2010, BIOCHEM BIOPH RES CO, V396, P626, DOI 10.1016/j.bbrc.2010.04.132; Miyagawa M, 2016, OTOL NEUROTOL, V37, pE126, DOI 10.1097/MAO.0000000000000936; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Moteki H, 2012, J HUM GENET, V57, P587, DOI 10.1038/jhg.2012.73; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Naito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063231; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Pauw RJ, 2008, ARCH OTOLARYNGOL, V134, P294, DOI 10.1001/archotol.134.3.294; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Van Camp G, HEREDITARY HEARING L; van Drunen FJW, 2009, AUDIOL NEURO-OTOL, V14, P303, DOI 10.1159/000212109; Verstreken M, 2001, OTOL NEUROTOL, V22, P874, DOI 10.1097/00129492-200111000-00028; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei QJ, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0311-1; Weiss S, 2003, MOL CELL BIOL, V23, P7957, DOI 10.1128/MCB.23.22.7957-7964.2003; Xia JH, 2002, J HUM GENET, V47, P635, DOI 10.1007/s100380200098; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; ZHANG C, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/1512831	42	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177636	10.1371/journal.pone.0177636	http://dx.doi.org/10.1371/journal.pone.0177636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545070	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700059
J	Nakatsu, Y; Mori, K; Matsunaga, Y; Yamamotoya, T; Ueda, K; Inoue, Y; Mitsuzaki-Miyoshi, K; Sakoda, H; Fujishiro, M; Yamaguchi, S; Kushiyama, A; Ono, H; Ishihara, H; Asano, T				Nakatsu, Yusuke; Mori, Keiichi; Matsunaga, Yasuka; Yamamotoya, Takeshi; Ueda, Koji; Inoue, Yuki; Mitsuzaki-Miyoshi, Keiko; Sakoda, Hideyuki; Fujishiro, Midori; Yamaguchi, Suguru; Kushiyama, Akifumi; Ono, Hiraku; Ishihara, Hisamitsu; Asano, Tomoichiro			The prolyl isomerase Pin1 increases beta-cell proliferation and enhances insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL ACTIVITY; ISLET HYPERPLASIA; CYCLIN D1; RESISTANCE; GROWTH; COMPENSATION; PATHOGENESIS; PROTEIN; OBESITY	The prolyl isomerase Pin1 binds to the phosphorylated Ser/Thr-Pro motif of target proteins and enhances their cis-trans conversion. This report is the first to show that Pin1 expression in pancreatic beta cells is markedly elevated by high-fat diet feeding and in ob/ob mice. To elucidate the role of Pin1 in pancreatic beta cells, we generated beta-cell-specific Pin1 KO (beta Pin1 KO) mice. These mutant mice showed exacerbation of glucose intolerance but had normal insulin sensitivity. We identified two independent factors underlying impaired insulin secretion in the beta Pin1 KO mice. Pin1 enhanced pancreatic beta-cell proliferation, as indicated by a reduced beta-cell mass in beta Pin1 KO mice compared with control mice. Moreover, a diet high in fat and sucrose failed to increase pancreatic beta-cell growth in the beta Pin1 KO mice, an observation to which up-regulation of the cell cycle protein cyclin D appeared to contribute. The other role of Pin1 was to activate the insulin-secretory step: Pin1 KO beta cells showed impairments in glucose- and KCl-induced elevation of the intracellular Ca2+ concentration and insulin secretion. We also identified salt-inducible kinase 2 (SIK2) as a Pin1-binding protein that affected the regulation of Ca2+ influx and found Pin1 to enhance SIK2 kinase activity, resulting in a decrease in p35 protein, a negative regulator of Ca2+ influx. Taken together, our observations demonstrate critical roles of Pin1 in pancreatic beta cells and that Pin1 both promotes beta-cell proliferation and activates insulin secretion.	[Nakatsu, Yusuke; Mori, Keiichi; Matsunaga, Yasuka; Yamamotoya, Takeshi; Ueda, Koji; Inoue, Yuki; Mitsuzaki-Miyoshi, Keiko; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan; [Sakoda, Hideyuki] Miyazaki Univ, Fac Med, Dept Internal Med, Div Neurol Respirol Endocrinol & Metab, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Fujishiro, Midori; Yamaguchi, Suguru; Ishihara, Hisamitsu] Nihon Univ, Sch Med, Div Diabet & Metab Dis, Tokyo 1738610, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chuo Ku, Tokyo 1030002, Japan; [Ono, Hiraku] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chuo Ku, 1-8-1 Inohara, Chiba, Chiba 2608670, Japan	Hiroshima University; University of Miyazaki; Nihon University; Asahi Life Foundation; Chiba University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348551, Japan.	tasano@hiroshima-u.ac.jp	祐介, 中津/AAP-8396-2020; Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276	Ministry of Education, Science, and Culture, Japan [3702]; Salt Science Research Foundation; Grants-in-Aid for Scientific Research [16J09463] Funding Source: KAKEN	Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C) (to Y. N.), a Grant-in-Aid for Scientific Research on Innovative Areas (area 3702) (to T. A.), and a Grant-in-Aid for Scientific Research (B) (to T. A.) from the Ministry of Education, Science, and Culture, Japan. This work was also supported by a Grant-in-Aid from The Salt Science Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Carboneau BA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12863; Cengiz M, 2014, DIGESTION, V90, P35, DOI 10.1159/000365415; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Hirose H, 1996, J BIOL CHEM, V271, P5633, DOI 10.1074/jbc.271.10.5633; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lv L, 2013, J CELL MOL MED, V17, P989, DOI 10.1111/jcmm.12082; Min SH, 2016, ARCH PHARM RES, V39, P1609, DOI 10.1007/s12272-016-0821-x; Nakatsu Y, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091495; Nakatsu Y, 2015, J BIOL CHEM, V290, P24255, DOI 10.1074/jbc.M115.658559; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Paneni F, 2015, EUR HEART J, V36, P817, DOI 10.1093/eurheartj/ehu179; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yoon WJ, 2013, J CELL PHYSIOL, V228, P2377, DOI 10.1002/jcp.24403; Zhang XB, 2005, DIABETES, V54, P712, DOI 10.2337/diabetes.54.3.712	36	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11886	11895		10.1074/jbc.M117.780726	http://dx.doi.org/10.1074/jbc.M117.780726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566287	Green Published, hybrid			2022-12-26	WOS:000405485600025
J	Masarone, M; Rosato, V; Aglitti, A; Bucci, T; Caruso, R; Salvatore, T; Sasso, FC; Tripodi, MF; Persico, M				Masarone, Mario; Rosato, Valerio; Aglitti, Andrea; Bucci, Tommaso; Caruso, Rosa; Salvatore, Teresa; Sasso, Ferdinando Carlo; Tripodi, Marie Francoise; Persico, Marcello			Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; HEPATOCELLULAR-CARCINOMA; CARDIOVASCULAR-DISEASE; PREVALENCE; RISK; ASSOCIATION; DIAGNOSIS; PATTERN; NAFLD	Recent studies report a prevalence of non-alcoholic fatty liver disease (NAFLD) of between 70% and 80% in patients with metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM). Nevertheless, it is not possible to differentiate between simple steatosis and nonalcoholic steatohepatitis (NASH) with non-invasive tests. The aim of this study was to differentiate between simple steatosis and NASH by liver biopsy in patients with hypertransaminasemia and MS or T2DM. Two hundred and fifteen patients with increased ALT levels and MS, and 136 patients at their first diagnosis of T2DM regardless of ALT values were consecutively admitted to a tertiary hepatology center between January 2004 and November 2014. Exclusion criteria were other causes of liver disease/ALT increase. Each patient underwent a clinical, laboratory and ultrasound evaluation, and a liver biopsy. Gender distribution, age, and body mass index were similar in the two groups of patients, whereas cholesterol levels, glycemia and blood pressure were significantly different between the two groups. The prevalence of NAFLD was 94.82% in MS patients and 100% in T2DM patients. NASH was present in 58.52% of MS patients and 96.82% of T2DM. Consequently, this study reveals that, by using liver biopsy, almost all patients with T2DM or MS have NAFLD, which in patients with T2DM means NASH. Importantly, it suggests that NASH may be one of the early complications of T2DM due to its pathophysiological correlation with insulin resistance.	[Masarone, Mario; Aglitti, Andrea; Bucci, Tommaso; Caruso, Rosa; Tripodi, Marie Francoise; Persico, Marcello] Univ Salerno, Internal Med & Hepatol Unit, Salerno, Italy; [Rosato, Valerio; Salvatore, Teresa; Sasso, Ferdinando Carlo] Univ Campania L Vanvitelli, Internal Med & Hepatol Dept, Naples, Italy	University of Salerno; Universita della Campania Vanvitelli	Persico, M (corresponding author), Univ Salerno, Internal Med & Hepatol Unit, Salerno, Italy.	mpersico@unisa.it	Rosato, Valerio/ABB-9874-2020; persico, marcello/AAB-3562-2019; Bucci, Tommaso/ABA-4162-2021; Sasso, Ferdinando Carlo/AAE-5665-2019; Aglitti, Andrea/Y-1705-2019; Sasso, Ferdinando Carlo/AAA-8423-2020; Masarone, Mario/H-8633-2017	Rosato, Valerio/0000-0002-3584-2414; Bucci, Tommaso/0000-0003-2895-6234; Sasso, Ferdinando Carlo/0000-0002-9142-7848; Aglitti, Andrea/0000-0001-9742-0172; salvatore, teresa/0000-0002-6532-7122; Masarone, Mario/0000-0003-0550-8201; Persico, Marcello/0000-0002-1399-6498				Abu Bakar MH, 2015, DIABETES-METAB RES, V31, P453, DOI 10.1002/dmrr.2601; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bedossa P, 2016, DIGEST DIS SCI, V61, P1348, DOI 10.1007/s10620-016-4062-0; Bril F, 2016, ENDOCRIN METAB CLIN, V45, P765, DOI 10.1016/j.ecl.2016.06.005; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DeLeve LD, 2007, SEMIN LIVER DIS, V27, P390, DOI 10.1055/s-2007-991515; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Gaidos JKJ, 2008, LIVER INT, V28, P650, DOI 10.1111/j.1478-3231.2008.01693.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lallukka S, 2016, BEST PRACT RES CL EN, V30, P385, DOI [10.1016/j.beem.2016.06.006, 10.101]; Lonardo A, 2009, AM J GASTROENTEROL, V104, P1851, DOI 10.1038/ajg.2009.233; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Palmentieri B, 2006, DIGEST LIVER DIS, V38, P485, DOI 10.1016/j.dld.2006.03.021; Perumpail RB, 2015, DIGEST DIS SCI, V60, P3142, DOI 10.1007/s10620-015-3821-7; Pocha C, 2015, SEMIN LIVER DIS, V35, P304, DOI 10.1055/s-0035-1562949; Shashaj B, 2016, ACTA DIABETOL, V53, P251, DOI 10.1007/s00592-015-0782-4; Targher G, 2016, J HEPATOL; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Tzirogiannis KN, 2006, DIGEST DIS SCI, V51, P1998, DOI 10.1007/s10620-006-9242-x; Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863; Valenti L, 2016, LIVER INT; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229; Yilmaz Y, 2012, ALIMENT PHARM THER, V36, P815, DOI 10.1111/apt.12046; Yki-Jarvinen H, 2016, DIABETOLOGIA, V59, P1104, DOI 10.1007/s00125-016-3944-1; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	33	61	65	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178473	10.1371/journal.pone.0178473	http://dx.doi.org/10.1371/journal.pone.0178473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570615	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800058
J	Robin, P; Le Roux, PY; Lacut, K; Planquette, B; Prevot-Bitot, N; Lavigne, C; Pastre, J; Merah, A; Le Gal, G; Salaun, PY				Robin, Philippe; Le Roux, Pierre-Yves; Lacut, Karine; Planquette, Benjamin; Prevot-Bitot, Nathalie; Lavigne, Christian; Pastre, Jean; Merah, Adel; Le Gal, Gregoire; Salaun, Pierre-Yves			Performance of F-18-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism	PLOS ONE			English	Article							OCCULT MALIGNANCY; FDG-PET/CT; THROMBOSIS	Purpose Small series have suggested that Fluorodesoxyglucose Positron-Emission-Tomography with Computed-Tomography (FDG-PET/CT) is feasible to screen for cancer in patients with unprovoked venous thromboembolism (VTE), but without validation in a large population. The aim was to assess diagnostic accuracy indices of FDG-PET/CT for occult cancer diagnosis in patients with unprovoked VTE. Materials and methods We analysed patients from the FDG-PET/CT group of a randomized trial that compared a screening strategy based on FDG-PET/CT with a limited screening strategy for occult malignancy detection in patients with unprovoked VTE. FDG-PET/CT was interpreted as positive for cancer, as negative or as equivocal. Patients were considered as having cancer on the basis of screening results, or of any test performed during a two-years follow-up period. We ran two sets of analysis, considering patients with equivocal FDG-PET/CT as positive, then as negative for malignancy. Results Between March 2009, and August 2012, 172 patients were included. FDG-PET/CT was interpreted as positive for malignancy in 10 patients (5.8%), as equivocal in 23 patients (13.4%) and as negative in 139 patients (80.8%). Malignancy was diagnosed in 7/10 (70.0%), 2/23 (8.7%) and 1/139 (0.7%) patients, respectively. Grouping positive and equivocal results, sensitivity and specificity were 90% (95% CI 60% to 98%) and 85% (95% CI 79% to 90%), respectively. Grouping negative and equivocal results, sensitivity and specificity were 70% (95% CI 40% to 89%) and 98% (95% CI 95% to 99%), respectively. Conclusion FDG-PET/CT showed good accuracy for occult cancer screening in patients with unprovoked VTE. Remaining challenges include the need to define specific interpretation criteria in this dedicated population.	[Robin, Philippe; Le Roux, Pierre-Yves; Salaun, Pierre-Yves] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, IFR 148, EA 3878,GETBO,Serv Med Nucl, Brest, France; [Lacut, Karine] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, CIC INSERM 1412, Dept Med Interne & Pneumol,EA 3878, Brest, France; [Planquette, Benjamin; Pastre, Jean] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,INSERM UMR S 1140,Serv Pneumo, Paris, France; [Prevot-Bitot, Nathalie] Univ Jean Monnet, Ctr Hosp Univ St Etienne, Inserm U1059, Serv Med Nucl, St Etienne, France; [Lavigne, Christian] Ctr Hosp Univ Angers, Dept Med Interne & Malad Vasc, Angers, France; [Merah, Adel] Ctr Hosp Univ St Etienne, Inserm CIC 1408, Serv Med Vasc & Therapeut, St Etienne, France; [Le Gal, Gregoire] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Ottawa, ON, Canada	CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Ottawa; Ottawa Hospital Research Institute	Salaun, PY (corresponding author), Univ Bretagne Occidentale, Ctr Hosp Univ Brest, IFR 148, EA 3878,GETBO,Serv Med Nucl, Brest, France.	pierre-yves.salaun@chu-brest.fr	Robin, Philippe/X-6290-2019; SALAUN, Pierre-Yves/X-6701-2019; PLANQUETTE, Benjamin/AAL-7166-2021; PREVOT, Nathalie/AAG-7682-2021	Robin, Philippe/0000-0001-5521-9454; SALAUN, Pierre-Yves/0000-0002-3899-2135; PREVOT, Nathalie/0000-0001-8442-2515; Lacut, Karine/0000-0002-4849-0454; Le Roux, Pierre-Yves/0000-0002-8534-8203	"Programme Hospitalier de Recherche Clinique" (French Department of Health); University Hospital of Brest	"Programme Hospitalier de Recherche Clinique" (French Department of Health); University Hospital of Brest	The study was supported by grants from the "Programme Hospitalier de Recherche Clinique" (French Department of Health), and the sponsor was the University Hospital of Brest.	Alfonso A, 2013, INT J CANCER, V133, P2157, DOI 10.1002/ijc.28229; Bastounis EA, 1996, J INTERN MED, V239, P153, DOI 10.1046/j.1365-2796.1996.426000.x; Bomanji JB, 2001, LANCET ONCOL, V2, P157, DOI 10.1016/S1470-2045(00)00257-6; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Chauchard M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000110; Delgado-Bolton RC, 2003, J NUCL MED, V44, P1301; GOLDBERG RJ, 1987, ARCH INTERN MED, V147, P251, DOI 10.1001/archinte.147.2.251; GRIFFIN MR, 1987, ARCH INTERN MED, V147, P1907, DOI 10.1001/archinte.147.11.1907; Jara-Palomares L, 2010, THROMB RES, V125, P29, DOI 10.1016/j.thromres.2009.04.012; MONREAL M, 1991, CANCER, V67, P541, DOI 10.1002/1097-0142(19910115)67:2<541::AID-CNCR2820670237>3.0.CO;2-J; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Robin P, 2016, LANCET ONCOL, V17, P193, DOI 10.1016/S1470-2045(15)00480-5; Rondina MT, 2012, THROMB RES, V129, P22, DOI 10.1016/j.thromres.2011.06.025; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x	18	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178849	10.1371/journal.pone.0178849	http://dx.doi.org/10.1371/journal.pone.0178849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570648	Green Submitted, gold, Green Published			2022-12-26	WOS:000402611800126
J	Zeigler, DF; Roque, R; Clegg, CH				Zeigler, David F.; Roque, Richard; Clegg, Christopher H.			Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides	PLOS ONE			English	Article							NONHUMAN-PRIMATES; EPITOPE DENSITY; HAPTEN DENSITY; IMMUNOGENICITY; ANTIBODY; CONJUGATE; MICE; AFFINITY; RATS; EFFICACY	Clinical outcomes of anti-nicotine vaccines may be improved through enhancements in serum antibody affinity and concentration. Two strategies were explored to improve vaccine efficacy in outbred mice: the use of enantiopure haptens and formulation of a bivalent vaccine. Vaccines incorporating natural (-) nicotine haptens improved relative antibody affinities > 10-fold over (+) haptens, stimulated a two-fold boost in nicotine serum binding capacity, and following injection with 3 cigarette equivalents of nicotine, prevented a larger proportion of nicotine (> 85%) from reaching the brain. The activity of a bivalent vaccine containing (-) 3'AmNic and (-) 1'SNic haptens was then compared to dose-matched monovalent groups. It was confirmed that antisera generated by these structurally distinct haptens have minimal cross-reactivity and stimulate different B cell populations. Equivalent antibody affinities were detected between the three groups, but the bivalent group showed two-fold higher titers and an additive increase in nicotine serum binding capacity as compared to the monovalent groups. Mice immunized with the bivalent formulation also performed better in a nicotine challenge experiment, and prevented > 85% of a nicotine dose equivalent to 12 cigarettes from reaching the brain. Overall, enantiopure conjugate vaccines appear to improve serum antibody affinity, while multivalent formulations increase total antibody concentration. These findings may help improve the performance of future clinical candidate vaccines.	[Zeigler, David F.; Roque, Richard; Clegg, Christopher H.] TRIA Biosci Corp, Seattle, WA 98102 USA		Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA 98102 USA.	cclegg@triabio.com			National Institute on Drug Abuse of the National Institutes of Health [UH2DA041162]; NATIONAL INSTITUTE ON DRUG ABUSE [UH2DA041162] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number UH2DA041162. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder provided support in the form of salaries for authors DFZ, RPR, and CHC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; [Anonymous], 2010, B WHO, V88, P171; [Anonymous], 2014, HLTH CONS SMOK D 50; Cerny T, 2005, RECENT RESULTS CANC, V166, P167; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Cornish KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082557; de Villiers SHL, 2013, VACCINE, V31, P6185, DOI 10.1016/j.vaccine.2013.10.051; Desai RI, 2015, NEUROPSYCHOPHARMACOL, V40, P2207, DOI 10.1038/npp.2015.64; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Fiore M C, 2000, Respir Care, V45, P1196; Fraser CC, 2014, VACCINE, V32, P2896, DOI 10.1016/j.vaccine.2014.02.024; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Hamblett KJ, 2004, CLIN CANCER RES, V10, P7063, DOI 10.1158/1078-0432.CCR-04-0789; Hartmann-Boyce J, 2012, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD007072.PUB2]; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Hu K, 2012, BIOSCI TRENDS, V6, P52, DOI 10.5582/bst.2012.v6.2.52; Hu Y, 2016, BIOMATERIALS, V106, P228, DOI 10.1016/j.biomaterials.2016.08.028; Hu Y, 2014, HUM VACC IMMUNOTHER, V10, P64, DOI 10.4161/hv.26635; Jacob NT, 2016, J MED CHEM, V59, P2523, DOI 10.1021/acs.jmedchem.5b01676; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; KLAUS GGB, 1974, CELL IMMUNOL, V14, P226, DOI 10.1016/0008-8749(74)90208-1; Kosten TA, 2013, PROG NEURO-PSYCHOPH, V45, P223, DOI 10.1016/j.pnpbp.2013.05.012; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Li QQ, 2011, J NEUROCHEM, V119, P1271, DOI 10.1111/j.1471-4159.2011.07502.x; Liu WL, 2005, EUR J IMMUNOL, V35, P505, DOI 10.1002/eji.200425749; Lockner JW, 2015, J MED CHEM, V58, P1005, DOI 10.1021/jm501625j; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; McCluskie MJ, 2015, INT IMMUNOPHARMACOL, V29, P663, DOI 10.1016/j.intimp.2015.09.012; McCluskie MJ, 2015, INT IMMUNOPHARMACOL, V25, P518, DOI 10.1016/j.intimp.2015.02.030; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; Miller KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114366; Miller ML, 2013, BIOL PSYCHIAT, V73, P721, DOI 10.1016/j.biopsych.2012.09.010; Pedersen MK, 2006, J IMMUNOL METHODS, V311, P198, DOI 10.1016/j.jim.2006.02.008; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pichichero ME, 2013, HUM VACC IMMUNOTHER, V9, P2505, DOI 10.4161/hv.26109; Pravetoni M, 2012, J PHARMACOL EXP THER, V341, P225, DOI 10.1124/jpet.111.189506; Pravetoni M, 2012, BIOCHEM PHARMACOL, V83, P543, DOI 10.1016/j.bcp.2011.11.004; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Pryde DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076557; Raupach Tobias, 2012, Drugs, V72, pe1, DOI 10.2165/11599900-000000000-00000; Rosenberg JB, 2012, HUM GENE THER, V23, P451, DOI 10.1089/hum.2011.178; Ruedi-Bettschen D, 2013, VACCINE, V31, P4596, DOI 10.1016/j.vaccine.2013.07.038; Shen XYY, 2013, DRUG ALCOHOL DEPEN, V129, P41, DOI 10.1016/j.drugalcdep.2012.09.007; STEVENS FJ, 1987, MOL IMMUNOL, V24, P1055, DOI 10.1016/0161-5890(87)90073-3; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; Wang CY, 2005, VACCINE, V23, P2049, DOI 10.1016/j.vaccine.2005.01.007; Wee S, 2012, NEUROPSYCHOPHARMACOL, V37, P1083, DOI 10.1038/npp.2011.200; World Health Organization, 2005, WHY TOB IS PUBL HLTH; Zhao ZM, 2017, NANOMED-NANOTECHNOL, V13, P443, DOI 10.1016/j.nano.2016.07.015	51	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178835	10.1371/journal.pone.0178835	http://dx.doi.org/10.1371/journal.pone.0178835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570609	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800125
J	Turingan, RS; Kaplun, L; Krautz-Peterson, G; Norsworthy, S; Zolotova, A; Joseph, SJ; Read, TD; Dean, D; Tan, E; Selden, RF				Turingan, Rosemary S.; Kaplun, Ludmila; Krautz-Peterson, Greice; Norsworthy, Sarah; Zolotova, Anna; Joseph, Sandeep J.; Read, Timothy D.; Dean, Deborah; Tan, Eugene; Selden, Richard F.			Rapid detection and strain typing of Chlamydia trachomatis using a highly multiplexed microfluidic PCR assay	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; RECOMBINATION; INFECTION; POINT; EVOLUTION; SELECTION; REGIONS	Nucleic acid amplification tests (NAATs) are recommended by the CDC for detection of Chlamydia trachomatis (Ct) urogenital infections. Current commercial NAATs require technical expertise and sophisticated laboratory infrastructure, are time-consuming and expensive, and do not differentiate the lymphogranuloma venereum (LGV) strains that require a longer duration of treatment than non-LGV strains. The multiplexed microfluidic PCR-based assay presented in this work simultaneously interrogates 13 loci to detect Ct and identify LGV and non-LGV strain-types. Based on amplified fragment length polymorphisms, the assay differentiates LGV, ocular, urogenital, and proctocolitis clades, and also serovars L-1, L-2, and L-3 within the LGV group. The assay was evaluated in a blinded fashion using 95 clinical swabs, with 76 previously reported as urogenital Ct-positive samples and typed by ompA genotyping and/or Multi-Locus Sequence Typing. Results of the 13-plex assay showed that 51 samples fell within urogenital clade 2 or 4, 24 samples showed both clade 2 and 4 signatures, indicating possible mixed infection, gene rearrangement, or inter-clade recombination, and one sample was a noninvasive trachoma biovar (either a clade 3 or 4). The remaining 19 blinded samples were correctly identified as LGV clade 1 (3), ocular clade 3 (4), or as negatives (12). To date, no NAAT assay can provide a point-of-care applicable turnaround time for Ct detection while identifying clinically significant Ct strain types to inform appropriate treatment. Coupled with rapid DNA processing of clinical swabs (approximately 60 minutes from swab-in to result-out), the assay has significant potential as a rapid POC diagnostic for Ct infections.	[Turingan, Rosemary S.; Kaplun, Ludmila; Krautz-Peterson, Greice; Norsworthy, Sarah; Zolotova, Anna; Tan, Eugene; Selden, Richard F.] NetBio, Waltham, MA 02451 USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Joseph, Sandeep J.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Dean, Deborah] Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA USA; [Dean, Deborah] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Dean, Deborah] Univ Calif Berkeley & Univ Calif San Francisco Jo, Berkeley, CA USA	Emory University; Emory University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Selden, RF (corresponding author), NetBio, Waltham, MA 02451 USA.	richard.selden@netbio.com		Joseph, Sandeep/0000-0003-0697-2487; Read, Timothy/0000-0001-8966-9680; Norsworthy, Sarah/0000-0001-8149-5129	NetBio	NetBio	NetBio provided support in the form of salaries for authors RST, LK, GKP, SN, AZ, ET, and RFS, but did not have any additional role in the study design, data collection and analysis, decisiontopublish, or preparation of the manuscrip.	Antimicrobe Schachter J., 2010, CHLAMYDIA TRACHOMATI; Batteiger BE, 2014, EMERG INFECT DIS, V20, P1841, DOI 10.3201/2011.140604; Brunelle BW, 2006, INFECT IMMUN, V74, P578, DOI 10.1128/IAI.74.1.578-585.2006; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; CDC, 2015, SEX TRANSM DIS TREAT; CDC, 2010, CHLAM INF AD AD; Ceovic R, 2015, INFECT DRUG RESIST, V8, P39, DOI [10.2147/IDR.S57540, 10.2147/DR.557540]; Dal Conte I, 2014, PANMINERVA MED, V56, P73; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; DEAN D, 1992, J INFECT DIS, V166, P383, DOI 10.1093/infdis/166.2.383; Dean D., 2010, DUANES FDN CLIN OPHT, P678; Dean D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051685; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Grover R, 2017, INT J LEGAL MED, P1; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Huang W, 2013, SEX TRANSM INFECT, V89, P108, DOI 10.1136/sextrans-2011-050355; Huppert J, 2010, POINT CARE, V9, P36, DOI 10.1097/POC.0b013e3181d2d8cc; Jalal H, 2011, J MED MICROBIOL, V60, P881, DOI 10.1099/jmm.0.028076-0; Joseph SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099290; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Joseph SJ, 2012, NAT GENET, V44, P364, DOI 10.1038/ng.2225; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; Madden T, 2002, NCBI HDB; Mardh PA, 2004, CURR OPIN INFECT DIS, V17, P49, DOI 10.1097/00001432-200402000-00010; Martin-Iguacel R, 2010, EUR J CLIN MICROBIOL, V29, P917, DOI 10.1007/s10096-010-0959-2; Morre SA, 1998, J CLIN MICROBIOL, V36, P345; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nunes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013171; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Somboonna N, 2008, EMERG INFECT DIS, V14, P445, DOI 10.3201/eid1403.071071; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Tan Eugene, 2013, Investig Genet, V4, P16, DOI 10.1186/2041-2223-4-16; Turingan RS, 2016, INVESTIG GENET, V7, DOI 10.1186/s13323-016-0033-7; Turingan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056093; Unemo M, 2007, Euro Surveill, V12, pE5; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Vodstrcil LA, 2015, J INFECT DIS, V211, P1628, DOI 10.1093/infdis/jiu670; Walker J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-35	44	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178653	10.1371/journal.pone.0178653	http://dx.doi.org/10.1371/journal.pone.0178653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562672	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700081
J	Zha, LS; He, LC; Xie, WD; Cheng, J; Li, T; Mohsen, MO; Lei, F; Storni, F; Bachmann, M; Chen, HQ; Zhang, Y				Zha, Lisha; He, Lichun; Xie, Weidong; Cheng, Jin; Li, Tong; Mohsen, Mona O.; Lei, Fan; Storni, Federico; Bachmann, Martin; Chen, Hongquan; Zhang, Yaou			Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; SIGNALING PATHWAY; MELANOMA GROWTH; IN-VIVO; CANCER; ANGIOGENESIS; EXPRESSION; RECEPTOR; CELLS; RNAI	Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human tumor such as colon cancer, lung cancer, gastric cancer and melanoma. It plays significant roles in angiogenesis, metastasis, differentiation and cell growth. The expression of PTN in the adult is limited to the hippocampus in an activity-dependent manner, making it a very attractive target for cancer therapy. RNA interference (RNAi) offers great potential as a new powerful therapeutic strategy based on its highly specific and efficient silencing of a target gene. However, efficient delivery of small interfering RNA (siRNA) in vivo remains a significant hurdle for its successful therapeutic application. In this study, we first identified, on a cell-based experiment, applying a 1:1 mixture of two PTN specific siRNA engenders a higher silencing efficiency on both mRNA and protein level than using any of them discretely at the same dose. As a consequence, slower melanoma cells growth was also observed for using two specific siRNA combinatorially. To establish a robust way for siRNA delivery in vivo and further investigate how silence of PTN affects tumor growth, we tested three different methods to deliver siRNA in vivo: first non-targeted in-vivo delivery of siRNA via jetPEI; second lung targeted delivery of siRNA via microbubble coated jetPEI; third tumor cell targeted delivery of siRNA via transferrin-polyethylenimine (If-PEI). As a result, we found that all three in-vivo siRNAs delivery methods led to an evident inhibition of melanoma growth in non-immune deficiency C57BL/6 mice without a measureable change of ALT and AST activities. Both targeted delivery methods showed more significant curative effect than jetPEI. The lung targeted delivery by microbubble coated jetPEI revealed a comparable therapeutic effect with Tf-PEI, indicating its potential application for target delivery of siRNA in vivo.	[Zha, Lisha; Cheng, Jin; Li, Tong; Chen, Hongquan] Anhui Agr Univ, Sch Anim Sci & Technol, Hefei, Anhui, Peoples R China; [He, Lichun; Xie, Weidong; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Key Lab Healthy Sci & Technol, Shenzhen, Peoples R China; [Mohsen, Mona O.] Univ Oxford, Jenner Inst, Oxford, England; [Zha, Lisha; Lei, Fan] Tsinghua Univ, Sch Med, Sch Life Sci, Lab Pharmaceut Sci, Beijing, Peoples R China; [Storni, Federico; Bachmann, Martin] Univ Bern, Inselspital, Dept Immunol, Salihaus 2, Bern, Switzerland; [Zhang, Yaou] Tsinghua Univ, Open FIESTA Ctr, Shenzhen, Peoples R China; [He, Lichun] Univ Basel, Biozent, Klingelbergstr 70, Basel, Switzerland	Anhui Agricultural University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Oxford; Jenner Institute; Tsinghua University; University of Bern; University Hospital of Bern; Tsinghua University; University of Basel	Chen, HQ (corresponding author), Anhui Agr Univ, Sch Anim Sci & Technol, Hefei, Anhui, Peoples R China.	chqchq@ahau.edu.cn; zhangyo@sz.tsinghua.edu.cn	Chen, Hongquan/AAJ-8602-2020; He, Lichun/AAQ-9058-2021; Storni, Federico/CAH-3483-2022	Chen, Hongquan/0000-0002-8426-0672; He, Lichun/0000-0002-0772-0452	National Natural Foundation Support, China [31172180]; Basic Research Fund of Shenzhen [JCYJ20150724173156330]	National Natural Foundation Support, China; Basic Research Fund of Shenzhen	This research was supported by grants from National Natural Foundation Support, China, No.31172180 and Basic Research Fund of Shenzhen [JCYJ20150724173156330], which received by Prof. Yaou Zhang. Prof. Yaou Zhang was participating in the study design and data analysis.	Aguirre Palma LM, 2014, CRIT REV ONCOL HEMAT, V93, P1; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Conhaim RL, 1997, MICROCIRCULATION-LON, V4, P51, DOI 10.3109/10739689709148317; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Dhanaliwala AH, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-014-9914-9; Du Zi-Yan, 2015, Asian Pac J Cancer Prev, V16, P1421; FEINSTEIN SB, 1984, J AM COLL CARDIOL, V3, P14, DOI 10.1016/S0735-1097(84)80424-6; FEINSTEIN SB, 1984, J AM COLL CARDIOL, V4, P595, DOI 10.1016/S0735-1097(84)80107-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hardy KM, 2010, CANCER RES, P70; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Huang NN, 2015, CANCER BIOL THER, V16, P941, DOI 10.1080/15384047.2015.1040963; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Lamprou M, 2014, INJURY, V45, P1816, DOI 10.1016/j.injury.2014.10.013; Lauri SE, 1996, NEUROREPORT, V7, P1670, DOI 10.1097/00001756-199607080-00029; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Omata D, 2015, ADV GENET, P25; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Rao DD, 2009, CANCER GENE THER, V16, P807, DOI 10.1038/cgt.2009.53; Sahagun D, 2014, FRONT CELL NEUROSCI, V8, P443; Satyamoorthy K, 2000, PIGM CELL RES, V13, P87, DOI 10.1034/j.1600-0749.13.s8.16.x; Sethi G, 2015, MOL CARCINOGEN, V54, P1772, DOI 10.1002/mc.22249; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Sirsi S, 2010, ULTRASOUND MED BIOL, V36, P935, DOI 10.1016/j.ultrasmedbio.2010.03.015; Skyba DM, 1996, J AM COLL CARDIOL, V28, P1292, DOI 10.1016/S0735-1097(96)00328-2; Tan HY, 2008, OPT COMMUN, V281, P3013, DOI 10.1016/j.optcom.2008.01.012; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Weng TT, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-80; Xie YR, 2016, J CONTROL RELEASE, V229, P120, DOI 10.1016/j.jconrel.2016.03.029; Yamaya Y, 2002, ULTRASOUND MED BIOL, V28, P1005, DOI 10.1016/S0301-5629(02)00549-5; Yi C, 2011, FEBS LETT, V585, P3303, DOI 10.1016/j.febslet.2011.09.015; Zhang K, 2012, ONCOGENE, V31, P4609, DOI 10.1038/onc.2011.606	36	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177964	10.1371/journal.pone.0177964	http://dx.doi.org/10.1371/journal.pone.0177964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562667	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700036
J	Sheng, ZH; Lv, YS; Li, W; Luo, RJ; Wei, XJ; Xie, LH; Jiao, GA; Shao, GN; Wang, JL; Tang, SQ; Hu, PS				Sheng, Zhonghua; Lv, Yusong; Li, Wei; Luo, Rongjian; Wei, Xiangjin; Xie, Lihong; Jiao, Guiai; Shao, Gaoneng; Wang, Jianlong; Tang, Shaoqing; Hu, Peisong			Yellow-Leaf 1 encodes a magnesium-protoporphyrin IX monomethyl ester cyclase, involved in chlorophyll biosynthesis in rice (Oryza sativa L.)	PLOS ONE			English	Article							CHLOROPLAST DEVELOPMENT; PHOTOSYSTEM-I; A-OXYGENASE; ARABIDOPSIS CHL27; DEFICIENT MUTANT; GENE-EXPRESSION; NUCLEAR GENE; PROTEIN; SUBUNIT; PHOTOSYNTHESIS	Magnesium-protoporphyrin IX monomethyl ester cyclase (MPEC) catalyzes the conversion of MPME to divinyl protochlorophyllide (DVpchlide). This is an essential enzyme during chlorophyll (Chl) biosynthesis but details of its function in rice are still lacking. Here, we identified a novel rice mutant yellow-leaf 1 (y1-1), which showed decreased Chl accumulation, abnormal chloroplast ultrastructure and attenuated photosynthetic activity. Map-based cloning and over-expression analysis suggested that YL-1 encodes a subunit of MPEC. The YL-1 protein localizes in chloroplasts, and it is mainly expressed in green tissues, with greatest abundance in leaves and young panicles. Results of qRT-PCR showed that Chl biosynthesis upstream genes were highly expressed in the y1-1 mutant, while downstream genes were compromised, indicating that YL-1 plays a pivotal role in the Chl biosynthesis. Furthermore, the expression levels of photosynthesis and chloroplast development genes were also affected. RNA-seq results futher proved that numerous membrane-associated genes, including many plastid membrane-associated genes, have altered expression pattern in the y1-1 mutant, implying that YL-1 is required for plastid membrane stability. Thus, our study confirms a putative MPME cyclase as a novel key enzyme essential for Chl biosynthesis and chloroplast membrane stability in rice.	[Sheng, Zhonghua; Lv, Yusong; Luo, Rongjian; Wei, Xiangjin; Xie, Lihong; Jiao, Guiai; Shao, Gaoneng; Tang, Shaoqing; Hu, Peisong] China Natl Rice Res Inst, Minist Agr, State Key Lab Rice Biol, Key Lab Rice Biol & Breeding, Hangzhou, Zhejiang, Peoples R China; [Lv, Yusong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Li, Wei; Wang, Jianlong] Hunan Agr Univ, Agr Coll, Changsha, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Hunan Agricultural University	Tang, SQ; Hu, PS (corresponding author), China Natl Rice Res Inst, Minist Agr, State Key Lab Rice Biol, Key Lab Rice Biol & Breeding, Hangzhou, Zhejiang, Peoples R China.	sqtang@126.com; peisonghu@126.com	Luo, Rongjian/R-2491-2019	Luo, Rongjian/0000-0002-8588-4022; Wei, Xiangjin/0000-0002-1190-5222	Zhejiang Natural Science Foundation [LY14C130012, LY14C130009]; Zhejiang Science and technology projects [2015C32045]; China Natural Science Foundation [31501285]; Central level, non-profit, scientific research institute basic R and D operations Special Fund [2014RG002-1]; National Key Research and Development Program of China [2016YFD0101801]	Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Science and technology projects; China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Central level, non-profit, scientific research institute basic R and D operations Special Fund; National Key Research and Development Program of China	This research was financially supported by the Zhejiang Natural Science Foundation (Grant No: LY14C130012, LY14C130009), Zhejiang Science and technology projects (Grant No: 2015C32045), China Natural Science Foundation (No. 31501285), and the Central level, non-profit, scientific research institute basic R and D operations Special Fund (2014RG002-1).; This research was financially supported by the Zhejiang Science and technology projects (Grant No: 2015C32045), Zhejiang Natural Science Foundation (Grant No: LY14C130009), China Natural Science Foundation (No. 31501285), the Central level, non-profit, scientific research institute basic R and D operations Special Fund (2014RG002-1), and National Key Research and Development Program of China (2016YFD0101801).	Bang WY, 2008, PLANT CELL PHYSIOL, V49, P1350, DOI 10.1093/pcp/pcn111; Bollivar D, 2014, FEBS J, V281, P2377, DOI 10.1111/febs.12790; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4; Harper AL, 2004, PHOTOSYNTH RES, V79, P149, DOI 10.1023/B:PRES.0000015375.40167.76; Huang JL, 2013, PLANT SCI, V210, P241, DOI 10.1016/j.plantsci.2013.06.003; Inada N, 1998, PLANTA, V205, P153, DOI 10.1007/s004250050307; Islam MR, 2013, PHOTOSYNTH RES, V117, P245, DOI 10.1007/s11120-013-9877-3; Ito H, 2011, P NATL ACAD SCI USA, V108, P18014, DOI 10.1073/pnas.1107590108; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Kauss D, 2012, FEBS LETT, V586, P211, DOI 10.1016/j.febslet.2011.12.029; Kong WY, 2016, PLANT MOL BIOL, V92, P177, DOI 10.1007/s11103-016-0513-4; Kusumi K, 2010, J PLANT RES, V123, P617, DOI 10.1007/s10265-009-0277-x; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee S, 2005, PLANT MOL BIOL, V57, P805, DOI 10.1007/s11103-005-2066-9; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mitchell PL, 2006, NEW PHYTOL, V171, P688, DOI 10.1111/j.1469-8137.2006.01855.x; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Rodriguez F, 2016, ENVIRON MICROBIOL, V18, P627, DOI 10.1111/1462-2920.13042; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Song J, 2014, PLANT MOL BIOL, V84, P301, DOI 10.1007/s11103-013-0134-0; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Wang P, 2010, PLANT PHYSIOL, V153, P994; Wang PR, 2013, PLANT PHYSIOL, V161, P521, DOI 10.1104/pp.112.208421; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Yang YL, 2016, J EXP BOT, V67, P1297, DOI 10.1093/jxb/erv529; Yang YT, 2009, NUCLEIC ACIDS RES, V37, P2630, DOI 10.1093/nar/gkp126; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; ZHANG QF, 1994, P NATL ACAD SCI USA, V91, P8675, DOI 10.1073/pnas.91.18.8675; Zheng CC, 1998, PLANT PHYSIOL, V116, P27, DOI 10.1104/pp.116.1.27; Zhou K, 2016, PLANTA, V244, P1, DOI DOI 10.1007/S00425-016-2493-7; Zhou SX, 2012, FEBS LETT, V586, P205, DOI 10.1016/j.febslet.2011.12.026; Zhu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0821-5	42	14	20	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177989	10.1371/journal.pone.0177989	http://dx.doi.org/10.1371/journal.pone.0177989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558018	Green Submitted, gold, Green Published			2022-12-26	WOS:000402607000020
J	Lutz, NW; Bernard, M				Lutz, Norbert W.; Bernard, Monique			Multiparametric quantification of thermal heterogeneity within aqueous materials by water H-1 NMR spectroscopy: Paradigms and algorithms	PLOS ONE			English	Article							MAGNETIC-RESONANCE THERMOGRAPHY; BRAIN TEMPERATURE; CHEMICAL-SHIFT; STEM-CELLS; HYDROGELS; THERMOMETRY; BIOMATERIALS; HYPERTHERMIA; CALIBRATION; HISTOGRAM	Processes involving heat generation and dissipation play an important role in the performance of numerous materials. The behavior of (semi-) aqueous materials such as hydrogels during production and application, but also properties of biological tissue in disease and therapy (e.g., hyperthermia) critically depend on heat regulation. However, currently available thermometry methods do not provide quantitative parameters characterizing the overall temperature distribution within a volume of soft matter. To this end, we present here a new paradigm enabling accurate, contactless quantification of thermal heterogeneity based on the line shape of a water proton nuclear magnetic resonance (H-1 NMR) spectrum. First, the H-1 NMR resonance from water serving as a "temperature probe" is transformed into a temperature curve. Then, the digital points of this temperature profile are used to construct a histogram by way of specifically developed algorithms. We demonstrate that from this histogram, at least eight quantitative parameters describing the underlying statistical temperature distribution can be computed: weighted median, weighted mean, standard deviation, range, mode(s), kurtosis, skewness, and entropy. All mathematical transformations and calculations are performed using specifically programmed EXCEL spreadsheets. Our new paradigm is helpful in detailed investigations of thermal heterogeneity, including dynamic characteristics of heat exchange at sub-second temporal resolution.	[Lutz, Norbert W.; Bernard, Monique] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech 7339, Fac Med Timone,CNRS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Lutz, NW (corresponding author), Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, Unite Mixte Rech 7339, Fac Med Timone,CNRS, Marseille, France.	Norbert.Lutz@univ-amu.fr	BERNARD, Monique/Q-7254-2017	BERNARD, Monique/0000-0002-3179-8698	Centre National de la Recherche Scientifique [UMR 7339]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique, grant UMR 7339 to MB (https://crmbm.univ-amu.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt MC, 2013, PROG COLL POL SCI S, V140, P175, DOI 10.1007/978-3-319-01683-2_14; Babourina-Brooks B, 2015, NMR BIOMED, V28, P792, DOI 10.1002/nbm.3303; Baumberger T, 2006, NAT MATER, V5, P552, DOI 10.1038/nmat1666; Chaudhuri O., 2015, NAT MAT; Coman D, 2009, NMR BIOMED, V22, P229, DOI 10.1002/nbm.1312; Corbett RJT, 1999, AM J NEURORADIOL, V20, P1851; Cover T. M., 1991, ELEMENTS INFORM THEO; DeCarlo L., 1997, RADIO SCI, V2, P292, DOI DOI 10.1037/1082-989X.2.3.292; DEPOORTER J, 1995, MAGNET RESON MED, V33, P74, DOI 10.1002/mrm.1910330111; Doane DP, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889611; Frigg R., 2011, PROBABILITIES PHYS, DOI DOI 10.1093/ACPROF:OSO/9780199577439.003.0005; Gellermann J, 2005, CANCER RES, V65, P5872, DOI 10.1158/0008-5472.CAN-04-3952; Germain D, 2001, MAGN RESON MATER PHY, V13, P47, DOI 10.1016/S1352-8661(01)00123-5; GRIFFITHS JR, 1981, BIOSCIENCE REP, V1, P319, DOI 10.1007/BF01114871; Guclu B, 2005, ACTA NEUROBIOL EXP, V65, P399; He K, 1997, J STAT PLAN INFER, V61, P49, DOI 10.1016/S0378-3758(96)00142-5; HINDMAN JC, 1966, J CHEM PHYS, V44, P4582, DOI 10.1063/1.1726676; Kohler U, 2005, DATA ANAL USING STAT; Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Lesne A, 2014, MATH STRUCT COMP SCI, V24, DOI 10.1017/S0960129512000783; Li L, 2014, INT J THERM SCI, V86, P219, DOI 10.1016/j.ijthermalsci.2014.07.006; Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]; Liu GS, 2014, NMR BIOMED, V27, P320, DOI 10.1002/nbm.3066; Liu MJ, 2015, NATURE, V517, P68, DOI 10.1038/nature14060; Ludemann L, 2010, INT J HYPERTHER, V26, P273, DOI 10.3109/02656731003596242; Lutz NW, 2013, CANCER RES, V73, P4616, DOI 10.1158/0008-5472.CAN-13-0767; LUTZ NW, 1993, MAGNET RESON MED, V29, P113, DOI 10.1002/mrm.1910290120; Mehta M, 2015, J BIOMED MATER RES A, V103, P3516, DOI 10.1002/jbm.a.35497; Meid J, 2013, PROGR COLLOID POLYM, P140; Mode Butler G., 2010, ENCY RES DESIGN, P140; MULLER N, 1965, J CHEM PHYS, V42, P3265, DOI 10.1063/1.1696408; Ogunnaike BA, 2010, RANDOM PHENOMENA; Rastogi A., 2011, THERMODYNAMICS PHYS; Raue M, 2013, PROG COLL POL SCI S, V140, P45, DOI 10.1007/978-3-319-01683-2_4; Raue M, 2013, PROG COLL POL SCI S, V140, P35, DOI 10.1007/978-3-319-01683-2_3; Schaffner DW, 2013, J FOOD PROTECT, V76, P1085, DOI 10.4315/0362-028X.JFP-12-424; SCHNEIDER WG, 1958, J CHEM PHYS, V28, P601, DOI 10.1063/1.1744199; Shapiro YE, 2011, PROG POLYM SCI, V36, P1184, DOI 10.1016/j.progpolymsci.2011.04.002; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; STORM FK, 1979, CANCER RES, V39, P2245; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Thrippleton MJ, 2014, NMR BIOMED, V27, P183, DOI 10.1002/nbm.3050; Vescovo E, 2013, NMR BIOMED, V26, P213, DOI 10.1002/nbm.2840; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Westfall PH, 2014, AM STAT, V68, P191, DOI 10.1080/00031305.2014.917055; Winter L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061661; Zhou GH, 2010, MEAT SCI, V86, P119, DOI 10.1016/j.meatsci.2010.04.033	48	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178431	10.1371/journal.pone.0178431	http://dx.doi.org/10.1371/journal.pone.0178431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552959	Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000046
J	Wondimu, T; Gizaw, A; Tusiime, FM; Masao, CA; Abdi, AA; Hou, Y; Nemomissa, S; Brochmann, C				Wondimu, Tigist; Gizaw, Abel; Tusiime, Felly M.; Masao, Catherine A.; Abdi, Ahmed A.; Hou, Yan; Nemomissa, Sileshi; Brochmann, Christian			Genetic structuring, dispersal and taxonomy of the high-alpine populations of the Geranium arabicum/kilimandscharicum complex in tropical eastern Africa	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; PHYLOGENETIC NETWORKS; FRAGMENTED SYSTEM; PHYLOGEOGRAPHY; VICARIANCE; SPECIATION; DIVERSITY; INFERENCE; APIACEAE; PROGRAM	The scattered eastern African high mountains harbor a renowned and highly endemic flora, but the taxonomy and phylogeographic history of many plant groups are still insufficiently known. The high-alpine populations of the Geranium arabicum/kilimandscharicum complex present intricate morphological variation and have recently been suggested to comprise two new endemic taxa. Here we aim to contribute to a clarification of the taxonomy of these populations by analyzing genetic (AFLP) variation in range-wide high-alpine samples, and we address whether hybridization has contributed to taxonomic problems. We identified only two genetic groups. One corresponded to G. kilimandscharicum, which has been reported as exclusively high-alpine and confined to the eastern Rift mountains in East Africa. The other corresponded to G. arabicum, reported from lower altitudes on the same mountains as well as from a wide altitudinal span in Ethiopia and on the western Rift mountains in East Africa. The four populations analyzed of a recently described species from the Bale Mts in Ethiopia were admixed, indicating that they result from recent long-distance dispersal of G. kilimandscharicum from East Africa followed by hybridization with local G. arabicum in naturally disturbed habitats. Some admixture between the two genetic groups was also inferred on other mountains, supporting earlier suggestions of introgression based on morphology. We did not find support for recognition of the recently suggested new subspecies of G. arabicum in Ethiopia. Interestingly, the high-alpine G. kilimandscharicum lacked clear geographic structuring, suggesting a recent history of colonization of the different mountains or extensive intermountain gene flow.	[Wondimu, Tigist; Gizaw, Abel; Nemomissa, Sileshi] Addis Ababa Univ, Dept Plant Biol & Biodivers Management, Coll Nat Sci, Addis Ababa, Ethiopia; [Wondimu, Tigist; Gizaw, Abel; Tusiime, Felly M.; Masao, Catherine A.; Abdi, Ahmed A.; Hou, Yan; Brochmann, Christian] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Tusiime, Felly M.] Makerere Univ, Dept Forestry & Tourism, Sch Forestry Geog & Environm Sci, Kampala, Uganda; [Masao, Catherine A.] Univ Dar Es Salaam, Inst Resource Assessment, Dar Es Salaam, Tanzania; [Abdi, Ahmed A.] Natl Museums Kenya, Nairobi, Kenya	Addis Ababa University; University of Oslo; Makerere University; University of Dar es Salaam	Wondimu, T (corresponding author), Addis Ababa Univ, Dept Plant Biol & Biodivers Management, Coll Nat Sci, Addis Ababa, Ethiopia.; Wondimu, T (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	twtigistw@gmail.com	Nemomissa, Sileshi/AAB-7270-2022; Brochmann, Christian/A-4105-2009; Wondimu, Tigist/HGB-9694-2022; Gizaw, Abel/I-5011-2015; Gizaw, Abel/Y-5429-2019	Wondimu, Tigist/0000-0003-2212-3362; Gizaw, Abel/0000-0002-2045-1285; Gizaw, Abel/0000-0002-2045-1285; Masao, Catherine Aloyce/0000-0002-1242-9117	Norwegian Programme for Development, Research and Higher Education (NUFU) [2007/1058]	Norwegian Programme for Development, Research and Higher Education (NUFU)	This work was funded by The Norwegian Programme for Development, Research and Higher Education (NUFU; project no 2007/1058) to S. Nemomissa and C. Brochmann.; This study formed part of the project 'AFROALP-II Afro-alpine 'sky islands': genetic versus taxonomic biodiversity, climate change, and conservation' funded by The Norwegian Programme for Development, Research and Higher Education (NUFU; project no 2007/1058) to S. Nemomissa and C. Brochmann. We thank the other members of the AFROALP-II team for discussions and help during the field work, and Manuel Pimentel who determined/verified the identity of our collections.	Alsos IG, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv036; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brochmann C, 2000, PLANT SYST EVOL, V220, P77, DOI 10.1007/BF00985372; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Gaudeul M, 2000, MOL ECOL, V9, P1625, DOI 10.1046/j.1365-294x.2000.01063.x; Gehrke B, 2014, ALPINE BOT, V124, P165, DOI 10.1007/s00035-014-0132-0; Gilbert MG, 2000, ADDIS ABABA NATL HER, V2, P346; Gizaw A, 2016, ALPINE BOT, V126, P59, DOI 10.1007/s00035-015-0162-2; Gizaw A, 2013, FLORA, V208, P453, DOI 10.1016/j.flora.2013.07.007; Gottelli D, 2004, MOL ECOL, V13, P2275, DOI 10.1111/j.1365-294X.2004.02226.x; Gussarova G, 2015, AM J BOT, V102, P1703, DOI 10.3732/ajb.1500072; HEDBERG OLOV, 1957, SYMBOLAE BOT UPSALIENSIS, V15, P1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kebede M, 2007, MOL ECOL, V16, P1233, DOI 10.1111/j.1365-294X.2007.03232.x; Kokwaro JO, 1971, GREAT BRITAIN WHITEF, V1, P1; Kosman E, 2003, PLANT PATHOL, V52, P533, DOI 10.1046/j.1365-3059.2003.00923.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rohlf F.J., 2000, NTSYSPC NUMERICAL TA; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Tusiime FM, 2013, ALPINE BOT, V123, P107; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Wondimu T, 2014, PLANT SYST EVOL, V300, P415, DOI 10.1007/s00606-013-0892-9; Yaba M., 2011, ASIAN J APPL SCI, V4, P735	33	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178208	10.1371/journal.pone.0178208	http://dx.doi.org/10.1371/journal.pone.0178208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552970	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000029
J	De Castro, O; Comparone, M; Di Maio, A; Del Guacchio, E; Menale, B; Troisi, J; Aliberti, F; Trifuoggi, M; Guida, M				De Castro, Olga; Comparone, Maria; Di Maio, Antonietta; Del Guacchio, Emanuele; Menale, Bruno; Troisi, Jacopo; Aliberti, Francesco; Trifuoggi, Marco; Guida, Marco			What is in your cup of tea? DNA Verity Test to characterize black and green commercial teas	PLOS ONE			English	Article							TRNL UAA INTRON; MOLECULAR PHYLOGENY; CHLOROPLAST GENOME; ITALIAN TRIANGLE; CAMELLIA; AUTHENTICATION; BARCODE; QUALITY; IDENTIFICATION; TECHNOLOGIES	In this study, we used several molecular techniques to develop a fast and reliable protocol (DNA Verity Test, DVT) for the characterization and confirmation of the species or taxa present in herbal infusions. As a model plant for this protocol, Camellia sinensis, a traditional tea plant, was selected due to the following reasons: its historical popularity as a (healthy) beverage, its high selling value, the importation of barely recognizable raw product (i.e., crushed), and the scarcity of studies concerning adulterants or contamination. The DNA Verity Test includes both the sequencing of DNA barcoding markers and genotyping of labeled-PCR DNA barcoding fragments for each sample analyzed. This protocol (DVT) was successively applied to verify the authenticity of 32 commercial teas (simple or admixture), and the main results can be summarized as follows: (1) the DVT protocol is suitable to detect adulteration in tea matrices (contaminations or absence of certified ingredients), and the method can be exported for the study of other similar systems; (2) based on the BLAST analysis of the sequences of rbcL+ matK +/- rps7-trnV (GAC) chloroplast markers, C. sinensis can be taxonomically characterized; (3) rps7-trnV (GAC) can be employed to discriminate C. sinensis from C. pubicosta; (4) ITS2 is not an ideal DNA barcode for tea samples, reflecting potential incomplete lineage sorting and hybridization/introgression phenomena in C. sinensis taxa; (5) the genotyping approach is an easy, inexpensive and rapid pre-screening method to detect anomalies in the tea templates using the trnH (GUG)-psbA barcoding marker; (6) two herbal companies provided no authentic products with a contaminant or without some of the listed ingredients; and (7) the leaf matrices present in some teabags could be constituted using an admixture of different C. sinensis haplotypes and/or allied species (C. pubicosta).	[De Castro, Olga; Comparone, Maria; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dept Biol, Bot Garden, Naples, Italy; [Del Guacchio, Emanuele] Univ Naples Federico II, Bot Garden, Naples, Italy; [Troisi, Jacopo] Univ Salerno, Dept Med & Surg & Dent, Salerno, Italy; [Aliberti, Francesco; Guida, Marco] Univ Naples Federico II, Dept Biol, Naples, Italy; [Trifuoggi, Marco] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Salerno; University of Naples Federico II; University of Naples Federico II	De Castro, O (corresponding author), Univ Naples Federico II, Dept Biol, Bot Garden, Naples, Italy.	odecastr@unina.it	guida, Marco/K-2262-2013; Troisi, Jacopo/ABC-1348-2021	Troisi, Jacopo/0000-0003-2962-7379; DE CASTRO, Olga/0000-0002-4861-3960; Del Guacchio, Emanuele/0000-0001-9349-1328				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2013, PLANT LIST VERSION 1; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bhattacharjya DK, 2008, INDIAN J TRADIT KNOW, V7, P501; Bianchi F, 2004, LANCET ONCOL, V5, P710, DOI 10.1016/S1470-2045(04)01645-6; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Bruni I, 2010, INT J LEGAL MED, V124, P595, DOI 10.1007/s00414-010-0447-3; CHANG HD, 1998, TOMUS, V49, P1; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Danezis GP, 2016, TRAC-TREND ANAL CHEM, V85, P123, DOI 10.1016/j.trac.2016.02.026; De Castro O, 2012, BOT J LINN SOC, V170, P12, DOI 10.1111/j.1095-8339.2012.01268.x; De Medici D, 2015, FOOD ANAL METHOD, V8, P255, DOI 10.1007/s12161-014-9915-6; Dhiman B, 2003, PLANTA MED, V69, P882, DOI 10.1055/s-2003-43211; Di Maio A, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200158; EFSA, 2009, EFSA J, V7, DOI [10.2903/j.efsa.2009.282r, 10.2903/j.efsa.2010.1828]; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Ellis DI, 2012, CHEM SOC REV, V41, P5706, DOI 10.1039/c2cs35138b; Fazekas AJ, 2010, TAXON, V59, P694, DOI 10.1002/tax.593002; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Forgacs E., 2003, FOOD AUTHENTICITY TR, V1st ed, P197; Galimberti A, 2015, FOOD RES INT, V69, P424, DOI 10.1016/j.foodres.2015.01.017; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Gutman R. L., 1996, HerbalGram, P33; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Jiarui C, 2003, FLORA OF CHINA 5; Jiyin G., 2005, COLLECTED SPECIES GE; Kaundun SS, 2011, J SCI FOOD AGR, V91, P2660, DOI 10.1002/jsfa.4508; Kravtsova T. I., 2003, Kew Bulletin, V58, P297, DOI 10.2307/4120618; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lee S-C, 2016, J FOOD DRUG IN PRESS; Li PY, 2011, J SERB CHEM SOC, V76, P709, DOI 10.2298/JSC100818063L; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Menale B, 2016, J ETHNOPHARMACOL, V192, P320, DOI 10.1016/j.jep.2016.07.049; Merrill E. D., 1942, JOUR ARNOLD ARBORETUM, V23, P156; Mezzasalma V, 2017, INT J LEGAL MED, V131, P1, DOI 10.1007/s00414-016-1460-y; Min T, 2007, FLORA CHINA, V12; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Nath TN, 2013, J ADV RES, V1, P561; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Peris M, 2016, TRENDS FOOD SCI TECH, V58, P40, DOI 10.1016/j.tifs.2016.10.014; Primrose S, 2010, TRENDS FOOD SCI TECH, V21, P582, DOI 10.1016/j.tifs.2010.09.006; Ratnam K.V., 2008, ETHNOBOT LEAFL, V12, P19; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ravikumar C, 2014, J PHARM SCI RES, V6, P236; Reygaert WC, 2017, BEVERAGES, V3, DOI 10.3390/beverages3010006; Sarkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043808; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sarma Hemen, 2016, Emerging Contaminants, V2, P119, DOI 10.1016/j.emcon.2016.05.004; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Senior K, 2004, LANCET ONCOL, V5, P525, DOI 10.1016/S1470-2045(04)01561-X; Shi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059620; Singh RK, 2010, INDIAN J TRADIT KNOW, V9, P754; Soukand R, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-58; Spaniolas S, 2010, FOOD CHEM, V122, P850, DOI 10.1016/j.foodchem.2010.02.039; Spink J, 2011, J FOOD SCI, V76, pR157, DOI 10.1111/j.1750-3841.2011.02417.x; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Sumpio BE, 2006, J AM COLL SURGEONS, V202, P813, DOI 10.1016/j.jamcollsurg.2006.01.018; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Vancouver JF, 2011, J TEA SCI RES, V1, P1; Vijayan K, 2008, BOT STUD, V49, P177; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Wheeler L, 2015, IUCN RED LIST THREAT; Wheeler L, 2015, IUCN RED LIST THREAT; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Wilmot-Dear CM, 2013, BLUMEA, V58, P85, DOI 10.3767/000651913X674116; Wilmot-Dear CM, 2004, NORD J BOT, V24, P5, DOI 10.1111/j.1756-1051.2004.tb00825.x; Wilmot-Dear C. M., 2009, Edinburgh Journal of Botany, V66, P51, DOI 10.1017/S096042860900523X; Wilmot-Dear C.M., 1996, OPERA BOT, V129, P1; Wilmot-Dear CM, 2015, NORD J BOT, V33, P354, DOI 10.1111/njb.00675; Wilmot-Dear CM, 2011, NORD J BOT, V29, P691, DOI 10.1111/j.1756-1051.2011.01386.x; World Health Organization, 2015, FOOD SAF WHAT YOU SH; Yang Jun-Bo, 2006, Acta Botanica Yunnanica, V28, P108; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Zhang YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157847	82	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178262	10.1371/journal.pone.0178262	http://dx.doi.org/10.1371/journal.pone.0178262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542606	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800053
J	Benozzo, D; Jylanki, P; Olivetti, E; Avesani, P; van Gerven, MAJ				Benozzo, Danilo; Jylanki, Pasi; Olivetti, Emanuele; Avesani, Paolo; van Gerven, Marcel A. J.			Bayesian estimation of directed functional coupling from brain recordings	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; EFFECTIVE CONNECTIVITY; AUTOREGRESSIVE MODELS; MULTIVARIATE; REGRESSION; TOOLBOX	In many fields of science, there is the need of assessing the causal influences among time series. Especially in neuroscience, understanding the causal interactions between brain regions is of primary importance. A family of measures have been developed from the parametric implementation of the Granger criteria of causality based on the linear autoregressive modelling of the signals. We propose a new Bayesian method for linear model identification with a structured prior (GMEP) aiming to apply it as linear regression method in the context of the parametric Granger causal inference. GMEP assumes a Gaussian scale mixture distribution for the group sparsity prior and it enables flexible definition of the coefficient groups. Approximate posterior inference is achieved using Expectation Propagation for both the linear coefficients and the hyperparameters. GMEP is investigated both on simulated data and on empirical fMRI data in which we show how adding information on the sparsity structure of the coefficients positively improves the inference process. In the same simulation framework, GMEP is compared with others standard linear regression methods. Moreover, the causal inferences derived from GMEP estimates and from a standard Granger method are compared across simulated datasets of different dimensionality, density connection and level of noise. GMEP allows a better model identification and consequent causal inference when prior knowledge on the sparsity structure are integrated in the structured prior.	[Benozzo, Danilo; Olivetti, Emanuele; Avesani, Paolo] Bruno Kessler Fdn, NeuroInformat Lab NILab, Trento, Italy; [Benozzo, Danilo] Univ Trento, Informat Engn & Comp Sci Dept DISI, Trento, Italy; [Olivetti, Emanuele; Avesani, Paolo] Univ Trento, Ctr Mind & Brain Sci CIMeC, Trento, Italy; [Jylanki, Pasi; van Gerven, Marcel A. J.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Fondazione Bruno Kessler; University of Trento; University of Trento; Radboud University Nijmegen	Benozzo, D (corresponding author), Bruno Kessler Fdn, NeuroInformat Lab NILab, Trento, Italy.; Benozzo, D (corresponding author), Univ Trento, Informat Engn & Comp Sci Dept DISI, Trento, Italy.	danilo.benozzo@gmail.com	van Gerven, Marcel A. J./D-7800-2012; Olivetti, Emanuele/AAT-2384-2020; Avesani, Paolo/AAY-9704-2021	van Gerven, Marcel A. J./0000-0002-2206-9098; Olivetti, Emanuele/0000-0001-7653-1519; Avesani, Paolo/0000-0001-8943-8911	Netherlands Organization for Scientific Research (NWO) [612.001.211, 639.072.513]; Bruno Kessler Foundation (FBK); Finnish Cultural Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Bruno Kessler Foundation (FBK); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This research was supported by grant numbers 612.001.211 and 639.072.513 of The Netherlands Organization for Scientific Research (NWO) and by funds from the Bruno Kessler Foundation (FBK) and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babacan SD, 2014, IEEE T SIGNAL PROCES, V62, P2906, DOI 10.1109/TSP.2014.2319775; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Garrigues PJ, 2010, P ADV NEUR INF PROC, V23, P676, DOI DOI 10.1007/978-3-319-59463-7_51; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Haufe S, 2009, SPARSE CAUSAL DISCOV; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Haufe S, 2010, IEEE T BIO-MED ENG, V57, P1954, DOI 10.1109/TBME.2010.2046325; Hernandez-Lobato D, 2013, J MACH LEARN RES, V14, P1891; Huang J, 2009, THE BENEFIT OF GROUP; Kaufmann RK, 1997, NATURE, V388, P39, DOI 10.1038/40332; Lee A, 2010, A HIERARCHICAL BAYES; Hernandez-Lobato JM, 2015, MACH LEARN, V99, P437, DOI 10.1007/s10994-014-5475-7; Minka T. P., 2001, P 17 C UNC ART INT, P362; MORF M, 1978, IEEE T GEOSCI REMOTE, V16, P85, DOI 10.1109/TGE.1978.294569; Nagarajan R, 2008, BIOINFORMATICS, V24, P1029, DOI 10.1093/bioinformatics/btm586; Nardi Y, 2008, ELECTRON J STAT, V2, P605, DOI 10.1214/08-EJS200; Nickisch H, 2008, J MACH LEARN RES, V9, P2035; Nishimoto S., 2014, GALLANT LAB NATURAL; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Penny WD, 2002, IEE P-VIS IMAGE SIGN, V149, P33, DOI 10.1049/ip-vis:20020149; Qi Y., 2008, P 25 INT C MACH LEAR, P768; Rao A, 2006, INT CONF ACOUST SPEE, P2276; Riihima E, 2012, NESTED EXPECTATION P; Sanchez-Bornot JM, 2008, STAT SINICA, V18, P1501; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Schlogl A, 2006, SIGNAL PROCESS, V86, P2426, DOI 10.1016/j.sigpro.2005.11.007; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; SIMS CA, 1972, AM ECON REV, V62, P540; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2004, NEUROINFORMATICS, V2, P239, DOI 10.1385/NI:2:2:239; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; VINOD HD, 1978, REV ECON STAT, V60, P121, DOI 10.2307/1924340; Wiener N., 1956, MODERN MATHEMATICS F; Wipf DP, 2007, IEEE T SIGNAL PROCES, V55, P3704, DOI 10.1109/TSP.2007.894265; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177359	10.1371/journal.pone.0177359	http://dx.doi.org/10.1371/journal.pone.0177359			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545066	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400038
J	Gao, C; Howard-Quijano, K; Rau, C; Takamiya, T; Song, Y; Shivkumar, K; Wang, YB; Mahajan, A				Gao, Chen; Howard-Quijano, Kimberly; Rau, Christoph; Takamiya, Tatsuo; Song, Yang; Shivkumar, Kalyanam; Wang, Yibin; Mahajan, Aman			Inflammatory and apoptotic remodeling in autonomic nervous system following myocardial infarction	PLOS ONE			English	Article							THORACIC EPIDURAL-ANESTHESIA; REFRACTORY VENTRICULAR-ARRHYTHMIAS; STELLATE GANGLION; ATRIAL-FIBRILLATION; ELECTRICAL STORM; STIMULATION; ISCHEMIA; NEURONS; MECHANISMS; HEART	Background Chronic myocardial infarction (MI) triggers pathological remodeling in the heart and cardiac nervous system. Abnormal function of the autonomic nervous system (ANS), including stellate ganglia (SG) and dorsal root ganglia (DRG) contribute to increased sympathoexcitation, cardiac dysfunction and arrythmogenesis. ANS modulation is a therapeutic target for arrhythmia associated with cardiac injury. However, the molecular mechanism involved in the pathological remodeling in ANS following cardiac injury remains to be established. Methods and results In this study, we performed transcriptome analysis by RNA-sequencing in thoracic SG and (T1-T4) DRG obtained from Yorkshire pigs following either acute (3 to 5 hours) or chronic (8 weeks) myocardial infarction. By differential expression and weighted gene co-expression network analysis (WGCNA), we identified significant transcriptome changes and specific gene modules in the ANS tissues in response to myocardial infarction at either acute or chronic phases. Both differential expressed genes and the member genes of the WGCNA gene module associated with post-infarct condition were significantly enriched for inflammatory signaling and apoptotic cell death. Targeted validation analysis supported a significant induction of inflammatory and apoptotic signal in both SG and DRG following myocardial infarction, along with cellular evidence of apoptosis induction based on TUNEL analysis. Importantly, these molecular changes were observed specifically in the thoracic segments but not in their counterparts obtained from lumbar sections. Conclusion Myocardial injury leads to time-dependent global changes in gene expression in the innervating ANS. Induction of inflammatory gene expression and loss of neuron cell viability in SG and DRG are potential novel mechanisms contributing to abnormal ANS function which can promote cardiac arrhythmia and pathological remodeling in myocardium.	[Gao, Chen; Rau, Christoph; Song, Yang; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Los Angeles, CA 90095 USA; [Gao, Chen; Howard-Quijano, Kimberly; Rau, Christoph; Takamiya, Tatsuo; Song, Yang; Wang, Yibin; Mahajan, Aman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA; [Shivkumar, Kalyanam] Univ Calif Los Angeles, David Geffen Sch Med, Cardiac Arrhythmia Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Los Angeles, CA 90095 USA.; Wang, YB; Mahajan, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol & Perioperat Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu; amahajan@mednet.ucla.edu	Rau, Christoph/AAC-3943-2020; Shivkumar, Kalyanam/AAI-1085-2019	Rau, Christoph/0000-0002-0782-207X; Shivkumar, Kalyanam/0000-0002-4121-1766; Wang, Yibin/0000-0003-0852-0767	NHLBI NIH HHS [R01 HL122737, R01 HL129639] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129639, R01HL122737] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ajijola OA, 2015, HEART RHYTHM, V12, P1027, DOI 10.1016/j.hrthm.2015.01.045; Ajijola OA, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1010, DOI 10.1161/CIRCEP.112.972836; Ardell JL, 2009, AM J PHYSIOL-REG I, V297, pR470, DOI 10.1152/ajpregu.90821.2008; Armour JA, 2010, HEART RHYTHM, V7, P994, DOI 10.1016/j.hrthm.2010.02.014; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Nguyen BL, 2012, CARDIOVASC PATHOL, V21, P143, DOI 10.1016/j.carpath.2011.08.001; BLOMBERG S, 1988, ACTA ANAESTH SCAND, V32, P173, DOI 10.1111/j.1399-6576.1988.tb02710.x; Bourke T, 2010, CIRCULATION, V121, P2255, DOI 10.1161/CIRCULATIONAHA.109.929703; Chen PS, 2014, CIRC RES, V114, P1500, DOI 10.1161/CIRCRESAHA.114.303772; Gao C, 2016, J CLIN INVEST, V126, P195, DOI 10.1172/JCI84015; Groban L, 1999, J CARDIOTHOR VASC AN, V13, P579, DOI 10.1016/S1053-0770(99)90011-3; Han S, 2012, J AM COLL CARDIOL, V59, P954, DOI 10.1016/j.jacc.2011.11.030; Hardwick JC, 2012, AM J PHYSIOL-REG I, V303, pR950, DOI 10.1152/ajpregu.00223.2012; Hardwick JC, 2008, AM J PHYSIOL-REG I, V295, pR1926, DOI 10.1152/ajpregu.90306.2008; KAMIBAYASHI T, 1995, ANESTHESIOLOGY, V82, P129, DOI 10.1097/00000542-199501000-00017; Kawashima T, 2005, ANAT EMBRYOL, V209, P425, DOI 10.1007/s00429-005-0462-1; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Mahajan A, 2005, HEART RHYTHM, V2, P1359, DOI 10.1016/j.hrthm.2005.09.004; Nakahara S, 2011, HEART RHYTHM, V8, P1060, DOI 10.1016/j.hrthm.2011.02.029; Nakamura M, 2016, TRANSPL P, V48, P874, DOI 10.1016/j.transproceed.2015.12.108; Pauza DH, 2002, CELLS TISSUES ORGANS, V172, P297, DOI 10.1159/000067198; Pinheiro AD, 2015, CURR MED RES OPIN, V31, P1849, DOI 10.1185/03007995.2015.1074065; Rajendran PS, 2016, J PHYSIOL-LONDON, V594, P321, DOI 10.1113/JP271165; SCHWARTZ PJ, 1992, J CARDIOVASC ELECTR, V3, P2, DOI 10.1111/j.1540-8167.1992.tb01090.x; SCHWARTZ PJ, 1984, CIRCULATION, V69, P790, DOI 10.1161/01.CIR.69.4.790; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Shen MJ, 2011, CIRCULATION, V123, P2204, DOI 10.1161/CIRCULATIONAHA.111.018028; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064611; Yagishita D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P174, DOI 10.1161/CIRCEP.114.002195; Yamakawa K, 2016, AM J PHYSIOL-REG I, V310, pR414, DOI 10.1152/ajpregu.00252.2015; Yamakawa K, 2015, AM J PHYSIOL-HEART C, V309, pH1579, DOI 10.1152/ajpheart.00558.2015; Zheng C, 2016, CURR PHARM DESIGN, V22, P485, DOI 10.2174/1381612822666151222160810; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zhou W, 2015, J CARDIOTHOR VASC AN, V29, P1148, DOI 10.1053/j.jvca.2014.12.008; Zhou W, 2012, AM J PHYSIOL-HEART C, V302, pH1818, DOI 10.1152/ajpheart.00030.2012	39	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177750	10.1371/journal.pone.0177750	http://dx.doi.org/10.1371/journal.pone.0177750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542617	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400076
J	Liu, Z; Guo, Y; Du, SH; Wu, GY; Pan, M				Liu, Zhen; Guo, Ye; Du, Shuheng; Wu, Gengyu; Pan, Mao			Research on calibrating rock mechanical parameters with a statistical method	PLOS ONE			English	Article							LOW-PERMEABILITY RESERVOIR; INTERPRETIVE TOOLS; FAULTS	Research on the modeling of rock mechanics parameters is of great significance to the exploration of oil and gas. The use of logging data with the Kriging interpolation to study rock mechanics parameters has been proven to be effective in reservoir prediction and other oilfield applications and can provide additional data. However, there will sometimes be a great deviation due to the limited samples and the strong heterogeneity of a layer. To solve this problem, a new approach was proposed to calibrate rock mechanical models through the statistical analysis of logging data. A module was developed to calibrate rock mechanics parameters automatically, which was then applied to the Wangyao area of the Ansai oilfield. This method significantly improved the accuracy of rock mechanics modeling.	[Liu, Zhen; Wu, Gengyu] Peking Univ, Key Lab Orogen Belts & Crustal Evolut MOE, Sch Earth & Space Sci, Beijing, Peoples R China; [Liu, Zhen; Du, Shuheng; Pan, Mao] Peking Univ, Oil & Gas Inst, Sch Earth & Space Sci, Beijing, Peoples R China; [Guo, Ye] Univ Houston, Petr Dept, Cullen Coll Engn, Houston, TX USA	Peking University; Peking University; University of Houston System; University of Houston	Pan, M (corresponding author), Peking Univ, Oil & Gas Inst, Sch Earth & Space Sci, Beijing, Peoples R China.	1301110508@pku.edu.cn	Du, Shuheng/ABA-9772-2020		National Megaproject of Science Research of China "Development of large scale oil-gas fields and CBM" [2016ZX05013005-009]	National Megaproject of Science Research of China "Development of large scale oil-gas fields and CBM"	This work was supported by the National Megaproject of Science Research of China "Development of large scale oil-gas fields and CBM" (No. 2016ZX05013005-009).	Caumon G, 2004, MATH GEOL, V36, P405, DOI 10.1023/B:MATG.0000029297.18098.8a; CRESSIE N, 1985, J INT ASS MATH GEOL, V17, P563, DOI 10.1007/BF01032109; Dang B, 2004, NATURAL GAS GEOSCIEN, V15, P597; De Kemp EA, 2003, GEOINFORMATICA, V7, P55, DOI 10.1023/A:1022822227691; [董经利 DONG Jing-li], 2009, [测井技术, Well Logging Technology], V33, P115; Du SH, 2015, ENERG EXPLOR EXPLOIT, V33, P491, DOI 10.1260/0144-5987.33.4.491; Erum Z, 2016, PLOS ONE, V11; Fang ZW, 2008, EXPRESS FORMATION MI, V40, P28; Feng L, 1998, COMPUT GRAPH-UK, V22, P641, DOI 10.1016/S0097-8493(98)00073-9; Hu GZ, 2014, CHINESE J GEOPHYS-CH, V57, P556, DOI 10.6038/cjg20140220; Jost G, 2005, GEODERMA, V128, P258, DOI 10.1016/j.geoderma.2005.04.008; Journel A. G., 1978, MINING GEOSTATISTICS; JOURNEL AG, 1983, J INT ASS MATH GEOL, V15, P445, DOI 10.1007/BF01031292; Krige DG, 1951, STAT APPROACH SOME M; Laurent G, 2013, TECTONOPHYSICS, V590, P83, DOI 10.1016/j.tecto.2013.01.015; Lecour M, 2001, PETROL GEOSCI, V7, pS31, DOI 10.1144/petgeo.7.S.S31; Li Guangquan, 2013, Acta Scientiarum Naturalium Universitatis Pekinensis, V49, P716; [刘震 Liu Zhen], 2012, [地质学报, Acta Geologica Sinica], V86, P1815; [罗周全 LUO Zhouquan], 2007, [地质与勘探, Geology and Prospecting], V43, P83; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; [穆斌 Mu Bin], 2010, [地理与地理信息科学, Geography and Geo-information Science], V26, P27; Oikarinen J, 1998, COMPUT GRAPH-UK, V22, P745, DOI 10.1016/S0097-8493(98)00095-8; ROUHANI S, 1990, WATER RESOUR RES, V26, P585, DOI 10.1029/WR026i004p00585; Roustant O, 2012, J STAT SOFTW, V51, P599; RUPPERT J, 1995, J ALGORITHM, V18, P548, DOI 10.1006/jagm.1995.1021; Sprague KB, 2005, GEOINFORMATICA, V9, P5, DOI 10.1007/s10707-004-5620-8; [王桂成 WANG Guicheng], 2010, [地质学报, Acta Geologica Sinica], V84, P286; Wu Q, 2003, COMPUT GEOSCI-UK, V29, P503, DOI 10.1016/S0098-3004(03)00018-9; Wu Xiaojun, 2004, Journal of Computer Aided Design & Computer Graphics, V16, P592; [颜丹平 Yan Danping], 2003, [地球科学, Earth science], V28, P275; Yan JF, 2006, CHINESE SCI BULL, V51, P51, DOI 10.1007/s11434-006-8222-z; Yin ZM, 1999, SCI GEOL SINICA, V3, P321; Zeng ZC, 2013, CHINESE SCI BULL, V58, P1948, DOI 10.1007/s11434-012-5652-7; Zhang XL, 2010, CHINESE J GEOPHYS-CH, V53, P205, DOI 10.3969/j.issn.0001-5733.2010.01.023	34	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176215	10.1371/journal.pone.0176215	http://dx.doi.org/10.1371/journal.pone.0176215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545105	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400005
J	Gingras, S; Kuliyev, E; Pelletier, S				Gingras, Sebastien; Kuliyev, Emin; Pelletier, Stephane			SCYL1 does not regulate REST expression and turnover	PLOS ONE			English	Article							CELL LUNG-CANCER; IN-VIVO; GENE; DEGRADATION; DIFFERENTIATION; CRISPR-CAS9; MUTATION	A recent study identified SCYL1 as one of the components of the oncogenic STP axis, which promotes triple-negative breast cancer by regulating degradation of the REST tumor suppressor. Contrary to the findings of that study, herein we show by using 3 distinct genetic approaches that SCYL1 does not regulate REST turnover. Specifically, REST protein levels and turnover were identical in Scyl1+/+ and Scyl1-/- mouse embryonic fibroblasts. Similarly, targeted inactivation of SCYL1 in Hek293T cells by using CRIPSR-Cas9 technology did not affect REST steady-state level and turnover. Furthermore, RNA interference-mediated depletion of SCYL1 in Hek293T or MDA-MB-231 cells did not alter REST steady-state level and turnover. Together, our findings indicate that SCYL1 does not contribute to REST turnover and thus do not support a previous study suggesting a role for SCYL1 in mediating REST degradation.	[Gingras, Sebastien] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Kuliyev, Emin; Pelletier, Stephane] St Jude Childrens Res Hosp, Dept Immunol, Embryon Stem Cell Lab, Memphis, TN 38105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital	Pelletier, S (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Embryon Stem Cell Lab, Memphis, TN 38105 USA.	stephane.pelletier@stjude.org			American Lebanese Syrian Associated Charities	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	Support was provided by American Lebanese Syrian Associated Charities.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BLOT S, 1995, J NEUROPATH EXP NEUR, V54, P812; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Coulson JM, 2000, CANCER RES, V60, P1840; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Karlin KL, 2014, CELL REP, V9, P1318, DOI 10.1016/j.celrep.2014.10.011; Kreisler A, 2010, ONCOGENE, V29, P5828, DOI 10.1038/onc.2010.321; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Nesti E, 2014, P NATL ACAD SCI USA, V111, pE3929, DOI 10.1073/pnas.1414770111; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Pelletier S, 2012, J NEUROSCI, V32, P16560, DOI 10.1523/JNEUROSCI.1787-12.2012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178680	10.1371/journal.pone.0178680	http://dx.doi.org/10.1371/journal.pone.0178680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570664	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800102
J	Pais, R; Omosun, Y; He, Q; Blas-Machado, U; Black, C; Igietseme, JU; Fujihashi, K; Eko, FO				Pais, Roshan; Omosun, Yusuf; He, Qing; Blas-Machado, Uriel; Black, Carolyn; Igietseme, Joseph U.; Fujihashi, Kohtaro; Eko, Francis O.			Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; HIGH-RISK WOMEN; IMMUNE-RESPONSES; VAGINAL IMMUNIZATION; TRACHOMATIS SEROVARS; MURINE; PATHOGENESIS; CHALLENGE; INDUCTION; EFFICACY	In this study, we tested the hypothesis that rectal immunization with a VCG-based chlamydial vaccine would cross-protect mice against heterologous genital Chlamydia trachomatis infection and Chlamydia-induced upper genital tract pathologies in mice. Female mice were immunized with a C. trachomatis serovar D-derived subunit vaccine or control or live serovar D elementary bodies (EBs) and the antigen-specific mucosal and systemic immune responses were characterized. Vaccine efficacy was determined by evaluating the intensity and duration of genital chlamydial shedding following intravaginal challenge with live serovar E chlamydiae. Protection against upper genital tract pathology was determined by assessing infertility and tubal inflammation. Rectal immunization elicited high levels of chlamydial-specific IFN-gamma-producing CD4 T cells and humoral immune responses in mucosal and systemic tissues. The elicited immune effectors cross-reacted with the serovar E chlamydial antigen and reduced the length and intensity of genital chlamydial shedding. Furthermore, immunization with the VCG-vaccine but not the rVCG-gD2 control reduced the incidence of tubal inflammation and protected mice against Chlamydia-induced infertility. These results highlight the potential of rectal immunization as a viable mucosal route for inducing protective immunity in the female genital tract.	[Pais, Roshan; Omosun, Yusuf; He, Qing; Eko, Francis O.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Blas-Machado, Uriel] Univ Georgia, Coll Vet Med, Vet Diagnost Lab, Athens, GA 30602 USA; [Black, Carolyn; Igietseme, Joseph U.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Fujihashi, Kohtaro] Univ Alabama Birmingham, Immunobiol Vaccine Ctr, Dept Pediat Dent, Birmingham, AL USA	Morehouse School of Medicine; University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Eko, FO (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	feko@msm.edu	Pais, Roshan/AAV-3585-2021; Omosun, Yusuf/P-9944-2019	Omosun, Yusuf/0000-0003-4759-6254	National Institute of Allergy & Infectious Diseases, National Institutes of Health, USA [5R01A1041231]; National Center for Research Resources, National Institutes of Health [1 C06 RR18386]	National Institute of Allergy & Infectious Diseases, National Institutes of Health, USA; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Public Health Service grant 5R01A1041231 from the National Institute of Allergy & Infectious Diseases, National Institutes of Health, USA (niaid.nih.gov) to FOE. The investigation was conducted in a facility constructed with support from Research Facilities Improvement Grant #1 C06 RR18386 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2009, J MICROBIOL IMMUNOL; Ajonuma LC, 2008, J OBSTET GYNAECOL RE, V34, P923, DOI 10.1111/j.1447-0756.2008.00826.x; Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; [Anonymous], 1996, HUM REPROD, V11, P1779; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Brunham RC, 1999, CHLAMYDIA, P211; BRUNHAM RC, 1994, INFECT AGENT DIS, V3, P218; CHUTIVONGSE S, 1995, SEX TRANSM DIS, V22, P71; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Davies B, 2013, SEX TRANSM DIS, V40, P230, DOI 10.1097/OLQ.0b013e31827b9d75; Eko FO, 2011, VACCINE, V29, P3802, DOI 10.1016/j.vaccine.2011.03.027; Eko FO, 2011, VACCINE, V29, P1472, DOI 10.1016/j.vaccine.2010.12.024; Eko FO, 2004, J IMMUNOL, V173, P3375, DOI 10.4049/jimmunol.173.5.3375; Eko FO, 2003, VACCINE, V21, P1694, DOI 10.1016/S0264-410X(02)00677-1; Fraillery D, 2009, VACCINE, V27, P2326, DOI 10.1016/j.vaccine.2009.02.029; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Hafner L, 2008, MUCOSAL IMMUNOL, V1, P116, DOI 10.1038/mi.2007.19; Hamajima K, 2002, CLIN IMMUNOL, V102, P12, DOI 10.1006/clim.2001.5141; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; Ifere Godwin O., 2007, Journal of Microbiology Immunology and Infection, V40, P188; Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129; Igietseme Joseph U, 2004, Expert Rev Vaccines, V3, P23; Igietseme JU, 2009, J INFECT DIS, V200, P926, DOI 10.1086/605411; Kimani J, 1996, J INFECT DIS, V173, P1437, DOI 10.1093/infdis/173.6.1437; Kubo A, 2000, MOL MICROBIOL, V38, P772, DOI 10.1046/j.1365-2958.2000.02167.x; Macmillan L, 2007, FEMS IMMUNOL MED MIC, V49, P46, DOI 10.1111/j.1574-695X.2006.00165.x; Mayr UB, 2012, MICROB BIOTECHNOL, V5, P283, DOI 10.1111/j.1751-7915.2011.00316.x; Mestecky J, 2005, AM J REPROD IMMUNOL, V53, P208, DOI 10.1111/j.1600-0897.2005.00267.x; Miguel RDV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162445; Mitchell LA, 2003, VACCINE, V21, P1527, DOI 10.1016/S0264-410X(02)00699-0; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Murthy AK, 2016, CURR TOP MICROBIOL I; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; O'Meara CP, 2014, IMMUNOL CELL BIOL, V92, P287, DOI 10.1038/icb.2013.92; Petrovay F, 2009, J MED MICROBIOL, V58, P760, DOI 10.1099/jmm.0.008607-0; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Ramsey KH, 1999, INFECT IMMUN, V67, P3019, DOI 10.1128/IAI.67.6.3019-3025.1999; Ramsey KH, 2000, INFECT IMMUN, V68, P7186, DOI 10.1128/IAI.68.12.7186-7189.2000; Reddy BS, 2004, CLIN EXP IMMUNOL, V137, P552, DOI 10.1111/j.1365-2249.2004.02564.x; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Singh V, 2003, J CLIN MICROBIOL, V41, P2700, DOI 10.1128/JCM.41.6.2700-2702.2003; SU H, 1995, VACCINE, V13, P1023, DOI 10.1016/0264-410X(95)00017-U; Sun X, 2015, INFECT IMMUN, V83, P2327, DOI 10.1128/IAI.00154-15; Tang LL, 2014, VACCINE, V32, P1407, DOI 10.1016/j.vaccine.2013.10.018; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Vajdy M, 2001, J INFECT DIS, V184, P1613, DOI 10.1086/324581; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075	50	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178537	10.1371/journal.pone.0178537	http://dx.doi.org/10.1371/journal.pone.0178537			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570663	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800072
J	Popiel, M; Perlejewski, K; Bednarska, A; Dzieciatkowski, T; Paciorek, M; Lipowski, D; Jablonowska, M; Czeszko-Paprocka, H; Bukowska-Osko, I; Cortes, KC; Pawelczyk, A; Fic, M; Horban, A; Radkowski, M; Laskus, T				Popiel, Marta; Perlejewski, Karol; Bednarska, Agnieszka; Dzieciatkowski, Tomasz; Paciorek, Marcin; Lipowski, Dariusz; Jablonowska, Monika; Czeszko-Paprocka, Hanna; Bukowska-Osko, Iwona; Cortes, Kamila Caraballo; Pawelczyk, Agnieszka; Fic, Maria; Horban, Andrzej; Radkowski, Marek; Laskus, Tomasz			Viral etiologies in adult patients with encephalitis in Poland: A prospective single center study	PLOS ONE			English	Article							REAL-TIME PCR; WEST NILE VIRUS; ASSAY; EPIDEMIOLOGY	Encephalitis is a severe neurological syndrome associated with high morbidity and mortality as well as long-term neurological sequelae. Despite being an important public health problem, very few extensive population-based studies were conducted so far in the world and none in Central Europe. Altogether 114 consecutive patients meeting the initial criteria for encephalitis were enrolled at the Warsaw Hospital for Infectious Diseases between June 2012 and July 2015. Eighteen patients were secondarily excluded from the analysis due to incomplete data or noinfectious cause. Potential pathogen sequences were searched for by molecular methods in the cerebrospinal fluid (CSF) and specific antibodies were detected in CSF and sera. An infectious agent was identified in 41 patients (42.7%). The most frequently diagnosed infections were Human herpesvirus 1 (HHV-1) (22 cases, 24%) followed by Enterovirus (6 cases, 6.3%), Varicella zoster virus (VZV) (5 cases, 5.2%), Tick-borne encephalitis virus (TBEV) (6 cases, 6.3%) and Cytomegalovirus (CMV) (2 cases, 2.1%). There were no cases of human adenovirus, Human herpesvirus 6 (HHV-6) or West Nile virus (WNV) infection identified. In 55 cases (57.3%) the cause of encephalitis remained unknown. Compared to patients in whom the diagnosis was determined the latter group contained more women, was less likely to manifest fever and had lower CSF pleocytosis (p < 0.05) In summary, we identified HHV-1 followed by Enterovirus, VZV and TBEV as the most common causes of encephalitis among adult patients in Poland. In a large proportion of patients the cause of encephalitis remained unknown.	[Popiel, Marta; Perlejewski, Karol; Bukowska-Osko, Iwona; Cortes, Kamila Caraballo; Pawelczyk, Agnieszka; Fic, Maria; Radkowski, Marek; Laskus, Tomasz] Warsaw Med Univ, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland; [Bednarska, Agnieszka; Lipowski, Dariusz; Horban, Andrzej] Warsaw Med Univ, Dept Infect Dis, Warsaw, Poland; [Bednarska, Agnieszka; Paciorek, Marcin; Jablonowska, Monika; Czeszko-Paprocka, Hanna] Hosp Infect Dis, Warsaw, Poland; [Dzieciatkowski, Tomasz] Warsaw Med Univ, Dept Microbiol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Laskus, T (corresponding author), Warsaw Med Univ, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland.	tlaskus@yahoo.com	Pawełczyk, Agnieszka/M-4934-2018; Bukowska-Ośko, Iwona/V-3859-2018; Dzieciatkowski, Tomasz/AAG-5382-2021; Perlejewski, Karol/V-3854-2018; Cortés, Kamila Caraballo/ABB-9291-2020; Caraballo Cortes, Kamila/W-2011-2018; Radkowski, Marek/V-3860-2018	Pawełczyk, Agnieszka/0000-0001-9336-8258; Bukowska-Ośko, Iwona/0000-0002-0216-7184; Perlejewski, Karol/0000-0002-3782-6442; Cortés, Kamila Caraballo/0000-0002-7924-7852; Caraballo Cortes, Kamila/0000-0002-7924-7852; Radkowski, Marek/0000-0003-1808-679X	Narodowe Centrum Nauki [N/N401/646940, N/NZ6/00961]; Fundacja Nauki Polskie [POMOST/2013-7/2]	Narodowe Centrum Nauki(National Science Centre, Poland); Fundacja Nauki Polskie	This study was supported by Narodowe Centrum Nauki (NC) grants no. N/N401/646940 (TL) and N/NZ6/00961 (MP) and Fundacja Nauki Polskiej no. POMOST/2013-7/2 (IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INF DIS POIS PO 2015; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Davies NWS, 2005, J NEUROL NEUROSUR PS, V76, P82, DOI 10.1136/jnnp.2004.045336; de Ory F, 2013, J MED VIROL, V85, P554, DOI 10.1002/jmv.23470; Dobler G, 2012, WIEN MED WOCHENSCHR, V162, P230, DOI 10.1007/s10354-012-0100-5; Dzieciqtkowski Tomasz, 2008, Medycyna Doswiadczalna i Mikrobiologia, V60, P259; Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330; Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65; Granerod J, 2007, NEUROPSYCHOL REHABIL, V17, P406, DOI 10.1080/09602010600989620; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Griffin DE, 2010, PROG NEUROBIOL, V91, P95, DOI 10.1016/j.pneurobio.2009.12.003; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Jablonska J, 2016, CENT EUR J IMMUNOL, V41, P383, DOI 10.5114/ceji.2016.65137; Kierat Szymon, 2012, Medycyna Doswiadczalna i Mikrobiologia, V64, P139; Les Katarzyna, 2010, Medycyna Doswiadczalna i Mikrobiologia, V62, P245; Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000; Lipowski D, 2017, J INFECT DIS, V215, P896, DOI 10.1093/infdis/jix040; Machura Paulina, 2015, Medycyna Doswiadczalna i Mikrobiologia, V67, P125; Mailles A, 2009, CLIN INFECT DIS, V49, P1838, DOI 10.1086/648419; Mantke  ODonoso, 2008, EURO SURVEILL, V13; Niczyporuk JS, 2011, POL J VET SCI, V14, P573, DOI 10.2478/v10181-011-0085-9; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Polkowska Aleksandra, 2011, Przegl Epidemiol, V65, P213; Rynans S, 2015, ARCH IMMUNOL THER EX, V63, P79, DOI 10.1007/s00005-014-0320-z; Solomon Tom, 2007, Pract Neurol, V7, P288, DOI 10.1136/jnnp.2007.129098; Sonneville R, 2009, J INFECTION, V58, P321, DOI 10.1016/j.jinf.2009.02.011; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780	34	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178481	10.1371/journal.pone.0178481	http://dx.doi.org/10.1371/journal.pone.0178481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570620	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800059
J	Mizuno, S; Arai, M; Todoko, F; Yamada, E; Goto, K				Mizuno, Sahiro; Arai, Mari; Todoko, Fumihiko; Yamada, Eri; Goto, Kazushige			Wearing lower-body compression garment with medium pressure impaired exercise induced performance decrement during prolonged running	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; STOCKINGS; RESPONSES; MUSCLE; RUNNERS; RECOVERY; FATIGUE; LIMB; PH	Objective To investigate the effect of wearing a lower body compression garment (CG) exerting different pressure levels during prolonged running on exercise-induced muscle damage and the inflammatory response. Methods Eight male participants completed three exercise trials in a random order. The exercise consisted of 120 min of uphill running at 60% of VO(2)max. The exercise trials included 1) wearing a lower-body CG with 30 mmHg pressure [HIGH]; 2) wearing a lower-body CG with 15 mmHg pressure [MED]; and 3) wearing a lower-body garment with < 5 mmHg pressure [CON]. Heart rate (HR), and rate of perceived exertion for respiration and legs were monitored continuously during exercise. Time-course change in jump height was evaluated before and immediately after exercise. Blood samples were collected to determine blood glucose, lactate, serum creatine kinase, myoglobin, free fatty acids, glycerol, cortisol, and plasma interleukin-6 (IL-6) concentrations before exercise, 60 min of the 120 min exercise period, immediately after exercise, and 60 min after exercise. Results Jump height was significantly higher immediately after the exercise in the MED trial compared with that in the HIGH trial (P=0.04). Mean HR during the 120 min exercise was significantly lower in the MED trial (162 +/- 4 bpm) than that in the CON trial (170 +/- 4 bpm, P=0.01). Plasma IL-6 concentrations increased significantly with exercise in all trials, but the area under the curve during exercise was significantly lower in the MED trial (397 +/- 58 pg/ m1.120 min) compared with that in the CON trial (670 +/- 86 pg/m1.120 min, P=0.04). Conclusion Wearing a lower body CG exerting medium pressure (approximately 15 mmHg) significantly attenuated decrease in jump performance than that with wearing a lower body CG exerting high pressure (approximately 30 mmHg). Furthermore, exercise-induced increases in HR and the inflammatory response were significantly smaller with CG exerted 15mmHg than that with garment exerted < 5 mmHg.	[Mizuno, Sahiro] Ritsumeikan Univ, Grad Sch Sports & Hlth Sci, Kusatsu, Shiga, Japan; [Arai, Mari; Todoko, Fumihiko; Yamada, Eri] DESCENTE Ltd, Osaka, Japan; [Goto, Kazushige] Ritsumeikan Univ, Fac Sports & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Ritsumeikan University	Goto, K (corresponding author), Ritsumeikan Univ, Fac Sports & Hlth Sci, Kusatsu, Shiga, Japan.	kagoto@fc.ritsumei.ac.jp	Mizuno, Sahiro/P-9238-2019	Mizuno, Sahiro/0000-0001-5866-8247	Ishimoto Memorialfoundation for the Promotion of Sports Science; Japan Society for the Promotion of Science [15K12660]	Ishimoto Memorialfoundation for the Promotion of Sports Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Ishimoto Memorialfoundation for the Promotion of Sports Science (http://www.descente.co.jp/ishimoto/) and the Japan Society for the Promotion of Science, Grant number; 15K12660 (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, J STRENGTH COND RES, V25, P1385, DOI 10.1519/JSC.0b013e3181d6848e; Ali A, 2010, EUR J APPL PHYSIOL, V109, P1017, DOI 10.1007/s00421-010-1447-1; Barwood MJ, 2013, INT J SPORT PHYSIOL, V8, P527, DOI 10.1123/ijspp.8.5.527; Beliard S, 2015, J SPORT SCI MED, V14, P75; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Born DP, 2013, INT J SPORT PHYSIOL, V8, P4, DOI 10.1123/ijspp.8.1.4; Bringard A, 2006, INT J SPORTS MED, V27, P373, DOI 10.1055/s-2005-865718; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043280; Doan BK, 2003, J SPORT SCI, V21, P601, DOI 10.1080/0264041031000101971; Engel FA, 2016, SPORTS MED, V46, P1939, DOI 10.1007/s40279-016-0546-5; Ibegbuna V, 2003, J VASC SURG, V37, P420, DOI 10.1067/mva.2003.104; Kemmler W, 2009, J STRENGTH COND RES, V23, P101, DOI 10.1519/JSC.0b013e31818eaef3; LAWRENCE D, 1980, BRIT J SURG, V67, P119, DOI 10.1002/bjs.1800670214; Lovell DI, 2011, J STRENGTH COND RES, V25, P3264, DOI 10.1519/JSC.0b013e31821764f8; MacRae BA, 2012, EUR J APPL PHYSIOL, V112, P1783, DOI 10.1007/s00421-011-2146-2; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; Miyamoto N, 2014, MED SCI SPORT EXER, V46, P2168, DOI 10.1249/MSS.0000000000000330; NIELSEN HV, 1983, ACTA PHYSIOL SCAND, V119, P253, DOI 10.1111/j.1748-1716.1983.tb07335.x; Nieman DC, 2014, BRAIN BEHAV IMMUN, V39, P180, DOI 10.1016/j.bbi.2013.09.004; Nishiyasu T, 2000, J APPL PHYSIOL, V88, P300, DOI 10.1152/jappl.2000.88.1.300; Rassier DE, 2002, J APPL PHYSIOL, V92, P1293, DOI 10.1152/japplphysiol.00912.2001; Sperlich B, 2011, PHLEBOLOGY, V26, P102, DOI 10.1258/phleb.2010.010017; Sperlich B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060923; Stickford ASL, 2015, INT J SPORT PHYSIOL, V10, P76, DOI 10.1123/ijspp.2014-0003; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Vecruyssen F, 2016, INT J SPORT PHYSIOL, P1; Vercruyssen F, 2014, EUR J SPORT SCI, V14, P144, DOI 10.1080/17461391.2012.730062; Wahl P, 2012, EUR J APPL PHYSIOL, V112, P2163, DOI 10.1007/s00421-011-2186-7; Westerblad H, 1997, J PHYSIOL-LONDON, V500, P193, DOI 10.1113/jphysiol.1997.sp022009	30	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178620	10.1371/journal.pone.0178620	http://dx.doi.org/10.1371/journal.pone.0178620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562650	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700078
J	Bibollet-Bahena, O; Okafuji, T; Hokamp, K; Tear, G; Mitchell, KJ				Bibollet-Bahena, Olivia; Okafuji, Tatsuya; Hokamp, Karsten; Tear, Guy; Mitchell, Kevin J.			A dual-strategy expression screen for candidate connectivity labels in the developing thalamus	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RECOGNITION MOLECULE NB-3; GENE-EXPRESSION; THALAMOCORTICAL AXONS; IMMUNOGLOBULIN SUPERFAMILY; PARAFASCICULAR NUCLEUS; ADHESION MOLECULES; NEURONAL MIGRATION; CLASSIC CADHERINS; SYNAPSE FORMATION	The thalamus or "inner chamber" of the brain is divided into 30 discrete nuclei, with highly specific patterns of afferent and efferent connectivity. To identify genes that may direct these patterns of connectivity, we used two strategies. First, we used a bioinformatics pipeline to survey the predicted proteomes of nematode, fruitfly, mouse and human for extracellular proteins containing any of a list of motifs found in known guidance or connectivity molecules. Second, we performed clustering analyses on the Allen Developing Mouse Brain Atlas data to identify genes encoding surface proteins expressed with temporal profiles similar to known guidance or connectivity molecules. In both cases, we then screened the resultant genes for selective expression patterns in the developing thalamus. These approaches identified 82 candidate connectivity labels in the developing thalamus. These molecules include many members of the Ephrin, Eph-receptor, cadherin, protocadherin, semaphorin, plexin, Odz/teneurin, Neto, cerebellin, calsyntenin and Netrin-G families, as well as diverse members of the immunoglobulin (Ig) and leucine-rich receptor (LRR) superfamilies, receptor tyrosine kinases and phosphatases, a variety of growth factors and receptors, and a large number of miscellaneous membrane-associated or secreted proteins not previously implicated in axonal guidance or neuronal connectivity. The diversity of their expression patterns indicates that thalamic nuclei are highly differentiated from each other, with each one displaying a unique repertoire of these molecules, consistent with a combinatorial logic to the specification of thalamic connectivity.	[Bibollet-Bahena, Olivia; Okafuji, Tatsuya; Hokamp, Karsten; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Tear, Guy] Kings Coll London, Dept Dev Neurobiol, New Hunts House,Guys Campus, London, England; [Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland	Trinity College Dublin; University of London; King's College London; Trinity College Dublin	Mitchell, KJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.; Mitchell, KJ (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland.	Kevin.Mitchell@tcd.ie		Tear, Guy/0000-0002-3114-7537; Hokamp, Karsten/0000-0001-7464-2370	Wellcome Trust [075264/A/04/Z]; Science Foundation Ireland [07/IN.1/B969, 09/IN.1/B2614]; Fonds de recherche Sante Quebec [23980]; BBSRC [BB/K002031/1, BB/F014287/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F014287/1, BB/K002031/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fonds de recherche Sante Quebec; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants to KJM and GT from the Wellcome Trust (075264/A/04/Z) and Science Foundation Ireland (07/IN.1/B969 and 09/IN.1/B2614) and to OBB from the Fonds de recherche Sante Quebec (23980).; The authors would like to thank Dr. Jackie Dolan for help in managing animal colonies and all the animal facility staff at Trinity College Dublin. This work was supported by grants to KJM from the Wellcome Trust (075264/A/04/Z) and Science Foundation Ireland (07/IN.1/B969 and 09/IN.1/B2614) and to OBB from the Fonds de recherche Sante Quebec (23980).	Andreae LC, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-27; Aruga J, 2003, GENE EXPR PATTERNS, V3, P727, DOI 10.1016/S1567-133X(03)00141-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu R, 2015, CELL ADHES MIGR, V9, P193, DOI 10.1080/19336918.2014.1000072; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Burazin TCD, 1999, MOL BRAIN RES, V73, P151, DOI 10.1016/S0169-328X(99)00217-X; Carcea I, 2014, P NATL ACAD SCI USA, V111, P13978, DOI 10.1073/pnas.1408680111; Chatterjee M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00066; Cheng J, 1997, J BIOL CHEM, V272, P7264, DOI 10.1074/jbc.272.11.7264; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Copits BA, 2012, NAT REV NEUROSCI, V13, P675, DOI 10.1038/nrn3335; de Wit J, 2016, NAT REV NEUROSCI, V17, P22, DOI 10.1038/nrn.2015.3; de Wit J, 2014, TRENDS NEUROSCI, V37, P539, DOI 10.1016/j.tins.2014.07.004; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Demyanenko GP, 2011, J NEUROSCI, V31, P1545, DOI 10.1523/JNEUROSCI.4467-10.2011; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Frei JA, 2014, EUR J NEUROSCI, V39, P1752, DOI 10.1111/ejn.12544; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Fukazawa N, 2008, MOL CELL BIOL, V28, P4494, DOI 10.1128/MCB.00074-08; Fukunishi A, 2011, J NEUROCHEM, V118, P1008, DOI 10.1111/j.1471-4159.2011.07390.x; Garcia-Gallastegui P, 2014, BIOL CELL, V106, P237, DOI 10.1111/boc.201300086; Garel S, 2014, CURR OPIN NEUROBIOL, V27, P143, DOI 10.1016/j.conb.2014.03.013; Gerstmann K, 2015, DEVELOPMENT, V142, P140, DOI 10.1242/dev.104927; Gil OD, 2002, J COMP NEUROL, V453, P372, DOI 10.1002/cne.10424; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Guijarro P, 2013, DEV NEUROBIOL, V73, P871, DOI 10.1002/dneu.22107; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Hansen M, 2013, NEUROCHEM RES, V38, P1236, DOI 10.1007/s11064-013-0999-y; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Hokamp K, 2004, ARRAYPIPE FLEXIBLE P, V32; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Hsieh CP, 2015, DEV NEUROBIOL, V75, P463, DOI 10.1002/dneu.22236; Ishikawa T, 2011, DEV DYNAM, V240, P96, DOI 10.1002/dvdy.22496; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Jones EG, 2004, J COMP NEUROL, V477, P55, DOI 10.1002/cne.20234; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kegel L, 2013, ASN NEURO, V5, DOI 10.1042/AN20120095; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kim YJ, 2012, GENE DEV, V26, P974, DOI 10.1101/gad.185165.111; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lam YW, 2011, J NEUROSCI, V31, P6791, DOI 10.1523/JNEUROSCI.3073-10.2011; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2014, SEMIN CELL DEV BIOL, V35, P173, DOI 10.1016/j.semcdb.2014.08.007; Lee K, 2013, P NATL ACAD SCI USA, V110, P336, DOI 10.1073/pnas.1219987110; Lee S, 2000, GENE, V245, P253, DOI 10.1016/S0378-1119(00)00031-7; Lehigh KM, 2013, GENE EXPR PATTERNS, V13, P454, DOI 10.1016/j.gep.2013.08.002; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Letunic I, 2014, SMART RECENT UPDATES; Liscovitch N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003185; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Lush ME, 2005, INT J DEV NEUROSCI, V23, P523, DOI 10.1016/j.ijdevneu.2005.04.003; Marcos-Mondejar P, 2012, J NEUROSCI, V32, P4372, DOI 10.1523/JNEUROSCI.5851-11.2012; Martin EA, 2015, ELIFE, V4, DOI 10.7554/eLife.09395; Matsukawa H, 2014, J NEUROSCI, V34, P15779, DOI 10.1523/JNEUROSCI.1141-14.2014; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mishra A, 2014, J NEUROSCI, V34, P4187, DOI 10.1523/JNEUROSCI.3671-13.2014; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; Mosca TJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00204, 10.3389/fncel.2015.00204]; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakagawa Y, 2001, J NEUROSCI, V21, P2711, DOI 10.1523/JNEUROSCI.21-08-02711.2001; Nakagawa Y, 2012, EUR J NEUROSCI, V35, P1554, DOI 10.1111/j.1460-9568.2012.08089.x; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nguyen DNT, 1997, DEVELOPMENT, V124, P3303; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Perez-Branguli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158686; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettem KL, 2013, J CELL BIOL, V200, P321, DOI 10.1083/jcb.201206028; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Poskanzer K, 2003, J NEUROSCI, V23, P2294; Price DJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00037; Prince JEA, 2013, DEVELOPMENT, V140, P2398, DOI 10.1242/dev.087262; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Robichaux MA, 2014, P NATL ACAD SCI USA, V111, P2188, DOI 10.1073/pnas.1324215111; Rubio-Garrido P, 2009, CEREB CORTEX, V19, P2380, DOI 10.1093/cercor/bhn259; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Sakurai K, 2010, NEUROSCI LETT, V473, P102, DOI 10.1016/j.neulet.2010.02.027; Sakurai K, 2009, DEV NEUROBIOL, V69, P811, DOI 10.1002/dneu.20742; Sato H, 2012, J NEUROSCI, V32, P15388, DOI 10.1523/JNEUROSCI.0293-12.2012; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seppala EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002194; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Smith Y, 2015, MOVEMENT DISORD, V30, P293, DOI 10.1002/mds.26095; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sotomayor M, 2014, TRENDS CELL BIOL, V24, P524, DOI 10.1016/j.tcb.2014.03.007; Su JM, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-11; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Suzuki-Hirano A, 2011, J COMP NEUROL, V519, P528, DOI 10.1002/cne.22531; Tai AX, 2014, NEUROSCIENCE, V274, P409, DOI 10.1016/j.neuroscience.2014.05.039; Takeda Y, 2003, J NEUROBIOL, V56, P252, DOI 10.1002/neu.10222; Takeuchi A, 2007, CEREB CORTEX, V17, P1531, DOI 10.1093/cercor/bhl064; Taniguchi Y, 1999, BLOOD, V94, P539, DOI 10.1182/blood.V94.2.539.414k40_539_549; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Tossell K, 2011, DEV BIOL, V352, P341, DOI 10.1016/j.ydbio.2011.02.002; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Tran H, 2015, EUR J NEUROSCI, V41, P55, DOI 10.1111/ejn.12767; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Um JW, 2014, CELL REP, V6, P1096, DOI 10.1016/j.celrep.2014.02.010; Uziel D, 2006, ANAT REC PART A, V288A, P135, DOI 10.1002/ar.a.20286; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yang XF, 2014, PROTEIN CELL, V5, P420, DOI 10.1007/s13238-014-0054-z; Yuge K, 2011, J COMP NEUROL, V519, P544, DOI 10.1002/cne.22532; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498	138	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177977	10.1371/journal.pone.0177977	http://dx.doi.org/10.1371/journal.pone.0177977			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558017	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000019
J	Liu, J; Zhang, B; Li, MT; Zhou, MJ; Li, F; Huang, XX; Pan, M; Xue, L; Yan, F				Liu, Jia; Zhang, Bo; Li, Maotong; Zhou, Meijun; Li, Fei; Huang, Xiuxian; Pan, Min; Xue, Li; Yan, Fei			Preparation and characterization of a novel silicon-modified nanobubble	PLOS ONE			English	Article							ULTRASOUND CONTRAST AGENTS; DRUG-DELIVERY; BREAST-CANCER; MICROBUBBLES; TUMOR; NANOSTRUCTURES; CHEMOTHERAPY; NANODROPLETS; GENE	Nanobubbles (NBs) opened a new field of ultrasound imaging. There is still no practical method to control the diameter of bubbles. In this study, we developed a new method to control the size by incorporating of silicon hybrid lipids into the bubble membrane. The range of particle size of resulting NBs is between 523.02 +/- 46.45 to 857.18 +/- 82.90, smaller than the conventional microbubbles. The size of resulting NBs increased with the decrease in amount of silicon hybrid lipids, indicating the diameter of NBs can be regulated through modulating the ratio of silicon hybrid lipids in the bubble shell. Typical harmonic signals could be detected. The in vitro and in vivo ultrasound imaging experiments demonstrated these silicon-modified NBs had significantly improved ultrasound contrast enhancement abilities. Cytotoxicity assays revealed that these NBs had no obvious cytotoxicity to the 293 cell line at the tested bubble concentration. Our results showed that the novel NBs could use as nanoscale ultrasound contrast agents, providing the foundation for NBs in future applications including contrast- enhanced imaging and drug/gene delivery.	[Liu, Jia; Xue, Li] Harbin Med Univ, Dept Echocardiog, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Zhang, Bo] Tongji Univ, Dept Echocardiog, Shanghai Eastern Hosp, Shanghai, Peoples R China; [Li, Maotong] Harbin Med Univ, Affiliated Hosp 1, CT Room, Harbin, Peoples R China; [Zhou, Meijun] Southern Med Univ, Dept Ultrasonog, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Fei; Huang, Xiuxian; Yan, Fei] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Pan, Min] Guangzhou Univ Chinese Med, Dept Echocardiog, Shenzhen Hosp, Shenzhen, Peoples R China	Harbin Medical University; Tongji University; Harbin Medical University; Southern Medical University - China; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Guangzhou University of Chinese Medicine	Xue, L (corresponding author), Harbin Med Univ, Dept Echocardiog, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China.; Yan, F (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	toxueli@163.com; fei.yan@siat.ac.cn			National Key Basic Research Program of China (973Program) [2014CB744502, 2013CB733804]; National Natural Science Foundation of China [81571690, 81371563, 81571701, 81571693]; Shenzhen Science and Technology Innovation Committee [JCYJ20150521144321010, JCYJ20150331091304763]	National Key Basic Research Program of China (973Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee	The authors gratefully acknowledge support for this research from National Key Basic Research Program of China (973Program) (Grant Nos. 2014CB744502, 2013CB733804 to FY), National Natural Science Foundation of China (GrantNos. 81571690 to LX, 81371563 and 81571701 to FY, 81571693 to BZ), Shenzhen Science and Technology Innovation Committee grants: (JCYJ20150521144321010 to FY and JCYJ20150331091304763 to MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlkanOnyuksel H, 1996, J PHARM SCI, V85, P486, DOI 10.1021/js950407f; Aydin O, 2016, MOL PHARMACEUT, V13, P4054, DOI 10.1021/acs.molpharmaceut.6b00617; Bachawal SV, 2013, CANCER RES, V73, P1689, DOI 10.1158/0008-5472.CAN-12-3391; Bartolotta TV, 2011, INVEST RADIOL, V46, P106, DOI 10.1097/RLI.0b013e3181f44184; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; Dai Z, 2009, CHEM COMMUN, V15, P2032; de Jong N, 2002, ECHOCARDIOGR-J CARD, V19, P229, DOI 10.1046/j.1540-8175.2002.00229.x; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442; Flegg MB, 2010, PHYS MED BIOL, V55, P3061, DOI 10.1088/0031-9155/55/11/005; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hwang TL, 2009, J PHARM SCI-US, V98, P3735, DOI 10.1002/jps.21687; Katagiri K, 2007, CHEM-EUR J, V13, P5272, DOI 10.1002/chem.200700175; Kim C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3302808; Krupka TM, 2010, MOL PHARMACEUT, V7, P49, DOI 10.1021/mp9001816; Lakshmanan A, 2016, ACS NANO, V10, P7314, DOI 10.1021/acsnano.6b03364; Lanza GM, 2001, PROG CARDIOVASC DIS, V44, P13, DOI 10.1053/pcad.2001.26440; Lanza GM, 1997, ULTRASOUND MED BIOL, V23, P863, DOI 10.1016/S0301-5629(97)00046-X; Marxer EEJ, 2011, EUR J PHARM BIOPHARM, V77, P430, DOI 10.1016/j.ejpb.2010.12.007; Oeffinger BE, 2004, ULTRASONICS, V42, P343, DOI 10.1016/j.ultras.2003.11.011; Paproski RJ, 2017, CANCER RES, V77, P3, DOI 10.1158/0008-5472.CAN-15-3231; Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0; Quaia E, 2011, EUR RADIOL, V21, P457, DOI 10.1007/s00330-010-2007-0; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Shapiro MG, 2014, NAT NANOTECHNOL, V9, P311, DOI [10.1038/nnano.2014.32, 10.1038/NNANO.2014.32]; Tian JL, 2015, ACS APPL MATER INTER, V7, P26579, DOI 10.1021/acsami.5b07778; Watanabe Y, 2010, J NUCL MED, V51, P951, DOI 10.2967/jnumed.109.074443; Wheatley MA, 2006, ULTRASOUND MED BIOL, V32, P83, DOI 10.1016/j.ultrasmedbio.2005.08.009; Xing ZW, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/14/145607; Yan F, 2015, ULTRASOUND MED BIOL, V41, P2765, DOI 10.1016/j.ultrasmedbio.2015.05.023; Yan F, 2012, ULTRASOUND MED BIOL, V38, P670, DOI 10.1016/j.ultrasmedbio.2011.12.025; Yan F, 2011, ULTRASOUND MED BIOL, V37, P768, DOI 10.1016/j.ultrasmedbio.2011.02.006; Yang HL, 2015, BIOMATERIALS, V37, P279, DOI 10.1016/j.biomaterials.2014.10.013; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830; Zong YJ, 2006, ULTRASONICS, V44, pE119, DOI 10.1016/j.ultras.2006.06.005	36	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178031	10.1371/journal.pone.0178031	http://dx.doi.org/10.1371/journal.pone.0178031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557995	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000023
J	Hui, M; Song, CW; Liu, Y; Li, CL; Cui, ZX				Hui, Min; Song, Chengwen; Liu, Yuan; Li, Chaolun; Cui, Zhaoxia			Exploring the molecular basis of adaptive evolution in hydrothermal vent crab Austinograea alayseae by transcriptome analysis	PLOS ONE			English	Article							RNA-SEQ DATA; SCYLLA-PARAMAMOSAIN; GENE-EXPRESSION; MUD CRAB; CRUSTACEA; PROTEINS; DECAPODA; SEQUENCE; BYTHOGRAEIDAE; THIOREDOXIN	Elucidating the genetic mechanisms of adaptation to the hydrothermal vent in organisms at genomic level is significant for understanding the adaptive evolution process in the extreme environment. We performed RNA-seq on four different tissues of a vent crab species, Austi-nograea alayseae, producing 725,461 unigenes and 134,489 annotated genes. Genes related to sensory, circadian rhythm, hormone, hypoxia stress, metal detoxification and immunity were identified. It was noted that in the degenerated eyestalk, transcription of phototransduction related genes which are important for retinal function was greatly reduced; three crucial neuropeptide hormones, one molt-inhibiting and two crustacean hyperglycemic hormone precursors were characterized with conserved domains; hypoxia-inducible factor 1 and two novel isoforms of metallothioneins in the vent crabs were discovered. An analysis of 6,932 orthologs among three crabs A. alayseae, Portunus trituberculutus and Eriocheir sinensis revealed 19 positive selected genes (PSGs). Most of the PSGs were involved in immune responses, such as crustins and anti-lipopolysaccharide factor, suggesting their function in the adaptation to environment. The characterization of the first vent crab transcriptome provides abundant resources for genetic and evolutionary studies of this species, and paves the way for further investigation of vent adaptation process in crabs.	[Hui, Min; Song, Chengwen; Liu, Yuan; Li, Chaolun; Cui, Zhaoxia] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Cui, Zhaoxia] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Cui, Zhaoxia] Natl & Local Joint Engn Lab Ecol Maricultu, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology	Cui, ZX (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.; Cui, ZX (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Cui, ZX (corresponding author), Natl & Local Joint Engn Lab Ecol Maricultu, Qingdao, Peoples R China.	zhxcui@qdio.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chaolun/0000-0003-1890-0587	Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02]; National Natural Science Foundation of China [31302187]	Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Scientific and Technological Innovation Project of Qingdao National Laboratory for Marine Science and Technology (No.2015ASKJ02, http://www.gnlm.ac/index) to ZC, and the National Natural Science Foundation of China (No.31302187, http://www.nsfc.gov.cr/) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaga-Cruz J. A., 2012, Journal of Aquaculture Research and Development, V3, P156; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Brown C, 2001, AFRICAN ZOOLOGY, V27, P119, DOI DOI 10.1080/15627020.2001.11657128; Carpene E, 2007, J TRACE ELEM MED BIO, V21, P35, DOI 10.1016/j.jtemb.2007.09.011; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Corey EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060551; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farca Luna Abud Jose, 2010, Front Biosci (Elite Ed), V2, P1414; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groh KC, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00266; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hardivillier A, 2004, COMP BIOCHEM PHYS C, V139, P111, DOI 10.1016/j.cca.2004.09.012; Hourdez S, 2005, J INORG BIOCHEM, V99, P130, DOI 10.1016/j.jinorgbio.2004.09.017; Hourdez S, 2002, J EXP BIOL, V205, P1669; Huang XS, 2014, ANIM REPROD SCI, V150, P139, DOI 10.1016/j.anireprosci.2014.09.004; Hui M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114187; Iseli C, 1999, P INT SYST MOL BIOL; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kim SJ, 2013, MOL ECOL RESOUR, V13, P781, DOI 10.1111/1755-0998.12119; Leignel V, 2008, COMP BIOCHEM PHYS C, V148, P6, DOI 10.1016/j.cbpc.2008.02.005; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Liu Y, 2011, FISH SHELLFISH IMMUN, V31, P29, DOI 10.1016/j.fsi.2011.02.016; Liu YA, 2011, FISH SHELLFISH IMMUN, V30, P583, DOI 10.1016/j.fsi.2010.12.005; Ma Yungfen, 2011, THESIS, V67, P467; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Mateos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032066; Meng FW, 2013, MOL BIOL EVOL, V30, P1527, DOI 10.1093/molbev/mst079; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Qian ZY, 2012, COMP BIOCHEM PHYS C, V156, P211, DOI 10.1016/j.cbpc.2012.06.001; Regoli F, 2005, ENVIRON TOXICOL CHEM, V24, P1475, DOI 10.1897/04-514R.1; Sainz-Hernandez JC, 2008, AQUACULTURE, V283, P188, DOI 10.1016/j.aquaculture.2008.07.002; Segonzac M, 2006, MARINE ECOLOGY, V27, P119; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 2007, SCI STKE, V2007, pcm8, DOI [10.1126/stke.4072007cm8, DOI 10.1126/STKE.4072007CM8]; Sheldon TJ, 2007, FEBS LETT, V581, P5268, DOI 10.1016/j.febslet.2007.10.016; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Stefanni S, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/267482; Strauss J, 2011, CELL MOL LIFE SCI, V68, P3403, DOI 10.1007/s00018-011-0636-3; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Sun SM, 2012, FISH SHELLFISH IMMUN, V33, P1222, DOI 10.1016/j.fsi.2012.09.023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toullec JY, 2002, PEPTIDES, V23, P31, DOI 10.1016/S0196-9781(01)00576-9; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Watthanasurorot A, 2011, PLOS PATHOG, V7, P265; Watthanasurorot A, 2011, CELL MOL LIFE SCI, V68, P315, DOI 10.1007/s00018-010-0458-8; WEISS RF, 1977, NATURE, V267, P600, DOI 10.1038/267600a0; WILLIAMS A B, 1980, Proceedings of the Biological Society of Washington, V93, P443; WILLIAMS DL, 1974, GEOPHYS J ROY ASTR S, V38, P587, DOI 10.1111/j.1365-246X.1974.tb05431.x; Wong YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16597; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Yang JS, 2010, ZOOL SCR, V39, P621, DOI 10.1111/j.1463-6409.2010.00442.x; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Yang JS, 2013, MOL BIOL EVOLUTION, V30; Yang W, 2013, PLOS ONE, V9; Yang YN, 2013, CELL STRESS CHAPERON, V18, P475, DOI 10.1007/s12192-013-0402-6; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yedery RD, 2009, FISH SHELLFISH IMMUN, V27, P275, DOI 10.1016/j.fsi.2009.05.009; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017	70	22	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178417	10.1371/journal.pone.0178417	http://dx.doi.org/10.1371/journal.pone.0178417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552991	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000045
J	Knudsen, KN; Lindebjerg, J; Nielsen, BS; Hansen, TF; Sorensen, FB				Kirsten Nguyen Knudsen; Lindebjerg, Jan; Nielsen, Boye Schnack; Hansen, Torben Frostrup; Sorensen, Flemming Brandt			MicroRNA-200b is downregulated in colon cancer budding cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LAMININ-5 GAMMA-2 CHAIN; COLORECTAL-CANCER; INVASIVE FRONT; EXPRESSION; EMT; PROGRESSION; CARCINOMA; FAMILY; IMMUNOHISTOCHEMISTRY	Background The microRNA-200 (miR-200) family acts as a major suppressor of epithelial-mesenchymal transition (EMT). Impaired miR-200 expression may lead to EMT initiation and eventually cancer dissemination. The presence of tumor budding cells (TBC) is associated with metastasis and poor prognosis, and molecular similarities to EMT indicate that these cells may reflect ongoing EMT. The aim of this study was to investigate the expression of miR-200b in budding cells of colon cancer and the relationship with the EMT-markers E-cadherin, beta-catenin and laminin-5 gamma 2. Material & methods MiR-200b was investigated by in situ hybridization in 58 cases of stage II (n = 36) and III colon (n = 22) cancers with tumor budding. Expression of E-cadherin, beta-catenin and laminin-5 gamma 2 was examined by immunohistochemistry. A multiplex fluorescence assay combining miR-200b with cytokeratin and laminin-5 gamma 2 was employed on a subset of 16 samples. Results MiR-200b was downregulated in the TBC at the invasive front of 41 out of 58 (71%) cases. The decline was present in both mismatch satellite stable and instable adenocarcinomas. The majority of cases also showed loss of membranous E-cadherin and increased nuclear beta-catenin in the TBC, while laminin-5 gamma 2 expression was upregulated at the invasive front and in the tumor buds of approximately half the adenocarcinomas. However, the miR-200b decline was not statistically associated with the expression of any of the EMT-markers. The miR-200b decline was also documented by multiplex fluorescence. Fourteen out of fifteen cases showed a decrease in miR-200b expression in the majority of the TBC, but no obvious relationship between miR-200b and laminin-5 gamma 2 expression was observed. Conclusion: The findings support the assumption of a miR-200b related downregulation in colon cancer budding cells. Whether miR-200b expression may be of clinical significance awaits further studies.	[Kirsten Nguyen Knudsen; Lindebjerg, Jan; Hansen, Torben Frostrup; Sorensen, Flemming Brandt] Part Lillebaelt Hosp, Vejle Hosp, Danish Colorectal Canc Ctr South, Kabbeltoft 25, Vejle, Denmark; [Kirsten Nguyen Knudsen; Lindebjerg, Jan; Sorensen, Flemming Brandt] Part Lillebaelt Hosp, Vejle Hosp, Dept Clin Pathol, Kabbeltoft 25, Vejle, Denmark; [Kirsten Nguyen Knudsen; Lindebjerg, Jan; Sorensen, Flemming Brandt] Univ Southern Denmark, Inst Reg Hlth Res, Winslowpk 19, Odense C, Denmark; [Nielsen, Boye Schnack] Bioneer AS, Kogle Alle 2, Horsholm, Denmark; [Hansen, Torben Frostrup] Part Lillebaelt Hosp, Vejle Hosp, Dept Oncol, Kabbeltoft 25, Vejle, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Bioneer A/S; University of Southern Denmark; Lillebaelt Hospital	Knudsen, KN (corresponding author), Part Lillebaelt Hosp, Vejle Hosp, Danish Colorectal Canc Ctr South, Kabbeltoft 25, Vejle, Denmark.; Knudsen, KN (corresponding author), Part Lillebaelt Hosp, Vejle Hosp, Dept Clin Pathol, Kabbeltoft 25, Vejle, Denmark.; Knudsen, KN (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Winslowpk 19, Odense C, Denmark.	kirsten.knudsen@rsyd.dk	Hansen, Torben Frøstrup/K-5583-2019	Hansen, Torben Frøstrup/0000-0001-7476-671X; Nguyen Knudsen, Kirsten/0000-0003-4258-4289; Sorensen, Flemming Brandt/0000-0002-5446-1035	Region of Southern Denmark's PhD Fund [12/6786]; University of Southern Denmark; Research Council of Lillebaelt Hospital; Aase and Ejnar Danielsen Foundation [10-000789]; Merchant Valdermar Foersom and wife Thyra Foersom Foundation; Frimodt-Heineke Foundation; Master Carpenter Jorgen Holm and Wife Elisa F Hansen Memorial Trust [48709]; Th. Maigaard's Successor Mrs. Lily Benthine Lund's Foundation [5652]	Region of Southern Denmark's PhD Fund; University of Southern Denmark; Research Council of Lillebaelt Hospital; Aase and Ejnar Danielsen Foundation; Merchant Valdermar Foersom and wife Thyra Foersom Foundation; Frimodt-Heineke Foundation; Master Carpenter Jorgen Holm and Wife Elisa F Hansen Memorial Trust; Th. Maigaard's Successor Mrs. Lily Benthine Lund's Foundation	This work was supported by Region of Southern Denmark's PhD Fund (12/6786), https://www.regionsyddamark.dk/wm325002; University of Southern Denmark, www.sdu.dk; The Research Council of Lillebaelt Hospital, http://www.sygehuslillebaelt.dk/wm321048; Aase and Ejnar Danielsen Foundation (10-000789), http://www.danielsensfond.dk/Default.aspx; Merchant Valdermar Foersom and wife Thyra Foersom Foundation; Frimodt-Heineke Foundation, http://frimodtheinekefonden.dk/; Master Carpenter Jorgen Holm and Wife Elisa F Hansen Memorial Trust (48709); and Th. Maigaard's Successor Mrs. Lily Benthine Lund's Foundation of June 1st 1978 (5652). All grants were given to KNK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aoki S, 2002, DIS COLON RECTUM, V45, P1520, DOI 10.1007/s10350-004-6460-1; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Dawson H, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00011; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; De Smedt L, 2016, VIRCHOWS ARCH, V468, P397, DOI 10.1007/s00428-015-1886-5; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Grigore AD, 2016, J CLIN MED, V5, P51, DOI 10.3390/jcm5050051; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Jensen DH, 2015, J PATHOL, V236, P505, DOI 10.1002/path.4550; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karamitopoulou E, 2013, MODERN PATHOL, V26, P295, DOI 10.1038/modpathol.2012.155; Kevans D, 2011, INT J SURG PATHOL, V19, P751, DOI 10.1177/1066896911414566; Koelzer VH, 2015, VIRCHOWS ARCH, V466, P485, DOI 10.1007/s00428-015-1740-9; Lenander C, 2001, ANAL CELL PATHOL, V22, P201, DOI 10.1155/2001/137404; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; Muto Y, 2016, INT J ONCOL, V49, P1057, DOI 10.3892/ijo.2016.3583; Nielsen Boye Schnack, 2013, Methods Mol Biol, V986, P353, DOI 10.1007/978-1-62703-311-4_22; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nielsen BS, 2012, MOLECULAR TRAITS OF; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Rogers AC, 2016, BRIT J CANCER, V115, P831, DOI 10.1038/bjc.2016.274; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Shinto E, 2006, DIS COLON RECTUM, V49, P1193, DOI 10.1007/s10350-006-0568-4; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Xie N, 2016, ONCOTARGET; Yamada N, 2017, HUM PATHOL, V60, P151, DOI 10.1016/j.humpath.2016.10.007; Zlobec I, 2007, VIRCHOWS ARCH, V451, P763, DOI 10.1007/s00428-007-0466-8; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199	34	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178564	10.1371/journal.pone.0178564	http://dx.doi.org/10.1371/journal.pone.0178564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552992	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000051
J	Mohamed, NV; Desjardins, A; Leclerc, N				Mohamed, Nguyen-Vi; Desjardins, Alexandre; Leclerc, Nicole			Tau secretion is correlated to an increase of Golgi dynamics	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE BRAIN; NEURONAL-ACTIVITY; HIPPOCAMPAL HYPERACTIVITY; CEREBROSPINAL-FLUID; TRANSGENIC MICE; BETA PRODUCTION; PURINE ANALOGS; AMYLOID-BETA	Tau protein can be released by neurons, an event linked to the propagation of Tau pathology in Alzheimer'disease (AD). Neuronal hyperexcitability was shown to significantly increase Tau release by neurons. We confirmed this in the present study. In a previous study, it was demonstrated that hyperexcitability induces Golgi apparatus dynamics resulting in its fragmentation. Our present results revealed that the increase of Tau secretion upon hyperexcitability could be significantly reduced by preventing Golgi dynamics through the inactivation of cdk5. We then verified whether a Golgi fragmentation not induced by hyperexcitability could also increase Tau secretion. The suppression of Rab1A, Rab GTPase associated with the Golgi membranes, known to induce a Golgi fragmentation increased Tau secretion by both neurons and HeLa cells. Although it remains to be demonstrated whether the Golgi is directly involved in Tau secretion, the present results demonstrate that its dynamics are correlated to a modulation of Tau secretion.	[Mohamed, Nguyen-Vi; Desjardins, Alexandre; Leclerc, Nicole] Univ Montreal, Ctr Rech, Ctr Hosp Univ Montreal Hosp CRCHUM, Dept Neurosci, Montreal, PQ, Canada	Universite de Montreal	Leclerc, N (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp Univ Montreal Hosp CRCHUM, Dept Neurosci, Montreal, PQ, Canada.	nicole.leclerc@umontreal.ca	Desjardins, Alexandre/K-6378-2012		Canadian Institute of Health Research [MOP-114874]; FRQS infrastructure grant	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); FRQS infrastructure grant	This work was supported by a grant from the Canadian Institute of Health Research [MOP-114874 to NL], and an FRQS infrastructure grant to the Groupe de Recherche sur le systeme nerveux central (GRSNC) to NL. N-VM. has a studentship from the GRSNC and the Faculte des Etudes Superieures et Post-Doctorales of University of Montreal (FESP).	Anton-Fernandez A, 2017, NEUROBIOL DIS, V97, P11, DOI 10.1016/j.nbd.2016.10.005; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Clavaguera F, 2015, NEUROPATH APPL NEURO, V41, P47, DOI 10.1111/nan.12197; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Coune PG, 2011, J PARKINSON DIS, V1, P373, DOI 10.3233/JPD-2011-11058; DalCanto MC, 1996, AM J PATHOL, V148, P355; Danielsen EM, 2003, BIOCHEMISTRY-US, V42, P14670, DOI 10.1021/bi0355239; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Dixit R, 2008, SCIENCE NEW YORK NY, V319, p1076 ; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Fan J, 2008, INT J DEV NEUROSCI, V26, P523, DOI 10.1016/j.ijdevneu.2008.05.006; Farah CA, 2006, CELL MOTIL CYTOSKEL, V63, P710, DOI 10.1002/cm.20157; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Haase G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00448; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Joshi G, 2014, P NATL ACAD SCI USA, V111, pE1230, DOI 10.1073/pnas.1320192111; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kanmert D, 2015, J NEUROSCI, V35, P10851, DOI 10.1523/JNEUROSCI.0387-15.2015; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kimura T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00065; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Liazoghli D, 2005, AM J PATHOL, V166, P1499, DOI 10.1016/S0002-9440(10)62366-8; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu SJ, 2015, INT REV CEL MOL BIO, V315, P1, DOI 10.1016/bs.ircmb.2014.12.002; Liu SL, 2016, MOL NEUROBIOL, V53, P4328, DOI 10.1007/s12035-015-9369-x; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Mohamed NV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05715; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P129, DOI 10.1080/0968768031000084172; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Simon D, 2012, NEURODEGENER DIS, V10, P73, DOI 10.1159/000334915; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Stieber A, 1996, AM J PATHOL, V148, P415; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Thayer DA, 2013, P NATL ACAD SCI USA, V110, P1482, DOI 10.1073/pnas.1220978110; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; Walker LC, 2012, ARCH NEUROL-CHICAGO, P1; Wu DC, 2000, NEUROCHEM RES, V25, P923, DOI 10.1023/A:1007544106645; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Wu JW, 2016, NAT NEUROSCI; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	74	31	33	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178288	10.1371/journal.pone.0178288	http://dx.doi.org/10.1371/journal.pone.0178288			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552936	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000033
J	Prada, ETA; Orth, M; Nolting, S; Spottl, G; Maurer, J; Auernhammer, C				Prada, Elke Tatjana Aristizabal; Orth, Michael; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian; Auernhammer, Christoph			The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells	PLOS ONE			English	Article							OXIDATIVE STRESS; RADIATION ONCOLOGY; CANCER-TREATMENT; MTOR INHIBITORS; DNA-DAMAGE; DNTP POOL; PATHWAY; RESISTANCE; THERAPY; GROWTH	Modulation of the redox system in cancer cells has been considered a promising target for anti-cancer therapy. The novel MTH1 inhibitor TH588 proved tremendous potential in terms of cancer cell eradication, yet its specificity has been questioned by recent reports, indicating that TH588 may also induce cancer cell death by alternative mechanisms than MTH1 inhibition. Here we used a panel of heterogeneous neuroendocrine tumor cells in order to assess cellular mechanisms and molecular signaling pathways implicated in the effects of TH588 alone as well as dual-targeting approaches combining TH588 with everolimus, cytotoxic 5-fluorouracil or Y-irradiation. Our results reflect that TH588 alone efficiently decreased the survival of neuroendocrine cancer cells by PI3K-Akt-mTOR axis downregulation, increased apoptosis and oxidative stress. However, in the dual-targeting approaches cell survival was further decreased due to an even stronger downregulation of the PI3K-Akt-mTOR axis and augmentation of apoptosis but not oxidative stress. Furthermore, we could attribute TH588 chemo- and radio-sensitizing properties. Collectively our data not only provide insights into how TH588 exactly kills cancer cells but also depict novel perspectives for combinatorial treatment approaches encompassing TH588.	[Prada, Elke Tatjana Aristizabal; Noelting, Svenja; Spoettl, Gerald; Maurer, Julian; Auernhammer, Christoph] Ludwig Maximilians Univ Munchen, Interdisciplinary Ctr Neuroendocrine Tumours Gast, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Bavaria, Germany; [Orth, Michael] Ludwig Maximilians Univ Munchen, Dept Radiat Oncol, Campus Grosshadern, Bavaria, Germany	University of Munich; University of Munich	Auernhammer, C (corresponding author), Ludwig Maximilians Univ Munchen, Interdisciplinary Ctr Neuroendocrine Tumours Gast, Univ Hosp, Dept Internal Med 2, Campus Grosshadern, Bavaria, Germany.	christoph.auernhammer@med.uni-muenchen.de	Orth, Michael/AAQ-7299-2021	Orth, Michael/0000-0002-4608-7151; Nolting, Svenja/0000-0002-7064-590X				Babu V, 2013, PANCREAS, V42, P912, DOI 10.1097/MPA.0b013e31827ae993; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; Cakir M, 2011, EXPERT OPIN THER TAR, V15, P457, DOI 10.1517/14728222.2011.555403; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Capozzi M, 2015, INT J SURG, V21, pS89, DOI 10.1016/j.ijsu.2015.06.064; Chan DL, 2017, THER ADV GASTROENTER, V10, P132, DOI 10.1177/1756283X16674660; CHENG KC, 1992, J BIOL CHEM, V267, P166; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Georgakilas AG, 2012, CANCER LETT, V327, P3, DOI 10.1016/j.canlet.2012.03.032; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; He K, 2016, ONCOTARGET; Hennel R, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-85; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kawamura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26521; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Kolby L, 2001, AM J PATHOL, V158, P745, DOI 10.1016/S0002-9440(10)64017-5; Kong LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137888; Leung EY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131400; Luo MH, 2010, ANTIOXID REDOX SIGN, V12, P1247, DOI 10.1089/ars.2009.2698; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nolting S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143830; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Orth M, 2014, RADIAT ENVIRON BIOPH, V53, P1, DOI 10.1007/s00411-013-0497-2; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Petrocchi A, 2016, BIOORG MED CHEM LETT, V26, P1503, DOI 10.1016/j.bmcl.2016.02.026; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Reuther C, 2016, NEUROENDOCRINOLOGY, V103, P383, DOI 10.1159/000439431; Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shipkova M, 2016, THER DRUG MONIT, V38, P143, DOI 10.1097/FTD.0000000000000260; Spampatti M, 2014, WORLD J GASTROENTERO, V20, P10038, DOI 10.3748/wjg.v20.i29.10038; Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tu YY, 2016, AM J TRANSL RES, V8, P2803; Vandamme T, 2016, BRIT J CANCER, V114, P650, DOI 10.1038/bjc.2016.25; Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wang JY, 2016, J INVESTIGATIVE DERM; Warpman Berglund U, 2016, ANN ONCOLOGY OFFICIA; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2016, J CLIN ONCOLOGY OFFI; Zatelli MC, 2016, ENDOCR-RELAT CANCER, V23, pR173, DOI 10.1530/ERC-15-0413; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zitzmann K, 2007, NEUROENDOCRINOLOGY, V85, P54, DOI 10.1159/000100057	51	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178375	10.1371/journal.pone.0178375	http://dx.doi.org/10.1371/journal.pone.0178375			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542590	Green Published, Green Accepted, gold			2022-12-26	WOS:000402062800083
J	Yu, GM; Kubota, H; Okita, M; Maeda, T				Yu, Guang-Min; Kubota, Hirokazu; Okita, Miki; Maeda, Teruo			The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED MASTITIS; ACUTE-PHASE PROTEINS; OXIDATIVE STRESS; AMNIOTIC-FLUID; EXPRESSION; PEROXYNITRITE; ACTIVATION; CHEMOKINES; NITRATION; DIAGNOSIS	Mastitis is the most prevalent disease in dairy cattle worldwide and not only causes huge economic losses in the dairy industry but also threatens public health. To evaluate the therapeutic potential of melatonin in mastitis, we examined the ability of melatonin to protect bovine mammary epithelial cells (bMECs) from the harmful effects of lipopolysaccharide (LPS). We found that melatonin inhibited the LPS-binding protein-CD14-TLR4 signaling pathway in bMECs, which had opposing effects on pro-inflammatory and anti-inflammatory mediators. Melatonin decreased LPS-induced expression of pro-inflammatory cytokines, chemokines, and positive acute-phase proteins (APPs), including tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6, granulocyte-monocyte colony-stimulating factor, chemokine CC motif ligand (CCL)(2), CCL5, serum amyloid A, haptoglobin, C-reactive protein, ceruloplasmin, and alpha-1 antitrypsin, and increased expression of the anti-inflammatory cytokine IL-1Ra and the negative APP fibrinogen. In addition, melatonin increased dityrosine levels but suppressed nitrite levels by upregulating the expression of Nrf2 and heme oxygenase-1 in the Nrf2 antioxidant defense pathway. Finally, melatonin administration increased the viability of LPS-stimulated bMECs. These results suggest that melatonin protects bMECs from LPS-induced inflammatory and oxidant stress damage and provide evidence that melatonin might have therapeutic utility in mastitis.	[Yu, Guang-Min; Maeda, Teruo] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Bioresource Sci, Higashihiroshima, Japan; [Kubota, Hirokazu; Okita, Miki; Maeda, Teruo] Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Higashihiroshima, Japan; [Okita, Miki; Maeda, Teruo] Hiroshima Univ, Res Ctr Anim Sci, Higashihiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Maeda, T (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Dept Bioresource Sci, Higashihiroshima, Japan.; Maeda, T (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Higashihiroshima, Japan.; Maeda, T (corresponding author), Hiroshima Univ, Res Ctr Anim Sci, Higashihiroshima, Japan.	temaeda@hiroshima-u.ac.jp						Abdel-Rahman MA, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/198652; Agil A, 2012, J PINEAL RES, V52, P203, DOI 10.1111/j.1600-079X.2011.00928.x; Andrukhov O, 2013, J CLIN PERIODONTOL, V40, P916, DOI 10.1111/jcpe.12145; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Boulanger V, 2002, J DAIRY SCI, V85, P562, DOI 10.3168/jds.S0022-0302(02)74109-X; Carrillo-Vico A, 2013, INT J MOL SCI, V14, P8638, DOI 10.3390/ijms14048638; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Eriksson L, 1998, ACTA VET SCAND, V39, P301; Fernandez B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174474; Fox LK, 2009, VET MICROBIOL, V134, P82, DOI 10.1016/j.vetmic.2008.09.005; Fu YH, 2014, FEBS J, V281, P2543, DOI 10.1111/febs.12801; Galano A, 2014, RSC ADV, V4, P5220, DOI 10.1039/c3ra44604b; Hardeland R, 2015, PROG NEUROBIOL, V127, P46, DOI 10.1016/j.pneurobio.2015.02.001; Hattori Y, 2015, J CLIN BIOCHEM NUTR, V56, P57, DOI 10.3164/jcbn.14-82; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lowes DA, 2013, BRIT J ANAESTH, V110, P472, DOI 10.1093/bja/aes577; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Moreira AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144517; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Nduhirabandi F, 2016, J PINEAL RES, V60, P39, DOI 10.1111/jpi.12286; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Osman KM, 2010, COMP IMMUNOL MICROB, V33, P85, DOI 10.1016/j.cimid.2008.08.009; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; Peschke E, 2015, J PINEAL RES, V59, P1, DOI 10.1111/jpi.12240; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Radogna F, 2010, BIOCHEM PHARMACOL, V80, P1844, DOI 10.1016/j.bcp.2010.07.041; Radogna F, 2009, ANN NY ACAD SCI, V1171, P509, DOI 10.1111/j.1749-6632.2009.04900.x; Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sakemi Y, 2011, J DAIRY RES, V78, P118, DOI 10.1017/S0022029910000828; Schmitz S, 2004, DOMEST ANIM ENDOCRIN, V26, P111, DOI 10.1016/j.domaniend.2003.09.003; Shao GX, 2015, INT IMMUNOPHARMACOL, V29, P263, DOI 10.1016/j.intimp.2015.11.011; Soderquist F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164354; Soulere L, 2001, BIOCHEM J, V360, P563, DOI 10.1042/0264-6021:3600563; Tamaki N, 2014, FREE RADICAL BIO MED, V75, P222, DOI 10.1016/j.freeradbiomed.2014.07.034; Thomas FC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0533-3; Tothova C, 2014, VET MED-CZECH, V59, P163, DOI 10.17221/7478-VETMED; Tyagi E, 2010, EUR J PHARMACOL, V640, P206, DOI 10.1016/j.ejphar.2010.04.041; Wellnitz O, 2006, VET MED-CZECH, V51, P125, DOI 10.17221/5531-VETMED; Wu UI, 2011, J PINEAL RES, V50, P159, DOI 10.1111/j.1600-079X.2010.00825.x; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu DX, 2007, J PINEAL RES, V43, P74, DOI 10.1111/j.1600-079X.2007.00445.x; Yu GM, 2017, TRENDS BIOTECHNOL; Yu GM, 2017, J POULT SCI IN PRESS; Yu GM, 2016, REPROD BIOL, V16, P295, DOI 10.1016/j.repbio.2016.10.006; Yu GM, 2015, PAK VET J, V35, P53; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006; Zhou W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166442; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	59	89	93	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178525	10.1371/journal.pone.0178525	http://dx.doi.org/10.1371/journal.pone.0178525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542575	Green Submitted, gold, Green Published			2022-12-26	WOS:000402062800100
J	Raj, A; Shah, P; Agrawal, N				Raj, Akanksha; Shah, Prasanna; Agrawal, Namita			Dose-dependent effect of silver nanoparticles (AgNPs) on fertility and survival of Drosophila: An in-vivo study	PLOS ONE			English	Article							OXIDATIVE STRESS; GOLD NANOPARTICLES; FRUIT-FLY; TOXICITY; GENOTOXICITY; CYTOTOXICITY; APOPTOSIS; FECUNDITY; RESPONSES; CELLS	Silver nanoparticles (AgNPs) containing consumer products have been proliferating in the market due to its unique antimicrobial property, however, lack of in-depth knowledge about their potential effect on human health in a longer run is of great concern. Therefore, we investigated dose-dependent in vivo effect of AgNPs using Drosophila as a model system. Drosophila, a genetically tractable organism with distinct developmental stages, short life cycle and significant homology with human serves as an ideal organism to study nanomaterial- mediated toxicity. Our studies suggest that ingestion of AgNPs in Drosophila during adult stage for short and long duration significantly affects egg laying capability along with impaired growth of ovary. Additionally, dietary intake of AgNPs from larval stage has more deleterious effects that result in reduced survival, longevity, ovary size and egg laying capability at a further lower dosage. Interestingly, the trans-generational effect of AgNPs was also observed without feeding progeny with AgNPs, thereby suggesting its impact from previous generation. Our results strongly imply that higher doses of AgNPs and its administration early during development is detrimental to the reproductive health and survival of Drosophila that follows in generations to come without feeding them to AgNPs.	[Raj, Akanksha; Agrawal, Namita] Univ Delhi, Dept Zool, Delhi, India; [Shah, Prasanna] Acropolis Inst Technol & Res, Indore, Madhya Pradesh, India	University of Delhi	Agrawal, N (corresponding author), Univ Delhi, Dept Zool, Delhi, India.	nagrawaluci@gmail.com		, Namita/0000-0002-9459-385X	DU/DST-PURSE grant from University of Delhi; R & D grant from University of Delhi; University Grants Commission (UGC) [JRF/AA/80/2012-13]	DU/DST-PURSE grant from University of Delhi; R & D grant from University of Delhi; University Grants Commission (UGC)(University Grants Commission, India)	This work was supported by DU/DST-PURSE grant and R & D grant from University of Delhi to N.A.A.R. acknowledges University Grants Commission (UGC) for the financial assistance provided in the form of research fellowship (Ref no. Sch. No/ JRF/AA/80/2012-13).	Affleck JG, 2006, TOXICOL SCI, V89, P495, DOI 10.1093/toxsci/kfj036; Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Avalos A, 2015, FOOD CHEM TOXICOL, V85, P114, DOI 10.1016/j.fct.2015.06.024; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chen Jiong, 2006, Zhonghua Wai Ke Za Zhi, V44, P50; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Cheng D., 2004, CHIN MED EQUIP J, V4, P26; Choi JE, 2010, AQUAT TOXICOL, V100, P151, DOI 10.1016/j.aquatox.2009.12.012; Cohen Michael S, 2007, Surg Infect (Larchmt), V8, P397, DOI 10.1089/sur.2006.032; Demir ER, 2011, NANOTOXICOLOGY, V5, P417, DOI 10.3109/17435390.2010.529176; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478; Hanson FB, 1929, J EXP ZOOL, V54, P485, DOI 10.1002/jez.1400540307; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Key C.S., 2011, ATLAS J BIOL, V1, P52, DOI DOI 10.5147/AJB.2011.0048; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim KT, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/11/115101; Kim SW, 2013, ENVIRON SCI TECHNOL, V47, P5393, DOI 10.1021/es304511z; Kim S, 2013, J APPL TOXICOL, V33, P78, DOI 10.1002/jat.2792; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g; Liu XL, 2010, CHEMMEDCHEM, V5, P468, DOI 10.1002/cmdc.200900502; Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025; Moon J, 2017, ENVIRON POLLUT, V220, P46, DOI 10.1016/j.envpol.2016.09.021; Muangman Pornprom, 2006, Journal of the Medical Association of Thailand, V89, P953; Poma A, 2014, ADV EXP MED BIOL, V811, P235, DOI 10.1007/978-94-017-8739-0_12; Posgai R, 2011, CHEMOSPHERE, V85, P34, DOI 10.1016/j.chemosphere.2011.06.040; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rejeski D, 2009, MICRO NANO TECHNOL, P509, DOI 10.1016/B978-0-8155-1578-4.50043-3; Roth S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001891; Shapiro H, 1932, BIOL BULL-US, V63, P456, DOI 10.2307/1537346; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Sung JH, 2008, INHAL TOXICOL, V20, P567, DOI 10.1080/08958370701874671 ; Uryu O, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0031-2; Wilson International Center for Scholars, 2007, NAN CONS PROD INV; Wu YA, 2010, AQUAT TOXICOL, V100, P160, DOI 10.1016/j.aquatox.2009.11.014	51	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178051	10.1371/journal.pone.0178051	http://dx.doi.org/10.1371/journal.pone.0178051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542630	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500059
J	Zou, SY; Teixeira, AM; Kostadima, M; Astle, WJ; Radhakrishnan, A; Simon, LM; Truman, L; Fang, JS; Hwa, J; Zhang, PX; van der Harst, P; Bray, PF; Ouwehand, WH; Frontini, M; Krause, DS				Zou, Siying; Teixeira, Alexandra M.; Kostadima, Myrto; Astle, William J.; Radhakrishnan, Aparna; Simon, Lukas Mikolaj; Truman, Lucy; Fang, Jennifer S.; Hwa, John; Zhang, Ping-xia; van der Harst, Pim; Bray, Paul F.; Ouwehand, Willem H.; Frontini, Mattia; Krause, Diane S.			SNP in human ARHGEF3 promoter is associated with DNase hypersensitivity, transcript level and platelet function, and Arhgef3 KO mice have increased mean platelet volume	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CARDIOVASCULAR-DISEASE; THROMBUS FORMATION; MOUSE PLATELETS; SHAPE CHANGE; RHOA; DIFFERENTIATION; EXPRESSION; PATHWAYS; INSIGHTS	Genome-wide association studies have identified a genetic variant at 3p14.3 (SNP rs1354034) that strongly associates with platelet number and mean platelet volume in humans. While originally proposed to be intronic, analysis of mRNA expression in primary human hematopoietic subpopulations reveals that this SNP is located directly upstream of the predominantly expressed ARHGEF3 isoform in megakaryocytes (MK). We found that ARHGEF3, which encodes a Rho guanine exchange factor, is dramatically upregulated during both human and murine MK maturation. We show that the SNP (rs1354034) is located in a DNase I hypersensitive region in human MKs and is an expression quantitative locus (eQTL) associated with ARHGEF3 expression level in human platelets, suggesting that it may be the causal SNP that accounts for the variations observed in human platelet traits and ARHGEF3 expression. In vitro human platelet activation assays revealed that rs1354034 is highly correlated with human platelet activation by ADP. In order to test whether ARHGEF3 plays a role in MK development and/or platelet function, we developed an Arhgef3 KO/LacZ reporter mouse model. Reflecting changes in gene expression, LacZ expression increases during MK maturation in these mice. Although Arhgef3 KO mice have significantly larger platelets, loss of Arhgef3 does not affect baseline MK or platelets nor does it affect platelet function or platelet recovery in response to antibody-mediated platelet depletion compared to littermate controls. In summary, our data suggest that modulation of ARHGEF3 gene expression in humans with a promoter-localized SNP plays a role in human MKs and human platelet function-a finding resulting from the biological follow-up of human genetic studies. Arhgef3 KO mice partially recapitulate the human phenotype.	[Zou, Siying; Krause, Diane S.] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Teixeira, Alexandra M.; Krause, Diane S.] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kostadima, Myrto; Astle, William J.; Radhakrishnan, Aparna; Ouwehand, Willem H.; Frontini, Mattia] Univ Cambridge, Dept Haematol, Cambridge Biomed Campus, Cambridge, England; [Simon, Lukas Mikolaj] Baylor Coll Med, Dept Struct & Computat Biol, Houston, TX 77030 USA; [Truman, Lucy] Addenbrookes Hosp, Dept ENT, Cambridge Biomed Campus, Cambridge, England; [Fang, Jennifer S.; Hwa, John] Yale Univ, Sch Med, Dept Cardiol, Yale Cardiovasc Res Ctr, New Haven, CT USA; [Zhang, Ping-xia; Krause, Diane S.] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhang, Ping-xia; Krause, Diane S.] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Bray, Paul F.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Bray, Paul F.] Univ Utah, Program Mol Med, Salt Lake City, UT USA; [Astle, William J.; Bray, Paul F.] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC, BHF Cardiovasc Epidemiol Unit, Cambridge, England	Yale University; Yale University; University of Cambridge; Baylor College of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Yale University; Yale University; Yale University; University of Groningen; University of Groningen; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Cambridge	Krause, DS (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA.; Krause, DS (corresponding author), Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA.	diane.krause@yale.edu	Fang, Jennifer S./AAK-8044-2020	Fang, Jennifer S./0000-0001-5703-2239; Simon, Lukas/0000-0001-6148-8861; Astle, William John/0000-0001-8866-6672; Kostadima, Myrto Areti/0000-0002-1818-4050	NIH [DK094934, DK086267, DK0724429, HL102482]; Cardeza Foundation for Hematologic Research; American Heart Association Fellowship [14PRE20480196]; BHF Cambridge Centre of Excellence [RE/13/6/30180]; Landsteiner Foundation for Blood Transfusion Research [LSBR1133]; Leukaemia & Lymphoma Research Fellowship [09018]; EU-FP7 project BLUEPRINT [282510]; National Institute for Health Research (NIHR); British Heart Foundation [RP-PG 0310-1002, RG/09/12/28096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482, R01HL115247, R01HL122815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094934, U54DK106857, P30DK072442, R01DK086267] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, RP-PG-0310-1002] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardeza Foundation for Hematologic Research; American Heart Association Fellowship(American Heart Association); BHF Cambridge Centre of Excellence; Landsteiner Foundation for Blood Transfusion Research; Leukaemia & Lymphoma Research Fellowship; EU-FP7 project BLUEPRINT; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was provided by NIH grants DK094934, DK086267, and DK0724429 to DSK, HL102482 to PB, the Cardeza Foundation for Hematologic Research (PB), and American Heart Association Fellowship 14PRE20480196 to LMS. MF is supported by the BHF Cambridge Centre of Excellence RE/13/6/30180. PvdH is supported by the Landsteiner Foundation for Blood Transfusion Research (http://www.lsbr.nl/) grant LSBR1133. LAT was supported by Leukaemia & Lymphoma Research Fellowship (https://bloodwise.org.uk/research-grants) 09018. Research in the Ouwehand laboratory is supported by EU-FP7 project BLUEPRINT (282510) and by program grants from the National Institute for Health Research (NIHR, https://urldefense.prootpoint.com/v2/url?u=http-3A_www.nihr.ac.uk&d=DwlGaQ&c=-dg2m7zWuuDZ0MUcV7Sdqw&r= IVJ7vXcRnyL00aM8sf1WCy6DaxDq9QZgZyV=Gu4EPUE&m=CCUk_ 5v_hCkySZw2q9_QnB0h-NkYalFaP5wzOg_Vatc&s=76dYk8ktWIfNj0CYx7 OMuQKSQuA1DVdNkhjdZd4_gpo&and the British Heart Foundation under numbers RP-PG 0310-1002 and RG/09/12/28096 (https://url defense.proofpointcornA/2/url?u=http-3A_www.bhf.org.uk&d=DWIGaQ&c=dg2m7zWuuDZ0MUcV7Sdqw& =IVJ7vXcRnyL00aM8sf1WCy6DaxDq9qZgZyV-GuT4EPUE&m=CCUk_5v_hCkySZkv2q9_ B0h-NkYaLFaP5wz0q_Vatc&s=QMKIHKMTw709uRS_rTJ8d 5qQ5UQNJKgar50gt9GG6U&e=). The laboratory receives funding from NHS Blood and Transplant for facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Chad D. Sanada for helpful discussions. Financial support provided by NIH grants DK094934, DK086267, and DK0724429 to DSK, HL102482 to PFB, the Cardeza Foundation for Hematologic Research (PFB), and American Heart Association Fellowship 14PRE20480196 to LMS. MF is supported by the BHF Cambridge Centre of Excellence RE/13/ 6/30180. Research in the Ouwehand laboratory is supported by EU-FP7 project BLUEPRINT (282510) and by program grants from the National Institute for Health Research (NIHR, hitp://www.nihr.ac.uk); and the British Heart Foundation under numbers RP-PG-0310-1002 and RG/09/12/28096 (http://www.bhf.org.uk). The laboratory receives funding from NHS Blood and Transplant for facilities.	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; D'Amato L, 2015, EPIGENETICS-US, V10, P6, DOI 10.4161/15592294.2014.988035; Dimasi DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022103; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; Eicher JD, 2016, AM J HUM GENET, V99, P40, DOI 10.1016/j.ajhg.2016.05.005; Fuhrken PG, 2007, EXP HEMATOL, V35, P476, DOI 10.1016/j.exphem.2006.10.017; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jones CI, 2009, BLOOD, V114, P1405, DOI 10.1182/blood-2009-02-202614; Kim YB, 1999, PLATELETS, V10, P399; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Longenecker G, 2009, CURR PROTOC CELL BIO; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Parekh C, 2013, J CLIN IMMUNOL, V33, P711, DOI 10.1007/s10875-012-9844-3; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Serbanovic-Canic J, 2011, BLOOD, V118, P4967, DOI 10.1182/blood-2011-02-337295; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van der Ende MY, 2017, INT J CARDIOL, V228, P495, DOI 10.1016/j.ijcard.2016.11.061; Zhang XL, 2014, HUM MOL GENET, V23, P782, DOI 10.1093/hmg/ddt461	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178095	10.1371/journal.pone.0178095	http://dx.doi.org/10.1371/journal.pone.0178095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542600	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800037
J	Ortega, MS; Kurian, JJ; McKenna, R; Hansen, PJ				Ortega, M. Sofia; Kurian, Justin J.; McKenna, Robert; Hansen, Peter J.			Characteristics of candidate genes associated with embryonic development in the cow: Evidence for a role for WBP1 in development to the blastocyst stage	PLOS ONE			English	Article							GENOME ACTIVATION; SIGNALING PATHWAY; BOVINE EMBRYOS; HEAT-SHOCK; I-TASSER; PROTEIN; CONSEQUENCES; EXPRESSION; COMPONENTS; APOPTOSIS	The goal was to gain understanding of how 12 genes containing SNP previously related to embryo competence to become a blastocyst (BRINP3, C1QB, HSPA1L, IRF9, MON1B, PARM1, PCCB, PMM2, SLC18A2, TBC1D24, TTLL3 and WBP1) participate in embryonic development. Gene expression was evaluated in matured oocytes and embryos. BRINP3 and C1QB were not detected at any stage. For most other genes, transcript abundance declined as the embryo developed to the blastocyst stage. Exceptions were for PARM1 and WBP1, where steady-state mRNA increased at the 9-16 cell stage. The SNP in WBP1 caused large differences in the predicted three-dimensional structure of the protein while the SNP in PARM1 caused smaller changes. The mutation in WBP1 causes an amino acid substitution located close to a P-P-X-Y motif involved in protein-protein interactions. Moreover, the observation that the reference allele varies between mammalian species indicates that the locus has not been conserved during mammalian evolution. Knockdown of mRNA for WBP1 decreased the percent of putative zygotes becoming blastocysts and reduced the number of trophectoderm cells and immunoreactive CDX2 in the resulting blastocysts. WBP1 is an important gene for embryonic development in the cow. Further research to identify how the SNP in WBP1 affects processes leading to differentiation of the embryo into TE and ICM lineages is warranted.	[Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA; [Ortega, M. Sofia; Hansen, Peter J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Kurian, Justin J.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ortega, M. Sofia] Univ Missouri, Div Anim Sci, Columbia, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Columbia	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, DH Barron Reprod & Perinatal Biol Res Program, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	pjhansen@ufl.edu	Kurian, Justin/AAG-7500-2019; Hansen, Peter/AAI-4693-2021; Ortega, Sofia/ABA-3654-2020	Hansen, Peter/0000-0003-3061-9333; Ortega, Sofia/0000-0003-4027-7314	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2013-68004-20365]; Southeast Milk Inc. Milk Check-off Program; L.E. "Red" Larson Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007110] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; Southeast Milk Inc. Milk Check-off Program; L.E. "Red" Larson Endowment; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-68004-20365 from the USDA National Institute of Food and Agriculture, a grant from the Southeast Milk Inc. Milk Check-off Program, and funds from the L.E. Red Larson Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; BRAUDE P, 1979, NATURE, V282, P102, DOI 10.1038/282102a0; Cerri RLA, 2009, REPRODUCTION, V137, P813, DOI 10.1530/REP-08-0242; Chandolia RK, 1999, BIOL REPROD, V61, P1644, DOI 10.1095/biolreprod61.6.1644; Chebel RC, 2008, THERIOGENOLOGY, V69, P98, DOI 10.1016/j.theriogenology.2007.09.008; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cochran SD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111260; Cochran SD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-49; Dobson H, 2007, REPROD DOMEST ANIM, V42, P17, DOI 10.1111/j.1439-0531.2007.00906.x; Fear JM, 2011, BIOL REPROD, V84, P43, DOI 10.1095/biolreprod.110.086249; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; Graf A, 2014, P NATL ACAD SCI USA, V111, P4139, DOI 10.1073/pnas.1321569111; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hendricks KEM, 2010, AUST VET J, V88, P307, DOI 10.1111/j.1751-0813.2010.00585.x; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Kaufmann M, 2012, FUNCTIONAL GENOMICS; Khatib H, 2008, J ANIM SCI, V86, P2063, DOI 10.2527/jas.2007-0791; Khatib H, 2008, J DAIRY SCI, V91, P784, DOI 10.3168/jds.2007-0669; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; La Rosa I, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-18; Lee E, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0286-4; Lee KB, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-67; Li G, 2012, J DAIRY RES, V79, P310, DOI 10.1017/S0022029912000210; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Maillo V, 2012, J DAIRY SCI, V95, P3865, DOI 10.3168/jds.2011-5270; McDonald CB, 2011, BIOCHEMISTRY-US, V50, P9616, DOI 10.1021/bi201286p; Nakanishi N, 2012, BIOCHEM BIOPH RES CO, V428, P500, DOI 10.1016/j.bbrc.2012.10.078; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ortega MS, 2016, J DAIRY SCI, V99, P9152, DOI 10.3168/jds.2016-11501; Pei JM, 2012, CELL SIGNAL, V24, P758, DOI 10.1016/j.cellsig.2011.11.011; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; Santos JEP, 2008, THERIOGENOLOGY, V69, P88, DOI 10.1016/j.theriogenology.2007.09.010; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirard MA, 2012, REPROD DOMEST ANIM, V47, P148, DOI 10.1111/j.1439-0531.2012.02069.x; Suzuki Y, 2011, REPRODUCTION, V142, P733, DOI 10.1530/REP-11-0275; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178041	10.1371/journal.pone.0178041	http://dx.doi.org/10.1371/journal.pone.0178041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542629	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400134
J	Klein, C; Terrao, M; Clayton, C				Klein, Cornelia; Terrao, Monica; Clayton, Christine			The role of the zinc finger protein ZC3H32 in bloodstream-form Trypanosoma brucei	PLOS ONE			English	Article							LIFE-CYCLE STAGES; GENE-EXPRESSION; WIDE ANALYSIS; DEPLETION; NETWORKS	Kinetoplastids rely heavily on post-transcriptional mechanisms for control of gene expression, with regulation of mRNA processing, translation and degradation by RNA-binding proteins. ZC3H32 is a cytosolic mRNA-binding protein with three non-canonical CCCH zinc finger domains. It is much more abundant in bloodstream-form Trypanosoma brucei than in procyclic forms. Tethering of ZC3H32 to a reporter mRNA suppressed translation and resulted in mRNA degradation, and deletion analysis suggested that this activity was present in both the N-and C-terminal domains, but not the central zinc finger-containing domain. Tandem affinity purification, however, revealed no interaction partners that might account for this activity. RNASeq analyses did not yield any evidence for sequence-specific binding or regulation of specific mRNAs. The presence of ZC3H32 homologues in monogenetic and free-living Euglenids also argues against a role in developmental regulation, although its function may have diverged in evolution. T. brucei ZC3H32 might be implicated in basal mRNA metabolism, with this role perhaps being taken over by another protein in procyclic forms.	[Klein, Cornelia; Terrao, Monica; Clayton, Christine] Heidelberg Univ, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Klein, Cornelia] 4 Rue Epine, Strasbourg, France; [Terrao, Monica] Uniklin Koln, Inst Neuropathol, Cologne, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Cologne	Clayton, C (corresponding author), Heidelberg Univ, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019	Clayton, Christine/0000-0002-6384-0731	Deutsche Forschungsgemeinschaft [CI112/17, CI112/24]; State of Baden Wurttemberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Baden Wurttemberg	This work was funded by the Deutsche Forschungsgemeinschaft (CI112/17 and CI112/24) and by core funding (State of Baden Wurttemberg) to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Antwi EB, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2624-3; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Clayton CE, 1999, PARASITOL TODAY, V15, P372, DOI 10.1016/S0169-4758(99)01498-2; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Fiebig M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005186; Jae N, 2011, RNA BIOL, V8, P90, DOI 10.4161/rna.8.1.13985; Jha BA, 2014, EUKARYOT CELL, V13, P664, DOI 10.1128/EC.00018-14; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; Leiss K, 2016, ZENODO; Li Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005511; Lott K, 2015, NUCLEIC ACIDS RES, V43, P5501, DOI 10.1093/nar/gkv428; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Maier A, 2001, MOL MICROBIOL, V39, P1443, DOI 10.1046/j.1365-2958.2001.02333.x; Minia I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004982; Mugo E, 2016, BIORXIV2016076273; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Ouellette Marc, 2009, Journal of Biology (London), V8, P8, DOI 10.1186/jbiol203; Ouna BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034256; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177901	10.1371/journal.pone.0177901	http://dx.doi.org/10.1371/journal.pone.0177901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545140	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700093
J	Pessentheiner, AR; Huber, K; Pelzmann, HJ; Prokesch, A; Radner, FPW; Wolinski, H; Lindroos-Christensen, J; Hoefler, G; Rulicke, T; Birner-Gruenberger, R; Bilban, M; Bogner-Strauss, JG				Pessentheiner, Ariane R.; Huber, Katharina; Pelzmann, Helmut J.; Prokesch, Andreas; Radner, Franz P. W.; Wolinski, Heimo; Lindroos-Christensen, Josefine; Hoefler, Gerald; Ruelicke, Thomas; Birner-Gruenberger, Ruth; Bilban, Martin; Bogner-Strauss, Juliane G.			APMAP interacts with lysyl oxidase-like proteins, and disruption of Apmap leads to beneficial visceral adipose tissue expansion	FASEB JOURNAL			English	Article						obesity; extracellular matrix; insulin resistance	DIET-INDUCED OBESITY; ADIPOCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; PPAR-GAMMA; METABOLICALLY HEALTHY; MAMMALIAN GENOMES; GENE-EXPRESSION; FAT; ADIPOGENESIS	Adipocyte plasma membrane-associated protein (APMAP) has been described as an adipogenic factor in 3T3-L1 cells with unknown biochemical function; we therefore aimed to investigate the physiologic function of APMAP in vivo. We generated Apmap-knockout mice and challenged them with an obesogenic diet to investigate their metabolic phenotype. We identified a novel truncated adipocyte-specific isoform of APMAP in mice that is produced by alternative transcription. Mice lacking the full-length APMAP protein, the only isoform that is expressed in humans, have an improved metabolic phenotype upon diet-induced obesity, indicated by enhanced insulin sensitivity, preserved glucose tolerance, increased respiratory exchange ratio, decreased inflammatory marker gene expression, and reduced adipocyte size. At the molecular level, APMAP interacts with the extracellular collagen cross-linking matrix proteins lysyl oxidase-like 1 and 3. On a high-fat diet, the expression of lysyl oxidase-like 1 and 3 is strongly decreased in Apmap-knockout mice, paralleled by reduced expression of profibrotic collagens and total collagen content in epididymal white adipose tissue, indicating decreased fibrotic potential. Together, our data suggest that APMAP is a novel regulator of extracellular matrix components, and establish that APMAP is a potential target to mitigate obesity-associated insulin resistance.	[Pessentheiner, Ariane R.; Huber, Katharina; Pelzmann, Helmut J.; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria; [Prokesch, Andreas] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Radner, Franz P. W.; Wolinski, Heimo] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Wolinski, Heimo] Karl Franzens Univ Graz, BioTechMed Graz, Graz, Austria; [Lindroos-Christensen, Josefine; Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Birner-Gruenberger, Ruth] Omics Ctr Graz, BioTechMed Graz, Graz, Austria	Graz University of Technology; Medical University of Graz; Medical University of Graz; University of Graz; University of Graz; Medical University of Vienna; University of Veterinary Medicine Vienna	Bogner-Strauss, JG (corresponding author), Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Birner-Gruenberger, Ruth/E-8623-2010; Birner-Gruenberger, Ruth/X-9433-2019; Hoefler, Gerald/H-1796-2016; PROKESCH, ANDREAS/B-6786-2019	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Hoefler, Gerald/0000-0002-9056-3063; Huber, Katharina/0000-0002-4072-4877; Pessentheiner, Ariane/0000-0002-5010-9528; Wolinski, Heimo/0000-0002-1583-6092; PROKESCH, ANDREAS/0000-0002-8487-7103; Radner, Franz/0000-0003-3466-0181	Austrian Science Fund (FWF) [P24103, 27108]; Doctoral Program-Metabolic and Cardiovascular Disease [W1226]; NAWI Graz; BioTechMed Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral Program-Metabolic and Cardiovascular Disease; NAWI Graz; BioTechMed Graz	This work was supported, in part, by the Austrian Science Fund (FWF; P24103, 27108), and the Doctoral Program-Metabolic and Cardiovascular Disease (DK-MCD; W1226). The authors gratefully acknowledge support from NAWI Graz and BioTechMed Graz, and the important technical assistance of T. Schreiner, W. Krispel, F. Stoeger, C. Gaug, B. Gadermaier, K. Leets (all from Graz University of Technology), L. Liesinger, and S. Schauer (both from the Medical University of Graz).	Albrektsen T, 2001, BIOCHEM J, V359, P393, DOI 10.1042/0264-6021:3590393; Badoud F, 2015, FASEB J, V29, P748, DOI 10.1096/fj.14-263913; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Buechler C, 2015, WORLD J DIABETES, V6, P548, DOI 10.4239/wjd.v6.i4.548; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DIMACULANGAN DD, 1994, DIFFERENTIATION, V58, P47, DOI 10.1046/j.1432-0436.1994.5810047.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh S, 2014, FASEB J, V28, P2577, DOI 10.1096/fj.14-249458; Grandl G, 2016, MOL METAB, V5, P937, DOI 10.1016/j.molmet.2016.07.008; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang GR, 2012, TRENDS ENDOCRIN MET, V23, P16, DOI 10.1016/j.tem.2011.09.006; Huang HY, 2013, STEM CELL RES, V10, P278, DOI 10.1016/j.scr.2012.12.005; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Ilhan A, 2008, BIOCHEM J, V414, P485, DOI 10.1042/BJ20080503; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lindroos J, 2013, CELL METAB, V18, P62, DOI 10.1016/j.cmet.2013.05.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mosser S, 2015, HUM MOL GENET, V24, P371, DOI 10.1093/hmg/ddu449; Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1111/j.1432-0436.1998.00193.x; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Ryden M, 2016, CELL REP, V16, P2317, DOI 10.1016/j.celrep.2016.07.070; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senol-Cosar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10686; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324	51	9	9	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4088	4103		10.1096/fj.201601337R	http://dx.doi.org/10.1096/fj.201601337R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28559441	Green Published, hybrid			2022-12-26	WOS:000408713300032
J	Zheng, KZ; Lu, P; Delpapa, E; Bellve, K; Deng, RT; Condon, JC; Fogarty, K; Lifshitz, LM; Simas, TAM; Shi, FX; ZhuGe, RH				Zheng, Kaizhi; Lu, Ping; Delpapa, Ellen; Bellve, Karl; Deng, Ruitang; Condon, Jennifer C.; Fogarty, Kevin; Lifshitz, Lawrence M.; Simas, Tiffany A. Moore; Shi, Fangxiong; ZhuGe, Ronghua			Bitter taste receptors as targets for tocolytics in preterm labor therapy	FASEB JOURNAL			English	Article						uterine smooth muscle; relaxation; chloroquine; G-protein coupled receptor	SALIVARY PROGESTERONE; ALPHA-GUSTDUCIN; ANIMAL-MODELS; CA2+ SPARKS; BIRTH; CONTRACTION; MECHANISMS; CALCIUM; CELLS; PREVENTION	Preterm birth (PTB) is the leading cause of neonatal mortality and morbidity, with few prevention and treatment options. Uterine contraction is a central feature of PTB, so gaining new insights into the mechanisms of this contraction and consequently identifying novel targets for tocolytics are essential for more successful management of PTB. Here we report that myometrial cells from human and mouse express bitter taste receptors (TAS2Rs) and their canonical signaling components (i.e., G-protein gustducin and phospholipase C beta 2). Bitter tastants can completely relax myometrium precontracted by different uterotonics. In isolated single mouse myometrial cells, a phenotypical bitter tastant (chloroquine, ChQ) reverses the rise in intracellular Ca2+ concentration ([Ca2+](i)) and cell shortening induced by uterotonics, and this reversal effect is inhibited by pertussis toxin and by genetic deletion of a-gustducin. In human myometrial cells, knockdown of TAS2R14 but not TAS2R10 inhibits ChQ's reversal effect on an oxytocin-induced rise in [Ca2+](i). Finally, ChQpreventsmouse PTBs induced by bacterial endotoxin LPS or progesterone receptor antagonist mifepristone more often than current commonly used tocolytics, and this prevention is largely lost in alpha-gustducin-knockout mice. Collectively, our results reveal that activation of the canonical TAS2R signaling system in myometrial cells produces profound relaxation of myometrium precontracted by a broad spectrum of contractile agonists, and that targeting TAS2Rs is an attractive approach to developing effective tocolytics for PTB management.	[Zheng, Kaizhi; Shi, Fangxiong] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Zheng, Kaizhi; Lu, Ping; ZhuGe, Ronghua] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Delpapa, Ellen; Simas, Tiffany A. Moore] Univ Massachusetts, Sch Med, Dept Obstet & Gynecol, Worcester, MA USA; [Simas, Tiffany A. Moore] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Bellve, Karl; Fogarty, Kevin; Lifshitz, Lawrence M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Deng, Ruitang] Univ Rhode Isl, Coll Pharm, Kingston, RI USA; [Condon, Jennifer C.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	Nanjing Agricultural University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Rhode Island; Wayne State University	Shi, FX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.; ZhuGe, RH (corresponding author), Univ Massachusetts, Sch Med, Biomed Imaging Grp, Dept Microbiol & Physiol Syst, 368 Plantat St,ASC8-1045, Worcester, MA 01605 USA.	fxshi@njau.edu.cn; ronghua.zhuge@umassmed.edu		Lu, Ping/0000-0002-8953-1494	National Natural Science Foundation of China [31172206, 31572403]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK098586]; NIH National Heart, Lung, and Blood Institute [HL117104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117104] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank R. F. Margolskee (Monell Chemical Senses Center, Philadelphia, PA, USA) for providing Gnat3<SUP>-/-</SUP> mice. This study was supported, in part, by the National Natural Science Foundation of China (31172206 and 31572403 to F.S.), and by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant NIDDK098586, and NIH National Heart, Lung, and Blood Institute Grant HL117104 (both to R.Z.G.). The authors declare no conflicts of interest.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Avau B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15985; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Behrman R. E., 2007, PRETERM BIRTH CAUSES, P259; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Caicedo A, 2003, J NEUROSCI, V23, P9947; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2010, J CELL BIOL, V191, P429, DOI 10.1083/jcb.20100314420100927c; Clapp TR, 2008, FEBS LETT, V582, P3783, DOI 10.1016/j.febslet.2008.10.007; DARNE J, 1987, BRIT MED J, V294, P270, DOI 10.1136/bmj.294.6567.270; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dudley DJ, 1996, BIOL REPROD, V55, P992, DOI 10.1095/biolreprod55.5.992; Ehn NL, 2007, PEDIATR RES, V62, P630, DOI 10.1203/PDR.0b013e3181567bfc; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Erdei C, 2014, PERSPECT BIOL MED, V57, P470, DOI 10.1353/pbm.2014.0036; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gupta S, 2012, WOMENS HEALTH, V8, P21, DOI [10.2217/WHE.11.78, 10.2217/whe.11.78]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Illanes SE, 2014, EXPERT OPIN INV DRUG, V23, P759, DOI 10.1517/13543784.2014.905541; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jarde A, 2017, BJOG-INT J OBSTET GY, V124, P1176, DOI 10.1111/1471-0528.14624; Kaga N, 1996, AM J OBSTET GYNECOL, V174, P754, DOI 10.1016/S0002-9378(96)70460-X; Krishna U, 2001, PREGNANCY RISK CURRE; Lachelin GCL, 2009, BJOG-INT J OBSTET GY, V116, P1515, DOI 10.1111/j.1471-0528.2009.02293.x; Maged AM, 2015, J MATERN-FETAL NEO M, V28, P1147, DOI 10.3109/14767058.2014.947474; Manuck TA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.048; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mitchell BF, 2013, FACTS VIEWS VIS OBGY, V5, P72; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Morrey C, 2008, J PHARMACOL EXP THER, V326, P871, DOI 10.1124/jpet.108.137919; Moynihan AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.074; Ngassa C, 2000, AFRICAN J REPROD HLT, V4, P53; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Ortinau C, 2015, CLIN ANAT, V28, P168, DOI 10.1002/ca.22430; Priya B, 2013, BJOG-INT J OBSTET GY, V120, P1003, DOI 10.1111/1471-0528.12217; Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sai WB, 2014, CLIN EXP PHARMACOL P, V41, P301, DOI 10.1111/1440-1681.12217; Sakai H, 2016, BIOL PHARM BULL, V39, P33, DOI 10.1248/bpb.b15-00426; Sanborn BM, 2005, J SOC GYNECOL INVEST, V12, P479, DOI 10.1016/j.jsgi.2005.07.002; Shmygol A, 2007, ANN NY ACAD SCI, V1101, P97, DOI 10.1196/annals.1389.031; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stamatelou F, 2009, ANN ACAD MED SINGAP, V38, P1011; Swaggart KA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023127; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Ueda T, 2003, J NEUROSCI, V23, P7376; Upadhyaya JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110373; van Vliet EOG, 2014, EXPERT OPIN PHARMACO, V15, P787, DOI 10.1517/14656566.2014.889684; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101578; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; ZhuGe RH, 1999, J GEN PHYSIOL, V113, P215, DOI 10.1085/jgp.113.2.215; Zhuge R, 2010, J BIOL CHEM, V285, P2203, DOI 10.1074/jbc.M109.067546	59	28	29	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4037	4052		10.1096/fj.201601323RR	http://dx.doi.org/10.1096/fj.201601323RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28559440	Green Published			2022-12-26	WOS:000408713300028
J	Dlamini, TAL; Heering, PJ; Chivese, T; Rayner, B				Dlamini, Thandiwe A. L.; Heering, Peter J.; Chivese, Tawanda; Rayner, Brian			A prospective study of the demographics, management and outcome of patients with acute kidney injury in Cape Town, South Africa	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; DISEASE; EPIDEMIOLOGY; MULTICENTER; MORTALITY; THERAPY; RISK	Aim To study the demographics and outcome of acute kidney injury (AKI) at Groote Schuur Hospital, Cape Town, South Africa. Methods and findings A prospective observational study of AKI fulfilling the Kidney Disease: Improving Global Outcomes definition, from 8 July 2012 to 8 July 2013. Ethics approval was granted by the University of Cape Town Human Research Ethics Committee. Consent was waived because patient data was de-identified and patient management was not adversely affected by the study. A clerking sheet was used for data collection. Patients were reassessed after 3 months. Main outcomes were renal recovery and 3 month mortality. Descriptive statistics and multivariate logistic regression were carried out for risk factors. Over this period there were 10,750 hospital admissions and 366 patients with AKI giving an incidence of 3.4%. Median age was 44 years (IQR 14-82) and 214 (58.5%) were male, with 152 (41.5%) female. Most, 265 (72.4%), had community acquired AKI. Common underlying comorbidities were hypertension (n = 152, 41.5%), diabetes mellitus (n = 65, 17.8%) Human immunodeficiency virus (HIV) (n = 75, 20.6%), heart disease (n = 58, 16.1%), and chronic kidney disease (n = 37, 10.1%). Renal biopsies were performed in 36 (9.8%) patients. In total, 202 (55.2%) patients were in the intensive care unit, and of the whole study population 204 (55.7%) were dialysed. Those admitted to ICU who required dialysis amounted to 145 (39.6%). The overall 3 month mortality was 38.8%. Among the 145 patients dialysed in ICU, there were 71 deaths (49%) at 3 month follow up. Of the 119 patients with follow up serum creatinine, 95 (79.8%) had full renal recovery, and 4 (3.4%) had end-stage renal disease. On multivariate analysis, mechanical ventilation was associated with 3 month mortality (OR 2.46, p-value 0.019, 95% CI 1.41-4.03). Sepsis had a borderline significant association (OR 1.83, P-value 0.066, 95% CI 1.02-3.27), as did prolonged time to dialysis (OR 1.93, p-value 0.08, 095% CI 0.93-4.03). HIV status did not affect outcome. The main study limitations were the large numbers of patients with AKI stage 3, reflecting the fact that the institution is a tertiary referral centre and that patients with earlier stages of AKI tended not to be referred. Another study limitation was the low number of patients who were available for follow up for 3 month serum creatinine. Conclusions The incidence of AKI in the population studied is 3.4% of hospital admissions and carries a high mortality risk, most significant in mechanically ventilated patients. Sepsis and late dialysis initiation may carry a risk of mortality, but HIV infection did not affect outcome. Follow up of patients at least 3 months after an episode of AKI is essential to detect and appropriately manage those with incomplete renal recovery. In this study 36 patients underwent a kidney biopsy, and in many of these the results guided patient management. This study demonstrates finally that it remains imperative that clinicians actively pursue underlying causes of acute decline in renal function, including urine analysis, renal ultrasonography and if indicated and safe, a renal biopsy.	[Dlamini, Thandiwe A. L.; Rayner, Brian] Univ Cape Town, Groote Schuur Hosp E13, Div Nephrol & Hypertens, Cape Town, South Africa; [Heering, Peter J.] Heinrich Heine Univ, Fac Med, Dusseldorf, Germany; [Chivese, Tawanda] Univ Cape Town, Dept Med, Chron Dis Initiat Africa, Fac Med & Hlth Sci, Cape Town, South Africa	University of Cape Town; Heinrich Heine University Dusseldorf; University of Cape Town	Dlamini, TAL (corresponding author), Univ Cape Town, Groote Schuur Hosp E13, Div Nephrol & Hypertens, Cape Town, South Africa.	taldlamini@gmail.com	Rayner, Brian/AAA-3174-2021; Chivese, Tawanda/AAU-3287-2021	Chivese, Tawanda/0000-0001-6621-6144				Anathhanam S, 2013, J ROY COLL PHYS EDIN, V43, P323, DOI 10.4997/JRCPE.2013.412; Bagshaw SM, 2009, J CRIT CARE, V24, P129, DOI 10.1016/j.jcrc.2007.12.017; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Cerda J, 2008, NAT CLIN PRACT NEPHR, V4, P138, DOI 10.1038/ncpneph0722; Feltes CM, 2008, NEPHRON PHYSIOL, V109, pP80, DOI 10.1159/000142940; Goldhill DR, 2005, ANAESTHESIA, V60, P547, DOI 10.1111/j.1365-2044.2005.04186.x; Gounden R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-26; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Grassmann A, 2006, ARTIF ORGANS, V30, P895, DOI 10.1111/j.1525-1594.2006.00321.x; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kaballo BG, 2007, SAUDI J KIDNEY DIS T, V18, P220; KDIGO, 2012, KDIGO CLIN PRACT GUI, P28; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Molitoris BA, 2007, NAT CLIN PRACT NEPHR, V3, P439, DOI 10.1038/ncpneph0551; Naicker S, 2009, ETHNIC DIS, V19, P13; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Okpechi I, 2010, NEPHROLOGY DIALYSIS; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487	26	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177460	10.1371/journal.pone.0177460	http://dx.doi.org/10.1371/journal.pone.0177460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570592	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800010
J	McGinnis, RS; Mahadevan, N; Moon, Y; Seagers, K; Sheth, N; Wright, JA; DiCristofaro, S; Silva, I; Jortberg, E; Ceruolo, M; Pindado, JA; Sosnoff, J; Ghaffari, R; Patel, S				McGinnis, Ryan S.; Mahadevan, Nikhil; Moon, Yaejin; Seagers, Kirsten; Sheth, Nirav; Wright, John A., Jr.; DiCristofaro, Steven; Silva, Ikaro; Jortberg, Elise; Ceruolo, Melissa; Pindado, Jesus A.; Sosnoff, Jacob; Ghaffari, Roozbeh; Patel, Shyamal			A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis	PLOS ONE			English	Article							WALKING SPEED; INERTIAL SENSOR; IMPAIRMENT; AMBULATION; PARAMETERS; DYNAMICS; VELOCITY; BALANCE; LENGTH	Gait speed is a powerful clinical marker for mobility impairment in patients suffering from neurological disorders. However, assessment of gait speed in coordination with delivery of comprehensive care is usually constrained to clinical environments and is often limited due to mounting demands on the availability of trained clinical staff. These limitations in assessment design could give rise to poor ecological validity and limited ability to tailor interventions to individual patients. Recent advances in wearable sensor technologies have fostered the development of new methods for monitoring parameters that characterize mobility impairment, such as gait speed, outside the clinic, and therefore address many of the limitations associated with clinical assessments. However, these methods are often validated using normal gait patterns; and extending their utility to subjects with gait impairments continues to be a challenge. In this paper, we present a machine learning method for estimating gait speed using a configurable array of skin-mounted, conformal accelerometers. We establish the accuracy of this technique on treadmill walking data from subjects with normal gait patterns and subjects with multiple sclerosis-induced gait impairments. For subjects with normal gait, the best performing model systematically overestimates speed by only 0.01 m/s, detects changes in speed to within less than 1%, and achieves a root-mean-square-error of 0.12 m/s. Extending these models trained on normal gait to subjects with gait impairments yields only minor changes in model performance. For example, for subjects with gait impairments, the best performing model systematically overestimates speed by 0.01 m/s, quantifies changes in speed to within 1%, and achieves a root-mean-square-error of 0.14 m/s. Additional analyses demonstrate that there is no correlation between gait speed estimation error and impairment severity, and that the estimated speeds maintain the clinical significance of ground truth speed in this population. These results support the use of wearable accelerometer arrays for estimating walking speed in normal subjects and their extension to MS patient cohorts with gait impairment.	[McGinnis, Ryan S.; Mahadevan, Nikhil; Seagers, Kirsten; Sheth, Nirav; Wright, John A., Jr.; DiCristofaro, Steven; Silva, Ikaro; Jortberg, Elise; Ceruolo, Melissa; Pindado, Jesus A.; Ghaffari, Roozbeh; Patel, Shyamal] MC10 Inc, Lexington, MA 02421 USA; [McGinnis, Ryan S.] Univ Vermont, Dept Biomed Engn, Burlington, VT 05405 USA; [Sosnoff, Jacob] Univ Illinois, Motor Control Res Lab, Champaign, IL USA	University of Vermont; University of Illinois System; University of Illinois Urbana-Champaign	McGinnis, RS (corresponding author), MC10 Inc, Lexington, MA 02421 USA.; McGinnis, RS (corresponding author), Univ Vermont, Dept Biomed Engn, Burlington, VT 05405 USA.	ryan.mcginnis@uvm.edu	McGinnis, R.S./I-7960-2019; Ghaffari, Roozbeh/ABD-6718-2021; Sosnoff, Jacob/P-3397-2019	McGinnis, R.S./0000-0001-8396-6967; Sosnoff, Jacob/0000-0002-0286-9207; Seagers, Kirsten/0000-0003-1632-5611	MC10, Inc.	MC10, Inc.	Funding for YM and JS, for this study, was provided by MC10, Inc. The remaining authors received no specific funding for this work. The following authors from MC10, Inc. contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript: RM, NM, KS, NS, JAW, SD, IS, EJ, MC, JAP, RG, SP.	Altini M, 2014, INT CONF PERVAS COMP, P10, DOI 10.1109/PerComW.2014.6815158; Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; ANTONSSON EK, 1985, J BIOMECH, V18, P39, DOI 10.1016/0021-9290(85)90043-0; Bethoux Francois, 2011, Int J MS Care, V13, P4, DOI 10.7224/1537-2073-13.1.4; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Burschka JM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-161; Givon U, 2009, GAIT POSTURE, V29, P138, DOI 10.1016/j.gaitpost.2008.07.011; Goldman MD, 2010, THERAPEUTIC ADV NEUR; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Harshvardhan V, 2010, P 4 INT C PERV COMP, P1, DOI DOI 10.4108/ICST.PERVASIVEHEALTH2010.8786; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Lenssen AF, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-83; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; McGinnis Ryan S., 2015, IFAC - Papers Online, V48, P423, DOI 10.1016/j.ifacol.2015.10.177; Miyazaki S, 1997, IEEE T BIO-MED ENG, V44, P753, DOI 10.1109/10.605434; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Motl RW, 2013, PHYS MED REH CLIN N, V24, P325, DOI 10.1016/j.pmr.2012.11.004; Motl RW, 2012, GAIT POSTURE, V35, P192, DOI 10.1016/j.gaitpost.2011.09.005; Motl RW, 2010, NEUROPSYCH DIS TREAT, V6, P767, DOI 10.2147/NDT.S10480; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Park JG, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P113; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; Preiningerova JL, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0001-0; Quach L, 2011, J AM GERIATR SOC, V59, P1069, DOI 10.1111/j.1532-5415.2011.03408.x; Rebula JR, 2013, GAIT POSTURE, V38, P974, DOI 10.1016/j.gaitpost.2013.05.012; Renaudin V, 2012, SENSORS-BASEL, V12, P8507, DOI 10.3390/s120708507; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Tanaka S, 2004, P ANN INT IEEE EMBS, V26, P2283; Tong KY, 1999, MED ENG PHYS, V21, P87, DOI 10.1016/S1350-4533(99)00030-2; Yang SZ, 2012, SENSORS-BASEL, V12, P6102, DOI 10.3390/s120506102; Yang SZ, 2011, GAIT POSTURE, V34, P462, DOI 10.1016/j.gaitpost.2011.06.019	32	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178366	10.1371/journal.pone.0178366	http://dx.doi.org/10.1371/journal.pone.0178366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570570	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800041
J	Shen, Z; Duan, JE; Ma, LY				Shen, Zhan; Duan, Jie; Ma, Luyi			Genetic diversity of Xanthoceras sorbifolium bunge germplasm using morphological traits and microsatellite molecular markers	PLOS ONE			English	Article							BIODIESEL PRODUCTION; SSR MARKERS; SEED OIL; L.; DIFFERENTIATION; SIMILARITY	Xanthoceras sorbifolium Bunge has great potential for producing biodiesel. In order to select and evaluate appropriate germplasm to produce biodiesel, we analyzed the genetic diversity of Xanthoceras sorbifolium Bunge germplasm based on morphological traits and simple sequence repeats (SSRs) in this study. Fifty-six germplasm samples were evaluated using nine morphological traits and 23 SSR loci. Significant differences among germplasms were observed in eight morphological characters. The SSR markers analysis showed high genetic diversity among the germplasms. All SSRs had polymorphisms, and we detected 77 alleles in total. The number of alleles at each locus ranged from two to six, averaging 3.35 per marker. The polymorphic information content values ranged from 0.36 to 0.61, averaging 0.49. Expected heterozygosity, observed heterozygosity, and Shannon's information index calculations detected large genetic variations among germplasms. The high average number of alleles per locus and the allelic diversity observed in the set of genotypes analyzed indicated that the genetic base of this species is relatively wide. Thus, microsatellite markers can be used to efficiently distinguish Xanthoceras sorbifolium Bunge germplasms and assess their genetic diversity. Hundred-grain weight and lateral diameter were positively correlated with monounsaturated fatty acids and depended on genotype. These results suggest that seeds with higher hundred-grain weight and lateral diameter could be more suitable to produce biodiesel. Our data will lay a foundation for selecting appropriate germplasm to produce biodiesel based on seed phenotype and will contribute to the conservation and management of this important plant genetic resource.	[Shen, Zhan; Duan, Jie; Ma, Luyi] Beijing Forestry Univ, Natl Energy R&D Ctr Nonfood Biomass, Beijing, Peoples R China; [Shen, Zhan; Ma, Luyi] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Duan, JE (corresponding author), Beijing Forestry Univ, Natl Energy R&D Ctr Nonfood Biomass, Beijing, Peoples R China.	duanjiebfu@vip.qq.com	duan, jie/GPS-4502-2022	DUAN, JIE/0000-0002-4562-4787	International S&T Cooperation Program of China [2014DFA31140]	International S&T Cooperation Program of China	The study was financially supported by the International S&T Cooperation Program of China (2014DFA31140). The funders designed the experiment but had no additional role in data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ayed R, 2014, BIOCHEM GENET, V52, P258, DOI 10.1007/s10528-014-9645-x; Bi QX, 2014, CONSERV GENET RESOUR, V6, P895, DOI 10.1007/s12686-014-0234-4; Brenner C, 1990, P INT S HUM ID 1989, V1989, P21; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Guan LiPing, 2010, Forestry Studies in China, V12, P37, DOI 10.1007/s11632-010-0003-8; Keneni G, 2012, PLANT MOL BIOL REP, V30, P654, DOI 10.1007/s11105-011-0374-6; Li J, 2012, BIORESOURCE TECHNOL, V108, P112, DOI 10.1016/j.biortech.2011.12.129; [芦娟 Lu Juan], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P32; Madhou M, 2013, TREE GENET GENOMES, V9, P387, DOI 10.1007/s11295-012-0560-1; McClean PE, 2012, GENET RESOUR CROP EV, V59, P499, DOI 10.1007/s10722-011-9699-0; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Pamidimarri DVNS, 2009, MOL BIOL REP, V36, P1357, DOI 10.1007/s11033-008-9320-6; Pelsy F, 2010, THEOR APPL GENET, V120, P1219, DOI 10.1007/s00122-009-1250-8; Pollegioni P, 2013, TREE GENET GENOMES, V9, P291, DOI 10.1007/s11295-012-0555-y; Riahi L, 2010, GENET RESOUR CROP EV, V57, P255, DOI 10.1007/s10722-009-9467-6; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Salem K. F. M., 2008, World Journal of Agricultural Sciences, V4, P538; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos RC, 2012, GENET RESOUR CROP EV, V59, P327, DOI 10.1007/s10722-011-9685-6; Sonnante G, 2008, GENET RESOUR CROP EV, V55, P1029, DOI 10.1007/s10722-008-9310-5; Suresh S, 2013, MOLECULES, V18, P1844, DOI 10.3390/molecules18021844; Vanhala TK, 2004, EUPHYTICA, V137, P297, DOI 10.1023/B:EUPH.0000040450.91906.c5; Xu M, 2010, NEW FOREST, V40, P361, DOI 10.1007/s11056-010-9205-0; Yang AH, 2012, AM J BOT, V99, pE460, DOI 10.3732/ajb.1200154; Yao ZY, 2013, RENEW SUST ENERG REV, V24, P57, DOI 10.1016/j.rser.2013.03.047; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Zhang S, 2010, BIORESOURCE TECHNOL, V101, P2537, DOI 10.1016/j.biortech.2009.11.082; [张燕 Zhang Yan], 2014, [动力工程学报, Journal of Chinese Society of Power Engineering], V34, P241	28	5	7	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177577	10.1371/journal.pone.0177577	http://dx.doi.org/10.1371/journal.pone.0177577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570701	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800013
J	Chang, CH; Chen, SY; Lu, JJ; Chang, CJ; Chang, YH; Hsieh, PH				Chang, Chih-Hsiang; Chen, Szu-Yuan; Lu, Jang-Jih; Chang, Chee-Jen; Chang, Yuhan; Hsieh, Pang-Hsin			Nasal colonization and bacterial contamination of mobile phones carried by medical staff in the operating room	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CELL PHONES; INFECTIONS; CHILDREN; CRITERIA; STRAIN; SPREAD	Background Mobile phones (MPs) have been an essential part of the lives of healthcare professionals and have improved communication, collaboration, and sharing of information. Nonetheless, the widespread use of MPs in hospitals has raised concerns of nosocomial infections, especially in areas requiring the highest hygienic standards such as operating rooms (ORs). This study evaluated the incidence of bacterial contamination of the MPs carried by medical staff working in the OR and determined its association with bacterial colonization of this personnel. Methods This is an observational cohort study. Medical staffs working in the OR were asked to take bacterial cultures from their MPs, anterior nares, and dominant hands. To identify the relation between MP contamination and bacterial colonization of the medical staff, genotyping of Staphylococcus aureus (SA) was done via Staphylococcus protein A gene (spa) typing and pulsed-field gel electrophoresis (PFGE). Results A total of 216 swab samples taken from 72 medical-staff members were analyzed. The culture -positive rate was 98.1% (212/216). In 59 (27.3%) samples, the bacteria were possible clinical pathogens. The anterior nares were the most common site of colonization by clinical pathogens (58.3%, 42/72), followed by MPs (13.9%, 10/72) and the dominant hand (9.7%, 7/72). SA was the most commonly isolated clinical pathogen and was found in 43 (19.9%) samples. In 66 (94.3%) of the 70 staff members for whom bacteria were detected on their MPs, the same bacteria were detected in nares or hand. Among 31 medical staff who were carriers of SA in the anterior nares or dominant hand, 8 (25.8%) were found to have SA on their MPs, and genotyping confirmed the same SA strain in 7 (87.5%) of them. Conclusion A high rate of bacterial nasal colonization and MPs contamination were found among the OR medical staff. An MP may be a reservoir for pathogen contamination in the OR.	[Chang, Chih-Hsiang; Chen, Szu-Yuan; Chang, Yuhan; Hsieh, Pang-Hsin] Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan; [Chang, Chih-Hsiang; Chen, Szu-Yuan; Chang, Yuhan; Hsieh, Pang-Hsin] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Chih-Hsiang; Chen, Szu-Yuan; Chang, Yuhan; Hsieh, Pang-Hsin] Chang Gung Mem Hosp, Bone & Joint Res Ctr, Linkou, Taiwan; [Chang, Chih-Hsiang; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lu, Jang-Jih] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Lu, Jang-Jih] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Res Serv Ctr Hlth Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Hsieh, Pang-Hsin] Chang Gung Mem Hosp, Dept Orthopaed Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Hsieh, PH (corresponding author), Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan.; Hsieh, PH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Hsieh, PH (corresponding author), Chang Gung Mem Hosp, Bone & Joint Res Ctr, Linkou, Taiwan.; Hsieh, PH (corresponding author), Chang Gung Mem Hosp, Dept Orthopaed Surg, Taoyuan, Taiwan.	Hsieh2634@gmail.com		Chang, Chih-Hsiang/0000-0002-6908-6215				Akinyemi KO, 2009, J INFECT DEV COUNTR, V3, P628, DOI 10.3855/jidc.556; Bhat S. S., 2011, ONLINE J HLTH ALLIED, V10, P14; Borer A, 2005, EMERG INFECT DIS, V11, P1160; Brady RRW, 2006, J HOSP INFECT, V62, P123, DOI 10.1016/j.jhin.2005.05.005; Chang CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138971; Chawla K., 2009, ONLINE J HLTH ALLIED, V8, P1; Chen SY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/345475; Hacek DM, 1999, AM J CLIN PATHOL, V111, P647; Hadley S, 2010, ARTHRITIS, DOI 10.1155/2010/924518; Haley RW, 1985, HOSP INFECT, P359; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang YC, 2005, PEDIATR INFECT DIS J, V24, P276, DOI 10.1097/01.inf.0000154333.46032.0f; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082472; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Khivsara A, 2006, CURR SCI INDIA, V90, P910; Kilic I H, 2009, Pak J Biol Sci, V12, P882, DOI 10.3923/pjbs.2009.882.884; Klein AA, 2003, ANAESTHESIA, V58, P353, DOI 10.1046/j.1365-2044.2003.03079.x; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kolmos Hans Jorn, 2007, Ugeskr Laeger, V169, P4138; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Neville SA, 2011, J CLIN MICROBIOL, V49, P2980, DOI 10.1128/JCM.00431-11; Pal Shekhar, 2015, Adv Biomed Res, V4, P144, DOI 10.4103/2277-9175.161553; Plowman R, 2001, J HOSP INFECT, V47, P198, DOI 10.1053/jhin.2000.0881; Russell CD, 2015, J MED MICROBIOL, V64, P446, DOI 10.1099/jmm.0.000026; Sadat-Ali M, 2010, AM J INFECT CONTROL, V38, P404, DOI 10.1016/j.ajic.2009.08.007; Semmelweis IF., 1861, AETIOLOGIE BEGRIFF P; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sprague Lisa, 2009, Issue Brief George Wash Univ Natl Health Policy Forum, P1; Talwar A, 2016, J ENVIRON BIOL, V37, P247; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Ulger F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-7; Van Der Zwet WC, 2002, J CLIN MICROBIOL, V40, P2520, DOI 10.1128/JCM.40.7.2520-2525.2002; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137593	36	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0175811	10.1371/journal.pone.0175811	http://dx.doi.org/10.1371/journal.pone.0175811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562676	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700002
J	Etemadi, MR; Ling, KH; Abidin, SZ; Chee, HY; Sekawi, Z				Etemadi, Mohammad Reza; Ling, King-Hwa; Abidin, Shahidee Zainal; Chee, Hui-Yee; Sekawi, Zamberi			Gene expression patterns induced at different stages of rhinovirus infection in human alveolar epithelial cells	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; I INTERFERON RESPONSE; RESPIRATORY VIRUSES; TRANSCRIPTION FACTOR; KAPPA-B; CHILDREN; INTERLEUKIN-8; RNA; HYPERRESPONSIVENESS; ACTIVATION	Human rhinovirus (HRV) is the common virus that causes acute respiratory infection (ARI) and is frequently associated with lower respiratory tract infections (LRTIs). We aimed to investigate whether HRV infection induces a specific gene expression pattern in airway epithelial cells. Alveolar epithelial cell monolayers were infected with HRV species B (HRV-B). RNA was extracted from both supernatants and infected monolayer cells at 6, 12, 24 and 48 hours post infection (hpi) and transcriptional profile was analyzed using Affymetrix Gene Chip and the results were subsequently validated using quantitative Real-time PCR method. HRV-B infects alveolar epithelial cells which supports implication of the virus with LRTIs. In total 991 genes were found differentially expressed during the course of infection. Of these, 459 genes were up-regulated whereas 532 genes were down-regulated. Differential gene expression at 6 hpi (187 genes up-regulated vs. 156 down-regulated)were significantly represented by gene ontologies related to the chemokines and inflammatory molecules indicating characteristic of viral infection. The 75 up-regulated genes surpassed the down-regulated genes (35) at 12 hpi and their enriched ontologies fell into discrete functional entities such as regulation of apoptosis, anti-apoptosis, and wound healing. At later time points of 24 and 48 hpi, predominated down-regulated genes were enriched for extracellular matrix proteins and airway remodeling events. Our data provides a comprehensive image of host response to HRV infection. The study suggests the underlying molecular regulatory networks genes which might be involved in pathogenicity of the HRV-B and potential targets for further validations and development of effective treatment.	[Etemadi, Mohammad Reza; Chee, Hui-Yee; Sekawi, Zamberi] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Upm Serdang 43400, Serdang De, Malaysia; [Ling, King-Hwa; Abidin, Shahidee Zainal] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Upm Serdang, Selangor De, Malaysia; [Ling, King-Hwa; Abidin, Shahidee Zainal] Univ Putra Malaysia, Fac Med & Hlth Sci, GRMRC, Upm Serdang, Selangor De, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Sekawi, Z (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Upm Serdang 43400, Serdang De, Malaysia.	zamberi@upm.edu.my	Etemadi, Mohammad Reza/M-6420-2019; Ling, King-Hwa/M-2349-2018; Chee, Hui Yee/ABB-8056-2021; Sekawi, Zamberi/I-1755-2013	Ling, King-Hwa/0000-0002-3968-7263; Chee, Hui Yee/0000-0002-5033-627X; Sekawi, Zamberi/0000-0002-5387-9640	Ministry of Science, Technology and Innovation Malaysia [5527107]	Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This work was funded by the Ministry of Science, Technology and Innovation Malaysia 6 (Exploratory research grant scheme (FRGS); Vote no: 5527107). Grant received by: Prof. Zamberi Sekawi.	AFFYMETRIX, 2003, GEN EXPR AN TECHN MA; Aponte FE, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0262-z; BECKER S, 1994, AM J PHYSIOL, V266, pL278, DOI 10.1152/ajplung.1994.266.3.L278; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blomqvist S, 2002, J MED VIROL, V66, P263, DOI 10.1002/jmv.2140; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Chun YH, 2013, ALLERGY ASTHMA IMMUN, V5, P216, DOI 10.4168/aair.2013.5.4.216; Deszcz L, 2005, J GEN VIROL, V86, P1379, DOI 10.1099/vir.0.80754-0; DOLAN TM, 1968, APPL MICROBIOL, V16, P1331, DOI 10.1128/AEM.16.9.1331-1336.1968; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Etemadi MR, 2013, J CLIN VIROL, V58, P671, DOI 10.1016/j.jcv.2013.05.017; Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; Haidaris P, 1992, BLOOD S, V80, p307a; HALPERIN SA, 1985, AM REV RESPIR DIS, V132, P976; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; He CH, 2005, J CLIN INVEST, V115, P1039, DOI 10.1172/JCI200523004; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Imakita M, 2000, CLIN INFECT DIS, V30, P611, DOI 10.1086/313723; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnston SL, 1998, J IMMUNOL, V160, P6172; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697; Lewis TC, 2012, CLIN EXP ALLERGY, V42, P1734, DOI 10.1111/cea.12005; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Ludwig S., 2007, Signal Transduction, V7, P81, DOI 10.1002/sita.200600114; Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000; Mastronarde JG, 1998, J INFECT DIS, V177, P1275, DOI 10.1086/515279; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Papadopoulos Nikolaos G, 2004, Paediatr Respir Rev, V5 Suppl A, pS191, DOI 10.1016/S1526-0542(04)90036-X; Patel JR, 2011, VIRAL IMMUNOL, V24, P89, DOI 10.1089/vim.2010.0122; Peltola V, 2009, J MED VIROL, V81, P1831, DOI 10.1002/jmv.21590; Peng T, 2006, J VIROL, V80, P5021, DOI 10.1128/JVI.80.10.5021-5031.2006; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Proud D, 2011, ASIAN PAC J ALLERGY, V29, P201; Racaniello VR, 2013, FIELDS VIROLOGY, V1, P453; Ramos M, 2015, VIRULENCE, V6, P710, DOI 10.1080/21505594.2015.1057389; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Schuler BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093897; SHUTE J, 1994, CLIN EXP ALLERGY, V24, P203, DOI 10.1111/j.1365-2222.1994.tb00220.x; Taimen P, 2004, VIROLOGY, V320, P85, DOI 10.1016/j.virol.2003.11.026; Tan YJ, 2005, J VIROL, V79, P10083, DOI 10.1128/JVI.79.15.10083-10087.2005; Walum E, 1991, J APPL TOXICOL, V11, P389; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Zhang YH, 2001, J VIROL, V75, P9044, DOI 10.1128/JVI.75.19.9044-9058.2001	58	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0176947	10.1371/journal.pone.0176947	http://dx.doi.org/10.1371/journal.pone.0176947			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558071	Green Submitted, gold, Green Published			2022-12-26	WOS:000402607000007
J	Kim, Y; Lee, J; Kim, J; Choi, CW; Hwang, YI; Kang, JS; Lee, WJ				Kim, Yejin; Lee, Junmyung; Kim, Jihoon; Choi, Chong Won; Hwang, Young-Il; Kang, Jae Seung; Lee, Wang Jae			The pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation	PLOS ONE			English	Article							KERATINOCYTE CELL-LINE; CYTOKINE PRODUCTION; GENE-EXPRESSION; IL-22; RADIATION; EPIDERMIS; INCREASES; PSORIASIS; IMMUNITY; DAMAGE	Recent studies show that IL-22, a cytokine produced by activated CD4(+) T cells and NK cells, plays a pathogenic role in acute and chronic skin diseases. While IL-22 is produced by immune cells, the expression of IL-22R alpha, the functional subunit of IL-22R, is mostly restricted to non-hematopoietic cells in organs such as the skin and pancreas. Although it is well known that ultraviolet B (UVB) radiation induces skin inflammation, there have been no reports regarding the effect of UVB on the expression of IL-22R alpha. This study investigated IL22R alpha expression and IL-22-mediated proliferation and pro-inflammatory cytokine production by UVB-irradiated keratinocytes. IL-22R alpha was increased in HaCaT and primary human keratinocytes after UVB irradiation through the translocation of IL-22R alpha from the cytosol to the membrane. This increase in the expression of IL-22R alpha was mediated by the PI3K/Akt pathway. Moreover, the suppression of keratinocyte proliferation by UVB irradiation was inhibited by treatment with IL-22. At the same time, IL-22 increased the production of IL-la, IL-6, and IL-18 in UVB-irradiated HaCaT cells and primary human keratinocytes. Finally, IL22R alpha expression was increased in UVB-irradiated human and mouse skin by immunohistochemistry. The increased expression of IL-22R alpha therefore promotes keratinocyte proliferation and pro-inflammatory cytokine production during UVB-induced skin inflammation, suggesting that UVB facilitates skin inflammation by increasing the responsiveness of keratinocytes to IL-22. This study provides a new insight into UVB-induced skin inflammation and the regulation of related inflammatory skin diseases.	[Kim, Yejin; Lee, Junmyung; Kim, Jihoon; Hwang, Young-Il; Kang, Jae Seung; Lee, Wang Jae] Seoul Natl Univ, Coll Med, Dept Anat & Cell Biol, Lab Vitamin C & Antioxidant Immunol, Seoul, South Korea; [Kim, Yejin; Kang, Jae Seung] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Choi, Chong Won] Seoul Natl Univ Hosp, Dept Dermatol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat & Cell Biol, Lab Vitamin C & Antioxidant Immunol, Seoul, South Korea.; Kang, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea.	genius29@snu.ac.kr	Kang, Jae Seung/J-5363-2012	Kang, Jaeseung/0000-0001-7675-9134; Kim, Jihoon/0000-0002-2573-4866				Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Anna Brozyna, 2007, Expert Rev Dermatol, V2, P451, DOI 10.1586/17469872.2.4.451; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brash DE, 1982, UV INDUCED MUTATION; Cengiz FP, 2015, ANN MED BIOMEDICAL S, V1; Chen X, 2013, BIOCH BIOPHYSICAL RE; Cho DH, 2002, BIOCHEM BIOPH RES CO, V298, P289, DOI 10.1016/S0006-291X(02)02433-6; Cho KA, 2012, INT IMMUNOL, V24, P147, DOI 10.1093/intimm/dxr110; Cho O, 2013, RELEVANCE INTERLEUKI, P1; Choi J, 2015, IMMUNE NETW, V15, P291, DOI 10.4110/in.2015.15.6.291; DEVOS S, 1994, J INVEST DERMATOL, V103, P92, DOI 10.1111/1523-1747.ep12391818; Donetti E, 2016, EXPT CELL RES, V706; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fujita H, 2013, J DERMATOL SCI, V72, P3, DOI 10.1016/j.jdermsci.2013.04.028; Godar D E, 1994, Cell Death Differ, V1, P59; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kang JS, 2007, J INVEST DERMATOL, V127, P698, DOI 10.1038/sj.jid.5700572; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Kim AL, 2005, J INVEST DERMATOL, V124, P1318, DOI 10.1111/j.0022-202X.2005.23747.x; Kim BJ, 2010, EFFECT CALCIPOTRIOL, V2009; Kim Y, 2012, IMMUNOLOGY LETT; Kim Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154904; Lindroos J, 2011, J INVEST DERMATOL, V131, P1110, DOI 10.1038/jid.2010.432; Mitra A, 2012, CYTOKINE; Na H, 2016, IMMUNE NETW, V16, P1, DOI 10.4110/in.2016.16.1.1; Nakagawa A, 1998, J INVEST DERMATOL, V110, P143, DOI 10.1046/j.1523-1747.1998.00100.x; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Seo JY, 2001, J INVEST DERMATOL, V116, P915, DOI 10.1046/j.1523-1747.2001.01358.x; Suh DH, 2002, EUR J DERMATOL, V12, P139; Terui T, 2000, J DERMATOL SCI, V23, pS1, DOI 10.1016/S0923-1811(99)00070-5; Tohyama M, 2012, J INVEST DERMATOL, V132, P1933, DOI 10.1038/jid.2011.468; Tohyama M, 2009, EUR J IMMUNOL, V39, P2779, DOI 10.1002/eji.200939473; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhu XF, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-13	44	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178567	10.1371/journal.pone.0178567	http://dx.doi.org/10.1371/journal.pone.0178567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558005	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000055
J	Ortiz-Rodriguez, JM; Anel-Lopez, L; Martin-Munoz, P; Alvarez, M; Gaitskell-Phillips, G; Anel, L; Rodriguez-Medina, P; Pena, FJ; Ferrusola, CO				Ortiz-Rodriguez, Jose M.; Anel-Lopez, Luis; Martin-Munoz, Patricia; Alvarez, Mercedes; Gaitskell-Phillips, Gemma; Anel, Luis; Rodriguez-Medina, Pedro; Pena, Fernando J.; Ortega Ferrusola, Cristina			Pulse Doppler ultrasound as a tool for the diagnosis of chronic testicular dysfunction in stallions	PLOS ONE			English	Article							CHROMATIN-STRUCTURE ASSAY; ARTERY BLOOD-FLOW; RESISTIVE INDEX; SEMEN QUALITY; SPERM DNA; CRYOPRESERVATION; COLOR; ULTRASONOGRAPHY; REPRODUCTION; TECHNOLOGIES	Testicular function is particularly susceptible to vascular insult, resulting in a negative impact on sperm production and quality of the ejaculate. A prompt diagnosis of testicular dysfunction enables implementation of appropriate treatment, hence improving fertility forecasts for stallions. The present research aims to: (1) assess if Doppler ultrasonography is a good tool to diagnose stallions with testicular dysfunction; (2) to study the relationship between Doppler parameters of the testicular artery and those of sperm quality assessed by flow cytometry and (3) to establish cut off values to differentiate fertile stallions from those with pathologies causing testicular dysfunction. A total of 10 stallions (n: 7 healthy stallions and n: 3 sub-fertile stallions) were used in this study. Two ejaculates per stallion were collected and preserved at 5 C in a commercial extender. The semen was evaluated at TO, T24 and T48h by flow cytometry. Integrity and viability of sperm (YoPro((R))-1/EthD-1), mitochondrial activity (MitoTracker Deep Red FM) and the DNA fragmentation index (Sperm Chromatin Structure Assay) were assessed. Doppler parameters were measured at three different locations on the testicular artery (Supratesticular artery (SA); Capsular artery (CA) and Intratesticular artery (IA)). The Doppler parameters calculated were: Resistive Index (RI), Pulsatility Index (PI), Peak Systolic Velocity (PSV), End Diastolic Velocity (EDV), Time Average Maximum Velocity (TAMV), Total Arterial Blood Flow (TABF) and TABF rate. The capsular artery was the most reliable location to carry out spectral Doppler assessment, since blood flow parameters of this artery were most closely correlated with sperm quality parameters. Significant differences in all the Doppler parameters studied were observed between fertile and subfertile stallions (p < 0.05). The principal components analysis assay determined that fertile stallions are characterized by high EDV, TAMV, TABF and TABF rate values (high vascular perfusion). In contrast, subfertile stallions tend to present high values of PI and RI (high vascular resistance). The ROC curves revealed that the best Doppler parameters to predict sperm quality in stallions were: Doppler velocities (PSV, EDV and TAMV), the diameter of the capsular artery and TABF parameters (tissue perfusion parameters). Cut off values were established using a Youden's Index to identify fertile stallions from stallions with testicular dysfunction. Spectral Doppler ultrasound is a good predictive tool for sperm quality since correlations were determined among Doppler parameters and markers of sperm quality. Doppler ultrasonography could be a valuable diagnostic tool for use by clinical practitioners for the diagnosis of stallions with testicular dysfunction and could be a viable alternative to invasive procedures traditionally used for diagnosis of sub-fertility disorders.	[Ortiz-Rodriguez, Jose M.; Martin-Munoz, Patricia; Gaitskell-Phillips, Gemma; Pena, Fernando J.] Univ Extremadura, Vet Teaching Hosp, Lab Equine Reprod & Equine Spermatol, Caceres, Spain; [Anel-Lopez, Luis; Alvarez, Mercedes; Anel, Luis; Ortega Ferrusola, Cristina] Univ Leon, Dept Anim Med Surg & Vet Anat, Leon, Spain; [Rodriguez-Medina, Pedro] Univ Extremadura, Dept Zootech Sci, Caceres, Spain	Universidad de Extremadura; Universidad de Leon; Universidad de Extremadura	Ferrusola, CO (corresponding author), Univ Leon, Dept Anim Med Surg & Vet Anat, Leon, Spain.	cortf@unileon.es	Ortiz-Rodríguez, Jose Manuel/AAP-2305-2021; Anel-Lopez, Luis/K-6546-2017; ANEL-LÓPEZ, LUIS/AAP-2438-2020; Ortega-Ferrusola, Cristina/AGI-8478-2022; Peña, Fernando J/D-8450-2012; Gaitskell-Phillips, Gemma/AAB-5919-2020; Anel, Luis/K-6573-2017	Ortiz-Rodríguez, Jose Manuel/0000-0002-3248-6493; Anel-Lopez, Luis/0000-0001-7179-5742; ANEL-LÓPEZ, LUIS/0000-0001-7179-5742; Ortega-Ferrusola, Cristina/0000-0002-7698-8735; Peña, Fernando J/0000-0002-1311-2947; Gaitskell-Phillips, Gemma/0000-0003-4308-7903; Anel, Luis/0000-0003-2423-4031	"Ministerio de Economia y Competitividad ". "Juan de la Cierva" [IJCI-2014-21671]; Ministerio de Economia y Competitividad-FEDER, Madrid, Spain [AGL2013-43211-R]; Junta de Extremadura-FEDER [GR 10010, PCE1002]; Ministerio de Educacion, Cultura y Deporte, Madrid Spain [FPU13/03991]; "Ministerio de Economia y Competitividad "Juan de la Cierva" [IJCI-2014-21671]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE001002] Funding Source: NIH RePORTER	"Ministerio de Economia y Competitividad ". "Juan de la Cierva"; Ministerio de Economia y Competitividad-FEDER, Madrid, Spain; Junta de Extremadura-FEDER; Ministerio de Educacion, Cultura y Deporte, Madrid Spain; "Ministerio de Economia y Competitividad "Juan de la Cierva"; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	C.O.F. is supported by a postdoctoral grant from "Ministerio de Economia y Competitividad ". "Juan de la Cierva" IJCI-2014-21671. The authors received financial support from: the Ministerio de Economia y Competitividad-FEDER, Madrid, Spain,grant AGL2013-43211-R;Junta de Extremadura-FEDER (GR 10010 and PCE1002). P.M.M. is supported by a predoctoral grant from the Ministerio de Educacion, Cultura y Deporte, Madrid Spain FPU13/03991.; C.O.F. is supported by a postdoctoral grant from "Ministerio de Economia y Competitividad "Juan de la Cierva" IJCI-2014-21671. The authors received financial support from the Ministerio de Economia y Competitividad-FEDER, Madrid, Spain, grant AGL2013-43211-R, and Junta de Extremadura-FEDER (GR 10010 and PCE1002). P.M.M. is supported by a pre-doctoral grant from the Ministerio de EducaciOn, Cultura y Deporte, Madrid Spain FPU13/03991.	Ball BA, 2008, J EQUINE VET SCI, V28, P650, DOI 10.1016/j.jevs.2008.10.003; Bergh A., 1993, MOL BIOL MALE REPROD, P439, DOI [10.1016/B978-0-08-091764-1.50017-9, DOI 10.1016/B978-0-08-091764-1.50017-9]; Biagiotti Giulio, 2002, Arch Ital Urol Androl, V74, P243; Bollwein H, 2008, J REPROD DEVELOP, V54, P335, DOI 10.1262/jrd.20014; Cassar S, 2008, J ULTRAS MED, V27, P1629, DOI 10.7863/jum.2008.27.11.1629; DOUGLAS RH, 1992, VET CLIN N AM-EQUINE, V8, P237, DOI 10.1016/S0749-0739(17)30478-9; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Foresta C, 1998, HUM REPROD, V13, P3090, DOI 10.1093/humrep/13.11.3090; Bolanos JMG, 2014, REPRODUCTION, V148, P221, DOI 10.1530/REP-13-0191; Ginther OJ, 2014, THERIOGENOLOGY, V81, P112, DOI 10.1016/j.theriogenology.2013.09.007; Ginther OJ, 2004, J EQUINE VET SCI, V24, P516, DOI 10.1016/j.jevs.2004.11.005; Gracia-Calvo LA, 2016, VET REC, V178, DOI 10.1136/vr.103236; Gracia-Calvo LA, 2015, THERIOGENOLOGY, V84, P797, DOI 10.1016/j.theriogenology.2015.05.014; Gracia-Calvo LA, 2014, REPROD DOMEST ANIM, V49, P1043, DOI 10.1111/rda.12434; Jee WH, 1997, ACTA RADIOL, V38, P1026; Love CC, 2005, ANIM REPROD SCI, V89, P39, DOI 10.1016/j.anireprosci.2005.06.019; Love CC, 1998, THERIOGENOLOGY, V50, P955, DOI 10.1016/S0093-691X(98)00199-X; Rodriguez AM, 2011, ANIM REPROD SCI, V127, P78, DOI 10.1016/j.anireprosci.2011.07.009; Morresey P. R., 2007, Clinical Techniques in Equine Practice, V6, P265, DOI 10.1053/j.ctep.2007.09.005; Ferrusola CO, 2009, REPRODUCTION, V138, P55, DOI [10.1530/REP-08-0484, 10.1530/RFP-08-0484]; Ortega-Ferrusola C, 2008, J ANDROL, V29, P213, DOI 10.2164/jandrol.107.003640; Ortega-Ferrusola C, 2014, REPROD DOMEST ANIM, V49, P88, DOI 10.1111/rda.12363; Ortega-Ferrusola C, 2009, ANIM REPROD SCI, V114, P393, DOI 10.1016/j.anireprosci.2008.10.005; Ortega-Ferrusola C, 2009, REPROD DOMEST ANIM, V44, P419, DOI 10.1111/j.1439-0531.2008.01097.x; Ortiz I, 2015, THERIOGENOLOGY, V84, P294, DOI 10.1016/j.theriogenology.2015.03.021; Pena FJ, 2015, REPROD DOMEST ANIM, V50, P529, DOI 10.1111/rda.12551; Pena FJ, 2011, THERIOGENOLOGY, V76, P1177, DOI 10.1016/j.theriogenology.2011.06.023; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Pena FJ, 2016, J EQUINE VET SCI, V43, pS23, DOI 10.1016/j.jevs.2016.06.004; Pena FJ, 2016, THERIOGENOLOGY, V86, P366, DOI 10.1016/j.theriogenology.2016.04.050; Pinggera GM, 2008, BJU INT, V101, P722, DOI 10.1111/j.1464-410X.2007.07343.x; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Pozor M. A., 2007, Clinical Techniques in Equine Practice, V6, P271, DOI 10.1053/j.ctep.2007.09.007; Pozor MA, 2004, THERIOGENOLOGY, V61, P799, DOI 10.1016/S0093-691X(03)00227-9; Pozor MA., 2014, J EQUINE VET SCI, V34, P38, DOI [10.1016/j.jevs.2013.10.021, DOI 10.1016/J.JEVS.2013.10.021]; Pozor MA, 2011, THERIOGENOLOGY, V76, P1027, DOI 10.1016/j.theriogenology.2011.05.005; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Schurich M, 2009, EUR J OBSTET GYN R B, V144, pS192, DOI 10.1016/j.ejogrb.2009.02.034; Tarhan S, 2003, SCAND J UROL NEPHROL, V37, P38, DOI 10.1080/00365590310008677; Turner R. M., 2005, Clinical Techniques in Equine Practice, V4, P257, DOI 10.1053/j.ctep.2005.07.007; Turner R. M. O., 2007, Clinical Techniques in Equine Practice, V6, P278, DOI 10.1053/j.ctep.2007.09.006; Wielgos M, 1998, Ginekol Pol, V69, P537; Zelli R, 2013, RES VET SCI, V95, P632, DOI 10.1016/j.rvsc.2013.04.023	44	32	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0175878	10.1371/journal.pone.0175878	http://dx.doi.org/10.1371/journal.pone.0175878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558006	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000004
J	In, HJ; Lim, H; Lee, JA; Kim, HJ; Kim, JW; Hyeon, JY; Yeo, SG; Lee, JW; Yoo, JS; Choi, YK; Lee, SW				In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Kim, Hye Jin; Kim, Jin-Won; Hyeon, Ji-Yeon; Yeo, Sang-Gu; Lee, June-Woo; Yoo, Jung Sik; Choi, Young Ki; Lee, Sang-Won			An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; EV71 VACCINE; DOUBLE-BLIND; LIPID-A; ADJUVANT; SAFETY	Enterovirus 71 (EV71) is a major causative agent of hand-foot-and-mouth disease (HFMD) frequently occurring in children. HFMD induced by EV71 can cause serious health problems and has been reported worldwide, particularly in the Asia-Pacific region. In this study, we assessed the immunogenicity of a formalin-inactivated HFMD vaccine using an EV71 strain (FI-EV71 C4a) isolated from a Korean patient. The vaccine candidate was evaluated in mice to determine the vaccination doses and vaccine schedules. BALB/c mice were intra-muscularly administered 5, 10, or 20 mu g FI-EV71 vaccine, followed by a booster 2 weeks later. EV71-specific antibodies and neutralizing antibodies were induced and maintained until the end of the experimental period in all vaccinated groups. To determine the effectiveness of adjuvant for the EV71 vaccine, three adjuvants, i.e., aluminium hydroxide gel, monophosphoryl lipid A, and polyinosinic-polycytidylic acid, were administered separately with the FI-EV71 vaccine to mice via the intramuscular route. Mice administered the FI-EV71 vaccine formulated with all three adjuvants induced a significantly increased antibody response compared with that of the single adjuvant groups. The vaccinated group with triple adjuvants exhibited more rapid induction of EV71-specific and neutralizing antibodies than the other groups. These results suggested that the role of adjuvant in inactivated vaccine was important for eliciting effective immune responses against EV71. In conclusion, our results showed that FI-EV71 was a potential candidate vaccine for prevention of EV71 infection.	[In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Kim, Hye Jin; Kim, Jin-Won; Hyeon, Ji-Yeon; Yeo, Sang-Gu; Lee, June-Woo; Yoo, Jung Sik; Lee, Sang-Won] Korea Ctr Dis Control & Prevent, Korea Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Coll Med, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Med Res Inst, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Chungbuk National University; Chungbuk National University	Lee, SW (corresponding author), Korea Ctr Dis Control & Prevent, Korea Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea.	epilsw@korea.kr	IN, HYUN JU/A-5623-2017	IN, HYUN JU/0000-0002-7783-4877	Korea National Institute of Health [NIH 4800-4845-300]	Korea National Institute of Health	This work was supported by grants from the Korea National Institute of Health (grant no. NIH 4800-4845-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alving CR, 2008, VACCINE, V26, P3036, DOI 10.1016/j.vaccine.2007.12.002; Ann J, 2014, VACCINE, V32, P5730, DOI 10.1016/j.vaccine.2014.08.029; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Dochez C, 2014, VACCINE, V32, P1595, DOI 10.1016/j.vaccine.2013.10.081; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Kim KH, 2009, KOREAN J PEDIAT, V53, P616, DOI DOI 10.3345/KJP.2010.53.5.616; Ku ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057601; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang Z, 2012, FRONTIERMED, V7, P111; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Rappuoli R, 2011, PHILOS T R SOC B, V366, P2756, DOI 10.1098/rstb.2011.0075; Rumke HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-348; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Schwarz TF, 2008, GYNECOL ONCOL, V110, pS1, DOI 10.1016/j.ygyno.2008.05.036; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Vogel FR, 2000, CLIN INFECT DIS, V30, pS266, DOI 10.1086/313883; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	39	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178259	10.1371/journal.pone.0178259	http://dx.doi.org/10.1371/journal.pone.0178259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542556	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500079
J	Iwakura, N; Yokoyama, T; Quaglia, F; Mitsuoka, K; Mio, K; Shigematsu, H; Shirouzu, M; Kaji, A; Kaji, H				Iwakura, Nobuhiro; Yokoyama, Takeshi; Quaglia, Fabio; Mitsuoka, Kaoru; Mio, Kazuhiro; Shigematsu, Hideki; Shirouzu, Mikako; Kaji, Akira; Kaji, Hideko			Chemical and structural characterization of a model Post-Termination Complex (PoTC) for the ribosome recycling reaction: Evidence for the release of the mRNA by RRF and EF-G	PLOS ONE			English	Article							ELONGATION-FACTOR-G; FACTOR-DEPENDENT RELEASE; INITIATION-FACTOR IF-3; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; BACTERIAL RIBOSOME; RIBONUCLEIC-ACID; 70S RIBOSOMES; TRANSLATION; SUBUNITS	A model Post-Termination Complex (PoTC) used for the discovery of Ribosome Recycling Factor (RRF) was purified and characterized by cryo-electron microscopic analysis and biochemical methods. We established that the model PoTC has mostly one tRNA, at the P/E or P/P position, together with one mRNA. The structural studies were supported by the biochemical measurement of bound tRNA and mRNA. Using this substrate, we establish that the release of tRNA, release of mRNA and splitting of ribosomal subunits occur during the recycling reaction. Order of these events is tRNA release first followed by mRNA release and splitting almost simultaneously. Moreover, we demonstrate that IF3 is not involved in any of the recycling reactions but simply prevents the re-association of split ribosomal subunits. Our finding demonstrates that the important function of RRF includes the release of mRNA, which is often missed by the use of a short ORF with the Shine-Dalgarno sequence near the termination site.	[Iwakura, Nobuhiro; Quaglia, Fabio; Kaji, Hideko] Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Iwakura, Nobuhiro; Quaglia, Fabio; Kaji, Akira] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yokoyama, Takeshi; Shigematsu, Hideki; Shirouzu, Mikako] RIKEN Ctr Life Sci Technol, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan; [Quaglia, Fabio] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy; [Mitsuoka, Kaoru] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, Osaka, Japan; [Mio, Kazuhiro] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Mio, Kazuhiro] Natl Inst Adv Ind Sci & Technol, OPERANDO Open Innovat Lab, Tokyo, Japan	Jefferson University; University of Pennsylvania; RIKEN; University of Camerino; Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Kaji, H (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.; Kaji, A (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	kaji@mail.med.upenn.edu; hideko.kaji@jefferson.edu	Iwakura, Nobuhiro/D-5394-2012; Shirouzu, Mikako/A-6521-2016; Mio, Kazuhiro/L-7488-2018; Shigematsu, Hideki/E-1052-2017	Mio, Kazuhiro/0000-0002-1655-8231; Shigematsu, Hideki/0000-0003-3951-8651; Mitsuoka, Kaoru/0000-0003-1782-675X	Creative Biomedical Research Institute, Philadelphia, (PA)	Creative Biomedical Research Institute, Philadelphia, (PA)	This work was supported by funding from Creative Biomedical Research Institute, Philadelphia, (PA). FQ is a PhD student of the University of Camerino, Camerino, Italy.; This work was supported by funds from the Creative Biomedical Research Institute, Philadelphia, (PA). FQ is a PhD student of the University of Camerino, Camerino, Italy.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Barat C, 2007, MOL CELL, V27, P250, DOI 10.1016/j.molcel.2007.06.005; Borg A, 2016, RNA, V22, P10, DOI 10.1261/rna.053157.115; Cougot N, 2013, J MOL BIOL; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; GOTTLIEB M, 1975, P NATL ACAD SCI USA, V72, P4238, DOI 10.1073/pnas.72.11.4238; GUALERZI C, 1971, BIOCHEM BIOPH RES CO, V45, P1312, DOI 10.1016/0006-291X(71)90162-8; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; HIRASHIMA A, 1972, BIOCHEMISTRY-US, V11, P4037, DOI 10.1021/bi00772a005; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hirokawa G, 2006, TRENDS BIOCHEM SCI, V31, P143, DOI 10.1016/j.tibs.2006.01.007; Hirokawa G, 2005, RNA, V11, P1317, DOI 10.1261/rna.2520405; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; HOU Y, 1994, J BACTERIOL, V176, P7038, DOI 10.1128/JB.176.22.7038-7044.1994; Inokuchi Y, 2000, EMBO J, V19, P3788, DOI 10.1093/emboj/19.14.3788; ISHITSUKA H, 1970, J BIOL CHEM, V245, P3346; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; KAEMPFER R, 1972, J MOL BIOL, V71, P583, DOI 10.1016/0022-2828(72)90033-8; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; KAZIRO Y, 1968, J BIOCHEM-TOKYO, V64, P423, DOI 10.1093/oxfordjournals.jbchem.a128913; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; MATTHAEI H, 1961, BIOCHEM BIOPH RES CO, V4, P404, DOI 10.1016/0006-291X(61)90298-4; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Nierhaus K., 1990, RIBOSOMES PROTEIN SY, V1990, P161; OGAWA K, 1975, BIOCHIM BIOPHYS ACTA, V402, P288, DOI 10.1016/0005-2787(75)90266-X; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Peske F, 2005, MOL CELL, V18, P403, DOI 10.1016/j.molcel.2005.04.009; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; REMME J, 1989, EUR J BIOCHEM, V183, P281, DOI 10.1111/j.1432-1033.1989.tb14925.x; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; SHIMIZU I, 1991, J BACTERIOL, V173, P5181, DOI 10.1128/jb.173.16.5181-5187.1991; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Singh NS, 2005, NUCLEIC ACIDS RES, V33, P5591, DOI 10.1093/nar/gki864; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Vivanco-Dominguez S, 2012, J MOL BIOL, V417, P425, DOI 10.1016/j.jmb.2012.02.008; WAHBA AJ, 1969, COLD SPRING HARB SYM, V34, P291, DOI 10.1101/SQB.1969.034.01.035; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yokoyama T, 2012, EMBO J, V31, P1836, DOI 10.1038/emboj.2012.22; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086	55	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177972	10.1371/journal.pone.0177972	http://dx.doi.org/10.1371/journal.pone.0177972			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542628	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500047
J	Obsa, BT; Eglinton, J; Coventry, S; March, T; Guillaume, M; Le, TP; Hayden, M; Langridge, P; Fleury, D				Obsa, Bulti Tesso; Eglinton, Jason; Coventry, Stewart; March, Timothy; Guillaume, Maxime; Le, Thanh Phuoc; Hayden, Matthew; Langridge, Peter; Fleury, Delphine			Quantitative trait loci for yield and grain plumpness relative to maturity in three populations of barley (Hordeum vulgare L.) grown in a low rain-fall environment	PLOS ONE			English	Article							AGRONOMIC TRAITS; VERNALIZATION RESPONSE; QTL ANALYSIS; PHOTOPERIOD; ADAPTATION; DROUGHT; GENES; IDENTIFICATION; DETERMINES; STABILITY	Identifying yield and grain plumpness QTL that are independent of developmental variation or phenology is of paramount importance for developing widely adapted and stable varieties through the application of marker assisted selection. The current study was designed to dissect the genetic basis of yield performance and grain plumpness in southern Australia using three doubled haploid (DH) populations developed from crosses between adapted parents that are similar in maturity and overall plant development. Three interconnected genetic populations, Commander x Fleet (CF), Commander x WI4304 (CW), and Fleet x WI4304 (FW) developed from crossing of Australian elite barley genotypes, were used to map QTL controlling yield and grain plumpness. QTL for grain plumpness and yield were analysed using genetic linkage maps made of genotyping-by-sequencing markers and major phenology genes, and field trials at three drought prone environments for two growing seasons. Seventeen QTL were detected for grain plumpness. Eighteen yield QTL explaining from 1.2% to 25.0% of the phenotypic variation were found across populations and environments. Significant QTL x environment interaction was observed for all grain plumpness and yield QTL, except QPlum. FW-4H.1 and QYld.FW-2H.1. Unlike previous yield QTL studies in barley, none of the major developmental genes, including Ppd-H1, Vrn-H1, Vrn-H2 and Vrn-H3, that drive barley adaption significantly affected grain plumpness and yield here. Twenty-two QTL controlled yield or grain plumpness independently of known maturity QTL or genes. Adjustment for maturity effects through co-variance analysis had no major effect on these yield QTL indicating that they control yield per se.	[Obsa, Bulti Tesso; Langridge, Peter; Fleury, Delphine] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Eglinton, Jason; Coventry, Stewart; March, Timothy; Langridge, Peter] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Glen Osmond, SA, Australia; [Guillaume, Maxime] Montpellier SupAgro, Montpellier, France; [Le, Thanh Phuoc] Can Tho Univ, Coll Agr & Appl Biol, Dept Plant Protect, Can Tho, Vietnam; [Hayden, Matthew] La Trobe Univ, Dept Econ Dev Jobs Transport & Resources, Agribio, Bundoora, Vic, Australia	University of Adelaide; University of Adelaide; Institut Agro; Montpellier SupAgro; Can Tho University; La Trobe University	Fleury, D (corresponding author), Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia.	delphine.fleury@adelaide.edu.au	Fleury, Delphine L/G-4464-2010; Langridge, Peter/G-5864-2010; Guilllaume, Maxime/G-6389-2018	Fleury, Delphine L/0000-0002-7077-4103; Langridge, Peter/0000-0001-9494-400X; Hayden, Matthew/0000-0003-3117-5500	South Australia Grain Industry Trust Fund [UA 1202]; Australian Research Council; Grains Research and Development Corporation; South Australian Government; Department of Further Education, Employment, Science and Technology; University of Adelaide through the Australian Centre for Plant Functional Genomics	South Australia Grain Industry Trust Fund; Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); South Australian Government; Department of Further Education, Employment, Science and Technology; University of Adelaide through the Australian Centre for Plant Functional Genomics	This work is partially funded by the South Australia Grain Industry Trust Fund (UA 1202), and by Australian Research Council, Grains Research and Development Corporation, the South Australian Government, the Department of Further Education, Employment, Science and Technology, and The University of Adelaide through the Australian Centre for Plant Functional Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Anthony Smith, Donna Marks and the Barley Program team, University of Adelaide, and Davis Leigh from Minnipa Agricultural Research Centre for their assistance to the field trials. We also thank Priyanka Kalambettu and Florian Krimpzer for assisting in the SNP genotyping. This work is partially funded by the South Australia Grain Industry Trust Fund (UA 1202), Australian Research Council, Grains Research and Development Corporation, the South Australian Government, the Department of Further Education, Employment, Science and Technology, and The University of Adelaide. The presented results were obtained by support of the International Barley Genome Sequencing Consortium through providing pre-publication access to the annotated barley reference sequence RefSeq v1.0 (downloadable after registration).	ABARES, 2012, AGR COMM; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Barr AR, 2003, AUST J AGR RES, V54, P1125, DOI 10.1071/AR02215; Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; Burger W., 1985, BARLEY, V26, P367, DOI [10.2134/agronmonogr26.c13, DOI 10.2134/AGRONMONOGR26.C13]; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Comadran J, 2008, EUPHYTICA, V161, P35, DOI 10.1007/s10681-007-9508-1; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Cuesta-Marcos A, 2009, PLANT BREEDING, V128, P46, DOI 10.1111/j.1439-0523.2008.01510.x; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Dunford RP, 2005, THEOR APPL GENET, V110, P925, DOI 10.1007/s00122-004-1912-5; Eshghi R., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P95; FAOSTAT, 2014, FOOD AGR ORG UN STAT; Fox GP, 2006, J CEREAL SCI, V43, P198, DOI 10.1016/j.jcs.2005.08.004; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; GTA, 2014, GTA BARL STAND; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kandemir N, 2000, MOL BREEDING, V6, P157, DOI 10.1023/A:1009602514106; Karakousis A, 2003, AUST J AGR RES, V54, P1131, DOI 10.1071/AR02179; Karsai I, 1999, PLANT BREEDING, V118, P399, DOI 10.1046/j.1439-0523.1999.00408.x; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; LANDER ES, 1989, GENETICS, V121, P185; Laurie D, 1995, CROSS GENOME, V38; LAURIE DA, 1994, HEREDITY, V72, P619, DOI 10.1038/hdy.1994.85; Le T, 2011, GENOTHPING 3 PARENTA; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Swamy BPM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-319; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Obsa B, 2016, THEORETICAL AND APPL; Rollins JA, 2013, THEOR APPL GENET, V126, P2803, DOI 10.1007/s00122-013-2173-y; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shahinnia F., 2014, Seed and Plant Improvement Journal, V30, pPe85; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Szucs P, 2006, THEOR APPL GENET, V112, P1277, DOI 10.1007/s00122-006-0229-y; Talame V, 2004, ANN APPL BIOL, V144, P309, DOI 10.1111/j.1744-7348.2004.tb00346.x; Taylor J, 2015, LINKAGE MAP CONSTRUC, P36; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Tondelli A, 2014, EUPHYTICA, V197, P73, DOI 10.1007/s10681-013-1053-5; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Walker CK, 2013, THEOR APPL GENET, V126, P2533, DOI 10.1007/s00122-013-2153-2; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; ZENG ZB, 1994, GENETICS, V136, P1457	55	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178111	10.1371/journal.pone.0178111	http://dx.doi.org/10.1371/journal.pone.0178111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542571	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800041
J	Florin, E; Vuvan, D; Peretz, I; Baillet, S				Florin, Esther; Vuvan, Dominique; Peretz, Isabelle; Baillet, Sylvain			Pre-target neural oscillations predict variability in the detection of small pitch changes	PLOS ONE			English	Article							NEURONAL OSCILLATIONS; FREQUENCY OSCILLATIONS; CORTICAL OSCILLATIONS; CONGENITAL AMUSIA; AUDITORY-CORTEX; BRAIN; PHASE; SPEECH; PERCEPTION; EEG	Pitch discrimination is important for language or music processing. Previous studies indicate that auditory perception depends on pre-target neural activity. However, so far the pre-target electrophysiological conditions which enable the detection of small pitch changes are not well studied, but might yield important insights into pitch-processing. We used magnetoen-cephalography (MEG) source imaging to reveal the pre-target effects of successful auditory detection of small pitch deviations from a sequence of standard tones. Participants heard a sequence of four pure tones and had to determine whether the last target tone was different or identical to the first three standard sounds. We found that successful pitch change detection could be predicted from the amplitude of theta (4-8 Hz) oscillatory activity in the right inferior frontal gyrus (IFG) as well as beta (12-30 Hz) oscillatory activity in the right auditory cortex. These findings confirm and extend evidence for the involvement of theta as well as beta-band activity in auditory perception.	[Florin, Esther; Baillet, Sylvain] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Florin, Esther] Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany; [Vuvan, Dominique; Peretz, Isabelle] Ctr Res Brain Language & Mus, Montreal, PQ, Canada; [Vuvan, Dominique] Skidmore Coll, Psychol Dept, Saratoga Springs, NY 12866 USA; [Peretz, Isabelle] Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada	McGill University; Heinrich Heine University Dusseldorf; Skidmore College; Universite de Montreal	Florin, E (corresponding author), McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada.; Florin, E (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany.	esther.florin@hhu.de	Florin, Esther/GWC-1118-2022; Baillet, Sylvain/AAF-6512-2019	Florin, Esther/0000-0001-8276-2508; Baillet, Sylvain/0000-0002-6762-5713	Centre for Research on Brain, Language and Music; "Deutsche Forschungsgemeinschaft" (DFG) [FL 760 2-1]; Montreal Neurological Institute's National Bank Fellowship (Canada); Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada; IARPA Knowledge Representation in Neural Systems Program [FA8650-14-C-7357]; NIH [2R01EB009048-05]	Centre for Research on Brain, Language and Music; "Deutsche Forschungsgemeinschaft" (DFG)(German Research Foundation (DFG)); Montreal Neurological Institute's National Bank Fellowship (Canada); Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada; IARPA Knowledge Representation in Neural Systems Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported through an award from the Centre for Research on Brain, Language and Music. EF gratefully acknowledges support from "Deutsche Forschungsgemeinschaft" (DFG: FL 760 2-1, Germany) and the Montreal Neurological Institute's National Bank Fellowship (Canada). SB was supported by the Killam Foundation, a Senior-Researcher grant from the Fonds de Recherche du Quebec - Sante, a Discovery Grant from the National Science and Engineering Research Council of Canada, the IARPA Knowledge Representation in Neural Systems Program (FA8650-14-C-7357) and the NIH (2R01EB009048-05).	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Attal Y, 2009, IRBM, V30, P133, DOI 10.1016/j.irbm.2009.01.005; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bokil H, 2007, J NEUROSCI METH, V159, P337, DOI 10.1016/j.jneumeth.2006.07.011; Bregman A.S., 1994, AUDITORY SCENE ANAL; Brochard R, 2013, COGNITION, V127, P214, DOI 10.1016/j.cognition.2013.01.007; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Doelling KB, 2014, NEUROIMAGE, V85, P761, DOI 10.1016/j.neuroimage.2013.06.035; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; GIARD MH, 1988, ELECTROEN CLIN NEURO, V69, P371, DOI 10.1016/0013-4694(88)90008-9; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Henry M.J., 2014, TIMING TIME PERCEPT, V2, P62, DOI [10.1163/22134468-00002011, DOI 10.1163/22134468-00002011]; Henry MJ, 2014, P NATL ACAD SCI USA, V111, P14935, DOI 10.1073/pnas.1408741111; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Kayser C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002717; Keil J, 2012, CEREB CORTEX, V22, P221, DOI 10.1093/cercor/bhr125; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lange J, 2011, NEUROIMAGE, V54, P1395, DOI 10.1016/j.neuroimage.2010.09.031; Lappe C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00260; Lappe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061296; Lenz D, 2008, BRAIN RES, V1220, P81, DOI 10.1016/j.brainres.2007.10.053; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00170; Macmillan NA, 2005, DETECTION THEORY USE; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mazaheri A, 2014, NEUROIMAGE, V87, P356, DOI 10.1016/j.neuroimage.2013.10.052; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Muller N, 2012, CEREB CORTEX, V22, P1604, DOI 10.1093/cercor/bhr232; Naatanen R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P125; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Nolte G, 1999, IEEE T BIO-MED ENG, V46, P400, DOI 10.1109/10.752937; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Riecke L, 2015, CURR BIOL, V25, P3196, DOI 10.1016/j.cub.2015.10.045; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Siedenberg R, 1996, ELECTROEN CLIN NEURO, V99, P191, DOI 10.1016/0013-4694(96)95215-3; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Strauss A, 2015, J NEUROSCI, V35, P3256, DOI 10.1523/JNEUROSCI.3357-14.2015; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; TARKKA IM, 1995, EVOKED POTENTIAL, V96, P538, DOI 10.1016/0013-4694(95)00087-F; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Trainor LJ, 2009, ANN NY ACAD SCI, V1169, P133, DOI 10.1111/j.1749-6632.2009.04589.x; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Weisz N, 2014, HEARING RES, V307, P16, DOI 10.1016/j.heares.2013.07.009; Wyart V, 2009, J NEUROSCI, V29, P8715, DOI 10.1523/JNEUROSCI.0962-09.2009; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zoefel B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00262	70	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177836	10.1371/journal.pone.0177836	http://dx.doi.org/10.1371/journal.pone.0177836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542644	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400096
J	Grelet, S; McShane, A; Hok, E; Tomberlin, J; Howe, PH; Geslain, R				Grelet, Simon; McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Howe, Philip H.; Geslain, Renaud			SPOt: A novel and streamlined microarray platform for observing cellular tRNA levels	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENES; EXPRESSION; ORGANIZATION; MATURATION; ABUNDANCE; REVEALS; CANCER	Recent studies have placed transfer RNA (tRNA), a housekeeping molecule, in the heart of fundamental cellular processes such as embryonic development and tumor progression. Such discoveries were contingent on the concomitant development of methods able to deliver high-quality tRNA profiles. The present study describes the proof of concept obtained in Escherichia coli (E. coli) for an original tRNA analysis platform named SPOt (Streamlined Platform for Observing tRNA). This approach comprises three steps. First, E. coli cultures are spiked with radioactive orthophosphate; second, labeled total RNAs are trizol-extracted; third, RNA samples are hybridized on in-house printed microarrays and spot signals, the proxy for tRNA levels, are quantified by phosphorimaging. Features such as reproducibility and specificity were assessed using several tRNA subpopulations. Dynamic range and sensitivity were evaluated by overexpressing specific tRNA species. SPOt does not require any amplification or post-extraction labeling and can be adapted to any organism. It is modular and easily streamlined with popular techniques such as polysome fractionation to profile tRNAs interacting with ribosomes and actively engaged in translation. The biological relevance of these data is discussed in regards to codon usage, tRNA gene copy number, and position on the genome.	[Grelet, Simon; Howe, Philip H.] MUSC, Dept Biochem & Mol Biol, Charleston, SC USA; [McShane, Ariel; Hok, Eveline; Tomberlin, Jensen; Geslain, Renaud] Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA	Medical University of South Carolina; College of Charleston	Geslain, R (corresponding author), Coll Charleston, Dept Biol, Lab tRNA Biol, Charleston, SC 29424 USA.	geslainr@cofc.edu		McShane, Ariel/0000-0003-3281-1302	SC INBRE grant from the National Institute of General Medical Science - NIH [P20GM103499]; National Cancer Institute [CA555536, CA154664]; NATIONAL CANCER INSTITUTE [R01CA154663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	SC INBRE grant from the National Institute of General Medical Science - NIH; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a SC INBRE grant from the National Institute of General Medical Science - NIH (P20GM103499 to R.G.) and grants CA555536 & CA154664 from the National Cancer Institute to P.H.H.	Camacho N, 2015, NUCLEIC ACIDS RES, V43, P5145; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Cognat V, 2008, GENETICS, V179, P113, DOI 10.1534/genetics.107.085688; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; Eriani G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130042; FOURNIER MJ, 1985, MICROBIOL REV, V49, P379, DOI 10.1128/MMBR.49.4.379-397.1985; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Jensen KF, NUCLEOTIDES NUCLEOSI; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; LAMOND AI, 1983, NATURE, V305, P248, DOI 10.1038/305248a0; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; NAKAJIMA N, 1981, CELL, V23, P239, DOI 10.1016/0092-8674(81)90288-9; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Rudolph KLM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006024; Saikia M, 2016, RNA, V22, P1719, DOI 10.1261/rna.058180.116; SCHMIDT CF, 1948, J BACTERIOL, V55, P705, DOI 10.1128/JB.55.5.705-710.1948; Schmitt BM, 2014, GENOME RES, V24, P1797, DOI 10.1101/gr.176784.114; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177939	10.1371/journal.pone.0177939	http://dx.doi.org/10.1371/journal.pone.0177939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545122	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700098
J	Lamberti, MJ; Pansa, MF; Vera, RE; Fernandez-Zapico, ME; Vittar, NBR; Rivarola, VA				Julia Lamberti, Maria; Florencia Pansa, Maria; Emanuel Vera, Renzo; Fernandez-Zapico, Martin Ernesto; Rumie Vittar, Natalia Belen; Alicia Rivarola, Viviana			Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; MITOCHONDRIAL COMPLEX-III; 5-AMINOLEVULINIC ACID; COLORECTAL-CANCER; OXIDATIVE STRESS; PROTEIN-KINASE; CELL; INDUCTION; IDENTIFICATION; HIF-1-ALPHA	Photodynamic therapy ( PDT), a promising treatment option for cancer, involves the activation of a photosensitizer (PS) by local irradiation with visible light. Excitation of the PS leads to a series of photochemical reactions and consequently the local generation of harmful reactive oxygen species (ROS) causing limited or none systemic defects. However, the development of resistance to this promising therapy has slowed down its translation into the clinical practice. Thus, there is an increase need in understanding of the molecular mechanism underlying resistance to PDT. Here, we aimed to examine whether a relationship exists between PDT outcome and ROS-involvement in the resistance mechanism in photosensitized cancer cells. In order to recapitulate tumor architecture of the respective original tumor, we developed a multicellular three-dimensional spheroid system comprising a normoxic periphery, surrounding a hypoxic core. Using Me-ALA, a prodrug of the PS PpIX, in human colorectal spheroids we demonstrate that HIF-1 transcriptional activity was strongly up-regulated and mediates PDT resistant phenotype. RNAi knockdown of HIF-1 impairs resistance to PDT. Oxidative stress-mediated activation of ERK1/2 followed PDT was involved on positive modulation of HIF-1 transcriptional activity after photodynamic treatment. ROS scavenging and MEK/ERK pathway inhibition abrogated the PDT-mediated HIF-1 upregulation. Together our data demonstrate that resistance to PDT is in part mediated by the activation of a ROS-ERK1/2-HIF-1 axis, thus, identifying novel therapeutic targets that could be used in combination with PDT.	[Julia Lamberti, Maria; Florencia Pansa, Maria; Emanuel Vera, Renzo; Rumie Vittar, Natalia Belen; Alicia Rivarola, Viviana] Univ Nacl Rio Cuarto, Fac Ciencias Exactas Fis Quim & Nat, Dept Biol Mol, Cordoba, Argentina; [Fernandez-Zapico, Martin Ernesto] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN USA	Universidad Nacional Rio Cuarto; Mayo Clinic	Vittar, NBR; Rivarola, VA (corresponding author), Univ Nacl Rio Cuarto, Fac Ciencias Exactas Fis Quim & Nat, Dept Biol Mol, Cordoba, Argentina.	belenrumie@gmail.com; vrivarola@exa.unrc.edu.ar	Lamberti, María Julia/AAM-4911-2020	Lamberti, María Julia/0000-0001-7162-0520	FONCyT [PICT-2013-2667]; CONICET [PIP 112-201101-00453]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (PICT); Secretaria de Ciencia y Tecnica (SECyT); Universidad Nacional de Rio Cuarto, Argentina; Fulbright-Ministerio de Educacion de Argentina	FONCyT(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (PICT)(ANPCyT); Secretaria de Ciencia y Tecnica (SECyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Rio Cuarto, Argentina; Fulbright-Ministerio de Educacion de Argentina	This work was supported PICT-2013-2667, FONCyT (http://www.agencia.mincyt.gob.ar/ frontend/ageocia/fondo/foncyt) to VAR; PIP 112-201101-00453, CONICET (http://www.conicet.gov.art) to VAR; PPI, SECyT, UNRC (https://www.unrc.edu.ar/cyt/) to VAR; and CONICET-NIH (http://www.conicet.gov.ar/) to NBRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT), Secretaria de Ciencia y Tecnica (SECyT), Universidad Nacional de Rio Cuarto, Argentina, Fulbright-Ministerio de Educacion de Argentina. VAR and NBRV are members of the Scientific Researcher Career at CONICET. MJL, MFP and REV hold fellowship from CONICET.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison RR, 2013, CLIN ENDOSC, V46, P24, DOI 10.5946/ce.2013.46.1.24; BARR H, 1990, BRIT J SURG, V77, P93, DOI 10.1002/bjs.1800770132; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bhuvaneswari R, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-56; Biswas S, 2013, BBA-MOL BASIS DIS, V1832, P293, DOI 10.1016/j.bbadis.2012.11.003; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Bown SG, 2002, GUT, V50, P549, DOI 10.1136/gut.50.4.549; Broekgaarden M, 2015, CANCER METAST REV, V34, P643, DOI 10.1007/s10555-015-9588-7; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen WH, 2015, CANCER LETT, V359, P65, DOI 10.1016/j.canlet.2014.12.052; Chetty NC, 2008, CLIN EXP DERMATOL, V33, P204, DOI 10.1111/j.1365-2230.2007.02600.x; Cosserat-Gerardin I, 2000, J PHOTOCH PHOTOBIO B, V59, P72, DOI 10.1016/S1011-1344(00)00142-1; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Donnelly RF, 2007, PERSPECT MED CHEM, V1, P49; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ducrest AL, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf064; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FINGAR VH, 1992, J SURG RES, V53, P524, DOI 10.1016/0022-4804(92)90101-5; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Galanis A, 2008, CANCER LETT, V266, P12, DOI 10.1016/j.canlet.2008.02.028; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ji ZY, 2006, CANCER LETT, V244, P182, DOI 10.1016/j.canlet.2005.12.010; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kashtan H, 1996, DIS COLON RECTUM, V39, P379, DOI 10.1007/BF02054050; Kelty CJ, 2002, PHOTOCH PHOTOBIO SCI, V1, P158, DOI 10.1039/b201027p; Koderhold G, 1996, J PHOTOCH PHOTOBIO B, V36, P221, DOI 10.1016/S1011-1344(96)07376-9; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Lamberti M, 2014, LASER PHYS, V24, P8; Lamberti MJ, 2013, PHYTOMEDICINE, V20, P1007, DOI 10.1016/j.phymed.2013.04.018; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liu YYL, 2004, LIFE SCI, V75, P2035, DOI 10.1016/j.lfs.2004.03.027; Marchetti P, 1996, J IMMUNOL, V157, P4830; Martin CM, 2008, CIRC RES, V102, P1075, DOI 10.1161/CIRCRESAHA.107.161729; Mathupala SP, 2009, BIOTECHNIQUES, V46, P305, DOI 10.2144/000113079; Metzger W, 2011, CYTOTHERAPY, V13, P1000, DOI 10.3109/14653249.2011.583233; Mitra S, 2000, BIOPHYS J, V78, P2597, DOI 10.1016/S0006-3495(00)76804-4; Mitra S, 2006, MOL CANCER THER, V5, P3268, DOI 10.1158/1535-7163.MCT-06-0421; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Nakamura M, 2015, WORLD J GASTROENTERO, V21, P6706, DOI 10.3748/wjg.v21.i21.6706; Ong QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153487; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sheleg SV, 2004, PHOTODERMATOL PHOTO, V20, P21, DOI 10.1111/j.1600-0781.2004.00078.x; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Weijer R, 2016, ONCOTARGET, V7, P3331, DOI 10.18632/oncotarget.6490; Wyld L, 1998, BRIT J CANCER, V77, P1621, DOI 10.1038/bjc.1998.265; Xiang L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-32; Yamamoto M, 2013, ACTA MED OKAYAMA, V67, P153; Yeh LH, 2004, ANTIOXID REDOX SIGN, V6, P944, DOI 10.1089/ars.2004.6.944	61	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177801	10.1371/journal.pone.0177801	http://dx.doi.org/10.1371/journal.pone.0177801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545088	Green Submitted, gold, Green Published			2022-12-26	WOS:000401487700082
J	Krauskopf, J; de Kok, TM; Schomaker, SJ; Gosink, M; Burt, DA; Chandler, P; Warner, RL; Johnson, KJ; Caiment, F; Kleinjans, JC; Aubrecht, J				Krauskopf, Julian; de Kok, Theo M.; Schomaker, Shelli J.; Gosink, Mark; Burt, Deborah A.; Chandler, Patricia; Warner, Roscoe L.; Johnson, Kent J.; Caiment, Florian; Kleinjans, Jos C.; Aubrecht, Jiri			Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CIRCULATING MICRORNAS; ACETAMINOPHEN HEPATOTOXICITY; POTENTIAL BIOMARKERS; EXPRESSION; REVEALS; MIRNAS; IDENTIFICATION; CIRRHOSIS; SEQUENCE	MicroRNAs (miRNAs) released into the peripheral circulation upon cellular injury have shown a promise as a new class of tissue-specific biomarkers. We were first to demonstrate that next-generation sequencing analysis of serum from human subjects with acetaminophen-induced liver injury revealed a specific signature of circulating miRNAs. We consequently hypothesized that different types of hepatic liver impairments might feature distinct signatures of circulating miRNAs and that this approach might be useful as minimally invasive diagnostic "liquid biopsies" enabling the interrogation of underlying molecular mechanisms of injury in distant tissues. Therefore we examined serum circulating miRNAs in a total of 72 serum samples from a group of 53 subjects that included patients with accidental acetaminophen overdose, hepatitis B infection, liver cirrhosis and type 2 diabetes as well as gender-and age-matched healthy subjects with no evidence of liver disease. The miRNA signatures were identified using next-generation sequencing that provided analysis for the whole miRNome, including miRNA isoforms. Compared to the healthy subjects, a total of 179 miRNAs showed altered serum levels across the diseased subjects. Although many subjects have elevated alanine aminotransferase suggesting liver impairments, we identified distinct miRNA signatures for different impairments with minimum overlap. Furthermore, the bioinformatics analysis of miRNA signatures revealed relevant molecular pathways associated with the mechanisms of toxicity and or pathogenesis of disease. Interestingly, the high proportion of miRNA isoforms present in the respective signatures indicated a new level of complexity in cellular response to stress or disease. Our study demonstrates for the first time that signatures of circulating miRNAs show specificity for liver injury phenotypes and, once validated, might become useful for diagnosis of organ pathologies as "liquid biopsies".	[Krauskopf, Julian; de Kok, Theo M.; Caiment, Florian; Kleinjans, Jos C.] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands; [Schomaker, Shelli J.; Gosink, Mark; Burt, Deborah A.; Aubrecht, Jiri] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA; [Chandler, Patricia] Pfizer Inc, Clin Res Unit, New Haven, CT USA; [Warner, Roscoe L.; Johnson, Kent J.] Univ Michigan, Pathol Dept, Ann Arbor, MI 48109 USA	Maastricht University; Pfizer; Pfizer; University of Michigan System; University of Michigan	Krauskopf, J (corresponding author), Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands.	j.krauskopf@maastrichtuniversity.nl	caiment, florian/N-7623-2015	Caiment, Florian/0000-0002-3325-0466; Krauskopf, Julian/0000-0002-4349-9900; Gosink, Mark/0000-0003-3009-3941	Pfizer Inc.	Pfizer Inc.(Pfizer)	The project was funded by Pfizer Inc. in forms of research grants to J.C.K. (University of Maastricht) and K.J.J. (University of Michigan). Pfizer Inc. provided support in the form of salaries for authors [S.J.S., M.G., D.B., P.C. and J.A.] and reviewed the final manuscript but the funding organization did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Christen V, 2007, J VIROL, V81, P159, DOI 10.1128/JVI.01292-06; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Dabney A, 2010, QVALUE Q VALUE ESTIM, V1; Ding HX, 2016, PARKINSONISM RELAT D, V22, P68, DOI 10.1016/j.parkreldis.2015.11.014; Du K, 2016, REDOX BIOL, V10, P148, DOI 10.1016/j.redox.2016.10.001; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Galimberti D, 2014, J ALZHEIMERS DIS, V42, P1261, DOI 10.3233/JAD-140756; Gosink Mark, 2011, Advances in Bioinformatics, V2011, P271563, DOI 10.1155/2011/271563; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jiang X, 2014, WORLD J GASTROENTERO, V20, P7197, DOI 10.3748/wjg.v20.i23.7197; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kaur K, 2015, DIABETES, V64, P3659, DOI 10.2337/db14-1924; Krauskopf J, 2015, TOXICOL SCI, V143, P268, DOI 10.1093/toxsci/kfu232; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li SH, 2015, ONCOTARGET, V6, P10045, DOI 10.18632/oncotarget.6631; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; Muller Heiko, 2014, Front Bioeng Biotechnol, V2, P38, DOI 10.3389/fbioe.2014.00038; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; PREHEIM LC, 1991, J INFECT DIS, V164, P1203, DOI 10.1093/infdis/164.6.1203; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seyhan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31479; Tonge DP, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0057-9; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vliegenthart ADB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15501; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Winther TN, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/791045; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Yang X, 2015, TOXICOL APPL PHARM, V284, P180, DOI 10.1016/j.taap.2015.02.013; Zhang ZZ, 2014, ARCH VIROL, V159, P3335, DOI 10.1007/s00705-014-2208-y	45	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177928	10.1371/journal.pone.0177928	http://dx.doi.org/10.1371/journal.pone.0177928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545106	Green Submitted, gold, Green Published			2022-12-26	WOS:000401487700096
J	Osazuwa-Peters, N; Boakye, EA; Hussaini, AS; Sujijantarat, N; Ganesh, RN; Snider, M; Thompson, D; Varvares, MA				Osazuwa-Peters, Nosayaba; Boakye, Eric Adjei; Hussaini, Adnan S.; Sujijantarat, Nanthiya; Ganesh, Rajan N.; Snider, Matthew; Thompson, Devin; Varvares, Mark A.			Characteristics and predictors of oral cancer knowledge in a predominantly African American community	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NECK-CANCER; INFORMATION LEAFLET; EXAMINATION EXPERIENCES; OROPHARYNGEAL CANCER; PHARYNGEAL CANCER; CIGARETTE-SMOKING; SCREENING-PROGRAM; SOUTH-CAROLINA; RISK-FACTORS	Purpose To characterize smoking and alcohol use, and to describe predictors of oral cancer knowledge among a predominantly African-American population. Methods A cross-sectional study was conducted between September, 2013 among drag racers and fans in East St. Louis. Oral cancer knowledge was derived from combining questionnaire items to form knowledge score. Covariates examined included age, sex, race, marital status, education status, income level, insurance status, tobacco and alcohol use. Adjusted linear regression analysis measured predictors of oral cancer knowledge. Results Three hundred and four participants completed questionnaire; 72.7% were African Americans. Smoking rate was 26.7%, alcohol use was 58.3%, and mean knowledge score was 4.60 +/- 2.52 out of 17. In final adjusted regression model, oral cancer knowledge was associated with race and education status. Compared with Caucasians, African Americans were 29% less likely to have high oral cancer knowledge (beta = - 0.71; 95% CI: -1.35, -0.07); and participants with a high school diploma or less were 124% less likely to have high oral cancer knowledge compared with college graduates (beta = -1.24; 95% CI: -2.44, -0.41). Conclusions There was lower oral cancer knowledge among African Americans and those with low education. The prevalence of smoking was also very high. Understanding predictors of oral cancer knowledge is important in future design of educational interventions specifically targeted towards high-risk group for oral cancer.	[Osazuwa-Peters, Nosayaba; Varvares, Mark A.] St Louis Univ, Canc Ctr, St Louis, MO 63103 USA; [Osazuwa-Peters, Nosayaba; Varvares, Mark A.] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA; [Boakye, Eric Adjei] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA; [Hussaini, Adnan S.; Sujijantarat, Nanthiya; Ganesh, Rajan N.; Snider, Matthew; Thompson, Devin] St Louis Univ, Sch Med, St Louis, MO USA; [Varvares, Mark A.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Osazuwa-Peters, N (corresponding author), St Louis Univ, Canc Ctr, St Louis, MO 63103 USA.; Osazuwa-Peters, N (corresponding author), St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63103 USA.	nosazuwa@slu.edu	Adjei Boakye, Eric/D-4448-2015	Adjei Boakye, Eric/0000-0001-9163-8103; Osazuwa-Peters, Nosayaba/0000-0002-1390-9753				American Cancer Society, 2015, CANC FACTS FIG 2015; Cannick GF, 2005, J AM DENT ASSOC, V136, P373, DOI 10.14219/jada.archive.2005.0180; Carter JM, 2013, LARYNGOSCOPE, V123, P1439, DOI 10.1002/lary.23981; Carter Lachlan M, 2007, BMC Med Educ, V7, P44; Choi Y, 2008, PATIENT EDUC COUNS, V71, P41, DOI 10.1016/j.pec.2007.11.011; Cruz GD, 2002, J AM DENT ASSOC, V133, P1064, DOI 10.14219/jada.archive.2002.0330; D'Souza G, 2011, PREV MED, V53, pS5, DOI 10.1016/j.ypmed.2011.08.001; Dwojak S, 2015, AM J PUBLIC HEALTH, V105, P1155, DOI 10.2105/AJPH.2014.302177; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; Gourin CG, 2009, LARYNGOSCOPE, V119, P679, DOI 10.1002/lary.20093; Hapner ER, 2011, J VOICE, V25, P480, DOI 10.1016/j.jvoice.2009.12.004; Hapner ER, 2011, OTOLARYNGOLOGY HEAD; Harris MS, 2013, JAMA OTOLARYNGOL, V139, P568, DOI 10.1001/jamaoto.2013.3153; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Horowitz AM, 1998, J PUBLIC HEALTH DENT, V58, P281, DOI 10.1111/j.1752-7325.1998.tb03010.x; Howell JL, 2013, PSYCHO-ONCOLOGY, V22, P1306, DOI 10.1002/pon.3137; Humphris GM, 2001, ORAL ONCOL, V37, P99, DOI 10.1016/S1368-8375(00)00069-5; Humphris GM, 1999, ORAL ONCOL, V35, P575, DOI 10.1016/S1368-8375(99)00040-8; Llewellyn CD, 2004, ORAL SURG ORAL MED O, V97, P707, DOI 10.1016/j.tripleo.2004.01.007; Lopez-Jornet P, 2013, PSYCHO-ONCOLOGY, V22, P1618, DOI 10.1002/pon.3189; Luryi AL, PUBLIC AWARENESS HEA; Malloy KM, 2013, JAMA OTOLARYNGOL, V139, P1037, DOI 10.1001/jamaoto.2013.4452; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Maybury C, 2012, J PUBLIC HEALTH DENT, V72, pS34, DOI 10.1111/j.1752-7325.2012.00320.x; Morse DE, 2006, J AM DENT ASSOC, V137, P203, DOI 10.14219/jada.archive.2006.0146; Moyer VA, 2014, ANN INTERN MED, V160, P55, DOI 10.7326/M13-2568; Oh JH, 2008, J PUBLIC HEALTH DENT, V68, P30, DOI 10.1111/j.1752-7325.2007.00075.x; Osazuwa-Peters N, 2013, VACCINE, V31, P5500, DOI 10.1016/j.vaccine.2013.09.031; Osazuwa-Peters N, 2016, HEAD NECK-J SCI SPEC, V38, pE1826, DOI 10.1002/hed.24327; Osazuwa-Peters N, 2015, ORAL ONCOL, V51, P452, DOI 10.1016/j.oraloncology.2015.01.011; Ostroff JS, 1999, PSYCHOL HEALTH, V14, P979, DOI 10.1080/08870440008407362; Patton LL, 2004, J PUBLIC HEALTH DENT, V64, P173, DOI 10.1111/j.1752-7325.2004.tb02748.x; Petti S, 2007, ORAL ONCOL, V43, P408, DOI 10.1016/j.oraloncology.2006.04.010; Prevention CfDCa, 2015, CURR CIG SMOK AD US; Ragin CC, 2011, HEAD NECK-J SCI SPEC, V33, P1092, DOI 10.1002/hed.21584; Reed SG, 2005, J CANCER EDUC, V20, P136, DOI 10.1207/s15430154jce2003_6; Riley JL, 2013, J RURAL HEALTH, V29, P294, DOI 10.1111/jrh.12003; Rodriguez T, 2004, ORAL ONCOL, V40, P207, DOI 10.1016/j.oraloncology.2003.08.014; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Services UDoHaH Oral Health in America, REP SURG GEN EX SUMM; Shepperd JA, 2014, PSYCHO-ONCOLOGY, V23, P276, DOI 10.1002/pon.3415; Siahpush M, 2006, TOB CONTROL, V15, P65, DOI 10.1136/tc.2005.013276; Silverman S, 2001, J AM DENT ASSOC, V132, p7S, DOI 10.14219/jada.archive.2001.0382; Subramanian S, 2013, JAMA OTOLARYNGOL, V139, P489, DOI 10.1001/jamaoto.2013.2549; Subramanian S, 2009, B WORLD HEALTH ORGAN, V87, P198, DOI 10.2471/BLT.08.053231; Tomar SL, 2005, J PUBLIC HEALTH DENT, V65, P221, DOI 10.1111/j.1752-7325.2005.tb03022.x; Warnakulasuriya KAAS, 1999, BRIT DENT J, V187, P319, DOI 10.1038/sj.bdj.4800269a; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; White LJ, 2012, OTOLARYNG HEAD NECK, V147, P63, DOI 10.1177/0194599812438662; White LJ, 2014, AM J CANC PREVENT, V2, P14	50	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177787	10.1371/journal.pone.0177787	http://dx.doi.org/10.1371/journal.pone.0177787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28545057	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700078
J	Pang, ZD; Kushiyama, A; Sun, J; Kikuchi, T; Yamazaki, H; Iwamoto, Y; Koriyama, H; Yoshida, S; Shimamura, M; Higuchi, M; Kawano, T; Takami, Y; Rakugi, H; Morishita, R; Nakagami, H				Pang, Zhengda; Kushiyama, Akifumi; Sun, Jiao; Kikuchi, Takako; Yamazaki, Hiroki; Iwamoto, Yasuhiko; Koriyama, Hiroshi; Yoshida, Shota; Shimamura, Munehisa; Higuchi, Masayoshi; Kawano, Tomohiro; Takami, Yoichi; Rakugi, Hiromi; Morishita, Ryuichi; Nakagami, Hironori			Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes	FASEB JOURNAL			English	Article						type 1 diabetes; GAD65; autoantibody; nonobese diabetic; type 2 diabetes	ISLET-CELL ANTIBODIES; ADULTS LADA; NOD MICE; INSULIN; DECARBOXYLASE; AUTOANTIGEN; MELLITUS; AUTOANTIBODIES; IDENTIFICATION; PROGRESSION	Glial fibrillary acidic protein (GFAP) is expressed in peri-islet Schwann cells, as well as in glia cells, and has been reported to be an autoantigen candidate for type 1 diabetes mellitus (T1DM). We confirmed that the production of the autoantibodies GFAP and glutamic acid decarboxylase 65 (GAD65) was increased and inversely correlated with the concentration of secreted C peptide in female nonobese diabetic mice (T1DM model). Importantly, the development of T1DM in female nonobese diabetic mice at 30 wk of age was predicted by the positive GFAP autoantibody titer at 17 wk. The production of GFAP and GAD65 autoantibodies was also increasedinKK-Ay mice [type 2 diabetes mellitus (T2DM) model]. In patients with diabetes mellitus, GFAP autoantibody levels were increased in patients with either T1DM or T2DM, and were significantly associated with GAD65 autoantibodies but not zinc transporter 8 autoantibodies. Furthermore, we identified a B-cell epitope of GFAP corresponding to the GFAP autoantibody in both mice and patients with diabetes. Thus, these results indicate that autoantibodies against GFAP could serve as apredictive marker for the development of overt autoimmunediabetes.	[Pang, Zhengda] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian, Peoples R China; [Pang, Zhengda; Yoshida, Shota; Higuchi, Masayoshi; Takami, Yoichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Osaka, Japan; [Kushiyama, Akifumi; Kikuchi, Takako; Yamazaki, Hiroki; Iwamoto, Yasuhiko] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Tokyo, Japan; [Sun, Jiao; Koriyama, Hiroshi; Shimamura, Munehisa; Nakagami, Hironori] Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, 2-1 Yamada Oka, Suita, Osaka, Japan; [Kawano, Tomohiro] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-1 Yamada Oka, Suita, Osaka, Japan	Xi'an Jiaotong University; Osaka University; Asahi Life Foundation; Osaka University; Osaka University; Osaka University	Nakagami, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, 2-1 Yamada Oka, Suita, Osaka, Japan.; Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-1 Yamada Oka, Suita, Osaka, Japan.	morishit@cgt.med.osaka-u.ac.jp; nakagami@gts.med.osaka-u.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019; Nakagami, Hironori/GLU-0570-2022	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakagami, Hironori/0000-0003-4494-3601; Rakugi, Hiromi/0000-0001-6508-4338; Takami, Yoichi/0000-0001-9018-6707; Yoshida, Shota/0000-0002-6830-7063	Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network	Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network	The authors thank all members in Department of Health Development and Medicine (Osaka University Graduate School of Medicine) for supporting this project. This work was supported, in part, by a grant from the Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network.	BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Brooks-Worrell B, 2013, DIABETES OBES METAB, V15, P137, DOI 10.1111/dom.12167; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fischbach F.T., 2009, MANUAL LAB DIAGNOSTI, V8th; Gomez-Tourino I, 2010, DIABETIC MED, V27, P247, DOI 10.1111/j.1464-5491.2009.02911.x; GROOP LC, 1986, DIABETES, V35, P237, DOI 10.2337/diabetes.35.2.237; Guan YY, 2012, DIABETES RES CLIN PR, V95, P93, DOI 10.1016/j.diabres.2011.09.019; IRVINE WJ, 1977, LANCET, V1, P1025; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Juneja R, 2001, METABOLISM, V50, P1008, DOI 10.1053/meta.2001.25654; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lohmann T, 1997, DIABETES CARE, V20, P524, DOI 10.2337/diacare.20.4.524; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Moroki T, 2013, IN VIVO, V27, P465; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Pang ZD, 2017, FEBS LETT, V591, P129, DOI 10.1002/1873-3468.12511; RABIN DU, 1994, J IMMUNOL, V152, P3183; Regoli M, 2000, J HISTOCHEM CYTOCHEM, V48, P259, DOI 10.1177/002215540004800211; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Towns R, 2011, DRUG FUTURE, V36, P847, DOI 10.1358/dof.2011.036.11.1710754; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Vuilleumier N, 2014, WORLD J CARDIOL, V6, P314, DOI 10.4330/wjc.v6.i5.314; Weaver DJ, 2001, J IMMUNOL, V167, P586, DOI 10.4049/jimmunol.167.1.586; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; ZIMMET PZ, 1994, DIABETIC MED, V11, P299, DOI 10.1111/j.1464-5491.1994.tb00275.x	33	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4053	4063		10.1096/fj.201700110R	http://dx.doi.org/10.1096/fj.201700110R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28546444				2022-12-26	WOS:000408713300029
J	Yi, JJ; Paranjape, SR; Walker, MP; Choudhury, R; Wolter, JM; Fragola, G; Emanuele, MJ; Major, MB; Zylka, MJ				Yi, Jason J.; Paranjape, Smita R.; Walker, Matthew P.; Choudhury, Rajarshi; Wolter, Justin M.; Fragola, Giulia; Emanuele, Michael J.; Major, Michael B.; Zylka, Mark J.			The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/-catenin pathway by inhibiting the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autism; -catenin; proteasome; proteomics; Wnt signaling; E6-AP; UBE3A	BETA-CATENIN; ANGELMAN SYNDROME; 26S PROTEASOME; SPECTRUM DISORDER; PROTEIN COMPLEXES; E6-AP; EXPRESSION; MUTATIONS; SUBSTRATE; E6	UBE3A is a HECT domain E3 ubiquitin ligase whose dysfunction is linked to autism, Angelman syndrome, and cancer. Recently, we characterized a de novo autism-linked UBE3A mutant (UBE3A(T485A)) that disrupts phosphorylation control of UBE3A activity. Through quantitative proteomics and reporter assays, we found that the UBE3A(T485A) protein ubiquitinates multiple proteasome subunits, reduces proteasome subunit abundance and activity, stabilizes nuclear -catenin, and stimulates canonical Wnt signaling more effectively than wild-type UBE3A. We also found that UBE3A(T485A) activates Wnt signaling to a greater extent in cells with low levels of ongoing Wnt signaling, suggesting that cells with low basal Wnt activity are particularly vulnerable to UBE3A(T485A) mutation. Ligase-dead UBE3A did not stimulate Wnt pathway activation. Overexpression of several proteasome subunits reversed the effect of UBE3A(T485A) on Wnt signaling. We also observed that subunits that interact with UBE3A and affect Wnt signaling are located along one side of the 19S regulatory particle, indicating a previously unrecognized spatial organization to the proteasome. Altogether, our findings indicate that UBE3A regulates Wnt signaling in a cell context-dependent manner and that an autism-linked mutation exacerbates these signaling effects. Our study has broad implications for human disorders associated with UBE3A gain or loss of function and suggests that dysfunctional UBE3A might affect additional proteins and pathways that are sensitive to proteasome activity.	[Yi, Jason J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Paranjape, Smita R.; Walker, Matthew P.; Wolter, Justin M.; Fragola, Giulia; Major, Michael B.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Paranjape, Smita R.; Wolter, Justin M.; Fragola, Giulia; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; [Zylka, Mark J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Choudhury, Rajarshi; Emanuele, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Walker, Matthew P.; Choudhury, Rajarshi; Emanuele, Michael J.; Major, Michael B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.; Zylka, MJ (corresponding author), Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022; Paranjape, Smita R/L-2658-2019	Major, Michael/0000-0002-6753-8513; Wolter, Justin/0000-0002-3021-3993	Angelman Syndrome Foundation; National Institute of Mental Health [R01MH093372]; National Institutes of Health Pioneer Award [DP1ES024088]; Simons Foundation Autism Research Initiative Bridge to Independence Award [387972]; Lymphoma Research Foundation; Susan G. Komen Foundation [CCR14298820]; National Institutes of Health [R01GM120309, R01CA187799]; Gabrielle's Angel Foundation; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA187799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER	Angelman Syndrome Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative Bridge to Independence Award; Lymphoma Research Foundation; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by grants from the Angelman Syndrome Foundation (to M. J. Z.), National Institute of Mental Health Grant R01MH093372 (to M. J. Z.), and National Institutes of Health Pioneer Award DP1ES024088 (to M. J. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Simons Foundation Autism Research Initiative Bridge to Independence Award 387972.; Supported by a fellowship from the Lymphoma Research Foundation.; Supported by Susan G. Komen Foundation Grant CCR14298820 and National Institutes of Health Grant R01GM120309.; Supported by a grant from the Gabrielle's Angel Foundation and National Institutes of Health Grant R01CA187799.	Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang XL, 2016, NAT STRUCT MOL BIOL, V23, P778, DOI 10.1038/nsmb.3273; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kim H, 2015, CELL REP, V11, P1151, DOI 10.1016/j.celrep.2015.04.048; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kuslansky Y, 2016, J GEN VIROL, V97, P3313, DOI 10.1099/jgv.0.000624; LaSalle JM, 2015, EPIGENOMICS-UK, V7, P1213, DOI 10.2217/epi.15.70; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan B, 2016, P NATL ACAD SCI USA, V113, pE2945, DOI 10.1073/pnas.1605691113; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Packer A, 2016, NEUROSCI BIOBEHAV R, V64, P185, DOI 10.1016/j.neubiorev.2016.03.002; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Sell GL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00322; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Sominsky S, 2014, VIROLOGY, V468, P510, DOI 10.1016/j.virol.2014.09.007; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tomaic V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.572; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Walker MP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005654; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wiltse J, 2005, CRIT REV TOXICOL, V35, P727, DOI 10.1080/10408440591007403; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107	69	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12503	12515		10.1074/jbc.M117.788448	http://dx.doi.org/10.1074/jbc.M117.788448			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	FC1ZM	28559284	Green Published, hybrid			2022-12-26	WOS:000406636900015
J	Frederiksen, SD; Karlskov-Mortensen, P; Pant, SD; Guerin, M; Lesnik, P; Jorgensen, CB; Cirera, S; Bruun, CS; Mark, T; Fredholm, M				Frederiksen, Simona D.; Karlskov-Mortensen, Peter; Pant, Sameer D.; Guerin, Maryse; Lesnik, Philippe; Jorgensen, Claus B.; Cirera, Susanna; Bruun, Camilla S.; Mark, Thomas; Fredholm, Merete			Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ASSOCIATION ANALYSIS; INSULIN SENSITIVITY; GOTTINGEN MINIPIGS; ALL-CAUSE; GENOME; MODEL; CHOLESTEROL; POPULATION; EXPRESSION	We have established a pig resource population specifically designed to elucidate the genetics involved in development of obesity and obesity related co-morbidities by crossing the obesity prone Gottingen Minipig breed with two lean production pig breeds. In this study we have performed genome wide association (GWA) to identify loci with effect on blood lipid levels. The most significantly associated single nucleotide polymorphisms (SNPs) were used for linkage disequilibrium (LD) and haplotype analyses. Three separate haploblocks which influence the ratio between high density lipoprotein cholesterol and total cholesterol (HDL-C/CT), triglycerides (TG) and low density lipoprotein cholesterol (LDL-C) levels respectively were identified on Sus Scrofa chromosome 3 (SSC3). Large additive genetic effects were found for the HDL-C/CT and LDL-C haplotypes. Haplotypes segregating from Gottingen Minipigs were shown to impose a positive effect on blood lipid levels. Thus, the genetic profile of the Gottingen Minipig breed seems to support a phenotype comparable to the metabolic healthy obese (MHO) phenotype in humans.	[Frederiksen, Simona D.; Karlskov-Mortensen, Peter; Jorgensen, Claus B.; Cirera, Susanna; Bruun, Camilla S.; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark; [Pant, Sameer D.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Guerin, Maryse; Lesnik, Philippe] INSERM UMR S1166, Integrat Biol Atherosclerosis Team, Paris, France; [Mark, Thomas] Scandinavia AB, Novo Nordisk, Malov, Denmark	University of Copenhagen; Charles Sturt University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Fredholm, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark.	mf@sund.ku.dk	Guerin, Maryse/N-5794-2017; Karlskov-Mortensen, Peter/C-3030-2013; Jorgensen, Claus B./GXH-7925-2022; Lesnik, Philippe F/F-7803-2011; Cirera, Susanna/K-8540-2017; Frederiksen, Simona Denise/AAN-2233-2020; Lesnik, Philippe/AAD-7393-2020	Karlskov-Mortensen, Peter/0000-0002-2491-2763; Jorgensen, Claus B./0000-0003-4749-5306; Lesnik, Philippe/0000-0002-6909-7715; Cirera, Susanna/0000-0001-8105-1579; Fredholm, Merete/0000-0002-3563-7648; Frederiksen, Simona Denise/0000-0002-9207-0350; GUERIN, Maryse/0000-0003-0150-1360; Pant, Sameer D./0000-0002-0672-4478	Danish Independent Research Council [DFF 1335-00127]	Danish Independent Research Council(Det Frie Forskningsrad (DFF))	The authors acknowledge the financial support by The Danish Independent Research Council Grant Number DFF 1335-00127. The coauthor Thomas Mark is presently employed by Novo Nordisk, however, at the time when the research generating the data presented in this manuscript was conducted, he was employed as Associate Professor at University of Copenhagen. Novo Nordisk has not contributed any funding to the research presented in this manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; [Anonymous], 2013, NAT GENET, DOI DOI 10.1038/NG.2797; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bollen PJA, 2005, LAB ANIM-UK, V39, P80, DOI 10.1258/0023677052886565; Bosello O, 2016, EAT WEIGHT DISORD-ST, V21, P165, DOI 10.1007/s40519-016-0278-4; Calvo D, 1998, J LIPID RES, V39, P777; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Christoffersen B, 2013, OBESITY, V21, P149, DOI 10.1002/oby.20249; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Cirera S, 2014, ANIM GENET, V45, P59, DOI 10.1111/age.12082; Falconer D. S., 1996, Introduction to quantitative genetics.; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao XY, 2011, GENET EPIDEMIOL, V35, P154, DOI 10.1002/gepi.20563; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; GOTTLIEB H, 1954, AM J PATHOL, V30, P851; Groenen MAM, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0204-2; Grundy SM, 2016, NAT REV CARDIOL, V13, P73, DOI 10.1038/nrcardio.2015.208; Hamamdzic D, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/761415; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Hwang LC, 2012, ASIA PAC J CLIN NUTR, V21, P227; Johansen T, 2001, COMPARATIVE MED, V51, P150; Kogelman Lisette J. A., 2013, Frontiers in Genetics, V4, P29, DOI 10.3389/fgene.2013.00029; Kuivenhoven JA, 2014, BBA-MOL BASIS DIS, V1842, P1993, DOI 10.1016/j.bbadis.2014.04.028; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Madsen P, 2014, DMU PACKAGE ANAL MUL; Manunza A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-758; Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521; Pant SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137356; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Ruiz-Velasco N, 2004, BIOCHEM PHARMACOL, V67, P303, DOI 10.1016/j.bcp.2003.09.006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vance DE, 2008, N COMP BIOC, P1; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131667	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178828	10.1371/journal.pone.0178828	http://dx.doi.org/10.1371/journal.pone.0178828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570654	gold, Green Published			2022-12-26	WOS:000402611800123
J	Sato, K; Nishijima, T; Yokokawa, T; Fujita, S				Sato, Koji; Nishijima, Takeshi; Yokokawa, Takumi; Fujita, Satoshi			Acute bout of exercise induced prolonged muscle glucose transporter-4 translocation and delayed counter-regulatory hormone response in type 1 diabetes	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; ANTECEDENT HYPOGLYCEMIA; COUNTERREGULATORY RESPONSES; GLUCOSE-TRANSPORT; PHYSICAL-ACTIVITY; INSULIN; HYPERGLYCEMIA; ADROPIN; DHEA; METABOLISM	Previous studies have demonstrated that an acute bout of aerobic exercise induces a subsequent delayed onset of hypoglycemia among patients with type 1 diabetes. However, the mechanisms of exercise-induced hypoglycemia in type 1 diabetes are still unclear. Streptozotocin (STZ) was injected to 6-week-old male Wistar rats, and three days after STZ injection, animals were randomly assigned into 2 groups: STZ with insulin only (STZ) and STZ with insulin and exercise (STZ+EX). Normal Wistar rats with exercise were used as control (CON+EX). Insulin was intraperitoneally injected (0.5 U/kg) to both STZ groups (-0.5 h), and a bout of aerobic exercise (15 m/min for 30 min) was conducted at euglycemic conditions (0 h). Blood was collected at 0, 1, 3, and 5 h after exercise from the carotid artery. While the blood glucose level was stable during the post-exercise period (0-5 h) in the STZ and CON+EX groups, it decreased significantly only in the STZ+EX group at 3 h. Plasma glucagon, adrenalin, and noradrenalin levels significantly increased at 1 h in the STZ group, whereas significant hormonal responses were observed at 5 h in the STZ+EX group. In skeletal muscle glucose metabolism-related pathway, the level of glucose transporter-4 (GLUT-4) translocation was significantly higher at 1 h in the CON and STZ groups. However, in the STZ+EX group, these activations were maintained by 5 h, indicating a sustained glucose metabolism in the STZ+EX group. A single bout of aerobic exercise induced a delayed onset of hypoglycemia in STZ-treated rats. A prolonged enhancement of GLUT-4 translocation and delayed counter-regulatory hormone responses may have contributed to the induction of hypoglycemia.	[Sato, Koji; Fujita, Satoshi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Sato, Koji] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Nishijima, Takeshi] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan; [Yokokawa, Takumi] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Ritsumeikan University; Kobe University; Tokyo Metropolitan University; Kyoto University	Sato, K (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan.; Sato, K (corresponding author), Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan.	sato712@people.kobe-u.ac.jp	Yokokawa, Takumi/ABG-3699-2020	Yokokawa, Takumi/0000-0002-3813-4958	Ministry of Education, Culture, Sports, Science and Technology of Japan [25282200]; THE DESCENTE AND ISHIMOTO MEMORIAL FOUNDATION FOR THE PROMOTION OF SPORTS SCIENCE; Japan Diabetes Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); THE DESCENTE AND ISHIMOTO MEMORIAL FOUNDATION FOR THE PROMOTION OF SPORTS SCIENCE; Japan Diabetes Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25282200), and from THE DESCENTE AND ISHIMOTO MEMORIAL FOUNDATION FOR THE PROMOTION OF SPORTS SCIENCE, and Japan Diabetes Foundation (Sato K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; BOYLE PJ, 1994, P NATL ACAD SCI USA, V91, P9352, DOI 10.1073/pnas.91.20.9352; BOYLE PJ, 1991, AM J PHYSIOL, V260, pE395, DOI 10.1152/ajpendo.1991.260.3.E395; Brazeau AS, 2008, DIABETES CARE, V31, P2108, DOI 10.2337/dc08-0720; COLEMAN DL, 1984, DIABETES, V33, P26, DOI 10.2337/diabetes.33.1.26; Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B; CUMMING DC, 1986, MED SCI SPORT EXER, V18, P369, DOI 10.1249/00005768-198608000-00001; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; Davis SN, 2000, DIABETES, V49, P73, DOI 10.2337/diabetes.49.1.73; Galassetti P, 2003, DIABETES, V52, P1761, DOI 10.2337/diabetes.52.7.1761; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Gao S, 2014, DIABETES, V63, P3242, DOI 10.2337/db14-0388; Grimm JJ, 2004, DIABETES METAB, V30, P465, DOI 10.1016/S1262-3636(07)70144-1; GULVE EA, 1990, AM J PHYSIOL, V259, pE685, DOI 10.1152/ajpendo.1990.259.5.E685; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Maran A, 2010, DIABETES TECHNOL THE, V12, P763, DOI 10.1089/dia.2010.0038; Marette A, 1999, ENDOCRINE, V10, P13, DOI 10.1385/ENDO:10:1:13; Mathoo JMR, 1999, DIABETES, V48, P1281, DOI 10.2337/diabetes.48.6.1281; Mohammad A, 2002, MOL CELL BIOCHEM, V233, P139, DOI 10.1023/A:1015558328757; Peirce NS, 1999, BRIT J SPORT MED, V33, P161, DOI 10.1136/bjsm.33.3.161; Sato K, 2009, ACTA PHYSIOL, V197, P217, DOI 10.1111/j.1748-1716.2009.02011.x; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Tsalikian E, 2005, J PEDIATR-US, V147, P528, DOI 10.1016/j.jpeds.2005.04.065; Yardley JE, 2012, DIABETES CARE, V35, P669, DOI 10.2337/dc11-1844; Zierath JR, 2002, J APPL PHYSIOL, V93, P773, DOI 10.1152/japplphysiol.00126.2002	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178505	10.1371/journal.pone.0178505	http://dx.doi.org/10.1371/journal.pone.0178505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570686	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800067
J	Choy, KW; Lau, YS; Murugan, D; Mustafa, MR				Choy, Ker Woon; Lau, Yeh Siang; Murugan, Dharmani; Mustafa, Mohd Rais			Chronic treatment with paeonol improves endothelial function in mice through inhibition of endoplasmic reticulum stress-mediated oxidative stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; BLOOD-PRESSURE; INDUCED APOPTOSIS; CARDIAC DAMAGE; NITRIC-OXIDE; MUSCLE-CELLS; ER STRESS; DYSFUNCTION; HYPERTENSION; ACTIVATION	Endoplasmic reticulum (ER) stress leads to endothelial dysfunction which is commonly associated in the pathogenesis of several cardiovascular diseases. We explored the vascular protective effects of chronic treatment with paeonol (2'-hydroxy-4'-methoxyacetophenone), the major compound from the root bark of Paeonia suffruticosa on ER stress-induced endothelial dysfunction in mice. Male C57BL/6J mice were injected intraperitoneally with ER stress inducer, tunicamycin (1 mg/kg/week) for 2 weeks to induce ER stress. The animals were co-administered with or without paeonol (20 mg/kg/oral gavage), reactive oxygen species (ROS) scavenger, tempol (20 mg/kg/day) or ER stress inhibitor, tauroursodeoxycholic acid (TUDCA, 150 mg/kg/day) respectively. Blood pressure and body weight were monitored weekly and at the end of treatment, the aorta was isolated for isometric force measurement. Protein associated with ER stress (GRP78, ATF6 and p-elF2 alpha) and oxidative stress (NOX2 and nitrotyrosine) were evaluated using Western blotting. Nitric oxide (NO) bioavailability were determined using total nitrate/nitrite assay and western blotting (phosphorylation of eNOS protein). ROS production was assessed by en face dihydroethidium staining and lucigenin-enhanced chemiluminescence assay, respectively. Our results revealed that mice treated with tunicamycin showed an increased blood pressure, reduction in body weight and impairment of endothelium-dependent relaxations (EDRs) of aorta, which were ameliorated by co-treatment with either paeonol, TUDCA and tempol. Furthermore, paeonol reduced the ROS level in the mouse aorta and improved NO bioavailability in tunicamycin treated mice. These beneficial effects of paeonol observed were comparable to those produced by TUDCA and tempol, suggesting that the actions of paeonol may involve inhibition of ER stress-mediated oxidative stress pathway. Taken together, the present results suggest that chronic treatment with paeonol preserved endothelial function and normalized blood pressure in mice induced by tunicamycin in vivo through the inhibition of ER stress-associated ROS.	[Choy, Ker Woon; Lau, Yeh Siang; Murugan, Dharmani; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia	Universiti Malaya	Mustafa, MR (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia.	rais@um.edu.my	Lau, Yeh Siang/D-2136-2016; Woon, Choy Ker/AAF-6738-2021; MURUGAN, DHARMANI DEVI/B-8436-2010; Mustafa, Mohamed R/B-1647-2009	Lau, Yeh Siang/0000-0002-1770-3058; Woon, Choy Ker/0000-0002-8432-9035; MURUGAN, DHARMANI DEVI/0000-0002-1345-0292; Mustafa, Mohamed R/0000-0002-7864-5189	postgraduate research fund (PPP) [PG254-2015B]; Fundamental Research Grant Scheme (FRGS) [FP021-2016, FRGS/1/2016/SKK10/UM/01/1]	postgraduate research fund (PPP); Fundamental Research Grant Scheme (FRGS)	This study was funded by postgraduate research fund (PPP): Project number PG254-2015B and Fundamental Research Grant Scheme (FRGS): Project code FP021-2016 (Reference code: FRGS/1/2016/SKK10/UM/01/1).	Al-Magableh MR, 2015, HYPERTENS RES, V38, P13, DOI 10.1038/hr.2014.125; [Anonymous], [No title captured]; Baradaran A, 2014, J RES MED SCI, V19, P358; Bhandary B, 2013, INT J MOL SCI, V14, P434, DOI 10.3390/ijms14010434; Brozovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076397; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Choi SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31925; Choy KW, 2016, BIOCHEM PHARMACOL, V116, P51, DOI 10.1016/j.bcp.2016.07.013; Demirtas L, 2016, INDIAN J MED RES, V144, P515, DOI 10.4103/0971-5916.200887; Ding Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154375; Dornas WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep46051; Fan LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062627; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Fu PK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/837513; Galan M, 2014, BBA-MOL CELL RES, V1843, P1063, DOI 10.1016/j.bbamcr.2014.02.009; Galan M, 2012, HYPERTENSION, V60, P71, DOI 10.1161/HYPERTENSIONAHA.112.192500; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128; Higashi Y, 2014, TRENDS CARDIOVAS MED, V24, P165, DOI 10.1016/j.tcm.2013.12.001; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Kalinowski L, 2004, ACTA BIOCHIM POL, V51, P459; Kassan M, 2011, J DIABETES METABOLIS, P2; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Laurindo FRM, 2014, ANTIOXID REDOX SIGN, V20, P2755, DOI 10.1089/ars.2013.5605; Lee H, 2013, ECAM, V2013; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li HK, 2009, PLANTA MED, V75, P7, DOI 10.1055/s-0028-1088332; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048872; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Li JF, 2003, NEUROSCI LETT, V350, P173, DOI 10.1016/S0304-3940(03)00881-4; Liang B, 2013, ARTERIOSCL THROM VAS, V33, P595, DOI 10.1161/ATVBAHA.112.300606; Lin C, 2015, INT J MOL SCI, V16, P8844, DOI 10.3390/ijms16048844; Liu JP, 2013, J MED FOOD, V16, P577, DOI 10.1089/jmf.2012.2654; Ma LN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00298; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mihalj M, 2016, KIDNEY BLOOD PRESS R, V41, P721, DOI 10.1159/000450562; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Montezano AC, 2012, ANN MED, V44, pS2, DOI 10.3109/07853890.2011.653393; Murugan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145413; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Rafieian-Kopaei Mahmoud, 2013, J Nephropathol, V2, P152, DOI 10.12860/JNP.2013.26; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santos CXC, 2014, ANTIOXID REDOX SIGN, V20, P121, DOI 10.1089/ars.2013.5262; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Shi XJ, 2016, MOL MED REP, V14, P2397, DOI 10.3892/mmr.2016.5573; Spitler KM, 2013, AM J PHYSIOL-HEART C, V305, pH344, DOI 10.1152/ajpheart.00952.2012; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang JY, 2013, CHIN J INTEGR MED, V19, P510, DOI 10.1007/s11655-013-1505-8; Zhang L H, 1996, Zhongguo Zhong Xi Yi Jie He Za Zhi, V16, P187; Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515; Zuo Li, 2013, [Frontiers in Biology, 生物学前沿], V8, P305	64	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178365	10.1371/journal.pone.0178365	http://dx.doi.org/10.1371/journal.pone.0178365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562691	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700054
J	Silva, CF; Seixas, VC; Barroso, R; Di Domenico, M; Amaral, ACZ; Paiva, PC				Silva, Camila F.; Seixas, Victor C.; Barroso, Romulo; Di Domenico, Maikon; Amaral, Antonia C. Z.; Paiva, Paulo C.			Demystifying the Capitella capitata complex (Annelida, Capitellidae) diversity by morphological and molecular data along the Brazilian coast	PLOS ONE			English	Article							ORGANIC ENRICHMENT; POLYCHAETA; FABRICIUS; GROWTH; DESIGNATION; DELINEATION; EXPOSURE; HABITAT; TELETA	The sibling species of Capitella capitata are globally known for their tolerance to disturbed habitats and the C. capitata complex is often used as an ecological indicator. A recent re description proposed that C. capitata, originally described in Greenland is restricted to the Artic and Subarctic regions. Given their ecological relevance, we conducted a morphological and molecular analyses based on mtDNA sequences to investigate the diversity and distribution of the C. capitata complex along the Brazilian coast. Our morphological and molecular data were congruent and revealed the existence of four new species distinct from C. capitata, collected from the type locality. This study is the first characterization of the biodiversity and distribution of Capitella species made along the Brazilian coast and yielded a set of morphological characters corroborated by the mtDNA sequences for species identification. Our results increase the biodiversity of the genus along the Brazilian coast by describing four new species (Capitella aracaensis sp. n., Capitella biota sp. n., Capitella neoaciculata sp. n. and Capitella nonatoi sp. n.). One species was collected from only one sampling site, while the others are distributed along the coast.	[Silva, Camila F.; Amaral, Antonia C. Z.] Univ Estadual Campinas UNICAMP, Dept Biol Anim, Campinas, SP, Brazil; [Seixas, Victor C.; Paiva, Paulo C.] Univ Fed Rio de Janeiro, Dept Zool, Rio de Janeiro, RJ, Brazil; [Barroso, Romulo] Pontificia Univ Catolica Rio de Janeiro, Dept Biol, Rio De Janeiro, RJ, Brazil; [Di Domenico, Maikon] Univ Fed Parana, Ctr Estudos Mar, Lab Modelagem Ecol, Curitiba, Parana, Brazil	Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; Universidade Federal do Parana	Silva, CF (corresponding author), Univ Estadual Campinas UNICAMP, Dept Biol Anim, Campinas, SP, Brazil.	fercamis@gmail.com	Silva, Camila/V-2749-2017; Paiva, Paulo C/I-6174-2012; de Paiva, Paulo Cesar/N-1234-2019; Seixas, Victor Correa/M-6934-2019	Silva, Camila/0000-0002-1600-5389; Paiva, Paulo C/0000-0003-1061-6549; de Paiva, Paulo Cesar/0000-0003-1061-6549; Seixas, Victor Correa/0000-0002-2067-9490	Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/50317-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [306558/2010-6, 500386/2012-9, 303939/2014-1]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [12/08581-0, 13/04358-7]	Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The development of this study was funded by the Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) (Proc. No. 2011/50317-5). In addition, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq provided fellowships for ACZA (Proc. No.306558/2010-6), RB (Proc. No. 500386/2012-9) and PCP (Proc. No. 303939/2014-1). MDD received post-doc scholarship (Proc. No. 12/08581-0) and internship funding (Proc. No. 13/04358-7) from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens JB, 2013, MOL ECOL, V22, P2280, DOI 10.1111/mec.12263; Albano MJ, 2013, MAR POLLUT BULL, V73, P102, DOI 10.1016/j.marpolbul.2013.05.032; Amaral A. C. Z., 2013, CATALOGO ESPECIES AN; Amaral ACZ, 2016, LIFE ARACA BAY DIVER, P1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Blainville H., 1828, DICTIONNAIRE SCI NAT, V57; Blake JA, 2009, ZOOSYMPOSIA, V2, P25, DOI 10.11646/zoosymposia.2.1.6; Blake JA, 2009, ZOOSYMPOSIA, V2, P55, DOI 10.11646/zoosymposia.2.1.7; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Capa M, 2013, ZOOL SCR, V42, P637, DOI 10.1111/zsc.12028; Capa M, 2015, ZOOL J LINN SOC-LOND, V175, P764, DOI 10.1111/zoj.12308; Corbisier TN, 1991, BOL I OCEANOGR, V39, P01; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ebach MC, 2005, BIOSCIENCE, V55, P822; ECKELBARGER K J, 1987, Bulletin of the Biological Society of Washington, P62; ECKELBARGER KJ, 1983, BIOL BULL, V165, P379, DOI 10.2307/1541203; Eisig H., 1887, FAUNA FLORA GOLF NEA, V16, P1, DOI DOI 10.5962/BHL.TITLE.11542; Fabricius O., 1780, FAUNA GROENLANDICA S; Fauchald K., 1984, P 1 INT POLYCH C SYD, P1; FAUVEL PIERRE, 1932, MEM INDIAN MUS, V12, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forbes VE, 2003, ECOL APPL, V13, P1094, DOI 10.1890/1051-0761(2003)13[1094:JEOPDA]2.0.CO;2; Gamenick I, 1998, MAR ECOL PROG SER, V175, P155, DOI 10.3354/meps175155; Gamenick Inez, 1994, Polychaete Research, V16, P44; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Grassle J., 1980, Aquatic Oligochaete Biology, V1, P25; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Gravier C., 1911, B MUSEUM NATL HIST N, V17, P310; Green Karen D., 2002, Phuket Marine Biological Center Special Publication, V24, P249; Grube AE, 1862, ARCH NATURGESCH, V28, P366; Hartman O., 1971, Allan Hancock Monogr mar Biol, VNo.6, P1; Hartman O., 1961, ZOOL ANZ, V167, P325; Hartman Olga, 1947, REPT ALLAN HANCOCK PACIFIC EXPED, V10, P391; HARTMAN OLGA, 1959, BULL MARINE SCI GULF AND CARIBBEAN, V9, P153; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hilliard J, 2016, INVERTEBR BIOL, V135, P415, DOI 10.1111/ivb.12152; HUTCHINGS P, 1991, OPHELIA, P565; Johnson HP, 1901, P BOSTON SOC NAT HIS, V29, P381; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Langerhans P., 1880, F R WISSENSCHAFTLICH, V34, P87; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lewis C, 2012, MAR ENVIRON RES, V75, P10, DOI 10.1016/j.marenvres.2011.08.002; Linke-Gamenick I, 2000, MAR ECOL PROG SER, V203, P191, DOI 10.3354/meps203191; Magalhaes WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112727; Magalhaes Wagner F., 2012, Zootaxa, V3581, P1; Mendez N, 2006, J MAR BIOL ASSOC UK, V86, P263, DOI 10.1017/S0025315406013117; Mendez N, 2002, SCI MAR, V66, P103, DOI 10.3989/scimar.2002.66n2103; Mendez N, 2000, INVERTEBR REPROD DEV, V38, P131, DOI 10.1080/07924259.2000.9652448; Mesnil F., 1897, ZOOL ANZ, V20, P441; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Morgado E.H., 1989, Revista Brasileira de Zoologia, V6, P535; NETTO SA, 1994, MAR ECOL PROG SER, V106, P239, DOI 10.3354/meps106239; Nygren A, 2011, MOL PHYLOGENET EVOL, V58, P132, DOI 10.1016/j.ympev.2010.10.010; Nygren A, 2009, MAR BIOL RES, V5, P315, DOI 10.1080/17451000802441301; Oliveira VM, 2010, ZOOLOGIA-CURITIBA, V27, P146, DOI 10.1590/S1984-46702010000100022; Pagliosa PR, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau002; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Pamungkas J, 2017, ZOOTAXA, V4227, P573, DOI 10.11646/zootaxa.4227.4.7; Pardo EV, 2010, IHERINGIA SER ZOOL, V100, P13, DOI 10.1590/S0073-47212010000100002; Paterson Gordon L. J., 2014, Memoirs of Museum Victoria, V71, P237; PEARSON M, 1991, OPHELIA, P363; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PECHENIK JA, 1991, J EXP MAR BIOL ECOL, V151, P17, DOI 10.1016/0022-0981(91)90012-L; QIAN PY, 1991, B MAR SCI, V48, P477; Radashevsky VI, 2016, ZOOTAXA, V4083, P239, DOI 10.11646/zootaxa.4083.2.4; Rambaut A., 2007, TRACER V1 5; Reis Margarete de O., 2000, Revista Brasileira de Oceanografia, V48, P107; Reish D. J., 1957, P195; Reish Donald J., 2014, Memoirs of Museum Victoria, V71, P271; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; Silva ACF, 2012, ESTUAR COAST SHELF S, V97, P38, DOI 10.1016/j.ecss.2011.11.006; Silva CF, 2016, DEEP-SEA RES PT I, V108, P23, DOI 10.1016/j.dsr.2015.12.004; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Summers M, 2015, INVERTEBR SYST, V29, P105, DOI 10.1071/IS14055; Sun YA, 2016, INVERTEBR SYST, V30, P41, DOI 10.1071/IS15015; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiyagarajan V, 2005, J EXP MAR BIOL ECOL, V323, P70, DOI 10.1016/j.jembe.2005.03.001; Thomassin B., 1970, Recl. Tray. Stn mar. Endoume-Marseille, V10, P71; Tomioka S, 2016, ZOOL SCI, V33, P545, DOI 10.2108/zs160059; TREADWELL AARON, 1939, AMER MUS NOVITATES, V1023, P1; TSUTSUMI H, 1990, MAR ECOL PROG SER, V63, P157, DOI 10.3354/meps063157; Verrill A.E., 1879, P US NATL MUS, V2, P165, DOI DOI 10.5479/SI.00963801.76.165; VONBOLETZKY S, 1967, VIE MILIEU A BIOL MA, V18, P79; Warren L.M., 1986, Bulletin of the British Museum (Natural History) Zoology, V50, P117; WARREN LM, 1976, J ZOOL, V180, P195; WESTON DP, 1990, MAR ECOL PROG SER, V61, P233, DOI 10.3354/meps061233; WU BL, 1991, OPHELIA, P391; Xia X., 2003, MOL BIOL EVOL, V30, P1720; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	93	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177760	10.1371/journal.pone.0177760	http://dx.doi.org/10.1371/journal.pone.0177760			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562616	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700026
J	Wu, YT; Luben, R; Wareham, N; Griffin, S; Jones, AP				Wu, Yu-Tzu; Luben, Robert; Wareham, Nicholas; Griffin, Simon; Jones, Andy P.			Weather, day length and physical activity in older adults: Cross-sectional results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Norfolk Cohort	PLOS ONE			English	Article							BUILT ENVIRONMENT; SEDENTARY TIME; BARRIERS; WALKING; BEHAVIOR; IMPACT	Background A wide range of environmental factors have been related to active ageing, but few studies have explored the impact of weather and day length on physical activity in older adults. We investigate the cross-sectional association between weather conditions, day length and activity in older adults using a population-based cohort in England, the European Prospective Investigation into Cancer and Nutrition (EPIC) Norfolk study. Methods Physical activity was measured objectively over 7 days using an accelerometer and this was used to calculate daily total physical activity (counts per minute), daily minutes of sedentary behaviour and light, moderate and vigorous physical activity (LMVPA). Day length and two types of weather conditions, precipitation and temperature, were obtained from a local weather station. The association between these variables and physical activity was examined by multilevel first-order autoregressive modelling. Results After adjusting for individual factors, short day length and poor weather conditions, including high precipitation and low temperatures, were associated with up to 10% lower average physical activity (p<0.01) and 8 minutes less time spent in LMVPA but 15 minutes more sedentary time, compared to the best conditions. Conclusion Day length and weather conditions appear to be an important factor related to active ageing. Future work should focus on developing potential interventions to reduce their impact on physical activity behaviours in older adults.	[Wu, Yu-Tzu; Jones, Andy P.] Univ East Anglia, Norwich Med Sch, Dept Populat Hlth & Primary Care, Norwich, Norfolk, England; [Wu, Yu-Tzu; Wareham, Nicholas; Griffin, Simon; Jones, Andy P.] Univ Cambridge, UKCRC, Ctr Diet & Activ Res CEDAR, Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge, England; [Luben, Robert] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Wu, Yu-Tzu] Univ Exeter, Coll Life & Environm Sci, Dept Psychol, REACH Ctr Res Ageing & Cognit Hlth, Washington Singer Bldg, Exeter, Devon, England	University of East Anglia; University of Cambridge; University of Cambridge; University of Exeter	Wu, YT (corresponding author), Univ East Anglia, Norwich Med Sch, Dept Populat Hlth & Primary Care, Norwich, Norfolk, England.; Wu, YT (corresponding author), Univ Cambridge, UKCRC, Ctr Diet & Activ Res CEDAR, Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge, England.; Wu, YT (corresponding author), Univ Exeter, Coll Life & Environm Sci, Dept Psychol, REACH Ctr Res Ageing & Cognit Hlth, Washington Singer Bldg, Exeter, Devon, England.	y.wu3@exeter.ac.uk	Luben, Robert N/H-5519-2015	Luben, Robert N/0000-0002-5088-6343; Wu, Yu-Tzu/0000-0002-0874-4448	Medical Research Council [G0401527]; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence - British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/4, MR/K023187/1, MR/N003284/1, MR/K025147/1, G1000143, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/1, MR/K023187/1, MC_UU_12015/4, MR/K025147/1, MR/N003284/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence - British Heart Foundation; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (Grant Number: G0401527; URL: http://www.mrc.ac.uk/). The work was undertaken under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence which is funded by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Medical Research Council (Grant Number: G0401527; URL: http://www.mrc.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Dr. Flo Harrison for her advice on weather data and statistical modelling.	Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Van Cauwenberg J, 2011, HEALTH PLACE, V17, P458, DOI 10.1016/j.healthplace.2010.11.010; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Chatfield C., 2013, ANAL TIME SERIES INT, V6th; Clarke P, 2014, P GERON SOC AM 67 SC; Cunningham GO, 2004, AM J HEALTH PROMOT, V18, P435, DOI 10.4278/0890-1171-18.6.435; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Day N, 1999, BRIT J CANCER, V80, P95; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dunlop DD, 2015, J PHYS ACT HEALTH, V12, P93, DOI 10.1123/jpah.2013-0311; Eronen J, 2014, PREV MED, V67, P106, DOI 10.1016/j.ypmed.2014.07.020; European Commission, 2013, INN AG FRIENDL BUILD; GOLDSTEIN H, 1994, STAT MED, V13, P1643, DOI 10.1002/sim.4780131605; Harrison F, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-47; Hayat SA, 2014, INT J EPIDEMIOL, V43, P1063, DOI 10.1093/ije/dyt086; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Klenk J, 2012, J EPIDEMIOL COMMUN H, V66, P474, DOI 10.1136/jech.2010.128090; Lail P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-148; Lawton M., 1973, PSYCHOL ADULT DEV AG, P619, DOI DOI 10.1037/10044-020; Lees FD, 2005, J AGING PHYS ACTIV, V13, P23, DOI 10.1123/japa.13.1.23; Mankowski RT, 2015, EXP GERONTOL, V70, P32, DOI 10.1016/j.exger.2015.06.018; Marquez DX, 2014, J APPL GERONTOLOGY; Martin A, BR J SPORTS MED; Prins RG, 2015, AGE AGEING, V44, P886, DOI 10.1093/ageing/afv103; Rosenberg DE, 2013, GERONTOLOGIST, V53, P268, DOI 10.1093/geront/gns119; Sugiyama T, 2007, ENVIRON PLANN A, V39, P1943, DOI 10.1068/a38226; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Witham MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085331; World Health Organization, 2002, ACT AG POL FRAM	30	38	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177767	10.1371/journal.pone.0177767	http://dx.doi.org/10.1371/journal.pone.0177767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562613	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000402608700027
J	Wu, CL; Hardy, S; Aubry, I; Landry, M; Haggarty, A; Saragovi, HU; Tremblay, ML				Wu, Chia-Lun; Hardy, Serge; Aubry, Isabelle; Landry, Melissa; Haggarty, Allison; Saragovi, Horacio Uri; Tremblay, Michel L.			Identification of function-regulating antibodies targeting the receptor protein tyrosine phosphatase sigma ectodomain	PLOS ONE			English	Article							SPINAL-CORD-INJURY; INHIBITORY WEDGE; STRUCTURAL BASIS; PTP-SIGMA; DIMERIZATION; PROTEOGLYCAN; REGENERATION; EXTENSION; ALPHA	Receptor tyrosine phosphatase sigma (RPTP sigma) plays an important role in the regulation of axonal outgrowth and neural regeneration. Recent studies have identified two RPTP sigma ligands, chondroitin sulfate proteoglycans (CSPGs) and heparan sulfate proteoglycans (HSPG), which can modulate RPTP sigma activity by affecting its dimerization status. Here, we developed a split luciferase assay to monitor RPTP sigma dimerization in living cells. Using this system, we demonstrate that heparin, an analog of heparan sulfate, induced the dimerization of RPTP sigma , whereas chondroitin sulfate increased RPTP sigma activity by inhibiting RPTP sigma dimerization. Also, we generated several novel RPTP sigma vertical bar gG monoclonal antibodies, to identify one that modulates its activity by inducing/stabilizing dimerization in living cells. Lastly, we demonstrate that this antibody promotes neurite outgrowth in SH-SY5Y cells. In summary, we demonstrated that the split luciferase RPTP sigma activity assay is a novel high throughput approach for discovering novel RPTP sigma modulators that can promote axonal outgrowth and neural regeneration.	[Wu, Chia-Lun; Hardy, Serge; Aubry, Isabelle; Landry, Melissa; Haggarty, Allison; Tremblay, Michel L.] Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Wu, Chia-Lun; Tremblay, Michel L.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Saragovi, Horacio Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, Horacio Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Tremblay, ML (corresponding author), Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada.; Tremblay, ML (corresponding author), McGill Univ, Dept Expt Med, Montreal, PQ, Canada.	michel.tremblay@mcgill.ca		Tremblay, Michel L./0000-0002-0281-541X	Canada-Israel Health Research Initiative - Canadian Institutes of Health Research; Israel Science Foundation; International Development Research Centre; Azrieli Foundation	Canada-Israel Health Research Initiative - Canadian Institutes of Health Research; Israel Science Foundation(Israel Science Foundation); International Development Research Centre; Azrieli Foundation	M.L.T. is a Jeanne and Jean-Louis Levesque chair in Cancer Research. This work was supported by the Canada-Israel Health Research Initiative, jointly funded by the Canadian Institutes of Health Research, the Israel Science Foundation, the International Development Research Centre, and the Azrieli Foundation.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; Horn KE, 2012, J NEUROCHEM, V122, P147, DOI 10.1111/j.1471-4159.2012.07762.x; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Leahy DJ, 2008, CANCER CELL, V13, P291; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald-Obermann JL, 2013, J BIOL CHEM, V288, P30773, DOI 10.1074/jbc.M113.489534; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Perron MD, 2014, MOL PHARMACOL, V85, P553, DOI 10.1124/mol.113.089847; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Sarrazin S, COLD SPRING HARB PER, V3; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Tertoolen LGJ, 2001, BMC CELL BIOL, V2, part. no., DOI 10.1186/1471-2121-2-8; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Yim YS, 2013, P NATL ACAD SCI USA, V110, P4057, DOI 10.1073/pnas.1209881110	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178489	10.1371/journal.pone.0178489	http://dx.doi.org/10.1371/journal.pone.0178489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558026	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000051
J	Kelley, MD; Phomakay, R; Lee, M; Niedzwiedz, V; Mayo, R				Kelley, Melissa D.; Phomakay, Raynin; Lee, Madison; Niedzwiedz, Victoria; Mayo, Rachel			Retinoic acid receptor gamma impacts cellular adhesion, Alpha5Beta1 integrin expression and proliferation in K562 cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR; VITAMIN-A; TRANSFORMED PHENOTYPE; FIBRONECTIN RECEPTOR; T-CELLS; DIFFERENTIATION; ALPHA; APOPTOSIS; ALPHA-5-BETA-1; IDENTIFICATION	The interplay between cellular adhesion and proliferation is complex; however, integrins, particularly the alpha 5 beta 1 subset, play a pivotal role in orchestrating critical cellular signals that culminate in cellular adhesion and growth. Retinoids modify the expression of a variety of adhesive/proliferative signaling proteins including alpha 5 beta 1 integrins; however, the role of specific retinoic acid receptors involved in these processes has not been elucidated. In this study, the effect of all-trans-retinoic acid receptor (RAR) agonists on K562 cellular adhesion, proliferation, and alpha 5 beta 1 integrin cell surface expression was investigated. RAR. agonist exposure increased K562 cellular adhesion to RGD containing extracellular matrix proteins fibronectin and FN-120 in a time-and concentration dependent manner, while RAR alpha or RAR beta agonist treatment had no effect on cellular adhesion. Due to the novel RAR gamma-dependent cellular adhesion response exhibited by K562 cells, we examined alpha 5 and beta 1 integrin subunit expression when K562 cells were exposed to retinoid agonists or vehicle for 24, 48, 72 or 96 hours. Our data demonstrates no differences in K562 cell surface expression of the a5 integrin subunit when cells were exposed to RAR alpha, RAR beta, or RAR gamma agonists for all time points tested. In contrast, RAR gamma agonist exposure resulted in an increase in cell surface beta 1 integrin subunit expression within 48 hours that was sustained at 72 and 96 hours. Finally, we demonstrate that while exposure to RAR alpha or RAR beta agonists have no effect on K562 cellular proliferation, the RAR gamma agonist significantly dampens K562 cellular proliferation levels in a time-and concentration-dependent manner. Our study is the first to report that treatment with a RAR gamma specific agonist augments cellular adhesion to alpha 5 beta 1 integrin substrates, increases cell surface levels of the beta 1 integrin subunit, and dampens cellular proliferation in a time and concentration dependent manner in a human erythroleukemia cell line.	[Kelley, Melissa D.; Phomakay, Raynin; Lee, Madison; Niedzwiedz, Victoria; Mayo, Rachel] Univ Cent Arkansas, Dept Chem & Biochem, Conway, AR 72035 USA	University of Central Arkansas	Kelley, MD (corresponding author), Univ Cent Arkansas, Dept Chem & Biochem, Conway, AR 72035 USA.	mkelley@uca.edu			National Institute of General Medical Sciences (NIGMS) from the National Institutes of Health [P20 GM103429]	National Institute of General Medical Sciences (NIGMS) from the National Institutes of Health	\ This publication was made possible by the Arkansas INBRE program, supported by a grant from the National Institute of General Medical Sciences (NIGMS), P20 GM103429 from the National Institutes of Health.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Blomhoff HK, 2004, BIOCHEM SOC T, V32, P982, DOI 10.1042/BST0320982; Bosch A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3247; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; Bridges LC, 2008, BIOCHEMISTRY-US, V47, P4544, DOI 10.1021/bi702447u; Brown DC, 1999, BRIT J HAEMATOL, V107, P86, DOI 10.1046/j.1365-2141.1999.01671.x; Cariati R, 2000, INT J CANCER, V86, P375, DOI 10.1002/(SICI)1097-0215(20000501)86:3<375::AID-IJC12>3.0.CO;2-Z; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; DEDHAR S, 1989, J CELL PHYSIOL, V138, P291, DOI 10.1002/jcp.1041380210; DEDHAR S, 1987, J CELL BIOL, V105, P1175, DOI 10.1083/jcb.105.3.1175; DILLEHAY DL, 1987, CELL IMMUNOL, V107, P130, DOI 10.1016/0008-8749(87)90273-5; Ertesvag A, 2009, SEMIN IMMUNOL, V21, P36, DOI 10.1016/j.smim.2008.06.005; Escribese Maria M, 2007, BMC Nephrol, V8, P3, DOI 10.1186/1471-2369-8-3; Fang ZY, 2007, J CELL BIOCHEM, V101, P654, DOI 10.1002/jcb.21223; FAULL RJ, 1993, J CELL BIOL, V121, P155, DOI 10.1083/jcb.121.1.155; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Gartel AL, 2002, MOL CANCER THER, V1, P639; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Guo YX, 2014, J IMMUNOL, V192, P3336, DOI 10.4049/jimmunol.1301949; Hanson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093005; Hsu CA, 1997, BLOOD, V89, P4470, DOI 10.1182/blood.V89.12.4470; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2009, SEMIN IMMUNOL, V21, P1, DOI 10.1016/j.smim.2008.09.001; Kinashi T, 2011, METHODS MOL BIOL, V757, P261, DOI 10.1007/978-1-61779-166-6_17; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Massimi M, 2007, LIVER INT, V27, P128, DOI 10.1111/j.1478-3231.2006.01391.x; Medhora MM, 2000, AM J PHYSIOL-HEART C, V279, pH382, DOI 10.1152/ajpheart.2000.279.1.H382; Mellanby E, 1929, BMJ-BRIT MED J, V1929, P984; Molla A, 2000, CELL GROWTH DIFFER, V11, P83; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Schwartz MA, 2001, J CELL SCI, V114, P2553; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; Sporn MB, 1994, THE RETINOIDS BIOLOG; SYMINGTON BE, 1990, CELL REGUL, V1, P637, DOI 10.1091/mbc.1.9.637; Valli C, 2008, MOL CANCER THER, V7, P2941, DOI 10.1158/1535-7163.MCT-08-0419; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Vivat-Hannah V, 2001, CANCER RES, V61, P8703; Whelan JT, 2014, BIOCHEM BIOPH RES CO, V454, P537, DOI 10.1016/j.bbrc.2014.10.120; Whelan JT, 2013, J NUTR BIOCHEM, V24, P832, DOI 10.1016/j.jnutbio.2012.05.001; Wu Y, 2011, CELL IMMUNOL, V268, P68, DOI 10.1016/j.cellimm.2011.03.002; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	47	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178116	10.1371/journal.pone.0178116	http://dx.doi.org/10.1371/journal.pone.0178116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552962	Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000021
J	Mosienko, V; Chang, AJ; Alenina, N; Teschemacher, AG; Kasparov, S				Mosienko, Valentina; Chang, Andy J.; Alenina, Natalia; Teschemacher, Anja G.; Kasparov, Sergey			Rodents and humans are able to detect the odour of L-Lactate	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; OLFACTORY RECEPTORS; FUNCTIONAL EXPRESSION; PARKINSONS-DISEASE; SEX-DIFFERENCES; IDENTIFICATION; DIAGNOSIS; DISCRIMINATION; SPECIFICITY; METABOLISM	L-Lactate (LL) is an essential cellular metabolite which can be used to generate energy. In addition, accumulating evidence suggests that LL is used for inter-cellular signalling. Some LL-sensitive receptors have been identified but we recently proposed that there may be yet another unknown G-protein coupled receptor (GPCR) sensitive to LL in the brain. Olfactory receptors (ORs) represent the largest family of GPCRs and some of them are expressed outside the olfactory system, including brain, making them interesting candidates for non-olfactory LL signalling. One of the "ectopically" expressed ORs, Olfr78 in mice (Olr59 in rats and OR51E2 in humans), reportedly can be activated by LL. This implies that both rodents and humans should be able to detect the LL odour. Surprisingly, this has never been demonstrated. Here we show that mice can detect the odour of LL in odour detection and habituation- dishabituation tasks, and discriminate it from peppermint and vanilla odours. Behaviour of the Olfr78 null mice and wildtype mice in odour detection task was not different, indicating that rodents are equipped with more than one LL-sensitive OR. Rats were also able to use the smell of LL as a cue in an odour-reward associative learning task. When presented to humans, more than 90% of participants detected a smell of LL in solution. Interestingly, LL was perceived differently than acetate or propionate-LL was preferentially reported as a pleasant sweet scent while acetate and propionate were perceived as repulsive sour/acid smells. Subjective perception of LL smell was different in men and women. Taken together, our data demonstrate that both rodents and humans are able to detect the odour of LL. Moreover, in mice, LL perception is not purely mediated by Olfr78. Discovery of further LL-sensitive OR might shed the light on their contribution to LL signalling in the body.	[Mosienko, Valentina; Teschemacher, Anja G.; Kasparov, Sergey] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Chang, Andy J.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Chang, Andy J.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Alenina, Natalia] Max Delbruck Ctr Mol Med MDC Berlin Buch, Berlin, Germany; [Kasparov, Sergey] Balt Fed Univ, Kaliningrad, Russia; [Chang, Andy J.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA; [Chang, Andy J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA	University of Bristol; Stanford University; Howard Hughes Medical Institute; Stanford University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Immanuel Kant Baltic Federal University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kasparov, S (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.; Kasparov, S (corresponding author), Balt Fed Univ, Kaliningrad, Russia.	Sergey.Kasparov@bristol.ac.uk	Kasparov, Sergey/AAH-5286-2019; Mosienko, Valentina/AAN-5983-2020	Kasparov, Sergey/0000-0002-1824-1764; Mosienko, Valentina/0000-0002-8562-532X	BBSRC [BB/L019396/1, BB/K009192/1]; MRC [MR/L020661/1]; Biotechnology and Biological Sciences Research Council [BB/L019396/1, BB/K009192/1] Funding Source: researchfish; Medical Research Council [MR/L020661/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BBSRC: BB/L019396/1, BB/K009192/1; and MRC MR/L020661/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arctander S., 1969, PERFUME FLAVOR CHEM, VI; Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; Buono MJ, 2010, J PHYSIOL SCI, V60, P103, DOI 10.1007/s12576-009-0073-3; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; Deeb J, 2010, QJM-INT J MED, V103, P941, DOI 10.1093/qjmed/hcq142; Dewan A, 2013, NATURE, V497, P486, DOI 10.1038/nature12114; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Hummel T, 2002, INT ARCH OCC ENV HEA, V75, P305, DOI 10.1007/s00420-002-0315-7; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; LUCAS F, 1995, BEHAV NEUROSCI, V109, P446, DOI 10.1037/0735-7044.109.3.446; MAGISTRETTI PJ, 1993, DEV NEUROSCI-BASEL, V15, P306, DOI 10.1159/000111349; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsui T, 2012, J PHYSIOL-LONDON, V590, P607, DOI 10.1113/jphysiol.2011.217919; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Moberg PJ, 1997, AM J PSYCHIAT, V154, P1016; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Oz G, 2009, DIABETES, V58, P1978, DOI 10.2337/db09-0226; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Scheijen JLJM, 2012, EXP DIABETES RES, DOI 10.1155/2012/234812; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Silveira-Moriyama L, 2008, MOVEMENT DISORD, V23, P2328, DOI 10.1002/mds.22241; Smith DR, 1998, NEUROSCIENCE, V86, P135, DOI 10.1016/S0306-4522(97)00608-8; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stamps JJ, 2013, J NEUROL SCI, V333, P19, DOI 10.1016/j.jns.2013.06.033; Steib BM, 2001, CHEM SENSES, V26, P523, DOI 10.1093/chemse/26.5.523; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Tekus E, 2012, ACTA BIOL HUNG, V63, P89, DOI 10.1556/ABiol.63.2012.Suppl.1.9; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Turin L, 2003, HDB OLFACTION GUSTAT, P275; Ugur T, 2005, EUR ARCH PSY CLIN N, V255, P94, DOI 10.1007/s00406-004-0536-8; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Xu LL, 2000, CANCER RES, V60, P6568	56	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178478	10.1371/journal.pone.0178478	http://dx.doi.org/10.1371/journal.pone.0178478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542639	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000402062800094
J	Koo, HJ; Kim, MY; Koo, JH; Sung, YS; Jung, J; Kim, SH; Choi, CM; Kim, HJ				Koo, Hyun Jung; Kim, Mi Young; Koo, Ja Hwan; Sung, Yu Sub; Jung, Jiwon; Kim, Sung-Han; Choi, Chang-Min; Kim, Hwa Jung			Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation	PLOS ONE			English	Article							BRONCHIOLOALVEOLAR CARCINOMA; TOMOGRAPHY; FEATURES; SOCIETY	Radiologists have used margin characteristics based on routine visual analysis; however, the attenuation changes at the margin of the lesion on CT images have not been quantitatively assessed. We established a CT-based margin analysis method by comparing a target lesion with normal lung attenuation, drawing a slope to represent the attenuation changes. This approach was applied to patients with invasive mucinous adenocarcinoma (n = 40) or bacterial pneumonia (n = 30). Correlations among multiple regions of interest (ROIs) were obtained using intraclass correlation coefficient (ICC) values. CT visual assessment, margin and texture parameters were compared for differentiating the two disease entities. The attenuation and margin parameters in multiple ROIs showed excellent ICC values. Attenuation slopes obtained at the margins revealed a difference between invasive mucinous adenocarcinoma and pneumonia (P< 0.001), and mucinous adenocarcinoma produced a sharply declining attenuation slope. On multivariable logistic regression analysis, pneumonia had an ill-defined margin (odds ratio (OR), 4.84; 95% confidence interval (CI), 1.26-18.52; P = 0.02), ground-glass opacity (OR, 8.55; 95% CI, 2.09-34.95; P = 0.003), and gradually declining attenuation at the margin (OR, 12.63; 95% CI, 2.77-57.51, P = 0.001). CT-based margin analysis method has a potential to act as an imaging parameter for differentiating invasive mucinous adenocarcinoma and bacterial pneumonia.	[Koo, Hyun Jung; Kim, Mi Young; Koo, Ja Hwan; Sung, Yu Sub] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Koo, Hyun Jung; Kim, Mi Young; Koo, Ja Hwan; Sung, Yu Sub] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Jung, Jiwon] Univ Ulsan, Dept Infect Dis, Ulsan, South Korea; [Kim, Sung-Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Pulm & Crit Care Med, Seoul, South Korea; [Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Kim, Hwa Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, MY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, MY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	mimowdr@gmail.com		Koo, Hyun Jung/0000-0001-5640-3835; Kim, Mi Young/0000-0003-0691-5546; Kim, Sung-Han/0000-0002-6596-8253	Korean Association for the Study of Lung Cancer	Korean Association for the Study of Lung Cancer	This work supported by research grant from Korean Association for the Study of Lung Cancer in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Aquino SL, 1998, AM J ROENTGENOL, V171, P359, DOI 10.2214/ajr.171.2.9694451; Bak SH, 2016, CHEST, V149, P180, DOI 10.1378/chest.15-0034; Dhara AK, 2015, INT J COMPUT ASSIST; Dhara AK, 2016, J DIGIT IMAGING; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Jung JI, 2001, BRIT J RADIOL, V74, P490, DOI 10.1259/bjr.74.882.740490; Kim H, 2015, INVEST RADIOL, V50, P571, DOI 10.1097/RLI.0000000000000152; Kim TH, 2006, EUR RADIOL, V16, P1763, DOI 10.1007/s00330-005-0101-5; Li JH, 2012, CHEST, V142, P1338, DOI 10.1378/chest.11-2026; Mattonen SA, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041010; Morichika D, 2014, INTERNAL MED, V53, P2795, DOI 10.2169/internalmedicine.53.2783; Sadohara J, 2004, J THORAC IMAG, V19, P63, DOI 10.1097/00005382-200401000-00014; Seitz KA GA, 2012, P SPIE INT SOC OPT E, P537; Sladoje N, 2005, IMAGE VISION COMPUT, V23, P123, DOI 10.1016/j.imavis.2004.06.011; Solomon J, 2015, RADIOLOGY; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tripathi A., 2011, 2011 INT C IM INF PR, P1; Watanabe H, 2015, ANN THORAC SURG, V99, P975, DOI 10.1016/j.athoracsur.2014.10.065; Wislez M, 2003, CHEST, V123, P1868, DOI 10.1378/chest.123.6.1868	21	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177379	10.1371/journal.pone.0177379	http://dx.doi.org/10.1371/journal.pone.0177379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545080	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400040
J	Shi, WH; Bloomberg, M; Li, GL; Su, SC; Jia, LM				Shi, Wenhui; Bloomberg, Mark; Li, Guolei; Su, Shuchai; Jia, Liming			Combined effects of cotyledon excision and nursery fertilization on root growth, nutrient status and outplanting performance of Quercus variabilis container seedlings	PLOS ONE			English	Article							SEED-GERMINATION; ROBUR SEEDLINGS; PLANT-GROWTH; OAK; SURVIVAL; DESICCATION; CONSUMPTION; DISPERSAL; EMERGENCE; REMOVAL	Artificial excision of the distal part of acorns in order to promote germination is well researched in oak seedling cultivation studies. However, studies of combined effects of cotyledon excision and nursery fertilization on container seedlings are lacking, especially for seedling root growth and outplanting performance. This study aimed to explore the main effects of cotyledon excision on Quercus variabilis seedling emergence characteristics and demonstrated the combined effects of cotyledon excision and nursery fertilization on seedling quality to improve Quercus variabilis seedling outplanting performance. Four cotyledon excision treatments and two classes of nursery fertilization were implemented. Seedling emergence was noted every week after sowing. Seedling dry mass, morphology, and nutrient status were assessed at the end of the nursery season. After the first outplanting season, the aforementioned measurements along with seedling survival were determined once again. The results showed that cotyledon excision generally induced greater and more rapid seedling emergence, but did not affect shoot emergence synchronicity. The highest total emergence and emergence rate occurred with Intermediate excision (1/2 of the distal end of acorn was excised). Effects of nutrient loss due to cotyledon excision on seedling quality and outplanting performance were somewhat compensated by nursery fertilization. Nursery fertilization promoted dry mass increment (the net increment from T-0 to T-2 for dry mass) for excised seedlings after outplanting, resulting in better performance for Slight (1/3 of the distal end of acorn was excised) and Intermediate excision treatments in the field. Thus we conclude Intermediate excision combined with reasonable nursery fertilization can be recommended for production of nursery grown seedlings for afforestation.	[Shi, Wenhui; Li, Guolei; Su, Shuchai; Jia, Liming] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Shi, Wenhui; Li, Guolei; Jia, Liming] Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Bloomberg, Mark] Lincoln Univ, Fac Agribusiness & Commerce, Dept Land Management & Syst, Christchurch, New Zealand	Beijing Forestry University; Lincoln University - New Zealand	Li, GL (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.; Li, GL (corresponding author), Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.	glli226@163.com	Shi, Wenhui/AAW-8090-2021	/0000-0002-9994-6896	National Natural Science Foundation of China [31670638]; Fundamental Research Funds for the Central Universities [TD2011-8]; Special Funds for Beijing Municipal Common Construction Project with Central Universities; Cultivation and Liquid Biofuels of High-starch Energy Plants [2015BAD151301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Funds for Beijing Municipal Common Construction Project with Central Universities; Cultivation and Liquid Biofuels of High-starch Energy Plants	This work was supported by the National Natural Science Foundation of China #31670638 (to Guolei Li), Fundamental Research Funds for the Central Universities #TD2011-8 (to Guolei Li), Special Funds for Beijing Municipal Common Construction Project with Central Universities (to Liming Jia), Cultivation and Liquid Biofuels of High-starch Energy Plants #2015BAD151301 (to Guolei Li).	Andersson C, 1996, ACTA BOT NEERL, V45, P85; ARMSTRONG DP, 1993, ECOLOGY, V74, P1092, DOI 10.2307/1940479; Bonner F. T., 1987, General Technical Report - Southern Forest Experiment Station, USDA Forest Service; Branco M, 2002, FOREST ECOL MANAG, V166, P159, DOI 10.1016/S0378-1127(01)00669-7; den Ouden Jan, 2005, P223, DOI 10.1079/9780851998060.0223; Doody CN, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008027; Finch-Savage WE, 1994, SEED SCI RES, V4, P315, DOI 10.1017/S096025850000235X; FinchSavage WE, 1997, SEED SCI RES, V7, P35, DOI 10.1017/S0960258500003342; [付瑞 Fu Rui], 2011, [西北林学院学报, Journal of Northwest Forestry College], V26, P101; Garcia-Cebrian F, 2003, ANN FOR SCI, V60, P69, DOI 10.1051/forest:2002075; Giertych MJ, 2011, ANN FOREST SCI, V68, P433, DOI 10.1007/s13595-011-0038-6; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; Grossman BC, 2003, AGROFOREST SYST, V59, P3, DOI 10.1023/A:1026124717097; Hanley ME, 2007, PLANT CELL ENVIRON, V30, P812, DOI 10.1111/j.1365-3040.2007.01671.x; Hanley ME, 2006, NEW PHYTOL, V169, P243, DOI 10.1111/j.1469-8137.2005.01578.x; Hanley ME, 2004, NEW PHYTOL, V163, P61, DOI 10.1111/j.1469-8137.2004.01094.x; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Hay FR, 2014, SEED SCI RES, V24, P165, DOI 10.1017/S096025851400021X; Herrera Carlos M., 2002, P185; Hou XG, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2010036; Jiang Ming-Min, 2010, Chinese Journal of Zoology, V45, P27; Johnson PS, 2009, ECOLOGY SILVICULTURE, P92; KIKUZAWA K, 1988, FOREST ECOL MANAG, V25, P1, DOI 10.1016/0378-1127(88)90129-6; Li GL, 2014, EUR J FOREST RES, V133, P983, DOI 10.1007/s10342-014-0816-4; Mancilla-Leyton J, 2013, PLANT SOIL, V370, P381, DOI 10.1007/s11104-013-1646-8; McCreary DD, 1996, ANN SCI FOREST, V53, P641, DOI 10.1051/forest:19960242; MELLANBY K, 1968, J APPL ECOL, V5, P359, DOI 10.2307/2401566; Merouani H, 2001, ANN FOR SCI, V58, P543, DOI 10.1051/forest:2001144; MOHAPATRA SC, 1987, AGRON J, V79, P468, DOI 10.2134/agronj1987.00021962007900030012x; Noli E, 1999, SEED SCI TECHNOL, V27, P1; Olson D.F., 1974, SEEDS WOODY PLANTS U, P692; Pill WG, 2000, HORTSCIENCE, V35, P907, DOI 10.21273/HORTSCI.35.5.907; Prewein C, 2006, TREES-STRUCT FUNCT, V20, P53, DOI 10.1007/s00468-005-0012-8; Rasaneh Y, 2001, P NO IR FOR MAN SUST, V1, P56; SERVELLO FA, 1987, J WILDLIFE MANAGE, V51, P749, DOI 10.2307/3801737; SONESSON LK, 1994, OIKOS, V69, P65, DOI 10.2307/3545284; STEELE MA, 1993, AM MIDL NAT, V130, P229, DOI 10.2307/2426123; Suszka B, 2006, DEBY QUERCUS ROBUR L, P305; Suszka B, 2000, ODZBIORU DO SIEWU, P307; Tilki F, 2006, NEW FOREST, V32, P243, DOI 10.1007/s11056-006-9001-z; Vallejo-Marin M, 2006, AM J BOT, V93, P369, DOI 10.3732/ajb.93.3.369; VANDENDRIESSCHE R, 1980, CAN J FOREST RES, V10, P65, DOI 10.1139/x80-011; Villar-Salvador P, 2013, NEW FOREST, V44, P733, DOI 10.1007/s11056-013-9374-8; Villar-Salvador P, 2012, NEW FOREST, V43, P755, DOI 10.1007/s11056-012-9328-6; Yang YQ, 2012, PLANT ECOL, V213, P197, DOI 10.1007/s11258-011-0016-y; Yu Fei, 2011, Journal of Northeast Forestry University, V39, P11; Zhang WenHui, 2004, Acta Phytoecologica Sinica, V28, P483	47	11	14	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177002	10.1371/journal.pone.0177002	http://dx.doi.org/10.1371/journal.pone.0177002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545103	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400017
J	Kearney, P; Hunsucker, SW; Li, XJ; Porter, A; Springmeyer, S; Mazzone, P				Kearney, Paul; Hunsucker, Stephen W.; Li, Xiao-Jun; Porter, Alex; Springmeyer, Steven; Mazzone, Peter			An integrated risk predictor for pulmonary nodules	PLOS ONE			English	Article							LUNG-CANCER; PROBABILITY; CLASSIFIER	It is estimated that over 1.5 million lung nodules are detected annually in the United States. Most of these are benign but frequently undergo invasive and costly procedures to rule out malignancy. A risk predictor that can accurately differentiate benign and malignant lung nodules could be used to more efficiently route benign lung nodules to non-invasive observation by CT surveillance and route malignant lung nodules to invasive procedures. The majority of risk predictors developed to date are based exclusively on clinical risk factors, imaging technology or molecular markers. Assessed here are the relative performances of previously reported clinical risk factors and proteomic molecular markers for assessing cancer risk in lung nodules. From this analysis an integrated model incorporating clinical risk factors and proteomic molecular markers is developed and its performance assessed on a subset of 222 lung nodules, between 8mm and 20mm in diameter, collected in a previously reported prospective study. In this analysis it is found that the molecular marker is most predictive. However, the integration of clinical and molecular markers is superior to both clinical and molecular markers separately. Clinical Trial Registration: Registered at ClinicalTrials.gov (NCT01752101).	[Kearney, Paul; Hunsucker, Stephen W.; Li, Xiao-Jun; Porter, Alex; Springmeyer, Steven] Integrated Diagnost, Seattle, WA 98109 USA; [Mazzone, Peter] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Kearney, P (corresponding author), Integrated Diagnost, Seattle, WA 98109 USA.	pkearney@indidx.com	Mazzone, Peter/AAW-5401-2021; Springmeyer, Steven/AAB-7074-2022	Mazzone, Peter/0000-0003-2121-0595; 	Integrated Diagnostics	Integrated Diagnostics	Integrated Diagnostics funded this work. The funder supported the clinical study, sample collection, sample analysis and data analysis.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Breiman L, 1993, CLASSIFICATION REGRE, Vx; Cristianini N, 2000, INTRO SUPPORT VECTOR, Vxiii; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; Freedman D., 2009, STAT MODELS THEORY P, Vxiv; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Hastie T, 2001, ELEMENTS STAT LEARNI, Vxvi; Li XJ, 2015, CLIN PROTEOM, V12, DOI 10.1186/1559-0275-12-3; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Micheel C.M., 2012, INTRO BIOMARKERS; Silvestri GA, 2015, NEW ENGL J MED, V373, P243, DOI 10.1056/NEJMoa1504601; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tanner NT, 2015, CHEST, V148, P1405, DOI 10.1378/chest.15-0630; Vachani A, 2015, LUNG, V193, P1023, DOI 10.1007/s00408-015-9800-0; Vachani A, 2015, J THORAC ONCOL, V10, P629, DOI 10.1097/JTO.0000000000000447; Vachani Anil, 2014, Ann Am Thorac Soc, V11, P1586, DOI 10.1513/AnnalsATS.201405-197BC	18	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177635	10.1371/journal.pone.0177635	http://dx.doi.org/10.1371/journal.pone.0177635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545097	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700058
J	Lin, WC; Lin, HH; Hung, CY; Shih, SC; Chu, CH				Lin, Wei-Chen; Lin, Hsaing-Hung; Hung, Chien-Yuan; Shih, Shou-Chuan; Chu, Cheng-Hsin			Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding	PLOS ONE			English	Article							EPINEPHRINE INJECTION; INDUCED HEMORRHAGE; RISK-FACTORS; ERCP; ANTICOAGULANTS; COMPLICATIONS; PANCREATITIS; MULTICENTER; HEMOSTASIS; PLACEMENT	Post-endoscopic sphincterotomy bleeding is a common complication of biliary sphincterotomy, and the incidence varies from 1% to 48%. It can be challenging to localize the bleeder or to administer various interventions through a side-viewing endoscope. This study aimed to evaluate the risk factors of post-endoscopic sphincterotomy bleeding and the outcome of endoscopic intervention therapies. We retrospectively reviewed the records of 513 patients who underwent biliary sphincterotomy in Mackay Memorial Hospital between 2011 and 2016. The blood biochemistry, comorbidities, indication for sphincterotomy, severity of bleeding, endoscopic features of bleeder, and type of endoscopic therapy were analyzed. Post-endoscopic sphincterotomy bleeding occurred in 65 (12.6%) patients. Forty-five patients had immediate bleeding and 20 patients had delayed bleeding. The multivariate analysis of risk factors associated with post-endoscopic sphincterotomy bleeding were liver cirrhosis (P = 0.029), end-stage renal disease (P = 0.038), previous antiplatelet drug use (P<0.001), and duodenal ulcer (P = 0.023). The complications of pancreatitis and cholangitis were higher in the bleeding group, with statistical significance. Delayed bleeding occurred within 1 to 7 days (mean, 2.5 days), and 60% (12/20) of the patients received endoscopic evaluation. In the delayed bleeding group, the successful hemostasis rate was 71.4% (5/7), and 65% (13/20) of the patients had ceased bleeding without endoscopic hemostasis therapy. Comparison of different therapeutic modalities showed that cholangitis was higher in patients who received epinephrine spray (P = 0.042) and pancreatitis was higher in patients who received epinephrine injection and electrocoagulation (P = 0.041 and P = 0.039 respectively). Clinically, post-endoscopic sphincterotomy bleeding and further endoscopic hemostasis therapy increase the complication rate of pancreatitis and cholangitis. Realizing the effectiveness of each therapeutic modalities and appropriate management of different levels bleeding are important.	[Lin, Wei-Chen; Lin, Hsaing-Hung; Hung, Chien-Yuan; Shih, Shou-Chuan; Chu, Cheng-Hsin] Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lin, Wei-Chen; Lin, Hsaing-Hung; Hung, Chien-Yuan; Shih, Shou-Chuan; Chu, Cheng-Hsin] Mackay Med Nursing & Management Coll, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management	Lin, WC (corresponding author), Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.; Lin, WC (corresponding author), Mackay Med Nursing & Management Coll, Taipei, Taiwan.	b8801040@gmail.com	Chu, Chu/T-6038-2019					[Anonymous], 2013, CLIN RES HEPATOL GAS, V37, P391; Baron TH, 2000, GASTROINTEST ENDOSC, V52, P662, DOI 10.1067/mge.2000.108621; Ferreira LEVVC, 2007, AM J GASTROENTEROL, V102, P2850, DOI 10.1111/j.1572-0241.2007.01563.x; Freeman Martin L, 2003, Curr Gastroenterol Rep, V5, P145, DOI 10.1007/s11894-003-0084-9; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Rodriguez LAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160046; Hui CK, 2002, ALIMENT PHARM THERAP, V16, P929, DOI 10.1046/j.1365-2036.2002.01251.x; Kim HJ, 1999, ENDOSCOPY, V31, P431; LEUNG JWC, 1995, GASTROINTEST ENDOSC, V42, P550, DOI 10.1016/S0016-5107(95)70009-9; Liu F, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0367-2; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Mosca S, 1999, ENDOSCOPY, V31, P278; Mutignani M, 2010, GASTROINTEST ENDOSC, V71, P856, DOI 10.1016/j.gie.2009.12.024; Paikos D, 2007, PANCREAS, V34, P168, DOI 10.1097/01.mpa.0000236738.62111.15; SAEED M, 1989, GASTROINTEST ENDOSC, V35, P300, DOI 10.1016/S0016-5107(89)72796-6; SANDBLOM P, 1977, ANN SURG, V185, P356, DOI 10.1097/00000658-197703000-00018; Shomei R, 2007, DIGEST ENDOSC, V19, pS60; Valats JC, 2013, GASTROINTEST ENDOSC, V78, P183, DOI 10.1016/j.gie.2013.02.035; Veitch AM, 2016, GUT, V65, P374, DOI 10.1136/gutjnl-2015-311110; Wang YD, 2015, INT J CLIN EXP MED, V8, P5753; Waye JD, 2002, GASTROINTEST ENDOSC, V55, P139, DOI 10.1067/mge.2002.119726; Wilcox CM, 2004, AM J GASTROENTEROL, V99, P244, DOI 10.1111/j.1572-0241.2004.04058.x	23	12	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177449	10.1371/journal.pone.0177449	http://dx.doi.org/10.1371/journal.pone.0177449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545082	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700050
J	Takagi, K				Takagi, Kosuke			A distribution model of functional connectome based on criticality and energy constraints	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; SMALL-WORLD; NEURONAL AVALANCHES; EVOLVING NETWORKS; CONNECTIVITY; DYNAMICS; ARCHITECTURE; FREQUENCY	The analysis of the network structure of the functional connectivity data constructed from fMRI images provides basic information about functions and features of the brain activity. We focus on the two features which are considered as relevant to the brain activity, the criticality and the constraint regarding energy consumptions. Within a wide variety of complex systems, the critical state occurs associated with a phase transition between distinct phases, random one and order one. Although the hypothesis that human brain activity is also in a state of criticality is supported by some experimental results, it still remains controversial. One issue is that experimental distributions exhibit deviations from the power law predicted by the criticality. Based on the assumption that constraints on brain from the biological costs cause these deviations, we derive a distribution model. The evaluation using the information criteria indicates an advantage of this model in fitting to experimental data compared to other representative distribution models, the truncated power law and the power law. Our findings also suggest that the mechanism underlying this model is closely related to the cost effective behavior in human brain with maximizing the network efficiency for the given network cost.	[Takagi, Kosuke] Uwado Shinmachi 5-4, Kawagoe, Saitama, Japan		Takagi, K (corresponding author), Uwado Shinmachi 5-4, Kawagoe, Saitama, Japan.	coutakagi@mse.biglobe.ne.jp						Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; NOEVER DA, 1993, PHYS REV E, V47, P724, DOI 10.1103/PhysRevE.47.724; Ricotta C, 2001, ECOL MODEL, V141, P307, DOI 10.1016/S0304-3800(01)00272-1; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns Olaf, 2002, Complexity, V8, P56, DOI 10.1002/cplx.10047; Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Takagi K, 2010, PHYSICA A, V389, P2143, DOI 10.1016/j.physa.2010.01.034; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xulvi-Brunet R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026118; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	58	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177446	10.1371/journal.pone.0177446	http://dx.doi.org/10.1371/journal.pone.0177446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545048	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700049
J	Kulyte, A; Ehrlund, A; Arner, P; Dahlman, I				Kulyte, Agne; Ehrlund, Anna; Arner, Peter; Dahlman, Ingrid			Global transcriptome profiling identifies KLF15 and SLC25A10 as modifiers of adipocytes insulin sensitivity in obese women	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; DOWN-REGULATION; METABOLICALLY HEALTHY; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; GENE; FAT; LIPOLYSIS; DIFFERENTIATION; ADIPOGENESIS	Although the mechanisms linking obesity to insulin resistance (IR) and type 2 diabetes (T2D) are not entirely understood, it is likely that alterations of adipose tissue function are involved. The aim of this study was to identify new genes controlling insulin sensitivity in adipocytes from obese women with either insulin resistant (OIR) or sensitive (OIS) adipocytes. Insulin sensitivity was first determined by measuring lipogenesis in isolated adipocytes from abdominal subcutaneous white adipose tissue (WAT) in a large observational study. Lipogenesis was measured under conditions where glucose transport was the rate limiting step and reflects in vivo insulin sensitivity. We then performed microarray-based transcriptome profiling on subcutaneous WAT specimen from a subgroup of 9 lean, 21 OIS and 18 obese OIR women. We could identify 432 genes that were differentially expressed between the OIR and OIS group (FDR <= 5%). These genes are enriched in pathways related to glucose and amino acid metabolism, cellular respiration, and insulin signaling, and include genes such as SLC2A4, AKT2, as well as genes coding for enzymes in the mitochondria respiratory chain. Two IR-associated genes, KLF15 encoding a transcription factor and SLC25A10 encoding a dicarboxylate carrier, were selected for functional evaluation in adipocytes differentiated in vitro. Knockdown of KLF15 and SLC25A10 using siRNA inhibited insulin-stimulated lipogenesis in adipocytes. Transcriptome profiling of siRNA-treated cells suggested that KLF15 might control insulin sensitivity by influencing expression of PPARG, PXMP2, AQP7, LPL and genes in the mitochondrial respiratory chain. Knockdown of SLC25A10 had only modest impact on the transcriptome, suggesting that it might directly influence insulin sensitivity in adipocytes independently of transcription due to its important role in fatty acid synthesis. In summary, this study identifies novel genes associated with insulin sensitivity in adipocytes in women independently of obesity. KFL15 and SLC25A10 are inhibitors of insulin-stimulated lipogenesis under conditions when glucose transport is the rate limiting step.	[Kulyte, Agne; Ehrlund, Anna; Arner, Peter; Dahlman, Ingrid] Karolinska Inst, Dept Med H7, Lipid Lab, Stockholm, Sweden	Karolinska Institutet	Dahlman, I (corresponding author), Karolinska Inst, Dept Med H7, Lipid Lab, Stockholm, Sweden.	ingrid.dahlman@ki.se		Arner, Peter/0000-0002-6208-6220; Kulyte, Agne/0000-0001-7745-2767; Dahlman, Ingrid/0000-0003-3819-5977	Swedish Research Council [201601376]; Karolinska Institutet; EU/EFPIA [115372]; Swedish Diabetes fund; Stockholm county council [20150011]; Novo Nordisk Fonden [NNF15OC0015894] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); EU/EFPIA(European Commission); Swedish Diabetes fund; Stockholm county council(Stockholm County Council); Novo Nordisk Fonden(Novo Nordisk Foundation)	The funding sources for this project are: Swedish Research Council (www.vr.se, 2016-01376), Strategic research program in diabetes at Karolinska Institutet (http.//ki.se/en/srp-diabetes/strategic-research-programme-in-diabetes), EU/EFPIA Innovative Medicines Initiative Joint Undertaking (grant number 115372), The Swedish Diabetes fund (https://www.diabetes.se/diabetesfonden/forskning/beviljade-projekt/), Stockholm county council (https://forskningsstod.vmi.se/Ansokan/start.asp, 20150011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508; ARNER P, 1987, AM J PHYSIOL, V253, pE193, DOI 10.1152/ajpendo.1987.253.2.E193; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; BOGARDUS C, 1984, J CLIN INVEST, V73, P800, DOI 10.1172/JCI111274; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; Dahlman I, 2017, AM J PHYSIOL ENDOCRI; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Enomoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083183; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Gao H, 2014, CELL METAB, V19, P981, DOI 10.1016/j.cmet.2014.03.032; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; HIRSCH J, 1968, J LIPID RES, V9, P110; Kang JW, 2008, BIOCHEM BIOPH RES CO, V366, P624, DOI 10.1016/j.bbrc.2007.11.080; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; KOLACZYNSKI JW, 1994, INT J OBESITY, V18, P161; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; Moreno-Navarrete JM, 2014, DIABETOLOGIA, V57, P1957, DOI 10.1007/s00125-014-3298-5; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Medina-Gomez G, 2007, PUBLIC HEALTH NUTR, V10, P1132, DOI 10.1017/S1368980007000614; Mizuarai S, 2005, J BIOL CHEM, V280, P32434, DOI 10.1074/jbc.M503152200; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Nagare T, 2009, BIOCHEM BIOPH RES CO, V379, P98, DOI 10.1016/j.bbrc.2008.12.020; Nilsson E, 2014, DIABETES; Rodbell M, 1974, Methods Enzymol, V31, P103; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryden M, 2016, CELL REP, V16, P2317, DOI 10.1016/j.celrep.2016.07.070; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125; Vapola MH, 2014, DEV BIOL, V391, P66, DOI 10.1016/j.ydbio.2014.03.022; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Xu X, 2013, INT J COMP METH-SING, V10, DOI 10.1142/S0219876213400112; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19661	52	20	21	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178485	10.1371/journal.pone.0178485	http://dx.doi.org/10.1371/journal.pone.0178485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570579	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800061
J	Mallavia, B; Kwaan, N; Marschner, S; Yonemura, S; Looney, MR				Mallavia, Benat; Kwaan, Nicholas; Marschner, Susanne; Yonemura, Susan; Looney, Mark R.			Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; TRANSFUSION; PLATELETS; INACTIVATION; SYSTEM; STORAGE; PLASMA; FUTURE; CELLS; LIGHT	In resource-limited settings and in the military theater, fresh human whole blood is commonly transfused, but infectious risks are a concern. Sophisticated molecular testing for potential infectious agents in the whole blood is often unavailable. To address this unmet need, pathogen reduction technology (PRT) has been developed, and it is an effective approach to inactivate a broad range of pathogens found in human blood. However, studies are needed to determine if it is harmful to blood cells and whether these cells could damage the transfused recipient, including the development of acute lung injury/acute respiratory distress syndrome. In this study, we used a commercial PRT system to treat human whole blood that was then transfused into immunodeficient mice, and the development of acute lung injury was determined. In a model of transfusion-related acute lung injury (TRALI), BALB/c SCID mice developed more robust lung injury when challenged with a MHC Class I monoclonal antibody compared to BALB/c wild-type and NOD/SCID mice. Transfusion of control versus Mirasol PRT-treated whole blood (25% blood volume exchange) into BALB/c SCID mice did not produce lung injury at storage day 1. However, mild lung injury at storage days 14 and 21 was observed without significant differences in lung injury measurements between Mirasol PRT-treated and control groups. The mild storage-dependent acute lung injury correlated with trends for increased levels of cell-free hemoglobin that accumulated in both the control and Mirasol PRT-treated groups. Neutrophil extracellular traps were elevated in the plasma of BALB/c SCID mice in the monoclonal antibody TRALI model, but were not different in mice that received exchange transfusions. In conclusion, exchange transfusion of human whole blood into immunodeficient mice produces mild lung injury that is storage-dependent and not related to pathogen reduction treatment.	[Mallavia, Benat; Kwaan, Nicholas; Looney, Mark R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Marschner, Susanne; Yonemura, Susan] Terumo BCT Inc, Lakewood, CO USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Looney, MR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Looney, MR (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	mark.looney@ucsf.edu		Yonemura, Susan/0000-0002-0121-7987	United States Department of Defense [W81XWH-13-C-0160]	United States Department of Defense(United States Department of Defense)	The study was funded by a United States Department of Defense Joint Warfighter Medical Research Program Award (#W81XWH-13-C-0160) to Terumo BCT, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors SM and SY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Caudrillier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133022; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chatterjee Kabita, 2016, Asian J Transfus Sci, V10, P127, DOI 10.4103/0973-6247.187946; Cookson P, 2012, TRANSFUSION, V52, P983, DOI 10.1111/j.1537-2995.2011.03388.x; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570; Goodrich RP, 2006, TRANSFUS APHER SCI, V35, P5, DOI 10.1016/j.transci.2006.01.007; Heddle NM, 2016, NEW ENGL J MED, V375, P1937, DOI 10.1056/NEJMoa1609014; Hume HA., 2013, TRANSFUSION MED; Ignatova AA, 2016, VOX SANG, V110, P244, DOI 10.1111/vox.12364; Jobes D, 2011, TRANSFUSION, V51, P43, DOI 10.1111/j.1537-2995.2010.02772.x; Kapur R, 2017, BLOOD, V129, P2557, DOI 10.1182/blood-2016-12-758185; Kapur R, 2015, BLOOD, V126, P2747, DOI 10.1182/blood-2015-09-672592; Keil SD, 2015, JOVE-J VIS EXP, V102, P52820, DOI DOI 10.3791/52820; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; McKenzie CGJ, 2014, BLOOD, V123, P3496, DOI 10.1182/blood-2013-11-536755; Nessen SC, 2013, TRANSFUSION, V53, p107S, DOI 10.1111/trf.12044; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC; Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646; Shinohara N, 2015, VOX SANG, V109, P417, DOI 10.1111/vox.12305; Silliman CC, 2005, BLOOD, V105, P2266, DOI 10.1182/blood-2004-07-2929; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Zielinski MD, 2014, SURGERY, V155, P883, DOI 10.1016/j.surg.2014.01.017	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178725	10.1371/journal.pone.0178725	http://dx.doi.org/10.1371/journal.pone.0178725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570672	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800110
J	O'Brien, J; Ottoboni, G; Tessari, A; Setti, A				O'Brien, Jessica; Ottoboni, Giovanni; Tessari, Alessia; Setti, Annalisa			One bout of open skill exercise improves cross-modal perception and immediate memory in healthy older adults who habitually exercise	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AUDIOVISUAL TEMPORAL DISCRIMINATION; ACUTE AEROBIC EXERCISE; INDUCED FLASH ILLUSION; OF-INTEGRATION MODEL; PHYSICAL-ACTIVITY; INDIVIDUAL-DIFFERENCES; WORKING-MEMORY; SHORT-TERM; MULTISENSORY INTEGRATION	One single bout of exercise can be associated with positive effects on cognition, due to physiological changes associated with muscular activity, increased arousal, and training of cognitive skills during exercise. While the positive effects of life-long physical activity on cognitive ageing are well demonstrated, it is not well established whether one bout of exercise is sufficient to register such benefits in older adults. The aim of this study was to test the effect of one bout of exercise on two cognitive processes essential to daily life and known to decline with ageing: audio-visual perception and immediate memory. Fifty-eight older adults took part in a quasi-experimental design study and were divided into three groups based on their habitual activity (open skill exercise (mean age = 69.65, SD = 5.64), closed skill exercise, N = 18, 94% female; sedentary activity-control group, N = 21, 62% female). They were then tested before and after their activity (duration between 60 and 80 minutes). Results showed improvement in sensitivity in audio-visual perception in the open skill group and improvements in one of the measures of immediate memory in both exercise groups, after controlling for baseline differences including global cognition and health. These findings indicate that immediate benefits for cross-modal perception and memory can be obtained after open skill exercise. However, improvements after closed skill exercise may be limited to memory benefits. Perceptual benefits are likely to be associated with arousal, while memory benefits may be due to the training effects provided by task requirements during exercise. The respective role of qualitative and quantitative differences between these activities in terms of immediate cognitive benefits should be further investigated. Importantly, the present results present the first evidence for a modulation of cross-modal perception by exercise, providing a plausible avenue for rehabilitation of cross-modal perception deficits, which are emerging as a significant contributor to functional decline in ageing.	[O'Brien, Jessica; Setti, Annalisa] Univ Coll Cork, Sch Appl Psychol, Cork, Ireland; [Ottoboni, Giovanni; Tessari, Alessia] Bologna Univ, Dept Psychol, Bologna, Italy	University College Cork; University of Bologna	Setti, A (corresponding author), Univ Coll Cork, Sch Appl Psychol, Cork, Ireland.	a.setti@ucc.ie	Tessari, Alessia/K-3457-2013; ottoboni, giovanni/E-3476-2010	Tessari, Alessia/0000-0002-6616-2454; ottoboni, giovanni/0000-0002-7649-6642; Setti, Annalisa/0000-0002-9741-2559; O'Brien, Jessica/0000-0002-6125-4659				Alves CRR, 2014, PERCEPT MOTOR SKILL, V118, P63, DOI 10.2466/22.06.PMS.118k10w4; Audiffren M, 2009, ACUTE EXERCISE PSYCH; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Ballesteros S, 2015, NEUROSCI BIOBEHAV R, V55, P453, DOI 10.1016/j.neubiorev.2015.06.008; Barnett-Cowan M, 2013, MULTISENS RES, V26, P387, DOI 10.1163/22134808-00002421; Bedard G, 2016, EXP BRAIN RES, V234, P331, DOI 10.1007/s00221-015-4466-7; BLUMENTHAL JA, 1989, J GERONTOL, V44, pM147, DOI 10.1093/geronj/44.5.M147; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Chan JS, 2015, CURR ALZHEIMER RES, V12, P61, DOI 10.2174/1567205012666141218124744; Chan YM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00226; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dai CT, 2013, BRAIN COGNITION, V83, P153, DOI 10.1016/j.bandc.2013.07.007; Davey C.P., 1972, AUSTR J SPORTS MED, V4, P25; Davranche K, 2005, J SPORT EXERCISE PSY, V27, P515, DOI 10.1123/jsep.27.4.515; Davranche K, 2004, J SPORT SCI, V22, P419, DOI 10.1080/02640410410001675289; de Boer-Schellekens L, 2014, EXP BRAIN RES, V232, P253, DOI 10.1007/s00221-013-3736-5; Diederich A, 2008, NEUROPSYCHOLOGIA, V46, P2556, DOI 10.1016/j.neuropsychologia.2008.03.026; DUSTMAN RE, 1984, NEUROBIOL AGING, V5, P35, DOI 10.1016/0197-4580(84)90083-6; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Etnier JL, 1997, J SPORT EXERCISE PSY, V19, P249, DOI 10.1123/jsep.19.3.249; Gajewski PD, 2016, EUR REV AGING PHYS A, V13, DOI 10.1186/s11556-016-0161-3; Gobbo S, 2014, ARCH GERONTOL GERIAT, V58, P177, DOI 10.1016/j.archger.2013.10.001; Green D. M., 1966, SIGNAL DETECTION THE, V888, P889; Grimm EK, 2012, J AGING PHYS ACTIV, V20, P64, DOI 10.1123/japa.20.1.64; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Huang CJ, 2014, PSYCHOL SPORT EXERC, V15, P205, DOI 10.1016/j.psychsport.2013.11.005; Humes LE, 2013, ATTEN PERCEPT PSYCHO, V75, P508, DOI 10.3758/s13414-012-0406-9; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Lambourne K, 2010, MED SCI SPORT EXER, V42, P1396, DOI 10.1249/MSS.0b013e3181cbee11; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lindenberger U, 2014, SCIENCE, V346, P572, DOI 10.1126/science.1254403; Mahoney JR, 2014, MULTISENS RES, V27, P17, DOI 10.1163/22134808-00002444; Marigold DS, 2005, J AM GERIATR SOC, V53, P416, DOI 10.1111/j.1532-5415.2005.53158.x; Merriman NA, 2015, COMPUT HUM BEHAV, V45, P192, DOI 10.1016/j.chb.2014.12.017; Molloy DW, QUICK MILD COGNITIVE; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; Netz Y, 2007, INT J SPORTS MED, V28, P82, DOI 10.1055/s-2006-924027; Nowak K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01599; O'Caoimh R, 2012, AGE AGEING, V41, P624, DOI 10.1093/ageing/afs059; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Pesce C., 2009, EXERCISE COGNITIVE F, P211, DOI DOI 10.1002/9780470740668.CH11; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Ratey JJ, 2011, REV NEUROSCI, V22; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; Scherder EJA, 2005, AGING MENT HEALTH, V9, P272, DOI 10.1080/13607860500089930; Schmidt Richard A, 2008, HUMAN KINETICS; Setti A, 2014, NEUROPSYCHOLOGIA, V61, P259, DOI 10.1016/j.neuropsychologia.2014.06.027; Setti A, 2011, NEUROREPORT, V22, P554, DOI 10.1097/WNR.0b013e328348c731; Setti A, 2011, EXP BRAIN RES, V209, P375, DOI 10.1007/s00221-011-2560-z; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Sibley BA, 2007, J SPORT EXERCISE PSY, V29, P783, DOI 10.1123/jsep.29.6.783; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Stapleton J, 2014, EXP BRAIN RES, V232, P423, DOI 10.1007/s00221-013-3750-7; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Themanson JR, 2006, NEUROSCIENCE, V141, P757, DOI 10.1016/j.neuroscience.2006.04.004; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Tranter LJ, 2008, AGING NEUROPSYCHOL C, V15, P184, DOI 10.1080/13825580701322163; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wassink-Vossen S, 2014, J AFFECT DISORDERS, V161, P65, DOI 10.1016/j.jad.2014.03.001; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wechsler D., 2012, WAIS 4 KASIKIRJA; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Zmigrod L, 2016, MULTISENS RES, V29, P679, DOI 10.1163/22134808-00002532	72	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178739	10.1371/journal.pone.0178739	http://dx.doi.org/10.1371/journal.pone.0178739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6HZ	28570704	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800115
J	Amegashie, CP; Gilbert, NM; Peipert, JF; Allsworth, JE; Lewis, WG; Lewis, AL				Amegashie, Courtney P.; Gilbert, Nicole M.; Peipert, Jeffrey F.; Allsworth, Jenifer E.; Lewis, Warren G.; Lewis, Amanda L.			Relationship between nugent score and vaginal epithelial exfoliation	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BACTERIAL VAGINOSIS; GRAM STAIN; RISK; IDENTIFICATION; PREMATURITY; PREGNANCY; VAGINITIS; FLORA; SWABS	Objective Clue cells characteristic of bacterial vaginosis (BV) are thought to arise due to exfoliation of the vaginal epithelium; however, there is little published data connecting total numbers of epithelial cells to markers of BV. The purpose of this study was to enumerate exfoliated epithelial cells (independent of clue cells) and examine the relationship to Nugent score. Study design We conducted a cross-sectional sub-study of the Contraceptive CHOICE Project cohort. Vaginal swabs were used to create vaginal smears for Gram staining and these smears were later scored using the Nugent method, and then two blinded observers used microscopy to enumerate exfoliated epithelial cells. The degree of epithelial cell exfoliation was compared between women diagnosed as BV-negative (Nugent score 0-3), BV-intermediate (Nugent score 4-6), and BV-positive (Nugent score 7-10). BV specimens (Nugent 7-10) were randomly matched to specimens in the two other groups (Nugent low and Nugent intermediate), in order to avoid comparing groups of women with potentially confounding baseline demographics. Results Exfoliated epithelial cell counts were higher in the vaginal smears from BV -positive women compared with BV-negative women. Higher levels of epithelial exfoliation were also evident in BV-intermediate women compared to those with low Nugent scores. After adjustment for clustering introduced by matching, the incidence ratio of increased epithelial cell counts was 2.09 (95% CI 1.50-2.90) for the BV -intermediate women and 1.71 (95% CI 1.23-2.38) for the BV positive women. Conclusion A vaginal epithelial exfoliation phenotype was measured in both Nugent -defined BV -positive and BV-intermediate women. Bacterial vaginosis and intermediate status (Nugent score >3) was associated with significantly more vaginal epithelial exfoliation compared to women with Lactobacillus-dominated microbiotas (Nugent 0-3).	[Amegashie, Courtney P.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA; [Amegashie, Courtney P.; Gilbert, Nicole M.; Lewis, Warren G.; Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA; [Gilbert, Nicole M.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63130 USA; [Gilbert, Nicole M.] Washington Univ, Sch Med, Ctr Reprod Hlth Sci, St Louis, MO 63130 USA; [Peipert, Jeffrey F.] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Allsworth, Jenifer E.] Univ Missouri Kansas City, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO USA; [Lewis, Warren G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL)	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63130 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63130 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019; Peipert, Jeffrey F./ABC-1981-2020; Allsworth, Jenifer/J-2475-2019	Lewis, Warren G/0000-0003-1210-6403; Lewis, Amanda/0000-0001-6195-3030	Susan T. Buffett Foundation; National Institutes of Health [R01AI114635]; Burroughs Wellcome Foundation [1012547]; March of Dimes Foundation; Washington University STAR program; American Heart Association; Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114635] Funding Source: NIH RePORTER	Susan T. Buffett Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); Washington University STAR program; American Heart Association(American Heart Association); Children's Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the Contraceptive CHOICE Project was provided by the Susan T. Buffett Foundation. This work was supported in part by the National Institutes of Health (R01AI114635, to AL and WL), the Burroughs Wellcome Foundation (Preterm Birth Initiative grant #1012547 to AL), and the March of Dimes Foundation (Basil O'Connor Award to AL). Trainees were supported by the Washington University STAR program (CA), the American Heart Association and Children's Discovery Institute (NG). The funders had no role in data collection, analysis, or interpretation.	Albert AYK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135620; Allsworth JE, 2008, SEX TRANSM DIS, V35, P791, DOI 10.1097/OLQ.0b013e3181788301; Allsworth JE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.060; Alnaif B, 2001, J Low Genit Tract Dis, V5, P7, DOI 10.1046/j.1526-0976.2001.51002.x; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; Balkus JE, 2014, SEX TRANSM DIS, V41, P123, DOI 10.1097/OLQ.0000000000000075; BASU J, 1992, AM J OBSTET GYNECOL, V167, P1904, DOI 10.1016/0002-9378(92)91795-C; Brotman RM, 2010, J INFECT DIS, V202, P1907, DOI 10.1086/657320; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; COOK RL, 1989, J INFECT DIS, V160, P490, DOI 10.1093/infdis/160.3.490; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Flynn CA, 1999, J FAM PRACTICE, V48, P885; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Guedou FA, 2014, SEX TRANSM INFECT, V90, P161, DOI 10.1136/sextrans-2012-050896; Guedou FA, 2012, SEX TRANSM INFECT, V88, P545, DOI 10.1136/sextrans-2011-050319; Hellberg D, 2000, INT J STD AIDS, V11, P603, DOI 10.1258/0956462001916461; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Meyn LA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.011; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Peipert JF, 2008, SEX TRANSM DIS, V35, P363, DOI 10.1097/OLQ.0b013e31815e4179; Phillips DM, 2004, CONTRACEPTION, V70, P107, DOI 10.1016/j.contraception.2004.04.008; Phillips DM, 1998, CONTRACEPTION, V57, P341, DOI 10.1016/S0010-7824(98)00040-7; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Pybus V, 1999, MICROBES INFECT, V1, P285, DOI 10.1016/S1286-4579(99)80024-0; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Rogers WH, 1993, REGRESSION STANDARD, P19; Schwebke JR, 1997, SEX TRANSM DIS, V24, P236, DOI 10.1097/00007435-199704000-00009; Secura GM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.017; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	40	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177797	10.1371/journal.pone.0177797	http://dx.doi.org/10.1371/journal.pone.0177797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562623	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700029
J	Andriantsoa, M; Hoibian, S; Autret, A; Gilabert, M; Sarran, A; Niccoli, P; Raoul, JL				Andriantsoa, Maeva; Hoibian, Solene; Autret, Aurelie; Gilabert, Marine; Sarran, Anthony; Niccoli, Patricia; Raoul, Jean-Luc			An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value	PLOS ONE			English	Article							ENDOCRINE TUMORS; F-18-FDG PET; SURVIVAL	Background In our clinical practice we have observed that despite a high hepatic metastatic tumor burden, serum alkaline phosphatase (AP) levels are frequently normal in cases of metastatic neuroendocrine tumor (NET). Patients and methods We retrospectively reviewed the records of patients with grade 1 and 2 NETs with liver metastases but without bone metastases seen at our institution in 2013. In total, 49 patients were included (22 female), with a median age of 60 years (range: 28 to 84 years). The primary tumors were located in the duodenum/pancreas (n = 29), small bowel (n = 17) or colon/rectum (n = 3); 10 cases were grade 1 and 39 grade 2. Hepatic involvement was bulky, with more than 10 lesions in 23 patients and a tumor burden above 10% of the liver volume in 26 patients. Results Serum AP levels were elevated (>= upper limit of normal (ULN)) in 16 patients. In multiparametric analysis, elevated serum AP levels were not associated with the primary site, grade, or number or volume of metastases. In multiparametric analysis, progression-free survival was only correlated with grade (p = 0.010) and AP level (p = 0.017). Conclusions Serum AP levels are frequently normal in liver metastases from NET, even in the event of a major tumor burden, and the serum AP level can be of prognostic value.	[Andriantsoa, Maeva; Hoibian, Solene; Gilabert, Marine; Niccoli, Patricia; Raoul, Jean-Luc] Paoli Calmettes Inst, Dept Med Oncol, Marseille, France; [Autret, Aurelie] Paoli Calmettes Inst, Dept Biostat, Marseille, France; [Sarran, Anthony] Paoli Calmettes Inst, Dept Med Imaging, Marseille, France; [Niccoli, Patricia] Aix Marseille Univ, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Raoul, JL (corresponding author), Paoli Calmettes Inst, Dept Med Oncol, Marseille, France.	raouljl@ipc.unicancer.fr		Raoul, Jean-Luc/0000-0001-6305-8953				Ambrosini V, 2015, J NUCL MED, V56, P1843, DOI 10.2967/jnumed.115.162719; Bahri H, 2014, J NUCL MED, V55, P1786, DOI 10.2967/jnumed.114.144386; Campana D, 2010, J NUCL MED, V51, P353, DOI 10.2967/jnumed.109.066662; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Chou WC, 2014, ANTICANCER RES, V34, P5661; Clancy TE, 2006, DIGEST DIS SCI, V51, P877, DOI 10.1007/s10620-006-9345-4; Durante C, 2009, ENDOCR-RELAT CANCER, V16, P585, DOI 10.1677/ERC-08-0301; Garin E, 2009, J NUCL MED, V50, P858, DOI 10.2967/jnumed.108.057505; Hauck L, 2016, SCAND J GASTROENTERO, V51, P55, DOI 10.3109/00365521.2015.1064994; Lepage C, 2004, GUT, V53, P549, DOI 10.1136/gut.2003.026401; Onesti JK, 2015, J GASTROINTEST SURG; Rindi G, 2007, ENDOCR PATHOL, V18, P145, DOI 10.1007/s12022-007-0020-x; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	13	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177971	10.1371/journal.pone.0177971	http://dx.doi.org/10.1371/journal.pone.0177971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562682	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700037
J	Hutton, JS; Phelan, K; Horowitz-Kraus, T; Dudley, J; Altaye, M; DeWitt, T; Holland, SK				Hutton, John S.; Phelan, Kieran; Horowitz-Kraus, Tzipi; Dudley, Jonathan; Altaye, Mekibib; DeWitt, Thomas; Holland, Scott K.			Story time turbocharger? Child engagement during shared reading and cerebellar activation and connectivity in preschool-age children listening to stories	PLOS ONE			English	Article							EARLY LITERACY SKILLS; LOW-INCOME FAMILIES; NARRATIVE COMPREHENSION; EMERGENT LITERACY; SPOKEN LANGUAGE; CONSENSUS PAPER; SEX-DIFFERENCES; FUNCTIONAL MRI; FMRI; HOME	Expanding behavioral and neurobiological evidence affirms benefits of shared (especially parent-child) reading on cognitive development during early childhood. However, the majority of this evidence involves factors under caregiver control, the influence of those intrinsic to the child, such as interest or engagement in reading, largely indirect or unclear. The cerebellum is increasingly recognized as playing a "smoothing" role in higher-level cognitive processing and learning, via feedback loops with language, limbic and association cortices. We utilized functional MRI to explore the relationship between child engagement during a mother-child reading observation and neural activation and connectivity during a story listening task, in a sample of 4-year old girls. Children exhibiting greater interest and engagement in the narrative showed increased activation in right-sided cerebellar association areas during the task, and greater functional connectivity between this activation cluster and language and executive function areas. Our findings suggest a potential cerebellar "boost" mechanism responsive to child engagement level that may contribute to emergent literacy development during early childhood, and synergy between caregiver and child factors during story sharing.	[Hutton, John S.; Phelan, Kieran; Horowitz-Kraus, Tzipi; DeWitt, Thomas] Cincinnati Childrens Hosp Med Ctr, Div Gen & Community Pediat, Cincinnati, OH 45229 USA; [Hutton, John S.; Horowitz-Kraus, Tzipi; Dudley, Jonathan; DeWitt, Thomas; Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Reading & Literacy Discovery Ctr, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi; Altaye, Mekibib; Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi; Dudley, Jonathan; Altaye, Mekibib; Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Commun Sci Res Ctr, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi] Technion, Fac Educ Sci & Technol, Educ Neuroimaging Ctr, Haifa, Israel; [Altaye, Mekibib; Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Technion Israel Institute of Technology; Cincinnati Children's Hospital Medical Center	Hutton, JS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gen & Community Pediat, Cincinnati, OH 45229 USA.; Hutton, JS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Reading & Literacy Discovery Ctr, Cincinnati, OH 45229 USA.	John1.Hutton@cchmc.org		Dudley, Jonathan/0000-0002-5189-9568	Eunice Kennedy Schriver National Institutes for Child Health and Human Development [1R01HD066115-01A1]; Ruth L Kirschstein National Research Service Award	Eunice Kennedy Schriver National Institutes for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The clinical trial from which children for this study were sampled was supported by grant #1R01HD066115-01A1 from the Eunice Kennedy Schriver National Institutes for Child Health and Human Development (Kieran Phelan, PI). Support for neuroimaging, reading observations and related analyses was provided via a Ruth L Kirschstein National Research Service Award (Hutton) and an Academic Pediatric Association Young Investigator Award for Primary Care Strategies for the Promotion of Early Literacy and School Readiness Supported by Reach Out and Read (Hutton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no financial relationships relevant to this study to disclose.	American Academy of Pediatrics Council on Early Brain and Child Development, 2014, EC MOD HUM HLTH DIS; Anderson R, 1985, BECOMING NATION READ; Baker L, 2001, J SCHOOL PSYCHOL, V39, P415, DOI 10.1016/S0022-4405(01)00082-6; Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Berl MM, 2010, BRAIN LANG, V114, P115, DOI 10.1016/j.bandl.2010.06.002; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Boukrina O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00518; Bracken SS, 2008, EARLY EDUC DEV, V19, P45, DOI 10.1080/10409280701838835; Bradley RH, 2001, CHILD DEV, V72, P1844, DOI 10.1111/1467-8624.t01-1-00382; Brett M, 2001, NEUROIMAGE, V13, pS85; Brissenden J., 2015, J VISION, V15, P232, DOI [10.1167/15.12.232, DOI 10.1167/15.12.232]; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; BUS AG, 1995, REV EDUC RES, V65, P1, DOI 10.3102/00346543065001001; Cancelliere A, 2013, AM J NEURORADIOL, V34, P1443, DOI 10.3174/ajnr.A3350; Cardillo-Lebdeva G, 2009, ANN M SOC DEV BEH PE; Carroll C., 2013, EFFECTS PARENTAL LIT; Cavanaugh C., 2011, CONNECT MODULE 6 DIA; Cree A., 2012, EC SOCIAL COST ILLIT; Davidse NJ, 2011, READ WRIT, V24, P395, DOI 10.1007/s11145-010-9233-3; Dehaene S., 2013, CEREBRUM DANA FORUM, V2013, P7; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Donoghue E, 2014, PEDIATRICS, V134, P404, DOI 10.1542/peds.2014-1384; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Frost SJ, 2009, ANN DYSLEXIA, V59, P78, DOI 10.1007/s11881-009-0024-y; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Gelinas JN, 2014, NEUROIMAGE-CLIN, V6, P296, DOI 10.1016/j.nicl.2014.06.016; Guell X, 2015, CEREBELLUM, V14, P50, DOI 10.1007/s12311-014-0630-z; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heath SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095255; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hoche F, 2015, CEREBELLUM; Hofferth SL, 2004, WORKSH NAT CHILDR ST; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Horowitz-Kraus T, 2015, BRAIN RES, V1629, P54, DOI 10.1016/j.brainres.2015.10.008; Horowitz-Kraus T, 2013, NEUROPSYCHOLOGIA, V51, P2651, DOI 10.1016/j.neuropsychologia.2013.09.002; Hutton JS, 2015, PEDIATRICS, V136, P466, DOI 10.1542/peds.2015-0359; Hutton JS, 2015, PEDIATRICS; Hutton JS, 2016, ASS HOME READ UNPUB; Hutton JS, 2016, SHARED READING QUALI; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Justice LM, 2002, LANG SPEECH HEAR SER, V33, P84, DOI 10.1044/0161-1461(2002/007); Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Koustenis E, 2016, EUR J PAEDIATR NEURO, V20, P25, DOI 10.1016/j.ejpn.2015.11.001; Kuper M, 2016, CEREBELLUM, V15, P322, DOI 10.1007/s12311-015-0703-7; Kuhl PK, 2011, MIND BRAIN EDUC, V5, P128, DOI 10.1111/j.1751-228X.2011.01121.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lanzilotto M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00198; Lara AH, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00173; Leppanen PHT, 2012, NEUROPHYSIOL CLIN, V42, P35, DOI 10.1016/j.neucli.2011.08.005; Lonigan CJ, 1999, J EARLY INTERVENTION, V22, P306, DOI 10.1177/105381519902200406; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; McClelland MM, 2007, DEV PSYCHOL, V43, P947, DOI 10.1037/0012-1649.43.4.947; Monzalvo K, 2013, BRAIN LANG, V127, P356, DOI 10.1016/j.bandl.2013.10.009; [National Center for Education Statistics Sciences. IfE], 2015, SCIENCES; National Early Literacy Panel, 2008, DEV EARL LIT REP NAT; National Household Education Survey, 2012, CHILDR SCH READ SKIL; National Literacy Trust, 2011, LIT STAT NAT; National Scientific Council on the Developing Child, 2008, 5 HARV U CTR DEV CHI; Norton ES, 2015, CURR OPIN NEUROBIOL, V30, P73, DOI 10.1016/j.conb.2014.09.007; PAYNE AC, 1994, EARLY CHILD RES Q, V9, P427, DOI 10.1016/0885-2006(94)90018-3; Plante E, 2006, NEUROPSYCHOLOGIA, V44, P1210, DOI 10.1016/j.neuropsychologia.2005.08.016; Pool JL, 2016, SCREENING READING PR; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rajagopal A, 2014, AM J NEURORADIOL, V35, P2319, DOI 10.3174/ajnr.A4062; Ramey CT, 1998, AM PSYCHOL, V53, P109, DOI 10.1037/0003-066X.53.2.109; SCARBOROUGH HS, 1994, DEV REV, V14, P245, DOI 10.1006/drev.1994.1010; Schmithorst VJ, 2007, NEUROIMAGE, V35, P406, DOI 10.1016/j.neuroimage.2006.11.046; Schmithorst VJ, 2006, NEUROIMAGE, V29, P254, DOI 10.1016/j.neuroimage.2005.07.020; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Snow C.E., 1998, PREVENTING READING D, DOI DOI 10.1002/PITS.10011; Sonnenschein S, 2002, EARLY CHILD RES Q, V17, P318, DOI 10.1016/S0885-2006(02)00167-9; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Swanson E, 2011, J LEARN DISABIL-US, V44, P258, DOI 10.1177/0022219410378444; Szaflarski JP, 2012, NEUROIMAGE, V63, P1188, DOI 10.1016/j.neuroimage.2012.08.049; The Annie E. Casey Foundation, 2012, DOUBL JEOP 3 GRAD RE; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Travis KE, 2015, HUM BRAIN MAPP, V36, P1536, DOI 10.1002/hbm.22721; U.S. Department of Education, 2007, DIAL READ; U.S. Department of Education, 2015, SHAR BOOK READ; Vannest J., 2014, NEUROPEDIATRICS; Vlachos F, 2007, FOLIA PHONIATR LOGO, V59, P177, DOI 10.1159/000102929; Weitzman CC, 2004, PEDIATRICS, V113, P1248, DOI 10.1542/peds.113.5.1248; Whitehurst GJ, 1998, CHILD DEV, V69, P848, DOI 10.2307/1132208; WHITEHURST GJ, 1994, DEV PSYCHOL, V30, P679, DOI 10.1037/0012-1649.30.5.679; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Zuckerman B, 2011, ACAD PEDIATR, V11, P11, DOI 10.1016/j.acap.2010.09.007; Zuckerman B, 2010, CURR OPIN PEDIATR, V22, P539, DOI 10.1097/MOP.0b013e32833a4673	98	28	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5								10.1371/journal.pone.0177398	http://dx.doi.org/10.1371/journal.pone.0177398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562619	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700014
J	Kepplinger, D; Takhar, M; Sasaki, M; Hollander, Z; Smith, D; McManus, B; McMaster, WR; Ng, RT; Freue, GVC				Kepplinger, David; Takhar, Mandeep; Sasaki, Mayu; Hollander, Zsuzsanna; Smith, Derek; McManus, Bruce; McMaster, W. Robert; Ng, Raymond T.; Freue, Gabriela V. Cohen			PGCA: An algorithm to link protein groups created from MS/MS data	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SHOTGUN PROTEOMIC DATA; INFERENCE PROBLEM; NEXT-GENERATION; IDENTIFICATION; PEPTIDES; SPECTRA; MODEL; TOOL	The quantitation of proteins using shotgun proteomics has gained popularity in the last decades, simplifying sample handling procedures, removing extensive protein separation steps and achieving a relatively high throughput readout. The process starts with the digestion of the protein mixture into peptides, which are then separated by liquid chromatography and sequenced by tandem mass spectrometry (MS/MS). At the end of the workflow, recovering the identity of the proteins originally present in the sample is often a difficult and ambiguous process, because more than one protein identifier may match a set of peptides identified from the MS/MS spectra. To address this identification problem, many MS/MS data processing software tools combine all plausible protein identifiers matching a common set of peptides into a protein group. However, this solution introduces new challenges in studies with multiple experimental runs, which can be characterized by three main factors: i) protein groups' identifiers are local, i.e., they vary run to run, ii) the composition of each group may change across runs, and iii) the supporting evidence of proteins within each group may also change across runs. Since in general there is no conclusive evidence about the absence of proteins in the groups, protein groups need to be linked across different runs in subsequent statistical analyses. We propose an algorithm, called Protein Group Code Algorithm (PGCA), to link groups from multiple experimental runs by forming global protein groups from connected local groups. The algorithm is computationally inexpensive and enables the connection and analysis of lists of protein groups across runs needed in biomarkers studies. We illustrate the identification problem and the stability of the PGCA mapping using 65 iTRAQ experimental runs. Further, we use two biomarker studies to show how PGCA enables the discovery of relevant candidate protein group markers with similar but non-identical compositions in different runs.	[Kepplinger, David; Freue, Gabriela V. Cohen] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Takhar, Mandeep; Sasaki, Mayu; Hollander, Zsuzsanna; McManus, Bruce; Ng, Raymond T.] NCE CECR PROOF Ctr Excellence, Vancouver, BC, Canada; [Smith, Derek] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Ng, Raymond T.] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada	University of British Columbia; University of Victoria; University of British Columbia; University of British Columbia	Freue, GVC (corresponding author), Univ British Columbia, Dept Stat, Vancouver, BC, Canada.	gcohen@stat.ubc.ca		Hollander, Zsuzsanna/0000-0003-4889-996X; Kepplinger, David/0000-0002-3776-4819				Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Bradshaw RA, 2006, MOL CELL PROTEOMICS, V5, P787, DOI 10.1074/mcp.E600005-MCP200; Chong PK, 2005, J PROTEOME RES, V4, P1789, DOI 10.1021/pr0501214; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freue GVC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002963; Freue GVC, 2010, MOL CELL PROTEOMICS, V9, P1954, DOI 10.1074/mcp.M110.000554; Hesse AM, 2016, J PROTEOME RES, V15, P3896, DOI 10.1021/acs.jproteome.5b00853; Huang T, 2013, COMPUT BIOL CHEM, V43, P46, DOI 10.1016/j.compbiolchem.2012.12.008; Huang T, 2012, BIOINFORMATICS, V28, P2956, DOI 10.1093/bioinformatics/bts540; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Lam MPY, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9124-y; Langella O, 2017, J PROTEOME RES, V16, P494, DOI 10.1021/acs.jproteome.6b00632; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rost HL, 2016, NAT METHODS, V13, P777, DOI [10.1038/NMETH.3954, 10.1038/nmeth.3954]; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Semanjski M, 2016, EXPERT REV PROTEOMIC, V13, P139, DOI 10.1586/14789450.2016.1132168; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Yang XY, 2004, J PROTEOME RES, V3, P1002, DOI 10.1021/pr049920x	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177569	10.1371/journal.pone.0177569	http://dx.doi.org/10.1371/journal.pone.0177569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562641	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700018
J	Ruta, LL; Lin, YF; Kissen, R; Nicolau, I; Neagoe, AD; Ghenea, S; Bones, AM; Farcasanu, IC				Ruta, Lavinia Liliana; Lin, Ya-Fen; Kissen, Ralph; Nicolau, Ioana; Neagoe, Aurora Daniela; Ghenea, Simona; Bones, Atle M.; Farcasanu, Ileana Cornelia			Anchoring plant metallothioneins to the inner face of the plasma membrane of Saccharomyces cerevisiae cells leads to heavy metal accumulation	PLOS ONE			English	Article							HYPERACCUMULATOR THLASPI-CAERULESCENS; SURFACE-ENGINEERED YEAST; CADMIUM ION; HEXA-HIS; PROTEIN; COPPER; DISPLAY; ARABIDOPSIS; EXPRESSION; GENE	In this study we engineered yeast cells armed for heavy metal accumulation by targeting plant metallothioneins to the inner face of the yeast plasma membrane. Metallothioneins (MTs) are cysteine-rich proteins involved in the buffering of excess metal ions, especially Cu(I), Zn(II) or Cd(II). The cDNAs of seven Arabidopsis thaliana MTs (AtMT1a, AtMT1c, AtMT2a, AtMT2b, AtMT3, AtMT4a and AtMT4b) and four Noccaea caerulescens MTs (NcMT1, NcMT2a, NcMT2b and NcMT3) were each translationally fused to the C-terminus of a myristoylation green fluorescent protein variant (myrGFP) and expressed in Saccharomyces cerevisiae cells. The myrGFP cassette introduced a yeast myristoylation sequence which allowed directional targeting to the cytosolic face of the plasma membrane along with direct monitoring of the intracellular localization of the recombinant protein by fluorescence microscopy. The yeast strains expressing plant MTs were investigated against an array of heavy metals in order to identify strains which exhibit the (hyper)accumulation phenotype without developing toxicity symptoms. Among the transgenic strains which could accumulate Cu(II), Zn(II) or Cd(II), but also non-canonical metal ions, such as Co(II), Mn(II) or Ni(II), myrGFP-NcMT3 qualified as the best candidate for bioremediation applications, thanks to the robust growth accompanied by significant accumulative capacity.	[Ruta, Lavinia Liliana; Nicolau, Ioana; Farcasanu, Ileana Cornelia] Univ Bucharest, Fac Chem, Bucharest, Romania; [Lin, Ya-Fen; Kissen, Ralph; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, Cell Mol Biol & Genom Grp, Trondheim, Norway; [Neagoe, Aurora Daniela] Univ Bucharest, Fac Biol, Bucharest, Romania; [Ghenea, Simona] Romanian Acad, Inst Biochem, Bucharest, Romania	University of Bucharest; Norwegian University of Science & Technology (NTNU); University of Bucharest; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Farcasanu, IC (corresponding author), Univ Bucharest, Fac Chem, Bucharest, Romania.	ileana.farcasanu@chimie.unibuc.ro	RUTA, LAVINIA LILIANA/P-2102-2014; Farcasanu, Ileana/A-1558-2008; Bones, Atle M/C-6202-2014; Neagoe, Aurora Daniela/N-6590-2014; Nicolau, Ioana/Y-6911-2019	RUTA, LAVINIA LILIANA/0000-0001-9287-5485; Farcasanu, Ileana/0000-0002-4901-7896; Bones, Atle M/0000-0003-0544-7437; Neagoe, Aurora Daniela/0000-0003-3930-7133; Ghenea, Simona/0000-0002-5566-0335	Romanian - EEA Research Programme;  [21 SEE/ 30.06.2014]	Romanian - EEA Research Programme; 	The research leading to these results has received funding from the Romanian - EEA Research Programme operated by the Ministry of National Education under the EEA Financial Mechanism 2009-2014 and Project Contract No 21 SEE/ 30.06.2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Peter B. Goldsbrough (Purdue University, USA) for supplying us with Arabidopsis MTs cDNA clones. The research leading to these results has received funding from the Romanian - EEA Research Programme operated by the Ministry of National Education under the EEA Financial Mechanism 2009-2014 and Project Contract No 21 SEE/ 30.06.2014.	Amberg DC., 2005, COLD SPRING HARBOR L; [Anonymous], 1991, Methods Enzymol, V194, P1; Ansarypour Z, 2017, BRAZ J MICROBIOL, pS1517; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradl H. Ed., 2002, HEAVY METALS ENV ORI, V6; BUTT TR, 1984, P NATL ACAD SCI-BIOL, V81, P3332, DOI 10.1073/pnas.81.11.3332; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Freisinger E, 2011, J BIOL INORG CHEM, V16, P1035, DOI 10.1007/s00775-011-0801-z; Gaur N, 2014, ENVIRON SCI-PROC IMP, V16, P180, DOI 10.1039/c3em00491k; Geva P, 2016, ENVIRON SCI POLLUT R, V23, P19613, DOI 10.1007/s11356-016-7157-4; Gillen KM, 1998, J CELL SCI, V111, P3235; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; He ZLL, 2005, J TRACE ELEM MED BIO, V19, P125, DOI 10.1016/j.jtemb.2005.02.010; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jin SM, 2014, J GENET, V93, P709, DOI 10.1007/s12041-014-0430-8; Kambe-Honjoh H, 2000, J GEN APPL MICROBIOL, V46, P113, DOI 10.2323/jgam.46.113; Kotrba P, 2010, APPL ENVIRON MICROB, V76, P2615, DOI 10.1128/AEM.01463-09; Kuroda K, 2006, APPL MICROBIOL BIOT, V70, P458, DOI 10.1007/s00253-005-0093-8; Kuroda K, 2003, APPL MICROBIOL BIOT, V63, P182, DOI 10.1007/s00253-003-1399-z; Kuroda K, 2002, APPL MICROBIOL BIOT, V59, P259, DOI 10.1007/s00253-002-1014-8; Kuroda K, 2001, APPL MICROBIOL BIOT, V57, P697, DOI 10.1007/s002530100813; Kuroda K, 2010, APPL MICROBIOL BIOT, V87, P53, DOI 10.1007/s00253-010-2581-8; Lauer CM, 2008, FEMS MICROBIOL LETT, V285, P79, DOI 10.1111/j.1574-6968.2008.01214.x; Liu Z, 2016, BIORESOURCE TECHNOL, V215, P324, DOI 10.1016/j.biortech.2016.03.132; Machado MD, 2009, J APPL MICROBIOL, V106, P1792, DOI 10.1111/j.1365-2672.2009.04170.x; Machado MD, 2008, BIORESOURCE TECHNOL, V99, P2107, DOI 10.1016/j.biortech.2007.05.047; Mishra GK, 2017, RECENT IN PRESS 0120; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Ofiteru AM, 2012, APPL MICROBIOL BIOT, V94, P425, DOI 10.1007/s00253-011-3784-3; Palacios O, 2011, J BIOL INORG CHEM, V16, P991, DOI 10.1007/s00775-011-0827-2; Roosens NH, 2005, PLANTA, V222, P716, DOI 10.1007/s00425-005-0006-1; Roosens NH, 2004, FEBS LETT, V577, P9, DOI 10.1016/j.febslet.2004.08.084; Ruta L, 2010, APPL MICROBIOL BIOT, V85, P763, DOI 10.1007/s00253-009-2266-3; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Soares EV, 2013, APPL MICROBIOL BIOT, V97, P6667, DOI 10.1007/s00253-013-5063-y; Tomas M, 2015, J INORG BIOCHEM, V148, P35, DOI 10.1016/j.jinorgbio.2015.02.016; Vasak M, 2011, J BIOL INORG CHEM, V16, P975, DOI 10.1007/s00775-011-0832-5; Verma N, 2017, RECENT IN PRESS 0111; Wei QG, 2016, J MICROBIOL BIOTECHN, V26, P846, DOI 10.4014/jmb.1512.12041; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875	45	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178393	10.1371/journal.pone.0178393	http://dx.doi.org/10.1371/journal.pone.0178393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562640	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700058
J	Scott, N; Carrotte, ER; Higgs, P; Stoove, MA; Aitken, CK; Dietze, PM				Scott, Nick; Carrotte, Elise R.; Higgs, Peter; Stoove, Mark A.; Aitken, Campbell K.; Dietze, Paul M.			Longitudinal changes in personal wellbeing in a cohort of people who inject drugs	PLOS ONE			English	Article							QUALITY-OF-LIFE; METHADONE-MAINTENANCE TREATMENT; PSYCHOLOGICAL DISTRESS; MENTAL-HEALTH; HEROIN USERS; TAIWAN; IMPROVEMENT; DRINKING; GENDER	Aims To determine whether the self-reported personal wellbeing of a cohort of people who inject drugs (PWID) changes over time, and to identify longitudinal correlates of change. Methods We used Personal Wellbeing Index (PWI) scores reported between April 2008 and February 2015 by 757 PWID (66% male) enrolled in the Melbourne Injecting Drug Use Cohort Study (2,862 interviews; up to seven follow-up waves). A mixed-effects model was used to identify correlations between changes in temporal variables and changes in individual PWI scores while controlling for demographic variables. Results The cohort's mean PWI score did not significantly differ over time (between 54.4/100 and 56.7/100 across the first four interview waves), and was 25-28% lower than general Australian population scores (76.0/100). However, there were large variations in individuals' PWI scores between interviews. Increased psychological distress, moving into unstable accommodation, reporting intentional overdose in the past 12 months and being the victim of assault in the past six months were associated with declines in PWI scores. Conclusions Participants experienced substantially lower levels of personal wellbeing than the general Australian population, influenced by experiences of psychological distress, assault, overdose and harms related to low socioeconomic status. The results of this study suggest a need to ensure referral to appropriate housing and health support services for PWID.	[Scott, Nick; Carrotte, Elise R.; Higgs, Peter; Stoove, Mark A.; Aitken, Campbell K.; Dietze, Paul M.] Burnet Inst, Melbourne, Vic, Australia; [Scott, Nick; Higgs, Peter; Stoove, Mark A.; Aitken, Campbell K.; Dietze, Paul M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Higgs, Peter] Curtin Univ, Natl Drug Res Inst, Fac Hlth Sci, Melbourne, Australia; [Higgs, Peter] La Trobe Univ, Dept Publ Hlth, Bundoora, Vic, Australia	Burnet Institute; Monash University; Curtin University; La Trobe University	Scott, N (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Scott, N (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	nick.scott@burnet.edu.au	Higgs, Peter/P-7816-2019	Higgs, Peter/0000-0002-5587-5379; Dietze, Paul/0000-0001-7871-6234; Aitken, Campbell/0000-0002-0923-4837; Stoove, Mark/0000-0003-2887-1409	Colonial Foundation Trust; National Health and Medical Research Council (NHMRC) [545891]; Centre for Research Excellence into Injecting Drug Use [APP1001144]; PD(NHMRC Senior ResearchFellowship); PH(Curtin Fellowship); MS(NHMRC Career Development Award); Victorian Operational Infrastructure; Gilead Sciences Inc; Reckitt Benckiser	Colonial Foundation Trust; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre for Research Excellence into Injecting Drug Use; PD(NHMRC Senior ResearchFellowship)(National Health and Medical Research Council (NHMRC) of Australia); PH(Curtin Fellowship); MS(NHMRC Career Development Award)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Operational Infrastructure; Gilead Sciences Inc(Gilead Sciences); Reckitt Benckiser	MIX was funded by The Colonial Foundation Trust and the National Health and Medical Research Council (NHMRC Grant #545891, and the Centre for Research Excellence into Injecting Drug Use, APP1001144). Fellowship funding has been received by PD(NHMRC Senior ResearchFellowship), PH(Curtin Fellowship) and MS(NHMRC Career Development Award).The Burnet Institutereceives valuable support from theVictorian Operational Infrastructure Support Program.PD, MS and PH have received funding from Gilead Sciences Inc for work unrelated to this study.PD has received funding from Reckitt Benckiser for work unrelated to this study. The funders had no role in the study design; in the collection, analysis and interpretation of data;in the writing of the report; and in the decision to submit the article for publication.	Armstrong G, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-151; Aspinall EJ, 2014, INT J DRUG POLICY, V25, P179, DOI 10.1016/j.drugpo.2013.08.005; Baharom N, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-32; Baum MK, 2008, J ADDICT DIS, V27, P37, DOI 10.1300/J069v27n02_05; Bradley C, 2001, LANCET, V357, P7, DOI 10.1016/S0140-6736(00)03562-5; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chou YC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-190; Costenbader EC, 2007, DRUG ALCOHOL DEPEN, V89, P251, DOI 10.1016/j.drugalcdep.2007.01.006; Cummins RA, 2013, MELBOURNE AUSTR CTR; Cummins RA., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/a:1015678915305]; Cummins Robert A, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P413, DOI 10.1586/14737167.4.4.413; Dietze P, 2013, DRUG ALCOHOL DEPEN, V128, P111, DOI 10.1016/j.drugalcdep.2012.08.013; Dietze P, 2010, ADDICTION, V105, P2141, DOI 10.1111/j.1360-0443.2010.03090.x; Domingo-Salvany A, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-145; Fischer JA, 2013, QUAL LIFE RES, V22, P2113, DOI 10.1007/s11136-013-0350-8; Gibbie TM, 2011, MED J AUSTRALIA, V195, pS16; Guo S, J GAMBLING STUDIES, V30, P89; Hides L, 2007, AUST NZ J PSYCHIAT, V41, P166, DOI 10.1080/00048670601109949; International Wellbeing Group, 2013, MEL BOURN AUSTR CTR; Karow A, 2011, SUBST USE MISUSE, V46, P705, DOI 10.3109/10826084.2010.509854; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Locascio JJ, 2011, DEMENT GER COGN D EX, V1, P330, DOI 10.1159/000330228; Mellor D, 2010, SEX ROLES, V63, P672, DOI 10.1007/s11199-010-9813-3; Migliorini C, 2013, J SPINAL CORD MED, V36, P660, DOI 10.1179/2045772313Y.0000000100; Millson P, 2006, EUR ADDICT RES, V12, P74, DOI 10.1159/000090426; Mitchell SG, 2015, J PSYCHOACTIVE DRUGS, V47, P149, DOI 10.1080/02791072.2015.1014948; Preau M, 2007, DRUG ALCOHOL DEPEN, V86, P175, DOI 10.1016/j.drugalcdep.2006.06.012; Psaros C, 2013, J PSYCHOACTIVE DRUGS, V45, P304, DOI 10.1080/02791072.2013.825030; Puigdollers E, 2004, SUBST USE MISUSE, V39, P1353, DOI 10.1081/JA-120039392; Ryan A, 2014, DRUG ALCOHOL REV, V33, P33, DOI 10.1111/dar.12083; Scott N, 2016, DRUG ALCOHOL DEPEN, V168, P140, DOI 10.1016/j.drugalcdep.2016.08.638; Stoove A M, 2006, ADM PROCEDURES MANUA; Surah S, 2013, INT J STD AIDS, V24, P867, DOI 10.1177/0956462413486454; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; Yen YF, 2015, J CHIN MED ASSOC, V78, P292, DOI 10.1016/j.jcma.2015.01.001; Zubaran C, 2009, CURR OPIN PSYCHIATR, V22, P281, DOI 10.1097/YCO.0b013e328328d154	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178474	10.1371/journal.pone.0178474	http://dx.doi.org/10.1371/journal.pone.0178474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562646	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700064
J	EL Hadad, S; Al-Hamdan, H; Linjawi, S				EL Hadad, Sahar; Al-Hamdan, Hesa; Linjawi, Sabah			Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia	PLOS ONE			English	Article							BLOOD-DONORS; HEPATOCELLULAR-CARCINOMA; NUCLEOTIDE-SEQUENCES; LIVER-DISEASE; HCV GENOTYPES; RISK-FACTORS; EPIDEMIOLOGY; SUBTYPES; PREVALENCE; DIVERSITY	Chronic hepatitis C virus (HCV) infection and its progression are major health problems that many countries including Saudi Arabia are facing. Determination of HCV genotypes and subgenotypes is critical for epidemiological and clinical analysis and aids in the determination of the ideal treatment strategy that needs to be followed and the expected therapy response. Although HCV infection has been identified as the second most predominant type of hepatitis in Saudi Arabia, little is known about the molecular epidemiology and genetic variability of HCV circulating in the Jeddah province of Saudi Arabia. The aim of this study was to determine the dominance of various HCV genotypes and subgenotypes circulating in Jeddah using partial sequencing of the NS5B region. To the best of our knowledge, this is the first study of its kind in Saudi Arabia. To characterize HCV genotypes and subgenotypes, serum samples from 56 patients with chronic HCV infection were collected and subjected to partial NS5B gene amplification and sequence analysis. Phylogenetic analysis of the NS5B partial sequences revealed that HCV/1 was the predominant genotype (73%), followed by HCV/4 (24.49%) and HCV/3 (2.04%). Moreover, pairwise analysis also confirmed these results based on the average specific nucleotide distance identity: +/- 0.112, +/- 0.112, and +/- 0.179 for HCV/1, HCV/4, and HCV/3, respectively, without any interference between genotypes. Notably, the phylogenetic tree of the HCV/1 subgenotypes revealed that all the isolates (100%) from the present study belonged to the HCV/1a subgenotype. Our findings also revealed similarities in the nucleotide sequences between HCV circulating in Saudi Arabia and those circulating in countries such as Morocco, Egypt, Canada, India, Pakistan, and France. These results indicated that determination of HCV genotypes and subgenotypes based on partial sequence analysis of the NS5B region is accurate and reliable for HCV subtype determination.	[EL Hadad, Sahar; Al-Hamdan, Hesa; Linjawi, Sabah] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia; [EL Hadad, Sahar] VACSERA, Res Ctr Genet Engn & Bioinformat, Cairo, Egypt	King Abdulaziz University; VACSERA	EL Hadad, S (corresponding author), King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.; EL Hadad, S (corresponding author), VACSERA, Res Ctr Genet Engn & Bioinformat, Cairo, Egypt.	Saharelhadad@hotmail.com	Elhadad, Sahar Ragab/I-8486-2012; Elhadad, sahar/ABA-7241-2021		King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia, research grant [0028-12]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia, research grant	This work was supported by King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia, research grant (Project No.0028-12).; The authors are grateful to the King Abdulaziz city for science and technology (KACST), Jeddah, KSA, for their technical and financial support as well as to Dr. Nezar Redhwan for providing us the laboratory for practical studies.	Abdo AA, 2012, SAUDI J GASTROENTERO, V18, P349, DOI 10.4103/1319-3767.103425; Akbar HO, 2012, HEPATITIS MONTHLY, DOI 10.5812/hepatmon.6178; Al-Ahdal NM, 1997, ANNALS OF SAUDI MEDI, V17, P201; Al-Tawfiq JA, 2008, MED SCI MONITOR, V14, pCR52; AlFaleh FZ, 1995, J VIRAL HEPATITIS, V2, P293, DOI 10.1111/j.1365-2893.1995.tb00044.x; Ali S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-193; Aljarbou AN., 2012, J ANTIVIRALS ANTIRET, V4, P75, DOI DOI 10.4172/JAA.1000049; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; ALTER MJ, 1993, GUT, V34, pS17, DOI 10.1136/gut.34.2_Suppl.S17; Ashfaq Usman Ali, 2011, Genet Vaccines Ther, V9, P7, DOI 10.1186/1479-0556-9-7; Baclig MO, 2010, INT J MOL EPIDEMIOL, V1, P236; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Bdour S, 2002, J MED MICROBIOL, V51, P700, DOI 10.1099/0022-1317-51-8-700; Boriskin YS, 1999, MICROBIOLOGICA, V22, P173; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Cantaloube JF, 2003, J GEN VIROL, V84, P441, DOI 10.1099/vir.0.18642-0; Chao DT, 2011, ALIMENT PHARM THER, V34, P286, DOI 10.1111/j.1365-2036.2011.04714.x; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; DARWISH MA, 1993, AM J TROP MED HYG, V49, P440, DOI 10.4269/ajtmh.1993.49.440; Das B R, 2002, Indian J Pathol Microbiol, V45, P323; El Hadad S, 2018, SAUDI J BIOL SCI, V25, P838, DOI 10.1016/j.sjbs.2016.03.003; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; El-Zayadi AR, 2001, HEPATOL RES, V19, P170; ElHadad S. R., 2013, African Journal of Microbiology Research, V7, P814; Fakeeh M, 1999, AM J TROP MED HYG, V61, P889, DOI 10.4269/ajtmh.1999.61.889; Fakhr AE, 2013, HEPAT MON, V13, P1; Fauquent CM, 2005, VIRUS TAXONOMY VIIIT; Foote BS, 2011, ANN PHARMACOTHER, V45, P1085, DOI 10.1345/aph.1P744; Germer JJ, 2003, J CLIN MICROBIOL, V41, P4855, DOI 10.1128/JCM.41.10.4855-4857.2003; Gul A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1488-0; HIBBS RG, 1993, J INFECT DIS, V168, P789, DOI 10.1093/infdis/168.3.789; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Karkar Ayman, 2007, Hemodial Int, V11, P354, DOI 10.1111/j.1542-4758.2007.00192.x; Khodabandehloo M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22915; Knip DM, 2007, FIELDS VIROLOGY; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Liu CJ, 2002, J MED VIROL, V68, P50, DOI 10.1002/jmv.10169; Lloyd AR, 2006, IMMUNOLOGY AND CELL, V85, P24; Lu L, 2014, J VIROL, V88, P7120, DOI 10.1128/JVI.00414-14; Madani TA, 2009, T ROY SOC TROP MED H, V103, P132, DOI 10.1016/j.trstmh.2008.08.001; Garcia-Montalvo BM, 2008, ANN HEPATOL, V7, P345; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; McElhinney LM, 2011, J GEN VIROL, V92, P2171, DOI 10.1099/vir.0.032748-0; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Memish ZA, 2010, INT J INFECT DIS, V14, pE115, DOI 10.1016/j.ijid.2009.03.027; Miyakawa Y, 2001, J GASTROEN HEPATOL, V16, P711, DOI 10.1046/j.1440-1746.2001.02543.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morice Y, 2001, J GEN VIROL, V82, P1001, DOI 10.1099/0022-1317-82-5-1001; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Ohba K, 1996, FEBS LETT, V378, P232, DOI 10.1016/0014-5793(95)01441-1; Osoba AO, 2002, SAUDI MED J, V23, P7; Osoba AO, 2000, ANN SAUDI MED, V20, P394, DOI 10.5144/0256-4947.2000.394; Pockros Paul J, 2010, Therap Adv Gastroenterol, V3, P191, DOI 10.1177/1756283X10363055; Poustchi H, 2010, Middle East J Dig Dis, V2, P31; Qiu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122082; Ramia S, 2006, INT J INFECT DIS, V10, P272, DOI 10.1016/j.ijid.2005.07.008; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Shobokshi OA, 2003, SAUDI MED J, V24, pS87; Shobokshi OA, 1999, J MED VIROL, V58, P44, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;44::AID-JMV6&gt;3.0.CO;2-U; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; STUYVER L, 1994, P NATL ACAD SCI USA, V91, P10134, DOI 10.1073/pnas.91.21.10134; STUYVER L, 1995, VIRUS RES, V38, P137, DOI 10.1016/0168-1702(95)00052-R; Stuyver L, 1996, J CLIN MICROBIOL, V34, P2259, DOI 10.1128/JCM.34.9.2259-2266.1996; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tokita H, 1996, J GEN VIROL, V77, P293, DOI 10.1099/0022-1317-77-2-293; Tokita H, 1998, J GEN VIROL, V79, P1847, DOI 10.1099/0022-1317-79-8-1847; White PA, 2000, J CLIN MICROBIOL, V38, P477, DOI 10.1128/JCM.38.2.477-482.2000; WHO, 2009, THE GROWING THREATS; YOTSUYANAGI H, 1995, CANCER, V76, P1352, DOI 10.1002/1097-0142(19951015)76:8<1352::AID-CNCR2820760809>3.0.CO;2-M; Zhou S, 2017, JOURNAL OF VIRAL HEP, DOI [10.1111/jvh.12677.1016/j.trstmh.2008.08.001, DOI 10.1111/JVH.12677.1016/J.TRSTMH.2008.08.001]	75	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178225	10.1371/journal.pone.0178225	http://dx.doi.org/10.1371/journal.pone.0178225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552946	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000030
J	Coutinho, CC; Rosa, ID; Teixeira, JDO; Andrade, LR; Costa, ML; Mermelstein, C				Coutinho, Cristiano C.; Rosa, Ivone de Andrade; de Oliveira Teixeira, John Douglas; Andrade, Leonardo R.; Costa, Manoel Luis; Mermelstein, Claudia			Cellular migration, transition and interaction during regeneration of the sponge Hymeniacidon heliophila	PLOS ONE			English	Article							CHONDROSIA-RENIFORMIS NARDO; MARINE SPONGES; MORPHOLOGICAL STRATEGIES; MULTICELLULARITY; DEMOSPONGIAE; PRIMMORPHS; EVOLUTION; RECOVERY; COLLAGEN; GROWTH	Sponges have a high capacity for regeneration and this process improves biomass production in some species, thus contributing to a solution for the biomass supply problem for biotechnological applications. The aim of this work is to characterize the dynamics of cell behavior during the initial stages of sponge regeneration, using bright-field microscopy, confocal microscopy and SEM. We focused on the first 20 h of regeneration, during which blastema formation and epithelium initialization occur. An innovative sponge organotypic culture of the regenerating internal region is described and investigated by confocal microscopy, cell transplantation and vital staining. Cell-cell interaction and cell density are shown to affect events in morphogenesis such as epithelial/mesenchymal and mesenchymal/epithelial transitions as well as distinct cell movements required for regeneration. Extracellular matrix was organized according to the morphogenetic process observed, with evidence for cell-signaling instructions and remodeling. These data and the method of organotypic culture described here provide support for the development of viable sponge biomass production.	[Coutinho, Cristiano C.; Rosa, Ivone de Andrade; de Oliveira Teixeira, John Douglas; Andrade, Leonardo R.; Costa, Manoel Luis; Mermelstein, Claudia] Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Mermelstein, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, UFRJ, Rio De Janeiro, RJ, Brazil.	mermelstein@histo.ufrj.br	Coutinho, Cristiano/V-4693-2018; Costa, Manoel/B-5009-2010; mermelstein, Claudia S/C-1464-2010	Coutinho, Cristiano/0000-0002-7768-1292; Costa, Manoel/0000-0002-9037-0085; mermelstein, Claudia S/0000-0002-8897-8526	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300787/2013-8]; Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/203.185/2015]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Brazilian grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-grant number 300787/2013-8 for CM and Fundagao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant number E-26/203.185/2015 for CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BE, 2015, PEERJ, V3, DOI 10.7717/peerj.820; AYLING AL, 1983, BIOL BULL, V165, P343, DOI 10.2307/1541200; Borisenko IE, 2015, PEERJ, V3, DOI 10.7717/peerj.1211; Boury-Esnault N., 1997, THESAURUS SPONGE MOR; Brooke NM, 2003, CURR OPIN GENET DEV, V13, P599, DOI 10.1016/j.gde.2003.09.002; Chernogor LI, 2011, MAR BIOTECHNOL, V13, P782, DOI 10.1007/s10126-010-9340-9; Custodio MR, 1998, MECH AGEING DEV, V105, P45, DOI 10.1016/S0047-6374(98)00078-5; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Eerkes-Medrano D, 2015, INVERTEBR BIOL, V134, P1, DOI 10.1111/ivb.12072; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009; Granito RN, 2016, J BIOMED MATER RES B, V10, P1; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Hoffmann F, 2003, J BIOTECHNOL, V100, P109, DOI 10.1016/S0168-1656(02)00258-4; Hooper JNA, 2002, SYSTEMA PORIFERA GUI, P721; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kornberg TB, 2014, WIRES DEV BIOL, V3, P445, DOI 10.1002/wdev.151; Lavrov AI, 2014, RUSS J DEV BIOL+, V45, P205, DOI 10.1134/S1062360414040067; Maldonado M, 2004, INVERTEBR BIOL, V123, P1; Muller WEG, 2009, APPL MICROBIOL BIOT, V83, P397, DOI 10.1007/s00253-009-2014-8; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Needham A. E., 1952, REGENERATION WOUND H; Nickel M, 2003, J BIOTECHNOL, V100, P147, DOI 10.1016/S0168-1656(02)00256-0; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807; Pozzolini M, 2012, MAR BIOTECHNOL, V14, P281, DOI 10.1007/s10126-011-9415-2; Ruiz C, 2013, MAR BIOTECHNOL, V15, P571, DOI 10.1007/s10126-013-9510-7; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Simpson T., 1984, CELL BIOL SPONGES; Sipkema D, 2005, BIOTECHNOL BIOENG, V90, P201, DOI 10.1002/bit.20404; Sipkema D, 2003, J BIOTECHNOL, V100, P127, DOI 10.1016/S0168-1656(02)00253-5; Sogabe S, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0042-x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff J, 2013, INTEGR COMP BIOL, V53, P512, DOI 10.1093/icb/ict059; Wulff J, 2010, INTEGR COMP BIOL, V50, P494, DOI 10.1093/icb/icq100; Yin Z, 2015, PNAS, V9, pE1453	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178350	10.1371/journal.pone.0178350	http://dx.doi.org/10.1371/journal.pone.0178350			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542651	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800080
J	Akl, MG; Fawzy, E; Deif, M; Farouk, A; Elshorbagy, AK				Akl, May G.; Fawzy, Eman; Deif, Maha; Farouk, Ayman; Elshorbagy, Amany K.			Perturbed adipose tissue hydrogen peroxide metabolism in centrally obese men: Association with insulin resistance	PLOS ONE			English	Article							TO-HEIGHT RATIO; OXIDATIVE STRESS; WAIST CIRCUMFERENCE; ANTIOXIDANT ENZYMES; GLUCOSE-UPTAKE; FAT; CATALASE; CELLS; RISK; H2O2	Objective Although adipose tissue hydrogen peroxide (H2O2) and its metabolizing enzymes have been linked to obesity and insulin resistance in animal studies, this relation remains to be evaluated in humans. Methods Non-diabetic men (N = 43, median age, 49 (37, 54 y)) undergoing abdominal surgeries were studied. Participants were classified by body mass index (BMI) into normal-weight (N = 19), or overweight/ obese (Ow/Ob; BMI >= 25; N = 24). Centrally obese men were identified by waist-height ratio >= 0.5. H2O2 and activities of superoxide dismutase, catalase and glutathione peroxidase enzymes were assayed in subcutaneous fat samples, and visceral fat (available from N = 33), and their associations with anthropometric parameters, fasting serum lipids, and the homeostasis model of insulin resistance (HOMA-IR) were tested using correlations and multivariate linear regression. Results H2O2 concentrations and catalase activity were increased in visceral fat from Ow/Ob men, compared to normal-weight subjects (+ 32%, P = 0.038 and + 51%, P = 0.043 respectively). Centrally obese subjects had > 2-fold higher superoxide dismutase activity (P = 0.005), 46% higher H2O2 (P = 0.028), and 89% higher catalase activity (P = 0.009) in visceral fat, compared to lean subjects. Central obesity did not alter these markers in subcutaneous fat, apart from a 50% increase in catalase, and did not affect glutathione peroxidase in either fat depot. H2O2 in visceral fat positively correlated with insulin resistance (r = 0.40, P = 0.032). Catalase activity in visceral fat was an independent determinant of HOMA-IR, explaining similar to 18% of the variance (ss = 0.42, P = 0.016), after adjustment for age and BMI. Conclusion These findings suggest that adipose tissue catalase shows compensatory up-regulation in response to obesity-induced H2O2 accumulation, and that perturbed H2O2 metabolism in visceral fat is linked to insulin resistance in obese humans.	[Akl, May G.; Fawzy, Eman; Deif, Maha; Elshorbagy, Amany K.] Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt; [Farouk, Ayman] Univ Alexandria, Med Res Inst, Dept Clin & Expt Surg, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	Elshorbagy, AK (corresponding author), Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt.	amany.elshorbagy@alexmed.edu.eg		Elshorbagy, Amany/0000-0002-8624-860X; Farouk, Ahmed/0000-0002-8122-4633	Egyptian Science and Technology Development Fund [6009]; Egyptian Science and Technology Development Fund (STDF) [6009]	Egyptian Science and Technology Development Fund(Science and Technology Development Fund (STDF)); Egyptian Science and Technology Development Fund (STDF)(Science and Technology Development Fund (STDF))	The study received funding from the Egyptian Science and Technology Development Fund (grant no. 6009, to AE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof Doaa Ghareeb for valuable discussions around the study, and to Ms Hanaa Soliman for expert assistance with the biochemical assays. The study has received funding from the Egyptian Science and Technology Development Fund (STDF; Grant 6009 to AE).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asayama K, 2001, FREE RADICAL RES, V34, P337, DOI 10.1080/10715760100300291; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159; Bednarek-Tupikowska G, 2006, CLIN ENDOCRINOL, V64, P463, DOI 10.1111/j.1365-2265.2006.02494.x; Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bouwman FG, 2014, OBESITY, V22, P819, DOI 10.1002/oby.20359; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; CIARALDI TP, 1982, J CELL PHYSIOL, V110, P323, DOI 10.1002/jcp.1041100318; de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200; Ding HW, 2016, BIOCHEM BIOPH RES CO, V478, P798, DOI 10.1016/j.bbrc.2016.08.028; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Fernandez-Real JM, 2010, OBESITY, V18, P482, DOI 10.1038/oby.2009.266; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; FURUKAWA S, 2004, J CLIN INVEST, V114, P1752, DOI [DOI 10.1172/JCI21625, DOI 10.1172/JCI200421625, 10.1172/JCI21625]; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Goth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4; Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Kesavulu MM, 2000, DIABETES METAB, V26, P387; Khoury M, 2013, J AM COLL CARDIOL, V62, P742, DOI 10.1016/j.jacc.2013.01.026; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kojima T, 2010, APOPTOSIS, V15, P83, DOI 10.1007/s10495-009-0415-x; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014; Lijnen HR, 2012, THROMB RES, V129, P74, DOI 10.1016/j.thromres.2011.05.023; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park YS, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8675905; Parker L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00411; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Ruperez AI, 2013, ANTIOXID REDOX SIGN, V19, P1970, DOI 10.1089/ars.2013.5386; Saiki R, 2007, J PHARMACOL SCI, V105, P157, DOI 10.1254/jphs.FP0070619; Serviddio G, 2002, J CLIN ENDOCR METAB, V87, P2843, DOI 10.1210/jc.87.6.2843; Shin MJ, 2006, CLIN CHIM ACTA, V365, P200, DOI 10.1016/j.cca.2005.08.019; Sozmen B, 1999, CLIN BIOCHEM, V32, P423, DOI 10.1016/S0009-9120(99)00034-X; Sozmen EY, 2001, ARCH MED RES, V32, P283, DOI 10.1016/S0188-4409(01)00285-5; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Wakabayashi I, 2013, METAB SYNDR RELAT D, V11, P189, DOI 10.1089/met.2012.0131	52	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177268	10.1371/journal.pone.0177268	http://dx.doi.org/10.1371/journal.pone.0177268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545081	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400033
J	Li, B; Lin, R; Liu, W; Chen, JY; Liu, WJ; Cheng, K; Pallan, M; Adab, P; Jones, L				Li, Bai; Lin, Rong; Liu, Wei; Chen, Jingyi; Liu, Weijia; Cheng, KarKeung; Pallan, Miranda; Adab, Peymane; Jones, Laura			Differences in perceived causes of childhood obesity between migrant and local communities in China: A qualitative study	PLOS ONE			English	Article							CHILDRENS PHYSICAL-ACTIVITY; OVERWEIGHT; CARE; BEHAVIORS; HEALTH	In developing countries, obesity traditionally affects more affluent children, butis spreading to a wider social group. Understanding the perceivedcontributors can provide valuable insights to plan preventive interventions. We exploreddifferences in the perceived causes of childhood obesity between local and migrant communities in a major Chinese city. We conducted 20 focus groups (137 parents, grandparents, school teachers) and 11semi-structured interviews with school Principals from migrant and local communities in Guangzhou. Data were transcribed and analysed using a thematic approach. We found that Lack of influence from grandparents, who were perceived to promote obesogenic behaviorin local children, fewer opportunities for unhealthy snacking and less pressure for academic attainment leading to moreactive play were interpreted as potential "protective" factors among migrant children. Nevertheless, two perceived causes of obesity were more pronounced in migrant than local children: lack of parental monitoring after-school andunsafe neighborhoods limiting physical-activity. Two barriers that restricted child physical activity were only found in the migrant community: limited home space, and cultural differences, inhabitinginteractive play with local children. Future interventions should consider uniquedeterminants of obesity in children from different social backgrounds, with tailored strategies to prevent further rise of the epidemic.	[Li, Bai; Cheng, KarKeung; Pallan, Miranda; Adab, Peymane; Jones, Laura] Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Lin, Rong; Liu, Wei; Liu, Weijia] Guangzhou Ctr Dis Control & Prevent, Fac Sch Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Jingyi] Guangzhou Hlth Care Promot Ctr, Res Off Hlth Educ, Primary Sch, Guangzhou, Guangdong, Peoples R China; [Chen, Jingyi] Guangzhou Hlth Care Promot Ctr, Res Off Hlth Educ, Middle Sch, Guangzhou, Guangdong, Peoples R China	University of Birmingham	Li, B (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Liu, WJ (corresponding author), Guangzhou Ctr Dis Control & Prevent, Fac Sch Hlth, Guangzhou, Guangdong, Peoples R China.	b.li.3@bham.ac.uk; liuweijia888@126.com	Pallan, Miranda/AAD-7795-2020; Cheng, Kar/AAL-8899-2021; Jones, Laura/AAY-6159-2020; Adab, Peymane/ABC-9651-2021	Pallan, Miranda/0000-0002-2868-4892; Cheng, Kar/0000-0002-1516-1857; Jones, Laura/0000-0002-4018-3855; Adab, Peymane/0000-0001-9087-3945; Li, Bai/0000-0003-2706-9799	Guangzhou Medical Foundation [20131A031001]	Guangzhou Medical Foundation	The study was funded by the Guangzhou Medical Foundation (20131A031001).	[Anonymous], 2014, 12TH INTERNATIONAL C; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bodvarsson O, 2009, VAN DEN BERG H THE E; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bureau BS, 2005, BEIJING STATISTICS B; China(CNBS) NBOSO, COMMUNIQUE A ON MAJO; Currie J, 2010, AM ECON J-ECON POLIC, V2, P32, DOI 10.1257/pol.2.3.32; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; de Brauw A, 2011, FOOD POLICY, V36, P88, DOI 10.1016/j.foodpol.2010.08.001; Du S, 2009, PUBLIC HEALTH NUTR, V5, P169; Federation CWs, 2008, NATIONAL SURVEY OF L; Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290; Galvez MP, 2010, CURR OPIN PEDIATR, V22, P202, DOI 10.1097/MOP.0b013e328336eb6f; Geoffroy MC, 2013, J PEDIATR-US, V162, P753, DOI 10.1016/j.jpeds.2012.09.026; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P1, DOI 10.3967/0895-3988.2013.01.001; Ji Y, 2012, POPULATION AND DEVEL, V18; Jia ZB, 2010, QUAL LIFE RES, V19, P775, DOI 10.1007/s11136-010-9638-0; Li B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0251-z; Li B, 2014, INT J BEHAV MED, V21, P700, DOI 10.1007/s12529-013-9333-y; Lin BN, 2013, MED SOC, V26; Liu KM, 2007, CHIN ECON, V40, P12, DOI 10.2753/CES1097-1475400301; Liu WJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3171-1; Luo JY, 2008, PUBLIC HEALTH REP, V123, P382; Maher EJ, 2008, PEDIATRICS, V122, P322, DOI 10.1542/peds.2007-2233; Maitland C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-99; Maturo CC, 2013, AM J PUBLIC HEALTH, V103, pE23, DOI 10.2105/AJPH.2013.301366; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; O'Reilly M, 2013, QUAL RES, V13, P190, DOI 10.1177/1468794112446106; Pbhsksmas J., 2001, NUTR REV, V59; Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; Pearce M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-45; Public Health England, OBESITY AND THE ENVI; Smith AL, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0246-9; Sun HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105469; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Wang LJ, 2011, ASIA PAC J CLIN NUTR, V20, P624; WHO, 2000, TECHNICAL REPORT, V894; WHO, 2015, DRAFT FINAL REPORT O; WHO, 2003, REPORT OF A JOINT WH, V916; Xu HL, 2015, J OBES, V2015, DOI 10.1155/2015/546925; Zhao KF, 2009, ACTA PAEDIATR, V98, P1483, DOI 10.1111/j.1651-2227.2009.01346.x	41	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177505	10.1371/journal.pone.0177505	http://dx.doi.org/10.1371/journal.pone.0177505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28545110	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700052
J	Ly, AT; Noto, JP; Walwyn, OL; Tanz, RR; Shulman, ST; Kabat, W; Bessen, DE				Ly, Anhphan T.; Noto, John P.; Walwyn, Odaelys L.; Tanz, Robert R.; Shulman, Stanford T.; Kabat, William; Bessen, Debra E.			Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease	PLOS ONE			English	Article							ACUTE RHEUMATIC-FEVER; CYSTEINE PROTEASE; VIRULENCE FACTORS; TISSUE TROPISM; UNITED-STATES; HEART-DISEASE; M PROTEINS; EMM TYPES; INFECTIONS; PYOGENES	The secreted cysteine proteinase SpeB is an important virulence factor of group A streptococci (GAS), whereby SpeB activity varies widely among strains. To establish the degree to which SpeB activity correlates with disease, GAS organisms were recovered from patients with pharyngitis, impetigo, invasive disease or acute rheumatic fever (ARF), and selected for analysis using rigorous sampling criteria; > 300 GAS isolates were tested for SpeB activity by casein digestion assays, and each GAS isolate was scored as a SpeB-producer or non-producer. Highly significant statistical differences (p < 0.01) in SpeB production are observed between GAS recovered from patients with ARF (41.5% SpeB-non-producers) compared to pharyngitis (20.5%), invasive disease (16.7%), and impetigo (5.5%). SpeB activity differences between pharyngitis and impetigo isolates are also significant, whereas pharyngitis versus invasive isolates show no significant difference. The disproportionately greater number of SpeB-non-producers among ARF-associated isolates may indicate an altered transcriptional program for many rheumatogenic strains and/or a protective role for SpeB in GAS-triggered autoimmunity.	[Ly, Anhphan T.; Noto, John P.; Walwyn, Odaelys L.; Bessen, Debra E.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Tanz, Robert R.; Shulman, Stanford T.; Kabat, William] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL USA; [Tanz, Robert R.; Shulman, Stanford T.; Kabat, William] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA	New York Medical College; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago	Bessen, DE (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	debra_bessen@nymc.edu			NIH [AI065572, AI117088]; The National Institutes of Health [AI065572, AI117088]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH AI065572 and AI117088 (www.nih.gov) to D.E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the many investigators who have provided bacterial strains over past years. This work was supported by The National Institutes of Health (AI065572 and AI117088, to D.E.B.).	Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; Bessen DE, 1996, J INFECT DIS, V173, P896, DOI 10.1093/infdis/173.4.896; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE., 2016, STREPTOCOCCUS PYOGEN; Bessen DE, 2016, CURR OPIN INFECT DIS, V29, P295, DOI 10.1097/QCO.0000000000000262; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; BISNO AL, 1977, J INFECT DIS, V136, P278, DOI 10.1093/infdis/136.2.278; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1996, MED J AUSTRALIA, V164, P146, DOI 10.5694/j.1326-5377.1996.tb122012.x; Carroll RK, EPIDEMICS, V3, P159; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2012, CURR OPIN RHEUMATOL, V24, P408, DOI 10.1097/BOR.0b013e32835461d3; Fiorentino TR, 1997, J INFECT DIS, V176, P177, DOI 10.1086/514020; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hauknes HA, 2002, J INFECT DIS, V185, P915, DOI 10.1086/339407; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kuttner AG, 1941, J CLIN INVEST, V20, P273, DOI 10.1172/JCI101220; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Lynskey NN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005137; McGregor KF, 2004, J INFECT DIS, V189, P717, DOI 10.1086/381452; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2015, INFECT IMMUN, V83, P4750, DOI 10.1128/IAI.00989-15; Olsen RJ, 2010, P NATL ACAD SCI USA, V107, P888, DOI 10.1073/pnas.0911811107; POTTER EV, 1978, J PEDIATR-US, V92, P325, DOI 10.1016/S0022-3476(78)80036-5; Quinn A, 2001, INFECT IMMUN, V69, P4072, DOI 10.1128/IAI.69.6.4072-4078.2001; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Shulman ST, 2006, CLIN INFECT DIS, V42, P441, DOI 10.1086/499812; Shulman ST, 2004, CLIN INFECT DIS, V39, P325, DOI 10.1086/421949; Shulman ST, 2014, CLIN INFECT DIS, V59, P1651, DOI 10.1093/cid/ciu649; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; STOLLERMAN GH, 1991, CLIN IMMUNOL IMMUNOP, V61, P131, DOI 10.1016/S0090-1229(05)80019-4; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Veasy LG, 2004, PEDIATRICS, V113, pE168, DOI 10.1542/peds.113.3.e168; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; WANNAMAKER LW, 1970, NEW ENGL J MED, V282, P23, DOI 10.1056/NEJM197001082820206; Williamson DA, 2015, J CLIN MICROBIOL, V53, P3618, DOI 10.1128/JCM.02129-15	53	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177784	10.1371/journal.pone.0177784	http://dx.doi.org/10.1371/journal.pone.0177784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545045	gold, Green Published			2022-12-26	WOS:000401487700075
J	Vazquez-Gomez, M; Garcia-Contreras, C; Torres-Rovira, L; Pesantez, JL; Gonzalez-Anover, P; Gomez-Fidalgo, E; Sanchez-Sanchez, R; Ovilo, C; Isabel, B; Astiz, S; Gonzalez-Bulnes, A				Vazquez-Gomez, Marta; Garcia-Contreras, Consolacion; Torres-Rovira, Laura; Luis Pesantez, Jose; Gonzalez-Anover, Pedro; Gomez-Fidalgo, Ernesto; Sanchez-Sanchez, Raul; Ovilo, Cristina; Isabel, Beatriz; Astiz, Susana; Gonzalez-Bulnes, Antonio			Polyphenols and IUGR pregnancies: Maternal hydroxytyrosol supplementation improves prenatal and early-postnatal growth and metabolism of the offspring	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; OXIDATIVE STRESS; ANIMAL-MODELS; SWINE; RESTRICTION; RETARDATION; PIGS; HYPOXIA; SHEEP; CONSEQUENCES	Hydroxytyrosol is a polyphenol with antioxidant, metabolism-regulatory, anti-inflammatory and immuno-modulatory properties. The present study aimed to determine whether supplementing the maternal diet with hydroxytyrosol during pregnancy can improve pre- and early post-natal developmental patterns and metabolic traits of the offspring. Experiment was performed in Iberian sows fed a restricted diet in order to increase the risk of IUGR. Ten sows were treated daily with 1.5 mg of hydroxytyrosol per kg of feed between Day 35 of pregnancy (30% of total gestational period) until delivery whilst 10 animals were left untreated as controls. Number and weight of offspring were assessed at birth, on post-natal Day 15 and at weaning (25 days-old). At weaning, body composition and plasma indexes of glucose and lipids were measured. Treatment with hydroxytyrosol was associated with higher mean birth weight, lower incidence of piglets with low birth weight. Afterwards, during the lactation period, piglets in the treated group showed a higher body-weight than control piglets; such effects were even stronger in the most prolific litters. These results suggest that maternal supplementation with hydroxytyrosol may improve pre- and early post-natal development of offspring in pregnancies at risk of IUGR.	[Vazquez-Gomez, Marta; Gonzalez-Anover, Pedro; Isabel, Beatriz] UCM, Fac Vet Sci, Madrid, Spain; [Garcia-Contreras, Consolacion; Torres-Rovira, Laura; Luis Pesantez, Jose; Gomez-Fidalgo, Ernesto; Sanchez-Sanchez, Raul; Ovilo, Cristina; Astiz, Susana; Gonzalez-Bulnes, Antonio] SGIT INIA, Madrid, Spain	Complutense University of Madrid	Gonzalez-Bulnes, A (corresponding author), SGIT INIA, Madrid, Spain.	bulnes@inia.es	Garcia Contreras, Consolacion/AAX-2057-2021; Garcia-Contreras, Consolacion/GSE-0766-2022; Vázquez-Gómez, Marta/L-7054-2014; Gonzalez-Bulnes, Antonio/K-7691-2015; Ovilo, Cristina/N-9931-2014; Sánchez, Raúl Sánchez/M-8694-2019; Astiz, Susana/AAN-8769-2021	Garcia-Contreras, Consolacion/0000-0003-4624-2585; Vázquez-Gómez, Marta/0000-0002-8916-2086; Gonzalez-Bulnes, Antonio/0000-0002-0917-4475; Ovilo, Cristina/0000-0002-5738-8435; Sánchez, Raúl Sánchez/0000-0002-2987-5906; Torres-Rovira, Laura/0000-0003-1467-7533	Ministry of Economy and Competitiveness - FEDER [AGL2013-48121-C3-0-R]	Ministry of Economy and Competitiveness - FEDER	The experimental work was supported by funds from the Ministry of Economy and Competitiveness (project AGL2013-48121-C3-0-R), co-funded by FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2006, J NUTR, V136, P2213, DOI 10.1093/jn/136.8.2213; Ashworth CJ, 2001, J REP FER S, P233; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biri A, 2007, GYNECOL OBSTET INVES, V64, P187, DOI 10.1159/000106488; Bulotta S, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0219-9; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Chen BS, 2012, AM J PHYSIOL-ENDOC M, V302, pE1142, DOI 10.1152/ajpendo.00003.2012; Close W.H., 2003, NUTRIENT REQUIREMENT; Dong L, 2014, J HISTOCHEM CYTOCHEM, V62, P510, DOI 10.1369/0022155414532655; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Gondret F, 2006, J ANIM SCI, V84, P93, DOI 10.2527/2006.84193x; Gonzalez-Bulnes A, 2016, THERIOGENOLOGY, V86, P110, DOI 10.1016/j.theriogenology.2016.03.024; Gonzalez-Bulnes A, 2012, REPRODUCTION, V144, P269, DOI 10.1530/REP-12-0105; Gonzalez-Bulnes A, 2016, CURR PHARM BIOTECHNO, V17, P848, DOI 10.2174/1389201017666160519111529; Gonzalez-Bulnes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142158; Granados-Principal S, 2010, NUTR REV, V68, P191, DOI 10.1111/j.1753-4887.2010.00278.x; Gupta Piyush, 2004, BMC Pediatr, V4, P14, DOI 10.1186/1471-2431-4-14; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hu T, 2014, J AGR FOOD CHEM, V62, P1449, DOI 10.1021/jf405820v; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850; Jauniaux E, 2016, J GYNECOL OBST BIO R, V45, P775, DOI 10.1016/j.jgyn.2016.02.012; Jones ML, 2014, REPRODUCTION, V147, pR143, DOI 10.1530/REP-13-0376; Kamath U, 2006, INDIAN J CLIN BIOCHE, V21, P111, DOI 10.1007/BF02913077; Kridli RT, 2016, THERIOGENOLOGY, V85, P135, DOI 10.1016/j.theriogenology.2015.08.001; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; Lin Yuan, 2009, Acta Nutrimenta Sinica, V31, P271; Lockyer S, 2016, EUROPEAN J NUTR, P1; Ly C, 2014, HUMAN REPROD UPDATE; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Parkinson L, 2016, MOLECULES, V21, DOI 10.3390/molecules21121734; Parraguez VH, 2013, REPROD FERT DEVELOP, V25, P639, DOI 10.1071/RD12020; Parraguez VH, 2011, REPROD FERT DEVELOP, V23, P285, DOI 10.1071/RD10016; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; POWELL SE, 1980, J ANIM SCI, V50, P860, DOI 10.2527/jas1980.505860x; Prior RL, 2007, J AM COLL NUTR, V26, P170, DOI 10.1080/07315724.2007.10719599; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2012, J ANIM SCI, V90, P184, DOI 10.2527/jas.2011-4234; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; Rigacci S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060843; Ross MG, 2013, CLIN OBSTET GYNECOL, V56, P529, DOI 10.1097/GRF.0b013e318299c39d; Suarez M. V., 2002, Archivos de Zootecnia, V51, P245; Thakor AS, 2015, J PINEAL RES, V59, P80, DOI 10.1111/jpi.12242; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; van der Lende T, 2001, J REP FER S, P247; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010; Zielinsky P, 2013, BIRTH DEFECTS RES C, V99, P256, DOI 10.1002/bdrc.21051	50	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177593	10.1371/journal.pone.0177593	http://dx.doi.org/10.1371/journal.pone.0177593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545153	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700056
J	Sato, M; Liebschner, D; Yamada, Y; Matsugaki, N; Arakawa, T; Wills, SS; Hattie, M; Stubbs, KA; Ito, T; Senda, T; Ashida, H; Fushinobu, S				Sato, Mayo; Liebschner, Dorothee; Yamada, Yusuke; Matsugaki, Naohiro; Arakawa, Takatoshi; Wills, Siobhan S.; Hattie, Mitchell; Stubbs, Keith A.; Ito, Tasuku; Senda, Toshiya; Ashida, Hisashi; Fushinobu, Shinya			The first crystal structure of a family 129 glycoside hydrolase from a probiotic bacterium reveals critical residues and metal cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASE; CARBOHYDRATE-ACTIVE ENZYMES; HUMAN-MILK OLIGOSACCHARIDES; GUT MICROBIOTA; BIFIDOBACTERIUM-BIFIDUM; L-ARABINOFURANOSIDASE; MUCIN DEGRADATION; MOLECULAR-CLONING; INSIGHTS; COMPLEX	The alpha-N-acetylgalactosaminidase from the probiotic bacterium Bifidobacterium bifidum (NagBb) belongs to the glycoside hydrolase family 129 and hydrolyzes the glycosidic bond of Tnantigen (GalNAc alpha 1-Ser/Thr). NagBb is involved in assimilation of O-glycans on mucin glycoproteins by B. bifidum in the human gastrointestinal tract, but its catalytic mechanism has remained elusive because of a lack of sequence homology around putative catalytic residues and of other structural information. Here we report the X-ray crystal structure of NagBb, representing the first GH129 family structure, solved by the single-wavelength anomalous dispersion method based on sulfur atoms of the native protein. We determined ligand-free, GalNAc, and inhibitor complex forms of NagBb and found that Asp-435 and Glu-478 are located in the catalytic domain at appropriate positions for direct nucleophilic attack at the anomeric carbon and proton donation for the glycosidic bond oxygen, respectively. A highly conserved Asp-330 forms a hydrogen bond with the O4 hydroxyl of GalNAc in the -1 subsite, and Trp-398 provides a stacking platform for the GalNAc pyranose ring. Interestingly, a metal ion, presumably Ca2+, is involved in the recognition of the GalNAc N-acetyl group. Mutations at Asp-435, Glu-478, Asp-330, and Trp-398 and residues involved in metal coordination (including an all-Ala quadruple mutant) significantly reduced the activity, indicating that these residues and the metal ion play important roles in substrate recognition and catalysis. Interestingly, NagBb exhibited some structural similarities to the GH101 endo-alpha-N-acetylgalactosaminidases, but several critical differences in substrate recognition and reaction mechanism account for the different activities of these two enzymes.	[Sato, Mayo; Arakawa, Takatoshi; Ito, Tasuku; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Liebschner, Dorothee; Yamada, Yusuke; Matsugaki, Naohiro; Senda, Toshiya] High Energy Accelerator Res Org, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan; [Wills, Siobhan S.; Hattie, Mitchell; Stubbs, Keith A.] Univ Western Australia, Sch Mol Sci, Crawley, WA 6009, Australia; [Ashida, Hisashi] Kindai Univ, Fac Biol Oriented Sci & Technol, 930 Nishimitani, Kinokawa, Wakayama 6496493, Japan; [Liebschner, Dorothee] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Ito, Tasuku] Yamada Apiculture Ctr Inc, 194 Ichiba, Kagamino, Okayama 7080393, Japan	University of Tokyo; High Energy Accelerator Research Organization (KEK); University of Western Australia; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Stubbs, Keith/H-5909-2014; Arakawa, Takatoshi/K-9739-2013; Ashida, Hisashi/HCI-0293-2022; Fushinobu, Shinya/E-4987-2011; Liebschner, Dorothee/AAH-2189-2019	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435; Senda, Toshiya/0000-0002-5153-928X; Yamada, Yusuke/0000-0002-2651-4005; Stubbs, Keith/0000-0001-6899-402X; Matsugaki, Naohiro/0000-0001-9640-1949; Ashida, Hisashi/0000-0001-5844-4075	JSPS-KAKENHI [15H02443, 26660083, 15K07448]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant [25010A]; Australian Postgraduate Awards from the University of Western Australia; Bruce and Betty Green scholarship; Jean Rogerson postgraduate scholarship; Australian Research Council; Japan Agency for Medical Research and Development;  [16J03683]	JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant; Australian Postgraduate Awards from the University of Western Australia; Bruce and Betty Green scholarship; Jean Rogerson postgraduate scholarship; Australian Research Council(Australian Research Council); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); 	This work was supported by JSPS-KAKENHI Grants 15H02443 and 26660083 (to S. F.) and 15K07448 (to H. A.), by Grant-in-aid for JSPS Research Fellow Grant 16J03683 (to M. S.), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry Grant 25010A, Australian Postgraduate Awards from the University of Western Australia (to S. S. W. and M. H.), a Bruce and Betty Green scholarship (to S. S. W.), a Jean Rogerson postgraduate scholarship (to M. H.), and the Australian Research Council (to K. A. S.). This work was supported in part by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamson C, 2016, ANGEW CHEM INT EDIT, V55, P14978, DOI 10.1002/anie.201607431; Amorelli B, 2008, BIOORG MED CHEM LETT, V18, P2944, DOI 10.1016/j.bmcl.2008.03.067; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Best D, 2010, TETRAHEDRON LETT, V51, P2222, DOI 10.1016/j.tetlet.2010.02.063; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fitter J, 2005, CELL MOL LIFE SCI, V62, P1925, DOI 10.1007/s00018-005-5079-2; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiraki M, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952852; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Katayama T, 2016, BIOSCI BIOTECH BIOCH, V80, P621, DOI 10.1080/09168451.2015.1132153; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Liebschner D, 2016, ACTA CRYSTALLOGR D, V72, P728, DOI 10.1107/S2059798316005349; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Mulakala C, 2002, PROTEINS, V49, P125, DOI 10.1002/prot.10206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nerinckx W, 2005, FEBS LETT, V579, P302, DOI 10.1016/j.febslet.2004.12.021; Okuyama M, 2014, FEBS LETT, V588, P3213, DOI 10.1016/j.febslet.2014.07.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Ruas-Madiedo P, 2008, APPL ENVIRON MICROB, V74, P1936, DOI 10.1128/AEM.02509-07; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Siguier B, 2014, J BIOL CHEM, V289, P5261, DOI 10.1074/jbc.M113.528133; Stubbs KA, 2009, ANGEW CHEM INT EDIT, V48, P1300, DOI 10.1002/anie.200804583; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2011, J BIOL CHEM, V286, P14065, DOI 10.1074/jbc.M110.182592; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Varrot A, 2005, J MOL BIOL, V346, P423, DOI 10.1016/j.jmb.2004.11.058; Yamada Y., 2013, PHYS C SER, V425; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	57	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12126	12138		10.1074/jbc.M117.777391	http://dx.doi.org/10.1074/jbc.M117.777391			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546425	Green Published, hybrid			2022-12-26	WOS:000406053300012
J	Aguilar-Pimentel, A; Graessel, A; Alessandrini, F; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Russkamp, D; Chaker, A; Ollert, M; Blank, S; Gutermuth, J; Schmidt-Weber, CB				Aguilar-Pimentel, Antonio; Graessel, Anke; Alessandrini, Francesca; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Russkamp, Dennis; Chaker, Adam; Ollert, Markus; Blank, Simon; Gutermuth, Jan; Schmidt-Weber, Carsten B.			Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma	PLOS ONE			English	Article							JANUS KINASE INHIBITOR; REGULATORY T-CELLS; IMMUNE TOLERANCE; MECHANISMS; TOFACITINIB; SUPPRESSION; INFLAMMATION; EXPRESSION; CP-690,550; REVERSAL	Background Allergen-specific immunotherapy (AIT) is the only curative treatment for type-1 allergies, but sometimes shows limited therapeutic response as well as local and systemic side effects. Limited control of local inflammation and patient symptoms hampers its widespread use in severe allergic asthma. Objective Our aim was to evaluate whether AIT is more effective in suppression of local inflammation if performed under the umbrella of short-term non-specific immunomodulation using a small molecule inhibitor of JAK pathways. Methods In C57BL/6J mice, a model of ovalbumin (OVA)-induced allergic airway inflammation and allergen-specific immunotherapy was combined with the administration of Tofacitinib (TOFA, a FDA-approved JAK inhibitor) from 48 hours prior to 48 hours after therapeutic OVA-injection. The effect of TOFA on human FOXP3(+)CD4(+) T cells was studied in vitro. Results AIT combined with short-term TOFA administration was significantly more effective in suppressing total cell and eosinophil infiltration into the lung, local cytokine production including IL-1 beta and CXCL1 and showed a trend for the reduction of IL-4, IL-13, TNF-alpha and IL-6 compared to AIT alone. Furthermore, TOFA co-administration significantly reduced systemic IL-6, IL-1 beta and OVA-specific IgE levels and induced IgG1 to the same extent as AIT alone. Additionally, TOFA enhanced the induction of human FOXP3(+)CD4(+) T cells. Conclusions This proof of concept study shows that JAK inhibition did not inhibit tolerance induction, but improved experimental AIT at the level of local inflammation. The improved control of local inflammation might extend the use of AIT in more severe conditions such as polyallergy, asthma and high-risk patients suffering from mastocytosis or anaphylaxis.	[Aguilar-Pimentel, Antonio; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] Helmholtz Ctr Munich, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Graessel, Anke; Alessandrini, Francesca; Russkamp, Dennis; Chaker, Adam; Blank, Simon; Schmidt-Weber, Carsten B.] Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany; [Graessel, Anke; Alessandrini, Francesca; Russkamp, Dennis; Chaker, Adam; Blank, Simon; Schmidt-Weber, Carsten B.] Helmholtz Ctr Munich, Munich, Germany; [Graessel, Anke; Alessandrini, Francesca; Russkamp, Dennis; Chaker, Adam; Blank, Simon; Schmidt-Weber, Carsten B.] German Ctr Lung Res DZL, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Sch Life Sci Weihenstephan, Expt Genet, Freising Weihenstephan, Germany; [Chaker, Adam] Tech Univ Munich, Klinikum Rechts Isar, Dept Otolaryngol, Munich, Germany; [Ollert, Markus] LIH, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Ollert, Markus] Univ Southern Denmark, Dept Dermatol, Odense, Denmark; [Ollert, Markus] Univ Southern Denmark, Odense Res Ctr Anaphylaxis, Allergy Ctr, Odense, Denmark; [Gutermuth, Jan] Vrije Univ Brussel, Dept Dermatol, Univ Ziekenhuis Brussel, Brussels, Belgium	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Luxembourg Institute of Health; University of Southern Denmark; University of Southern Denmark; University Hospital Brussels; Vrije Universiteit Brussel	Schmidt-Weber, CB (corresponding author), Tech Univ Munich, Ctr Allergy & Environm ZAUM, Munich, Germany.; Schmidt-Weber, CB (corresponding author), Helmholtz Ctr Munich, Munich, Germany.; Schmidt-Weber, CB (corresponding author), German Ctr Lung Res DZL, Munich, Germany.	csweber@tum.de	Gailus-Durner, Valerie/M-7337-2014; Blank, Simon/M-7708-2013; Schmidt-Weber, Carsten B./AAU-1621-2021; de Angelis, Martin Hrabe/F-5531-2012	Schmidt-Weber, Carsten B./0000-0002-3203-8084; de Angelis, Martin Hrabe/0000-0002-7898-2353; Ollert, Markus W./0000-0002-8055-0103; Blank, Simon/0000-0002-5649-1078; Chaker, Adam/0000-0002-5117-4073; Graessel, Anke/0000-0001-9670-3269	Helmholtz Center Munich; German Federal Ministry of Education and Research [01KX1012]	Helmholtz Center Munich(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work has been in part funded by the Translational and Clinical Projects Fund of the Helmholtz Center Munich to the ZAUM and by the German Federal Ministry of Education and Research to the GMC (Infrafrontier grant 01KX1012).	Abramson MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001186.pub2; Aguilar-Pimentel JA, 2010, AM J RESP CRIT CARE, V181, P7, DOI 10.1164/rccm.200902-0190OC; Akdis CA, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0063-2; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Alessandrini F, 2006, J ALLERGY CLIN IMMUN, V117, P824, DOI 10.1016/j.jaci.2005.11.046; Anderson CF, 2002, J ENDOTOXIN RES, V8, P477, DOI 10.1179/096805102125001118; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Ashino S, 2014, J ALLERGY CLIN IMMUN, V133, P1162, DOI 10.1016/j.jaci.2013.10.036; Calderon MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001936.pub2; Chesne J, 2016, IMMUNOL ALLERGY CLIN, V36, P125, DOI 10.1016/j.iac.2015.08.009; Dowty ME, 2014, DRUG METAB DISPOS, V42, P759, DOI 10.1124/dmd.113.054940; Frati F, 2013, IMMUNOTHERAPY-UK, V5, P131, DOI [10.2217/IMT.12.154, 10.2217/imt.12.154]; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Golden DBK, 2007, IMMUNOL ALLERGY CLIN, V27, P261, DOI 10.1016/j.iac.2007.03.008; GOLDEN DB, 2007, IMMUNOL ALLERGY CLIN, V27, pR7; He Y, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-298; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Karagiannidis C, 2004, J ALLERGY CLIN IMMUN, V114, P1425, DOI 10.1016/j.jaci.2004.07.014; LEE JS, 1989, SOMAT CELL MOLEC GEN, V15, P143, DOI 10.1007/BF01535075; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Migita K, 2014, CLIN EXP IMMUNOL, V175, P208, DOI 10.1111/cei.12234; Miroux C, 2009, TRANSPL P, V41, P3371, DOI 10.1016/j.transproceed.2009.08.043; Moote William, 2011, Allergy Asthma Clin Immunol, V7 Suppl 1, pS5, DOI 10.1186/1710-1492-7-S1-S5; Nguyen XD, 2004, J ALLERGY CLIN IMMUN, V114, P296, DOI 10.1016/j.jaci.2004.04.048; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Okiyama N, 2014, J INVEST DERMATOL, V134, P992, DOI 10.1038/jid.2013.476; Piscianz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085463; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Rizzi M, 2017, J AUTOIMMUN, V77, P55, DOI 10.1016/j.jaut.2016.10.005; Roskoski R, 2016, PHARMACOL RES, V111, P784, DOI 10.1016/j.phrs.2016.07.038; Schmidt-Weber Carsten B., 2006, Inflammation & Allergy Drug Targets, V5, P15, DOI 10.2174/187152806775269321; Schmidt-Weber CB, 1999, J IMMUNOL, V162, P238; Sewgobind VDKD, 2010, AM J TRANSPLANT, V10, P1785, DOI 10.1111/j.1600-6143.2010.03200.x; Shirinbak S, 2010, J IMMUNOL, V185, P3857, DOI 10.4049/jimmunol.0903909; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; Vissers JLM, 2004, J ALLERGY CLIN IMMUN, V113, P1204, DOI 10.1016/j.jaci.2004.02.041; Wu ZQ, 2013, CELL IMMUNOL, V283, P75, DOI 10.1016/j.cellimm.2013.06.014; Zhou Y, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5021537	43	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178563	10.1371/journal.pone.0178563	http://dx.doi.org/10.1371/journal.pone.0178563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570653	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800078
J	Hirose, T; Tanaka, Y; Tanaka, A; Sakai, H; Sasaki, Y; Shinohara, N; Ohdan, H				Hirose, Takayuki; Tanaka, Yuka; Tanaka, Asuka; Sakai, Hiroshi; Sasaki, Yu; Shinohara, Nobuo; Ohdan, Hideki			PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice	PLOS ONE			English	Article							REGULATORY B-CELLS; DONOR-SPECIFIC TRANSFUSION; TRANSPLANTATION TOLERANCE; ANTIGEN PRESENTATION; B10 CELLS; BLOCKADE; AUTOIMMUNITY; PHENOTYPE; INFUSION; SUBSET	B cells constitute a complex system of antigen-presenting cells (APCs) and exist as distinct subsets that differ in their lineage affiliation, surface molecule expression, and biological function, thus potentially regulating the immune response. In this study, we investigated the immune-regulatory roles of murine B cell subsets as regulatory APCs targeting alloreactive T cells. Either splenic B cells, peritoneal cavity (PerC) B cells, or non-B cells from Balb/c mice were intravenously injected into B6 mice. Serum levels of anti-Balb/c antibodies in the recipients of PerC B cells were significantly lower than those in the recipients of splenic B cells and PerC non-B cells, as determined over a 4-week period after the injection. Mixed-lymphocyte reaction (MLR) assays using splenocytes from the B6 mice at 2 weeks after the injection revealed the significantly reduced anti-Balb/c T cell-responses in the recipients of PerC B cells, as compared to those in the recipients of splenic B cells or untreated control mice. Since PerC B cells contained MHC class II+ CD80(+) CD86(+) PD-L1(+) PD-L2(+\) cells among the CD5(+) B-1a cell subset, PerC B cells from Balb/c mice were pre-incubated with anti-PD-L1/PD-L2 mAbs prior to injection. This treatment abrogated their immune-regulatory effects on anti-Balb/c T cells in the MLR assays. In addition, the inoculation with Balb/c PerC B cells significantly prolonged the survival of subsequently grafted Balb/c hearts in B6 mouse recipients, whereas that with SPL B cells did not. These findings indicate that the PerC B cells, including PD-L1/PD-L2 B-1a cells, may suppress T cells responding to allostimulation, and thus may be optimal for donor lymphocyte injection.	[Hirose, Takayuki; Tanaka, Yuka; Tanaka, Asuka; Sakai, Hiroshi; Sasaki, Yu; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan; [Hirose, Takayuki; Shinohara, Nobuo] Hokkaido Univ, Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hiroshima University; Hokkaido University	Ohdan, H (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Transplant Surg, Hiroshima, Japan.	hohdan@hiroshima-u.ac.jp	Tanaka, Yuka/G-9580-2019; Ohdan, Hideki/G-4719-2019	Ohdan, Hideki/0000-0002-9066-1288; Hirose, Takayuki/0000-0001-7950-0961	Ministry of Education, Culture, Sports, Science and Technology [15H02555]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. Jinlian Piao for expert technical assistance. This work was carried out in part at the Analysis Center of Life Science, Hiroshima University. This work was carried out in part at the Research Facilities for Laboratory Animal Science, Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University. This work was supported by a Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology (15H02555).; This work was carried out in part at the Research Facilities for Laboratory Animal Science, Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University. This work was supported by a Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology (15H02555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett LG, 2014, J IMMUNOL, V192, P3607, DOI 10.4049/jimmunol.1301284; BRENNAN DC, 1995, AM J KIDNEY DIS, V26, P701, DOI 10.1016/0272-6386(95)90432-8; Chai JG, 2015, EUR J IMMUNOL, V45, P2017, DOI 10.1002/eji.201545455; Chesneau M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00497; Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Du JF, 2009, TRANSPL P, V41, P1840, DOI 10.1016/j.transproceed.2009.01.106; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Gao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077761; Ghosn EEB, 2008, P NATL ACAD SCI USA, V105, P5195, DOI 10.1073/pnas.0712350105; Hastings WD, 2006, EUR J IMMUNOL, V36, P1114, DOI 10.1002/eji.200535142; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; KANTOR AB, 1992, P NATL ACAD SCI USA, V89, P3320, DOI 10.1073/pnas.89.8.3320; Khan AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6997; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klinker MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070131; Knight AM, 2015, EUR J IMMUNOL, V45, P1600, DOI 10.1002/eji.201545684; KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5; Lal G, 2015, TRANSPLANTATION, V99, P1817, DOI 10.1097/TP.0000000000000718; Marti HP, 2006, TRANSPLANT INT, V19, P19, DOI 10.1111/j.1432-2277.2005.00233.x; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Muzzio DO, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00006; Noorchashm H, 2006, J IMMUNOL, V177, P7715, DOI 10.4049/jimmunol.177.11.7715; Ohdan H, 1999, J CLIN INVEST, V104, P281, DOI 10.1172/JCI6656; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Rosser EC, 2014, MOL IMMUNOL, V62, P296, DOI 10.1016/j.molimm.2014.01.014; Rozali EN, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/656340; Sandner SE, 2005, AM J TRANSPLANT, V5, P31, DOI 10.1111/j.1600-6143.2004.00640.x; Tanaka Y, 2004, IMMUNOL INVEST, V33, P309, DOI 10.1081/IMM-120038079; Tazawa H, 2013, BLOOD, V122, P2582, DOI 10.1182/blood-2012-02-407452; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wu DL, 1996, VET IMMUNOL IMMUNOP, V55, P63, DOI 10.1016/S0165-2427(96)05631-0; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461; Zhou W, 2005, TRANSPL P, V37, P1808, DOI 10.1016/j.transproceed.2005.03.129	43	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178765	10.1371/journal.pone.0178765	http://dx.doi.org/10.1371/journal.pone.0178765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570665	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800119
J	Ketelboeter, LM; Bardy, SL				Ketelboeter, Laura M.; Bardy, Sonia L.			Characterization of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione resistance in pyomelanogenic Pseudomonas aeruginosa DKN343	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMPS; VIBRIO-CHOLERAE; MEXAB-OPRM; LEGIONELLA-PNEUMOPHILA; (4-HYDROXYPHENYL)PYRUVATE DIOXYGENASE; ANTIBIOTIC-RESISTANCE; TYROSINE DEGRADATION; SECRETED PYOMELANIN; MELANIN PIGMENT; CYSTIC-FIBROSIS	Pyomelanin is a reddish-brown pigment that provides bacteria and fungi protection from oxidative stress, and is reported to contribute to infection persistence. Production of this pigment can be inhibited by the anti-virulence agent 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). The Pseudomonas aeruginosa clinical isolate DKN343 exhibited high levels of resistance to NTBC, and the mechanism of pyomelanin production in this strain was uncharacterized. We determined that pyomelanin production in the clinical Pseudomonas aeruginosa isolate DKN343 was due to a loss of function in homogentisate 1,2-dioxygenase (HmgA). Several potential resistance mechanisms were investigated, and the MexAB-OprM efflux pump is required for resistance to NTBC. DKN343 has a frameshift mutation in NalC, which is a known indirect repressor of the mexAB-oprM operon. This frameshift mutation may contribute to the increased resistance of DKN343 to NTBC. Additional studies investigating the prevalence of resistance in pyomelanogenic microbes are necessary to determine the future applications of NTBC as an anti-virulence therapy.	[Ketelboeter, Laura M.; Bardy, Sonia L.] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI 53211 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Bardy, SL (corresponding author), Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI 53211 USA.	bardy@uwm.edu			 [NIH P30 DK089507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dianne Newman and Carrie Harwood for their generous contribution of strains. We thank Michael Mamerow, Zachery Kunkel, and Colin Opay for their contributions. University of Wisconsin Milwaukee Research Foundation holds patent no. 8,354,451; with claims broadly directed to treating or inhibiting the progression of infection of a microorganism in a patient by administering a 4-hydroxyphenylpyruvate dioxygenase-inhibiting compound such as 2-(2-nitro-4-trifluoromethylbenzoy1)-1,3-cyclohexanedione (NTBC). Inventors are Graham Moran and Pang He. The University of Washington P. aeruginosa transposon mutant library is supported by NIH P30 DK089507.; The authors received no specific funding for this work. The University of Washington P. aeruginosa transposon mutant library is supported by NIH P30 DK089507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh M, 2014, INFECT GENET EVOL, V24, P187, DOI 10.1016/j.meegid.2014.03.018; Almeida-Paes R, 2012, APPL ENVIRON MICROB, V78, P8623, DOI 10.1128/AEM.02414-12; [Anonymous], 2016, CLIN INFECT DIS; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Aubi O, 2015, J MED CHEM, V58, P8402, DOI 10.1021/acs.jmedchem.5b01589; Azimi L, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/436952; Braz VS, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw166; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Brownlee JM, 2004, BIOCHEMISTRY-US, V43, P6370, DOI 10.1021/bi049317s; Cao L, 2004, MOL MICROBIOL, V53, P1423, DOI 10.1111/j.1365-2958.2004.04210.x; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P6844, DOI 10.1128/AAC.03681-14; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; Chen W, 2016, MOL MICROBIOL; Coelho-Souza T, 2014, J MED MICROBIOL, V63, P152, DOI 10.1099/jmm.0.064089-0; De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dreier J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00660; El Zowalaty ME, 2015, FUTURE MICROBIOL, V10, P1683, DOI 10.2217/fmb.15.48; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Gonyar LA, 2015, ENV MICROBIOL REP, V7, P180, DOI 10.1111/1758-2229.12217; Han HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128967; Harmer CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134229; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hocquet D, 2016, ENVIRON MICROBIOL, V18, P3482, DOI 10.1111/1462-2920.13336; Holme E, 1998, J INHERIT METAB DIS, V21, P507, DOI 10.1023/A:1005410820201; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; Kavana M, 2003, BIOCHEMISTRY-US, V42, P10238, DOI 10.1021/bi034658b; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Ketelboeter LM, 2015, JOVE-J VIS EXP, DOI 10.3791/53105; Ketelboeter LM, 2014, CURR MICROBIOL, V69, P343, DOI 10.1007/s00284-014-0593-9; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Li XZ, 2000, J ANTIMICROB CHEMOTH, V45, P433, DOI 10.1093/jac/45.4.433; Li XZ, 1998, ANTIMICROB AGENTS CH, V42, P399; Milcamps A, 1999, MICROBIOL-UK, V145, P935, DOI 10.1099/13500872-145-4-935; Orlandi VT, 2015, MICROBIOL-SGM, V161, P2298, DOI 10.1099/mic.0.000193; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Sanchez-Amat A, 1998, COMP BIOCHEM PHYS B, V119, P557, DOI 10.1016/S0305-0491(98)00028-5; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Starr LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032684; STEINERT M, 1995, APPL ENVIRON MICROB, V61, P2428, DOI 10.1128/AEM.61.6.2428-2430.1995; Turick CE, 2003, FEMS MICROBIOL LETT, V220, P99, DOI 10.1016/S0378-1097(03)00096-X; Turick CE, 2002, APPL ENVIRON MICROB, V68, P2436, DOI 10.1128/AEM.68.5.2436-2444.2002; Turick CE, 2010, BIOPOLYMERS, P449; Vahdani M, 2012, Ann Burns Fire Disasters, V25, P78; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120923; Wang RB, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-109; Wang Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00379; YABUUCHI E, 1972, International Journal of Systematic Bacteriology, V22, P53; Yang H, 2007, MOL MICROBIOL, V65, P1064, DOI 10.1111/j.1365-2958.2007.05848.x; Zheng HX, 2013, INFECT IMMUN, V81, P4182, DOI 10.1128/IAI.00858-13; Zhu SD, 2015, FOLIA MICROBIOL, V60, P309, DOI 10.1007/s12223-015-0386-y; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178084	10.1371/journal.pone.0178084	http://dx.doi.org/10.1371/journal.pone.0178084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570601	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800027
J	Lampo, M; Senaris, C; Garcia, CZ				Lampo, Margarita; Senaris, Celsa; Zulay Garcia, Carmen			Population dynamics of the critically endangered toad Atelopus cruciger and the fungal disease chytridiomycosis	PLOS ONE			English	Article							CHYTRID BATRACHOCHYTRIUM-DENDROBATIDIS; CAPTURE-RECAPTURE; PROJECTION MATRICES; HARLEQUIN TOADS; PATHOGEN; DECLINES; COSTA; EXTINCTIONS; PREVALENCE; BUFONIDAE	Harlequin toads (Atelopus) are among the most severely impacted amphibians by the emergence of chytridiomycosis, a fungal disease caused by the pathogen Batrachochytrium dendrobatidis (Bd). Many species disappeared while others suffered drastic contractions of their geographic distribution to lower altitudes. A diminished virulence of Bd in warm habitats was proposed to explain the survival of lowland populations of harlequin toads (i.e. thermal refuge hypothesis). To understand the mechanisms that allow some populations to reach an endemic equilibrium with this pathogen, we estimated demographic and epidemiological parameters at one remnant population of Atelopus cruciger in Venezuela using mark-recapture data from 2007-2013. We demonstrated that Bd is highly virulent for A. cruciger, increasing the odds of dying of infected adults four times in relation to uninfected ones and reducing the life expectancy of reproductive toads to a few weeks. Despite an estimated annual loss of 18% of the reproductive population due to Bd-induced mortality, this population has persisted in an endemic equilibrium for the last decade through the large recruitment of healthy adults every year. Given the high vulnerability of harlequin toads to Bd in lowland populations, thermal refuges need to be redefined as habitats of reduced transmission rather than attenuated virulence.	[Lampo, Margarita; Senaris, Celsa; Zulay Garcia, Carmen] Inst Venezolano Invest Cient, Ctr Ecol, Kilometro 11 Carretera Panamer, Caracas, Venezuela	Venezuelan Institute Science Research	Lampo, M (corresponding author), Inst Venezolano Invest Cient, Ctr Ecol, Kilometro 11 Carretera Panamer, Caracas, Venezuela.	mlampo@gmail.com	; Senaris Vazquez, Josefa Celsa/F-1672-2019	Lampo, Margarita/0000-0002-3669-701X; Senaris Vazquez, Josefa Celsa/0000-0001-8673-7385	Institute Venezolano de Investigaciones Cientificas [141]	Institute Venezolano de Investigaciones Cientificas	This study was funded by Institute Venezolano de Investigaciones Cientificas, Project No. 141 http://www.ivic.gob.ve/es.investigacion-3/centros-31/ecologia-316/laboratorios/ecologia-y -genetica-de-poblaciones/proyectos/2-enfermedades-emergentes-cambio-climatico-y-conservacion-de-antibios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 2004, MODEL SELECTION MULT; Barrio-Amoros Cesar L., 2016, Mesoamerican Herpetology, V3, P128; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2006, NATURE, V439, P143, DOI 10.1038/439143a; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cooch E., 2017, PROGRAM MARK GENTLE, V12th edition; Crawley M.J., 2007, R BOOK; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Dobson AP, 1995, MICROPARASITES OBSER; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Flechas S. V., 2015, Herpetological Review, V46, P528; Flechas SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044832; Fujiwara M, 2002, ECOLOGY, V83, P3257, DOI 10.2307/3072076; Gonzalez-Maya JF, 2013, AMPHIBIA-REPTILIA, V34, P573, DOI 10.1163/15685381-00002910; Granda-Rodriguez H. D., 2008, HERPETOTROPICOS, V4, P87; Halliday TR, 1998, J HERPETOL, V22, P253; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kolby JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125386; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Laake J, 2008, RMARK AN ALTERNATIVE, pC1; Laake JL, 2014, R CODE MARK ANAL VER; Lampo M, 2012, BIOTROPICA, V44, P420, DOI 10.1111/j.1744-7429.2011.00830.x; Langhammer PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077630; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; LOTTERS S, 2004, HERPETOTROPICOS, V1, P29; Lotters S, 1997, MONITORING DECLINES, P207; LOTTERS S, 1996, NEOTROPICAL TOAD GEN; Louca S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2783; Luger Martina, 2009, Salamandra, V45, P211; Maguire C, 2016, DIS AQUAT ORGAN, V119, P179, DOI 10.3354/dao02991; McCaffery R, 2015, GLOB ECOL CONSERV, V4, P232, DOI 10.1016/j.gecco.2015.07.003; MEBS D, 1980, Salamandra, V16, P65; Mitchell KM, 2008, P ROY SOC B-BIOL SCI, V275, P329, DOI 10.1098/rspb.2007.1356; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; NICHOLS JD, 1992, ECOLOGY, V73, P306, DOI 10.2307/1938741; OLSON D. H., 2014, FROGLOG, V22, P17, DOI DOI 10.1371/JOURNAL; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pradel R, 2003, BIOMETRICS, V59, P43, DOI 10.1111/1541-0420.00006; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rodriguez-Contreras A, 2008, ORYX, V42, P301, DOI 10.1017/S0030605308000082; RON SR, 2000, FROGLOG, V42, P2; Rueda-Almonacid J. V., 2005, RANAS ARLEQUINES; Scheele BC, 2016, J ANIM ECOL, V85, P1453, DOI 10.1111/1365-2656.12569; Scheele BC, 2015, BIOL CONSERV, V182, P36, DOI 10.1016/j.biocon.2014.11.032; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 2007, PROGRAM MARK GENTLE; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stevenson LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073830; Viallefont A, 1998, BIOMETRICAL J, V40, P313, DOI 10.1002/(SICI)1521-4036(199807)40:3<313::AID-BIMJ313>3.0.CO;2-2; Flechas SV, 2012, ECOHEALTH, V9, P298, DOI 10.1007/s10393-012-0771-9; von May R, 2008, TROP CONSERV SCI, V1, P376, DOI 10.1177/194008290800100406; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS BG, 1994, PARASITOL TODAY, V10, P489, DOI 10.1016/0169-4758(94)90163-5; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	68	14	14	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0179007	10.1371/journal.pone.0179007	http://dx.doi.org/10.1371/journal.pone.0179007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570689	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800136
J	Smith, MK; Miller, WC; Liu, HX; Ning, CY; He, WS; Cohen, MS; Wang, N				Smith, M. Kumi; Miller, William C.; Liu, Huixin; Ning, Chuanyi; He, Wensheng; Cohen, Myron S.; Wang, Ning			Effects of patient load and travel distance on HIV transmission in rural China: Implications for treatment as prevention	PLOS ONE			English	Article							SERODISCORDANT COUPLES; PLASMA DONORS; CARE; HIV/AIDS; QUALITY; SATISFACTION; ADHERENCE; PROVINCE; OUTCOMES; AFRICA	Background Sustained viral suppression through ART reduces sexual HIV transmission risk, but may require routine access to reliable and effective medical care which may be difficult to obtain in resource constrained areas. We investigated the roles of patient load and travel distance to HIV care clinic on transmission risk in HIV serodiscordant couples in Henan Province, China. Methods Cox proportional hazard models were used to compare HIV transmission events across couples living near, medium, or farther distances from their assigned HIV care clinics, as well as those attending clinics where clinicians bore high versus low patient loads. Results Most (84.4%) of the 3695 serodiscordant couples lived within 10 kilometers of their assigned HIV clinic, and most (73.5%) attended clinics with patient-to-provider ratios of at least 100:1. In adjusted Cox models, attending clinics where clinicians bore average patient loads of 100 or more elevated HIV transmission risk (aHR, 1-50,95% CI, 1.00-4-84), an effect amplified in village tier clinics (aHR =1.55; 95% CI, 1-23-6-78). Travel distance was associated with HIV transmission only after stratification; traveling medium distances to village clinics (5-10km) increased transmission risk (aHR = 1-83,95% CI, 1.04-3-21) whereas traveling longer distances to township or county level clinics lowered transmission risk (aHR = 0-10,95% CI, 0-01-0-75). Conclusion Higher patient loads at HIV clinics was associated with risk of HIV transmission in our population, particularly at village level clinics. Farther travel distance had divergent effects based on clinic tier, suggesting unique mechanisms operating across levels of resource availability. The resource intensity of long-term HIV treatment may place significant strains on small rural clinics, for which investments in additional support staff or time-saving tools such as point-of-care laboratory testing may bring about impactful change in treatment outcomes.	[Smith, M. Kumi] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Miller, William C.] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Liu, Huixin] Peking Univ, Peoples Hosp, Dept Clin Epidemiol, Beijing, Peoples R China; [Ning, Chuanyi; Cohen, Myron S.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [He, Wensheng] Zhumadian City Ctr Dis Control, Zhumadian, Henan, Peoples R China; [Wang, Ning] Natl Ctr AIDS STD Control & Prevent, China Ctr Dis Control, Beijing, Peoples R China; [Wang, Ning] Natl Ctr AIDS STD Control & Prevent, China Ctr Prevent, Beijing, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; Peking University; University of North Carolina; University of North Carolina Chapel Hill; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Smith, MK (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.	kumi.smith@unc.edu	Ning, Chuanyi/AAF-5601-2020; Miller, William C/H-4800-2014	Ning, Chuanyi/0000-0002-8748-2780; Miller, William C/0000-0002-1934-7827; Smith, M. Kumi/0000-0001-5861-8100	Chinese Government grant under the 12th Five-Year Plan [2012ZX10001-002]; National Institute of Allergy and Infectious Disease [T32 AI007001, T32 AI102623]; Fulbright-Hayes Fellowship for Dissertation Research Abroad; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001, T32AI102623] Funding Source: NIH RePORTER	Chinese Government grant under the 12th Five-Year Plan; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fulbright-Hayes Fellowship for Dissertation Research Abroad; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Chinese Government grant under the 12th Five-Year Plan (2012ZX10001-002) and the National Institute of Allergy and Infectious Disease (T32 AI007001; T32 AI102623). MKS was also supported by the Fulbright-Hayes Fellowship for Dissertation Research Abroad.; The authors would like to thank local clinicians and staff involved in surveillance, laboratory testing, and treatment for human immunodeficiency virus (HIV) at the study sites in Henan, as well as the HIV patients and their families for participating in this research. We would also like to thank Keith Kaneda at GIS and Data Services at the Johns Hopkins University for assistance with map construction. This work was supported by Chinese Government grant under the 12th Five-Year Plan (2012ZX10001-002) and the National Institute of Allergy and Infectious Disease (T32 AI007001; T32 AI102623). MKS was also supported by the Fulbright-Hayes Fellowship for Dissertation Research Abroad.	Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; BHIVA, 2014, HIV MED, V15, P1; Chen WT, 2007, ADV NURS SCI, V30, P329, DOI 10.1097/01.ANS.0000300182.48854.65; Conley NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043138; Davis-Michaud M, 2004, HIV CLIN TRIALS, V5, P406, DOI 10.1310/GQ98-PGK7-0T97-47XH; Department of Health and Human Services Health D Department of Health Services H. Panel on Anti-retroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Eggleston K., 2010, TENSIONS OPPORTUNITY; Granich R, 2016, LANCET, V387, P27, DOI 10.1016/S0140-6736(15)01293-3; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lambdin BH, 2015, CURR HIV RES, V13, P244, DOI 10.2174/1570162X1303150506185423; Lankowski AJ, 2014, AIDS BEHAV, V18, P1199, DOI 10.1007/s10461-014-0729-8; Lei P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-436; Liu Huan, 2014, Journal of Tropical and Subtropical Botany, V22, P1; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Qian DF, 2009, HEALTH POLICY PLANN, V24, P324, DOI 10.1093/heapol/czp016; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Smith MK, 2015, CLIN INFECT DIS, V61, P111, DOI 10.1093/cid/civ200; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; UNAIDS, 2015, WORLD AIDS DAY REP; Wang L, 2013, CHINESE MED J-PEKING, V126, P3694, DOI 10.3760/cma.j.issn.0366-6999.20123311; Wang LD, 2007, AIDS, V21, pS3, DOI 10.1097/01.aids.0000304690.24390.c2; Wang L, 2010, JAIDS-J ACQ IMM DEF, V55, P232, DOI 10.1097/QAI.0b013e3181e9b6b7; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2001, HEALTH POLICY PLANN, V16, P41, DOI 10.1093/heapol/16.1.41; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	31	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177976	10.1371/journal.pone.0177976	http://dx.doi.org/10.1371/journal.pone.0177976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562661	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700039
J	Howarth, M				Howarth, Mark			Smart superglue in streptococci? The proof is in the pulling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BONDS; THIOESTER	Gram-positive bacteria use reactive thioester-containing proteins to form covalent bonds, which may enable strong adhesion to host surfaces, but how these proteins selectively adhere to different surfaces is not clear. The Editors' Pick by Echelman et al. applied single-molecule force spectroscopy to show that an adhesin protein can regenerate its thioester in the absence of pulling. This selective interaction would represent a new principle of mechanical proof-reading, whereby only reactions supporting anchorage of the bacterium are maintained.	[Howarth, Mark] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England	University of Oxford	Howarth, M (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	mark.howarth@bioch.ox.ac.uk			University of Oxford Department of Biochemistry	University of Oxford Department of Biochemistry	This work was supported by the University of Oxford Department of Biochemistry. The author declares that he has no conflicts of interest with the content of this article.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Echelman DJ, 2017, J BIOL CHEM, V292, P8988, DOI 10.1074/jbc.M117.777466; Hinnebusch BJ, 2016, INFECT IMMUN, V84, P1932, DOI 10.1128/IAI.00188-16; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Law SKA, 1997, PROTEIN SCI, V6, P263; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638	10	0	0	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8998	8999		10.1074/jbc.H117.777466	http://dx.doi.org/10.1074/jbc.H117.777466			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28550142	Green Published, hybrid			2022-12-26	WOS:000402153900050
J	Hsieh, TH; Kang, JW; Lai, JH; Huang, YZ; Rotenberg, A; Chen, KY; Wang, JY; Chan, SY; Chen, SC; Chiang, YH; Peng, CW				Hsieh, Tsung-Hsun; Kang, Jing-Wei; Lai, Jing-Huei; Huang, Ying-Zu; Rotenberg, Alexander; Chen, Kai-Yun; Wang, Jia-Yi; Chan, Shu-Yen; Chen, Shih-Ching; Chiang, Yung-Hsiao; Peng, Chih-Wei			Relationship of mechanical impact magnitude to neurologic dysfunction severity in a rat traumatic brain injury model	PLOS ONE			English	Article							AXONAL INJURY; BEHAVIORAL DEFICITS; ACCELERATION MODEL; FLUID PERCUSSION; ANIMAL-MODELS; GFAP; PATHOPHYSIOLOGY; MODERATE; MOUSE; SERUM	Objective Traumatic brain injury (TBI) is a major brain injury type commonly caused by traffic accidents, falls, violence, or sports injuries. To obtain mechanistic insights about TBI, experimental animal models such as weight-drop-induced TBI in rats have been developed to mimic closed-head injury in humans. However, the relationship between the mechanical impact level and neurological severity following weight-drop-induced TBI remains uncertain. In this study, we comprehensively investigated the relationship between physical impact and graded severity at various weight-drop heights. Approach The acceleration, impact force, and displacement during the impact were accurately measured using an accelerometer, a pressure sensor, and a high-speed camera, respectively. In addition, the longitudinal changes in neurological deficits and balance function were investigated at 1, 4, and 7 days post TBI lesion. The inflammatory expression markers tested by Western blot analysis, including glial fibrillary acidic protein, beta-amyloid precursor protein, and bone marrow tyrosine kinase gene in chromosome X, in the frontal cortex, hippocampus, and corpus callosum were investigated at 1 and 7 days post-lesion. Results Gradations in impact pressure produced progressive degrees of injury severity in the neurological score and balance function. Western blot analysis demonstrated that all inflammatory expression markers were increased at 1 and 7 days post-impact injury when compared to the sham control rats. The severity of neurologic dysfunction and induction in inflammatory markers strongly correlated with the graded mechanical impact levels. Conclusions We conclude that the weight-drop-induced TBI model can produce graded brain injury and induction of neurobehavioral deficits and may have translational relevance to developing therapeutic strategies for TBI.	[Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Dept Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Coll Med, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Linkou, Taiwan; [Hsieh, Tsung-Hsun; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Kang, Jing-Wei; Lai, Jing-Huei; Chen, Kai-Yun; Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Kang, Jing-Wei; Chan, Shu-Yen] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Huang, Ying-Zu] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Huang, Ying-Zu] Chang Gung Mem Hosp, Dept Neurol, Taoyuan, Taiwan; [Rotenberg, Alexander] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Shih-Ching; Peng, Chih-Wei] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Peng, CW (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Coll Biomed Engn, Int PhD Program Biomed Engn, Taipei, Taiwan.	cwpeng@tmu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941; Huang, Ying-Zu/0000-0002-8666-4013; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology of Taiwan [MOST103-2321-B-038-013, MOST103-2221E-038-007-MY3, MOST 103-2320-B182-033-MY2, MOST 105-2314-B-182-016]; Chang Gung Memorial Hospital [CMRPD1F0501]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088583] Funding Source: NIH RePORTER	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Ministry of Science and Technology of Taiwan (MOST103-2321-B-038-013 and MOST103-2221E-038-007-MY3 to C.W. Peng, MOST 103-2320-B182-033-MY2, MOST 105-2314-B-182-016 to T.H. Hsieh) and Chang Gung Memorial Hospital (CMRPD1F0501) to T.H.Hsieh.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Faul M, 2010, CENTERS FOR DISEASE; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/neu.2004.21.1553; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Viano DC, 2012, ANN BIOMED ENG, V40, P213, DOI 10.1007/s10439-011-0386-2; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wu JCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039226; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yu YW, 2016, J NEUROTRAUMA	31	25	25	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178186	10.1371/journal.pone.0178186	http://dx.doi.org/10.1371/journal.pone.0178186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552947	gold, Green Submitted, Green Published			2022-12-26	WOS:000402063000025
J	Ferreiro, JLL; Otero, JA; Gonzalez, LG; Lamazares, LN; Blanco, AA; Sanjurjo, JRB; Conde, IR; Soneira, MF; Aguado, JD				Lamas Ferreiro, Jose Luis; Alvarez Otero, Judith; Gonzalez Gonzalez, Lucia; Novoa Lamazares, Luis; Arca Blanco, Alexandra; Bermudez Sanjurjo, Jose Ramon; Rodriguez Conde, Irene; Fernandez Soneira, Maria; de la Fuente Aguado, Javier			Pseudomonas aeruginosa urinary tract infections in hospitalized patients: Mortality and prognostic factors	PLOS ONE			English	Article							COMBINATION ANTIMICROBIAL THERAPY; RISK-FACTORS; 30-DAY MORTALITY; BACTEREMIA; RESISTANCE; IMPACT; ANTIBIOTICS	Background The aim of this study was to analyze the mortality and predictors of 30-day mortality among hospitalized patients with Pseudomonas aeruginosa urinary tract infection (PAUTI) and the impact of antibiotic treatment on survival. Methods Patients admitted to our hospital with PAUTI or those diagnosed of PAUTI during hospitalization for other disease between September 2012 and September 2014 were included. Repeated episodes from the same patient were excluded. Database with demographic, clinical and laboratory items was created. Empirical and definitive antibiotic therapy, antimicrobial resistance and all-cause mortality at 30 and 90 days were included. Results 62 patients were included, with a mean age of 75 years. 51% were male. Mortality was 17.7% at 30 days and 33.9% at 90 days. Factors associated with reduced survival at 30 days were chronic liver disease with portal hypertension (P<0,01), diabetes mellitus (P = 0,04) chronic renal failure (P = 0,02), severe sepsis or septic shock (P<0,01), Charlson index > 3 (P = 0.02) and inadequated definitive antibiotic treatment (P<0,01). Independent risk factors for mortality in multivariate analysis were advanced chronic liver disease (HR 77,4; P<0,01), diabetes mellitus (HR 3,6; P = 0,04), chronic renal failure (HR 4,1; P = 0,03) and inadequated definitive antimicrobial treatment (HR 6,8; P = 0,01). Conclusions PAUTI are associated with high mortality in hospitalized patients, which increases significantly in those with severe comorbidity such as chronic renal failure, advanced liver disease or diabetes mellitus. Inadequated antibiotic treatment is associated with poor outcome, which remarks the importance of adjusting empirical antibiotic treatment based on the microbiological susceptibility results.	[Lamas Ferreiro, Jose Luis; Alvarez Otero, Judith; Gonzalez Gonzalez, Lucia; Novoa Lamazares, Luis; Arca Blanco, Alexandra; Bermudez Sanjurjo, Jose Ramon; de la Fuente Aguado, Javier] Povisa Hosp, Internal Med, Vigo, Spain; [Rodriguez Conde, Irene; Fernandez Soneira, Maria] Povisa Hosp, Microbiol, Vigo, Spain		Ferreiro, JLL (corresponding author), Povisa Hosp, Internal Med, Vigo, Spain.	jlamfer@gmail.com	de la Fuente Aguado, Javier/I-1431-2019					Aliaga L, 2000, EUR J CLIN MICROBIOL, V19, P871, DOI 10.1007/s100960000392; Almagro P, 2012, RESPIRATION, V84, P36, DOI 10.1159/000331224; Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; Bouza E, 2001, CLIN MICROBIOL INFEC, V7, P523, DOI 10.1046/j.1198-743x.2001.00326.x; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; Chamot E, 2003, ANTIMICROB AGENTS CH, V47, P2756, DOI 10.1128/AAC.47.9.2756-2764.2003; Cheong HS, 2008, EUR J CLIN MICROBIOL, V27, P1219, DOI 10.1007/s10096-008-0568-5; Dantas RC, 2014, J MED MICROBIOL, V63, P1679, DOI 10.1099/jmm.0.073262-0; Djordjevic Z, 2013, AM J INFECT CONTROL, V41, P1182, DOI 10.1016/j.ajic.2013.02.018; Gastmeier P, 2001, CLIN MICROBIOL INFEC, V7, P521, DOI 10.1111/j.1469-0691.2001.00353.x; Horcajada JP, 2013, CLIN MICROBIOL INFEC, V19, P962, DOI 10.1111/1469-0691.12089; Horino T, 2012, INTERNAL MED, V51, P59, DOI 10.2169/internalmedicine.51.5698; Joo EJ, 2011, INFECTION, V39, P309, DOI 10.1007/s15010-011-0124-6; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; Gonzalez AL, 2014, BIOMEDICA, V34, P58, DOI [10.1590/S0120-41572014000500008, 10.7705/biomedica.v34i0.1691]; Liu QQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11715; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Morata L, 2012, ANTIMICROB AGENTS CH, V56, P4833, DOI 10.1128/AAC.00750-12; Osih RB, 2007, ANTIMICROB AGENTS CH, V51, P839, DOI 10.1128/AAC.00901-06; Schechner V, 2011, DIAGN MICR INFEC DIS, V71, P38, DOI 10.1016/j.diagmicrobio.2011.05.010; Vitkauskiene A, 2010, MEDICINA-LITHUANIA, V46, P490, DOI 10.3390/medicina46070071	23	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178178	10.1371/journal.pone.0178178	http://dx.doi.org/10.1371/journal.pone.0178178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552972	Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000024
J	Li, M; Zheng, Y; Fan, RR; Zhong, QL; Cheng, DL				Li, Man; Zheng, Yuan; Fan, RuiRui; Zhong, QuanLin; Cheng, DongLiang			Scaling relationships of twig biomass allocation in Pinus hwangshanensis along an altitudinal gradient	PLOS ONE			English	Article							WHOLE-PLANT RESPIRATION; BELOW-GROUND BIOMASS; LEAF SIZE; ALLOMETRIC RELATIONSHIPS; HYDRAULIC ARCHITECTURE; ABOVEGROUND BIOMASS; DIMINISHING RETURNS; SHOOT ALLOMETRY; GENERAL-MODEL; TRADE-OFF	Understanding the response of biomass allocation in twigs (the terminal branches of current-year shoots) to environmental change is crucial for elucidating forest ecosystem carbon storage, carbon cycling, and plant life history strategies under a changing climate. On the basis of interspecies investigations of broad-leaved plants, previous studies have demonstrated that plants respond to environmental factors by allocating biomass in an allometric manner between support tissues (i.e., stems) and the leaf biomass of twigs, where the scaling exponent (i.e., slope of a log - log linear relationship, a) is constant, and the scaling constant (i.e., intercept of a log - log linear relationship, log beta) varies with respect to environmental factors. However, little is known about whether the isometric scaling exponents of such biomass allocations remain invariant for single species, particularly conifers, at different altitudes and in different growing periods. In this study, we investigated how twig biomass allocation varies with elevation and period among Pinus hwangshanensis Hsia trees growing in the mountains of Southeast China. Specifically, we explored how twig stem mass, needle mass, and needle area varied throughout the growing period (early, mid-, late) and at three elevations in the Wuyi Mountains. Standardized major axis analysis was used to compare the scaling exponents and scaling constants between the biomass allocations of within-twig components. Scaling relationships between these traits differed with growing period and altitude gradient. During the different growing periods, there was an isometric scaling relationship, with a common slope of 1.0(i.e., a approximate to 1.0), between needle mass and twig mass (the sum of the total needle mass and the stem mass), whereas there were allometric scaling relationships between the stem mass and twig mass and between the needle mass and stem mass of P. hwangshanensis. The scaling constants (log beta) for needle mass vs. twig mass and for needle mass vs. stem mass increased progressively across the growing stages, whereas the scaling constants of stem mass vs. twig mass showed the opposite pattern. The scaling exponents (a) of needle area with respect to needle biomass increased significantly with growing period, changing from an allometric relationship (i.e., a < 1.0) during the early growing period to a nearly isometric relationship (i.e., a approximate to 1.0) during the late growing period. This change possibly reflects the functional adaptation of twigs in different growing periods to meet their specific reproductive or survival needs. At different points along the altitudinal gradient, the relationships among needle mass, twig mass, and stem mass were all isometric (i.e., alpha approximate to 1.0). Moreover, significant differences were found in scaling constants ( log beta) along the altitudinal gradient, such that species had a smaller stem biomass but a relatively larger needle mass at low altitude. In addition, the scaling exponents remained numerically invariant among all three altitudes, with a common slope of 0.8, suggesting that needle area failed to keep pace with the increasing needle mass at different altitudes. Our results indicated that the twig biomass allocation pattern was significantly influenced by altitude and growing period, which reflects the functional adaptation of twigs to meet their specific survival needs under different climatic conditions.	[Li, Man; Zheng, Yuan; Fan, RuiRui; Cheng, DongLiang] Fujian Normal Univ, Fujian Prov Key Lab Plant Ecophysiol, Fuzhou, Fujian Province, Peoples R China; [Li, Man; Zheng, Yuan; Fan, RuiRui; Zhong, QuanLin; Cheng, DongLiang] Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou, Fujian Province, Peoples R China	Fujian Normal University	Cheng, DL (corresponding author), Fujian Normal Univ, Fujian Prov Key Lab Plant Ecophysiol, Fuzhou, Fujian Province, Peoples R China.; Cheng, DL (corresponding author), Minist Educ, Key Lab Humid Subtrop Ecogeog Proc, Fuzhou, Fujian Province, Peoples R China.	chengdl02@aliyun.com			National Natural Science Foundation of China [31370589, 31170374, 31170596]; Fujian Provincial Young Talent Support Plan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Young Talent Support Plan	This study was supported by grants from the National Natural Science Foundation of China (31370589, 31170374 and 31170596) and the Fujian Provincial Young Talent Support Plan.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Bazzaz FA., 1997, PLANT RESOURCE ALLOC; Cavender-Bares J, 2001, PLANT CELL ENVIRON, V24, P1243, DOI 10.1046/j.1365-3040.2001.00797.x; Chen FS, 2012, PLANT ECOL, V213, P1489, DOI 10.1007/s11258-012-0106-5; Chen JF, 2000, CHINESE J SOIL SCI, V31, P97; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cheng DL, 2010, BIOL LETTERS, V6, P715, DOI 10.1098/rsbl.2010.0070; Cheng DL, 2015, ANN BOT-LONDON, V115, P303, DOI 10.1093/aob/mcu238; Cheng DL, 2014, AM J BOT, V101, P617, DOI 10.3732/ajb.1300360; Cheng J, 2015, FUNCT ECOL, V30, P1; Davis SD, 1999, AM J BOT, V86, P1367, DOI 10.2307/2656919; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fang J. Y., 2004, BIODIVERSITY SCI, V12, P63; Morote FAG, 2012, FOREST ECOL MANAG, V270, P85, DOI 10.1016/j.foreco.2012.01.007; Guo Hong, 2013, Forest Research, V26, P698; Hogue ATMR, 2010, MAR ECOL PROG SER, V404, P31, DOI 10.3354/meps08505; Huang YX, 2016, FUNCT ECOL, V30, P199, DOI 10.1111/1365-2435.12491; Kangkuso A, 2016, FOR SCI TECHNOL, V12, P43, DOI 10.1080/21580103.2015.1034191; Kleiman D, 2007, J ECOL, V95, P376, DOI 10.1111/j.1365-2745.2006.01205.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Li GY, 2008, FUNCT ECOL, V22, P557, DOI 10.1111/j.1365-2435.2008.01407.x; Li Ling-ling, 2014, Yingyong Shengtai Xuebao, V25, P1849; Li Man, 2017, Yingyong Shengtai Xuebao, V28, P537, DOI 10.13287/j.1001-9332.201702.039; Lin ZG, 1982, METEOROL SCI TECHNOL, V2, P79; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; [刘金福 Liu Jinfu], 2013, [生态学报, Acta Ecologica Sinica], V33, P5731; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; Lusk CH, 2003, NEW PHYTOL, V160, P329, DOI 10.1046/j.1469-8137.2003.00879.x; Lusk CH, 2000, J BIOGEOGR, V27, P1011, DOI 10.1046/j.1365-2699.2000.00449.x; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McCulloh KA, 2005, TREE PHYSIOL, V25, P257, DOI 10.1093/treephys/25.3.257; Mensah S, 2016, ANN FOR RES, V59, P49, DOI 10.15287/afr.2016.458; Milla R, 2011, P ROY SOC B, V274, P2109; Milla R, 2009, J ECOL, V97, P972, DOI 10.1111/j.1365-2745.2009.01524.x; Mori S, 2010, P NATL ACAD SCI USA, V107, P1447, DOI 10.1073/pnas.0902554107; Niinemets U, 2007, ANN BOT-LONDON, V100, P283, DOI 10.1093/aob/mcm107; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2008, AM J BOT, V95, P549, DOI 10.3732/ajb.0800034; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2009, AM J BOT, V96, P531, DOI 10.3732/ajb.0800250; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; NIKLAS KJ, 1992, OECOLOGIA, V90, P518, DOI 10.1007/BF01875445; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Nikolova PS, 2009, EUR J FOREST RES, V128, P145, DOI 10.1007/s10342-008-0211-0; Normand F, 2008, NEW PHYTOL, V178, P590, DOI 10.1111/j.1469-8137.2008.02380.x; Pan S, 2013, PLOS ONE, V8, P65; Pan Shao-An, 2015, Chinese Journal of Plant Ecology, V39, P971, DOI 10.17521/cjpe.2015.0094; Peng YH, 2010, FUNCT ECOL, V24, P502, DOI 10.1111/j.1365-2435.2009.01667.x; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Preston KA, 2003, AM J BOT, V90, P1502, DOI 10.3732/ajb.90.10.1502; Pretzsch H, 2012, SOUTH FORESTS, V74, P237, DOI 10.2989/20702620.2012.741794; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; R Development Core Team, 2013, LANGUANGE ENV STAT C; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Scheepens JF, 2010, OECOLOGIA, V164, P141, DOI 10.1007/s00442-010-1650-0; Seifert T, 2009, EUR J FOREST RES, V128, P155, DOI 10.1007/s10342-008-0219-5; Sun SC, 2006, ANN BOT-LONDON, V97, P97, DOI 10.1093/aob/mcj004; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2003, OECOLOGIA, V135, P621, DOI 10.1007/s00442-003-1231-6; Xiang SA, 2009, TREES-STRUCT FUNCT, V23, P637, DOI 10.1007/s00468-008-0308-6; Yang XD, 2014, ACTA OECOL, V60, P17, DOI 10.1016/j.actao.2014.07.004; Yang YX, 2015, TREES-STRUCT FUNCT, V29, P737, DOI 10.1007/s00468-014-1151-6; Zhang H, 2016, ECOL ENG, V91, P7, DOI 10.1016/j.ecoleng.2016.01.040; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2; Zhu Jie-Dong, 2011, Chinese Journal of Plant Ecology, V35, P687, DOI 10.3724/SP.J.1258.2011.00687	77	7	12	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178344	10.1371/journal.pone.0178344	http://dx.doi.org/10.1371/journal.pone.0178344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552954	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000038
J	Ngwa, VM; Axford, DS; Healey, AN; Nowak, SJ; Chrestensen, CA; McMurry, JL				Ngwa, Verra M.; Axford, David S.; Healey, Allison N.; Nowak, Scott J.; Chrestensen, Carol A.; McMurry, Jonathan L.			A versatile cell-penetrating peptide-adaptor system for efficient delivery of molecular cargos to subcellular destinations	PLOS ONE			English	Article							CALCIUM; CALMODULIN; MEMBRANE; BINDING; ENDOCYTOSIS; DOMAIN	Cell penetrating peptides have long held great potential for delivery of biomolecular cargos for research, therapeutic and diagnostic purposes. They allow rapid, relatively nontoxic passage of a wide variety of biomolecules through the plasma membranes of living cells. However, CPP-based research tools and therapeutics have been stymied by poor efficiency in release from endosomes and a great deal of effort has been made to solve this 'endosomal escape problem.' Previously, we showed that use of a reversible, noncovalent coupling between CPP and cargo using calmodulin and a calmodulin binding motif allowed efficient delivery of cargo proteins to the cytoplasm in baby hamster kidney and other mammalian cell lines. The present report demonstrates the efficacy of our CPP-adaptor scheme for efficient delivery of model cargos to the cytoplasm using a variety of CPPs and adaptors. Effective overcoming of the endosomal escape problem is further demonstrated by the delivery of cargo to the nucleus, endoplasmic reticulum and peroxisomes by addition of appropriate subcellular localization signals to the cargos. CPP-adaptors were also used to deliver cargo to myotubes, demonstrating the feasibility of the system as an alternative to transfection for the manipulation of hard-to-transfect cells.	[Ngwa, Verra M.; Chrestensen, Carol A.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA USA; [Axford, David S.; Nowak, Scott J.; McMurry, Jonathan L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA; [Healey, Allison N.] New Echota Biotechnol, Kennesaw, GA USA; [Ngwa, Verra M.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Healey, Allison N.] Mississippi State Univ, Dept Agr & Biomed Engn, Starkville, MS USA	University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University; Vanderbilt University; Mississippi State University	McMurry, JL (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	jmcmurr1@kennesaw.edu	Nowak, Scott J/H-2974-2012	Nowak, Scott J/0000-0001-8548-8356	National Institute on General Medical Sciences [GM120691, GM102826, GM110634]; NIH [R25 GM111565]; Birla Carbon Summer Undergraduate Research Fellowship (KSU College of Science Mathematics); New Echota Biotechnology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM111565, R15GM102826, R15GM120691] Funding Source: NIH RePORTER	National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Birla Carbon Summer Undergraduate Research Fellowship (KSU College of Science Mathematics); New Echota Biotechnology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute on General Medical Sciences (https://www.nigms.nih.gov) grants GM120691 (to JLM), GM102826 (to SJN) and GM110634 (to CAC). VMN was supported by NIH R25 GM111565 and DSA received a Birla Carbon Summer Undergraduate Research Fellowship (KSU College of Science & Mathematics, http://csm.ennesaw.edu/). New Echota Biotechnology provided support in the form of salary to ANH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2016, NUCLEIC ACIDS RES, V44, pD1098, DOI 10.1093/nar/gkv1266; Balci Burcu, 2009, Biotechnology Journal, V4, P1042, DOI 10.1002/biot.200800269; Cerrato CP, 2017, EXPERT OPIN DRUG DEL, V14, P245, DOI 10.1080/17425247.2016.1213237; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dolman NJ, 2013, CURR PROTOC CYTOM, V12; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Fernandez-Carneado J, 2004, BIOPOLYMERS, V76, P196, DOI 10.1002/bip.10585; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Fuchs H, 2007, J CONTROL RELEASE, V117, P342, DOI 10.1016/j.jconrel.2006.11.019; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Imai K, 2010, PROTEOMICS, V10, P3970, DOI 10.1002/pmic.201000274; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; Kawaguchi Y, 2016, BIOCONJUGATE CHEM, V27, P1119, DOI 10.1021/acs.bioconjchem.6b00082; Krebs J, 2007, N COMP BIOC, V41, P1; Li MX, 2002, EUR BIOPHYS J BIOPHY, V31, P245, DOI 10.1007/s00249-002-0227-1; Lonn P, 2015, EXPERT OPIN DRUG DEL, V12, P1627, DOI 10.1517/17425247.2015.1046431; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Martin I, 2011, CHEMBIOCHEM, V12, P896, DOI 10.1002/cbic.201000679; McMurry JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134884; McMurry JL, 2011, FEBS J, V278, P4943, DOI 10.1111/j.1742-4658.2011.08395.x; Newman E, 2004, J BIOL CHEM, V279, P33547, DOI 10.1074/jbc.M403892200; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Presente A, 2013, CURR PHARM DESIGN, V19, P2943; RHYNER JA, 1992, BIOCHEMISTRY-US, V31, P12826, DOI 10.1021/bi00166a017; Salerno JC, 2016, J CELL SCI, V129, P893, DOI 10.1242/jcs.182113; Sebbage V., 2009, BIOSCI HORIZONS, V2, P64, DOI DOI 10.1093/BIOHORIZONS/HZP001; Stratton MM, 2013, CURR OPIN STRUC BIOL, V23, P292, DOI 10.1016/j.sbi.2013.04.002; Tan RY, 1996, J BIOL CHEM, V271, P7479, DOI 10.1074/jbc.271.13.7479; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Xie XY, 2015, J DRUG TARGET, V23, P789, DOI 10.3109/1061186X.2015.1009077	35	13	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5								10.1371/journal.pone.0178648	http://dx.doi.org/10.1371/journal.pone.0178648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552994	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000052
J	Csosz, E; Labiscsak, P; Kallo, G; Markus, B; Emri, M; Szabo, A; Tar, I; Tozser, J; Kiss, C; Marton, I				Csosz, Eva; Labiscsak, Peter; Kallo, Gergo; Markus, Bernadett; Emri, Miklos; Szabo, Adrienn; Tar, Ildiko; Tozser, Jozsef; Kiss, Csongor; Marton, Ildiko			Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL-CANCER MORTALITY; INCREASED EXPRESSION; MASS-SPECTROMETRY; ADULT-POPULATION; GROWTH-FACTOR; TNF-ALPHA; PROTEINS; CAVITY; S100A9	Oral squamous cell carcinoma (OSCC) accounting for about 90% of malignant oral lesions is the 6th most common malignancy worldwide. Diagnostic delay may contribute to dismal survival rate therefore, there is a need for developing specific and sensitive biomarkers to improve early detection. Hungarian population occupies the top places of statistics regarding OSCC incidence and mortality figures therefore, we aimed at finding potential salivary protein biomarkers suitable for the Hungarian population. In this study we investigated 14 proteins which were previously reported as significantly elevated in saliva of patients with OSCC. In case of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF-alpha and VEGF a Luminex-based multiplex kit was utilized and the salivary concentrations were determined. In case of catalase, profilin-1, S100A9, CD59, galectin-3-bindig protein, CD44, thioredoxin and keratin-19, SRM-based targeted proteomic method was developed and the relative amount of the proteins was determined in the saliva of patients with OSCC and controls. After several rounds of optimization and using stable isotope-containing peptides, we developed an SRM-based method for rapid salivary protein detection. The validation of the selected potential biomarkers by ELISA revealed salivary protein S100A9 and IL-6 as useful protein biomarkers for OSCC detection improving the diagnostic accuracy for OSCC in the Hungarian population. A noninvasive diagnostic method to detect biomarkers useful for the early diagnosis of OSCC was developed. This can be an attractive strategy in screening saliva samples collected in a nation-wide multi-centric study in order to decrease morbidity, mortality, to enhance survival rate and to improve quality of life. The heterogeneity of protein biomarkers found in different ethnic groups presented in the literature highlights the importance of identification of population-tailored protein biomarkers.	[Csosz, Eva; Labiscsak, Peter; Kallo, Gergo; Markus, Bernadett; Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, 1 Egyet Ter, Debrecen, Hungary; [Emri, Miklos] Univ Debrecen, Fac Med, Dept Med Imaging, 1 Egyet Ter, Debrecen, Hungary; [Szabo, Adrienn] Univ Debrecen, Fac Dent, Dept Oral & Maxillofacial Surg, 1 Egyet Ter, Debrecen, Hungary; [Tar, Ildiko; Marton, Ildiko] Univ Debrecen, Fac Dent, Dept Periodontol, 1 Egyet Ter, Debrecen, Hungary; [Kiss, Csongor] Univ Debrecen, Fac Med, Dept Pediat, 1 Egyet Ter, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Marton, I (corresponding author), Univ Debrecen, Fac Dent, Dept Periodontol, 1 Egyet Ter, Debrecen, Hungary.	marton.ildiko@dental.unideb.hu	Emri, Miklós/AAK-3515-2020; Tozser, Jozsef/A-7840-2008; Ildikó, Tar/ABC-6487-2020	Emri, Miklós/0000-0001-9884-9202; Tozser, Jozsef/0000-0003-0274-0056; Csosz, Eva/0000-0003-4373-2175	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [TAMOP-4.2.2.D-15/1/KONV-2015-0016]; European Social Fund; Hungarian Scientific Research Fund [OTKA K105034]; Astellas Pharma Ltd. Fellowship	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Social Fund(European Social Fund (ESF)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Astellas Pharma Ltd. Fellowship(Astellas Pharmaceuticals)	This work was supported in part by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, TAMOP-4.2.2.D-15/1/KONV-2015-0016 project implemented through the New Szechenyi Plan co-financed by the European Social Fund, and Hungarian Scientific Research Fund OTKA K105034. Gergo Kallo is receiver of Astellas Pharma Ltd. Fellowship in form of support for chemicals and consumables, which does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, TAMOP-4.2.2.D-15/1/KONV-2015-0016 project implemented through the New Szechenyi Plan co-financed by the European Social Fund, and Hungarian Scientific Research Fund OTKA K105034. Gergo Kallo is receiver of Astellas Pharma Ltd. Fellowship in form of support for chemicals and consumables which does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of Dr. Maria Fera for sample collection is greatly acknowledged.	Arduino PG, 2015, INT J BIOL MARKER, V30, pE262, DOI 10.5301/jbm.5000142; Arellano-Garcia MT, 2008, ORAL DIS, V14, P705, DOI 10.1111/j.1601-0825.2008.01488.x; Balan JJ, J CONT DENT PRACT, V13, P671; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell RB, 2015, J ORAL MAXIL SURG, V73, pS107, DOI 10.1016/j.joms.2015.05.026; Bonifazi M, 2011, ORAL ONCOL, V47, P400, DOI 10.1016/j.oraloncology.2010.06.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Carstensen B, 2015, PACKAGE STAT ANAL EP; Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Chen YC, 2002, RAPID COMMUN MASS SP, V16, P364, DOI 10.1002/rcm.588; Cheng YSL, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-3; Cheng YSL, 2011, ORAL ONCOL, V47, P1122, DOI 10.1016/j.oraloncology.2011.07.032; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Clough T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S6; Contucci AM, 2005, ORAL DIS, V11, P95, DOI 10.1111/j.1601-0825.2004.01057.x; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; de Jong EP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011148; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062092; Eiro N, 2012, WORLD J GASTRO SURG, V4, P62, DOI 10.4240/wjgs.v4.i3.62; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Franzmann EJ, 2007, CANCER EPIDEM BIOMAR, V16, P1348, DOI 10.1158/1055-9965.EPI-06-0011; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110378; Garavello W, 2010, INT J CANCER, V127, P160, DOI 10.1002/ijc.25019; Gorugantula LM, 2012, OR SURG OR MED OR PA, V114, P215, DOI 10.1016/j.oooo.2012.03.013; Grogan TM, 2000, HUM PATHOL, V31, P475, DOI 10.1053/hp.2000.6546; He H, 2009, J CANCER RES CLIN, V135, P1315, DOI 10.1007/s00432-009-0572-x; He QY, 2004, PROTEOMICS, V4, P271, DOI 10.1002/pmic.200300550; Hermann P, 2009, J CLIN PERIODONTOL, V36, P449, DOI 10.1111/j.1600-051X.2009.01395.x; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huang JS, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2265-6; Jessie K, 2013, ELECTROPHORESIS, V34, P2495, DOI 10.1002/elps.201300107; Jinno T, 2015, ONCOL REP, V33, P2161, DOI 10.3892/or.2015.3838; Jou YJ, 2014, CLIN CHIM ACTA, V436, P121, DOI 10.1016/j.cca.2014.05.009; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kallo G, 2016, J PROTEOMICS, V1874-3919, P30364; Katakura Akira, 2007, Bull Tokyo Dent Coll, V48, P199, DOI 10.2209/tdcpublication.48.199; Kawahara R, 2016, PROTEOMICS, V16, P159, DOI 10.1002/pmic.201500224; Kawai H, 2011, TUMOR BIOL, V32, P641, DOI 10.1007/s13277-011-0163-8; Komohara Y, 2016, ADV DRUG DELIVER REV, V99, P180, DOI 10.1016/j.addr.2015.11.009; Korostoff A, 2011, ORAL ONCOL, V47, P282, DOI 10.1016/j.oraloncology.2011.02.006; La Vecchia C, 2004, ORAL ONCOL, V40, P433, DOI 10.1016/j.oraloncology.2003.09.013; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Leanderson T, 2012, ONCOIMMUNOLOGY, V1, P1404, DOI 10.4161/onci.21027; Lisa Cheng YS, 2014, J PERIODONTOL, V85, P956, DOI DOI 10.1902/J0P.2013.130320; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Madlena M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-364; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Marton IJ, 2014, J ENDODONT, V40, P155, DOI 10.1016/j.joen.2013.10.036; Mascitti M SA, 2013, J CARCINOG MUTAGEN O, V2013; Mizukawa N, 1998, ANTICANCER RES, V18, P4645; Nagler R, 2006, CLIN CANCER RES, V12, P3979, DOI 10.1158/1078-0432.CCR-05-2412; Noike T, 2008, HUM PATHOL, V39, P201, DOI 10.1016/j.humpath.2007.04.024; Pan S, 2012, J PROTEOME RES, V11, P1937, DOI 10.1021/pr201117w; Pickering V, 2007, ORAL ONCOL, V43, P37, DOI 10.1016/j.oraloncology.2005.12.027; Piva MR, 2013, ONCOL LETT, V5, P1909, DOI 10.3892/ol.2013.1302; Punyani SR, 2013, CLIN ORAL INVEST, V17, P517, DOI 10.1007/s00784-012-0723-3; Raffel J, 2003, J LAB CLIN MED, V142, P46, DOI 10.1016/S0022-2143(03)00068-4; Rhodus NL, 2005, MOL CARCINOGEN, V44, P77, DOI 10.1002/mc.20113; Rhodus NL, 2004, CANCER DETECT PREV, V29, P42, DOI 10.1016/j.cdp.2004.10.003; Rodriguez H, 2010, PROTEOM CLIN APPL, V4, P904, DOI 10.1002/prca.201000057; SahebJamee M, 2008, MED ORAL PATOL ORAL, V13, pE292; Sato J, 2010, ORAL SURG ORAL MED O, V110, P330, DOI 10.1016/j.tripleo.2010.03.040; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Shetty SR, 2012, J CANCER RES THER, V8, P123, DOI 10.4103/0973-1482.92226; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Shpitzer T, 2007, J CANCER RES CLIN, V133, P613, DOI 10.1007/s00432-007-0207-z; SHULTZ EK, 1995, CLIN CHEM, V41, P1248; Skrinjar I, 2015, MED ORAL PATOL ORAL, V20, pE402, DOI 10.4317/medoral.20373; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Streckfus CF, 2008, CANCER INVEST, V26, P159, DOI 10.1080/07357900701783883; Suba Zsuzsanna, 2009, Fogorv Sz, V102, P63; Thiel UJE, 2011, J ORAL PATHOL MED, V40, P369, DOI 10.1111/j.1600-0714.2010.00982.x; Thumbigere-Math V, 2015, ORAL DIS, V21, P46, DOI 10.1111/odi.12204; Van Raemdonck G, 2014, VIROLOGY, V458, P11, DOI 10.1016/j.virol.2014.04.015; Vucicevic Boras V, 2005, Minerva Stomatol, V54, P569; Walsh T, 1996, COCHRANE DATABASE SY; Warnakulasuriya S, 2000, J PATHOL, V192, P52; Wu CC, 2015, PROTEOMICS, V15, P3394, DOI 10.1002/pmic.201500157; Wu W, 2012, PROTEOM CLIN APPL, V6, P152, DOI 10.1002/prca.201100050; Zhang H, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-30	83	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177282	10.1371/journal.pone.0177282	http://dx.doi.org/10.1371/journal.pone.0177282			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545132	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000401672400034
J	Jacob, K; Rasmussen, A; Tyler, P; Servos, MM; Sylla, M; Prado, C; Daniele, E; Sharp, JS; Purdy, AE				Jacob, Kristin; Rasmussen, Anna; Tyler, Paul; Servos, Mariah M.; Sylla, Mariame; Prado, Cecilia; Daniele, Elizabeth; Sharp, Josh S.; Purdy, Alexandra E.			Regulation of acetyl-CoA synthetase transcription by the CrbS/R two-component system is conserved in genetically diverse environmental pathogens	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HYBRID SENSOR KINASE; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; CYSTIC-FIBROSIS; ORAL INFECTION; HOST; VIRULENCE	The CrbS/R two-component signal transduction system is a conserved regulatory mechanism through which specific Gram-negative bacteria control acetate flux into primary metabolic pathways. CrbS/R governs expression of acetyl-CoA synthase (acsA), an enzyme that converts acetate to acetyl-CoA, a metabolite at the nexus of the cell's most important energy-harvesting and biosynthetic reactions. During infection, bacteria can utilize this system to hijack host acetate metabolism and alter the course of colonization and pathogenesis. In toxigenic strains of Vibrio cholerae, CrbS/R-dependent expression of acsA is required for virulence in an arthropod model. Here, we investigate the function of the CrbS/R system in Pseudomonas aeruginosa, Pseudomonas entomophila, and non-toxigenic V. cholerae strains. We demonstrate that its role in acetate metabolism is conserved; this system regulates expression of the acsA gene and is required for growth on acetate as a sole carbon source. As a first step towards describing the mechanism of signaling through this pathway, we identify residues and domains that may be critical for phosphotransfer. We further demonstrate that although CrbS, the putative hybrid sensor kinase, carries both a histidine kinase domain and a receiver domain, the latter is not required for acsA transcription. In order to determine whether our findings are relevant to pathogenesis, we tested our strains in a Drosophila model of oral infection previously employed for the study of acetate-dependent virulence by V. cholerae. We show that non-toxigenic V. cholerae strains lacking CrbS or CrbR are significantly less virulent than are wild-type strains, while P. aeruginosa and P. entomophila lacking CrbS or CrbR are fully pathogenic. Together, the data suggest that the CrbS/R system plays a central role in acetate metabolism in V. cholerae, P. aeruginosa, and P. entomophila. However, each microbe's unique environmental adaptations and pathogenesis strategies may dictate conditions under which CrbS/R-mediated acs expression is most critical.	[Jacob, Kristin; Sharp, Josh S.] Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Rasmussen, Anna; Tyler, Paul; Servos, Mariah M.; Sylla, Mariame; Prado, Cecilia; Daniele, Elizabeth; Purdy, Alexandra E.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Jacob, Kristin] Univ Michigan, Ann Arbor, MI 48109 USA; [Rasmussen, Anna] Stanford Univ, Dept Earth Syst Sci, Palo Alto, CA 94304 USA; [Tyler, Paul] Yale Univ, Yale Combined Program Biol & Biomed Sci, New Haven, CT USA; [Servos, Mariah M.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Sylla, Mariame] Harvard Med Sch, Boston, MA USA	Northern Michigan University; Amherst College; University of Michigan System; University of Michigan; Stanford University; Yale University; Dartmouth College; Harvard University; Harvard Medical School	Sharp, JS (corresponding author), Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA.; Purdy, AE (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	jsharp@nmu.edu; apurdy@amherst.edu		Rasmussen, Anna/0000-0002-0031-2835	Amherst College; Northern Michigan University	Amherst College; Northern Michigan University	The authors received funding from start up funds from Amherst College and Northern Michigan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007167; Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Borisova SA, 2011, J BIOL CHEM, V286, P22283, DOI 10.1074/jbc.M111.237735; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; DORING G, 1983, J INFECT DIS, V147, P744, DOI 10.1093/infdis/147.4.744; Fauvarque Marie-Odile, 2014, Cell Microbiol, V16, P824, DOI 10.1111/cmi.12292; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Freeman JA, 2000, MOL MICROBIOL, V35, P139, DOI 10.1046/j.1365-2958.2000.01684.x; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Geszvain K, 2008, J BACTERIOL, V190, P4437, DOI 10.1128/JB.00055-08; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hang SY, 2014, CELL HOST MICROBE, V16, P592, DOI 10.1016/j.chom.2014.10.006; He K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004002; Hentchel KL, 2015, MICROBIOL MOL BIOL R, V79, P321, DOI 10.1128/MMBR.00020-15; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Jimenez-Pearson MA, 2005, MICROBIOL-SGM, V151, P3299, DOI 10.1099/mic.0.28217-0; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kim MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0418-4; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110; Korycinski M, 2015, J MOL BIOL, V427, P3327, DOI 10.1016/j.jmb.2015.08.017; Kretzschmar U, 2010, ARCH MICROBIOL, V192, P685, DOI 10.1007/s00203-010-0593-5; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mulcahy H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002299; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Panayidou S, 2014, VIRULENCE, V5, P253, DOI 10.4161/viru.27524; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Vallet-Gely I, 2010, CELL MICROBIOL, V12, P1666, DOI 10.1111/j.1462-5822.2010.01501.x; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Walker KA, 2010, J BACTERIOL, V192, P5887, DOI 10.1128/JB.00745-10; Wang F- F, 2013, ENVIRON MICROBIOL, V18, P1534; Watve SS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01396-16; Wise AA, 2010, J BACTERIOL, V192, P1534, DOI 10.1128/JB.01007-09; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zaoui C, 2012, MOL MICROBIOL, V83, P536, DOI 10.1111/j.1365-2958.2011.07947.x; Zhang XX, 2015, J BACTERIOL, V197, P2867, DOI 10.1128/JB.00361-15	67	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177825	10.1371/journal.pone.0177825	http://dx.doi.org/10.1371/journal.pone.0177825			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542616	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400091
J	De Laet, T; Papageorgiou, E; Nieuwenhuys, A; Desloovere, K				De Laet, Tinne; Papageorgiou, Eirini; Nieuwenhuys, Angela; Desloovere, Kaat			Does expert knowledge improve automatic probabilistic classification of gait joint motion patterns in children with cerebral palsy?	PLOS ONE			English	Article							BAYESIAN-APPROACH	Background This study aimed to improve the automatic probabilistic classification of joint motion gait patterns in children with cerebral palsy by using the expert knowledge available via a recently developed Delphi-consensus study. To this end, this study applied both Naive Bayes and Logistic Regression classification with varying degrees of usage of the expert knowledge (expert-defined and discretized features). A database of 356 patients and 1719 gait trials was used to validate the classification performance of eleven joint motions. Hypotheses Two main hypotheses stated that: (1) Joint motion patterns in children with CP, obtained through a Delphi-consensus study, can be automatically classified following a probabilistic approach, with an accuracy similar to clinical expert classification, and (2) The inclusion of clinical expert knowledge in the selection of relevant gait features and the discretization of continuous features increases the performance of automatic probabilistic joint motion classification. Findings This study provided objective evidence supporting the first hypothesis. Automatic probabilistic gait classification using the expert knowledge available from the Delphi-consensus study resulted in accuracy (91%) similar to that obtained with two expert raters (90%), and higher accuracy than that obtained with non-expert raters (78%). Regarding the second hypothesis, this study demonstrated that the use of more advanced machine learning techniques such as automatic feature selection and discretization instead of expert-defined and discretized features can result in slightly higher joint motion classification performance. However, the increase in performance is limited and does not outweigh the additional computational cost and the higher risk of loss of clinical interpretability, which threatens the clinical acceptance and applicability.	[De Laet, Tinne] Katholieke Univ Leuven, Fac Engn Sci, Leuven, Belgium; [Papageorgiou, Eirini; Nieuwenhuys, Angela; Desloovere, Kaat] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci FaBeR, Dept Rehabil Sci, Leuven, Belgium; [Desloovere, Kaat] UZ Leuven, Univ Hosp Leuven, CERM, Clin Mot Anal Lab, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	De Laet, T (corresponding author), Katholieke Univ Leuven, Fac Engn Sci, Leuven, Belgium.	Tinne.DeLaet@kuleuven.be	Desloovere, Kaat/F-3240-2014; De Laet, Tinne/AAK-8612-2020	Desloovere, Kaat/0000-0002-8507-5276; De Laet, Tinne/0000-0003-0624-3305	'Onderzoekstoelage' (OT) of KU Leuven university [OT/12/100]; MD Paedigree project, a Model-Driven Paediatric European Digital Repository; European Commission under FP7 - ICT Programme [600932]	'Onderzoekstoelage' (OT) of KU Leuven university; MD Paedigree project, a Model-Driven Paediatric European Digital Repository; European Commission under FP7 - ICT Programme	AN is supported by an 'Onderzoekstoelage' (OT) of KU Leuven university (OT/12/100). EP is supported by the MD Paedigree project, a Model-Driven Paediatric European Digital Repository, partially funded by the European Commission under FP7 - ICT Programme (grant agreement no: 600932, http://www.md-paedigree.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Chau T, 2001, GAIT POSTURE, V13, P49, DOI 10.1016/S0966-6362(00)00094-1; Dobson F, 2007, GAIT POSTURE, V25, P140, DOI 10.1016/j.gaitpost.2006.01.003; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Fayyad UM, 1993, P INT JOINT C UNC AI, P1022; Herrera F, 2015, DATA PREPROCESSING D; Koller D., 2009, PROBABILISTIC GRAPHI; Lofterod B, 2008, DEV MED CHILD NEUROL, V50, P503, DOI 10.1111/j.1469-8749.2008.03018.x; Murphy P., 2012, MACHINE LEARNING PRO; Nieuwenhuys A, 2017, PLOS ONE; Nieuwenhuys A, 2017, DEV MED CHILD NEUROL; Nieuwenhuys A, 2016, CONSENSUS BASED CLAS; Nieuwenhuys A, 2016, DEV MED CHILD NEUROL, V58, P306, DOI 10.1111/dmcn.12892; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Van Gestel L, 2011, RES DEV DISABIL, V32, P2542, DOI 10.1016/j.ridd.2011.07.004; Witten IH, 2011, MOR KAUF D, P1; Wren TAL, 2011, GAIT POSTURE, V34, P364, DOI 10.1016/j.gaitpost.2011.06.002; Zhang BL, 2009, PATTERN RECOGN, V42, P581, DOI 10.1016/j.patcog.2008.09.025	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178378	10.1371/journal.pone.0178378	http://dx.doi.org/10.1371/journal.pone.0178378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570616	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800042
J	Mastropasqua, R; Nubile, M; Salgari, N; Lanzini, M; Calienno, R; Mattei, PA; Sborgia, A; Agnifili, L				Mastropasqua, Rodolfo; Nubile, Mario; Salgari, Niccolo; Lanzini, Manuela; Calienno, Roberta; Mattei, Peter A.; Sborgia, Alessandra; Agnifili, Luca			Interference figures of polarimetric interferometry analysis of the human corneal stroma	PLOS ONE			English	Article							SCANNING LASER POLARIMETRY; X-RAY-DIFFRACTION; COLLAGEN ORIENTATION; IN-VIVO; POLARIZATION; ORGANIZATION; LAMELLAE; EYES; KERATOCONUS; MICROSCOPY	A rotating polarimetric 90 degrees-cross linear-filter interferometry system was used to detect the morphological characteristics and features of interference patterns produced in in-vivo corneal stroma in healthy human corneas of 23 subjects. The characteristic corneal isogyres presenting with an evident cross-shaped pattern, grossly aligned with the fixation axis, were observed in all patients with centers within the pupillary dark area, impeding the exact determination of the center point. During the rotational scan in 78.3% of the eyes the cross-shaped pattern of the isogyre gradually separated to form two distinct hyperbolic arcs in opposite quadrants, reaching their maximal separation at 45 degrees with respect to angle of cross-shaped pattern formation. The corneal cross and hyperbolic-pattern repeated every 90 degrees throughout the 360 degrees rotational scan. While the interpretation of the isogyres presents particular difficulties, two summary parameters can be extracted for each cornea: the presence/orientation of a single or two dark areas in post-processed images and isochromes. However, the development of dedicated software for semi-quantitative analysis of these parameters and enantiomorphism may become available in the near future. The possible application of polarimetric interferometry in the field of both corneal pathologies and corneal surgery may be of great interest for clinical purposes.	[Mastropasqua, Rodolfo] Univ Verona, Ophthalmol Unit, Dept Neurol Neuropsychol Morphol & Movement Sci, Verona, Italy; [Nubile, Mario; Salgari, Niccolo; Lanzini, Manuela; Calienno, Roberta; Mattei, Peter A.; Agnifili, Luca] Univ G DAnnunzio, Natl Ctr High Technol CNAT Ophthalmol, Chieti, Italy; [Sborgia, Alessandra] Univ Bari, Ophthalmol Dept, Bari, Italy	University of Verona; G d'Annunzio University of Chieti-Pescara; Universita degli Studi di Bari Aldo Moro	Nubile, M (corresponding author), Univ G DAnnunzio, Natl Ctr High Technol CNAT Ophthalmol, Chieti, Italy.	m.nubile@unich.it	Mastropasqua, Rodolfo/AAC-6453-2022; Agnifili, Luca/AAC-6345-2022; Salgari, Niccolò/ABH-6817-2020	Salgari, Niccolò/0000-0001-9766-3668				Abahussin M, 2009, INVEST OPHTH VIS SCI, V50, P5159, DOI 10.1167/iovs.09-3669; Aghamohammadzadeh H, 2004, STRUCTURE, V12, P249, DOI 10.1016/j.str.2004.01.002; Bone RA, 2007, APPL OPTICS, V46, P8351, DOI 10.1364/AO.46.008351; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; COPE WT, 1978, J OPT SOC AM, V68, P1139, DOI 10.1364/JOSA.68.001139; Daxer A, 1997, INVEST OPHTH VIS SCI, V38, P121; Greenfield DS, 2000, AM J OPHTHALMOL, V129, P715, DOI 10.1016/S0002-9394(00)00353-6; Iovieno A, 2016, CORNEA, V35, P519, DOI 10.1097/ICO.0000000000000776; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Lombardo M, 2006, J OPT SOC AM A, V23, P777, DOI 10.1364/JOSAA.23.000777; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; MEEK KM, 1987, CURR EYE RES, V6, P841, DOI 10.3109/02713688709034853; Misson GP, 2007, OPHTHAL PHYSL OPT, V27, P256, DOI 10.1111/j.1475-1313.2007.00482.x; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; NAYLOR EJ, 1953, BRIT J OPHTHALMOL, V37, P77, DOI 10.1136/bjo.37.2.77; PIERSCIONEK BK, 1993, OPHTHAL PHYSL OPT, V13, P91, DOI 10.1111/j.1475-1313.1993.tb00431.x; Pierscionek BK, 1996, EXP EYE RES, V62, P573, DOI 10.1006/exer.1996.0067; Pierscionek BK, 1998, APPL OPTICS, V37, P6845, DOI 10.1364/AO.37.006845; Pierscionek BK, 1997, EYE, V11, P361, DOI 10.1038/eye.1997.76; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; Radner W, 2002, CORNEA, V21, P598, DOI 10.1097/00003226-200208000-00013; Saad A, 2014, J REFRACT SURG, V30, P542, DOI 10.3928/1081597X-20140711-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STANWORTH A., 1950, BRIT JOUR OPHTHALMOL, V34, P201, DOI 10.1136/bjo.34.4.201; Swatland HJ, 2009, BIOTECH HISTOCHEM, V84, P329, DOI 10.3109/10520290903081369; VANBLOKLAND GJ, 1987, J OPT SOC AM A, V4, P82, DOI 10.1364/JOSAA.4.000082; Weinreb RN, 2002, J GLAUCOMA, V11, P378, DOI 10.1097/00061198-200210000-00002; Weinreb RN, 2002, ARCH OPHTHALMOL-CHIC, V120, P901, DOI 10.1001/archopht.120.7.901; WILSON SE, 1991, CORNEA, V10, P2	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178397	10.1371/journal.pone.0178397	http://dx.doi.org/10.1371/journal.pone.0178397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570631	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800049
J	Muuronen, AT; Taina, M; Onatsu, J; Korhonen, M; Pulkki, K; Jakala, P; Vanninen, R; Mustonen, P				Muuronen, Antti Tapani; Taina, Mikko; Onatsu, Juha; Korhonen, Miika; Pulkki, Kari; Jakala, Pekka; Vanninen, Ritva; Mustonen, Pirjo			vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR LEVELS INCREASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; ENDOTHELIAL DYSFUNCTION; VONWILLEBRAND-FACTOR; COMPUTED-TOMOGRAPHY; RISK-FACTOR; OBESITY	Aims A chronically elevated level of von Willebrand factor (vWF) is a common finding in patients with cardiovascular diseases. Obesity is a well-recognized risk factor for thrombotic cardiovascular complications including ischemic stroke, and it has been linked with increased plasma vWF. We evaluated whether elevated plasma levels of vWF associate with areas of visceral (VAT), pericardial (PAT), and subcutaneous adipose tissue (SAT) compartments in patients with acute/subacute stroke. Methods and results A total of 69 patients with stroke of suspected cardiogenic etiology were examined. The plasma level of vWF antigen (vWF-ag) was measured both in the acute phase and in the chronic phase three months after stroke. The areas of VAT and/or PAT were assessed with computed tomography. As expected, in stroke patients, the levels of plasma vWF-ag were significantly higher than in the national reference population both in the acute and in the chronic phase. The level of vWF-ag in the chronic phase correlated with the amounts of VAT and PAT, but not with subcutaneous adipose tissue. Conclusions These results agree with previous observations of the chronic inflammation/prothrombotic tendency in patients with cerebrovascular disease. Future studies should seek to clarify the role of visceral type adipose tissue in the pathophysiology of ischemic stroke.	[Muuronen, Antti Tapani; Taina, Mikko; Korhonen, Miika; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, Diagnost Imaging Ctr, Kuopio, Finland; [Muuronen, Antti Tapani; Taina, Mikko; Korhonen, Miika; Vanninen, Ritva] Univ Eastern Finland, Inst Clin Med, Unit Radiol, Kuopio, Finland; [Muuronen, Antti Tapani; Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Med, Jyvaskyla, Finland; [Onatsu, Juha; Jakala, Pekka] Kuopio Univ Hosp, Neuro Ctr, Kuopio, Finland; [Pulkki, Kari] Univ Eastern Finland, Dept Clin Chem, Kuopio, Finland; [Pulkki, Kari] Eastern Finland Lab Ctr, Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Unit Neurol, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Muuronen, AT (corresponding author), Kuopio Univ Hosp, Dept Clin Radiol, Diagnost Imaging Ctr, Kuopio, Finland.; Muuronen, AT (corresponding author), Univ Eastern Finland, Inst Clin Med, Unit Radiol, Kuopio, Finland.; Muuronen, AT (corresponding author), Keski Suomi Cent Hosp, Dept Med, Jyvaskyla, Finland.	Antti.Muuronen@kuh.fi		Pulkki, Kari/0000-0003-0690-9883	Kuopio University Hospital [5063519, 5063535]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grants number 5063519 and 5063535). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bays HE, 2013, J CLIN LIPIDOL, V7, P304, DOI 10.1016/j.jacl.2013.04.001; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P1104; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Hanson E, 2011, J THROMB HAEMOST, V9, P275, DOI 10.1111/j.1538-7836.2010.04134.x; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; JANSSON JH, 1991, BRIT HEART J, V66, P351; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Mertens I, 2006, METABOLISM, V55, P650, DOI 10.1016/j.metabol.2006.01.001; Montalescot G, 1998, CIRCULATION, V98, P294, DOI 10.1161/01.CIR.98.4.294; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Muuronen AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120598; Nakamura Y, 2003, THROMB RES, V111, P137, DOI 10.1016/S0049-3848(03)00405-5; Nguyen NT, 2011, OBES SURG, V21, P351, DOI 10.1007/s11695-010-0335-4; Peyvandi F, 2011, BLOOD TRANSFUS-ITALY, V9, pS3, DOI 10.2450/2011.002S; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Sakai H, 2000, THROMB HAEMOSTASIS, V84, P204; Schafer K, 2011, HELL J CARDIOL, V52, P327; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; Suk SH, 2003, STROKE, V34, P1586, DOI 10.1161/01.STR.0000075294.98582.2F; Taina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090903; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; van Schie MC, 2011, BLOOD, V117, P1393, DOI 10.1182/blood-2010-03-273961; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Wheeler GL, 2005, INVEST RADIOL, V40, P97, DOI 10.1097/00004424-200502000-00007; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178508	10.1371/journal.pone.0178508	http://dx.doi.org/10.1371/journal.pone.0178508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570705	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800068
J	Chertkova, RV; Brazhe, NA; Bryantseva, TV; Nekrasov, AN; Dolgikh, DA; Yusipovich, AI; Sosnovtseva, O; Maksimov, GV; Rubin, AB; Kirpichnikov, MP				Chertkova, Rita V.; Brazhe, Nadezda A.; Bryantseva, Tatiana V.; Nekrasov, Alexey N.; Dolgikh, Dmitry A.; Yusipovich, Alexander I.; Sosnovtseva, Olga; Maksimov, Georgy V.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.			New insight into the mechanism of mitochondrial cytochrome c function	PLOS ONE			English	Article							ENHANCED RAMAN-SPECTROSCOPY; ELECTRON-TRANSFER; INFORMATIONAL STRUCTURE; INTERACTION DOMAIN; OXIDASE; PROTEINS; COMPLEX; DEFINITION; BINDING; STATE	We investigate functional role of the P(76)GTKMIFA(83) fragment of the primary structure of cytochrome c. Based on the data obtained by the analysis of informational structure (ANIS), we propose a model of functioning of cytochrome c. According to this model, conformational rearrangements of the P(78)GTKMIFA(83) loop fragment have a significant effect on conformational mobility of the heme. It is suggested that the conformational mobility of cytochrome c heme is responsible for its optimal orientation with respect to electron donor and acceptor within ubiquinol cytochrome coxidoreductase (complex III) and cytochrome coxidase (complex IV), respectively, thus, ensuring electron transfer from complex III to complex IV. To validate the model, we design several mutant variants of horse cytochrome c with multiple substitutions of amino acid residues in the P(78)GTKMIFA(83) sequence that reduce its ability to undergo conformational rearrangements. With this, we study the succinate cytochrome c reductase and cytochrome coxidase activities of rat liver mitoplasts in the presence of mutant variants of cytochrome c. The electron transport activity of the mutant variants decreases to different extent. Resonance Raman spectroscopy (RRS) and surface-enhanced Raman spectroscopy (SERS) data demonstrate, that all mutant cytochromes possess heme with the higher degree of ruffling deformation, than that of the wild type (WT) cytochrome c. The increase in the ruffled deformation of the heme of oxidized cytochromes correlated with the decrease in the electron transport rate of ubiquinol cytochrome c reductase (complex III). Besides, all mutant cytochromes have lower mobility of the pyrrol rings and methine bridges, than WT cytochrome c. We show that a decrease in electron transport activity in the mutant variants correlates with conformational changes and reduced mobility of heme porphyrin. This points to a significant role of the P(78)GTKMIFA(83) fragment in the electron transport function of cytochrome c.	[Chertkova, Rita V.; Bryantseva, Tatiana V.; Nekrasov, Alexey N.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Brazhe, Nadezda A.; Bryantseva, Tatiana V.; Dolgikh, Dmitry A.; Yusipovich, Alexander I.; Maksimov, Georgy V.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Biol Fac, Biophys Dept, Moscow, Russia; [Sosnovtseva, Olga] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; University of Copenhagen	Chertkova, RV (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Brazhe, NA (corresponding author), Moscow MV Lomonosov State Univ, Biol Fac, Biophys Dept, Moscow, Russia.	cherita@inbox.ru; nadezda.brazhe@biophys.msu.ru	Dolgikh, Dmitry A/F-2369-2014; Sosnovtseva, Olga/H-5115-2016; Yusipovich, Alexander I/R-1847-2016; Chertkova, Rita/AAX-7288-2020; Nekrasov, Alexei/S-1322-2016	Sosnovtseva, Olga/0000-0001-7334-9869; Kirpichnikov, Mikhail/0000-0001-8170-1607; Yusipovich, Alexander/0000-0002-7896-9845; Nekrasov, Alexei/0000-0001-6814-3735; Parshina, Evgenia/0000-0001-7072-0693	Program for Molecular and Cellular Biology of the Russian Academy of Sciences; Program for fundamental research of the Russian Academy of Sciences Presidium in strategic directions of science development "The Fundamental Problems of Mathematical Simulation" on the topic "The Mathematical Mode; Moscow Government [15-34-70028_mol-a-mos]; Russian Foundation for Basic Research	Program for Molecular and Cellular Biology of the Russian Academy of Sciences; Program for fundamental research of the Russian Academy of Sciences Presidium in strategic directions of science development "The Fundamental Problems of Mathematical Simulation" on the topic "The Mathematical Mode; Moscow Government; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study was supported by the Program for Molecular and Cellular Biology of the Russian Academy of Sciences (RVC, TVB, DAD, MPK), the Program for fundamental research of the Russian Academy of Sciences Presidium in strategic directions of science development "The Fundamental Problems of Mathematical Simulation" on the topic "The Mathematical Model of Spatial Organization for Native Polypeptide Chains Based on the Informational Content of the Primary Structure" (ANN), and by the Russian Foundation for Basic Research and Moscow Government (grant 15-34-70028_mol-a-mos) (NAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Program for Molecular and Cellular Biology of the Russian Academy of Sciences and the Program for fundamental research of the Russian Academy of Sciences Presidium in strategic directions of science development "The Fundamental Problems of Mathematical Simulation" on the topic "The Mathematical Model of Spatial Organization for Native Polypeptide Chains Based on the Informational Content of the Primary Structure". NAB acknowledges the financial support from Russian Foundation for Basic Research and Moscow Government (project 15-34-70028_mol-a-mos).	ADAR F, 1977, FEBS LETT, V80, P195, DOI 10.1016/0014-5793(77)80438-9; [Anonymous], 1997, QUIKCHANGE SIT DIR M; BABUL J, 1972, BIOCHEMISTRY-US, V11, P1195, DOI 10.1021/bi00757a013; Banci L., 2001, HDB METALLOPROTEINS; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Bortolotti C, 2007, J PHYS CHEM C, V111, P12100, DOI 10.1021/jp072813g; Brazhe NA, 2013, J RAMAN SPECTROSC, V44, P686, DOI 10.1002/jrs.4274; Brazhe NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13793; Brazhe NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070488; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; Brazhe NA, 2009, BIOPHYS J, V97, P3206, DOI 10.1016/j.bpj.2009.09.029; Chertkova RV, 2008, MOL CELL BIOCHEM, V314, P85, DOI 10.1007/s11010-008-9768-7; Dolgikh DA, 1998, BIOORG KHIM+, V24, P756; Dopner S, 1999, EUR J BIOCHEM, V261, P379, DOI 10.1046/j.1432-1327.1999.00249.x; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hoang L, 2003, J MOL BIOL, V331, P37, DOI 10.1016/S0022-2836(03)00698-3; Hsiao HC, 2007, J INORG BIOCHEM, V101, P1133, DOI 10.1016/j.jinorgbio.2007.04.012; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; Inoue T, 2003, J MOL BIOL, V333, P117, DOI 10.1016/j.jmb.2003.08.002; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; JORDAN T, 1995, PROTEIN SCI, V4, P716; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Leopold N, 2003, J PHYS CHEM B, V107, P5723, DOI 10.1021/jp027460u; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Liptak MD, 2010, J AM CHEM SOC, V132, P9753, DOI 10.1021/ja102098p; Liu WX, 2009, PROTEIN SCI, V18, P670, DOI 10.1002/pro.72; Ma JG, 1998, BIOCHEMISTRY-US, V37, P12431, DOI 10.1021/bi981189i; MOSKOVITS M, 1984, J PHYS CHEM-US, V88, P5526, DOI 10.1021/j150667a013; Nekrasov AN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P399, DOI 10.1134/S0006297909040075; Nekrasov A.N., 2014, P PROC 2 INT C THEOR, P1; Nekrasov AN, 2008, J BIOMOL STRUCT DYN, V25, P553, DOI 10.1080/07391102.2008.10507202; Nekrasov AN, 2007, J BIOMOL STRUCT DYN, V24, P455, DOI 10.1080/07391102.2007.10507133; Nekrasov AN, 2010, J BIOMOL STRUCT DYN, V28, P85, DOI 10.1080/07391102.2010.10507345; Nekrasov AN, 2004, J BIOMOL STRUCT DYN, V21, P615, DOI 10.1080/07391102.2004.10506952; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; Ostroverkhova T.V., 2011, MOSC U BIOL SCI B, V66, P65, DOI [10.3103/S0096392511020064, DOI 10.3103/S0096392511020064]; Ostroverkhova TV, 2010, COLLECTION SCI ARTIC, P138; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Pepelina T Iu, 2010, Bioorg Khim, V36, P98; Pepelina TY, 2009, BIOCHEMISTRY-MOSCOW+, V74, P625, DOI 10.1134/S0006297909060066; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; RIEDER R, 1980, J BIOL CHEM, V255, P4732; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT RA, 1995, CYTOCHROME C MULTIDI; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; SMITH HT, 1981, J BIOL CHEM, V256, P4984; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sun YH, 2014, P NATL ACAD SCI USA, V111, P6570, DOI 10.1073/pnas.1322274111; Sun YH, 2013, J PHYS CHEM B, V117, P9615, DOI 10.1021/jp404881k; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; TAKANO T, 1980, P NATL ACAD SCI-BIOL, V77, P6371, DOI 10.1073/pnas.77.11.6371; Vinogradov A., 1977, MANUAL PRACTICAL STU, P19; Volkov AN, 2012, J BIOMOL NMR, V52, P245, DOI 10.1007/s10858-012-9607-8; Wang KF, 1999, J BIOL CHEM, V274, P38042, DOI 10.1074/jbc.274.53.38042; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	59	26	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178280	10.1371/journal.pone.0178280	http://dx.doi.org/10.1371/journal.pone.0178280			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562658	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700051
J	Voigt, CC; Roeleke, M; Marggraf, L; Petersons, G; Voigt-Heucke, SL				Voigt, Christian C.; Roeleke, Manuel; Marggraf, Lara; Petersons, Gunars; Voigt-Heucke, Silke L.			Migratory bats respond to artificial green light with positive phototaxis	PLOS ONE			English	Article							PIPISTRELLUS-NATHUSII; CRYPTOCHROME 1; BIPOLAR CELLS; IMPACTS; MAGNETORECEPTION; VESPERTILIONIDAE; POLLUTION; STRATEGY; RETINA; ENERGY	Artificial light at night is spreading worldwide at unprecedented rates, exposing strictly nocturnal animals such as bats to a novel anthropogenic stressor. Previous studies about the effect of artificial light on bats focused almost exclusively on non-migratory species, yet migratory animals such as birds are known to be largely affected by light pollution. Thus, we conducted a field experiment to evaluate if bat migration is affected by artificial light at night. In late summer, we presented artificial green light of 520 nm wavelength to bats that were migrating south along the shoreline of the Baltic Sea. Using a light on-off treatment, we observed that the activity of Pipistrellus nathusfiand P. pygmaeus, the two most abundant migratory species at our site, increased by more than 50% in the light-on compared to the light-off treatment. We observed an increased number of feeding buzzes during the light-on compared to the light-off treatment for P. nathusii. However, feeding activity was low in general and did not increase disproportionately during the light-on treatment in relation to the overall echolocation call activity of bats. Further, P. nathusii were attracted towards the green light at a distance of about 23 m, which is way beyond the echolocation detection range for insects of Nathusius' bats. We therefore infer that migratory bats were not attracted to artificial green light because of high insect densities, but instead by positive phototaxis. We conclude that artificial light at night may potentially impact bat migration in a yet unrecognized way.	[Voigt, Christian C.; Roeleke, Manuel; Marggraf, Lara; Voigt-Heucke, Silke L.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany; [Voigt, Christian C.; Roeleke, Manuel; Voigt-Heucke, Silke L.] Free Univ Berlin, Inst Biol, AG Verhaltensbiol, Takustr 6, Berlin, Germany; [Marggraf, Lara] Univ Potsdam, Inst Biochem & Biol, Maulbeerallee 1, Potsdam, Germany; [Petersons, Gunars] Latvia Univ Agr, Fac Vet Med, Jelgava, Latvia	Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin; University of Potsdam; Latvia University of Life Sciences & Technologies	Voigt, CC (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany.; Voigt, CC (corresponding author), Free Univ Berlin, Inst Biol, AG Verhaltensbiol, Takustr 6, Berlin, Germany.	voigt@izw-berlin.de	Roeleke, Manuel/AAC-1734-2021	Roeleke, Manuel/0000-0001-5298-8071; Voigt, Christian/0000-0002-0706-3974; , Gunars/0000-0003-3914-3554	Oshino GmbH	Oshino GmbH	The funding was provided by Oshino GmbH with no commercial interest in the outcome of the experiment. Oshino GmbH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I, 1997, Z SAUGETIERKD, V62, P375; Ahlen I, 2009, J MAMMAL, V90, P1318, DOI 10.1644/09-MAMM-S-223R.1; [Anonymous], 2010, BATCORDER MANUAL V 2; Butz E, 2015, J COMP NEUROL, V523, P963, DOI 10.1002/cne.23726; CHILDS SB, 1981, ANIM BEHAV, V29, P1028, DOI 10.1016/S0003-3472(81)80056-5; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Dominoni DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085069; Du XL, 2014, PHOTOCHEM PHOTOBIOL, V90, P989, DOI 10.1111/php.12276; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gauthreaux Sidney A. Jr., 2006, P67; GEGGIE JF, 1985, CAN J ZOOL, V63, P263, DOI 10.1139/z85-040; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Kruger F, 2014, MOL ECOL, V23, P3672, DOI 10.1111/mec.12547; Kurvits T., 2011, LIVING PLANET CONNEC; Lacoeuilhe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103042; Lewanzik D, 2017, J APPL ECOL, V54, P264, DOI 10.1111/1365-2664.12758; Lewanzik D, 2014, J APPL ECOL, V51, P388, DOI 10.1111/1365-2664.12206; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lindecke O, 2015, BIOL LETT, V11, P20; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Mathews F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0124; Muller B, 2013, J NEUROSCI, V33, P1014, DOI 10.1523/JNEUROSCI.2072-12.2013; Muller B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006390; Niessner C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21848; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; Petersons G, 2004, MYOTIS, V41, P29; PETERSONS G., 2004, NYCTALUS, V3, P81; Poot H, 2008, ECOL SOC, V13; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Rich C., 2006, ECOLOGICAL CONSEQUEN; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Rowse E.G., 2016, P187; Russo D, 2016, ECOL INDIC, V66, P598, DOI 10.1016/j.ecolind.2016.02.036; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Rydell J, 2014, ACTA CHIROPTEROL, V16, P139, DOI 10.3161/150811014X683354; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Schoeman MC, 2016, ANIM CONSERV, V19, P120, DOI 10.1111/acv.12220; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Stone EL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0127; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Suba J, 2012, ACTA CHIROPTEROL, V14, P379, DOI 10.3161/150811012X661693; van Langevelde F, 2011, BIOL CONSERV, V144, P2274, DOI 10.1016/j.biocon.2011.06.004; Voigt CC, 2015, EUR J WILDLIFE RES, V61, P213, DOI 10.1007/s10344-015-0903-y; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Wiltschko R, 2009, DIRECTIONAL ORIENTAT; Wiltschko R, 2014, BIOSENSORS-BASEL, V4, P221, DOI 10.3390/bios4030221; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971	54	26	26	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177748	10.1371/journal.pone.0177748	http://dx.doi.org/10.1371/journal.pone.0177748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562607	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700025
J	Ahmed, S; Olsen, JE; Herrero-Fresno, A				Ahmed, Shahana; Olsen, John E.; Herrero-Fresno, Ana			The genetic diversity of commensal Escherichia coli strains isolated from non antimicrobial treated pigs varies according to age group	PLOS ONE			English	Article							VIRULENCE GENES; ANTIBIOTIC-RESISTANCE; NURSERY PIGS; PREVALENCE; DIARRHEA; DISEASE; HUMANS; CATTLE; RIVER	This is the first report on the genetic diversity of commensal E. coli from pigs reared in an antibiotic free production system and belonging to different age groups. The study investigated the genetic diversity and relationship of 900 randomly collected commensal E. coli strains from non-antimicrobial treated pigs assigned to five different age groups in a Danish farm. Fifty-two unique REP profiles were detected suggesting a high degree of diversity. The number of strains per pig ranged from two to 13. The highest and the lowest degree of diversity were found in the early weaners group (Shannon diversity index, H'of 2.22) and piglets (H'of 1.46) respectively. The REP profiles, R1, R7 and R28, were the most frequently observed in all age groups. E. co/istrains representing each REP profile and additional strains associated with the dominant profiles were subjected to PFGE and were assigned to 67 different genotypes. Whole genome sequence analysis of 52 isolates leading to unique REP profiles identified a high level of sequence variation. Six and six strains were assigned to sequence type ST10 and sequence type ST58, respectively. Virulence and antimicrobial resistance genes, as well as, genes associated with mobile genetic elements were commonly found among these commensal E. coli strains. Interestingly, strains yielding the three most common REP profiles clustered together in the SNPs phylogenetic tree, and such strains may represent the archetypal commensal E. coli in Danish pigs.	[Ahmed, Shahana; Olsen, John E.; Herrero-Fresno, Ana] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark	University of Copenhagen	Herrero-Fresno, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark.	ahefr@sund.ku.dk	Herrero Fresno, Ana/GLU-6728-2022; Olsen, John Elmerdahl/N-9271-2019	Ahmed, Shahana/0000-0002-4399-7774; Herrero-Fresno, Ana/0000-0001-5026-7852; Olsen, John Elmerdahl/0000-0001-6225-6587	Danish Council (Danmarks Strategiske Forskningsrad; DFS) [0603-00358B]	Danish Council (Danmarks Strategiske Forskningsrad; DFS)	This work was part of the project "Minimizing Antibiotic Resistance DevelopmentMINIRESIST" funded by the Danish Council (Danmarks Strategiske Forskningsrad; DFS). Grant number 0603-00358B.	Abd-El-Haleem D, 2002, J MICROBIOLOGICAL ME; Agerso Y, VOLUNTARY BAN CEPHAL; Anderson MA, 2006, APPL ENVIRON MICROB, V72, P6914, DOI 10.1128/AEM.01029-06; Bok E, 2013, POL J MICROBIOL, V62, P165, DOI 10.33073/pjm-2013-021; Byappanahalli MN, 2007, WATER RES, V41, P3649, DOI 10.1016/j.watres.2007.03.009; Catry B, 2003, J VET PHARMACOL THER, V26, P81, DOI 10.1046/j.1365-2885.2003.00463.x; Centers for Disease Control Prevention, 2013, STANDARD OPERATING P; Chandran A, 2013, APPL ENVIRON MICROB, V79, P7371, DOI 10.1128/AEM.02653-13; Chen PA, 2016, APPL ENVIRON MICROB, V82, P1889, DOI 10.1128/AEM.03222-15; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; Frydendahl K, 2002, VET MICROBIOL, V85, P169, DOI 10.1016/S0378-1135(01)00504-1; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Gordon DM, 2001, MICROBIOL-SGM, V147, P1079, DOI 10.1099/00221287-147-5-1079; Hamelin K, 2007, APPL ENVIRON MICROB, V73, P477, DOI 10.1128/AEM.01445-06; Hamelin K, 2006, APPL ENVIRON MICROB, V72, P4200, DOI 10.1128/AEM.00137-06; Hermann-Bank ML, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0419-4; Herrero-Fresno A, 2015, J APPL MICROBIOL, V119, P342, DOI 10.1111/jam.12840; Herrero-Fresno A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-016-0912-3; Herrero-Fresno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084566; Hoffmann SA, 2014, J FOOD SCI, V79, pM1175, DOI 10.1111/1750-3841.12477; Islam MZ, 2015, EPIDEMIOL INFECT, V143, P94, DOI 10.1017/S0950268814000351; Johnson LK, 2004, APPL ENVIRON MICROB, V70, P4478, DOI 10.1128/AEM.70.8.4478-4485.2004; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; KATOULI M, 1995, APPL ENVIRON MICROB, V61, P778, DOI 10.1128/AEM.61.2.778-783.1995; Khachatryan AR, 2006, APPL ENVIRON MICROB, V72, P4583, DOI 10.1128/AEM.02584-05; Laroche E, 2009, FEMS MICROBIOL ECOL, V68, P118, DOI 10.1111/j.1574-6941.2009.00655.x; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lucena F, 2003, J APPL MICROBIOL, V94, P808, DOI 10.1046/j.1365-2672.2003.01812.x; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333; Mohapatra BR, 2007, FEMS MICROBIOL LETT, V277, P98, DOI 10.1111/j.1574-6968.2007.00948.x; Mora A, 2012, VET MICROBIOL, V156, P347, DOI 10.1016/j.vetmic.2011.10.033; Patton TG, 2001, FEMS MICROBIOL LETT, V194, P19, DOI 10.1016/S0378-1097(00)00494-8; Sander A, 1998, J CLIN MICROBIOL, V36, P2973, DOI 10.1128/JCM.36.10.2973-2981.1998; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Sousa NG, 2005, J CLIN MICROBIOL, V43, P4696, DOI 10.1128/JCM.43.9.4696-4703.2005; SPENCER BT, 1989, J S AFR VET ASSOC, V60, P62; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Thomsen MCF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157718; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09	42	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178623	10.1371/journal.pone.0178623	http://dx.doi.org/10.1371/journal.pone.0178623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558003	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000058
J	Jiang, FP; Shen, YZ; Ma, CX; Zhang, XW; Cao, WD; Rui, YK				Jiang, Fuping; Shen, Yunze; Ma, Chuanxin; Zhang, Xiaowen; Cao, Weidong; Rui, Yukui			Effects of TiO2 nanoparticles on wheat (Triticum aestivum L.) seedlings cultivated under super-elevated and normal CO2 conditions	PLOS ONE			English	Article							NANO-ANATASE TIO2; OXIDE NANOPARTICLES; TOXICITY; GROWTH; PHYTOTOXICITY; PARTICLES; RESPONSES; PLANTS	Concerns over the potential risks of nanomaterials to ecosystem have been raised, as it is highly possible that nanomaterials could be released to the environment and result in adverse effects on living organisms. Carbon dioxide (CO2) is one of the main greenhouse gases. The level of CO2 keeps increasing and subsequently causes a series of environmental problems, especially for agricultural crops. In the present study, we investigated the effects of TiO2 NPs on wheat seedlings cultivated under super-elevated CO2 conditions (5000 mg/L CO2) and under normal CO2 conditions (400 mg/L CO2). Compared to the normal CO2 condition, wheat grown under the elevated CO2 condition showed increases of root biomass and large numbers of lateral roots. Under both CO2 cultivation conditions, the abscisic acid (ABA) content in wheat seedlings increased with increasing concentrations of TiO2 NPs. The indolepropioponic acid (IPA) and jasmonic acid (JA) content notably decreased in plants grown under super-elevated CO2 conditions, while the JA content increased with increasing concentrations of TiO2 NPs. Ti accumulation showed a doseresponse manner in both wheat shoots and roots as TiO2 NPs concentrations increased. Additionally, the presence of elevated CO2 significantly promoted Ti accumulation and translocation in wheat treated with certain concentrations of TiO2 NPs. This study will be of benefit to the understanding of the joint effects and physiological mechanism of high-CO2 and nanoparticle to terrestrial plants.	[Jiang, Fuping; Zhang, Xiaowen; Rui, Yukui] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China; [Shen, Yunze] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Ma, Chuanxin; Rui, Yukui] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA; [Ma, Chuanxin] Connecticut Agr Expt Stn, Dept Analyt Chem, New Haven, CT 06504 USA; [Cao, Weidong] Chinese Acad Agr Sci, Key Lab Plant Nutr & Fertilizer, Minist Agr PR China, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Cao, Weidong] Qinghai Univ, Qinghai Acad Agr & Forestry, Xining, Peoples R China	China Agricultural University; University of Massachusetts System; University of Massachusetts Amherst; Connecticut Agricultural Experiment Station; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Qinghai University	Rui, YK (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China.; Rui, YK (corresponding author), Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.	ruiyukui@163.com	Ma, Chuanxin/AFO-5267-2022	Ma, Chuanxin/0000-0001-5125-7322	National Natural Science Foundation of China [41371471, 41130526]; NSFC-Guangdong Joint Fund [U1401234]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-Guangdong Joint Fund	The project was supported by National Natural Science Foundation of China (No. 41371471 and No. 41130526) and NSFC-Guangdong Joint Fund (U1401234)	ADAM G, 1986, PHYTOCHEMISTRY, V25, P1787, DOI 10.1016/S0031-9422(00)81151-6; Asli S, 2009, PLANT CELL ENVIRON, V32, P577, DOI 10.1111/j.1365-3040.2009.01952.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrena R, 2009, CHEMOSPHERE, V75, P850, DOI 10.1016/j.chemosphere.2009.01.078; Castiglione MR, 2011, J NANOPART RES, V13, P2443, DOI 10.1007/s11051-010-0135-8; Chen XY, 2016, CHEM ENG J, V295, P192, DOI 10.1016/j.cej.2016.03.047; Corredor E, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-45; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Du WC, 2011, J ENVIRON MONITOR, V13, P822, DOI 10.1039/c0em00611d; El-Temsah YS, 2012, ENVIRON TOXICOL, V27, P42, DOI 10.1002/tox.20610; Feng YZ, 2013, ENVIRON SCI TECHNOL, V47, P9496, DOI 10.1021/es402109n; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gui X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134261; Guo SS, 2014, ACTA ASTRONAUT, V100, P140, DOI 10.1016/j.actaastro.2014.01.013; He P, 2005, J EXP BOT, V56, P1117, DOI 10.1093/jxb/eri103; Hedden P, 2016, SIGNAL ACHIEVEMENTS; Ji Y, 2017, PLANT PHYSIOL BIOCH, V110, P82, DOI 10.1016/j.plaphy.2016.05.010; JOHNSON HE, 1960, J ORG CHEM, V25, P569, DOI 10.1021/jo01074a020; Josko I, 2013, CHEMOSPHERE, V92, P91, DOI 10.1016/j.chemosphere.2013.02.048; Kende H, 1997, PLANT CELL, V9, P1197, DOI 10.1105/tpc.9.7.1197; Kurepa J, 2010, NANO LETT, V10, P2296, DOI 10.1021/nl903518f; Nhan LV, 2015, SCI REP-UK, V5, DOI 10.1038/srep11618; Lee CW, 2010, ENVIRON TOXICOL CHEM, V29, P669, DOI 10.1002/etc.58; Lee WM, 2012, CHEMOSPHERE, V86, P491, DOI 10.1016/j.chemosphere.2011.10.013; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Ma XM, 2010, SCI TOTAL ENVIRON, V408, P3053, DOI 10.1016/j.scitotenv.2010.03.031; Ma YH, 2010, CHEMOSPHERE, V78, P273, DOI 10.1016/j.chemosphere.2009.10.050; Mattiello A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01043; Miralles P, 2012, ENVIRON SCI TECHNOL, V46, P9224, DOI 10.1021/es202995d; Musante C, 2012, ENVIRON TOXICOL, V27, P510, DOI 10.1002/tox.20667; Roco MC, 2011, J NANOPART RES, V13, P897, DOI 10.1007/s11051-011-0275-5; Rui MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00815; Schwab F, 2016, NANOTOXICOLOGY, V10, P257, DOI 10.3109/17435390.2015.1048326; Shen YZ, 2014, ACTA ASTRONAUT, V105, P24, DOI 10.1016/j.actaastro.2014.08.024; Shigeta T, 2011, PLANT SIGNAL BEHAV, V6, P1824, DOI 10.4161/psb.6.11.17478; Song U, 2013, BIOL TRACE ELEM RES, V155, P93, DOI 10.1007/s12011-013-9765-x; Su MY, 2009, SPECTROCHIM ACTA A, V72, P1112, DOI 10.1016/j.saa.2009.01.010; Wang JJ, 2007, MUTAT RES-GEN TOX EN, V628, P99, DOI 10.1016/j.mrgentox.2006.12.003; Warheit DB, 2008, PHARMACOL THERAPEUT, V120, P35, DOI 10.1016/j.pharmthera.2008.07.001; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; WONG SC, 1991, AUST J PLANT PHYSIOL, V18, P137, DOI 10.1071/PP9910137; Yadav R. C., 2014, International Journal of Bio-resource and Stress Management, V5, P207, DOI 10.5958/0976-4038.2014.00557.0; Yadav RC, 2013, MASTER SCI SOIL SCI, P1; Yang F, 2007, BIOL TRACE ELEM RES, V119, P77, DOI 10.1007/s12011-007-0046-4; Zhang ZY, 2011, METALLOMICS, V3, P816, DOI 10.1039/c1mt00049g	47	36	38	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178088	10.1371/journal.pone.0178088	http://dx.doi.org/10.1371/journal.pone.0178088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558015	gold, Green Published, Green Submitted			2022-12-26	WOS:000402607000027
J	dos Santos, DV; Silva, GSE; Weber, EJ; Hasenack, H; Groff, FHS; Todeschini, B; Borba, MR; Medeiros, AAR; Leotti, VB; Canal, CW; Corbellini, LG				dos Santos, Diego Viali; Sousa e Silva, Gustavo; Weber, Eliseu Jose; Hasenack, Heinrich; Sautter Groff, Fernando Henrique; Todeschini, Bernardo; Borba, Mauro Riegert; Rosa Medeiros, Antonio Augusto; Leotti, Vanessa Bielefeldt; Canal, Claudio Wageck; Corbellini, Luis Gustavo			Identification of foot and mouth disease risk areas using a multi-criteria analysis approach	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BRUCELLOSIS MODEL; VIRUS; SURVEILLANCE; AUSTRALIA; INDUSTRY; SYSTEM; HEALTH; BRAZIL; STATE	Foot and mouth disease (FMD) is a highly infectious disease that affects cloven-hoofed livestock and wildlife. FMD has been a problem for decades, which has led to various measures to control, eradicate and prevent FMD by National Veterinary Services worldwide. Currently, the identification of areas that are at risk of FMD virus incursion and spread is a priority for FMD target surveillance after FMD is eradicated from a given country or region. In our study, a knowledge-driven spatial model was built to identify risk areas for FMD occurrence and to evaluate FMD surveillance performance in Rio Grande do Sul state, Brazil. For this purpose, multi-criteria decision analysis was used as a tool to seek multiple and conflicting criteria to determine a preferred course of action. Thirteen South American experts analyzed 18 variables associated with FMD introduction and dissemination pathways in Rio Grande do Sul. As a result, FMD higher risk areas were identified at international borders and in the central region of the state. The final model was expressed as a raster surface. The predictive ability of the model assessed by comparing, for each cell of the raster surface, the computed model risk scores with a binary variable representing the presence or absence of an FMD outbreak in that cell during the period 1985 to 2015. Current FMD surveillance performance was assessed, and recommendations were made to improve surveillance activities in critical areas.	[dos Santos, Diego Viali; Todeschini, Bernardo] Minist Agr Pecuaria & Abastecimento, Dept Saude Anim, Secretaria Def Agr, Brasilia, DF, Brazil; [dos Santos, Diego Viali; Sousa e Silva, Gustavo; Todeschini, Bernardo; Borba, Mauro Riegert; Rosa Medeiros, Antonio Augusto; Corbellini, Luis Gustavo] Univ Fed Rio Grande do Sul, Lab Epidemiol Vet, Fac Vet, Porto Alegre, RS, Brazil; [Weber, Eliseu Jose; Hasenack, Heinrich] Univ Fed Rio Grande do Sul, Ctr Ecol, Lab Geoproc, Porto Alegre, RS, Brazil; [Sautter Groff, Fernando Henrique; Rosa Medeiros, Antonio Augusto] Secretaria Agr Pecuaria & Irrigacao Estado Rio Gr, Dept Def Agr, Porto Alegre, RS, Brazil; [Leotti, Vanessa Bielefeldt] Univ Fed Rio Grande do Sul, Inst Matemat & Estat, Dept Estat, Porto Alegre, RS, Brazil; [Canal, Claudio Wageck] Univ Fed Rio Grande do Sul, Lab Virol, Fac Vet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Corbellini, LG (corresponding author), Univ Fed Rio Grande do Sul, Lab Epidemiol Vet, Fac Vet, Porto Alegre, RS, Brazil.	luis.corbellini@ufrgs.br	Dos Santos, Diego Viali/AAO-3236-2021; Hasenack, Heinrich/AAD-7332-2022; Canal, Cláudio W./J-7253-2012; Weber, Eliseu José/AAK-6525-2021	Dos Santos, Diego Viali/0000-0001-8092-3064; Canal, Cláudio W./0000-0002-0621-243X; Weber, Eliseu José/0000-0003-4873-0232; Corbellini, Luis Gustavo/0000-0003-3255-6321; GROFF, FERNANDO/0000-0002-0532-531X	Fundo de Desenvolvimento e Defesa Sanitaria Animal (FUNDESA)	Fundo de Desenvolvimento e Defesa Sanitaria Animal (FUNDESA)	The research leading to these results have received funding from the Fundo de Desenvolvimento e Defesa Sanitaria Animal (FUNDESA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL T. R. S, 2013, THESIS; Belton V., 2002, MULTIPLE CRITERIA DE, DOI DOI 10.1007/978-1-4615-1495-4; Brito BP, 2017, TRANSBOUND EMERG DIS, V64, P316, DOI 10.1111/tbed.12373; Brookes VJ, 2014, PREV VET MED, V113, P103, DOI 10.1016/j.prevetmed.2013.10.014; Casas Olascoaga R., 1999, FIEBRE AFTOSA; Cox RC, 2012, PLOS ONE, V7, P1; Dias RA, 2011, REV PANAM SALUD PUBL, V30, P370; Dutra MGB, 2007, VET FOCO, V5, P1; East IJ, 2013, PREV VET MED, V112, P230, DOI 10.1016/j.prevetmed.2013.09.012; Erickson BH, 1979, SOCIOL METHODOL, P276, DOI [10.2307/270774, DOI 10.2307/270774]; FAO, 2015, FOOT AND MOUTH DIS S; FAO, 2011, P INT WORKSH FAO AN; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Fracastorius H, SYMPATHIA ANTIPATHIA; Garabed RB, 2009, PREV VET MED, V92, P20, DOI 10.1016/j.prevetmed.2009.06.010; Hsu C-C, 2007, PRACTICAL ASSESSMENT, V12, P8; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Madder M, 2012, PARASITOLOGY, V139, P1831, DOI 10.1017/S0031182012000571; Malczewski J, 2015, MULTICRITERIA DECISO; Mapa, 2007, VET SURV VES DIS GEN; Martinez-Lopez B, 2014, PREV VET MED, V114, P47, DOI 10.1016/j.prevetmed.2014.01.013; OIE, 2016, FOOT MOUTH DIS PORT; OIE, 2012, WILDL FOOT MOUTH DIS; OIE, 2013, AN HLTH DAT; Panaftosa, 2010, FOC FIEBR AFT AM 197; Panaftosa, 2016, 43 ORD M S AM COMM F; Park JH, 2013, EMERG INFECT DIS, V19, P655, DOI 10.3201/eid1904.121320; Silva APSP, 2013, PESQUI VET BRASIL, V33, P1453, DOI 10.1590/S0100-736X2013001200010; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P239, DOI 10.1016/S0167-8809(01)00187-6; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Santos DV, 2014, HORA VET, V201, P14; Seapi, 2013, REL AN AT DEP; Silva GS, 2014, C ACTA SCI VET, V42, P1; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Valarcher JF, 2008, TRANSBOUND EMERG DIS, V55, P14, DOI 10.1111/j.1865-1682.2007.01010.x; Willeberg P., 2011, Revue Scientifique et Technique - Office International des Epizooties, V30, P381; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zang YT, 2012, PROCEDIA ENGINEER, V37, P274, DOI 10.1016/j.proeng.2012.04.239	41	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178464	10.1371/journal.pone.0178464	http://dx.doi.org/10.1371/journal.pone.0178464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552973	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000048
J	Kurotani, K; Sato, M; Yasuda, K; Kashima, K; Tanaka, S; Hayashi, T; Shirouchi, B; Akter, S; Kashino, I; Hayabuchi, H; Mizoue, T				Kurotani, Kayo; Sato, Masao; Yasuda, Kazuki; Kashima, Kentaro; Tanaka, Shoji; Hayashi, Takuya; Shirouchi, Bungo; Akter, Shamima; Kashino, Ikuko; Hayabuchi, Hitomi; Mizoue, Tetsuya			Even- and odd-chain saturated fatty acids in serum phospholipids are differentially associated with adipokines	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CIRCULATING ADIPONECTIN; PENTADECANOIC ACID; INSULIN-RESISTANCE; LEPTIN LEVELS; ERYTHROCYTE-MEMBRANE; CHOLESTEROL ESTER; ADIPOSE-TISSUE; MILK-FAT; RISK	Background Saturated fatty acids are generally thought to have detrimental effects on health. However, a recent study showed that even-and odd-chain saturated fatty acids had opposite associations with type 2 diabetes. Limited studies of Western populations examined the associations of circulating saturated fatty acids with adipokines, an important role in glucose metabolism. Objective We examined the associations of saturated fatty acids in serum phospholipids with circulating levels of adipokines among a Japanese population. Design A cross-sectional study was conducted among 484 Japanese employees (284 men and 200 women) aged 20-65 years. The serum fatty acid composition in the phospholipid fraction was measured by gas-chromatography. Serum leptin, adiponectin, plasminogen activator inhibitor-1 (PAI-1), resistin, and visfatin were measured using a Luminex suspension bead-based multiplexed array. Multiple linear regression analysis was performed to assess the association between saturated fatty acids and adipokines, with adjustment for potential confounding variables. Results Even-and odd-chain saturated fatty acids were differentially associated with adipokines. Higher levels of even-chain saturated fatty acids (14: 0 myristic, 16: 0 palmitic, and 18: 0 stearic acids) were associated with higher levels of resistin (P for trend = 0.048) and lower levels of adiponectin (P for trend = 0.003). By contrast, odd-chain saturated fatty acids (15: 0 pentadecanoic and 17: 0 heptadecanoic acids) showed inverse associations with leptin and PAI-1 (P for trend = 0.048 and 0.02, respectively). Visfatin was positively associated with both even-and odd-chain saturated fatty acids. Conclusions The results suggest that even-and odd-chain saturated fatty acids are differentially associated with adipokine profile.	[Kurotani, Kayo; Akter, Shamima; Kashino, Ikuko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Sato, Masao; Kashima, Kentaro; Tanaka, Shoji; Hayashi, Takuya; Shirouchi, Bungo] Kyushu Univ, Grad Sch, Dept Biosci & Biotechnol, Lab Nutr Chem,Fac Agr, Fukuoka, Japan; [Yasuda, Kazuki] Natl Ctr Global Hlth & Med, Dept Metab Disorder, Diabet Res Ctr, Tokyo, Japan; [Hayabuchi, Hitomi] Fukuoka Womens Univ, Grad Sch Nutr & Hlth Sci, Fukuoka, Japan; [Kurotani, Kayo] Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo, Japan; [Kurotani, Kayo] Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo, Japan; [Kurotani, Kayo] Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Shokuiku, Tokyo, Japan; [Kurotani, Kayo] Natl Inst Hlth & Nutr, Shokuiku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kyushu University; National Center for Global Health & Medicine - Japan; National Institute of Health & Nutrition - Japan; National Institute of Health Sciences - Japan; National Institute of Health & Nutrition - Japan; National Institute of Health & Nutrition - Japan; National Institute of Health Sciences - Japan; National Institute of Health & Nutrition - Japan	Kurotani, K (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan.; Kurotani, K (corresponding author), Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo, Japan.; Kurotani, K (corresponding author), Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo, Japan.; Kurotani, K (corresponding author), Natl Inst Biomed Innovat, Natl Inst Hlth & Nutr, Shokuiku, Tokyo, Japan.; Kurotani, K (corresponding author), Natl Inst Hlth & Nutr, Shokuiku, Tokyo, Japan.	kurotani@nibiohn.go.jp	KASHINO, IKUKO/AAS-4008-2020; Shirouchi, Bungo/J-4849-2019	Shirouchi, Bungo/0000-0003-4237-5081	JSPS KAKENHI [21390213, 21790598, 25293146]; f National Center for Global Health and Medicine; National Institute of Biomedical Innovation; Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus [15ek0210021h0002]; Japan Agency for Medical Research and Development	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); f National Center for Global Health and Medicine; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by JSPS KAKENHI Grant Number 21390213, 21790598, 25293146, a grant of National Center for Global Health and Medicine, a grant from the National Institute of Biomedical Innovation, and Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus (15ek0210021h0002), Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Chaturvedi AK, 2011, CANCER EPIDEM BIOMAR, V20, P1902, DOI 10.1158/1055-9965.EPI-11-0221; Chen BH, 2009, DIABETES CARE, V32, P329, DOI 10.2337/dc08-1625; Chen GC, 2014, OBES REV, V15, P134, DOI 10.1111/obr.12088; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Crown SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145850; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; Fernandez-Real JM, 2005, CLIN CHEM, V51, P603, DOI 10.1373/clinchem.2004.041350; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Fu Q, 2010, CLIN CHEM, V56, P314, DOI 10.1373/clinchem.2009.135087; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Heshka JT, 2001, LIFE SCI, V69, P987, DOI 10.1016/S0024-3205(01)01201-2; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; HOLMAN RT, 1989, P NATL ACAD SCI USA, V86, P4720, DOI 10.1073/pnas.86.12.4720; HOLMAN RT, 1995, J NUTR, V125, P901; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Kashino I, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0046-8; Katan MB, 1997, J LIPID RES, V38, P2012; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kimura Y, 2012, AM J CLIN NUTR, V95, P1209, DOI 10.3945/ajcn.111.030817; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Mattu HS, 2013, J ENDOCRINOL, V216, pT17, DOI 10.1530/JOE-12-0232; Miyatake N, 2014, ENVIRON HEALTH PREV, V19, P279, DOI 10.1007/s12199-014-0390-x; Pham NM, 2015, EUR J NUTR, V54, P205, DOI 10.1007/s00394-014-0701-4; Reilly MP, 2004, J CLIN ENDOCR METAB, V89, P3872, DOI 10.1210/jc.2003-031676; Santaren ID, 2014, AM J CLIN NUTR, V100, P1532, DOI 10.3945/ajcn.114.092544; Santos S, 2014, EUR J CLIN NUTR, V68, P555, DOI 10.1038/ejcn.2014.36; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Smedman AEM, 1999, AM J CLIN NUTR, V69, P22; Soderberg S, 2003, CEREBROVASC DIS, V15, P63, DOI 10.1159/000067128; Soderberg S, 1999, J INTERN MED, V246, P409, DOI 10.1046/j.1365-2796.1999.00571.x; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Warensjo E, 2004, BRIT J NUTR, V91, P635, DOI 10.1079/BJN20041080; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291	51	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178192	10.1371/journal.pone.0178192	http://dx.doi.org/10.1371/journal.pone.0178192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552966	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000026
J	Gupta, S; Bhar, A; Chatterjee, M; Ghosh, A; Das, S				Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Ghosh, Amartya; Das, Sampa			Transcriptomic dissection reveals wide spread differential expression in chickpea during early time points of Fusarium oxysporum f. sp ciceri Race 1 attack	PLOS ONE			English	Article							MAP KINASE 6; CELL-DEATH; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PLANT DEFENSE; PURINE BIOSYNTHESIS; ARIETINUM L.; KEY ENZYMES; DNA-DAMAGE; RESISTANCE	Plants' reaction to underground microorganisms is complex as sessile nature of plants compels them to prioritize their responses to diverse microorganisms both pathogenic and symbiotic. Roots of important crops are directly exposed to diverse microorganisms, but investigations involving root pathogens are significantly less. Thus, more studies involving root pathogens and their target crops are necessitated to enrich the understanding of underground interactions. Present study reported the molecular complexities in chickpea during Fusarium oxysporum f. sp. ciceri Race 1 (Foc1) infection. Transcriptomic dissections using RNA-seq showed significantly differential expression of molecular transcripts between infected and control plants of both susceptible and resistant genotypes. Radar plot analyses showed maximum expressional undulations after infection in both susceptible and resistant plants. Gene ontology and functional clustering showed large number of transcripts controlling basic metabolism of plants. Network analyses demonstrated defense components like peptidyl cis/trans isomerase, MAP kinase, beta 1,3 glucanase, serine threonine kinase, patatin like protein, lactolylglutathione lyase, coproporphyrinogen III oxidase, sulfotransferases; reactive oxygen species regulating components like respiratory burst oxidase, superoxide dismutases, cytochrome b5 reductase, glutathione reductase, thioredoxin reductase, ATPase; metabolism regulating components, myo inositol phosphate, carboxylate synthase; transport related gamma tonoplast intrinsic protein, and structural component, ubiquitins to serve as important nodals of defense signaling network. These nodal molecules probably served as hub controllers of defense signaling. Functional characterization of these hub molecules would not only help in developing better understanding of chickpea-Foc1 interaction but also place them as promising candidates for resistance management programs against vascular wilt of legumes.	[Gupta, Sumanti; Bhar, Anirban; Chatterjee, Moniya; Ghosh, Amartya; Das, Sampa] Bose Inst, Div Plant Biol, CIT Scheme, VII M, Centenary Campus,P 1-12, Kolkata, W Bengal, India; [Gupta, Sumanti] Rabindra Mahavidyalaya, Dept Bot, Pin, W Bengal, India; [Bhar, Anirban] Ramakrishna Mission Vivekananda Centenary Coll, Post Grad Dept Bot, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Das, S (corresponding author), Bose Inst, Div Plant Biol, CIT Scheme, VII M, Centenary Campus,P 1-12, Kolkata, W Bengal, India.	sampa@jcbose.ac.in	Bhar, Anirban/ADE-5445-2022; Gupta, Vijai Kumar/O-2445-2014	Gupta, Vijai Kumar/0000-0003-1565-5918; BHAR, ANIRBAN/0000-0002-7535-3447	Genotypic Technology, Pvt. Ltd., Bangalore, India; Bose Institute; Council of Scientific and Industrial Research, India [09/015(0378)/2009EMR-1, 09/015(0481)/2015-EMR-1]; central instrumentation facilities	Genotypic Technology, Pvt. Ltd., Bangalore, India; Bose Institute(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); central instrumentation facilities	The authors are indebted to Director, Bose Institute for providing the central instrumentation facilities. The authors would like to acknowledge the support on data generation, processing and analysis from Genotypic Technology, Pvt. Ltd., Bangalore, India. The authors express their gratitude to Prof. Debabrata Basu, Bose Institute for many of his valuable suggestions during the course of this study.; The authors are indebted to Director, Bose Institute for partially supporting the funds to perform the present study and providing the central instrumentation facilities. SG and MC are thankful to Bose Institute for their fellowships as Research Associates. AB (09/015(0378)/2009EMR-1) and AG (09/015(0481)/2015-EMR-1) are grateful to Council of Scientific and Industrial Research, India for their fellowships. There was no additional external funding received for this study.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Arasimowicz-Jelonek M, 2014, MOL PLANT PATHOL, V15, P406, DOI 10.1111/mpp.12095; Arner ES, 2001, CURRENT PROTOC TOXIC; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Aumuller T, 2010, BIOCHEMISTRY-US, V49, P1042, DOI 10.1021/bi901813e; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Buono RA, 2016, PLANT PHYSIOL, V171, P251, DOI 10.1104/pp.16.00240; Cha JY, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1017698; Chatterjee M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-949; Chen Y, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-33; Cheung AY, 2014, PLANT PHYSIOL, V166, P748, DOI 10.1104/pp.114.246926; Choi DS, 2015, PLANT MOL BIOL, V89, P99, DOI 10.1007/s11103-015-0354-6; Chung K, 2011, PLANT CELL PHYSIOL, V52, P1657, DOI 10.1093/pcp/pcr099; Clement M, 2011, PLANT PHYSIOL, V156, P1481, DOI 10.1104/pp.111.174425; Cui FQ, 2013, NEW PHYTOL, V200, P634, DOI 10.1111/nph.12456; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Durand M, 2016, PLANT PHYSIOL, V170, P1460, DOI 10.1104/pp.15.01926; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; Ewald R, 2014, PLANT PHYSIOL, V165, P978, DOI 10.1104/pp.114.238311; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Flandez-Galvez H, 2003, THEOR APPL GENET, V106, P1447, DOI 10.1007/s00122-003-1199-y; Fukuchi-Mizutani M, 1999, PLANT PHYSIOL, V119, P353, DOI 10.1104/pp.119.1.353; Gallardo K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00580; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Giovannetti M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00480; Giri AP, 1998, PLANT PATHOL, V47, P693, DOI 10.1046/j.1365-3059.1998.00299.x; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Guo CY, 2013, PLANT CELL REP, V32, P687, DOI 10.1007/s00299-013-1403-8; Gupta S., 2016, DNA RES; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073163; Gupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009030; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; Ha JM, 2012, G3-GENES GENOM GENET, V2, P321, DOI 10.1534/g3.111.001834; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hirschmann F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00556; Hossain M. M., 2013, African Journal of Biotechnology, V12, P4699; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Hwang IS, 2011, PLANT J, V67, P749, DOI 10.1111/j.1365-313X.2011.04622.x; Jing HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8395; John F, 2011, PLANT SIGNAL BEHAV, V6, P1700, DOI 10.4161/psb.6.11.17662; Johnson KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025154; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Kalunke RM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00146; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Korasick DA, 2010, J BIOL CHEM, V285, P23340, DOI 10.1074/jbc.M109.090787; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; La Camera S, 2009, MOL PLANT MICROBE IN, V22, P469, DOI 10.1094/MPMI-22-4-0469; Lapin D, 2013, TRENDS PLANT SCI, V18, P546, DOI 10.1016/j.tplants.2013.05.005; Lee JH, 2012, MOL CELLS, V34, P109, DOI 10.1007/s10059-012-0121-3; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Li XH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00717; Liu JZ, 2014, MOL PLANT MICROBE IN, V27, P824, DOI 10.1094/MPMI-11-13-0350-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Duran R, 2015, MOL PLANT MICROBE IN, V28, P511, DOI 10.1094/MPMI-10-14-0322-CR; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Meadows R., 2013, PLOS BIOL, V1; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Navas-Cortes JA, 2000, PHYTOPATHOLOGY, V90, P1269, DOI 10.1094/PHYTO.2000.90.11.1269; Nimbalkar SB, 2006, PHYSIOL MOL PLANT P, V68, P176, DOI 10.1016/j.pmpp.2006.10.003; Nomura Y, 2014, BIOSCI BIOTECH BIOCH, V78, P1022, DOI 10.1080/09168451.2014.910103; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Papdi C, 2015, PLANT J, V82, P772, DOI 10.1111/tpj.12848; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Poraty-Gavra L, 2013, PLANT PHYSIOL, V161, P1172, DOI 10.1104/pp.112.213165; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Qamar A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00503; Rachwal-Rosiak D, 2015, CRIT REV FOOD SCI, V55, P1135, DOI 10.1080/10408398.2012.687418; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Sadanandom A, 2012, NEW PHYTOL, V196, P13, DOI 10.1111/j.1469-8137.2012.04266.x; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Schoch GA, 2003, PLANT PHYSIOL, V133, P1198, DOI 10.1104/pp.103.020305; Schubert V, 2009, CYTOGENET GENOME RES, V124, P202, DOI 10.1159/000218126; Schussler MD, 2008, PLANT J, V56, P756, DOI 10.1111/j.1365-313X.2008.03632.x; Seifert GJ, 2014, ANN BOT-LONDON, V114, P1125, DOI 10.1093/aob/mcu010; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Sharma B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00806; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shiwen WU, 2014, J INTEG AGR, V13, P926; Singh D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00895; Singh VK, 2016, PLANT BIOTECHNOL J, V14, P1183, DOI 10.1111/pbi.12470; Stanley D, 2005, BIOLOGIA, V60, P65; Stratmann JW, 2012, PLANT SCI, V185, P50, DOI 10.1016/j.plantsci.2011.10.004; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Thuleau P, 2013, BIOCHIM BIOPHYS ACTA, V7, P1590; Tian SP, 2007, PHYTOPATHOLOGY, V97, P260, DOI 10.1094/PHYTO-97-3-0260; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2009, CURR OPIN PLANT BIOL, V12, P202, DOI 10.1016/j.pbi.2008.12.004; Voiniciuc C, 2015, INT J MOL SCI, V16, P3452, DOI 10.3390/ijms16023452; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004243; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang PC, 2010, PLANT CELL, V22, P2981, DOI 10.1105/tpc.109.072959; Watt G, 2004, PLANT PHYSIOL, V134, P1337, DOI 10.1104/pp.103.037192; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Zeng WQ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002291; Zhai H, 2016, PLANT BIOTECHNOL J, V14, P592, DOI 10.1111/pbi.12402; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	117	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178164	10.1371/journal.pone.0178164	http://dx.doi.org/10.1371/journal.pone.0178164			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542579	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800047
J	Stram, AR; Wagner, GR; Fogler, BD; Pride, PM; Hirschey, MD; Payne, RM				Stram, Amanda R.; Wagner, Gregory R.; Fogler, Brian D.; Pride, P. Melanie; Hirschey, Matthew D.; Payne, R. Mark			Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SIRT3 DEACETYLATES; CARDIAC-FUNCTION; DEFICIENCY; METABOLISM; STRESS; DEHYDROGENASE; REPERFUSION; DYSFUNCTION; FRATAXIN	Introduction The childhood heart disease of Friedreich's Ataxia (FRDA) is characterized by hypertrophy and failure. It is caused by loss of frataxin (FXN), a mitochondrial protein involved in energy homeostasis. FRDA model hearts have increased mitochondrial protein acetylation and impaired sirtuin 3 (SIRT3) deacetylase activity. Protein acetylation is an important regulator of cardiac metabolism and loss of SIRT3 increases susceptibility of the heart to stress-induced cardiac hypertrophy and ischemic injury. The underlying pathophysiology of heart failure in FRDA is unclear. The purpose of this study was to examine in detail the physiologic and acetylation changes of the heart that occur over time in a model of FRDA heart failure. We predicted that increased mitochondrial protein acetylation would be associated with a decrease in heart function in a model of FRDA. Methods A conditional mouse model of FRDA cardiomyopathy with ablation of FXN (FXN KO) in the heart was compared to healthy controls at postnatal days 30, 45 and 65. We evaluated hearts using echocardiography, cardiac catheterization, histology, protein acetylation and expression. Results Acetylation was temporally progressive and paralleled evolution of heart failure in the FXN KO model. Increased acetylation preceded detectable abnormalities in cardiac function and progressed rapidly with age in the FXN KO mouse. Acetylation was also associated with cardiac fibrosis, mitochondrial damage, impaired fat metabolism, and diastolic and systolic dysfunction leading to heart failure. There was a strong inverse correlation between level of protein acetylation and heart function. Conclusion These results demonstrate a close relationship between mitochondrial protein acetylation, physiologic dysfunction and metabolic disruption in FRDA hypertrophic cardiomyopathy and suggest that abnormal acetylation contributes to the pathophysiology of heart disease in FRDA. Mitochondrial protein acetylation may represent a therapeutic target for early intervention. Conclusion These results demonstrate a close relationship between mitochondrial protein acetylation, physiologic dysfunction and metabolic disruption in FRDA hypertrophic cardiomyopathy and suggest that abnormal acetylation contributes to the pathophysiology of heart disease in FRDA. Mitochondrial protein acetylation may represent a therapeutic target for early intervention.	[Stram, Amanda R.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Stram, Amanda R.; Payne, R. Mark] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Stram, Amanda R.; Fogler, Brian D.; Pride, P. Melanie; Payne, R. Mark] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wagner, Gregory R.; Hirschey, Matthew D.] Duke Univ, Div Endocrinol Metab & Nutr, Durham, NC USA; [Payne, R. Mark] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Duke University; Indiana University System; Indiana University Bloomington	Payne, RM (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA.; Payne, RM (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Payne, RM (corresponding author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.	rpayne@iu.edu		Hirschey, Matthew/0000-0003-4541-5376	NHLBI NRSA fellowship grant [F31HL126489]; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA); NIH/NIDDK training grant [2T32-DK007012-36A1]	NHLBI NRSA fellowship grant; Friedreich's Ataxia Research Alliance (FARA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NIH/NIDDK training grant	This work was supported by an NHLBI NRSA fellowship grant #F31HL126489 to ARS, grants from the Friedreichs Ataxia Research Alliance (FARA) and Muscular Dystrophy Association (MDA) to RMP, and an NIH/NIDDK training grant to Duke University Department of Endocrinology, Metabolism, and Nutrition (2T32-DK007012-36A1) to GRW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066; Chen TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118909; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0493-6; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Mazumder PK, 2004, DIABETES, V53, P2366, DOI 10.2337/diabetes.53.9.2366; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raffaele R B Lodi, 2001, CARDIOVASC RES, V125, P1626; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Vyas PM, 2012, HUM MOL GENET, V21, P1230, DOI 10.1093/hmg/ddr554; Wagner GR, 2013, IUPUI SCHOLARWORKS I; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Xiong DD, 2014, AM J PHYSIOL-HEART C, V306, pH326, DOI 10.1152/ajpheart.00931.2012; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297	42	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178354	10.1371/journal.pone.0178354	http://dx.doi.org/10.1371/journal.pone.0178354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542596	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800081
J	Taylor, GC; Hill, JM; Jackson, MC; Peel, RA; Weyl, OLF				Taylor, Geraldine C.; Hill, Jaclyn M.; Jackson, Michelle C.; Peel, Richard A.; Weyl, Olaf L. F.			Estimating delta N-15 fractionation and adjusting the lipid correction equation using Southern African freshwater fishes	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; FOOD-WEB; CARBON ISOTOPES; TROPHIC POSITION; STOMACH CONTENT; MIXING MODELS; BODY-SIZE; DELTA-C-13; DIET; NITROGEN	Stable isotope analysis is an important tool for characterising food web structure; however, interpretation of isotope data can often be flawed. For instance, lipid normalisation and trophic fractionation values are often assumed to be constant, but can vary considerably between ecosystems, species and tissues. Here, previously determined lipid normalisation equations and trophic fractionation values were re-evaluated using freshwater fish species from three rivers in the Upper Zambezian floodplain ecoregion in southern Africa. The parameters commonly used in lipid normalisation equations were not correct for the 18 model species ( new D and I parameters were estimated as D = 4.46 parts per thousand [95% CI: 2.62, 4.85] and constant I = 0 [ 95% CI: 0, 0.17]). We suggest that future isotopic analyses on freshwater fishes use our new values if the species under consideration do not have a high lipid content in their white muscle tissue. Nitrogen fractionation values varied between species and river basin; however, the average value closely matched that calculated in previous studies on other species (delta N-15 fractionation factor of 3.37 +/- 1.30 parts per thousand). Here we have highlighted the need to treat stable isotope data correctly in food web studies to avoid misinterpretation of the data.	[Taylor, Geraldine C.; Hill, Jaclyn M.; Jackson, Michelle C.; Peel, Richard A.; Weyl, Olaf L. F.] SOUTH African Inst Aquat Biodivers, Grahamstown, South Africa; [Taylor, Geraldine C.; Peel, Richard A.; Weyl, Olaf L. F.] Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa; [Hill, Jaclyn M.] Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa; [Jackson, Michelle C.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Peel, Richard A.] NNF EU Community Conservat Fisheries KAZA Project, Katima Mulilo, Namibia	National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Rhodes University; Rhodes University; Imperial College London	Taylor, GC (corresponding author), SOUTH African Inst Aquat Biodivers, Grahamstown, South Africa.; Taylor, GC (corresponding author), Rhodes Univ, Dept Ichthyol & Fisheries Sci, Grahamstown, South Africa.	gc88taylor@gmail.com	Hill, Jaclyn/D-3780-2012	Hill, Jaclyn/0000-0003-0703-3772; Weyl, Olaf/0000-0002-8935-3296; Jackson, Michelle/0000-0003-2227-1111	Southern African Scientific Service Centre for Climate Change and Adaptive Land Management; Nedbank Namibia Go Green Fund through the NNF-EU Community Conservation in Fisheries in KAZA Project; Joint Research Committee of Rhodes University; National Research foundation of South Africa [74015, 77444]	Southern African Scientific Service Centre for Climate Change and Adaptive Land Management; Nedbank Namibia Go Green Fund through the NNF-EU Community Conservation in Fisheries in KAZA Project; Joint Research Committee of Rhodes University; National Research foundation of South Africa(National Research Foundation - South Africa)	Funding was provided by the Southern African Scientific Service Centre for Climate Change and Adaptive Land Management and Nedbank Namibia Go Green Fund which was channelled through the NNF-EU Community Conservation in Fisheries in KAZA Project. Personal funding was provided by the Joint Research Committee of Rhodes University and the National Research foundation of South Africa (UID: 74015; 77444). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUTTON T W, 1991, P155; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Efron GP, 1980, JACKNIFE BOOTSTRAP O; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gorokhova E, 1999, CAN J FISH AQUAT SCI, V56, P2203, DOI 10.1139/cjfas-56-11-2203; HARRIGAN P, 1989, B MAR SCI, V44, P65; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Kadye WT, 2012, BIOL INVASIONS, V14, P779, DOI 10.1007/s10530-011-0116-6; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; MCCLELLAND G, 1995, CAN J FISH AQUAT SCI, V52, P161, DOI 10.1139/f95-016; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Pedreschi D, 2015, J FISH BIOL, V87, P876, DOI 10.1111/jfb.12755; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; Rojbek MC, 2014, ICES J MAR SCI, V71, P56, DOI 10.1093/icesjms/fst106; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; Skinner MM, 2016, RAPID COMMUN MASS SP, V30, P881, DOI 10.1002/rcm.7480; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V352, P165, DOI 10.1016/j.jembe.2007.07.007; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Sweeting CJ, 2006, RAPID COMMUN MASS SP, V20, P595, DOI 10.1002/rcm.2347; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z	38	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178047	10.1371/journal.pone.0178047	http://dx.doi.org/10.1371/journal.pone.0178047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542647	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500057
J	Moore, C; Parrish, JK; Jedlicka, P				Moore, Colin; Parrish, Janet K.; Jedlicka, Paul			MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; PLASMINOGEN-ACTIVATOR UPA; TUMOR PROGRESSION; MICRORNAS; CANCER; SUPPRESSOR	Ewing Sarcoma is an aggressive, oncofusion-driven, malignant neoplasm of bone and soft tissue affecting predominantly children and young adults. Seeking to identify potential novel therapeutic targets/agents for this disease, our previous studies uncovered microRNAs regulated by EWS/Fli1, the most common oncofusion, with growth modulatory properties. In the present study, we sought to identify EWS/Fli1-repressed, growth suppressive, microRNAs potentially amenable to replacement in Ewing Sarcoma cells. Eight microRNAs (143, 153, 184, 193b, 195, 203, 206 and 223) were selected for evaluation as EWS/Fli1-repressed and underexpressed in Ewing Sarcoma cells, and reported to be growth suppressive in other pediatric or/and adult cancers. The selected miRs, and appropriate non-targeting controls, were introduced into two different Ewing Sarcoma cell lines (A673 and SK-ES-1), and effects on growth were examined using a high and low-density growth assay. MiR-193b was growth inhibitory in both assays and cell lines. In subsequent analyses, we found that stable overexpression of miR-193b also inhibits anchorage-independent growth in both A673 and SK-ES-1 cells. We further show that miR-193b negatively regulates expression of the ErbB4 oncogene in A673 and SK-ES-1 cells, and that depletion of ErbB4 is itself inhibitory to anchorage-independent growth in the same cell lines. Together, our studies show that the EWS/Fli1-repressed miR-193b is growth suppressive in Ewing Sarcoma, and identify ErbB4 as a target gene and candidate mediator of this growth suppression.	[Moore, Colin] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA; [Parrish, Janet K.; Jedlicka, Paul] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA; [Moore, Colin] Johns Hopkins All Childrens Hosp, Vincent Lecavalier Pediat Canc & Blood Disorders, St Petersburg, FL USA	Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University; Johns Hopkins Medicine	Jedlicka, P (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA.	paul.jedlicka@ucdenver.edu			Cancer League of Colorado; Ruth L. Kirschstein National Research Service Award Institutional Training Grant; Boettcher Foundation's Webb-Waring Biomedical Research Program; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado Cancer Center and School of Medicine;  [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Cancer League of Colorado; Ruth L. Kirschstein National Research Service Award Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boettcher Foundation's Webb-Waring Biomedical Research Program; Alex's Lemonade Stand Foundation for Childhood Cancer; University of Colorado Cancer Center and School of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank the University of Colorado Cancer Center DNA Sequencing, Flow Cytometry and Functional Genomics Core Facilities, supported by P30-CA046934. Funding support for this work was provided by the Cancer League of Colorado (CM), Ruth L. Kirschstein National Research Service Award Institutional Training Grant (CM), Boettcher Foundation's Webb-Waring Biomedical Research Program (PJ), Alex's Lemonade Stand Foundation for Childhood Cancer (PJ), and the University of Colorado Cancer Center and School of Medicine (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; Dylla L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00065; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Haetscher N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9928; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Jin XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125515; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Lenarduzzi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053765; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Liang HW, 2015, J BIOL CHEM, V290, P926, DOI 10.1074/jbc.M114.621409; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Mendoza-Naranjo A, 2013, EMBO MOL MED, V5, P1087, DOI 10.1002/emmm.201202343; Mets E, 2015, LEUKEMIA, V29, P798, DOI 10.1038/leu.2014.276; Mitra AK, 2015, ONCOGENE; Nana-Sinkam SP, 2011, TRANSL RES, V157, P216, DOI 10.1016/j.trsl.2011.01.013; Niemeyer BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116895; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xie C, 2013, ONCOGENE, V32, P2282, DOI 10.1038/onc.2012.251; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178028	10.1371/journal.pone.0178028	http://dx.doi.org/10.1371/journal.pone.0178028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542597	gold, Green Submitted, Green Published			2022-12-26	WOS:000401672400131
J	de Souza, JD; Silva, EMD; Coelho, MA; Morillon, R; Bonatto, D; Micheli, F; Gesteira, AD				de Souza, Joadson Dutra; de Andrade Silva, Edson Mario; Coelho Filho, Mauricio Antonio; Morillon, Raphael; Bonatto, Diego; Micheli, Fabienne; Gesteira, Abelmon da Silva			Different adaptation strategies of two citrus scion/rootstock combinations in response to drought stress	PLOS ONE			English	Article							PHOTOSYSTEM-I; RANGPUR LIME; HISTONE ACETYLTRANSFERASES; ALTERNATIVE OXIDASE; ELECTRON-TRANSPORT; CRYSTAL-STRUCTURE; PSBY PROTEIN; ARABIDOPSIS; TOLERANCE; SUBUNIT	Scion/rootstock interaction is important for plant development and for breeding programs. In this context, polyploid rootstocks presented several advantages, mainly in relation to biotic and abiotic stresses. Here we analyzed the response to drought of two different scion/root-stock combinations presenting different polyploidy: the diploid (2x) and autotetraploid (4x) Rangpur lime (Citrus limonia, Osbeck) rootstocks grafted with 2x Valencia Delta sweet orange (Citrus sinensis) scions, named V/2xRL and V/4xRL, respectively. Based on previous gene expression data, we developed an interactomic approach to identify proteins involved in V/2xRL and V/4xRL response to drought. A main interactomic network containing 3,830 nodes and 97,652 edges was built from V/2xRL and V/4xRL data. Exclusive proteins of the V/2xRL and V/4xRL networks (2,056 and 1,001, respectively), as well as common to both networks (773) were identified. Functional clusters were obtained and two models of drought stress response for the V/2xRL and V/4xRL genotypes were designed. Even if the V/2xRL plant implement some tolerance mechanisms, the global plant response to drought was rapid and quickly exhaustive resulting in a general tendency to dehydration avoidance, which presented some advantage in short and strong drought stress conditions, but which, in long terms, does not allow the plant survival. At the contrary, the V/4xRL plants presented a response which strong impacts on development but that present some advantages in case of prolonged drought. Finally, some specific proteins, which presented high centrality on interactomic analysis were identified as good candidates for subsequent functional analysis of citrus genes related to drought response, as well as be good markers of one or another physiological mechanism implemented by the plants.	[de Souza, Joadson Dutra; de Andrade Silva, Edson Mario; Micheli, Fabienne] Univ Estadual Santa Cruz, DCB, CBG, Rodovia Ilheus Itabuna, Ilheus, BA, Brazil; [Coelho Filho, Mauricio Antonio; Gesteira, Abelmon da Silva] Embrapa Mandioca & Fruticultura, Dept Biol Mol, Rua Embrapa S-N, Cruz Das Almas, BA, Brazil; [Morillon, Raphael; Micheli, Fabienne] CIRAD, UMR AGAP, Montpellier, France; [Bonatto, Diego] Univ Fed Rio Grande do Sul, Dept Biol Mol & Biotecnol, Ctr Biotecnol, Ave Bento Goncalves 9500,Predio 43421, Porto Alegre, RS, Brazil	Universidade Estadual de Santa Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Universidade Federal do Rio Grande do Sul	Micheli, F (corresponding author), Univ Estadual Santa Cruz, DCB, CBG, Rodovia Ilheus Itabuna, Ilheus, BA, Brazil.; Micheli, F (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	fabienne.micheli@cirad.fr	Micheli, Fabienne/AAL-9895-2021; Bonatto, Diego/F-5893-2010; da Silva Gesteira, Abelmon/I-2136-2013	Bonatto, Diego/0000-0001-8679-2448; da Silva Gesteira, Abelmon/0000-0002-7590-0455; Micheli, Fabienne/0000-0002-9031-362X; Morillon, Raphael/0000-0001-6762-1715	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Joadson Dutra de Souza Universidade Estadual de Santa Cruz (ICB); Edson Mario de Andrade Silva Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Joadson Dutra de Souza Universidade Estadual de Santa Cruz (ICB); Edson Mario de Andrade Silva Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	This study was funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Joadson Dutra de Souza Universidade Estadual de Santa Cruz (ICB), Edson Mario de Andrade Silva Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Dr Diego Bonatto, Dr Fabienne Micheli, Dr Abelmon da Silva Gesteira). This work was made in the frame of the Consortium International in Advanced Biology (CIBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allario T, 2013, PLANT CELL ENVIRON, V36, P856, DOI 10.1111/pce.12021; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Benjamin G, 2013, J AGR FOOD CHEM, V61, P11286, DOI 10.1021/jf402892p; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P11, DOI 10.1007/978-1-4419-7491-4_2; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brunetti C, 2015, ENVIRON EXP BOT, V119, P54, DOI 10.1016/j.envexpbot.2015.04.007; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Caine RS, 2016, DEVELOPMENT, V143, P3306, DOI 10.1242/dev.135038; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Casaretto JA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2659-5; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Chandler JW, 2016, PLANT CELL ENVIRON, V39, P1014, DOI 10.1111/pce.12662; Chen J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01173; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Dahal K, 2017, NEW PHYTOL, V213, P560, DOI 10.1111/nph.14169; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Fang H, 2014, BIOCHEM BIOPH RES CO, V443, P400, DOI 10.1016/j.bbrc.2013.11.102; Ghandchi FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162327; Gilroy S, 2014, TRENDS PLANT SCI, V19, P623, DOI 10.1016/j.tplants.2014.06.013; Girolomoni L, 2016, J EXPT BOT; Go YS, 2014, PLANT CELL, V26, P1666, DOI 10.1105/tpc.114.123307; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Hao GY, 2013, NEW PHYTOL, V197, P970, DOI 10.1111/nph.12051; Homayoun H., 2011, Middle East Journal of Scientific Research, V9, P418; Hussain S, 2012, SCI HORTIC-AMSTERDAM, V134, P100, DOI 10.1016/j.scienta.2011.11.008; Ilhan S, 2015, PLANT BIOLOGY, V17, P402, DOI 10.1111/plb.12227; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jarvi S, 2015, BBA-BIOENERGETICS, V1847, P900, DOI 10.1016/j.bbabio.2015.01.006; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Jensen PE, 2002, J BIOL CHEM, V277, P2798, DOI 10.1074/jbc.M110448200; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kim SK, 2016, METAB ENG, V38, P228, DOI 10.1016/j.ymben.2016.08.006; Kintzer AF, 2016, NATURE, V531, P258, DOI 10.1038/nature17194; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; Koepke T, 2013, PLANT CELL REP, V32, P1321, DOI 10.1007/s00299-013-1471-9; Kohzuma K, 2009, PLANT CELL ENVIRON, V32, P209, DOI 10.1111/j.1365-3040.2008.01912.x; Krogan NT, 2016, NEW PHYTOL, V212, P42, DOI 10.1111/nph.14107; Larsson AS, 1998, GENETICS, V149, P597; Lawlor DW, 2013, J EXP BOT, V64, P83, DOI 10.1093/jxb/ers326; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Lorch S, 2015, J PHYS CHEM B, V119, P12172, DOI 10.1021/acs.jpcb.5b06594; LRd Amaral, DEFICIENCIA HIDRICA; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Machado Eduardo Caruso, 2002, Sci. agric. (Piracicaba, Braz.), V59, P53, DOI 10.1590/S0103-90162002000100007; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Medina CL, 1998, FOTOSSINTESE LARANJE, P57; Meetam M, 1999, PLANT PHYSIOL, V121, P1267, DOI 10.1104/pp.121.4.1267; MOREIRA L. M, 2015, CIENCIAS GENOMICAS F; Moriwaki T, 2014, PLANT SCI, V215, P141, DOI 10.1016/j.plantsci.2013.11.002; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Neves DM, 2013, MOL BIOL REP, V40, P5339, DOI 10.1007/s11033-013-2634-z; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Papaefthimiou D, 2010, PLANT PHYSIOL BIOCH, V48, P98, DOI 10.1016/j.plaphy.2010.01.002; Pompeu Junior J., 1991, CITRICULTURA BRASILE, P265; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ribeiro RV, 2006, CIENC AGROTEC, V30, P670, DOI 10.1590/S1413-70542006000400012; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rott M, 2011, PLANT CELL, V23, P304, DOI 10.1105/tpc.110.079111; Saha B, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1256530; Saini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00950; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiratake K, 2016, BREEDING SCI, V66, P122, DOI 10.1270/jsbbs.66.122; Santana-Vieira DDS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38775; Spirin V, 2003, PNAS, P100; Suh MC, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.1105/tpc.114.123307; Tanaka H, 2014, PLANT CELL PHYSIOL, V55, P737, DOI 10.1093/pcp/pct196; Tanou G, 2014, PLANT CELL ENVIRON, V37, P864, DOI 10.1111/pce.12204; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Van Norman JM, 2009, WIRES SYST BIOL MED, V1, P372, DOI 10.1002/wsbm.25; Vanlerberghe GC, 2016, PHYSIOL PLANTARUM, V157, P322, DOI 10.1111/ppl.12451; Varotto C, 2002, PLANT PHYSIOL, V129, P616, DOI 10.1104/pp.002089; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; von Sydow L, 2016, BBA-BIOENERGETICS, V1857, P1524, DOI 10.1016/j.bbabio.2016.05.004; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10; WARD JM, 1994, PLANT CELL, V6, P669; Zhang F, 2015, TREES-STRUCT FUNCT, V29, P1773, DOI 10.1007/s00468-015-1258-4; Zhao P, 2014, J EXPT BOT; Zhao ZX, 2011, J EXP BOT, V62, P5179, DOI 10.1093/jxb/err223; Ziogas V, 2015, PLANT MOL BIOL, V89, P433, DOI 10.1007/s11103-015-0379-x; Ziogas V, 2013, PLANT PHYSIOL BIOCH, V68, P118, DOI 10.1016/j.plaphy.2013.04.004	92	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177993	10.1371/journal.pone.0177993	http://dx.doi.org/10.1371/journal.pone.0177993			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545114	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700102
J	Hammer, Y; Soudry, A; Levi, A; Talmor-Barkan, Y; Leshem-Lev, D; Singer, J; Kornowski, R; Lev, EI				Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Leshem-Lev, Dorit; Singer, Joel; Kornowski, Ran; Lev, Eli I.			Effect of vitamin D on endothelial progenitor cells function	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR EVENTS; HEMODIALYSIS-PATIENTS; DYSFUNCTION; POPULATION; RISK; NEOVASCULARIZATION; MOBILIZATION	Background Endothelial progenitor cells (EPCs) are a population of bone marrow-derived cells, which have an important role in the process of endothelialization and vascular repair following injury. Impairment of EPCs, which occurs in patients with diabetes, was shown to be related to endothelial dysfunction, coronary artery disease (CAD) and adverse clinical outcomes. Recent evidence has shown that calcitriol, the active hormone of vitamin D, has a favorable impact on the endothelium and cardiovascular system. There is limited data on the effect of vitamin D on EPCs function. Aim To examine the in vitro effects of Calcitriol on EPCs from healthy subjects and patients with diabetes. Methods Fifty-one patients with type 2 diabetes (60 +/- 11 years, 40% women, HbA1C: 9.1 +/- 0.8%) and 23 healthy volunteers were recruited. EPCs were isolated and cultured with and without calcitriol. The capacity of the cells to form colony-forming units (CFUs), their viability (measured by MTT assay), KLF-10 levels and angiogenic markers were evaluated after 1 week of culture. Results In diabetic patients, EPC CFUs and cell viability were higher in EPCs exposed to calcitriol vs. EPCs not exposed to calcitriol [EPC CFUs: 1.25 (IQR 1.0-2.0) vs. 0.5 (IQR 0.5-1.9), p < 0.001; MTT: 0.62 (IQR 0.44-0.93) vs. 0.52 (IQR 0.31-0.62), p = 0.001]. KLF-10 levels tended to be higher in EPCs exposed to vitamin D, with no differences in angiopoietic markers. In healthy subjects, calcitriol supplementation also resulted in higher cell viability [MTT: 0.23 (IQR 0.11-0.46) vs. 0.19 (0.09-0.39), p = 0.04], but without differences in CFU count or angiopoietic markers. Conclusion In patients with diabetes mellitus, in vitro vitamin D supplementation improved EPCs capacity to form colonies and viability. Further studies regarding the mechanisms by which vitamin D exerts its effect are required.	[Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Singer, Joel; Kornowski, Ran; Lev, Eli I.] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Hammer, Yoav; Soudry, Alissa; Levi, Amos; Talmor-Barkan, Yeela; Leshem-Lev, Dorit; Kornowski, Ran; Lev, Eli I.] Felsenstein Med Res Inst, Petah Tiqwa, Israel; [Hammer, Yoav; Levi, Amos; Talmor-Barkan, Yeela; Kornowski, Ran; Lev, Eli I.] Beilinson Hasharon Hosp, Rabin Med Ctr, Cardiol Inst, Petah Tiqwa, Israel; [Singer, Joel] Beilinson Hasharon Hosp, Rabin Med Ctr, Endocrinol Inst, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Rabin Medical Center	Lev, EI (corresponding author), Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel.; Lev, EI (corresponding author), Felsenstein Med Res Inst, Petah Tiqwa, Israel.; Lev, EI (corresponding author), Beilinson Hasharon Hosp, Rabin Med Ctr, Cardiol Inst, Petah Tiqwa, Israel.	elilev01@gmail.com						Chen Jian, 2010, MODERN DESIGN ADV MA, V3, P25; Chen JX, 2010, J BIOL CHEM, V285, P37041, DOI 10.1074/jbc.M110.157115; Cianciolo G, 2013, BLOOD PURIFICAT, V35, P187, DOI 10.1159/000347102; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Lev EI, 2014, EUR J PREV CARDIOL, V21, P1153, DOI 10.1177/2047487313488300; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shoji T, 2004, NEPHROL DIAL TRANSPL, V19, P179, DOI 10.1093/ndt/gfg513; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801; Yiu YF, 2011, J CLIN ENDOCR METAB, V96, pE830, DOI 10.1210/jc.2010-2212; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621	28	17	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0178057	10.1371/journal.pone.0178057	http://dx.doi.org/10.1371/journal.pone.0178057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545072	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700105
J	Bengtson, S; Knudsen, KB; Kyjovska, ZO; Berthing, T; Skaug, V; Levin, M; Koponen, IK; Shivayogimath, A; Booth, TJ; Alonso, B; Pesquera, A; Zurutuza, A; Thomsen, BL; Troelsen, JT; Jacobsen, NR; Vogel, U				Bengtson, Stefan; Knudsen, Kristina B.; Kyjovska, Zdenka O.; Berthing, Trine; Skaug, Vidar; Levin, Marcus; Koponen, Ismo K.; Shivayogimath, Abhay; Booth, Timothy J.; Alonso, Beatriz; Pesquera, Amaia; Zurutuza, Amaia; Thomsen, Birthe L.; Troelsen, Jesper T.; Jacobsen, Nicklas R.; Vogel, Ulla			Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MOUSE LUNG; MECHANICAL-PROPERTIES; DIOXIDE PARTICLES; NANOPARTICLES; INSTILLATION; INHALATION; TOXICITY	We investigated toxicity of 2-3 layered >1 mu m sized graphene oxide (GO) and reduced graphene oxide (rGO) in mice following single intratracheal exposure with respect to pulmonary inflammation, acute phase response (biomarker for risk of cardiovascular disease) and genotoxicity. In addition, we assessed exposure levels of particulate matter emitted during production of graphene in a clean room and in a normal industrial environment using chemical vapour deposition. Toxicity was evaluated at day 1, 3, 28 and 90 days (18, 54 and 162 mu g/mouse), except for GO exposed mice at day 28 and 90 where only the lowest dose was evaluated. GO induced a strong acute inflammatory response together with a pulmonary (Serum-Amyloid A, Saa3) and hepatic (Saa1) acute phase response. rGO induced less acute, but a constant and prolonged inflammation up to day 90. Lung histopathology showed particle agglomerates at day 90 without signs of fibrosis. In addition, DNA damage in BAL cells was observed across time points and doses for both GO and rGO. In conclusion, pulmonary exposure to GO and rGO induced inflammation, acute phase response and genotoxicity but no fibrosis.	[Bengtson, Stefan; Knudsen, Kristina B.; Kyjovska, Zdenka O.; Berthing, Trine; Levin, Marcus; Koponen, Ismo K.; Thomsen, Birthe L.; Jacobsen, Nicklas R.; Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen O, Denmark; [Bengtson, Stefan; Troelsen, Jesper T.] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Skaug, Vidar] Natl Inst Occupat Hlth, Oslo, Norway; [Shivayogimath, Abhay; Booth, Timothy J.; Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark; [Alonso, Beatriz; Pesquera, Amaia; Zurutuza, Amaia] Graphenea SA, R&D Dept, San Sebastian, Spain	National Research Centre for the Working Environment; Roskilde University; Technical University of Denmark	Vogel, U (corresponding author), Natl Res Ctr Working Environm, Copenhagen O, Denmark.; Vogel, U (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Lyngby, Denmark.	ubv@nrcwe.dk	Troelsen, Jesper Thorvald T/B-6264-2013; Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012; Shivayogimath, Abhay/AAJ-6687-2021	Troelsen, Jesper Thorvald T/0000-0002-4177-3267; Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Berthing, Trine/0000-0003-0723-9869; Alonso, Beatriz/0000-0002-6282-2670; Jacobsen, Nicklas Raun/0000-0002-2504-2229	European Union Seventh Framework Programme [FP7-604000]	European Union Seventh Framework Programme(European Commission)	The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no FP7-604000. The funder provided support in the form of salaries for authors [BA, AP, AZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbach C., 2014, MEASUREMENT MONITORI; Bengtson S, 2016, ENVIRON MOL MUTAGEN, V57, P469, DOI 10.1002/em.22017; Bianco A, 2013, CARBON, V65, P1, DOI 10.1016/j.carbon.2013.08.038; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Bussy C, 2013, ACCOUNTS CHEM RES, V46, P692, DOI 10.1021/ar300199e; Christophersen DV, 2016, TOXICOLOGY, V371, P29, DOI 10.1016/j.tox.2016.10.003; Dong L, 2009, J ASTHMA, V46, P229, DOI 10.1080/02770900802610050; Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Duch MC, 2011, NANO LETT, V11, P5201, DOI 10.1021/nl202515a; Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639; Heitbrink WA, 2015, J OCCUP ENVIRON HYG, V12, P16, DOI 10.1080/15459624.2014.930559; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; Jackson P, 2015, ENVIRON MOL MUTAGEN, V56, P183, DOI 10.1002/em.21922; Jackson P, 2013, MUTAGENESIS, V28, P699, DOI 10.1093/mutage/get049; Jackson P, 2011, BASIC CLIN PHARMACOL, V108, P202, DOI 10.1111/j.1742-7843.2010.00644.x; Jacobsen NR, 2008, MUTAT RES-FUND MOL M, V641, P54, DOI 10.1016/j.mrfmmm.2008.03.001; Jacobsen NR, 2008, ENVIRON MOL MUTAGEN, V49, P476, DOI 10.1002/em.20406; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jacobsen NR, 2011, ENVIRON MOL MUTAGEN, V52, P331, DOI 10.1002/em.20629; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; Jayjock MA, 2011, J OCCUP ENVIRON HYG, V8, pD114, DOI 10.1080/15459624.2011.624387; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kaminski H, 2015, AEROSOL AIR QUAL RES, V15, P129, DOI 10.4209/aaqr.2014.03.0065; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim JK, 2015, NANOTOXICOLOGY, V10, P1, DOI DOI 10.1108/0IR-01-2015-0022; Koivisto AJ, 2014, INT J ENV RES PUB HE, V11, P5382, DOI 10.3390/ijerph110505382; Kyjovska ZO, 2015, MUTAGENESIS, V30, P499, DOI 10.1093/mutage/gev009; Kyjovska ZO, 2015, ENVIRON MOL MUTAGEN, V56, P41, DOI 10.1002/em.21888; Li B, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.7; Lindhorst E, 1997, BBA-PROTEIN STRUCT M, V1339, P143, DOI 10.1016/S0167-4838(96)00227-0; Liu JH, 2015, TOXICOL RES-UK, V4, P83, DOI 10.1039/c4tx00044g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma-Hock L, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-23; Mao L, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0120-1; Mikkelsen L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-32; Moller P, 2016, CRIT REV TOXICOL, V46, P437, DOI 10.3109/10408444.2016.1149451; Morimoto Y, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-4; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Paci JT, 2007, J PHYS CHEM C, V111, P18099, DOI 10.1021/jp075799g; Park EJ, 2014, ARCH TOXICOL, V89; Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/nnano.2009.58, 10.1038/NNANO.2009.58]; Poulsen SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174167; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Poulsen SS, 2015, TOXICOL APPL PHARM, V283, P210, DOI 10.1016/j.taap.2015.01.011; Poulsen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080452; Poulsen SS, 2016, NANOTOXICOLOGY, P1; Ren WC, 2014, NAT NANOTECHNOL, V9, P726, DOI 10.1038/nnano.2014.229; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saber AT, 2014, WIRES NANOMED NANOBI, V6, P517, DOI 10.1002/wnan.1279; Saber AT, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0148-2; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2012, NANOTOXICOLOGY, V6, P776, DOI 10.3109/17435390.2011.620745; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Saber AT, 2005, ARCH TOXICOL, V79, P177, DOI 10.1007/s00204-004-0613-9; Saber AT, 2012, PART FIBRE TOXICOL, V9, P1; Schinwald A, 2014, NANOTOXICOLOGY, V8, P824, DOI 10.3109/17435390.2013.831502; Schinwald A, 2012, ACS NANO, V6, P736, DOI 10.1021/nn204229f; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Fonseca AS, 2015, ANN OCCUP HYG, V59, P586, DOI 10.1093/annhyg/meu110; Su WC, 2016, J OCCUP ENVIRON HYG, V13, P48, DOI 10.1080/15459624.2015.1076162; Suk JW, 2010, ACS NANO, V4, P6557, DOI 10.1021/nn101781v; Sydlik SA, 2015, ACS NANO, V9, P3866, DOI 10.1021/acsnano.5b01290; Taubes G, 2002, SCIENCE, V296, P242, DOI 10.1126/science.296.5566.242; The National Institutes for Occupational Safety and Health, 2013, NAT I OCC SAF HLTH C, V65, P2013; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UK Intellectual Property Office Informatics Team, 2015, 0RAPH WORLDW PAT LAN; Wallin H, 2016, MUTAGENESIS; Warheit DB, 2003, EXP LUNG RES, V29, P593, DOI 10.1080/01902140390240104; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Westberg H, 2016, INT ARCH OCC ENV HEA, V89, P813, DOI 10.1007/s00420-016-1119-5; Wick P, 2014, ANGEW CHEM INT EDIT, V53, P7714, DOI 10.1002/anie.201403335; Xu M, 2016, ACS NANO, V10, P3267, DOI 10.1021/acsnano.6b00539; Zhang WD, 2015, TOXICOL LETT, V237, P61, DOI 10.1016/j.toxlet.2015.05.021; Zhang Y, 2013, ACCOUNTS CHEM RES, V46, P2329, DOI 10.1021/ar300203n; Zurutuza A, 2014, NAT NANOTECHNOL, V9, P730, DOI 10.1038/nnano.2014.225	80	41	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178355	10.1371/journal.pone.0178355	http://dx.doi.org/10.1371/journal.pone.0178355			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570647	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800040
J	Salman, KN; Ismail, A; Abdullah, RSAR; Saeedi, T				Salman, Karrar Naji; Ismail, Alyani; Abdullah, Raja Syamsul Azmir Raja; Saeedi, Tale			Coplanar UHF RFID tag antenna with U-shaped inductively coupled feed for metallic applications	PLOS ONE			English	Article							RADIO-FREQUENCY IDENTIFICATION; ELECTRICALLY SMALL ANTENNAS; PATCH ANTENNA; QUALITY FACTOR; SLOT ANTENNA; MEANDER-LINE; DESIGN; SURFACES; OBJECTS; SIZE	In this paper, we present a novel compact, coplanar, tag antenna design for metallic objects. Electrically small antenna has designed for a UHF RFID (860-960 MHz) based on a proximity-coupled feed through. Furthermore, two symmetrical Via-loaded coplanar grounds fed by a U-shaped inductively coupled feed through an embedded transmission line. This configuration results in an antenna with dimensions of 31 x 19.5 x 3.065 mm(3) at 915 MHz, and the total gain for the antenna is 0.12 dBi. The Via-loaded coplanar and U-shaped inductively coupled feeds allow the antenna to provide flexible tuning in terms of antenna impedance. In addition, a figure of merit is applied for the proposed tag antenna, and the results are presented. The read range is measured to be 4.2 m, which is very close to simulated values. This antenna measurement shows very good agreement with simulations.	[Salman, Karrar Naji; Ismail, Alyani; Abdullah, Raja Syamsul Azmir Raja; Saeedi, Tale] Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst, Upm Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia	Salman, KN (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst, Upm Serdang 43400, Selangor, Malaysia.	karrarnaji0@gmail.com	Abdullah, Raja Syamsul Azmir Raja/G-8606-2017	Abdullah, Raja Syamsul Azmir Raja/0000-0002-9375-2038				Abdulhadi AE, 2012, IEEE ANTENN WIREL PR, V11, P248, DOI 10.1109/LAWP.2012.2187632; Alhawari ARH, 2014, ELECTROMAGNETICS, V34, P487, DOI 10.1080/02726343.2014.922767; Bhattacharyya R., THESIS; Bhattacharyya R, 2010, P IEEE, V98, P1593, DOI 10.1109/JPROC.2010.2051790; Bjorninen T, 2011, IEEE ANTENN WIREL PR, V10, P1147, DOI 10.1109/LAWP.2011.2171911; Byunggil Yu, 2006, 2006 IEEE Antennas and Propagation Society International Symposium (IEEE Cat. No. 06CH37758C), P3237, DOI 10.1109/APS.2006.1711301; Chen SL, 2009, IEEE ANTENN WIREL PR, V8, P1043, DOI 10.1109/LAWP.2009.2032252; Chen SY, 2004, ELECTRON LETT, V40, P1516, DOI 10.1049/el:20046780; Chen WJ, 2011, AM J GERIAT PSYCHIAT, V19, P597, DOI 10.1097/JGP.0b013e3181faec0e; Chiu CY, 2007, IEEE T ANTENN PROPAG, V55, P65, DOI 10.1109/TAP.2006.888389; Choi W, 2008, MICROW OPT TECHN LET, V50, P2978, DOI 10.1002/mop.23831; Choi W, 2008, ETRI J, V30, P597, DOI 10.4218/etrij.08.0208.0063; CHU LJ, 1948, J APPL PHYS, V19, P1163, DOI 10.1063/1.1715038; Deleruyelle T, 2010, IEEE ANTENN PROPAG M, V52, P14, DOI 10.1109/MAP.2010.5638229; EPCglobal, 2008, STAT TEST METH APPL; Fukasawa T, 2012, IEEE T ANTENN PROPAG, V60, P5645, DOI 10.1109/TAP.2012.2210181; Galchdar A, 2009, IEEE T ANTENN PROPAG, V57, P339, DOI 10.1109/TAP.2008.2011227; Golfarb M. E., 1991, IEEE Microwave and Guided Wave Letters, V1, P135, DOI 10.1109/75.91090; Griffin JD, 2006, IEEE ANTENN WIREL PR, V5, P247, DOI 10.1109/LAWP.2006.874072; Hirvonen M, 2004, ELECTRON LETT, V40, P848, DOI 10.1049/el:20045156; Jadon A.S, 2013, INT J ELECT COMMUN E, P95; Jalal Ali S. A., 2013, Progress In Electromagnetics Research C, V39, P25; Kim JS, 2008, ELECTRON LETT, V44, P1181, DOI 10.1049/el:20080952; Kim J.-S, 2008, Progress In Electromagnetics Research C, V4, P129; Kim JS, 2008, ETRI J, V30, P600, DOI 10.4218/etrij.08.0208.0074; Kim T, 2011, MICROW OPT TECHN LET, V53, P239, DOI 10.1002/mop.25753; Koski E, 2013, IEEE T ANTENN PROPAG, V61, P4026, DOI 10.1109/TAP.2013.2261448; Krevsky S., 1960, IRE T ANTENNAS PROPA, V8, P343; Kwon H, 2005, ELECTRON LETT, V41, P1308, DOI 10.1049/el:20052940; Lee J.-H., 2008, P IEEE IND APPL SOC, P1, DOI DOI 10.1074/JBC.M806108200; Lee YH, 2013, IEEE T ANTENN PROPAG, V61, P362, DOI 10.1109/TAP.2012.2216493; Li RL, 2004, IEEE T ANTENN PROPAG, V52, P555, DOI 10.1109/TAP.2004.823884; Lin Ken-Huang, 2013, ANTENNAS PROPAGATION, V61, P505, DOI DOI 10.1109/TAP.2012; Manzari S, 2014, IEEE T ANTENN PROPAG, V62, P94, DOI 10.1109/TAP.2013.2287008; Manzari S, 2012, IEEE SENS J, V12, P2851, DOI 10.1109/JSEN.2012.2202897; Marrocco G, 2008, IEEE ANTENN PROPAG M, V50, P66, DOI 10.1109/MAP.2008.4494504; Mavridis GA, 2011, IEEE ANTENN PROPAG M, V53, P216, DOI 10.1109/MAP.2011.6097329; McLean JS, 1996, IEEE T ANTENN PROPAG, V44, P672, DOI 10.1109/8.496253; Murata Manufacturing Co, 2012, MUR MAGICSTRAP APPL; Ng ML, 2006, INT TECHN C CIRC SYS; Nikitin PV, 2009, IEEE T MICROW THEORY, V57, P1297, DOI 10.1109/TMTT.2009.2017297; Nilsson HE, 2007, IET MICROW ANTENNA P, V1, P776, DOI 10.1049/iet-map:20060148; Occhiuzzi C, 2010, IEEE T ANTENN PROPAG, V58, P2490, DOI 10.1109/TAP.2010.2050435; Palmer KD, 2006, IEEE T INSTRUM MEAS, V55, P266, DOI 10.1109/TIM.2005.861493; Park JY, 2008, ELECTRON LETT, V44, P1339, DOI 10.1049/el:20082102; Qing XM, 2009, IEEE T MICROW THEORY, V57, P1268, DOI 10.1109/TMTT.2009.2017288; Rao KVS, 2005, IEEE T ANTENN PROPAG, V53, P3870, DOI 10.1109/TAP.2005.859919; Rokunuzzaman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161293; Rokunuzzaman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132530; Ryu HK, 2007, ELECTRON LETT, V43, P372, DOI 10.1049/el:20070398; Sievenpiper DF, 2012, IEEE T ANTENN PROPAG, V60, P8, DOI 10.1109/TAP.2011.2167938; Sim DU, 2007, ANT PROP SOC INT S 2, P1333; Simons R. N., 2004, COPLANAR WAVEGUIDE C; Son HW, 2008, ELECTRON LETT, V44, P711, DOI 10.1049/el:20081141; Son HW, 2006, ETRI J, V28, P383, DOI 10.4218/etrij.06.0205.0077; Son HW, 2007, MICROW OPT TECHN LET, V49, P715, DOI 10.1002/mop.22222; Son HW, 2011, IEEE ANTENN WIREL PR, V10, P377, DOI 10.1109/LAWP.2011.2148151; Son HW, 2005, ELECTRON LETT, V41, P994, DOI 10.1049/el:20051536; Sten JCE, 2001, IEEE T ANTENN PROPAG, V49, P829, DOI 10.1109/8.929637; Ukkonen L, 2005, IEEE ANTENN WIREL PR, V4, P410, DOI 10.1109/LAWP.2005.860212; Wen GY, 2003, IEEE T ANTENN PROPAG, V51, P2116, DOI 10.1109/TAP.2003.814754; WHEELER HA, 1947, P IRE, V35, P1479, DOI 10.1109/JRPROC.1947.226199; Yaghjian AD, 2005, IEEE T ANTENN PROPAG, V53, P1298, DOI 10.1109/TAP.2005.844443; Yang PH, 2011, IEEE T ANTENN PROPAG, V59, P4454, DOI 10.1109/TAP.2011.2165484; Yi XH, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/8/085009; Zhang J., 2014, MATH PROBL ENG, V2014, P62, DOI DOI 10.1109/TAP.2014.2354412; Zhang J, 2013, IEEE ANTENN WIREL PR, V12, P1184, DOI 10.1109/LAWP.2013.2281842; Zhang L, 2008, J ELECTROMAGNET WAVE, V22, P1050, DOI 10.1163/156939308784158931; Ziolkowski RW, 2006, IEEE T ANTENN PROPAG, V54, P2113, DOI 10.1109/TAP.2006.877179	69	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178388	10.1371/journal.pone.0178388	http://dx.doi.org/10.1371/journal.pone.0178388			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570706	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800045
J	Seon, JJ; Lim, YJ; Lee, HW; Yoon, JM; Kim, SJ; Choi, S; Kawachi, I; Park, SM				Seon, Jong Ju; Lim, Yu Jin; Lee, Hae Won; Yoon, Jae Moon; Kim, Sang June; Choi, Seulggie; Kawachi, Ichiro; Park, Sang Min			Cardiovascular health status between standard and nonstandard workers in Korea	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERCEIVED JOB INSECURITY; MENTAL-HEALTH; EMPLOYMENT; PREVENTION; TEMPORARY; WORKING	Objectives The effect of employment insecurity on employee health is an important public health issue due to the recent effects of neoliberalism and the global financial crisis (2007-2008) on labor markets. This study aims to evaluate the differences in cardiovascular health status and the use of preventive screening services between standard and nonstandard workers. Methods Waged employees (N = 5,338) between the ages of 20 and 64 were grouped into standard (full-time, permanent) and nonstandard (part-time, temporary, or daily) employees. Data from the Fourth Korea National Health and Nutrition Examination Survey, 2007-2009, a nationwide representative survey, were examined, including cardiovascular health risk behaviors (tobacco, alcohol, physical inactivity), measured morbidities (blood pressure, blood glucose level, lipid profiles, body mass index), and the use of screening services for hypertension and diabetes mellitus. Results Female nonstandard employees tended to have higher blood pressure than did female standard employees (adjusted odds ratio, aOR 1.42, 95% confidence interval, CI 1.02 to 1.98). However, nonstandard employees (both men and women) were less likely to use preventive screening services for hypertension (aOR 0.72, 95% CI 0.54 to 0.94 in men; aOR 0.56, 95% CI 0.43 to 0.73 in women) and diabetes (aOR 0.58, 95% CI 0.43 to 0.79 in men; aOR 0.55, 95% CI 0.43 to 0.71 in women). Conclusion Nonstandard work is associated with the underuse of screening services and poorer cardiovascular health in a specific population. Policies to reduce employment insecurity and encourage nonstandard employees to receive health screening services should be prioritized.	[Seon, Jong Ju; Lee, Hae Won; Yoon, Jae Moon; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Seon, Jong Ju; Lee, Hae Won; Yoon, Jae Moon; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Seon, Jong Ju] Natl Canc Ctr, Goyang, South Korea; [Lim, Yu Jin] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Kim, Sang June] Chungha Geriatr Hosp, Gyeongju, South Korea; [Choi, Seulggie] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, 103 Daehakro, Seoul, South Korea; [Kawachi, Ichiro] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Park, Sang Min] Harvard Sch Publ Hlth, Dept Global & Populat Hlth, Boston, MA 02115 USA	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Park, SM (corresponding author), Harvard Sch Publ Hlth, Dept Global & Populat Hlth, Boston, MA 02115 USA.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019; Lim, Yu Jin/AAJ-5422-2020		National Research Foundation of Korea	National Research Foundation of Korea(National Research Foundation of Korea)	Each author contributed in the preparation of this review and has seen and approved the final version. SC received a scholarship from the BK21-plus education program by the National Research Foundation of Korea. We thank Doosup Shin, Donghoon Lee, SoonHo Lee, YunHee Choi for helpful comments on this paper.	American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; Baily M.N., 2009, US FINANCIAL EC CRIS; Benach J, 2000, AM J PUBLIC HEALTH, V90, P1316, DOI 10.2105/AJPH.90.8.1316; Benavides FG, 2000, J EPIDEMIOL COMMUN H, V54, P494, DOI 10.1136/jech.54.7.494; Burgard SA, 2009, SOC SCI MED, V69, P777, DOI 10.1016/j.socscimed.2009.06.029; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; *CDC, 2007, MMWR-MORBID MORTAL W, P1157; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; CSDH, 2008, CLOS GAP GEN HLTH EQ, P72; DAHL E, 1993, SOC SCI MED, V36, P1077, DOI 10.1016/0277-9536(93)90126-O; Ferrie JE, 2013, ATHEROSCLEROSIS, V227, P178, DOI 10.1016/j.atherosclerosis.2012.12.027; Glozier N, 2013, MED J AUSTRALIA, V199, P179, DOI 10.5694/mja13.10440; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; IPAQ, 2005, GUIDELINES DATA PROC; Kalleberg AL, 2000, ANNU REV SOCIOL, V26, P341, DOI 10.1146/annurev.soc.26.1.341; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kim IH, 2008, AM J IND MED, V51, P748, DOI 10.1002/ajim.20626; Kim IH, 2006, SOC SCI MED, V63, P566, DOI 10.1016/j.socscimed.2006.02.004; Kim Y, 2003, MONTHLY MAGAZINE LAB, V12, P72; Kivimaki M, 2000, BRIT MED J, V320, P971, DOI 10.1136/bmj.320.7240.971; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; KNSO, 2007, KOR STAND CLASS OCC; Korea National Statistical Office, 2004, ANN REP EC ACT POP K; Laszlo KD, 2013, INT J CARDIOL, V167, P2824, DOI 10.1016/j.ijcard.2012.07.005; Laszlo KD, 2010, SOC SCI MED, V70, P867, DOI 10.1016/j.socscimed.2009.11.022; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Marchand A, 2012, INT J SOC PSYCHIATR, V58, P596, DOI 10.1177/0020764011418404; Mewes R, 2013, PSYCHOTHER PSYCH MED, V63, P138, DOI 10.1055/s-0032-1332981; Naswall K., 2011, STRESS HLTH; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2005, HELP PAT WHO DRINK T; Pearson T. A., CIRCULATION, V106, P399; Schnall PL, 2016, INT J HEALTH SERV, V46, P656, DOI 10.1177/0020731416664687; Slopen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040512; Stull DE, 2009, CURR MED RES OPIN, V25, P929, DOI [10.1185/03007990902774765, 10.1185/03007990902774765 ]; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Virtanen M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4746; Virtanen P, 2011, OCCUP ENVIRON MED, V68, P570, DOI 10.1136/oem.2010.054890; Weitoft GR, 2005, J EPIDEMIOL COMMUN H, V59, P794, DOI 10.1136/jech.2005.033076; Williams Carol J., 2012, LOS ANGELES TIMES	39	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178395	10.1371/journal.pone.0178395	http://dx.doi.org/10.1371/journal.pone.0178395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6HZ	28570650	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800048
J	Villa-Bellosta, R				Villa-Bellosta, Ricardo			Impact of magnesium: calcium ratio on calcification of the aortic wall	PLOS ONE			English	Article							EXTRACELLULAR PYROPHOSPHATE METABOLISM; VASCULAR CALCIFICATION; SERUM MAGNESIUM; ARTERIAL CALCIFICATION; MOUSE MODEL; PHOSPHATE DEPOSITION; PARATHYROID-HORMONE; DIALYSIS; PREVENTS	Objective An inverse relationship between serum magnesium concentration and vascular calcification has been reported following observational clinical studies. Moreover, several studies have been suggesting a protective effect of magnesium on the vascular calcification. However, the exact mechanism remains elusive, and investigators have speculated among a myriad of potential actions. The effect of magnesium on calcification of the aortic wall is yet to be investigated. In the present study, the effects of magnesium and calcium on the metabolism of extracellular PPi, the main endogenous inhibitor of vascular calcification, were investigated in the rat aorta. Approach and results Calcium and magnesium have antagonist effects on PPi hydrolysis in the aortic wall. K-m and K-i values for PPi hydrolysis in rat aortic rings were 1.1 mmol/L magnesium and 32 mu mol/L calcium, respectively, but ATP hydrolysis was not affected with calcium. Calcium deposition in the rat aortic wall dramatically increased when the magnesium concentration was increased (ratio of Mg:Ca = 1:1;1.5 mmol/L calcium and 1.5 mmol/L magnesium) respect to low magnesium concentration (ratio Mg: Ca = 1:3, 1.5 mmol/L calcium and 0.75 mmol/L magnesium). Conclusion Data from observational clinical studies showing that the serum magnesium concentration is inversely correlated with vascular calcification could be reinterpreted as a compensatory regulatory mechanism that reduces both PPi hydrolysis and vascular calcification. The impact of magnesium in vascular calcification in humans could be studied in association with calcium levels, for example, as the magnesium: calcium ratio.	[Villa-Bellosta, Ricardo] FIIS FJD, Ave Reyes Catolicos 2, Madrid, Spain; [Villa-Bellosta, Ricardo] Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain	Fundacion Jimenez Diaz	Villa-Bellosta, R (corresponding author), FIIS FJD, Ave Reyes Catolicos 2, Madrid, Spain.; Villa-Bellosta, R (corresponding author), Spanish Biomed Res Network Diabet & Associated Me, Madrid, Spain.	ricardo.villa@fjd.es		Villa-Bellosta, Ricardo/0000-0002-1680-552X	Spanish Ministerio de Economia y Competitividad (MINECO) [SAF-2014-60699-JIN]	Spanish Ministerio de Economia y Competitividad (MINECO)	This study was supported by grant SAF-2014-60699-JIN from the Spanish Ministerio de Economia y Competitividad (MINECO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecil DL, 2011, J VASC RES, V48, P227, DOI 10.1159/000318805; Gorgels TGMF, 2010, J MOL MED, V88, P467, DOI 10.1007/s00109-010-0596-3; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Lomashvili KA, 2014, KIDNEY INT, V85, P1351, DOI 10.1038/ki.2013.521; Louvet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115342; MEEMA HE, 1987, KIDNEY INT, V32, P388, DOI 10.1038/ki.1987.222; O'Neill WC, 2007, KIDNEY INT, V72, P792, DOI 10.1038/sj.ki.5002412; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Riser BL, 2011, NEPHROL DIAL TRANSPL, V26, P3349, DOI 10.1093/ndt/gfr039; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2011, CIRC RES, V109, P578, DOI 10.1161/CIRCRESAHA.111.247965; SCHIBLER D, 1968, CLIN SCI, V35, P363; Turgut F, 2008, INT UROL NEPHROL, V40, P1075, DOI 10.1007/s11255-008-9410-3; URRY DW, 1971, P NATL ACAD SCI USA, V68, P810, DOI 10.1073/pnas.68.4.810; Villa-Bellosta R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159858; Villa-Bellosta R, 2015, METHODS MOL BIOL, V1339, P119, DOI 10.1007/978-1-4939-2929-0_8; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571; Villa-Bellosta R, 2011, CIRC J, V75, P2705, DOI 10.1253/circj.CJ-11-0477; Villa-Bellosta R, 2011, AM J PHYSIOL-HEART C, V301, pH61, DOI 10.1152/ajpheart.01020.2010; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Wei MX, 2006, INT UROL NEPHROL, V38, P317, DOI 10.1007/s11255-006-0082-6; Wei MX, 2006, PERITON DIALYSIS INT, V26, P366	27	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178872	10.1371/journal.pone.0178872	http://dx.doi.org/10.1371/journal.pone.0178872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570619	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800129
J	Campbell, TJ; Decloe, M; Gill, S; Ho, G; McCready, J; Powis, J				Campbell, Tonya J.; Decloe, Melissa; Gill, Suzanne; Ho, Grace; McCready, Janine; Powis, Jeff			Every antibiotic, every day: Maximizing the impact of prospective audit and feedback on total antibiotic use	PLOS ONE			English	Article							ANTIMICROBIAL STEWARDSHIP PROGRAM; CLOSTRIDIUM-DIFFICILE INFECTION; INTERRUPTED TIME-SERIES; HIGH-RISK ANTIBIOTICS; GUIDELINES; OUTCOMES; UNIT	Background The success of antimicrobial stewardship is dependent on how often it is completed and which antimicrobials are targeted. We evaluated the impact of an antimicrobial stewardship program (ASP) in three non-ICU settings where all systemic antibiotics, regardless of spectrum, were targeted on the first weekday after initiation. Methods Prospective audit and feedback (PAAF) was initiated on the surgical, respiratory, and medical wards of a community hospital on July 1, 2010, October 1, 2010, and April 1, 2012, respectively. We evaluated rates of total antibiotic use, measured in days on therapy (DOTs), among all patients admitted to the wards before and after PAAF initiation using an interrupted time series analysis. Changes in antibiotic costs, rates of C. difficile infection (CDI), mortality, readmission, and length of stay were evaluated using univariate analyses. Results Time series modelling demonstrated that total antibiotic use decreased (+/- standard error) by 100 +/- 51 DOTs/1,000 patient-days on the surgical wards (p = 0.049), 100 +/- 46 DOTs/1,000 patient-days on the respiratory ward (p = 0.029), and 91 +/- 33 DOTs/1,000 patient-days on the medical wards (p = 0.006) immediately following PAAF initiation. Reductions in antibiotic use were sustained up to 50 months after intervention initiation, and were accompanied by decreases in antibiotic costs. There were no significant changes to patient outcomes on the surgical and respiratory wards following intervention initiation. On the medical wards, however, readmission increased from 4.6 to 5.6 per 1,000 patient-days (p = 0.043), while mortality decreased from 7.4 to 5.0 per 1,000 patient-days (p = 0.001). CDI rates showed a nonsignificant declining trend after PAAF initiation.	[Campbell, Tonya J.; Decloe, Melissa; Gill, Suzanne; Ho, Grace; McCready, Janine; Powis, Jeff] Michael Garron Hosp, Div Infect Dis, Toronto, ON, Canada; [McCready, Janine; Powis, Jeff] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Toronto East General Hospital; University of Toronto	Powis, J (corresponding author), Michael Garron Hosp, Div Infect Dis, Toronto, ON, Canada.; Powis, J (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	jpowi@tegh.on.ca		Powis, Jeff/0000-0003-2053-6083; Campbell, Tonya/0000-0001-8459-208X	MichaelGarron Hospital; Michael Garron Hospital Foundation	MichaelGarron Hospital(University of Toronto); Michael Garron Hospital Foundation	J.P.receives salary support through the Michael Garron Hospital. The Michael Garron Hospital Foundation provided grant funding for the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparationofthemanuscript.	Aldeyab MA, 2012, J ANTIMICROB CHEMOTH, V67, P2988, DOI 10.1093/jac/dks330; Borde JP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-201; Boyles TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079747; Cakmakci M, 2015, J HOSP INFECT, V89, P264, DOI 10.1016/j.jhin.2015.01.006; Canadian Institute for Health Information, 2013, HIG WEIGHTS ELOS VAL; Canadian Institute for Health Information, 2012, ALL CAUS READM ACUT; Cheng VCC, 2009, EUR J CLIN MICROBIOL, V28, P1447, DOI 10.1007/s10096-009-0803-8; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Duane TM, 2013, AM SURGEON, V79, P1269; Elligsen M, 2012, INFECT CONT HOSP EP, V33, P354, DOI 10.1086/664757; Fleming D, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw115; Karanika S, 2016, ANTIMICROB AGENTS CH, V60, P4840, DOI 10.1128/AAC.00825-16; Leung Valerie, 2011, Can J Hosp Pharm, V64, P314; Ng CK, 2008, QUAL SAF HEALTH CARE, V17, P387, DOI 10.1136/qshc.2007.023267; Palmay L, 2014, CLIN INFECT DIS, V59, P867, DOI 10.1093/cid/ciu445; Sartelli M, 2016, SURG INFECT, V17, P485, DOI 10.1089/sur.2016.015; Talpaert MJ, 2011, J ANTIMICROB CHEMOTH, V66, P2168, DOI 10.1093/jac/dkr253; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yeo CL, 2012, EUR J CLIN MICROBIOL, V31, P583, DOI 10.1007/s10096-011-1351-6	21	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178434	10.1371/journal.pone.0178434	http://dx.doi.org/10.1371/journal.pone.0178434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562638	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700061
J	Figueroa, RJ; Carrasco-Avino, G; Wichmann, IA; Lange, M; Owen, GI; Siekmann, AF; Corvalan, AH; Opazo, JC; Amigo, JD				Figueroa, Ricardo J.; Carrasco-Avino, Gonzalo; Wichmann, Ignacio A.; Lange, Martin; Owen, Gareth I.; Siekmann, Arndt F.; Corvalan, Alejandro H.; Opazo, Juan C.; Amigo, Julio D.			Reprimo tissue-specific expression pattern is conserved between zebrafish and human	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; TUMOR-SUPPRESSOR; ABERRANT METHYLATION; POTENTIAL BIOMARKER; GASTRIC-CANCER; HUMAN-DISEASE; EVOLUTION; GENE; DIVERSIFICATION; ADENOCARCINOMA	Reprimo (RPRM), a member of the RPRM gene family, is a tumor-suppressor gene involved in the regulation of the p53-mediated cell cycle arrest at G2/M. RPRM has been associated with malignant tumor progression and proposed as a potential biomarker for early cancer detection. However, the expression and role of RPRM, as well as its family, are poorly understood and their physiology is as yet unstudied. In this scenario, a model system like the zebrafish could serve to dissect the role of the RPRM family members in vivo. Phylogenetic analysis reveals that RPRMand RPRML have been differentially retained by most species throughout vertebrate evolution, yet RPRM3 has been retained only in a small group of distantly related species, including zebrafish. Herein, we characterized the spatiotemporal expression of RPRM (present in zebrafish as an infraclass duplication rprma/rprmb), RPRML and RPRM3 in the zebrafish. By whole-mount in situ hybridization (WISH) and fluorescent in situ hybridization (FISH), we demonstrate that rprm (rprma/rprmb) and rprml show a similar spatiotemporal expression profile during zebrafish development. At early developmental stages rprmb is expressed in somites. After one day post-fertilization, rprm (rprma/rprmb) and rprml are expressed in the notochord, brain, blood vessels and digestive tube. On the other hand, rprm3 shows the most unique expression profile, being expressed only in the central nervous system (CNS). We assessed the expression patterns of RPRM gene transcripts in adult zebrafish and human RPRM protein product in tissue samples by RT-qPCR and immunohistochemistry (IHC) staining, respectively. Strikingly, tissue-specific expression patterns of the RPRMtranscripts and protein are conserved between zebrafish and humans. We propose the zebrafish as a powerful tool to elucidate the both physiological and pathological roles of the RPRM gene family.	[Figueroa, Ricardo J.; Owen, Gareth I.; Amigo, Julio D.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile; [Carrasco-Avino, Gonzalo; Wichmann, Ignacio A.; Owen, Gareth I.; Corvalan, Alejandro H.] ACCDiS, Santiago, Chile; [Carrasco-Avino, Gonzalo] Univ Chile, Hosp Clin, Pathol Dept, Santiago, Chile; [Wichmann, Ignacio A.; Owen, Gareth I.; Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Fac Med, Dept Oncol & Hematol, Santiago, Chile; [Lange, Martin; Siekmann, Arndt F.] Max Planck Inst Mol Biomed, Munster, Germany; [Owen, Gareth I.] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Ctr UC Invest Oncol CITO, Santiago, Chile; [Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolut, Valdivia, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Max Planck Society; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Amigo, JD (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile.	jamigo@bio.puc.cl	Siekmann, Arndt/AAE-4769-2021	amigo, julio/0000-0002-6481-8034; Wichmann, Ignacio/0000-0002-1115-2937; Corvalan, Alejandro/0000-0001-5492-3853; Siekmann, Arndt/0000-0001-6972-2173; Opazo, Juan C./0000-0001-7938-4083; Amigo, Julio/0000-0001-8718-2676	BMBF-CONICYT [20140027]; CONICYT-ANILLO [ACT1402]; CRP-ICGEB [CH15-01]; FONDECYT [1160627, 1140970, 1151411]; BMRC [13CTI-21526-P6, IMII P09/016-F]; CONICYT-FONDAP [15130011]	BMBF-CONICYT(Federal Ministry of Education & Research (BMBF)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT-ANILLO(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); CRP-ICGEB; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); BMRC(Agency for Science Technology & Research (A*STAR)); CONICYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was funded by grants BMBF-CONICYT 20140027 to AFS and JDA, CONICYT-ANILLO ACT1402 and CRP-ICGEB CH15-01 to JDA, FONDECYT 1160627, to JCO, 1140970 to GIO, 1151411 to AHC, BMRC 13CTI-21526-P6, IMII P09/016-F and CONICYT-FONDAP 15130011 to GIO and AHC.	Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Buchegger K, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0066-7; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ellinger J, 2008, UROLOGY, V71, P161, DOI 10.1016/j.urology.2007.09.056; Garcia-Bloj B, 2016, ONCOTARGET, V7, P60535, DOI 10.18632/oncotarget.11142; Hamilton JP, 2006, CLIN CANCER RES, V12, P6637, DOI 10.1158/1078-0432.CCR-06-1781; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Luo J, 2011, DIAGN CYTOPATHOL, V39, P752, DOI 10.1002/dc.21461; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Maxwell EK, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0212-1; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Nakajima T, 2009, J BRONCHOL INTERN PU, V16, P10, DOI 10.1097/LBR.0b013e318195d930; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Opazo JC, 2013, MOL BIOL EVOL, V30, P140, DOI 10.1093/molbev/mss212; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Saavedra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125834; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Sato N, 2006, CANCER-AM CANCER SOC, V107, P251, DOI 10.1002/cncr.21977; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tobia C, 2011, INT J DEV BIOL, V55, P505, DOI 10.1387/ijdb.103238ct; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; WESTERFIELD M, 1995, ZEBRAFISH BOOK; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Wichmann IA, 2016, GENE, V591, P245, DOI 10.1016/j.gene.2016.07.036	38	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178274	10.1371/journal.pone.0178274	http://dx.doi.org/10.1371/journal.pone.0178274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562620	Green Submitted, gold, Green Published			2022-12-26	WOS:000402608700049
J	Freitas, CMT; Hamblin, GJ; Raymond, CM; Weber, KS				Freitas, Claudia M. Tellez; Hamblin, Garrett J.; Raymond, Carlee M.; Weber, K. Scott			Naive helper T cells with high CD5 expression have increased calcium signaling	PLOS ONE			English	Article							FLOW-CYTOMETRY; ACTIVATION; LYMPHOCYTES; RESPONSES; AVIDITY; LIGAND; INTERLEUKIN-2; HOMEOSTASIS; THRESHOLDS; STRENGTH	The adaptive immune response is orchestrated by T helper cells and their function is dependent upon interactions between the T cell receptor (TCR), peptide MHC (pMHC) and coreceptors. TCR-pMHC interactions initiate calcium signaling cascades which determine T cell activation, survival, proliferation and differentiation. CD5 is a co-receptor that plays an important role in regulating T cell signaling and fate during thymocyte education. CD5 surface expression on mature single positive thymocytes correlates with the TCR signal strength for positive selecting self-ligands. CD5 also plays a role in T cell function after thymic development is complete. Peripheral T cells with higher CD5 expression respond better to foreign antigen than those with lower CD5 expression and CD5-high T cells are enriched in memory populations. In our study, we examined the role of CD5 expression and calcium signaling in the primary response of T cells using two Listeria monocytogenes specific T helper cells (LLO118 and LLO56). These T cells recognize the same immunodominant epitope (LLO190-205) of L. monocytogenes and have divergent primary and secondary responses and different levels of CD5 expression. We found that each T cell has unique calcium mobilization in response to in vitro stimulation with LLO190-205 and that CD5 expression levels in these cells changed over time following stimulation. LLO56 naive T helper cells, which expresses higher levels of CD5, have higher calcium mobilization than naive LLO118 T cells. Three days after in vitro stimulation, LLO118 T cells had more robust calcium mobilization than LLO56 and there were no differences in calcium mobilization 8 days after in vitro stimulation. To further evaluate the role of CD5, we measured calcium signaling in CD5 knockout LLO118 and LLO56 T cells at these three time points and found that CD5 plays a significant role in promoting the calcium signaling of naive CD5-high LLO56 T cells.	[Freitas, Claudia M. Tellez; Hamblin, Garrett J.; Raymond, Carlee M.; Weber, K. Scott] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Weber, KS (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	scott_weber@byu.edu	Weber, Scott/O-1022-2014; Freitas, Claudia/GQR-0520-2022	Weber, Scott/0000-0003-3688-2191; Freitas, Claudia/0000-0002-9218-3021	National Institute of Allergy and Infectious Diseases [R0102063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107753] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institute of Allergy and Infectious Diseases (R0102063) to KSW.The funder had no role in study design,data collection and analysis, decision to publish,or preparatio nof the manuscript.	Adair P, 2016, CELL IMMUNOL, V299, P30, DOI 10.1016/j.cellimm.2015.10.003; ALBEROLAILA J, 1992, J IMMUNOL, V148, P1287; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Bajnok A, 2013, CYTOM PART A, V83A, P287, DOI 10.1002/cyto.a.22256; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bikah G, 1998, INT IMMUNOL, V10, P1185, DOI 10.1093/intimm/10.8.1185; Brossard U, 2003, J IMMUNOL, V170, P4623, DOI 10.4049/jimmunol.170.9.4623; Brown MH, 2010, J IMMUNOL, V185, P6068, DOI 10.4049/jimmunol.0903823; Christo SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07760; Dalloul A, 2009, AUTOIMMUN REV, V8, P349, DOI 10.1016/j.autrev.2008.11.007; Daniels MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00617; Dasu T, 2008, IMMUNOL LETT, V119, P103, DOI 10.1016/j.imlet.2008.05.008; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong BX, 2016, INT J MOL MED, V38, P45, DOI 10.3892/ijmm.2016.2592; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gallegos AM, 2016, NAT IMMUNOL, V17, P379, DOI 10.1038/ni.3386; Gascoigne NRJ, 2011, CURR OPIN IMMUNOL, V23, P207, DOI 10.1016/j.coi.2010.12.017; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Joseph N, 2014, BBA-BIOMEMBRANES, V1838, P557, DOI 10.1016/j.bbamem.2013.07.009; Kaposi AS, 2008, CYTOM PART A, V73A, P246, DOI 10.1002/cyto.a.20518; Lee SH, 2012, MBIO, V3, DOI 10.1128/mBio.00411-12; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Martin CE, 2014, NAT IMMUNOL, V15, P217, DOI 10.1038/ni.2832; Meszaros G, 2012, ASSAY DRUG DEV TECHN, V10, P97, DOI 10.1089/adt.2011.0368; Milam AV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00621; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Serafini N, 2012, J IMMUNOL, V189, P3689, DOI 10.4049/jimmunol.1102969; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Singh NJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw092; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SPERTINI F, 1991, J IMMUNOL, V146, P47; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stojakovic M, 2008, J IMMUNOL, V181, P6770, DOI 10.4049/jimmunol.181.10.6770; Tabbekh M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22841; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Weber KS, 2008, J IMMUNOL, V180, P1442, DOI 10.4049/jimmunol.180.3.1442; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109	47	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178799	10.1371/journal.pone.0178799	http://dx.doi.org/10.1371/journal.pone.0178799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562659	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700088
J	Kim, SH; Park, WS; Kim, SH; Seo, HK; Joung, JY; Lee, KH; Chung, J				Kim, Sung Han; Park, Weon Seo; Kim, Sun Ho; Seo, Ho Kyung; Joung, Jae Young; Lee, Kang Hyun; Chung, Jinsoo			Initial computed tomography imaging details during first-line systemic therapy is of significant prognostic value in patients with naive, unresectable metastatic renal cell carcinoma	PLOS ONE			English	Article							RECEIVING ANTIANGIOGENIC THERAPY; RESPONSE EVALUATION CRITERIA; CONTRAST-ENHANCED CT; TARGETED THERAPY; SOLID TUMORS; CLEAR-CELL; CANCER; SUNITINIB; SIZE; NECROSIS	Purpose We aimed to determine the prognostic significance of computed tomography imaging parameters of unresectable primary renal tumor lesions, obtained at baseline and at first follow-up, on overall survival in naive, unresectable metastatic renal cell carcinoma patients during first-line systemic therapy. Materials and methods Clinicopathological parameters of 56 patients treated between 2007 and 2015, including imaging parameters (such as the longest tumor diameter, necrotic area diameter, and attenuation in primary renal tumor lesions on baseline vs. follow-up computed tomography), were retrospectively reviewed to derive predictive factors of overall survival. The best overall response was measured according to the RECIST v1.1. Results The median treatment period was 206.3 days and the median follow-up was 14.6 months. Forty-four (78.6%) patients progressed after a median 4.6 months of progression-free survival, and 6 (10.7%) patients survived with a median overall survival of 12.5 months. Multivariate analysis showed that the baseline tumor diameter (hazard ratio [HR] 0.903) and mean attenuation (HR 0.936), change of tumor diameter (HR 0.714) and necrosis diameter (HR 0.861), change in the percentage of tumor diameter (HR 1.483) and of necrosis diameter (HR 1.028) between baseline and follow-up computed tomography images; treatment duration (HR 0.986) and baseline serum hemoglobin (HR 1.790) and albumin level (HR 0.060) were significant factors for overall survival (p<0.05). Conclusion The study showed that baseline and first follow-up computed tomography findings of primary renal lesions during first-line systemic therapy are useful and significant predictors of OS in patients with naive unresectable mRCC.	[Kim, Sung Han; Seo, Ho Kyung; Joung, Jae Young; Lee, Kang Hyun; Chung, Jinsoo] Natl Canc Ctr, Ctr Prostate Canc, Dept Urol, Goyang, South Korea; [Park, Weon Seo] Res Inst, Dept Pathol, Goyang, South Korea; [Park, Weon Seo; Kim, Sun Ho] Hosp Natl Canc Ctr, Goyang, South Korea; [Kim, Sun Ho] Res Inst, Dept Radiol, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, J (corresponding author), Natl Canc Ctr, Ctr Prostate Canc, Dept Urol, Goyang, South Korea.	cjs5225@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203				Abel EJ, 2011, EUR UROL, V60, P1273, DOI 10.1016/j.eururo.2011.07.008; Abel EJ, 2011, EUR UROL, V59, P10, DOI 10.1016/j.eururo.2010.09.034; Aslam MZ, 2014, ISRN UROL, V2014; ATZPODIEN J, 1993, EUR J CANCER, V29A, pS6, DOI 10.1016/0959-8049(93)90617-O; Cetin B, 2014, INT UROL NEPHROL, V46, P1081, DOI 10.1007/s11255-013-0613-x; Chang YH, 2011, KAOHSIUNG J MED SCI, V27, P59, DOI 10.1016/j.kjms.2010.12.004; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fournier LS, 2010, RADIOLOGY, V256, P511, DOI 10.1148/radiol.10091362; Gold P J, 1996, Semin Urol Oncol, V14, P216; Han KS, 2010, CANCER-AM CANCER SOC, V116, P2332, DOI 10.1002/cncr.25019; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hittinger M, 2012, UROL ONCOL-SEMIN ORI, V30, P695, DOI 10.1016/j.urolonc.2010.10.011; HONDA H, 1992, ACTA RADIOL, V33, P39; Hu B, 2012, UROL CLIN N AM, V39, P233, DOI 10.1016/j.ucl.2012.02.002; Iacovelli R, 2012, BJU INT, V110, P1747, DOI 10.1111/j.1464-410X.2012.11518.x; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Julka PK, 2008, BRIT J RADIOL, V81, P444, DOI 10.1259/bjr/32785946; Klatte T, 2009, J UROLOGY, V181, P1558, DOI 10.1016/j.juro.2008.11.098; Krajewski KM, 2014, CANCER-AM CANCER SOC, V120, P711, DOI 10.1002/cncr.28493; Krajewski KM, 2011, EUR UROL, V59, P856, DOI 10.1016/j.eururo.2011.01.038; Kwon WA, 2013, ANN SURG ONCOL, V20, P4397, DOI 10.1245/s10434-013-3290-1; Lam JS, 2005, CANCER-AM CANCER SOC, V103, P2517, DOI 10.1002/cncr.21127; Lee HO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131464; Lee SE, 2006, J UROLOGY, V176, P1332, DOI 10.1016/j.juro.2006.06.021; Leon L, 2014, TARGET ONCOL, V9, P9, DOI 10.1007/s11523-013-0304-7; Motoi F, 2011, ANN SURG ONCOL, V18, P371, DOI 10.1245/s10434-010-1311-x; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Brufau BP, 2013, RADIOGRAPHICS, V33, P1691, DOI 10.1148/rg.336125110; Park I, 2013, CLIN GENITOURIN CANC, V11, P276, DOI 10.1016/j.clgc.2012.12.005; Park JY, 2014, HUM PATHOL, V45, P1437, DOI 10.1016/j.humpath.2014.02.019; Pecuchet N, 2013, ONCOLOGY-BASEL, V84, P22, DOI 10.1159/000342962; Pichler M, 2012, AM J CLIN PATHOL, V137, P283, DOI 10.1309/AJCPLBK9L9KDYQZP; Porta C, 2016, FUTURE ONCOL, V12, P533, DOI 10.2217/fon.15.313; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; Salem ME, 2014, CLIN GENITOURIN CANC, V12, P117, DOI 10.1016/j.clgc.2013.08.001; Smith AD, 2016, RADIOLOGY, V281, P484, DOI 10.1148/radiol.2016160143; Smith AD, 2013, UROL ONCOL-SEMIN ORI, V31, P1283, DOI 10.1016/j.urolonc.2011.08.010; Smith AD, 2010, AM J ROENTGENOL, V194, P1470, DOI 10.2214/AJR.09.3456; Smith AD, 2010, AM J ROENTGENOL, V194, P157, DOI 10.2214/AJR.09.2941; Stenman M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0841-7; Tonini G, 2011, EXPERT REV ANTICANC, V11, P921, DOI [10.1586/era.11.63, 10.1586/ERA.11.63]; van der Veldt AAM, 2010, BRIT J CANCER, V102, P803, DOI 10.1038/sj.bjc.6605567; Vano YA, 2014, EXPERT REV ANTICANC, V14, P523, DOI 10.1586/14737140.2014.882773; Zhi Wanqing Iris, 2014, Ann Cancer Res, V1, P1	45	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177975	10.1371/journal.pone.0177975	http://dx.doi.org/10.1371/journal.pone.0177975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562690	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700038
J	Kutwin, M; Sawosz, E; Jaworski, S; Wierzbicki, M; Strojny, B; Grodzik, M; Chwalibog, A				Kutwin, Marta; Sawosz, Ewa; Jaworski, Slawomir; Wierzbicki, Mateusz; Strojny, Barbara; Grodzik, Marta; Chwalibog, Andre			Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment	PLOS ONE			English	Article							PLATINUM NANOPARTICLES; DNA-DAMAGE; CISPLATIN; GLIOMAS; RADIOTHERAPY; APOPTOSIS; INHIBIT; MARKERS	Glioblastoma is one of the most frequent primary brain tumours of the central nervous system, with a poor survival time. With inefficient chemotherapy, it is urgent to develop new strategies for tumour therapy. The present approach is based on the inhibition of cell proliferation using platinum nanoparticles (NP-Pt). The aim of the study was to evaluate and compare the antiproliferative properties of NP-Pt and cisplatin against U87 and U118 glioma cell lines and U87 tumour tissue. NP-Pt and cisplatin were incubated with U87 and U118 glioma cells or administered directly into glioma tumour tissue. Cell morphology, the level of DNA synthesis, the migration of cells, protein expression levels of proliferating cell nuclear antigen (PCNA) and the level of DNA oxidation in glioma tumours were investigated. The results showed that NP-Pt treatment of U87 and U118 glioma cells decreased the level of DNA synthesis and the migration of cancer cells but also downregulated the level of PCNA protein expression in tumour tissue. Furthermore, NP-Pt caused oxidative DNA damage in tumour tissue to a higher degree than cisplatin. Consequently, NP-Pt can be considered as an effective inhibitor of glioblastoma tumour cell proliferation. However, the mechanism of action and potential side effects need to be elucidated further.	[Kutwin, Marta; Sawosz, Ewa; Jaworski, Slawomir; Wierzbicki, Mateusz; Strojny, Barbara; Grodzik, Marta; Chwalibog, Andre] Warsaw Univ Life Sci, Fac Anim Sci, Dept Anim Nutr & Biotechnol, Warsaw, Poland; [Chwalibog, Andre] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark	Warsaw University of Life Sciences; University of Copenhagen	Chwalibog, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg, Denmark.	ach@sund.ku.dk	Jaworski, Sławomir/AAI-2313-2020; Grodzik, Marta/J-9404-2015; Wierzbicki, Mateusz/ABF-5482-2020; Kutwin, Marta/AAI-6887-2020; Grodzik, Marta/AAO-4319-2021	Jaworski, Sławomir/0000-0002-4619-941X; Grodzik, Marta/0000-0001-5359-1885; Wierzbicki, Mateusz/0000-0003-3623-8929; Grodzik, Marta/0000-0001-5359-1885; Kutwin, Marta/0000-0001-7059-7875; Strojny, Barbara/0000-0002-2642-5491; Sawosz Chwalibog, Ewa/0000-0002-0016-4721; Chwalibog, Andre/0000-0001-8150-2392	National Centre of Science, Poland [NCN 2013/09/N/NZ9/01895]; NCN 2013/09/N/NZ9/01895	National Centre of Science, Poland; NCN 2013/09/N/NZ9/01895	This work was supported by the National Centre of Science, Poland, grant NCN 2013/09/N/NZ9/01895 to MK.; This work was supported by grant NCN 2013/09/N/NZ9/01895.	Alen M, 2016, SCI TRANSL MED, V354; Alshatwi AA, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5468-5; Artelt S, 1999, SCI TOTAL ENVIRON, V228, P219, DOI 10.1016/S0048-9697(99)00049-2; Asharani PV, 2010, NANOMEDICINE-UK, V5, P51, DOI [10.2217/nnm.09.85, 10.2217/NNM.09.85]; Bhattacharya R, 2007, ADV MATER, V19, P711, DOI 10.1002/adma.200602098; Butler JS, 2013, CURR OPIN CHEM BIOL, V17, P175, DOI 10.1016/j.cbpa.2013.01.004; Cemazar M, 1998, ANTI-CANCER DRUG, V9, P525; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Cloughesy T, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.09.007; Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121; Elder A, 2007, ADV MATER, V19, P3124, DOI 10.1002/adma.200701962; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Gehrke H, 2011, ARCH TOXICOL, V85, P799, DOI 10.1007/s00204-010-0636-3; Grodzik M, 2011, INT J NANOMED, V6, P3041, DOI 10.2147/IJN.S25528; Jawaid P, 2014, APOPTOSIS, V19, P1006, DOI 10.1007/s10495-014-0972-5; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; KONDO S, 1995, BRIT J CANCER, V71, P282, DOI 10.1038/bjc.1995.57; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kutwin M, 2016, ARCH MED SCI; Li H, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON RECENT TRENDS IN ELECTRONICS, INFORMATION & COMMUNICATION TECHNOLOGY (RTEICT), P1, DOI 10.1109/RTEICT.2016.7807769; Lopez T, 2010, EUR J MED CHEM, V45, P1982, DOI 10.1016/j.ejmech.2010.01.043; Mohammadi H, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-28; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Porcel E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085103; Prasek M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-251; Strojnik T, 2010, ANTICANCER RES, V30, P4851; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Swift LH, 2014, INT J MOL SCI, V15, P3403, DOI 10.3390/ijms15033403; Urbanska K, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0823-5; Ustymowicz K, 2009, ANTICANCER RES, V29, P3049; Walid Mohammad Sami, 2008, Perm J, V12, P45; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamagishi Y., 2013, J NANOSCALE RES LETT, V8, P1; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Zhang X, 2012, EXP THER MED, V3, P9, DOI 10.3892/etm.2011.367	35	20	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178277	10.1371/journal.pone.0178277	http://dx.doi.org/10.1371/journal.pone.0178277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562655	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700050
J	Nivelle, E; Verzeaux, J; Chabot, A; Roger, D; Spicher, F; Lacoux, J; Nava-Saucedo, JE; Catterou, M; Tetu, T				Nivelle, Elodie; Verzeaux, Julien; Chabot, Amelie; Roger, David; Spicher, Fabien; Lacoux, Jerome; Nava-Saucedo, Jose-Edmundo; Catterou, Manuella; Tetu, Thierry			Does nitrogen fertilization history affects short-term microbial responses and chemical properties of soils submitted to different glyphosate concentrations?	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; HERBICIDE GLYPHOSATE; ENZYME-ACTIVITIES; COVER CROPS; INDICATORS; DIVERSITY; TILLAGE; CARBON; MANURE; DEHYDROGENASE	The use of nitrogen (N) fertilizer and glyphosate-based herbicides is increasing worldwide, with agriculture holding the largest market share. The agronomic and socioeconomic utilities of glyphosate are well established; however, our knowledge of the potential effects of glyphosate applied in the presence or absence of long-term N fertilization on microbial functional activities and the availability of soil nutrients remains limited. Using an ex situ approach with soils that did (N+) or did not (N0) receive synthetic N fertilization for 6 years, we assessed the impact of different rates (no glyphosate, CK; field rate, FR; 100 x field rate, 100FR) of glyphosate application on biological and chemical parameters. We observed that, after immediate application (1 day), the highest dose of glyphosate (100FR) negatively affected the alkaline phosphatase (AlP) activity in soils without N fertilization history and decreased the cation exchange capacity (CEC) in N0 compared to CK and FR treatments with N+. Conversely, the 100FR application increased nitrate (NO3-) and available phosphorus (PO4(3-)) regardless of N fertilization history. Then, after 8 and 15 days, the N+\100FR and N+\FR treatments exhibited the lowest values for dehydrogenase (DH) and AlP activities, respectively, while urease (URE) activity was mainly affected by N fertilization. After 15 days and irrespective of N fertilization history, the FR glyphosate application negatively affected the degradation of carbon substrates by microbial communities (expressed as the average well color development, AWCD). By contrast, the 100FR treatment positively affected AWCD, increasing PO4(3-) by 5 and 16% and NO3- by 126 and 119% in the N+ and N0 treatments, respectively. In addition, the 100FR treatment resulted in an increase in the average net nitrification rate. Principal component analysis revealed that the 100FR glyphosate treatment selected microbial communities that were able to metabolize amine substrates. Overall, the lack of N fertilization in the 6 past years combined with the highest glyphosate application rate (100FR) induced the highest values of AWCD, functional diversity, NO3-, PO43- and nitrification. We concluded that the intensive use of N fertilization for 6 years may change the non-target effects of glyphosate application on enzyme activities. The functional activities, nitrification and nutrient contents were increased by glyphosate only when applied at 100 times the field application rate.	[Nivelle, Elodie; Verzeaux, Julien; Roger, David; Spicher, Fabien; Lacoux, Jerome; Nava-Saucedo, Jose-Edmundo; Catterou, Manuella; Tetu, Thierry] Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, FRE CNRS UPJV 3498, Ecol & Dynam Syst Anthropises EDYSAN, 33 Rue St Leu, Amiens, France; [Chabot, Amelie] Univ Picardie Jules Verne, Dept Sci Vie & Terre, 33 Rue St Leu, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Tetu, T (corresponding author), Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, FRE CNRS UPJV 3498, Ecol & Dynam Syst Anthropises EDYSAN, 33 Rue St Leu, Amiens, France.	thierry.tetu@u-picardie.fr			Bonduelle; Syngenta; University of Picardy Jules Verne; French Ministry of Higher Education and Research	Bonduelle; Syngenta(Syngenta); University of Picardy Jules Verne; French Ministry of Higher Education and Research	The study was funded by Bonduelle and Syngenta and the University of Picardy Jules Verne in the context of the collaborative project VEGESOL. The PhD studies of Elodie Nivelle are funded by a scholarship from the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2002, INT J ENV AN CH, V82, P8; Alef K., 1995, METHODS APPL SOIL MI, DOI DOI 10.1016/B978-0-12-513840-6.X5014-9; Allegrini M, 2015, SCI TOTAL ENVIRON, V533, P60, DOI 10.1016/j.scitotenv.2015.06.096; Bennicelli RP, 2009, INT AGROPHYS, V23, P117; Bonny S, 2011, SUSTAINABILITY-BASEL, V3, P1302, DOI 10.3390/su3091302; Brown Lester R., 1999, V1999, P115; Bruto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06261; Buffin D, 2011, HLTH ENV IMPACTS GLY; Busse MD, 2001, SOIL BIOL BIOCHEM, V33, P1777, DOI 10.1016/S0038-0717(01)00103-1; Caravaca F, 2002, SOIL TILL RES, V68, P23, DOI 10.1016/S0167-1987(02)00080-6; CASIDA L. E., 1964, SOIL SCI, V98, P371, DOI 10.1097/00010694-196412000-00004; Cernohlavkova J, 2009, ECOTOX ENVIRON SAFE, V72, P80, DOI 10.1016/j.ecoenv.2008.07.001; Ciesielski H, 1997, AGRONOMIE, V17, P9, DOI 10.1051/agro:19970102; De Mendiburu F., 2014, AGRICOLAE STAT PROCE, DOI DOI 10.2307/2287932; Deng SP, 2006, APPL SOIL ECOL, V33, P258, DOI 10.1016/j.apsoil.2005.10.004; DICK RP, 1994, SSSA SPEC PUBL, P107; Dick W. A., 1992, SOIL MICROBIAL ECOLO, P99; Duke S. O., 2009, AgBioForum, V12, P346; Floch C, 2011, EUR J SOIL BIOL, V47, P256, DOI 10.1016/j.ejsobi.2011.05.007; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gaupp-Berghausen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12886; Gomez E, 2009, EUR J SOIL BIOL, V45, P163, DOI 10.1016/j.ejsobi.2008.10.001; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Haney RL, 2000, WEED SCI, V48, P89, DOI 10.1614/0043-1745(2000)048[0089:EOGOSM]2.0.CO;2; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Karaca A, 2010, SOIL ENZYMOLOGY SOIL, V22; Klimek M, 2001, PEST MANAG SCI, V57, P815, DOI 10.1002/ps.366; Lane M, 2012, PEDOBIOLOGIA, V55, P335, DOI 10.1016/j.pedobi.2012.08.001; Lang M, 2009, J ENVIRON SCI, V21, P458, DOI 10.1016/S1001-0742(08)62292-5; Machet J. M., 1990, P 1 C EUR SOC AGR 5; Mangalassery S, 2015, EUR J SOIL BIOL, V68, P9, DOI 10.1016/j.ejsobi.2015.03.001; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Masto RE, 2006, SOIL BIOL BIOCHEM, V38, P1577, DOI 10.1016/j.soilbio.2005.11.012; Munoz-Leoz B, 2012, SOIL BIOL BIOCHEM, V48, P125, DOI 10.1016/j.soilbio.2012.01.021; MUNSON AD, 1993, SOIL SCI SOC AM J, V57, P246, DOI 10.2136/sssaj1993.03615995005700010043x; Nivelle E, 2016, APPL SOIL ECOL, V108, P147, DOI 10.1016/j.apsoil.2016.08.004; O'Keeffe M. G., 1980, P BR CROP PROT COUNC, V15, P53; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olsen S.R., 1954, ESTIMATION AVAILABLE; Partoazar M, 2011, AFR J BIOTECHNOL, V10, P19419, DOI 10.5897/AJB11.2440; Pohlert T, 2016, PMCMR CALCULATE PAIR; Ratcliff AW, 2006, APPL SOIL ECOL, V34, P114, DOI 10.1016/j.apsoil.2006.03.002; Reicosky DC., 2002, ENCY SOIL SCI, P1333, DOI DOI 10.4324/9781315161860; Richard S, 2005, ENVIRON HEALTH PERSP, V113, P716, DOI 10.1289/ehp.7728; Schloter M, 2003, AGR ECOSYST ENVIRON, V98, P255, DOI 10.1016/S0167-8809(03)00085-9; Sheibani S, 2013, J NOVEL APPL SCI, V2, P273; Shen WS, 2010, PLANT SOIL, V337, P137, DOI 10.1007/s11104-010-0511-2; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Sumalan R., 2009, Analele Universitatii din Oradea, Fascicula Biologie, V16, P142; Sun RB, 2015, SOIL BIOL BIOCHEM, V88, P9, DOI 10.1016/j.soilbio.2015.05.007; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; Utobo EB, 2015, APPL ECOL ENV RES, V13, P147; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; Van Eerd LL, 2003, WEED SCI, V51, P472, DOI 10.1614/0043-1745(2003)051[0472:PMIPAM]2.0.CO;2; Verzeaux J, 2016, GEODERMA, V281, P49, DOI 10.1016/j.geoderma.2016.06.035; VITOUSEK PM, 1985, ECOLOGY, V66, P1360, DOI 10.2307/1939189; Weaver MA, 2007, PEST MANAG SCI, V63, P388, DOI 10.1002/ps.1351; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004; Zabaloy MC, 2012, APPL SOIL ECOL, V61, P333, DOI 10.1016/j.apsoil.2011.12.004; Zhao SC, 2014, AGR ECOSYST ENVIRON, V194, P29, DOI 10.1016/j.agee.2014.05.006; Zhou J, 2015, SOIL BIOL BIOCHEM, V90, P42, DOI 10.1016/j.soilbio.2015.07.005	64	4	4	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178342	10.1371/journal.pone.0178342	http://dx.doi.org/10.1371/journal.pone.0178342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552945	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000037
J	Yanez, A; Tapia, G; Guerra, F; del Pozo, A				Yanez, Alejandra; Tapia, Gerardo; Guerra, Fernando; del Pozo, Alejandro			Stem carbohydrate dynamics and expression of genes involved in fructan accumulation and remobilization during grain growth in wheat (Triticum aestivum L.) genotypes with contrasting tolerance to water stress	PLOS ONE			English	Article							WINTER-WHEAT; FUNCTIONAL-ANALYSIS; DROUGHT TOLERANCE; YIELD; CLONING; MOBILIZATION; METABOLISM; COMPONENTS; CULTIVARS; SUCROSE	The genetic and physiological mechanisms underlying the relationship between water-soluble carbohydrates (WSC) and water stress tolerance are scarcely known. This study aimed to evaluate the main WSC in stems, and the expression of genes involved in fructan metabolism in wheat genotypes growing in a glasshouse with water stress (WS; 50% field capacity from heading) and full irrigation (FI; 100% field capacity). Eight wheat genotypes (five tolerant and three susceptible to water stress) were evaluated initially (experiment 1) and the two most contrasting genotypes in terms of WSC accumulation were evaluated in a subsequent experiment (experiment 2). Maximum accumulation of WSC occurred 10-20 days after anthesis. Under WS, the stress-tolerant genotype exhibited higher concentrations of WSC, glucose, fructose and fructan in the stems, compared to FI. In addition, the stress-tolerant genotype exhibited higher up-regulation of the fructan 1-fructosyltransferase B (1-FFTB) and fructan 1-exohydrolase w2 (1-FEHw2) genes, whereas the susceptible cultivar presented an up-regulation of the fructan 6-fructosyltransferase (6-SFT) and fructan 1-exohydrolase w3 (1-FEHw3) genes. Our results indicated clear differences in the pattern of WSC accumulation and the expression of genes regulating fructan metabolism between the tolerant and susceptible genotypes under WS.	[Yanez, Alejandra; del Pozo, Alejandro] Univ Talca, PIEI Adaptac Agr Cambio Climat A2C2, Fac Ciencias Agr, Ctr Mejoramiento Genet & Fenorn Vegetal, Talca, Chile; [Tapia, Gerardo] Inst Invest Agr, CRI Quilamapu, Chillan, Chile; [Guerra, Fernando] Univ Talca, Inst Ciencias Biol, Talca, Chile; [Yanez, Alejandra] Univ Catolica Maule, Fac Ciencias Agr & Forestales, Dept Ciencias Agr, Curico, Chile	Universidad de Talca; Universidad Catolica del Maule	del Pozo, A (corresponding author), Univ Talca, PIEI Adaptac Agr Cambio Climat A2C2, Fac Ciencias Agr, Ctr Mejoramiento Genet & Fenorn Vegetal, Talca, Chile.	adelpozo@utalca.cl	Guerra, Fernando P./B-7164-2018; Campos, Gustavo R C Ribeiro/O-3981-2017	Guerra, Fernando/0000-0001-7174-9738	FONDECYT [1150353]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funded by FONDECYT No 1150353.; This work was supported by the research grant FONDECYT No 1150353.	Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Bass A, 2015, QVALUE Q VALUE ESTIM; Blum A, 1998, EUPHYTICA, V100, P77, DOI 10.1023/A:1018303922482; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chen W, 2015, J PLANT NUTR, V38, P13, DOI 10.1080/01904167.2014.892989; Cimini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00089; Cruz-Aguado JA, 2000, FIELD CROP RES, V66, P129, DOI 10.1016/S0378-4290(00)00070-8; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Coninck B, 2005, PLANT CELL ENVIRON, V28, P432, DOI 10.1111/j.1365-3040.2004.01281.x; del Viso F, 2009, PLANTA, V231, P13, DOI 10.1007/s00425-009-1020-5; Dencic S, 2000, EUPHYTICA, V113, P43, DOI 10.1023/A:1003997700865; Dreccer MF, 2014, FIELD CROP RES, V159, P70, DOI 10.1016/j.fcr.2014.01.001; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Ehdaie B, 2008, FIELD CROP RES, V106, P34, DOI 10.1016/j.fcr.2007.10.012; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Estrada-Campuzano G, 2012, FIELD CROP RES, V128, P167, DOI 10.1016/j.fcr.2012.01.003; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Foulkes MJ, 2007, J AGR SCI-CAMBRIDGE, V145, P17, DOI 10.1017/S0021859607006740; Gebbing T, 2003, NEW PHYTOL, V159, P245, DOI 10.1046/j.1469-8137.2003.00799.x; Gebbing T, 1999, PLANT PHYSIOL, V121, P871, DOI 10.1104/pp.121.3.871; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; Habauzit D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109435; Hisano H, 2008, NEW PHYTOL, V178, P766, DOI 10.1111/j.1469-8137.2008.02409.x; Ji XM, 2010, PLANT CELL ENVIRON, V33, P926, DOI 10.1111/j.1365-3040.2010.02130.x; Joudi M, 2012, PHYSIOL PLANTARUM, V144, P1, DOI 10.1111/j.1399-3054.2011.01517.x; Kadam NN, 2015, PLANT PHYSIOL, V167, P1389, DOI 10.1104/pp.114.253328; Kawakami A, 2012, J PLANT PHYSIOL, V169, P294, DOI 10.1016/j.jplph.2011.09.003; Lammens W, 2012, PLANT J, V70, P205, DOI 10.1111/j.1365-313X.2011.04858.x; Li H, 2013, J AGRON CROP SCI, V199, P38, DOI 10.1111/j.1439-037X.2012.00532.x; Li HJ, 2007, PLANT CELL TISS ORG, V89, P37, DOI 10.1007/s11240-007-9213-8; Lobos GA, 2014, J INTEGR PLANT BIOL, V56, P470, DOI 10.1111/jipb.12114; Suarez-Gonzalez EM, 2014, J PLANT PHYSIOL, V171, P359, DOI 10.1016/j.jplph.2013.08.002; Matus I, 2016, FRONTIERS PLANT SCI; Michiels A, 2004, J EXP BOT, V55, P1325, DOI 10.1093/jxb/erh153; Monneveux P, 2006, PLANT SCI, V170, P867, DOI 10.1016/j.plantsci.2005.12.008; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; SAS Institute Inc, 2012, SAS 9 4 SYST OPT REF, V2nd; SCHONFELD MA, 1988, CROP SCI, V28, P526, DOI 10.2135/cropsci1988.0011183X002800030021x; Sikder S, 2015, PHOTOSYNTHETICA, V53, P47, DOI 10.1007/s11099-015-0082-9; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tamura K, 2009, J EXP BOT, V60, P893, DOI 10.1093/jxb/ern337; Teulat B, 2003, THEOR APPL GENET, V108, P181, DOI 10.1007/s00122-003-1417-7; Van den Ende W, 2006, J EXP BOT, V57, P775, DOI 10.1093/jxb/erj065; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Van Riet L, 2006, J EXP BOT, V57, P213, DOI 10.1093/jxb/erj031; Van Riet L, 2008, PHYSIOL PLANTARUM, V133, P242, DOI 10.1111/j.1399-3054.2008.01070.x; Verspreet J, 2013, PLANT CELL PHYSIOL, V54, P2047, DOI 10.1093/pcp/pct144; Vijn I, 1999, PLANT PHYSIOL, V120, P351, DOI 10.1104/pp.120.2.351; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Wardlaw IF, 2000, NEW PHYTOL, V148, P413, DOI 10.1046/j.1469-8137.2000.00777.x; Xue GP, 2008, PLANT PHYSIOL, V146, P441, DOI 10.1104/pp.107.113076; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Yoshida M., 2007, Recent advances in fructooligosaccharides research, P201; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang JJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00624; Zhang JJ, 2015, NEW PHYTOL, V205, P293, DOI 10.1111/nph.13030; Zhang JJ, 2009, NEW PHYTOL, V181, P843, DOI 10.1111/j.1469-8137.2008.02713.x; Zhang X, 2011, J AGRON CROP SCI, V197, P31, DOI 10.1111/j.1439-037X.2010.00438.x; Zhang YP, 2013, INT J PLANT PROD, V7, P97	62	22	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177667	10.1371/journal.pone.0177667	http://dx.doi.org/10.1371/journal.pone.0177667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552955	gold, Green Published, Green Submitted			2022-12-26	WOS:000402063000011
J	Operario, DJ; Koeppel, AF; Turner, SD; Bao, YD; Pholwat, S; Banu, S; Foongladda, S; Mpagama, S; Gratz, J; Ogarkov, O; Zhadova, S; Heysell, SK; Houpt, ER				Operario, Darwin J.; Koeppel, Alexander F.; Turner, Stephen D.; Bao, Yongde; Pholwat, Suporn; Banu, Sayera; Foongladda, Suporn; Mpagama, Stellah; Gratz, Jean; Ogarkov, Oleg; Zhadova, Svetlana; Heysell, Scott K.; Houpt, Eric R.			Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DIAGNOSIS; SAMPLES	Amplicon-based Next Generation Sequencing (NGS)is an emerging method for Mycobacterium tuberculosis drug susceptibility testing (DST) but has not been well described. We examined 158 clinical multidrug-resistant M. tuberculosis isolates via NGS of 11 resistance-associated gene regions covering 3519 nucleotides. Across these gene regions, complete resistance or heteroresistance (defined as 1%-99% mutation) was present in at least one isolate in 6.3% of loci. The number of isolates with heteroresistance was highest for gyrA codon 94, rpoB codons 526 and 531, and embB codons 306, 372 and 406 (range 11-26% of isolates exhibited heteroresistance). 57% of MDR strains had heteroresistance of one or more recognized resistance-associated mutation. Heteroresistant loci generally exhibited high or low degrees of mutation (>90% or <10%). The deep sensitivity of NGS for detecting low level pncA heteroresistance appeared to improve genotypic-phenotypic PZA susceptibility correlations over that of Sanger. NGS demonstrates that heteroresistance in TB in the regions of key genes is common and will need to be bioinformatically managed. The clinical significance of such heteroresistance is unclear, and further study of pncA should be pursued.	[Operario, Darwin J.; Pholwat, Suporn; Gratz, Jean; Heysell, Scott K.; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Koeppel, Alexander F.; Turner, Stephen D.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Bao, Yongde] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Banu, Sayera] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Foongladda, Suporn] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand; [Mpagama, Stellah] Kibongoto Infect Dis Hosp, Kilimanjaro, Tanzania; [Ogarkov, Oleg; Zhadova, Svetlana] Sci Ctr Family Hlth & Human Reprod Problems, Irkutsk, Siberia, Russia	University of Virginia; University of Virginia; University of Virginia; International Centre for Diarrhoeal Disease Research (ICDDR); Mahidol University; Irkutsk Science Centre of the Russian Academy of Sciences; Scientific Centre for Family Health & Human Reproduction Problems	Houpt, ER (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	erh6k@virginia.edu	Pholwat, Suporn/CAG-9380-2022; Ogarkov, Oleg/A-1715-2014; Turner, Stephen/GXM-4654-2022; Ogarkov, Oleg B./G-6966-2011	Ogarkov, Oleg/0000-0002-3168-1983; Ogarkov, Oleg B./0000-0002-3168-1983; Turner, Stephen/0000-0001-9140-9028; Banu, Sayera/0000-0002-5121-1962	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI093358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI099019, R01AI093358] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, R01 AI093358 to Eric R. Houpt. The funder had no role in study design, collection, analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E ea-utils, 2011, COMMAND LINE TOOLS P; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910; Cirillo D M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS33, DOI 10.1016/j.ijmyco.2016.11.009; Colman RE, 2016, J CLIN MICROBIOL, V54, P2058, DOI 10.1128/JCM.00535-16; Colman RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126626; Daum LT, 2012, J CLIN MICROBIOL, V50, P3831, DOI 10.1128/JCM.01893-12; Dolinger David L, 2016, Int J Mycobacteriol, V5 Suppl 1, pS27, DOI 10.1016/j.ijmyco.2016.09.021; Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585; Eilertson B, 2014, ANTIMICROB AGENTS CH, V58, P3270, DOI 10.1128/AAC.02066-13; Faksri K, 2016, INFECT GENET EVOL, V45, P359, DOI 10.1016/j.meegid.2016.09.013; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Foongladda S, 2016, INT J TUBERC LUNG D, V20, P1105, DOI 10.5588/ijtld.15.0896; Garrison E, 2012, ARXIV 12073907; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maningi NE, 2015, J CLIN MICROBIOL, V53, P3779, DOI 10.1128/JCM.01179-15; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Petkau A, 2016, SNVPHYL SINGLE NUCL; Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238; ReSeq TB, 2016, RELATIONAL SEQUENCIN; Rinder H, 2001, J MED MICROBIOL, V50, P1018, DOI 10.1099/0022-1317-50-12-1018; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; World Health Organization, 2016, US MOL LIN PROB ASS; World Health Organization, 2015, GLOB TUB REP 2015; Yakrus MA, 2015, TUBERC RES TREAT, V2015; Zheng C, 2015, J CLIN MICROBIOL, V53, P2138, DOI 10.1128/JCM.03507-14	35	48	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176522	10.1371/journal.pone.0176522	http://dx.doi.org/10.1371/journal.pone.0176522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545050	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400010
J	Pellegrini, E; Signor, L; Singh, S; Erba, EB; Cusack, S				Pellegrini, Erika; Signor, Luca; Singh, Saurabh; Erba, Elisabetta Boeri; Cusack, Stephen			Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; PROTEIN-KINASE; EARLY-ONSET; MOLECULAR-MECHANISMS; MASS-SPECTROMETRY; CARD15 MUTATIONS; RECEPTOR NOD1; EGF RECEPTOR; DOMAIN; IDENTIFICATION	Innate immune receptors NOD1 and NOD2 are activated by bacterial peptidoglycans leading to recruitment of adaptor kinase RIP2, which, upon phosphorylation and ubiquitination, becomes a scaffold for downstream effectors. The kinase domain (RIP2K) is a pharmaceutical target for inflammatory diseases caused by aberrant NOD2-RIP2 signalling. Although structures of active RIP2K in complex with inhibitors have been reported, the mechanism of RIP2K activation remains to be elucidated. Here we analyse RIP2K activation by combining crystal structures of the active and inactive states with mass spectrometric characterization of their phosphorylation profiles. The active state has Helix alpha C inwardly displaced and the phosphorylated Activation Segment (AS) disordered, whilst in the inactive state Helix aC is outwardly displaced and packed against the helical, non-phosphorylated AS. Biophysical measurements show that the active state is a stable dimer whilst the inactive kinase is in a monomer-dimer equilibrium, consistent with the observed structural differences at the dimer interface. We conclude that RIP2 kinase auto-phosphorylation is intimately coupled to dimerization, similar to the case of BRAF. Our results will help drug design efforts targeting RIP2 as a potential treatment for NOD2-RIP2 related inflammatory diseases.	[Pellegrini, Erika; Singh, Saurabh; Cusack, Stephen] European Mol Biol Lab, Grenoble, France; [Signor, Luca; Erba, Elisabetta Boeri] Univ Grenoble Alpes, IBS, Grenoble, France; [Signor, Luca; Erba, Elisabetta Boeri] CNRS, IBS, Grenoble, France; [Signor, Luca; Erba, Elisabetta Boeri] CEA, IBS, Grenoble, France; [Singh, Saurabh] Unilever R&D, Bangalore, Karnataka, India	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Unilever	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble, France.	cusack@embl.fr	Erba, Elisabetta Boeri/J-1058-2014; Signor, Luca/O-7489-2014	Erba, Elisabetta Boeri/0000-0002-5910-4707; Signor, Luca/0000-0003-3880-2466; Pellegrini, Erika/0000-0001-8799-3372; Cusack, Stephen/0000-0002-9324-0796	ANR (FR) [ANR12-BSV3-0010-01]; CARDINNATE; FRISBI [ANR-10-INSB-05-0]; GRAL within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]; ANR [ANR12-BSV3-0010-01]	ANR (FR)(French National Research Agency (ANR)); CARDINNATE; FRISBI; GRAL within the Grenoble Partnership for Structural Biology (PSB); ANR(French National Research Agency (ANR))	Support was provided by ANR (FR) [http://www.agence-nationale-recherche.fr/] Number: ANR12-BSV3-0010-01, grant name: CARDINNATE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We used the mass spectrometry and analytical ultracentrifugation platforms of the Grenoble Instruct Centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). We thank Sylvie Kieffer-Jaquinod and Christophe Masselon (CEA, Grenoble, France) for LC/MS-MS experiments and Aline Le Roy and Christine Ebel for assistance with AUC. We thank members of the ESRF-EMBL Joint Structural Biology Group, in particular Matthew W. Bowler, for access to ESRF beamlines, the staff of the EMBL eukaryotic expression (EEF) and high-throughput crystallization (HTX) facilities and Stephanie Gaudon for help in crystal harvesting. This work was partly financed by ANR grant CARDINNATE (ANR12-BSV3-0010-01) to SC. The authors declare to not have any conflict of interest.	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beenstock J, 2016, TRENDS BIOCHEM SCI, V41, P938, DOI 10.1016/j.tibs.2016.08.006; Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Canning P, 2015, CHEM BIOL, V22, P1174, DOI 10.1016/j.chembiol.2015.07.017; Charnley AK, 2015, BIOORGAN MED CHEM, V23, P7000, DOI 10.1016/j.bmc.2015.09.038; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; DeLano W.L., PYMOL MOL GRAPHICS S; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erba EB, 2005, MOL CELL PROTEOMICS, V4, P1107, DOI 10.1074/mcp.M500070-MCP200; Erba EB, 2007, J PROTEOME RES, V6, P2768, DOI 10.1021/pr060675m; Erba EB, 2015, PROTEIN SCI, V24, P1176, DOI 10.1002/pro.2661; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goh FY, 2013, J IMMUNOL, V191, P2691, DOI 10.4049/jimmunol.1202416; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Haile PA, 2016, J MED CHEM, V59, P4867, DOI 10.1021/acs.jmedchem.6b00211; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harris PA, 2013, ACS MED CHEM LETT, V4, P1238, DOI 10.1021/ml400382p; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Irving AT, 2014, CELL HOST MICROBE, V15, P623, DOI 10.1016/j.chom.2014.04.001; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020; Magalhaes JG, 2011, EUR J IMMUNOL, V41, P1445, DOI 10.1002/eji.201040827; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGovern DPB, 2001, GUT, V49, P752, DOI 10.1136/gut.49.6.752; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Morgner N, 2012, ANAL CHEM, V84, P2939, DOI 10.1021/ac300056a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachbur U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7442; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Okafuji I, 2009, ARTHRITIS RHEUM-US, V60, P242, DOI 10.1002/art.24134; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rosenberg OS, 2006, FEBS J, V273, P682, DOI 10.1111/j.1742-4658.2005.05088.x; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schurmann M, 2003, EUR RESPIR J, V22, P748, DOI 10.1183/09031936.03.00040602; Shaw MH, 2011, TRENDS IMMUNOL, V32, P73, DOI 10.1016/j.it.2010.12.007; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Signor L, 2013, JOVE-J VIS EXP, DOI 10.3791/50635; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Taylor SS, 2015, BIOCH BIOPHYSICA ACT; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tigno-Aranjuez JT, 2014, J BIOL CHEM, V289, P29651, DOI 10.1074/jbc.M114.591388; Tigno-Aranjuez JT, 2010, GENE DEV, V24, P2666, DOI 10.1101/gad.1964410; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Wang J, 2011, STRUCTURE, V19, P1752, DOI 10.1016/j.str.2011.10.013; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Xie T, 2013, CELL REP, V5, P70, DOI 10.1016/j.celrep.2013.08.044; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; Zorba A, 2014, ELIFE, V3, DOI 10.7554/eLife.02667	78	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177161	10.1371/journal.pone.0177161	http://dx.doi.org/10.1371/journal.pone.0177161			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545134	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400025
J	Burton, EN; Cohn, LA; Reinero, CN; Rindt, H; Moore, SG; Ericsson, AC				Burton, Erin N.; Cohn, Leah A.; Reinero, Carol N.; Rindt, Hans; Moore, Stephen G.; Ericsson, Aaron C.			Characterization of the urinary microbiome in healthy dogs	PLOS ONE			English	Article							COMPANION ANIMALS; EXTENDED-SPECTRUM; TRACT INFECTIONS; PHYLOGENETIC CHARACTERIZATION; SKIN MICROBIOME; 16S RDNA; CANINE; BACTERIURIA; PREVALENCE; RECURRENT	The urinary bladder in healthy dogs has dogmatically been considered free of bacteria. This study used culture independent techniques to characterize the healthy canine urinary microbiota. Urine samples collected by antepubic cystocentesis from dogs without urinary infection were used for DNA extraction. Genital tract and rectal samples were collected simultaneously from the same dogs. The V4 hypervariable region of the 16S rRNA bacterial gene was amplified and compared against Greengenes database for OTU assignment and relative abundance for urine, genital, and rectal samples. After excluding 4 dogs with cultivable bacteria, samples from 10 male (M; 1 intact) and 10 female (F) spayed dogs remained. All samples provided adequate genetic material for analysis. Four taxa (Pseudomonas sp., Acinetobacter sp., Sphingobium sp. and Bradyrhizobiaceae) dominated the urinary microbiota in all dogs of both sexes. These taxa were also detected in the genital swabs of both sexes, while the rectal microbiota differed substantially from the other sample sites. Principal component (PC) analysis of PC1 through PC3 showed overlap of urinary and genital microbiota and a clear separation of rectal swabs from the other sample sites along PC1, which explained 44.94% variation. Surprisingly, the urinary microbiota (mean # OTU 92.6 F, 90.2 M) was significantly richer than the genital (67.8 F, 66.6 M) or rectal microbiota (68.3 F, 71.2 M) (p < 0.0001), with no difference between sexes at any sample site. The canine urinary bladder is not a sterile environment and possesses its own unique and diverse microbiota compared to the rectal and genital microbiota. There was no difference between the sexes at any microbiota sample site (urine, genital, and rectal). The predominant bacterial genus for either sex in the urine and genital tracts was Pseudomonas sp.	[Burton, Erin N.; Ericsson, Aaron C.] Univ Missouri, Coll Vet Med, Dept Vet Pathol, Columbia, MO 65211 USA; [Cohn, Leah A.; Reinero, Carol N.; Rindt, Hans] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Columbia, MO USA; [Moore, Stephen G.] Univ Missouri, Div Anim Sci, Coll Agr Food & Nat Resources, Columbia, MO USA; [Burton, Erin N.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Minnesota System; University of Minnesota Twin Cities	Burton, EN (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathol, Columbia, MO 65211 USA.; Burton, EN (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.	burt0233@umn.edu	Burton, Erin/H-9993-2019; Ericsson, Aaron C./AAJ-1406-2021; Moore, Stephen/K-2507-2019	Burton, Erin/0000-0001-9364-3205; Ericsson, Aaron C./0000-0002-3053-7269; Moore, Stephen/0000-0001-9896-8519	College of Veterinary Medicine at the University of Missouri; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	College of Veterinary Medicine at the University of Missouri; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this study was provided by a Clinician Scientist grant from the College of Veterinary Medicine at the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakken JS, 2009, ANAEROBE, V15, P285, DOI 10.1016/j.anaerobe.2009.09.007; Barsanti J, 2012, INFECT DIS DOG CAT, P1013; Bradley CW, 2016, J INVEST DERMATOL, V136, P1182, DOI 10.1016/j.jid.2016.01.023; Brubaker L, 2016, CURR OPIN OBSTET GYN, V28, P407, DOI 10.1097/GCO.0000000000000298; Clare S, 2014, J VET INTERN MED, V28, P818, DOI 10.1111/jvim.12324; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154646; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Ewers C, 2011, BERL MUNCH TIERARZTL, V124, P94, DOI 10.2376/0005-9366-124-94; Ewers C, 2011, INT J ANTIMICROB AG, V37, P86, DOI 10.1016/j.ijantimicag.2010.09.007; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Fricke WF, 2014, AM J TRANSPLANT, V14, P416, DOI 10.1111/ajt.12588; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Hutchins RG, 2014, J VET INTERN MED, V28, P300, DOI 10.1111/jvim.12299; Karstens L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00078; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LEES GE, 1986, J AM VET MED ASSOC, V189, P648; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling GV, 2001, J VET INTERN MED, V15, P341, DOI 10.1892/0891-6640(2001)015&lt;0341:IOOPSC&gt;2.3.CO;2; LING GV, 1984, J AM VET MED ASSOC, V185, P1162; Liu FP, 2017, ONCOTARGET, V8, P3798, DOI 10.18632/oncotarget.14028; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McGhie JA, 2014, AUST VET J, V92, P33, DOI 10.1111/avj.12140; Middelbos IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009768; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Norris CR, 2000, J AM ANIM HOSP ASSOC, V36, P484, DOI 10.5326/15473317-36-6-484; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Prescott JF, 2002, CAN VET J, V43, P107; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Rodrigues Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083197; Rubin TA, 2013, ANAEROBE, V19, P22, DOI 10.1016/j.anaerobe.2012.11.004; Rudick CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109321; Salipante SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065226; Seguin MA, 2003, J VET INTERN MED, V17, P622, DOI 10.1892/0891-6640(2003)017&lt;0622:PUTIAR&gt;2.3.CO;2; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Stapleton AE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0025-2016; Stapleton AE, 2014, INFECT DIS CLIN N AM, V28, P149, DOI 10.1016/j.idc.2013.10.006; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Sturgeon A, 2012, VET DERMATOLOGY S, V68; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Thomas-White K. J., 2016, AM J OBSTET GYNECOL; Thomas-White K, 2016, CURR BLADDER DYSFUNC, V11, P18, DOI 10.1007/s11884-016-0345-8; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Thompson MF, 2011, VET J, V190, P22, DOI 10.1016/j.tvjl.2010.11.013; Thompson MF, 2011, VET MICROBIOL, V147, P205, DOI 10.1016/j.vetmic.2010.06.007; Wagner S, 2014, VET MICROBIOL, V169, P171, DOI 10.1016/j.vetmic.2014.01.003; Wan SY, 2014, JAVMA-J AM VET MED A, V245, P106, DOI 10.2460/javma.245.1.106; Weese JS, 2013, VET DERMATOL, V24, P137, DOI 10.1111/j.1365-3164.2012.01076.x; Willner D, 2014, MBIO, V5, DOI 10.1128/mBio.01064-13; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; WOOLEY RE, 1976, J CLIN MICROBIOL, V4, P326; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	61	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177783	10.1371/journal.pone.0177783	http://dx.doi.org/10.1371/journal.pone.0177783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545071	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700074
J	Phillip, V; Schwab, M; Haf, D; Algul, H				Phillip, Veit; Schwab, Miriam; Haf, David; Alguel, Hana			Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center	PLOS ONE			English	Article							ERCP PANCREATITIS; COMPLICATIONS; SPHINCTEROTOMY	Background/Objectives Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Several patients A or procedure related risk factors for post-ERCP pancreatitis (PEP) have been suggested. The aim of this study was to validate the risk factors for PEP in a high-volume center. Methods All patients undergoing first time ERCP at a tertiary referral center between December 2010 and October 2013 were retrospectively included. PEP was defined according to the Atlanta Classification. Results 344 patients were included in the final analysis. The risk to develop PEP was increased in patients with chronic pancreatitis (odds ratio 3.7) and after inadvertent cannulation of the pancreatic duct (odds ratio 2.2), which occurred in 26.5% of the patients. Inadvertent cannulation occurred significantly more frequently in patients with difficult cannulation of the papilla duodeni major (odds ratio 12.7; p<0.001). ERCP on call was associated with an increased risk for difficult cannulation (odds ratio 3.0). Conclusion Inadvertent cannulation of the pancreatic duct is a procedure related risk factor for PEP. Measurements on preventing inadvertent cannulation of the pancreatic duct should be established and studies on prophylactic measurements should focus particularly on patients with inadvertent cannulation of the pancreatic duct.	[Phillip, Veit; Schwab, Miriam; Haf, David; Alguel, Hana] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany	Technical University of Munich	Algul, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Innere Med 2, Munich, Germany.	hana.alguel@mri.tum.de	Phillip, Veit/ABE-4899-2021	Phillip, Veit/0000-0002-0921-2523; Algul, Hana/0000-0002-5067-7031				Anderson MA, 2012, GASTROINTEST ENDOSC, V75, P467, DOI 10.1016/j.gie.2011.07.010; Andriulli A, 2007, AM J GASTROENTEROL, V102, P1781, DOI 10.1111/j.1572-0241.2007.01279.x; [Anonymous], 1989, GASTROINTEST ENDOSC, V35, p189A; Bradley EL, 1992, SUMM INT S AC PANCR; BUB H, 1983, SCAND J GASTROENTERO, V18, P581, DOI 10.3109/00365528309181642; CHEN YK, 1994, AM J GASTROENTEROL, V89, P327; Dickinson RJ, 1998, EUR J GASTROEN HEPAT, V10, P423, DOI 10.1097/00042737-199805000-00012; Dumonceau JM, 2014, ENDOSCOPY, V46, P798, DOI 10.1055/s-0034-1377875; Freeman ML, 2007, CLIN GASTROENTEROL H, V5, P1354, DOI 10.1016/j.cgh.2007.09.007; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Johnson GK, 1997, GASTROINTEST ENDOSC, V46, P217, DOI 10.1016/S0016-5107(97)70089-0; Kapral C, 2012, EUR J GASTROEN HEPAT, V24, P1447, DOI 10.1097/MEG.0b013e3283583c6f; Kochar B, 2015, GASTROINTEST ENDOSC, V81, P143, DOI 10.1016/j.gie.2014.06.045; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Masci E, 2003, ENDOSCOPY, V35, P830; SHERMAN S, 1991, GASTROENTEROLOGY, V101, P1068, DOI 10.1016/0016-5085(91)90735-4; SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013; Testoni Pier Alberto, 2002, JOP, V3, P195; Thiruvengadam NR, 2016, GASTROENTEROLOGY, V151, P288, DOI 10.1053/j.gastro.2016.04.048; Zhao ZH, 2017, GASTROINTEST ENDOSC	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177874	10.1371/journal.pone.0177874	http://dx.doi.org/10.1371/journal.pone.0177874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545067	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700091
J	Cho, JH; Kim, SA; Seo, YS; Park, SG; Park, BC; Kim, JH; Kim, S				Cho, Jin Hwa; Kim, Sung Ah; Seo, Yeon-Soo; Park, Sung Goo; Park, Byoung Chul; Kim, Jeong-Hoon; Kim, Sunhong			The p90 ribosomal S6 kinase-UBR5 pathway controls Toll-like receptor signaling via miRNA-induced translational inhibition of tumor necrosis factor receptor-associated factor 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; microRNA (miRNA); phosphorylation; post-translational modification (PTM); Toll-like receptor (TLR); RISC; TRAF3; UBR5; p90RSK	DNA-DAMAGE RESPONSE; HYPERPLASTIC-DISCS; E3 LIGASE; DEUBIQUITINASE DUBA; UBIQUITIN LIGASE; PROTEIN-KINASES; BINDING-PROTEIN; EDD; FAMILY; CELLS	MicroRNAs (miRNAs) are small, noncoding RNAs that post-transcriptionally regulate gene expression. For example, miRNAs repress gene expression by recruiting the miRNA-induced silencing complex (miRISC), a ribonucleoprotein complex that contains miRNA-engaged Argonaute (Ago) and the scaffold protein GW182. Recently, ubiquitin-protein ligase E3 component N-recognin 5 (UBR5) has been identified as a component of miRISC. UBR5 directly interacts with GW182 proteins and participates in miRNA silencing by recruiting downstream effectors, such as the translation regulator DEAD-box helicase 6 (DDX6) and transducer of ERBB2,1/2,2 (Tob1/2), to the Ago-GW182 complex. However, the regulation of miRISC-associated UBR5 remains largely elusive. In the present study, we showed that UBR5 down-regulates the levels of TNF receptor-associated factor 3 (TRAF3), a key component of Toll-like receptor signaling, via the miRNA pathway. We further demonstrated that p90 ribosomal S6 kinase (p90RSK) is an upstream regulator of UBR5. p90RSK phosphorylates UBR5 at Thr(637), Ser(1227), and Ser(2483), and this phosphorylation is required for the translational repression of TRAF3 mRNA. Phosphorylated UBR5 co-localized with GW182 and Ago2 in cytoplasmic speckles, which implies that miRISC is affected by phospho-UBR5. Collectively, these results indicated that the p90RSK-UBR5 pathway stimulates miRNA-mediated translational repression of TRAF3. Our work has added another layer to the regulation of miRISC.	[Cho, Jin Hwa; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Cho, Jin Hwa; Kim, Sung Ah; Park, Sung Goo; Park, Byoung Chul; Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon 34141, South Korea; [Kim, Sung Ah; Park, Sung Goo; Kim, Jeong-Hoon] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Funct Genom, Daejeon 34113, South Korea; [Park, Byoung Chul] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Bioanalyt Sci, Daejeon 34113, South Korea; [Kim, Jeong-Hoon] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea; [Kim, Sunhong] Univ Sci & Technol, Korea Res Inst Biosci & Biotechnol, Sch Biosci, Dept Biomol Sci, Daejeon 34113, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Park, BC; Kim, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon 34141, South Korea.; Kim, JH (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea.	parkbc@kribb.re.kr; jhoonkim@kribb.re.kr; sunhong@kribb.re.kr	Seo, Yeonsoo/C-1605-2011		National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea [CAP-15-11-KRICT]; KRIBB (Korea Research Institute of Bioscience and Biotechnology)	National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea; KRIBB (Korea Research Institute of Bioscience and Biotechnology)	This work was supported by Grant CAP-15-11-KRICT from the National Research Council of Science and Technology, Ministry of Science, ICT, and Future Planning, Korea and by a grant from the KRIBB (Korea Research Institute of Bioscience and Biotechnology) Research Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen HW, 2013, BBA-GENE REGUL MECH, V1829, P1309, DOI 10.1016/j.bbagrm.2013.10.006; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Gu H, 2015, TOXICOL SCI, V144, P186, DOI 10.1093/toxsci/kfu271; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mishra R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-131; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Perkins DJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003479; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	43	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11804	11814		10.1074/jbc.M117.785170	http://dx.doi.org/10.1074/jbc.M117.785170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28559278	Green Published, hybrid			2022-12-26	WOS:000405485600018
J	Anturaniemi, J; Uusitalo, L; Hielm-Bjorkman, A				Anturaniemi, Johanna; Uusitalo, Liisa; Hielm-Bjorkman, Anna			Environmental and phenotype-related risk factors for owner-reported allergic/atopic skin symptoms and for canine atopic dermatitis verified by veterinarian in a Finnish dog population	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; STEM-CELL FACTOR; HYGIENE HYPOTHESIS; INFECTIOUS BURDEN; BIRTH COHORT; KIT RECEPTOR; PREVALENCE; EXPOSURE; ASTHMA; AGE	The aim of this cross-sectional study was to observe whether environmental factors and phenotypic traits are associated with owner-reported skin problems and with veterinary diagnosed canine atopic dermatitis (CAD). Data were collected using the validated online DOGRISK questionnaire. Out of the data that the questionnaire provides for analysis, focus was first turned towards addressing questions regarding 'Atopy/allergy (skin symptoms)' using a total of 8643 dogs: 1585 dogs with owner-reported allergic/atopic skin symptoms and 7058 dogs without. A subsequent analysis compared dogs with veterinary-verified CAD (n = 322) as a case group against the 7058 dogs without owner-reported skin symptoms. The association between 21 factors related to the environment, canine phenotypes and breed groups within both populations were analysed using univariable and multivariable logistic regression. The environmental factors that showed a significant inverse association with the risk of owner-reported allergic/atopic skin symptoms were as following: whether the dog was living in a detached house, whether there were other dogs in the household, and whether the dog was born in the current household. Having over 50% white colour in the coat and living in an extremely clean household were significantly associated with an increased risk of owner-reported allergic/atopic skin symptoms. The five breeds demonstrating the highest proportion of owner-reported allergic/atopic skin symptoms were West Highland white terrier, Boxer, English bulldog, Dalmatian and French bulldog. The Fe A de A ration Cynologique Internationale dog breed groups 3 (Terriers) and 6 (Scent hounds and related breeds) showed a significantly higher risk for owner-reported allergic/atopic skin symptoms than mixed breed dogs. In the second population, the inverse association was observed between the risk of CAD and the presence of other dogs in the household, and whether the dog had been born in the current household. The results indicate that some environmental factors and canine phenotypes are associated with CAD and owner-reported skin symptoms, but they still do not prove causality.	[Anturaniemi, Johanna; Uusitalo, Liisa; Hielm-Bjorkman, Anna] Univ Helsinki, Dept Equine & Small Anim Med, Fac Vet Med, Helsinki, Finland; [Anturaniemi, Johanna] Univ Helsinki, Dept Agr Sci, Fac Agr & Forestry, Helsinki, Finland	University of Helsinki; University of Helsinki	Anturaniemi, J (corresponding author), Univ Helsinki, Dept Equine & Small Anim Med, Fac Vet Med, Helsinki, Finland.; Anturaniemi, J (corresponding author), Univ Helsinki, Dept Agr Sci, Fac Agr & Forestry, Helsinki, Finland.	johanna.anturaniemi@helsinki.fi		Hielm-Bjorkman, Anna/0000-0003-1343-3473; Anturaniemi, Johanna/0000-0002-2766-6254	Svenska Kulturfonden [13/3307-1304]; Vetcare Ltd	Svenska Kulturfonden; Vetcare Ltd	Support was provided by Svenska Kulturfonden 13/3307-1304 [http://www.kulturfonden.fi/in-english] and Vetcare Ltd [https://www.vetcare.fi/]. None of the authors have any financial disclosures to report. The companies had no input on study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Al-Muhsen SZ, 2004, CLIN EXP ALLERGY, V34, P911, DOI 10.1111/j.1365-2222.2004.01975.x; Almqvist C, 2010, PAEDIATR PERINAT EP, V24, P171, DOI 10.1111/j.1365-3016.2010.01095.x; [Anonymous], [No title captured]; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P1355, DOI 10.1016/j.jaci.2009.03.046; Bizikova P, 2015, VET DERMATOL, V26, DOI 10.1111/vde.12198; Bond R, 1996, J SMALL ANIM PRACT, V37, P103, DOI 10.1111/j.1748-5827.1996.tb02353.x; Cadot P, 2011, VET DERMATOL, V22, P554, DOI 10.1111/j.1365-3164.2011.00990.x; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Carson CG, 2013, DAN MED J, V60; Celedon JC, 2003, AM J RESP CRIT CARE, V167, P1239, DOI 10.1164/rccm.200209-1063OC; Chen W, 2013, MOL BIOL REP, V40, P1987, DOI 10.1007/s11033-012-2256-x; Clements DN, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-13; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Daigle J, 2010, VET RES COMMUN, V34, P51, DOI 10.1007/s11259-009-9332-2; DeBoer DJ, 2001, VET IMMUNOL IMMUNOP, V81, P239, DOI 10.1016/S0165-2427(01)00345-2; Dohoo I, 2012, METHODS EPIDEMIOLOGI, P413; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Epstein TG, 2011, J PEDIATR-US, V158, P265, DOI 10.1016/j.jpeds.2010.07.026; Etori M, 2012, J INVEST DERMATOL, V132, P1925, DOI 10.1038/jid.2012.68; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; FCI, 2010, STAND NOM; Fohr C, 2005, BRIT J DERMATOL, V152, P202, DOI [10.1111/J.1365-2133.2005.06436.X, 10.1111/j.1365-2133.2004.06436.x]; Halliwell R, 2006, VET IMMUNOL IMMUNOP, V114, P207, DOI 10.1016/j.vetimm.2006.08.013; Hill P, 2010, VET DERMATOL, V21, P450, DOI 10.1111/j.1365-3164.2010.00881.x; Horak E, 2014, WIEN KLIN WOCHENSCHR, V126, P532, DOI 10.1007/s00508-014-0571-z; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Huttunen M, 2002, ARCH DERMATOL RES, V294, P324, DOI 10.1007/s00403-002-0331-1; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Janson C, 2007, J ALLERGY CLIN IMMUN, V120, P673, DOI 10.1016/j.jaci.2007.05.003; Johnson CC, 2002, CURR OPIN ALLERGY CL, V2, P133, DOI 10.1097/00130832-200204000-00009; Jordaan HF, 2014, SAMJ S AFR MED J, V104, P706, DOI 10.7196/SAMJ.8840; Ka D, 2014, FOOD CHEM TOXICOL, V66, P329, DOI 10.1016/j.fct.2014.01.015; Kisich KO, 2008, J ALLERGY CLIN IMMUN, V122, P62, DOI 10.1016/j.jaci.2008.04.022; Lampi J, 2011, CLIN EXP ALLERGY, V41, P987, DOI 10.1111/j.1365-2222.2011.03777.x; Lee JH, 2012, ASIA PAC ALLERGY, V2, P59, DOI 10.5415/apallergy.2012.2.1.59; Leonard BC, 2012, J INNATE IMMUN, V4, P248, DOI 10.1159/000334566; Linneberg A, 2003, J ALLERGY CLIN IMMUN, V111, P847, DOI 10.1067/mai.2003.1335; Martino DJ, 2013, CURR ALLERGY ASTHM R, V13, P85, DOI 10.1007/s11882-012-0312-1; Meury S, 2011, VET DERMATOL, V22, P327, DOI 10.1111/j.1365-3164.2010.00950.x; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Myers JMB, 2010, J INVEST DERMATOL, V130, P430, DOI 10.1038/jid.2009.300; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Nodtvedt A, 2006, VET REC, V159, P241, DOI 10.1136/vr.159.8.241; Nodtvedt A, 2006, ACTA VET SCAND, V48, P1, DOI 10.1186/1751-0147-48-8; Notvedt A, 2007, VET DERMATOL, V18, P309, DOI 10.1111/j.1365-3164.2007.00617.x; Oguro-Okano M, 2011, J VET MED SCI, V73, P853, DOI 10.1292/jvms.10-0439; Ong PY, 2003, PEDIATRICS, V112, P461; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pelucchi C, 2013, J ALLERGY CLIN IMMUN, V132, P616, DOI 10.1016/j.jaci.2013.04.009; Pucheu-Haston CM, 2015, VET DERMATOL, V26, P77, DOI [10.1111/vde.12196, 10.1111/vde.12207]; Purvis DJ, 2005, BRIT J DERMATOL, V152, P742, DOI 10.1111/j.1365-2133.2005.06540.x; Roduit C, 2011, J ALLERGY CLIN IMMUN, V127, P179, DOI 10.1016/j.jaci.2010.10.010; Roine J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0658-z; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Rothers J, 2007, J ALLERGY CLIN IMMUN, V120, P1201, DOI 10.1016/j.jaci.2007.07.036; Saari S, 2016, ELINYMPARISTONAKOIRA; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Stetina KM, 2015, VET DERMATOL, V26, P246, DOI 10.1111/vde.12219; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Tamsmark TH, 2001, ACTA PAEDIATR, V90, P982; Torrelo A, 2014, J EUR ACAD DERMATOL, V28, P2, DOI 10.1111/jdv.12480; Tse K, 2008, SEMIN IMMUNOPATHOL, V30, P53, DOI 10.1007/s00281-007-0098-8; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; van Damme CMM, 2009, MOL IMMUNOL, V46, P2449, DOI 10.1016/j.molimm.2009.05.028; von Hertzen L, 2006, J ALLERGY CLIN IMMUN, V117, P151, DOI 10.1016/j.jaci.2005.07.028; von Hertzen LC, 2006, INT ARCH ALLERGY IMM, V140, P89, DOI 10.1159/000092251; WILLIAMS HC, 1995, J AM ACAD DERMATOL, V32, P212, DOI 10.1016/0190-9622(95)90128-0; Wong AK, 2013, ANIM GENET, V44, P305, DOI 10.1111/age.12006; Wynchank D, 1998, Depress Anxiety, V8, P21, DOI 10.1002/(SICI)1520-6394(1998)8:1<21::AID-DA4>3.0.CO;2-8; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036174; Yemaneberhan H, 2004, CLIN EXP ALLERGY, V34, P779, DOI 10.1111/j.1365-2222.2004.1946.x; Zeyrek CD, 2006, J INVEST ALLERG CLIN, V16, P290	80	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178771	10.1371/journal.pone.0178771	http://dx.doi.org/10.1371/journal.pone.0178771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570617	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800121
J	Bilinski, P; Han, YH; Hufford, MB; Lorant, A; Zhang, PD; Estep, MC; Jiang, JM; Ross-Ibarra, J				Bilinski, Paul; Han, Yonghua; Hufford, Matthew B.; Lorant, Anne; Zhang, Pingdong; Estep, Matt C.; Jiang, Jiming; Ross-Ibarra, Jeffrey			Genomic abundance is not predictive of tandem repeat localization in grass genomes	PLOS ONE			English	Article							MEIOTIC DRIVE; DNA; CENTROMERE; EVOLUTION; MAIZE; ORGANIZATION; DIVERSIFICATION; ACCUMULATION; CHROMOSOME; DIVERSITY	Highly repetitive regions have historically posed a challenge when investigating sequence variation and content. High-throughput sequencing has enabled researchers to use wholegenome shotgun sequencing to estimate the abundance of repetitive sequence, and these methodologies have been recently applied to centromeres. Previous research has investigated variation in centromere repeats across eukaryotes, positing that the highest abundance tandem repeat in a genome is often the centromeric repeat. To test this assumption, we used shotgun sequencing and a bioinformatic pipeline to identify common tandem repeats across a number of grass species. We find that de novo assembly and subsequent abundance ranking of repeats can successfully identify tandem repeats with homology to known tandem repeats. Fluorescent in-situ hybridization shows that de novo assembly and ranking of repeats from non-model taxa identifies chromosome domains rich in tandem repeats both near pericentromeres and elsewhere in the genome.	[Bilinski, Paul; Lorant, Anne; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Han, Yonghua] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Peoples R China; [Han, Yonghua; Zhang, Pingdong; Jiang, Jiming] Univ Wisconsin Madison, Dept Hort, Madison, WI USA; [Hufford, Matthew B.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Zhang, Pingdong] Beijing Forestry Univ, Coll Biosci & Biotechnol, Beijing, Peoples R China; [Estep, Matt C.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Jiangsu Normal University; University of Wisconsin System; University of Wisconsin Madison; Iowa State University; Beijing Forestry University; University of North Carolina; Appalachian State University; University of California System; University of California Davis; University of California System; University of California Davis	Bilinski, P; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	paul.bilinski@tuebingen.mpg.de; rossibarra@ucdavis.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Jiang, Jiming/V-6060-2019; Hufford, Matthew/E-7810-2012	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Jiang, Jiming/0000-0002-6435-6140; Hufford, Matthew/0000-0003-3945-1143	USDA Hatch project [CA-D-PLS-2066-H]; NSF Plant Genome award [IOS-0922703]; UC Davis Department of Plant Sciences; DuPont Pioneer Howie Smith Honorary Plant Breeding Fellowship	USDA Hatch project; NSF Plant Genome award(National Science Foundation (NSF)); UC Davis Department of Plant Sciences; DuPont Pioneer Howie Smith Honorary Plant Breeding Fellowship	JRI would like to acknowledge support from USDA Hatch project CA-D-PLS-2066-H and NSF Plant Genome award IOS-0922703. PB would like to acknowledge support from the UC Davis Department of Plant Sciences and the DuPont Pioneer Howie Smith Honorary Plant Breeding Fellowship.; JR-I would like to acknowledge support from USDA Hatch project CA-D-PLS-2066-H and NSF Plant Genome award IOS-0922703. PB would like to acknowledge support from the UC Davis Department of Plant Sciences and the DuPont Pioneer Howie Smith Honorary Plant Breeding Fellowship. We would also like to thank R. Kelly Dawe, Luis Avila, and Michelle Stitzer for helpful commentary on the manuscript.	Albert PS, 2010, CYTOGENET GENOME RES, V129, P6, DOI 10.1159/000314342; Bennett MD, 2005, ROYAL BOT GARDEN KEW; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bilinski P., 2014, CHROMOSOMA, P1; Buckler ES, 1999, GENETICS, V153, P415; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Dawe RK, 1996, P NATL ACAD SCI USA, V93, P8512, DOI 10.1073/pnas.93.16.8512; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Estep MC, 2013, HEREDITY, V110, P194, DOI 10.1038/hdy.2012.99; Estep MC, 2014, P NATL ACAD SCI USA, V111, P15149, DOI 10.1073/pnas.1404177111; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; GILL BS, 1974, P NATL ACAD SCI USA, V71, P1247, DOI 10.1073/pnas.71.4.1247; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; JIANG JM, 1995, P NATL ACAD SCI USA, V92, P4487, DOI 10.1073/pnas.92.10.4487; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Klemme S, 2013, NEW PHYTOL, V199, P550, DOI 10.1111/nph.12289; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; Koo DH, 2016, CHROMOSOME RES, V24, P467, DOI 10.1007/s10577-016-9537-5; Lamb JC, 2006, GENETICS, V173, P1007, DOI 10.1534/genetics.105.053165; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Makarevitch I, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1004915, 10.1371/journal.pgen.1005566]; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Miller JT, 1998, THEOR APPL GENET, V96, P832, DOI 10.1007/s001220050809; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; RAYBURN AL, 1994, PLANT BREEDING, V112, P318, DOI 10.1111/j.1439-0523.1994.tb00690.x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Torres GA, 2011, G3-GENES GENOM GENET, V1, P85, DOI 10.1534/g3.111.000125; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wolfgruber TK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00308; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Zhang HQ, 2014, PLANT CELL, V26, P1436, DOI 10.1105/tpc.114.123877; Zhu Q., 2016, CROP J	42	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177896	10.1371/journal.pone.0177896	http://dx.doi.org/10.1371/journal.pone.0177896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570674	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800020
J	Deffieux, X; Vinchant, M; Wigniolle, I; Goffinet, F; Sentilhes, L				Deffieux, Xavier; Vinchant, Marie; Wigniolle, Ingrid; Goffinet, Francois; Sentilhes, Loic			Maternal outcome after abdominal packing for uncontrolled postpartum hemorrhage despite peripartum hysterectomy	PLOS ONE			English	Article							DAMAGE CONTROL; OBSTETRIC HEMORRHAGE; PELVIC HEMORRHAGE; PLACENTA-ACCRETA; PRESSURE PACK; MANAGEMENT; MORTALITY; SECONDARY; INJURY; TRAUMA	Background Intra-abdominal packing is a possible option for persistent bleeding following hysterectomy for postpartum hemorrhage. However, to date, only very limited data about maternal outcome after intra-abdominal packing for surgically uncontrolled hemorrhage following hysterectomy are available. The objective of the current study was to estimate maternal outcome after intra-abdominal packing following unsuccessful peripartum hysterectomy for postpartum hemorrhage. Methods A questionnaire was mailed to all maternity units performing more than 850 deliveries per year. Inclusion criteria were: all cases of abdominal packing performed following unsuccessful peripartum hysterectomy for postpartum hemorrhage between 2003 and 2013. The primary outcome was success of intra-abdominal packing, defined as the arrest of hemorrhage with no need of additional procedure. Results The total number of deliveries during the study period that occurred in the 51 participating centers was 1,430,142. The centers reported a total of 718 (1 per 2000 deliveries) peripartum hysterectomies for PPH and 53 abdominal packings performed after unsuccessful peripartum hysterectomy (about 1 per 14 hysterectomies). A median of 5 [IQR 3-7] pads were used for packing. Abdominal packing was removed after a median of 39.5 hours [IQR 24-48]. The success rate of abdominal packing was 62% (33/53). Among the 20 (38%) women in whom bleeding did not stop following the use of abdominal packing, 6 required a second surgical intervention, 6 a pelvic artery embolization and the 8 other women had "only" further intensive resuscitation and pharmacological treatments. Finally, mortality rate was 24% (13/53). Conclusion Our results suggest that abdominal packing, used for duration of 24 to 48 hours, seems to be an option as an ultimate procedure to control persistent life-threatening postpartum hemorrhage following peripartum hysterectomy.	[Deffieux, Xavier; Vinchant, Marie; Wigniolle, Ingrid] Hop Antoine Beclere, AP HP, GHU Sud, Serv Gynecol Obstet & Med Reprod, Clamart, France; [Goffinet, Francois] Univ Paris 05, AP HP, Maternite Port Royal, EPOPe INSERM U953,DHU Risque & Grossesses, Paris, France; [Sentilhes, Loic] CHU Bordeaux, Serv Gynecol Obstet, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux	Deffieux, X (corresponding author), Hop Antoine Beclere, AP HP, GHU Sud, Serv Gynecol Obstet & Med Reprod, Clamart, France.	xavier.deffieux@aphp.fr						Abikhaled JA, 1997, AM SURGEON, V63, P1109; Agostini A, 2001, Gynecol Obstet Fertil, V29, P613, DOI 10.1016/S1297-9589(01)00201-6; Bouvier-Colle MH, 2012, BJOG-INT J OBSTET GY, V119, P880, DOI 10.1111/j.1471-0528.2012.03330.x; BURCH JM, 1992, ANN SURG, V215, P476, DOI 10.1097/00000658-199205000-00010; Caruso DM, 1999, ARCH SURG-CHICAGO, V134, P958, DOI 10.1001/archsurg.134.9.958; Dildy GA, 2006, OBSTET GYNECOL, V108, P1222, DOI 10.1097/01.AOG.0000241098.11583.a4; Finan MA, 1996, GYNECOL ONCOL, V62, P390, DOI 10.1006/gyno.1996.0254; Ghourab S., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P155; HALLAK M, 1991, OBSTET GYNECOL, V78, P938; Howard RJ, 2002, OBSTET GYNECOL, V100, P1061, DOI 10.1016/S0029-7844(02)02016-1; Johnson JW, 2001, J TRAUMA, V51, P261, DOI 10.1097/00005373-200108000-00007; Kapan M, 2013, EUR REV MED PHARMACO, V17, P1681; Kayem G, 2016, BJOG-INT J OBSTET GY, V123, P598, DOI 10.1111/1471-0528.13477; Kendrick JE, 2006, OBSTET GYNECOL, V107, P493, DOI 10.1097/01.AOG.0000168445.41145.7b; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Palacios-Jaraquemada JM, 2011, ACTA OBSTET GYN SCAN, V90, P1036, DOI 10.1111/j.1600-0412.2011.01176.x; Nicol AJ, 2007, WORLD J SURG, V31, P569, DOI 10.1007/s00268-006-0070-0; PARENTE JT, 1962, OBSTET GYNECOL, V19, P218; Richardson JD, 2000, ANN SURG, V232, P324, DOI 10.1097/00000658-200009000-00004; ROBIE GF, 1990, AM J PERINAT, V7, P327, DOI 10.1055/s-2007-999514; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Santhosh MCB, 2014, REV BRAS ANESTESIOL, V64, P199, DOI 10.1016/j.bjane.2013.03.012; Savage SA, 2014, EUR J TRAUMA EMERG S, V40, P143, DOI 10.1007/s00068-014-0386-7; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sentilhes L., 2016, BJOG; Sentilhes L, 2016, EUR J OBSTET GYN R B, V198, P12, DOI 10.1016/j.ejogrb.2015.12.012; Sentilhes L, 2010, OBSTET GYNECOL, V115, P526, DOI 10.1097/AOG.0b013e3181d066d4; SHARP KW, 1992, ANN SURG, V215, P467, DOI 10.1097/00000658-199205000-00009; Touhami O, 2016, EUR J OBSTET GYN R B, V202, P32, DOI 10.1016/j.ejogrb.2016.04.013; Wuethrich PY, 2015, J UROLOGY, V194, P146, DOI 10.1016/j.juro.2014.12.094	30	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177092	10.1371/journal.pone.0177092	http://dx.doi.org/10.1371/journal.pone.0177092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570643	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800005
J	Martin, RL; Maiorano, J; Beitel, GJ; Marko, JF; McVicker, G; Fondufe-Mittendorf, YN				Martin, Rebecca L.; Maiorano, John; Beitel, Greg J.; Marko, John F.; McVicker, Graham; Fondufe-Mittendorf, Yvonne N.			A comparison of nucleosome organization in Drosophila cell lines	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SEQUENCE MOTIFS; GENE-EXPRESSION; HIGH-RESOLUTION; DNA-SEQUENCE; IN-VITRO; CHROMATIN-STRUCTURE; MAPPING REVEALS; HISTONE OCTAMER; FREE REGIONS	Changes in the distribution of nucleosomes along the genome influence chromatin structure and impact gene expression by modulating the accessibility of DNA to transcriptional machinery. However, the role of genome-wide nucleosome positioning in gene expression and in maintaining differentiated cell states remains poorly understood. Drosophila melanogaster cell lines represent distinct tissue types and exhibit cell-type specific gene expression profiles. They thus could provide a useful tool for investigating cell-type specific nucleosome organization of an organism's genome. To evaluate this possibility, we compared genome-wide nucleosome positioning and occupancy in five different Drosophila tissue-specific cell lines, and in reconstituted chromatin, and then tested for correlations between nucleosome positioning, transcription factor binding motifs, and gene expression. Nucleosomes in all cell lines were positioned in accordance with previously known DNA-nucleosome interactions, with helically repeating A/T di-nucleotide pairs arranged within nucleosomal DNAs and AT-rich pentamers generally excluded from nucleosomal DNA. Nucleosome organization in all cell lines differed markedly from in vitro reconstituted chromatin, with highly expressed genes showing strong nucleosome organization around transcriptional start sites. Importantly, comparative analysis identified genomic regions that exhibited cell line-specific nucleosome enrichment or depletion. Further analysis of these regions identified 91 out of 16,384 possible heptamer sequences that showed differential nucleosomal occupation between cell lines, and 49 of the heptamers matched one or more known transcription factor binding sites. These results demonstrate that there is differential nucleosome positioning between these Drosophila cell lines and therefore identify a system that could be used to investigate the functional significance of differential nucleosomal positioning in cell type specification.	[Martin, Rebecca L.; Beitel, Greg J.; Marko, John F.; Fondufe-Mittendorf, Yvonne N.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Maiorano, John; Fondufe-Mittendorf, Yvonne N.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [McVicker, Graham] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Northwestern University; University of Kentucky; Northwestern University; Salk Institute	Fondufe-Mittendorf, YN (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Fondufe-Mittendorf, YN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.; McVicker, G (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gmcvicker@salk.edu; y.fondufe-mittendorf@uky.edu	Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530; Beitel, Greg/0000-0003-4413-6324; McVicker, Graham/0000-0003-0991-0951	National Institute of General Medical Sciences [F31 GM098037]; National Science foundation [MCB 1517986]; National Institute of Environmental Health [R01-ES024478]; National Cancer Institute [U54-CA193419 (CR-PS-OC)]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024478] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science foundation(National Science Foundation (NSF)); National Institute of Environmental Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by grant F31 GM098037 from the National Institute of General Medical Sciences; Grant MCB 1517986 from the National Science foundation; Grant R01-ES024478 from the National Institute of Environmental Health and Grant U54-CA193419 (CR-PS-OC) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Baanannou A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003581; Baum Buzz, 2008, V420, P391, DOI 10.1007/978-1-59745-583-1_25; Breiling A, 1999, MOL CELL BIOL, V19, P8451; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Chang GS, 2012, GENOME RES, V22, P1098, DOI 10.1101/gr.131649.111; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Couderc JL, 2002, DEVELOPMENT, V129, P2419; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gracey LE, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-13; Grunstein MHaM, 1988, NUCLEOSOME LOSS ACTI, V55, P1137; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Ioshikhes I, 2011, GENOME RES, V21, P1863, DOI 10.1101/gr.116228.110; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lei LL, 2015, J BIOL CHEM, V290, P19343, DOI 10.1074/jbc.M115.637389; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu MJ, 2015, GENOME RES, V25, P1182, DOI 10.1101/gr.188680.114; Lorch Y, 2014, GENE DEV, V28, P2492, DOI 10.1101/gad.250704.114; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 2000, J BIOMOL STRUCT DYN, P185, DOI 10.1080/07391102.2000.10506619; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Minakhina S, 2011, DEV BIOL, V352, P308, DOI 10.1016/j.ydbio.2011.01.035; Moyle-Heyrman G, 2013, P NATL ACAD SCI USA, V110, P20158, DOI 10.1073/pnas.1315809110; Nalabothula N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-92; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Nocetti N, 2016, GENE DEV, V30, P660, DOI 10.1101/gad.274910.115; Prasad P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/347571; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rapoport AE, 2011, J BIOMOL STRUCT DYN, V28, P567, DOI 10.1080/07391102.2011.10531243; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Sasse S, 2015, WIRES DEV BIOL, V4, P623, DOI 10.1002/wdev.198; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sebeson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127214; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Small EC, 2014, P NATL ACAD SCI USA, V111, pE2462, DOI 10.1073/pnas.1400517111; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; UI K, 1987, IN VITRO CELL DEV B, V23, P707; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wolfstetter G, 2012, CELL MOL LIFE SCI, V69, P267, DOI 10.1007/s00018-011-0652-3; Yazdi PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136314; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081; Yigit E, 2013, NUCLEIC ACIDS RES, V41, P2857, DOI 10.1093/nar/gks1462; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	71	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178590	10.1371/journal.pone.0178590	http://dx.doi.org/10.1371/journal.pone.0178590			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570602	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800085
J	Urbano, JJ; da Palma, RK; de Lima, FM; Fratini, P; Guimaraes, LL; Uriarte, JJ; Alvarenga, LH; Miglino, MA; Vieira, RD; Prates, RA; Navajas, D; Farre, R; Oliveira, LVF				Urbano, Jessica Julioti; da Palma, Renata Kelly; de Lima, Flavia Mafra; Fratini, Paula; Guimaraes, Leticia Lopes; Uriarte, Juan J.; Alvarenga, Leticia Heineck; Miglino, Maria Angelica; Vieira, Rodolfo de Paula; Prates, Renato Araujo; Navajas, Daniel; Farre, Ramon; Franco Oliveira, Luis Vicente			Effects of two different decellularization routes on the mechanical properties of decellularized lungs	PLOS ONE			English	Article							TRANSPLANTATION; MATRIX	Considering the limited number of available lung donors, lung bioengineering using whole lung scaffolds has been proposed as an alternative approach to obtain lungs suitable for transplantation. However, some decellularization protocols can cause alterations on the structure, composition, or mechanical properties of the lung extracellular matrix. Therefore, the aim of this study was to compare the acellular lung mechanical properties when using two different routes through the trachea and pulmonary artery for the decellularization process. This study was performed by using the lungs excised from 30 healthy male C57BL/6 mice, which were divided into 3 groups: tracheal decellularization (TDG), perfusion decellularization (PDG), and control groups (CG). Both decellularized groups were subjected to decellularization protocol with a solution of 1% sodium dodecyl sulfate. The behaviour of mechanical properties of the acellular lungs was measured after decellularization process. Static (Est) and dynamic (Edyn) elastances were obtained by the end-inspiratory occlusion method. TDG and PDG showed reduced Est and Edyn elastances after lung decellularization. Scanning electron microscopy showed no structural changes after lung decellularization of the TDG and PDG. In conclusion, was demonstrated that there is no significant difference in the behaviour of mechanical properties and extracellular matrix of the decellularized lungs by using two different routes through the trachea and pulmonary artery.	[Urbano, Jessica Julioti; da Palma, Renata Kelly; Guimaraes, Leticia Lopes; Vieira, Rodolfo de Paula; Franco Oliveira, Luis Vicente] Nove De Julho Univ, Rehabil Sci, Expt Cardioresp Physiol Lab, Sao Paulo, Brazil; [de Lima, Flavia Mafra] Fed Univ Sao Paulo UNIFESP, Dept Med, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil; [Fratini, Paula; Miglino, Maria Angelica] Univ Sao Paulo, Fac Vet Med & Zootecny, Dept Surg, Sao Paulo, Brazil; [Uriarte, Juan J.; Navajas, Daniel; Farre, Ramon] Univ Barcelona, IDIBAPS, Fac Med,IBEC, Unitat Biofis & Bioengn,CIBER Enfermedades Resp, Barcelona, Spain; [Alvarenga, Leticia Heineck; Prates, Renato Araujo] Nove De Julho Univ, Biophoton Appl Hlth Sci, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade Nove de Julho	Oliveira, LVF (corresponding author), Nove De Julho Univ, Rehabil Sci, Expt Cardioresp Physiol Lab, Sao Paulo, Brazil.	oliveira.lvf@uninove.br	Miglino, Maria Angelica/B-9519-2012; de Paula Vieira, Rodolfo/E-9315-2011; Farre, Ramon/L-2664-2017; Prates, Renato A/F-8235-2014; Navajas, Daniel/E-4233-2010; Oliveira, Luis V F/K-8838-2013; Palma, Renata/N-5259-2015	Miglino, Maria Angelica/0000-0003-4979-115X; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Farre, Ramon/0000-0002-9084-7824; Prates, Renato A/0000-0002-8115-9237; Navajas, Daniel/0000-0001-7150-9363; Oliveira, Luis V F/0000-0002-3852-9415; Palma, Renata/0000-0002-4799-0385; Fratini, Paula/0000-0002-4780-4829	Ministerio de Economia y Competitividad [PI1400280, PI14/0004]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (acronym CNPq); Research Productivity modality PQIB [311426/2014-0]	Ministerio de Economia y Competitividad(Spanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (acronym CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Research Productivity modality PQIB	This work was partially funded by Ministerio de Economia y Competitividad (PI1400280 and PI14/0004). LVFO received grants of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (acronym CNPq), Research Productivity modality PQIB, process 311426/2014-0, Luis Vicente Franco Oliveira.	Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; da Palma RK, 2015, J MECH BEHAV BIOMED, V49, P69, DOI 10.1016/j.jmbbm.2015.04.024; Farre R, 2005, INTENS CARE MED, V31, P487, DOI 10.1007/s00134-004-2534-8; da Palma RK, 2016, J BIOMECH, V49, P1230, DOI 10.1016/j.jbiomech.2016.02.043; Melo E, 2014, TISSUE ENG PART C-ME, V20, P412, DOI [10.1089/ten.tec.2013.0325, 10.1089/ten.TEC.2013.0325]; Nonaka PN, 2014, RESP PHYSIOL NEUROBI, V200, P1, DOI 10.1016/j.resp.2014.04.008; Nonaka PN, 2014, J BIOMED MATER RES A, V102, P413, DOI 10.1002/jbm.a.34708; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Song JJ, 2011, ANN THORAC SURG, V92, P998, DOI 10.1016/j.athoracsur.2011.05.018; Stabler CT, 2016, TISSUE ENG PART C-ME, V22, P439, DOI [10.1089/ten.tec.2016.0012, 10.1089/ten.TEC.2016.0012]; Uriarte JJ, 2014, J MECH BEHAV BIOMED, V40, P168, DOI 10.1016/j.jmbbm.2014.08.017; Valapour M, 2013, AM J TRANSPLANT S1, P149; Wang Z, 2016, J BIOMED MAT RES A, V26; Yusen RD, 2010, AM J TRANSPLANT, V10, P1047, DOI 10.1111/j.1600-6143.2010.03055.x	18	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178696	10.1371/journal.pone.0178696	http://dx.doi.org/10.1371/journal.pone.0178696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570606	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800105
J	Wu, SQ; Huang, ZC; Rebeca, CL; Zhu, XL; Guo, YJ; Lin, QN; Hu, X; Wang, R; Liang, GH; Guan, X; Zhang, FP				Wu, Songqing; Huang, Zhicheng; Rebeca, Carballar-Lejarazu; Zhu, Xiaoli; Guo, Yajie; Lin, Qiannan; Hu, Xia; Wang, Rong; Liang, Guanghong; Guan, Xiong; Zhang, Feiping			De novo characterization of the pine aphid Cinara pinitabulaeformis Zhang et Zhang transcriptome and analysis of genes relevant to pesticides	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; GLUTATHIONE S-TRANSFERASES; EXPRESSION PATTERN; CHEMOSENSORY PROTEINS; SCAVENGER RECEPTORS; ODORANT RECEPTORS; PHEROMONE-BINDING; RNA INTERFERENCE; SALIVARY-GLANDS; UP-REGULATION	The pine aphid Cinara pinitabulaeformis Zhang et Zhang is the main pine pest in China, it causes pine needles to produce dense dew (honeydew) which can lead to sooty mold (black filamentous saprophytic ascomycetes). Although common chemical and physical strategies are used to prevent the disease caused by C. pinitabulaeformis Zhang et Zhang, new strategies based on biological and/or genetic approaches are promising to control and eradicate the disease. However, there is no information about genomics, proteomics or transcriptomics to allow the design of new control strategies for this pine aphid. We used next generation sequencing technology to sequence the transcriptome of C. pinitabulaeformis Zhang et Zhang and built a transcriptome database. We identified 80,259 unigenes assigned for Gene Ontology (GO) terms and information for a total of 11,609 classified unigenes was obtained in the Clusters of Orthologous Groups (COGs). A total of 10,806 annotated unigenes were analyzed to identify the represented biological pathways, among them 8,845 unigenes matched with 228 KEGG pathways. In addition, our data describe propagative viruses, nutrition-related genes, detoxification related molecules, olfactory related receptors, stressed-related protein, putative insecticide resistance genes and possible insecticide targets. Moreover, this study provides valuable information about putative insecticide resistance related genes and for the design of new genetic/biological based strategies to manage and control C. pinitabulaeformis Zhang et Zhang populations.	[Wu, Songqing; Guo, Yajie; Lin, Qiannan; Hu, Xia; Wang, Rong; Liang, Guanghong; Zhang, Feiping] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China; [Wu, Songqing; Huang, Zhicheng; Zhu, Xiaoli; Guo, Yajie; Lin, Qiannan; Hu, Xia; Wang, Rong; Liang, Guanghong; Guan, Xiong] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Peoples R China; [Wu, Songqing; Huang, Zhicheng; Zhu, Xiaoli; Guo, Yajie; Lin, Qiannan; Guan, Xiong] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou, Peoples R China; [Huang, Zhicheng; Guan, Xiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Rebeca, Carballar-Lejarazu] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy; [Zhu, Xiaoli] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of Pavia; Xiamen University	Zhang, FP (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou, Peoples R China.; Guan, X (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China.	guanxfafu@126.com; fpzhang1@163.com	hu, xia hong/GQP-8544-2022; Huang, Zhicheng/GRF-0932-2022		Forestry Research in the Public Interest of China [201304401]; Fujian Taiwan Joint Center for Ecological Control of Crop Pests [Minjiaoke (2013) 51]; United Fujian Provincial Health and Education [WKJ-FJ-25]; National Natural Science Foundation of China [31601905, 31301724, 41501272, 31201574, 31401802]; Fujian Agriculture and Forestry University [xjq201614, 6112C035003]; Natural Science Foundation of Fujian Province [2016J01097]; Programme for New Century Excellent Talents in Fujian Province [JA13089]; National Undergraduate Training Programme for Innovation and Entrepreneurship [201610389006, 201610389046, 201610389055, 201610389051]; Fujian Province Department of Education [JA15161]; Central Finance Forestry Science and Technology Demonstration Project [Min (2015) TG017]	Forestry Research in the Public Interest of China; Fujian Taiwan Joint Center for Ecological Control of Crop Pests; United Fujian Provincial Health and Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Agriculture and Forestry University; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Programme for New Century Excellent Talents in Fujian Province; National Undergraduate Training Programme for Innovation and Entrepreneurship; Fujian Province Department of Education; Central Finance Forestry Science and Technology Demonstration Project	This study was supported by the Special Fund for Forestry Research in the Public Interest of China [Grant No. 201304401], Project of Fujian Taiwan Joint Center for Ecological Control of Crop Pests [Minjiaoke (2013) 51], the United Fujian Provincial Health and Education Project for Tackling Key Research [Grant No. WKJ-FJ-25], National Natural Science Foundation of China [Grant No. 31601905, No. 31301724, No. 41501272, No. 31201574 and No. 31401802], Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [Grant No. xjq201614], Natural Science Foundation of Fujian Province [Grant No. 2016J01097] and Programme for New Century Excellent Talents in Fujian Province [JA13089], the Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [Grant No. 6112C035003], National Undergraduate Training Programme for Innovation and Entrepreneurship [Grant No. 201610389006, No. 201610389046, No. 201610389055 and No. 201610389051], Science and Technology Project in Fujian Province Department of Education [JA15161], Central Finance Forestry Science and Technology Demonstration Project [Min (2015) TG017].; We wish to thank Dr. Rebeca Carballar-Lejarazu for proofreading this paper. This study was supported by the Special Fund for Forestry Research in the Public Interest of China [Grant No. 201304401], Project of Fujian-Taiwan Joint Center for Ecological Control of Crop Pests [Minjiaoke (2013) 51], the United Fujian Provincial Health and Education Project for Tackling Key Research [Grant No. WKJ-FJ-25], National Natural Science Foundation of China [Grant No. 31601905, No. 31301724, No. 41501272, No. 31201574 and No. 31401802], Science Fund for Distinguished Young Scholars of Fujian Agriculture and Forestry University [Grant No. xjq201614], Natural Science Foundation of Fujian Province [Grant No. 2016J01097] and Programme for New Century Excellent Talents in Fujian Province [JA13089], the Special Fund for Key Construction Project of Fujian Agriculture and Forestry University [Grant No. 6112C035003], National Undergraduate Training Programme for Innovation and Entrepreneurship [Grant No. 201610389006, No. 201610389046, No. 201610389055 and No. 201610389051], Science and Technology Project in Fujian Province Department of Education [JA15161], Central Finance Forestry Science and Technology Demonstration Project [Min (2015) TG017].	Ai JW, 2011, GENE, V480, P42, DOI 10.1016/j.gene.2011.03.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahar MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073901; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bonaventure G, 2012, PLANT BIOLOGY, V14, P872, DOI 10.1111/j.1438-8677.2012.00650.x; Bonning BC, 2014, NAT BIOTECHNOL, V32, P102, DOI 10.1038/nbt.2753; BURDON RH, 1988, ENDEAVOUR, V12, P133, DOI 10.1016/0160-9327(88)90134-2; Caballero-Lopez B, 2012, BIOL CONTROL, V63, P222, DOI 10.1016/j.biocontrol.2012.03.012; Cai XM, 1999, PAKISTAN J BIOL SCI, V7, P1478; Cancino-Rodezno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037034; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Choi BG, 2014, COMP BIOCHEM PHYS A, V168, P90, DOI 10.1016/j.cbpa.2013.11.011; Cillo F, 2014, ADV VIRUS RES, V90, P35, DOI 10.1016/B978-0-12-801246-8.00002-0; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Diaz F, 2015, J THERM BIOL, V52, P199, DOI 10.1016/j.jtherbio.2015.07.004; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Havukainen H, 2013, J BIOL CHEM, V288, P28369, DOI 10.1074/jbc.M113.465021; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jedlicka P, 2015, COMP BIOCHEM PHYS A, V180, P32, DOI 10.1016/j.cbpa.2014.11.009; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P13; Kim YH, 2015, PESTIC BIOCHEM PHYS, V120, P109, DOI 10.1016/j.pestbp.2015.01.002; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Li CX, 2016, ACTA TROP, V157, P84, DOI 10.1016/j.actatropica.2016.01.019; Li Y, 2015, PESTICIDE BIOCH PHYS; Li ZQ, 2015, COMP BIOCHEM PHYS D, V15, P28, DOI 10.1016/j.cbd.2015.05.002; Lommen STE, 2008, BIOL CONTROL, V47, P340, DOI 10.1016/j.biocontrol.2008.09.002; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Makarova Kira S, 2003, Genome Biol, V4, P115, DOI 10.1186/gb-2003-4-8-115; Mannervik B, 2008, CRITICAL REV BIOCH M, V23, P283; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Mukhopadhyay S, 2004, IMMUNOBIOLOGY, V209, P39, DOI 10.1016/j.imbio.2004.02.004; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nault LR, 1997, ANN ENTOMOL SOC AM, V90, P521, DOI 10.1093/aesa/90.5.521; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Niu GD, 2011, INSECT BIOCHEM MOLEC, V41, P244, DOI 10.1016/j.ibmb.2010.12.009; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Rahmani S, 2013, CROP PROT, V54, P168, DOI 10.1016/j.cropro.2013.08.002; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Rk C, CHARACTERIZATION REG; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Schuler MA, 2013, J CHEM ECOL, V39, P1232, DOI 10.1007/s10886-013-0335-7; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shim JK, 2015, J ASIA-PAC ENTOMOL, V18, P709, DOI 10.1016/j.aspen.2015.08.005; Silva ALS, 2006, NEOTROP ENTOMOL, V35, P551; Sogawa K., 1971, Japanese Journal of Applied Entomology and Zoology, V15, P132; TAYLOR LR, 1986, J ANIM ECOL, V55, P1, DOI 10.2307/4690; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Vandermoten S, 2014, INSECT MOL BIOL, V23, P67, DOI 10.1111/imb.12061; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, BIOCH DIVERSITY ODOR, P391; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wu S, 2016, PLOS ONE, V11, P9; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xu Q, 2011, COMP BIOCHEM PHYS B, V159, P92, DOI 10.1016/j.cbpb.2011.02.005; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Zhang YN, 2014, GENE, V536, P279, DOI 10.1016/j.gene.2013.12.011; Zhu JY, 2012, PLOS ONE, V7, P476	100	4	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178496	10.1371/journal.pone.0178496	http://dx.doi.org/10.1371/journal.pone.0178496			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570707	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800064
J	Khurram, S; Burney, OT; Morrissey, RC; Jacobs, DF				Khurram, Safiullah; Burney, Owen T.; Morrissey, Robert C.; Jacobs, Douglass F.			Bottles to trees: Plastic beverage bottles as an alternative nursery growing container for reforestation in developing countries	PLOS ONE			English	Article							FIELD PERFORMANCE; PINE-SEEDLINGS; GROWTH; TEMPERATURES; MORPHOLOGY	Reforestation is needed globally to help restore degraded sites, combat desertification, protect watersheds, and provide forest products. This involves planting forest tree seedlings grown in local nurseries, but technologies to produce quality seedlings are lacking in developing countries. Modern nursery containers used to propagate seedlings have internal-surface barriers (ribs or ridges) or side-slits to prevent root spiraling. These are cost prohibitive or unavailable in developing countries and so polybags (plastic bags) are more commonly used, despite their tendency to produce seedlings with deformed root systems that have less potential to establish on field sites. Discarded plastic bottles, which are readily available worldwide, may be a feasible alternative for seedling propagation. We conducted two experiments to assess the potential of repurposed plastic beverage bottles to grow quality trees: 1) Container Comparison to evaluate Arizona walnut (Juglans major [Toor.] Heller) and Afghan pine (Pinus eldarica Medw.) seedling root and shoot development in two plastic bottle types compared to modern nursery containers and polybags, and 2) Bottle Modification to examine the effects of root spiraling prevention techniques (side-slits, internal-ridges, and control) and container opacity (green, black, and clear) on Afghan pine seedling morphological attributes. Nursery growth and first-year seedling field performance were evaluated for both experiments. In experiment one, seedlings of both species had fewer spiraled roots in bottle containers compared to polybags. Arizona walnut had more fibrous root systems in polybags, while Afghan pine root system fibrosity was greatest in bottle containers. First year field performance of both species was not affected by container type. In experiment two, less spiraled roots occurred in containers with air-slits and interior-ridges compared to the control. The effects of container opacity on seedling morphology were inconsistent. Root spiral prevention and opacity had no influence on Afghan pine one-year survival, field height and diameter, with the exception of opacity for height growth, whereby seedlings grown in green containers were taller than those grown in black containers, but seedlings grown in clear containers were similar to both. Our results provide the first evidence that plastic bottle containers may provide an effective alternative for production of high quality seedlings, which may benefit agroforestry, reforestation, restoration, and conservation programs in developing countries.	[Khurram, Safiullah; Jacobs, Douglass F.] Purdue Univ, Hardwood Tree Improvement & Regenerat Ctr, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Burney, Owen T.; Morrissey, Robert C.] New Mexico State Univ, John T Harrington Forestry Res Center, Mora, NM USA; [Khurram, Safiullah] Kabul Univ, Dept Forestry & Nat Resources, Kabul, Afghanistan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; New Mexico State University	Jacobs, DF (corresponding author), Purdue Univ, Hardwood Tree Improvement & Regenerat Ctr, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	djacobs@purdue.edu		Jacobs, Douglass/0000-0002-5580-2516	USAID [306-A-00-11-00516]; New Mexico State University; Purdue University	USAID(United States Agency for International Development (USAID)); New Mexico State University; Purdue University	Funding for this project was provided USAID grant #306-A-00-11-00516, Purdue University, and New Mexico State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided USAID grant #306-A-00-11-00516, Purdue University, and New Mexico State University. Kevin McNamara helped to facilitate the opportunity for the lead author to engage in this project. The authors express gratitude to Diane Haase and Anthony Davis for their partnership in the Bottles to Trees project. Additionally, we would like to thank Nasir Shalizi, Tammy Parsons, Lorenzo Gallegos, Benji Espinoza, Joshua Trujillo, and Jeremy Pinto for their contributions to this study. A portion of the bottles used in this study were provided by The Coca-Cola (R) Company.	Adane L., 2011, J TOXICOL ENV HLTH S, V3, P234; Al-Zalzaleh H, 2013, SCI PAP-SER B-HORTIC, V57, P255; Aldrete A, 2002, FOREST ECOL MANAG, V163, P197, DOI 10.1016/S0378-1127(01)00579-5; [Anonymous], 1984, INT168 USDA FOR SERV; Bell TIW, 1978, P ROOT FORM PLANT TR, V8, P91; Bewket W., 2005, E AFR SOC SCI RES RE, V21, P19, DOI DOI 10.1353/EAS.2005; Bilderback TE, 2007, INT S GROW MED, V819, P317; Blanchard MG, 2007, INT WORKSH ORN PLANT, V788, P115; Budy JD, 1983, COMPILER CHALLENGE P; BURDETT AN, 1986, FOREST CHRON, V62, P433, DOI 10.5558/tfc62433-5; Cedamon ED, 2004, P ASEM 2000 088 END; Cedamon ED, 2005, ACIAR SMALLHOLDER FO; Davis RE, 1975, P INT PLANT PROPAGAT, V25, P448; Donahue R.L., 1983, INTRO SOILS PLANT GR; Dumroese R. K., 1997, Tree Planters' Notes, V48, P60; Dumroese RK., 2015, NATIV PLANTS J, V16, P67, DOI [DOI 10.3368/NPJ.16.1.67, 10.3368/npj.16.1.67]; FAO, 2014, GLOBAL FOREST RESOUR; Gao ZhangGui, 2007, Journal of Zhejiang Forestry Science and Technology, V27, P54; Gasvoda DS, 2002, MONITORING TEMPERATU; Gleick P. H., 2010, BOTTLED SOLD STORY O; Gregorio N. O., 2008, Small-scale Forestry, V7, P245, DOI 10.1007/s11842-008-9053-3; Gregorio NO, 2005, ACIAR SMALLHOLDER FO, P163; Grossnickle SC, 2005, NEW FOREST, V30, P273, DOI 10.1007/s11056-004-8303-2; HALTER MR, 1993, FOREST ECOL MANAG, V56, P131, DOI 10.1016/0378-1127(93)90108-Y; Harrington JT, 2012, P RMRS P, V68, P59; Harrison S., 2008, Small-scale Forestry, V7, P207, DOI 10.1007/s11842-008-9051-5; INGRAM DL, 1981, HORTSCIENCE, V16, P762; Irmak S, 2005, HORTSCIENCE, V40, P808, DOI 10.21273/HORTSCI.40.3.808; Jacobs DF, 2015, NEW FOREST, V46, P601, DOI 10.1007/s11056-015-9513-5; Jaenicke H., 1999, TREE NURSERY PRACTIC; Landis T.D., 1990, CONTAINER TREE NURSE, V2, P1; Landis TD, 2009, AGR HDB USDA, V730, P15; Lapis A, 2001, CANOPY INT, P3; Li GuoLei, 2012, Scientia Silvae Sinicae, V48, P35; Lindstrom A., 1990, STABILITY YOUNG STAN; Liu Yong, 2000, Journal of Beijing Forestry University, V22, P38; Markham JW, 2011, HORTSCIENCE, V46, P721, DOI 10.21273/HORTSCI.46.5.721; Marshall Michael D., 1998, Journal of Environmental Horticulture, V16, P55; Mexal JG, 1994, P INT PLANT PROPAGAT, V44, P327; Mexal JG, 1997, PNWGTR389 USDA FOR S, P228; Muriuki J, 2007, APANEWS ASIA PACIFIC, V31, P3; Ortega U, 2006, NEW FOREST, V31, P97, DOI 10.1007/s11056-004-7364-6; Radoglou K, 2001, ANN FOR SCI, V58, P59, DOI 10.1051/forest:2001106; Rune G, 2003, SILVA FENN, V37, P333, DOI 10.14214/sf.493; Sanghi S, 2008, ABHIGYAN, V26, P3; Soil Survey Staff Natural Resources Conservation Service and United States Dept. of Agriculture, 2016, WEB SOIL SURV; Stein WI, 1978, P ROOT FORM PLANT TR, V8, P28; Sutherland R. J., 1988, NORTH J APPL FOR, V5, P185; Takoutsing B, 2014, SMALL-SCALE FOR, V13, P65, DOI 10.1007/s11842-013-9241-7; TANAKA Y, 1976, Canadian Journal of Forest Research, V6, P453, DOI 10.1139/x76-061; Thompson B.E., 1985, EVALUATING SEEDLING, P59	51	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177904	10.1371/journal.pone.0177904	http://dx.doi.org/10.1371/journal.pone.0177904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562684	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700034
J	Tollis, M; DeNardo, DF; Cornelius, JA; Dolby, GA; Edwards, T; Henen, BT; Karl, AE; Murphy, RW; Kusumi, K				Tollis, Marc; DeNardo, Dale F.; Cornelius, John A.; Dolby, Greer A.; Edwards, Taylor; Henen, Brian T.; Karl, Alice E.; Murphy, Robert W.; Kusumi, Kenro			The Agassiz's desert tortoise genome provides a resource for the conservation of a threatened species	PLOS ONE			English	Article							RESPIRATORY-TRACT DISEASE; PHYLOGENETIC ANALYSIS; GOPHERUS-AGASSIZII; EVOLUTION; SEQUENCE; TURTLE; SELECTION; INSIGHTS; REVEALS; CLOCK	Agassiz's desert tortoise (Gopherus agassizii) is a long-lived species native to the Mojave Desert and is listed as threatened under the US Endangered Species Act. To aid conservation efforts for preserving the genetic diversity of this species, we generated a whole genome reference sequence with an annotation based on deep transcriptome sequences of adult skeletal muscle, lung, brain, and blood. The draft genome assembly for G. agassizii has a scaffold N50 length of 252 kbp and a total length of 2.4 Gbp. Genome annotation reveals 20,172 protein-coding genes in the G. agassizii assembly, and that gene structure is more similar to chicken than other turtles. We provide a series of comparative analyses demonstrating (1) that turtles are among the slowest-evolving genome-enabled reptiles, (2) amino acid changes in genes controlling desert tortoise traits such as shell development, longevity and osmoregulation, and (3) fixed variants across the Gopherus species complex in genes related to desert adaptations, including circadian rhythm and innate immune response. This G. agassizii genome reference and annotation is the first such resource for any tortoise, and will serve as a foundation for future analysis of the genetic basis of adaptations to the desert environment, allow for investigation into genomic factors affecting tortoise health, disease and longevity, and serve as a valuable resource for additional studies in this species complex.	[Tollis, Marc; DeNardo, Dale F.; Cornelius, John A.; Dolby, Greer A.; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Edwards, Taylor] Univ Arizona, Genet Core, Tucson, AZ USA; [Henen, Brian T.] Marine Corps Air Ground Combat Ctr, Marine Air Ground Task Force Training Command, Nat Resources & Environm Affairs, Twentynine Palms, CA USA; [Karl, Alice E.] Alice E Karl & Associates, Davis, CA USA; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON, Canada	Arizona State University; Arizona State University-Tempe; University of Arizona; Royal Ontario Museum	Kusumi, K (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	kenro@asu.edu	Dolby, Greer/K-9468-2015; Tollis, Marc/AAX-2332-2020; Kusumi, Kenro/J-2626-2012	Dolby, Greer/0000-0002-5923-0690; Tollis, Marc/0000-0002-1917-2473; Henen, Brian/0000-0003-3412-4944; Kusumi, Kenro/0000-0002-1458-4540; Edwards, Taylor/0000-0002-7235-6175				Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ATKIN NB, 1965, CHROMOSOMA, V17, P1, DOI 10.1007/BF00285152; Barrows CW, 2011, J ARID ENVIRON, V75, P629, DOI 10.1016/j.jaridenv.2011.01.018; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berry KH, 1995, US DEP INT, V1995, P135, DOI DOI 10.3996/052015-JFWM-046.S4);ALS0; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blankenberg D, 2011, BIOINFORMATICS, V27, P2426, DOI 10.1093/bioinformatics/btr398; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bromham L, 2002, MOL BIOL EVOL, V19, P302, DOI 10.1093/oxfordjournals.molbev.a004083; BROWN MB, 1994, INFECT IMMUN, V62, P4580, DOI 10.1128/IAI.62.10.4580-4586.1994; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Caulin AF, 2011, TRENDS ECOL EVOL, V26, P175, DOI 10.1016/j.tree.2011.01.002; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Dalla Valle L, 2009, J ANAT, V214, P284, DOI 10.1111/j.1469-7580.2008.01030.x; DANTZLER WH, 1966, AM J PHYSIOL, V210, P198, DOI 10.1152/ajplegacy.1966.210.1.198; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edwards T, 2016, ZOOKEYS, P131, DOI 10.3897/zookeys.562.6124; Edwards T, 2016, ECOL EVOL, V6, P379, DOI 10.1002/ece3.1865; Edwards T, 2013, CONSERV GENET, V14, P649, DOI 10.1007/s10592-013-0458-y; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Ernst CH, 2009, TURTLES US CANADA; Fay JC, 2003, ANNU REV GENOM HUM G, V4, P213, DOI 10.1146/annurev.genom.4.020303.162528; Franz R, 2014, BIOLOGY AND CONSERVATION OF NORTH AMERICAN TORTOISES, P13; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hagerty BE, 2010, CONSERV GENET, V11, P1795, DOI 10.1007/s10592-010-0073-0; Harris R. S., 2007, THESIS PENNSYLVANIA, DOI 10.1016/j.brainres.2008.03.070; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; JACOBSON ER, 1991, J WILDLIFE DIS, V27, P296, DOI 10.7589/0090-3558-27.2.296; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kaplinsky NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066357; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Kwon O, 2010, J HISTOCHEM CYTOCHEM, V58, P687, DOI 10.1369/jhc.2010.956011; Loire E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r136; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McGaugh SE, 2015, P NATL ACAD SCI USA, V112, P7055, DOI 10.1073/pnas.1419659112; McMahon BJ, 2014, EVOL APPL, V7, P999, DOI 10.1111/eva.12193; Medica PA, 2012, J HERPETOL, V46, P213, DOI 10.1670/11-327; Meuti ME, 2015, J EXP BIOL, V218, P412, DOI 10.1242/jeb.113233; Murphy RW, 2007, CHELONIAN CONSERV BI, V6, P229, DOI 10.2744/1071-8443(2007)6[229:AGAOTR]2.0.CO;2; Murphy RW, 2011, ZOOKEYS, P39, DOI 10.3897/zookeys.113.1353; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schmid M, 2015, CYTOGENET GENOME RES, V145, P78, DOI 10.1159/000430927; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smit A, REPEATMASKER OPEN 4; Smit AFA., REPEATMODELER OPEN 1; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; U.S. Fish and Wildlife Service, 1990, FED REG, V55, P12178; US Fish and WIldlife Service, 2015, RANG WID MON MOJ DES; Waltari E, 2002, AM NAT, V160, P539, DOI 10.1086/342079; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-604; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091399	83	23	23	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177708	10.1371/journal.pone.0177708	http://dx.doi.org/10.1371/journal.pone.0177708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562605	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700021
J	Nemchinov, LG; Grinstead, SC; Mollov, DS				Nemchinov, Lev G.; Grinstead, Samuel C.; Mollov, Dimitre S.			Alfalfa virus S, a new species in the family Alphaflexiviridae	PLOS ONE			English	Article							INFECTING ALFALFA; TRANSLATION; INITIATION; SEQUENCE; SHALLOT; LUCERNE; IRAN; TOOL	A new species of the family Alphaflexiviridae provisionally named alfalfa virus S (AVS) was discovered in alfalfa samples originating from Sudan. A complete nucleotide sequence of the viral genome consisting of 8,349 nucleotides excluding the 3' poly(A) tail was determined by high throughput sequencing (HTS) on an Illumina platform. NCBI BLAST searches revealed that the virus shares the greatest degree of sequence identity with members of the family Alphaflexiviridae, genus Allexivirus. The AVS genome contains six computationally predicted open reading frames (ORF) encoding viral replication protein, triple gene block protein 1 (TGB1), TGB2, TGB3-like protein, unknown 38.4 kDa protein resembling serinerich 40 kDa protein characteristic for allexiviruses, and coat protein (CP). AVS lacks a clear 3' proximal ORF that encodes a nucleic acid-binding protein typical for allexiviruses. The identity of the virus was confirmed by RT-PCR with primers derived from the HTS-generated sequence, dot blot hybridization with DIG-labeled virus-specific RNA probes, and Western blot analysis with antibodies produced against a peptide derived from the CP sequence. Transmission electron microscopic observations of the infected tissues showed the presence of filamentous particles similar to allexiviruses in their length and appearance. To the best of our knowledge, this is the first report on the identification of a putative allexivirus in alfalfa (Medicago sativa). The genome sequence of AVS has been deposited in NCBI Gen Bank on 03/02/2016 as accession No KY696659.	[Nemchinov, Lev G.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA; [Grinstead, Samuel C.; Mollov, Dimitre S.] USDA ARS, Natl Germplasm Recourses Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Nemchinov, LG (corresponding author), USDA ARS, Mol Plant Pathol Lab, Beltsville, MD 20705 USA.	lev.nemchinov@ars.usda.gov		Mollov, Dimitre/0000-0002-4750-6194; Grinstead, Samuel/0000-0002-1708-8235	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture, Agricultural Research Service.	Adams MJ, 2004, ARCH VIROL, V149, P1045, DOI [10.1007/s00705-003-0304-0, 10.1007/s00705-004-0304-0]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILISS KW, 1986, PLANT PATHOL, V35, P162, DOI 10.1111/j.1365-3059.1986.tb02000.x; Bananej K, 1998, PLANT PATHOL, V47, P355, DOI 10.1046/j.1365-3059.1998.00222.x; Bao YM, 2014, ARCH VIROL, V159, P3293, DOI 10.1007/s00705-014-2197-x; Bejerman N, 2011, PLANT DIS, V95, P771, DOI 10.1094/PDIS-10-10-0764; Bejerman N, 2016, ARCH VIROL, V161, P2029, DOI 10.1007/s00705-016-2854-3; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Frate CA, 2008, U CALIFORNIA PUBLICA, V8296; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lezzhov AA, 2015, J GEN VIROL, V96, P3159, DOI 10.1099/jgv.0.000248; Li XH, 2012, AGRONOMY-BASEL, V2, P40, DOI 10.3390/agronomy2010040; Machado-Caballero JE, 2013, PLANT HLTH PROGR PLA; Massumi H, 2012, J AGR SCI TECH-IRAN, V14, P1141; Monteros MJ, 2009, P W ALF FOR C DEC 2; Neinchinov LG, 2007, PROTEIN EXPRES PURIF, V56, P153, DOI 10.1016/j.pep.2007.05.015; Perez-Egusquiza Z, 2009, PLANT PATHOL, V58, P407, DOI 10.1111/j.1365-3059.2009.02031.x; Sabanadzovic S, 2011, ARCH VIROL, V156, P1665, DOI 10.1007/s00705-011-1015-y; Samac DA, 2017, DIS ALFALFA MEDICAGO; Sanchez PAG, 2016, REV FACULTAD NACL AG; Vaira AM, 2011, VIRUS TAXONOMY, P904; van Leur JAG, 2011, AUSTRALAS PLANT PATH, V40, P180, DOI 10.1007/s13313-011-0028-z; VANMILTENBURG R, 1995, DIG SYSTEM USERS GUI; Zavriev S. K., 2008, ENCY VIROLOGY, P96	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178222	10.1371/journal.pone.0178222	http://dx.doi.org/10.1371/journal.pone.0178222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558046	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000033
J	Kahn, M; LaRue, N; Zhu, CC; Pal, S; Mo, JS; Barrett, LK; Hewitt, SN; Dumais, M; Hemmington, S; Walker, A; Joynson, J; Leader, BT; Van Voorhis, WC; Domingo, GJ				Kahn, Maria; LaRue, Nicole; Zhu, Changcheng; Pal, Sampa; Mo, Jack S.; Barrett, Lynn K.; Hewitt, Steve N.; Dumais, Mitchell; Hemmington, Sandra; Walker, Adrian; Joynson, Jeff; Leader, Brandon T.; Van Voorhis, Wesley C.; Domingo, Gonzalo J.			Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; MALARIA; TESTS; SAMPLES	Background A large gap for the support of point-of-care testing is the availability of reagents to support quality control (QC) of diagnostic assays along the supply chain from the manufacturer to the end user. While reagents and systems exist to support QC of laboratory screening tests for glucose-6-phosphate dehydrogenase (G6PD) deficiency, they are not configured appropriately to support point-of-care testing. The feasibility of using lyophilized recombinant human G6PD as a QC reagent in novel point-of-care tests for G6PD deficiency is demonstrated. Methods Human recombinant G6PD (r-G6PD) was expressed in Escherichia coli and purified. Aliquots were stored at -80 degrees C. Prior to lyophilization, aliquots were thawed, and three concentrations of r-G6PD (representing normal, intermediate, and deficient clinical G6PD levels) were prepared and mixed with a protective formulation, which protects the enzyme activity against degradation from denaturation during the lyophilization process. Following lyophilization, individual single-use tubes of lyophilized r-G6PD were placed in individual packs with desiccants and stored at five temperatures for one year. An enzyme assay for G6PD activity was used to ascertain the stability of r-G6PD activity while stored at different temperatures. Results Lyophilized r-G6PD is stable and can be used as a control indicator. Results presented here show that G6PD activity is stable for at least 365 days when stored at -80 degrees C, 4 degrees C, 30 degrees C, and 45 degrees C. When stored at 55 degrees C, enzyme activity was found to be stable only through day 28. Conclusions Lyophilized r-G6PD enzyme is stable and can be used as a control for point-of-care tests for G6PD deficiency.	[Kahn, Maria; LaRue, Nicole; Zhu, Changcheng; Pal, Sampa; Leader, Brandon T.; Domingo, Gonzalo J.] PATH Diagnost Grp, Seattle, WA 98109 USA; [Mo, Jack S.; Barrett, Lynn K.; Hewitt, Steve N.; Dumais, Mitchell; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, CERID, Seattle, WA USA; [Hemmington, Sandra; Walker, Adrian; Joynson, Jeff] Mologic Ltd, Bedford Technol Pk, Thurleigh, Beds, England	University of Washington; University of Washington Seattle	Domingo, GJ (corresponding author), PATH Diagnost Grp, Seattle, WA 98109 USA.	gdomingo@path.org		Domingo, Gonzalo/0000-0002-1004-4395; Dumais, Mitchell/0000-0003-1730-5604	Bill & Melinda Gates Foundation [OPP1034534]; UK Department for International Development (DFID) [204139]; Medicines for Malaria Venture Grand Challenge [12/0081]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development (DFID); Medicines for Malaria Venture Grand Challenge	This work was funded by the Bill & Melinda Gates Foundation, grant number OPP1034534; the UK Department for International Development (DFID), grant number 204139; and the Medicines for Malaria Venture Grand Challenge, grant number 12/0081. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions of the Bill & Melinda Gates Foundation or DFID. The funders provided support in the form of salaries and supplies and project expenses for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aidoo M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-239; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; Baird JK, 2012, ADV PARASIT, V80, P203, DOI 10.1016/B978-0-12-397900-1.00004-9; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; Chu CS, 2016, EXPERT REV ANTI-INFE, V14, P885, DOI 10.1080/14787210.2016.1220304; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Fonjungo PN, 2016, AIDS, V30, P1317, DOI 10.1097/QAD.0000000000001031; Golden A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004292; Howes RE, 2013, ADV PARASIT, V81, P133, DOI 10.1016/B978-0-12-407826-0.00004-7; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Kahn M, 2015, J HISTOCHEM CYTOCHEM, V63, P454, DOI 10.1369/0022155415580594; Lambert WJ, 2010, AAPS PHARMSCITECH, V11, P1476, DOI 10.1208/s12249-010-9521-x; Ley B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0896-8; Luzzatto L, 2016, HEMATOL ONCOL CLIN N, V30, P373, DOI 10.1016/j.hoc.2015.11.006; Masanja IM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0597-3; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Tamiru A, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0524-z; Tantular IS, 2003, TROP MED INT HEALTH, V8, P569, DOI 10.1046/j.1365-3156.2003.01055.x; VANNOORDEN CJF, 1985, BRIT J HAEMATOL, V60, P57, DOI 10.1111/j.1365-2141.1985.tb07385.x; von Seidlein L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-112; Wang XT, 2002, EUR J BIOCHEM, V269, P3417, DOI 10.1046/j.1432-1033.2002.03015.x; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2015, GUID TREATM MAL, Vthird	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177885	10.1371/journal.pone.0177885	http://dx.doi.org/10.1371/journal.pone.0177885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552983	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000015
J	Parkinson, NJ; Buechner-Maxwell, VA; Witonsky, SG; Pleasant, RS; Werre, SR; Ahmed, SA				Parkinson, Nicholas J.; Buechner-Maxwell, Virginia A.; Witonsky, Sharon G.; Pleasant, R. Scott; Werre, Stephen R.; Ahmed, S. Ansar			Characterization of basal and lipopolysaccharide-induced microRNA expression in equine peripheral blood mononuclear cells using Next-Generation Sequencing	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; POSSIBLE ROLES; MESSENGER-RNA; INFLAMMATORY RESPONSE; CORD BLOOD; IN-VIVO; ENDOTOXIN; HORSES; INDUCTION; MONOCYTES	The innate immune response to lipopolysaccharide contributes substantially to the morbidity and mortality of gram-negative sepsis. Horses and humans share an exquisite sensitivity to lipopolysaccharide and thus the horse may provide valuable comparative insights into this aspect of the inflammatory response. MicroRNAs, small non-coding RNA molecules acting as post-transcriptional regulators of gene expression, have key roles in toll-like receptor signaling regulation but have not been studied in this context in horses. The central hypothesis of this study was that lipopolysaccharide induces differential microRNA expression in equine peripheral blood mononuclear cells in a manner comparable to humans. Illumina Next Generation Sequencing was used to characterize the basal microRNA transcriptome in isolated peripheral blood mononuclear cells from healthy adult horses, and to evaluate LPS-induced changes in microRNA expression in cells cultured for up to four hours. Selected expression changes were validated using quantitative reverse-transcriptase PCR. Only miR-155 was significantly upregulated by LPS, changing in parallel with supernatant tumor necrosis factora concentration. Eight additional microRNAs, including miR-146a and miR-146b, showed significant expression change with time in culture without a clear LPS effect. Target predictions indicated a number of potential immunity-associated targets for miR-155 in the horse, including SOCS1, TAB2 and elements of the PI3K signaling pathway, suggesting that it is likely to influence the acute inflammatory response to LPS. Gene alignment showed extensive conservation of the miR-155 precursor gene and associated promoter regions between horses and humans. The basal and LPS-stimulated microRNA expression pattern characterized here were similar to those described in human leukocytes. As well as providing a resource for	[Parkinson, Nicholas J.; Buechner-Maxwell, Virginia A.; Witonsky, Sharon G.; Pleasant, R. Scott] Virginia Polytech & State Univ, Virginia Maryland Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA; [Werre, Stephen R.] Virginia Polytech & State Univ, Virginia Maryland Coll Vet Med, Lab Study Design & Stat Anal, Blacksburg, VA USA; [Ahmed, S. Ansar] Virginia Polytech & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA; [Parkinson, Nicholas J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Edinburgh	Parkinson, NJ (corresponding author), Virginia Polytech & State Univ, Virginia Maryland Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA.; Parkinson, NJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	nick.parkinson@ed.ac.uk		Parkinson, Nicholas/0000-0001-6336-5654	Morris Animal Foundation [D16EQ-825]; Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic and State University	Morris Animal Foundation; Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic and State University	This work was funded by Morris Animal Foundation grant no. D16EQ-825 (www, morrisanimalfoundation.org), and by internal funding from the Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic and State University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aharonson-Raz K, 2010, CAN J VET RES, V74, P45; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barton MH, 2004, EQUINE VET J, V36, P397, DOI 10.2746/0425164044868350; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BREUHAUS BA, 1993, J VET INTERN MED, V7, P296, DOI 10.1111/j.1939-1676.1993.tb01022.x; BURROWS GE, 1981, CAN J COMP MED, V45, P207; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen JD, 2014, PEDIATR RES, V75, P595, DOI 10.1038/pr.2014.18; Chen KQ, 2015, EBIOMEDICINE, V2, P324, DOI 10.1016/j.ebiom.2015.03.001; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; De Santis R, 2016, RNA BIOL, V13, P43, DOI 10.1080/15476286.2015.1109768; Dilda F, 2012, VET J, V192, P514, DOI 10.1016/j.tvjl.2011.08.018; Ding WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13098; Dinges MM, 2001, INFECT IMMUN, V69, P7169, DOI 10.1128/IAI.69.11.7169-7172.2001; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Fessler J F, 1989, Equine Vet J Suppl, P24, DOI 10.1111/j.2042-3306.1989.tb05650.x; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V127, P125, DOI 10.1016/j.vetimm.2008.09.028; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Horohov DW, 2015, MOL IMMUNOL, V66, P89, DOI 10.1016/j.molimm.2014.09.020; Iwai H, 2015, TUBERCULOSIS, V95, P246, DOI 10.1016/j.tube.2015.03.006; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kim MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093662, 10.1371/journal.pone.0101486]; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Lee SH, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1541-3; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Lv X, 2015, MOL MED REP, V12, P6013, DOI 10.3892/mmr.2015.4188; Mach N, 2016, SCI REP-UK, V6, DOI 10.1038/srep22932; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moore JN, 2014, VET CLIN N AM-EQUINE, V30, P337, DOI 10.1016/j.cveq.2014.04.003; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Pacholewska A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3390-y; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rossato M, 2012, P NATL ACAD SCI USA, V109, pE3101, DOI 10.1073/pnas.1209100109; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Schnabel CL, 2015, VET IMMUNOL IMMUNOP, V165, P64, DOI 10.1016/j.vetimm.2015.02.011; Senior JM, 2011, EQUINE VET J, V43, P585, DOI 10.1111/j.2042-3306.2010.00328.x; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi N, 2012, EUR J HAEMATOL, V88, P31, DOI 10.1111/j.1600-0609.2011.01707.x; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tizard IR, 2013, HELPER T CELLS AND T, P137; Vaz Candida, 2013, BMC Res Notes, V6, P390, DOI 10.1186/1756-0500-6-390; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Wagner B, 2009, VET IMMUNOL IMMUNOP, V127, P242, DOI 10.1016/j.vetimm.2008.10.313; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang XB, 2016, MOL MED REP, V13, P4969, DOI 10.3892/mmr.2016.5197; Werners AH, 2012, EQUINE VET J, V44, P490, DOI 10.1111/j.2042-3306.2012.00574.x; Xie WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058639; Xu CL, 2013, J BIOL CHEM, V288, P11074, DOI 10.1074/jbc.M112.414862; Zheng YJ, 2012, FREE RADICAL BIO MED, V52, P1307, DOI 10.1016/j.freeradbiomed.2012.01.031; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	70	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177664	10.1371/journal.pone.0177664	http://dx.doi.org/10.1371/journal.pone.0177664			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552958	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000010
J	Nakamura, K; Kusama, K; Bai, R; Ishikawa, S; Fukushima, S; Suda, Y; Imakawa, K				Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Ishikawa, Sadamasa; Fukushima, Sayuri; Suda, Yoshihito; Imakawa, Kazuhiko			Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice	PLOS ONE			English	Article							CELLS; ACTIVATION; C3; DIFFERENTIATION; MECHANISMS; TOLERANCE; COMPONENT; TISSUE; CRRY	Immunological tolerance between fetal allograft and mother is crucial for pregnancy establishment and maintenance; however, these mechanisms particularly those during the latter part of pregnancy have not been definitively elucidated. The aim of this study was to examine the presence and potential function of innate immunity characteristic to the middle to late pregnancy. We first characterized up-regulated proteins in decidua from day 11 pregnant (P11) mice using 2D-PAGE, followed by MALDI-TOF/MS analysis. These analyses identified increased complement component 3 (C3) and its derivatives in P11 decidua. We then found that in the decidual tissues, C3 mRNA increased on P15 and remained high on P19. C3 is converted to C3b and then iC3b by complement component factor I (Cfi) and complement receptor 1-like protein (Crry), both of which were present in P19 placentas. In addition, iC3b proteins and its receptor CR3 (Cd11b/Cd18) in decidual and placental tissues increased toward the latter phase of pregnancy. Moreover, CR3 subunit CD11b protein was predominantly localized to spongiotrophoblast layer in the P19 placenta. Because iC3b is known to induce anti-inflammatory cytokine production, the analysis was extended to examine changes in pro-and anti-inflammatory cytokines, Il12, Il10, and Tgfb1. Il12 expression decreased in P15 and P19 placenta, while high mRNA expression of Il10 and Tgfb1 was found in P19 placental tissues. Furthermore, placental Il10 and Tgfb1 mRNAs were downregulated when pregnant mice were treated with an anti-C3 antibody, detecting C3, C3b and iC3b. These results indicated that C3 derivatives, in particular, iC3b and its receptor CR3 were up-regulated at the fetal-maternal interface, and suggest that iC3b may regulate the placental expression of anti-inflammatory cytokines, IL10 and TGFB1, during the latter phase of pregnancy.	[Nakamura, Keigo; Kusama, Kazuya; Bai, Rulan; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Kasama, Ibaraki, Japan; [Ishikawa, Sadamasa; Fukushima, Sayuri; Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Taihaku Ku, Sendai, Miyagi, Japan	University of Tokyo; Miyagi University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Anim Resource Sci Ctr, Kasama, Ibaraki, Japan.; Suda, Y (corresponding author), Miyagi Univ, Dept Food Agr & Environm, Taihaku Ku, Sendai, Miyagi, Japan.	suda@myu.ac.jp; akaz@mail.ecc.u-tokyo.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Imakawa, Kazuhiko/0000-0002-3798-3560	Japan Society for Promotion of Science [15K18767]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Young Scientists (B) from Japan Society for Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KK), and Grants-in-Aid for Scientific Research (A) from Japan Society for Promotion of Science (15K18767, https://www.jsps.go.jp/english/index.html) (to KI). The funder had roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2006, SEMIN FETAL NEONAT M, V11, P279, DOI 10.1016/j.siny.2006.04.003; Albieri A, 1999, AM J REPROD IMMUNOL, V41, P343; Amdahl H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172675; ANDERSON DJ, 1979, BIOL REPROD, V21, P1143, DOI 10.1095/biolreprod21.5.1143; Billington WD., NORMAL FETOMATERNAL; BRANDON JM, 1995, J REPROD FERTIL, V103, P9, DOI 10.1530/jrf.0.1030009; Bulla R, 2009, J REPROD IMMUNOL, V82, P119, DOI 10.1016/j.jri.2009.06.124; Buurma A, 2012, HYPERTENSION, V60, P1332, DOI 10.1161/HYPERTENSIONAHA.112.194324; Cazander G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534291; Chaouat G, 1988, Reg Immunol, V1, P143; Chow WN, 2009, MOL REPROD DEV, V76, P647, DOI 10.1002/mrd.21013; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Davila J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005458; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; LANMAN JT, 1965, J EXP MED, V122, P579, DOI 10.1084/jem.122.3.579; Lebel ME, 2016, J IMMUNOL IN PRESS; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Markiewski MM, 2004, J IMMUNOL, V173, P747, DOI 10.4049/jimmunol.173.2.747; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miao J, 2014, KIDNEY INT, V86, P726, DOI 10.1038/ki.2014.103; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Molina H, 2005, IMMUNOL RES, V32, P187, DOI 10.1385/IR:32:1-3:187; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; OHKAWA R, 1984, ADV EXP MED BIOL, V176, P111; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schmidt BZ, 2000, IMMUNOL REV, V178, P166, DOI 10.1034/j.1600-065X.2000.17801.x; Shamonki JM, 2007, AM J OBSTET GYNECOL, V196; Sheldon M, 2004, VET CLIN N AM-FOOD A, V20, P569, DOI 10.1016/j.cvfa.2004.06.008; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Xu CG, 2000, SCIENCE, V287, P498, DOI 10.1126/science.287.5452.498; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Zenclussen AC, 2003, CYTOKINE, V24, P150, DOI 10.1016/j.cyto.2003.08.002	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178442	10.1371/journal.pone.0178442	http://dx.doi.org/10.1371/journal.pone.0178442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542608	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800090
J	Turnbull, AE; Hashem, MD; Rabiee, A; To, A; Chessare, CM; Needham, DM				Turnbull, Alison E.; Hashem, Mohamed D.; Rabiee, Anahita; To, An; Chessare, Caroline M.; Needham, Dale M.			Evaluation of a strategy for enrolling the families of critically ill patients in research using limited human resources	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; END-OF-LIFE; PROLONGED MECHANICAL VENTILATION; POSTTRAUMATIC STRESS; DECISION-MAKING; QUALITY; MEMBERS; SURROGATES; COMMUNICATION; SYMPTOMS	Rationale Clinical trials of interventions aimed at the families of intensive care unit (ICU) patients have proliferated but recruitment for these trials can be challenging. Objectives To evaluate a strategy for recruiting families of patients currently being treated in an ICU using limited human resources and time-varying daily screening over 7 consecutive days Methods We screened the Johns Hopkins Hospital medical ICU census 7 days per week to identify eligible family members. We then made daily, in-person attempts to enroll eligible families during a time-varying 2-hour enrollment period until families declined participation, consented, or were no longer eligible. Measurements and main results The primary outcome was the proportion of eligible patients for whom >= 1 family member was enrolled. Secondary outcomes included enrollment of legal healthcare proxies, the consent rate among families approached for enrollment, and success rates for recruiting at different times during the day and week. Among 284 eligible patients, 108 (38%, 95% CI 32%-44%) had >= 1 family member enrolled, and 75 (26%, 95% CI 21%-32%) had their legal healthcare proxy enrolled. Among 117 family members asked to participate, 108 (92%, 95% CI 86%-96%) were enrolled. Patients with versus without an enrolled proxy were more likely to be white (44% vs. 30%, P = .02), live in a zip code with a median income of >=$100,000 15% vs. 5%, P = .01), be mechanically ventilated (63% vs. 47%, P = .01), die in the ICU (19% vs. 9%, P = .03), and to have longer ICU stays (median 5.0 vs. 1.8 days, P<.001). Day of the week and time of day were not associated with family presence in the ICU or consent rate. Conclusions Family members were recruited for more than one third of eligible patients, and >90% of approached consented to participate. There are important demographic differences between patients with vs without an enrolled family member.	[Turnbull, Alison E.; Hashem, Mohamed D.; Rabiee, Anahita; To, An; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21218 USA; [Turnbull, Alison E.; To, An; Chessare, Caroline M.; Needham, Dale M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD 21218 USA; [Turnbull, Alison E.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Hashem, Mohamed D.] Cleveland Clin, Dept Med, Cleveland, OH 44106 USA; [Rabiee, Anahita] Yale Univ, Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Needham, Dale M.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cleveland Clinic Foundation; Yale University; Johns Hopkins University	Turnbull, AE (corresponding author), Johns Hopkins Univ, Outcomes Crit Illness & Surg Grp, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, Sch Med, Baltimore, MD 21218 USA.; Turnbull, AE (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	turnbull@jhmi.edu	Rabiee, Anahita/AAI-2450-2019	Turnbull, Alison/0000-0002-1564-6547; To, An/0000-0003-3170-2999; Rabiee, Anahita/0000-0002-8833-3592	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine	This research was supported by the Johns Hopkins School of Medicine, Division of Pulmonary and Critical Care Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Anderson WG, 2014, ANN AM THORAC SOC, V12, P142; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Burns KEA, 2015, INTENS CARE MED, V41, P58, DOI 10.1007/s00134-014-3558-3; Burns KEA, 2017, ANN AM THORAC SOC, V14, P238, DOI 10.1513/AnnalsATS.201606-425OC; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Chiarchiaro J, 2015, ANN AM THORAC SOC, V12, P526, DOI 10.1513/AnnalsATS.201411-495OC; Chiarchiaro J, 2015, CRIT CARE MED, V43, P542, DOI 10.1097/CCM.0000000000000719; Choi J, 2012, CRIT CARE MED, V40, P1546, DOI 10.1097/CCM.0b013e3182451c58; Cohen AB, 2015, JAMA INTERN MED, V175, P1687, DOI 10.1001/jamainternmed.2015.3956; Cox CE, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0045-0; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2015, AM J RESPIR CRIT CAR; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davidson JE, 2012, CRIT CARE MED, V40, P1675, DOI 10.1097/CCM.0b013e318249594a; Davidson JE, 2012, CRIT CARE MED, V40, P671, DOI 10.1097/CCM.0b013e3182372998; Douglas Sara L, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2009.09.004; Douglas SL, 2005, CHEST, V128, P3925, DOI 10.1378/chest.128.6.3925; Downar J, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.11.024; Ernecoff NC, 2016, J CRIT CARE, V33, P19, DOI 10.1016/j.jcrc.2016.01.030; Grap MJ, 2003, HEART LUNG, V32, P162, DOI 10.1016/S0147-9563(03)00031-1; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hwang DY, J CRIT CARE; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Kon AA, 2015, CRIT CARE MED; Kross EK, 2012, J PAIN SYMPTOM MANAG, V44, P671, DOI 10.1016/j.jpainsymman.2011.11.008; Kynoch Kate, 2016, JBI Database System Rev Implement Rep, V14, P181, DOI 10.11124/JBISRIR-2016-2477; Larkin ME, 2013, CLIN TRIALS, V10, P93, DOI 10.1177/1740774512464727; LeClaire MM, 2005, CHEST, V128, P1728, DOI 10.1378/chest.128.3.1728; Lemiale V, 2010, J PALLIAT MED, V13, P1131, DOI 10.1089/jpm.2010.0109; Marks MAZ, 2008, MED DECIS MAKING, V28, P524, DOI 10.1177/0272989X08315244; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Mistraletti G., 2016, INTENS CARE MED, V1, P1; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Nelson JE, 2010, CRIT CARE MED, V38, P808, DOI 10.1097/CCM.0b013e3181c5887c; Netzer Giora, 2014, Ann Am Thorac Soc, V11, P435, DOI 10.1513/AnnalsATS.201309-308OT; Nunez ER, 2015, CRIT CARE MED, V43, P2387, DOI 10.1097/CCM.0000000000001270; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; Schuster RA, 2014, CRIT CARE MED, V42, P328, DOI 10.1097/CCM.0b013e3182a27598; Schwartz AAGJS, 2006, DEFINING HEALTH CARE; Sudore RL, 2014, J PAIN SYMPTOM MANAG, V48, P1108, DOI 10.1016/j.jpainsymman.2014.04.001; Torke AM, 2014, JAMA INTERN MED, V174, P370, DOI 10.1001/jamainternmed.2013.13315; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; Volandes AE, 2009, J AM MED DIR ASSOC, V10, P575, DOI 10.1016/j.jamda.2009.05.006; White DB, 2007, ANN INTERN MED, V147, P34, DOI 10.7326/0003-4819-147-1-200707030-00006	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177741	10.1371/journal.pone.0177741	http://dx.doi.org/10.1371/journal.pone.0177741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542632	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800024
J	Guan, F; Lu, XJ; Li, CH; Chen, J				Guan, Feng; Lu, Xin-Jiang; Li, Chang-Hong; Chen, Jiong			Molecular characterization of mudskipper (Boleophthalmus pectinirostris) hypoxia-inducible factor-1 alpha(HIF-1 alpha) and analysis of its function in monocytes/ macrophages	PLOS ONE			English	Article							FACTOR-ALPHA SUBUNITS; NF-KAPPA-B; IMMUNE-RESPONSES; EXPRESSION ANALYSIS; MESSENGER-RNA; TELEOST FISH; FACTOR HIF; HIF-1-ALPHA; LIPOPOLYSACCHARIDE; FACTOR-1	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays a critical role in immune and inflammatory responses and is important in controlling a variety of processes in monocytes and macrophages. However, very little information is available about the functions of HIF-1a in fish monocytes/macrophages (MO/M phi). In this study, the cDNA sequence of the mudskipper (Boleophthalmus pectinirostris) HIF-1 alpha gene (BpHIF-1 alpha) was determined. Sequence comparison and phylogenetic tree analysis showed that BpHIF-1 alpha is clustered in the fish HIF-1a tree. Constitutive expression of BpHIF-1 alpha mRNA was detected by real-time quantitative PCR in all tested tissues, and the expression was found to be dramatically increased in the skin, liver, spleen, and kidney after Edwardsiella tarda infection. In addition, hypoxia and infection induced the expression of the BpHIF-1a transcript and protein in MO/M., respectively. Hypoxia caused an increase in phagocytic and bactericidal capacity of mudskipper MO/M. in a BpHIF-1 alpha-dependent manner. BpHIF-1 alpha induced an anti-inflammatory status in MO/M. upon E. tarda infection and hypoxia. Therefore, BpHIF-1 alpha may play a predominant role in the modulation of mudskipper MO/M. function in the innate immune system.	[Guan, Feng; Lu, Xin-Jiang; Li, Chang-Hong; Chen, Jiong] Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo, Zhejiang, Peoples R China; [Guan, Feng] Zhejiang Wanli Univ, Coll Biol & Environm Sci, Ningbo, Zhejiang, Peoples R China; [Chen, Jiong] Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China	Ningbo University; Zhejiang Wanli University; Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Lab Biochem & Mol Biol, Ningbo, Zhejiang, Peoples R China.; Chen, J (corresponding author), Ningbo Univ, Collaborat Innovat Ctr Zhejiang Marine High Effic, Ningbo, Zhejiang, Peoples R China.	jchen1975@163.com			Program for the National Natural Science Foundation of China [31472300]; Zhejiang Provincial Natural Science Foundation of China [LY17C190003]; Young Talent Cultivation Project of Zhejiang Association for Science and Technology [2016YCGC003]	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Young Talent Cultivation Project of Zhejiang Association for Science and Technology	The project was supported by the Program for the National Natural Science Foundation of China (31472300) (http://www.nsfc.gov.cn/), Zhejiang Provincial Natural Science Foundation of China (LY17C190003) (http://www.zinsf.gov.cn/), and Young Talent Cultivation Project of Zhejiang Association for Science and Technology (2016YCGC003) (http://www.zast.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Chen J, 2014, FISH SHELLFISH IMMUN, V41, P586, DOI 10.1016/j.fsi.2014.10.012; Chen N, 2012, GENE, V498, P81, DOI 10.1016/j.gene.2011.12.058; Chen Q, 2016, ZOOL RES, V37, P96, DOI 10.13918/j.issn.2095-8137.2016.2.96; Choi K, 2007, J AQUAT ANIM HEALTH, V19, P128, DOI 10.1577/H06-010.1; Couturier CS, 2013, COMP BIOCHEM PHYS A, V166, P482, DOI 10.1016/j.cbpa.2013.07.025; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ellis AE, 1999, FISH SHELLFISH IMMUN, V9, P291, DOI 10.1006/fsim.1998.0192; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Hagberg H, 1996, PEDIATR RES, V40, P603, DOI 10.1203/00006450-199610000-00015; Herbert N.A., 2013, P129; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kvamme BO, 2013, FISH SHELLFISH IMMUN, V34, P55, DOI 10.1016/j.fsi.2012.10.006; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Legendre C, 2012, INFECT IMMUN, V80, P3985, DOI 10.1128/IAI.00554-12; Li XF, 2016, FISH SHELLFISH IMMUN, V49, P298, DOI 10.1016/j.fsi.2016.01.004; Lu XJ, 2009, NEUROSCIENCE, V162, P404, DOI 10.1016/j.neuroscience.2009.05.011; Lu XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12719; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mi Z, 2008, CELL CYCLE, V7, P232, DOI 10.4161/cc.7.2.5193; Mulder IE, 2007, FISH SHELLFISH IMMUN, V23, P747, DOI 10.1016/j.fsi.2007.02.002; Ng KT, 2011, J PERIODONTOL, V82, P136, DOI 10.1902/jop.2010.100100; Ni M, 2014, FISH SHELLFISH IMMUN, V36, P325, DOI 10.1016/j.fsi.2013.12.002; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Sharma M, 2011, CELL MICROBIOL, V13, P1573, DOI 10.1111/j.1462-5822.2011.01642.x; Sollid J, 2006, J COMP PHYSIOL B, V176, P359, DOI 10.1007/s00360-005-0059-2; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Tingbo MG, 2012, FISH SHELLFISH IMMUN, V33, P582, DOI 10.1016/j.fsi.2012.06.025; Tsang PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-101; Walmsley SR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2632; Wei H, 2015, FISH SHELLFISH IMMUN, V44, P445, DOI 10.1016/j.fsi.2015.03.023; Wiegertjes GF, 2016, MOL IMMUNOL, V69, P146, DOI 10.1016/j.molimm.2015.09.026; Wiese M, 2012, INFECT IMMUN, V80, P1455, DOI 10.1128/IAI.05972-11; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yang GJ, 2015, FISH SHELLFISH IMMUN, V44, P603, DOI 10.1016/j.fsi.2015.03.037; You XX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6594; Zhang RC, 2011, FISH SHELLFISH IMMUN, V31, P911, DOI 10.1016/j.fsi.2011.08.008; Zhao Y, 2015, AQUACULTURE RES; Zhu CD, 2013, J COMP PHYSIOL B, V183, P1005, DOI 10.1007/s00360-013-0762-3; Zinkernagel AS, 2007, J MOL MED, V85, P1339, DOI 10.1007/s00109-007-0282-2	52	16	20	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177960	10.1371/journal.pone.0177960	http://dx.doi.org/10.1371/journal.pone.0177960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542591	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500046
J	Steinhausen, HC; Jakobsen, H; Munk-Jorgensen, P				Steinhausen, Hans-Christoph; Jakobsen, Helle; Munk-Jorgensen, Povl			Family aggregation and risk factors in substance use disorders over three generations in a nation-wide study	PLOS ONE			English	Article							ANXIETY DISORDERS; ALCOHOL-USE; DRUG-ABUSE; TRANSMISSION; SCHIZOPHRENIA; ADOLESCENCE; DEPENDENCE; PARENTS; AGE	Objective This nation-wide register-based study investigated how often substance use disorders (SUD) and co-morbid disorders occurred in affected families compared to control families. Method A total of N = 2504 child and adolescent psychiatric participants who were born between 1969 and 1986 and were registered in the Danish Psychiatric Central Research Register (DPCRR) had a mental disorder before the age of 18 and developed SUD at some point during their life-time. In addition, N = 7472 controls without any psychiatric diagnosis before age 18 and matched for age, sex, and residential region were included. Psychiatric diagnoses of the first-degree relatives were also obtained. A family load component was assessed. Results SUD occurred significantly more often in case families than in control families. SUD risk factors included SUD, depression, anxiety disorders, personality disorders, or conduct disorders in the family. Furthermore, male sex, more recent year of birth, and living in the capital city of Copenhagen were also significantly associated with having SUD. The family load explained 30% of the SUD manifestation in the case-probands. The findings in the total SUD group were mostly replicated in the two major subgroups of pure alcohol or multiple substance use disorders. Discussion These findings based on a very large and representative dataset provide additional evidence for the strong family aggregation and further risk factors in SUD. The pattern of risk factors is largely the same for the total group of SUD and the major subgroups of pure alcohol and multiple substance use disorders.	[Steinhausen, Hans-Christoph] Capital Reg Psychiat, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark; [Steinhausen, Hans-Christoph] Univ Basel, Inst Psychol, Clin Psychol & Epidemiol, Basel, Switzerland; [Steinhausen, Hans-Christoph] Univ Zurich, Dept Child & Adolescent Psychiat, Neumunsterallee 9, Zurich, Switzerland; [Jakobsen, Helle] Aalborg Univ Hosp, Psychiat Hosp, Res Unit Child & Adolescent Psychiat, Aalborg, Denmark; [Munk-Jorgensen, Povl] Dept Psychiat, Odense, Denmark	University of Basel; University of Zurich; Aalborg University; Aalborg University Hospital	Steinhausen, HC (corresponding author), Capital Reg Psychiat, Child & Adolescent Mental Hlth Ctr, Copenhagen, Denmark.; Steinhausen, HC (corresponding author), Univ Basel, Inst Psychol, Clin Psychol & Epidemiol, Basel, Switzerland.; Steinhausen, HC (corresponding author), Univ Zurich, Dept Child & Adolescent Psychiat, Neumunsterallee 9, Zurich, Switzerland.	hc.steinhausen@kjpd.uzh.ch						Bierut LJ, 1998, ARCH GEN PSYCHIAT, V55, P982, DOI 10.1001/archpsyc.55.11.982; Chassin L, 1999, J ABNORM PSYCHOL, V108, P106, DOI 10.1037/0021-843X.108.1.106; D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Hartman CA, 2006, J STUD ALCOHOL, V67, P657, DOI 10.15288/jsa.2006.67.657; Helenius D, 2014, PSYCHIAT RES, V216, P351, DOI 10.1016/j.psychres.2014.02.026; Helenius D, 2013, J AFFECT DISORDERS, V150, P146, DOI 10.1016/j.jad.2012.12.013; Helenius D, 2012, SCHIZOPHR RES, V139, P183, DOI 10.1016/j.schres.2012.05.014; HOLDERNESS HC, 1994, INT J EAT DISORDER, V16, P1, DOI 10.1002/1098-108X(199407)16:1<1::AID-EAT2260160102>3.0.CO;2-T; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; Kendler KS, 2015, AM J PSYCHIAT, V172, P553, DOI 10.1176/appi.ajp.2014.14091127; Kendler KS, 2014, AM J PSYCHIAT, V171, P209, DOI 10.1176/appi.ajp.2013.12101300; Kendler KS, 2013, JAMA PSYCHIAT, V70, P235, DOI 10.1001/jamapsychiatry.2013.276; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Krug I, 2009, PSYCHIAT CLIN NEUROS, V63, P82, DOI 10.1111/j.1440-1819.2008.01908.x; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; LOFFLER W, 1994, ACTA PSYCHIAT SCAND, V90, P196, DOI 10.1111/j.1600-0447.1994.tb01577.x; Marmorstein NR, 2009, PSYCHOL MED, V39, P149, DOI 10.1017/S0033291708003085; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; Merikangas KR, 1998, PSYCHOL MED, V28, P773, DOI 10.1017/S0033291798006941; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Merikangas KR, 1998, J CHILD PSYCHOL PSYC, V39, P711, DOI 10.1017/S0021963098002522; Miller B, 2011, SCHIZOPHRENIA BULL, V37, P1039, DOI 10.1093/schbul/sbq011; Morgan PT, 2010, ALCOHOL CLIN EXP RES, V34, P1759, DOI 10.1111/j.1530-0277.2010.01263.x; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Munk-Jorgensen P, 2011, SCAND J PUBLIC HEALT, V39, P170, DOI 10.1177/1403494810390728; Organization WH, 1992, INTERNATIONA STATIST; Organization WH, 1967, MANUAL OF THE INTERN; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; R Development Core Team, 2010, R A LANGUAGE AND ENV; Rodgers S, 2015, SOC PSYCH PSYCH EPID, V50, P7, DOI 10.1007/s00127-014-0898-9; Skoglund C, 2015, BIOL PSYCHIAT, V77, P880, DOI 10.1016/j.biopsych.2014.10.006; Stata Corp, 2013, STATA STATISTICAL SO; Steinhausen HC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-5; Steinhausen HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146591; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P1, DOI 10.1002/eat.22293; Steinhausen HC, 2013, DEPRESS ANXIETY, V30, P1177, DOI 10.1002/da.22163; Steinhausen HC, 2009, EUR ARCH PSY CLIN N, V259, P270, DOI 10.1007/s00406-008-0865-0; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177700	10.1371/journal.pone.0177700	http://dx.doi.org/10.1371/journal.pone.0177700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28545101	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700065
J	Basu, R; Bose, A; Thomas, D; Das Sarma, J				Basu, Rahul; Bose, Abhishek; Thomas, Deepthi; Das Sarma, Jayasri			Microtubule-assisted altered trafficking of astrocytic gap junction protein connexin 43 is associated with depletion of connexin 47 during mouse hepatitis virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; NONDEMYELINATING STRAINS; CULTURED ASTROCYTES; MULTIPLE CONNEXINS; CYTOPLASMIC DYNEIN; CALCIUM WAVES; GLIAL-CELLS; IN-VITRO; EXPRESSION; MEMBRANE	Gap junctions (GJs) are important for maintenance of CNS homeostasis. GJ proteins, connexin 43 (Cx43) and connexin 47 (Cx47), play a crucial role in production and maintenance of CNS myelin. Cx43 is mainly expressed by astrocytes in the CNS and forms gap junction intercellular communications between astrocytes-astrocytes (Cx43-Cx43) and between astrocytes-oligodendrocytes (Cx43-Cx47). Mutations of these connexin (Cx) proteins cause dysmyelinating diseases in humans. Previously, it has been shown that Cx43 localization and expression is altered due to mouse hepatitis virus (MHV)-A59 infection both in vivo and in vitro; however, its mechanism and association with loss of myelin protein was not elaborated. Thus, we explored potential mechanisms by which MHV-A59 infection alters Cx43 localization and examined the effects of viral infection on Cx47 expression and its association with loss of the myelin marker proteolipid protein. Immunofluorescenceandtotalinternalreflectionfluo-rescence microscopy confirmed that MHV-A59 used microtubules (MTs) as a conduit to reach the cell surface and restricted MT-mediated Cx43 delivery to the cell membrane. Co-immunoprecipitation experiments demonstrated that Cx43-beta-tubulin molecular interaction was depleted due to protein-protein interaction between viral particles and MTs. During acute MHV-A59 infection, oligodendrocytic Cx47, which is mainly stabilized by Cx43 in vivo, was down-regulated, and its characteristic staining remained disrupted even at chronic phase. The loss of Cx47 was associated with loss of proteolipid protein at the chronic stage of MHV-A59 infection.	[Basu, Rahul; Bose, Abhishek; Thomas, Deepthi; Das Sarma, Jayasri] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India.	dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020		Wellcome Trust DBT-India Alliance [IA/I/13/1/500885 T]	Wellcome Trust DBT-India Alliance(Wellcome Trust)	We thank the Indian Institute of Science Education and Research Kolkata apoptome and confocal facility and Ritabrata Ghosh for apoptome and confocal microscopy assistance. We also thank Dr. Bidisha Sinha and Arikta Biswas for the TIRF facility and for assistance in TIRF imaging. We also thank Kenneth S. Shindler for critically reading and editing the manuscript. The IISER-K TIRF facility is supported by Wellcome Trust DBT-India Alliance Grant IA/I/13/1/500885 T.	Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Arishima H, 2002, J NEUROPATH EXP NEUR, V61, P1048, DOI 10.1093/jnen/61.12.1048; Basu R, 2016, J VIROL, V90, P2586, DOI 10.1128/JVI.02420-15; Biswas K, 2014, J VIROL, V88, P3043, DOI 10.1128/JVI.02545-13; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bugiani M, 2006, NEUROLOGY, V67, P273, DOI 10.1212/01.wnl.0000223832.66286.e4; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma Jayasri, 2010, Interdiscip Perspect Infect Dis, V2010, P109239, DOI 10.1155/2010/109239; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Fatemi SH, 2008, SCHIZOPHR RES, V98, P163, DOI 10.1016/j.schres.2007.09.031; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Iacobas DA, 2003, PHYSIOL GENOMICS, V15, P177, DOI 10.1152/physiolgenomics.00062.2003; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kenyon LC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00488; Kleopa KA, 2013, CLIN EXP NEUROIM SS1, V4, P45; Koester-Patzlaff C, 2007, BRAIN RES, V1184, P316, DOI 10.1016/j.brainres.2007.09.062; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; LAVI E, 1987, MICROB PATHOGENESIS, V3, P79, DOI 10.1016/0882-4010(87)90066-0; Li XB, 2008, EUR J NEUROSCI, V28, P1503, DOI 10.1111/j.1460-9568.2008.06431.x; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Markoullis K, 2012, ACTA NEUROPATHOL, V123, P873, DOI 10.1007/s00401-012-0978-4; Markoullis K, 2012, GLIA, V60, P1053, DOI 10.1002/glia.22334; Martin PEM, 2001, J CELL SCI, V114, P3845; May D, 2013, J NEUROSCI, V33, P7985, DOI 10.1523/JNEUROSCI.5874-12.2013; Mingo RM, 2012, J VIROL, V86, P7084, DOI 10.1128/JVI.00463-12; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Parenti R, 2010, GLIA, V58, P1594, DOI 10.1002/glia.21032; PASICK JMM, 1994, J VIROL, V68, P2915, DOI 10.1128/JVI.68.5.2915-2928.1994; Qu CY, 2009, EXP CELL RES, V315, P1683, DOI 10.1016/j.yexcr.2009.03.001; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tabernero A, 1996, GLIA, V16, P187, DOI 10.1002/(SICI)1098-1136(199603)16:3<187::AID-GLIA1>3.0.CO;2-#; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; Xiao PJ, 2012, J VIROL, V86, P10462, DOI 10.1128/JVI.00935-12; Xu AM, 2000, EMBO J, V19, P6465, DOI 10.1093/emboj/19.23.6465; Yea C, 2007, J VIROL, V81, P6899, DOI 10.1128/JVI.02330-05	54	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14747	14763		10.1074/jbc.M117.786491	http://dx.doi.org/10.1074/jbc.M117.786491			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28566289	Green Published, hybrid			2022-12-26	WOS:000409902100003
J	Hobley, L; Li, B; Wood, JL; Kim, SH; Naidoo, J; Ferreira, AS; Khomutov, M; Khomutov, A; Stanley-Wall, NR; Michael, AJ				Hobley, Laura; Li, Bin; Wood, Jennifer L.; Kim, Sok Ho; Naidoo, Jacinth; Ferreira, Ana Sofia; Khomutov, Maxim; Khomutov, Alexey; Stanley-Wall, Nicola R.; Michael, Anthony J.			Spermidine promotes Bacillus subtilis biofilm formation by activating expression of the matrix regulator slrR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-P; AGROBACTERIUM-TUMEFACIENS; POLYAMINE BIOSYNTHESIS; VIBRIO-CHOLERAE; EF-P; PROTEIN; IDENTIFICATION; PATHWAY; GROWTH; TRANSLATION	Ubiquitous polyamine spermidine is not required for normal planktonic growth of Bacillus subtilis but is essential for robust biofilm formation. However, the structural features of spermidine required for B. subtilis biofilm formation are unknown and so are the molecular mechanisms of spermidine-stimulated biofilm development. We report here that in a spermidine-deficient B. subtilis mutant, the structural analogue norspermidine, but not homospermidine, restored biofilm formation. Intracellular biosynthesis of another spermidine analogue, aminopropylcadaverine, from exogenously supplied homoagmatine also restored biofilm formation. The differential ability of C-methylated spermidine analogues to functionally replace spermidine in biofilm formation indicated that the aminopropyl moiety of spermidine is more sensitive to C-methylation, which it is essential for biofilm formation, but that the length and symmetry of the molecule is not critical. Transcriptomic analysis of a spermidine-depleted B. subtilis speD mutant uncovered a nitrogen-, methionine-, and S-adenosylmethionine-sufficiency response, resulting in repression of gene expression related to purine catabolism, methionine and S-adenosylmethionine biosynthesis and methionine salvage, and signs of altered membrane status. Consistent with the spermidine requirement in biofilm formation, single-cell analysis of this mutant indicated reduced expression of the operons for production of the exopolysaccharide and TasA protein biofilm matrix components and SinR antagonist slrR. Deletion of sinR or ectopic expression of slrR in the spermidine-deficient Delta speD background restored biofilm formation, indicating that spermidine is required for expression of the biofilm regulator slrR. Our results indicate that spermidine functions in biofilm development by activating transcription of the biofilm matrix exopolysaccharide and TasA operons through the regulator slrR.	[Hobley, Laura; Li, Bin; Kim, Sok Ho; Michael, Anthony J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Li, Bin; Naidoo, Jacinth; Michael, Anthony J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hobley, Laura; Wood, Jennifer L.; Ferreira, Ana Sofia; Stanley-Wall, Nicola R.] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD15EH, Scotland; [Khomutov, Maxim; Khomutov, Alexey] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov St 32, Moscow 119991, Russia; [Hobley, Laura] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland; [Kim, Sok Ho] Realtox Labs, Reisterstown, MD 21136 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Dundee; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Queens University Belfast	Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Michael, AJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Stanley-Wall, NR (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD15EH, Scotland.	n.r.stanleywall@dundee.ac.uk; anthony.michael@utsouthwestern.edu	Khomutov, Alex/G-2128-2015	Hobley, Laura/0000-0002-2153-0946; Khomutov, Alex/0000-0001-6833-7855; Stanley-Wall, Nicola/0000-0002-5936-9721; Khomutov, Maxim/0000-0003-2833-9834	University of Texas Southwestern Medical Center at Dallas; Biotechnology and Biological Sciences Research Council, UK [BB/1019464/1]; SULSA LEADERS award; Russian Science Foundation [RSF 14-14-01099, 14-50-00060]	University of Texas Southwestern Medical Center at Dallas; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SULSA LEADERS award; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by University of Texas Southwestern Medical Center at Dallas (to A.J.M), Biotechnology and Biological Sciences Research Council, UK Grant BB/1019464/1 (to N.R.S.-W.), a SULSA LEADERS award (to L.H.), and Grants RSF 14-14-01099 and RSF 14-50-00060 from the Russian Science Foundation (to M.K. and A.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Beier L, 2002, J BACTERIOL, V184, P3232, DOI 10.1128/JB.184.12.3232-3241.2002; Bottcher T, 2013, J AM CHEM SOC, V135, P2927, DOI 10.1021/ja3120955; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Cairns LS, 2014, MOL MICROBIOL, V93, P587, DOI 10.1111/mmi.12697; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Cybulski LE, 2002, MOL MICROBIOL, V45, P1379, DOI 10.1046/j.1365-2958.2002.03103.x; Diethmaier C, 2014, J BACTERIOL, V196, P265, DOI 10.1128/JB.00826-13; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Ding YZ, 2014, APPL ENVIRON MICROB, V80, P1498, DOI 10.1128/AEM.03461-13; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dominguez-Escobar J, 2014, MOL MICROBIOL, V92, P716, DOI 10.1111/mmi.12586; Feichtinger K, 1998, J ORG CHEM, V63, P3804, DOI 10.1021/jo980425s; FERRARI FA, 1985, P NATL ACAD SCI USA, V82, P2647, DOI 10.1073/pnas.82.9.2647; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Green R, 2011, MOL MICROBIOL, V81, P1109, DOI 10.1111/j.1365-2958.2011.07757.x; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hagan AK, 2016, MOL MICROBIOL, V102, P196, DOI 10.1111/mmi.13465; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Hanfrey CC, 2011, J BIOL CHEM, V286, P43301, DOI 10.1074/jbc.M111.307835; Hobley L, 2014, CELL, V156, P844, DOI 10.1016/j.cell.2014.01.012; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hofer U, 2014, NAT REV MICROBIOL, V12, P234, DOI 10.1038/nrmicro3233; HONJO M, 1990, J BACTERIOL, V172, P1783, DOI 10.1128/jb.172.4.1783-1790.1990; ISHII I, 1994, CELL MOL BIOL, V40, P925; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kim SH, 2016, ACS CHEM BIOL, V11, P491, DOI 10.1021/acschembio.5b00893; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Li B, 2016, ACS CHEM BIOL, V11, P2782, DOI 10.1021/acschembio.6b00629; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Meeske AJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002341; Michael AJ, 2016, BIOCHEM J, V473, P2315, DOI 10.1042/BCJ20160185; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; Murray EJ, 2009, J BACTERIOL, V191, P6822, DOI 10.1128/JB.00618-09; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Park JH, 2003, J BIOL CHEM, V278, P32683, DOI 10.1074/jbc.M304247200; PARK MH, 1988, J BIOL CHEM, V263, P15264; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Potter AJ, 2014, J BACTERIOL, V196, P3556, DOI 10.1128/JB.01981-14; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Sekowska A, 2000, MOL MICROBIOL, V36, P1135, DOI 10.1046/j.1365-2958.2000.01930.x; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; TROWSDALE J, 1978, J BACTERIOL, V135, P99, DOI 10.1128/JB.135.1.99-113.1978; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Verhamme DT, 2009, J BACTERIOL, V191, P100, DOI 10.1128/JB.01236-08; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang Y, 2016, J BACTERIOL, V198, P2682, DOI 10.1128/JB.00265-16; Weber MHW, 2001, MOL MICROBIOL, V39, P1321, DOI 10.1046/j.1365-2958.2001.02322.x; Winkelman JT, 2013, MOL MICROBIOL, V88, P984, DOI 10.1111/mmi.12235; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yoshida K, 2003, MOL MICROBIOL, V49, P157, DOI 10.1046/j.1365-2958.2003.03567.x	67	26	27	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12041	12053		10.1074/jbc.M117.789644	http://dx.doi.org/10.1074/jbc.M117.789644			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546427	Green Published, hybrid			2022-12-26	WOS:000406053300004
J	Li, M; Chen, DH; Huang, HX; Wang, JW; Wan, XY; Xu, CF; Li, CX; Ma, H; Yu, CH; Li, YM				Li, Meng; Chen, Dahua; Huang, Haixiu; Wang, Jiewei; Wan, Xingyong; Xu, Chengfu; Li, Chunxiao; Ma, Han; Yu, Chaohui; Li, Youming			Caveolin1 protects against diet induced hepatic lipid accumulation in mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; SIGNALING PATHWAY; ADIPOSE-TISSUE; EXPRESSION; GENE; CHOLESTEROL; TRANSCRIPTION; REGENERATION	Background and aim Caveolin1 (CAV1) is involved in lipid homeostasis and endocytosis, but little is known about the significance of CAV1 in the pathogenesis and development of nonalcoholic fatty liver disease (NAFLD). This study aimed to determine the role of CAV1 in NAFLD. Methods Expression of CAV1 in the in vitro and in vivo models of NAFLD was analyzed. The effects of CAV1 knockdown or overexpression on free fatty acid (FFA)-induced lipid accumulation in L02 cells and AML12 cells were determined. CAV1 knockout (CAV1-KO) mice and their wild-type (WT) littermates were subjected to a high fat diet (HFD) for 4 weeks, and the functional consequences of losing the CAV1 gene and its subsequent molecular mechanisms were also examined. Results Noticeably, CAV1 expression was markedly reduced in NAFLD. CAV1 knockdown led to the aggravation of steatosis that was induced by FFA in both L02 cells and AML12 cells, while CAV1 overexpression markedly attenuated lipid accumulation in the cells. Consistent with CAV1 repression in the livers of HFD-induced mice, the CAV1-KO mice exhibited more severe hepatic steatosis upon HFD intake. In addition, increased cholesterol levels and elevated transaminases were detected in the plasma of CAV1-KO mice. The protein expression of SREBP1, a key gene involved in lipogenesis, was augmented following CAV1 suppression in FFA-treated hepatocytes and in the livers of HFD-fed CAV1-KO mice. Conclusions CAV1 serves as an important protective factor in the development of NAFLD by modulating lipid metabolism gene expression.	[Li, Meng; Chen, Dahua; Huang, Haixiu; Wang, Jiewei; Wan, Xingyong; Xu, Chengfu; Li, Chunxiao; Ma, Han; Yu, Chaohui; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yu, CH; Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	ych623@sina.com; zliyouming@126.com	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81230012, 81100278, 81470838, 81170378, 81270487, 81570523]; National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; Zhejiang Provincial Natural Science Foundation of China [LQ15H030002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (No. 81230012), National Key Basic Research Development Program (No. 2012CB524905), National Science and Technology Support Plan Project (No. 2012BAI06B04); National Natural Science Foundation of China (No. 81100278, 81470838, 81170378, 81270487 and 81570523); Zhejiang Provincial Natural Science Foundation of China (No. LQ15H030002).	Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Arora N, 2006, CIRCULATION, V113, pE698, DOI 10.1161/CIRCULATIONAHA.105.603100; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Bosch M, 2011, CURR BIOL, V21, P681, DOI 10.1016/j.cub.2011.03.030; Catalan V, 2008, CLIN ENDOCRINOL, V68, P213, DOI 10.1111/j.1365-2265.2007.03021.x; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; Fernandez-Rojo MA, 2016, TRENDS MOL MED, V22, P889, DOI 10.1016/j.molmed.2016.08.007; Fernandez-Rojo MA, 2013, CELL REP, V4, P238, DOI 10.1016/j.celrep.2013.06.017; Fernandez-Rojo MA, 2012, HEPATOLOGY, V55, P1574, DOI 10.1002/hep.24810; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hitkova I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003251; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Li B, 2014, J MOL ENDOCRINOL, V53, P393, DOI 10.1530/JME-14-0127; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mandy MM, 2016, J CLIN TRANSL HEPATO, V4, P293, DOI 10.14218/JCTH.2016.00046; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mukherjee R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090918; Oh YS, 2008, DIABETOLOGIA, V51, P1025, DOI 10.1007/s00125-008-0993-0; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Sala-Vila A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27351; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Wu DQ, 2002, J BIOL CHEM, V277, P40449, DOI 10.1074/jbc.M206270200; Yuan HY, 2008, ACTA PHARMACOL SIN, V29, P555, DOI 10.1111/j.1745-7254.2008.00783.x	34	16	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178748	10.1371/journal.pone.0178748	http://dx.doi.org/10.1371/journal.pone.0178748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570612	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800118
J	Li, ZY; Lin, BL; Lin, GL; Wu, YK; Jie, YS; Li, XY; Ko, B; Chong, YT; Luo, J				Li, Zhanyi; Lin, Bingliang; Lin, Guoli; Wu, Yuankai; Jie, Yusheng; Li, Xiangyong; Ko, Brian; Chong, Yutian; Luo, Jian			Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis	PLOS ONE			English	Article							GROWTH-FACTOR 19; URSODEOXYCHOLIC ACID; LIVER-DISEASE; EXPRESSION; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; PROGNOSIS; HEALTH; INJURY	Background and aim Bile acid (BA) synthesis in the liver is regulated by Fibroblast Growth Factor 19 (FGF19) secreted from the ileum as an enterohepatic feedback mechanism. Although FGF19 mRNA is absent in normal liver, FGF19 gene expression was reported to increase in response to both extrahepatic and intrahepatic cholestasis. The impact of upregulated FGF19 expression on BA synthesis is unclear and the overall role of circulating FGF19 and BA synthesis under cholestatic conditions needs to be further investigated. Methods BA synthesis was directly quantified by measuring serum concentrations of 7alpha-hydroxy-cholest-4-en-3-one (C4), along with serum FGF19 and other parameters, in 44 patients with primary biliary cirrhosis (PBC) and 10 healthy subjects. Results Serum C4 were substantially lower, while those of FGF19 were higher, in cirrhotic PBC patients, as compared to those of either healthy or non-cirrhotic PBC patients. Analyses of the relationships between circulating FGF19, BA synthesis and cholestasis revealed that circulating FGF19 was strongly correlated with BA synthesis (r = -0.735, p < 0.0001) and the severity of cholestasis (r = 0.590, p < 0.001). Moreover, BA synthesis was found to be strongly correlated with the degree of cholestasis (r = 0.522, p = 0.0005). Conclusion These findings demonstrate that the regulation of BA synthesis in response to cholestasis is primarily controlled by circulating FGF19 and that under cholestatic conditions, the FGF19-BA synthesis feedback mechanism remains intact. Administering FGF19, or suitable mimetic, as a pharmacological intervention to increase circulating levels of FGF19 and suppress BA synthesis by inhibiting CYP7A1 gene expression is likely to provide therapeutic benefits for many PBC patients.	[Li, Zhanyi; Lin, Bingliang; Lin, Guoli; Wu, Yuankai; Jie, Yusheng; Li, Xiangyong; Chong, Yutian] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Ko, Brian; Luo, Jian] NGM Biopharmaceut Inc, San Francisco, CA 94080 USA	Sun Yat Sen University	Chong, YT (corresponding author), Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.; Luo, J (corresponding author), NGM Biopharmaceut Inc, San Francisco, CA 94080 USA.	ytchongkyzy@126.com; jluo@ngmbio.com						Camilleri M, 2009, NEUROGASTROENT MOTIL, V21, P734, DOI 10.1111/j.1365-2982.2009.01288.x; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Corpechot C, 2012, CLIN RES HEPATOL GAS, V36, pS13, DOI 10.1016/S2210-7401(12)70016-5; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; Galman C, 2003, J LIPID RES, V44, P859, DOI 10.1194/jlr.D200043-JLR200; Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011; Heathcote EJ, 2007, CLIN GASTROENTEROL H, V5, P776, DOI 10.1016/j.cgh.2007.05.008; Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004; Jones SA, 2012, ADV EXP MED BIOL, V728, P171, DOI 10.1007/978-1-4614-0887-1_11; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Mayo MJ, 2015, HEPATOLOGY, V62, p263A; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Purohit T, 2015, WORLD J HEPATOL, V7, P926, DOI 10.4254/wjh.v7.i7.926; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Rust C, 2009, J BIOL CHEM, V284, P2908, DOI 10.1074/jbc.M804585200; Sauter G, 1996, HEPATOLOGY, V24, P123, DOI 10.1053/jhep.1996.v24.pm0008707250; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; SCHMUCKER DL, 1990, HEPATOLOGY, V12, P1216, DOI 10.1002/hep.1840120523; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Ulrich Beuers, 2010, DIGEST LIVER DIS, V42, P409; Wunsch E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13462; Zweers SJLB, 2012, HEPATOLOGY, V55, P575, DOI 10.1002/hep.24702	26	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178580	10.1371/journal.pone.0178580	http://dx.doi.org/10.1371/journal.pone.0178580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570655	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800082
J	de Melo, TP; de Camargo, GMF; de Albuquerque, LG; Carvalheiro, R				de Melo, Thaise Pinto; Ferreira de Camargo, Gregorio Miguel; de Albuquerque, Lucia Galvao; Carvalheiro, Roberto			Genome-wide association study provides strong evidence of genes affecting the reproductive performance of Nellore beef cows	PLOS ONE			English	Article							POLYMERASE-ZETA; EXPRESSION; TRAITS; CATTLE; CELLS; TRANSCRIPTOME; PROLIFERATION; NEUROGENESIS; INFORMATION; MAINTENANCE	Reproductive traits are economically important for beef cattle production; however, these traits are still a bottleneck in indicine cattle since these animals typically reach puberty at older ages when compared to taurine breeds. In addition, reproductive traits are complex phenotypes, i.e., they are controlled by both the environment and many small-effect genes involved in different pathways. In this study, we conducted genome-wide association study (GWAS) and functional analyses to identify important genes and pathways associated with heifer rebreeding (HR) and with the number of calvings at 53 months of age (NC53) in Nellore cows. A total of 142,878 and 244,311 phenotypes for HR and NC53, respectively, and 2,925 animals genotyped with the Illumina Bovine HD panel (Illumine, San Diego, CA, USA) were used in GWAS applying the weighted single-step GBLUP (WssGBLUP) method. Several genes associated with reproductive events were detected in the 20 most important 1Mb windows for both traits. Significant pathways for HR and NC53 were associated with lipid metabolism and immune processes, respectively. MHC class II genes, detected on chromosome 23 (window 25-26Mb) for NC53, were significantly associated with pregnancy success of Nellore cows. These genes have been proved previously to be associated with reproductive traits such as mate choice in other breeds and species. Our results suggest that genes associated with the reproductive traits HR and NC53 may be involved in embryo development in mammalian species. Furthermore, some genes associated with mate choice may affect pregnancy success in Nellore cattle.	[de Melo, Thaise Pinto; de Albuquerque, Lucia Galvao; Carvalheiro, Roberto] Sao Paulo State Univ, FCAV UNESP, Sch Agr & Veterinarian Sci, Dept Anim Sci, Jaboticabal, SP, Brazil; [Ferreira de Camargo, Gregorio Miguel] Univ Fed Bahia, Sch Vet Med & Anim Sci, Dept Anim Sci, Salvador, BA, Brazil; [de Albuquerque, Lucia Galvao; Carvalheiro, Roberto] Natl Council Sci & Technol Dev CNPq, Brasilia, DF, Brazil	Universidade Estadual Paulista; Universidade Federal da Bahia	Carvalheiro, R (corresponding author), Sao Paulo State Univ, FCAV UNESP, Sch Agr & Veterinarian Sci, Dept Anim Sci, Jaboticabal, SP, Brazil.	rcar@fcav.unesp.br	Camargo, Gregorio M. F./J-9511-2016; de Melo, Thaise Pinto/I-3059-2013; Albuquerque, Lucia/A-7402-2013; Carvalheiro, Roberto/I-2239-2013; Carvalheiro, Roberto/AAG-2222-2020	de Melo, Thaise Pinto/0000-0003-0983-4602; Albuquerque, Lucia/0000-0002-2030-7590; Carvalheiro, Roberto/0000-0002-4506-0555; Carvalheiro, Roberto/0000-0002-4506-0555; de Camargo, Gregorio Miguel Ferreira/0000-0002-8736-5576	Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES); Fundacao de Amparo a Pesquisa (FAPESP) [2014/09603-2]; CNPq [559631/2009-0]; FAPESP [2009/16118-5]	Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support provided by Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES) and Fundacao de Amparo a Pesquisa (FAPESP), process no 2014/09603-2 to (TPM), CNPq (no 559631/2009-0) to (LGA), and FAPESP (no 2009/16118-5) to (LGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from Coordenacao de Aperfeicoamento de Pessoal de nivel superior (CAPES) and Fundacao de Amparo a Pesquisa (FAPESP), process no 2014/09603-2. Also financial supports from CNPq (no 559631/2009-0) and FAPESP (no 2009/16118-5) are acknowledged. DeltaGen (R) breeding program for providing the data used in this study.	Aarnink A, 2014, IMMUNOGENETICS, V66, P105, DOI 10.1007/s00251-013-0752-3; Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; [Anonymous], 2015, CELL MOL IMMUNOL; Bindea G, 2012, CLUEGO CYTOSCAPE PLU; Bolcun-Filas E, 2014, SCIENCE, V343, P533, DOI 10.1126/science.1247671; Boligon AA, 2012, GENET MOL RES, V11, P4516, DOI 10.4238/2012.October.17.2; Boligon AA, 2012, REV BRAS ZOOTECN, V41, P598, DOI 10.1590/S1516-35982012000300017; Carvalho H.F., 2007, CELULA; Ciccioli NH, 2003, J ANIM SCI, V81, P3107; Clelland CLT, 2000, GENOMICS, V63, P391, DOI 10.1006/geno.1999.6089; Correa ES, 2001, DESEMPENHO REPRODUTI; COSTA RB, 2015, GENET SEL EVOL, V47, P1, DOI DOI 10.1186/s12711-015-0150-4; De Luca A, 2014, REPROD BIOL, V14, P140, DOI 10.1016/j.repbio.2014.01.007; DeSouza L, 2005, PROTEOMICS, V5, P270, DOI 10.1002/pmic.200400920; Dickinson RE, 2010, REPRODUCTION, V139, P395, DOI 10.1530/REP-09-0182; Diedrichs F, 2012, INT J DEV BIOL, V56, P789, DOI 10.1387/ijdb.120230ja; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Fong CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-151; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Fortes MRS, 2014, LIVEST SCI, V166, P158, DOI 10.1016/j.livsci.2014.06.017; Foster WH, 2013, DEV DYNAM, V242, P1101, DOI 10.1002/dvdy.23990; Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; GIANOLA D, 1983, GENET SEL EVOL, V15, P201, DOI 10.1186/1297-9686-15-2-201; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Guarini AR, 2014, ANIMAL, V9; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Hawken RJ, 2012, J ANIM SCI, V90, P1398, DOI 10.2527/jas.2011-4410; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hyttel P, 2009, ESSENTIALS DOMESTIC; Irano N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159502; Janeway CA, 2007, IMMUNOBIOLOGY; Khan S, 2006, MOL ENDOCRINOL, V20, P2199, DOI 10.1210/me.2006-0100; Kim Yunna, 2012, Clin Exp Reprod Med, V39, P58, DOI 10.5653/cerm.2012.39.2.58; Kommagani R, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117531; Ledgard AM, 2015, REPROD FERT DEVELOP, V27, P395, DOI 10.1071/RD13144; Liu Q, 2016, AM J REPROD IMMUNOL, V75, P569, DOI 10.1111/aji.12498; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Luna-Nevarez P, 2011, J ANIM SCI, V89, P926, DOI 10.2527/jas.2010-3483; Luo JP, 2010, REPROD FERT DEVELOP, V22, P966, DOI 10.1071/RD09311; Marks M, 2015, ANAL FAM181 GENE F 2, V575, P438; Mazur EC, 2015, ENDOCRINOLOGY, V156, P2239, DOI 10.1210/en.2014-1566; Mc Geady T.A., 2006, VET EMBRIOLOGY, Vfirst; Meganathan K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.121; Melo TP, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0394-1; Miao J, 2005, J ENDOCRINOL, V185, P507, DOI 10.1677/joe.1.06079; Michalak Marek, 2015, Clin Exp Reprod Med, V42, P1, DOI 10.5653/cerm.2015.42.1.1; Misztal I., 2012, USER MANUAL ANIMAL D; Monzo C, 2012, HUM REPROD, V27, P2160, DOI 10.1093/humrep/des153; Navone F, 2001, J NEUROCHEM, V77, P741, DOI 10.1046/j.1471-4159.2001.00277.x; Nelson DL., 2014, PRINCIPIOS BIOQUIMIC, V6; Neves HHR, 2012, J ANIM SCI, V90, P4209, DOI 10.2527/jas.2011-4766; NICHOLAS FW, 1996, INTRO VET GENETICS; Oki Y, 2004, PEPTIDES, V25, P1745, DOI 10.1016/j.peptides.2004.06.023; Park HJ, 2013, BIOCHEM BIOPH RES CO, V441, P344, DOI 10.1016/j.bbrc.2013.10.056; Ramos RD, 2014, MOL REPROD DEV, V81, P584, DOI 10.1002/mrd.22323; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith B. J., 2015, BAYESIAN OUTPUT ANAL; Sorensen DA., 2002, STAT BIOL HEALTH; Sotelo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093672; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Spessotto P, 2006, J CELL SCI, V119, P4574, DOI 10.1242/jcs.03232; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Swain JE, 2007, BIOL REPROD, V76, P628, DOI 10.1095/biolreprod.106.055798; Tao J, 2007, CELL PHYSIOL BIOCHEM, V19, P303, DOI 10.1159/000100649; TSURUTA S., 2006, WORLD C GEN APPL LIV, V8, P27; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Xu JC, 2014, J CELL SCI, V127, P641, DOI 10.1242/jcs.137612; Yeh ML, 2014, J NEUROSCI, V34, P5717, DOI 10.1523/JNEUROSCI.4256-13.2014; Yu Y, 2010, ANIM REPROD SCI, V120, P1, DOI 10.1016/j.anireprosci.2010.01.004; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541; Zhang JY, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095059; Zhang SB, 2015, REPROD SCI, V22, P1236, DOI 10.1177/1933719115572485; Ziegler Andreas, 2010, Self Nonself, V1, P176, DOI 10.4161/self.1.3.12736	83	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178551	10.1371/journal.pone.0178551	http://dx.doi.org/10.1371/journal.pone.0178551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562680	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700073
J	Iwata, T; Uchino, T; Koyama, A; Johmura, Y; Koyama, K; Saito, T; Ishiguro, S; Arikawa, T; Komatsu, S; Miyachi, M; Sano, T; Nakanishi, M; Shimada, M				Iwata, Tsutomu; Uchino, Tairin; Koyama, Ayako; Johmura, Yoshikazu; Koyama, Kenichi; Saito, Takuya; Ishiguro, Seiji; Arikawa, Takashi; Komatsu, Shunichiro; Miyachi, Masahiko; Sano, Tsuyoshi; Nakanishi, Makoto; Shimada, Midori			The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; CYCLE CHECKPOINT; PLUS BEVACIZUMAB; DNA; CHK1; THERAPY; KINASE; ATR; GEMCITABINE; OXALIPLATIN	CBP-93872 suppresses maintenance of DNA double-stranded break-induced G2 checkpoint, by inhibiting the pathway between ataxia-telangiectasia mutated (ATM) and ATMand Rad3-related (ATR) activation. To examine the potential use of CBP-93872 for clinical applications, we analyzed the synergistic effects of platinum-containing drugs, oxaliplatin and cisplatin, pyrimidine antimetabolites, gemcitabine and 5-fluorouracil (5-FU), in combination with CBP-93872, on cell lethality in colorectal and pancreatic cancer cell lines. Treatment with CBP-93872 significantly increased cancer cell sensitivities to various chemotherapeutic agents tested through suppression of checkpoint activation. Our results thus reveal that combination treatment of CBP-93872 with known chemotherapeutic agents inhibits phosphorylation of ATR and Chk1, and induces cell death.	[Iwata, Tsutomu; Uchino, Tairin; Koyama, Ayako; Johmura, Yoshikazu; Nakanishi, Makoto; Shimada, Midori] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Nagoya, Aichi, Japan; [Iwata, Tsutomu; Uchino, Tairin; Koyama, Kenichi; Saito, Takuya; Ishiguro, Seiji; Arikawa, Takashi; Komatsu, Shunichiro; Miyachi, Masahiko; Sano, Tsuyoshi] Aichi Med Univ, Dept Gastroenterol Surg, Sch Med, Nagakute, Aichi, Japan; [Johmura, Yoshikazu; Nakanishi, Makoto] Univ Tokyo, Inst Med Sci, Div Canc Cell Biol, Dept Canc Biol,Minato Ku, Tokyo, Japan; [Shimada, Midori] Yamaguchi Univ, Joint Fac Vet Sci, Dept Biochem, Yoshida, Yamaguchi, Japan	Nagoya City University; Aichi Medical University; University of Tokyo; Yamaguchi University	Shimada, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Nagoya, Aichi, Japan.; Shimada, M (corresponding author), Yamaguchi Univ, Joint Fac Vet Sci, Dept Biochem, Yoshida, Yamaguchi, Japan.	shimada@yamaguchi-u.ac.jp			Grants-in-Aid for Scientific Research [16K15238] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Doi T, 2010, JPN J CLIN ONCOL, V40, P913, DOI 10.1093/jjco/hyq069; FAN SJ, 1995, CANCER RES, V55, P1649; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Geenen JJJ, 2017, CLIN CANC RES; Goto H, 2012, CANCER SCI, V103, P1195, DOI 10.1111/j.1349-7006.2012.02280.x; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Harada N, 2011, ANTI-CANCER DRUG, V22, P986, DOI 10.1097/CAD.0b013e328349dd43; Hirokawa T, 2014, CANCER RES, V74, P3880, DOI 10.1158/0008-5472.CAN-13-3604; Hsieh MC, 2016, CANCER MED-US, V5, P871, DOI 10.1002/cam4.632; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Liu QH, 2000, GENE DEV, V14, P1448; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Morgan MA, 2005, CANCER RES, V65, P6835, DOI 10.1158/0008-5472.CAN-04-2246; Murakami Y, 2016, J SURG ONCOL, V113, P405, DOI 10.1002/jso.24156; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Rizvi NA, 2016, J CLIN ONCOL, V34, P2969, DOI 10.1200/JCO.2016.66.9861; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Visconti R, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0433-9; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Yamada Y, 2013, LANCET ONCOL, V14, P1278, DOI 10.1016/S1470-2045(13)70490-X; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	37	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178221	10.1371/journal.pone.0178221	http://dx.doi.org/10.1371/journal.pone.0178221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558031	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000032
J	Del Papa, B; Priesemann, V; Triesch, J				Del Papa, Bruno; Priesemann, Viola; Triesch, Jochen			Criticality meets learning: Criticality signatures in a self-organizing recurrent neural network	PLOS ONE			English	Article							NEURONAL AVALANCHES; DISTRIBUTIONS; EDGE; CHAOS	Many experiments have suggested that the brain operates close to a critical state, based on signatures of criticality such as power-law distributed neuronal avalanches. In neural network models, criticality is a dynamical state that maximizes information processing capacities, e.g. sensitivity to input, dynamical range and storage capacity, which makes it a favorable candidate state for brain function. Although models that self-organize towards a critical state have been proposed, the relation between criticality signatures and learning is still unclear. Here, we investigate signatures of criticality in a self-organizing recurrent neural network (SORN). Investigating criticality in the SORN is of particular interest because it has not been developed to show criticality. Instead, the SORN has been shown to exhibit spatiotemporal pattern learning through a combination of neural plasticity mechanisms and it reproduces a number of biological findings on neural variability and the statistics and fluctuations of synaptic efficacies. We show that, after a transient, the SORN spontaneously self-organizes into a dynamical state that shows criticality signatures comparable to those found in experiments. The plasticity mechanisms are necessary to attain that dynamical state, but not to maintain it. Furthermore, onset of external input transiently changes the slope of the avalanche distributions - matching recent experimental findings. Interestingly, the membrane noise level necessary for the occurrence of the criticality signatures reduces the model's performance in simple learning tasks. Overall, our work shows that the biologically inspired plasticity and homeostasis mechanisms responsible for the SORN's spatio-temporal learning abilities can give rise to criticality signatures in its activity when driven by random input, but these break down under the structured input of short repeating sequences.	[Del Papa, Bruno; Triesch, Jochen] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany; [Del Papa, Bruno] Max Planck Inst Brain Res, Int Max Planck Res Sch Neural Circuits, Frankfurt, Germany; [Priesemann, Viola] Max Planck Inst Dynam & Self Org, Dept Nonlinear Dynam, Gottingen, Germany; [Priesemann, Viola] Bernstein Ctr Computat Neurosci, Gottingen, Germany	Goethe University Frankfurt; Max Planck Society; Max Planck Society	Del Papa, B (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany.; Del Papa, B (corresponding author), Max Planck Inst Brain Res, Int Max Planck Res Sch Neural Circuits, Frankfurt, Germany.	delpapa@fias.uni-frankfurt.de	Priesemann, Viola/R-3042-2017	Priesemann, Viola/0000-0001-8905-5873	Quandt foundation; German Ministry for Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen [01GQ1005B]	Quandt foundation; German Ministry for Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen(Federal Ministry of Education & Research (BMBF))	This work was supported by the Quandt foundation. Viola Priesemann received financial support from the German Ministry for Education and Research (BMBF) via the Bernstein Center for Computational Neuroscience (BCCN) Gottingen under Grant No. 01GQ1005B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bedard C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.118102; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boedecker J, 2012, THEOR BIOSCI, V131, P205, DOI 10.1007/s12064-011-0146-8; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Brochini L, 2016, SCI REPORTS, P6; Campos JGF, 2017, REVIEW E, V95; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costa AD, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/06/P06004; de Arcangelis L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028107; Duarte R., 2014, P 36 ANN C COGN SCI, P427; Eser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086962; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Gautam H, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004576; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; Harris T. E., 1963, THEORY BRANCHING PRO; Hartley C, 2014, J MATH NEUROSCI, V4, DOI 10.1186/2190-8567-4-9; Hartmann C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004640; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Lazar A, 2009, FRONTIERS COMPUTATIO, P3; Lazar A, 2011, LECT NOTES COMPUT SC, V6792, P127, DOI 10.1007/978-3-642-21738-8_17; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levina A, 2017, ARXIV170104277; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Magnasco MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258102; Meisel C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002312; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Miner D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004759; Moretti P, 2013, NATURE COMMUNICATION, P4; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D., 2013, PHYSICS, V6, P47, DOI DOI 10.1103/PHYSICS.6.47; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Priesemann V, 2014, FRONTIERS SYSTEMS NE, P8; Priesemann V, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-40; Privman V., 1990, FINITE SIZE SCALING, P1; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Schwab DJ, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.068102; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shew WL, 2015, NAT PHYS, V11, P659, DOI 10.1038/NPHYS3370; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Stepp N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004043; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Teixeira FPP, 2015, NEUR NETW IJCNN 2015, P1; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Touboul J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008982; Uhlig M, 2013, FRONTIERS COMPUTATIO, P7; Williams-Garcia RV, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062714; Wilting J., 2016, ARXIV160807035; Zheng PS, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00066; Zheng PS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002848	60	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178683	10.1371/journal.pone.0178683	http://dx.doi.org/10.1371/journal.pone.0178683			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552964	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000053
J	Liu, CB; Wang, TS; Bai, YW; Wang, J				Liu, Chuanbo; Wang, Tianshu; Bai, Yawen; Wang, Jin			Electrostatic forces govern the binding mechanism of intrinsically disordered histone chaperones	PLOS ONE			English	Article							PROTEIN-PROTEIN ASSOCIATION; MOLECULAR RECOGNITION; ENERGY LANDSCAPE; CHZ1; DNA; THERMODYNAMICS; ENHANCEMENT; H2A.Z-H2B; BARNASE; COMPLEX	A unified picture to understand the protein recognition and function must include the native binding complex structure ensembles and the underlying binding mechanisms involved in specific biological processes. However, quantifications of both binding complex structures and dynamical mechanisms are still challenging for IDP. In this study, we have investigated the underlying molecular mechanism of the chaperone Chz1 and histone H2A. Z-H2B association by equilibrium and kinetic stopped-flow fluorescence spectroscopy. The dependence of free energy and kinetic rate constant on electrolyte mean activity coefficient and urea concentration are uncovered. Our results indicate a previous unseen binding kinetic intermediate. An initial conformation selection step of Chz1 is also revealed before the formation of this intermediate state. Based on these observations, a mixed mechanism of three steps including both conformation selection and induced fit is proposed. By combination of the ion- and denaturant-induced experiments, we demonstrate that electrostatic forces play a dominant role in the recognition of bipolar charged intrinsically disordered protein Chz1 to its preferred partner H2A. Z-H2B. Both the intra-chain and inter-chain electrostatic interactions have direct impacts on the native collapsed structure and binding mechanism.	[Liu, Chuanbo; Wang, Tianshu; Wang, Jin] Chinese Acad Sci, State Key Lab Electroanalyt Chem, Changchun Inst Appl Chem, Changchun 130022, Jilin, Peoples R China; [Liu, Chuanbo] Univ Chinese Acad Sci, Beijing 130022, Peoples R China; [Wang, Tianshu; Wang, Jin] Jilin Univ, Coll Phys, Chuangchun 130012, Jilin, Peoples R China; [Bai, Yawen] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD USA; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, State Key Lab Electroanalyt Chem, Changchun Inst Appl Chem, Changchun 130022, Jilin, Peoples R China.; Wang, J (corresponding author), Jilin Univ, Coll Phys, Chuangchun 130012, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	Jin.wang.1@stonybrook.edu			National Natural Science Foundation of China [91430217]; National Natural Science Foundation of China; National Key Research & Development Plan, MOST, China [2016YFA0203200]; Ministry of Science and Technology of the People's Republic of China; National Science Foundation [PHY-76066]; National Science Foundation of American; NATIONAL CANCER INSTITUTE [ZIABC010808] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research & Development Plan, MOST, China; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Science Foundation of American; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China, grant numbers 91430217, URL = http://www.nsfc.gov.cn/, National Natural Science Foundation of China, Jin Wang; The National Key Research & Development Plan, MOST, China, grant number 2016YFA0203200, URL = http://www.most.gov.cn/eng/programmes1/200610/0061009_36224. htm, Ministry of Science and Technology of the People's Republic of China, Jin Wang; and The National Science Foundation, grant number PHY-76066, URL = https://www.nsf.gov/, National Science Foundation of American, Jin Wang.	Aguilar-Gurrieri C, 2016, EMBO J, V35, P1465, DOI 10.15252/embj.201694105; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Alsallaq R, 2007, STRUCTURE, V15, P215, DOI 10.1016/j.str.2007.01.005; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Chien FT, 2014, BIOPHYS J, V107, P373, DOI 10.1016/j.bpj.2014.05.036; Chu XK, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003782; Chu XK, 2013, P NATL ACAD SCI USA, V110, pE2342, DOI 10.1073/pnas.1220699110; Chu XK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002608; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; Fersht A., 1999, STRUCTURE MECH PROTE; Fischer E, 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Hansen DF, 2009, J MOL BIOL, V387, P1, DOI 10.1016/j.jmb.2009.01.009; Hong JJ, 2014, MOL CELL, V53, P498, DOI 10.1016/j.molcel.2014.01.010; Huang F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S4; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li GH, 2010, MOL CELL, V38, P41, DOI 10.1016/j.molcel.2010.01.042; Liu HD, 2014, BIOSCIENCE REP, V34, P559, DOI 10.1042/BSR20140092; Liu HD, 2014, BIOCHEM J, V460, P387, DOI 10.1042/BJ20140186; Lu Q, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128105; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Marouzi S, 2017, INT J BIOL MACROMOL, V97, P688, DOI 10.1016/j.ijbiomac.2017.01.047; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; Rocha W, 2008, FEBS LETT, V582, P1938, DOI 10.1016/j.febslet.2008.03.006; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; RUSH JD, 1987, J AM CHEM SOC, V109, P2679, DOI 10.1021/ja00243a020; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045; SCHELLMAN JA, 1994, BIOPOLYMERS, V34, P1015, DOI 10.1002/bip.360340805; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Straube K, 2010, TRAFFIC, V11, P185, DOI 10.1111/j.1600-0854.2009.01010.x; Truesdell A.H., 1974, J RES; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang Y, 2013, P NATL ACAD SCI USA, V110, pE3743, DOI 10.1073/pnas.1308381110; Wendt H, 1997, BIOCHEMISTRY-US, V36, P204, DOI 10.1021/bi961672y; Yao J, 2015, J PHYS CHEM LETT, V6, P2022, DOI 10.1021/acs.jpclett.5b00524; Zhang B, 2016, J AM CHEM SOC, V138, P8126, DOI 10.1021/jacs.6b02893; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	61	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178405	10.1371/journal.pone.0178405	http://dx.doi.org/10.1371/journal.pone.0178405			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552960	gold, Green Submitted, Green Published			2022-12-26	WOS:000402063000043
J	Zhou, J; Cui, LJ; Pan, X; Li, W; Zhang, MY; Kang, XM				Zhou, Jian; Cui, Lijuan; Pan, Xu; Li, Wei; Zhang, Manyin; Kang, Xiaoming			Does salt stress affect the interspecific interaction between regionally dominant Suaeda salsa and Scirpus planiculumis?	PLOS ONE			English	Article							PLANT-PLANT INTERACTIONS; POSITIVE SPECIES INTERACTIONS; ABIOTIC STRESS; GRADIENT HYPOTHESIS; FACILITATION; COMPETITION; SALINITY; INTERFERENCE; METAANALYSIS; COMMUNITIES	Plant-plant interactions that change along environmental gradients can be affected by different combinations of environmental characteristics, such as the species and planting density ratios. Suaeda salsa and Scirpus planiculumis are regionally dominant species in the Shuangtai estuarine wetland. Compared with non-clonal S. salsa, clonal S. planiculumis has competitive advantages because of its morphological plasticity. However, salt-tolerant S. salsa may grow faster than S. planiculumis in saline-alkali estuary soil. Whether the interactions between these two species along salinity gradients are affected by the level of salt stress and mixed planting density ratio remains unclear. Thus, to test the effects of salt stress and planting density ratios on the interactions between S. planiculumis and S. salsa in the late growing season, we conducted a greenhouse experiment consisting of 3 salinity levels (0, 8 and 15ppt) and 5 planting density ratios. Our results showed that the promotion of S. salsa growth and inhibition of S. planiculumis growth at low salinity levels (8 ppt) did not alter the interactions between the two species. Facilitation of S. salsa occurred at high salinity levels, and the magnitude of this net outcome decreased with increases in the proportion of S. salsa. These results suggest that competition and facilitation processes not only depend on the combinations of different life-history characteristics of species but also on the planting density ratio. These findings may contribute to the understanding of the responses of estuarine wetland plant-plant interactions to human modifications of estuarine salinity.	[Zhou, Jian; Cui, Lijuan; Pan, Xu; Li, Wei; Zhang, Manyin; Kang, Xiaoming] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Zhou, Jian; Cui, Lijuan; Pan, Xu; Li, Wei; Zhang, Manyin; Kang, Xiaoming] Beijing Key Lab Wetland Ecol Funct & Restorat, Beijing, Peoples R China; [Zhou, Jian; Cui, Lijuan; Pan, Xu; Li, Wei] Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China	Chinese Academy of Forestry; Institute of Wetland Research, CAF	Cui, LJ (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Key Lab Wetland Ecol Funct & Restorat, Beijing, Peoples R China.; Cui, LJ (corresponding author), Beijing Hanshiqiao Natl Wetland Ecosyst Res Stn, Beijing, Peoples R China.	lkyclj@126.com	Zhang, Manyin/AAK-5171-2020; Pan, Xu/W-1607-2017; 李, 伟/GWQ-2838-2022; Kang, Xiaoming/GLU-1610-2022	Pan, Xu/0000-0003-3733-1981; Kang, Xiaoming/0000-0002-0528-1396	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" [201404305]	Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China"	This work was funded by the Forestry Nonprofit Industry Scientific Research Special Project "The research of ecosystem service and evaluation techniques of coastal wetlands, China" (No.201404305). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1995, OIKOS, V74, P149, DOI 10.2307/3545684; Alpert P, 2003, J ECOL, V91, P27, DOI 10.1046/j.1365-2745.2003.00737.x; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Badano EI, 2007, J ECOL, V95, P682, DOI 10.1111/j.1365-2745.2007.01262.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; Brooker RW, 2008, J ECOL, V96, P703, DOI 10.1111/j.1365-2745.2008.01373.x; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; CRAMER GR, 1985, PLANT PHYSIOL, V79, P207, DOI 10.1104/pp.79.1.207; Cuda J, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv033; Donovan LA, 2000, J ECOL, V88, P1, DOI 10.1046/j.1365-2745.2000.00411.x; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; Grant K, 2014, ECOL RES, V29, P991, DOI 10.1007/s11284-014-1187-5; Greenlee JT, 1996, AM NAT, V148, P386, DOI 10.1086/285931; Guo HY, 2012, ECOLOGY, V93, P90, DOI 10.1890/11-0487.1; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; He Q, 2012, ECOLOGY, V93, P2023, DOI 10.1890/12-0241.1; Herbert ER, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00534.1; Holzapfel C, 1999, ECOLOGY, V80, P1747, DOI 10.2307/176564; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Li PH, 2004, ACTA BOT SIN, V46, P93; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Liu BL, 2011, FRONT ENVIRON SCI EN, V5, P435, DOI 10.1007/s11783-011-0352-0; Liu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149262; Lortie CJ, 2006, J ECOL, V94, P7, DOI 10.1111/j.1365-2745.2005.01066.x; Lu CM, 2003, J EXP BOT, V54, P851, DOI 10.1093/jxb/erg080; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Michalet R, 2014, J VEG SCI, V25, P609, DOI 10.1111/jvs.12123; Morzaria-Luna HN, 2014, WETLANDS, V34, P31, DOI 10.1007/s13157-013-0479-9; Noto AE, 2016, OECOLOGIA, V180, P499, DOI 10.1007/s00442-015-3473-5; Peng Yi-Ke, 2013, Chinese Journal of Plant Ecology, V37, P335, DOI 10.3724/SP.J.1258.2013.00033; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Puijalon S, 2008, ANN BOT-LONDON, V102, P989, DOI 10.1093/aob/mcn190; Tang L, 2015, ANN OPER RES, V234, P111, DOI 10.1007/s10479-014-1595-5; TILMAN D, 1988; Wang CH, 2016, OECOLOGIA, V182, P139, DOI 10.1007/s00442-016-3650-1; Weigelt A, 2002, BASIC APPL ECOL, V3, P85, DOI 10.1078/1439-1791-00080; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; Yu FH, 2010, J ARID ENVIRON, V74, P632, DOI 10.1016/j.jaridenv.2009.12.008; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	46	10	10	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177497	10.1371/journal.pone.0177497	http://dx.doi.org/10.1371/journal.pone.0177497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552965	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000006
J	Meyer, T; Nikoubashman, O; Kabelitz, L; Muller, M; Othman, A; Afat, S; Kramer, M; Wiesmann, M; Brockmann, MA; Brockmann, C				Meyer, Tareq; Nikoubashman, Omid; Kabelitz, Lisa; Mueller, Marguerite; Othman, Ahmed; Afat, Saif; Kramer, Martin; Wiesmann, Martin; Brockmann, Marc A.; Brockmann, Carolin			Endovascular stentectomy using the snare over stent-retriever (SOS) technique: An experimental feasibility study	PLOS ONE			English	Article								Feasibility of endovascular stentectomy using a snare over stent-retriever (SOS) technique was evaluated in a silicon flow model and an in vivo swine model. In vitro, stentectomy of different intracranial stents using the SOS technique was feasible in 22 out of 24 (92%) retrieval maneuvers. In vivo, stentectomy was successful in 10 out of 10 procedures (100%). In one case self-limiting vasospasm was observed angiographically as a technique related complication in the animal model. Endovascular stentectomy using the SOS technique is feasible in an experimental setting and may be transferred to a clinical scenario.	[Meyer, Tareq; Nikoubashman, Omid; Kabelitz, Lisa; Mueller, Marguerite; Othman, Ahmed; Afat, Saif; Wiesmann, Martin; Brockmann, Marc A.; Brockmann, Carolin] Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Meyer, Tareq; Brockmann, Marc A.; Brockmann, Carolin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, Mainz, Germany; [Nikoubashman, Omid] Forschungszentrum Julich, Inst Neurosci & Med 4, Med Imaging Phys, Julich, Germany; [Kramer, Martin] Justus Liebig Univ, Dept Vet Clin Sci, Small Anim Clin, Giessen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Johannes Gutenberg University of Mainz; Helmholtz Association; Research Center Julich; Justus Liebig University Giessen	Brockmann, C (corresponding author), Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany.; Brockmann, C (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, Mainz, Germany.	brockmann@gmx.de	Wiesmann, Martin/GLU-1902-2022; Afat, Saif/AAF-7183-2020; Afat, Saif/AAF-6679-2020	Afat, Saif/0000-0002-6861-6245; Othman, Ahmed/0000-0002-3827-8695; othman, ahmed mohamed abdel ghany/0000-0002-0405-8918				Ansari S, 2011, WORLD NEUROSURG, V76, pS24, DOI 10.1016/j.wneu.2011.02.031; Barburoglu M, 2015, WORLD NEUROSURGERY; Broadbent LP, 2003, AM J NEURORADIOL, V24, P1819; Castano C, 2016, J NEUROINTERVENTIONA; Chapot R., 2015, INTERVENT NEURORADIO, V21, P160; Kerl HU, 2012, CLIN NEURORADIOL, V22, P47, DOI 10.1007/s00062-011-0128-8; Kerl HU, 2014, NEUROSURGERY, V74, P321, DOI 10.1227/NEU.0000000000000253; Kung DK, 2012, CASE REPORTS MED, V2012; Meyer T, 2015, CLIN NEURORADIOL S25, P18; Miley JT, 2015, WORLD J RADIOL, V7, P139, DOI 10.4329/wjr.v7.i6.139; Oh Yul, 2012, Neurointervention, V7, P50, DOI 10.5469/neuroint.2012.7.1.50; Parthasarathy Rajsrinivas, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-012547; Schechter MA, 2013, J VASC SURG, V57, P276, DOI 10.1016/j.jvs.2012.09.002; Turek G, 2015, J NEUROSURG, P1	14	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178197	10.1371/journal.pone.0178197	http://dx.doi.org/10.1371/journal.pone.0178197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542580	Green Submitted, gold, Green Published			2022-12-26	WOS:000402062800052
J	Zainabadi, K; Liu, CJ; Guarente, L				Zainabadi, Kayvan; Liu, Cassie J.; Guarente, Leonard			SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXTENDS LIFE-SPAN; BONE-FORMATION; CALORIE RESTRICTION; HISTONE DEACETYLASE; OSTEOCALCIN GENE; IMPROVES HEALTH; STANDARD DIET; BETA-CATENIN; PPAR-GAMMA	Activation of SIRT1 has previously been shown to protect mice against osteoporosis through yet ill-defined mechanisms. In this study, we outline a role for SIRT1 as a positive regulator of the master osteoblast transcription factor, RUNX2. We find that ex vivo deletion of sirt1 leads to decreased expression of runx2 downstream targets, but not runx2 itself, along with reduced osteoblast differentiation. Reciprocally, treatment with a SIRT1 agonist promotes osteoblast differentiation, as well as the expression of runx2 downstream targets, in a SIRT1-dependent manner. Biochemical and luciferase reporter assays demonstrate that SIRT1 interacts with and promotes the transactivation potential of RUNX2. Intriguingly, mice treated with the SIRT1 agonist, resveratrol, show similar increases in the expression of RUNX2 targets in their calvaria (bone tissue), validating SIRT1 as a physiologically relevant regulator of RUNX2.	[Zainabadi, Kayvan; Liu, Cassie J.; Guarente, Leonard] MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zainabadi, Kayvan] Univ Maryland, Sch Med, Div Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore	Zainabadi, K (corresponding author), MIT, Dept Biol, Koch Inst, Glenn Ctr Sci Aging, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zainabadi, K (corresponding author), Univ Maryland, Sch Med, Div Malaria Res, Inst Global Hlth, Baltimore, MD 21201 USA.	kayvan@alum.mit.edu			NIH; Glenn Foundation for Medical Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research	This work was supported by grants from the NIH and The Glenn Foundation for Medical Research to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the NIH and The Glenn Foundation for Medical Research.	Artsi H, 2014, ENDOCRINOLOGY, V155, P3508, DOI 10.1210/en.2014-1334; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Durbin SM, 2014, J BONE MINER METAB, V32, P38, DOI 10.1007/s00774-013-0469-2; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Graff J, 2013, J NEUROSCI, V33, P8951, DOI 10.1523/JNEUROSCI.5657-12.2013; Gurt I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134391; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hawse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019429; Helfrich MH, 2003, METHODS MOL MED, P80; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Holleville N, 2007, DEV BIOL, V304, P860, DOI 10.1016/j.ydbio.2007.01.003; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Kane AE, 2016, J GERONTOL A-BIOL, V71, P333, DOI 10.1093/gerona/glu315; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kawaguchi H, 2005, J BONE MINER METAB, V23, P275, DOI 10.1007/s00774-005-0599-2; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Zhang R, 1997, J BIOL CHEM, V272, P110, DOI 10.1074/jbc.272.1.110; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	52	44	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178520	10.1371/journal.pone.0178520	http://dx.doi.org/10.1371/journal.pone.0178520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542607	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800099
J	Wang, SS; Yang, CJ; Liu, YJ; Shao, Z; Jackson, T				Wang, Shanshan; Yang, Chunjuan; Liu, Yijun; Shao, Zhi; Jackson, Todd			Early and late stage processing abnormalities in autism spectrum disorders: An ERP study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BILATERAL STIMULUS ARRAYS; INDEX FOCUSED ATTENTION; SELECTIVE-ATTENTION; MISMATCH NEGATIVITY; CHILDREN; IMPAIRMENT	This research assessed event-related potentials (ERPs) elicited during the processing of different kinds of visual stimuli among children with Autism Spectrum Disorder (ASD) (n = 15) and typically developing (TD) children (n = 19). Within a simple visual oddball paradigm, participating children passively viewed fruit and vegetable images that were used as standard stimuli in addition to images of these foods with their usual colors modified to create novel stimuli and cartoon depictions of these images (i.e., "deviant" stimuli). Analyses revealed significant main effect differences between the groups for P100, N100 and P300 components; ASD group children showing longer P100 latencies, weaker N100 amplitudes and larger P300 amplitudes than did the TD group. A Group x Hemisphere interaction also emerged for N400 amplitudes but differences were not significant in simple-effects analyses. Together these results suggested children with ASD may be characterized by lower attention resource allocation and engagement during early stages of processing visual stimuli. However, ERPs in later processing stages suggested children with ASD and TD children have similar neural responses in attending to visual images as stimulus presentations continue.	[Wang, Shanshan; Liu, Yijun; Jackson, Todd] Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Yang, Chunjuan; Shao, Zhi] Chongqing Ninth Peoples Hosp, Rehabil Ctr Children Autism, Chongqing, Peoples R China; [Jackson, Todd] Univ Macau, Dept Psychol, Macau, Peoples R China	Southwest University - China; University of Macau	Jackson, T (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Chongqing, Peoples R China.; Jackson, T (corresponding author), Univ Macau, Dept Psychol, Macau, Peoples R China.	toddjackson@hotmail.com			Chinese National Natural Science Foundation [31371037]; Chongqing 100 Persons Fellowship	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing 100 Persons Fellowship	This work was supported by grants from the Chinese National Natural Science Foundation (#31371037) and a Chongqing 100 Persons Fellowship. Professor Todd Jackson received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Azizian A, 2007, J COGNITIVE NEUROSCI, V19, P2071, DOI 10.1162/jocn.2007.19.12.2071; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Boyd BA, 2010, AUTISM RES, V3, P78, DOI 10.1002/aur.124; CELESIA GG, 1992, CURR OPIN NEUROL NEU, V5, P733; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Clery H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00062; Clery H, 2013, PSYCHOPHYSIOLOGY, V50, P240, DOI 10.1111/psyp.12006; Coles MGH, 1995, ELECTROPHYSIOLOGY MI, P40; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Frodl T, 2002, PSYCHOPHYSIOLOGY, V39, P175, DOI 10.1017/S0048577201392077; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; Gomot M, 2012, INT J PSYCHOPHYSIOL, V83, P240, DOI 10.1016/j.ijpsycho.2011.09.017; Gomot M, 2011, J AUTISM DEV DISORD, V41, P705, DOI 10.1007/s10803-010-1091-y; Hall GBC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010804; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Jeste SS, 2009, J AUTISM DEV DISORD, V39, P495, DOI 10.1007/s10803-008-0652-9; KARAYANIDIS F, 1995, PSYCHOPHYSIOLOGY, V32, P335, DOI 10.1111/j.1469-8986.1995.tb01216.x; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; Larson MJ, 2011, PSYCHIAT RES, V187, P198, DOI 10.1016/j.psychres.2010.11.006; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Marsh LE, 2011, NEUROIMAGE, V56, P1511, DOI 10.1016/j.neuroimage.2011.02.003; MCEVOY RE, 1993, J CHILD PSYCHOL PSYC, V34, P563, DOI 10.1111/j.1469-7610.1993.tb01036.x; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; NAATANEN R, 1995, EAR HEARING, V16, P6; Sokhadze E, 2009, APPL PSYCHOPHYS BIOF, V34, P37, DOI 10.1007/s10484-009-9074-5; Sokhadze Estate M, 2012, J Neurother, V16, P12; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Whitehouse AJO, 2006, J CHILD PSYCHOL PSYC, V47, P857, DOI 10.1111/j.1469-7610.2006.01624.x; Yamazaki T, 2000, BRAIN TOPOGR, V12, P159, DOI 10.1023/A:1023467806268	43	9	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178542	10.1371/journal.pone.0178542	http://dx.doi.org/10.1371/journal.pone.0178542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542618	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500088
J	Lima, GZDS; Lopes, SR; Prado, TL; Lobao-Soares, B; do Nascimento, GC; Fontenele-Araujo, J; Corso, G				dos Santos Lima, Gustavo Zampier; Lopes, Sergio Roberto; Prado, Thiago Lima; Lobao-Soares, Bruno; do Nascimento, George C.; Fontenele-Araujo, John; Corso, Gilberto			Predictability of arousal in mouse slow wave sleep by accelerometer data	PLOS ONE			English	Article							IRREGULAR ACTIVITY STATE; HYPOTHALAMIC REGULATION; WAKE TRANSITIONS; NREM SLEEP; DYNAMICS; RAT; EEG; STAGE	Arousals can be roughly characterized by punctual intrusions of wakefulness into sleep. In a standard perspective, using human electroencephalography (EEG) data, arousals are associated to slow-wave rhythms and K-complex brain activity. The physiological mechanisms that give rise to arousals during sleep are not yet fully understood. Moreover, subtle body movement patterns, which may characterize arousals both in human and in animals, are usually not detectable by eye perception and are not in general present in sleep studies. In this paper, we focus attention on accelerometer records (AR) to characterize and predict arousal during slow wave sleep (SWS) stage of mice. Furthermore, we recorded the local field potentials (LFP) from the CA1 region in the hippocampus and paired with accelerometer data. The hippocampus signal was also used here to identify the SWS stage. We analyzed the AR dynamics of consecutive arousals using recurrence technique and the determinism (DET) quantifier. Recurrence is a fundamental property of dynamical systems, which can be exploited to characterize time series properties. The DET index evaluates how similar are the evolution of close trajectories: in this sense, it computes how accurate are predictions based on past trajectories. For all analyzed mice in this work, we observed, for the first time, the occurrence of a universal dynamic pattern a few seconds that precedes the arousals during SWS sleep stage based only on the AR signal. The predictability success of an arousal using DET from AR is nearly 90%, while similar analysis using LFP of hippocampus brain region reveal 88% of success. Noteworthy, our findings suggest an unique dynamical behavior pattern preceding an arousal of AR data during sleep. Thus, the employment of this technique applied to AR data may provide useful information about the dynamics of neuronal activities that control sleep-waking switch during SWS sleep period. We argue that the predictability of arousals observed through DET(AR) can be functionally explained by a respiratory-driven modification of neural states. Finally, we believe that the method associating AR data with other physiologic events such as neural rhythms can become an accurate, convenient and non-invasive way of studying the physiology and physiopathology of movement and respiratory processes during sleep.	[dos Santos Lima, Gustavo Zampier] Univ Fed Rio Grande do Norte, Escola Ciencias & Tecnol, Natal, RN, Brazil; [dos Santos Lima, Gustavo Zampier; Lobao-Soares, Bruno; Corso, Gilberto] Univ Fed Rio Grande do Norte, Dept Biofis & Farmacol, BR-59078970 Natal, RN, Brazil; [Lopes, Sergio Roberto] Univ Fed Parana, Dept Fis, BR-81531980 Curitiba, Parana, Brazil; [do Nascimento, George C.] Univ Fed Rio Grande do Norte, Dept Engn Biomed, BR-59078970 Natal, RN, Brazil; [Prado, Thiago Lima] Brazilian Natl Inst Space Res, Associate Lab Comp & Appl Math, BR-12227010 Sao Jose Dos Campos, SP, Brazil; [Prado, Thiago Lima] Univ Fed Vales Jequitinhonha & Mucuri, Inst Engn Ciencia & Tecnol, BR-39440000 Janauba, MG, Brazil; [Fontenele-Araujo, John] Univ Fed Rio Grande do Norte, Dept Fisiol, BR-59056450 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Parana; Universidade Federal do Rio Grande do Norte; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal do Rio Grande do Norte	Lobao-Soares, B (corresponding author), Univ Fed Rio Grande do Norte, Dept Biofis & Farmacol, BR-59078970 Natal, RN, Brazil.; Lopes, SR (corresponding author), Univ Fed Parana, Dept Fis, BR-81531980 Curitiba, Parana, Brazil.	lopes@fisica.ufpr.br; brunolobaosoare@gmail.com	Prado, Thiago de Lima/I-2956-2017; Corso, Gilberto/G-6160-2012; Corso, Gilberto/AAE-9056-2021; Soares, Bruno L/N-1142-2018; dos Santos Lima, Gustavo Zampier/S-6984-2019; Araujo, John F/A-6345-2010; Lopes, Sergio Roberto/I-8967-2012	Prado, Thiago de Lima/0000-0001-6897-3034; Corso, Gilberto/0000-0003-1748-4040; Corso, Gilberto/0000-0003-1748-4040; Soares, Bruno L/0000-0003-4564-2288; dos Santos Lima, Gustavo Zampier/0000-0002-4462-0522; Araujo, John F/0000-0002-8022-2425; Lopes, Sergio Roberto/0000-0002-7049-4902	Capes [11264/13-6]; CNPq [552148/2011-3, 470716/2013-4, 307149/2013-7, 484408/2013-5]; FlNEP-CT-INFRA; FINEP [01.06.1092.00]; FAPESP post-doc [2015/23487-8]	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FlNEP-CT-INFRA; FINEP(Financiadora de Inovacao e Pesquisa (Finep)); FAPESP post-doc	This work has been supported by Capes: 11264/13-6, http.//www.capes.gov.br/; CNPq: 552148/2011-3, http.//cnpq.bri; CNPq: 470716/2013-4, http://cnpq.br/; CNPq: 307149/2013-7, http://cnpq.br/; FlNEP-CT-INFRA, http://www.finep.gov.br/a-finep-externo/fontes-de-recurso/fundos-setoriais/quais/sao-os-fundos-setoriais/ct-infra; CNPq: 484408/2013-5, http://cnpq.br/; and FINEP; 01.06.1092.00, http://www.finep.gov.br/.; This work has financial support from CNPq (Grants 552148/2011-3, 470716/2013-4), CAPES (Grant: BEX: 11264/13-6) and FINEP(CT-Infra) (Brazilian agencies). FAPESP post-doc for financial support (2015/23487-8). We would also like to thank Neuroscience Institute of Natal (IINN-ELS) allowing data collection in their laboratories and Miguel Nicolelis and Sidarta Ribeiro for the kind support.	Al-Mardini M, 2014, J BIOMED INFORM, V52, P251, DOI 10.1016/j.jbi.2014.07.004; Anna Hudson L., 2016, J NEUROPHYSIOL, V115, P2214; Atlas Task Force, 1992, ATLAS TASK FORCE AM, V15, P174; Bartscha R. P., 2012, PNAS, V09, P10181; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; BERGMANN BM, 1987, SLEEP, V10, P1; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Bruce EN, 2011, NEUROSCIENCE, V175, P184, DOI 10.1016/j.neuroscience.2010.11.036; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; dos Santos Lima G. Z., 2014, PLOSONE, V9; Douglas NJ, 2005, PRINCIPLES PRACTICE; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Garcia A. J., 2002, J NEUROSCI, V30, P8251; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Halasz P., 2004, J SLEEP RES, V13, P1; Ivanov PC, 2007, IEEE ENG MED BIOL, V26, P33, DOI 10.1109/MEMB.2007.907093; Jarosiewicz B, 2004, J NEUROPHYSIOL, V91, P2649, DOI 10.1152/jn.01082.2003; Jarosiewicz B, 2002, J NEUROSCI, V22, P1373, DOI 10.1523/JNEUROSCI.22-04-01373.2002; Kantelhardt JW, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051908; Kantelhardt JW, 2003, EUROPHYS LETT, V62, P147, DOI 10.1209/epl/i2003-00332-7; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Lo CC, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/10008; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; Peter-Derex L, 2015, NEUROIMAGE, V123, P229, DOI 10.1016/j.neuroimage.2015.07.057; Peters O, 2006, NAT PHYS, V2, P393, DOI 10.1038/nphys314; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Shneerson J., 2005, SLEEP MED GUIDE SLEE; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Talkner P, 2000, PHYS REV E, V62, P150, DOI 10.1103/PhysRevE.62.150; TERZANO MG, 1985, SLEEP, V8, P137, DOI 10.1093/sleep/8.2.137; Wu HT, 2015, IEEE T BIO-MED ENG, V62, P1159, DOI 10.1109/TBME.2014.2375292; Zheng J., 2016, J MED ENG PHYS, V8, P671	37	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176761	10.1371/journal.pone.0176761	http://dx.doi.org/10.1371/journal.pone.0176761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545123	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400013
J	Baczyk, D; Audette, MC; Drewlo, S; Levytska, K; Kingdom, JC				Baczyk, Dora; Audette, Melanie C.; Drewlo, Sascha; Levytska, Khrystyna; Kingdom, John C.			SUMO-4: A novel functional candidate in the human placental protein SUMOylation machinery	PLOS ONE			English	Article							GROWTH-FACTOR; STRESS; TRANSCRIPTION; PREECLAMPSIA; EXPRESSION; CELLS; SENP3	Background Small ubiquitin-like modifiers (SUMOs) conjugate to proteins post-translationally, thereby affecting target localization, activity and stability. Functional SUMO family members identified in the human placenta include SUMO-1 to SUMO-3, which are elevated in pre-eclampsia. Whether the fourth isoform, SUMO-4, plays a role in placental development and function remains unknown. Objectives We tested the hypothesis that SUMO-4 is expressed in the human placenta and demonstrates altered SUMOylation in pre-eclamptic pregnancies. Methods SUMO-4 mRNA (qRT-PCR) and protein (Western blot and immunohistochemistry) were measured in Jar cells, BeWo cells, first trimester placental villous explants and placental tissues across normal gestation and in pre-eclampsia. SUMO-4 expression in response to oxidative stress (H2O2: 0, 0.1, 1 and 5mM), as well as, hypoxia-reperfusion (O-2: 1%, 8% and 20%) was measured. Lastly, SUMO-4 binding (covalently vs. non-covalently) to target proteins was investigated. Results SUMO-4 mRNA and protein were unchanged across gestation. SUMO-4 was present in the villous trophoblast layer throughout gestation. SUMO-4 mRNA expression and protein levels were increased similar to 2.2-fold and similar to 1.8-fold in pre-eclamptic placentas compared to age-matched controls, respectively (p<0.01). SUMO-4 mRNA and protein expression increased in Jars, BeWos and first trimester placental explants with 5mM H2O2 treatment, as well as with exposure to hypoxia-reperfusion. SUMO-1 to SUMO-3 did not show consistent trends across models. SUMO-4 hyper-SUMOylation was predominantly covalent in nature. Conclusions SUMO-4 is expressed in normal placental development. SUMO-4 expression was increased in pre-eclamptic placentas and in models of oxidative stress and hypoxic injury. These data suggests that SUMO-4 hyper-SUMOylation may be a potential post-translational mechanism in the stressed pre-eclamptic placenta.	[Baczyk, Dora; Audette, Melanie C.; Levytska, Khrystyna; Kingdom, John C.] Mt Sinai Hosp, Program Dev & Fetal Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Audette, Melanie C.; Kingdom, John C.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Drewlo, Sascha; Levytska, Khrystyna] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Kingdom, John C.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kingdom, John C.] Mt Sinai Hosp, Maternal Fetal Med Div, Dept Obstet & Gynecol, Toronto, ON, Canada; [Kingdom, John C.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Wayne State University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Audette, MC (corresponding author), Mt Sinai Hosp, Program Dev & Fetal Hlth, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.; Audette, MC (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.	m.audette@mail.utoronto.ca	Drewlo, Sascha/AAS-9890-2020; Kingdom, John/A-3247-2013; Kingdom, John/AAF-2145-2020		Rose Torno Chair; CIHR from Mount Sinai Hospital [643020]	Rose Torno Chair; CIHR from Mount Sinai Hospital	This work was funded by Funded by the Rose Torno Chair and CIHR grant (643020) to J.C.K from Mount Sinai Hospital. The funding sources had no involvement in study design, analysis, interpretation, review, or approval of this manuscript.	Baczyk D, 2013, PLACENTA, V34, P606, DOI 10.1016/j.placenta.2013.03.012; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baczyk D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051837; Bhattacharjee J, 2016, PLACENTA, V40, P8, DOI 10.1016/j.placenta.2016.02.002; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen SJ, 2014, INFLAMM RES, V63, P23, DOI 10.1007/s00011-013-0675-3; Chiu SY, 2008, PLOS BIOL, V6, P2801, DOI 10.1371/journal.pbio.0060310; Chou CC, 2007, J BIOL CHEM, V282, P27239, DOI 10.1074/jbc.M700351200; Czikk MJ, 2013, PLACENTA, V34, P174, DOI 10.1016/j.placenta.2012.11.029; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; Levytska K, 2014, PPAR RES, V2014, DOI 10.1155/2014/637251; Ma C, 2014, MAGN RESON IMAGING, V32, P125, DOI 10.1016/j.mri.2013.10.005; Mizuuchi M, 2016, J PATHOL, V238, P550, DOI 10.1002/path.4678; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Palczewska M, 2011, BBA-MOL CELL RES, V1813, P1050, DOI 10.1016/j.bbamcr.2010.11.001; Roberge S, 2016, CLIN LAB MED, V36, P319, DOI 10.1016/j.cll.2016.01.013; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Said JM, 2010, OBSTET GYNECOL, V115, P5, DOI 10.1097/AOG.0b013e3181c68907; Scioscia Marco, 2011, Pregnancy Hypertens, V1, P247, DOI 10.1016/j.preghy.2011.08.016; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Walker MG, 2012, PLACENTA, V33, P568, DOI 10.1016/j.placenta.2012.03.011; Wang CY, 2008, DIABETES-METAB RES, V24, P93, DOI 10.1002/dmrr.797; Wang LL, 2014, EMBO REP, V15, P878, DOI 10.15252/embr.201438534; Wei WZ, 2008, BIOCHEM BIOPH RES CO, V375, P454, DOI 10.1016/j.bbrc.2008.08.028; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6	35	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0178056	10.1371/journal.pone.0178056	http://dx.doi.org/10.1371/journal.pone.0178056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545138	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700104
J	Araujo, T; Aresta, G; Castro, E; Rouco, J; Aguiar, P; Eloy, C; Polonia, A; Campilho, A				Araujo, Teresa; Aresta, Guilherme; Castro, Eduardo; Rouco, Jose; Aguiar, Paulo; Eloy, Catarina; Polonia, Antonio; Campilho, Aurelio			Classification of breast cancer histology images using Convolutional Neural Networks	PLOS ONE			English	Article							DIAGNOSIS	Breast cancer is one of the main causes of cancer death worldwide. The diagnosis of biopsy tissue with hematoxylin and eosin stained images is non-trivial and specialists often disagree on the final diagnosis. Computer-aided Diagnosis systems contribute to reduce the cost and increase the efficiency of this process. Conventional classification approaches rely on feature extraction methods designed for a specific problem based on field-knowledge. To overcome the many difficulties of the feature-based approaches, deep learning methods are becoming important alternatives. A method for the classification of hematoxylin and eosin stained breast biopsy images using Convolutional Neural Networks (CNNs) is proposed. Images are classified in four classes, normal tissue, benign lesion, in situ carcinoma and invasive carcinoma, and in two classes, carcinoma and non-carcinoma. The architecture of the network is designed to retrieve information at different scales, including both nuclei and overall tissue organization. This design allows the extension of the proposed system to whole-slide histology images. The features extracted by the CNN are also used for training a Support Vector Machine classifier. Accuracies of 77.8% for four class and 83.3% for carcinoma/non-carcinoma are achieved. The sensitivity of our method for cancer cases is 95.6%.	[Araujo, Teresa; Aresta, Guilherme; Castro, Eduardo; Campilho, Aurelio] FEUP, R Dr Roberto Frias S-N, P-4200465 Oporto, Portugal; [Araujo, Teresa; Aresta, Guilherme; Rouco, Jose; Campilho, Aurelio] Inst Engn Sistemas & Computadores Tecnol & Cienci, R Dr Roberto Frias, P-4200 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Aguiar, Paulo] Univ Porto, Inst Engn Biomed INEB, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Eloy, Catarina; Polonia, Antonio] Ipatimup Diagnost, Lab Anat Patol, Rua Julio Amaral Carvalho 45, P-4200135 Oporto, Portugal; [Eloy, Catarina; Polonia, Antonio] Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Oporto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Araujo, T (corresponding author), FEUP, R Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.; Araujo, T (corresponding author), Inst Engn Sistemas & Computadores Tecnol & Cienci, R Dr Roberto Frias, P-4200 Oporto, Portugal.	tfaraujo@inesctec.pt	DE CASTRO ROQUE, EDUARDO ALBERTO/AAA-6271-2019; Rouco, J./A-7255-2011; Aguiar, Paulo/AAD-2462-2020; Castro, Eduardo Meca/AAK-9754-2020; Araújo, Teresa/F-5629-2016; Eloy, Catarina/J-8937-2013; Campilho, Aurelio/M-4869-2013	Rouco, J./0000-0003-4407-9091; Aguiar, Paulo/0000-0003-4164-5713; Castro, Eduardo Meca/0000-0003-4144-695X; Araújo, Teresa/0000-0001-9687-528X; Polonia, Antonio/0000-0001-8312-1681; Aresta, Guilherme/0000-0002-4225-2156; Eloy, Catarina/0000-0001-7642-1280; Campilho, Aurelio/0000-0002-5317-6275	North Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement [NORTE-01-0145-FEDER-000016]; European Regional Development Fund (ERDF); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/122365/2016, SFRH/BD/120435/2016, SFRH/BPD/79154/2011]	North Portugal Regional Operational Programme (NORTE), under the PORTUGAL Partnership Agreement; European Regional Development Fund (ERDF)(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Project "NanoSTIMA: Macro-to-Nano Human Sensing: Towards Integrated Multimodal Health Monitoring and Analytics/NORTE-01-0145-FEDER-000016" is financed by the North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). Teresa Araujo is funded by the grant contract SFRH/BD/122365/2016 (Fundacao para a Ciencia e a Tecnologia). Guilherme Aresta is funded by the grant contract SFRH/BD/120435/2016 (Fundacao para a Ciencia e a Tecnologia). Jose Rouco is funded by the grant contract SFRH/BPD/79154/2011 (Fundacao para a Cienciae a Tecnologia).	Bailing Zhang, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P180, DOI 10.1109/BMEI.2011.6098229; Belsare AD, 2015, TENCON IEEE REGION; Brook A, 2007, BREAST CANC DIAGNOSI, P1; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Cruz-Roa A, 2014, PROC SPIE, V9041, DOI 10.1117/12.2043872; ELMORE JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI DOI 10.1001/JAMA.2015.1405; Elston C W, 2002, Histopathology, V41, P154; Filipczuk P, 2013, IEEE T MED IMAGING, V32, P2169, DOI 10.1109/TMI.2013.2275151; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; George YM, 2014, IEEE SYST J, V8, P949, DOI 10.1109/JSYST.2013.2279415; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Kowal M, 2013, COMPUT BIOL MED, V43, P1563, DOI 10.1016/j.compbiomed.2013.08.003; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Macenko M, 2009, I S BIOMED IMAGING, P1107, DOI 10.1109/ISBI.2009.5193250; Nair V., 2010, P 27 INT C INT C MAC, P807; NationalBreastCancerFoundation, 2015, BREAST CANC DIAGN; Pego A, 2015, BIOIMAGING; Rosen PP., 2001, LWW DOODYS ALL REVIE; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; Spanhol FA, 2016, IEEE IJCNN, P2560, DOI 10.1109/IJCNN.2016.7727519; Tang JS, 2009, IEEE T INF TECHNOL B, V13, P236, DOI 10.1109/TITB.2008.2009441; Van Der Maaten L. J. P., 2008, J MACH LEARN RES, V9, P2579; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Zeiler M. D., 2012, ARXIV 12125701, V1212.5701	28	394	406	11	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177544	10.1371/journal.pone.0177544	http://dx.doi.org/10.1371/journal.pone.0177544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570557	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800012
J	Cook, JR; Chatfield, S; Chandiramani, M; Kindinger, L; Cacciatore, S; Sykes, L; Teoh, T; Shennan, A; Terzidou, V; Bennett, PR				Cook, Joanna R.; Chatfield, Susan; Chandiramani, Manju; Kindinger, Lindsay; Cacciatore, Stefano; Sykes, Lynne; Teoh, Tiong; Shennan, Andrew; Terzidou, Vasso; Bennett, Phillip R.			Cerclage position, cervical length and preterm delivery in women undergoing ultrasound indicated cervical cerclage: A retrospective cohort study	PLOS ONE			English	Article							BIRTH; SONOGRAPHY; LABOR	Objective The objectives were to assess whether anatomical location of ultrasound (USS) indicated cervical cerclage and/or the degree of cervical shortening (cervical length; CL) prior to and following cerclage affects the risk of preterm birth (PTB). Method A retrospective cohort study of 179 women receiving cerclage for short cervix (<= 25mm) was performed. Demographic data, CL before and after cerclage insertion, height of cerclage (distance from external os) and gestation at delivery were collected. Relative risk (RR) and odds ratio (OR) of preterm delivery were calculated according to the anatomical location of the cerclage within the cervix and the CL before and after cerclage as categorical and continuous variables. Partition tree analysis was used to identify the threshold cerclage height that best predicts PTB. Results 25% (n = 45) delivered < 34 weeks and 36% (n = 65) delivered < 37 weeks. Risk of PTB was greater with cerclage in the distal 10mm (RR2.37, 95% CI 1.45-3.87) or the distal half of a closed cervix (RR2.16, 95% CI 1.45-3.87). Increasing absolute cerclage height was associated with a reduction in PTB (OR 0.87, 95% CI 0.82-0.94). A cerclage height < 14.5 mm best predicts PTB (70.8%). Increasing CL following cerclage was associated with a reduction in PTB (OR0.87, 95% CI 0.82-0.94). Conversely, the risk of PTB was increased where CL remained static or shortened further following cerclage (RR2.34, 95% CI 1.04-5.25). Conclusion The higher a cerclage was placed within a shortened cervix, the lower the subsequent odds of PTB. Women whose cerclage is placed in the distal 10mm of closed cervix or whose cervix fails to elongate subsequently, should remain under close surveillance as they have the highest risk of PTB.	[Cook, Joanna R.; Chatfield, Susan; Chandiramani, Manju; Kindinger, Lindsay; Cacciatore, Stefano; Sykes, Lynne; Teoh, Tiong; Terzidou, Vasso; Bennett, Phillip R.] Imperial Coll London, Parturit Res Grp, Inst Reprod & Dev Biol, Hammersmith Hosp Campus,Du Cane Rd, London, England; [Chandiramani, Manju; Shennan, Andrew] Kings Coll London, Womens Hlth Acad Ctr, Kings Hlth Partners, St Thomas Hosp Campus,Westminster Bridge Rd, London, England	Imperial College London; University of London; King's College London	Terzidou, V (corresponding author), Imperial Coll London, Parturit Res Grp, Inst Reprod & Dev Biol, Hammersmith Hosp Campus,Du Cane Rd, London, England.	v.terzidou@imperial.ac.uk		Cook, Joanna/0000-0001-6013-9651; Bennett, Phillip/0000-0002-6253-4919; Shennan, Andrew/0000-0001-5273-3132; Sykes, Lynne/0000-0002-7806-5707; Cacciatore, Stefano/0000-0001-7052-7156	Imperial Healthcare Trust NIHR Biomedical Research Centre; Action Medical Research [GN2248]; Academy of Medical Sciences (AMS) [SGL016\\1089] Funding Source: researchfish; National Institute for Health Research [ACF-2011-21-020, CL-2006-21-011, CL-2015-21-005] Funding Source: researchfish; Action Medical Research [2248] Funding Source: researchfish	Imperial Healthcare Trust NIHR Biomedical Research Centre; Action Medical Research; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); Action Medical Research	This study was supported by the Imperial Healthcare Trust NIHR Biomedical Research Centre. JRC was supported by a research training fellowship from Action Medical Research (GN2248) to JRC. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi-Isama L, 2012, EUR J OBSTET GYN R B, V165, P235, DOI 10.1016/j.ejogrb.2012.09.005; Berghella V, 2005, OBSTET GYN CLIN N AM, V32, P383, DOI 10.1016/j.ogc.2005.04.007; Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1311, DOI 10.1016/j.ajog.2004.06.054; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Breiman L., 1984, CLASSIFICATION REGRE; Fick AL, 2007, J MATERN-FETAL NEO M, V20, P63, DOI 10.1080/14767050601059156; Guzman ER, 1996, AM J OBSTET GYNECOL, V175, P471, DOI 10.1016/S0002-9378(96)70164-3; MCDONALD IA, 1957, J OBSTET GYNAECOL, V64, P346; Mella MT, 2009, SEMIN PERINATOL, V33, P317, DOI 10.1053/j.semperi.2009.06.007; Miroshnichenko G, 2011, AM J PERINAT, V28, P83, DOI 10.1055/s-0030-1262908; Reinhard J, 2012, J PERINAT MED, V40, P551, DOI 10.1515/jpm-2011-0267; Rust OA, 2003, AM J OBSTET GYNECOL, V189, P1688, DOI 10.1016/S0002-9378(03)00779-8; Scheib S, 2009, AM J OBSTET GYNECOL, V200, pE12, DOI 10.1016/j.ajog.2008.09.021; Shennan Andrew, 2004, Semin Fetal Neonatal Med, V9, P471, DOI 10.1016/j.siny.2004.09.001; To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4	16	12	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178072	10.1371/journal.pone.0178072	http://dx.doi.org/10.1371/journal.pone.0178072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570639	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800024
J	Haile, S; Pandoh, P; McDonald, H; Corbett, RD; Tsao, P; Kirk, H; MacLeod, T; Jones, M; Bilobram, S; Brooks, D; Smailus, D; Steidl, C; Scott, DW; Bala, M; Hirst, M; Miller, D; Moore, RA; Mungall, AJ; Coope, RJ; Ma, Y; Zhao, YJ; Holt, RA; Jones, SJ; Marra, MA				Haile, Simon; Pandoh, Pawan; McDonald, Helen; Corbett, Richard D.; Tsao, Philip; Kirk, Heather; MacLeod, Tina; Jones, Martin; Bilobram, Steve; Brooks, Denise; Smailus, Duane; Steidl, Christian; Scott, David W.; Bala, Miruna; Hirst, Martin; Miller, Diane; Moore, Richard A.; Mungall, Andrew J.; Coope, Robin J.; Ma, Yussanne; Zhao, Yongjun; Holt, Rob A.; Jones, Steven J.; Marra, Marco A.			Automated high throughput nucleic acid purification from formalin-fixed paraffin-embedded tissue samples for next generation sequence analysis	PLOS ONE			English	Article							RIBONUCLEIC-ACID; MESSENGER-RNA; EXTRACTION; ACCURATE; DNA; MICROARRAY	Curation and storage of formalin-fixed, paraffin-embedded (FFPE) samples are standard procedures in hospital pathology laboratories around the world. Many thousands of such samples exist and could be used for next generation sequencing analysis. Retrospective analyses of such samples are important for identifying molecular correlates of carcinogenesis, treatment history and disease outcomes. Two major hurdles in using FFPE material for sequencing are the damaged nature of the nucleic acids and the labor-intensive nature of nucleic acid purification. These limitations and a number of other issues that span multiple steps from nucleic acid purification to library construction are addressed here. We optimized and automated a 96-well magnetic bead-based extraction protocol that can be scaled to large cohorts and is compatible with automation. Using sets of 32 and 91 individual FFPE samples respectively, we generated libraries from 100 ng of total RNA and DNA starting amounts with 95-100% success rate. The use of the resulting RNA in micro-RNA sequencing was also demonstrated. In addition to offering the potential of scalability and rapid throughput, the yield obtained with lower input requirements makes these methods applicable to clinical samples where tissue abundance is limiting.	[Haile, Simon; Pandoh, Pawan; McDonald, Helen; Corbett, Richard D.; Tsao, Philip; Kirk, Heather; MacLeod, Tina; Jones, Martin; Bilobram, Steve; Brooks, Denise; Smailus, Duane; Bala, Miruna; Hirst, Martin; Miller, Diane; Moore, Richard A.; Mungall, Andrew J.; Coope, Robin J.; Ma, Yussanne; Zhao, Yongjun; Holt, Rob A.; Jones, Steven J.; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Steidl, Christian; Scott, David W.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Marra, MA (corresponding author), BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada.; Marra, MA (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	mmarra@bcgsc.ca	Marra, Marco A/B-5987-2008; Mungall, Andrew J./U-7067-2018; Jones, Steven J/C-3621-2009; Holt, Robert A/C-3303-2009	Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247	BC Cancer Foundation; Genome Canada/Genome British Columbia [212SEQ/202SEQ]; Canadian Institutes of Health Research [FDN-143288]	BC Cancer Foundation; Genome Canada/Genome British Columbia(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the BC Cancer Foundation, and grants from Genome Canada/Genome British Columbia (Grant# 212SEQ/202SEQ), and the Canadian Institutes of Health Research (FDN-143288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; [Anonymous], 2011, NAT METHODS; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Butterfield YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102398; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Fedorowicz G, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-23; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Hosein A, 2012, HEREDITARY CANC C S2, V10, pA85; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kakimoto Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163125; Kasaian K, 2013, J PATHOL, V230, P249, DOI 10.1002/path.4203; Khokhar SK, 2012, CLIN CHEM LAB MED, V50, P267, DOI 10.1515/CCLM.2011.763; Kocjan BJ, 2015, ACTA DERMATOVEN ALP, V24, P47, DOI 10.15570/actaapa.2015.12; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y; LUCAS MC, 1977, J BACTERIOL, V130, P1192, DOI 10.1128/JB.130.3.1192-1198.1977; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Mouttham N, 2015, BIOTECHNIQUES, V59, P19, DOI 10.2144/000114307; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; STURANI E, 1979, EUR J BIOCHEM, V99, P1, DOI 10.1111/j.1432-1033.1979.tb13224.x; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419	26	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178706	10.1371/journal.pone.0178706	http://dx.doi.org/10.1371/journal.pone.0178706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570594	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800108
J	Kaan, HYK; Sim, AYL; Tan, SKJ; Verma, C; Song, HW				Kaan, Hung Yi Kristal; Sim, Adelene Y. L.; Tan, Siew Kim Joyce; Verma, Chandra; Song, Haiwei			Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HIPPO SIGNALING PATHWAY; CELL-PROLIFERATION; DRUG DISCOVERY; YAP; TRANSCRIPTION; TAZ; DESIGN; LOCALIZATION; FLEXIBILITY	The Hippo signaling pathway, which is implicated in the regulation of organ size, has emerged as a potential target for the development of cancer therapeutics. YAP, TAZ (transcription co-activators) and TEAD (transcription factor) are the downstream transcriptional machinery and effectors of the pathway. Formation of the YAP/TAZ-TEAD complex leads to transcription of growth-promoting genes. Conversely, disrupting the interactions of the complex decreases cell proliferation. Herein, we screened a 1000-member fragment library using Thermal Shift Assay and identified a hit fragment. We confirmed its binding at the YAP/TAZ-TEAD interface by X-ray crystallography, and showed that it occupies the same hydrophobic pocket as a conserved phenylalanine of YAP/TAZ. This hit fragment serves as a scaffold for the development of compounds that have the potential to disrupt YAP/TAZ-TEAD interactions. Structure-activity relationship studies and computational modeling were also carried out to identify more potent compounds that may bind at this validated druggable binding site.	[Kaan, Hung Yi Kristal; Tan, Siew Kim Joyce; Song, Haiwei] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore, Singapore; [Sim, Adelene Y. L.; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore, Singapore; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore, Singapore; [Song, Haiwei] Natl Univ Singapore, Dept Biochem, 14 Sci Dr, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Song, HW (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore, Singapore.; Verma, C (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.; Verma, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore, Singapore.; Verma, C (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore, Singapore.; Song, HW (corresponding author), Natl Univ Singapore, Dept Biochem, 14 Sci Dr, Singapore, Singapore.	chandra@bii.a-star.edu.sg; haiwei@imcb.a-star.edu.sg		song, haiwei/0000-0001-6398-9280	BMRC Young Investigator Grant [1310151003]; Agency for Science, Technology, and Research in Singapore; NMRC Open Fund Individual Research (OF-IRG) in Singapore [NMRC/OFIRG/0024/2016]; NSRRC [BL13B1]	BMRC Young Investigator Grant; Agency for Science, Technology, and Research in Singapore(Agency for Science Technology & Research (A*STAR)); NMRC Open Fund Individual Research (OF-IRG) in Singapore; NSRRC	This work is financially supported by the 2013 BMRC Young Investigator Grant (No.: 1310151003) awarded by the Agency for Science, Technology, and Research in Singapore to HYKK, and NMRC Open Fund Individual Research (OF-IRG) Grant (No: NMRC/OFIRG/0024/2016) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jean, Yuch-Cheng and other beamline scientists for their support at the NSRRC beamline BL13B1. We also thank Yaw Sing Tan for help setting up the ligand-mapping simulations and the Verma lab for useful discussions. This work is financially supported by the 2013 BMRC Young Investigator Grant (No.: 1310151003), and NMRC Open Fund Individual Research (OF-IRG) Grant (No: NMRC/OFIRG/0024/2016) in Singapore.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakan A, 2012, J CHEM THEORY COMPUT, V8, P2435, DOI 10.1021/ct300117j; Bock JE, 2013, ACS CHEM BIOL, V8, P488, DOI 10.1021/cb300515u; Case D., 2015, AMBER, V14; Chan P, 2016, NAT CHEM BIOL, V12, P282, DOI [10.1038/nchembio.2036, 10.1038/NCHEMBIO.2036]; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Durrant JD, 2009, CHEM BIOL DRUG DES, V73, P168, DOI 10.1111/j.1747-0285.2008.00761.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Hall DR, 2015, TRENDS PHARMACOL SCI, V36, P724, DOI 10.1016/j.tips.2015.08.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hoffer L, 2013, J CHEM INF MODEL, V53, P836, DOI 10.1021/ci4000163; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knight JF, 2008, BRIT J CANCER, V99, P1849, DOI 10.1038/sj.bjc.6604774; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lexa KW, 2011, J AM CHEM SOC, V133, P200, DOI 10.1021/ja1079332; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Noland CL, 2016, STRUCTURE, V24, P179, DOI 10.1016/j.str.2015.11.005; Oku Y, 2015, FEBS OPEN BIO, V5, P542, DOI 10.1016/j.fob.2015.06.007; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pobbati AV, 2015, STRUCTURE, V23, P2076, DOI 10.1016/j.str.2015.09.009; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Reddy BVVG, 2013, DEV CELL, V24, P459, DOI 10.1016/j.devcel.2013.01.020; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Schrodinger LLC, 2010, THE PYMOL MOLECULAR; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Tan YS, 2015, J CHEM THEORY COMPUT, V11, P3199, DOI 10.1021/ct5010577; Tan YS, 2012, ANGEW CHEM INT EDIT, V51, P10078, DOI 10.1002/anie.201205676; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Wang CY, 2015, ONCOTARGET, V6, P17685, DOI 10.18632/oncotarget.3779; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu W, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-7; Yang CY, 2011, ACS MED CHEM LETT, V2, P280, DOI 10.1021/ml100276b; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang ZZ, 2014, ACS MED CHEM LETT, V5, P993, DOI 10.1021/ml500160m; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao YL, 2014, CANCER RES, V74, P4493, DOI 10.1158/0008-5472.CAN-13-2712; Zhou Z, 2015, FASEB J, V29, P724, DOI 10.1096/fj.14-262980; Zhu M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811831	77	22	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178381	10.1371/journal.pone.0178381	http://dx.doi.org/10.1371/journal.pone.0178381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570566	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800044
J	Tonelli, GB; Tanure, A; Rego, FD; Carvalho, GMD; Simoes, TC; Andrade, JD				Tonelli, Gabriel Barbosa; Tanure, Aline; Rego, Felipe Dutra; de Lima Carvalho, Gustavo Mayr; Simoes, Taynana Cesar; Andrade Filho, Jose Dilermando			Aspects of the ecology of phlebotomine sand flies (Diptera: Psychodidae) in the Private Natural Heritage Reserve Sanctuary Caraca	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; IBITIPOCA STATE-PARK; GROSSO-DO-SUL; CUTANEOUS LEISHMANIASIS; MINAS-GERAIS; LUTZOMYIA-LONGIPALPIS; MATO-GROSSO; ENDEMIC AREA; BRAZIL; VECTOR	Leishmaniases are a set of parasitic diseases of zoonotic origin that are transmitted by sandfly vectors in wild, rural and urban environments. Their distribution is dependent not only the distribution of vectors, but also on the distribution of mammalian reservoirs. Only by understanding the transmission cycle of these diseases, such as knowing the participating vectors and reservoirs, can one can understand the epidemiology and ecological relationships of leishmaniases. Ecotourism has become an important area of economic growth in Brazil. One of the most visited tourist attractions in the state of Minas Gerais, the Reserva Particular do Patrimonio Natural Santuario do Caraca (RPPNSC) is located in the Quadrilatero Ferrifero. The aim of this study was to contribute to the control of leishmaniasis among tourists of the RPPNPC by surveying its sand fly fauna and testing for the presence of Leishmania DNA in females. Twenty-five CDC light traps were exposed on 7 trails of the RPPNPC where samples were collected bimonthly for a year, starting in June 2013. A total of 376 specimens of 18 species and 10 genera of sandflies were captured. The predominant species were Psychodopygus lloydi (72.34%) and Pintomyia monticola (5.59%). HaeIII restriction enzyme detected and characterized Leishmania braziliensis DNA in 2 of the samples for an infection rate of 0.7% (2/266). Recent studies found specimens of Ps. lloyd infected with Leishmania braziliensis elsewhere in Minas Gerais, which may be an indication that this species is involved in the transmission of Leishmania in this state.	[Tonelli, Gabriel Barbosa; Tanure, Aline; Rego, Felipe Dutra; de Lima Carvalho, Gustavo Mayr; Andrade Filho, Jose Dilermando] Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil; [Simoes, Taynana Cesar] Fiocruz MS, Pesquisa Clin & Polit Publ Doencas Infecciosas &, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Andrade, JD (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil.	jandrade@cpqrr.fiocruz.br	Rêgo, Felipe Dutra/S-6013-2017; Andrade Filho, José Dilermando/B-7852-2013; Rego, Felipe Dutra/V-4646-2019; Simões, Taynãna César/ABE-8964-2021	Rêgo, Felipe Dutra/0000-0002-2799-8267; Andrade Filho, José Dilermando/0000-0002-9754-8464; Rego, Felipe Dutra/0000-0002-2799-8267; Barbosa Tonelli, Gabriel/0000-0002-8415-3199	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG [RDP-00149-10, PPM-00438-14]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq [301421/2013-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq [301421/2013-7]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We would like to thank all collaborators for their work and also to those responsible for RPPN Santuario do Caraca as well as their employees and friends won for giving us support. We thank Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (RDP-00149-10 and PPM-00438-14) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq (301421/2013-7) for the awarded grant.; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/FAPEMIG (RDP-00149-10 and PPM-00438-14). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (301421/2013-7).	Felipe IMA, 2011, MEM I OSWALDO CRUZ, V106, P207, DOI 10.1590/S0074-02762011000200015; Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; Andrade MS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004137; Andrade-F. Jose D., 1997, Anais da Sociedade Entomologica do Brasil, V26, P403, DOI 10.1590/S0301-80591997000200027; Antinori S, 2005, CLIN MICROBIOL INFEC, V11, P343, DOI 10.1111/j.1469-0691.2004.01046.x; Silva EAE, 2007, REV SOC BRAS MED TRO, V40, P420, DOI 10.1590/S0037-86822007000400010; ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; AZEVEDO ACR, 1991, MEM I OSWALDO CRUZ, V86, P405, DOI 10.1590/S0074-02761991000400005; Bafica ALB, 2003, INFECT DIS SOC AM; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; Brazil Reginaldo Pecanha and Brazil Beatriz Gomes, 2003, BIOL FLEB NEOTR, P257; Campos AM, 2013, J MED ENTOMOL, V50, P52, DOI 10.1603/ME12074; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cunha A. M., 1937, O HOSP, V11, P3; Mestre GLD, 2011, REV BRAS PARASITOL V, V20, P228; Carvalho GMD, 2011, J MED ENTOMOL, V48, P764, DOI 10.1603/ME10258; Deane L. d. M., 1956, THESIS; DEQUEIROZ RG, 1994, AM J TROP MED HYG, V50, P693, DOI 10.4269/ajtmh.1994.50.693; Nascimento João Cezar do, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P119, DOI 10.1590/S0036-46652007000200011; dos Santos DR, 2007, REV BRAS ENTOMOL, V51, P524, DOI 10.1590/S0085-56262007000400021; Ferreira ED, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0392-y; Forattini OP., 1973, ENTOMOLOGIA MED, V4; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Gomes AC, 1998, REV SOC BRAS MED TRO, V31, P549; Gontijo CMF, 2002, ACTA TROP, V81, P143, DOI 10.1016/S0001-706X(01)00205-4; Hayeck L. A. C., 1997, SURVEYING NATURAL PO, P347; HOCH A, 1986, Memorias do Instituto Oswaldo Cruz, V81, P62; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; KILLICKKENDRICK R, 1981, PARASITOLOGY, V82, P143; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lainson R., 1979, P1; LAINSON R, 1985, T ROY SOC TROP MED H, V79, P223, DOI 10.1016/0035-9203(85)90340-2; Lana RS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/385493; Lara-Silva FD, 2015, ACTA TROP, V148, P128, DOI 10.1016/j.actatropica.2015.04.002; Lima BS, 2013, SMALL MAMMALS HOSTS, V107; Luz BYE, 2000, LUTZOMYIA WHITEMANI, V94; Rebelo JMM, 2010, REV BRAS ENTOMOL, V54, P494, DOI 10.1590/S0085-56262010000300022; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; Massafera R, 2005, REV SAUDE PUBL, V39, P571, DOI 10.1590/S0034-89102005000400009; Michalsky EM, 2011, REV SOC BRAS MED TRO, V44, DOI 10.1590/S0037-86822011000100014; MILES MA, 1983, AM J TROP MED HYG, V32, P1251, DOI 10.4269/ajtmh.1983.32.1251; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Paiva BR, 2006, ACTA TROP, V99, P252, DOI 10.1016/j.actatropica.2006.08.009; Paiva BR, 2010, ACTA TROP, V115, P126, DOI 10.1016/j.actatropica.2010.02.013; Pereira A.L., 2015, THESIS; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; Ranasinghe S, 2008, T ROY SOC TROP MED H, V102, P875, DOI 10.1016/j.trstmh.2008.04.003; Rangel E F, 1984, Mem Inst Oswaldo Cruz, V79, P395, DOI 10.1590/S0074-02761984000300020; Rangel EF, 2003, FLEBOTOMINEOS BRASIL, P291; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Rego FD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-220; ROBERTS DR, 1979, ENV ENTOMOL, V8; Rocha LS, 2010, T ROY SOC TROP MED H, V104, P461, DOI 10.1016/j.trstmh.2010.02.005; Ryan L, 1984, Mem Inst Oswaldo Cruz, V79, P383, DOI 10.1590/S0074-02761984000300016; RYAN L, 1990, T ROY SOC TROP MED H, V84, P786, DOI 10.1016/0035-9203(90)90080-X; Saraiva L, 2015, SURVEYS SAND FILES D, V10; Schallig HDFH, 2007, VECTOR-BORNE ZOONOT, V7, P387, DOI 10.1089/vbz.2006.0651; SHAW J, 2003, FLEBOTOMINEOS BRASIL, P337; Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003; Souza CF, 2009, NEOTROP ENTOMOL, V38, P267, DOI 10.1590/S1519-566X2009000200016; Talamoni Sonia A., 2014, Check List, V10, P1005	68	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178628	10.1371/journal.pone.0178628	http://dx.doi.org/10.1371/journal.pone.0178628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570640	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800091
J	Sachdeva, J; Mahajan, A; Cheng, J; Baeten, JT; Lilly, B; Kuivaniemi, H; Hans, CP				Sachdeva, Jaspreet; Mahajan, Advitiya; Cheng, Jeeyun; Baeten, Jeremy T.; Lilly, Brenda; Kuivaniemi, Helena; Hans, Chetan P.			Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; NF-KAPPA-B; NUCLEAR TRANSLOCATION; DIFFERENTIATION; INHIBITION; PATHOGENESIS; MICE; ATHEROSCLEROSIS; SUFFICIENT; PHENOTYPE	Aims Infiltration of macrophages and apoptosis of vascular smooth muscle cells (VSMCs) promote the development of abdominal aortic aneurysm (AAA). Previously, we demonstrated that global Notch1 deficiency prevents the formation of AAA in a mouse model. Herein, we sought to explore the cell-specific roles of Notch1 in AAA development. Methods and results Cell-specific Notch1 haploinsufficient mice, generated on Apoe(-/-)background using Cre-lox technology, were infused with angiotensin II (1000 ng/min/kg) for 28 days. Notch1 haploinsufficiency in myeloid cells (n = 9) prevented the formation of AAA attributed to decreased inflammation. Haploinsufficiency of Notch1 in SMCs (n = 14) per se did not prevent AAA formation, but histoarchitectural traits of AAA including elastin degradation and aortic remodeling, were minimal in SMC-Notch1(+/-); Apoe(-/-) mice compared to Apoe(-/-) mice (n = 33). Increased immunostaining of the contractile SMC-phenotype markers and concomitant decreased expression of synthetic SMC-phenotype markers were observed in the aortae of SMC-Notch1(+/-); Apoe(-/-) mice. Expression of connective tissue growth factor (CTGF), a matrix-associated protein that modulates the synthetic VSMC phenotype, increased in the abdominal aorta of Apoe(-/-) mice and in the adventitial region of the abdominal aorta in human AAA. Notch1 haploinsufficiency decreased the expression of Ctgf in the aorta and in vitro cell culture system. In vitro studies on SMCs using the Notch1 intracellular domain (NICD) plasmid, dominant negative mastermind-like (dnMAML), or specific siRNA suggest that Notch1, not Notch3, directly modulates the expression of CTGF. Conclusions Our data suggest that lack of Notch1 in SMCs limits dilation of the abdominal aorta by maintaining contractile SMC-phenotype and preventing matrix-remodeling.	[Sachdeva, Jaspreet; Hans, Chetan P.] Ohio State Univ, Columbus, OH 43210 USA; [Mahajan, Advitiya; Hans, Chetan P.] Univ Missouri, Cardiol Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Mahajan, Advitiya; Hans, Chetan P.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Cheng, Jeeyun; Baeten, Jeremy T.; Lilly, Brenda; Hans, Chetan P.] Nationwide Childrens Hosp, Ctr Cardiovasc Res, Columbus, OH 43205 USA; [Cheng, Jeeyun; Baeten, Jeremy T.; Lilly, Brenda; Hans, Chetan P.] Nationwide Childrens Hosp, Heart Ctr, Columbus, OH 43205 USA; [Kuivaniemi, Helena] Univ Stellenbosch, Dept Biomed Sci, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Tygerberg, South Africa; [Hans, Chetan P.] Univ Missouri, Dalton Cardiovasc Res Ctr, Sch Med Cardiovasc Med, Columbia, MO 65211 USA	University System of Ohio; Ohio State University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Stellenbosch University; University of Missouri System; University of Missouri Columbia	Hans, CP (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.; Hans, CP (corresponding author), Univ Missouri, Cardiol Med Pharmacol & Physiol, Columbia, MO 65211 USA.; Hans, CP (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.; Hans, CP (corresponding author), Nationwide Childrens Hosp, Ctr Cardiovasc Res, Columbus, OH 43205 USA.; Hans, CP (corresponding author), Nationwide Childrens Hosp, Heart Ctr, Columbus, OH 43205 USA.; Hans, CP (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Sch Med Cardiovasc Med, Columbia, MO 65211 USA.	HansCP@health.missouri.edu	Sachdeva, Jaspreet/AAG-8533-2022; Kuivaniemi, Helena/Q-8178-2019; Sachdeva, Jaspreet/AFL-8453-2022	Kuivaniemi, Helena/0000-0001-5753-8766; Sachdeva, Jaspreet/0000-0003-2213-132X	Research Institute at Nationwide Children's Hospital [R01 HL124155]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124155] Funding Source: NIH RePORTER	Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R01 (HL124155) and an AHA-National Center SDG and funding from the Research Institute at Nationwide Children's Hospital to Dr.Hans.	Acharya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027743; Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Airhart N, 2014, J VASC SURG, V60, P1033, DOI 10.1016/j.jvs.2013.07.097; Akyurek LM, 1996, TRANSPLANTATION, V62, P1526; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bosse K, 2013, J MOL CELL CARDIOL, V60, P27, DOI 10.1016/j.yjmcc.2013.04.001; Branchetti E, 2013, CARDIOVASC RES, V100, P316, DOI 10.1093/cvr/cvt205; Canalis E, 2014, BONE, V64, P273, DOI 10.1016/j.bone.2014.04.028; Cheng J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001064; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Cicha I, 2014, INT J BIOCHEM CELL B, V46, P39, DOI 10.1016/j.biocel.2013.11.014; Cooper DG, 2009, POSTGRAD MED J, V85, P688, DOI 10.1136/pgmj.2009.085498; Curci JA, 2009, VASCULAR, V17, pS21, DOI 10.2310/6670.2008.00085; Dai XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10180; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Englesbe MJ, 2003, J VASC SURG, V37, P27, DOI 10.1067/mva.2003.57; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Gu J, 2012, EXP CELL RES, V318, P2105, DOI 10.1016/j.yexcr.2012.06.015; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Ha DM, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0790-3; Hans CP, 2008, CARDIOVASC RES, V78, P429, DOI 10.1093/cvr/cvn018; Hans CP, 2012, ARTERIOSCL THROM VAS, V32, P3012, DOI 10.1161/ATVBAHA.112.254219; Hurks R, 2010, EUR J VASC ENDOVASC, V39, P569, DOI 10.1016/j.ejvs.2010.01.030; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Koenig SN, 2015, J CARDIOVASC DEV DIS, V2, P17, DOI 10.3390/jcdd2010017; Kuivaniemi H, 2015, EXPERT REV CARDIOVAS, V13, P975, DOI 10.1586/14779072.2015.1074861; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lin CH, 2014, STEM CELLS DEV, V23, P2581, DOI 10.1089/scd.2014.0163; Lindeman JHN, 2011, CIRCULATION, V124, pE463, DOI 10.1161/CIRCULATIONAHA.110.008573; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17189; Lu H, 2012, CURR ATHEROSCLER REP, V14, P402, DOI 10.1007/s11883-012-0271-y; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Moxon JV, 2010, CURR PROB CARDIOLOGY, V35, P512, DOI 10.1016/j.cpcardiol.2010.08.004; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; RAINES EW, 1993, BRIT HEART J, V69, pS30; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Rostama B, 2014, VASC PHARMACOL, V63, P97, DOI 10.1016/j.vph.2014.10.003; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Tanigaki K, 2010, CURR TOP DEV BIOL, V92, P231, DOI 10.1016/S0070-2153(10)92007-3; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang Q, 2014, NANOTOXICOLOGY, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0108934; Wang YW, 2015, LIFE SCI, V127, P39, DOI 10.1016/j.lfs.2015.02.009; Wanhainen A, 2008, SCAND J SURG, V97, P105, DOI 10.1177/145749690809700204; Wilson WRW, 2010, EUR J VASC ENDOVASC, V40, P191, DOI 10.1016/j.ejvs.2010.04.014; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zheng CG, 2015, CANCER BIOMARK, V15, P889, DOI 10.3233/CBM-150533; Zou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052833	63	32	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178538	10.1371/journal.pone.0178538	http://dx.doi.org/10.1371/journal.pone.0178538			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562688	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700069
J	Blanco, N; Perencevich, E; Li, SS; Morgan, DJ; Pineles, L; Johnson, JK; Robinson, G; Anderson, DJ; Jacob, JT; Maragakis, LL; Harris, AD				Blanco, Natalia; Perencevich, Eli; Li, Shan Shan; Morgan, Daniel J.; Pineles, Lisa; Johnson, J. Kristie; Robinson, Gwen; Anderson, Deverick J.; Jacob, Jesse T.; Maragakis, Lisa L.; Harris, Anthony D.		CDC Prevention Epicenter Program	Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US	PLOS ONE			English	Article							UNITED-STATES; INFECTIONS; SEASONALITY; COMMUNITY; BACTERIA; RISK; AGE	Background Little is known about the effect of meteorological conditions and geographical location on bacterial colonization rates particularly of antibiotic-resistant Gram-positive bacteria. We aimed to evaluate the effect of season, meteorological factors, and geographic location on methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) colonization. Methods The prospective cohort included all adults admitted to 20 geographically-dispersed ICUs across the US from September 1, 2011 to October 4, 2012. Nasal and perianal swabs were collected at admission and tested for MRSA and VRE colonization respectively. Poisson regression models using monthly aggregated colonization counts as the outcome and mean temperature, relative humidity, total precipitation, season, and/or latitude as predictors were constructed for each pathogen. Results A total of 24,704 ICU-admitted patients were tested for MRSA and 24,468 for VRE. On admission, 10% of patients were colonized with MRSA and 12% with VRE. For MRSA and VRE, a 10% increase in relative humidity was associated with approximately a 9% increase in prevalence rate. Southerly latitudes in the US were associated with higher MRSA colonization, while northerly latitudes were associated with higher VRE colonization. In contrast to MRSA, the association between VRE colonization and latitude was observed only after adjusting for relative humidity, which demonstrates how this effect is highly driven by this meteorological factor. Conclusions To our knowledge, we are the first to study the effect of meteorological factors and geographical location/latitude on MRSA and VRE colonization in adults. Increasing humidity was associated with greater MRSA and VRE colonization. Southerly latitudes in the US were associated with greater MRSA and less VRE. The effect of these factors on MRSA and VRE rates has the potential not only to inform patient management and treatment, but also infection prevention interventions.	[Blanco, Natalia; Morgan, Daniel J.; Pineles, Lisa; Johnson, J. Kristie; Robinson, Gwen; Harris, Anthony D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Perencevich, Eli] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Li, Shan Shan] Indiana Univ, Dept Biostat, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Morgan, Daniel J.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Johnson, J. Kristie] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Anderson, Deverick J.] Duke Univ, Dept Med, Sch Med, Durham, NC 27706 USA; [Jacob, Jesse T.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Maragakis, Lisa L.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Maryland; University of Maryland Baltimore; Duke University; Emory University; Johns Hopkins University	Blanco, N (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.	nblanco@som.umaryland.edu	jacob, jesse/P-5664-2019; Maragakis, Lisa/AAW-9806-2020; Jacob, Jesse/A-8836-2009	jacob, jesse/0000-0001-9811-6260; Anderson, Deverick/0000-0001-6882-5496; Perencevich, Eli/0000-0002-3721-3355; Pineles, Lisa/0000-0002-2377-5971	Agency for Healthcare Research and Quality (AHRQ) [HHSA290200600015, 1R18HS024045]; National Institutes of Health (NIH) [5K24AI079040]; Centers for Disease Control and Prevention (CDC) [1U54CK000450]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by grants HHSA290200600015 and 1R18HS024045 from the Agency for Healthcare Research and Quality (AHRQ), 5K24AI079040 from the National Institutes of Health (NIH) (Dr. Harris), and 1U54CK000450 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnoor M, 2016, CLIN EPIDEMIOL, V8, P151, DOI 10.2147/CLEP.S96107; Brooks S, 1998, INFECT CONT HOSP EP, V19, P333; Caldeira SM, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005438; Dauner D, 2000, APHA ANN M; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Giuffre M, 2015, AM J INFECT CONTROL, V43, P476, DOI 10.1016/j.ajic.2014.12.027; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Harris AD, 2010, ANTIMICROB AGENTS CH, V54, P3143, DOI 10.1128/AAC.01590-09; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hess AS, 2014, DIAGN MICR INFEC DIS, V79, P73, DOI 10.1016/j.diagmicrobio.2014.01.022; Hufnagel M, ENTEROCOCCAL COLONIZ; Kaier K, 2010, INFECT CONT HOSP EP, V31, P1154, DOI 10.1086/656748; Klein EY, 2013, AM J EPIDEMIOL, V177, P666, DOI 10.1093/aje/kws273; Leekha S, 2012, CLIN MICROBIOL INFEC, V18, P927, DOI 10.1111/j.1469-0691.2012.03955.x; NASA, 2016, LAT LONG FIND; NOAA, CLIM DAT ONL DAT DIS; Ogawa Tadatomo, 1994, Journal of Dermatology (Tokyo), V21, P453; Pedan A., 2001, SUGI, P247; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Robinson Joan, 2004, Paediatr Child Health, V9, P21; Sahoo KC, 2014, INT J ENV RES PUB HE, V11, P8996, DOI 10.3390/ijerph110908996; Schwab F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091105; Sun L, 2012, CLIN INFECT DIS, V55, P687, DOI 10.1093/cid/cis509; Wang XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060872, 10.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f138]; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178254	10.1371/journal.pone.0178254	http://dx.doi.org/10.1371/journal.pone.0178254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558010	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000036
J	Liu, MC; Chen, WH; Chiou, CS; Lo, WC; Dubey, NK; Chen, YC; Lai, WFT; Yeh, SD; Chiang, HS; Deng, WP				Liu, Ming-Che; Chen, Wei-Hong; Chiou, Chi-Sheng; Lo, Wen-Cheng; Dubey, Navneet Kumar; Chen, Yu-Chin; Lai, Wen-Fu T.; Yeh, Shauh-Der; Chiang, Han-Sun; Deng, Win-Ping			Inhibition of chronic prostate inflammation by hyaluronic acid through an immortalized human prostate stromal cell line model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; G-F 20; PHENOTYPIC CHARACTERIZATION; UP-REGULATION; CANCER CELLS; HYPERPLASIA; EXPRESSION; TISSUE; HYLAN; THERAPY	Benign prostatic hyperplasia (BPH) is the most common urologic disease among elderly men. A well-established in vitro cell model is required to determine the therapeutic mechanism of BPH inflammation. In this study, we attempted to establish an immortalized human prostate stromal cell line by transfecting with HPV-16 E6/E7 and designated as ihPSC. No significant difference was found in fibroblast-like morphology between primary hPSC and ihPSC. The ihPSC possessed a significantly higher cell proliferation rate than primary hPSC. The prostatespecific markers and proteins including cytoskeleton (alpha-SMA and vimentin) and smooth muscle (calponin), especially the androgen receptor (AR) were also examined in ihPSC, almost identical to the primary hPSC. To create an in vitro model featuring chronic prostatic inflammation, ihPSC was stimulated with IFN-gamma+IL-17 and then treated with the high molecular weight hyaluronic acid hylan G-F 20 as an alternative strategy for inhibiting BPH inflammation. Hylan G-F 20 could dose-dependently diminish the inflammation-induced proliferation in ihPSC. The enhanced expressions of inflammatory molecules including IL-1 beta, IL-6, IL-8, cyclooxygenase 2 (COX2), inducible nitrogen oxide synthase (iNOS), and Toll-like receptor 4 (TLR4) were all abolished by hylan G-F 20. For inflammatory signaling, hylan G-F 20 can also diminish the IFN-gamma+IL-17-increased expression of iNOS and p65 in ihPSC. These findings suggest that ihPSC could provide a mechanism-based platform for investigating prostate inflammation. The hylan G-F 20 showed strong anti-inflammatory effects by decreasing inflammatory cytokines and signalings in the ihPSC, indicating its therapeutic potentials in BPH treatment in the future.	[Liu, Ming-Che] Taipei Med Univ, Dept Urol, Sch Med, Coll Med, Taipei, Taiwan; [Liu, Ming-Che; Yeh, Shauh-Der] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Ming-Che; Chen, Wei-Hong; Dubey, Navneet Kumar; Deng, Win-Ping] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Chen, Wei-Hong; Dubey, Navneet Kumar; Chen, Yu-Chin; Deng, Win-Ping] Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Chiou, Chi-Sheng] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Chiou, Chi-Sheng] Taipei Med Univ Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taipei, Taiwan; [Lo, Wen-Cheng] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Lo, Wen-Cheng] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Lai, Wen-Fu T.] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yeh, Shauh-Der] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chiang, Han-Sun] Cardinal Tien Hosp, Div Urol, Dept Surg, Taipei, Taiwan; [Chiang, Han-Sun] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [Deng, Win-Ping] Taipei Med Univ, Coll Oral Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Academia Sinica - Taiwan; Fu Jen Catholic University; Taipei Medical University	Deng, WP (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Deng, WP (corresponding author), Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Deng, WP (corresponding author), Taipei Med Univ, Coll Oral Med, Taipei, Taiwan.	wpdeng@tmu.edu.tw	Dubey, Navneet Kumar/H-3870-2019	Dubey, Navneet Kumar/0000-0002-3540-5281	National Science Council [NSC 99-2628B-038-010-MY3, 101-2314-B-038-023, 102-2314B-038-058, 102-2314-B-038-015]; Department of Health [DOH102-TD-PB-111NSC009]; Taipei Medical University/Taipei Medical University Hospital [95 TMU-TMUH-02]; Stem Cell Research Center and Cancer Center, Taipei Medical University, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Taipei Medical University/Taipei Medical University Hospital; Stem Cell Research Center and Cancer Center, Taipei Medical University, Taipei, Taiwan	National Science Council (NSC 99-2628B-038-010-MY3, 101-2314-B-038-023, 102-2314B-038-058 and 102-2314-B-038-015), the Department of Health (DOH102-TD-PB-111NSC009)'',Taipei Medical University/Taipei Medical University Hospital (95 TMU-TMUH-02),and Stem Cell Research Center and Cancer Center, Taipei Medical University, Taipei, Taiwan.	Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Benitez A, 2011, CANCER RES, V71, P4085, DOI 10.1158/0008-5472.CAN-10-4610; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Chen WH, 2009, ARTHRITIS RHEUM-US, V60, P450, DOI 10.1002/art.24265; Chen WH, 2006, J BIOMED MATER RES A, V76A, P512, DOI 10.1002/jbm.a.30560; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; Dragomir CL, 2012, OSTEOARTHR CARTILAGE, V20, P791, DOI 10.1016/j.joca.2012.03.020; Duygu G, 2011, INT J ORAL MAX SURG, V40, P1406, DOI 10.1016/j.ijom.2011.07.909; Eaton CL, 2003, CURR OPIN UROL, V13, P7, DOI 10.1097/00042307-200301000-00002; Fibbi B, 2010, INT J ANDROL, V33, P475, DOI 10.1111/j.1365-2605.2009.00972.x; Galois L, 2012, BIO-MED MATER ENG, V22, P235, DOI 10.3233/BME-2012-0713; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Giri D, 2001, AM J PATHOL, V159, P139, DOI 10.1016/S0002-9440(10)61681-1; Gravina GL, 2013, INT J ONCOL, V42, P2116, DOI 10.3892/ijo.2013.1892; Greenberg DD, 2006, OSTEOARTHR CARTILAGE, V14, P814, DOI 10.1016/j.joca.2006.02.006; Gronthos S, 2003, J BONE MINER RES, V18, P716, DOI 10.1359/jbmr.2003.18.4.716; Hamid Agus Rizal A H, 2011, Acta Med Indones, V43, P59; Haverkamp J, 2008, J CELL BIOCHEM, V103, P1344, DOI 10.1002/jcb.21536; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Izumi K, 2013, AM J PATHOL, V182, P1942, DOI 10.1016/j.ajpath.2013.02.028; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Li P, 2012, OSTEOARTHR CARTILAGE, V20, P1336, DOI 10.1016/j.joca.2012.07.004; Liu MC, 2014, TISSUE ENG PART C-ME, V20, P1, DOI [10.1089/ten.tec.2013.0048, 10.1089/ten.TEC.2013.0048]; McVary KT, 2006, AM J MANAG CARE, V12, pS122; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Penna G, 2009, J IMMUNOL, V182, P4056, DOI 10.4049/jimmunol.0801875; Price DT, 2000, J UROLOGY, V164, P2145, DOI 10.1016/S0022-5347(05)66987-X; Rick FG, 2011, P NATL ACAD SCI USA, V108, P3755, DOI 10.1073/pnas.1018086108; Roehrborn CG, 2008, BJU INT, V101, P17, DOI 10.1111/j.1464-410X.2008.07497.x; Roehrborn CG, 2008, J UROLOGY, V179, P616, DOI 10.1016/j.juro.2007.09.084; Royuela M, 2000, EUR CYTOKINE NETW, V11, P119; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; THEYER G, 1992, LAB INVEST, V66, P96; Wang L, 2008, MED HYPOTHESES, V70, P1021, DOI 10.1016/j.mehy.2007.08.022; Wang WZ, 2005, CLIN CANCER RES, V11, P3250, DOI 10.1158/1078-0432.CCR-04-2405; Wang WZ, 2004, PROSTATE, V61, P60, DOI 10.1002/pros.20061; Wu CC, 2011, BIOMATERIALS, V32, P5847, DOI 10.1016/j.biomaterials.2011.05.002; Yoo TK, 2012, KOREAN J UROL, V53, P139, DOI 10.4111/kju.2012.53.3.139	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178152	10.1371/journal.pone.0178152	http://dx.doi.org/10.1371/journal.pone.0178152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558037	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000030
J	Zafar, R; Dass, SC; Malik, AS				Zafar, Raheel; Dass, Sarat C.; Malik, Aamir Saeed			Electroencephalogram-based decoding cognitive states using convolutional neural network and likelihood ratio based score fusion	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; VOXEL PATTERN-ANALYSIS; SIGNAL CLASSIFICATION; NATURAL IMAGES; EEG; RECONSTRUCTION; ACTIVATION; PREDICTION; FRAMEWORK; OBJECTS	Electroencephalogram (EEG)-based decoding human brain activity is challenging, owing to the low spatial resolution of EEG. However, EEG is an important technique, especially for brain computer interface applications. In this study, a novel algorithm is proposed to decode brain activity associated with different types of images. In this hybrid algorithm, convolutional neural network is modified for the extraction of features, a t-test is used for the selection of significant features and likelihood ratio-based score fusion is used for the prediction of brain activity. The proposed algorithm takes input data from multichannel EEG time series, which is also known as multivariate pattern analysis. Comprehensive analysis was conducted using data from 30 participants. The results from the proposed method are compared with current recognized feature extraction and classification/prediction techniques. The wavelet transform-support vector machine method is the most popular currently used feature extraction and prediction method. This method showed an accuracy of 65.7%. However, the proposed method predicts the novel data with improved accuracy of 79.9%. In conclusion, the proposed algorithm outperformed the current feature extraction and prediction method.	[Zafar, Raheel; Dass, Sarat C.; Malik, Aamir Saeed] Univ Teknol PETRONAS, Ctr Intelligent Signal & Imaging Res CISIR, Bandar Seri Iskandar, Perak, Malaysia	Universiti Teknologi Petronas	Malik, AS (corresponding author), Univ Teknol PETRONAS, Ctr Intelligent Signal & Imaging Res CISIR, Bandar Seri Iskandar, Perak, Malaysia.	aamir_saeed@utp.edu.my	Malik, Aamir S/C-6904-2009; Zafar, Raheel/GQA-8381-2022	Malik, Aamir S/0000-0003-1085-3157; Dass, Sarat/0000-0002-7376-0436	Ministry of Education (MOE), Malaysia under the Grant of Higher Institution Centre of Excellence (HICoE) [0153CA-002, 0153AB-i12]	Ministry of Education (MOE), Malaysia under the Grant of Higher Institution Centre of Excellence (HICoE)	This research is supported by the Ministry of Education (MOE), Malaysia under the Grant of Higher Institution Centre of Excellence (HICoE) for CISIR (Ref: 0153CA-002) and ERGS (Ref: 0153AB-i12).	Agrawal P., PROBE DECODING BRAIN; Bashivan P., 2015, COMPT SCI; Bengio Y., 2007, LARGE SCALE KERNEL M, V34; Cauchoix M, 2014, J NEUROSCI, V34, P846, DOI 10.1523/JNEUROSCI.3030-13.2014; Cecotti H, 2011, J PHYSIOL-PARIS, V105, P106, DOI 10.1016/j.jphysparis.2011.08.003; Cecotti H, 2011, IEEE T PATTERN ANAL, V33, P433, DOI 10.1109/TPAMI.2010.125; Chou CA, 2014, IEEE T MED IMAGING, V33, P925, DOI 10.1109/TMI.2014.2298856; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Crouzet SM, 2015, CURR BIOL, V25, P890, DOI 10.1016/j.cub.2015.01.057; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Deshpande A., 2016, UNDERSTANDING CNNS; Douglas P. K., 2013, FRONTIERS HUMAN NEUR; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; EGI, 2016, NET STAT 5 SOFTW; Elgammal A, 2002, P IEEE, V90, P1151, DOI 10.1109/JPROC.2002.801448; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Gardumi A, 2016, NEUROIMAGE, V132, P32, DOI 10.1016/j.neuroimage.2016.02.033; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Hajinoroozi M, 2015, 2015 IEEE CHINA SUMMIT & INTERNATIONAL CONFERENCE ON SIGNAL AND INFORMATION PROCESSING, P812, DOI 10.1109/ChinaSIP.2015.7230517; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; He B., 2013, NEURAL ENG, P87, DOI [DOI 10.1007/978-1-4614-5227-0_2, 10.1088/1741-2560/10/4/046003, DOI 10.1088/1741-2560/10/4/046003]; He B, 2016, CLIN NEUROPHYSIOL, V127, P5, DOI 10.1016/j.clinph.2015.04.074; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; Herrmann N, 2015, WHOLE BRAIN BUSINESS, V2nd; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Kriegeskorte N, 2011, NEUROIMAGE, V56, P411, DOI 10.1016/j.neuroimage.2011.01.061; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Laxhammar R, 2009, FUSION: 2009 12TH INTERNATIONAL CONFERENCE ON INFORMATION FUSION, VOLS 1-4, P756; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y., MNIST DATABASE HANDW; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Meng J., 2016, SCI REPORTS, V6; Mirowski Philip, 2009, ROAD MONT PELERIN; Mirowski PW, 2008, MACHINE LEARN SIGN P, P244, DOI 10.1109/MLSP.2008.4685487; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mporas I, 2015, EXPERT SYST APPL, V42, P3227, DOI 10.1016/j.eswa.2014.12.009; Mumford JA, 2014, NEUROIMAGE, V103, P130, DOI 10.1016/j.neuroimage.2014.09.026; Mumford JA, 2012, NEUROIMAGE, V59, P2636, DOI 10.1016/j.neuroimage.2011.08.076; Nagi J, 2012, 2012 11TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2012), VOL 1, P27, DOI 10.1109/ICMLA.2012.14; Nandakumar K, 2008, IEEE T PATTERN ANAL, V30, P342, DOI 10.1109/TPAMI.2007.70796; Nanni L, 2011, EXPERT SYST APPL, V38, P58, DOI 10.1016/j.eswa.2010.06.006; Naselaris T, 2009, NEURON, V63, P902, DOI 10.1016/j.neuron.2009.09.006; Nielsen M.A., 2015, NEURAL NETWORKS DEEP; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plis SM, 2013, ARXIV13125847; Raykar V. C., 2006, VERY FAST OPTIMAL BA; Schoenmakers S, 2013, NEUROIMAGE, V83, P951, DOI 10.1016/j.neuroimage.2013.07.043; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Silverman B. W., 1986, DENSITY ESTIMATION S, V26; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Stober S, 2014, ADV NEUR IN, V27; Subasi A, 2010, EXPERT SYST APPL, V37, P8659, DOI 10.1016/j.eswa.2010.06.065; Tabibiazar A., 2011, P IEEE VEH TECHN C V, P1; Taghizadeh-Sarabi M, 2015, BRAIN TOPOGR, V28, P33, DOI 10.1007/s10548-014-0371-9; Tang Y., 2013, ARXIV; Vatsa Mayank, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563103; Wang PQ, 2015, J NEUROSCI, V35, P15769, DOI 10.1523/JNEUROSCI.3454-15.2015; Winters-Hilt S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S18; Yang X., 2015, SPECIALIZATION EC OR, V215; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397; Zhang X., 2015, ARXIV150201710	73	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178410	10.1371/journal.pone.0178410	http://dx.doi.org/10.1371/journal.pone.0178410			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558002	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000042
J	Anklam, K; Kulow, M; Yamazaki, W; Dopfer, D				Anklam, Kelly; Kulow, Megan; Yamazaki, Wataru; Dopfer, Dorte			Development of real-time PCR and loop-mediated isothermal amplification (LAMP) assays for the differential detection of digital dermatitis associated treponemes	PLOS ONE			English	Article							DAIRY-CATTLE; CALIFORNIA DAIRY; RAPID DETECTION; PREVALENCE; LESIONS; DNA; UNIQUE	Bovine digital dermatitis (DD) is a severe infectious cause of lameness in cattle worldwide, with important economic and welfare consequences. There are three treponeme phylogroups (T. pedis, T. phagedenis, and T. medium) that are implicated in playing an important causative role in DD. This study was conducted to develop real-time PCR and loopmediated isothermal amplification (LAMP) assays for the detection and differentiation of the three treponeme phylogroups associated with DD. The real-time PCR treponeme phylogroup assays targeted the 16S-23S rDNA intergenic space (ITS) for T. pedis and T. phagedenis, and the flagellin gene (flaB2) for T. medium. The 3 treponeme phylogroup LAMP assays targeted the flagellin gene (flaB2) and the 16S rRNA was targeted for the Treponeme ssp. LAMP assay. The real-time PCR and LAMP assays correctly detected the target sequence of all control strains examined, and no cross-reactions were observed, representing 100% specificity. The limit of detection for each of the three treponeme phylogroup realtime PCR and LAMP assays was <= 70 fg/mu l. The detection limit for the Treponema spp. LAMP assay ranged from 7-690 fg/mu l depending on phylogroup. Treponemes were isolated from 40 DD lesion biopsies using an immunomagnetic separation culture method. The treponeme isolation samples were then subjected to the real-time PCR and LAMP assays for analysis. The treponeme phylogroup real-time PCR and LAMP assay results had 100% agreement, matching on all isolation samples. These results indicate that the developed assays are a sensitive and specific test for the detection and differentiation of the three main treponeme phylogroups implicated in DD.	[Anklam, Kelly; Kulow, Megan; Dopfer, Dorte] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Yamazaki, Wataru] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Miyazaki	Anklam, K (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	kelly.anklam@wisc.edu	Yamazaki, Wataru/ACT-3267-2022	Yamazaki, Wataru/0000-0002-7874-8014	Japan Society for the Promotion of Science KAKENHI [JP26450406]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science KAKENHI, grant number JP26450406. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArgaezRodriguez FDJ, 1997, PREV VET MED, V32, P275, DOI 10.1016/S0167-5877(97)00031-7; Berry SL, 2012, VET J, V193, P654, DOI 10.1016/j.tvjl.2012.06.048; BLOWEY RW, 1988, VET REC, V122, P505, DOI 10.1136/vr.122.21.505; Brandt S, 2011, VET MICROBIOL, V148, P161, DOI 10.1016/j.vetmic.2010.08.031; Bruijnis MRN, 2012, ANIMAL, V6, P962, DOI 10.1017/S1751731111002606; Clegg SR, 2016, APPL ENVIRON MICROB, V82, P4523, DOI 10.1128/AEM.00025-16; Cogoni V, 2012, MICROBIOL-SGM, V158, P759, DOI 10.1099/mic.0.055939-0; Demirkan I, 1999, Vet Rec, V145, P497; Demirkan I, 2001, J MED MICROBIOL, V50, P1061, DOI 10.1099/0022-1317-50-12-1061; Dopfer D, 1997, VET REC, V140, P620, DOI 10.1136/vr.140.24.620; Evans NJ, 2008, VET MICROBIOL, V130, P141, DOI 10.1016/j.vetmic.2007.12.019; Evans NJ, 2009, J CLIN MICROBIOL, V47, P689, DOI 10.1128/JCM.01914-08; Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155; Goto M, 2007, LETT APPL MICROBIOL, V45, P100, DOI 10.1111/j.1472-765X.2007.02142.x; Hernandez J, 2001, J AM VET MED ASSOC, V218, P1611, DOI 10.2460/javma.2001.218.1611; Holzhauer M, 2006, J DAIRY SCI, V89, P580, DOI 10.3168/jds.S0022-0302(06)72121-X; Houston S, 2015, INFECT IMMUN, V83, P4204, DOI 10.1128/IAI.00643-15; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Klitgaard K, 2013, J CLIN MICROBIOL, V51, P2212, DOI 10.1128/JCM.00320-13; Lim KT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/895816; Liu W., 2016, INT J MOL SCI, V17; Moore LJ, 2005, VET MICROBIOL, V111, P199, DOI 10.1016/j.vetmic.2005.10.016; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Nordhoff M, 2008, VET MICROBIOL, V131, P293, DOI 10.1016/j.vetmic.2008.04.019; Nordhoff M, 2008, VET MICROBIOL, V127, P334, DOI 10.1016/j.vetmic.2007.09.011; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Read DH, 1998, J VET DIAGN INVEST, V10, P67, DOI 10.1177/104063879801000112; Seyrig G, 2015, J MICROBIOL METH, V119, P223, DOI 10.1016/j.mimet.2015.11.004; Stamm LV, 2002, J CLIN MICROBIOL, V40, P3463, DOI 10.1128/JCM.40.9.3463-3469.2002; Tie Z, 2012, J BIOMED BIOTECHNOL; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Walker RL, 1995, VET MICROBIOL, V47, P343, DOI 10.1016/0378-1135(95)00114-X; WEINBERG A, 1991, J BACTERIOL, V173, P6935, DOI 10.1128/jb.173.21.6935-6947.1991; Wells SJ, 1999, PREV VET MED, V38, P11, DOI 10.1016/S0167-5877(98)00132-9; Whay HR, 1997, VET J, V154, P155, DOI 10.1016/S1090-0233(97)80053-6; Wilson-Welder JH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-280; Yamamoto Y, 2002, CLIN DIAGN LAB IMMUN, V9, P508, DOI 10.1128/CDLI.9.3.508-514.2002; Yang J, 2013, TRANSBOUND EMERG DIS, V60, P238, DOI 10.1111/j.1865-1682.2012.01335.x; Yano T, 2010, VET MICROBIOL, V143, P352, DOI 10.1016/j.vetmic.2009.12.009	39	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178349	10.1371/journal.pone.0178349	http://dx.doi.org/10.1371/journal.pone.0178349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542573	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800079
J	Gawli, K; Ramesh, N; Unniappan, S				Gawli, Kavishankar; Ramesh, Naresh; Unniappan, Suraj			Nesfatin-1-like peptide is a novel metabolic factor that suppresses feeding, and regulates whole-body energy homeostasis in male Wistar rats	PLOS ONE			English	Article							FOOD-INTAKE; INSULIN-SECRETION; BINDING-PROTEIN; NUCLEOBINDIN; MICE; CELLS; EXPRESSION; OBESITY; WEIGHT; CALNUC	Nucleobindin-1 has high sequence similarity to nucleobindin-2, which encodes the anorectic and metabolic peptide, nesfatin-1. We previously reported a nesfatin-1-like peptide (NLP), anorectic in fish and insulinotropic in mice islet beta-like cells. The main objective of this research was to determine whether NLP is a metabolic regulator in male Wistar rats. A single intraperitoneal (IP) injection of NLP (100 mu g/kg BW) decreased food intake and increased ambulatory movement, without causing any change in total activity or energy expenditure when compared to saline-treated rats. Continuous subcutaneous infusion of NLP (100 mu g/kg BW) using osmotic mini-pumps for 7 days caused a reduction in food intake on days 3 and 4. Similarly, water intake was also reduced for two days (days 3 and 4) with the effect being observed during the dark phase. This was accompanied by an increased RER and energy expenditure. However, decreased whole-body fat oxidation, and total activity were observed during the long-term treatment (7 days). Body weight gain was not significantly different between control and NLP infused rats. The expression of mRNAs encoding adiponectin, resistin, ghrelin, cholecystokinin and uncoupling protein 1 (UCP1) were significantly upregulated, while leptin and peptide YY mRNA expression was downregulated in NLP-treated rats. These findings indicate that administration of NLP at 100 mu g/kg BW reduces food intake and modulates whole body energy balance. In summary, NLP is a novel metabolic peptide in rats.	[Gawli, Kavishankar; Ramesh, Naresh; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK, Canada	University of Saskatchewan	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK, Canada.	suraj.unniappan@usask.ca			Canadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI); SHRF; University of Saskatchewan; College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation (SHRF); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); SHRF; University of Saskatchewan; College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan	SU is a recipient of an open operating grant and a New Investigator Salary Award award from the Canadian Institutes of Health Research (CIHR), an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The CLAMS was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI). KG received a postdoctoral research fellowship from the SHRF. NR is a recipient of college of graduate and postdoctoral studies (CGPS) Dean's scholarship from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SU is a recipient of an open operating grant and a New Investigator Salary Award from the Canadian Institutes of Health Research (CIHR), an Establishment Grant from the Saskatchewan Health Research Foundation (SHRF). The CLAMS was purchased using a Leaders Opportunities Fund from the Canada Foundation for Innovation (CFI). KG received a postdoctoral research fellowship from the SHRF. NR is a recipient of the Dean's scholarship from the College of Graduate and Post-doctoral studies (CGPS), University of Saskatchewan.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Blundell JE, 2015, OBES REV, V16, P67, DOI 10.1111/obr.12257; Diamanti-Kandarakis E, 2012, INT J OBES LOND, V33, P981; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Garcia-Galiano D, 2010, J NEUROSCI, V30, P7783, DOI 10.1523/JNEUROSCI.5828-09.2010; Goebel M, 2011, PEPTIDES, V32, P36, DOI 10.1016/j.peptides.2010.09.027; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2012, GEN COMP ENDOCR, V176, P341, DOI 10.1016/j.ygcen.2011.11.021; Gupta R, 2012, J MOL BIOL, V421, P378, DOI 10.1016/j.jmb.2012.04.017; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hofmann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132058; Kubota T, 2001, IMMUNOL LETT, V75, P111, DOI 10.1016/S0165-2478(00)00290-X; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Lents CA, 2013, DOMEST ANIM ENDOCRIN, V45, P89, DOI 10.1016/j.domaniend.2013.06.002; Li ZR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071513, 10.1371/journal.pone.0074635]; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Mortazavi S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00022; Nair N, 2016, GEN COMP ENDOCR, V234, P142, DOI 10.1016/j.ygcen.2016.02.015; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Prinz P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00422; Ramesh N, 2016, BIOCHEM BIOPH RES CO, V472, P201, DOI 10.1016/j.bbrc.2016.02.095; Ramesh N, 2015, GEN COMP ENDOCR, V216, P182, DOI 10.1016/j.ygcen.2015.04.011; Reidelberger R, 2014, AM J PHYSIOL-ENDOC M, V307, pE619, DOI 10.1152/ajpendo.00024.2014; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Sundarrajan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28377; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Unniappan S, 2006, DIABETOLOGIA, V49, P1915, DOI 10.1007/s00125-006-0310-8; Unniappan S, 2008, AM J PHYSIOL-REG I, V295, pR51, DOI 10.1152/ajpregu.00234.2007; Valencia CA, 2008, FEBS LETT, V582, P286, DOI 10.1016/j.febslet.2007.12.019; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; Wernecke K, 2014, OBESITY, V22, P1662, DOI 10.1002/oby.20736; Williams P, 2014, CELL TISSUE RES, V358, P331, DOI 10.1007/s00441-014-1948-z; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178329	10.1371/journal.pone.0178329	http://dx.doi.org/10.1371/journal.pone.0178329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542568	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800071
J	Wang, YY; Zhang, J; Zhang, L; Gao, P; Wu, XY				Wang, Yuanyuan; Zhang, Juan; Zhang, Lian; Gao, Ping; Wu, Xiaoyan			Adiponectin attenuates high glucose-induced apoptosis through the AMPK/p38 MAPK signaling pathway in NRK-52E cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETIC-PATIENTS; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; ENDOTHELIAL-CELL; NADPH OXIDASE; CANCER; RESISTIN; LIVER	Excessive apoptosis of proximal tubule cell is closely related to the development of diabetes. Recent evidence suggests that adiponectin (ADPN) protects cells from high glucose induced apoptosis. However, the precise mechanisms remain poorly understood. We sought to investigate the role of p38 mitogen-activated protein kinase (p38 MAPK) and AMP activated protein kinase (AMPK) in anti-apoptotic of adiponectin under high glucose condition in rat tubular NRK-52E cells. Cells were cultured in constant and oscillating high glucose media with or without recombinant rat adiponectin for 48 h. Cell counting kit-8 (CCK-8) was used to detect cell viability, flow cytometry and Hoechst Staining were applied to investigate cell apoptosis, and western blotting was used to examine protein expression, such as phospho-AMPK and phospho-p38MAPK. Exposure to oscillating high glucose exerted lower cell viability and higher early apoptosis than constant high glucose, which were both partially prevented by adiponectin. Further studies revealed that adiponectin suppressed p38MAPK phosphorylation, but led to an increase in AMPK a phosphorylation. Compared to stable high glucose group, blockage of p38MAPK cascade with SB203580 attenuated apoptosis significantly, but failed to affect the phosphorylation level of AMPK. While AMPK inhibitor, Compound C, increased apoptosis and remarkably inhibited the p38MAPK phosphorylation. Adiponectin exert a crucial protective role against apoptosis induced by high glucose via AMPK/p38MAPK pathway.	[Wang, Yuanyuan; Zhang, Juan; Zhang, Lian; Gao, Ping; Wu, Xiaoyan] Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China	Wuhan University	Wu, XY (corresponding author), Wuhan Univ, Dept Nephrol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.	wuxychh@163.com	Lv, Yuanjie/AER-0767-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022		National Natural Science Foundation of China [2011N5FL]; Natural Science Foundation of Hubei Province [2013CFA074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (No: 2011N5FL, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Hubei Province (No: 2013CFA074, http://www.hbstd.gov.cn/).	Aleidi S, 2015, SAUDI PHARM J, V23, P250, DOI 10.1016/j.jsps.2014.11.011; Bondor CI, 2015, INT UROL NEPHROL, V47, P1173, DOI 10.1007/s11255-015-1004-2; Brown KA, 2009, CANCER RES, V69, P5392, DOI 10.1158/0008-5472.CAN-09-0108; Cardaci S, 2012, J CELL SCI, V125, P2115, DOI 10.1242/jcs.095216; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Guan GY, 2014, ENDOCRINE, V47, P764, DOI 10.1007/s12020-014-0186-1; Habib SL, 2013, WORLD J DIABETES, V4, P27, DOI 10.4239/wjd.v4.i2.27; Huang BQ, 2014, ONCOTARGET, V5, P4732, DOI 10.18632/oncotarget.1963; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Ishijima N, 2015, CANCER SCI, V106, P567, DOI 10.1111/cas.12633; Jiang QL, 2015, MOL CELL BIOCHEM, V399, P113, DOI 10.1007/s11010-014-2238-5; Jing YY, 2015, J HEPATOL, V62, P1319, DOI 10.1016/j.jhep.2014.12.032; Jung DS, 2008, AM J PHYSIOL-RENAL, V295, pF595, DOI 10.1152/ajprenal.00624.2007; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Kim A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08394; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kim N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120104; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lai XH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-10; Langer S, 2016, J NEPHROL, V29, P765, DOI 10.1007/s40620-015-0258-1; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Li X, 2012, CHINESE MED J-PEKING, V125, P4209, DOI 10.3760/cma.j.issn.0366-6999.2012.23.009; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Shao BL, 2014, REDOX BIOL, V2, P694, DOI 10.1016/j.redox.2014.05.005; Sun JZ, 2010, J MOL ENDOCRINOL, V44, P179, DOI 10.1677/JME-09-0088; Tsai CH, 2015, ONCOTARGET, V6, P258, DOI 10.18632/oncotarget.2724; Weisova P, 2011, ANTIOXID REDOX SIGN, V14, P1863, DOI 10.1089/ars.2010.3544; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang YQ, 2015, AM J PHYSIOL-ENDOC M, V309, pE275, DOI 10.1152/ajpendo.00577.2014; Zhao HY, 2011, CHINESE MED J-PEKING, V124, P2540, DOI 10.3760/cma.j.issn.0366-6999.2011.16.026	33	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178215	10.1371/journal.pone.0178215	http://dx.doi.org/10.1371/journal.pone.0178215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542560	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800055
J	Miller, C; Pachanski, MJ; Kirkland, ME; Kosinski, DT; Mane, J; Bunzel, M; Cao, J; Souza, S; Thomas-Fowlkes, B; Di Salvo, J; Weinglass, AB; Li, XY; Myers, RW; Knagge, K; Carrington, PE; Hagmann, WK; Trujillo, ME				Miller, Corin; Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Bunzel, Michelle; Cao, Jin; Souza, Sarah; Thomas-Fowlkes, Brande; Di Salvo, Jerry; Weinglass, Adam B.; Li, Xiaoyan; Myers, Robert W.; Knagge, Kevin; Carrington, Paul E.; Hagmann, William K.; Trujillo, Maria E.			GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production	PLOS ONE			English	Article							DEPENDENT INSULIN-SECRETION; PANCREATIC BETA-CELLS; RECEPTOR 1 AGONIST; TYPE-2; GLUCONEOGENESIS; GLYCOGENOLYSIS; TAK-875; STIMULATION; IMPROVES; OBESITY	GPR40 (FFA1) is a fatty acid receptor whose activation results in potent glucose lowering and insulinotropic effects in vivo. Several reports illustrate that GPR40 agonists exert glucose lowering in diabetic humans. To assess the mechanisms by which GPR40 partial agonists improve glucose homeostasis, we evaluated the effects of MK-2305, a potent and selective partial GPR40 agonist, in diabetic Goto Kakizaki rats. MK-2305 decreased fasting glucose after acute and chronic treatment. MK-2305-mediated changes in glucose were coupled with increases in plasma insulin during hyperglycemia and glucose challenges but not during fasting, when glucose was normalized. To determine the mechanism(s) mediating these changes in glucose metabolism, we measured the absolute contribution of precursors to glucose production in the presence or absence of MK-2305. MK-2305 treatment resulted in decreased endogenous glucose production (EGP) driven primarily through changes in gluconeogenesis from substrates entering at the TCA cycle. The decrease in EGP was not likely due to a direct effect on the liver, as isolated perfused liver studies showed no effect of MK-2305 ex vivo and GPR40 is not expressed in the liver. Taken together, our results suggest MK-2305 treatment increases glucose stimulated insulin secretion (GSIS), resulting in changes to hepatic substrate handling that improve glucose homeostasis in the diabetic state. Importantly, these data extend our understanding of the underlying mechanisms by which GPR40 partial agonists reduce hyperglycemia.	[Miller, Corin; Bunzel, Michelle; Cao, Jin] Merck & Co Inc, Dept Translat Imaging Biomarkers, Kenilworth, NJ USA; [Pachanski, Michele J.; Kirkland, Melissa E.; Kosinski, Daniel T.; Mane, Joel; Trujillo, Maria E.] Merck & Co Inc, In Vivo Pharmacol, Kenilworth, NJ 07033 USA; [Souza, Sarah; Thomas-Fowlkes, Brande; Di Salvo, Jerry; Weinglass, Adam B.; Myers, Robert W.] Merck & Co Inc, In Vitro Pharmacol, Kenilworth, NJ USA; [Li, Xiaoyan; Carrington, Paul E.] Merck & Co Inc, Cardiometab Dis, Kenilworth, NJ USA; [Myers, Robert W.] David H Murdock Res Inst, Kannapolis, NC USA; [Hagmann, William K.] Merck & Co Inc, Chem, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Trujillo, ME (corresponding author), Merck & Co Inc, In Vivo Pharmacol, Kenilworth, NJ 07033 USA.	maria_trujillo@merck.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022		Merck and Co Inc.	Merck and Co Inc.(Merck & Company)	The funder Merck and Co Inc. provided support in the form of salaries for authors [CM, MJP, MEK, DTK, JM, MB, JC, SS, BTF, JD, ABW, XL, RWM, KK, PEC, WKH, MET], study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adkins A, 2003, DIABETES, V52, P2213, DOI 10.2337/diabetes.52.9.2213; [Anonymous], 2005, DIABETES-METAB RES, V21, P495; Aoki K, 2004, LIFE SCI, V74, P3075, DOI 10.1016/j.lfs.2003.10.031; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Basu R, 2004, DIABETES, V53, P2042, DOI 10.2337/diabetes.53.8.2042; Bergman RN, 1997, RECENT PROG HORM RES, V52, P359; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; COHEN SM, 1987, BIOCHEMISTRY-US, V26, P563, DOI 10.1021/bi00376a031; DEFRONZO RA, 1992, DIABETOLOGIA, V35, P389, DOI 10.1007/BF00401208; Delgado TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034042; Edgerton DS, 2001, DIABETES, V50, P1872, DOI 10.2337/diabetes.50.8.1872; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Li XL, 2013, IEEE CONF IMAGING SY, P1, DOI 10.1109/IST.2013.6729651; Lin DK, 2011, COMPUT FLUIDS, V40, P333, DOI 10.1016/j.compfluid.2010.08.018; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Negoro N, 2012, J MED CHEM, V55, P3960, DOI 10.1021/jm300170m; Nielsen MF, 1998, DIABETES, V47, P1735, DOI 10.2337/diabetes.47.11.1735; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; ROSSETTI L, 1993, J CLIN INVEST, V92, P2963, DOI 10.1172/JCI116919; Sena CM, 2007, DIABETES METAB, V33, P296, DOI 10.1016/j.diabet.2007.03.002; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Wang S-P, 2016, AM J PHYSL ENDOCRINO; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708	36	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176182	10.1371/journal.pone.0176182	http://dx.doi.org/10.1371/journal.pone.0176182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542610	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800001
J	Afiatin; Khoe, LC; Kristin, E; Masytoh, LS; Herlinawaty, E; Werayingyong, P; Nadjib, M; Sastroasmoro, S; Teerawattananon, Y				Afiatin; Khoe, Levina Chandra; Kristin, Erna; Masytoh, Lusiana Siti; Herlinawaty, Eva; Werayingyong, Pitsaphun; Nadjib, Mardiati; Sastroasmoro, Sudigdo; Teerawattananon, Yot			Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia	PLOS ONE			English	Article							PERITONEAL-DIALYSIS; CENTER HEMODIALYSIS; KIDNEY-DISEASE	Objectives This study aims to assess the value for money and budget impact of offering hemodialysis (HD) as a first-line treatment, or the HD-first policy, and the peritoneal dialysis (PD) first policy compared to a supportive care option in patients with end-stage renal disease (ESRD) in Indonesia. Methods A Markov model-based economic evaluation was performed using local and international data to quantify the potential costs and health-related outcomes in terms of life years (LYs) and quality-adjusted life years (QALYs). Three policy options were compared, i.e., the PD-first policy, HD-first policy, and supportive care. Results The PD-first policy for ESRD patients resulted in 5.93 life years, equal to the HD-first policy, with a slightly higher QALY gained (4.40 vs 4.34). The total lifetime cost for a patient under the PD-first policy is around 700 million IDR, which is lower than the cost under the HD-first policy, i.e. 735 million IDR per patient. Compared to supportive care, the incremental cost-effectiveness ratio of the PD-first policy is 193 million IDR per QALY, while the HD-first policy resulted in 207 million IDR per QALY. Budget impact analysis indicated that the required budget for the PD-first policy is 43 trillion IDR for 53% coverage and 75 trillion IDR for 100% coverage in five years, which is less than the HD-first policy, i.e. 88 trillion IDR and 166 trillion IDR. Conclusions The PD-first policy was found to be more cost-effective compared to the HD-first policy. Budget impact analysis provided evidence on the enormous financial burden for the country if the current practice, where HD dominates PD, continues for the next five years.	[Afiatin] Univ Padjadjaran, Fac Med, Dept Internal Med, Bandung, Indonesia; [Khoe, Levina Chandra] Univ Indonesia, Fac Med, Dept Community Med, Jakarta, Indonesia; [Kristin, Erna] Univ Gadjah Mada, Fac Med, Dept Pharmacol & Therapy, Yogyakarta, Indonesia; [Masytoh, Lusiana Siti; Herlinawaty, Eva] Minist Hlth, Ctr Hlth Financing & Secur, Jakarta, Indonesia; [Werayingyong, Pitsaphun; Teerawattananon, Yot] Minist Publ Hlth, HITAP, Bangkok, Thailand; [Nadjib, Mardiati; Sastroasmoro, Sudigdo] Indonesian Hlth Technol Assessment Comm, Jakarta, Indonesia	Universitas Padjadjaran; University of Indonesia; Gadjah Mada University; Ministry of Health - Indonesia; Ministry of Public Health - Thailand	Khoe, LC (corresponding author), Univ Indonesia, Fac Med, Dept Community Med, Jakarta, Indonesia.	levinachandramd@gmail.com	Kristin, Erna/AAB-7461-2021	Kristin, Erna/0000-0002-5609-6078; Teerawattananon, Yot/0000-0003-2217-2930; Khoe, Levina/0000-0002-2050-392X	Ministry of Health, Indonesia; Australian Indonesian Partnership for Health Systems Strengthening (AIPHSS) under the Department of Foreign Affairs Trade, Australia; International Decision Support Initiative (iDSI); Bill & Melinda Gates Foundation; UK's Department for International Development; Rockefeller Foundation	Ministry of Health, Indonesia; Australian Indonesian Partnership for Health Systems Strengthening (AIPHSS) under the Department of Foreign Affairs Trade, Australia; International Decision Support Initiative (iDSI); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK's Department for International Development; Rockefeller Foundation	This work received funding support from the state budget from the Ministry of Health, Indonesia and the Australian Indonesian Partnership for Health Systems Strengthening (AIPHSS) under the Department of Foreign Affairs Trade, Australia. Technical assistance from the Health Intervention and Technology Assessment Program (HITAP) International Unit was supported by International Decision Support Initiative (iDSI) to provide technical assistance on health intervention and technology assessment to governments in low- and middle-income countries. iDSI is funded by the Bill & Melinda Gates Foundation, the UK's Department for International Development, and the Rockefeller Foundation. The HITAP team provided technical assistance to the authors throughout the conduct of the research, the writing of the report, and the publication process. The other funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STAND TAR HLTH SERV; Berns JS, 2015, PATIENT INFORM HEMOD; BPJS-K, 2014, INF BPJS KES; Chanouzas D, 2012, NEPHROL DIAL TRANSPL, V27, P1542, DOI 10.1093/ndt/gfr452; de Wit GA, 2002, NEPHROL DIAL TRANSPL, V17, P86, DOI 10.1093/ndt/17.1.86; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; Hooi LS, 2005, NEPHROLOGY, V10, P25, DOI 10.1111/j.1440-1797.2005.00360.x; Indonesian Renal Registry, 2014, 7 IND REN REG; Indonesian Renal Registry, 2013, 6 IND REN REG; Just PM, 2008, HEALTH POLICY, V86, P163, DOI 10.1016/j.healthpol.2007.12.004; KARLBERG I, 1995, INT J TECHNOL ASSESS, V11, P611, DOI 10.1017/S026646230000876X; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li PKT, 2001, PERITON DIALYSIS INT, V21, pS307; Lim T O, 1999, Med J Malaysia, V54, P442; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; National Healthcare Security Agency, 2015, MIN HLTH; National Institute of Health Research and Development, 2013, BAS HLTH SURV; Novelia E., 2014, THESIS; Sennfalt K, 2001, PERITON DIALYSIS INT, V22, P39; Smith C, 2003, NEPHRON CLIN PRACT, V95, pC40, DOI 10.1159/000073708; Stanley M, 2010, NEPHROLOGY, V15, pS24, DOI 10.1111/j.1440-1797.2010.01228.x; Teerawattananon Y, 2007, VALUE HEALTH, V10, P61, DOI 10.1111/j.1524-4733.2006.00145.x; Teerawattananon Y, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0090-7; Tongsiri S, 2011, VALUE HEALTH, V14, P1142, DOI 10.1016/j.jval.2011.06.005; Treharne C, 2014, APPL HEALTH ECON HEA, V12, P409, DOI 10.1007/s40258-014-0108-7; Vale L, 2004, COCHRANE DATABASE SY; Wasserfallen JB, 2004, NEPHROL DIAL TRANSPL, V19, P1594, DOI 10.1093/ndt/gfh175; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong CF, 2007, RENAL FAILURE, V29, P653, DOI 10.1080/08860220701459634	31	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177436	10.1371/journal.pone.0177436	http://dx.doi.org/10.1371/journal.pone.0177436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545094	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400043
J	Beyreuther, E; Bruchner, K; Krause, M; Schmidt, M; Szabo, R; Pawelke, J				Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Szabo, Rita; Pawelke, Joerg			An optimized small animal tumour model for experimentation with low energy protons	PLOS ONE			English	Article							LASER-DRIVEN; CELL-LINE; CANCER; MATRIGEL; FADU	Background The long-term aim of developing laser based particle acceleration towards clinical application requires not only substantial technological progress, but also the radiobiological characterization of the resulting ultra-short and ultra-intensive particle beam pulses. After comprehensive cell studies a mouse ear tumour model was established allowing for the penetration of low energy protons (similar to 20 MeV) currently available at laser driven accelerators. The model was successfully applied for a first tumour growth delay study with laser driven electrons, whereby the need of improvements crop out. Methods To optimise the mouse ear tumour model with respect to a stable, high take rate and a lower number of secondary tumours, Matrigel was introduced for tumour cell injection. Different concentrations of two human tumour cell lines (FaDu, LN229) and Matrigel were evaluated for stable tumour growth and fulfilling the allocation criteria for irradiation experiments. The originally applied cell injection with PBS was performed for comparison and to assess the long-term stability of the model. Finally, the optimum suspension of cells and Matrigel was applied to determine applicable dose ranges for tumour growth delay studies by 200 kV Xray irradiation. Results Both human tumour models showed a high take rate and exponential tumour growth starting at a volume of similar to 10 mm(3). As disclosed by immunofluorescence analysis these small tumours already interact with the surrounding tissue and activate endothelial cells to form vessels. The formation of delimited, solid tumours at irradiation size was shown by standard H&E staining and a realistic dose range for inducing tumour growth delay without permanent tumour control was obtained for both tumour entities. Conclusion The already established mouse ear tumour model was successfully upgraded now providing stable tumour growth with high take rate for two tumour entities (HNSCC, glioblastoma) that are of interest for future irradiation experiments at experimental accelerators.	[Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Pawelke, Joerg] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Pawelke, Joerg] Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Beyreuther, Elke; Bruechner, Kerstin; Krause, Mechthild; Schmidt, Margret; Pawelke, Joerg] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Bruechner, Kerstin] Tech Univ Dresden, Dresden, Germany; [Krause, Mechthild] Tech Univ Dresden, Dept Radiotherapy & Radiat Oncol, Fac Med, Dresden, Germany; [Krause, Mechthild] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Krause, Mechthild] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Krause, Mechthild] German Canc Res Ctr, Heidelberg, Germany; [Krause, Mechthild; Schmidt, Margret] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Szabo, Rita] ELI HU Nonprofit Ltd, Attosecond Light Pulse Source, Szeged, Hungary	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; ELI-HU Research & Development Non-Profit	Beyreuther, E (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany.	E.Beyreuther@hzdr.de		Krause, Mechthild/0000-0003-1776-9556; Beyreuther, Elke/0000-0002-0582-1444	German Federal Ministry of Education and Research (BMBF) [03ZIK445, 03Z1N511]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by the German Federal Ministry of Education and Research (BMBF), grant nos. 03ZIK445 and 03Z1N511.	Benton G, 2014, ADV DRUG DELIVER REV, V79-80, P3, DOI 10.1016/j.addr.2014.06.005; Bin JH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4769372; Daido H, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/5/056401; DISERENS AC, 1981, ACTA NEUROPATHOL, V53, P21, DOI 10.1007/BF00697180; Doria D, 2012, AIP ADV, V2, DOI 10.1063/1.3699063; Fernandez-Palomo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119924; Fliedner FP, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0105-4; Helbig L, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-207; Jermann M., 2015, INT J PART THER, V2, P50, DOI 10.14338/IJPT-15-00013; Kraft SD, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085003; Krause M, 2007, RADIOTHER ONCOL, V83, P316, DOI 10.1016/j.radonc.2007.04.014; Ledingham KWD, 2007, BRIT J RADIOL, V80, P855, DOI 10.1259/bjr/29504942; Oppelt M, 2015, RADIAT ENVIRON BIOPH, V54, P155, DOI 10.1007/s00411-014-0582-1; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schurer M, 2012, BIOMED ENG-BIOMED TE, V57, P62, DOI 10.1515/bmt-2012-4244; SUIT HD, 1965, CELLULAR RAD BIOL, P514; Yaromina A, 2010, RADIOTHER ONCOL, V96, P116, DOI 10.1016/j.radonc.2010.04.020; Yogo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551623; Zeil K, 2013, APPL PHYS B-LASERS O, V110, P437, DOI 10.1007/s00340-012-5275-3	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177428	10.1371/journal.pone.0177428	http://dx.doi.org/10.1371/journal.pone.0177428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545054	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400042
J	Velasquez-Mao, AJ; Tsao, CJM; Monroe, MN; Legras, X; Bissig-Choisat, B; Bissig, KD; Ruano, R; Jacot, JG				Velasquez-Mao, Aaron J.; Tsao, Christopher J. M.; Monroe, Madeline N.; Legras, Xavier; Bissig-Choisat, Beatrice; Bissig, Karl-Dimiter; Ruano, Rodrigo; Jacot, Jeffrey G.			Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells	PLOS ONE			English	Article							PLURIPOTENCY; MODULATION; GENERATION; THERAPY; NANOG	Congenital heart defects are the most common birth defect. The limiting factor in tissue engineering repair strategies is an autologous source of functional cardiomyocytes. Amniotic fluid contains an ideal cell source for prenatal harvest and use in correction of congenital heart defects. This study aims to investigate the potential of amniotic fluid-derived stem cells (AFSC) to undergo non-viral reprogramming into induced pluripotent stem cells (iPSC) followed by growth-factor-free differentiation into functional cardiomyocytes. AFSC from human second trimester amniotic fluid were transfected by non-viral vesicle fusion with modified mRNA of OCT4, KLF4, SOX2, LIN28, cMYC and nuclear GFP over 18 days, then differentiated using inhibitors of GSK3 followed 48 hours later by inhibition of WNT. AFSC-derived iPSC had high expression of OCT4, NANOG, TRA-1-60, and TRA-1-81 after 18 days of mRNA transfection and formed teratomas containing mesodermal, ectodermal, and endodermal germ layers in immunodeficient mice. By Day 30 of cardiomyocyte differentiation, cells contracted spontaneously, expressed connexin 43 and beta-myosin heavy chain organized in sarcomeric banding patterns, expressed cardiac troponin T and beta-myosin heavy chain, showed upregulation of NKX2.5, ISL-1 and cardiac troponin T with downregulation of POU5F1, and displayed calcium and voltage transients similar to those in developing cardiomyocytes. These results demonstrate that cells from human amniotic fluid can be differentiated through a pluripotent state into functional cardiomyocytes.	[Velasquez-Mao, Aaron J.; Tsao, Christopher J. M.; Monroe, Madeline N.; Jacot, Jeffrey G.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Legras, Xavier; Bissig-Choisat, Beatrice; Bissig, Karl-Dimiter] Baylor Coll Med, Ctr Cell & Gene Therapy, Dept Mol & Cellular Biol, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Ruano, Rodrigo] Maternal Fetal Med Texas Childrens Hosp, Dept Obstet & Gynecol, Houston, TX USA; [Jacot, Jeffrey G.] Texas Childrens Hosp, Congenital Heart Surg Serv, Houston, TX 77030 USA; [Jacot, Jeffrey G.] Univ Colorado Denver, Dept Bioengn, Aurora, CO 80204 USA	Rice University; Baylor College of Medicine; Baylor College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Jacot, JG (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Jacot, JG (corresponding author), Texas Childrens Hosp, Congenital Heart Surg Serv, Houston, TX 77030 USA.; Jacot, JG (corresponding author), Univ Colorado Denver, Dept Bioengn, Aurora, CO 80204 USA.	jeffrey.jacot@ucdenver.edu			American Heart Association [14BGIA18750004]; National Science Foundation [CBET-1547838]; National Institutes of Health [1R01HL130436-01]; Texas Children's Hospital; National Heart Lung and Blood Institute (NHLBI) [R01HL134510]; Texas Hepatocellular Carcinoma Consortium (THCCC) [RP150587]; Diana Helis Henry; Adrienne Helis Malvin Medical Research Foundations; Directorate For Engineering [1724640] Funding Source: National Science Foundation	American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital; National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas Hepatocellular Carcinoma Consortium (THCCC); Diana Helis Henry; Adrienne Helis Malvin Medical Research Foundations; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by grants from the American Heart Association (14BGIA18750004 to J. Jacot), the National Science Foundation (CBET-1547838 to J. Jacot), the National Institutes of Health (1R01HL130436-01 to J. Jacot), and Texas Children's Hospital. K.D. B. is supported by the National Heart Lung and Blood Institute (NHLBI) grant R01HL134510, the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587) and the Diana Helis Henry and Adrienne Helis Malvin Medical Research Foundations.; This work was supported in part by grants from the American Heart Association (14BGIA18750004 to J. Jacot), the National Science Foundation (CBET-1547838 to J. Jacot), the National Institutes of Health (1R01HL130436-01 to J. Jacot), and Texas Children's Hospital. K.D.B. is supported by the National Heart Lung and Blood Institute (NHLBI) grant R01HL134510, the Texas Hepatocellular Carcinoma Consortium (THCCC) (CPRIT #RP150587) and the Diana Helis Henry and Adrienne Helis Malvin Medical Research Foundations. We wish to also acknowledge Frank Braun for his technical support with qRT-PCR and western blot developing.	Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Batalov I, 2015, BIOMARK INSIGHTS, V10, P71, DOI 10.4137/BMI.S20050; Benavides OM, 2012, TISSUE ENG PT A, V18, P1123, DOI [10.1089/ten.tea.2011.0392, 10.1089/ten.TEA.2011.0392]; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Connell JP, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Gao Y, 2014, ANN BIOMED ENG, V42, P2490, DOI 10.1007/s10439-014-1114-5; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Jiang GH, 2016, STEM CELL TRANSL MED, V5, P1595, DOI 10.5966/sctm.2016-0016; Jiang GH, 2014, STEM CELLS DEV, V23, P2613, DOI 10.1089/scd.2014.0110; Kim J, 2007, CELL PROLIFERAT, V40, P75; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Malik Nasir, 2013, Methods Mol Biol, V997, P23, DOI 10.1007/978-1-62703-348-0_3; Moschidou D, 2012, MOL THER, V20, P1953, DOI 10.1038/mt.2012.117; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Qin MD, 2016, INT J BIOL SCI, V12, P558, DOI 10.7150/ijbs.11051; Riegler J, 2015, CIRC RES, V117, P720, DOI 10.1161/CIRCRESAHA.115.306985; Schwarz BA, 2014, CURR BIOL, V24, P347, DOI 10.1016/j.cub.2013.12.050; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Xu HS, 2012, CELL RES, V22, P142, DOI 10.1038/cr.2011.171; Yagel S, 1997, CIRCULATION, V96, P550	29	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177824	10.1371/journal.pone.0177824	http://dx.doi.org/10.1371/journal.pone.0177824			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545044	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700085
J	Hundie, GB; Raj, VS; GebreMichael, D; Pas, SD; Haagmans, BL				Hundie, Gadissa Bedada; Raj, V. Stalin; GebreMichael, Daniel; Pas, Suzan D.; Haagmans, Bart L.			Genetic diversity of hepatitis C virus in Ethiopia	PLOS ONE			English	Article							GENOTYPE 4; VIRAL-HEPATITIS; EPIDEMIOLOGY; SUBTYPES; HISTORY; PHYLOGEOGRAPHY; RECOMBINATION; PREDOMINANCE; TRANSMISSION; PREVALENCE	Hepatitis C virus (HCV) is genetically highly divergent and classified in seven major genotypes and approximately hundred subtypes. These genotypes/subtypes have different geographic distribution and response to antiviral therapy. In Ethiopia, however, little is known about their molecular epidemiology and genetic diversity. The aim of this study was to investigate the distribution and genetic diversity of HCV genotypes/subtypes in Ethiopia, using 49 HCV RNA positive samples. HCV genotypes and subtypes were determined based on the sequences of the core and the nonstructural protein 5B (NS5B) genomic regions. Phylogenetic analysis revealed that the predominant was genotype 4 (77.6%) followed by 2 (12.2%), 1 (8.2%), and 5 (2.0%). Seven subtypes were identified (1b, 1c, 2c, 4d, 4l, 4r and 4v), with 4d (34.7%), 4r (34.7%) and 2c (12.2%) as the most frequent subtypes. Consistent with the presence of these subtypes was the identification of a potential recombinant virus. One strain was typed as genotype 2c in the NS5B region sequence and genotype 4d in the core region. In conclusion, genotype 4 HCV viruses, subtypes 4d and 4r, are most prevalent in Ethiopia. This genotype is considered to be difficult to treat, thus, our finding has an important impact on the development of treatment strategies and patient management in Ethiopia.	[Hundie, Gadissa Bedada; Raj, V. Stalin; Pas, Suzan D.; Haagmans, Bart L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [GebreMichael, Daniel] Minist Hlth, Natl Blood Bank Serv, Addis Ababa, Ethiopia	Erasmus University Rotterdam; Erasmus MC	Haagmans, BL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	b.haagmans@erasmusmc.nl	Hundie, Gadissa/GPF-9108-2022; Haagmans, Bart/E-9791-2015; Raj, Victor Stalin/E-9670-2016	Hundie, Gadissa/0000-0002-5627-9675; Haagmans, Bart/0000-0001-6221-2015; Raj, Victor Stalin/0000-0003-2250-8481	Nuffic, Netherlands Fellowship Programmes [CF8605]	Nuffic, Netherlands Fellowship Programmes	This work is supported by Nuffic, Netherlands Fellowship Programmes (https://www.epnuffic.nl/en) grant number: CF8605. GBH received the funding grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghaffar TY, 2015, WORLD J HEPATOL, V7, P2792, DOI 10.4254/wjh.v7.i28.2792; Abreha T, 2011, J MED VIROL, V83, P776, DOI 10.1002/jmv.21788; Al Ashgar HI, 2013, SAUDI J GASTROENTERO, V19, P28, DOI 10.4103/1319-3767.105920; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bull RA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2575-8; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Cantaloube JF, 2010, J MED VIROL, V82, P562, DOI 10.1002/jmv.21724; Ciccozzi M, 2012, J MED VIROL, V84, P1613, DOI 10.1002/jmv.23384; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; FROMMEL D, 1993, AM J TROP MED HYG, V49, P435, DOI 10.4269/ajtmh.1993.49.435; Galli A, 2014, TRENDS MICROBIOL, V22, P354, DOI 10.1016/j.tim.2014.02.005; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hundie GB, 2017, J VIRAL HEPATITIS, V24, P163, DOI 10.1111/jvh.12631; Hundie GB, 2017, J MED VIROL; Iles JC, 2015, J CLIN MICROBIOL, V53, P3155, DOI 10.1128/JCM.00483-15; Iles JC, 2014, VIROLOGY, V464, P233, DOI 10.1016/j.virol.2014.07.006; Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; Kamal SM, 2011, LIVER INT, V31, P45, DOI 10.1111/j.1478-3231.2010.02385.x; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Markov PV, 2012, J VIROL, V86, P7677, DOI 10.1128/JVI.06910-11; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Murphy DG, 2015, J CLIN MICROBIOL, V53, P967, DOI 10.1128/JCM.02831-14; Ndong-Atome GR, 2008, J MED VIROL, V80, P1581, DOI 10.1002/jmv.21252; Njouom R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042002; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Noppornpanth S, 2006, J VIROL, V80, P7569, DOI 10.1128/JVI.00312-06; Noppornpath S, 2008, J GEN VIROL, V89, P1276, DOI 10.1099/vir.0.83593-0; Purdy MA, 2015, J GEN VIROL, V96, P2157, DOI 10.1099/vir.0.000153; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rose R, 2013, INFECT GENET EVOL, V20, P418, DOI 10.1016/j.meegid.2013.09.029; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Shire AM, 2012, MAYO CLIN PROC, V87, P17, DOI 10.1016/j.mayocp.2011.08.001; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wantuck JM, 2014, ALIMENT PHARM THER, V39, P137, DOI 10.1111/apt.12551	45	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0179064	10.1371/journal.pone.0179064	http://dx.doi.org/10.1371/journal.pone.0179064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570623	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800137
J	Park, JY; Kim, SH; Lee, SM; Lee, JS; Han, JK				Park, Jin Young; Kim, Se Hyung; Lee, Sang Min; Lee, Jeong Sub; Han, Joon Koo			CT volumetric measurement of colorectal cancer helps predict tumor staging and prognosis	PLOS ONE			English	Article							MULTIDETECTOR ROW CT; RECTAL-CANCER; GASTRIC-CARCINOMA; DIAGNOSTIC-VALUE; COLONOGRAPHY; CHEMORADIOTHERAPY; MULTIPLANAR; ENEMA	Purpose To evaluate feasibility of CT colonography (CTC) volumetry of colorectal cancer (CRC) and its correlation with disease stage and patients' survival. Materials and methods CTC volumetry was performed for 126 patients who underwent preoperative CTC. Reproducibility of tumor volume (Tvol) between two readers was assessed. One-way ANOVA and ROC analysis evaluated correlation between Tvol and pTNM staging. ROC analysis compared diagnostic performance to predict pTNM staging between Tvol and radiologist. Kaplan-Meier test compared overall survival. Results Reproducibility among readers was excellent (interclass correlation = 0.9829). Mean Tvol showed an incremental trend with T stage and Tvol of pT4b stage was significantly larger than other stages (P < 0.0001). Az value (0.780) of Tvol to predict pT4b stage was significantly larger than that (0.591) of radiologist (P = 0.004). However, Tvol was not significantly different according to pN stage. Az values (0.723 similar to 0.857) of Tvol to predict M1 or M1b were comparable to those (0.772 similar to 0.690) of radiologist (P > 0.05). Smaller tumor burden (<= 12.85cm(3)), <= T3, N0, M0 stages, and curative surgery were significantly associated with patients' longer survival (P < 0.05). Conclusion CT volumetry has a limited value to predict N stage; however, it may outperform the radiologist's performance when predicting pT4b and M1b stage and can be a useful prognostic marker.	[Park, Jin Young] Dongnam Inst, Radiol & Med Sci Canc Ctr, Busan, South Korea; [Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Lee, Sang Min] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Anyang, South Korea; [Lee, Jeong Sub] Jeju Natl Univ Hosp, Dept Radiol, Jeju, South Korea; [Han, Joon Koo] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University; Jeju National University; Seoul National University (SNU)	Kim, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.	shkim7071@gmail.com			National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning [NRF 2016R1A2B4007762]; Seoul National University Hospital [03-2016-450]	National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning; Seoul National University Hospital	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea [NRF] funded by the Ministry of Science, ICT & Future Planning [NRF 2016R1A2B4007762] http://www.nrf.re.kr and by the Seoul National University Hospital Research Fund No. 03-2016-450(http://www.snuh.org) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Dighe S, 2010, CLIN RADIOL, V65, P708, DOI 10.1016/j.crad.2010.01.024; Filippone A, 2004, RADIOLOGY, V231, P83, DOI 10.1148/radiol.2311021152; Hallinan JTPD, 2014, EUR RADIOL, V24, P3105, DOI 10.1007/s00330-014-3316-5; Jin KN, 2006, EUR RADIOL, V16, P2284, DOI 10.1007/s00330-006-0316-0; Kato T, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1027-x; Kikuchi S, 2001, IN VIVO, V15, P295; Kikuchi S, 2000, LANGENBECK ARCH SURG, V385, P225, DOI 10.1007/s004230050269; Kim YH, 2005, INT J RADIAT ONCOL, V62, P761, DOI 10.1016/j.ijrobp.2004.11.005; Murono K, 2014, DIS COLON RECTUM, V57, P715, DOI 10.1097/DCR.0000000000000070; Nagata K, 2004, DIGEST SURG, V21, P352, DOI 10.1159/000081543; Nougaret S, 2012, RADIOLOGY, V263, P409, DOI 10.1148/radiol.12111263; Seierstad T, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150097; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sinha R, 2006, CLIN RADIOL, V61, P924, DOI 10.1016/j.crad.2006.03.019; Utano K, 2008, DIS COLON RECTUM, V51, P875, DOI 10.1007/s10350-008-9261-0; VanderMeer TJ, 1997, HEMATOL ONCOL CLIN N, V11, P759, DOI 10.1016/S0889-8588(05)70459-7; Wang C, 2005, LANGENBECK ARCH SURG, V390, P312, DOI 10.1007/s00423-005-0562-7	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178522	10.1371/journal.pone.0178522	http://dx.doi.org/10.1371/journal.pone.0178522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570580	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800071
J	Rangel, M; Castro, FFD; Mota-Lima, LD; Clissa, PB; Martins, DB; Cabrera, MPD; Mortari, MR				Rangel, Marisa; dos Santos Castro, Fabiola Fernandes; Mota-Lima, Lilian Daiene; Clissa, Patricia Bianca; Martins, Danubia Batista; dos Santos Cabrera, Marcia Perez; Mortari, Marcia Renata			Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction	PLOS ONE			English	Article							BIOLOGICAL CHARACTERIZATION; ANTIBACTERIAL PEPTIDES; MASTOPARAN PEPTIDES; LIPID-COMPOSITION; ANTIBIOTICS; RESISTANCE; MECHANISM; VENOM; PERMEABILITY; INVERTEBRATES	The rapid spread of multi-drug resistant pathogens represents a serious threat to public health, considering factors such as high mortality rates, treatment restrictions and high prevalence of multi-drug resistant bacteria in the hospital environment. Antimicrobial peptides (AMPs) may exhibit powerful antimicrobial activity against different and diverse microorganisms, also presenting the advantage of absence or low toxicity towards animal cells. In this study, the evaluation of the antimicrobial activity against multi-drug resistant bacteria of a recently described AMP from wasp, Polydim-I, was performed. Polydim-I presented activity against standard strains (non-carriers of multi-resistant genes) that are susceptible to commercial antimicrobials, and also against multi-drug resistant strains at concentrations bellow 1 mu g/ml (0.41 mu M). This is a rather low concentration among those reported for AMPs. At this concentration we found out that Polydim-I inhibits almost 100% of the tested pathogens growth, while with the ATCC strains the minimum inhibitory concentration (MIC100) is 400 times higher. Also, in relation to in vitro activity of conventional drugs against multi-drug resistant bacteria strains, Polydim-I is almost 10 times more efficient and with broader spectrum. Cationic AMPs are known as multi-target compounds and specially for targeting the phospholipid matrix of bacterial membranes. Exploring the interactions of Polydim-I with lipid bilayers, we have confirmed that this interaction is involved in the mechanism of action. Circular dichroism experiments showed that Polydim-I undergoes a conformational transition from random coil to a mostly helical conformation in the presence of membrane mimetic environments. Zeta potential measurements confirmed the binding and partial charge neutralization of anionic asolectin vesicles, and also suggested a possible aggregation of peptide molecules. FTIR experiments confirmed that some peptide aggregation occurs, which is minimized in the presence of strongly anionic micelles of sodium dodecyl sulfate. Also, Polydim-I induced channel-like structures formation to asolectin lipid bilayers, as demonstrated in the electrophysiology experiments. We suggest that cationic Polydim-I targets the membrane lipids due to electrostatic attraction, partially accumulates, neutralizing the opposite charges and induces pore formation. Similar mechanism of action has already been suggested for other peptides from wasp venoms, especially mastoparans.	[Rangel, Marisa; Mota-Lima, Lilian Daiene; Clissa, Patricia Bianca] Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil; [Rangel, Marisa; dos Santos Castro, Fabiola Fernandes; Mortari, Marcia Renata] Univ Brasilia, Inst Biol Sci, Dept Physiol Sci, Lab Neuropharmacol, Brasilia, DF, Brazil; [Martins, Danubia Batista; dos Santos Cabrera, Marcia Perez] Univ Estadual Paulista, UNESP, Dept Fis, Sao Jose Do Rio Preto, SP, Brazil; [dos Santos Cabrera, Marcia Perez] Univ Estadual Paulista, UNESP, Dept Quim & Ciencias Ambientais, Sao Jose Do Rio Preto, SP, Brazil	Instituto Butantan; Universidade de Brasilia; Universidade Estadual Paulista; Universidade Estadual Paulista	Rangel, M (corresponding author), Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil.; Rangel, M (corresponding author), Univ Brasilia, Inst Biol Sci, Dept Physiol Sci, Lab Neuropharmacol, Brasilia, DF, Brazil.	marisarangel2112@gmail.com	dos Santos Cabrera, Marcia Perez/K-3815-2012; Mortari, Márcia R/K-6119-2015; Rangel, Marisa/P-5189-2019; Clissa, Patricia Bianca/AAW-1569-2020	dos Santos Cabrera, Marcia Perez/0000-0001-7443-2883; Castro, Fabiola/0000-0002-5535-045X; Rangel, Marisa/0000-0002-0545-2490; Mortari, Marcia Renata/0000-0002-6849-6001	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2008/00173-4, 2012/24259-0, 2014/08372-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [473645/2012-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grants 2008/00173-4 to M.R.; 2012/24259-0 and 2014/08372-7 to M.P.S.C.). Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grant 473645/2012-2 to M.R.). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES to D.B.M., fellowship recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, KONEMANS COLOR ATLAS; Arcisio-Miranda M, 2008, TOXICON, V51, P736, DOI 10.1016/j.toxicon.2007.11.023; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Boland MP, 2006, BBA-BIOMEMBRANES, V1758, P1178, DOI 10.1016/j.bbamem.2006.02.010; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cabrera MPD, 2004, J PEPT RES, V64, P95, DOI 10.1111/j.1399-3011.2004.00173.x; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; das Neves RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149729; de Souza BM, 2009, PEPTIDES, V30, P1387, DOI 10.1016/j.peptides.2009.05.008; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Cabrera MPDS, 2008, J PEPT SCI, V14, P661, DOI 10.1002/psc.960; Cabrera MPD, 2009, ARCH BIOCHEM BIOPHYS, V486, P1, DOI 10.1016/j.abb.2009.03.009; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Dunnick JK, 1970, J BACTERIOL, V101, P892, DOI 10.1128/JB.101.3.892-900.1970; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Haney EF, 2013, BIOPOLYMERS, V100, P572, DOI 10.1002/bip.22250; Kong KF, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2009.02563.x; Konno K, 2006, PEPTIDES, V27, P2624, DOI 10.1016/j.peptides.2006.04.013; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Leite NB, 2011, AMINO ACIDS, V40, P91, DOI 10.1007/s00726-010-0511-9; Li ML, 2000, INT J ANTIMICROB AG, V13, P203, DOI 10.1016/S0924-8579(99)00127-2; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; Mendes MA, 2005, TOXICON, V45, P101, DOI 10.1016/j.toxicon.2004.09.015; Mingeot-Leclercq MP, 2016, MEDCHEMCOMM, V7, P586, DOI 10.1039/c5md00503e; Mortari MR, 2007, PHARMACOL THERAPEUT, V114, P171, DOI 10.1016/j.pharmthera.2007.01.009; Nakajima T., 1986, P309; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; ONeill J., 2014, REV ANTIMICROB RESIS; Orsini Jose, 2012, J Clin Med Res, V4, P371, DOI 10.4021/jocmr1099w; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Rangel M, 2011, TOXICON, V57, P1081, DOI 10.1016/j.toxicon.2011.04.014; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Sal-Man N, 2002, BIOCHEMISTRY-US, V41, P11921, DOI 10.1021/bi0260482; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6820; Souza BM, 2005, PEPTIDES, V26, P2157, DOI 10.1016/j.peptides.2005.04.026; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Tomasinsig L, 2006, J BIOL CHEM, V281, P383, DOI 10.1074/jbc.M510354200; Vila-Farres X, 2012, CLIN MICROBIOL INFEC, V18, P383, DOI 10.1111/j.1469-0691.2011.03581.x; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yamachika S, 2013, J MED MICROBIOL, V62, P429, DOI 10.1099/jmm.0.051631-0; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zgurskaya HI, 2015, ACS INFECT DIS, V1, P512, DOI 10.1021/acsinfecdis.5b00097; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	61	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178785	10.1371/journal.pone.0178785	http://dx.doi.org/10.1371/journal.pone.0178785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570651	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800122
J	Bell, KL; Hamm, CA; Shapiro, AM; Nice, CC				Bell, Katherine L.; Hamm, Christopher A.; Shapiro, Arthur M.; Nice, Chris C.			Sympatric, temporally isolated populations of the pine white butterfly Neophasia menapia, are morphologically and genetically differentiated	PLOS ONE			English	Article							INCIPIENT ALLOCHRONIC SPECIATION; HOST FIDELITY; RACES; MOTH; LEPIDOPTERA; DISRUPTION; DIVERSITY; INFERENCE; APPLE	Temporal isolation remains an understudied, and potentially under-appreciated, mechanism of reproductive isolation. Phenological differences have been discovered in populations of the pine white butterfly (Neophasia menapia), a typically univoltine species found throughout western North America. At two locations in the Coast Range of California there are two periods of adult emergence per year, one in early summer (July) and one in late summer/ autumn (September/October). Differences in flight time are accompanied by differences in wing shape and pigmentation. Here we use a combination of population genomics and morphological analyses to assess the extent to which temporal isolation is able to limit gene flow between sympatric early and late flights. Not only did we detect both genetic and morphological differences between early and late flights at the two sites, we also found that the patterns of differentiation between the two flights were different at each location, suggesting an independent origin for the two sympatric flights. Additionally, we found no evidence that these sympatric flights originated via colonization from any of the other sampled localities. We discuss several potential hypotheses about the origin of these temporally isolated sympatric flights.	[Bell, Katherine L.; Nice, Chris C.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Hamm, Christopher A.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Shapiro, Arthur M.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Texas State University System; Texas State University San Marcos; University of Kansas; University of California System; University of California Davis	Bell, KL (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	kbell@txstate.edu		Bell, Katherine/0000-0003-1563-2468	Office of the Associate Vice President for Research, Texas State University	Office of the Associate Vice President for Research, Texas State University	This work was supported by Office of the Associate Vice President for Research, Texas State University awarded to CCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot P, 2004, EVOLUTION, V58, P539, DOI 10.1111/j.0014-3820.2004.tb01677.x; ALEXANDER RD, 1960, EVOLUTION, V14, P334, DOI 10.1111/j.1558-5646.1960.tb03095.x; Blevins T. B., 1944, BULL SO CALIFORNIA ACAD SCI, V43, P122; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Boumans L, 2017, ECOL EVOL, V7, P1635, DOI 10.1002/ece3.2638; Brock JP, 2006, KAUFMAN FIELD GUIDE; Comstock J. A., 1924, Bulletin of the Southern California Academy of Sciences, V23, P18; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Devaux C, 2009, J EVOLUTION BIOL, V22, P1460, DOI 10.1111/j.1420-9101.2009.01762.x; Elrod MJ, 1906, BUTTERFLIES MONTANA, V10; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evenden JC, 1926, J AGRIC RES, V33, P0339; Falush D, 2003, GENETICS, V164, P1567; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; Ferris C.D., 1981, BUTTERFLIES ROCKY MO; Fitzpatrick BM, 2012, INT J ECOL, V2012, P1, DOI [rg/10.1155/2012/256017, DOI 10.1155/2012/256017]; Fletcher J., 1905, CAN ENTOMOL, V37, P157; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Garth J.S., 1986, CALIFORNIA BUTTERFLI, V51; Garth JS, 1930, B SO CALIF ACAD SCI, V29, P37; Gillespie J. H., 2004, POPULATION GENETICS; Glassberg J, 1999, BUTTERFLIES BINOCULA; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gompert Z, 2012, EVOLUTION, V66, P2167, DOI 10.1111/j.1558-5646.2012.01587.x; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; GUPPY CS, 2001, BUTTERFLIES BRIT COL; Hanson D, 2016, J EVOLUTION BIOL, V29, P47, DOI 10.1111/jeb.12761; Hedrick P.W., 2011, GENETICS POPULATIONS; Hillis DM, 1996, MOL SYSTEMATICS, V23; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; LAYBERRY R., 1998, BUTTERFLIES CANADA; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marrone G. M, 2002, FIELD GUIDE BUTTERFL; Monteiro CA, 2016, SCI REPORTS, P6; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ording GJ, 2010, OECOLOGIA, V162, P523, DOI 10.1007/s00442-009-1493-8; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Santos H, 2011, J EVOLUTION BIOL, V24, P1897, DOI 10.1111/j.1420-9101.2011.02318.x; Santos H, 2011, J EVOLUTION BIOL, V24, P146, DOI 10.1111/j.1420-9101.2010.02147.x; Santos H, 2007, P ROY SOC B-BIOL SCI, V274, P935, DOI 10.1098/rspb.2006.3767; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott J., 1992, BUTTERFLIES N AM NAT; Scott J. A., 1986, BUTTERFLIES N AM NAT; Shapiro A.M., 1981, Journal of Research on the Lepidoptera, V18, P69; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; Shapiro A.M., 2007, FIELD GUIDE BUTTERFL, V1, P167; Shapiro Arthur M., 2005, Journal of the Lepidopterists' Society, V59, P161; Thomas Y, 2003, EVOLUTION, V57, P261; Tomaiuolo M, 2007, EVOLUTION, V61, P2584, DOI 10.1111/j.1558-5646.2007.00218.x; Yamamoto S, 2012, MOL ECOL, V21, P174, DOI 10.1111/j.1365-294X.2011.05371.x; Yamamoto S, 2009, P R SOC B, V276, P2711, DOI 10.1098/rspb.2009.0349	56	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0176989	10.1371/journal.pone.0176989	http://dx.doi.org/10.1371/journal.pone.0176989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562656	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700007
J	Krafft, FC; Stetter, BJ; Stein, T; Ellermann, A; Flechtenmacher, J; Eberle, C; Sell, S; Potthast, W				Krafft, Frieder Cornelius; Stetter, Bernd Josef; Stein, Thorsten; Ellermann, Andree; Flechtenmacher, Johannes; Eberle, Christian; Sell, Stefan; Potthast, Wolfgang			How does functionality proceed in ACL reconstructed subjects? Proceeding of functional performance from pre -to six months post-ACL reconstruction	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; HOP TESTS; STRENGTH TEST; TEST BATTERY; FOLLOW-UP; INJURY; KNEE; QUADRICEPS; REHABILITATION; SYMMETRY	This is the first study examining functionality of subjects with anterior cruciate ligament (ACL) tears and a subsequent reconstruction comprehensively by multiple test sessions from pre to six months post-reconstruction. The purpose was to evaluate if a generally applied rehabilitation program restores functionality to levels of healthy controls. Subjects with unilateral tears of the ACL were compared to matched healthy controls throughout the rehabilitation. 20 recreational athletes were tested: T-1 (preoperative), 6 weeks after tear; T-2, 6 weeks, T-3, 3 months, T-4, 6 months post-reconstruction. At all test sessions, subjects self-evaluated their activity level with the Tegner activity score and their knee state with the Knee Injury and Osteoarthritis Outcome Score. Passive range of motion during knee flexion and extension and leg circumference were measured as functional clinical tests. Bilateral countermovement jumps, one-leg jumps for distance and isometric force tests in knee flexion and extension with 90 and 110 knee angle were conducted as functional performance tests. For determination of functionality, leg symmetry indices (LSIs) were calculated by dividing values of the injured by the uninjured leg. In the ACL group most LSIs decreased from T-1 to T2, and increased from T2 and T3 to T4. LSIs of ACL subjects remained lower than LSIs of healthy controls at 6 months post-reconstruction in nearly all parameters. Self-evaluation of ACL subjects showed, additionally, that activity level was lower than the pre-injury level at 6 months post-reconstruction. Low LSIs and low self-evaluation indicate that knee joint functionality is not completely restored at 6 months post-reconstruction. The study shows that multiple comprehensive testing throughout the rehabilitation gives detailed images of the functional state. Therefore, the functional state of ACL reconstructed individuals should be evaluated comprehensively and continuously throughout the rehabilitation to detect persisting deficiencies detailed and adapt rehabilitation programs individually depending on the functionality.	[Krafft, Frieder Cornelius; Stetter, Bernd Josef; Sell, Stefan] KIT, Inst Sports & Sports Sci, Sports Orthopaed, Karlsruhe, Germany; [Krafft, Frieder Cornelius; Stein, Thorsten] KIT, Inst Sports & Sports Sci, BioMot Ctr, Karlsruhe, Germany; [Ellermann, Andree; Eberle, Christian; Potthast, Wolfgang] Arcus Sports Clin, Pforzheim, Germany; [Flechtenmacher, Johannes] Ortho Zentrum, Karlsruhe, Germany; [Sell, Stefan] Hosp Neuenburg, Joint Ctr Black Forest, Neuenburg, Germany; [Potthast, Wolfgang] GSU, Inst Biomech & Orthopaed, Cologne, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; German Sport University Cologne	Krafft, FC (corresponding author), KIT, Inst Sports & Sports Sci, Sports Orthopaed, Karlsruhe, Germany.; Krafft, FC (corresponding author), KIT, Inst Sports & Sports Sci, BioMot Ctr, Karlsruhe, Germany.	frieder.krafft@kit.edu	Krafft, Frieder/AAP-4971-2021	Krafft, Dr. Frieder C./0000-0002-1865-9255; Stetter, Bernd/0000-0002-5291-4299	Hanns-Seidel-Foundation; Feasibility Study for Young Scientists (FYS) of the Karlsruhe Institute of Technology (KIT); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the KIT	Hanns-Seidel-Foundation; Feasibility Study for Young Scientists (FYS) of the Karlsruhe Institute of Technology (KIT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the KIT	This study was supported by the Hanns-Seidel-Foundation e.V., which funded the first author with a PhD scholarship, and by a Feasibility Study for Young Scientists (FYS) of the Karlsruhe Institute of Technology (KIT). Additionally, we acknowledge the support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the KIT.; This study was supported by the Hanns-Seidel-Foundation e.V., which funded the first author with a PhD scholarship, and by a Feasibility Study for Young Scientists (FYS) of the Karlsruhe Institute of Technology (KIT). Additionally, we acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the KIT.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Almangoush A, 2014, INT SCH RES NOTICES; Arampatzis A, 2004, CLIN BIOMECH, V19, P277, DOI 10.1016/j.clinbiomech.2003.11.011; BARBER SD, 1990, CLIN ORTHOP RELAT R, P204; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511; de Fontenay BP, 2015, KNEE, V22, P309, DOI 10.1016/j.knee.2015.04.012; Eastlack ME, 1999, MED SCI SPORT EXER, V31, P210, DOI 10.1097/00005768-199902000-00002; Fitzgerald GK, 2000, KNEE SURG SPORT TR A, V8, P76, DOI 10.1007/s001670050190; Gokeler A, 2009, SCAN J MED SCI SPOR, V20, P12; Gustavsson A, 2006, KNEE SURG SPORT TR A, V14, P778, DOI 10.1007/s00167-006-0045-6; Hartigan EH, 2010, J ORTHOP SPORT PHYS, V40, P141, DOI 10.2519/jospt.2010.3168; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; HOLM S, 1979, SCAND J STAT, V6, P65; Janda V, 2000, MANUELLE MUSKELFUNKT, V4; Kubo K, 2004, EUR J APPL PHYSIOL, V91, P349, DOI 10.1007/s00421-003-1025-x; Lentz TA, 2009, SPORTS HEALTH, V1, P47, DOI 10.1177/1941738108326700; Li RCT, 1996, BRIT J SPORT MED, V30, P161, DOI 10.1136/bjsm.30.2.161; LORENTZON R, 1989, AM J SPORT MED, V17, P423, DOI 10.1177/036354658901700318; McHugh MP, 2002, AM J SPORT MED, V30, P334, DOI 10.1177/03635465020300030601; Myer GD, 2008, J STRENGTH COND RES, V22, P987, DOI 10.1519/JSC.0b013e31816a86cd; Myklebust G, 2003, AM J SPORT MED, V31, P981, DOI 10.1177/03635465030310063901; Narducci E, 2011, INT J SPORTS PHYS TH, V6, P333; Neeter C, 2006, KNEE SURG SPORT TR A, V14, P571, DOI 10.1007/s00167-006-0040-y; NOYES FR, 1991, AM J SPORT MED, V19, P513, DOI 10.1177/036354659101900518; Orishimo KF, 2010, KNEE SURG SPORT TR A, V18, P1587, DOI 10.1007/s00167-010-1185-2; Petersen W, 2013, ARCH ORTHOP TRAUM SU, V133, P969, DOI 10.1007/s00402-013-1746-1; Petschnig R, 1998, J ORTHOP SPORT PHYS, V28, P23, DOI 10.2519/jospt.1998.28.1.23; Phillips N, 2000, PHYS THER SPORT, V1, P106; Reid A, 2007, PHYS THER, V87, P337, DOI 10.2522/ptj.20060143; Rohman E, 2015, AM J SPORT MED, V43, P1391, DOI 10.1177/0363546515576127; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Rudolph KS, 2000, KNEE SURG SPORT TR A, V8, P262, DOI 10.1007/s001670000130; Sernert N, 1999, KNEE SURG SPORT TR A, V7, P160, DOI 10.1007/s001670050141; Shelbourne KD, 2006, J ORTHOP SCI, V11, P318, DOI 10.1007/s00776-006-1007-z; Soderberg G L, 1996, Physiother Res Int, V1, P7, DOI 10.1002/pri.43; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Thomas AC, 2016, J SCI MED SPORT, V19, P7, DOI 10.1016/j.jsams.2014.12.009; Walden M, 2011, KNEE SURG SPORT TR A, V19, P11, DOI 10.1007/s00167-010-1170-9; Whiting WC, BIOMECHANICS MUSCULO, V2; WILK KE, 1994, J ORTHOP SPORT PHYS, V20, P60, DOI 10.2519/jospt.1994.20.2.60; Williams GN, 2001, J ORTHOP SPORT PHYS, V31, P546, DOI 10.2519/jospt.2001.31.10.546; Wright RW, 2010, AM J SPORT MED, V38, P1979, DOI 10.1177/0363546510378645	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178430	10.1371/journal.pone.0178430	http://dx.doi.org/10.1371/journal.pone.0178430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562674	gold, Green Published			2022-12-26	WOS:000402608700060
J	Ruzafa, D; Hernandez-Gomez, YS; Bisello, G; Broersen, K; Morel, B; Conejero-Lara, F				Ruzafa, David; Hernandez-Gomez, Yuriko S.; Bisello, Giovanni; Broersen, Kerensa; Morel, Bertrand; Conejero-Lara, Francisco			The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; HELICAL CONFORMATION; EXTENDED-HELIX; COMPLEX-FORMATION; MEMBRANE-BINDING; LIPID VESICLES; WILD-TYPE; MUTATION; FORMS; FIBRILLATION	The biological function of alpha-Synuclein has been related to binding to lipids and membranes but these interactions can also mediate alpha-Synuclein aggregation, which is associated to Parkinson's disease and other neuropathologies. In brain tissue alpha-Synuclein is constitutively N-acetylated, a modification that plays an important role in its conformational propensity, lipid and membrane binding, and aggregation propensity. We studied the interactions of the lipid-mimetic SDS with N-acetylated and non-acetylated alpha-Synuclein, as well as their early onset Parkinson's disease variants A30P, E46K and A53T. At low SDS/protein ratios aSynuclein forms oligomeric complexes with SDS micelles with relatively low alpha-helical structure. These micellar oligomers can efficiently nucleate aggregation of monomeric alpha-Synuclein, with successive formation of oligomers, protofibrils, curly fibrils and mature amyloid fibrils. N-acetylation reduces considerably the rate of aggregation of WT alpha-Synuclein. However, in presence of any of the early-onset Parkinson's disease mutations the protective effect of N-acetylation against micelle-induced aggregation becomes impaired. At higher SDS/protein ratios, N-acetylation favors another conformational transition, in which a second type of alpha-helix-rich, non-aggregating oligomers become stabilized. Once again, the Parkinson's disease mutations disconnect the influence of N-acetylation in promoting this transition. These results suggest a cooperative link between the N-terminus and the region of the mutations that may be important for alpha-Synuclein function.	[Ruzafa, David; Hernandez-Gomez, Yuriko S.; Bisello, Giovanni; Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Ruzafa, David; Hernandez-Gomez, Yuriko S.; Bisello, Giovanni; Morel, Bertrand; Conejero-Lara, Francisco] Univ Granada, Fac Ciencias, Inst Biotecnol, Granada, Spain; [Broersen, Kerensa] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Nanobiophys Grp, Enschede, Netherlands	University of Granada; University of Granada; University of Twente	Conejero-Lara, F (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain.; Conejero-Lara, F (corresponding author), Univ Granada, Fac Ciencias, Inst Biotecnol, Granada, Spain.	conejero@ugr.es	Lara, Francisco Conejero/F-2962-2016	Lara, Francisco Conejero/0000-0002-8282-2168; Morel, Bertrand/0000-0002-2708-8589; Bisello, Giovanni/0000-0002-3803-9555	Spanish Ministry of Economy and Competitivity [BIO2009-07317, BIO2013-40697-R]; Andalusian Government [FQM-02838]; Research Program of the University of Granada [PP2012-PI06]; European Regional Development Fund of the European Union	Spanish Ministry of Economy and Competitivity(Spanish Government); Andalusian Government; Research Program of the University of Granada; European Regional Development Fund of the European Union	This research was funded by Grants BIO2009-07317 and BIO2013-40697-R from the Spanish Ministry of Economy and Competitivity (http://www.mineco.gob.es), Grant FQM-02838 from the Andalusian Government (http://www.juntadeandalucia.es), Grant PP2012-PI06 from the Research Program of the University of Granada (http://investigacion.ugr.es) and by the European Regional Development Fund of the European Union.	Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Barhoum S, 2013, EUR BIOPHYS J BIOPHY, V42, P405, DOI 10.1007/s00249-013-0890-4; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Cheng FR, 2011, J CHEM NEUROANAT, V42, P242, DOI 10.1016/j.jchemneu.2010.12.001; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; Dettmer U, 2016, CURR OPIN NEUROBIOL, V36, P15, DOI 10.1016/j.conb.2015.07.007; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Ferreon ACM, 2010, ANGEW CHEM INT EDIT, V49, P3469, DOI 10.1002/anie.201000378; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Iljina M., 2016, SCI REP, V6; Iyer A, 2016, J BIOL CHEM, V291, P21110, DOI 10.1074/jbc.M116.726612; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075018; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Perlmutter JD, 2009, J BIOL CHEM, V284, P7177, DOI 10.1074/jbc.M808895200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Price WS, 1997, CONCEPT MAGNETIC RES, V9, P299, DOI 10.1002/(SICI)1099-0534(1997)9:5<299::AID-CMR2>3.3.CO;2-2; Rao JN, 2009, J MOL BIOL, V390, P516, DOI 10.1016/j.jmb.2009.05.058; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Ruzafa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049690; Serra-Batiste M, 2016, P NATL ACAD SCI USA, V113, P10866, DOI 10.1073/pnas.1605104113; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Wang LN, 2014, CURR BIOL, V24, P2319, DOI 10.1016/j.cub.2014.08.027; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	71	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178576	10.1371/journal.pone.0178576	http://dx.doi.org/10.1371/journal.pone.0178576			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562630	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700075
J	Stich, S; Loch, A; Park, SJ; Haupl, T; Ringe, J; Sittinger, M				Stich, Stefan; Loch, Alexander; Park, Su-Jin; Haeupl, Thomas; Ringe, Jochen; Sittinger, Michael			Characterization of single cell derived cultures of periosteal progenitor cells to ensure the cell quality for clinical application	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MAXILLARY SINUS AUGMENTATION; IN-VITRO; BONE; CARTILAGE; TISSUES; KNEE	For clinical applications of cells and tissue engineering products it is of importance to characterize the quality of the used cells in detail. Progenitor cells from the periosteum are already routinely applied in the clinics for the regeneration of the maxillary bone. Periosteal cells have, in addition to their potential to differentiate into bone, the ability to develop into cartilage and fat. However, the question arises whether all cells isolated from periosteal biopsies are able to differentiate into all three tissue types, or whether there are subpopulations. For an efficient and approved application in bone or cartilage regeneration the clarification of this question is of interest. Therefore, 83 different clonal cultures of freshly isolated human periosteal cells derived from mastoid periosteum biopsies of 4 donors were generated and growth rates calculated. Differentiation capacities of 51 clonal cultures towards the osteogenic, the chondrogenic, and the adipogenic lineage were investigated. Histological and immunochemical stainings showed that 100% of the clonal cultures differentiated towards the osteogenic lineage, while 94.1% demonstrated chondrogenesis, and 52.9% could be stimulated to adipogenesis. For osteogenesis real-time polymerase chain reaction (PCR) of BGLAP and RUNX2 and for adipogenesis of FABP4 and PPARG confirmed the results. Overall, 49% of the cells exhibited a tripotent potential, 45.1% showed a bipotent potential (without adipogenic differentiation), 3.9% bipotent (without chondrogenic differentiation), and 2% possessed a unipotent osteogenic potential. In FACS analyses, no differences in the marker profile of undifferentiated clonal cultures with bi- and tripotent differentiation capacity were found. Genome-wide microarray analysis revealed 52 differentially expressed genes for clonal subpopulations with or without chondrogenic differentiation capacity, among them DCN, NEDD9, TGFBR3, and TSLP. For clinical applications of periosteal cells in bone regeneration all cells were inducible. For a chondrogenic application a fraction of 6% of the mixed population could not be induced.	[Stich, Stefan; Park, Su-Jin; Ringe, Jochen; Sittinger, Michael] Charite, Dept Rheumatol & Clin Immunol, Tissue Engn Lab, Berlin, Germany; [Stich, Stefan; Park, Su-Jin; Ringe, Jochen; Sittinger, Michael] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Loch, Alexander] Charite, Dept Otorhinolaryngol, Berlin, Germany; [Haeupl, Thomas] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Park, Su-Jin] Charite, Inst Medicial Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stich, S (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Tissue Engn Lab, Berlin, Germany.; Stich, S (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	stefan.stich@charite.de			European Regional Development Fund [10128098]; Berlin-Brandenburg Center for Regenerative Therapies (Bundesministerium fur Bildung und Forschung) [13GW0099]; Investitionsbank Berlin	European Regional Development Fund(European Commission); Berlin-Brandenburg Center for Regenerative Therapies (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Investitionsbank Berlin(European Commission)	This study was supported by the Investitionsbank Berlin and the European Regional Development Fund (grant 10128098), and the Berlin-Brandenburg Center for Regenerative Therapies (Bundesministerium fur Bildung und Forschung, grant 13GW0099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully thank Anja Wachtel, Johanna Golla and Samuel Vetterlein for their excellent technical assistance. This study was supported by the Investitionsbank Berlin and the European Regional Development Fund (grant 10128098), and the Berlin-Brandenburg Center for Regenerative Therapies (Bundesministerium fur Bildung und Forschung, grant 13GW0099).	Aquino JB, 2008, GENE EXPR PATTERNS, V8, P217, DOI 10.1016/j.gep.2008.01.001; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Muraglia A, 2000, J CELL SCI, V113, P1161; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; Ossendorf C, 2007, SAUDI MED J, V28, P1251; Park BW, 2007, ARCH ORAL BIOL, V52, P983, DOI 10.1016/j.archoralbio.2007.04.007; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ringe J, 2008, J TISSUE ENG REGEN M, V2, P136, DOI 10.1002/term.75; ROUGHLEY PJ, 1989, BIOCHEM J, V262, P823, DOI 10.1042/bj2620823; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009; Schmelzeisen Rainer, 2002, Ann R Australas Coll Dent Surg, V16, P50; Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x; Shin JU, 2016, J INVEST DERMATOL, V136, P507, DOI 10.1016/j.jid.2015.11.008; Stich S, 2008, EUR J CELL BIOL, V87, P365, DOI 10.1016/j.ejcb.2008.03.009; Tardif G, 2009, OSTEOARTHR CARTILAGE, V17, P263, DOI 10.1016/j.joca.2008.06.022; Trautvetter W, 2011, J ORAL MAXIL SURG, V69, P2753, DOI 10.1016/j.joms.2011.02.096; Ullah M, 2013, DIFFERENTIATION, V85, P78, DOI 10.1016/j.diff.2013.02.001; Zheng Yi-xiong, 2006, J Zhejiang Univ Sci B, V7, P817, DOI 10.1631/jzus.2006.B0817; Zhu SJ, 2006, ORAL SURG ORAL MED O, V101, P166, DOI 10.1016/j.tripleo.2005.04.006	24	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178560	10.1371/journal.pone.0178560	http://dx.doi.org/10.1371/journal.pone.0178560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562645	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700074
J	Doya, C; Chatzievangelou, D; Bahamon, N; Purser, A; De Leo, FC; Juniper, SK; Thomsen, L; Aguzzi, J				Doya, Carolina; Chatzievangelou, Damianos; Bahamon, Nixon; Purser, Autun; De Leo, Fabio C.; Juniper, S. Kim; Thomsen, Laurenz; Aguzzi, Jacopo			Seasonal monitoring of deep-sea megabenthos in Barkley Canyon cold seep by internet operated vehicle (IOV)	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; CONTINENTAL MARGINS; SUBMARINE CANYONS; CABLED OBSERVATORIES; DECAPOD CRUSTACEANS; BEHAVIORAL RHYTHMS; BUCCINUM-UNDATUM; NEPTUNE-CANADA; SITE FIDELITY; TIME-SERIES	Knowledge of the processes shaping deep-sea benthic communities at seasonal scales in cold-seep environments is incomplete. Cold seeps within highly dynamic regions, such as submarine canyons, where variable current regimes may occur, are particularly understudied. Novel Internet Operated Vehicles (10Vs), such as tracked crawlers, provide new techniques for investigating these ecosystems over prolonged periods. In this study a benthic crawler connected to the NEPTUNE cabled infrastructure operated by Ocean Networks Canada was used to monitor community changes across 60 m(2) of a cold-seep area of the Barkley Canyon, North East Pacific, at similar to 890 m depth within an Oxygen Minimum Zone (OMZ). Short video-transects were run at 4-h intervals during the first week of successive calendar months, over a 14 month period (February 14th 2013 to April 14th 2014). Within each recorded transect video megafauna abundances were computed and changes in environmental conditions concurrently measured. The responses of fauna to environmental conditions as a proxy of seasonality were assessed through analysis of abundances in a total of 438 video-transects (over 92 h of total footage). 7698 fauna individuals from 6 phyla (Cnidaria, Ctenophora, Arthropoda, Echinodermata, Mollusca, and Chordata) were logged and patterns in abundances of the 7 most abundant taxa (i.e. rockfish Sebastidae, sablefish Anoplopoma fimbria, hagfish Eptatretus stoutii, buccinids (Buccinoidea), undefined small crabs, ctenophores Bolinopsis infundibulum, and Scyphomedusa Poralia rufescens) were identified. Patterns in the reproductive behaviour of the grooved tanner crab (Chionnecetes tanner!) were also indicated. Temporal variations in biodiversity and abundance in megabenthic fauna was significantly influenced by variabilities in flow velocity flow direction (up or down canyon), dissolved oxygen concentration and month of study. Also reported here for the first time are transient mass aggregations of grooved tanner crabs through these depths of the canyon system, in early spring and likely linked to the crab's reproductive cycle.	[Doya, Carolina; Aguzzi, Jacopo] Inst Ciencias Mar ICM CSIC, Barcelona, Spain; [Chatzievangelou, Damianos; Thomsen, Laurenz] Jacobs Univ Bremen, Bremen, Germany; [Bahamon, Nixon] Ctr Estudios Avanzados Blanes CEAB CSIC, Blanes, Spain; [Purser, Autun] Alfred Wegener Inst, Deep Sea Ecol & Technol Grp, Bremerhaven, Germany; [De Leo, Fabio C.; Juniper, S. Kim] Univ Victoria, Ocean Networks Canada, Victoria, BC, Canada; [De Leo, Fabio C.; Juniper, S. Kim] Univ Victoria, Dept Biol, Victoria, BC, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Victoria; University of Victoria	Doya, C; Aguzzi, J (corresponding author), Inst Ciencias Mar ICM CSIC, Barcelona, Spain.	crldoya@icm.csic.es; jaguzzi@icm.csic.es	Bahamon, Nixon/O-2476-2019; Bahamon, Nixon/K-8922-2014; Doya, Carolina/AAK-3441-2021; Chatzievangelou, Damianos/AAE-4039-2020; Juniper, Kim/N-6769-2015; Aguzzi, Jacopo/D-6574-2012	Bahamon, Nixon/0000-0002-5802-7367; Bahamon, Nixon/0000-0002-5802-7367; Chatzievangelou, Damianos/0000-0001-7512-5105; Juniper, Kim/0000-0002-7608-260X; Doya Le Besnerais, Carolina/0000-0003-0083-7348; Aguzzi, Jacopo/0000-0002-1484-8219	Robotic Exploration of Extreme Environments (ROBEX) project; Helmholtz Alliance [HA-304]; RITFIM of the Spanish National RTD program [CTM2010-16274]; Ocean Networks Canada; Spanish Industry, Economy, and Competitiveness Ministry (MINECO); ROBEX project of the Helmholtz Society	Robotic Exploration of Extreme Environments (ROBEX) project; Helmholtz Alliance; RITFIM of the Spanish National RTD program; Ocean Networks Canada; Spanish Industry, Economy, and Competitiveness Ministry (MINECO); ROBEX project of the Helmholtz Society	This work was funded by the Robotic Exploration of Extreme Environments (ROBEX) project by Helmholtz Alliance (HA-304), http://www.helmoltz.de/ to DC AP; RITFIM (ref. CTM2010-16274) of the Spanish National RTD program to CD. Development and deployment of the crawler was co-funded by Ocean Networks Canada, http://www.oceannetworks.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted within the framework of Ocean Networks Canada (ONC) scientific activities, being led by Dr. J. Aguzzi "Science Theme Leader" for "Life in the North-East Pacific". C. Doya is a PhD Student with a FPI grant by Spanish Industry, Economy, and Competitiveness Ministry (MINECO). The authors would like to thank the shipboard teams and staff scientists of Ocean Networks Canada and OceanLab Bremen. Dr. S. Mihaly provided CTD and fluorometer data. The study was supported by ROBEX project of the Helmholtz Society.	Adams DK, 2011, SCIENCE, V332, P580, DOI 10.1126/science.1201066; Aguzzi J, 2015, REV FISH BIOL FISHER, V25, P463, DOI 10.1007/s11160-015-9387-9; Aguzzi J, 2013, PROG OCEANOGR, V118, P210, DOI 10.1016/j.pocean.2013.07.025; Aguzzi J, 2010, MAR ECOL PROG SER, V418, P47, DOI 10.3354/meps08835; Aguzzi J, 2015, DEEP-SEA RES PT I, V95, P1, DOI 10.1016/j.dsr.2014.10.003; Aguzzi J, 2012, OCEANOGR MAR BIOL, V50, P235; Aguzzi J, 2011, FRONT BIOSCI-LANDMRK, V16, P131, DOI 10.2741/3680; Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Aguzzi J, 2009, MAR ECOL-EVOL PERSP, V30, P93, DOI 10.1111/j.1439-0485.2008.00252.x; Allen SE, 2010, J GEOPHYS RES-OCEANS, V115, DOI [10.1029/2009JC00573, 10.1029/2009JC005731]; Armstrong CW, 2012, ECOSYST SERV, V2, P2, DOI 10.1016/j.ecoser.2012.07.001; Baillon S, 2012, FRONT ECOL ENVIRON, V10, P351, DOI 10.1890/120022; Bamstedt U, 2015, HYDROBIOLOGIA, V759, P3, DOI 10.1007/s10750-015-2180-x; Barnes C.R., 2015, SEAFLOOR OBSERVATORI, P415, DOI [10.1007/978-3-642-11374-1_16, DOI 10.1007/978-3-642-11374-1_16]; Barnes C.R., 2008, OCEANS 2008 MTS IEEE, P1, DOI [DOI 10.1109/OCEANSKOBE.2008.4531076, 10.1109/OCEANSKOBE.2008.4531076, DOI 10.1109/0CEANSK0BE.2008.4531076]; Belley R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151110; Brickley PJ, 2004, DEEP-SEA RES PT II, V51, P229, DOI 10.1016/j.dsr2.2003.06.003; Ceramicola S, 2015, CIESM MONOGRAPH, V47, P7; Chatzievangelou D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163808; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; Chu JWF, 2015, GLOBAL CHANGE BIOL, V21, P2989, DOI 10.1111/gcb.12898; Csepp DJ, 2011, FISH RES, V108, P307, DOI 10.1016/j.fishres.2011.01.003; Darnis G, 2014, J PLANKTON RES, V36, P1092, DOI 10.1093/plankt/fbu035; De Leo FC, 2012, DEEP-SEA RES PT I, V64, P54, DOI 10.1016/j.dsr.2012.01.014; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; Doya C, 2014, J MARINE SYST, V130, P69, DOI 10.1016/j.jmarsys.2013.04.003; Doya C, 2016, J MARINE SYST, V154, P280, DOI 10.1016/j.jmarsys.2015.09.005; Favali P, 2006, ANN GEOPH, V49, P2; Fernandez M, 2003, MAR BIOL, V142, P559, DOI 10.1007/s00227-002-0965-8; Fernandez-Arcaya U, 2013, PROG OCEANOGR, V118, P222, DOI 10.1016/j.pocean.2013.07.019; Gallo ND, 2016, ADV MAR BIOL, V74, P117, DOI 10.1016/bs.amb.2016.04.001; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gervais F., 2012, MARINE LIFE FIELD GU; Glover AG, 2010, ADV MAR BIOL, V58, P1, DOI [10.1016/B978-0-12-381015-1.00001-0, 10.1016/S0065-2881(10)58001-5]; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; HIMMELMAN JH, 1993, MAR BIOL, V116, P423, DOI 10.1007/BF00350059; Jamieson GS, 1990, P INT S KING TANN CR, P153; Juniper SK, 2013, DEEP-SEA RES PT II, V92, P114, DOI 10.1016/j.dsr2.2013.03.038; Keller AA, 2012, DEEP-SEA RES PT I, V67, P44, DOI 10.1016/j.dsr.2012.05.002; Laidig Thomas E., 1997, NOAA Technical Report NMFS, V130, P65; LAPOINTE V, 1992, MAR ECOL PROG SER, V85, P245, DOI 10.3354/meps085245; LeBris N., 2016, 1 GLOBAL INTEGRATED, P1; Levin L, 2002, PROG OCEANOGR, V53, P1, DOI 10.1016/S0079-6611(02)00022-8; Levin LA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00072; Marliave Jeff, 2013, Canadian Field-Naturalist, V127, P255; Martinussen MB, 1999, J EXP MAR BIOL ECOL, V232, P61, DOI 10.1016/S0022-0981(98)00101-4; Matabos M, 2014, J MARINE SYST, V130, P56, DOI 10.1016/j.jmarsys.2013.05.002; Minchin PR, 1987, THEORY MODELS VEGETA, P89; Moranta J, 2008, J MARINE SYST, V71, P346, DOI 10.1016/j.jmarsys.2007.02.029; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Osborn DA, 2007, DEEP-SEA RES PT I, V54, P1241, DOI 10.1016/j.dsr.2007.04.015; Papiol V, 2012, DEEP-SEA RES PT I, V61, P84, DOI 10.1016/j.dsr.2011.11.008; Pereyra WT, 1966, DEEP SEA RES OCEAN A, P1185; Purser A., 2013, METHODS OCEANOGR, V5, P1, DOI 10.1016/j.mio.2013.07.001; R_ Development_ Core_ Team, 2008, LANG ENV STAT COMP; Reynolds BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012130; Ruhl HA, 2011, PROG OCEANOGR, V91, P1, DOI 10.1016/j.pocean.2011.05.001; SARDA F, 1994, MAR BIOL, V120, P211, DOI 10.1007/BF00349681; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2009.00286.x; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Tecchio S, 2013, PROG OCEANOGR, V118, P188; THEEDE H, 1973, Netherlands Journal of Sea Research, V7, P244, DOI 10.1016/0077-7579(73)90048-3; Thomsen L, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052462; Thuesen EV, 2005, J MAR BIOL ASSOC UK, V85, P627, DOI 10.1017/S0025315405011550; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; VETTER EW, 1995, MAR ECOL PROG SER, V120, P251, DOI 10.3354/meps120251; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Wagner HJ, 2007, DEEP-SEA RES PT I, V54, P1944, DOI 10.1016/j.dsr.2007.08.005; YOSHIYAMA RM, 1992, J EXP MAR BIOL ECOL, V160, P115, DOI 10.1016/0022-0981(92)90114-P; Zar JH, 2010, PEARSON ED INT, P241	72	38	38	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0176917	10.1371/journal.pone.0176917	http://dx.doi.org/10.1371/journal.pone.0176917			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557992	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000006
J	Herzog, R; Hadrys, H				Herzog, Rebecca; Hadrys, Heike			Long-term genetic monitoring of a riverine dragonfly, Orthetrum coerulescens (Odonata: Libellulidae]: Direct anthropogenic impact versus climate change effects	PLOS ONE			English	Article							POPULATION-GENETICS; ODONATA; CONSERVATION; BOTTLENECKS; DIVERSITY; EMERGENCE; SOFTWARE; MODELS	Modern conservationists call for long term genetic monitoring datasets to evaluate and understand the impact of human activities on natural ecosystems and species on a global but also local scale. However, long-term monitoring datasets are still rare but in high demand to correctly identify, evaluate and respond to environmental changes. In the presented study, a population of the riverine dragonfly, Orthetrum coerulescens (Odonata: Libellulidae), was monitored over a time period from 1989 to 2013. Study site was an artificial irrigation ditch in one of the last European stone steppes and "nature heritage", the Crau in Southern France. This artificial riverine habitat has an unusual high diversity of odonate species, prominent indicators for evaluating freshwater habitats. A clearing of the canal and destruction of the bank vegetation in 1996 was assumed to have great negative impact on the odonate larval and adult populations. Two mitochondrial markers (CO1 & ND1) and a panel of nuclear microsatellite loci were used to assess the genetic diversity. Over time they revealed a dramatic decline in diversity parameters between the years 2004 and 2007, however not between 1996 and 1997. From 2007 onwards the population shows a stabilizing trend but has not reached the amount of genetic variation found at the beginning of this survey. This decline cannot be referred to the clearing of the canal or any other direct anthropogenic impact. Instead, it is most likely that the populations decay was due to by extreme weather conditions during the specific years. A severe drought was recorded for the summer months of these years, leading to reduced water levels in the canal causing also other water parameters to change, and therefore impacting temperature sensitive riverine habitat specialists like the O. coerulescens in a significant way. The data provide important insights into population genetic dynamics and metrics not always congruent with traditional monitoring data (e.g. abundance); a fact that should be regarded with caution when management plans for developed landscapes are designed.	[Herzog, Rebecca; Hadrys, Heike] Univ Vet Med Hannover, ITZ, Ecol & Evolut, Hannover, Germany; [Hadrys, Heike] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Hadrys, Heike] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; American Museum of Natural History (AMNH); Yale University	Herzog, R (corresponding author), Univ Vet Med Hannover, ITZ, Ecol & Evolut, Hannover, Germany.	rebecca.herzog@ecolevol.de			PROMOS scholarship by the German Academic Exchange Service (DAAD)	PROMOS scholarship by the German Academic Exchange Service (DAAD)	This work was supported by a PROMOS scholarship by the German Academic Exchange Service (DAAD) given to RH and the Schierwater lab. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Antonia Wargel, Sandra Damm and Frank Bernhard Kraus for providing data. We further thank Anne-Lisa Mitter for help in the lab and Sarah Rolfes, Nils Krause and Felix David for fieldwork support. We are grateful to Axel Wolff, Conservateur de la RNN des Coussouls de Crau for permits and information, Gisella Caccone for hosting RH at Yale University and Bernd Schierwater for valuable comments. For financial support we appreciate a PROMOS scholarship by the German Academic Exchange Service (DAAD) given to RH and the Schierwater lab.	Abraham D, 2001, MOL PHYLOGENET EVOL, V20, P65, DOI 10.1006/mpev.2001.0949; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Bellmann H., 2007, DER KOSMOS LIBELLENF; Bergmann T, 2013, MOL ECOL RESOUR, V13, P1069, DOI 10.1111/1755-0998.12125; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clausnitzer V, 2009, BIOL CONSERV, V142, P1864, DOI 10.1016/j.biocon.2009.03.028; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corbet P., 1962, BIOL DRAGONFLIES, P247; CORBET PS, 1964, CAN ENTOMOL, V96, P264, DOI 10.4039/Ent96264-1; Damm S, 2012, ORG DIVERS EVOL, V12, P267, DOI 10.1007/s13127-012-0079-1; Damm S, 2010, MOL PHYLOGENET EVOL, V54, P870, DOI 10.1016/j.ympev.2009.12.006; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Devaux J., 1983, BIOLOGIE ECOLOGIE M, V10, P5, DOI DOI 10.1126/SCIEN; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Fincke OM, 2001, EVOLUTION, V55, P762, DOI 10.1554/0014-3820(2001)055[0762:UOSITD]2.0.CO;2; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Foucart A, 1998, SURVEILLANCE DUN ACR; Gaggiotti OE, 2003, ANN ZOOLOGICI FENNIC; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hadrys H, 1992, MOL ECOL, V1, P55, DOI 10.1111/j.1365-294X.1992.tb00155.x; Hadrys H, 2007, MOL ECOL NOTES, V7, P287, DOI 10.1111/j.1471-8286.2006.01582.x; Hof C, 2006, J BIOGEOGR, V33, P63, DOI 10.1111/j.1365-2699.2005.01358.x; Hof C, 2012, BIOL LETT; Jakob C, 1999, AQUAT INSECT, V21, P1, DOI 10.1076/aqin.21.1.1.4537; Jaunatre R, 2012, PLANT ECOL EVOL, V145, P13, DOI 10.5091/plecevo.2012.690; Jurzitza G., 2000, DER KOSMOS LIBELLENF; Kalkman VJ, 2008, HYDROBIOLOGIA, V595, P351, DOI 10.1007/s10750-007-9029-x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kraus B., 2000, THESIS; Kruckenhauser L, 2009, CONSERV GENET, V10, P1223, DOI 10.1007/s10592-008-9654-6; Lahmann, 2015, MASTERARBEIT AM ITZ; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lee J, 1994, Odonatologica, V23, P291; MARUYAMA T, 1985, GENETICS, V111, P675; Megerle A, 1987, DIE CRAU STEINSTEPPE; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Ott J., 1998, SCHRIFTENREIHE LANDS, V55, P260; Pritchard JK, 2000, GENETICS, V155, P945; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; REHFELDT G, 1992, OECOLOGIA, V89, P550, DOI 10.1007/BF00317162; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rudnick JA, 2005, MOL ECOL, V14, P2959, DOI 10.1111/j.1365-294X.2005.02641.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schridde P., 1994, Advances in Odonatology, V6, P89; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wildermuth H, 2008, INT J ODONATOL, V11, P261, DOI 10.1080/13887890.2008.9748328; Wolff A, 2013, STEPPE ME A DITERRAN, P13	55	3	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178014	10.1371/journal.pone.0178014	http://dx.doi.org/10.1371/journal.pone.0178014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552975	gold, Green Submitted, Green Published			2022-12-26	WOS:000402063000018
J	Zheng, F; Grigoryan, G				Zheng, Fan; Grigoryan, Gevorg			Sequence statistics of tertiary structural motifs reflect protein stability	PLOS ONE			English	Article							ENERGY FUNCTIONS; AMINO-ACID; PREDICTION; POTENTIALS; FRAGMENTS; PROPENSITIES; SIMULATION; MUTATIONS; MUTANTS; SEARCH	The Protein Data Bank (PDB) has been a key resource for learning general rules of sequence-structure relationships in proteins. Quantitative insights have been gained by defining geometric descriptors of structure (e.g., distances, dihedral angles, solvent exposure, etc.) and observing their distributions and sequence preferences. Here we argue that as the PDB continues to grow, it may become unnecessary to reduce structure into a set of elementary descriptors. Instead, it could be possible to deduce quantitative sequence-structure relationships in the context of precisely-defined complex structural motifs by mining the PDB for closely matching backbone geometries. To validate this idea, we turned to the the task of predicting changes in protein stability upon amino-acid substitution-a difficult problem of broad significance. We defined non-contiguous tertiary motifs (TERMs) around a protein site of interest and extracted sequence preferences from ensembles of closelym-atching substructures in the PDB to predict mutational stability changes at the site,Delta Delta G(m). We demonstrate that these ensemble statistics predict Delta Delta G(m) on par with state-of-the-art statistical and machine-learning methods on large thermodynamic datasets, and outperform these, along with a leading structure-based modeling approach, when tested in the context of unbiased diverse mutations. Further, we show that the performance of the TERM-based method is directly related to the amount of available relevant structural data, automatically improving with the growing PDB. This enables a means of estimating prediction accuracy. Our results clearly demonstrate that: 1) statistics of non-contiguous structural motifs in the PDB encode fundamental sequence-structure relationships related to protein thermodynamic stability, and 2) the PDB is now large enough that such statistics are already useful in practice, with their accuracy expected to continue increasing as the database grows. These observations suggest new ways of using structural data towards addressing problems of computational structural biology.	[Zheng, Fan; Grigoryan, Gevorg] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Grigoryan, Gevorg] Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; [Grigoryan, Gevorg] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Grigoryan, G (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.; Grigoryan, G (corresponding author), Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA.; Grigoryan, G (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	gevorg.grigoryan@dartmouth.edu	Zheng, Fan/ABF-6176-2020	Zheng, Fan/0000-0002-4403-112X; Grigoryan, Gevorg/0000-0003-4645-7666	National Science Foundation [DMR1534246]; National Institutes of Health [P20-GM113132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113132] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1534246] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation, DMR1534246 (GG) and National Institutes of Health, P20-GM113132 (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2015, ELIFE, V4, DOI 10.7554/eLife.09410; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Baeten L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000083; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Betancourt MR, 2004, J MOL BIOL, V342, P635, DOI 10.1016/j.jmb.2004.06.091; Boas FE, 2007, CURR OPIN STRUC BIOL, V17, P199, DOI 10.1016/j.sbi.2007.03.006; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Echols N, 2002, NUCLEIC ACIDS RES, V30, P2515, DOI 10.1093/nar/30.11.2515; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng X, 2016, NAT CHEM BIOL, V12, P167, DOI [10.1038/nchembio.2001, 10.1038/NCHEMBIO.2001]; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Grigoryan G, 2013, J COMPUT CHEM, V34, P2726, DOI 10.1002/jcc.23448; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kmiecik S, 2016, CHEM REV, V116, P7898, DOI 10.1021/acs.chemrev.6b00163; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mackenzie CO, 2016, P NATL ACAD SCI USA, V113, pE7438, DOI 10.1073/pnas.1607178113; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; Mirny LA, 1996, J MOL BIOL, V264, P1164, DOI 10.1006/jmbi.1996.0704; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Olson CA, 2014, CURR BIOL, V24, P2643, DOI 10.1016/j.cub.2014.09.072; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Quan L., 2016, BIOINFORMATICS; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; Smock RG, 2016, CELL, V164, P476, DOI 10.1016/j.cell.2015.12.024; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Vallat B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004419; Vanhee P, 2011, NUCLEIC ACIDS RES, V39, pD435, DOI 10.1093/nar/gkq972; Verschueren E, 2013, STRUCTURE, V21, P789, DOI 10.1016/j.str.2013.02.023; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Wu NC, 2016, PROTEIN SCI, V25, P530, DOI 10.1002/pro.2840; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yuan C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-292; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang SQ, 2015, STRUCTURE, V23, P527, DOI 10.1016/j.str.2015.01.009; Zheng F, 2015, STRUCTURE, V23, P961, DOI 10.1016/j.str.2015.03.015; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou J, 2014, PROTEIN SCI	60	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178272	10.1371/journal.pone.0178272	http://dx.doi.org/10.1371/journal.pone.0178272			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552940	Green Submitted, gold, Green Published			2022-12-26	WOS:000402063000031
J	Lai, XL; Friedman, A				Lai, Xiulan; Friedman, Avner			Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model	PLOS ONE			English	Article							SECRETING TUMOR VACCINE; GM-CSF; DENDRITIC CELLS; ANTI-PD-1 ANTIBODY; PANCREATIC-CANCER; T-CELLS; PHASE-I; SAFETY; IMMUNOTHERAPY; BLOCKADE	In this paper we consider a combination therapy of cancer. One drug is a vaccine which activates dendritic cells so that they induce more T cells to infiltrate the tumor. The other drug is a checkpoint inhibitor, which enables the T cells to remain active against the cancer cells. The two drugs are positively correlated in the sense that an increase in the amount of each drug results in a reduction in the tumor volume. We consider the question whether a treatment with combination of the two drugs at certain levels is preferable to a treatment by one of the drugs alone at 'roughly' twice the dosage level; if that is the case, then we say that there is a positive 'synergy' for this combination of dosages. To address this question, we develop a mathematical model using a system of partial differential equations. The variables include dendritic and cancer cells, CD4(+) and CD8(+) T cells, IL-12 and IL-2, GM-CSF produced by the vaccine, and a T cell checkpoint inhibitor associated with PD-1. We use the model to explore the efficacy of the two drugs, separately and in combination, and compare the simulations with data from mouse experiments. We next introduce the concept of synergy between the drugs and develop a synergy map which suggests in what proportion to administer the drugs in order to achieve the maximum reduction of tumor volume under the constraint of maximum tolerated dose.	[Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Renmin University of China; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lai, XL (corresponding author), Renmin Univ China, Inst Math Sci, Beijing, Peoples R China.	xiulanlai@ruc.edu.cn	Lai, Xiula/GMX-1854-2022		Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; Renmin University of China; International Postdoctoral Exchange Fellowship Program; Office of China Postdoctoral Council	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); Renmin University of China; International Postdoctoral Exchange Fellowship Program; Office of China Postdoctoral Council	This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642), and the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council.; This work is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642), and the Renmin University of China and the International Postdoctoral Exchange Fellowship Program 2016 by the Office of China Postdoctoral Council.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Ali OA, 2015, CANC IMMUNOLOGY RES; Blinman P, 2012, ANN ONCOL, V23, P1104, DOI 10.1093/annonc/mdr559; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Cheng XX, 2013, J BIOL CHEM, V288, P11771, DOI 10.1074/jbc.M112.448126; DAcunto B., 2004, SERIES ADV MATH APPL, V67; Dale DC, 1998, AM J HEMATOL, V57, P7, DOI 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0; de Pillis LG, 2006, J THEOR BIOL, V238, P841, DOI 10.1016/j.jtbi.2005.06.037; Dumortier H, 2005, J IMMUNOL, V175, P855, DOI 10.4049/jimmunol.175.2.855; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; FIEHN C, 1992, Z RHEUMATOL, V51, P121; Fu J, 2014, CANCER RES, V74, P4042, DOI 10.1158/0008-5472.CAN-13-2685; Gong JL, 2000, P NATL ACAD SCI USA, V97, P2715, DOI 10.1073/pnas.050587197; Guo CQ, 2013, ADV CANCER RES, V119, P421, DOI 10.1016/B978-0-12-407190-2.00007-1; Gupta R, 2010, DISCOV MED, V10, P52; Haabeth OAW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00174; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hao W, 2017, B MATH BIOL IN PRESS; Hao WR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148738; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Joshi B, 2009, J THEOR BIOL, V259, P820, DOI 10.1016/j.jtbi.2009.05.001; Kaufman HL, 2014, J IMMUNOTHER CANCER, V13, P2; Kleponis J, 2015, CANCER BIOL MED, V12, P201, DOI 10.7497/j.issn.2095-3941.2015.0046; Laheru D, 2008, CLIN CANCER RES, V14, P1455, DOI 10.1158/1078-0432.CCR-07-0371; Lee CK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-391; Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091844; Lutz E, 2011, ANN SURG, V253, P328, DOI 10.1097/SLA.0b013e3181fd271c; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Mailliard RB, 2002, J EXP MED, V195, P473, DOI 10.1084/jem.20011662; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marshall DA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010981; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; Owonikoko TK, 2015, J CLIN ONCOL, V33, P534, DOI 10.1200/JCO.2014.59.5033; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Rini B, 2014, SEMIN ONCOL, V41, pS30, DOI 10.1053/j.seminoncol.2014.09.005; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Serre R, 2016, CANCER RES, V76, P4931, DOI 10.1158/0008-5472.CAN-15-3567; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Simmons AD, 2007, CANCER IMMUNOL IMMUN, V56, P1653, DOI 10.1007/s00262-007-0315-2; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Soares KC, 2015, J IMMUNOTHER, V38, P1, DOI 10.1097/CJI.0000000000000062; Steptoe RJ, 2000, TRANSPL IMMUNOL, V8, P49, DOI 10.1016/S0966-3274(00)00010-1; Swart M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00233; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tian HW, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2016.25; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Zandarashvili L, 2013, J BIOL CHEM, V288, P11621, DOI 10.1074/jbc.M113.449942	61	57	58	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178479	10.1371/journal.pone.0178479	http://dx.doi.org/10.1371/journal.pone.0178479			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542574	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800095
J	van der Horst, K; Sleddens, EFC				van der Horst, Klazine; Sleddens, Ester F. C.			Parenting styles, feeding styles and food-related parenting practices in relation to toddlers' eating styles: A cluster-analytic approach	PLOS ONE			English	Article							BODY-MASS INDEX; BEHAVIOR QUESTIONNAIRE; WEIGHT STATUS; CHILD WEIGHT; RESTRICTING ACCESS; PHYSICAL-ACTIVITY; OBESITY; ADIPOSITY; ASSOCIATIONS; CONSUMPTION	Introduction Toddlers' eating behaviors are influenced by the way parents interact with their children. The objective of this study was to explore how five major constructs of general parenting behavior cluster in parents of toddlers. These parenting clusters were further explored to see how they differed in the use of feeding strategies (i.e. feeding styles and food parenting practices) and by reported child eating styles. Methods An online survey with 1005 mothers/caregivers (legal guardians) with at least one child between 12 and 36 months old was conducted in the United States in 2012, assessing general parenting behavior, feeding style, food parenting practices and the child eating styles. Results A three cluster solution of parenting style was found and clusters were labelled as overprotective/supervising, authoritarian, and authoritative. The clusters differed in terms of general parenting behaviors. Both overprotective and authoritative clusters showed high scores on structure, behavioral control, and nurturance. The overprotective cluster scored high on overprotection. The 'authoritarian' cluster showed lowest levels of nurturance, structure and behavioral control. Overprotective and authoritative parents showed very similar patterns in the use of food parenting practices, e.g. monitoring food intake, modeling, and promoting healthy food intake and availability at home. Overprotective parents also reported higher use of pressure to eat and involvement. Authoritarian parents reported high use of giving the child control over their food behaviors, emotion regulation, using food as a reward, and controlling food intake for weight control. Children's eating styles did not largely vary by parenting cluster. Conclusion This study showed that a relatively new parenting style of overprotection is relevant for children's eating behaviors. Overprotective parents reported food parenting practices that are known to be beneficial for children's food intake, such as modelling healthy food intake, as well as more unfavorable practices such as pressure. Longitudinal data on parenting practices and their relation to healthy eating in children is needed to inform communication and interventions for parents, reinforcing key feeding strategies which have positive effects on child eating behaviors and addressing parenting styles that have unintended negative effects.	[van der Horst, Klazine] Nestle Res Ctr, Inst Nutr Sci, Lausanne, Switzerland; [Sleddens, Ester F. C.] Maastricht Univ, Med Ctr, Dept Hlth Promot, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands	Nestle SA; Maastricht University; Maastricht University Medical Centre (MUMC)	van der Horst, K (corresponding author), Nestle Res Ctr, Inst Nutr Sci, Lausanne, Switzerland.	Klazine.vanderhorst@rdls.nestle.com		van der Horst, Klazine/0000-0001-7265-428X; van der Borgh-Sleddens, Ester/0000-0002-9421-6712	Nestec Ltd.; Netherlands Heart Foundation [2014T037]	Nestec Ltd.(Nestle SA); Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was partly funded by Nestec Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salary for author KVDH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. This study was also partially funded by the Netherlands Heart Foundation (project number 2014T037) awarded to Ester Sleddens	Afonso L, 2016, AM J CLIN NUTR, V103, P861, DOI 10.3945/ajcn.115.120824; Baranowski T, 2013, CHILD OBES, V9, pS1, DOI 10.1089/chi.2013.0040; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; Blissett J, 2008, APPETITE, V50, P477, DOI 10.1016/j.appet.2007.10.003; Blissett J, 2011, APPETITE, V57, P826, DOI 10.1016/j.appet.2011.05.318; Brown KA, 2008, APPETITE, V50, P252, DOI 10.1016/j.appet.2007.07.010; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Cislak A, 2012, CHILD CARE HLTH DEV, V38, P321, DOI 10.1111/j.1365-2214.2011.01285.x; Clark HR, 2007, J PUBLIC HEALTH-UK, V29, P132, DOI 10.1093/pubmed/fdm012; Collins C, 2014, J HUM NUTR DIET, V27, P557, DOI 10.1111/jhn.12192; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; Dovey TM, 2008, APPETITE, V50, P181, DOI 10.1016/j.appet.2007.09.009; Ek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147257; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Faith MS, 2005, MATERN CHILD NUTR, V1, P164, DOI 10.1111/j.1740-8709.2005.00024.x; Fisher JO, 1999, APPETITE, V32, P405, DOI 10.1006/appe.1999.0231; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; Frankel LA, 2014, APPETITE, V76, P166, DOI 10.1016/j.appet.2014.01.077; Gregory JE, 2010, APPETITE, V54, P550, DOI 10.1016/j.appet.2010.02.013; Hancock KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100686; Hennessy E, 2010, APPETITE, V54, P369, DOI 10.1016/j.appet.2010.01.004; Hughes SO, 2013, CHILD OBES, V9, pS95, DOI 10.1089/chi.2013.0032; Hughes SO, 2012, APPETITE, V58, P393, DOI 10.1016/j.appet.2011.11.011; Hughes SO, 2005, APPETITE, V44, P83, DOI 10.1016/j.appet.2004.08.007; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Jansen PW, 2014, AM J CLIN NUTR, V100, P1329, DOI 10.3945/ajcn.114.088922; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Janssen I, 2015, PREV MED, V73, P55, DOI 10.1016/j.ypmed.2015.01.015; JOHNSON SL, 1994, PEDIATRICS, V94, P653; Maccoby E., 1983, HDB CHILD PSYCHOL SO, V4, P1; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Padilla-Walker LM, 2012, J ADOLESCENCE, V35, P1177, DOI 10.1016/j.adolescence.2012.03.007; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Shloim N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01849; Sleddens EFC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-15; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Spruijt-Metz D, 2002, AM J CLIN NUTR, V75, P581, DOI 10.1093/ajcn/75.3.581; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; van der Horst K, 2016, APPETITE, V103, P286, DOI 10.1016/j.appet.2016.04.027; Vandeweghe L, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00928; Vaughn AE, 2016, NUTR REV, V74, P98, DOI 10.1093/nutrit/nuv061; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007	48	25	25	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178149	10.1371/journal.pone.0178149	http://dx.doi.org/10.1371/journal.pone.0178149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542555	gold, Green Submitted, Green Published			2022-12-26	WOS:000402061500065
J	Friedrichs-Maeder, CL; Griffa, A; Schneider, J; Huppi, PS; Truttmann, A; Hagmann, P				Friedrichs-Maeder, Cecilia L.; Griffa, Alessandra; Schneider, Juliane; Huppi, Petra Susan; Truttmann, Anita; Hagmann, Patric			Exploring the role of white matter connectivity in cortex maturation	PLOS ONE			English	Article							DIFFUSION MRI TRACTOGRAPHY; HUMAN CORTICAL DEVELOPMENT; CEREBRAL-CORTEX; HUMAN BRAIN; GRAY-MATTER; PERIVENTRICULAR LEUKOMALACIA; ELECTRICAL-ACTIVITY; WATER DIFFUSION; NERVOUS-SYSTEM; INFANT BRAIN	The maturation of the cortical gray matter (GM) and white matter (WM) are described as sequential processes following multiple, but distinct rules. However, neither the mechanisms driving brain maturation processes, nor the relationship between GM and WM maturation are well understood. Here we use connectomics and two MRI measures reflecting maturation related changes in cerebral microstructure, namely the Apparent Diffusion Coefficient (ADC) and the T1 relaxation time (T1), to study brain development. We report that the advancement of GM and WM maturation are inter-related and depend on the underlying brain connectivity architecture. Particularly, GM regions and their incident WM connections show corresponding maturation levels, which is also observed for GM regions connected through a WM tract. Based on these observations, we propose a simple computational model supporting a key role for the connectome in propagating maturation signals sequentially from external stimuli, through primary sensory structures to higher order functional cortices.	[Friedrichs-Maeder, Cecilia L.; Griffa, Alessandra; Hagmann, Patric] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Griffa, Alessandra; Hagmann, Patric] Ecole Polytech Fed Lausanne, Signal Proc Lab LTSS, Lausanne, Switzerland; [Schneider, Juliane; Truttmann, Anita] CHU Vaudois, Dept Pediat, Clin Neonatol & Follow Up, Lausanne, Switzerland; [Schneider, Juliane] Univ Toronto, Hosp Sick Children, Div Neurol, Toronto, ON, Canada; [Huppi, Petra Susan] Univ Geneva, Dept Pediat, Div Dev & Growth, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Geneva	Friedrichs-Maeder, CL (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.	ceciliamaeder@gmail.com	Huppi, Petra S/A-4079-2009; Schneider, Juliane/Q-4054-2018; Huppi, Petra/A-4079-2009	Huppi, Petra S/0000-0002-7383-6648; Griffa, Alessandra/0000-0003-1923-1653; Huppi, Petra/0000-0002-7063-4215	Swiss National Science Foundation [33CM30D124101, 51AU40_125759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The research and authors were supported by the Swiss National Science Foundation (#33CM30D124101, #51AU40_125759).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; [Anonymous], NETWORKS AN INTRODUC; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P1397; BARKOVICH AJ, 1988, RADIOLOGY, V166, P173, DOI 10.1148/radiology.166.1.3336675; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Brodmann K, 1909, VERGLEICHENDE LOKALI; Chittajallu R, 2010, NAT NEUROSCI, V13, P1240, DOI 10.1038/nn.2639; Conel JL, 1939, THE POSTNATAL DEVELO, V1; Croteau-Chonka EC, 2016, NEUROIMAGE, V125, P413, DOI 10.1016/j.neuroimage.2015.10.038; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Deoni SCL, 2015, NEUROIMAGE, V115, P147, DOI 10.1016/j.neuroimage.2015.04.058; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Dubowitz L M, 1980, Brain Dev, V2, P3; Flechsig PE, 1920, THIEME G, V1; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilmore JH, 2012, CEREB CORTEX, V22, P2478, DOI 10.1093/cercor/bhr327; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic PSRP, 1984, CEREBRAL DOMINANCE B, P179; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Guillery RW, 2005, TRENDS NEUROSCI, V28, P512, DOI 10.1016/j.tins.2005.08.006; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hanganu-Opatz IL, 2010, BRAIN RES REV, V64, P160, DOI 10.1016/j.brainresrev.2010.03.005; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Huppi PS, 1998, PEDIATR RES, V44, P584; Jeon T, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fhana.2015.00158, 10.3389/fnana.2015.00158]; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2014, PEDIATRICS, V134, pE444, DOI 10.1542/peds.2013-2336; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kiss JZ, 2014, CURR OPIN NEUROL, V27, P133, DOI 10.1097/WCO.0000000000000068; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kulikova S, 2015, BRAIN STRUCT FUNCT, V220, P3657, DOI 10.1007/s00429-014-0881-y; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Leipsic P. F. O., 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; Lerch JP, 2006, NEUROIMAGE, V31, P993, DOI 10.1016/j.neuroimage.2006.01.042; Leroy F, 2011, J NEUROSCI, V31, P1500, DOI 10.1523/JNEUROSCI.4141-10.2011; Levine D, 1999, RADIOLOGY, V210, P751, DOI 10.1148/radiology.210.3.r99mr47751; Lobel U, 2009, NEURORADIOLOGY, V51, P253, DOI 10.1007/s00234-008-0488-1; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Marret S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062683; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; Melbourne A, 2014, NEUROIMAGE, V89, P23, DOI 10.1016/j.neuroimage.2013.11.048; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nossin-Manor R, 2012, RADIOLOGY, V263, P510, DOI 10.1148/radiol.12110367; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pujol J, 2006, NEUROLOGY, V66, P339, DOI 10.1212/01.wnl.0000201049.66073.8d; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schmidt R, 2016, NEUROIMAGE, V124, P762, DOI 10.1016/j.neuroimage.2015.04.005; Schneider J, 2016, AM J NEURORADIOL, V37, P155, DOI 10.3174/ajnr.A4510; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Smyser TA, 2015, CEREB CORTEX, DOI DOI 10.1093/CERCOR/BHV164; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Steriade M, 1997, THALAMUS V 1 ORGANIS, V1; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Travis K, 2005, DEV NEUROSCI-BASEL, V27, P277, DOI 10.1159/000086707; Van Essen DC, 2005, PROG BRAIN RES, V149, P173, DOI 10.1016/S0079-6123(05)49013-5; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wierenga LM, 2016, HUM BRAIN MAPP, V37, P717, DOI 10.1002/hbm.23062; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zalesky A, 2016, NEUROIMAGE, V142, P397, DOI 10.1016/j.neuroimage.2016.06.035; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	101	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177466	10.1371/journal.pone.0177466	http://dx.doi.org/10.1371/journal.pone.0177466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545040	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700051
J	Hu, DW; Zhang, S; Luo, JY; Lu, LM; Cui, JJ; Zhang, X				Hu, Dao-Wu; Zhang, Shuai; Luo, Jun-Yu; Lu, Li-Min; Cui, Jin-Jie; Zhang, Xiao			An example of host plant expansion of host-specialized Aphis gossypii Glover in the field	PLOS ONE			English	Article							EVOLUTION; APHIDIDAE; ALTERNATION; HOMOPTERA; SELECTION; RACES; HERBIVORES; HEMIPTERA; QUALITY; CHOICE	The host plant expansion of host-specialized Aphis gossypii (Glover) has been well studied in the laboratory; however, this phenomenon is poorly understood in the field. Here, we provide a series of laboratory and field experiments to assess the role of zucchini in the host plant expansion of cotton-specialized aphids. We observed that cotton-specialized aphids possessed the ability to expand on a new host plant (cucumber), with individuals first recorded on June 12 and consequently increasing exponentially in number in a field cage. A bioassay experiment showed that aphids from both cotton and cucumber preferred their natal host, but clones from zucchini have a stronger preference for cucumber than cotton or zucchini. A total of 1512 individuals were collected from a cotton field (mixed cotton and cucurbit plot), cotton farmland (cotton alone) and a field cage and sequenced to identify their biotypes. The results for apterous individuals from the cotton field showed that more cucurbit- specialized biotypes occurred on cucumber and more cotton-specialized biotypes occurred on cotton and zucchini. A majority (>97.0%) of aphids from both the field cage and cotton farmland were cotton-specialized individuals. Consequently, eliminating intermediate host plants may be an effective measure to suppress A. gossypii outbreaks, because cotton and cucumber are often grown together in fields and greenhouses.	[Hu, Dao-Wu; Zhang, Shuai; Luo, Jun-Yu; Lu, Li-Min; Cui, Jin-Jie] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Hu, Dao-Wu; Zhang, Xiao] Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Henan University	Cui, JJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.; Zhang, X (corresponding author), Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Henan, Peoples R China.	cuijinjie@126.com; xzhang@henu.edu.cn		Zhang, Shuai/0000-0003-3646-1522	National Special Transgenic Project of China [2016ZX08011-002]	National Special Transgenic Project of China	This work was funded by the National Special Transgenic Project of China (2016ZX08011-002).	Behmer ST, 2002, ECOLOGY, V83, P2489, DOI 10.1890/0012-9658(2002)083[2489:HFICHE]2.0.CO;2; BLACKMAN R.L., 1984, ORIENT INSECTS; Boivin T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139634; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Capinera JL, 2014, FLA ENTOMOL, V97, P38, DOI 10.1653/024.097.0105; CARRIERE Y, 1995, HEREDITY, V74, P357, DOI 10.1038/hdy.1995.54; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Dixon AFG, 2010, APHID BIODIVERSITY UNDER ENVIRONMENTAL CHANGE: PATTERNS AND PROCESSES, P129, DOI 10.1007/978-90-481-8601-3_8; Emden H.F.V., 2007, APHIDS CROP PESTS; Garima Singh, 2014, International Journal of Life Sciences Biotechnology and Pharma Research, V3, P1; Glinwood R, 2000, B ENTOMOL RES, V90, P57, DOI 10.1017/S0007485300000080; Glynn C, 2004, ENVIRON ENTOMOL, V33, P748, DOI 10.1603/0046-225X-33.3.748; GULDEMOND JA, 1994, ENVIRON ENTOMOL, V23, P1235, DOI 10.1093/ee/23.5.1235; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; Komazaki S, 1998, ENTOMOL EXP APPL, V89, P201, DOI 10.1023/A:1003491810680; Leebens-Mack J, 1998, EVOLUTION, V52, P1376, DOI [10.2307/2411307, 10.1111/j.1558-5646.1998.tb02019.x]; MORAN NA, 1988, AM NAT, V132, P681, DOI 10.1086/284882; MORAN NA, 1983, ECOL ENTOMOL, V8, P371, DOI 10.1111/j.1365-2311.1983.tb00517.x; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Orsucci M, 2016, J EVOLUTION BIOL, V29, P114, DOI 10.1111/jeb.12766; Pogue MG, 2013, SYST ENTOMOL, V38, P523, DOI 10.1111/syen.12010; Sandstrom J, 2000, CHEMOECOLOGY, V10, P17, DOI 10.1007/s000490050003; Satar S, 2013, ANN APPL BIOL, V162, P41, DOI 10.1111/j.1744-7348.2012.00578.x; Shufran KA, 2000, INSECT MOL BIOL, V9, P179, DOI 10.1046/j.1365-2583.2000.00177.x; Sileshi G, 2008, WEEDS DIS INSECT PES, P73; Szelegiewicz H., 1985, P INT APH S JABL 5 1; Takahashi R., 1938, Kontyu Tokyo, V12, P130; Tariq M, 2012, AGR FOREST ENTOMOL, V14, P177, DOI 10.1111/j.1461-9563.2011.00557.x; Thompson JN, 1998, J EVOLUTION BIOL, V11, P563, DOI 10.1007/s000360050106; Toki W, 2010, ENVIRON ENTOMOL, V39, P1336, DOI 10.1603/EN09347; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; VIA S, 1991, ECOLOGY, V72, P1420, DOI 10.2307/1941114; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146345; WAY MJ, 1968, ANN APPL BIOL, V62, P177, DOI 10.1111/j.1744-7348.1968.tb02815.x; WILLIAMS AG, 1986, ECOLOGY, V67, P1619, DOI 10.2307/1939093; Wolfe LM, 2002, AM NAT, V160, P705, DOI 10.1086/343872; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Xu TT, 2014, INSECT SCI, V21, P334, DOI 10.1111/1744-7917.12114; [郑彩玲 ZHENG CaiLing], 2007, [生态学报, Acta Ecologica Sinica], V27, P1879	41	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177981	10.1371/journal.pone.0177981	http://dx.doi.org/10.1371/journal.pone.0177981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545139	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700101
J	Mittra, B; Laranjeira-Silva, MF; Miguel, DC; de Menezes, JPB; Andrews, NW				Mittra, Bidyottam; Laranjeira-Silva, Maria Fernanda; Miguel, Danilo Ciccone; de Menezes, Juliana Perrone Bezerra; Andrews, Norma W.			The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METACYCLIC PROMASTIGOTES; HYDROGEN-PEROXIDE; AMAZONENSIS; GENERATION; DIFFERENTIATION; TRANSPORTER; METABOLISM; SURVIVAL; CHAGASI; DEATH	Leishmaniasis is one of the leading globally neglected diseases, affecting millions of people worldwide. Leishmania infection depends on the ability of insect-transmitted metacyclic promastigotes to invade mammalian hosts, differentiate into amastigotes, and replicate inside macrophages. To counter the hostile oxidative environment inside macrophages, these protozoans contain anti-oxidant systems that include iron-dependent superoxide dismutases (SODs) in mitochondria and glycosomes. Increasing evidence suggests that in addition to this protective role, Leishmania mitochondrial SOD may also initiate H2O2-mediated redox signaling that regulates gene expression and metabolic changes associated with differentiation into virulent forms. To investigate this hypothesis, we examined the specific role of SODA, the mitochondrial SOD isoform in Leishmania amazonensis. Our inability to generate L. amazonensis SODA null mutants and the lethal phenotype observed following RNAi-mediated silencing of the Trypanosoma brucei SODA ortholog suggests that SODA is essential for trypanosomatid survival. L. amazonensis metacyclic promastigotes lacking one SODA allele failed to replicate in macrophages and were severely attenuated in their ability to generate cutaneous lesions in mice. Reduced expression of SODA also resulted in mitochondrial oxidative damage and failure of SODA/Delta sodA promastigotes to differentiate into axenic amastigotes. SODA expression above a critical threshold was also required for the development of metacyclic promastigotes, as SODA/Delta sodA cultures were strongly depleted in this infective form and more susceptible to reactive oxygen species (ROS)-induced stress. Collectively, our data suggest that SODA promotes Leishmania virulence by protecting the parasites against mitochondrion-generated oxidative stress and by initiating ROS-mediated signaling mechanisms required for the differentiation of infective forms.	[Mittra, Bidyottam; Laranjeira-Silva, Maria Fernanda; Miguel, Danilo Ciccone; de Menezes, Juliana Perrone Bezerra; Andrews, Norma W.] Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Andrews, NW (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 2134 Biosci Res Bldg, College Pk, MD 20742 USA.	andrewsn@umd.edu	Miguel, Danilo Ciccone/C-1484-2012; de Menezes, Juliana Perrone Bezerra/AAO-5290-2021; Laranjeira-Silva, Maria Fernanda/H-9056-2012	Miguel, Danilo Ciccone/0000-0003-0522-6562; de Menezes, Juliana Perrone Bezerra/0000-0002-9380-8839; Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Andrews, Norma/0000-0002-0611-2412	National Institutes of Health [R01 AI067979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 AI067979 (to N. W. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2013, ANTIOXID REDOX SIGN, V19, P746, DOI 10.1089/ars.2012.4745; Alzate JF, 2007, MOL BIOCHEM PARASIT, V152, P192, DOI 10.1016/j.molbiopara.2007.01.006; Bates PA, 2008, CURR OPIN MICROBIOL, V11, P340, DOI 10.1016/j.mib.2008.06.003; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Boitz JM, 2013, J BIOL CHEM, V288, P8977, DOI 10.1074/jbc.M112.431486; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Diebold L, 2016, FREE RADICAL BIO MED, V100, P86, DOI 10.1016/j.freeradbiomed.2016.04.198; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Flannery AR, 2011, J BIOL CHEM, V286, P23266, DOI 10.1074/jbc.M111.229674; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gaur U, 2009, EXP PARASITOL, V122, P182, DOI 10.1016/j.exppara.2009.03.014; Getachew F, 2007, MOL BIOCHEM PARASIT, V154, P62, DOI 10.1016/j.molbiopara.2007.04.007; Getachew F, 2012, MOL BIOCHEM PARASIT, V183, P42, DOI 10.1016/j.molbiopara.2012.01.005; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Kima PE, 2014, MICROBES INFECT, V16, P721, DOI 10.1016/j.micinf.2014.07.012; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Miguel DC, 2013, INFECT IMMUN, V81, P3620, DOI 10.1128/IAI.00687-13; Mittra B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005340; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Oberholzer M, 2009, METHOD CELL BIOL, V93, P21, DOI 10.1016/S0091-679X(08)93002-8; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Oyola SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051300; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Pinto-da-Silva LH, 2005, INT J PARASITOL, V35, P757, DOI 10.1016/j.ijpara.2005.03.004; Plewes KA, 2003, INFECT IMMUN, V71, P5910, DOI 10.1128/IAI.71.10.5910-5920.2003; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Tabbara KS, 2005, INFECT IMMUN, V73, P4714, DOI 10.1128/IAI.73.8.4714-4722.2005; Taylor MC, 2010, PARASITOLOGY, V137, P899, DOI 10.1017/S0031182009991880; Tsigankov P, 2012, PARASITOLOGY, V139, P1146, DOI 10.1017/S0031182012000157; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Turco SJ, 2003, METHOD ENZYMOL, V363, P377; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; WHO, 2010, WHO TECH REP SER, V949, P1; WILSON ME, 1994, INFECT IMMUN, V62, P5133, DOI 10.1128/IAI.62.11.5133-5141.1994; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	53	37	39	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12324	12338		10.1074/jbc.M116.772624	http://dx.doi.org/10.1074/jbc.M116.772624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28550086	Green Published, hybrid			2022-12-26	WOS:000406053300027
J	Ekstrand, M; Widell, E; Hammar, A; Akyurek, LM; Johansson, M; Fagerberg, B; Bergstrom, G; Levin, MC; Fogelstrand, P; Boren, J; Levin, M				Ekstrand, Matias; Widell, Emma; Hammar, Anna; Akyurek, Levent M.; Johansson, Martin; Fagerberg, Bjorn; Bergstrom, Goran; Levin, Malin C.; Fogelstrand, Per; Boren, Jan; Levin, Max			Depletion of ATP and glucose in advanced human atherosclerotic plaques	PLOS ONE			English	Article							IN-VIVO; ARTERIAL-WALL; HYPOXIA; INFLAMMATION; MACROPHAGES; CORE	Objective Severe hypoxia develops close to the necrotic core of advanced human atherosclerotic plaques, but the energy metabolic consequences of this hypoxia are not known. In animal models, plaque hypoxia is also associated with depletion of glucose and ATP. ATP depletion may impair healing of plaques and promote necrotic core expansion. To investigate if ATP depletion is present in human plaques, we analyzed the distribution of energy metabolites (ATP, glucose, glycogen and lactate) in intermediate and advanced human plaques. Approach and results Snap frozen carotid endarterectomies from 6 symptomatic patients were analyzed. Each endarterectomy included a large plaque ranging from the common carotid artery (CCA) to the internal carotid artery (ICA). ATP, glucose, and glycogen concentrations were lower in advanced (ICA) compared to intermediate plaques (CCA), whereas lactate concentrations were higher. The lowest concentrations of ATP, glucose and glycogen were detected in the perinecrotic zone of advanced plaques. Conclusions Our study demonstrates severe ATP depletion and glucose deficiency in the perinecrotic zone of human advanced atherosclerotic plaques. ATP depletion may impair healing of plaques and promote disease progression.	[Ekstrand, Matias; Widell, Emma; Hammar, Anna; Fagerberg, Bjorn; Bergstrom, Goran; Levin, Malin C.; Fogelstrand, Per; Boren, Jan; Levin, Max] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Ekstrand, Matias; Widell, Emma; Hammar, Anna; Fagerberg, Bjorn; Bergstrom, Goran; Levin, Malin C.; Fogelstrand, Per; Boren, Jan; Levin, Max] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Akyurek, Levent M.] Sahlgrens Univ Hosp, Dept Pathol, Gothenburg, Sweden; [Johansson, Martin] Lund Univ, Malmo Univ Hosp, Dept Pathol, Malmo, Sweden; [Levin, Max] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital	Levin, M (corresponding author), Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.; Levin, M (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Levin, M (corresponding author), Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden.	max.levin@wlab.gu.se		Ekstrand, Matias/0000-0002-0403-9266; Levin, Malin/0000-0003-1069-5275; Bergstrom, Goran/0000-0003-4289-5722	Swedish Research Council; Swedish Heart-Lung Foundation; Sahlgrenska University Hospital ALF funds; Jubileumsklinikens fond	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska University Hospital ALF funds; Jubileumsklinikens fond	This study was supported by grants from Swedish Research Council (JB), Swedish Heart-Lung Foundation (JB), Sahlgrenska University Hospital ALF funds (JB) and Jubileumsklinikens fond (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORNHEDEN T, 1987, ARTERIOSCLEROSIS, V7, P238, DOI 10.1161/01.ATV.7.3.238; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Fagerberg B, 2010, J VASC RES, V47, P221, DOI 10.1159/000255965; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; GEIRINGER E, 1951, J PATHOL BACTERIOL, V63, P201, DOI 10.1002/path.1700630204; Howard JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091787; Hulten LM, 2009, CURR OPIN LIPIDOL, V20, P409, DOI 10.1097/MOL.0b013e3283307be8; Lee-Rueckert M, 2010, ARTERIOSCL THROM VAS, V30, P1766, DOI 10.1161/ATVBAHA.110.211276; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Leppanen O, 2012, J BIOPHOTONICS, V5, P336, DOI 10.1002/jbio.201100096; Levin M, 2003, ARTERIOSCL THROM VAS, V23, P1801, DOI 10.1161/01.ATV.0000092872.54026.8D; Levin M, 1999, ARTERIOSCL THROM VAS, V19, P950, DOI 10.1161/01.ATV.19.4.950; Marsch E, 2014, ARTERIOSCL THROM VAS, V34, P2545, DOI 10.1161/ATVBAHA.114.304023; Martinet W, 2011, BASIC RES CARDIOL, V106, P749, DOI 10.1007/s00395-011-0192-x; Nagao K, 2012, J LIPID RES, V53, P126, DOI 10.1194/jlr.M019976; Oorni K, 2015, J LIPID RES, V56, P203, DOI 10.1194/jlr.R050252; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Tarkin JM, 2014, NAT REV CARDIOL, V11, P443, DOI 10.1038/nrcardio.2014.80	22	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178877	10.1371/journal.pone.0178877	http://dx.doi.org/10.1371/journal.pone.0178877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570702	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800131
J	McKenney, J; Chen, A; Hoover, KW; Kelly, J; Dowdy, D; Sharifi, P; Sullivan, PS; Rosenberg, ES				McKenney, Jennie; Chen, Anders; Hoover, Karen W.; Kelly, Jane; Dowdy, David; Sharifi, Parastu; Sullivan, Patrick S.; Rosenberg, Eli S.			Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men	PLOS ONE			English	Article							UNITED-STATES; HEALTH-CARE; TRANSMISSION; PREVENTION; INFECTION; UTILITY; IMPACT; RISK; PREP; LIFE	Introduction Men who have sex with men (MSM) are disproportionately affected by HIV due to their increased risk of infection. Oral pre-exposure prophylaxis (PrEP) is a highly effictive HIV-prevention strategy for MSM. Despite evidence of its effectiveness, PrEP uptake in the United States has been slow, in part due to its cost. As jurisdictions and health organizations begin to think about PrEP scale-up, the high cost to society needs to be understood. Methods We modified a previously-described decision-analysis model to estimate the cost per quality-adjusted life-year (QALY) gained, over a 1-year duration of PrEP intervention and lifetime time horizon. Using updated parameter estimates, we calculated: 1) the cost per QALY gained, stratified over 4 strata of PrEP cost (a function of both drug cost and provider costs); and 2) PrEP drug cost per year required to fall at or under 4 cost per QALY gained thresholds. Results When PrEP drug costs were reduced by 60% (with no sexual disinhibition) to 80% (assuming 25% sexual disinhibition), PrEP was cost-effective (at <$100,000 per QALY averted) in all scenarios of base-case or better adherence, as long as the background HIV prevalence was greater than 10%. For PrEP to be cost saving at base-case adherence/efficacy levels and at a background prevalence of 20%, drug cost would need to be reduced to $8,021 per year with no disinhibition, and to $2,548 with disinhibition. Conclusion Results from our analysis suggest that PrEP drug costs need to be reduced in order to be cost-effective across a range of background HIV prevalence. Moreover, our results provide guidance on the pricing of generic emtricitabine/tenofovir disoproxil fumarate, in order to provide those at high risk for HIV an affordable prevention option without financial burden on individuals or jurisdictions scaling-up coverage.	[McKenney, Jennie; Sullivan, Patrick S.; Rosenberg, Eli S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Chen, Anders] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Hoover, Karen W.] CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA; [Kelly, Jane] Georgia Dept Publ Hlth, HIV AIDS Epidemiol Unit, Atlanta, GA USA; [Dowdy, David; Sharifi, Parastu] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Emory University; Rollins School Public Health; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	McKenney, J (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	jennie.l.mckenney@emory.edu		Chen, Anders/0000-0002-1376-0629; Sullivan, Patrick Sean/0000-0002-7728-0587; McKenney, Jennie/0000-0003-1377-0445	 [CDC U38 PS004646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by CDC U38 PS004646. Dr. Karen Hoover is employed by the Centers for Disease Control and Prevention, the funders of the project. Dr. Hoover wrote a piece of the manuscript and provided edits.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anglemyer A, 2013, COCHRANE DB SYST REV, V4; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baggaley RF, 2013, EPIDEMIOLOGY, V24, P110, DOI 10.1097/EDE.0b013e318276cad7; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Bush S, 2016, ASM MICROBE; Centers for Disease Control and Prevention, 2015, HIV GAY BIS MEN; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2015, EST NEW HIV INF US; Chen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108742; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Gill N., 2016, PROSPECTS PREP ENGLA; Golub S, 2013, J ACQ IMMUN DEF SYND, V54, P548; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grey J, 2016, JMIR PUB HLTH SURVEI; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hojilla J, 2015, AIDS; Hoover KW., 2015, NATIONAL HIV PREVENT; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Kelley C, 2015, CLIN INFECT DIS; Kelley CF, 2015, CLIN INFECT DIS, V61, P1590, DOI 10.1093/cid/civ664; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Kessler J, 2014, AIDS, V28, P2683, DOI 10.1097/QAD.0000000000000460; Kim J, 2015, ANN INTERN MED; Koppenhaver RT, 2011, JAIDS-J ACQ IMM DEF, V58, pE51, DOI 10.1097/QAI.0b013e31822b74fe; Krakower D, 2014, 9TH INTERNATIONAL CO; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Mayer Kenneth, 2013, J Int Assoc Provid AIDS Care, V12, P208, DOI 10.1177/2325957413475839; McCormack S, 2015, LANCET; Mera R, AIDS 2016; Mera R, 21ST INTERNATIONAL A; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga M, 2009, SEX TRANSM DIS, V36, P07; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Quinn RR, 2007, AM J KIDNEY DIS, V50, P421, DOI 10.1053/j.ajkd.2007.05.019; Ryan B., 2014, AIDSMEDS; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thigpen M, 2010, NEW ENGL J MED, V367, P423; U. S. Public Health Service Centers for Disease Control and Prevention, 2014, PRE EXPOSURE PROPHYL; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b	60	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178170	10.1371/journal.pone.0178170	http://dx.doi.org/10.1371/journal.pone.0178170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570572	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800033
J	Tschauner, S; Marterer, R; Nagy, E; Apfaltrer, G; Riccabona, M; Singer, G; Stucklschweiger, G; Guss, H; Sorantin, E				Tschauner, Sebastian; Marterer, Robert; Nagy, Eszter; Apfaltrer, Georg; Riccabona, Michael; Singer, Georg; Stuecklschweiger, Georg; Guss, Helmuth; Sorantin, Erich			Surface radiation dose comparison of a dedicated extremity cone beam computed tomography (CBCT) device and a multidetector computed tomography (MDCT) machine in pediatric ankle and wrist phantoms	PLOS ONE			English	Article							NON-WEIGHT-BEARING; BONE-MARROW; INITIAL-EXPERIENCE; CHEST CT; X-RAY; CONVERSION; MOSFET; KNEE; RESOLUTION; CHILDREN	Objectives To evaluate and compare surface doses of a cone beam computed tomography (CBCT) and a multidetector computed tomography (MDCT) device in pediatric ankle and wrist phantoms. Methods Thermoluminescent dosimeters (TLD) were used to measure and compare surface doses between CBCT and MDCT in a left ankle and a right wrist pediatric phantom. In both modalities adapted pediatric dose protocols were utilized to achieve realistic imaging conditions. All measurements were repeated three times to prove test-retest reliability. Additionally, objective and subjective image quality parameters were assessed. Results Average surface doses were 3.8 +/- 2.1 mGy for the ankle, and 2.2 +/- 1.3 mGy for the wrist in CBCT. The corresponding surface doses in optimized MDCT were 4.5 +/- 1.3 mGy for the ankle, and 3.4 +/- 0.7 mGy for the wrist. Overall, mean surface dose was significantly lower in CBCT (3.0 +/- 1.9 mGy vs. 3.9 +/- 1.2 mGy, p<0.001). Subjectively rated general image quality was not significantly different between the study protocols (p = 0.421), whereas objectively measured image quality parameters were in favor of CBCT (p<0.001). Conclusions Adapted extremity CBCT imaging protocols have the potential to fall below optimized pediatric ankle and wrist MDCT doses at comparable image qualities. These possible dose savings warrant further development and research in pediatric extremity CBCT applications.	[Tschauner, Sebastian; Marterer, Robert; Nagy, Eszter; Apfaltrer, Georg; Riccabona, Michael; Sorantin, Erich] Med Univ Graz, Dept Radiol, Div Pediat Radiol, Graz, Austria; [Singer, Georg] Med Univ Graz, Div Gen Pediat & Adolescence Surg, Graz, Austria; [Stuecklschweiger, Georg; Guss, Helmuth] Univ Hosp Graz, Competence Ctr Med Phys & Radiat Protect, Graz, Austria	Medical University of Graz; Medical University of Graz	Tschauner, S (corresponding author), Med Univ Graz, Dept Radiol, Div Pediat Radiol, Graz, Austria.	sebastian.tschauner@medunigraz.at	Tschauner, Sebastian/A-4372-2016; Marterer, Robert/Y-5278-2019	Tschauner, Sebastian/0000-0002-7873-9839; Marterer, Robert/0000-0001-6806-122X; Singer, Georg/0000-0003-4770-3144				Agrawal Jiwanasha Manish, 2013, J Contemp Dent Pract, V14, P153; Alamri Hadi Mohammed, 2012, General Dentistry, V60, P390; Brady Z, 2012, AUSTRALAS PHYS ENG S, V35, P117, DOI 10.1007/s13246-012-0134-4; Brenner DJ, 2008, BRIT J RADIOL, V81, P521, DOI 10.1259/bjr/22942198; BURCH WM, 1967, AUSTRALAS RADIOL, V11, P280, DOI 10.1111/j.1440-1673.1967.tb01537.x; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Cho ES, 2012, INVEST RADIOL, V47, P142, DOI 10.1097/RLI.0b013e31823076a4; Colin F, 2014, FOOT ANKLE INT, V35, P1057, DOI 10.1177/1071100714540890; Collan L, 2013, FOOT ANKLE SURG, V19, P155, DOI 10.1016/j.fas.2013.01.003; Silva IMDC, 2012, BRAZ ORAL RES, V26, P550, DOI 10.1590/S1806-83242012000600011; De Lin M, 2008, RADIAT RES, V170, P260, DOI 10.1667/RR1328.1; Faccioli N, 2010, SKELETAL RADIOL, V39, P1087, DOI 10.1007/s00256-010-0911-7; Guillerman RP, 2013, PEDIATR RADIOL, V43, pS181, DOI 10.1007/s00247-012-2582-0; Halonen KS, 2014, J BIOMECH, V47, P2467, DOI 10.1016/j.jbiomech.2014.04.013; Hardie AD, 2015, CLIN IMAG, V39, P642, DOI 10.1016/j.clinimag.2015.02.017; Harrison J, 2008, J RADIOL PROT, V28, P137, DOI 10.1088/0952-4746/28/2/R01; Hirschmann A, 2014, EUR RADIOL, V24, P553, DOI 10.1007/s00330-013-3028-2; Hol C, 2015, ACTA ODONTOL SCAND, V73, P195, DOI 10.3109/00016357.2014.979866; Huang A, 2015, SKELETAL RADIOL, V44, P797, DOI 10.1007/s00256-015-2105-9; International Commission on Radiological Protection, 1977, ICRP PUBL, V26; Jaju PP, 2015, CONE BEAM COMPUTED T, Vxvii; Jin JY, 2010, MED PHYS, V37, P5634, DOI 10.1118/1.3497272; Kagaku Kyoto, 2016, PED WHOL BOD PHANT P; Kapila SD, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140282; Kiljunen T, 2015, PHYS MEDICA, V31, P844, DOI 10.1016/j.ejmp.2015.09.004; Kinhikar RA, 2009, APPL RADIAT ISOTOPES, V67, P1683, DOI 10.1016/j.apradiso.2009.03.008; Koivisto J, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20140202; Koivisto J, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0067-8; Koivisto J, 2013, RADIAT PROT DOSIM, V157, P515, DOI 10.1093/rpd/nct162; Lang H, 2016, EUROPEAN RADIOLOGY; Lee C, 2017, AM J ROENTGENOL, V208, P1082, DOI 10.2214/AJR.16.16979; Lee C, 2015, J RADIOL PROT, V35, P891, DOI 10.1088/0952-4746/35/4/891; Li J, 2013, J APPL CLIN MED PHYS, V14, P167, DOI 10.1120/jacmp.v14i6.4346; Li X, 2011, RADIOLOGY, V259, P862, DOI 10.1148/radiol.11101900; Ludlow JB., 2014, INT J DIAGN IMAGING, V1, P1, DOI [10.5430/ijdi.v1n2p1, DOI 10.5430/IJDI.V1N2P1]; Machado GL, 2015, SAUDI DENT J, V27, P12, DOI 10.1016/j.sdentj.2014.08.004; Makins Scott R, 2014, Dent Clin North Am, V58, P485, DOI 10.1016/j.cden.2014.04.007; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Millon D, 2017, EUR RADIOL, V27, P927, DOI 10.1007/s00330-016-4444-x; Nagarajappa AK, 2015, J INT SOC PREV COMMU, V5, P440, DOI 10.4103/2231-0762.170523; Neubauer J, 2016, COMPARISON RADIATION; Newman B, 2012, AM J ROENTGENOL, V199, pW232, DOI 10.2214/AJR.10.5895; Pugmire BS, 2016, AM J ROENTGENOL, V206, P431, DOI 10.2214/AJR.15.15099; Seidenbusch MC, 2014, Z MED PHYS, V24, P123, DOI 10.1016/j.zemedi.2014.02.001; Shaw C, 2014, CONE BEAM COMPUTED T, DOI DOI 10.1201/B16465; Shaw CC, 2014, CONE BEAM COMPUTED T, Vxviii; Siewerdsen JH, 2001, MED PHYS, V28, P220, DOI 10.1118/1.1339879; Strauss KJ, 2014, PEDIATR RADIOL, V44, P450, DOI 10.1007/s00247-014-3104-z; TACCONE A, 1995, PEDIATR RADIOL, V25, P596, DOI 10.1007/BF02011826; Thawait GK, 2015, EUR J RADIOL, V84, P2564, DOI 10.1016/j.ejrad.2015.09.003; Tuominen EKJ, 2013, AM J ROENTGENOL, V200, P146, DOI 10.2214/AJR.12.8481; Varshowsaz Masoud, 2016, J Dent (Tehran), V13, P108; von Falck C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056875; WAITCHES G, 1994, AM J ROENTGENOL, V162, P1399, DOI 10.2214/ajr.162.6.8192007; Weber Marie-Theres, 2015, Swiss Dent J, V125, P293; ZAWIN JK, 1993, RADIOLOGY, V188, P159, DOI 10.1148/radiology.188.1.8511291	56	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178747	10.1371/journal.pone.0178747	http://dx.doi.org/10.1371/journal.pone.0178747			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570626	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800117
J	Asiedu, MN; Agudogo, J; Krieger, MS; Miros, R; Proeschold-Bell, RJ; Schmitt, JW; Ramanujam, N				Asiedu, Mercy Nyamewaa; Agudogo, Julia; Krieger, Marlee S.; Miros, Robert; Proeschold-Bell, Rae Jean; Schmitt, John W.; Ramanujam, Nimmi			Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening	PLOS ONE			English	Article							VISUAL INSPECTION; PAP-SMEAR; PREVALENCE; VIOLENCE	Objective Cervical cancer screening usually requires use of a speculum to provide a clear view of the cervix. The speculum is one potential barrier to screening due to fear of pain, discomfort and embarrassment. The aim of this paper is to present and demonstrate the feasibility of a tampon-sized inserter and the POCkeT Colposcope, a miniature pen sized-colposcope, for comfortable, speculum-free and potentially self-colposcopy. Study design We explored different designs using 3D computer-aided design (CAD) software and performed mechanical testing simulations on each. Designs were rapid prototyped and tested using a custom vaginal phantom across a range of vaginal pressures and uterine tilts to select an optimal design. Two final designs were tested with fifteen volunteers to assess cervix visualization, comfort and usability compared to the speculum and the optimal design, the curved-tip inserter, was selected for testing in volunteers. Results We present a vaginal inserter as an alternative to the standard speculum for use with the POCkeT Colposcope. The device has a slim tubular body with a funnel-like curved tip measuring approximately 2.5 cm in diameter. The inserter has a channel through which a 2 megapixel (MP) mini camera with LED illumination fits to enable image capture. Mechanical finite element testing simulations with an applied pressure of 15 cm H2O indicated a high factor of safety (90.9) for the inserter. Testing of the device with a custom vaginal phantom, across a range of supine vaginal pressures and uterine tilts (retroverted, anteverted and sideverted), demonstrated image capture with a visual area comparable to the speculum for a normal/axial positioned uteri and significantly better than the speculum for anteverted andsideverted uteri (p<0.00001). Volunteer studies with self-insertion and physician-assisted cervix image capture showed adequate cervix visualization for 83% of patients. In addition, questionnaire responses from volunteers indicated a 92.3% overall preference for the inserter over the speculum and all indicated that the inserter was more comfortable than the speculum. The inserter provides a platform for self-cervical cancer screening and also enables acetic acid/Lugol's iodine application and insertion of swabs for Pap smear sample collection. Conclusion This study demonstrates the feasibility of an inserter and miniature -imaging device for comfortable cervical image capture of women with potential for synergistic HPV and Pap smear sample collection.	[Asiedu, Mercy Nyamewaa; Agudogo, Julia; Krieger, Marlee S.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Asiedu, Mercy Nyamewaa; Proeschold-Bell, Rae Jean; Schmitt, John W.; Ramanujam, Nimmi] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Krieger, Marlee S.; Proeschold-Bell, Rae Jean; Ramanujam, Nimmi] Duke Univ, Ctr Global Womens Hlth Technol, Durham, NC USA; [Miros, Robert] 3rd Stone Design, San Rafael, CA USA; [Schmitt, John W.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Asiedu, MN (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.; Asiedu, MN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	mercy.asiedu@duke.edu		Agudogo, Julia Sroda/0000-0002-3603-1269	National Institute of Health Quick Trials [1R01CA195500]; National Institute of Health Academic-Industrial Partnerships [1R01CA193380]; 3rd Stone Design; NATIONAL CANCER INSTITUTE [R01CA193380, R01CA195500] Funding Source: NIH RePORTER	National Institute of Health Quick Trials; National Institute of Health Academic-Industrial Partnerships; 3rd Stone Design; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health Quick Trials (Grant: 1R01CA195500 https://projectreporter.nih.govproject_info_description.cfm?projectnumber = 1R01CA195500-01) to NR and National Institute of Health Academic-Industrial Partnerships (Grant: 1R01CA193380 https://projectreporter.nih.gov/project info description.cfm?aid=8864360&icde=0) to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3rd Stone Design provided support in the form of salaries for author RM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	(ACCP) A.f.C.C.P, 2011, AFCCP CERV CANC PREV; Barnhart KT, 2006, HUM REPROD, V21, P1618, DOI 10.1093/humrep/del022; Carr KC, 2004, J MIDWIFERY WOM HEAL, V49, P329, DOI 10.1016/j.jmwh.2004.02.015; Cox M. E. J., 2011, MODERN COLPOSCOPY TX; Crowley D L G., 2012, COMPREHENSIVE GYNECO; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; FDA, 2015, CLEAR STER HKGH LEV; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gallenberg M.M., 2014, TILTED UTERUS CAN IT; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Hill DA, 2014, INT J GYNECOL OBSTET, V125, P116, DOI 10.1016/j.ijgo.2013.10.025; Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021; (IARC) I.A.f.R.o.C, 2012, IAFROC GLOB CERV UT; International Organization for Standardization, 2009, 10993 ISO; ISO, 2010, 10993102010 ISO, P10993; Khan M, 2015, J PAK MED ASSOC, V65, P192; Lam CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135869; Larsen M, 1997, FAM PRACT, V14, P148, DOI 10.1093/fampra/14.2.148; Longmore PG, 2004, AUST NZ J OBSTET GYN, V44, P140, DOI 10.1111/j.1479-828X.2004.00180.x; O'Dell KK, 2007, INT UROGYNECOL J, V18, P1481, DOI 10.1007/s00192-007-0387-8; Orfanoudaki IM, 2005, GYNECOL ONCOL, V96, P119, DOI 10.1016/j.ygyno.2004.09.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Riley L., 2008, REDESIGNING VAGINAL; Rossmann J.S., 2008, BUILT SPEC VAGINAL S; Rutala W.A., 2019, GUIDELINE DISINFECTI; Seehusen DA, 2006, BMJ-BRIT MED J, V333, P171, DOI 10.1136/bmj.38888.588519.55; Society A.C., 2016, AM CANC SOC GUIDELIN; Thomas A, 2001, AUST NZ J OBSTET GYN, V41, P379, DOI 10.1111/j.1479-828X.2001.tb01313.x; Tizanno Anthony P., 2015, UROGYNECOLOGY RECONS; Williams CM, 2008, POP STUD-J DEMOG, V62, P335, DOI 10.1080/00324720802315459; Wright D, 2005, J CLIN NURS, V14, P1098, DOI 10.1111/j.1365-2702.2005.01205.x	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177782	10.1371/journal.pone.0177782	http://dx.doi.org/10.1371/journal.pone.0177782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562669	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700028
J	de Dassel, JL; Fittock, MT; Wilks, SC; Poole, JE; Carapetis, JR; Ralph, AP				de Dassel, Jessica Langloh; Fittock, Marea Therese; Wilks, Sagen Cheyenne; Poole, Jane Elizabeth; Carapetis, Jonathan Rhys; Ralph, Anna P.			Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data	PLOS ONE			English	Article							PREVENTION; PENICILLIN; REMEDY; FEVER	Objective In high-burden Australian states and territories, registers of patients with acute rheumatic fever and rheumatic heart disease are maintained for patient management, monitoring of system performance and research. Data validation was undertaken for the Australian Northern Territory Rheumatic Heart Disease Register to determine quality and impact of data cleaning on reporting against key performance indicators: overall adherence, and proportion of patients receiving >80% of scheduled penicillin doses for secondary prophylaxis. Methods Register data were compared with data from health centres. Inconsistencies were identified and corrected; adherence was calculated before and after cleaning. Results 2780 penicillin doses were validated; 426 inconsistencies were identified, including 102 incorrect dose dates. After cleaning, mean adherence increased (63.5% to 67.3%, p<0.001) and proportion of patients receiving >80% of doses increased (34.2% to 42.1%, p = 0.06). Conclusions The Northern Territory Rheumatic Heart Disease Register underestimates adherence, although the key performance indicator of >80% adherence was not significantly affected. Program performance is better than hitherto appreciated. However some errors could affect patient management, as well as accuracy of longitudinal or inter-jurisdictional comparisons. Adequate resources are needed for maintenance of data quality in acute rheumatic fever/rheumatic heart disease registers to ensure provision of evidence-based care and accurate assessment of program impact.	[de Dassel, Jessica Langloh] Charles Darwin Univ, Inst Adv Studies, Darwin, NT, Australia; [de Dassel, Jessica Langloh; Wilks, Sagen Cheyenne; Poole, Jane Elizabeth; Ralph, Anna P.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Fittock, Marea Therese] Northern Terr Dept Hlth, Northern Terr Rheumat Heart Dis Control Program, Darwin, NT, Australia; [Carapetis, Jonathan Rhys] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Carapetis, Jonathan Rhys] Perth Childrens Hosp, Perth, WA, Australia; [Ralph, Anna P.] Royal Darwin Hosp, Darwin, NT, Australia	Charles Darwin University; Charles Darwin University; Menzies School of Health Research; Telethon Kids Institute; University of Western Australia	de Dassel, JL (corresponding author), Charles Darwin Univ, Inst Adv Studies, Darwin, NT, Australia.; de Dassel, JL (corresponding author), Menzies Sch Hlth Res, Darwin, NT, Australia.	jess.dedassel@menzies.edu.au	Ralph, Anna/AAB-6103-2021; Carapetis, Jonathan R/H-8933-2014	Carapetis, Jonathan R/0000-0002-1182-9792	National Health and Medical Research Council [1027040]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council, grant reference: 1027040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nhmrc.gov.au/.	Australian Institute of Health and Welfare, 2016, AUSTR BURD DIS STUD, V6; Edwards K, 2013, NT DIS CONTROL B, V20, P24; Eissa S, 2005, AUST NZ J PUBL HEAL, V29, P521, DOI 10.1111/j.1467-842X.2005.tb00243.x; Francis JR, 2016, IDCases, V4, P6, DOI 10.1016/j.idcr.2016.02.001; Gray C, 2013, REV ACUTE RHEUMATIC; Karthikeyan G, 2012, AM HEART J, V163, P535, DOI 10.1016/j.ahj.2012.01.003; Kearns TM, 2010, RURAL REMOTE HEALTH, V10; Lawrence JG, 2013, CIRCULATION, V128, P492, DOI 10.1161/CIRCULATIONAHA.113.001477; McDonald M, 2005, HEART, V91, P1131, DOI 10.1136/hrt.2004.057570; McNeil JJ, 2010, MED J AUSTRALIA, V192, P244, DOI 10.5694/j.1326-5377.2010.tb03499.x; Parnaby MG, 2010, J PAEDIATR CHILD H, V46, P527, DOI 10.1111/j.1440-1754.2010.01841.x; Ralph A, AUST PRESCR IN PRESS; Ralph AP, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1166-y; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; RHD Australia, SURV QUAL IMPR; WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, WHO TECHN REP SER; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	18	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178264	10.1371/journal.pone.0178264	http://dx.doi.org/10.1371/journal.pone.0178264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562621	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700047
J	Qader, G; Hamim, A; Sayedi, M; Rashidi, M; Manzoor, L; Seddiq, MK; Ikram, N; Suarez, PG				Qader, G.; Hamim, A.; Sayedi, M.; Rashidi, M.; Manzoor, L.; Seddiq, M. K.; Ikram, N.; Suarez, P. G.			Addressing tuberculosis control in fragile states: Urban DOTS experience in Kabul, Afghanistan, 2009-2015	PLOS ONE			English	Article							PUBLIC-PRIVATE MIX; TREATMENT OUTCOMES; PULMONARY TUBERCULOSIS	Tuberculosis (TB) is a major public health problem in Afghanistan, but experience in implementing effective strategies to prevent and control TB in urban areas and conflict zones is limited. This study shares programmatic experience in implementing DOTS in the large city of Kabul. We analyzed data from the 2009-2015 reports of the National TB Program (NTP) for Kabul City and calculated treatment outcomes and progress in case notification using rates, ratios, and confidence interval. Urban DOTS was implemented by the NTP in partnership with United States Agency for International Development (USAID)-funded TB projects, the World Health Organization (WHO), and the private sector. Between 2009 and 2015, the number of DOTS-providing centers in Kabul increased from 22 to 85. In total, 24,619 TB patients were enrolled in TB treatment during this period. The case notification rate for all forms of TB increased from 59 per 100,000 population to 125 per 100,000. The case notification rate per 100,000 population for sputum-smear-positive TB increased from 25 to 33. The treatment success rate for all forms of TB increased from 31% to 67% and from 47% to 77% for sputum-smear-positive TB cases. The treatment success rate for private health facilities increased from 52% in 2010 to 80% in 2015. In 2013, contact screening was introduced, and the TB yield was 723 per 100,000 more than two times higher than the estimated national prevalence of 340 per 100,000. Contact screening contributed to identifying 2,509 child contacts of people with TB, and 76% of those children received isoniazid preventive therapy. The comprehensive urban DOTS program significantly improved service accessibility, TB case finding, and treatment outcomes in Kabul. Public-and private-sector involvement also improved treatment outcomes; however, the treatment success rate remains higher in private health facilities. While the treatment success rate increased significantly, it remains lower than the national average, and more efforts are needed to improve treatment outcomes in Kabul. We recommend that the urban DOTS approach be replicated in other countries and cities in Afghanistan with settings similar to Kabul.	[Qader, G.; Hamim, A.; Sayedi, M.; Rashidi, M.] Challenge TB Project Management Sci Hlth, Kabul, Afghanistan; [Manzoor, L.; Seddiq, M. K.] Minist Publ Hlth, Natl TB Program, Kabul, Afghanistan; [Ikram, N.] US Agcy Int Dev, Off Hlth & Nutr, Kabul, Afghanistan; [Suarez, P. G.] Management Sci Hlth, Arlington, VA USA	United States Agency for International Development (USAID)	Qader, G (corresponding author), Challenge TB Project Management Sci Hlth, Kabul, Afghanistan.	gqader@msh.org	sayedi, mohammad/AAR-2237-2021; Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761				Akhtar S, 2011, INT J TUBERC LUNG D, V15, P90; Daniel OJ, 2013, INT J TUBERC LUNG D, V17, P1195, DOI 10.5588/ijtld.12.0759; de Abreu ESM, 2016, BMC PUBLIC HEALTH, V16, P912; Dememew ZG, 2016, INT J TUBERC LUNG D, V20, P1192, DOI 10.5588/ijtld.16.0005; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Goswami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109563; Jerene D, 2015, INT J TUBERC LUNG D, V19, P898, DOI 10.5588/ijtld.14.0978; Kizito KW, 2011, T ROY SOC TROP MED H, V105, P52, DOI 10.1016/j.trstmh.2010.08.015; Lucenko I, 2014, PUBLIC HEALTH ACTION, V4, pS54, DOI 10.5588/pha.14.0040; McLaren ZM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163083; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Naqvi SA, 2012, INT J TUBERC LUNG D, V16, P817, DOI 10.5588/ijtld.11.0440; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; Ogbudebe CL, 2016, INT J MYCOBACT, V5, P205, DOI 10.1016/j.ijmyco.2016.03.003; Pio A, 1999, DESAFIOS OPORTUNIDAD; Prasad A, 2016, T ROY SOC TROP MED H, V110, P151, DOI 10.1093/trstmh/trw004; Pungrassami P, 2002, TROP MED INT HEALTH, V7, P271, DOI 10.1046/j.1365-3156.2002.00849.x; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Ullah AZ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001534; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Zhuben M, 2013, E MEDITERR HEALTH J, V19, P694	23	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178053	10.1371/journal.pone.0178053	http://dx.doi.org/10.1371/journal.pone.0178053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562675	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700041
J	Vasireddi, M; Hilliard, JK				Vasireddi, Mugdha; Hilliard, Julia K.			Regulation of PI3K/Akt dependent apoptotic markers during b virus infection of human and macaque fibroblasts asdfsadfs	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL KINASE; ONCOGENIC TRANSFORMATION; SIGNAL-TRANSDUCTION; AKT ACTIVATION; RHESUS-MONKEYS; PATHWAY; REPLICATION; SURVIVAL	B virus (Macacine herpesvirus 1), a simplex virus endemic in macaques, causes encephalitis, encephalomyelitis, and death in 80% of untreated zoonotically infected humans with delayed or no treatment. Here we report a significant difference in PI3K/Akt-dependent apoptosis between B virus infected human and macaque dermal fibroblasts. Our data show that B virus infection in either human or macaque fibroblasts results in activation of Akt via P13K and this activation does not require viral de novo protein synthesis. Inhibition of P13K with LY294002 results in a significant reduction of viral titers in B virus infected macaque and human fibroblasts with only a modest difference in the reduction of virus titers between the two cell types. We, therefore, tested the hypothesis that B virus results in the phosphorylation of Akt (S473), which prevents apoptosis, enhancing virus replication in B virus infected macaque dermal fibroblasts. We observed markers of intrinsic apoptosis when P13K activation of Akt was inhibited in B virus infected macaque cells, while, these apoptotic markers were absent in B virus infected human fibroblasts under the same conditions. From these data we suggest that P13K activates Akt in B virus infected macaque and human fibroblasts, but this enhances virus replication in macaque fibroblast cells by blocking apoptosis.	[Vasireddi, Mugdha; Hilliard, Julia K.] Georgia State Univ, Biol Dept, Viral Immunol Ctr, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Hilliard, JK (corresponding author), Georgia State Univ, Biol Dept, Viral Immunol Ctr, Atlanta, GA 30303 USA.	jhilliard@gsu.edu			B Virus Resource Center in the Viral Immunology Center at Georgia State University; Georgia Research Alliance	B Virus Resource Center in the Viral Immunology Center at Georgia State University; Georgia Research Alliance	This work was supported by the B Virus Resource Center in the Viral Immunology Center at Georgia State University and the Georgia Research Alliance. The authors also acknowledge Yerkes National Primate Center (Emory University) Tissue Sharing Program for rhesus macaque dermal tissue samples from which we isolated and established a line of primary dermal fibroblasts used in these experiments. We also recognize and appreciate the value of the critical discussions provided by the members of the research and diagnostic teams in the Viral Immunology Center.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Benetti L, 2006, J VIROL, V80, P3341, DOI 10.1128/JVI.80.7.3341-3348.2006; Bhatt AP, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00401; BJORGE JD, 1990, P NATL ACAD SCI USA, V87, P3816, DOI 10.1073/pnas.87.10.3816; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285; CLARKE AS, 1995, J BIOL CHEM, V270, P22673, DOI 10.1074/jbc.270.39.22673; COCHET C, 1991, J BIOL CHEM, V266, P637; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Dunn EF, 2009, J VIROL, V83, P11665, DOI 10.1128/JVI.01092-09; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Fukuda M, 2007, J VIROL, V81, P9299, DOI 10.1128/JVI.00537-07; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Hsu MJ, 2010, VIRUS RES, V153, P36, DOI 10.1016/j.virusres.2010.07.002; Jelaska A, 1998, J CELL PHYSIOL, V175, P19, DOI 10.1002/(SICI)1097-4652(199804)175:1<19::AID-JCP3>3.0.CO;2-F; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KATO H, 1993, J BIOL CHEM, V268, P2655; KEEBLE SA, 1958, J PATHOL BACTERIOL, V76, P189, DOI 10.1002/path.1700760121; KEEBLE SA, 1960, ANN NY ACAD SCI, V85, P960, DOI 10.1111/j.1749-6632.1960.tb50016.x; LONDON WT, 1974, CANCER RES, V34, P1118; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; PALMER AE, 1987, J MED PRIMATOL, V16, P99; Rahaus M, 2007, CELL SIGNAL, V19, P312, DOI 10.1016/j.cellsig.2006.07.003; Reszka N, 2010, VIROLOGY, V398, P243, DOI 10.1016/j.virol.2009.11.041; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Tiwari V, 2010, J GEN VIROL, V91, P3002, DOI 10.1099/vir.0.024166-0; Wagner MJ, 2011, J VIROL, V85, P2803, DOI 10.1128/JVI.01877-10; Weidinger C, 2011, J CLIN ENDOCR METAB, V96, pE1361, DOI 10.1210/jc.2010-2453; WEIGLER BJ, 1992, CLIN INFECT DIS, V14, P555, DOI 10.1093/clinids/14.2.555; YAMADA M, 1983, BIKEN J, V26, P35	46	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178314	10.1371/journal.pone.0178314	http://dx.doi.org/10.1371/journal.pone.0178314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558072	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000039
J	Glato, K; Aidam, A; Kane, NA; Bassirou, D; Couderc, M; Zekraoui, L; Scarcelli, N; Barnaud, A; Vigouroux, Y				Glato, Kodjo; Aidam, Atsou; Kane, Ndjido Ardo; Bassirou, Diallo; Couderc, Marie; Zekraoui, Leila; Scarcelli, Nora; Barnaud, Adeline; Vigouroux, Yves			Structure of sweet potato (Ipomoea batatas) diversity in West Africa covaries with a climatic gradient	PLOS ONE			English	Article							GENETIC DIVERSITY; SSR; DISPERSAL	Sub-Saharan agriculture has been identified as vulnerable to ongoing climate change. Adaptation of agriculture has been suggested as a way to maintain productivity. Better knowledge of intra-specific diversity of varieties is prerequisites for the successful management of such adaptation. Among crops, root and tubers play important roles in food security and economic growth for the most vulnerable populations in Africa. Here, we focus on the sweet potato. The Sweet potato (Ipomoea batatas) was domesticated in Central and South America and was later introduced into Africa and is now cultivated throughout tropical Africa. We evaluated its diversity in West Africa by sampling a region extending from the coastal area of Togo to the northern Sahelian region of Senegal that represents a range of climatic conditions. Using 12 microsatellite markers, we evaluated 132 varieties along this gradient. Phenotypic data from field trials conducted in three seasons was also obtained. Genetic diversity in West Africa was found to be 18% lower than in America. Genetic diversity in West Africa is structured into five groups, with some groups found in very specific climatic areas, e.g. under a tropical humid climate, or under a Sahelian climate. We also observed genetic groups that occur in a wider range of climates. The genetic groups were also associated with morphological differentiation, mainly the shape of the leaves and the color of the stem or root. This particular structure of diversity along a climatic gradient with association to phenotypic variability can be used for conservation strategies. If such structure is proved to be associated with specific climatic adaptation, it will also allow developing strategies to adapt agriculture to ongoing climate variation in West Africa.	[Glato, Kodjo; Aidam, Atsou] Univ Lome, Lome, Togo; [Glato, Kodjo; Kane, Ndjido Ardo; Bassirou, Diallo; Zekraoui, Leila; Barnaud, Adeline] ISRA, Dakar, Senegal; [Glato, Kodjo; Kane, Ndjido Ardo; Bassirou, Diallo; Barnaud, Adeline] Lab Mixte Int Adaptat Plantes & Microorganismes S, Dakar, Senegal; [Glato, Kodjo; Couderc, Marie; Scarcelli, Nora; Vigouroux, Yves] Inst Rech Dev, Montpellier, France	Institut de Recherche pour le Developpement (IRD)	Glato, K (corresponding author), Univ Lome, Lome, Togo.; Glato, K (corresponding author), ISRA, Dakar, Senegal.; Glato, K (corresponding author), Lab Mixte Int Adaptat Plantes & Microorganismes S, Dakar, Senegal.; Glato, K (corresponding author), Inst Rech Dev, Montpellier, France.	glatokodjo@gmail.com	vigouroux, Yves/A-9056-2011; Kane, Ndjido Ardo/AAM-7656-2020	vigouroux, Yves/0000-0002-8361-6040; Kane, Ndjido Ardo/0000-0002-1879-019X; Scarcelli, Nora/0000-0003-4382-9583; barnaud, adeline/0000-0001-9896-1210	Agropolis Foundation's "Agropolis Resource Center for Crop Adaptation and Diversity" (ARCAD) project, Dakar, Senegal; French embassy in Togo (SCAC), Dakar, Senegal; Institut Senegalais de la Recherche Agricole (ISRA), Dakar, Senegal; Institut de la Recherche pour le Developpement (IRD) in Dakar, Senegal and Montpellier, France; West African Economic and Monetary Union (UEMOA) [11514/2011/DDS/DESFP/PAES-436]; University of Lome, Togo	Agropolis Foundation's "Agropolis Resource Center for Crop Adaptation and Diversity" (ARCAD) project, Dakar, Senegal; French embassy in Togo (SCAC), Dakar, Senegal; Institut Senegalais de la Recherche Agricole (ISRA), Dakar, Senegal; Institut de la Recherche pour le Developpement (IRD) in Dakar, Senegal and Montpellier, France; West African Economic and Monetary Union (UEMOA); University of Lome, Togo	This study was partly funded by the Agropolis Foundation's "Agropolis Resource Center for Crop Adaptation and Diversity" (ARCAD) project, the French embassy in Togo (SCAC), Institut Senegalais de la Recherche Agricole (ISRA), Dakar, Senegal; the Institut de la Recherche pour le Developpement (IRD) in Dakar, Senegal and Montpellier, France; the West African Economic and Monetary Union (UEMOA) grant No 11514/2011/DDS/DESFP/PAES-436 to Kodjo Glato and the University of Lome, Togo. We thank C. Roullier and Professor K. Akpagana for early on advice on this study, V. Lebot for helpful comments and the farmers who willingly participated in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Austin D.F., 1987, EXPLORATION MAINTENA, P27; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; Champagne A, 2009, J FOOD COMPOS ANAL, V23, P763; *CIP, 2005, ANN SUBPR PROGR REP; Doyle J. J., 1987, PHYTOCHEM B, P11; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; Ellen R., 1996, REDEFINING NATURE, P233; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAOSTAT, 2014, AGR PROD CROP PRIM D; Faush D, GENETICS, V164, P1567; Gichuru V, 2006, ACTA HORTIC, P159, DOI 10.17660/ActaHortic.2006.703.18; Gwandu C., 2012, African Journal of Biotechnology, V11, P9582; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huaman Z, BIODIVERSITY TRUST; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Karuri HW, 2010, INT J AGRIC BIOL, V12, P33; Kosh-Komba E., 2013, THESIS U LOME; Koussao S., 2014, African Journal of Biotechnology, V13, P729; Lebot V, 2003, PLANT PATHOL, V52, P303, DOI 10.1046/j.1365-3059.2003.00851.x; Lebot Vincent, 2013, Environment Development and Sustainability, V15, P1405, DOI 10.1007/s10668-013-9445-1; Lebot V, 2010, HANDB PLANT BREED, V7, P97, DOI 10.1007/978-0-387-92765-7_3; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li P, 2009, AFR J BIOTECHNOL, V8, P2102; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maquia I, 2013, S AFRICAN J BOT, P142; Mitra S., 2012, J NUTR FOOD SCI, V2, P160; Pagnotta MA, 2009, GENET RESOUR CROP EV, V56, P299, DOI 10.1007/s10722-008-9364-4; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Rodriguez-Bonilla L, 2014, PLOS ONE, V9, P1; Roullier C, 2013, HEREDITY, V110, P594, DOI 10.1038/hdy.2013.14; Roullier C, 2011, MOL ECOL, V20, P3963, DOI 10.1111/j.1365-294X.2011.05229.x; Roullier C, 2012, P NATL ACAD SCI US; Tairo F., 2008, AFRICAN J PLANT SCI, V2, P77; Tumwegamire S, 2011, CROP SCI, V51, P1132, DOI 10.2135/cropsci2010.07.0407; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; Yada B, 2010, HORTICULTURAL SCI, V45; Zhang D, 2000, CIP PROGRAMME REPORT, P295; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177697	10.1371/journal.pone.0177697	http://dx.doi.org/10.1371/journal.pone.0177697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552989	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000012
J	Wang, SJ; Zaitoun, IS; Johnson, RP; Jamali, N; Gurel, Z; Wintheiser, CM; Strasser, A; Lindner, V; Sheibani, N; Sorenson, CM				Wang, Shoujian; Zaitoun, Ismail S.; Johnson, Ryan P.; Jamali, Nasim; Gurel, Zafer; Wintheiser, Catherine M.; Strasser, Andreas; Lindner, Volkhard; Sheibani, Nader; Sorenson, Christine M.			Bim expression in endothelial cells and pericytes is essential for regression of the fetal ocular vasculature	PLOS ONE			English	Article							MEDIATED VESSEL OBLITERATION; MICE EXHIBIT; MOUSE; BCL-2; GROWTH; DEATH; RETINOPATHY; DELETION; NEOVASCULARIZATION; ATTENUATION	Apoptosis plays a central role in developmental and pathological angiogenesis and vessel regression. Bim is a pro-apoptotic Bcl-2 family member that plays a prominent role in both developmental and pathological ocular vessel regression, and neovascularization. Endothelial cells (EC) and pericytes (PC) each play unique roles during vascular development, maintenance and regression. We recently showed that germline deletion of Bim results in persistent hyaloid vasculature, increased retinal vascular density and prevents retinal vessel regression in response to hyperoxia. To determine whether retinal vascular regression is attributable to Bim expression in EC or PC we generated mice carrying a conditional Bim allele (Bim (Flox/Flox)) and VE-cadherin-cre (Bim(EC) mice) or Pdgfrb-cre (Bim(PC) mice). Bim(EC) and Bim PC mice demonstrated attenuated hyaloid vessel regression and postnatal retinal vascular remodeling. We also observed decreased retinal vascular apoptosis and proliferation. Unlike global Bim -/-mice, mice conditionally lacking Bim in EC or PC underwent hyperoxia- mediated vessel obliteration and subsequent retinal neovascularization during oxygeninduced ischemic retinopathy similar to control littermates. Thus, understanding the cell autonomous role Bim plays in the retinal vascular homeostasis will give us new insight into how to modulate pathological retinal neovascularization and vessel regression to preserve vision.	[Wang, Shoujian; Zaitoun, Ismail S.; Jamali, Nasim; Gurel, Zafer; Wintheiser, Catherine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Johnson, Ryan P.; Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Jamali, Nasim; Sheibani, Nader; Sorenson, Christine M.] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA; [Strasser, Andreas] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Lindner, Volkhard] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Maine Medical Center	Sorenson, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.; Sorenson, CM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA.	cmsorenson@wisc.edu	Strasser, Andreas/C-7581-2013; Gurel, Zafer/AAF-3072-2021; Jamali, Nasim/Z-3534-2019; Sheibani, Nader/AAG-2379-2020	Strasser, Andreas/0000-0002-5020-4891; Jamali, Nasim/0000-0003-1851-6585; Sheibani, Nader/0000-0003-2723-9217	Lions Pediatric Ophthalmology Research Fund; Retina Research Foundation/Daniel M. Albert Chair; National Institutes of Health [R21EY023024]; NIH [R24 EY022883, P30 CA014520]; Carbone Cancer Center [P30 EY016665]; Retina Research Foundation; Hilldale Fellowship at the University of Wisconsin -Madison;  [P30GM103392]; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392] Funding Source: NIH RePORTER	Lions Pediatric Ophthalmology Research Fund; Retina Research Foundation/Daniel M. Albert Chair; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carbone Cancer Center; Retina Research Foundation; Hilldale Fellowship at the University of Wisconsin -Madison; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Lions Pediatric Ophthalmology Research Fund and Retina Research Foundation/Daniel M. Albert Chair. CMS was supported by grant from the National Institutes of Health R21EY023024. NS is supported by NIH grant R24 EY022883, P30 CA014520 UW Paul P. Carbone Cancer Center support grant, P30 EY016665, and an unrestricted departmental award from Research to Prevent Blindness. NS is a recipient of an award from the Retina Research Foundation. RPJ is a recipient of a Hilldale Fellowship at the University of Wisconsin -Madison. Generation of the Tg (Pdgfrb-cre)45Vli mice was enabled by the Mouse Transgenic and In Vivo Imaging Core Facility supported by P30GM103392 (VL).	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Cuttler AS, 2011, GENESIS, V49, P673, DOI 10.1002/dvg.20769; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Grutzmacher C, 2010, AM J PHYSIOL-LUNG C, V299, pL607, DOI 10.1152/ajplung.00390.2009; Hahn P, 2005, ARCH OPHTHALMOL-CHIC, V123, P797, DOI 10.1001/archopht.123.6.797; Hayden MR, 2010, OXID MED CELL LONGEV, V3, P290, DOI 10.4161/oxim.3.5.13653; Herold MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.409; Hofmann JJ, 2012, DEVELOPMENT, V139, P4449, DOI 10.1242/dev.084871; Huang Q, 2008, EXP EYE RES, V87, P226, DOI 10.1016/j.exer.2008.06.003; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Koenig MN, 2014, CELL DEATH DIFFER, V21, P1687, DOI 10.1038/cdd.2014.90; Kondo S, 2008, AM J PHYSIOL-CELL PH, V294, pC1521, DOI 10.1152/ajpcell.90633.2007; LANG R, 1994, DEVELOPMENT, V120, P3395; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Morrison ME, 2013, INT J CELL BIOL, V2013; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; Shiose S, 2000, INVEST OPHTH VIS SCI, V41, P2395; Silbert M, 2000, CLIN EYE VIS CARE, V12; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Taniguchi H, 1999, ANN ANAT, V181, P555, DOI 10.1016/S0940-9602(99)80061-2; Trisciuoglio D, 2011, CELL DEATH DIFFER, V18, P1024, DOI 10.1038/cdd.2010.175; Wang SJ, 2011, DEV BIOL, V349, P296, DOI 10.1016/j.ydbio.2010.10.034; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Yoshikawa Y, 2016, J EXP MED, V213, P1175, DOI 10.1084/jem.20151966; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaitoun IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139994; Zhu MD, 2000, EXP EYE RES, V70, P767, DOI 10.1006/exer.2000.0844; Zhu WH, 2000, LAB INVEST, V80, P545, DOI 10.1038/labinvest.3780060	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178198	10.1371/journal.pone.0178198	http://dx.doi.org/10.1371/journal.pone.0178198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552963	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000028
J	Mellisho, EA; Velasquez, AE; Nunez, MJ; Cabezas, JG; Cueto, JA; Fader, C; Castro, FO; Rodriguez-Alvarez, L				Mellisho, Edwin A.; Velasquez, Alejandra E.; Nunez, Maria J.; Cabezas, Joel G.; Cueto, Juan A.; Fader, Claudio; Castro, Fidel O.; Rodriguez-Alvarez, Lleretny			Identification and characteristics of extracellular vesicles from bovine blastocysts produced in vitro	PLOS ONE			English	Article							MULTIVESICULAR BODIES; AUTOPHAGY; EXOSOMES; VIVO	Extracellular vesicles (EVs) have been identified within different body fluids and cell culture media. However, there is very little information on the secretion of these vesicles during early embryonic development. The aims of this work were first to demonstrate the secretion of extracellular vesicles by pre-implantation bovine embryos and second to identify and characterize the population of EVs secreted by bovine blastocysts during the period from day seven to nine of embryo culture and its correlation with further embryo development up to day 11. Bovine embryos were produced by in vitro fertilization (IVF) or parthenogenetic activation (PA) and cultured until blastocyst stage. Blastocyst selection was performed at day 7 post IVF/PA considering two variables: stage of development and quality of embryos. Selected blastocysts were cultured in vitro for 48 hours in groups (exp. 1) or individually (exp. 2) in SOF media depleted of exosomes. At day 9 post IVF/PA the media was collected and EVs isolated by ultracentrifugation. Transmission electron microscopy revealed the presence of heterogeneous vesicles of different sizes and population: microvesicles (MVs) and exosomes (EXs) of rounded shape, enclosed by a lipid bi-layer and ranging from 30 to 385 nm of diameter. Flow cytometry analysis allowed identifying CD63 and CD9 proteins as exosome markers. Nanoparticle tracking analysis generated a large number of variables, which required the use of multivariate statistics. The results indicated that the concentration of vesicles is higher in those blastocysts with arrested development from day 9 up to day 11 of in vitro development (6.7 x 10(8) particles/ml) derived from IVF (p < 0.05), compared to PA blastocysts (4.7 x 10(8) particles/ml). Likewise, the profile (concentration and diameter) of particles secreted by embryos derived from IVF were different from those secreted by PA embryos. In conclusion, we demonstrated that bovine blastocysts secrete MVs/EXs to the culture media. Data suggest that characteristics of the population of EVs vary depending on embryo competence.	[Mellisho, Edwin A.; Velasquez, Alejandra E.; Nunez, Maria J.; Cabezas, Joel G.; Castro, Fidel O.; Rodriguez-Alvarez, Lleretny] Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Lab Anim Biotechnol, Concepcion, Chile; [Cueto, Juan A.; Fader, Claudio] Natl Univ Cuyo, Lab Cell & Mol Biol, IHEM CONICET, Fac Med Sci, Mendoza, Argentina	Universidad de Concepcion; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Rodriguez-Alvarez, L (corresponding author), Univ Concepcion, Dept Anim Sci, Fac Vet Sci, Lab Anim Biotechnol, Concepcion, Chile.	llrodriguez@udec.cl	Mellisho, Edwin ALBERTO/Z-2570-2019; Mellisho, Edwin A./A-4986-2012; Rodriguez-Alvarez, Lleretny/AAH-9420-2019	Mellisho, Edwin ALBERTO/0000-0001-7171-1991; Rodriguez-Alvarez, Lleretny/0000-0003-4364-1097; Cabezas, Joel/0000-0001-8931-2630	Fondef IdeA [15110178]; Conicyt	Fondef IdeA(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondef IdeA ID15110178, Conicyt, http://www.conicyt.cl/fondef/lineas-de-programa/instrumentos-vigentes/programa-Idea/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Brandao DO, 2004, BIOL REPROD, V71, P2048, DOI 10.1095/biolreprod.103.025916; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Ferreira YJ, 2013, SESSION 66 EMBRYO QU, V28, P1445, DOI DOI 10.1093/HUMREP/DET200); Gedye CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105602; Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680; Kawamura N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2069; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Melo RCN, 2014, NAT PROTOC, V9, P2382, DOI 10.1038/nprot.2014.163; Mulvey HE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1568-3; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodriguez L, 2008, J ASSIST REPROD GEN, V25, P13, DOI 10.1007/s10815-007-9194-x; Saadeldin IM, 2015, STEM CELLS CLONING, V8, P103, DOI 10.2147/SCCAA.S84991; Saadeldin IM, 2014, CELL REPROGRAM, V16, P223, DOI 10.1089/cell.2014.0003; Tannetta D, 2014, CELL MOL IMMUNOL, V11, P548, DOI 10.1038/cmi.2014.42; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Velasquez AE, 2016, ZYGOTE, V24, P18, DOI 10.1017/S0967199414000677; Yang Qiwei, 2016, J Clin Epigenet, V2; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]	30	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178306	10.1371/journal.pone.0178306	http://dx.doi.org/10.1371/journal.pone.0178306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542562	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800069
J	Buchet, A; Belloc, C; Leblanc-Maridor, M; Merlot, E				Buchet, Arnaud; Belloc, Catherine; Leblanc-Maridor, Mily; Merlot, Elodie			Effects of age and weaning conditions on blood indicators of oxidative status in pigs	PLOS ONE			English	Article							LIPPIA-CITRIODORA VERBASCOSIDE; GROWTH-PERFORMANCE; PLASMA-CONCENTRATIONS; ANTIOXIDANT STATUS; VITAMIN-E; STRESS; PIGLETS; TOCOPHERYL; RESPONSES; OXIDANTS	Weaning is a source of social, nutritional and environmental disorders that challenge piglet health. This study assesses the relevance of using plasma indicators of oxidative status as biomarkers of health around weaning in pigs. Blood antioxidant potential (BAP), hydroperoxides (HPO), oxidative stress index (OSI, e.g. HPO/BAP), vitamin A and E concentrations were investigated in two different trials. Trial A was carried out in an experimental unit to investigate the effects of age (from 12 to 147 days of age), weaning (at 21 or 28 days of age) and management at weaning (in optimal (OC) or deteriorated (DC) conditions) on those parameters. Trial B was performed in 16 commercial pig farms to describe the variability of these indicators on field between 26 and 75 days of age. In trial A, between 12 and 147 days of age, HPO globally increased (P < 0.001), vitamin E concentration decreased (P < 0.001) whereas BAP and vitamin A concentration remained relatively stable (P > 0.1). Vitamins E and A concentrations dropped 5 days after weaning independently of weaning age, weaning conditions and expression of diarrhea (P < 0.001). Twelve days after weaning, whatever the weaning age, HPO and OSI increased in DC compared to OC piglets (P = 0.05 and P < 0.01) and in piglets exhibiting diarrhea compared to those without diarrhea (P < 0.01 and P < 0.001). In DC pigs, BAP was also decreased (P < 0.05) 12 days after weaning. On trial B, plasma concentrations of vitamins A and E decreased and HPO increased 5 and 19 days respectively after weaning (P < 0,001). Contrarily to trial A, BAP values did not drop after weaning. Piglets which had the lowest ADG (Average Daily Gain) after weaning had greater HPO and OSI and lower vitamin A and E concentrations after weaning but also lower vitamin E concentration before weaning (P < 0.05). In conclusion, HPO or OSI seem to be good indicators of health disorders around weaning and plasma concentration of vitamin E before weaning is associated to growth after weaning.	[Buchet, Arnaud; Merlot, Elodie] INRA, Agrocampus Ouest, PEGASE, St Gilles, France; [Buchet, Arnaud] Cooperl Arc Atlantique, Lamballe, France; [Buchet, Arnaud; Belloc, Catherine; Leblanc-Maridor, Mily] INRA, ONIRIS, BIOEPAR, Nantes, France	INRAE; Institut Agro; Agrocampus Ouest; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Buchet, A (corresponding author), INRA, Agrocampus Ouest, PEGASE, St Gilles, France.; Buchet, A (corresponding author), Cooperl Arc Atlantique, Lamballe, France.; Buchet, A (corresponding author), INRA, ONIRIS, BIOEPAR, Nantes, France.	arnaud.buchet@inra.fr	Merlot, Elodie/AAQ-8761-2020	Merlot, Elodie/0000-0003-2300-0970	Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project; Cooperl Arc Atlantique	Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project; Cooperl Arc Atlantique	Authors gratefully thank A. Lacoste, B. Lieubeau, J. Herve, G. Mignot P. Mormede, JN. Sialelli and E. Terenina for their scientific contributions to the project, N. Le Floc'h for its critical advices on the manuscript and JY. Audiard, D. Boutin, B. Carrissant, R. Comte, S. Dare A, J. Delamarre, H. Demay, B. Duteil, F. Guerin, P. Knapen, A. Lecorgne, M. Lefebvre, G. Martin, N. Meziere, H. Renoult, P. Roger, Y. Surel, F. Thomas and P. Touanel for their technical assistance in lab and animal care and all pig producers who participated to this experiment. This experiment was supported by a grant from the Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project (www.gisa.inra.fr/en). and Cooperl Arc Atlantique. Cooperl Arc Atlantique provided support in the form of salaries for authors [AB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This experiment was supported by a grant from the Integrated Management of Animal Health metaprogram of INRA for the "GISA-SEVROBUST" project (www.gisainra.frien).and Cooperl Arc Atlantique. Cooperl Arc Atlantique provided support in the form of salaries for authors [AB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian A, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0097-5; Alberti A, 2000, RES CHEM INTERMEDIAT, V26, P253, DOI 10.1163/156856700X00769; bacterial types, 2005, ANIM HEALTH RES REV, V6, P17; BARK LJ, 1986, J ANIM SCI, V62, P1233, DOI 10.2527/jas1986.6251233x; Bates D, 2014, FITTING LINEAR MIXED; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Brambilla G, 2002, REDOX REP, V7, P159, DOI 10.1179/135100002125000406; Casamassima D, 2013, J ANIM FEED SCI, V22, P204, DOI 10.22358/jafs/65989/2013; Celi P, 2011, IMMUNOPHARM IMMUNOT, V33, P233, DOI 10.3109/08923973.2010.514917; Colson V, 2012, PHYSIOL BEHAV, V107, P59, DOI 10.1016/j.physbeh.2012.06.001; Corino C, 2007, ITAL J ANIM SCI, V6, P292, DOI 10.4081/ijas.2007.1s.292; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FUNDERBURKE DW, 1990, J ANIM SCI, V68, P155; Gyles CL, ESCHERICHIA COLI POS; Halliwell B., 2015, FREE RADICALS BIOL M; Jensen MS, 1997, J ANIM SCI, V75, P437; KAYDEN HJ, 1993, J LIPID RES, V34, P343; Lauridsen C, 2005, J ANIM SCI, V83, P1274; Lauridsen C, 2001, J NUTR BIOCHEM, V12, P219, DOI 10.1016/S0955-2863(00)00156-X; Lauritzen B, 2005, RES VET SCI, V79, P61, DOI 10.1016/j.rvsc.2004.09.011; Lenth RV, 2015, LSMEANS LEAST SQUARE; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Madec F, 1998, PREV VET MED, V35, P53, DOI 10.1016/S0167-5877(97)00057-3; MCCRACKEN BA, 1995, J NUTR, V125, P2838; McCracken BA, 1999, J NUTR, V129, P613, DOI 10.1093/jn/129.3.613; Merlot E, 2012, ANIMAL, V6, P1290, DOI 10.1017/S1751731112000080; Moreira I, 2002, J ANIM SCI, V80, P663; Mutinati M, 2014, REPROD DOMEST ANIM, V49, P7, DOI 10.1111/rda.12230; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oriani G, 2001, J NUTR BIOCHEM, V12, P138, DOI 10.1016/S0955-2863(00)00132-7; Palazzo M, 2011, ANIMAL, V5, P844, DOI 10.1017/S1751731110002569; Pastorelli G, 2012, CZECH J ANIM SCI, V57, P312, DOI 10.17221/6006-CJAS; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; R Core Team, 2015, LANG ENV STAT COMP; Royer E., 2016, Journees de la Recherche Porcine en France, V48, P341; Sauerwein H, 2007, J ANIM PHYSIOL AN N, V91, P369, DOI 10.1111/j.1439-0396.2006.00663.x; Sauerwein H, 2005, REDOX REP, V10, P295, DOI 10.1179/135100005X83725; Sharma RK, 1999, HUM REPROD, V14, P2801, DOI 10.1093/humrep/14.11.2801; Sivertsen T, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-1; Traber MG, 2012, MODERN NUTR HLTH DIS; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Wilburn EE, 2008, J ANIM SCI, P86; Zhu LH, 2012, J ANIM SCI, V90, P2581, DOI [10.2527/jas.2011-4444, 10.2527/jas.2012-4444]	44	44	48	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178487	10.1371/journal.pone.0178487	http://dx.doi.org/10.1371/journal.pone.0178487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542567	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500086
J	Eda, H; Fukui, H; Uchiyama, R; Kitayama, Y; Hara, K; Yang, M; Kodani, M; Tomita, T; Oshima, T; Watari, J; Tsutsui, H; Miwa, H				Eda, Hirotsugu; Fukui, Hirokazu; Uchiyama, Ryosuke; Kitayama, Yoshitaka; Hara, Ken; Yang, Mo; Kodani, Mio; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Tsutsui, Hiroko; Miwa, Hiroto			Effect of Helicobacter pylori infection on the link between GLP-1 expression and motility of the gastrointestinal tract	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; IRRITABLE-BOWEL-SYNDROME; GENE-EXPRESSION; INSULIN-SECRETION; ERADICATION; MICE; INFLAMMATION; DYSPEPSIA; PANCREAS; ANTIBODY	Background Although Helicobacter pylori (H. pylori) infection is closely associated with the development of peptic ulcer, its involvement in pathophysiology in the lower intestinal tract and gastrointestinal (GI) motility remains unclear. Glucagon-like peptide-1 (GLP-1) is a gut hormone produced in the lower intestinal tract and involved in GI motility. Here, we investigated the effect of H. pylori infection on the link between GLP-1 expression and motility of the GI tract. Methods C57BL/6 mice were inoculated with a H. pylori strain. Twelve weeks later, the H. pylori-infected mice underwent H. pylori eradication treatment. GI tissues were obtained from the mice at various time intervals, and evaluated for the severity of gastric inflammatory cell infiltration and immunohistochemical expression of GLP-1 and PAX6 in the colonic mucosa. Gastrointestinal transit time (GITT) was measured by administration of carmine-red solution. Results GLP-1 was expressed in the endocrine cells of the colonic mucosa, and PAX6 immunoreactivity was co-localized in such cells. The numbers of GLP-1-and PAX6-positive cells in the colon were significantly increased at 12 weeks after H. pylori infection and showed a positive correlation with each other. The GITT was significantly longer in H. pylori-infected mice than in non-infected controls and showed a positive correlation with GLP-1 expression. When H. pylori-infected mice underwent H. pylori eradication, GITT and PAX6/GLP-1 expression did not differ significantly from those in untreated H. pylori-infected mice. Conclusions H. pylori infection may impair GI motility by enhancing the colonic GLP-1/PAX6 expression.	[Eda, Hirotsugu; Fukui, Hirokazu; Kitayama, Yoshitaka; Hara, Ken; Yang, Mo; Kodani, Mio; Tomita, Toshihiko; Oshima, Tadayuki; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo, Japan; [Uchiyama, Ryosuke; Tsutsui, Hiroko] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan; [Yang, Mo] Tianjin Med Univ Gen Hosp, Dept Digest Dis, Tianjin, Peoples R China	Hyogo College of Medicine; Hyogo College of Medicine; Tianjin Medical University	Fukui, H (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo, Japan.	hfukui@hyo-med.ac.jp		Tsutsui, Hiroko/0000-0001-7928-4875; Fukui, Hirokazu/0000-0002-8642-5784	Ministry of Education, Culture, Sports, Science and Technology, Japan [26460953]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.; We thank Mayumi Yamada and Chiyomi Itoh (Hyogo College of Medicine) for their technical assistance. This work was supported in part by Grants-in-aid for Scientific Research 26460953 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amoto A, 2010, NEUROGASTROENT MOTIL, V22; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Budzynski J, 2014, WORLD J GASTROENTERO, V20, P5212, DOI 10.3748/wjg.v20.i18.5212; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; DuPont AW, 2008, CLIN INFECT DIS, V46, P594, DOI 10.1086/526774; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Fukui H, 2014, BRIT J CANCER, V111, P763, DOI 10.1038/bjc.2014.336; Fukui H, 2003, LAB INVEST, V83, P1777, DOI 10.1097/01.LAB.0000106501.56339.CE; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Gerards C, 2001, DIGEST DIS, V19, P170, DOI 10.1159/000050673; Gosmain Y, 2011, DIABETES OBES METAB, V13, P31, DOI 10.1111/j.1463-1326.2011.01445.x; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Mizuta Y, 2006, J GASTROENTEROL, V41, P1025, DOI 10.1007/s00535-006-1966-z; Moayyedi P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002096.pub2, 10.1002/14651858.CD002096.pub4]; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Rajpal DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145499; Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Su YC, 2000, AM J GASTROENTEROL, V95, P1900, DOI 10.1111/j.1572-0241.2000.02252.x; Talley NJ, 2015, J GASTROENTEROL, V50, P601, DOI 10.1007/s00535-015-1076-x; Trinh DKY, 2003, DIABETES, V52, P425, DOI 10.2337/diabetes.52.2.425; Watanabe K, 2004, ANTIMICROB AGENTS CH, V48, P4582, DOI 10.1128/AAC.48.12.4582-4588.2004; Welch MG, 2014, AM J PHYSIOL-GASTR L, V307, pG848, DOI 10.1152/ajpgi.00176.2014; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiong F, 2016, GASTROENT RES PRACT, V2016; Yap TWC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135771	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177232	10.1371/journal.pone.0177232	http://dx.doi.org/10.1371/journal.pone.0177232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545056	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400030
J	van den Bergh, T; Tamo, G; Nobili, A; Tao, YF; Tan, TW; Bornscheuer, UT; Kuipers, RKP; Vroling, B; de Jong, RAM; Subramanian, K; Schaap, PJ; Desmet, T; Nidetzky, B; Vriend, G; Joosten, HJ				van den Bergh, Tom; Tamo, Giorgio; Nobili, Alberto; Tao, Yifeng; Tan, Tianwei; Bornscheuer, Uwe T.; Kuipers, Remko K. P.; Vroling, Bas; de Jong, Rene A. M.; Subramanian, Kalyanasundaram; Schaap, Peter J.; Desmet, Tom; Nidetzky, Bernd; Vriend, Gert; Joosten, Henk-Jan			CorNet: Assigning function to networks of co-evolving residues by automated literature mining	PLOS ONE			English	Article							CORRELATED MUTATION ANALYSES; PROTEIN-STRUCTURE PREDICTION; ENANTIOSELECTIVITY; IDENTIFICATION; ESTERASE; DESIGN; TOOL	CorNet is a web-based tool for the analysis of co-evolving residue positions in protein superfamily sequence alignments. CorNet projects external information such as mutation data extracted from literature on interactively displayed groups of co-evolving residue positions to shed light on the functions associated with these groups and the residues in them. We used CorNet to analyse six enzyme super-families and found that groups of strongly co-evolving residues tend to consist of residues involved in a same function such as activity, specificity, co-factor binding, or enantioselectivity. This finding allows to assign a function to residues for which no data is available yet in the literature. A mutant library was designed to mutate residues observed in a group of co-evolving residues predicted to be involved in enantioselectivity, but for which no literature data is available yet. The resulting set of mutations indeed showed many instances of increased enantioselectivity.	[van den Bergh, Tom; Tamo, Giorgio; Kuipers, Remko K. P.; Vroling, Bas; Joosten, Henk-Jan] Bioprodict, Nijmegen, Netherlands; [van den Bergh, Tom; Subramanian, Kalyanasundaram; Schaap, Peter J.] Wageningen Univ, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Nobili, Alberto; Tao, Yifeng; Bornscheuer, Uwe T.] Greifswald Univ, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany; [Tao, Yifeng; Tan, Tianwei] Beijing Univ Chem Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China; [de Jong, Rene A. M.] DSM Biotechnol Ctr, Delft, Netherlands; [Desmet, Tom] Univ Ghent, Ctr Ind Biotechnol & Biocatalysis, Ghent, Belgium; [Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, Graz, Austria; [Vriend, Gert; Joosten, Henk-Jan] Radboudumc, CMBI, Nijmegen, Netherlands	Wageningen University & Research; Beijing University of Chemical Technology; DSM NV; Ghent University; Graz University of Technology; Radboud University Nijmegen	Joosten, HJ (corresponding author), Bioprodict, Nijmegen, Netherlands.; Joosten, HJ (corresponding author), Radboudumc, CMBI, Nijmegen, Netherlands.	joosten@bio-prodict.nl	Desmet, Tom RJ/I-3313-2012; Vriend, G./H-8112-2014; Bornscheuer, Uwe T/C-4612-2012; Nobili, Alberto/AAM-5422-2021	Desmet, Tom RJ/0000-0002-5788-3022; Bornscheuer, Uwe T/0000-0003-0685-2696; Schaap, Peter/0000-0002-4346-6084; Subramanian, Kalyanasundaram/0000-0002-6110-1046	Technology Foundation, the Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO) [11319]; European Union's Seventh Framework Programme (FP7) [289646, 289350, 613633]; National Basic Research Program of China (973 program) [2013CB733600]; National Nature Science Foundation of China [21106005]; China Scholarship Council; Bio-Prodict	Technology Foundation, the Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); European Union's Seventh Framework Programme (FP7); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Bio-Prodict	This research was supported and funded in part by the Technology Foundation, the Applied Science Division (STW) of the Netherlands Organization for Scientific Research (NWO), project number 11319 (www.stw.nl) of which K.S. is the principal receiver. This research was co-funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no: 289646 (KYROBIO). This research was co-funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no: 289350 (NewProt). This research was co-funded by the European Union's Seventh Framework Programme (FP7/2013-2017) under grant agreement no: 613633 (SuSy). T. Tan and Y. Tao thank the financial support from the National Basic Research Program of China (973 program: 2013CB733600), the National Nature Science Foundation of China (21106005) and China Scholarship Council. Bio-Prodict provided support in the form of salaries for authors TB, RK, BV, HJ, and was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Folkertsma S, 2004, J MOL BIOL, V341, P321, DOI 10.1016/j.jmb.2004.05.075; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gouldson PR, 2001, PROTEIN ENG, V14, P759, DOI 10.1093/protein/14.10.759; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; Krebsfanger N, 1998, ENZYME MICROB TECH, V22, P641, DOI 10.1016/S0141-0229(98)00004-0; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MARENGERE LEM, 1994, J CELL SCI, P97; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Nobili A, 2015, CHEMBIOCHEM, V16, P805, DOI 10.1002/cbic.201402665; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Park S, 2005, CHEM BIOL, V12, P45, DOI 10.1016/j.chembiol.2004.10.012; Proctor EA, 2013, PROTEINS, V81, P884, DOI 10.1002/prot.24247; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sreekumar J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-444; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Vroling B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-362; Wilkins AD, 2012, CURR OPIN STRUC BIOL, V22, P316, DOI 10.1016/j.sbi.2012.05.001; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	38	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176427	10.1371/journal.pone.0176427	http://dx.doi.org/10.1371/journal.pone.0176427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545124	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400006
J	Barrios, J; Patel, KR; Aven, L; Achey, R; Minns, MS; Lee, Y; Trinkaus-Randall, VE; Ai, XB				Barrios, Juliana; Patel, Kruti R.; Aven, Linh; Achey, Rebecca; Minns, Martin S.; Lee, Yoonjoo; Trinkaus-Randall, Vickery E.; Ai, Xingbin			Early life allergen-induced mucus overproduction requires augmented neural stimulation of pulmonary neuroendocrine cell secretion	FASEB JOURNAL			English	Article						NT4; innervation; GABA; childhood asthma	MICE LACKING NT4; NEUROEPITHELIAL BODIES; AIRWAY HYPERRESPONSIVENESS; PROXIMAL AIRWAYS; INNERVATION; EPITHELIUM; EXPOSURE; ASTHMA; MUCIN; GABA	Pulmonary neuroendocrine cells (PNECs) are the only innervated airway epithelial cells. To what extent neural innervation regulates PNEC secretion and function is unknown. Here, we discover that neurotrophin 4 (NT4) plays an essential role in mucus overproduction after early life allergen exposure by orchestrating PNEC innervation and secretion of GABA. We found that PNECs were the only cellular source of GABA in airways. In addition, PNECs expressed NT4 as a target-derived mechanism underlying PNEC innervation during development. Early life allergen exposure elevated the level of NT4 and caused PNEC hyperinnervation and nodose neuron hyperactivity. Associated with aberrant PNEC innervation, the authors discovered that GABA hypersecretion was required for the induction of mucin Muc5ac expression. In contrast, NT4(-/-) mice were protected from allergen-induced mucus overproduction and changes along the nerve-PNEC axis without any defects in inflammation. Last, GABA installation restored mucus overproduction in NT4(-/-) mice after early life allergen exposure. Together, our findings provide the first evidence for NT4-dependent neural regulation of PNEC secretion of GABA in a neonatal disease model. Targeting the nerve-PNEC axis may be a valid treatment strategy for mucus overproduction in airway diseases, such as childhood asthma.	[Barrios, Juliana; Patel, Kruti R.; Aven, Linh; Achey, Rebecca] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Minns, Martin S.; Lee, Yoonjoo; Trinkaus-Randall, Vickery E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ai, Xingbin] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Ai, XB (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Med, Thorn Bldg,Rm 905,75 Francis St, Boston, MA 02115 USA.	xai@partners.org		Patel, Kruti/0000-0002-4303-8717; Minns, Martin/0000-0002-9793-5819	American Asthma Foundation [12-0086]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI) [1R01HL116163, 1R01HL132991]; NIH/NHLBI [HL007035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116163, T32HL007035, F31HL126443, R01HL132991] Funding Source: NIH RePORTER	American Asthma Foundation; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Y. Bai and K. Trieu (both from Brigham and Women's Hospital) for technical assistance, and K. C. Kim, (University of Arizona, Tucson, AZ, USA) for critical reading. This work is supported by an American Asthma Foundation award (12-0086), U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI) Grants 1R01HL116163 and 1R01HL132991 (to X.A.), and NIH/NHLBI F31 Training Grant HL007035 (to J.B.).	Adriaensen D, 2015, AUTON NEUROSCI-BASIC, V191, P39, DOI 10.1016/j.autneu.2015.04.006; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Brouns I, 2000, AM J RESP CELL MOL, V23, P52, DOI 10.1165/ajrcmb.23.1.3936; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Dakhama A, 2005, AM J PHYSIOL-LUNG C, V288, pL761, DOI 10.1152/ajplung.00143.2004; Erickson JT, 1996, J NEUROSCI, V16, P5361; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; HUNG KS, 1982, ANAT RECORD, V203, P285, DOI 10.1002/ar.1092030210; Ito T, 2000, DEVELOPMENT, V127, P3913; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Larson SD, 2004, TOXICOL APPL PHARM, V194, P211, DOI 10.1016/j.taap.2003.09.025; Lazarowski ER, 2011, SUBCELL BIOCHEM, V55, P1, DOI 10.1007/978-94-007-1217-1_1; Li JF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00260; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Oswald DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044574; Pardo-Saganta A, 2013, AM J RESP CELL MOL, V48, P364, DOI 10.1165/rcmb.2012-0146OC; Park SW, 2009, AM J RESP CRIT CARE, V180, P603, DOI 10.1164/rccm.200811-1768OC; Patel KR, 2016, MUCOSAL IMMUNOL, V9, P1466, DOI 10.1038/mi.2016.11; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Schnorbusch K, 2013, HISTOCHEM CELL BIOL, V140, P549, DOI 10.1007/s00418-013-1093-x; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Szczepankiewicz A, 2012, EUR RESPIR J, V39, P1035, DOI 10.1183/09031936.00136611; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wu ZX, 2016, RESP PHYSIOL NEUROBI, V223, P1, DOI 10.1016/j.resp.2015.11.009; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038	46	32	34	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4117	4128		10.1096/fj.201700115R	http://dx.doi.org/10.1096/fj.201700115R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28566470	Green Published			2022-12-26	WOS:000408713300034
J	Zwart, SR; Gibson, CR; Gregory, JF; Mader, TH; Stover, PJ; Zeisel, SH; Smith, SM				Zwart, Sara R.; Gibson, Charles R.; Gregory, Jesse F.; Mader, Thomas H.; Stover, Patrick J.; Zeisel, Steven H.; Smith, Scott M.			Astronaut ophthalmic syndrome	FASEB JOURNAL			English	Article						B vitamins; cerebrospinal fluid; endothelial dysfunction; oxidative stress; microgravity	DURATION SPACE-FLIGHT; OPTIC DISC EDEMA; DOSE FOLIC-ACID; ENDOTHELIAL DYSFUNCTION; METHYLENETETRAHYDROFOLATE REDUCTASE; INSULIN-RESISTANCE; BLOOD-PRESSURE; FLUID SHIFTS; SIGNIFICANT PREDICTORS; ARTERIAL PERMEABILITY	During and after missions on the International Space Station, some astronauts experience ophthalmic changes, including choroidal folds, optic disc edema, cotton-wool spots, globe flattening, and refraction changes. Astronauts with ophthalmic issues had significantly higher plasma concentrations of metabolites that are associated with the 1-carbon metabolic pathway than those without ophthalmic issues. We hypothesized that genetic differences might explain the metabolite differences. Indeed, genetics and B vitamin status were significant predictors of ophthalmic issues. We now have developed a hypothesis regarding the mechanisms that link 1-carbon pathway genetics and the condition that we suggest calling, "astronaut ophthalmic syndrome." We maintain that this condition is genetically predisposed and is associated with endothelial dysfunction that is induced by oxidative stress. Subsequent edema can hinder cerebrospinal fluid efflux and can lead to locally increased pressures in the subarachnoid space within the orbit, which impinges on the optic nerve and/or eye in affected individuals. Confirming this hypothesis will help characterize the genetics of 1-carbon pathway metabolism, homocysteine, oxidative stress, endothelial dysfunction, and cardiovascular and potentially other diseases.	[Zwart, Sara R.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Gibson, Charles R.] Coastal Eye Associates, Webster, TX USA; [Gregory, Jesse F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC USA; [Smith, Scott M.] NASA, Human Hlth & Performance Directorate, Lyndon B Johnson Space Ctr, Houston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Smith, SM (corresponding author), NASA, Lyndon B Johnson Space Ctr, Mail Code SK3,2101 NASA Pkwy, Houston, TX 77058 USA.	scott.m.smith@nasa.gov			National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element	National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element	This work was supported by the National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element. The authors thank Antony Jeevarajan (NASA Johnson Space Center) for helpful discussions, and Jane Krauhs (KBRwyle, Houston, TX, USA) for editorial assistance. The authors declare no conflicts of interest.	Aleyasin A, 2010, IRAN J PUBLIC HEALTH, V39, P53; Alfrey CP, 1996, MED SCI SPORT EXER, V28, pS42; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Antoniades C, 2009, CIRCULATION, V119, P2507, DOI 10.1161/CIRCULATIONAHA.108.808675; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Blanc S, 2000, J CLIN ENDOCR METAB, V85, P2223, DOI 10.1210/jc.85.6.2223; Brosnan ME, 2016, ANNU REV NUTR, V36, P369, DOI 10.1146/annurev-nutr-071715-050738; Bueno O, 2016, J NUTR, V146, P1, DOI 10.3945/jn.115.223685; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chalupsky K, 2015, ANTIOXID REDOX SIGN, V23, P1076, DOI 10.1089/ars.2015.6329; Chancellor Jeffery C., 2014, Life-Basel, V4, P491, DOI 10.3390/life4030491; Cherla DV, 2013, ALLERGY RHINOL, V4, pE49, DOI 10.2500/ar.2013.4.0047; CLAYTON PT, 1986, J NEUROL NEUROSUR PS, V49, P920, DOI 10.1136/jnnp.49.8.920; Clifford AJ, 2012, J NUTR, V142, P1764, DOI 10.3945/jn.112.160333; Colson NJ, 2017, EUR J NUTR, V56, P247, DOI 10.1007/s00394-015-1076-x; Corrigan FE, 2015, INT J CARDIOL, V194, P94, DOI 10.1016/j.ijcard.2015.05.065; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Cronyn P. D., 2012, NASATP2012217358; Davis SR, 2005, J NUTR, V135, P1045, DOI 10.1093/jn/135.5.1045; Diedrich A, 2007, AM J MED SCI, V334, P80, DOI 10.1097/MAJ.0b013e318065b89b; Empen K, 2012, ARTERIOSCL THROM VAS, V32, P481, DOI 10.1161/ATVBAHA.111.232876; Flyunt R, 2001, CHEM-EUR J, V7, P796, DOI 10.1002/1521-3765(20010216)7:4<796::AID-CHEM796>3.3.CO;2-A; Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181; Garcia-Minguillan CJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0435-1; Gauger G E, 1986, Adv Space Res, V6, P243, DOI 10.1016/0273-1177(86)90298-X; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; HERBERT V, 1973, AM J CLIN NUTR, V26, P77, DOI 10.1093/ajcn/26.1.77; Hladik D, 2016, MUTAT RES-REV MUTAT, V770, P219, DOI 10.1016/j.mrrev.2016.08.003; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; JEEVARAJAN AS, 1990, J PHYS CHEM-US, V94, P1372, DOI 10.1021/j100367a033; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Knowles L, 2016, JIMD REP, V29, P103, DOI 10.1007/8904_2016_529; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Lambrinoudaki I, 2008, EUR J ENDOCRINOL, V159, P233, DOI 10.1530/EJE-07-0848; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Lee AG, 2016, J NEURO-OPHTHALMOL, V36, P85, DOI 10.1097/WNO.0000000000000334; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Li WX, 2015, NUTRIENTS, V7, P6670, DOI 10.3390/nu7085303; Maass H., 1995, P NORD S SCI RES GER, P732; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; Mader TH, 2017, J NEURO-OPHTHALMOL, V37, P133, DOI 10.1097/WNO.0000000000000467; Mader TH, 2015, J NEURO-OPHTHALMOL, V35, P226, DOI 10.1097/WNO.0000000000000207; Mader TH, 2013, J NEURO-OPHTHALMOL, V33, P249, DOI 10.1097/WNO.0b013e31829b41a6; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Marshall-Bowman K, 2013, ACTA ASTRONAUT, V87, P77, DOI 10.1016/j.actaastro.2013.01.014; Marshall-Goebel K, 2017, AEROSP MED HUM PERF, V88, P10, DOI 10.3357/AMHP.4653.2017; McMahon A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110720; Moat SJ, 2004, AM J PHYSIOL-HEART C, V287, pH1, DOI 10.1152/ajpheart.00952.2003; Moens AL, 2008, AM J PHYSIOL-HEART C, V294, pH1971, DOI 10.1152/ajpheart.91503.2007; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Mohammad NS, 2016, PSYCHIAT GENET, V26, P281, DOI 10.1097/YPG.0000000000000152; Molero-Luis M, 2015, EXPERT REV NEUROTHER, V15, P793, DOI 10.1586/14737175.2015.1055322; MOORE TP, 1987, AVIAT SPACE ENVIR MD, V58, pA91; Moreira ES, 2011, FREE RADICAL BIO MED, V51, P876, DOI 10.1016/j.freeradbiomed.2011.05.034; Morrow GP, 2015, J BIOL CHEM, V290, P2244, DOI 10.1074/jbc.M114.600718; Mullick AE, 2006, AM J PHYSIOL-REG I, V291, pR1349, DOI 10.1152/ajpregu.00335.2006; Norsk P, 2006, HYPERTENSION, V47, P69, DOI 10.1161/01.HYP.0000194332.98674.57; Norsk P, 2005, CURR PHARM BIOTECHNO, V6, P325, DOI 10.2174/1389201054553734; Norsk P, 2015, J PHYSIOL-LONDON, V593, P573, DOI 10.1113/jphysiol.2014.284869; Olin JT, 2011, RESP PHYSIOL NEUROBI, V175, P176, DOI 10.1016/j.resp.2010.09.011; Perry JL, 2003, S CHINA MORNING  JAN, P1; Pravenec M, 2013, AM J HYPERTENS, V26, P135, DOI 10.1093/ajh/hps015; PRISK GK, 1993, J APPL PHYSIOL, V75, P15, DOI 10.1152/jappl.1993.75.1.15; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Shelnutt KP, 2003, J NUTR, V133, P4107, DOI 10.1093/jn/133.12.4107; Shin JH, 2011, OTOLARYNG HEAD NECK, V145, P1040, DOI 10.1177/0194599811418040; Shirodaria C, 2007, CIRCULATION, V115, P2262, DOI 10.1161/CIRCULATIONAHA.106.679084; Smith SM, 2012, J CLIN ENDOCR METAB, V97, P270, DOI 10.1210/jc.2011-2233; Solomon LR, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.07.017; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Stein TP, 1997, ADV EXP MED BIOL, V407, P443; STEIN TP, 1994, AVIAT SPACE ENVIR MD, V65, P1091; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Stover PJ, 2017, CURR OPIN BIOTECH, V44, P146, DOI 10.1016/j.copbio.2017.01.006; Symons JD, 2006, ARTERIOSCL THROM VAS, V26, P814, DOI 10.1161/01.ATV.0000204408.01416.16; Symons JD, 2006, AM J PHYSIOL-HEART C, V290, pH181, DOI 10.1152/ajpheart.00765.2005; Symons JD, 2002, ARTERIOSCL THROM VAS, V22, P772, DOI 10.1161/01.ATV.0000014588.71807.0A; Taibbi G, 2016, INVEST OPHTH VIS SCI, V57, P495, DOI 10.1167/iovs.15-18530; Taibbi G, 2014, AVIAT SPACE ENVIR MD, V85, P983, DOI 10.3357/ASEM.4055.2014; Taibbi G, 2013, SURV OPHTHALMOL, V58, P155, DOI 10.1016/j.survophthal.2012.04.002; Taibbi G, 2013, AVIAT SPACE ENVIR MD, V84, P148, DOI 10.3357/ASEM.3520.2013; THORNTON WE, 1987, AVIAT SPACE ENVIR MD, V58, pA86; Tousoulis D, 2010, MINERVA MED, V101, P271; Tousoulis D, 2011, AM J HYPERTENS, V24, P936, DOI 10.1038/ajh.2011.65; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; VERNIKOSDANELLIS J, 1976, AVIAT SPACE ENVIR MD, V47, P583; Virdis A, 2001, J AM COLL CARDIOL, V38, P1106, DOI 10.1016/S0735-1097(01)01492-9; Vitvitsky V, 2007, AM J PHYSIOL-RENAL, V293, pF594, DOI 10.1152/ajprenal.00171.2007; Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Wilkerson MK, 2005, AM J PHYSIOL-HEART C, V288, pH1652, DOI 10.1152/ajpheart.00925.2004; Wilson CP, 2013, HYPERTENSION, V61, P1302, DOI 10.1161/HYPERTENSIONAHA.111.01047; Zeisel SH, 2011, J NUTR, V141, P531, DOI 10.3945/jn.110.130369; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219; Zwart SR, 2014, HANDBOOK OF NUTRITION, DIET, AND THE EYE, P393, DOI 10.1016/B978-0-12-401717-7.00040-X; Zwart SR, 2016, FASEB J, V30, P141, DOI 10.1096/fj.15-278457; Zwart SR, 2012, J NUTR, V142, P427, DOI 10.3945/jn.111.154245	103	25	25	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3746	3756		10.1096/fj.201700294	http://dx.doi.org/10.1096/fj.201700294			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28546443	Green Submitted, Bronze			2022-12-26	WOS:000408713300005
J	Kaczmarek, M; Mullett, MS; McDonald, JE; Denman, S				Kaczmarek, Maciej; Mullett, Martin S.; McDonald, James E.; Denman, Sandra			Multilocus sequence typing provides insights into the population structure and evolutionary potential of Brenneria goodwinii, associated with acute oak decline	PLOS ONE			English	Article							BACTERIAL PATHOGENS; STATISTICAL TESTS; PHYLOGENY; IDENTIFICATION; NEUTRALITY; INFERENCE; PROPOSAL; NUMBER; CLADE; NOV.	Brenneria goodwinii is one of the most frequently isolated Gram-negative bacteria from native oak species, Quercus robur and Q. petraea, affected by acute oak decline (AOD) in the UK. We investigated the population biology of this bacterial species using a multilocus sequence analysis to determine the population structure and evolutionary potential. Seven partial housekeeping genes were used in the analyses. Amongst 44 bacterial strains from seven different locations, we identified 22 unique sequence types [STs]; only one ST was found at two separate locations. Phylogenetic and cluster-based analyses suggested that B. goodwinii STs form two main distinct groups; however, no geographical pattern of their distribution could be observed. Clonality and recombination tests demonstrated that the studied population is primarily clonal, however both mutation and recombination processes play a role in shaping the genetic structure and evolution of the population. Our study suggests that the B. goodwinii population on oak in the UK has an endemic form, with background recombination appearing to generate new alleles more frequently than mutation, despite the introduction of nucleotide substitutions being approximately twice less likely than mutation. The newly emerged STs subsequently undergo clonal expansion to become dominant genotypes within their specific geographical locations and even within the individual host oak trees.	[Kaczmarek, Maciej; McDonald, James E.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Kaczmarek, Maciej; Mullett, Martin S.; Denman, Sandra] Ctr Ecosyst Soc & Biosecur, Forest Res, Farnham, Surrey, England; [Kaczmarek, Maciej] Edinburgh Napier Univ, Sch Appl Sci, Sighthill Court, Edinburgh, Midlothian, Scotland	Bangor University; Edinburgh Napier University	Kaczmarek, M (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.; Kaczmarek, M; Denman, S (corresponding author), Ctr Ecosyst Soc & Biosecur, Forest Res, Farnham, Surrey, England.; Kaczmarek, M (corresponding author), Edinburgh Napier Univ, Sch Appl Sci, Sighthill Court, Edinburgh, Midlothian, Scotland.	M.Kaczmarek@napier.ac.uk; Sandra.Denman@forestry.gsi.gov.uk	Mullett, Martin Sidney/O-5868-2017	Mullett, Martin Sidney/0000-0002-6013-0347; Denman, Sandra/0000-0001-6138-3402; McDonald, James/0000-0002-6328-3752	Woodland Heritage; Department for Environment, Food and Rural Affairs	Woodland Heritage; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by Woodland Heritage (www.woodlandhentage.org) to MK, JEM and the Department for Environment, Food and Rural Affairs (https://www.gov.uk/government/ organisationsidepartment-for-environment food-rural -affairs) to SD, MK, MSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485; Antony-Babu S, 2008, ANTON LEEUW INT J G, V94, P63, DOI 10.1007/s10482-008-9246-y; Brady C, 2008, SYST APPL MICROBIOL, V31, P447, DOI 10.1016/j.syapm.2008.09.004; Brady C, 2010, SYST APPL MICROBIOL, V33, P444, DOI 10.1016/j.syapm.2010.08.006; Brown N., 2014, FORESTRY, P1; Brown N, 2016, FOREST ECOL MANAG, V360, P97, DOI 10.1016/j.foreco.2015.10.026; Camy C, 2003, ANN FOREST SCI, V60, P419, DOI 10.1051/forest:2003034; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Denman S., 2009, Quarterly Journal of Forestry, V103, P285; Denman S., 2014, FORESTRY, P1; Denman S., 2016, FORESTRY, P1; Denman S, 2016, SYST APPL MICROBIOL, V39, P484, DOI 10.1016/j.syapm.2016.07.002; Denman S, 2012, INT J SYST EVOL MICR, V62, P2451, DOI 10.1099/ijs.0.037879-0; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dykhuizen D., 2007, EVOLUTION HLTH DIS, P185; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jombart T., 2015, TUTORIAL DISCRIMINAN, DOI DOI 10.1007/s10750-017-3486-7; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan NH, 2008, APPL ENVIRON MICROB, V74, P6194, DOI 10.1128/AEM.02322-07; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manion P.D., 1992, FOREST DECLINE CONCE; Martens M, 2007, INT J SYST EVOL MICR, V57, P489, DOI 10.1099/ijs.0.64344-0; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Rong XY, 2010, INT J SYST EVOL MICR, V60, P696, DOI 10.1099/ijs.0.012419-0; Rong XY, 2009, SYST APPL MICROBIOL, V32, P314, DOI 10.1016/j.syapm.2009.05.003; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sapp M, 2016, FORESTS, V7, DOI 10.3390/f7050095; SIMONSEN KL, 1995, GENETICS, V141, P413; SMITH JM, 1992, J MOL EVOL, V34, P126; Smith JM, 2000, BIOESSAYS, V22, P1115, DOI 10.1002/1521-1878(200012)22:12&lt;1115::AID-BIES9&gt;3.0.CO;2-R; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinatzer BA, 2014, ANNU REV PHYTOPATHOL, V52, P19, DOI 10.1146/annurev-phyto-102313-045907; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178390	10.1371/journal.pone.0178390	http://dx.doi.org/10.1371/journal.pone.0178390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570630	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800046
J	Piceno, YM; Pecora-Black, G; Kramer, S; Roy, M; Reid, FC; Dubinsky, EA; Andersen, GL				Piceno, Yvette M.; Pecora-Black, Gabrielle; Kramer, Sasha; Roy, Monika; Reid, Francine C.; Dubinsky, Eric A.; Andersen, Gary L.			Bacterial community structure transformed after thermophilically composting human waste in Haiti	PLOS ONE			English	Article							GEL-ELECTROPHORESIS ANALYSIS; MICROBIAL SOURCE TRACKING; HUMAN GUT MICROBIOTA; ESCHERICHIA-COLI; SEWAGE-SLUDGE; HUMAN FECES; GEN. NOV.; MICROARRAY ANALYSIS; CLOSTRIDIUM-TETANI; MOLECULAR ANALYSIS	Recycling human waste for beneficial use has been practiced for millennia. Aerobic (thermophilic) composting of sewage sludge has been shown to reduce populations of opportunistically pathogenic bacteria and to inactivate both Ascaris eggs and culturable Escherichia coli in raw waste, but there is still a question about the fate of most fecal bacteria when raw material is composted directly. This study undertook a comprehensive microbial community analysis of composting material at various stages collected over 6 months at two composting facilities in Haiti. The fecal microbiota signal was monitored using a high-density DNA microarray (PhyloChip). Thermophilic composting altered the bacterial community structure of the starting material. Typical fecal bacteria classified in the following groups were present in at least half the starting material samples, yet were reduced below detection in finished compost: Prevotella and Erysipelotrichaceae (100% reduction of initial presence), Ruminococcaceae (98-99%), Lachnospiraceae (83-94%, primarily unclassified taxa remained), Escherichia and Shigella (100%). Opportunistic pathogens were reduced below the level of detection in the final product with the exception of Clostridium tetani, which could have survived in a spore state or been reintroduced late in the outdoor maturation process. Conversely, thermotolerant or thermophilic Actinomycetes and Firmicutes (e.g., Thermobifida, Bacillus, Geobacillus) typically found in compost increased substantially during the thermophilic stage. This community DNA-based assessment of the fate of human fecal microbiota during thermophilic composting will help optimize this process as a sanitation solution in areas where infrastructure and resources are limited.	[Piceno, Yvette M.; Reid, Francine C.; Dubinsky, Eric A.; Andersen, Gary L.] Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Ecol Dept, Berkeley, CA USA; [Pecora-Black, Gabrielle] Univ Calif Davis, Agr & Environm Chem Grad Grp, Davis, CA 95616 USA; [Kramer, Sasha; Roy, Monika] Sustainable Organ Integrated Livelihoods, Port Au Prince, Haiti	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Davis	Andersen, GL (corresponding author), Lawrence Berkeley Natl Lab, Earth & Environm Sci Area, Ecol Dept, Berkeley, CA USA.	glandersen@lbl.gov	Black, Gabrielle/ABC-4519-2020; Andersen, Gary/G-2792-2015; Dubinsky, Eric A/D-3787-2015	Andersen, Gary/0000-0002-1618-9827; Dubinsky, Eric A/0000-0002-9420-6661; Roy, Monika/0000-0001-6927-2803	11th Hour Project, Palo Alto CA; Rathmann Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108556] Funding Source: NIH RePORTER	11th Hour Project, Palo Alto CA; Rathmann Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the 11th Hour Project, Palo Alto CA (http://www.11thhourproject.org/) to GA. The Rathmann Family Foundation provided additional funding (http://www.rathmannfamilyfoundation.org/ to GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Apprill A, 2016, DISTINGUISHING MICRO, P1; Arumugam M, 2011, ENTEROTYPES HUMAN GU; Berendes D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125336; Blanc M, 1999, FEMS MICROBIOL ECOL, V28, P141, DOI 10.1111/j.1574-6941.1999.tb00569.x; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; Bourque AS, 2015, AQUAT MICROB ECOL, V74, P43, DOI 10.3354/ame01725; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Byappanahalli MN, 2012, SCI TOTAL ENVIRON, V417, P273, DOI 10.1016/j.scitotenv.2011.12.041; Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192; Carbonetto B, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicp.2016.00051, 10.3389/fmicb.2016.00051]; CARRILLO M, 1985, APPL ENVIRON MICROB, V50, P468, DOI 10.1128/AEM.50.2.468-476.1985; Ceustermans A, 2007, J APPL MICROBIOL, V103, P53, DOI 10.1111/j.1365-2672.2006.03224.x; Clarke K, 2006, PRIMER V6 USER MANUA, P190; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cuiv PO, 2011, J BACTERIOL, V193, P1288, DOI 10.1128/JB.01328-10; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Danon M, 2007, SOIL BIOL BIOCHEM, V39, P1936, DOI 10.1016/j.soilbio.2007.02.012; DEMHARTER W, 1989, SYST APPL MICROBIOL, V11, P272; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dubinsky EA, 2016, WATER RES, V105, P56, DOI 10.1016/j.watres.2016.08.035; Dubinsky EA, 2012, ENVIRON SCI TECHNOL, V46, P4340, DOI 10.1021/es2040366; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Feachem RG, 1983, JAWRA J AM WATER RES; Finstein MS, 1987, BIOCYCLE, V28, P14; Franke-Whittle IH, 2009, MICROB ECOL, V57, P510, DOI 10.1007/s00248-008-9435-2; Gavish Y, 2014, PLOS ONE, P9; HARDINA CM, 1991, ENVIRON TOXIC WATER, V6, P185, DOI 10.1002/tox.2530060208; Haruta S, 2004, J BIOSCI BIOENG, V98, P20, DOI 10.1263/jbb.98.20; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Hruska K, 2012, VET MED-CZECH, V57, P623, DOI 10.17221/6558-VETMED; Ishii K, 2000, J APPL MICROBIOL, V89, P768, DOI 10.1046/j.1365-2672.2000.01177.x; Ishii K, 2003, J APPL MICROBIOL, V95, P109, DOI 10.1046/j.1365-2672.2003.01949.x; Jayasree S., 2012, Biochemical and Cellular Archives, V12, P403; JIMENEZ L, 1989, J APPL BACTERIOL, V67, P61, DOI 10.1111/j.1365-2672.1989.tb04955.x; Johnson MM, 2014, J THORAC DIS, V6, P210, DOI 10.3978/j.issn.2072-1439.2013.12.24; KING FH, 1911, FARMERS 40 CENTURIES; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kowalchuk GA, 1999, APPL ENVIRON MICROB, V65, P396; Kramer S, 2013, 36 WEDC INT C, V2011, P1; Lawson PA, 2015, INT J SYST EVOL MICR, V65, P789, DOI 10.1099/ijs.0.000015; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lupatini M, 2013, PLOS ONE, P8; Marin JM, 2014, ARQ BRAS MED VET ZOO, V66, P1771, DOI 10.1590/1678-6001; Martins LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061928; Mehl J, 2011, J WATER HEALTH, V9, P187, DOI 10.2166/wh.2010.138; Monciardini P, 2003, INT J SYST EVOL MICR, V53, P569, DOI 10.1099/ijs.0.02400-0; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Park SK, 2013, INT J SYST EVOL MICR, V63, P599, DOI 10.1099/ijs.0.036541-0; Partanen P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-94; Pecora GN, 2016, LBNL1005110; Pecson BM, 2007, WATER RES, V41, P2893, DOI 10.1016/j.watres.2007.03.040; Pedro MS, 2001, J BIOSCI BIOENG, V91, P159, DOI 10.1263/jbb.91.159; Peters S, 2000, APPL ENVIRON MICROB, V66, P930, DOI 10.1128/AEM.66.3.930-936.2000; Plourde-Owobi L, 2005, APPL ENVIRON MICROB, V71, P5604, DOI 10.1128/AEM.71.9.5604-5606.2005; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Pourcher AM, 2005, J APPL MICROBIOL, V99, P528, DOI 10.1111/j.1365-2672.2005.02642.x; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAINEY FA, 1994, FEMS MICROBIOL LETT, V115, P205, DOI 10.1111/j.1574-6968.1994.tb06639.x; Ramsey M, 2014, PHYSL METABOLISM ENT, P1; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Rawat S., 2013, THERMOPHILIC MICROBE, VSecond, P137; Redlinger T, 2001, APPL ENVIRON MICROB, V67, P4036, DOI 10.1128/AEM.67.9.4036-4040.2001; Rees GN, 2004, ANTON LEEUW INT J G, V86, P339, DOI 10.1007/s10482-004-0498-x; Rogers GB, 2015, ISME J, V9, P217, DOI 10.1038/ismej.2014.124; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Schloss PD, 2003, FEMS MICROBIOL ECOL, V46, P1, DOI 10.1016/S0168-6496(03)00153-3; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sharmin F, 2013, SCI REP-UK, V3, DOI 10.1038/srep03107; Smith MB, 2015, MBIO, V6, DOI 10.1128/mBio.00326-15; Steger K, 2007, J APPL MICROBIOL, V103, P487, DOI 10.1111/j.1365-2672.2006.03271.x; STROM PF, 1985, APPL ENVIRON MICROB, V50, P899, DOI 10.1128/AEM.50.4.899-905.1985; Su JQ, 2015, ENVIRON SCI TECHNOL, V49, P7356, DOI 10.1021/acs.est.5b01012; Ting ASY, 2013, BIOCATAL AGRIC BIOTE, V2, P162, DOI 10.1016/j.bcab.2012.11.004; Tonner-Klank L, 2007, WASTE MANAGE, V27, P1144, DOI 10.1016/j.wasman.2006.04.021; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Vanatta LE, 2003, ENV REGULATIONS TECH; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Wells GF, 2014, APPL MICROBIOL BIOT, V98, P4723, DOI 10.1007/s00253-014-5564-3; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	85	29	30	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177626	10.1371/journal.pone.0177626	http://dx.doi.org/10.1371/journal.pone.0177626			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570610	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800014
J	Born, J; Galeazzi, JM; Stringer, SM				Born, Jannis; Galeazzi, Juan M.; Stringer, Simon M.			Hebbian learning of hand-centred representations in a hierarchical neural network model of the primate visual system	PLOS ONE			English	Article							INVARIANT OBJECT RECOGNITION; POSTERIOR PARIETAL CORTEX; REFERENCE FRAMES; SPACE; REACH; POSITION; TRANSFORMATIONS; INFORMATION; NEURONS; BRAIN	A subset of neurons in the posterior parietal and premotor areas of the primate brain respond to the locations of visual targets in a hand-centred frame of reference. Such hand centred visual representations are thought to play an important role in visually-guided reaching to target locations in space. In this paper we show how a biologically plausible, Hebbian learning mechanism may account for the development of localized hand-centred representations in a hierarchical neural network model of the primate visual system, VisNet. The hand-centered neurons developed in the model use an invariance learning mechanism known as continuous transformation (CT) learning. In contrast to previous theoretical proposals for the development of hand-centered visual representations, CT learning does not need a memory trace of recent neuronal activity to be incorporated in the synaptic learning rule. Instead, CT learning relies solely on a Hebbian learning rule, which is able to exploit the spatial overlap that naturally occurs between successive images of a hand-object configuration as it is shifted across different retinal locations due to saccades. Our simulations show how individual neurons in the network model can learn to respond selectively to target objects in particular locations with respect to the hand, irrespective of where the hand-object configuration occurs on the retina. The response properties of these hand-centred neurons further generalise to localised receptive fields in the hand-centred space when tested on novel hand-object configurations that have not been explored during training. Indeed, even when the network is trained with target objects presented across a near continuum of locations around the hand during training, the model continues to develop hand-centred neurons with localised receptive fields in hand-centred space. With the help of principal component analysis, we provide the first theoretical framework that explains the behavior of Hebbian learning in VisNet.	[Born, Jannis; Galeazzi, Juan M.; Stringer, Simon M.] Univ Oxford, Oxford Ctr Theoret Neurosci & Artificial Intellig, Dept Expt Psychol, Oxford, Oxon, England; [Born, Jannis] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	University of Oxford; University Osnabruck	Born, J; Galeazzi, JM (corresponding author), Univ Oxford, Oxford Ctr Theoret Neurosci & Artificial Intellig, Dept Expt Psychol, Oxford, Oxon, England.; Born, J (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	jborn@uos.de; juan.galeazzigonzalez@psy.ox.ac.uk	Born, Jannis/AAD-6697-2021	Born, Jannis/0000-0001-8307-5670; Galeazzi, Juan M/0000-0003-4221-6988	Oxford Foundation of Theoretical Neuroscience and Artificial Intelligence	Oxford Foundation of Theoretical Neuroscience and Artificial Intelligence	We gratefully acknowledge support from the Oxford Foundation of Theoretical Neuroscience and Artificial Intelligence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We gratefully acknowledge support from the Oxford Foundation of Theoretical Neuroscience and Artificial Intelligence.	Arnoldussen DM, 2011, P NATL ACAD SCI USA, V108, P11668, DOI 10.1073/pnas.1102984108; Batista AP, 2007, J NEUROPHYSIOL, V98, P966, DOI 10.1152/jn.00421.2006; Bengio Y, 2015, ARXIV15020415, P18; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; Brozzoli C, 2011, J NEUROSCI, V31, P9023, DOI 10.1523/JNEUROSCI.1172-11.2011; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Buneo CA, 2012, J NEUROPHYSIOL, V108, P187, DOI 10.1152/jn.00137.2011; Chang SWC, 2008, J NEUROSCI, V28, P6128, DOI 10.1523/JNEUROSCI.1442-08.2008; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Foldiak P., NEURAL COMPUTATION, V3, P194; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Galeazzi JM, 2016, NETWORK COMPUTATION; Galeazzi JM, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00147; Galeazzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066272; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Graziano MS, 2001, IS REACHING EYE CENT; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Gross CG, 1995, NEUROSCIENTIST ISSN; Hadjidimitrakis K, 2014, CEREB CORTEX, V24, P3209, DOI 10.1093/cercor/bht181; Haykin S. S., 2009, PEARSON ED; Hertz JA, 1991, PERSEUS PUBLISHING; Juett J, 2016, IEEE-RAS INT C HUMAN, P1141, DOI 10.1109/HUMANOIDS.2016.7803414; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Levine S., 2016, ARXIV; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P7508, DOI 10.1073/pnas.83.19.7508; Magosso E, 2008, 8 IEEE INT C BIOINF, V2008; Magosso E, 2010, NEURAL COMPUT, V22, P190, DOI 10.1162/neco.2009.01-08-694; Makin TR, 2007, J NEUROSCI, V27, P731, DOI 10.1523/JNEUROSCI.3653-06.2007; Makin TR, 2009, J NEUROSCI, V29, P11841, DOI 10.1523/JNEUROSCI.2955-09.2009; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Perry G, 2010, EXP BRAIN RES, V204, P255, DOI 10.1007/s00221-010-2309-0; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Piserchia V, 2016, MIXED BODY HAND REFE; Pitti A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41056; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Prevosto V, 2011, EUR J NEUROSCI, V33, P444, DOI 10.1111/j.1460-9568.2010.07541.x; Riesenhuber M, NATURE NEUROSCIENCE, P1019; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; Robinson L, 2015, BIOL CYBERN, V109, P505, DOI 10.1007/s00422-015-0658-2; Rolls ET, 2011, PROG NEUROBIOL, V95, P448, DOI 10.1016/j.pneurobio.2011.08.002; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Rolls ET, FRONTIERS COMPUTATIO, P7; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Soechting JF, 1992, ANN REV NEUROSCI; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Stringer SM, 2000, NEURAL NETWORKS, V13, P305, DOI 10.1016/S0893-6080(00)00017-4; Tromans JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025616; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	59	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178304	10.1371/journal.pone.0178304	http://dx.doi.org/10.1371/journal.pone.0178304			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562618	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700053
J	Zink, FA; Tembrock, LR; Timm, AE; Farris, RE; Perera, OP; Gilligan, TM				Zink, Frida A.; Tembrock, Luke R.; Timm, Alicia E.; Farris, Roxanne E.; Perera, Omaththage P.; Gilligan, Todd M.			A droplet digital PCR (ddPCR) assay to detect Helicoverpa armigera (Lepidoptera: Noctuidae) in bulk trap samples	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; TARGET DETECTION; ZEA; DIFFERENTIATION; QUANTIFICATION; IDENTIFICATION; POPULATIONS; HELIOTHINAE	Moths in the genus Helicoverpa are some of the most important agricultural pests in the world. Two species, H. armigera (Hubner) and H. zea (Boddie), cause the majority of damage to crops and millions of dollars are spent annually on control of these pests. The recent introduction of H. armigera into the New World has prompted extensive survey efforts for this species in the United States. Surveys are conducted using bucket traps baited with H. armigera pheromone, and, because the same pheromone compounds attract both species, these traps often capture large numbers of the native H. zea. Adult H. armigera and H. zea are very similar and can only be separated morphologically by minor differences in the genitalia. Thus, a time consuming genitalic dissection by a trained specialist is necessary to reliably identify either species, and every specimen must be dissected. Several molecular methods are available for differentiating and identifying H. armigera and H. zea, including two recently developed rapid protocols using real-time PCR. However, none of the published methods are capable of screening specimens in large batches. Here we detail a droplet digital PCR (ddPCR) assay that is capable of detecting a single H. armigera in a background of up to 999 H. zea. The assay has been tested using bulk extractions of 1,000 legs from actual trap samples and is effective even when using poor quality samples. This study provides an efficient, rapid, reproducible, and scalable method for processing H. armigera survey trap samples in the U.S. and demonstrates the potential for applying ddPCR technology to screen and diagnose invasive species.	[Zink, Frida A.; Tembrock, Luke R.; Timm, Alicia E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Farris, Roxanne E.] USDA APHIS PPQ Sci & Technol, Mission Lab, Edinburg, TX USA; [Perera, Omaththage P.] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA; [Gilligan, Todd M.] USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA	Colorado State University; United States Department of Agriculture (USDA)	Gilligan, TM (corresponding author), USDA APHIS PPQ Sci & Technol, Identificat Technol Program, Ft Collins, CO 80526 USA.	todd.m.gilligan@aphis.usda.gov	Timm, Alicia E/A-1866-2008	Timm, Alicia/0000-0002-5800-5512	US Department of Agriculture	US Department of Agriculture(United States Department of Agriculture (USDA))	This work was funded by the US Department of Agriculture in a grant to LRT.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIO RAD B; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Brambila J., 2009, INSTRUCTIONS DISSECT; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Gerdes Lars, 2016, Biomol Detect Quantif, V7, P9, DOI 10.1016/j.bdq.2015.12.003; Gilligan TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142912; GLOOR GB, 1993, GENETICS, V135, P81; Guerrero S, 2014, FLA ENTOMOL, V97, P1671, DOI 10.1653/024.097.0441; Hardwick D. F., 1965, Mem ent Soc Canada Ottawa, Vno. 40, P1; HARTSTACK AW, 1979, J ECON ENTOMOL, V72, P519, DOI 10.1093/jee/72.4.519; Hayden J., 2015, PEST ALERT HELICOVER; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jones M, 2014, J VIROL METHODS, V202, P46, DOI 10.1016/j.jviromet.2014.02.020; Kranthi S, 2005, CURR SCI INDIA, V89, P1322; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Li QQ, 2011, MOL BIOL REP, V38, P5107, DOI 10.1007/s11033-010-0658-1; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; MATTHEWS M, 1999, MONOGRAPHS AUSTR LEP, V7; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Ming Qing-Lei, 2006, Insect Science, V13, P437, DOI 10.1111/j.1744-7917.2006.00113.x; Nagoshi RN, 2016, J ECON ENTOMOL, V109, P2115, DOI 10.1093/jee/tow177; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Perera OP, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew023; Perera OP, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev137; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; USDA (U.S. Department of Agriculture), 2014, NEW PEST RESP GUID H; Zucchi MI, 2014, PLOS ONE, V9	34	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178704	10.1371/journal.pone.0178704	http://dx.doi.org/10.1371/journal.pone.0178704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562660	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700082
J	Gweon, HM; Jeong, J; Son, EJ; Youk, JH; Kim, JA; Ko, KH				Gweon, Hye Mi; Jeong, Joon; Son, Eun Ju; Youk, Ji Hyun; Kim, Jeong-Ah; Ko, Kyung Hee			The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients	PLOS ONE			English	Article							CARCINOMA IN-SITU; TUMOR SIZE; DIAGNOSTIC-ACCURACY; MAMMOGRAPHY; CONCORDANCE; RECURRENCE; LESIONS; US	Purpose To investigate the significance of accompanying NME in invasive ductal carcinoma (IDC) on preoperative MR imaging and assess the factors affecting the significance. Methods Between January 2015 and February 2016, 163 consecutive patients with IDC who underwent preoperative MR imaging and subsequent surgery were enrolled and reviewed. Index cancer mass size and total extent with accompanying NME on MR images was measured and compared with pathologic size. Positive NME was defined as pathological result of IDC or DCIS. To identify affecting factors associated with frequency of accompanying NME on MR and positive pathologic result, clinicopathologic features were compared between breast cancers with NME and without NME, and between breast cancers with positive NME and negative NME using the Student t-test or Chi-square test. Results Of the 163 invasive breast cancers, 123(75.5%) cancers presented as only mass feature and 40(24.5%) cancers had accompanying NME around the index mass. Of the 40 accompanying NME, 22 (55%) had positive pathologic results and 18 (45%) had negative results. The HER2 positive status was significantly associated with positive pathologic results of accompanying NME (P=.016). Conclusion Accompanying NME on preoperative MR imaging showed malignant pathologic results in 55%. The HER2 positive IDC was more frequently accompanied by malignant NME.	[Gweon, Hye Mi; Son, Eun Ju; Youk, Ji Hyun; Kim, Jeong-Ah] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea; [Jeong, Joon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Ko, Kyung Hee] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Gyeonggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University	Son, EJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	ejsonrd@yuhs.ac		Son, Eun Ju/0000-0002-7895-0335; Gweon, Hye Mi/0000-0002-3054-1532; Jeong, Joon/0000-0003-0397-0005; Kim, Jeong-Ah/0000-0003-4949-4913				Allred DC, 1998, MODERN PATHOL, V11, P155; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Biglia N, 2011, EJSO-EUR J SURG ONC, V37, P199, DOI 10.1016/j.ejso.2010.12.011; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P180, DOI 10.1016/j.jamcollsurg.2009.04.010; Brennan ME, 2009, J CLIN ONCOL, V27, P5640, DOI 10.1200/JCO.2008.21.5756; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; Greenwood HI, 2013, RADIOGRAPHICS, V33, P1569, DOI 10.1148/rg.336125055; Grimsby GM, 2009, AM J SURG, V198, P500, DOI 10.1016/j.amjsurg.2009.07.012; Hata T, 2004, J AM COLL SURGEONS, V198, P190, DOI 10.1016/j.jamcollsurg.2003.10.008; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Liberman L, 2002, AM J ROENTGENOL, V179, P171, DOI 10.2214/ajr.179.1.1790171; Lopez JK, 2009, RADIOGRAPHICS, V29, P165, DOI 10.1148/rg.291085100; Mennella S, 2015, ACTA RADIOL, V56, P260, DOI 10.1177/0284185114524089; Meric F, 2003, CANCER, V97, P926, DOI 10.1002/cncr.11222; Plana MN, 2012, EUR RADIOL, V22, P26, DOI 10.1007/s00330-011-2238-8; Onesti JK, 2008, AM J SURG, V196, P844, DOI 10.1016/j.amjsurg.2008.07.028; Orel SG, 1997, RADIOLOGY, V202, P413, DOI 10.1148/radiology.202.2.9015067; Rominger M, 2016, EUR RADIOL, V26, P1457, DOI 10.1007/s00330-015-3935-5; Rosen EL, 2007, BREAST J, V13, P545, DOI 10.1111/j.1524-4741.2007.00513.x; Schuh F, 2010, PATHOL RES PRACT, V206, P705, DOI 10.1016/j.prp.2010.06.004; Tozaki M, 2006, AM J ROENTGENOL, V187, P330, DOI 10.2214/AJR.05.0998; van Deurzen CH, 2016, ANN SURG ONCOL; Voogd AC, 2001, J CLIN ONCOL, V19, P1688, DOI 10.1200/JCO.2001.19.6.1688; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178445	10.1371/journal.pone.0178445	http://dx.doi.org/10.1371/journal.pone.0178445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558007	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000045
J	McMahan, CD; Ginger, L; Cage, M; David, KT; Chakrabarty, P; Johnston, M; Matamoros, WA				McMahan, Caleb D.; Ginger, Luke; Cage, Marcy; David, Kyle T.; Chakrabarty, Prosanta; Johnston, Mark; Matamoros, Wilfredo A.			Pleistocene to holocene expansion of the black-belt cichlid in Central America, Vieja maculicauda (Teleostei: Cichlidae)	PLOS ONE			English	Article							PHYLOGEOGRAPHY; PHYLOGENY; DIVERSITY; HISTORY	The distributions of many Northern Hemisphere organisms have been influenced by fluctuations in sea level and climatic conditions during Pleistocene interglacial periods. These cycles are associated with range contraction and refugia for northern-distributed organisms as a response to glaciers. However, lower sea levels in the tropics and sub-tropics created available habitat for expansion of the ranges of freshwater organisms. The goal of this study was to use ecological niche modeling to test the hypothesis of north to south range expansion of Vieja maculicauda associated with Pleistocene glacial cycles. Understanding the biogeography of this widespread species may help us better understand the geology and interconnectivity of Central American freshwaters. Occurrence data for V. maculicauda was based on georeferencing of all museum records of specimens recovered from FishNet2. General patterns of phylogeographic structure were assessed with mtDNA. Present day niche models were generated and subsequently projected onto paleoclimatic maps of the region during the Last Interglacial, Last Glacial Maximum, and mid-Holocene. Phylogenetic analysis of mtDNA sequence data showed no phylogeographic structure throughout the range of this widespread species. Present day niche models were congruent with the observed distribution of V. maculicauda in Central America. Results showed a lack of suitable freshwater habitat in northern Central America and Mexico during the Last Interglacial, with greatest range expansion during the Last Glacial Maximum and mid-Holocene. Results support the hypothesis of a north to south range expansion of V. maculicauda associated with glacial cycles. The wide distribution of this species compared to other closely related cichlids indicates the latter did not respond to the degree of V. maculicauda in expansion of their distributions. Future work aimed at comparisons with other species and modeling of future climatic scenarios will be a fruitful area of investigation.	[McMahan, Caleb D.; Ginger, Luke; David, Kyle T.; Johnston, Mark] Field Museum Nat Hist, Chicago, IL 60605 USA; [Cage, Marcy; Chakrabarty, Prosanta] Louisiana State Univ, Dept Biol Sci, LSU Museum Nat Sci, Baton Rouge, LA 70803 USA; [Matamoros, Wilfredo A.] Univ Ciencias & Artes Chiapas, Inst Ciencias Biol, Museo Zool, Tuxtla Gutierrez, Chiapas, Mexico; [Ginger, Luke] Celly Serv Inc, Long Beach, CA USA	Field Museum of Natural History (Chicago); Louisiana State University System; Louisiana State University	McMahan, CD (corresponding author), Field Museum Nat Hist, Chicago, IL 60605 USA.	cmcmahan@fieldmuseum.org	Matamoros, Wilfredo/CAG-2245-2022; Chakrabarty, Prosanta/E-3307-2010	Matamoros, Wilfredo/0000-0002-6241-5354; 	NSF [DEB 1311408, DEB 1354149]; Pritzker Foundation	NSF(National Science Foundation (NSF)); Pritzker Foundation	This work was supported by NSF grants DEB 1311408 to CDM and DEB 1354149 to PC. Part of this research was carried out in The Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution, which is operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Susan Mochel and Kevin Swagel for logistical support (FMNH). Cathy Newman (LSUMZ) and Hannah Owens (UF) kindly provided invaluable discussion on ENM methods and procedures. Marc Lambruschi (FMNH) offered helpful advice and discussion regarding ENM analyses. We thank Arturo Angulo and Carlos Garita-Alvarado for assistance with specimen records from UCR. Part of this research was carried out in The Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation.	Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Bagley JC, 2016, BIOL J LINN SOC LOND; Bagley JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121139; Bagley JC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-223; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bussing WA, 1998, REV BIOL TROP S2, V46, P2; Chakrabarty P, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P293; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coates Anthony G., 1996, P21; Cochran DM, 2009, AREA, V41, P425, DOI 10.1111/j.1475-4762.2009.00886.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Greendfield D.W., 1997, FISHES CONTINENTAL W, V1st; Harrison E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104173; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jungclaus JH, 2013, J ADV MODEL EARTH SY, V5, P422, DOI 10.1002/jame.20023; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lomolino M.V., 2004, FDN BIOGEOGRAPHY; Lopez-Fernandez H, 2010, MOL PHYLOGENET EVOL, V55, P1070, DOI 10.1016/j.ympev.2010.02.020; Ludt WB, 2015, J BIOGEOGR, V42, P25, DOI 10.1111/jbi.12416; Marchio EA, 2013, BIOL J LINN SOC, V109, P848, DOI 10.1111/bij.12076; Matamoros WA, 2015, CLADISTICS, V31, P177, DOI 10.1111/cla.12081; Matamoros WA, 2009, ZOOTAXA, P1; Mcmahan CD, 2015, ZOOTAXA, V3999, P211, DOI 10.11646/zootaxa.3999.2.3; McMahan CD, 2013, J BIOGEOGR, V40, P894, DOI 10.1111/jbi.12036; McMahan CD, 2010, MOL PHYLOGENET EVOL, V57, P1293, DOI 10.1016/j.ympev.2010.09.005; Newman CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130131; OPialek L, 2013, J BIOGEOGR, V40, P579; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Porretta D, 2011, J BIOGEOGR, V38, P20, DOI 10.1111/j.1365-2699.2010.02385.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Regan C. T., 1905, ANN MAG NAT HIST, V16, P225; Rogers RD., 2003, THESIS; Soto-Centeno J. Angel, 2015, American Museum Novitates, V3847, P1; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1992, GENETICS, V132, P619; Waldrop E, 2016, J BIOGEOGR, V43, P1116, DOI 10.1111/jbi.12680; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x	44	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178439	10.1371/journal.pone.0178439	http://dx.doi.org/10.1371/journal.pone.0178439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558052	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000044
J	Prakash, P; Nambiar, A; Sheeba, V				Prakash, Pavitra; Nambiar, Aishwarya; Sheeba, Vasu			Oscillating PDF in termini of circadian pacemaker neurons and synchronous molecular clocks in downstream neurons are not sufficient for sustenance of activity rhythms in constant darkness	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; DROSOPHILA-MELANOGASTER; HUNTINGTONS-DISEASE; BEHAVIORAL RHYTHMS; LATERAL NEURONS; IN-VIVO; NEUROPEPTIDE; BRAIN; RECEPTOR; CIRCUIT	In Drosophila, neuropeptide Pigment Dispersing Factor (PDF) is expressed in small and large ventral Lateral Neurons (sLNv and lLNv), among which sLNv are critical for activity rhythms in constant darkness. Studies show that this is mediated by rhythmic accumulation and likely secretion of PDF from sLNv dorsal projections, which in turn synchronises molecular oscillations in downstream circadian neurons. Using targeted expression of a neurodegenerative protein Huntingtin in LNv, we evoke a selective loss of neuropeptide PDF and clock protein PERIOD from sLNv soma. However, PDF is not lost from sLNv dorsal projections and lLNv. These flies are behaviourally arrhythmic in constant darkness despite persistence of PDF oscillations in sLNv dorsal projections and synchronous PERIOD oscillations in downstream circadian neurons. We find that PDF oscillations in sLNv dorsal projections are not sufficient for sustenance of activity rhythms in constant darkness and this is suggestive of an additional component that is possibly dependent on sLNv molecular clock and PDF in sLNv soma. Additionally, despite loss of PERIOD in sLNv, their activity rhythms entrain to light/dark cycles indicating that sLNv molecular clocks are not necessary for entrainment. Under constant light, these flies lack PDF from both soma and dorsal projections of sLNv, and when subjected to light/dark cycles, show morning and evening anticipation and accurately phased morning and evening peaks. Thus, under light/dark cycles, PDF in sLNv is not necessary for morning anticipation.	[Prakash, Pavitra; Nambiar, Aishwarya; Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Integrat Biol Unit, Bangalore, Karnataka, India; [Sheeba, Vasu] Jawaharlal Nehru Ctr Adv Sci Res, Neurosci Unit, Bangalore, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Sheeba, V (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Integrat Biol Unit, Bangalore, Karnataka, India.; Sheeba, V (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Neurosci Unit, Bangalore, Karnataka, India.	sheeba@jncasr.ac.in		Vasu, Sheeba/0000-0003-2924-7130; Prakash, Pavitra/0000-0002-5952-9625	Department of Science and Technology, Science and Engineering Research Board [SR/S2/RJN-42/2008]; Council of Science and Industrial Research [09/733(0117)12009-EMR-I]; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Science and Technology, Science and Engineering Research Board(Department of Science & Technology (India)); Council of Science and Industrial Research; Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	The studies reported here were supported by a Ramanujan fellowship to VS (SR/S2/RJN-42/2008) from the Department of Science and Technology, Science and Engineering Research Board and a Senior Research Fellowship to PP (09/733(0117)12009-EMR-I) from the Council of Science and Industrial Research and intramural funding from Jawaharlal Nehru Centre for Advanced Scientific Research.	Agrawal P, 2016, J NEUROSCI, V36, P3860, DOI 10.1523/JNEUROSCI.4523-15.2016; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Gorostiza EA, 2014, CURR BIOL, V24, P2161, DOI 10.1016/j.cub.2014.07.063; Gorostiza EA, 2013, J NEUROSCI, V33, P687, DOI 10.1523/JNEUROSCI.3448-12.2013; Beckwith EJ, 2015, J COMP NEUROL, V523, P982, DOI 10.1002/cne.23728; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Cavey M, 2016, NAT NEUROSCI, V19, P587, DOI 10.1038/nn.4263; Chen KF, 2014, DIS MODEL MECH, V7, P445, DOI 10.1242/dmm.014134; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Depetris-Chauvin A, 2011, CURR BIOL, V21, P1783, DOI 10.1016/j.cub.2011.09.027; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Frenkel L, 2011, INT REV NEUROBIOL, V99, P107, DOI 10.1016/B978-0-12-387003-2.00005-7; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; Kula E, 2006, J BIOL RHYTHM, V21, P104, DOI 10.1177/0748730405285715; Kumar A, 2014, DRUG DISCOV TODAY, V19, P956, DOI 10.1016/j.drudis.2014.03.016; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Levitan ES, 2007, NAT PROTOC, V2, P1117, DOI 10.1038/nprot.2007.142; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Muraro NI, 2013, NEUROSCIENCE, V247, P280, DOI 10.1016/j.neuroscience.2013.05.036; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Okray Z, 2015, EMBO MOL MED, V7, P423, DOI 10.15252/emmm.201404576; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Pfeiffenberger C, 2010, COLD SPRING HARB PRO, V2010, DOI [10.1101/pdb.prot5519, DOI 10.1101/PDB.PROT5519]; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schlichting M, 2016, J NEUROSCI, V36, P9084, DOI 10.1523/JNEUROSCI.0992-16.2016; Seluzicki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001810; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Shafer OT, 2002, J NEUROSCI, V22, P5946; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Sheeba V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011628; Sheeba V, 2008, J GENET, V87, P485, DOI 10.1007/s12041-008-0071-x; Song Q, 2016, MOL NEUROBIOL; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yoshii T, 2009, J NEUROSCI, V29, P2597, DOI 10.1523/JNEUROSCI.5439-08.2009; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056	60	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0175073	10.1371/journal.pone.0175073	http://dx.doi.org/10.1371/journal.pone.0175073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558035	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000001
J	Puthenveetil, S; He, HY; Loganzo, F; Musto, S; Teske, J; Green, M; Tan, XZ; Hosselet, C; Lucas, J; Tumey, LN; Sapra, P; Subramanyam, C; O'Donnell, CJ; Graziani, EI				Puthenveetil, Sujiet; He, Haiyin; Loganzo, Frank; Musto, Sylvia; Teske, Jesse; Green, Michael; Tan, Xingzhi; Hosselet, Christine; Lucas, Judy; Tumey, L. Nathan; Sapra, Puja; Subramanyam, Chakrapani; O'Donnell, Christopher J.; Graziani, Edmund I.			Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SPLICING INHIBITORS; THERAPEUTIC INDEX; CANCER; PHARMACOKINETICS; SPLICEOSTATIN; OPTIMIZATION; RESISTANCE; STABILITY; DISCOVERY	Antibody drug conjugates (ADCs) are no longer an unknown entity in the field of cancer therapy with the success of marketed ADCs like ADCETRIS and KADCYLA and numerous others advancing through clinical trials. The pursuit of novel cytotoxic payloads beyond the mictotubule inhibitors and DNA damaging agents has led us to the recent discovery of an mRNA splicing inhibitor, thailanstatin, as a potent ADC payload. In our previous work, we observed that the potency of this payload was uniquely tied to the method of conjugation, with lysine conjugates showing much superior potency as compared to cysteine conjugates. However, the ADC field is rapidly shifting towards site-specific ADCs due to their advantages in manufacturability, characterization and safety. In this work we report the identification of a highly efficacious site-specific thailanstatin ADC. The site of conjugation played a critical role on both the in vitro and in vivo potency of these ADCs. During the course of this study, we developed a novel methodology of loading a single site with multiple payloads using an in situ generated multi-drug carrying peptidic linker that allowed us to rapidly screen for optimal conjugation sites. Using this methodology, we were able to identify a double-cysteine mutant ADC delivering four-loaded thailanstatin that was very efficacious in a gastric cancer xenograft model at 3mg/kg and was also shown to be efficacious against T-DM1 resistant and MDR1 overexpressing tumor cell lines.	[Puthenveetil, Sujiet; He, Haiyin; Teske, Jesse; Green, Michael; Tumey, L. Nathan; Subramanyam, Chakrapani; O'Donnell, Christopher J.; Graziani, Edmund I.] Pfizer Global R&D, Worldwide Med Chem, Groton, CT 06340 USA; [Loganzo, Frank; Musto, Sylvia; Tan, Xingzhi; Hosselet, Christine; Lucas, Judy; Sapra, Puja] Pfizer Oncol Res, Pearl River, NY USA; [Puthenveetil, Sujiet] AbbVie Biores Ctr, R&D, Worcester, MA USA; [He, Haiyin] Biosortia Pharmaceut, 3210 Merryfield Row, San Diego, CA USA; [Teske, Jesse] AbbVie Inc, Discovery Res, N Chicago, IL USA	Pfizer; Pfizer; AbbVie; AbbVie	Puthenveetil, S (corresponding author), Pfizer Global R&D, Worldwide Med Chem, Groton, CT 06340 USA.	sujiet@gmail.com		Puthenveetil, Sujiet/0000-0001-9005-8422	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided support in the form of salaries for authors S.P., H.H., F.L., S.M., J.T., M.G., X.T., C.H., J.L., L.N.T., P.S.,C.S., C.J.O'D. and E.I.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Chari RVJ, 2016, ACS MED CHEM LETT; de Goeij BECG, 2016, CURR OPIN IMMUNOL, V40, P14, DOI 10.1016/j.coi.2016.02.008; Dirico KJ, 2014, WO WOpatent, Patent No. [2013-IB59553, 201359553]; Dorywalska M, 2015, BIOCONJUGATE CHEM, V26, P650, DOI 10.1021/bc5005747; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Elgundi Z., 2016, ADV DRUG DELIV REV; Eustaquio AS, 2014, P NATL ACAD SCI USA, V111, pE3376, DOI 10.1073/pnas.1408300111; Gao WL, 2016, CURR CANCER DRUG TAR, V16, P469, DOI 10.2174/1568009616666160512144715; Hamann Philip R., 2002, P239; He HY, 2014, J NAT PROD, V77, P1864, DOI 10.1021/np500342m; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kim EG, 2015, BIOMOL THER, V23, P493, DOI 10.4062/biomolther.2015.116; Kim MT, 2014, BIOCONJUGATE CHEM, V25, P1223, DOI 10.1021/bc5000109; Kovtun YV, 2010, CANCER RES, V70, P2528, DOI 10.1158/0008-5472.CAN-09-3546; Lhospice F, 2015, MOL PHARMACEUT, V12, P1863, DOI 10.1021/mp500666j; Liu XY, 2013, J NAT PROD, V76, P685, DOI 10.1021/np300913h; Loganzo F, 2015, MOL CANCER THER, V14, P952, DOI 10.1158/1535-7163.MCT-14-0862; Lyon RP, 2015, NAT BIOTECHNOL, V33, P733, DOI 10.1038/nbt.3212; Marquette K, 2013, Application: WO WO patent, Patent No. [2012-IB57491, 201257491]; Matthew S., 2016, P 107 ANN M AM ASS C; Moldenhauer G, 2012, JNCI-J NATL CANCER I, V104, P622, DOI 10.1093/jnci/djs140; Nakajima H, 1996, J ANTIBIOT, V49, P1204; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; PIETERSZ GA, 1994, J DRUG TARGET, V2, P183, DOI 10.3109/10611869408996804; Pillow TH, 2014, J MED CHEM, V57, P7890, DOI 10.1021/jm500552c; Puthenveetil S, 2016, BIOCONJUGATE CHEM, V27, P1880, DOI 10.1021/acs.bioconjchem.6b00291; Puthenveetil S, 2016, BIOCONJUGATE CHEM, V27, P1030, DOI 10.1021/acs.bioconjchem.6b00054; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Schumacher D, 2016, J CLIN IMMUNOL, V36, pS100, DOI 10.1007/s10875-016-0265-6; Senter PD, 2012, NAT BIOTECHNOL, V30, P631, DOI 10.1038/nbt.2289; Sochaj AM, 2015, BIOTECHNOL ADV, V33, P775, DOI 10.1016/j.biotechadv.2015.05.001; Stein EM, 2016, BLOOD, V127, P71, DOI 10.1182/blood-2015-07-604538; Thompson P, 2016, J CONTROL RELEASE, V236, P100, DOI 10.1016/j.jconrel.2016.06.025; Tumey LN, 2016, ACS MED CHEM LETT, V7, P977, DOI 10.1021/acsmedchemlett.6b00195	36	15	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178452	10.1371/journal.pone.0178452	http://dx.doi.org/10.1371/journal.pone.0178452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558059	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000047
J	Xie, BB; Wang, PF; Zhao, C; Qiu, LH				Xie, Bobo; Wang, Pengfei; Zhao, Chao; Qiu, Lihua			Genomic structure, expression pattern, and functional characterization of transcription factor E2F-2 from black tiger shrimp (Penaeus monodon)	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; MARSUPENAEUS-JAPONICUS; GONADAL DEVELOPMENT; OVARIAN MATURATION; FAMILY-MEMBERS; PROTEIN; GENE; PROMOTER; IDENTIFICATION; SPECIFICITY	Transcription factor E2F-2 is a regulator of cell cycle. Researchers identified E2F-2 genes from yeasts to humans, but few reports investigated E2F-2 gene from black tiger shrimp. In the present study, we cloned E2F-2 gene from black tiger shrimp (Penaeus monodon). Full-length PmE2F-2 complementary DNA sequence measures 3,189 bp with an open reading frame of 1,371 bp. Complete PmE2F-2genomic sequence (17,305 bp) of P. monodon contains nine exons, which are separated by eight introns. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis indicated that PmE2F-2 is highly expressed in hepato-pancreas and ovaries of P. monodon. Highest PmE2F-2 expression levels were observed in stage III ovarian development of P. monodon. PmE2F-2 expression levels were significantly augmented in ovaries of P. monodon after 5-hydroxytryptamine injection and eyestalk ablation. RNA interference experiments were conducted to examine PmE2F-2, PmCDK2, and PmCyclin E expression profiles. PmE2F-2 was successfully knocked down in ovaries and hepatopancreas via double-stranded RNA (dsRNA) E2F-2 injection. In the same organs, PmE2F-2 expression localization and level were investigated through in situ hybridization, which revealed consistent results with those of qRT-PCR. After dsRNA E2F-2 injection, gonadosomatic index of shrimp was significantly lower than those following dsRNA-GFP and phosphate-buffered solution injections. Therefore, PmE2F-2 may be involved in ovarian maturation in P. monodon.	[Xie, Bobo; Wang, Pengfei; Zhao, Chao; Qiu, Lihua] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Xie, Bobo] Shanghai Ocean Univ, Coll Aqua Life Sci & Technol, Shanghai, Peoples R China; [Xie, Bobo; Wang, Pengfei; Zhao, Chao; Qiu, Lihua] Minist Agr, Key Lab South China Sea Fishery Resources Exploit, Guangzhou, Guangdong, Peoples R China; [Qiu, Lihua] Trop Aquaculture Res & Dev Ctr South China Fisher, Sanya, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Shanghai Ocean University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Qiu, LH (corresponding author), Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.; Qiu, LH (corresponding author), Minist Agr, Key Lab South China Sea Fishery Resources Exploit, Guangzhou, Guangdong, Peoples R China.; Qiu, LH (corresponding author), Trop Aquaculture Res & Dev Ctr South China Fisher, Sanya, Peoples R China.	qiugroup_bio@outlook.com			Guangdong Provincial Science and Technology Program [2015A020209037]; Natural Science Foundation of Hainan Province, China [2017CXTD021]; Guangdong province marine fishery science and technology and industrial development of special scientific and technological research and development projects [A201601A08]	Guangdong Provincial Science and Technology Program; Natural Science Foundation of Hainan Province, China; Guangdong province marine fishery science and technology and industrial development of special scientific and technological research and development projects	This study was supported by The Guangdong Provincial Science and Technology Program (2015A020209037), Natural Science Foundation of Hainan Province, China (2017CXTD021), The Guangdong province marine fishery science and technology and industrial development of special scientific and technological research and development projects (A201601A08).	Bai HK, 2015, GENE, V562, P22, DOI 10.1016/j.gene.2014.12.008; Benzie JAH, 1998, AQUACULTURE, V164, P23, DOI 10.1016/S0044-8486(98)00175-6; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Dai WT, 2016, MOL BIOL REP, V43, P549, DOI 10.1007/s11033-016-3988-9; DeGregori J, 2006, CURR MOL MED, V6, P739; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Feijo RG, 2016, MAR BIOTECHNOL, V18, P117, DOI 10.1007/s10126-015-9676-2; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; Korah J, 2016, J BIOL CHEM, V291, P2043, DOI 10.1074/jbc.M115.678557; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; Lee FY, 1997, COMP BIOCHEM PHYS A, V117, P433, DOI 10.1016/S0300-9629(96)00260-5; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Nakahata AM, 2014, ONCOL LETT, V8, P1487, DOI 10.3892/ol.2014.2369; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Phinyo M, 2014, AQUACULTURE, V432, P286, DOI 10.1016/j.aquaculture.2014.05.022; Phinyo M, 2013, GEN COMP ENDOCR, V193, P103, DOI 10.1016/j.ygcen.2013.07.012; Qiu GF, 2008, ANIM REPROD SCI, V105, P209, DOI 10.1016/j.anireprosci.2007.03.005; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rodriguez-Gonzalez H, 2006, AQUACULTURE, V254, P637, DOI 10.1016/j.aquaculture.2005.10.020; Schug J., 2008, CURR PROTOC BIOINFOR, V2, P15; Shi J, 2015, CELL STRESS CHAPERON, P1; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Sun BZ, 2016, AQUACULTURE, V455, P87, DOI 10.1016/j.aquaculture.2016.01.002; Tang KFJ, 2015, J INVERTEBR PATHOL, V130, P37, DOI 10.1016/j.jip.2015.06.009; Tassanakajon A, 1998, J MAR BIOTECHNOL, V6, P249; TEAM MGC, 2002, P NATL ACAD SCI USA, V99, P16899, DOI DOI 10.1073/PNAS; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Vatanavicharn T, 2009, COMP BIOCHEM PHYS B, V153, P244, DOI 10.1016/j.cbpb.2009.03.004; Viger RS, 1998, DEVELOPMENT, V125, P2665; Wang Y, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017367; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wongprasert K, 2006, AQUACULTURE, V261, P1447, DOI 10.1016/j.aquaculture.2006.08.044; Zhao C, 2015, GENET MOL RES, V14, P13380, DOI 10.4238/2015.October.26.36	35	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177420	10.1371/journal.pone.0177420	http://dx.doi.org/10.1371/journal.pone.0177420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558060	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000011
J	Zhang, JB; Yan, JJ; Shen, XY; Chang, D; Bai, SQ; Zhang, Y; Zhang, J				Zhang, Jianbo; Yan, Jiajun; Shen, Xiaoyun; Chang, Dan; Bai, Shiqie; Zhang, Yu; Zhang, Jin			How genetic variation is affected by geographic environments and ploidy level in Erianthus arundinaceus?	PLOS ONE			English	Article							DIVERSITY	Erianthus arundinaceus is not only a candidate plant for sugarcane breeding programs, but also a potential bioenergy grass. Genetic variation that is affected by geographic environments and ploidy level is very important for the utilization of Erianthus arundinaceus. In this study, effects of geographic environments and ploidy level on genetic variation were studied through analyzing the genetic diversity, genetic similarity and cluster analysis of 46 E. arundinaceus materials from natural habitats in China by using 7 ISSRs and 15 SSRs. Results showed that: 1) Seven ISSRs generated total 66 bands, of which 77% were polymorphic bands, the Nei's genetic similarity coefficient of tested materials ranged from 0.642 to 0.904 with an average value of 0.765. Fifteen SSRs generated 138 bands, of which 81% were polymorphic bands, the Nei's genetic similarity coefficient of tested materials ranged from 0.634 to 0.963 with an average value of 0.802. The results indicated great genetic diversity existed in the tested materials. 2)The tested materials were clustered into 3 groups and 7 subgroups, which demonstrated a strong geographic effect on variation of the local E. arundinaceus, and weak relationship was found between genetic distance and geographic distance. Five tetraploid materials were not clustered together, and were clustered together with materials from similar geographical location. 3) The genetic variation and cluster results were affected by geographic landforms and environments, the gene flow was blocked by Ocean and mountains, and promoted by river. The effect of ploidy level on genetic variation was little.	[Zhang, Jianbo; Yan, Jiajun; Chang, Dan; Bai, Shiqie; Zhang, Yu; Zhang, Jin] Sichuan Acad Grassland Sci, Chengdu, Sichuan, Peoples R China; [Shen, Xiaoyun] Guizhou Normal Univ, State Engn Technol Inst Karst Desertificat Contro, Guiyang, Peoples R China; [Shen, Xiaoyun] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China; [Shen, Xiaoyun] Guizhou Proverty Alleviat & Dev Off, Foreign Capital Project Management Ctr, Guiyang, Peoples R China	Guizhou Normal University; Southwest University of Science & Technology - China	Bai, SQ (corresponding author), Sichuan Acad Grassland Sci, Chengdu, Sichuan, Peoples R China.	baiforage@163.com			Technology Fund for Youth of Sichuan [2017JQ0056]; National Natural Science Foundation of China [41671041]; earmarked fund for China Agriculture Research System [CARS-35-35]; state key research and development program in the 13th five-year [2016YFC0502601]	Technology Fund for Youth of Sichuan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for China Agriculture Research System; state key research and development program in the 13th five-year	The study was supported by the Technology Fund for Youth of Sichuan (#2017JQ0056), the National Natural Science Foundation of China (#41671041), the earmarked fund for China Agriculture Research System (#CARS-35-35), the state key research and development program in the 13th five-year (#2016YFC0502601).	Besse P, 1996, THEOR APPL GENET, V92, P733, DOI 10.1007/BF00226096; Besse P, 1997, EUPHYTICA, V93, P283, DOI 10.1023/A:1002940701171; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cai Q, 2012, GENET RESOUR CROP EV, V59, P1483, DOI 10.1007/s10722-011-9776-4; Chen S, 2006, FLORA CHINA, V12, P165; Clayton W. D., 2006, GRASSBASE ONLINE WOR; Deng HH, 2002, SUGARCANE CANESUGAR, V1, P1, DOI DOI 10.3969/J.ISSN.1005-9695.2002.01.001; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; He, 1997, J YUNNAN AGR U, V12, P253; He SC, 1987, J YUNNAN AGR U, V2, P105; JACKSON P, 2011, WILD CROP RELATIVES, P97, DOI DOI 10.1007/978-3-642-21102-7_5; Koike, 1980, HAWAII PLANT REC, V59, P176; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; MANTEL N, 1967, CANCER RES, V27, P209; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Ming R, 2006, PL BRED RE, V27, P15; Mukherjee S. K, 1957, BOT GAZ, V119, P55, DOI DOI 10.1086/335962; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nevo E, 1998, GENET RESOUR CROP EV, V45, P355, DOI 10.1023/A:1008689304103; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Tew Thomas L., 2008, P249, DOI 10.1007/978-0-387-70805-8_9; Tsuruta S, 2012, GRASSL SCI, V58, P174, DOI 10.1111/j.1744-697X.2012.00258.x; [王涛 Wang Tao], 2015, [植物学报, Chinese Bulletin of Botany], V50, P504; Yan JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151948; [曾兵 Zeng Bing], 2011, [植物遗传资源学报, Journal of Plant Genetic Resources], V12, P709; Zhang HY, 2008, AFR J BIOTECHNOL, V7, P3414; Zhang J, 2013, J COMPUT, V8, P10, DOI 10.4304/jcp.8.1.10-17; Zhang Mu-qing, 2004, Journal of Plant Resources and Environment, V13, P1	30	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178451	10.1371/journal.pone.0178451	http://dx.doi.org/10.1371/journal.pone.0178451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28557997	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000046
J	Oluwole, OA; Mahboubi, K; Favetta, LA; Revay, T; Kroetsch, T; King, WA				Oluwole, Olutobi A.; Mahboubi, Kiana; Favetta, Laura A.; Revay, Tamas; Kroetsch, Tom; King, William Allan			Highly dynamic temporal changes of TSPY gene copy number in aging bulls	PLOS ONE			English	Article							TESTIS-SPECIFIC PROTEIN; MALE-SPECIFIC REGION; Y-ENCODED TSPY; SOMATIC MOSAICISM; TELOMERE LENGTH; BOS-TAURUS; AGE; CHROMOSOME; FERTILITY; QUALITY	The Y-chromosomal TSPY gene is one of the highest copy number mammalian protein coding gene and represents a unique biological model to study various aspects of genomic copy number variations. This study investigated the age-related copy number variability of the bovine TSPY gene, a new and unstudied aspect of the biology of TSPY that has been shown to vary among cattle breeds, individual bulls and somatic tissues. The subjects of this prospective 30-month long study were 25 Holstein bulls, sampled every six months. Realtime quantitative PCR was used to determine the relative TSPY copy number (rTSPY CN) and telomere length in the DNA samples extracted from blood. Twenty bulls showed an altered rTSPY CN after 30 months, although only 9 bulls showed a significant change (4 significant increase while 5 significant decrease, P<0.01). The sequential sampling provided the flow of rTSPY CN over six observations in 30 months and wide-spread variation of rTSPY CN was detected. Although a clear trend of the direction of change was not identifiable, the highly dynamic changes of individual rTSPY CN in aging bulls were observed here for the first time. In summary we have observed a highly variable rTSPY CN in bulls over a short period of time. Our results suggest the importance of further long term studies of the dynamics of rTSPY CN variablility.	[Oluwole, Olutobi A.; Mahboubi, Kiana; Favetta, Laura A.; Revay, Tamas; King, William Allan] Univ Guelph, Dept Biomed Sci, Guelph, ON, Canada; [Kroetsch, Tom] Semex, Guelph, ON, Canada	University of Guelph	Revay, T (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON, Canada.	trevay@uoguelph.ca	Revay, Tamas/AAU-7731-2020; Laura, Favetta/AAN-3927-2021		Natural Science and Engineering Research Council of Canada; Canada Research Chairs Program; Ontario Veterinary College, University of Guelph	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs); Ontario Veterinary College, University of Guelph	The work was funded by the Natural Science and Engineering Research Council of Canada, the Canada Research Chairs Program and the Ontario Veterinary College, University of Guelph. The funders provided support in the form of operating costs and salaries for authors OAO, KM, LAF, and TR. Neither the funding agencies nor the commercial affiliation had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Case LK, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0024-z; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang TC, 2013, P NATL ACAD SCI USA, V110, P12373, DOI 10.1073/pnas.1221104110; Dumanski JP, 2012, METHODS MOL BIOL, V838, P249, DOI 10.1007/978-1-61779-507-7_12; Fairlie J, 2016, AGING CELL, V15, P140, DOI 10.1111/acel.12417; Gilchrist GC, 2015, REPROD DOMEST ANIM, V50, P58, DOI 10.1111/rda.12449; Hamilton CK, 2012, SEX DEV, V6, P231, DOI 10.1159/000338938; Hamilton CK, 2009, SEX DEV, V3, P205, DOI 10.1159/000228721; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; Krausz C, 2010, GENES-BASEL, V1, P308, DOI 10.3390/genes1020308; Kuningas M, 2011, HUM MOL GENET, V20, P4290, DOI 10.1093/hmg/ddr340; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Mazeyrat S, 1998, HUM MOL GENET, V7, P557, DOI 10.1093/hmg/7.3.557; Mukherjee A, 2015, ANIM BIOTECHNOL, V26, P65, DOI 10.1080/10495398.2014.887020; Nygaard M, 2016, AGING CELL, V15, P49, DOI 10.1111/acel.12407; Oluwole OA, 2016, CYTOGENET GENOME RES, V149, P176, DOI 10.1159/000448368; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quach AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131745; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; Sharma R, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0028-x; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Svenson U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021485; Vilakazi DM, 2004, S AFR J ANIM SCI, V34, P62; Xue YL, 2011, GENES-BASEL, V2, P36, DOI 10.3390/genes2010036	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178558	10.1371/journal.pone.0178558	http://dx.doi.org/10.1371/journal.pone.0178558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552978	Green Published, gold, Green Submitted			2022-12-26	WOS:000402063000050
J	Peng, YC; Lin, CL; Sung, FC				Peng, Yen-Chun; Lin, Cheng-Li; Sung, Fung-Chang			The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study	PLOS ONE			English	Article							RISK; CANCER; CARCINOMA	Background & aims Inflammatory bowel diseases (IBD) and cholecystectomy are associated with the risk of colorectal cancer (CRC). Our aim was to determine the association between cholecystectomy and the CRC risk in IBD. Methods We first obtained the Taiwan National Health Insurance Research Database (NHRID), which contains information on approximately 24.7 million insured individuals. A cohort study was conducted using the data from the NHIRD, and included cohort patients with IBD who had experienced a cholecystectomy between the years 1998 and 2010. The non-cholecystectomy cohort comprised the remaining IBD patients who had not undergone a cholecystectomy. Multivariate Cox proportional hazard regression analysis was used to determine the effects cholecystectomy have on the risks of developing CRC, as shown by Hazard Ratios (HRs) with 95% confidence intervals (CIs). Results The incidence rate of CRC among IBD patients who had undergone a cholecystectomy (n = 525) was 1.75 per 1,000 person-years, compared to 1.41 per 1,000 person-years among IBD patients who had not had a cholecystectomy (n = 525). The adjusted HRs for CRC was found to be 0.76 (95% CI 0.25-2.32) for IBD patients having received a cholecystectomy, after adjusting for age, gender, and comorbidities. By type of IBD, neither ulcerative colitis nor Crohns diseases are associated with CRC after a cholecystectomy adjusted HR (2.78 [95% CI 0.54-14.3]) and (0.13 [95% CI 0.01-1.49]). Conclusion In Taiwan, cholecystectomies are not associated with a risk of CRC in patients with IBD.	[Peng, Yen-Chun] Taichung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan; [Peng, Yen-Chun] Natl Yang Ming Univ, Taipei, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan.	sungfc2016@gmail.com		Peng, Yen-Chun/0000-0002-8993-3039	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	ADAMI HO, 1987, BRIT J SURG, V74, P675, DOI 10.1002/bjs.1800740807; Baars JE, 2011, AM J GASTROENTEROL, V106, P319, DOI 10.1038/ajg.2010.428; Beger HG, 2003, SURG ENDOSC, V17, P342, DOI 10.1007/s00464-002-8553-z; Chen YK, 2014, J GASTROENTEROL, V49, P923, DOI 10.1007/s00535-013-0846-6; Coats M, 2015, WORLD J GASTROENTERO, V21, P3679, DOI 10.3748/wjg.v21.i12.3679; EKBOM A, 1993, GASTROENTEROLOGY, V105, P142, DOI 10.1016/0016-5085(93)90019-9; Goldacre MJ, 2005, BRIT J CANCER, V92, P1307, DOI 10.1038/sj.bjc.6602392; Lagergren J, 2001, GASTROENTEROLOGY, V121, P542, DOI 10.1053/gast.2001.27083; Lin JM, 2012, J CROHNS COLITIS, V6, P895, DOI 10.1016/j.crohns.2012.02.002; Navaneethan U, 2013, J CROHNS COLITIS, V7, pE164, DOI 10.1016/j.crohns.2012.07.032; NIELSEN GP, 1991, AM J GASTROENTEROL, V86, P1486; Nogueira L, 2014, AM J EPIDEMIOL, V179, P731, DOI 10.1093/aje/kwt322; Potack J, 2008, GUT LIVER, V2, P61, DOI 10.5009/gnl.2008.2.2.61; Schernhammer ES, 2003, BRIT J CANCER, V88, P79, DOI 10.1038/sj.bjc.6600661; Sebastian S, 2014, J CROHNS COLITIS, V8, P5, DOI 10.1016/j.crohns.2013.04.008; Shang J, 2016, INT J COLORECTAL DIS; Shao T, 2005, AM J GASTROENTEROL, V100, P1813, DOI 10.1111/j.1572-0241.2005.41610.x; Vinikoor LC, 2007, CANCER EPIDEM BIOMAR, V16, P1523, DOI 10.1158/1055-9965.EPI-07-0243; Zhang FM, 2015, J DIGEST DIS, V16, P634, DOI 10.1111/1751-2980.12286	19	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177745	10.1371/journal.pone.0177745	http://dx.doi.org/10.1371/journal.pone.0177745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28549071	Green Submitted, gold, Green Published			2022-12-26	WOS:000402063000013
J	Borena, W; Hofer, T; Stiasny, K; Aberle, SW; Gaber, M; Von Laer, D; Schennach, H				Borena, Wegene; Hofer, Tamara; Stiasny, Karin; Aberle, Stephan W.; Gaber, Manfred; Von Laer, Dorothee; Schennach, Harald			No molecular or serological evidence of Zikavirus infection among healthy blood donors living in or travelling to regions where Aedes albopictus circulates	PLOS ONE			English	Article							ZIKA VIRUS; MOSQUITOS	Background Previous studies have shown that Zika virus can infect and be transmitted by A. albopictus. The World Health organization (WHO) has raised concerns of autochthonous transmission of the virus in regions where the vector is endemic. The aim of this pilot study was to assess the occurrence of Zika virus (ZIKV) in western Austria (Tyrol) especially after a history of travel to A. albopictus endemic regions. Methods The study participants were healthy blood donors at randomly selected donation sites in the west Austrian region Tyrol. Rest blood (plasma) samples were tested for the presence of ZIKV nucleic acid and antibodies against the virus. Results Mean age of the study participants was 44.6 (SD = 12.9) and 58.8% were men. Eighty percent reported to have received vaccine against TBEV, whereas only 4.9 and 0.9% had received YFV and JEV vaccines. Three out of 1001 (0.03%) participants tested positive solely for ZIKV IgM antibody but not for other flaviviruses. Only one individual had ZIKV IgG antibody. All four donors were negative in the neutralization (confirmation) assay. No viral RNA was detected in any of the samples. Conclusion The null finding of our study refutes WHO's initial fear of global expansion of ZIKV infection including its occurrence in Europe. There appears to be no urgent need to introduce universal screening of donated blood for ZIKV in central Europe at least until the next warm season. Further, Euroimmun anti-Zika ELISA proved to be a highly suitable and reliable test system in populations with high prevalence of TBEV infection and/or immunization.	[Borena, Wegene; Hofer, Tamara; Von Laer, Dorothee] Med Univ Innsbruck, Div Virol, Innsbruck, Austria; [Stiasny, Karin; Aberle, Stephan W.] Med Univ Vienna, Ctr Virol, Vienna, Austria; [Gaber, Manfred] Tyrolean Red Cross Blood Donor Serv, Innsbruck, Austria; [Schennach, Harald] Med Univ Hosp Innsbruck, Cent Inst Blood Transfus & Immunol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Innsbruck	Borena, W (corresponding author), Med Univ Innsbruck, Div Virol, Innsbruck, Austria.	wegene.borena@i-med.ac.at		Stiasny, Karin/0000-0002-1902-8674; von Laer, Dorothee/0000-0001-5825-7237; Borena, Wegene/0000-0001-8011-5825	MFF Tirol [271]	MFF Tirol	Support was provided by MFF Tirol, project Nr. 271. The fund provided was used to buy test kits.	Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664; [Anonymous], WHO DIR GEN SUMM OUT; Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Gallian P, 2016, BLOOD; Gulland A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2887; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Huzly D, 2016, EURO SURVEILL, V21; Kunze U, 2015, CENT EUR J PUBL HEAL, V23, P223; Lupton Kelly, 2016, Br J Nurs, V25, P200, DOI 10.12968/bjon.2016.25.4.198; Musso D, 2014, EURO SURVEILL, V19; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Stiasny K, 2013, EURO SURVEILL, V18; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348	17	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178175	10.1371/journal.pone.0178175	http://dx.doi.org/10.1371/journal.pone.0178175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542611	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500069
J	Teixeira, AD; Games, PD; Katz, BB; Tomich, JM; Zanuncio, JAC; Serrao, JE				Teixeira, Aparecida das Dores; Games, Patricia D.; Katz, Benjamin B.; Tomich, John M.; Zanuncio, Jose A. C.; Serrao, Jose Eduardo			Proteomic analysis in the Dufour's gland of Africanized Apis mellifera workers (Hymenoptera: Apidae)	PLOS ONE			English	Article							BOMBUS-TERRESTRIS L-(HYMENOPTERA; OXIDATIVE STRESS-RESPONSE; ODORANT-BINDING PROTEINS; HONEY-BEE; PHEROMONE BINDING; ARGININE KINASE; QUEEN-SIGNAL; EXPRESSION; CERANA; CASTE	The colony of eusocial bee Apis mellifera has a reproductive queen and sterile workers performing tasks such as brood care and foraging. Chemical communication plays a crucial role in the maintenance of sociability in bees with many compounds released by the exocrine glands. The Dufour's gland is a non-paired gland associated with the sting apparatus with important functions in the communication between members of the colony, releasing volatile chemicals that influence workers roles and tasks. However, the protein content in this gland is not well studied. This study identified differentially expressed proteins in the Dufour's glands of nurse and forager workers of A. mellifera through 2D-gel electrophoresis and mass spectrometry. A total of 131 spots showed different expression between nurse and forager bees, and 28 proteins were identified. The identified proteins were categorized into different functions groups including protein, carbohydrate, energy and lipid metabolisms, cytoskeleton-associated proteins, detoxification, homeostasis, cell communication, constitutive and allergen. This study provides new insights of the protein content in the Dufour's gland contributing to a more complete understanding of the biological functions of this gland in honeybees.	[Teixeira, Aparecida das Dores; Games, Patricia D.; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Katz, Benjamin B.; Tomich, John M.] Kansas State Univ, Biotechnol Core Facil, Manhattan, KS 66506 USA; [Katz, Benjamin B.; Tomich, John M.] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Zanuncio, Jose A. C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Kansas State University; Kansas State University; Universidade Federal de Vicosa	Serrao, JE (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jeserrao@ufv.br		Games, Patricia/0000-0001-7603-2816; TOMICH, JOHN/0000-0001-7848-8307; Serrao, Jose Eduardo/0000-0002-0477-4252	Brazilian research agencies CNPq; FAPEMIG	Brazilian research agencies CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Brazilian research agencies CNPq and FAPEMIG. These funder supplied grants for usage in reagents. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla FC, 2006, REV BRAS ENTOMOL, V50, P153, DOI 10.1590/S0085-56262006000200002; Abdalla Fabio Camargo, 2001, Revista Brasileira de Entomologia, V45, P123; Abdalla FC, 2004, J BRAZIL CHEM SOC, V15, P621, DOI 10.1590/S0103-50532004000500002; Abdalla FC, 1999, NETH J ZOOL, V49, P139, DOI 10.1163/156854299505650; Abdalla FC, 2004, ACTA HISTOCHEM CYTOC, V37, P65, DOI 10.1267/ahc.37.65; Abdalla FC, 1999, NETH J ZOOL, V49, P251, DOI 10.1163/156854299505722; Abdalla FC, 2004, REV BRAS ENTOMOL, V48, P1; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Amsalem E, 2009, P R SOC B, V276, P1295, DOI 10.1098/rspb.2008.1688; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; BARROWS EM, 1986, J KANSAS ENTOMOL SOC, V59, P480; Blatt J, 2001, J EXP BIOL, V204, P2709; Blomquist G. J., 2012, INSECT ENDOCRINOLOGY, P523; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Bonckaert W, 2012, J CHEM ECOL, V38, P42, DOI 10.1007/s10886-011-0055-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen XB, 2015, CELL STRESS CHAPERON, V20, P169, DOI 10.1007/s12192-014-0535-2; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cruz-Landim C., 1996, ANAIS SEGUNDO ENCONT, V2, P67; DOUMEN C, 1990, J COMP PHYSIOL B, V160, P449, DOI 10.1007/BF01075677; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Elekonich MM, 2009, CELL STRESS CHAPERON, V14, P219, DOI 10.1007/s12192-008-0063-z; Elias-Santos D, 2013, APIDOLOGIE, V44, P684, DOI 10.1007/s13592-013-0217-6; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Erban T, 2014, APIDOLOGIE, V45, P53, DOI 10.1007/s13592-013-0230-9; Esteves FG, 2017, J PROTEOMICS, V151, P122, DOI 10.1016/j.jprot.2016.01.009; Falcon T, 2014, INSECT BIOCHEM MOLEC, V50, P68, DOI 10.1016/j.ibmb.2014.04.006; Fang Y, 2014, MOL CELL PROTEOMICS, V13, P2306, DOI 10.1074/mcp.M114.037846; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Fruttero LL, 2014, INSECT BIOCHEM MOLEC, V52, P1, DOI 10.1016/j.ibmb.2014.06.002; Garcia L, 2009, J PROTEOME RES, V8, P1464, DOI 10.1021/pr800823r; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; GMEINBAUER R, 1993, J INSECT PHYSIOL, V39, P959, DOI 10.1016/0022-1910(93)90005-C; Grimaldi David, 2005, pi; Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Hrassnigg N, 2003, AMINO ACIDS, V24, P205, DOI 10.1007/s00726-002-0311-y; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Katzav-Gozansky T, 2004, P ROY SOC B-BIOL SCI, V271, P2065, DOI 10.1098/rspb.2004.2839; Katzav-Gozansky T, 2003, INSECT SOC, V50, P20, DOI 10.1007/s000400300003; Katzav-Gozansky T, 2002, APIDOLOGIE, V33, P525, DOI 10.1051/apido:2002035; Katzav-Gozansky T, 2000, J INSECT PHYSIOL, V46, P993, DOI 10.1016/S0022-1910(99)00209-7; Katzav-Gozansky T, 2007, NATURWISSENSCHAFTEN, V94, P407, DOI 10.1007/s00114-006-0206-y; Kim BY, 2014, J ASIA-PAC ENTOMOL, V17, P695, DOI 10.1016/j.aspen.2014.07.002; Konus M, 2013, COMP BIOCHEM PHYS D, V8, P152, DOI 10.1016/j.cbd.2013.04.001; Krishna SH, 2002, CATAL REV, V44, P499, DOI 10.1081/CR-120015481; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Lattorff HMG, 2013, TRENDS GENET, V29, P641, DOI 10.1016/j.tig.2013.08.002; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Li JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013455; Malka O, 2008, NATURWISSENSCHAFTEN, V95, P553, DOI 10.1007/s00114-008-0358-z; Martin SJ, 2005, APIDOLOGIE, V36, P543, DOI 10.1051/apido:2005041; Martin SJ, 2004, NATURWISSENSCHAFTEN, V91, P232, DOI 10.1007/s00114-004-0517-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Michener CD, 1974, SOCIAL BEHAV BEES; MINGARRO I, 1995, FEBS LETT, V372, P131, DOI 10.1016/0014-5793(95)00964-B; Mitra A, 2013, J HYMENOPT RES, V35, P33, DOI 10.3897/JHR.35.4783; Mitra A, 2011, J INSECT PHYSIOL, V57, P280, DOI 10.1016/j.jinsphys.2010.11.014; Miura E, 2007, PLANT CELL, V19, P1313, DOI 10.1105/tpc.106.049270; MUNNEKE LR, 1988, BIOCHEM GENET, V26, P131, DOI 10.1007/BF00555494; Nelson DL, 2014, PRINCIPIOS BIOQUIRNI; NICHOL H, 1990, TISSUE CELL, V22, P767, DOI 10.1016/0040-8166(90)90042-8; PAGE RE, 1981, ENVIRON ENTOMOL, V10, P359, DOI 10.1093/ee/10.3.359; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; PICKETT JA, 1982, J CHEM ECOL, V8, P163, DOI 10.1007/BF00984013; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; Roat TC, 2014, ECOTOXICOLOGY, V23, P1659, DOI 10.1007/s10646-014-1305-8; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schwaighofer A, 2014, BIOCHEM BIOPH RES CO, V446, P1042, DOI 10.1016/j.bbrc.2014.03.054; SEVERSON DW, 1990, EXPERIENTIA, V46, P737, DOI 10.1007/BF01939951; Tan K, 2015, J INSECT PHYSIOL, V82, P33, DOI 10.1016/j.jinsphys.2015.08.003; Van der Horst DJ, 2009, MOL CELL BIOCHEM, V326, P105, DOI 10.1007/s11010-008-0011-3; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Winston M., 1987, The biology of the honey bee.; Wolschin F, 2007, ANAL BIOANAL CHEM, V389, P1095, DOI 10.1007/s00216-007-1523-5; Woyciechowski M, 2012, CURR BIOL, V22, P707, DOI 10.1016/j.cub.2012.02.063; Yan HR, 2013, CELL STRESS CHAPERON, V18, P415, DOI 10.1007/s12192-012-0394-7; Yao PB, 2014, FREE RADICAL BIO MED, V68, P335, DOI 10.1016/j.freeradbiomed.2013.12.020; Yao PB, 2013, J INSECT PHYSIOL, V59, P273, DOI 10.1016/j.jinsphys.2012.11.005; Zheng AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020428; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	86	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177415	10.1371/journal.pone.0177415	http://dx.doi.org/10.1371/journal.pone.0177415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542566	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500023
J	Ball, JP; Springer, MJ; Ni, YW; Finger-Baker, I; Martinez, J; Hahn, J; Suber, JF; DiMarco, AV; Talton, JD; Cobb, RR				Ball, Jordan P.; Springer, Michael J.; Ni, Yawei; Finger-Baker, Isaac; Martinez, Juan; Hahn, Jessica; Suber, John F.; DiMarco, Ashley V.; Talton, James D.; Cobb, Ronald R.			Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder	PLOS ONE			English	Article							BLOOD GROUP ANTIGENS; VIRUS-LIKE PARTICLES; CELLULAR IMMUNE-RESPONSES; FOOD-RELATED ILLNESS; UNITED-STATES; ANTIBODY-RESPONSE; NORWALK; MUCOSAL; GASTROENTERITIS; PROTECTION	The global health community is beginning to understand the burden of norovirus-associated disease, which has a significant impact in both developed and developing countries. Norovirus virus like particle (VLP)-based vaccines are currently under development and have been shown to elicit systemic and mucosal immune responses when delivered intranasally. In the present study, we describe the use of a dry powder formulation (GelVac (TM)) with an in situ gelling polysaccharide (GelSite (TM)) extracted from Aloe vera for nasal delivery of a bivalent vaccine formulation containing both GI and GII. 4 norovirus VLPs. Dose-ranging studies were performed to identify the optimal antigen dosages based on systemic and mucosal immune responses in guinea pigs and determine any antigenic interference. A dose-dependent increase in systemic and mucosal immunogenicity against each of the VLPs were observed as well as a boosting effect for each VLP after the second dosing. A total antigen dose of >= 50 mu g of each GI and GII. 4 VLPs was determined to be the maximally immunogenic dose in guinea pigs. The immunogenicity results of this bivalent formulation, taken together with previous work on monovalent GelVac (TM) norovirus vaccine formulation, provides a basis for future development of this norovirus VLP vaccine.	[Ball, Jordan P.; Springer, Michael J.; Ni, Yawei; Finger-Baker, Isaac; Martinez, Juan; Hahn, Jessica; Suber, John F.; DiMarco, Ashley V.; Talton, James D.; Cobb, Ronald R.] Nanotherapeut Inc, Res & Dev Dept, Alachua, FL 32615 USA		Cobb, RR (corresponding author), Nanotherapeut Inc, Res & Dev Dept, Alachua, FL 32615 USA.	rcobb@nanotherapeutics.com		Talton, James/0000-0002-4310-661X	National Institutes of Allergy and Infectious Disease [4R44AI094919-03]; Nanotherapeutics, Inc.	National Institutes of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nanotherapeutics, Inc.	This research was funded by a grant from the National Institutes of Allergy and Infectious Disease (4R44AI094919-03). The authors would also like to thank Nanotherapeutics, Inc. for their continued support of this research. The funder provided support in the form of salaries for authors [JPB, MJS, YN, IFB, JM, JH, JFS, AVD, JDT and RRC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Atmar RL, 2015, CLIN VACCINE IMMUNOL, V22, P923, DOI 10.1128/CVI.00196-15; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; CAUL EO, 1994, LANCET, V343, P1240, DOI 10.1016/S0140-6736(94)92146-6; Czako R, 2015, CLIN VACCINE IMMUNOL, V22, P221, DOI 10.1128/CVI.00516-14; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Harrington PR, 2002, J VIROL, V76, P12335, DOI 10.1128/JVI.76.23.12335-12343.2002; Hedberg C, 1999, EMERG INFECT DIS, V5, P840, DOI 10.3201/eid0506.990624; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; JOHNSON PC, 1990, J INFECT DIS, V161, P18, DOI 10.1093/infdis/161.1.18; Jones MK, 2015, NAT PROTOC, V10, P1939, DOI 10.1038/nprot.2015.121; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kirk MD, 2008, CLIN INFECT DIS, V47, P392, DOI 10.1086/589861; Kocher J, 2014, J VIROL, V88, P9728, DOI 10.1128/JVI.01249-14; Kowalzik F, 2015, PEDIATR INFECT DIS J, V34, P229, DOI 10.1097/INF.0000000000000546; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807; Lindesmith LC, 2013, J VIROL, V87, P2803, DOI 10.1128/JVI.03106-12; Lindesmith LC, 2012, J VIROL, V86, P873, DOI 10.1128/JVI.06200-11; Lindesmith LC, 2010, J VIROL, V84, P1800, DOI 10.1128/JVI.02179-09; LoBue AD, 2006, VACCINE, V24, P5220, DOI 10.1016/j.vaccine.2006.03.080; Lobue AD, 2009, J VIROL, V83, P3212, DOI 10.1128/JVI.01650-08; Malm M, 2015, J CLIN CELL IMMUNOL, V6, P284, DOI [10.4172/2155-9899.1000284, DOI 10.4172/2155-9899.1000284]; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Mead PS, 1999, EMERG INFECT DIS, V5, P841, DOI 10.3201/eid0506.990625; Siqueira JAM, 2012, DIAGN MICR INFEC DIS, V73, P101, DOI 10.1016/j.diagmicrobio.2012.02.006; Moore MD, 2015, ANNU REV FOOD SCI T, V6, P411, DOI 10.1146/annurev-food-022814-015643; Parker TD, 2005, J VIROL, V79, P7402, DOI 10.1128/JVI.79.12.7402-7409.2005; Parra GI, 2012, VACCINE, V30, P3580, DOI 10.1016/j.vaccine.2012.03.050; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Plotkin SA, 2008, VACCINES, pxvii; Ramani S, 2015, J INFECT DIS, V212, P397, DOI 10.1093/infdis/jiv053; Reeck A, 2010, J INFECT DIS, V202, P1212, DOI 10.1086/656364; Singh BK, 2015, J VIROL, V89, P2024, DOI 10.1128/JVI.02968-14; Springer MJ, 2016, VACCINE, V34, P1452, DOI 10.1016/j.vaccine.2016.01.064; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Tamminen K, 2016, VIRAL IMMUNOL, V29, P315, DOI 10.1089/vim.2015.0141; Tamminen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070409; Treanor JJ, 2014, J INFECT DIS, V210, P1763, DOI 10.1093/infdis/jiu337; Trivedi TK, 2012, JAMA-J AM MED ASSOC, V308, P1668, DOI 10.1001/jama.2012.14023; Vega E, 2014, J CLIN MICROBIOL, V52, P147, DOI 10.1128/JCM.02680-13; Velasquez LS, 2011, VACCINE, V29, P5221, DOI 10.1016/j.vaccine.2011.05.027; Velasquez LS, 2010, CLIN VACCINE IMMUNOL, V17, P1850, DOI 10.1128/CVI.00230-10; Verhoef L, 2015, EMERG INFECT DIS, V21, P592, DOI 10.3201/eid2104.141073; Wang XL, 2015, VACCINE, V33, P5779, DOI 10.1016/j.vaccine.2015.09.043; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	54	14	16	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177310	10.1371/journal.pone.0177310	http://dx.doi.org/10.1371/journal.pone.0177310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545100	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400035
J	Knytl, M; Smolik, O; Kubickova, S; Tlapakova, T; Evans, BJ; Krylov, V				Knytl, Martin; Smolik, Ondrej; Kubickova, Svatava; Tlapakova, Tereza; Evans, Ben J.; Krylov, Vladimir			Chromosome divergence during evolution of the tetraploid clawed frogs, Xenopus mellotropicalis and Xenopus epitropicalis as revealed by Zoo-FISH	PLOS ONE			English	Article							KARYOTYPE ANALYSIS; TROPICALIS GRAY; ANURA; GENES; REARRANGEMENTS; MECHANISMS; FISCHBERG; LAEVIS	Whole genome duplication (WGD) generates new species and genomic redundancy. In African clawed frogs of the genus Xenopus, this phenomenon has been especially important in that (i) all but one extant species are polyploid and (ii) whole genome sequences of some species provide an evidence for genomic rearrangements prior to or after WGD. Within Xenopus in the subgenus Silurana, at least one allotetraploidization event gave rise to three extant tetraploid (2n = 4x = 40) species-Xenopus mellotropicalis, X. epitropicalis, and X. cal-caratus -but it is not yet clear the degree to which these tetraploid genomes experienced rearrangements prior to or after allotetraploidization. To explore genome evolution during diversification of these species, we performed cytogenetic analyses of X. mellotropicalis, including assessment of the localization of nucleolar organizer region, chromosome banding, and determination of the p/q arm ratios for each chromosome pair. We compared these data to a previously characterized karyotype of X. epitropicalis. Morphometric, C-banding and Zoo-FISH data support a previously hypothesized common allotetraploid predecessor of these species. Zoo-FISH with whole chromosome painting (WCP) probes derived from the closely related diploid species X. tropicalis confirmed the existence of ten chromosomal quartets in X. mellotropicalis somatic cells, as expected by its ploidy level and tetraploid ancestry. The p/q arm ratio of chromosome 2a was found to be substantially different between X. mellotropicalis (0.81) and X. epitropicalis (0.67), but no substantial difference between these two species was detected in this ratio for the homoeologous chromosome pair 2b, or for other chromosome pairs. Additionally, we identified variation between these two species in the locations of a heterochromatic block on chromosome pair 2a. These results are consistent with a dynamic history of genomic rearrangements before and/or after genome duplication, a surprising finding given the otherwise relatively conserved genomic structure of most frogs.	[Knytl, Martin; Smolik, Ondrej; Tlapakova, Tereza; Krylov, Vladimir] Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic; [Kubickova, Svatava] CEITEC Vet Res Inst, Dept Genet & Reprod, Brno, Czech Republic; [Evans, Ben J.] Mc Master Univ, Dept Biol, Life Sci Bldg,Room 328, Hamilton, ON, Canada	Charles University Prague; McMaster University	Knytl, M (corresponding author), Charles Univ Prague, Dept Cell Biol, Fac Sci, Prague, Czech Republic.	martin.knytl@natur.cuni.cz	Kubickova, Svatava/GZL-5927-2022; Smolik, Ondrej/AAL-7085-2020; Krylov, Vladimir/A-2369-2014; Smolik, Ondrej/L-2360-2017; Tlapakova, Tereza/F-8553-2016; Knytl, Martin/V-7793-2017	Kubickova, Svatava/0000-0002-1006-9453; Krylov, Vladimir/0000-0001-8678-7155; Smolik, Ondrej/0000-0003-1250-2684; Tlapakova, Tereza/0000-0001-8841-1573; Knytl, Martin/0000-0002-6325-6957; Evans, Ben/0000-0002-9512-8845	Charles University program UNCE [204013]; Charles University program PRVOUK P41 [20504151]; Charles University program SVV [244-260435]; Ministry of Youth, Education and Sports of the Czech Republic project CEITEC [LQ1601]	Charles University program UNCE; Charles University program PRVOUK P41; Charles University program SVV; Ministry of Youth, Education and Sports of the Czech Republic project CEITEC	The research was funded by the Charles University programs UNCE, PRVOUK P41 and SVV [grant no. 204013, 20504151 and 244-260435, respectively, to M.K., O.S., T.T., V.K.] and by the Ministry of Youth, Education and Sports of the Czech Republic project CEITEC 2020 [grant no. LQ1601 to S.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Bi K, 2006, CYTOGENET GENOME RES, V112, P307, DOI 10.1159/000089885; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chenuil A, 1999, HEREDITY, V82, P373, DOI 10.1038/sj.hdy.6884890; Daudin FM, 1802, AN XI HISTOIRE NATUR; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Evans BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142823; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Fischberg M., 1982, Alytes (Paris), V1, P53; Gray J.E., 1864, ANN MAG NAT HIST, V14, P315; JOTTERAN.M, 1974, EXPERIENTIA, V30, P1003, DOI 10.1007/BF01938973; KAHN J, 1962, Q J MICROSC SCI, V103, P407; Khokha MK, 2009, DEV DYNAM, V238, P1398, DOI 10.1002/dvdy.21965; Krylov V, 2010, CHROMOSOME RES, V18, P431, DOI 10.1007/s10577-010-9127-x; Kubickova S, 2002, CHROMOSOME RES, V10, P571, DOI 10.1023/A:1020914702767; Liu SJ, 2010, SCI CHINA LIFE SCI, V53, P416, DOI 10.1007/s11427-010-0057-9; Martins C, 1999, CHROMOSOME RES, V7, P363, DOI 10.1023/A:1009216030316; Morishima K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093302; NAITO E, 1992, J FORENSIC SCI, V37, P396; PARDUE ML, 1973, COLD SPRING HARB SYM, V38, P475, DOI 10.1101/SQB.1974.038.01.051; Parker HW, 1936, ANN MAG NAT HIST, V10, P594; Peters W.C.H., 1844, MONATSBERICHT KONIGL, V1844, P32; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; SCHMID M, 1991, CHROMOSOMA, V101, P123, DOI 10.1007/BF00357062; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Seifertova E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-357; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Sinzelle L, 2012, GENESIS, V50, P316, DOI 10.1002/dvg.20822; Song C, 2012, SCI CHINA LIFE SCI, V55, P301, DOI 10.1007/s11427-012-4310-2; Toledo LFA., 2015, FISH CYTOGENETIC TEC, P92, DOI DOI 10.1201/618534-15; TYMOWSKA J, 1973, CYTOGENET CELL GENET, V12, P297, DOI 10.1159/000130468; TYMOWSKA J, 1977, CYTOGENET CELL GENET, V19, P344, DOI 10.1159/000130828; TYMOWSKA J, 1980, CYTOGENET CELL GENET, V27, P39, DOI 10.1159/000131462; TYMOWSKA J, 1972, CYTOGENETICS, V11, P270, DOI 10.1159/000130197; TYMOWSKA J, 1982, CYTOGENET CELL GENET, V34, P149, DOI 10.1159/000131803; Tymowska J., 1991, P259; TYMOWSKA J, 1973, CHROMOSOMA, V44, P335, DOI 10.1007/BF00291027; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Wagler J., 1827, ISIS OKEN, V20, P726	42	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177087	10.1371/journal.pone.0177087	http://dx.doi.org/10.1371/journal.pone.0177087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545147	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400022
J	Koski, M; Boutorh, J; de la Rocha, C				Koski, Marja; Boutorh, Julia; de la Rocha, Christina			Feeding on dispersed vs. aggregated particles: The effect of zooplankton feeding behavior on vertical flux	PLOS ONE			English	Article							COPEPOD ACARTIA-TONSA; OCEANS TWILIGHT ZONE; SUB-ARCTIC PACIFIC; MARINE SNOW; FECAL PELLETS; PLANKTONIC COPEPOD; RESPIRATION RATES; NORTHEAST PACIFIC; CALANOID COPEPODS; SEASONAL PATTERNS	Zooplankton feeding activity is hypothesized to attenuate the downward flux of elements in the ocean. We investigated whether the zooplankton community composition could influence the flux attenuation, due to the differences of feeding modes (feeding on dispersed vs. aggregated particles) and of metabolic rates. We fed 5 copepod species-three calanoid, one harpacticoid and one poecilamastoid-microplankton food, in either dispersed or aggregated form and measured rates of respiration, fecal pellet production and egg production. Calanoid copepods were able to feed only on dispersed food; when their food was introduced as aggregates, their pellet production and respiration rates decreased to rates observed for starved individuals. In contrast, harpacticoids and the poecilamastoid copepod Oncaea spp. were able to feed only when the food was in the form of aggregates. The sum of copepod respiration, pellet production and egg production rates was equivalent to a daily minimum carbon demand of ca. 10% body weight-(1) for all non-feeding copepods; the carbon demand of calanoids feeding on dispersed food was 2-3 times greater, and the carbon demand of harpacticoids and Oncaea spp. feeding on aggregates was >7 times greater, than the resting rates. The zooplankton species composition combined with the type of available food strongly influences the calculated carbon demand of a copepod community, and thus also the attenuation of vertical carbon flux.	[Koski, Marja] Tech Univ Denmark, Natl Inst Aquat Resources, Bldg 202, Lyngby, Denmark; [Boutorh, Julia; de la Rocha, Christina] Univ Bretagne Occidentale, CNRS UMR 6539, Inst Univ Europeen Mer, Technopole Brest Iroise, Pl Nicholas Copernic, Plouzane, France	Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Koski, M (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Bldg 202, Lyngby, Denmark.	mak@aqua.dtu.dk		Koski, Marja/0000-0002-1860-9768	European Community [261520, 264933]; Danish Strategic Research Council	European Community(European Commission); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF))	This research was supported by the European Community's 7th Framework Programme's Integrating Activity HYDRALAB IV (No. 261520), Integrating Project EURO-BASIN (No. 264933) and Danish Strategic Research Council project NAACOS (North Atlantic - Arctic coupling in a changing climate: impacts on ocean circulation, carbon cycling and sea-ice).	ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; ALLDREDGE AL, 1972, SCIENCE, V177, P885, DOI 10.1126/science.177.4052.885; Arendt KE, 2013, J PLANKTON RES, V35, P105, DOI 10.1093/plankt/fbs087; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Besiktepe S, 2002, MAR ECOL PROG SER, V229, P151, DOI 10.3354/meps229151; BOCHDANSKY AB, 1992, MAR ECOL PROG SER, V87, P135, DOI 10.3354/meps087135; BOTTGERSCHNACK R, 1995, MAR ECOL PROG SER, V118, P81, DOI 10.3354/meps118081; BRETELER WCMK, 1982, NETH J SEA RES, V16, P195, DOI 10.1016/0077-7579(82)90030-8; BROEKHUIZEN N, 1995, MAR ECOL PROG SER, V118, P103, DOI 10.3354/meps118103; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Burd AB, 2010, DEEP-SEA RES PT II, V57, P1557, DOI 10.1016/j.dsr2.2010.02.022; BUTLER M, 1994, MAR ECOL PROG SER, V114, P81, DOI 10.3354/meps114081; Castellani C, 2005, MAR ECOL PROG SER, V285, P129, DOI 10.3354/meps285129; DAGG M, 1993, DEEP-SEA RES PT I, V40, P1431, DOI 10.1016/0967-0637(93)90121-I; Dilling L, 1998, MAR ECOL PROG SER, V170, P189, DOI 10.3354/meps170189; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; Feinberg LR, 1998, MAR ECOL PROG SER, V175, P87, DOI 10.3354/meps175087; GAUDY R, 1975, MAR BIOL, V29, P109, DOI 10.1007/BF00388982; Giering SLC, 2016, J GEOPHYS RES-OCEANS, V121, P6929, DOI 10.1002/2016JC012048; Giering SLC, 2014, NATURE, V507, P480, DOI 10.1038/nature13123; Green EP, 1997, J PLANKTON RES, V19, P435, DOI 10.1093/plankt/19.4.435; Halsband C, 2001, MAR ECOL PROG SER, V209, P219, DOI 10.3354/meps209219; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hansen B, 1996, J PLANKTON RES, V18, P275, DOI 10.1093/plankt/18.2.275; Hays GC, 1995, LIMNOL OCEANOGR, V40, P1461, DOI 10.4319/lo.1995.40.8.1461; HERMAN PMJ, 1983, J EXP MAR BIOL ECOL, V71, P249, DOI 10.1016/0022-0981(83)90118-1; Huskin I, 2000, J EXP MAR BIOL ECOL, V248, P239, DOI 10.1016/S0022-0981(00)00167-2; Ikeda T, 2001, MAR BIOL, V139, P587, DOI 10.1007/s002270100608; Ikeda T, 2007, MAR ECOL PROG SER, V339, P215, DOI 10.3354/meps339215; Iversen MH, 2010, BIOGEOSCIENCES, V7, P2613, DOI 10.5194/bg-7-2613-2010; JACKSON GA, 1993, LIMNOL OCEANOGR, V38, P1328, DOI 10.4319/lo.1993.38.6.1328; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jakobsen HH, 2016, LIMNOL OCEANOGR, V61, P1853, DOI 10.1002/lno.10338; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T, 2000, LIMNOL OCEANOGR, V45, P479, DOI 10.4319/lo.2000.45.2.0479; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Koski M, 2005, LIMNOL OCEANOGR, V50, P1254, DOI 10.4319/lo.2005.50.4.1254; LEE WY, 1985, MAR ECOL PROG SER, V24, P273; Lo WT, 2004, J PLANKTON RES, V26, P88, DOI 10.1093/plankt/fbh004; Lombard F, 2013, LIMNOL OCEANOGR, V58, P185, DOI 10.4319/lo.2013.58.1.0185; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Moller EF, 2011, MAR BIOL, V158, P677, DOI 10.1007/s00227-010-1591-5; Nishibe Y, 2008, MAR BIOL, V153, P397, DOI 10.1007/s00227-007-0816-8; PAFFENHOFER GA, 1982, MAR BIOL, V67, P193, DOI 10.1007/BF00401285; Paffenhofer GA, 2003, J PLANKTON RES, V25, P1139, DOI 10.1093/plankt/25.9.1139; Paffenhofer GA, 2006, MAR ECOL PROG SER, V317, P187, DOI 10.3354/meps317187; PAGANO M, 1993, ESTUAR COAST SHELF S, V37, P251, DOI 10.1006/ecss.1993.1055; Pankoke LM, 2012, THESIS; Ploug H, 2008, LIMNOL OCEANOGR, V53, P469, DOI 10.4319/lo.2008.53.2.0469; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; SHANKS AL, 1989, MAR BIOL, V101, P463, DOI 10.1007/BF00541648; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; STEINBERG DK, 1994, LIMNOL OCEANOGR, V39, P1606, DOI 10.4319/lo.1994.39.7.1606; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; Stukel MR, 2011, LIMNOL OCEANOGR, V56, P1866, DOI 10.4319/lo.2011.56.5.1866; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Thor P, 2003, J EXP MAR BIOL ECOL, V283, P133, DOI 10.1016/S0022-0981(02)00473-2; Thor P, 2002, J EXP MAR BIOL ECOL, V272, P159, DOI 10.1016/S0022-0981(02)00131-4; Turner JT, 2004, ZOOL STUD, V43, P255; Wassmann P, 1998, HYDROBIOLOGIA, V363, P29; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wilson SE, 2013, LIMNOL OCEANOGR, V58, P881, DOI 10.4319/lo.2013.58.3.0881; Wilson SE, 2010, MAR ECOL PROG SER, V412, P11, DOI 10.3354/meps08648	65	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177958	10.1371/journal.pone.0177958	http://dx.doi.org/10.1371/journal.pone.0177958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545095	Green Published, gold			2022-12-26	WOS:000401487700100
J	Lalonde, S; Stone, OA; Lessard, S; Lavertu, A; Desjardins, J; Beaudoin, M; Rivas, M; Stainier, DYR; Lettre, G				Lalonde, Simon; Stone, Oliver A.; Lessard, Samuel; Lavertu, Adam; Desjardins, Jessica; Beaudoin, Melissa; Rivas, Manuel; Stainier, Didier Y. R.; Lettre, Guillaume			Frameshift indels introduced by genome editing can lead to in-frame exon skipping	PLOS ONE			English	Article							HUMAN FETAL; EXPRESSION; BINDING; CELLS	The introduction of frameshift indels by genome editing has emerged as a powerful technique to study the functions of uncharacterized genes in cell lines and model organisms. Such mutations should lead to mRNA degradation owing to nonsense-mediated mRNA decay or the production of severely truncated proteins. Here, we show that frameshift indels engineered by genome editing can also lead to skipping of "multiple of three nucleotides" exons. Such splicing events result in in-frame mRNA that may encode fully or partially functional proteins. We also characterize a segregating nonsense variant (rs2273865) located in a "multiple of three nucleotides" exon of LGALS8 that increases exon skipping in human erythroblast samples. Our results highlight the potentially frequent contribution of exonic splicing regulatory elements and are important for the interpretation of negative results in genome editing experiments. Moreover, they may contribute to a better annotation of loss-of-function mutations in the human genome.	[Lalonde, Simon; Lessard, Samuel; Desjardins, Jessica; Beaudoin, Melissa; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ, Canada; [Stone, Oliver A.; Stainier, Didier Y. R.] UCSF, Dept Biochem & Biophys, San Francisco, CA USA; [Stone, Oliver A.; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Lessard, Samuel; Lettre, Guillaume] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Lavertu, Adam; Rivas, Manuel] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	Universite de Montreal; University of California System; University of California San Francisco; Max Planck Society; Universite de Montreal; Stanford University	Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Lettre, G (corresponding author), Univ Montreal, Fac Med, Montreal, PQ, Canada.	guillaume.lettre@umontreal.ca	Stone, Oliver/O-2439-2018; Rivas, Manuel/ABE-8173-2020	Stone, Oliver/0000-0002-4695-4569; Rivas, Manuel/0000-0003-1457-9925; Stainier, Didier/0000-0002-0382-0026; Lavertu, Adam/0000-0003-2396-1915	NIH [HL54737]; Packard Foundation; Max Planck Society; Canadian Institutes of Health Research [136979, 123382]; Montreal Heart Institute Foundation; Canada Research Chair Program; NATIONAL LIBRARY OF MEDICINE [T32LM012409] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); Max Planck Society(Max Planck Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute Foundation; Canada Research Chair Program(Canada Research Chairs); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	D.Y.R.S. is funded by NIH (HL54737), Packard Foundation and Max Planck Society. G.L. is supported by grants from the Canadian Institutes of Health Research (operating grants #136979 and #123382), the Montreal Heart Institute Foundation, and the Canada Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoin M, 2015, ARTERIOSCL THROM VAS, V35, P1472, DOI 10.1161/ATVBAHA.115.305534; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charton K, 2016, HUM MOL GENET, V25, P4518, DOI 10.1093/hmg/ddw280; Fu XD, 2014, NAT REV GENET, V15, P689, DOI 10.1038/nrg3778; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Julien P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11558; Kapahnke M, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5040045; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lessard S, 2016, HUM MOL GENET, V25, P2082, DOI 10.1093/hmg/ddw055; Lessard S, 2015, GENOME MED, V7, DOI 10.1186/s13073-014-0122-2; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MAQUAT LE, 1995, RNA, V1, P453; Masiero M, 2013, CANCER CELL, V24, P229, DOI 10.1016/j.ccr.2013.06.004; McCarthy S, 2016, BIORXIV; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reischauer S, 2016, NATURE, V535, P294, DOI 10.1038/nature18614; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	27	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178700	10.1371/journal.pone.0178700	http://dx.doi.org/10.1371/journal.pone.0178700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570605	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800107
J	Zhan, XY; Guo, X; Liu, R; Hu, WK; Zhang, L; Xiang, N				Zhan, Xinyuan; Guo, Xin; Liu, Rong; Hu, Weikun; Zhang, Lei; Xiang, Nan			Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease	PLOS ONE			English	Article							NASOLACRIMAL DUCT; SILICONE STENTS; IN-VITRO; INTUBATION; MANAGEMENT; BIOCOMPATIBILITY; STENOSIS; MUCOSA; SYSTEM; VIVO	Lacrimal duct obstruction disease (LDOD) is a common ophthalmologic disease. Stent implantation surgery is one of the most effective therapies. In this study, we intended to find out the satisfactory biodegradable stents containing poly-L-lactic acid-polycaprolactone-polyethylene glycol (PLLA-PCL-PEG) complexes for therapeutic application in LDOD. Stents made of PLLA-PCL-PEG complexes in various ratios, were prepared and used in vitro to determine stents with appropriate mechanical properties and shorter range of biodegradation for study in vivo. Thirty-two rabbits were randomized into eight groups of four eyes each in advance for test in vivo. The selected stents were implanted into the left lacrimal ducts of 16 rabbits and silica gel stents as the control for the other 16 rabbits. At four points in time (1, 4, 10 and 16 weeks after the implantation), weight loss rate (WLR) of the stents was measured and analysed. To access the change of lacrimal duct, fluorescein excretion test, lacrimal duct endoscopy and histopathological testing were conducted. The stent containing PLLA: PCL6: 4+ 15%PEG was selected for study in vivo. Analysis of weight loss rate (WLR), fluorescein excretion test, lacrimal duct endoscopy and histopathological testing indicated that the selected stent was biodegradable and caused minimal stimulation and earlier tissue restoration in the lacrimal epithelium compared with the silica gel stent used as the control. The study results suggest that the PLLA: PCL6: 4+ 15% PEG stent is a satisfactory biodegradable stent as a promising alternative for therapeutic application in LDOD, which showed tissue compatibility, biodegradation and adequate mechanical intensity.	[Zhan, Xinyuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Anesthesiol, Wuhan, Peoples R China; [Guo, Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Puai Hosp, Dept Orthoped, Wuhan, Peoples R China; [Liu, Rong; Hu, Weikun; Xiang, Nan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan, Peoples R China; [Zhang, Lei] Huazhong Univ Sci & Technol, Coll Chem & Chem Engn, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, N (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan, Peoples R China.	hongnam2@vip.163.com			Natural Science Foundation Project of China [81501552]	Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC))	The research was supported by a grant from the Natural Science Foundation Project of China (No. 81501552).	ANDERSON RL, 1979, OPHTHALMOLOGY, V86, P1474; Angrist R C, 1985, Ophthalmic Plast Reconstr Surg, V1, P51, DOI 10.1097/00002341-198501000-00008; Charalampidou S, 2009, ORBIT, V28, P115, DOI 10.1080/01676830802674342; Choontanom Raveewan, 2010, J Med Assoc Thai, V93 Suppl 6, pS197; CONLON MR, 1994, CAN J OPHTHALMOL, V29, P3; De Castro DK, 2013, OPHTHAL PLAST RECONS, V29, P367, DOI 10.1097/IOP.0b013e31829a72d4; Demirci H, 2008, OPHTHALMOLOGY, V115, P383, DOI 10.1016/j.ophtha.2007.03.078; DORTZBACH RK, 1982, AM J OPHTHALMOL, V94, P585, DOI 10.1016/0002-9394(82)90001-0; Fayet B, 2012, J AAPOS, V16, P468, DOI 10.1016/j.jaapos.2012.07.003; Korpela A, 1999, CHEST, V115, P490, DOI 10.1378/chest.115.2.490; Lee HY, 2012, J MATER SCI-MATER M, V23, P1271, DOI 10.1007/s10856-012-4588-4; Ng AHC, 2012, J BIOMED MATER RES B, V100B, P693, DOI 10.1002/jbm.b.32501; Saito Y, 2002, J THORAC CARDIOV SUR, V123, P161, DOI 10.1067/mtc.2002.118503; Samimi DB, 2013, OPHTHAL PLAST RECONS, V29, P376, DOI 10.1097/IOP.0b013e31829a7313; Sasaki T, 2009, JPN J OPHTHALMOL, V53, P145, DOI 10.1007/s10384-008-0624-9; Tamboli V, 2013, COLLOID POLYM SCI, V291, P1235, DOI 10.1007/s00396-012-2854-0; Vila A, 2004, J CONTROL RELEASE, V98, P231, DOI 10.1016/j.jconrel.2004.04.026; Wilhelm KE, 2006, CARDIOVASC INTER RAD, V29, P846, DOI 10.1007/s00270-005-0232-8; Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008; Ye L, 2015, GENET MOL RES, V14, P7929, DOI 10.4238/2015.July.14.19	20	3	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178679	10.1371/journal.pone.0178679	http://dx.doi.org/10.1371/journal.pone.0178679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570687	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800101
J	Danneels, B; Tanghe, M; Joosten, HJ; Gundinger, T; Spadiut, O; Stals, I; Desmet, T				Danneels, Barbara; Tanghe, Magali; Joosten, Henk-Jan; Gundinger, Thomas; Spadiut, Oliver; Stals, Ingeborg; Desmet, Tom			A quantitative indicator diagram for lytic polysaccharide monooxygenases reveals the role of aromatic surface residues in HjLPMO9A regioselectivity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CELLULOSE; FAMILY; CLEAVAGE; DISCOVERY; INSIGHTS	Lytic polysaccharide monooxygenases ( LPMOs) have changed our understanding of lignocellulosic degradation dramatically over the last years. These metalloproteins catalyze oxidative cleavage of recalcitrant polysaccharides and can act on the C1 and/or C4 position of glycosidic bonds. Structural data have led to several hypotheses, but we are still a long way from reaching complete understanding of the factors that determine their divergent regioselectivity. Site-directed mutagenesis enables the investigation of structure-function relationship in enzymes and will be of major importance in unraveling this intriguing matter. In this context, it is crucial to have an enzyme assay or screening approach with a direct correlation with the desired functionality. LPMOs render this search extra challenging due to their insoluble substrates, complex pattern of reaction products and lack of synthetic standards of most oxidized products. Here, we describe a regioselectivity indicator diagram based on the time-course of only 2 HPAEC-PAD signals. The diagram was successfully used to confirm the hypothesis that aromatic surface residues influence the C1/C4 oxidation ratio in Hypocrea jecorina LPMO9A. Consequently, the diagram should become a valuable tool in the search towards better understanding and engineering of regioselectivity in LPMOs.	[Danneels, Barbara; Tanghe, Magali; Desmet, Tom] Univ Ghent, Fac Biosci Engn, Dept Biochem & Microbial Technol, Ctr Synthet Biol, Ghent, Belgium; [Joosten, Henk-Jan] Bioprodict BV, Nijmegen, Netherlands; [Gundinger, Thomas; Spadiut, Oliver] TU Wien, Inst Chem Engn, Res Div Biochem Engn, Vienna, Austria; [Stals, Ingeborg] Univ Ghent, Fac Engn & Architecture, Ind Catalysis & Adsorpt Technol INCAT, Ghent, Belgium	Ghent University; Technische Universitat Wien; Ghent University	Desmet, T (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Biochem & Microbial Technol, Ctr Synthet Biol, Ghent, Belgium.	tom.desmet@ugent.be	Desmet, Tom RJ/I-3313-2012	Desmet, Tom RJ/0000-0002-5788-3022	Bio-Prodict BV	Bio-Prodict BV	The company Bio-Prodict BV provided support in the form of salaries for author HJ, but didnot have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Corradini Claudio, 2012, International Journal of Carbohydrate Chemistry, DOI 10.1155/2012/487564; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Dietzsch C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-85; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2015, TRENDS BIOTECHNOL, V33, P747, DOI 10.1016/j.tibtech.2015.09.006; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kuipers RK, 2010, PROTEINS, V78, P2101, DOI 10.1002/prot.22725; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Moses V, 2016, BIOMED CENTRAL, P9; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Patel I, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0520-3; Preims M, 2016, P NATL ACAD SCI USA, V113; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tanghe M, 2015, MOL BIOTECHNOL, V57, P1010, DOI 10.1007/s12033-015-9887-9; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Westereng B, 2016, J CHROMATOGR A, V1445, P46, DOI 10.1016/j.chroma.2016.03.064; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Zou RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079557	40	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178446	10.1371/journal.pone.0178446	http://dx.doi.org/10.1371/journal.pone.0178446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562644	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700062
J	Kabir, M; Barradas, A; Tzotzos, GT; Hentges, KE; Doig, AJ				Kabir, Mitra; Barradas, Ana; Tzotzos, George T.; Hentges, Kathryn E.; Doig, Andrew J.			Properties of genes essential for mouse development	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; PHYLOGENETIC TREES; KNOCKOUT MICE; IDENTIFICATION; DATABASE; NETWORK; LOCALIZATION; CENTRALITY; BIOLOGY; EVOLUTION	Essential genes are those that are critical for life. In the specific case of the mouse, they are the set of genes whose deletion means that a mouse is unable to survive after birth. As such, they are the key minimal set of genes needed for all the steps of development to produce an organism capable of life ex utero. We explored a wide range of sequence and functional features to characterise essential (lethal) and non-essential (viable) genes in mice. Experimental data curated manually identified 1301 essential genes and 3451 viable genes. Very many sequence features show highly significant differences between essential and viable mouse genes. Essential genes generally encode complex proteins, with multiple domains and many introns. These genes tend to be: long, highly expressed, old and evolutionarily conserved. These genes tend to encode ligases, transferases, phosphorylated proteins, intracellular proteins, nuclear proteins, and hubs in protein-protein interaction networks. They are involved with regulating protein-protein interactions, gene expression and metabolic processes, cell morphogenesis, cell division, cell proliferation, DNA replication, cell differentiation, DNA repair and transcription, cell differentiation and embryonic development. Viable genes tend to encode: membrane proteins or secreted proteins, and are associated with functions such as cellular communication, apoptosis, behaviour and immune response, as well as housekeeping and tissue specific functions. Viable genes are linked to transport, ion channels, signal transduction, calcium binding and lipid binding, consistent with their location in membranes and involvement with cell-cell communication. From the analysis of the composite features of essential and viable genes, we conclude that essential genes tend to be required for intracellular functions, and viable genes tend to be involved with extracellular functions and cell-cell communication. Knowledge of the features that are over-represented in essential genes allows for a deeper understanding of the functions and processes implemented during mammalian development.	[Kabir, Mitra; Barradas, Ana; Hentges, Kathryn E.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Kabir, Mitra; Doig, Andrew J.] Univ Manchester, Fac Sci & Engn, Manchester Inst Biotechnol, Manchester, Lancs, England; [Kabir, Mitra; Doig, Andrew J.] Univ Manchester, Fac Sci & Engn, Dept Chem, Manchester, Lancs, England; [Tzotzos, George T.] Marche Polytech Univ, Dept Agr Food & Environm Sci, Ancona, Italy	University of Manchester; University of Manchester; University of Manchester; Marche Polytechnic University	Hentges, KE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.; Doig, AJ (corresponding author), Univ Manchester, Fac Sci & Engn, Manchester Inst Biotechnol, Manchester, Lancs, England.; Doig, AJ (corresponding author), Univ Manchester, Fac Sci & Engn, Dept Chem, Manchester, Lancs, England.	Kathryn.hentges@manchester.ac.uk; andrew.doig@manchester.ac.uk	Doig, Andrew/AAD-7456-2019; Barradas, Ana/ABC-7830-2021	Doig, Andrew/0000-0003-0346-2270; Tzotzos, George/0000-0001-9258-4338; Hentges, Kathryn/0000-0001-8917-3765	BBSRC grant [BB/L018276/1]; British Commonwealth; Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/BD/84834/2012]; BBSRC [BB/L018276/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L018276/1] Funding Source: researchfish	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Commonwealth; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grant (www.bbsrc.ac.uk) BB/L018276/1 to KEH and AJ D. MK was supported by a British Commonwealth PhD studentship. AB was supported by grant SFRH/BD/84834/2012 from Fundacao para a Ciencia e a Tecnologia (Portugal) (www.fct.pt).	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Budagyan B, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P515; Bull SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055484; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; Chin CS, 2003, BIOINFORMATICS, V19, P2413, DOI 10.1093/bioinformatics/btg339; Choi JK, 2007, GENETICS, V175, P199, DOI 10.1534/genetics.106.066027; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gierut Jessica J, 2014, Cold Spring Harb Protoc, V2014, P339, DOI 10.1101/pdb.top069807; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Housden BE, 2017, NAT REV GENET; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hwang YC, 2009, MOL BIOSYST, V5, P1672, DOI [10.1039/b900611g, 10.1039/B900611G]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jeong Hawoong, 2003, ComPlexUs, V1, P19, DOI 10.1159/000067640; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Montoya-Burgos JI, 2003, TRENDS GENET, V19, P128, DOI 10.1016/S0168-9525(03)00021-0; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Palaniappan K, 2011, MACH LEARN APPL WORK, V2, P189; Pan JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080747; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Puente LG, 2006, MOL CELL PROTEOMICS, V5, P57, DOI 10.1074/mcp.M500166-MCP200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Ryan Kenneth, 2003, Birth Defects Research, V69, P25, DOI 10.1002/bdrc.10001; Saha S, 2006, GENET MOL RES, V5, P224; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Stanton Jo-Ann L, 2003, Appl Bioinformatics, V2, pS65; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Weng TY, 2013, BBA-MOL CELL RES, V1833, P1133, DOI 10.1016/j.bbamcr.2013.01.018; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Yan K, 2002, J AM SOC NEPHROL, V13; Yang L, 2014, GENE, V551, P138, DOI 10.1016/j.gene.2014.08.046; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Yuan Y, 2012, BIOINFORMATICS, V28, P1246, DOI 10.1093/bioinformatics/bts120; Zhang Chun-Ting, 2008, V416, P391, DOI 10.1007/978-1-59745-321-9_27; Zhang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056346, 10.1371/journal.pone.0057885]; Zhong JC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S7; Zhu LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-47	84	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178273	10.1371/journal.pone.0178273	http://dx.doi.org/10.1371/journal.pone.0178273			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562614	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700048
J	Dorey, L; Pelligand, L; Cheng, ZR; Lees, P				Dorey, Lucy; Pelligand, Ludovic; Cheng, Zhangrui; Lees, Peter			Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida	PLOS ONE			English	Article							DRUGS; AMOXICILLIN; SELECTION	Pharmacokinetic-pharmacodynamic (PK/PD) integration and modelling were used to predict dosage schedules for florfenicol for two pig pneumonia pathogens, Actinobacillus pleuropneumoniae and Pasteurella multocida. Pharmacokinetic data were pooled for two bioequivalent products, pioneer and generic formulations, administered intramuscularly to pigs at a dose rate of 15 mg/kg. Antibacterial potency was determined in vitro as minimum inhibitory concentration (MIC) and Mutant Prevention Concentration in broth and pig serum, for six isolates of each organism. For both organisms and for both serum and broth MICs, average concentration: MIC ratios over 48 h were similar and exceeded 2.5:1 and times greater than MIC exceeded 35 h. From in vitro time-kill curves, PK/PD modelling established serum breakpoint values for the index AUC24h/MIC for three levels of inhibition of growth, bacteriostasis and 3 and 4log(10) reductions in bacterial count; means were 25.7, 40.2 and 47.0 h, respectively, for P. multocida and 24.6, 43.8 and 58.6 h for A. pleuropneumoniae. Using these PK and PD data, together with literature MIC distributions, doses for each pathogen were predicted for: (1) bacteriostatic and bactericidal levels of kill; (2) for 50 and 90% target attainment rates (TAR); and (3) for single dosing and daily dosing at steady state. Monte Carlo simulations for 90% TAR predicted single doses to achieve bacteriostatic and bactericidal actions over 48 h of 14.4 and 22.2 mg/kg (P. multocida) and 44.7 and 86.6 mg/kg (A. pleuropneumoniae). For daily doses at steady state, and 90% TAR bacteriostatic and bactericidal actions, dosages of 6.2 and 9.6 mg/kg (P. multocida) and 18.2 and 35.2 mg/kg (A. pleuropneumoniae) were required. PK/PD integration and modelling approaches to dose determination indicate the possibility of tailoring dose to a range of end-points.	[Dorey, Lucy; Pelligand, Ludovic; Cheng, Zhangrui; Lees, Peter] Univ London, Royal Vet Coll, Comparat Biol Sci, London, England	University of London; University of London Royal Veterinary College	Dorey, L (corresponding author), Univ London, Royal Vet Coll, Comparat Biol Sci, London, England.	ldorey@rvc.ac.uk		Pelligand, Ludovic/0000-0001-6005-1975	Biotechnology and Biological Sciences Research Council CASE Scholarship; Norbrook Laboratories Ltd. [BB/101649X/1]	Biotechnology and Biological Sciences Research Council CASE Scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Norbrook Laboratories Ltd.	This work was supported by the Biotechnology and Biological Sciences Research Council CASE Scholarship and Norbrook Laboratories Ltd. for PhD project Grant number BB/101649X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondeau J M, 2004, J Chemother, V16 Suppl 3, P1; CLSI, 2004, M31A3 CLSI; de Jong A, 2014, VET MICROBIOL, V172, P202, DOI 10.1016/j.vetmic.2014.04.008; Dorey L, 2016, VET J, V218, P65, DOI 10.1016/j.tvjl.2016.11.004; Giraudel JM, 2005, J VET PHARMACOL THER, V28, P275, DOI 10.1111/j.1365-2885.2005.00639.x; Illambas J, 2013, VET REC, V172, DOI 10.1136/vr.101155; Lees P, 2015, J VET PHARMACOL THER, V38, P457, DOI 10.1111/jvp.12207; Lees P., 2015, PHARM MATTERS, V8, P22; Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11; Nielsen EI, 2013, PHARMACOL REV, V65, P1053, DOI 10.1124/pr.111.005769; Nielsen EI, 2011, ANTIMICROB AGENTS CH, V55, P4619, DOI 10.1128/AAC.00182-11; Papich MG, 2014, VET MICROBIOL, V171, P480, DOI 10.1016/j.vetmic.2013.12.021; Rey JE, 2014, AM J VET RES, V75, P124, DOI 10.2460/ajvr.75.2.124; Sidhu P, 2014, J VET PHARMACOL THER, V37, P231, DOI 10.1111/jvp.12093; Toutain P.-L, 2016, J VET PHARM THER; Toutain P.L., 2004, REGULATORY AFFAIRS J, V15, P175; Toutain P.-L., 2006, J VETER PHARM THER, V29, P26, DOI [10.1111/j.1365-2885.2006.00773_4.x, DOI 10.1111/J.1365-2885.2006.00773_4.X]; Toutain PL, 2004, J VET PHARMACOL THER, V27, P467, DOI 10.1111/j.1365-2885.2004.00613.x; Vidaillac C, 2009, ANTIMICROB AGENTS CH, V53, P4712, DOI 10.1128/AAC.00636-09; Vilalta C, 2014, J VET PHARMACOL THER, V37, P542, DOI 10.1111/jvp.12134	20	22	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177568	10.1371/journal.pone.0177568	http://dx.doi.org/10.1371/journal.pone.0177568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552968	gold, Green Published, Green Submitted			2022-12-26	WOS:000402063000009
J	Brodowski, L; Burlakov, J; Hass, S; von Kaisenberg, C; von Versen-Hoynck, F				Brodowski, Lars; Burlakov, Jennifer; Hass, Sarah; von Kaisenberg, Constantin; von Versen-Hoeynck, Frauke			Impaired functional capacity of fetal endothelial cells in preeclampsia	PLOS ONE			English	Article							PLACENTAL VASCULAR DEVELOPMENT; GROWTH-FACTOR; INHIBITS ANGIOGENESIS; PROGENITOR CELLS; ADULT LIFE; IN-VITRO; HYPOXIA; EXPRESSION; OXYGEN; RISK	Objectives Preeclampsia is one of the main contributers to maternal and fetal morbidity and mortality during pregnancy. A history of preeclampsia puts mother and offspring at an increased cardiovascular risk in later life. We hypothesized that at the time of birth functional impairments of fetal endothelial cells can be detected in pregnancies complicated by preeclampsia and that a therapeutic intervention using 1,25 (OH)(2) vitamin D-3 can reverse the adverse effects of preeclampsia on cell function. Methods Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical cords obtained from preeclamptic (N = 12) and uncomplicated pregnancies (N = 13, control). Placental villous tissue fragments from uncomplicated term pregnancies were incubated in explant culture for 48 h at 2% (hypoxia), 8% or 21% O-2. Explant conditioned media (CM) was collected and pooled according to oxygen level. We compared the ability of preeclampsia vs. control HUVEC to migrate, proliferate, and form tubule-like networks in a Matrigel assay, in the presence/absence of CM and 1,25(OH)(2) vitamin D-3. Results HUVEC from preeclamptic pregnancies showed reduced migration (P = 0.04) and tubule formation (P = 0.04), but no change in proliferation (P = 0.16) compared to healthy pregnancies. Placental villous explant CM derived from 2% O-2 incubations significantly reduced HUVEC migration, when compared to non-CM (P = 0.04). Vitamin D-3 improved HUVEC function in neither of the groups. There was no significant difference in VEGF gene expression between healthy and preeclamptic pregnancies and no effect of Vitamin D-3 on VEGF expression. Conclusions Reduced functional abilities of fetal endothelial cells from preeclamptic pregnancies suggests that disease pathways, possibly originating from the dysfunctional placenta, negatively impact fetal endothelium. The neutral effect of 1,25(OH)(2) vitamin D-3 contrasts with previous findings that vitamin D rescues the poor migration, proliferation and tubule formation exhibited by cord blood fetal endothelial progenitor cells from preeclamptic pregnancies. Further investigations to distinguish pathways by which offspring exposed to preeclampsia are at risk for cardiovascular disease are needed.	[Brodowski, Lars; Burlakov, Jennifer; Hass, Sarah; von Kaisenberg, Constantin; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany	Hannover Medical School	von Versen-Hoynck, F (corresponding author), Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany.	vonVersen-Hoeynck.Frauke@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021; von Versen-Höynck, Frauke/H-3719-2019	von Versen-Höynck, Frauke/0000-0002-1924-5695	Deutsche Forschungsgemeinschaft [VE490/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by a grant from the Deutsche Forschungsgemeinschaft (VE490/7-1) to Frauke von Versen-Hoynck. http://www.dfg.de/en/.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Albert DM, 2007, INVEST OPHTH VIS SCI, V48, P2327, DOI 10.1167/iovs.06-1210; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Brodowski L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098527; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Halhali A, 2013, J STEROID BIOCH MOL; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Hisa T, 1996, ARCH DERMATOL RES, V288, P262, DOI 10.1007/s004030050058; Hwang HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.060; Indelicato M, 2010, J CELL PHYSIOL, V223, P359, DOI 10.1002/jcp.22041; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kingdom JCP, 1999, ADV EXP MED BIOL, V474, P259; Kumazaki K, 2002, HUM PATHOL, V33, P1069, DOI 10.1053/hupa.2002.129420; Lazdam M, 2010, HYPERTENSION, V56, P159, DOI 10.1161/HYPERTENSIONAHA.110.150235; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Levine MJ, 2004, J NUTR, V134, P2244, DOI 10.1093/jn/134.9.2244; Lewandowski AJ, 2014, EARLY HUM DEV, V90, P725, DOI 10.1016/j.earlhumdev.2014.08.012; Lewandowski AJ, 2012, CIRCULATION, V126; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moyes AJ, 2011, REPROD SCI, V18, P374, DOI 10.1177/1933719110385131; Munarin F, 2015, IEEE ENG MED BIO, P1741, DOI 10.1109/EMBC.2015.7318714; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; OLSEN SF, 1990, BRIT J NUTR, V64, P599, DOI 10.1079/BJN19900063; Pan C. C., 2016, ONCOTARGET, DOI 10.18632/oncotarget.9307; Rebsamen MC, 2002, CIRCULATION RES, V91; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Robinson NJ, 2008, LAB INVEST, V88, P293, DOI 10.1038/labinvest.3700746; Schlaeppi JM, 1997, ENDOCR RES, V23, P213, DOI 10.3109/07435809709031855; Sipos PI, 2010, PLACENTA, V31, P1, DOI 10.1016/j.placenta.2009.10.006; Trollmann R, 2003, AM J OBSTET GYNECOL, V188, P517, DOI 10.1067/mob.2003.138; von Versen-Hoynck F, 2009, PLACENTA, V30, P434, DOI 10.1016/j.placenta.2009.02.004; von Versen-Hoynck F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098990; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Zhao LX, 2012, J CELL MOL MED, V16, P1840, DOI 10.1111/j.1582-4934.2011.01479.x	52	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178340	10.1371/journal.pone.0178340	http://dx.doi.org/10.1371/journal.pone.0178340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542561	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058800055
J	Barcelo, MA; Rodriguez-Poncelas, A; Saez, M; Coll-De-Tuero, G				Barcelo, Maria A.; Rodriguez-Poncelas, Antonio; Saez, Marc; Coll-de-Tuero, Gabriel			The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; BLOOD-PRESSURE; PREVALENCE; ASSOCIATION; DEFINITION; EXERCISE; DISEASE; OBESITY	Background The significant rise in the prevalence of obesity coincides with the considerable increase in the prevalence of metabolic syndrome (MS) currently being observed worldwide. The components of MS are not static and their dynamics, such as the order of their occurrence, or the time of exposure to them are, as yet, unknown but could well be clinically relevant. Our objective was to study the dynamic behaviour of MS and its components in a large population-based cohort from a Mediterranean region. Methods and findings Our study employed a retrospective cohort (between January 1, 2005 and December 31, 2012) made up of individuals from the general population in a region in the northeast of Catalonia, Spain. Given that most of the explicative variables of the risk of having MS were time dependent and, therefore, the risk was not proportional, we used the Andersen-Gill (AG) model to perform a multivariate survival analysis and inferences were performed using a Bayesian framework. Thirty-nine percent of the participants developed MS; 44.6% of them with a single limited episode. Triglycerides and low HDL cholesterol, together with obesity, are components associated with the first occurrence of MS. Components related to the metabolism of glucose are associated with a medium risk of having a first episode of MS, and those related to blood pressure are associated with a lower risk. When the components related to blood pressure and the metabolism of glucose appear first, they determine the appearance of the first episode of MS. The variables concerning the persistence of MS are those that correspond to clinical conditions that do not have well-established drug treatment criteria. Conclusions Our results suggest that the components related to the metabolism of glucose and to high blood pressure appear early on and act as biomarkers for predicting MS, while the components related to obesity and dyslipidaemia, although essential for the development of MS, appear later. Making lifestyle changes reduces the conditions associated with the persistence of MS.	[Barcelo, Maria A.; Saez, Marc] Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain; [Barcelo, Maria A.; Saez, Marc; Coll-de-Tuero, Gabriel] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Rodriguez-Poncelas, Antonio; Coll-de-Tuero, Gabriel] Univ Inst Res Primary Care Jordi Gol IdIAP Gol, Res Support Unit, Girona, Spain; [Coll-de-Tuero, Gabriel] Univ Girona, Dept Med Sci, Girona, Spain	Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Girona	Saez, M (corresponding author), Univ Girona, Res Grp Stat Econometr & Hlth GRECS, Girona, Spain.; Saez, M (corresponding author), CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	marc.saez@udg.edu	Barceló, Maria A/AAT-6212-2020; Rodriguez Poncelas, Antonio/F-9397-2016; Coll-de-Tuero, Gabriel/H-3475-2016	Barceló, Maria A/0000-0001-9720-690X; Rodriguez Poncelas, Antonio/0000-0003-2100-9701; Coll-de-Tuero, Gabriel/0000-0001-7578-9569	Health Research Fund (Fondo de Investigacion Sanitaria), Institute de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain, through the 'A way to making Europe', European Regional Development Fund (FEDER) [FIS 15/0040]; European Union; GIBER of Epidemiology and Public Health (CIBERESP); Research Groups of the University of Girona [MPCUdG2016/69]	Health Research Fund (Fondo de Investigacion Sanitaria), Institute de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain, through the 'A way to making Europe', European Regional Development Fund (FEDER); European Union(European Commission); GIBER of Epidemiology and Public Health (CIBERESP); Research Groups of the University of Girona	This paper was developed within the scope of the project 'Compositional and Spatial Analysis' (COSDA), AGAUR, 'Generalitat de Catalunya', 2014SGR551. It was partly funded through Project FIS 15/0040 from the Health Research Fund (Fondo de Investigacion Sanitaria), Institute de Salud Carlos III, Ministry of Economy and Competitiveness, Government of Spain, through the 'A way to making Europe', European Regional Development Fund (FEDER), European Union, by the GIBER of Epidemiology and Public Health (CIBERESP) through the strategic subprogram 'Crisis and Health', and through the Research Grant to Improve the Scientific Productivity of the Research Groups of the University of Girona 2016-2018 (MPCUdG2016/69). The work did not obtain additional funding for its development.	Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Andersen P. K., 2012, STAT MODELS BASED CO; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Balkau B, 2003, DIABETES METAB, V29, P526, DOI 10.1016/S1262-3636(07)70067-8; Barcelo MA, 2002, GAC SANIT S, V16, P59; Biino G, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1049-9; Bo S, 2008, EUR J ENDOCRINOL, V159, P685, DOI 10.1530/EJE-08-0334; Bo S, 2009, J HYPERTENS, V27, P102, DOI 10.1097/HJH.0b013e328317a7bb; Chen XX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1033; Cheung BMY, 2008, CLIN ENDOCRINOL, V68, P730, DOI 10.1111/j.1365-2265.2007.03110.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Fernandez-Berges D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.rec.2011.10.017, 10.1016/j.recesp.2011.10.015]; Gaillard T, 2010, METABOLISM, V59, P1115, DOI 10.1016/j.metabol.2009.09.035; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Haring R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039461; Hosseinpanah F, 2014, EUR J CLIN NUTR, V68, P295, DOI 10.1038/ejcn.2013.142; Huo D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-912; Hwang LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067436; Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537; Kablfleisch JD, 1980, STAT ANAL FAILURE TI; Martins TG, ARXIV14034630V4; Pattyn N, 2013, SPORTS MED, V43, P121, DOI 10.1007/s40279-012-0003-z; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; R Core Team, 2013, R LANG ENV STAT COMP; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Ryan MC, 2008, AM J CARDIOL, V102, P40, DOI 10.1016/j.amjcard.2008.02.096; Saez M, 2009, COMPUT METH PROG BIO, V93, P228, DOI 10.1016/j.cmpb.2008.10.010; Scuteri A, 2009, J GERONTOL A-BIOL, V64, P590, DOI 10.1093/gerona/glp004; Slagter SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096406; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Martinez-Larrad MT, 2016, DIABETES RES CLIN PR, V114, P23, DOI 10.1016/j.diabres.2016.02.003; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Zhou H, 2012, IRAN J PUBLIC HEALTH, V41, P26	40	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176665	10.1371/journal.pone.0176665	http://dx.doi.org/10.1371/journal.pone.0176665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545089	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400012
J	Eng, GWL; Edison; Virshup, DM				Eng, Gracie Wee Ling; Edison; Virshup, David M.			Site-specific phosphorylation of casein kinase 1 delta (CK1 delta) regulates its activity towards the circadian regulator PER2	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SLEEP PHASE SYNDROME; CELL-CYCLE; I-EPSILON; POSTTRANSLATIONAL MODIFICATIONS; CLOCK; MUTATION; PROTEIN; RHYTHM; DEGRADATION	Circadian rhythms are intrinsic similar to 24 hour cycles that regulate diverse aspects of physiology, and in turn are regulated by interactions with the external environment. Casein kinase 1 delta (CK1 delta, CSNK1D) is a key regulator of the clock, phosphorylating both stabilizing and destabilizing sites on the PER2 protein, in a mechanism known as the phosphoswitch. CK1 delta can itself be regulated by phosphorylation on its regulatory domain, but the specific sites involved, and the role this plays in control of circadian rhythms as well as other CK1-dependent processes is not well understood. Using a sensitized PER2:: LUC reporter assay, we identified a specific phosphorylation site, T347, on CK1 delta, that regulates CK1 delta activity towards PER2. A mutant CK1 delta T347A was more active in promoting PER2 degradation. This CK1 delta regulatory site is phosphorylated in cells in trans by dinaciclib- and staurosporine-sensitive kinases, consistent with their potential regulation by cyclin dependent and other proline-directed kinases. The regulation of CK1 delta by site-specific phosphorylation via the cell cycle and other signaling pathways provides a mechanism to couple external stimuli to regulation of CK1 delta-dependent pathways including the circadian clock.	[Eng, Gracie Wee Ling; Edison; Virshup, David M.] Duke NUS Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore; [Virshup, David M.] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA	National University of Singapore; Duke University	Virshup, DM (corresponding author), Duke NUS Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore.; Virshup, DM (corresponding author), Duke Univ, Sch Med, Dept Pediat, Durham, NC 27708 USA.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; , Edison/0000-0002-8261-0931	National Research Foundation Singapore [IRG NMRC/1291/2011]; Duke-NUS; Agency for Science Technology and Research (A*STAR); National Medical Research Council (NMRC) of the Ministry of Health, Singapore	National Research Foundation Singapore(National Research Foundation, Singapore); Duke-NUS; Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council (NMRC) of the Ministry of Health, Singapore(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This research was supported by the National Research Foundation Singapore IRG NMRC/1291/2011 and administered by the Singapore Ministry of Health's National Medical Research Council, and startup funding to DMV from Duke-NUS, provided by the Agency for Science Technology and Research (A*STAR) and the National Medical Research Council (NMRC) of the Ministry of Health, Singapore. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Bieler J, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145218; Bischof J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068803; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cao Q, 2009, CANCER RES, V69, P7619, DOI 10.1158/0008-5472.CAN-08-4199; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; EDMUNDS LN, 1969, SCIENCE, V165, P500, DOI 10.1126/science.165.3892.500; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Hirano A, 2016, NAT STRUCT MOL BIOL, V23, P1053, DOI 10.1038/nsmb.3326; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ianes C, 2015, AMINO ACIDS; Iurisci I, 2009, CHRONOBIOL INT, V26, P1169, DOI 10.1080/07420520903209942; Krucher NA, 1997, CELL MOL NEUROBIOL, V17, P495, DOI 10.1023/A:1026358821640; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu F, 2002, J BIOL CHEM, V277, P45393, DOI 10.1074/jbc.M204499200; Liu F, 2001, P NATL ACAD SCI USA, V98, P11062, DOI 10.1073/pnas.191353898; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Matsu-ura T, 2016, MOL CELL, V64, P900, DOI 10.1016/j.molcel.2016.10.015; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Shanware NP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.224014; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takahashi JS, 2016, NATURE REV GENETICS; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Vogel M, 2012, J NEURAL TRANSM, V119, P1121, DOI 10.1007/s00702-012-0800-4; Walton KM, 2009, J PHARMACOL EXP THER, V330, P430, DOI 10.1124/jpet.109.151415; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhou M, 2015, MOL CELL, V60, P77, DOI 10.1016/j.molcel.2015.08.022	46	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177834	10.1371/journal.pone.0177834	http://dx.doi.org/10.1371/journal.pone.0177834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545154	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700087
J	Lo, CH; Yang, JF; Liu, MY; Jen, YM; Lin, CS; Chao, HL; Huang, WY				Lo, Cheng-Hsiang; Yang, Jen-Fu; Liu, Ming-Yueh; Jen, Yee-Min; Lin, Chun-Shu; Chao, Hsing-Lung; Huang, Wen-Yen			Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy	PLOS ONE			English	Article							BODY RADIATION-THERAPY; PHASE-I; FEASIBILITY; EFFICACY; OUTCOMES	Objective To evaluate the survival outcomes and prognostic factors of patients with advanced hepatocellular carcinoma (HCC) who underwent stereotactic ablative radiotherapy (SABR). Methods This retrospective study evaluated patients with advanced HCC who underwent SABR between December 2007 and July 2015. All patients had Barcelona Clinic Liver Cancer stage C disease and Child-Turcotte-Pugh (CTP) class A-B function. In-field control (IFC), overall survival (OS), prognostic factors, and toxicity were evaluated. Results In this study of 89 patients, the 3-year IFC rate was 78.1%, and the 1-year and 3-year OS rates were 45.9% and 24.3%, respectively. The multivariate analysis revealed that CTP class, the presence of main portal vein tumor thrombosis, and the presence of extrahepatic spread were independent predictors of OS. The expected median OS values among patients with >= 2, 1, and 0 predictors were 4.2, 8.6, and 26.4 months, respectively (p < 0.001). Conclusions SABR may be useful for patients with advanced HCC, and patient selection could be based on the CTP classification, main portal vein tumor thrombosis, and extrahepatic spread.	[Lo, Cheng-Hsiang; Yang, Jen-Fu; Liu, Ming-Yueh; Jen, Yee-Min; Lin, Chun-Shu; Chao, Hsing-Lung; Huang, Wen-Yen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Jen, Yee-Min] Yee Ren Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Huang, Wen-Yen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University	Huang, WY (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Radiat Oncol, Taipei, Taiwan.; Huang, WY (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	hwyyi@yahoo.com.tw	huang, wen/GXW-0661-2022	Lo, Cheng-Hsiang/0000-0001-5002-587X	Tri-Service General Hospital [TSGH-C106-039, TSGH-C105-172, TSGH-C105-049]	Tri-Service General Hospital	This study is supported by Tri-Service General Hospital (TSGH-C106-039, TSGH-C105-172, and TSGH-C105-049). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Bae SH, 2013, J KOREAN MED SCI, V28, P213, DOI 10.3346/jkms.2013.28.2.213; BARTON M, 1995, INT J RADIAT ONCOL, V31, P371, DOI 10.1016/0360-3016(94)E0126-5; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Cardenes HR, 2010, CLIN TRANSL ONCOL, V12, P218, DOI 10.1007/s12094-010-0492-x; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng JCH, 2004, INT J RADIAT ONCOL, V60, P1502, DOI 10.1016/j.ijrobp.2004.05.048; Choi C, 2014, LIVER CANCER, V3, P405, DOI 10.1159/000343861; Culleton S, 2014, RADIOTHER ONCOL, V111, P412, DOI 10.1016/j.radonc.2014.05.002; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Huertas A, 2015, RADIOTHER ONCOL, V115, P211, DOI 10.1016/j.radonc.2015.04.006; Kang JK, 2012, CANCER-AM CANCER SOC, V118, P5424, DOI 10.1002/cncr.27533; Kudo M, 2010, JPN J CLIN ONCOL, V40, pi19, DOI 10.1093/jjco/hyq123; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo CH, 2014, EUR J GASTROEN HEPAT, V26, P345, DOI 10.1097/MEG.0000000000000032; Sanuki N, 2014, ACTA ONCOL, V53, P399, DOI 10.3109/0284186X.2013.820342; Scorsetti M, 2015, J CANCER RES CLIN, V141, P1301, DOI 10.1007/s00432-015-1929-y; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Su TS, 2016, J SURG ONCOL, V113, P181, DOI 10.1002/jso.24128; Torzilli G, 2013, ANN SURG, V257, P929, DOI 10.1097/SLA.0b013e31828329b8; Wahl DR, 2016, J CLIN ONCOL, V34, P452, DOI 10.1200/JCO.2015.61.4925; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Yang T, 2012, J CANCER RES CLIN, V138, P1121, DOI 10.1007/s00432-012-1188-0; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019	28	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177793	10.1371/journal.pone.0177793	http://dx.doi.org/10.1371/journal.pone.0177793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545098	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700079
J	Chen, D; Fan, Z; Rauh, M; Buchfelder, M; Eyupoglu, IY; Savaskan, N				Chen, D.; Fan, Z.; Rauh, M.; Buchfelder, M.; Eyupoglu, I. Y.; Savaskan, N.			ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner	ONCOGENE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-4; ENDOPLASMIC-RETICULUM STRESS; TUMOR ANGIOGENESIS; ER-STRESS; MALIGNANT GLIOMAS; CANCER-THERAPY; GROWTH; BRAIN; PATHWAY; RESISTANCE	Activating transcription factor 4 (ATF4) is a critical mediator of metabolic and oxidative homeostasis and cell survival. ATF4 is elevated in response to diverse microenvironmental stresses, including starvation, ER stress damages and exposure to toxic factors. Here we show that ATF4 expression fosters the malignancy of primary brain tumors (WHO grade III and IV gliomas) and increases proliferation and tumor angiogenesis. Hence, ATF4 expression promotes cell migration and anchorage-independent cell growth, whereas siRNA-mediated knockdown of ATF4 attenuates these features of malignancy in human gliomas. Further experiments revealed that ATF4-dependent tumor promoting effects are mediated by transcriptional targeting the glutamate antiporter xCT/SCL7A11 (also known as system Xc(-)). Thus, xCT is elevated as a consequence of ATF4 activation. We further found evidence that ATF4-induced proliferation can be attenuated by pharmacological or genetic xCT inhibition and ferroptosis inducers such as sorafenib, erastin and GPx4 inhibitor RSL3. Further, fostered xCT expression promotes cell survival and growth in ATF4 knockdown cells. Moreover, increased xCT levels ameliorate sorafenib and erastin-induced ferroptosis. Conversely, ATF4 knockdown renders cells susceptible for erastin, sorafenib and RSL3-induced ferroptosis. We further identified that ATF4 promotes tumor-mediated neuronal cell death which can be alleviated by xCT inhibition. Moreover, elevated ATF4 expression in gliomas promotes tumor angiogenesis. Noteworthy, ATF4-induced angiogenesis could be diminished by ferroptosis inducers erastin and by GPx4 inhibitor RSL3. Our data provide proof-of-principle evidence that ATF4 fosters proliferation and induces a toxic microenvironmental niche. Furthermore, ATF4 increases tumor angiogenesis and shapes the vascular architecture in a xCT-dependent manner. Thus, inhibition of ATF4 is a valid target for diminishing tumor growth and vasculature via sensitizing tumor cells for ferroptosis.	[Chen, D.; Fan, Z.; Eyupoglu, I. Y.; Savaskan, N.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen UKER, Translat Cell Biol & Neurooncol Lab, Schwabachanlage 6, D-91054 Erlangen, Germany; [Chen, D.] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Fan, Z.] ETHZ Zurich, ETH Zurich, Lab Exercise & Hlth, Dept Hlth Sci & Technol, Zurich, Switzerland; [Rauh, M.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen UKER, Dept Pediat & Adolescent Med, Erlangen, Germany; [Buchfelder, M.; Eyupoglu, I. Y.; Savaskan, N.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen UKER, Dept Neurosurg, Erlangen, Germany; [Savaskan, N.] BiMECON Ent, Berlin, Germany	University of Erlangen Nuremberg; Chinese People's Liberation Army General Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Savaskan, N (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen UKER, Translat Cell Biol & Neurooncol Lab, Schwabachanlage 6, D-91054 Erlangen, Germany.; Savaskan, N (corresponding author), BiMECON, Schwabachanlage 6, D-91054 Erlangen, Germany.	savaskan@gmx.net	Savaskan, Nicolai/D-2923-2018	Savaskan, Nicolai/0000-0003-1348-094X	China Scholarship Council (CSC) [201308110471]; Verein zur Forderung des Tumorzentrums der Universitat Erlangen-Nurnberg e.V.	China Scholarship Council (CSC)(China Scholarship Council); Verein zur Forderung des Tumorzentrums der Universitat Erlangen-Nurnberg e.V.	We thank all members of the Translational Neurooncology laboratory for valuable comments on this study and helpful suggestions. Christiane Muhle (Department of Psychiatry, Erlangen, Germany) is gratefully acknowledged for providing assistance with the digital qRT-PCR procedure. Christoph J. Wruck (from the RWTH Aachen, Germany) as well as Jana Wrosch and Marc Dahlmanns (from the Department of Psychiatry, Erlangen, Germany, and Molecular Medicine program at the Universitatsklinikum Erlangen) are acknowledged for sharing imaging technics and constructs exchange. DC holds a grant from the China Scholarship Council (CSC: 201308110471). This study was funded by the Verein zur Forderung des Tumorzentrums der Universitat Erlangen-Nurnberg e.V. to NES.	Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Broggini T, 2016, AGING-US, V8, P2463, DOI 10.18632/aging.101066; Castranova D, 2016, ARTERIOSCL THROM VAS, V36, P655, DOI 10.1161/ATVBAHA.115.307087; Chakraborty G, 2008, CANCER RES, V68, P152, DOI 10.1158/0008-5472.CAN-07-2126; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Eyupoglu IY, 2013, NAT REV NEUROL, V9, P141, DOI 10.1038/nrneurol.2012.279; Fan Z, 2016, ONCOTARGET, V7, P26692, DOI 10.18632/oncotarget.8592; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093264; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160; Ghoochani A, 2016, ONCOTARGET, V7, P38306, DOI 10.18632/oncotarget.9439; Ghoochani A, 2016, ONCOTARGET, V7, P1838, DOI 10.18632/oncotarget.6550; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Iurlaro R, 2016, FEBS J, V283, P2640, DOI 10.1111/febs.13598; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Mao XY, 2016, ONCOTARGET, V7, P33451, DOI 10.18632/oncotarget.7962; McConkey DJ, 2017, BIOCHEM BIOPH RES CO, V482, P450, DOI 10.1016/j.bbrc.2016.11.047; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Savaskan NE, 2011, ONCOGENE, V30, P43, DOI 10.1038/onc.2010.391; Savaskan NE, 2010, ANN ANAT, V192, P309, DOI 10.1016/j.aanat.2010.07.003; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Savaskan NE, 2015, CURR NEUROPHARMACOL, V13, P258, DOI 10.2174/1570159X13666150122224158; Sehm T, 2016, ONCOTARGET, V7, P74630, DOI 10.18632/oncotarget.11858; Sehm T, 2016, ONCOTARGET, V7, P36021, DOI 10.18632/oncotarget.8651; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Tanabe M, 2003, CANCER RES, V63, P8592; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wang YG, 2013, NEOPLASIA, V15, P989, DOI 10.1593/neo.13262; Xu TF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19799; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zeng H, 2016, ONCOTARGET, V7, P7329, DOI 10.18632/oncotarget.6940; Zhao EH, 2016, CELL REP, V14, P506, DOI 10.1016/j.celrep.2015.12.053	42	171	177	8	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5593	5608		10.1038/onc.2017.146	http://dx.doi.org/10.1038/onc.2017.146			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28553953	hybrid, Green Published			2022-12-26	WOS:000412293600004
J	Dumont, V; Tolvanen, TA; Kuusela, S; Wang, H; Nyman, TA; Lindfors, S; Tienari, J; Nisen, H; Suetsugu, S; Plomann, M; Kawachi, H; Lehtonen, S				Dumont, Vincent; Tolvanen, Tuomas A.; Kuusela, Sara; Wang, Hong; Nyman, Tuula A.; Lindfors, Sonja; Tienari, Jukka; Nisen, Harry; Suetsugu, Shiro; Plomann, Markus; Kawachi, Hiroshi; Lehtonen, Sanna			PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease	FASEB JOURNAL			English	Article						endocytosis; recycling; rabenosyn-5; palmitate; podocyte	SLIT DIAPHRAGM; MEMBRANE-TRAFFICKING; FATTY-ACIDS; PROTEIN; NEPHROPATHY; PODOCYTES; COMPLEX; INJURY; GENE; ORGANIZATION	Nephrin is a core component of podocyte (glomerular epithelial cell) slit diaphragm and is required for kidney ultrafiltration. Down-regulation or mislocalization of nephrin has been observed in diabetic kidney disease (DKD), characterized by albuminuria. Here, we investigate the role of protein kinase C and casein kinase 2 substrate in neurons 2 (PACSIN2), a regulator of endocytosis and recycling, in the trafficking of nephrin and development of DKD. We observe that PACSIN2 is up-regulated and nephrin mislocalized in podocytes of obese Zucker diabetic fatty (ZDF) rats that have altered renal function. In cultured podocytes, PACSIN2 and nephrin colocalize and interact. We show that nephrin is endocytosed in PACSIN2-positive membrane regions and that PACSIN2 overexpression increases both nephrin endocytosis and recycling. We identify rabenosyn-5, which is involved in early endosome maturation and endosomal sorting, as a novel interaction partner of PACSIN2. Interestingly, rabenosyn-5 expression is increased in podocytes in obese ZDF rats, and, in vitro, its overexpression enhances the association of PACSIN2 and nephrin. We also show that palmitate, which is elevated in diabetes, enhances this association. Collectively, PACSIN2 is up-regulated and nephrin is abnormally localized in podocytes of diabetic ZDF rats. In vitro, PACSIN2 enhances nephrin turnover apparently via a mechanism involving rabenosyn-5. The data suggest that elevated PACSIN2 expression accelerates nephrin trafficking and associates with albuminuria.	[Dumont, Vincent; Tolvanen, Tuomas A.; Kuusela, Sara; Wang, Hong; Lindfors, Sonja; Tienari, Jukka; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland; [Nyman, Tuula A.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Tienari, Jukka] Helsinki Univ Hosp, Dept Pathol, Hyvinkaa, Finland; [Nisen, Harry] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Suetsugu, Shiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Japan; [Plomann, Markus] Univ Cologne, Ctr Biochem, Cologne, Germany; [Kawachi, Hiroshi] Niigata Univ, Kidney Res Ctr, Dept Cell Biol, Grad Sch Med & Dent Sci, Niigata, Japan; [Nyman, Tuula A.] Univ Oslo, Dept Immunol, Inst Clin Med, Oslo, Norway; [Nyman, Tuula A.] Natl Hosp Norway, Oslo, Norway	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Nara Institute of Science & Technology; University of Cologne; Niigata University; University of Oslo; University of Oslo; National Hospital Norway	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland.	sanna.h.lehtonen@helsinki.fi	Lehtonen, Sanna/AAE-4545-2020; Lehtonen, Sanna/GRJ-3642-2022; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019; Wang, Hong/AAW-6913-2020; Lindfors, Sonja/AAP-2050-2021; Suetsugu, Shiro/B-3300-2010	Lehtonen, Sanna/0000-0003-4189-2415; Suetsugu, Shiro/0000-0002-4612-0628; Wang, Hong/0000-0001-5700-6786; Lindfors, Sonja/0000-0002-2024-0760; Suetsugu, Shiro/0000-0002-4612-0628; Dumont, Vincent/0000-0002-2893-5479; Kuusela, Sara/0000-0002-2790-5841; Tolvanen, Tuomas Aleksi/0000-0002-3581-208X	Academy of Finland [121248, 131255, 218021]; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Faculty of Medicine, University of Helsinki; Research Foundation of the University of Helsinki; Helsinki Biomedical Graduate Program; Finnish Cultural Foundation; Helsinki University Hospital grant; Japan Society for the Promotion of Science (JSPS) [15H05902]; Grants-in-Aid for Scientific Research [17H06006] Funding Source: KAKEN	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Faculty of Medicine, University of Helsinki; Research Foundation of the University of Helsinki; Helsinki Biomedical Graduate Program; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Hospital grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Andrey S. Shaw (Washington University School of Medicine, St. Louis, MO, USA) for the mouse podocyte cell line, and Dr. Silvia Corvera (University of Massachusetts Medical School, Worcester, MA, USA) for providing the rabenosyn-5 IgG; Dr. Yosuke Senju and Dr. Johan Peranen (both from the University of Helsinki) for fruitful discussions; Niina Ruoho and Leena Saikko (both from the University of Helsinki) for skillful technical assistance; and the Biomedicum Imaging Unit and Biochemical Analysis Core for Experimental Research of the University of Helsinki for help in imaging and metabolic measurements, respectively. This work was supported by the Academy of Finland (121248, 131255, 218021; to S.L.); the Sigrid Juselius Foundation (to S.L.); the Paivikki and Sakari Sohlberg Foundation (to S.L.); the Diabetes Research Foundation (to S.L.); the Faculty of Medicine, University of Helsinki (to S.L.); the Research Foundation of the University of Helsinki (to V.D.); the Helsinki Biomedical Graduate Program (to V.D. and T.A.T.); the Finnish Cultural Foundation (to V.D.); the Helsinki University Hospital grant (to J.T.); and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (15H05902; to S.S.).	Baynes J, 2009, OXID MED CELL LONGEV, V2, P328, DOI 10.4161/oxim.2.5.9831; Billcliff PG, 2016, MOL BIOL CELL, V27, P90, DOI 10.1091/mbc.E15-06-0329; Bonnet F, 2001, DIABETOLOGIA, V44, P874; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; HAGENFEL.L, 1972, J CLIN INVEST, V51, P2324, DOI 10.1172/JCI107043; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hoshi S, 2002, LAB INVEST, V82, P25, DOI 10.1038/labinvest.3780392; HOSTETTER TH, 1981, KIDNEY INT, V19, P410, DOI 10.1038/ki.1981.33; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Hyvonen ME, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102969; Ina K, 2002, J ELECTRON MICROSC, V51, P275, DOI 10.1093/jmicro/51.4.275; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Liu L, 2001, HUM MOL GENET, V10, P2637, DOI 10.1093/hmg/10.23.2637; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Modregger J, 2000, J CELL SCI, V113, P4511; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Satoh D, 2014, J BIOCHEM, V156, P115, DOI 10.1093/jb/mvu022; Savijoki K, 2011, J PROTEOME RES, V10, P3460, DOI 10.1021/pr2000896; Senju Y, 2015, J CELL SCI, V128, P2766, DOI 10.1242/jcs.167775; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sorensson J, 2002, J AM SOC NEPHROL, V13, P2639, DOI 10.1097/01.ASN.0000033277.32822.23; Stockler S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0141-5; Subramanian B, 2016, KIDNEY INT, V90, P363, DOI 10.1016/j.kint.2016.04.020; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tolvanen TA, 2015, J CELL SCI, V128, P4588, DOI 10.1242/jcs.175075; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Wasik AA, 2017, EXP CELL RES, V350, P336, DOI 10.1016/j.yexcr.2016.12.010; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514; Yao G, 2014, HUM MOL GENET, V23, P2769, DOI 10.1093/hmg/ddt672; Yao G, 2013, KIDNEY INT, V83, P426, DOI 10.1038/ki.2012.379; Yasuda M, 2014, BBA-MOL BASIS DIS, V1842, P1097, DOI 10.1016/j.bbadis.2014.04.001	44	23	23	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3978	3990		10.1096/fj.201601265R	http://dx.doi.org/10.1096/fj.201601265R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28550045	Green Published, hybrid			2022-12-26	WOS:000408713300023
J	Iyer, SS; Sabula, MJ; Mehta, CC; Haddad, LB; Brown, NL; Amara, RR; Ofotokun, I; Sheth, AN				Iyer, Smita S.; Sabula, Michael J.; Mehta, C. Christina; Haddad, Lisa B.; Brown, Nakita L.; Amara, Rama R.; Ofotokun, Igho; Sheth, Anandi N.			Characteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative women	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; INTEGRIN ALPHA(4)BETA(7); ENVELOPE PROTEIN; CUTTING EDGE; INFECTION; TISSUE; TRANSMISSION; EXPANSION; GUT; CORECEPTOR	Background Understanding the immune profile of CD4 T cells, the primary targets for HIV, in the female genital tract (FGT) is critical for evaluating and developing effective biomedical HIV prevention strategies in women. However, longitudinal investigation of HIV susceptibility markers expressed by FGT CD4 T cells has been hindered by low cellular yield and risk of sampling-associated trauma. We investigated three minimally invasive FGT sampling methods to characterize and compare CD4 T cell yield and phenotype with the goal of establishing feasible sampling strategies for immune profiling of mucosal CD4 T cells. Methods and results FGT samples were collected bimonthly from 12 healthy HIV negative women of reproductive age in the following order: 1) Cervicovaginal lavage (CVL), 2) two sequential endocervical flocked swabs (FS), and 3) two sequential endocervical cytobrushes (CB1, CB2). Cells were isolated and phentoyped via flow cytometry. CD4 T cell recovery was highest from each individual CB compared to either CVL or FS (p < 0.0001). The majority of CD4 T cells within the FGT, regardless of sampling method, expressed CCR5 relative to peripheral blood (p < 0.01). Within the CB, CCR5(+) CD4 T cells expressed significantly higher levels of alpha(4)beta(7), CD69, and low levels of CD27 relative to CCR5(-) CD4 T cells (all p < 0.001). We also identified CD4 Treg lineage cells expressing CCR5 among CB samples. Conclusions Using three different mucosal sampling methods collected longitudinally we demonstrate that CD4 T cells within the FGT express CCR5 and alpha(4)beta(7) and are highly activated, attributes which could act in concert to facilitate HIV acquisition. FS and CB sampling methods can allow for investigation of strategies to reduce HIV target cells in the FGT and could inform the design and interpretation microbicide and vaccine studies in women.	[Iyer, Smita S.; Sabula, Michael J.; Amara, Rama R.] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Div Microbiol & Immunol,Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Mehta, C. Christina] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; [Haddad, Lisa B.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Brown, Nakita L.; Ofotokun, Igho; Sheth, Anandi N.] Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA; [Amara, Rama R.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ofotokun, Igho; Sheth, Anandi N.] Grady Hlth Syst, Grady Infect Dis Program, Atlanta, GA USA	Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; Emory University	Sheth, AN (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30322 USA.; Sheth, AN (corresponding author), Grady Hlth Syst, Grady Infect Dis Program, Atlanta, GA USA.	ansheth@emory.edu	Amara, Rama/AAO-8136-2021; Iyer, Smita/S-5398-2017; Iyer, Swaminathan/GRS-9668-2022; D'Albuquerque, Luiz A Carneiro/I-4011-2012	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Sheth, Anandi/0000-0002-6305-2727; Haddad, Lisa/0000-0002-7631-6760	NIH [1K23AI114407]; NIAID [HHSN 272201300031C]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI114407, U24AI126683, U01AI103408] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976, K01OD023034] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the NIH (1K23AI114407 to ANS). The alpha 4 beta 7 reagent used in these studies was provided by the NIH Nonhuman Primate Reagent Resource (R24 OD010976, and NIAID contract HHSN 272201300031C). Data in this manuscript were collected by the Women's Interagency HIV Study (WINS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). Atlanta WINS Principal Investigators are lghovwerha Ofotokun and Gina Wingood, U01 -AI-103408. The WINS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WINS data collection is also supported by UL1-TR000454 (Atlanta CTSA).; The authors are grateful to Drs. Francois Villinger, Lyle McKinnon, Rupert Kaul, Alison S. Kohlmeier, and Charlene Dezzutti for helpful suggestions on sample processing and analysis. This study was funded by the NIH (1K23AI114407 to ANS). The alpha<INF>4</INF>beta<INF>7</INF> reagent used in these studies was provided by the NIH Nonhuman Primate Reagent Resource (R24 OD010976, and NIAID contract HHSN 272201300031C). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). Atlanta WIHS Principal Investigators are Ighovwerha Ofotokun and Gina Wingood, U01-AI-103408. The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000454 (Atlanta CTSA).	Achilles SL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.016; Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y; Archary D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131906; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bere A, 2010, J IMMUNOL METHODS, V354, P68, DOI 10.1016/j.jim.2010.02.002; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Bull ME, 2014, JAIDS-J ACQ IMM DEF, V67, P357, DOI 10.1097/QAI.0000000000000336; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Chen Nadine E, 2011, Infect Dis Rep, V3; Choi RY, 2012, AIDS, V26, P2155, DOI 10.1097/QAD.0b013e328359b99b; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Dezzutti CS, 2013, CURR HIV-AIDS REP, V10, P12, DOI 10.1007/s11904-012-0148-2; Esra RT, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00245; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Iyer SS, 2015, J IMMUNOL, V195, P994, DOI 10.4049/jimmunol.1500083; Jespers V, 2011, AM J REPROD IMMUNOL, V65, P368, DOI 10.1111/j.1600-0897.2010.00938.x; Jiang Janina, 2011, Curr Trends Immunol, V12, P89; Joag VR, 2015, MUCOSAL IMMUNOLOGY; Koelle DM, 1998, J VIROL, V72, P7476, DOI 10.1128/JVI.72.9.7476-7483.1998; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; Lajoie J, 2014, J INFECT DIS, V210, P319, DOI 10.1093/infdis/jiu023; McClure CP, 2005, AIDS, V19, P1257, DOI 10.1097/01.aids.0000180096.50393.96; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Mestecky J, 2009, J REPROD IMMUNOL, V83, P196, DOI 10.1016/j.jri.2009.07.005; Miles B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9608; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Nakra NA, 2015, J INFECT DIS; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Polanczyk MJ, 2004, J IMMUNOL, V173, P2227, DOI 10.4049/jimmunol.173.4.2227; Prodger JL, 2012, MUCOSAL IMMUNOL, V5, P121, DOI 10.1038/mi.2011.56; Quayle AJ, 2004, AIDS RES HUM RETROV, V20, P543, DOI 10.1089/088922204323087796; Sabbaj S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028894; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Seaton KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101863; Shacklett BL, 2000, AIDS, V14, P1911, DOI 10.1097/00002030-200009080-00005; Turner DL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00331; Veazey RS, 2005, NAT MED, V11, P469, DOI 10.1038/nm0505-469; Yi TH, 2012, INT J DISTRIB SENS N, V2012, P1; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	48	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178193	10.1371/journal.pone.0178193	http://dx.doi.org/10.1371/journal.pone.0178193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570576	Green Published, gold			2022-12-26	WOS:000402611800034
J	Li, W				Li, Wei			How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; DISEASE GENE-PRODUCT; MOTOR-NEURON PROTEIN; TUDOR DOMAIN; MISSENSE MUTATION; STRUCTURAL BASIS; SNRNP PROTEINS; COMPLEX; SURVIVAL; BINDING	Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease with dysfunctional alpha-motor neurons in the anterior horn of the spinal cord. SMA is caused by loss (similar to 95% of SMA cases) or mutation (similar to 5% of SMA cases) of the survival motor neuron 1 gene SMN1. As the product of SMN1, SMN is a component of the SMN complex, and is also involved in the biosynthesis of the small nuclear ribonucleoproteins (snRNPs), which play critical roles in pre-mRNA splicing in the pathogenesis of SMA. To investigate how SMA-linked mutations of SMN1 lead to structural/functional deficiency of SMN, a set of computational analysis of SMN-related structures were conducted and are described in this article. Of extraordinary interest, the structural analysis highlights three SMN residues (Asp44, Glu134 and Gln136) with SMA-linked missense mutations, which cause disruptions of electrostatic interactions for Asp44, Glu134 and Gln136, and result in three functionally deficient SMA-linked SMN mutants, Asp44Val, Glu134Lys and Gln136Glu. From the computational analysis, it is also possible that SMN's Lys45 and Asp36 act as two electrostatic clips at the SMN-Gemin2 complex structure interface.	[Li, Wei] Shantou Univ, Med Coll, Shantou City, Guangdong, Peoples R China	Shantou University	Li, W (corresponding author), Shantou Univ, Med Coll, Shantou City, Guangdong, Peoples R China.	liweiqidong@stu.edu.cn						Alias Laura, 2009, Hum Genet, V125, P29, DOI 10.1007/s00439-008-0598-1; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Cusco I, 2004, NEUROLOGY, V63, P146, DOI 10.1212/01.WNL.0000132634.48815.13; Grimm C, 2013, MOL CELL, V49, P692, DOI 10.1016/j.molcel.2012.12.009; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Hubbard SJ., 1993, NACCESS COMPUTER PRO, P2; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kotani T, 2007, J NEUROL, V254, P624, DOI 10.1007/s00415-006-0410-x; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Man NT, 2008, NEUROLOGY, V71, P1757, DOI 10.1212/01.wnl.0000313038.34337.b1; Martin R, 2012, STRUCTURE, V20, P1929, DOI 10.1016/j.str.2012.08.024; Monani UR, 2003, J CELL BIOL, V160, P41, DOI 10.1083/jcb.200208079; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Prior TW, 2007, J CHILD NEUROL, V22, P952, DOI 10.1177/0883073807305668; Sarachan KL, 2012, BIOCHEM J, V445, P361, DOI 10.1042/BJ20120241; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Seng CO, 2015, HUM MOL GENET, V24, P2138, DOI 10.1093/hmg/ddu734; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Sossi V, 2001, EUR J HUM GENET, V9, P113, DOI 10.1038/sj.ejhg.5200599; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Takarada T, 2017, BRAIN DEV; Tapia O, 2014, J CELL SCI, V127, P939, DOI 10.1242/jcs.138537; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043	44	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178519	10.1371/journal.pone.0178519	http://dx.doi.org/10.1371/journal.pone.0178519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570645	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800070
J	Lim, CH; Chen, HH; Chen, YH; Chen, DY; Huang, WN; Tsai, JJ; Hsieh, TY; Hsieh, CW; Hung, WT; Lin, CT; Lai, KL; Tang, KT; Tseng, CW; Chen, YM				Lim, Chong Hong; Chen, Hsin-Hua; Chen, Yi-Hsing; Chen, Der-Yuan; Huang, Wen-Nan; Tsai, Jaw-Ji; Hsieh, Tsu-Yi; Hsieh, Chia-Wei; Hung, Wei-Ting; Lin, Ching-Tsai; Lai, Kuo-Lung; Tang, Kuo-Tung; Tseng, Chih-Wei; Chen, Yi-Ming			The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan	PLOS ONE			English	Article							POSTMARKETING SURVEILLANCE; TOCILIZUMAB; INFECTIONS; SAFETY; TNF	The objective of this study is to determine the risk of tuberculosis (TB) disease in biologics users among rheumatoid arthritis (RA) patients in Taiwan from 2000 to 2015. This retrospective cohort study enrolled adult RA patients initiated on first biologics at Taichung Veterans General Hospital. TB risks were determined as hazard ratio (HR) with 95% confidence interval (CI) using cox regression. A total of 951 patients were recruited; etanercept (n = 443), adalimumab (n = 332), abatacept (n = 74), golimumab (n = 60), tocilizumab (n = 31) and tofacitinib (n = 11). Twenty-four TB cases were identified; 13 in etanercept and 11 in adalimumab group with the TB incidence rate of 889.3/ 100,000 and 1055.6/ 100,000 patient-years respectively. There was no significant difference in TB risk between adalimumab and etanercept users with an incidence rate ratio of 1.27 (p = 0.556 by Poisson model). Significant 2-year TB risk factors included elderly patient > 65 year-old (HR: 2.72, 95% CI: 1.06-6.99, p = 0.037), history of TB (HR: 6.24, 95% CI: 1.77-22.00, p = 0.004) and daily glucocorticoid use >= 5mg (HR: 5.01, 95% CI: 1.46-17.21, p = 0.010). Sulfasalazine treatment appeared to be protective (HR: 0.32, 95% CI: 0.11-0.97, p = 0.043). Risk management plan (RMP) for TB before initiation of biologics commenced in 2012. The 2-year TB risks after RMP was compared with that before 2012 (HR: 0.67, 95% CI: 0.30-1.49, p = 0.323). Elderly RA patients with a history of previous TB infection and concomitant moderate dose glucocorticoid were at higher risk of TB disease. Concurrent sulfasalazine treatment appeared to be a protective factor against TB disease.	[Lim, Chong Hong] Pulau Pinang Gen Hosp, Dept Internal Med, Rheumatol Unit, Georgetown, Malaysia; [Lim, Chong Hong; Chen, Hsin-Hua; Chen, Yi-Hsing; Chen, Der-Yuan; Huang, Wen-Nan; Tsai, Jaw-Ji; Hsieh, Tsu-Yi; Hsieh, Chia-Wei; Hung, Wei-Ting; Lin, Ching-Tsai; Lai, Kuo-Lung; Tang, Kuo-Tung; Tseng, Chih-Wei; Chen, Yi-Ming] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan; Hsieh, Tsu-Yi; Hung, Wei-Ting; Chen, Yi-Ming] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Yi-Hsing; Chen, Der-Yuan; Huang, Wen-Nan; Chen, Yi-Ming] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Hsin-Hua; Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University	Chen, YM (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Dept Internal Med, Taichung, Taiwan.; Chen, YM (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Chen, YM (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, YM (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.	ymchen1@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Lim, Chong Hong/0000-0003-0752-2154; Tang, Kuo-Tung/0000-0002-5468-1329; Hsieh, Tsu-Yi/0000-0001-9897-6957	Taichung Veterans General Hospital, Taiwan [TCVGH-1057309C]	Taichung Veterans General Hospital, Taiwan	This study was supported by a grant from Taichung Veterans General Hospital, Taiwan (TCVGH-1057309C) to YMC, http://vghtc.gov.tw/home/index.html.	Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; Barnes PF, 2000, AM J RESP CRIT CARE, V161, P1773, DOI 10.1164/ajrccm.161.6.16167; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Brassard P, 2009, ARTHRIT RHEUM-ARTHR, V61, P300, DOI 10.1002/art.24476; Brode SK, 2015, THORAX, V70, P677, DOI 10.1136/thoraxjnl-2014-206470; Cantini F, 2014, J RHEUMATOL, V41, P1, DOI 10.3899/jrheum.140095; Cantini F, 2015, AUTOIMMUN REV, V14, P503, DOI 10.1016/j.autrev.2015.01.011; Carmona L, 2003, J RHEUMATOL, V30, P1436; Centers for Disease Control MoHaW R.O.C. (Taiwan), 2016, TAIW CDC JOINTS HAND; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; CHEN YS, 2012, FORMOS J RHEUMATOL, V26, P8; Chiu YM, 2014, INT J RHEUM DIS, V17, P9, DOI 10.1111/1756-185X.12539; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Kay J, 2015, ANN RHEUM DIS, V74, P538, DOI 10.1136/annrheumdis-2013-204195; Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368; Koike T, 2014, J RHEUMATOL, V41, P15, DOI 10.3899/jrheum.130466; Koike T, 2011, ANN RHEUM DIS, V70, P2148, DOI 10.1136/ard.2011.151092; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lim CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166339; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Lorenzetti R, 2014, ANN MED, V46, P547, DOI 10.3109/07853890.2014.941919; Rainsford KD, 2015, INFLAMMOPHARMACOLOGY, V23, P231, DOI 10.1007/s10787-015-0239-y; Roth A. R., 2012, RHEUMATOLOGY, V51, P38, DOI DOI 10.1093/RHEUMAT0L0GY/KES114; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Weinblatt ME, 2013, J RHEUMATOL, V40, P787, DOI 10.3899/jrheum.120906; Westhovens R, 2009, J RHEUMATOL, V36, P736, DOI 10.3899/jrheum.080813; Winthrop KL, 2016, ANN RHEUM DIS, V75, P1133, DOI 10.1136/annrheumdis-2015-207319; Xie X, 2014, J MICROBIOL IMMUNOL, V47, P268, DOI 10.1016/j.jmii.2013.03.005; Yasui K, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-45	31	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178035	10.1371/journal.pone.0178035	http://dx.doi.org/10.1371/journal.pone.0178035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570568	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800023
J	Martin-Fores, I; Guerin, GR; Lowe, AJ				Martin-Fores, Irene; Guerin, Greg R.; Lowe, Andrew J.			Weed abundance is positively correlated with native plant diversity in grasslands of southern Australia	PLOS ONE			English	Article							INVASIVE ALIEN PLANTS; SPECIES COMPOSITION; IMPACTS; DOMINANCE; POLICY; BIODIVERSITY; COMMUNITIES; ECOSYSTEMS; MANAGEMENT; CALIFORNIA	Weeds are commonly considered a threat to biodiversity, yet interactions between native and exotic species in grasslands are poorly understood and reported results vary depending on the spatial scale of study, the factors controlled for and the response variables analysed. We tested whether weed presence and abundance is related to declines in biodiversity in Australian grasslands. We employed existing field data from 241 plots along a disturbance gradient and correlated species richness, cover and Shannon diversity for natives and exotics, controlling for seasonal rainfall, climatic gradients and nutrient status. We found no negative relationships in terms of emergent diversity metrics and occupation of space, indeed, many positive relationships were revealed. When split by land-use, differences were found along the disturbance gradient. In high-moderately disturbed grasslands associated with land-uses such as cropping and modified pastures, positive associations were enhanced. Tolerance and facilitation mechanisms may be involved, such as complementary roles through different life history strategies: the exotic flora was dominated mainly by annual grasses and herbs whereas the native flora represented more diverse growth-forms with a higher proportion of perennials. The positive relationships existing between native and exotic plant species in high-moderately disturbed grasslands of South Australia are most likely due to facilitation through different strategies in occupation of space given that the effect of habitat suitability was controlled for by including environmental and disturbance factors. Consequently, although particular weeds may negatively impact biodiversity, this cannot be generalised and management focusing on general weed eradication in grasslands might be ineffectual.	[Martin-Fores, Irene] Univ Complutense Madrid, Dept Ecol, Madrid, Spain; [Martin-Fores, Irene; Guerin, Greg R.] Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide, SA, Australia; [Lowe, Andrew J.] Univ Adelaide, Sch Biol Sci, Environm Inst, Adelaide, SA, Australia	Complutense University of Madrid; University of Adelaide; University of Adelaide	Martin-Fores, I (corresponding author), Univ Complutense Madrid, Dept Ecol, Madrid, Spain.; Martin-Fores, I (corresponding author), Univ Adelaide, Sch Biol Sci, Terr Ecosyst Res Network, Adelaide, SA, Australia.	imfores@pdi.ucm.es	Guerin, Greg R./R-8955-2019; Martín-Forés, Irene/F-3544-2016	Martín-Forés, Irene/0000-0003-3627-0347; Lowe, Andrew/0000-0003-1139-2516; Guerin, Greg/0000-0002-2104-6695	Australian Transect Network; Terrestrial Ecosystem Research Network (TERN)	Australian Transect Network; Terrestrial Ecosystem Research Network (TERN)	This project was supported by the 'Australian Transect Network' and AusPlots facilities of the Terrestrial Ecosystem Research Network (TERN). We thank Emrys Leitch, Michelle Rodrigo and the South Australian Department of Environment, Water and Natural Resources.	[Anonymous], 2016, LAND US AUSTR 2010 1; Arianoutsou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079174; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; Casado MA, 2015, DIVERS DISTRIB, V21, P609, DOI 10.1111/ddi.12326; Cleland EE, 2004, ECOL LETT, V7, P947, DOI 10.1111/j.1461-0248.2004.00655.x; Courchamp F., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P285; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; De Miguel JM, 2010, PLANT ECOL, V210, P97, DOI 10.1007/s11258-010-9741-x; FIGUEROA ME, 1991, J ECOL, V79, P925, DOI 10.2307/2261089; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Gornish ES, 2016, RESTOR ECOL, V24, P222, DOI 10.1111/rec.12308; Guo QF, 2015, PLANT ECOL, V216, P1225, DOI 10.1007/s11258-015-0503-7; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Heard L.M., 1997, GUIDE NATIVE VEGETAT; Humphries SE, 1991, PLANT INVASIONS INCI, V2, P1; Hutchinson M, 2014, MONTHLY TOTAL PRECIP; Hyde M.K., 1995, TEMPERATE GRASSLANDS; Kalusova V, 2013, DIVERS DISTRIB, V19, P199, DOI 10.1111/ddi.12008; Keeley JE, 2003, ECOL APPL, V13, P1355, DOI 10.1890/02-5002; Kim S., 2015, PART SEM PART PART C; KLOOT P M, 1987, Journal of the Adelaide Botanic Gardens, V10, P99; Kulmatiski A, 2006, PLANT ECOL, V187, P261, DOI 10.1007/s11258-006-9140-5; Lenz TI, 2003, AUSTRAL ECOL, V28, P23, DOI 10.1046/j.1442-9993.2003.01238.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lowe S, 2000, 100 WORLDS WORST INV, P12; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Martin-Fores I, 2016, J PLANT ECOL, V9, P682, DOI 10.1093/jpe/rtw043; Martin-Fores I, 2015, BIOL INVASIONS, V17, P1425, DOI 10.1007/s10530-014-0805-z; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Parry J, 2016, AUST J BOT, V64, P484, DOI 10.1071/BT16094; PECO B, 1983, Ecologia Mediterranea, V9, P63; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pienkowski T, 2015, ECOL ECON, V112, P68, DOI 10.1016/j.ecolecon.2015.02.012; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prober SM, 2016, BIOL INVASIONS, V18, P3001, DOI 10.1007/s10530-016-1194-2; R Core Team, 2013, R LANG ENV STAT COMP; ROBERTSON MA, 1998, BIOL SURVEY GRASSLAN; Robinson A. C., 1988, BIOL SURVEY GAWLER R; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Saul Wolf-Christian, 2013, NeoBiota, V17, P57; Sax DF, 2002, DIVERS DISTRIB, V8, P193, DOI 10.1046/j.1472-4642.2002.00147.x; Schlaepfer MA, 2012, CONSERV BIOL, V26, P1156, DOI 10.1111/j.1523-1739.2012.01948.x; Seabloom EW, 2013, GLOBAL CHANGE BIOL, V19, P3677, DOI 10.1111/gcb.12370; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Tognetti PM, 2012, BIOL INVASIONS, V14, P2531, DOI 10.1007/s10530-012-0249-2; Tognetti PM, 2010, BIOL CONSERV, V143, P2494, DOI 10.1016/j.biocon.2010.06.016; Turner J, 2012, NATL RECOVERY PLAN I; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; van der Maarel E, 2007, J VEG SCI, V18, P767, DOI 10.1111/j.1654-1103.2007.tb02592.x; Van Riel P, 2000, TRENDS ECOL EVOL, V15, P515; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	59	22	23	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178681	10.1371/journal.pone.0178681	http://dx.doi.org/10.1371/journal.pone.0178681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570604	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800103
J	Stronen, AV; Salmela, E; Baldursdottir, BK; Berg, P; Espelien, IS; Jarvi, K; Jensen, H; Kristensen, TN; Melis, C; Manenti, T; Lohi, H; Pertoldi, C				Stronen, Astrid V.; Salmela, Elina; Baldursdottir, Birna K.; Berg, Peer; Espelien, Ingvild S.; Jarvi, Kirsi; Jensen, Henrik; Kristensen, Torsten N.; Melis, Claudia; Manenti, Tommaso; Lohi, Hannes; Pertoldi, Cino			Genetic rescue of an endangered domestic animal through outcrossing with closely related breeds: A case study of the Norwegian Lundehund	PLOS ONE			English	Article							POPULATION; CONSERVATION; ANCESTRY; MODEL; LOCI	Genetic rescue, outcrossing with individuals from a related population, is used to augment genetic diversity in populations threatened by severe inbreeding and extinction. The endangered Norwegian Lundehund dog underwent at least two severe bottlenecks in the 1940s and 1960s that each left only five inbred dogs, and the approximately 1500 dogs remaining world-wide today appear to descend from only two individuals. The Lundehund has a high prevalence of a gastrointestinal disease, to which all remaining dogs may be predisposed. Outcrossing is currently performed with three Nordic Spitz breeds: Norwegian Buhund, Icelandic Sheepdog, and Norrbottenspets. Examination of single nucleotide polymorphism (SNP) genotypes based on 165K loci in 48 dogs from the four breeds revealed substantially lower genetic diversity for the Lundehund (H-E 0.035) than for other breeds (H-E 0.209-0.284). Analyses of genetic structure with > 15K linkage disequilibrium-pruned SNPs showed four distinct genetic clusters. Pairwise F-ST values between Lundehund and the candidate breeds were highest for Icelandic Sheepdog, followed by Buhund and Norrbottenspets. We assessed the presence of outlier loci among candidate breeds and examined flanking genome regions (1 megabase) for genes under possible selection to identify potential adaptive differences among breeds; outliers were observed in flanking regions of genes associated with key functions including the immune system, metabolism, cognition and physical development. We suggest crossbreeding with multiple breeds as the best strategy to increase genetic diversity for the Lundehund and to reduce the incidence of health problems. For this project, the three candidate breeds were first selected based on phenotypes and then subjected to genetic investigation. Because phenotypes are often paramount for domestic breed owners, such a strategy could provide a helpful approach for genetic rescue and restoration of other domestic populations at risk, by ensuring the involvement of owners, breeders and managers at the start of the project.	[Stronen, Astrid V.; Kristensen, Torsten N.; Pertoldi, Cino] Aalborg Univ, Sect Biol & Environm Sci, Dept Chem & Biosci, Aalborg, Denmark; [Salmela, Elina; Jarvi, Kirsi; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Salmela, Elina; Jarvi, Kirsi; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Salmela, Elina; Jarvi, Kirsi; Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland; [Salmela, Elina] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Baldursdottir, Birna K.] Icelandic Genet Resource Ctr, Hvanneyri, Borganes, Iceland; [Berg, Peer] Nordic Genet Resource Ctr, As, Norway; [Espelien, Ingvild S.] Norwegian Lundehund Club, Trondheim, Norway; [Jensen, Henrik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Biodivers Dynam, Trondheim, Norway; [Kristensen, Torsten N.; Manenti, Tommaso] Aarhus Univ, Sect Genet Ecol & Evolut, Dept Biosci, Aarhus C, Denmark; [Melis, Claudia] Queen Maud Univ, Coll Early Childhood Educ, Trondheim, Norway; [Pertoldi, Cino] Aalborg Zoo, Aalborg, Denmark	Aalborg University; University of Helsinki; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Norwegian University of Science & Technology (NTNU); Aarhus University	Stronen, AV (corresponding author), Aalborg Univ, Sect Biol & Environm Sci, Dept Chem & Biosci, Aalborg, Denmark.	avs@bio.aau.dk	Pertoldi, Cino/I-1746-2012; Melis, Claudia/B-5411-2009; Dietz, Rune/F-9154-2015; Melis, Claudia/Y-3538-2019; Lohi, Hannes/F-4596-2011; Stronen, Astrid Vik/AFJ-8208-2022; Kristensen, Torsten N/C-5031-2015; Melis, Claudia/AAK-9267-2020; Jensen, Henrik/B-5085-2011	Pertoldi, Cino/0000-0002-4644-8981; Dietz, Rune/0000-0001-9652-317X; Lohi, Hannes/0000-0003-1087-5532; Stronen, Astrid Vik/0000-0002-5169-6736; Kristensen, Torsten N/0000-0001-6204-8753; Melis, Claudia/0000-0001-8315-9129; Jensen, Henrik/0000-0001-7804-1564; Salmela, Elina/0000-0003-1326-4462	Danish Natural Science Research Council [1337-00007, 21-01- 0526, 21-03-0125, 95095995]; Aalborg Zoo Conservation Foundation (AZCF); Jane and Aatos Erkko Foundation; Jenny and Antti Wihuri Foundation (ES); Academy of Finland; Biocentrum Helsinki; Research Council of Norway [221956]; Norwegian Genetic Resource Center	Danish Natural Science Research Council(Danish Natural Science Research Council); Aalborg Zoo Conservation Foundation (AZCF); Jane and Aatos Erkko Foundation; Jenny and Antti Wihuri Foundation (ES); Academy of Finland(Academy of Finland); Biocentrum Helsinki; Research Council of Norway(Research Council of Norway); Norwegian Genetic Resource Center	AVS received funding from the Danish Natural Science Research Council (postdoctoral grant 1337-00007). The study was partly supported by the Danish Natural Science Research Council grant number: #21-01- 0526, #21-03-0125 and 95095995, and the Aalborg Zoo Conservation Foundation (AZCF) for CP, the Jane and Aatos Erkko Foundation (HL), the Jenny and Antti Wihuri Foundation (ES), the Academy of Finland (HL), and Biocentrum Helsinki (HL). HJ was supported by grant number 221956 from the Research Council of Norway. A portion of the SNP analyses was financed by the Norwegian Genetic Resource Center.	Alexander D.H., 2015, ADMIXTURE 1 3 SOFTWA; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Berghoff N, 2007, COMP CONT EDUC PRACT, V29, P456; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Espelien I.S., 2012, LUNDEHUNDBOKA; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Galis F, 2001, TRENDS ECOL EVOL, V16, P637, DOI 10.1016/S0169-5347(01)02289-3; Heber S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2228; Hedrick PW, 2016, TRENDS ECOL EVOL, V31, P940, DOI 10.1016/j.tree.2016.09.005; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Kettunen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170039; Kristensen TN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00038; Kropatsch R, 2015, J HERED, V106, P403, DOI 10.1093/jhered/esv031; Melis C, 2013, ANIM GENET, V44, P348, DOI 10.1111/age.12000; Metzger J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2844-6; Miller JM, 2012, MOL ECOL, V21, P1583, DOI 10.1111/j.1365-294X.2011.05427.x; Noh H, 2014, J CLIN PHARM THER, V39, P215, DOI 10.1111/jcpt.12136; Park K, 2008, GENETICS, V179, P2163, DOI 10.1534/genetics.108.087114; Pfahler S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122680; Pfahler S, 2014, ANIM GENET, V45, P154, DOI 10.1111/age.12084; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qvigstad G, 2008, J COMP PATHOL, V139, P194, DOI 10.1016/j.jcpa.2008.07.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Sarig O, 2012, AM J HUM GENET, V91, P337, DOI 10.1016/j.ajhg.2012.06.003; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Voikar V, 2013, BEHAV BRAIN RES, V238, P69, DOI 10.1016/j.bbr.2012.10.013; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009	33	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177429	10.1371/journal.pone.0177429	http://dx.doi.org/10.1371/journal.pone.0177429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570553	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800009
J	Flaherty, M; Dent, ML; Sawusch, JR				Flaherty, Mary; Dent, Micheal L.; Sawusch, James R.			Experience with speech sounds is not necessary for cue trading by budgerigars (Melopsittacus undulatus)	PLOS ONE			English	Article							VOICED-VOICELESS DISTINCTION; INITIAL STOP CONSONANTS; NONSPEECH SOUNDS; MOTOR THEORY; FORMANT TRANSITIONS; AMERICAN ENGLISH; JUDGMENTS RESULT; CROSS-LANGUAGE; ACOUSTIC CUES; PERCEPTION	The influence of experience with human speech sounds on speech perception in budgerigars, vocal mimics whose speech exposure can be tightly controlled in a laboratory setting, was measured. Budgerigars were divided into groups that differed in auditory exposure and then tested on a cue-trading identification paradigm with synthetic speech. Phonetic cue trading is a perceptual phenomenon observed when changes on one cue dimension are offset by changes in another cue dimension while still maintaining the same phonetic percept. The current study examined whether budgerigars would trade the cues of voice onset time (VOT) and the first formant onset frequency when identifying syllable initial stop consonants and if this would be influenced by exposure to speech sounds. There were a total of four different exposure groups: No speech exposure (completely isolated), Passive speech exposure (regular exposure to human speech), and two Speech-trained groups. After the exposure period, all budgerigars were tested for phonetic cue trading using operant conditioning procedures. Birds were trained to peck keys in response to different synthetic speech sounds that began with "d" or "t" and varied in VOT and frequency of the first formant at voicing onset. Once training performance criteria were met, budgerigars were presented with the entire intermediate series, including ambiguous sounds. Responses on these trials were used to determine which speech cues were used, if a trading relation between VOT and the onset frequency of the first formant was present, and whether speech exposure had an influence on perception. Cue trading was found in all birds and these results were largely similar to those of a group of humans. Results indicated that prior speech experience was not a requirement for cue trading by budgerigars. The results are consistent with theories that explain phonetic cue trading in terms of a rich auditory encoding of the speech signal.	[Flaherty, Mary; Dent, Micheal L.; Sawusch, James R.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dent, ML (corresponding author), SUNY Buffalo, Dept Psychol, Buffalo, NY 14226 USA.	mdent@buffalo.edu	Flaherty, Mary/AAU-3768-2020		Mark Diamond Research Fund	Mark Diamond Research Fund	This work was supported by the Mark Diamond Research Fund to MF. The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Banta P. A., 1995, Society for Neuroscience Abstracts, V21, P964; Benki J. R., 2005, P 4 INT S BIL, P240; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Best C., 2007, HONOR JAMES EMIL FLE, V1334, P1, DOI DOI 10.1075/LLLT.17.07BES; BEST CT, 1981, PERCEPT PSYCHOPHYS, V29, P191, DOI 10.3758/BF03207286; Dent ML, 1997, J ACOUST SOC AM, V102, P1891, DOI 10.1121/1.420111; Diehl, 1989, ECOL PSYCHOL, V1, P1, DOI [10.1207/s15326969eco0102_2, DOI 10.1207/s15326969eco0102_2]; Diehl RL, 2004, ANNU REV PSYCHOL, V55, P149, DOI 10.1146/annurev.psych.55.090902.142028; DOOLING RJ, 1989, PERCEPT PSYCHOPHYS, V46, P65, DOI 10.3758/BF03208075; DOOLING RJ, 1990, PERCEPT PSYCHOPHYS, V47, P568, DOI 10.3758/BF03203109; EIMAS PD, 1985, SCI AM, V252, P46, DOI 10.1038/scientificamerican0185-46; Engen T., 1971, WOODWORTH SCHLOSBERG, P47; Fadiga L, 2003, BRAIN COGNITION, V53, P514, DOI 10.1016/S0278-2626(03)00212-4; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Finney D.J., 1971, PROBIT ANAL; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fowler CA, 2003, HDB BRAIN THEORY NEU, P705; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; HILLENBRAND J, 1984, J ACOUST SOC AM, V75, P231, DOI 10.1121/1.390400; Klatt DH, 1980, J ACOUST SOC AM, P67; Kluender K.R., 1994, HDB PSYCHOLINGUISTIC, P173; KLUENDER KR, 1994, J ACOUST SOC AM, V95, P1044, DOI 10.1121/1.408466; KLUENDER KR, 1991, J ACOUST SOC AM, V90, P83, DOI 10.1121/1.402285; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; KUHL PK, 1981, J ACOUST SOC AM, V70, P340, DOI 10.1121/1.386782; Leech R, 2009, J NEUROSCI, V29, P5234, DOI 10.1523/JNEUROSCI.5758-08.2009; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1981, PERCEPT PSYCHOPHYS, V30, P133, DOI 10.3758/BF03204471; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; LIBERMAN AM, 1958, LANG SPEECH, V1, P153, DOI 10.1177/002383095800100301; LISKER L, 1986, LANG SPEECH, V29, P3, DOI 10.1177/002383098602900102; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; LISKER L, 1975, J ACOUST SOC AM, V57, P1547, DOI 10.1121/1.380602; LISKER L, 1970, P 6 INT C PHON SCI P, P563; Lotto AJ, 1998, PERCEPT PSYCHOPHYS, V60, P602, DOI 10.3758/BF03206049; Lotto AJ, 1997, J ACOUST SOC AM, V102, P1134, DOI 10.1121/1.419865; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; Massaro DW, 2008, PSYCHON B REV, V15, P453, DOI 10.3758/PBR.15.2.453; MILLER JL, 1983, COGNITION, V13, P135, DOI 10.1016/0010-0277(83)90020-3; Mirman D, 2004, J ACOUST SOC AM, V116, P1198, DOI 10.1121/1.1766020; MORRONGIELLO BA, 1984, J EXP CHILD PSYCHOL, V38, P429, DOI 10.1016/0022-0965(84)90086-9; Moulin-Frier C, 2013, BIOL CYBERN, V107, P421, DOI 10.1007/s00422-013-0557-3; NITTROUER S, 1992, J PHONETICS, V20, P351, DOI 10.1016/S0095-4470(19)30639-4; Ohms VR, 2012, ANIM COGN, V15, P155, DOI 10.1007/s10071-011-0441-2; Pisoni DB, 1987, PSYCHOPHYSICS SPEECH; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; RAND TC, 1974, J ACOUST SOC AM, V55, P678, DOI 10.1121/1.1914584; REPP BH, 1979, LANG SPEECH, V22, P173, DOI 10.1177/002383097902200207; Repp BH, 1981, SS73 HASK LAB STAT R; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; SAWUSCH JR, 1995, J EXP PSYCHOL HUMAN, V21, P635, DOI 10.1037/0096-1523.21.3.635; Schwartz JL, 2012, J NEUROLINGUIST, V25, P336, DOI 10.1016/j.jneuroling.2009.12.004; SIMON C, 1978, J ACOUST SOC AM, V63, P925, DOI 10.1121/1.381772; Sinnott JM, 1997, J ACOUST SOC AM, V102, P588, DOI 10.1121/1.419732; Sinnott JM, 2000, PERCEPT PSYCHOPHYS, V62, P1312, DOI 10.3758/BF03212132; Sinnott JM, 1998, PERCEPT PSYCHOPHYS, P60; STEVENS KN, 1974, J ACOUST SOC AM, V55, P653, DOI 10.1121/1.1914578; SUMMERFIELD Q, 1977, J ACOUST SOC AM, V62, P435, DOI 10.1121/1.381544; UNDERBAKKE M, 1988, J ACOUST SOC AM, V84, P90, DOI 10.1121/1.396878; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Welch TE, 2009, J ACOUST SOC AM, V126, P2779, DOI 10.1121/1.3212923; WHALEN DH, 1987, SCIENCE, V237, P169, DOI 10.1126/science.3603014	66	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177676	10.1371/journal.pone.0177676	http://dx.doi.org/10.1371/journal.pone.0177676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562597	Green Submitted, gold, Green Published			2022-12-26	WOS:000402608700020
J	LeKieffre, C; Spangenberg, JE; Mabilleau, G; Escrig, S; Meibom, A; Geslin, E				LeKieffre, Charlotte; Spangenberg, Jorge E.; Mabilleau, Guillaume; Escrig, Stephane; Meibom, Anders; Geslin, Emmanuelle			Surviving anoxia in marine sediments: The metabolic response of ubiquitous benthic foraminifera (Ammonia tepida)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; OXYGEN MINIMUM ZONE; GULF-OF-MEXICO; DEEP-SEA; DIFFERENTIAL RESPONSE; MEIOFAUNA; BIOMARKER; HYPOXIA; CARBON; PHYTODETRITUS	High input of organic carbon and/or slowly renewing bottom waters frequently create periods with low dissolved oxygen concentrations on continental shelves and in coastal areas; such events can have strong impacts on benthic ecosystems. Among the meiofauna living in these environments, benthic foraminifera are often the most tolerant to low oxygen levels. Indeed, some species are able to survive complete anoxia for weeks to months. One known mechanism for this, observed in several species, is denitrification. For other species, a state of highly reduced metabolism, essentially a state of dormancy, has been proposed but never demonstrated. Here, we combined a 4 weeks feeding experiment, using C-13-enriched diatom biofilm, with correlated TEM and NanoSIMS imaging, plus bulk analysis of concentration and stable carbon isotopic composition of total organic matter and individual fatty acids, to study metabolic differences in the intertidal species Ammonia tepida exposed to oxic and anoxic conditions. Strongly contrasting cellular-level dynamics of ingestion and transfer of the ingested biofilm components were observed between the two conditions. Under oxic conditions, within a few days, intact diatoms were ingested, degraded, and their components assimilated, in part for biosynthesis of different cellular components: C-13-labeled lipid droplets formed after a few days and were subsequently lost (partially) through respiration. In contrast, in anoxia, fewer diatoms were initially ingested and these were not assimilated or metabolized further, but remained visible within the foraminiferal cytoplasm even after 4 weeks. Under oxic conditions, compound specific C-13 analyses showed substantial de novo synthesis by the foraminifera of specific polyunsaturated fatty acids (PUFAs), such as 20:4(n-6). Very limited PUFA synthesis was observed under anoxia. Together, our results show that anoxia induced a greatly reduced rate of heterotrophic metabolism in Ammonia tepida on a time scale of less than 24 hours, these observations are consistent with a state of dormancy.	[LeKieffre, Charlotte; Escrig, Stephane; Meibom, Anders] Ecole Polytech Fed Lausanne, ENAC, Sch Architecture Civil & Environm Engn, Lab Biol Geochem, Lausanne, Switzerland; [Spangenberg, Jorge E.] Univ Lausanne, IDYST, Inst Earth Surface Dynam, Stable Isotope & Organ Geochem Labs, Lausanne, Switzerland; [Mabilleau, Guillaume] Univ Angers, Inst Biol Sante, SCIAM, Angers, France; [Meibom, Anders] Univ Lausanne, Inst Earth Sci, Ctr Adv Surface Anal, Lausanne, Switzerland; [Geslin, Emmanuelle] Univ Angers, BIAF, LPG, UMR CNRS 6112, Angers, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Universite d'Angers; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers	LeKieffre, C; Meibom, A (corresponding author), Ecole Polytech Fed Lausanne, ENAC, Sch Architecture Civil & Environm Engn, Lab Biol Geochem, Lausanne, Switzerland.; Meibom, A (corresponding author), Univ Lausanne, Inst Earth Sci, Ctr Adv Surface Anal, Lausanne, Switzerland.; Geslin, E (corresponding author), Univ Angers, BIAF, LPG, UMR CNRS 6112, Angers, France.	charlotte.lekieffre@epfl.ch; anders.meibom@epfl.ch; emmanuelle.geslin@univ-angers.fr	Mabilleau, Guillaume/M-8261-2018	Mabilleau, Guillaume/0000-0003-1445-329X; Escrig, Stephane/0000-0002-7525-4000; Meibom, Anders/0000-0002-4542-2819; Spangenberg, Jorge E./0000-0001-8636-6414	French Centre National de la Recherche Scientifique - Institut Nationaldes Sciences de l'Univers [EC2CO N-Forlab]; Swiss National Science Foundation [200021_149333]	French Centre National de la Recherche Scientifique - Institut Nationaldes Sciences de l'Univers(Centre National de la Recherche Scientifique (CNRS)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Experiment I was supported by a grant EC2CO N-Forlab from the French Centre National de la Recherche Scientifique - Institut Nationaldes Sciences de l'Univers (www.insu.cnrs.fr) (EG). Experiment II was funded by a grant no. 200021_149333 from the Swiss National Science Foundation (AM). The funders had no role in study design, data collection and analysis, decisionto publish, or preparation of the manuscript.	Alve E, 2001, J FORAMIN RES, V31, P12, DOI 10.2113/0310012; ANGELL RW, 1967, J PROTOZOOL, V14, P299, DOI 10.1111/j.1550-7408.1967.tb02001.x; [Anonymous], 1977, CAH MICROPALEONTOLOG, V3, P1; Be A. W. H, 1977, Micropaleontology, V23, P155, DOI 10.2307/1485330; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; Bernhard JM, 1996, MAR MICROPALEONTOL, V28, P5, DOI 10.1016/0377-8398(95)00036-4; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; Bernhard JM, 1999, EARTH-SCI REV, V46, P149, DOI 10.1016/S0012-8252(99)00017-3; Bernhard JM, 2003, SCIENCE, V299, P861, DOI 10.1126/science.1077314; BERNHARD JM, 1995, J EUKARYOT MICROBIOL, V42, P357, DOI 10.1111/j.1550-7408.1995.tb01594.x; Bernhard JM, 2010, ENVIRON MICROBIOL, V12, P2107, DOI 10.1111/j.1462-2920.2009.02073.x; Bianchi TS, 2000, J EXP MAR BIOL ECOL, V251, P161, DOI 10.1016/S0022-0981(00)00212-4; Bollmann J, 2004, DEV PALEOENVIRON RES, V7, P229; Bouchet VMP, 2009, J EXP MAR BIOL ECOL, V371, P20, DOI 10.1016/j.jembe.2008.12.012; Caulle C, 2014, BIOGEOSCIENCES, V11, P1155, DOI 10.5194/bg-11-1155-2014; Debenay JP, 2000, T GEOBIOL, V15, P39; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Enge AJ, 2014, BIOGEOSCIENCES, V11, P2017, DOI 10.5194/bg-11-2017-2014; Geslin E, 2011, J EXP MAR BIOL ECOL, V396, P108, DOI 10.1016/j.jembe.2010.10.011; Geslin E, 2014, ENVIRON SCI ENG, P163, DOI 10.1007/978-4-431-54388-6_10; Glud RN, 2009, LIMNOL OCEANOGR, V54, P723, DOI 10.4319/lo.2009.54.3.0723; GOLDSTEIN ST, 1994, DEEP-SEA RES PT I, V41, P229, DOI 10.1016/0967-0637(94)90001-9; Gooday AJ, 2008, GEOL SOC SPEC PUBL, V303, P97, DOI 10.1144/SP303.8; Gooday AJ, 2000, DEEP-SEA RES PT II, V47, P25, DOI 10.1016/S0967-0645(99)00099-5; GOODAY AJ, 1992, NATO ADV SCI I C-MAT, V360, P63; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; GRAEVE M, 1994, J EXP MAR BIOL ECOL, V182, P97, DOI 10.1016/0022-0981(94)90213-5; Grzymski J, 2002, LIMNOL OCEANOGR, V47, P1569, DOI 10.4319/lo.2002.47.6.1569; Heinz P, 2012, CELL ORIG LIFE EXTRE, V21, P289; Helly JJ, 2004, DEEP-SEA RES PT I, V51, P1159, DOI 10.1016/j.dsr.2004.03.009; Hogslund S, 2008, J EXP MAR BIOL ECOL, V359, P85, DOI 10.1016/j.jembe.2008.02.015; Hoppe P, 2013, GEOSTAND GEOANAL RES, V37, P111, DOI 10.1111/j.1751-908X.2013.00239.x; HOTTINGER L, 1982, NATURWISSENSCHAFTEN, V69, P361, DOI 10.1007/BF00396687; HOTTINGER L, 1974, MAR BIOL, V25, P41, DOI 10.1007/BF00395107; Jorissen FJ, 1999, MODERN FORAMINIFERA, P161; JOSEFSON AB, 1988, MAR BIOL, V100, P31, DOI 10.1007/BF00392952; Kamp A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01492; KITAZATO H, 1995, BIOGEOCHEMICAL PROCE, P331; Kopp C, 2013, MBIO, V4, DOI 10.1128/mBio.00052-13; Kopp C, 2015, MBIO, V6, DOI 10.1128/mBio.02299-14; Langlet D, 2013, BIOGEOSCIENCES, V10, P7463, DOI 10.5194/bg-10-7463-2013; Larkin KE, 2014, BIOGEOSCIENCES, V11, P3729, DOI 10.5194/bg-11-3729-2014; Le Cadre V, 2006, ENVIRON POLLUT, V143, P304, DOI 10.1016/j.envpol.2005.11.033; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Linshy VN, 2014, ENVIRON SCI ENG, P115, DOI 10.1007/978-4-431-54388-6_8; Maire O, 2016, MAR ECOL PROG SER, V561, P83, DOI 10.3354/meps11929; Mallon J, 2012, CELL ORIG LIFE EXTRE, V21, P307; MCENERY M E, 1981, Micropaleontology (New York), V27, P71, DOI 10.2307/1485378; Moodley L, 2000, MAR ECOL PROG SER, V202, P289, DOI 10.3354/meps202289; Moodley L, 1997, MAR ECOL PROG SER, V158, P151, DOI 10.3354/meps158151; Moodley L, 2008, J EXP MAR BIOL ECOL, V357, P41, DOI 10.1016/j.jembe.2007.12.025; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Nardelli MP, 2014, BIOGEOSCIENCES, V11, P4029, DOI 10.5194/bg-11-4029-2014; Nomaki H, 2005, LIMNOL OCEANOGR, V50, P134, DOI 10.4319/lo.2005.50.1.0134; Nomaki H, 2016, AQUAT MICROBIOL, V163; Nomaki H, 2006, MAR ECOL PROG SER; Nomaki H, 2014, LIMNOL OCEANOGR, V59, P1879, DOI 10.4319/lo.2014.59.6.1879; Nomaki H, 2009, DEEP-SEA RES PT I, V56, P1488, DOI 10.1016/j.dsr.2009.04.013; Pascal PY, 2008, J SEA RES, V60, P151, DOI 10.1016/j.seares.2008.05.003; Pascal PY, 2008, J EXP MAR BIOL ECOL, V359, P55, DOI 10.1016/j.jembe.2008.02.018; Pawlowski J, 1995, P 4 INT WORKSH AGGL, P233; Pernice M, 2012, ISME J, V6, P1314, DOI 10.1038/ismej.2011.196; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; Polerecky L, 2012, ENVIRON MICROBIOL, V14, P1009, DOI 10.1111/j.1462-2920.2011.02681.x; PREVOT P, 1978, CR ACAD SCI D NAT, V287, P833; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Ross BJ, 2016, J FORAMINIFER RES, V46; Sargent J.R., 1987, P119; SenGupta BK, 1997, J FORAMIN RES, V27, P292, DOI 10.2113/gsjfr.27.4.292; SENGUPTA BK, 1994, GEO-MAR LETT, V14, P88, DOI 10.1007/BF01203719; SNIDER LJ, 1984, DEEP-SEA RES, V31, P1225, DOI 10.1016/0198-0149(84)90059-1; Spangenberg JE, 2014, ORG GEOCHEM, V69, P11, DOI 10.1016/j.orggeochem.2014.01.015; Stachowitsch Michael, 1991, Geological Society Special Publication, V58, P119, DOI 10.1144/GSL.SP.1991.058.01.09; Suhr SB, 2003, MAR ECOL PROG SER, V262, P153, DOI 10.3354/meps262153; Suhr SB, 2008, MAR ECOL PROG SER, V371, P155, DOI 10.3354/meps07693; Thibault de Chanvalon A, 2015, BIOGEOSCIENCES, V12, P6219, DOI 10.5194/bg-12-6219-2015; Ward JN, 2003, MAR ENVIRON RES, V56, P515, DOI 10.1016/S0141-1136(03)00040-0; Wetzel MA, 2001, COAST EST S, V58, P165; Woulds C, 2007, LIMNOL OCEANOGR, V52, P1698, DOI 10.4319/lo.2007.52.4.1698; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P2027, DOI 10.1016/j.dsr2.2011.05.013; ZHUKOVA NV, 1995, PHYTOCHEMISTRY, V39, P351, DOI 10.1016/0031-9422(94)00913-E	83	42	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177604	10.1371/journal.pone.0177604	http://dx.doi.org/10.1371/journal.pone.0177604			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562648	gold, Green Published, Green Submitted			2022-12-26	WOS:000402608700019
J	Shin, S; Thapa, SK; Fung, HL				Shin, Soyoung; Thapa, Subindra Kazi; Fung, Ho-Leung			Cellular interactions between L-arginine and asymmetric dimethylarginine: Transport and metabolism	PLOS ONE			English	Article							PLASMA-MEMBRANE VESICLES; AORTIC ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHESIS; CARDIOVASCULAR-DISEASE; ENDOGENOUS INHIBITOR; NO PRODUCTION; DIMETHYLAMINOHYDROLASE; PURIFICATION; SYNTHASE; PARADOX	This study was aimed to examine the effect of L-arginine (ARG) exposure on the disposition of asymmetric dimethylarginine (ADMA) in human endothelial cells. Although the role of ADMA as an inhibitor of endothelial nitric oxide synthase (eNOS) is well-recognized, cellular interactions between ARG and ADMA are not well-characterized. EA. hy926 human vascular endothelial cells were exposed to N-15(4)-ARG, and the concentrations of N-15(4)-ARG and ADMA in the cell lysate and incubation medium were determined by a liquid chromatography- electrospray tandem mass spectrometry (LC-MS/MS) assay. Nitric oxide (NO) production was estimated by utilizing cumulative nitrite concentration via a fluorometric assay. Cells incubated with (15)N(4-)ARG exhibited enhanced nitrite production as well as N-15(4)-ARG cellular uptake. These changes were accompanied by a decrease in cellular ADMA level and increase in extracellular ADMA level, indicating an efflux of endogenous ADMA from the cell. The time courses of ADMA efflux as well as nitrite accumulation in parallel with N-15(4)-ARG uptake were characterized. Following preincubation with N-15(4)-ARG and D(7)ADMA, the efflux of cellular N-15(4)-ARG and D-7-ADMA was significantly stimulated by high concentrations of ARG or ADMA in the incubation medium, demonstrating trans-stimulated cellular transport of these two amino acids. D-7-ADMA metabolism was inhibited in the presence of added ARG. These results demonstrated that in addition to an interaction at the level of eNOS, ARG and ADMA may mutually influence their cellular availability via transport and metabolic interactions.	[Shin, Soyoung; Thapa, Subindra Kazi] Wonkwang Univ, Coll Pharm, Dept Pharm, Iksan, Jeonbuk, South Korea; [Fung, Ho-Leung] Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY USA	Wonkwang University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shin, S (corresponding author), Wonkwang Univ, Coll Pharm, Dept Pharm, Iksan, Jeonbuk, South Korea.	shins@wku.ac.kr			National Research Foundation of Korea (NRF) [NRF-2014R1A2053333]; NIH [HL81580]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Research Foundation of Korea (NRF) grant NRF-2014R1A2053333 (SS) and NIH grant HL81580 (HLF).	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; [Anonymous], 2011, L ARG MEDL SUPPL; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; BHAT GB, 1990, AM J RESP CELL MOL, V3, P363, DOI 10.1165/ajrcmb/3.4.363; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Chin-Dusting JPF, 2007, PHARMACOL THERAPEUT, V116, P428, DOI 10.1016/j.pharmthera.2007.08.001; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Kakoki M, 2006, AM J PHYSIOL-RENAL, V291, pF297, DOI 10.1152/ajprenal.00417.2005; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Mohan S, 2011, CONTINUOUS EXPOSURE; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Pettersson A, 1998, ACTA OBSTET GYN SCAN, V77, P808, DOI 10.1034/j.1600-0412.1998.770805.x; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Pope AJ, 2009, J BIOL CHEM, V284, P35338, DOI 10.1074/jbc.M109.037036; Shin S, 2011, BIOCHEM BIOPH RES CO, V414, P660, DOI 10.1016/j.bbrc.2011.09.112; Shin S, 2011, J CHROMATOGR B, V879, P467, DOI 10.1016/j.jchromb.2011.01.006; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Ueda S, 2007, NEPHROLOGY, V12, P582, DOI 10.1111/j.1440-1797.2007.00840.x; VALLANCE P, 1992, LANCET, V339, P572; Wang J, 2006, CELL MOL LIFE SCI, V63, P2838, DOI 10.1007/s00018-006-6271-8; Xiao S, 2001, AM J PHYSIOL-RENAL, V280, pF989, DOI 10.1152/ajprenal.2001.280.6.F989; Zharikov SI, 1998, BBA-BIOMEMBRANES, V1369, P173, DOI 10.1016/S0005-2736(97)00191-0	29	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178710	10.1371/journal.pone.0178710	http://dx.doi.org/10.1371/journal.pone.0178710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562663	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700083
J	Wu, HY; Huang, JJ; Zhong, Y; Huang, QS				Wu, Hongyu; Huang, Jinjiang; Zhong, Yang; Huang, Qingshan			DrugSig: A resource for computational drug repositioning utilizing gene expression signatures	PLOS ONE			English	Article							FRAMEWORK	Computational drug repositioning has been proved as an effective approach to develop new drug uses. However, currently existing strategies strongly rely on drug response gene signatures which scattered in separated or individual experimental data, and resulted in low efficient outputs. So, a fully drug response gene signatures database will be very helpful to these methods. We collected drug response microarray data and annotated related drug and targets information from public databases and scientific literature. By selecting top 500 up-regulated and down-regulated genes as drug signatures, we manually established the DrugSig database. Currently DrugSig contains more than 1300 drugs, 7000 microarray and 800 targets. Moreover, we developed the signature based and target based functions to aid drug repositioning. The constructed database can serve as a resource to quicken computational drug repositioning. Database URL: http://biotechlabiudamedu.cnidatabase/drugsig/.	[Wu, Hongyu; Huang, Jinjiang; Zhong, Yang; Huang, Qingshan] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China; [Wu, Hongyu; Huang, Qingshan] Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai, Peoples R China	Fudan University	Huang, QS (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, QS (corresponding author), Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai, Peoples R China.	qshuang@fudan.edu.cn			Major scientific and technological specialized project of China for 'significant new formulation of new drugs' - National health and family planning commission of the people's republic of china [2013ZX09102057]; Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB); SHUB	Major scientific and technological specialized project of China for 'significant new formulation of new drugs' - National health and family planning commission of the people's republic of china; Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB); SHUB	This study was supported by the Major scientific and technological specialized project of China for 'significant new formulation of new drugs' funded by National health and family planning commission of the people's republic of china [Grant 2013ZX09102057, http://www.moh.gov.cn, QH]. There was no additional external funding received for this study. Hongyu Wu is affiliated Shanghai High-Tech United BioTechnological R&D Co. Ltd (SHUB) as a paid employee and works for projects on State Key Laboratory of Genetic Engineering (SKLGE) at Fudan University as a PHD student. Qingshan Huang is affiliated Fudan University and as a paid consultant at SHUB. Shanghai High-Tech United Bio-Technological R&D Co. Ltd (SHUB) provided support in the form of salaries for authors QH and HW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Carrella D, 2014, BIOINFORMATICS, V30, P1787, DOI 10.1093/bioinformatics/btu058; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Corbett A, 2013, PHARMACEUTICALS, V6, P1304, DOI 10.3390/ph6101304; Corbett A, 2012, NAT REV DRUG DISCOV, V11, P833, DOI 10.1038/nrd3869; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Harrison C, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3076; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li J, 2016, BRIEF BIOINFORM, V17, P2, DOI 10.1093/bib/bbv020; Rastegar-Mojarad M, 2015, NAT BIOTECHNOL, V33, DOI 10.1038/nbt.3183; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rubio-Perez C, 2015, CANCER CELL, V27, P382, DOI 10.1016/j.ccell.2015.02.007; Sardana D, 2011, BRIEF BIOINFORM, V12, P346, DOI 10.1093/bib/bbr021; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595; von Eichborn J, 2011, NUCLEIC ACIDS RES, V39, pD1060, DOI 10.1093/nar/gkq1037; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230	28	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177743	10.1371/journal.pone.0177743	http://dx.doi.org/10.1371/journal.pone.0177743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562632	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700024
J	Lee, MJ; Hung, SH; Huang, MC; Tsai, TM; Chen, CT				Lee, Ming-Jen; Hung, Shih-Hsuan; Huang, Mu-Ching; Tsai, Tsuimin; Chen, Chin-Tin			Doxycycline potentiates antitumor effect of 5aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells	PLOS ONE			English	Article							DELTA-AMINOLEVULINIC-ACID; TOPICAL 5-AMINOLEVULINIC ACID; PROTOPORPHYRIN-IX; ADENOCARCINOMA CELLS; BETA TRANSPORTERS; B16 MELANOMA; CANCER-CELLS; IN-VITRO; ACCUMULATION; DEATH	Neurofibromatosis type 1 (NF1) is one of the most common neurocutaneous disorders. Some NF1 patients develop benign large plexiform neurofibroma(s) at birth, which can then transform into a malignant peripheral nerve sheath tumor (MPNST). There is no curative treatment for this rapidly progressive and easily metastatic neurofibrosarcoma. Photodynamic therapy (PDT) has been developed as an anti-cancer treatment, and 5-aminolevulinic (ALA) mediated PDT (ALA-PDT) has been used to treat cutaneous skin and oral neoplasms. Doxycycline, a tetracycline derivative, can substantially reduce the tumor burden in human and animal models, in addition to its antimicrobial effects. The purpose of this study was to evaluate the effect and to investigate the mechanism of action of combined doxycycline and ALA-PDT treatment of MPNST cells. An 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed that the combination of ALA-PDT and doxycycline significantly reduce MPNST survival rate, compared to cells treated with each therapy alone. Isobologram analysis showed that the combined treatment had a synergistic effect. The increased cytotoxic activity could be seen by an increase in cellular protoporphyrin IX (PpIX) accumulation. Furthermore, we found that the higher retention of PpIX was mainly due to increasing ALA uptake, rather than activity changes of the enzymes porphobilinogen deaminase and ferrochelatase. The combined treatment inhibited tumor growth in different tumor cell lines, but not in normal human Schwann cells or fibroblasts. Similarly, a synergistic interaction was also found in cells treated with ALA-PDT combined with minocycline, but not tetracycline. In summary, doxycycline can potentiate the effect of ALA-PDT to kill tumor cells. This increased potency allows for a dose reduction of doxycycline and photo dynamic radiation, reducing the occurrence of toxic side effects in vivo.	[Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Ming-Jen] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Hung, Shih-Hsuan; Huang, Mu-Ching; Chen, Chin-Tin] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei, Taiwan; [Tsai, Tsuimin] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Taipei Medical University	Chen, CT (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei, Taiwan.	chintin@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	CHEN, CHIN-TIN/0000-0002-7439-8774	Ministry of Science and Technology, Government of Taiwan [MOST 105-2314-B-002 -002 -MY3, MOST 101-2320-B-002 -047 -MY3]; Ministry of Science and Technology, Executive Yuan, Taiwan [MOST 105-2314-B-002-002 -MY3, MOST 101-2320-B-002-047 -MY3]	Ministry of Science and Technology, Government of Taiwan; Ministry of Science and Technology, Executive Yuan, Taiwan	This work was supported by two grants from Ministry of Science and Technology, Government of Taiwan grant number: MOST 105-2314-B-002 -002 -MY3 for Ming-Jen Lee MOST 101-2320-B-002 -047 -MY3 for Chin-Tin Chen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the grants provided by the Ministry of Science and Technology, Executive Yuan, Taiwan (grant numbers: MOST 105-2314-B-002-002 -MY3 and MOST 101-2320-B-002-047 -MY3). The authors would like to thank the third common laboratory in National Taiwan University Hospital for technical support.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Angelov L, 1998, NEUROSURGERY, V43, P56, DOI 10.1097/00006123-199807000-00035; Apostolou F, 2009, J LIPID RES, V50, P2532, DOI 10.1194/jlr.P900063-JLR200; Assayag F, 2009, AM J HEMATOL, V84, P387, DOI 10.1002/ajh.21415; Babilas P, 2006, EUR J DERMATOL, V16, P340; Berg K, 1996, BRIT J CANCER, V74, P688, DOI 10.1038/bjc.1996.423; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Chen-Roetling J, 2009, BIOCHEM BIOPH RES CO, V386, P322, DOI 10.1016/j.bbrc.2009.06.026; Choudry K, 2003, BRIT J DERMATOL, V149, P124, DOI 10.1046/j.1365-2133.2003.05351.x; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; CLARK JM, 1965, J BIOL CHEM, V240, P4734; Cornelius JF, 2014, PHOTODIAGN PHOTODYN, V11, P1, DOI 10.1016/j.pdpdt.2014.01.001; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Fiori A, 2012, ANTIMICROB AGENTS CH, V56, P3785, DOI 10.1128/AAC.06017-11; GARDNER LC, 1991, J BIOL CHEM, V266, P22010; GESSNER PK, 1970, J PHARMACOL EXP THER, V174, P247; Grenier D, 2000, ANTIMICROB AGENTS CH, V44, P763, DOI 10.1128/AAC.44.3.763-766.2000; Hamdoon Z, 2012, HEAD NECK ONCOL, V4, P5; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Ji HT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-91; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Kulig K, 2008, MINI-REV MED CHEM, V8, P1214, DOI 10.2174/138955708786141070; Lee MJ, 2007, CURR OPIN NEUROL, V20, P135, DOI 10.1097/WCO.0b013e3280895da8; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Macedo GD, 2014, LASER MED SCI, V29, P881, DOI 10.1007/s10103-013-1285-6; Mojzisova H, 2007, BBA-BIOMEMBRANES, V1768, P2748, DOI 10.1016/j.bbamem.2007.07.002; Moretti MB, 2002, BRIT J CANCER, V87, P471, DOI 10.1038/sj.bjc.6600481; Namjoshi S, 2007, J CHROMATOGR B, V852, P49, DOI 10.1016/j.jchromb.2006.12.040; Nanda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151539; NAVONE NM, 1991, COMP BIOCHEM PHYS B, V98, P67, DOI 10.1016/0305-0491(91)90309-2; Neumann J, 2003, J PHARMACOL EXP THER, V305, P219, DOI 10.1124/jpet.102.046573; Ohgari Y, 2011, J BIOCHEM, V149, P153, DOI 10.1093/jb/mvq126; ORTEL B, 1993, J PHOTOCH PHOTOBIO B, V17, P273, DOI 10.1016/1011-1344(93)80025-5; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Pervaiz S, 2006, CLIN EXP PHARMACOL P, V33, P551, DOI 10.1111/j.1440-1681.2006.04406.x; Rodriguez L, 2006, BRIT J PHARMACOL, V147, P825, DOI 10.1038/sj.bjp.0706668; Rud E, 2000, PHOTOCHEM PHOTOBIOL, V71, P640, DOI 10.1562/0031-8655(2000)071<0640:AABNAA>2.0.CO;2; Saikali Zeina, 2003, Anticancer Drugs, V14, P773; Schulten R, 2012, N-S ARCH PHARMACOL, V385, P969, DOI 10.1007/s00210-012-0777-4; Shen LC, 2010, ORAL ONCOL, V46, P178, DOI 10.1016/j.oraloncology.2009.11.013; Son K, 2009, ANTICANCER RES, V29, P3995; Sparsa A, 2013, ONCOL REP, V29, P1196, DOI 10.3892/or.2012.2190; Sun BC, 2007, EXP BIOL MED, V232, P1300, DOI 10.3181/0705-RM-145; Sun T, 2009, CANCER LETT, V285, P141, DOI 10.1016/j.canlet.2009.05.004; VANHILLEGERSBERG R, 1992, GASTROENTEROLOGY, V103, P647, DOI 10.1016/0016-5085(92)90860-2; Wang CH, 2015, MOL MED REP, V12, P3374, DOI 10.3892/mmr.2015.3833; Wang XL, 2008, PHOTODIAGN PHOTODYN, V5, P127, DOI 10.1016/j.pdpdt.2008.05.003; Wang XL, 2004, BRIT J DERMATOL, V151, P880, DOI 10.1111/j.1365-2133.2004.06189.x; Whitaker CJ, 2000, ANTI-CANCER DRUG DES, V15, P161; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129138; Yang GL, 2013, PHOTODERMATOL PHOTO, V29, P233, DOI 10.1111/phpp.12059	52	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178493	10.1371/journal.pone.0178493	http://dx.doi.org/10.1371/journal.pone.0178493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558025	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000052
J	Lee, MJ; Park, JT; Han, SH; Kim, YL; Kim, YS; Yang, CW; Kim, NH; Kang, SW; Kim, HJ; Yoo, TH				Lee, Mi Jung; Park, Jung Tak; Han, Seung Hyeok; Kim, Yong-Lim; Kim, Yon Su; Yang, Chul Woo; Kim, Nam-Ho; Kang, Shin-Wook; Kim, Hyung Jong; Yoo, Tae-Hyun			The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; STAGE RENAL-DISEASE; CHOLESTEROL RATIO; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR EVENTS; PERITONEAL-DIALYSIS; MAINTENANCE HEMODIALYSIS; MYOCARDIAL-INFARCTION; HDL-CHOLESTEROL; ASSOCIATION	Background The atherogenic index of plasma (AIP), which is the logarithmic ratio of triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C), had a linear relationship with clinical outcomes in the general population. However, the association of each lipid profile, TG and HDL-C, with survival was not straightforward in dialysis patients. This non-linear association led us to further investigate the prognostic impact of the AIP in these patients. Methods From a nationwide prospective cohort, 1,174 incident dialysis patients were included. Patients were categorized into quintiles according to the AIP. An independent association of the AIP with all-cause and cardiovascular mortality was determined. Results During a mean follow-up duration of 33.2 months, 170 patients (14.5%) died, and cardiovascular death was observed in 55 patients (4.7%). Multivariate Cox analyses revealed that the lowest (quintile 1, hazard ratio [HR] = 1.76, 95% confidence interval [CI] = 1.02-3.03) and the highest (quintile 5, HR = 2.15, 95% CI = 1.26-3.65) AIP groups were significantly associated with higher all-cause mortality compared to patients in quintile 3 (reference group). In terms of cardiovascular mortality, only the highest AIP group (quintile 5, HR = 2.59, 95% CI = 1.06-6.34) was significantly associated with increased risk of mortality. Sensitivity analyses showed that a U-shaped association between the AIP and all-cause mortality remained significant in non-diabetic and underweight to normal body mass index patients. Conclusions Both the highest and the lowest AIP groups were independently associated with all-cause mortality, showing a U-shaped association. It suggested further studies are needed to identify targets and subgroups that can benefit from intervention of the AIP in incident dialysis patients.	[Lee, Mi Jung; Kim, Hyung Jong] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea; [Park, Jung Tak; Han, Seung Hyeok; Kang, Shin-Wook; Yoo, Tae-Hyun] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Kim, Yong-Lim; Kim, Yon Su; Yang, Chul Woo; Kim, Nam-Ho; Kang, Shin-Wook] Clin Res Ctr End Stage Renal Dis, Daegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea	Pochon Cha University; Yonsei University; Yonsei University Health System; Kyungpook National University; Seoul National University (SNU); Catholic University of Korea; Chonnam National University	Kim, HJ (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea.; Yoo, TH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	khj04@cha.ac.kr; yoosy0316@yush.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Park, Jung Tak/0000-0002-2325-8982; Kang, Shin-Wook/0000-0002-5677-4756; Lee, Mi Jung/0000-0001-8888-029X; Yoo, Tae-Hyun/0000-0002-9183-4507	Brain Korea 21 PLUS Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2011-0030711]; Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1129]	Brain Korea 21 PLUS Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant - Korea government (MEST); Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported by the Brain Korea 21 PLUS Project for Medical Science, Yonsei University, by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. NRF-2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HC15C1129). Clinical research center for end stage renal disease received the funding, and the leader of the center is YLK. The "Ministry of Health and Welfare URL is: http://www.mw.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Chen HY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000619; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Eeg-Olofsson K, 2014, DIABETES RES CLIN PR, V106, P136, DOI 10.1016/j.diabres.2014.07.010; Erdur MF, 2013, RENAL FAILURE, V35, P1193, DOI 10.3109/0886022X.2013.823826; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Habib AN, 2006, NEPHROL DIAL TRANSPL, V21, P2881, DOI 10.1093/ndt/gfl272; Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132; Hermans MP, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-88; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; Jin DC, 2015, KIDNEY RES CLIN PRAC, V34, P132, DOI 10.1016/j.krcp.2015.08.004; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; Moradi H, 2014, NEPHROL DIAL TRANSPL, V29, P1554, DOI 10.1093/ndt/gfu022; Moradi H, 2013, J RENAL NUTR, V23, P203, DOI 10.1053/j.jrn.2013.01.022; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Postorino M, 2011, KIDNEY INT, V79, P765, DOI 10.1038/ki.2010.493; Silbernagel G, 2015, J AM SOC NEPHROL, V26, P484, DOI 10.1681/ASN.2013080816; Sirimarco G, 2014, STROKE, V45, P1429, DOI 10.1161/STROKEAHA.113.004229; Turak O, 2016, J CLIN HYPERTENS, V18, P772, DOI 10.1111/jch.12758; Vaziri ND, 2009, KIDNEY INT, V76, P437, DOI 10.1038/ki.2009.177; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weichhart T, 2012, J AM SOC NEPHROL, V23, P934, DOI 10.1681/ASN.2011070668; Wu H, 2015, NUTR METAB CARDIOVAS, V25, P749, DOI 10.1016/j.numecd.2015.05.006; Yamamoto S, 2012, J AM COLL CARDIOL, V60, P2372, DOI 10.1016/j.jacc.2012.09.013; Yildiz G, 2013, HEMODIAL INT, V17, P397, DOI 10.1111/hdi.12041; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	30	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177499	10.1371/journal.pone.0177499	http://dx.doi.org/10.1371/journal.pone.0177499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28549070	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000007
J	Lu, GY; Zhang, XP; Shen, L; Qiao, Q; Li, Y; Sun, JQ; Zhang, JP				Lu, Guoyuan; Zhang, Xiaopan; Shen, Lei; Qiao, Qing; Li, Yuan; Sun, Jieqiong; Zhang, Jinping			CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR6; T-CELLS; RENAL-DISEASE; TNF-ALPHA; KAPPA-B; PROLIFERATION; EXPRESSION; GLOMERULONEPHRITIS; IL-17; INTERLEUKIN-17	IgA nephropathy (IgAN) is the most common primary glomerulonephritis characterized by human mesangial cells (HMC) proliferation and extracellular matrix expansion associated with immune deposits consisting of galactose-deficient IgA1. However, how IgA1 contributes to IgAN has yet to be completely elucidated. In this study, the expression profile of chemokines was more altered in IgA1-treated HMC than in the control group. CCL20 was significantly higher either in the serum of IgAN patients or in IgA1-treated HMC. Further experiments demonstrated that CCR6, the only receptor of CCL20, was highly expressed in activated T cells. Intracellular staining assay and cytokine expression profile implied that CCR6 + T cells produced high IL-17 levels. Transwell experiment immunohistochemistry and immunofluorescence experiments extensively demonstrated that CCL20 could recruit inflammatory Th17 cells to the kidneys. These phenomena caused a series of immune inflammatory responses and further damaged the kidneys. Therefore, HMC stimulated by IgA1 could produce CCL20 and consequently recruit inflammatory Th17 cells to the kidneys to induce further lesion in IgA nephropathy.	[Lu, Guoyuan; Zhang, Xiaopan; Shen, Lei; Qiao, Qing; Li, Yuan; Sun, Jieqiong] Soochow Univ, Affiliated Hosp 1, Div Nephrol, Dept Internal Med, Suzhou, Jiangsu, Peoples R China; [Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China; [Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhang, JP (corresponding author), Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China.; Zhang, JP (corresponding author), Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China.	j_pzhang@suda.edu.cn	zhang, jin/GXV-9154-2022		Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; Soochow University [Q413401810]; National Natural Science Foundation of China [31270939, 81471526]; Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China [91442110]; Key University Science Research Project of Jiangsu Province [13KJA310004]	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; Soochow University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province	This work was supported by grants from the Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075); Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; Soochow University (Q413401810); National Natural Science Foundation of China (31270939, 81471526); Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China (91442110); Key University Science Research Project of Jiangsu Province (13KJA310004).	Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Azadegan-Dehkordi Fatemeh, 2015, J Nephropathol, V4, P32, DOI 10.12860/jnp.2015.07; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Chin CC, 2015, J CELL PHYSIOL, V230, P1430, DOI 10.1002/jcp.24796; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Duque N, 1997, J IMMUNOL, V159, P3474; Frick VO, 2013, SCAND J IMMUNOL, V78, P298, DOI 10.1111/sji.12087; Ghali JR, 2015, CURR MED CHEM, V22, P4341, DOI 10.2174/0929867322666151030163022; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hunemorder S, 2015, J PATHOL, V237, P62, DOI 10.1002/path.4559; Kim MJ, 2012, J IMMUNOL, V189, P3751, DOI 10.4049/jimmunol.1102603; Klein M, 2014, PLOS ONE; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lai KN, 2003, J AM SOC NEPHROL, V14, P3127, DOI 10.1097/01.ASN.0000095639.56212.BF; Lee AYS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00194; Leung JCK, 2003, NEPHROL DIAL TRANSPL, V18, P36, DOI 10.1093/ndt/18.1.36; Leung JCK, 2008, NEPHROL DIAL TRANSPL, V23, P72, DOI 10.1093/ndt/gfm581; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Meng T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108723; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Mony JT, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00187; Novak J, 2005, KIDNEY INT, V67, P504, DOI 10.1111/j.1523-1755.2005.67107.x; Panzer U, 2006, CURR DRUG TARGETS, V7, P65, DOI 10.2174/138945006775270213; Paust HJ, 2012, KIDNEY INT, V82, P72, DOI 10.1038/ki.2012.101; Peng XG, 2015, J PATHOL, V235, P79, DOI 10.1002/path.4430; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Segerer S, 2003, AM J KIDNEY DIS, V41, pS15, DOI 10.1053/ajkd.2003.50076; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Strippoli GFM, 2009, AM J KIDNEY DIS, V53, P5, DOI 10.1053/j.ajkd.2008.10.035; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Turner JE, 2010, J AM SOC NEPHROL, V21, P974, DOI 10.1681/ASN.2009070741; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Welsh-Bacic D, 2011, NEPHROL DIAL TRANSPL, V26, P1211, DOI 10.1093/ndt/gfq560; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066286; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu LH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054028, 10.1371/journal.pone.0065680]	44	14	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178352	10.1371/journal.pone.0178352	http://dx.doi.org/10.1371/journal.pone.0178352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552941	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000039
J	Talar, U; Kielbowicz-Matuk, A; Czarnecka, J; Rorat, T				Talar, Urszula; Kielbowicz-Matuk, Agnieszka; Czarnecka, Jagoda; Rorat, Tadeusz			Genome-wide survey of B-box proteins in potato (Solanum tuberosum)-Identification, characterization and expression patterns during diurnal cycle, etiolation and de-etiolation	PLOS ONE			English	Article							CONSTANS-LIKE GENE; FLOWERING-TIME; PLANT-GROWTH; CIRCADIAN CLOCK; ARABIDOPSIS; TRANSCRIPTION; TOLERANCE; COP1; FT; PHOTOPERIOD	Plant B-box domain proteins (BBX) mediate many light-influenced developmental processes including seedling photomorphogenesis, seed germination, shade avoidance and photoperiodic regulation of flowering. Despite the wide range of potential functions, the current knowledge regarding BBX proteins in major crop plants is scarce. In this study, we identify and characterize the StBBX gene family in potato, which is composed of 30 members, with regard to structural properties and expression profiles under diurnal cycle, etiolation and de-etiolations. Based on domain organization and phylogenetic relationships, StBBX genes have been classified into five groups. Using real-time quantitative PCR, we found that expression of most of them oscillates following a 24-h rhythm; however, large differences in expression profiles were observed between the genes regarding amplitude and position of the maximal and minimal expression levels in the day/night cycle. On the basis of the time-of-day/time-of-night, we distinguished three expression groups specifically expressed during the light and two during the dark phase. In addition, we showed that the expression of several StBBX genes is under the control of the circadian clock and that some others are specifically associated with the etiolation and de-etiolation conditions. Thus, we concluded that StBBX proteins are likely key players involved in the complex diurnal and circadian networks regulating plant development as a function of light conditions and day duration.	[Talar, Urszula; Kielbowicz-Matuk, Agnieszka; Czarnecka, Jagoda; Rorat, Tadeusz] Polish Acad Sci, Inst Plant Genet, Dept Environm Stress Biol, Poznan, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences	Kielbowicz-Matuk, A (corresponding author), Polish Acad Sci, Inst Plant Genet, Dept Environm Stress Biol, Poznan, Poland.	akie@igr.poznan.pl			National Science Centre [2014/15/B/NZ9/04809]	National Science Centre(National Science Centre, Poland)	This work was supported by the National Science Centre under grant no. 2014/15/B/NZ9/04809. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda JA, 2016, CURR BIOL, V26, P872, DOI 10.1016/j.cub.2016.01.066; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Chang CSJ, 2011, PLANT PHYSIOL, V156, P228, DOI 10.1104/pp.111.175042; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chu ZN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01552; Crocco CD, 2013, GENE, V531, P44, DOI 10.1016/j.gene.2013.08.037; Crocco CD, 2011, PLANT SIGNAL BEHAV, V6, P101, DOI 10.4161/psb.6.1.14185; Crocco CD, 2010, PLANT J, V64, P551, DOI 10.1111/j.1365-313X.2010.04360.x; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan XY, 2012, MOL PLANT, V5, P591, DOI 10.1093/mp/sss041; Farre EM, 2012, PLANT BIOLOGY, V14, P401, DOI 10.1111/j.1438-8677.2011.00548.x; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gangappa SN, 2016, MOL PLANT, V9, P1353, DOI 10.1016/j.molp.2016.07.002; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gangappa SN, 2013, PLANT CELL, V25, P1243, DOI 10.1105/tpc.113.109751; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Hardigan MA, 2016, PLANT CELL, V28, P388, DOI 10.1105/tpc.15.00538; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; Huang JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048242; Indorf M, 2007, PLANT J, V51, P563, DOI 10.1111/j.1365-313X.2007.03162.x; Ito S, 2012, P NATL ACAD SCI USA, V109, P3582, DOI 10.1073/pnas.1118876109; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kielbowicz-Matuk A, 2017, PLANT CELL ENVIRON, V40, P424, DOI 10.1111/pce.12875; Kielbowicz-Matuk A, 2014, EMERGING TECHNOLOGIES AND MANAGEMENT OF CROP STRESS TOLERANCE, VOL 1: BIOLOGICAL TECHNIQUES, P487, DOI 10.1016/B978-0-12-800876-8.00020-5; Kielbowicz-Matuk A, 2014, ANN BOT-LONDON, V113, P831, DOI 10.1093/aob/mct303; Kim JH, 2015, J EXP BOT, V66, P6093, DOI 10.1093/jxb/erv349; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kumagai T, 2008, BIOSCI BIOTECH BIOCH, V72, P1539, DOI 10.1271/bbb.80041; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Ledger S, 2001, PLANT J, V26, P14; McClung CR, 2013, SEMIN CELL DEV BIOL, V24, P430, DOI 10.1016/j.semcdb.2013.02.007; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sarmiento F, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23831; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; Wang HG, 2013, J EXP BOT, V64, P1017, DOI 10.1093/jxb/ers376; Yan HL, 2011, PLANT PHYSIOL, V156, P1772, DOI 10.1104/pp.111.180208; Yang YJ, 2014, PLANT CELL, V26, P2038, DOI 10.1105/tpc.114.124867; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yeom M, 2014, MOL PLANT, V7, P1701, DOI 10.1093/mp/ssu086	49	27	32	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177471	10.1371/journal.pone.0177471	http://dx.doi.org/10.1371/journal.pone.0177471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552939	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000005
J	Tennill, TA; Gross, ME; Frieboes, HB				Tennill, Thomas A.; Gross, Mitchell E.; Frieboes, Hermann B.			Automated analysis of co-localized protein expression in histologic sections of prostate cancer	PLOS ONE			English	Article							RISK-ASSESSMENT; PREDICTION; SEGMENTATION; RECURRENCE; STRAIGHTFORWARD; VALIDATION; SURVIVAL; GROWTH; CELLS; MODEL	An automated approach based on routinely-processed, whole-slide immunohistochemistry (IHC) was implemented to study co-localized protein expression in tissue samples. Expression of two markers was chosen to represent stromal (CD31) and epithelial (Ki-67) compartments in prostate cancer. IHC was performed on whole-slide sections representing low-, intermediate-, and high-grade disease from 15 patients. The automated workflow was developed using a training set of regions-of-interest in sequential tissue sections. Protein expression was studied on digital representations of IHC images across entire slides representing formalin-fixed paraffin embedded blocks. Using the training-set, the known association between Ki-67 and Gleason grade was confirmed. CD31 expression was more heterogeneous across samples and remained invariant with grade in this cohort. Interestingly, the Ki-67/CD31 ratio was significantly increased in high (Gleason >= 8) versus low/intermediate (Gleason >= 7) samples when assessed in the training-set and the whole-tissue block images. Further, the feasibility of the automated approach to process Tissue Microarray (TMA) samples in high throughput was evaluated. This work establishes an initial framework for automated analysis of co-localized protein expression and distribution in high-resolution digital microscopy images based on standard IHC techniques. Applied to a larger sample population, the approach may help to elucidate the biologic basis for the Gleason grade, which is the strongest, single factor distinguishing clinically aggressive from indolent prostate cancer.	[Tennill, Thomas A.; Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Gross, Mitchell E.] Univ Southern Calif, Lawrence J Elliston Inst Transformat Med, Los Angeles, CA USA; [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA	University of Louisville; University of Southern California; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.; Gross, ME (corresponding author), Univ Southern Calif, Lawrence J Elliston Inst Transformat Med, Los Angeles, CA USA.; Frieboes, HB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	mitchell.gross@usc.edu; hbfrie01@louisville.edu		Frieboes, Hermann/0000-0001-5959-4286; Gross, Mitchell/0000-0002-1691-921X	Department of Defense Prostate Cancer Research Program Prostate Cancer Biorepository Network (PCBN) [W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, W81XWH-15-2-0062]; National Institutes of Health/National Cancer Institute [P30CA014089, U54CA143907]; NATIONAL CANCER INSTITUTE [P30CA014089, U54CA143907] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program Prostate Cancer Biorepository Network (PCBN)(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Department of Defense Prostate Cancer Research Program, Award No W81XWH-14-2-0182, W81XWH-14-2-0183, W81XWH-14-2-0185, W81XWH-14-2-0186, and W81XWH-15-2-0062 Prostate Cancer Biorepository Network (PCBN). MEG acknowledges partial support from National Institutes of Health/National Cancer Institute P30CA014089. HBF acknowledges partial support from National Institutes of Health/National Cancer Institute U54CA143907. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khazraji BK, 2011, BIOL PROCED ONLINE, V13, P1, DOI 10.1186/1480-9222-13-9; Alyassin MA, 2009, LAB CHIP, V9, P3364, DOI 10.1039/b911882a; Ambrosio MR, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0495-1; American Cancer Society, 2016, KEY STATISTICS FOR P; Azar JC, 2012, ANAL CELL PATHOL, V35, P381, DOI [10.1155/2012/801598, 10.3233/ACP-2012-0067]; Bariamis D, 2010, COMPUT MED IMAG GRAP, V34, P418, DOI 10.1016/j.compmedimag.2009.09.005; Bearer EL, 2009, CANCER RES, V69, P4493, DOI 10.1158/0008-5472.CAN-08-3834; Bredies K, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-59; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; D'Amico AV, 1998, CANCER, V82, P1887, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1887::AID-CNCR11>3.3.CO;2-T; Davis JW, 2014, BJU INT, V114, P320, DOI 10.1111/bju.12695; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Frieboes HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129433; Frieboes HB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003008; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; Halwes ME, 2016, EUR J PHARM SCI, V93, P410, DOI 10.1016/j.ejps.2016.08.037; Katzer M, 2003, MARKOV RANDOM FIELD; Khouja MH, 2010, ONCOL LETT, V1, P827, DOI 10.3892/ol_00000145; Klauschen F, 2015, CLIN CANCER RES, V21, P3651, DOI 10.1158/1078-0432.CCR-14-1283; Lan CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16317; Lee G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097954; Lee JJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003231; Li QH, 2005, BIOINFORMATICS, V21, P2875, DOI 10.1093/bioinformatics/bti447; Liew AWC, 2003, PATTERN RECOGN, V36, P1251, DOI 10.1016/S0031-3203(02)00170-X; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Mohammed ZMA, 2012, BRIT J CANCER, V106, P383, DOI 10.1038/bjc.2011.569; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Mucci LA, 2009, J CLIN ONCOL, V27, P5627, DOI 10.1200/JCO.2008.20.8876; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perkins S, 2005, PROC SPIE, V5806, P139, DOI 10.1117/12.604519; Pham K, 2011, J R SOC INTERFACE, V8, P16, DOI 10.1098/rsif.2010.0194; Rizzardi AE, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0511-5; Rizzardi AE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-244; Shukla-Dave A, 2009, CLIN CANCER RES, V15, P3842, DOI 10.1158/1078-0432.CCR-08-2453; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Tseng KS, 2010, J UROLOGY, V183, P1779, DOI 10.1016/j.juro.2010.01.001; Wang Y, 2013, J CLIN ENDOCR METAB, V98, pE586, DOI 10.1210/jc.2012-3490; WEIDNER N, 1993, AM J PATHOL, V143, P401; Yan H, 2016, IEEE TRANS BIOMED EN; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhang MF, 2013, CANCER EPIDEM BIOMAR, V22, P2354, DOI 10.1158/1055-9965.EPI-13-0668	48	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178362	10.1371/journal.pone.0178362	http://dx.doi.org/10.1371/journal.pone.0178362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552967	Green Submitted, Green Published, gold			2022-12-26	WOS:000402063000040
J	Rizos, T; Bartsch, AJ; Johnson, TD; Dittgen, F; Nichols, TE; Malzahn, U; Veltkamp, R				Rizos, Timolaos; Bartsch, Andreas J.; Johnson, Timothy D.; Dittgen, Felix; Nichols, Thomas E.; Malzahn, Uwe; Veltkamp, Roland			Voxelwise distribution of acute ischemic stroke lesions in patients with newly diagnosed atrial fibrillation: Trigger of arrhythmia or only target of embolism?	PLOS ONE			English	Article							INSULAR CORTEX LESIONS; BRAIN INFARCTION; ROBUST; DIFFERENTIATION; LOCALIZATION; OPTIMIZATION; REGISTRATION; ASSOCIATION; DIFFUSION; RISK	Objective Atrial fibrillation (AF) is frequently detected after ischemic stroke for the first time, and brain regions involved in autonomic control have been suspected to trigger AF. We examined whether specific brain regions are associated with newly detected AF after ischemic stroke. Methods Patients with acute cerebral infarctions on diffusion-weighted magnetic resonance imaging were included in this lesion mapping study. Lesions were mapped and modeled voxelwise using Bayesian Spatial Generalised Linear Mixed Modeling to determine differences in infarct locations between stroke patients with new AF, without AF and with AF already known before the stroke. Results 582 patients were included (median age 68 years; 63.2% male). AF was present in 109/582 patients [(18.7%); new AF: 39/109 (35.8%), known AF: 70/109 (64.2%)]. AF patients had larger infarct volumes than patients without AF (mean: 29.7 +/- 45.8 ml vs. 15.2 +/- 35.1 ml; p<0.001). Lesions in AF patients accumulated in the right central middle cerebral artery territory. Increasing stroke size predicted progressive cortical but not pontine and thalamic involvement. Patients with new AF had more frequently lesions in the right insula compared to patients without AF when stroke size was not accounted for, but no specific brain region was more frequently involved after adjustment for infarct volume. Controlled for stroke size, left parietal involvement was less likely for patients with new AF than for those without AF or with known AF. Conclusions In the search for brain areas potentially triggering cardiac arrhythmias infarct size should be accounted for. After controlling for infarct size, there is currently no evidence that ischemic stroke lesions of specific brain areas are associated with new AF compared to patients without AF. This challenges the neurogenic hypothesis of AF according to which a relevant proportion of new AF is triggered by ischemic brain lesions of particular locations.	[Rizos, Timolaos; Dittgen, Felix; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Bartsch, Andreas J.; Nichols, Thomas E.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Oxford, England; [Bartsch, Andreas J.] Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry, W Midlands, England; [Malzahn, Uwe] Univ Hosp Wurzburg, Clin Trial Ctr Wurzburg, Wurzburg, Germany; [Veltkamp, Roland] Imperial Coll London, Dept Stroke Med, London, England	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Oxford; University of Wurzburg; University of Michigan System; University of Michigan; University of Warwick; University of Warwick; University of Wurzburg; Imperial College London	Rizos, T (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	timolaos.rizos@med.uni-heidelberg.de	Nichols, Thomas E./N-9902-2017	Nichols, Thomas E./0000-0002-4516-5103	University of Heidelberg; Wellcome Trust [100309/A/12/Z] Funding Source: researchfish	University of Heidelberg; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the University of Heidelberg. The funding source provided support in the form of salaries for authors [TR, AB, RV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, ANN NEUROL, V59, P691, DOI 10.1002/ana.20806; Algra A, 2003, STROKE, V34, P2871, DOI 10.1161/01.STR.0000099964.34430.2D; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benjamini Y, 2001, ANN STAT, V29, P1165; Boes AD, 2015, BRAIN, V138, P3061, DOI 10.1093/brain/awv228; Colivicchi F, 2004, STROKE, V35, P2094, DOI 10.1161/01.STR.0000138452.81003.4c; Ge T, 2014, ANN APPL STAT, V8, P1095, DOI 10.1214/14-AOAS718; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grond M, 2013, STROKE, V44, P3357, DOI 10.1161/STROKEAHA.113.001884; Higgins P, 2014, STROKE, V45, P2134, DOI 10.1161/STROKEAHA.114.005405; Horstmann S, 2015, EUR J NEUROL, V22, P1355, DOI 10.1111/ene.12608; Jaakkola J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168010; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Oppenheimer SM, 1996, CLIN AUTON RES, V6, P131, DOI 10.1007/BF02281899; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; Palma Jose-Alberto, 2014, Neurology, V83, P261, DOI 10.1212/WNL.0000000000000605; Patten M, 2006, J CARDIOVASC ELECTR, V17, P1216, DOI 10.1111/j.1540-8167.2006.00609.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rincon F, 2008, STROKE, V39, P2425, DOI 10.1161/STROKEAHA.107.506055; Rizos T, 2016, STROKE, V47, P336, DOI 10.1161/STROKEAHA.115.011465; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Roche FDR, 2002, PACE, V25, P1587, DOI 10.1046/j.1460-9592.2002.01587.x; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Schaefer PW, 2002, AM J NEURORADIOL, V23, P1785; Scheitz JF, 2015, STROKE, V46, P1196, DOI 10.1161/STROKEAHA.115.008681; Seifert F, 2015, J NEUROL, V262, P1182, DOI 10.1007/s00415-015-7684-9; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sposato LA, 2015, LANCET NEUROL, V14, P377, DOI 10.1016/S1474-4422(15)70027-X; Sposato LA, 2014, NEUROLOGY, V82, P1180, DOI 10.1212/WNL.0000000000000265; TIMSIT SG, 1993, NEUROLOGY, V43, P728, DOI 10.1212/WNL.43.4.728; TIMSIT SG, 1992, STROKE, V23, P486, DOI 10.1161/01.STR.23.4.486; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177474	10.1371/journal.pone.0177474	http://dx.doi.org/10.1371/journal.pone.0177474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542605	gold, Green Published			2022-12-26	WOS:000402061500028
J	Xiong, Y; Li, J; Wang, NL; Liu, X; Wang, Z; Tsai, FF; Wan, XH				Xiong, Ying; Li, Jing; Wang, Ningli; Liu, Xue; Wang, Zhao; Tsai, Frank F.; Wan, Xiuhua			The analysis of corneal asphericity (Q value) and its related factors of 1,683 Chinese eyes older than 30 years	PLOS ONE			English	Article							POSTERIOR SURFACE; ANTERIOR; CURVATURE; TOPOGRAPHY; LASIK; MODEL; SHAPE	Purpose To determine corneal Q value and its related factors in Chinese subjects older than 30 years. Design Cross sectional study. Methods 1,683 participants (1,683 eyes) from the Handan Eye Study were involved, including 955 female and 728 male with average age of 53.64 years old (range from 30 to 107 years). The corneal Q values of anterior and posterior surfaces were measured at 3.0, 5.0 and 7.0mm aperture diameters using Bausch & Lomb Orbscan IIz (software version 3.12). Age, gender and refractive power were recorded. Results The average Q values of the anterior surface at 3.0, 5.0 and 7.0mm aperture diameters were -0.28 +/- 0.18, -0.28 +/- 0.18, and -0.29 +/- 0.18, respectively. The average Q value of the anterior surface at the 5.0mm aperture diameter was negatively correlated with age (B = -0.003, p<0.01) and the refractive power (B = -0.013, p = 0.016). The average Q values of the posterior surface at 3.0, 5.0, and 7.0mm were -0.26 +/- 0.216, -0.26 +/- 0.214, and -0.26 +/- 0.215, respectively. The average Q value of the posterior surface at the 5.0mm aperture diameter was positively correlated with age (B = 0.002, p = 0.036) and the refractive power (B = 0.016, p = 0.043). Conclusion The corneal Q value of the elderly Chinese subjects is different from that of previously reported European and American subjects, and the Q value appears to be correlated with age and refractive power.	[Xiong, Ying; Li, Jing; Wang, Zhao] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China; [Wang, Ningli; Liu, Xue; Wan, Xiuhua] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Wang, Ningli; Liu, Xue; Wan, Xiuhua] Capital Med Univ, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [Tsai, Frank F.] Sharp Rees Stealy Med Grp, San Diego, CA USA	Capital Medical University; Capital Medical University; Capital Medical University	Wan, XH (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.; Wan, XH (corresponding author), Capital Med Univ, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China.	xiuhuawan@126.com		Li, Jing/0000-0001-9392-6600				Budak K, 1999, J CATARACT REFR SURG, V25, P814, DOI 10.1016/S0886-3350(99)00036-X; Carney LG, 1997, INVEST OPHTH VIS SCI, V38, P311; Chan KY, 2012, CLIN EXP OPTOM, V95, P160, DOI 10.1111/j.1444-0938.2011.00682.x; Cheung SW, 2000, OPHTHAL PHYSL OPT, V20, P119, DOI 10.1016/S0275-5408(99)00045-9; Davis WR, 2005, INVEST OPHTH VIS SCI, V46, P1899, DOI 10.1167/iovs.04-0558; Douthwaite WA, 2009, J REFRACT SURG, V25, P435, DOI 10.3928/1081597X-20090422-06; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; EGHBALI F, 1995, AM J OPHTHALMOL, V119, P275, DOI 10.1016/S0002-9394(14)71167-5; Fuller DG, 2013, OPTOMETRY VISION SCI, V90, P667, DOI 10.1097/OPX.0b013e318296befe; Gatinel D, 2002, J FR OPHTALMOL, V25, P81; Gonzalez-Meijome JM, 2007, J CATARACT REFR SURG, V33, P465, DOI 10.1016/j.jcrs.2006.11.004; Holmes-Higgin DK, 1999, J REFRACT SURG, V15, P520; Horner DG, 2000, OPTOMETRY VISION SCI, V77, P198, DOI 10.1097/00006324-200004000-00012; Huang H, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-15; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; MANDELL RB, 1971, BRIT J PHYSIOL OPT, V26, P183; Manns F, 2004, EXP EYE RES, V78, P39, DOI 10.1016/j.exer.2003.09.025; Queiros A., 2012, J OPTOM, V5, P171, DOI [DOI 10.1016/j.optom.2012.08.002, 10.1016/j.optom.2012.08.002, DOI 10.1016/J.OPTOM.2012.08.002]; Queiros A, 2011, EYE CONTACT LENS, V37, P354, DOI 10.1097/ICL.0b013e318232e32d; Queiros A, 2010, OPTOMETRY VISION SCI, V87, P432, DOI 10.1097/OPX.0b013e3181da8628; Scholz K, 2009, J CATARACT REFR SURG, V35, P1046, DOI 10.1016/j.jcrs.2009.01.019; Townsley MG, 1970, CONTACTO, V14, P38; Ying JL, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.075005; Zheng SL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.065002	25	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176913	10.1371/journal.pone.0176913	http://dx.doi.org/10.1371/journal.pone.0176913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545078	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400015
J	Dos Santos, DA; Fratani, J; Ponssa, ML; Abdala, V				Andres Dos Santos, Daniel; Fratani, Jessica; Laura Ponssa, Maria; Abdala, Virginia			Network architecture associated with the highly specialized hindlimb of frogs	PLOS ONE			English	Article							COMPLEX MORPHOLOGICAL STRUCTURES; QUANTITATIVE TRAIT LOCI; NEW-WORLD MONKEYS; DEVELOPMENTAL INTEGRATION; DROSOPHILA-MELANOGASTER; CRANIAL INTEGRATION; SEMIAQUATIC FROG; TAKE-OFF; MODULARITY; EVOLUTION	Network analyses have been increasingly used in the context of comparative vertebrate morphology. The structural units of the vertebrate body are treated as discrete elements (nodes) of a network, whose interactions at their physical contacts (links) determine the phenotypic modules. Here, we use the network approach to study the organization of the locomotor system underlying the hindlimb of frogs. Nodes correspond to fibrous knots, skeletal and muscular units. Edges encode the ligamentous and monoaxial tendinous connections in addition to joints. Our main hypotheses are that: (1) the higher centrality scores (measured as betweenness) are recorded for fibrous elements belonging to the connective system, (2) the organization of the musculoskeletal network belongs to a non-trivial modular architecture and (3) the modules in the hindlimb reflect functional and/or developmental constraints. We confirm all our hypotheses except for the first one, since bones overpass the fibrous knots in terms of centrality. Functionally, there is a correlation between the proximal-to- distal succession of modules and the progressive recruitment of elements involved with the motion of joints during jumping. From a developmental perspective, there is a correspondence between the order of the betweenness scores and the ontogenetic chronology of hindlimbs in tetrapods. Modular architecture seems to be a successful organization, providing of the building blocks on which evolution forges the many different functional specializations that organisms exploit.	[Andres Dos Santos, Daniel; Abdala, Virginia] CONICET UNT, Inst Biodiversidad Neotrop, San Miguel De Tucuman, Argentina; [Fratani, Jessica; Laura Ponssa, Maria] CONICET FML, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina; [Abdala, Virginia] Univ Nacl Tucuman, Catedra Biol Gen, Fac Ciencias Nat, San Miguel De Tucuman, Argentina; [Abdala, Virginia] Univ Nacl Tucuman, IML, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Nacional de Tucuman	Dos Santos, DA (corresponding author), CONICET UNT, Inst Biodiversidad Neotrop, San Miguel De Tucuman, Argentina.	dadossantos@csnat.unt.edu.ar	Fratani, Jéssica/H-6604-2019	Ponssa, Maria Laura/0000-0002-8750-9680	PIP [0284]; PICT [1910-2012]; CONICET, Argentina	PIP; PICT(ANPCyT); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support: PIP 0284 to VA and PICT 1910-2012 to DADS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank CONICET, Argentina, for their continued support. We are also grateful to the reviewers Rasskin-Gutman D. and Diogo R. for their constructive criticisms and thoughtful comments.	Abdala V, ANAT REC IN PRESS; Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; [Anonymous], 2021, LANG ENV STAT COMP; Apostolakos John, 2014, Muscles Ligaments Tendons J, V4, P333; Astley HC, 2014, J EXP BIOL, V217, P4372, DOI 10.1242/jeb.110296; ATCHLEY WR, 1992, SYST BIOL, V41, P196, DOI 10.2307/2992521; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Azizi E, 2010, P ROY SOC B-BIOL SCI, V277, P1523, DOI 10.1098/rspb.2009.2051; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Birdsall K, 2000, EVOL DEV, V2, P16, DOI 10.1046/j.1525-142x.2000.00034.x; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Callebaut W, 2005, MODULARITY UNDERSTAN; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Diogo R, 2014, ANAT REC, V297, P1076, DOI 10.1002/ar.22906; Diogo R, 2010, MUSCLES VERTEBRATES; Diogo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140030; Diogo R, 2014, J EXP ZOOL PART B, V322, P86, DOI 10.1002/jez.b.22549; DUNLAP DONALD G., 1960, JOUR MORPHOL, V106, P1, DOI 10.1002/jmor.1051060102; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Esteve-Altava B., 2016, BIOL REV CAMBPHILOS; Esteve-Altava B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08298; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; GANS C, 1966, EVOLUTION, V20, P92, DOI 10.1111/j.1558-5646.1966.tb03345.x; Gaupp E., 1986, ANATOMIE FROSCHES, P1; Geoffroy Saint-Hilaire E., 1818, PHILOSOPHIEANATOMIQU, V1; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Howell AB, 1932, PROCAMERACAD ARTS SC, V67; Jenkins FA, 1998, J VERTEBR PALEONTOL, V18, P495, DOI 10.1080/02724634.1998.10011077; Jorgensen ME, 2013, J EVOLUTION BIOL, V26, P929, DOI 10.1111/jeb.12128; Kardon G, 1998, DEVELOPMENT, V125, P4019; Kargo WJ, 2002, J EXP BIOL, V205, P1987; Kassolik K, 2007, J BACK MUSCULOSKELET, V20, P15, DOI 10.3233/BMR-2007-20103; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; Koyabu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4625; Ponssa ML, 2010, ANAT REC, V293, P1646, DOI 10.1002/ar.21212; Leamy LJ, 1999, AM NAT, V153, P201, DOI 10.1086/303165; Lecointre G., 2006, TREE LIFE PHYLOGENET; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; LUTZ GJ, 1994, SCIENCE, V263, P370, DOI 10.1126/science.8278808; Manzano A, 2013, ACTA ZOOL-STOCKHOLM, V94, P420, DOI 10.1111/j.1463-6395.2012.00571.x; Marquez EJ, 2008, EVOLUTION, V62, P2688, DOI 10.1111/j.1558-5646.2008.00476.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2005, EVOLUTION, V59, P1128; Marroig G, 2009, EVOL BIOL, V36, P136, DOI 10.1007/s11692-009-9051-1; Minkoff E, 1975, LAB GUIDE FROG ANATO; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Monteiro LR, 2005, EVOL DEV, V7, P429, DOI 10.1111/j.1525-142X.2005.05047.x; Nauwelaerts S, 2006, J EXP BIOL, V209, P66, DOI 10.1242/jeb.01969; Nauwelaerts S, 2005, ANIM BIOL, V55, P3, DOI 10.1163/1570756053276934; Nauwelaerts S, 2007, J ANAT, V210, P304, DOI 10.1111/j.1469-7580.2007.00691.x; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Prikryl T, 2009, J ANAT, V214, P100, DOI 10.1111/j.1469-7580.2008.01006.x; Rasskin-Gutman Diego, 2014, Biological Theory, V9, P178, DOI 10.1007/s13752-014-0175-x; Reilly SM, 2011, J MORPHOL, V272, P149, DOI 10.1002/jmor.10902; Reilly SM, 2016, J MORPHOL, V277, P1539, DOI 10.1002/jmor.20594; Reno PL, 2016, J EXP ZOOL PART B, V326, P303, DOI 10.1002/jez.b.22688; Roberts TJ, 2011, PHILOS T R SOC B, V366, P1488, DOI 10.1098/rstb.2010.0326; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Sanger TJ, 2012, EVOLUTION, V66, P1525, DOI 10.1111/j.1558-5646.2011.01519.x; Schlosser G, 2004, MODULARITY DEV EVOLU; Shubin NH, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P429; SHUBIN NH, 1995, NATURE, V377, P49, DOI 10.1038/377049a0; Simons V., 2008, THESIS; Tagliaferri C, 2015, AGEING RES REV, V21, P55, DOI 10.1016/j.arr.2015.03.002; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; Vickaryous Matthew K., 2007, P323; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1995, ADV ARTIFICIAL LIFE, V929, P315; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064; Zelditch ML, 2008, EVOL DEV, V10, P756, DOI 10.1111/j.1525-142X.2008.00290.x; Zimmerman E, 2000, GENETICS, V155, P671	93	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177819	10.1371/journal.pone.0177819	http://dx.doi.org/10.1371/journal.pone.0177819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545115	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700084
J	Idris, H; Ezugwu, AE; Junaidu, SB; Adewumi, AO				Idris, Hajara; Ezugwu, Absalom E.; Junaidu, Sahalu B.; Adewumi, Aderemi O.			An improved ant colony optimization algorithm with fault tolerance for job scheduling in grid computing systems	PLOS ONE			English	Article							MANAGEMENT	The Grid scheduler, schedules user jobs on the best available resource in terms of resource characteristics by optimizing job execution time. Resource failure in Grid is no longer an exception but a regular occurring event as resources are increasingly being used by the scientific community to solve computationally intensive problems which typically run for days or even months. It is therefore absolutely essential that these long-running applications are able to tolerate failures and avoid re-computations from scratch after resource failure has occurred, to satisfy the user's Quality of Service (QoS) requirement. Job Scheduling with Fault Tolerance in Grid Computing using Ant Colony Optimization is proposed to ensure that jobs are executed successfully even when resource failure has occurred. The technique employed in this paper, is the use of resource failure rate, as well as checkpoint-based roll back recovery strategy. Check-pointing aims at reducing the amount of work that is lost upon failure of the system by immediately saving the state of the system. A comparison of the proposed approach with an existing Ant Colony Optimization (ACO) algorithm is discussed. The experimental results of the implemented Fault Tolerance scheduling algorithm show that there is an improvement in the user's QoS requirement over the existing ACO algorithm, which has no fault tolerance integrated in it. The performance evaluation of the two algorithms was measured in terms of the three main scheduling performance metrics: makespan, throughput and average turnaround time.	[Idris, Hajara; Junaidu, Sahalu B.] Ahmadu Bello Univ Zaria, Dept Math, Zaria, Nigeria; [Ezugwu, Absalom E.] Fed Univ Lafia, Dept Comp Sci, Lafia, Nasarawa State, Nigeria; [Ezugwu, Absalom E.; Adewumi, Aderemi O.] Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, South Africa	Ahmadu Bello University; University of Kwazulu Natal	Ezugwu, AE (corresponding author), Fed Univ Lafia, Dept Comp Sci, Lafia, Nasarawa State, Nigeria.; Ezugwu, AE (corresponding author), Univ Kwazulu Natal, Sch Math Stat & Comp Sci, Westville Campus, Durban, South Africa.	Ezugwua@ukzn.ac.za	Ezugwu, Absalom El-Shamir/G-3015-2017	Ezugwu, Absalom El-Shamir/0000-0002-3721-3400				Abdulhamid SM, 2018, NEURAL COMPUT APPL, V29, P279, DOI 10.1007/s00521-016-2448-8; Amoon M., 2012, INT J ADV SCI TECHNO, V48, P115; Amoon M, 2012, COMPUT ELECTR ENG, V38, P399, DOI 10.1016/j.compeleceng.2011.11.004; Andrade H, 2013, U.S. Patent, Patent No. [8,473,783, 8473783]; Balasangameshwara J, 2012, J NETW COMPUT APPL, V35, P412, DOI 10.1016/j.jnca.2011.09.005; Barboni S., 2011, THESIS; Buligon C, 2005, LECT NOTES COMPUT SC, V3563, P246; Buyya R, 2002, CONCURR COMP-PRACT E, V14, P1175, DOI 10.1002/cpe.710; Chervenak A, 2000, J NETW COMPUT APPL, V23, P187, DOI 10.1006/jnca.2000.0110; Delavar AG, 2012, INT J COMPUTER APPL, V52; Ezugwu AE, 2016, MULTIAGENT GRID SYST, V12, P13, DOI 10.3233/MGS-160241; Ezugwu AE, 2013, INT J CLOUD APPL COM, V3, P47, DOI 10.4018/ijcac.2013040105; Fialho de Queiroz L, 2012, FAULT TOLERANCE CONF; Foster I, 2001, INT J HIGH PERFORM C, V15, P200, DOI 10.1177/109434200101500302; Garg R., 2011, J COMPUT SCI ENG SUR, V2, P88, DOI [10.5121/ijcses.2011.2107, DOI 10.5121/IJCSES.2011.2107]; Haider S, 2011, P CSIT, V5; Khan FG, 2010, COMPUT ELECTR ENG, V36, P1110, DOI 10.1016/j.compeleceng.2010.04.004; Khanli LM, 2010, INT C COMPUT ENG APP, P422, DOI 10.1109/ICCEA.2010.88; Kowalczyk D, 2016, J SCHEDULING, V1, P1; Latchoumy P., 2011, INT J COMPUT SCI ENG, V2, P97, DOI [10.5121/ijcses.2011.2407, DOI 10.5121/IJCSES.2011.2407]; Ludwig S, 2011, J GRID COMPUT, V9, P279, DOI 10.1007/s10723-011-9180-5; Diana ROM, 2015, NEUROCOMPUTING, V163, P94, DOI 10.1016/j.neucom.2014.06.091; Nazir B, 2009, J SUPERCOMPUT, V50, P1, DOI 10.1007/s11227-008-0245-6; Patial Sushant, 2014, International Journal of Advanced Networking and Applications, V6, P2308; Poola D, 2014, PROCEDIA COMPUT SCI, V29, P523, DOI 10.1016/j.procs.2014.05.047; Priya SB, 2007, SIXTH INTERNATIONAL CONFERENCE ON GRID AND COOPERATIVE COMPUTING, PROCEEDINGS, P676, DOI 10.1109/GCC.2007.67; Townend P, 2003, TIMEOUT, V1, pS3	27	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177567	10.1371/journal.pone.0177567	http://dx.doi.org/10.1371/journal.pone.0177567			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545075	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700054
J	Biesemann, A; Gorontzi, A; Barr, F; Gerke, V				Biesemann, Anja; Gorontzi, Alexandra; Barr, Francis; Gerke, Volker			Rab35 protein regulates evoked exocytosis of endothelial Weibel-Palade bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; endothelial cell; membrane trafficking; Rab; vascular biology; Calcium; endothelial cells; membrane traffic; von-Willebrand factor	VON-WILLEBRAND-FACTOR; GTPASE-ACTIVATING PROTEIN; NEURITE OUTGROWTH; BODY EXOCYTOSIS; ANNEXIN A2; CELLS; SECRETION; ARF6; RAB27A; MYRIP	Weibel-Palade bodies (WPB) are secretory organelles of endothelial cells that undergo evoked exocytosis following intracellular Ca2+ or cAMP elevation, thereby supplying the vasculature with factors controlling hemostasis. Several cytosolic and membrane-associated proteins, including the Rab family members Rab3, Rab15, and Rab27a, have been implicated in regulating the acute exocytosis of WPB. Here, we carried out a genome-wide screen to identify Rab pathways affecting WPB exocytosis. Overexpression of a specific subset of Rab GTPase-activating proteins (RabGAPs) inhibited histamine-evoked, Ca2+-dependent WPB exocytosis, presumably by inactivating the target Rab GTPases. Among these RabGAPs, we concentrated on TBC1D10A and showed that the inhibitory effect depends on its GAP activity. We confirmed that Rab35 was a target Rab of TBC1D10A in human endothelial cells; Rab35 interacted with TBC1D10A, and expression of the GAP-insensitive Rab35(Q67A) mutant rescued the inhibitory effect of TBC1D10A overexpression on WPB exocytosis. Furthermore, knockdown of Rab35 and expression of a dominant-negative Rab35 mutant both inhibited histamine-evoked secretion of the WPB cargos von Willebrand factor and P-selectin. Pulldown and co-immunoprecipitation experiments identified the ArfGAP with coiled-coil, Ank repeat, and pleckstrin homology domain-containing protein ACAP2 as an Rab35 effector in endothelial cells, and depletion as well as overexpression approaches revealed that ACAP2 acts as a negative regulator of WPB exocytosis. Interestingly, a known ACAP2 target, the small GTPase Arf6, supported histamine-evoked WPB exocytosis, as shown by knockdown and overexpression of a dominant-negative Arf6 mutant. Our data identify Rab35 as a novel regulator of WPB exocytosis, most likely acting through the downstream effectors ACAP2 and Arf6.	[Biesemann, Anja; Gorontzi, Alexandra; Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany; [Barr, Francis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Munster; University of Oxford	Gerke, V (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Cells in Mot Cluster Excellence EXC CiM 1003, von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de			German Research Council (DFG) [GE514/6-2, GE514/10-1]; Wellcome Trust Senior Investigator Award [097769/Z/11/Z]	German Research Council (DFG)(German Research Foundation (DFG)); Wellcome Trust Senior Investigator Award(Wellcome Trust)	This work was supported by German Research Council (DFG) Grants GE514/6-2 and GE514/10-1 (to V. G.) and Wellcome Trust Senior Investigator Award 097769/Z/11/Z (to F. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Bierings R, 2012, BLOOD, V120, P2757, DOI 10.1182/blood-2012-05-429936; Brandherm I, 2013, BLOOD, V122, P1042, DOI 10.1182/blood-2012-12-475251; Cauvin C, 2016, CURR BIOL, V26, P120, DOI 10.1016/j.cub.2015.11.040; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Conte IL, 2016, J CELL SCI, V129, P592, DOI 10.1242/jcs.178285; Datta YH, 2001, THROMB HAEMOSTASIS, V86, P1148; Disse J, 2009, BLOOD, V113, P973, DOI 10.1182/blood-2008-06-165282; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Egami Y, 2011, J CELL SCI, V124, P3557, DOI 10.1242/jcs.083881; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Gerke V, 2016, BIOL CHEM, V397, P995, DOI 10.1515/hsz-2016-0207; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Huang J, 2012, BLOOD, V120, P1143, DOI 10.1182/blood-2012-01-408096; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Klinkert K, 2016, TRAFFIC, V17, P1063, DOI 10.1111/tra.12422; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; Kobayashi H, 2013, J CELL SCI, V126, P2424, DOI 10.1242/jcs.117846; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Nightingale T, 2013, J THROMB HAEMOST, V11, P192, DOI 10.1111/jth.12225; Nightingale TD, 2009, BLOOD, V113, P5010, DOI 10.1182/blood-2008-09-181206; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pulido IR, 2011, TRAFFIC, V12, P1371, DOI 10.1111/j.1600-0854.2011.01248.x; Pulido IR, 2011, BBA-MOL CELL RES, V1813, P1038, DOI 10.1016/j.bbamcr.2010.11.007; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schuberth CE, 2015, J CELL SCI, V128, P1279, DOI 10.1242/jcs.154443; Valentijn KM, 2013, J THROMB HAEMOST, V11, P581, DOI 10.1111/jth.12160; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Vischer UM, 2000, ARTERIOSCL THROM VAS, V20, P883, DOI 10.1161/01.ATV.20.3.883; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; Zografou S, 2012, J CELL SCI, V125, P4780, DOI 10.1242/jcs.104174	48	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11631	11640		10.1074/jbc.M116.773333	http://dx.doi.org/10.1074/jbc.M116.773333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566286	Green Published, hybrid			2022-12-26	WOS:000405485600004
J	Aguilera, S; Alvarez-Morales, A; Murillo, J; Hernandez-Flores, JL; Bravo, J; De la Torre-Zavala, S				Aguilera, Selene; Alvarez-Morales, Ariel; Murillo, Jesus; Luis Hernandez-Flores, Jose; Bravo, Jaime; De la Torre-Zavala, Susana			Temperature-mediated biosynthesis of the phytotoxin phaseolotoxin by Pseudomonas syringae pv. phaseolicola depends on the autoregulated expression of the phtABC genes	PLOS ONE			English	Article							RESISTANT ORNITHINE CARBAMOYLTRANSFERASE; TRANSITION-STATE ANALOG; FATTY-ACID DESATURASES; HALO BLIGHT; BETA-GLUCURONIDASE; ARGK GENE; CLUSTER; TRANSCARBAMOYLASE; NPS3121; PROTEIN	Pseudomonas syringae pv. phaseolicola produces phaseolotoxin in a temperature dependent manner, being optimally synthesized between 18 degrees C and 20 degrees C, while no detectable amounts are present above 28 degrees C. The Pht cluster, involved in the biosynthesis of phaseolotoxin, contains 23 genes that are organized in five transcriptional units. The function of most of the genes from the Pht cluster is still unknown and little information about the regulatory circuitry leading to expression of these genes has been reported. The purpose of the present study was to investigate the participation of pht genes in the regulation of the operons coded into the Pht cluster. We conducted Northern blot, uidA fusions and reverse transcription- PCR assays of pht genes in several mutants unable to produce phaseolotoxin. This allowed us to determine that, in P. syringae pv. phaseolicola NPS3121, genes phtABC are essential to prevent their own expression at 28 degrees C, a temperature at which no detectable amounts of the toxin are present. We obtained evidence that the phtABC genes also participate in the regulation of the phtD, phtM and phtL operons. According to our results, we propose that PhtABC and other Pht product activities could be involved in the synthesis of the sulfodiaminophosphinyl moiety of phaseolotoxin, which indirectly could be involved in the transcriptional regulation of the phtA operon.	[Aguilera, Selene] CONACYT Inst Tecnol Tepic, Lab Integral Invest Alimentos, Tepic, Nayarit, Mexico; [Alvarez-Morales, Ariel; Luis Hernandez-Flores, Jose] CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Guanajuato, Mexico; [Murillo, Jesus] Univ Publ Navarra, Dept Prod Agr, Pamplona, Spain; [Bravo, Jaime] Inst Tecnol Tepic, Lab Integral Invest Alimentos, Tepic, Nayarit, Mexico; [De la Torre-Zavala, Susana] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Inst Biotecnol, Monterrey, Nuevo Leon, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Publica de Navarra; Universidad Autonoma de Nuevo Leon	Aguilera, S (corresponding author), CONACYT Inst Tecnol Tepic, Lab Integral Invest Alimentos, Tepic, Nayarit, Mexico.	saguileraag@conacyt.mx	Murillo, Jesus/D-2901-2009	Murillo, Jesus/0000-0001-6585-2421; DE LA TORRE-ZAVALA, SUSANA/0000-0002-7109-0467; Hernandez-Flores, Jose Luis/0000-0001-6331-526X	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2015-01-255155]; Ministerio de Economia y Competitividad (MINECO) [AGL2014-53242-C2-2-R]; Fondo Europeo de Desarrollo Regional (FEDER)	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was funded by grants from the Consejo Nacional de Ciencia y Tecnologia (CONACyT; http://www.conacyt.mx), research grant CB-2015-01-255155 to SA, and from the Spanish Plan Nacional I + D + i grant AGL2014-53242-C2-2-R, from the Ministerio de Economia y Competitividad (MINECO; http://www.mineco.gobes), co-financed by the Fondo Europeo de Desarrollo Regional (FEDER) to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera S, 2007, J BACTERIOL, V189, P2834, DOI 10.1128/JB.01845-06; Aguilera S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046815; Arai T, 2008, BIOSCI BIOTECH BIOCH, V72, P3048, DOI 10.1271/bbb.80439; Bachmann AS, 1998, PHYSIOL MOL PLANT P, V53, P287, DOI 10.1006/pmpp.1998.0183; Bardaji L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46254; BECK CF, 1988, MICROBIOL REV, V52, P318, DOI 10.1128/MMBR.52.3.318-326.1988; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12892; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; De la Torre-Zavala S, 2011, RES MICROBIOL, V162, P488, DOI 10.1016/j.resmic.2011.04.010; FERGUSON AR, 1980, PHYSIOL PLANT PATHOL, V16, P269, DOI 10.1016/0048-4059(80)90041-7; FERGUSON AR, 1980, FEMS MICROBIOL LETT, V7, P123, DOI 10.1111/j.1574-6941.1980.tb01590.x; Gonzalez-Villanueva L, 2014, MICROBIOL RES, V169, P221, DOI 10.1016/j.micres.2013.05.002; Goss RW, 1940, PHYTOPATHOLOGY, V30, P258; HATZILOUKAS E, 1995, GENE, V166, P83, DOI 10.1016/0378-1119(95)00569-5; HATZILOUKAS E, 1992, J BACTERIOL, V174, P5895, DOI 10.1128/jb.174.18.5895-5909.1992; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; JAHN O, 1987, ARCH MICROBIOL, V147, P174, DOI 10.1007/BF00415280; JAHN O, 1985, J BASIC MICROB, V25, P543, DOI 10.1002/jobm.3620250821; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KING EO, 1954, J LAB CLIN MED, V44, P301; Langley DB, 2000, J BIOL CHEM, V275, P20012, DOI 10.1074/jbc.M000585200; Arvizu-Gomez JL, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-90; Lopez-Lopez K, 2004, J BACTERIOL, V186, P146, DOI 10.1128/JB.186.1.146-153.2004; METCALF WW, 1993, GENE, V129, P17, DOI 10.1016/0378-1119(93)90691-U; MITCHELL RE, 1981, PHYSIOL PLANT PATHOL, V19, P227; MITCHELL RE, 1976, PHYTOCHEMISTRY, V15, P1941, DOI 10.1016/S0031-9422(00)88851-2; MITCHELL RE, 1978, PHYSIOL PLANT PATHOL, V13, P37, DOI 10.1016/0048-4059(78)90073-5; MOSQUEDA G, 1990, MOL GEN GENET, V222, P461, DOI 10.1007/BF00633857; Murillo J, 2011, RES MICROBIOL, V162, P253, DOI 10.1016/j.resmic.2010.10.011; NUSKE J, 1989, J BASIC MICROB, V29, P441, DOI 10.1002/jobm.3620290713; PEET RC, 1986, J BACTERIOL, V166, P1096, DOI 10.1128/jb.166.3.1096-1105.1986; Rico A, 2003, PHYTOPATHOLOGY, V93, P1553, DOI 10.1094/PHYTO.2003.93.12.1553; ROWLEY KB, 1993, MOL MICROBIOL, V8, P625, DOI 10.1111/j.1365-2958.1993.tb01606.x; Rowley KB, 2000, MOL PLANT MICROBE IN, V13, P1071, DOI 10.1094/MPMI.2000.13.10.1071; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sawada H, 1999, J MOL EVOL, V49, P627, DOI 10.1007/PL00006584; STASKAWICZ BJ, 1980, J BACTERIOL, V142, P720, DOI 10.1128/JB.142.2.720-723.1980; STASKAWICZ BJ, 1979, PHYTOPATHOLOGY, V69, P663, DOI 10.1094/Phyto-69-663; Tamura K, 2002, PHYSIOL MOL PLANT P, V60, P207, DOI 10.1006/pmpp.2002.0405; TEMPLETON MD, 1984, BIOCHEM J, V224, P379, DOI 10.1042/bj2240379; Templeton MD, 2005, BIOCHEMISTRY-US, V44, P4408, DOI 10.1021/bi047432x; TOURTE C, 1995, EUR J PLANT PATHOL, V101, P483, DOI 10.1007/BF01874471; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Zhang YX, 1997, MOL PLANT MICROBE IN, V10, P947, DOI 10.1094/MPMI.1997.10.8.947; Zhao CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114722	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178441	10.1371/journal.pone.0178441	http://dx.doi.org/10.1371/journal.pone.0178441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570637	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000402611800055
J	Hart, KM; Moeder, KE; Ho, CMW; Zimmerman, MI; Frederick, TE; Bowman, GR				Hart, Kathryn M.; Moeder, Katelyn E.; Ho, Chris M. W.; Zimmerman, Maxwell I.; Frederick, Thomas E.; Bowman, Gregory R.			Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators	PLOS ONE			English	Article							PROTEIN-KINASE; ACTIVATORS; SITES; DISCOVERY	Allosteric drugs, which bind to proteins in regions other than their main ligand-binding or active sites, make it possible to target proteins considered "undruggable" and to develop new therapies that circumvent existing resistance. Despite growing interest in allosteric drug discovery, rational design is limited by a lack of sufficient structural information about alternative binding sites in proteins. Previously, we used Markov State Models (MSMs) to identify such "cryptic pockets," and here we describe a method for identifying compounds that bind in these cryptic pockets and modulate enzyme activity. Experimental tests validate our approach by revealing both an inhibitor and two activators of TEM beta-lactamase (TEM). To identify hits, a library of compounds is first virtually screened against either the crystal structure of a known cryptic pocket or an ensemble of structures containing the same cryptic pocket that is extracted from an MSM. Hit compounds are then screened experimentally and characterized kinetically in individual assays. We identify three hits, one inhibitor and two activators, demonstrating that screening for binding to allosteric sites can result in both positive and negative modulation. The hit compounds have modest effects on TEM activity, but all have higher affinities than previously identified inhibitors, which bind the same cryptic pocket but were found, by chance, via a computational screen targeting the active site. Site-directed mutagenesis of key contact residues predicted by the docking models is used to confirm that the compounds bind in the cryptic pocket as intended. Because hit compounds are identified from docking against both the crystal structure and structures from the MSM, this platform should prove suitable for many proteins, particularly targets whose crystal structures lack obvious druggable pockets, and for identifying both inhibitory and activating small-molecule modulators.	[Hart, Kathryn M.; Moeder, Katelyn E.; Ho, Chris M. W.; Zimmerman, Maxwell I.; Frederick, Thomas E.; Bowman, Gregory R.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Bowman, Gregory R.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Bowman, Gregory R.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bowman, GR (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Bowman, GR (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Bowman, GR (corresponding author), Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA.	bowman@biochem.wustl.edu	Hart, Kathryn/AAE-1983-2019	Hart, Kathryn/0000-0002-5277-8872	NSF CAREER [MCB-1552471, NIH CETR 7 U19 AI 109664-04]; Wellcome Fund; David & Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109664] Funding Source: NIH RePORTER	NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wellcome Fund(Burroughs Wellcome Fund); David & Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Carrie Sibbald for purifying TEM protein. This work was funded by NSF CAREER Award MCB-1552471 and NIH CETR 7 U19 AI 109664-04. G.R.B. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Packard Fellowship for Science and Engineering from The David & Lucile Packard Foundation.; This work was funded by NSF CAREER Award MCB-1552471 and NIH CETR 7 U19 AI 109664-04. G.R.B. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and a Packard Fellowship for Science and Engineering from The David & Lucile Packard Foundation.	Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Bowman GR, 2012, P NATL ACAD SCI USA, V109, P11681, DOI 10.1073/pnas.1209309109; Bruns RF, 2012, J MED CHEM, V55, P9763, DOI 10.1021/jm301008n; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Goode DR, 2008, J MED CHEM, V51, P2346, DOI 10.1021/jm701583b; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Horn JR, 2004, J MOL BIOL, V336, P1283, DOI 10.1016/j.jmb.2003.12.068; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Rettenmaier TJ, 2016, FRAGMENT BASED DRUG, P247; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; SEBASTIAN JF, 1987, J CHEM EDUC, V64, P1031, DOI 10.1021/ed064p1031; Sittampalam GS, 2004, INHIBITION PROTEIN I; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	26	30	30	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178678	10.1371/journal.pone.0178678	http://dx.doi.org/10.1371/journal.pone.0178678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570708	gold, Green Published			2022-12-26	WOS:000402611800100
J	Lee, SY; Noh, Y; Goo, JH; Rho, S; Kim, MJ; Kang, CY; Song, M; Kim, JO				Lee, Seung Young; Noh, Youran; Goo, Jung Hyun; Rho, Semi; Kim, Min Jung; Kang, Chang-Yuil; Song, Manki; Kim, Jae-Ouk			Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice	PLOS ONE			English	Article							IN-VIVO; AIRWAY HYPERREACTIVITY; GLYCOLIPID ANTIGENS; CHILDHOOD ASTHMA; VIRAL-INFECTION; MESSENGER-RNA; NKT CELLS; IL-13; INTERLEUKIN-5; IMMUNITY	Respiratory syncytial virus (RSV) is a major viral pathogen that causes severe lower respiratory tract infections in infants and the elderly worldwide. Infants with severe RSV bronchiolitis tend to experience more wheezing and asthma in later childhood. Because invariant natural killer T (iNKT) cells are associated with the asthma pathology, we investigated whether neonatal iNKT cells are involved in the aggravation of pulmonary diseases following RSV infection in mice. Intranasal exposure to the iNKT cell ligand alpha-galactosylceramide (alpha-GC) with RSV primary infection in neonatal mice elicited neither cytokine production (except for a slight increase of IL-5) nor pulmonary eosinophilia, despite the presence of both CD1d(+) cells and NKT cells. Interestingly, in adult mice re-infected with RSV, neonatal iNKT cell sensitization by alpha-GC during RSV primary infection resulted in much higher levels of pulmonary Th2 cytokines and elevated eosinophilia with airway hyperresponsiveness, whereas this was not observed in cd1d knockout mice. In contrast, alpha-GC priming of adults during RSV re-infection did not induce more severe airway symptoms than RSV re-infection in the absence of alpha-GC. alpha-GC co-administration during RSV primary infection facilitated RSV clearance regardless of age, but viral clearance following re-infection was not iNKT cell-dependent. This study clearly demonstrates that RSV-induced immune responses can be altered by iNKT cells, suggesting that neonatal iNKT cell sensitization during RSV primary infection is associated with exacerbation of pulmonary diseases following RSV re-infection in adulthood.	[Lee, Seung Young; Noh, Youran; Goo, Jung Hyun; Rho, Semi; Kim, Min Jung; Song, Manki; Kim, Jae-Ouk] Int Vaccine Inst, Mol Immunol Sect, Clin Res Lab, SNU Res Pk,1 Gwankak Ro, Seoul, South Korea; [Lee, Seung Young; Kang, Chang-Yuil] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	International Vaccine Institute; Seoul National University (SNU); Seoul National University (SNU)	Kim, JO (corresponding author), Int Vaccine Inst, Mol Immunol Sect, Clin Res Lab, SNU Res Pk,1 Gwankak Ro, Seoul, South Korea.	jokim@ivi.int		Kim, Jae-Ouk/0000-0002-4556-5553; Noh, Youran/0000-0001-9765-2598	NRF of Korea [NRF-2014R1A1A3049897]; government of the Republic of Korea [NRF-2013K1A2A1058637]; government of the Sweden (SIDA)	NRF of Korea; government of the Republic of Korea(Korean Government); government of the Sweden (SIDA)	This work was supported by women scientist grants from NRF of Korea (NRF-2014R1A1A3049897) and from the governments of the Republic of Korea (NRF-2013K1A2A1058637) and Sweden (SIDA).	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Adkins B, 1999, IMMUNOL TODAY, V20, P330, DOI 10.1016/S0167-5699(99)01473-5; Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blanco J. C. G., 2014, HUM VACCINES, V6, P482; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Chuang YH, 2011, J IMMUNOL, V186, P4687, DOI 10.4049/jimmunol.1003659; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Cormier SA, 2010, EXPERT REV ANTI-INFE, V8, P1371, DOI [10.1586/eri.10.125, 10.1586/ERI.10.125]; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Dakhama A, 2005, J IMMUNOL, V175, P1876, DOI 10.4049/jimmunol.175.3.1876; Dakhama Azzeddine, 2005, Pediatr Infect Dis J, V24, pS159, DOI 10.1097/01.inf.0000188155.46381.15; DeKruyff RH, 2014, IMMUNOL REV, V260, P235, DOI 10.1111/imr.12187; Doucet C, 1998, J CLIN INVEST, V101, P2129, DOI 10.1172/JCI741; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HUANG YT, 1982, J VIROL, V43, P150, DOI 10.1128/JVI.43.1.150-157.1982; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Humbert M, 1996, CLIN EXP ALLERGY, V26, P123, DOI 10.1111/j.1365-2222.1996.tb00069.x; Humbert M, 1999, IMMUNOL TODAY, V20, P528, DOI 10.1016/S0167-5699(99)01535-2; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kristan KA, 2003, CANCER CHEMOTH PHARM, V51, P321, DOI 10.1007/s00280-003-0572-5; Lee YM, 2008, AM J RESP CRIT CARE, V177, P208, DOI 10.1164/rccm.200612-1890OC; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MAUSER PJ, 1995, AM J RESP CRIT CARE, V152, P467, DOI 10.1164/ajrccm.152.2.7633694; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Naseer T, 1997, AM J RESP CRIT CARE, V155, P845, DOI 10.1164/ajrccm.155.3.9117015; PENE J, 1988, P NATL ACAD SCI USA, V85, P6880, DOI 10.1073/pnas.85.18.6880; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667; Rowe J., 2001, Journal of Infectious Diseases, V184, P80, DOI 10.1086/320996; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Shi HZ, 1998, AM J RESP CRIT CARE, V157, P204, DOI 10.1164/ajrccm.157.1.9703027; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Van Kaer L, 2005, NAT REV IMMUNOL, V5, P31, DOI 10.1038/nri1531; Van Kaer L, 2011, IMMUNOTHERAPY-UK, V3, P59, DOI 10.2217/IMT.10.85; Wark PAB, 2002, EUR RESPIR J, V19, P68, DOI 10.1183/09031936.02.00226302; Welliver RC, 2003, PEDIATR INFECT DIS J, V22, pS6, DOI 10.1097/00006454-200302001-00002; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0176940	10.1371/journal.pone.0176940	http://dx.doi.org/10.1371/journal.pone.0176940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570692	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800004
J	Liu, PF; Kang, BH; Wu, YM; Sun, JH; Yen, LM; Fu, TY; Lin, YC; Liou, HH; Lin, YS; Sie, HC; Hsieh, IC; Tseng, YK; Shu, CW; Hsieh, YD; Ger, LP				Liu, Pei-Feng; Kang, Bor-Hwang; Wu, Yi-Min; Sun, Ju-Hsin; Yen, Liang-Ming; Fu, Ting-Ying; Lin, Yun-Chung; Liou, Huei-Han; Lin, Yaoh-Shiang; Sie, Huei-Cin; Hsieh, I-Chien; Tseng, Yu-Kai; Shu, Chih-Wen; Hsieh, Yao-Dung; Ger, Luo-Ping			Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins	PLOS ONE			English	Article							E-CADHERIN; EXPRESSION; CATENIN	We aimed to investigate the association of the expression levels of five epithelial-mesenchymal transition (EMT)-related proteins (Snail, Twist, E-cadherin, N-cadherin, and Vimentin) with tumorigenesis, pathologic parameters and prognosis in tongue squamous cell carcinoma (TSCC) patients by immunohistochemistry of tissue microarray. The expression levels of Snail, E-cadherin, N-cadherin and Vimentin were significantly different between the tumor adjacent normal and tumor tissues. In tumor tissues, lower E-cadherin and higher N-cadherin levels were associated with a higher grade of cell differentiation, advanced stage of disease, and lymph node metastasis. However, higher Vimentin expression was associated with poor cell differentiation and lymph node metastasis. Patients with low E-cadherin expression had poor disease-specific survival (DSS). Conversely, positive N-cadherin and higher Vimentin expression levels were associated with poor DSS and disease-free survival. Notably, our multivariate Cox regression model indicated that high Vimentin expression was an adverse prognostic factor for DSS in TSCC patients, even after the adjustment for cell differentiation, pathological stage, and expression levels of Snail, Twist, E-cadherin, and N-cadherin. Snail, E-cadherin, N-cadherin, and Vimentin were associated with tumorigenesis and pathological outcomes. Among the five EMT-related proteins, Vimentin was a potential prognostic factor for TSCC patients.	[Liu, Pei-Feng; Liou, Huei-Han; Shu, Chih-Wen; Ger, Luo-Ping] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Liu, Pei-Feng] Fooyin Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Kang, Bor-Hwang] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Kang, Bor-Hwang] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan; [Wu, Yi-Min; Sun, Ju-Hsin] Kaohsiung Med Univ, Grad Inst Oral Hlth Sci, Coll Dent Med, Kaohsiung, Taiwan; [Wu, Yi-Min] Kaohsiung Med Univ Hosp, Div Periodont, Dept Dent, Kaohsiung, Taiwan; [Sun, Ju-Hsin] Kaohsiung Vet Gen Hosp, Dept Med Management, Kaohsiung, Taiwan; [Yen, Liang-Ming; Fu, Ting-Ying; Sie, Huei-Cin; Hsieh, I-Chien] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Lin, Yun-Chung] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lin, Yaoh-Shiang] Natl Def Med Ctr, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Tseng, Yu-Kai] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan; [Tseng, Yu-Kai] Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan; [Hsieh, Yao-Dung] Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan; [Hsieh, Yao-Dung] Kaohsiung Vet Gegeral Hosp, Pingtung Branch, Dept Dent, Pingtung, Taiwan; [Ger, Luo-Ping] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Fooyin University; Kaohsiung Veterans General Hospital; National Defense Medical Center; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Defense Medical Center; National Cheng Kung University; National Cheng Kung University Hospital; Show Chwan Memorial Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University	Ger, LP (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.; Hsieh, YD (corresponding author), Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan.; Hsieh, YD (corresponding author), Kaohsiung Vet Gegeral Hosp, Pingtung Branch, Dept Dent, Pingtung, Taiwan.; Ger, LP (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.	mrusmrus@gmail.com; lpger@vghks.gov.tw	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002; Liu, Pei-Feng/0000-0002-7849-8940	VGHKS [VGHKS-101-033, VGHKS-103-011]; Kaohsiung Veterans General Hospital in Taiwan, ROC [VGHKS-101-033, VGHKS-103-011]	VGHKS; Kaohsiung Veterans General Hospital in Taiwan, ROC	This study was supported by VGHKS Grants VGHKS-101-033 and VGHKS-103-011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a research grant from Kaohsiung Veterans General Hospital (VGHKS-101-033 and VGHKS-103-011) in Taiwan, ROC.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Afrem MC, 2014, ROM J MORPHOL EMBRYO, V55, P1049; Aparna M, 2015, J ORAL PATHOL MED, V44, P345, DOI 10.1111/jop.12245; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Byers RM, 1997, HEAD NECK-J SCI SPEC, V19, P14, DOI 10.1002/(SICI)1097-0347(199701)19:1<14::AID-HED3>3.0.CO;2-Y; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Chen HC, 2015, J ORAL PATHOL MED; Di Domenico M, 2011, ANTICANCER RES, V31, P4211; Ding L, 2014, J ORAL PATHOL MED, V43, P335, DOI 10.1111/jop.12143; FAKIH AR, 1989, AM J SURG, V158, P309, DOI 10.1016/0002-9610(89)90122-0; FRANCESCHI D, 1993, AM J SURG, V166, P360, DOI 10.1016/S0002-9610(05)80333-2; Fu TY, 2016, ONCOTARGET; Hayry V, 2010, BRIT J CANCER, V102, P892, DOI 10.1038/sj.bjc.6605544; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Islam S, 1996, J CELL BIOL, V135, P1643, DOI 10.1083/jcb.135.6.1643; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li S, 2009, ONCOL REP, V21, P1223, DOI 10.3892/or_00000345; Liang XH, 2011, ORAL ONCOL, V47, P92, DOI 10.1016/j.oraloncology.2010.11.014; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Luo SL, 2014, TUMOR BIOL, V35, P5533, DOI 10.1007/s13277-014-1728-0; Mohamet L, 2011, J ONCOL, V2011, DOI 10.1155/2011/352616; Sakamoto K, 2012, ANN SURG ONCOL, V19, P612, DOI 10.1245/s10434-011-2052-1; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Schildberg CW, 2014, ADV MED SCI-POLAND, V59, P142, DOI 10.1016/j.advms.2014.03.002; Shimizu D, 2006, INT J CANCER, V119, P765, DOI 10.1002/ijc.21922; Tang YL, 2015, J ORAL PATHOL MED, V44, P337, DOI 10.1111/jop.12237; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Usami Y, 2008, J PATHOL, V215, P330, DOI 10.1002/path.2365; Wang C, 2013, MOL CARCINOGEN, V52, P229, DOI 10.1002/mc.21848; Wang C, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/801694; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Zheng M, 2015, ONCOTARGET, V6, P6794	35	32	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178581	10.1371/journal.pone.0178581	http://dx.doi.org/10.1371/journal.pone.0178581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570699	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800083
J	Wang, Q; Li, QL; Zhou, M; Sun, Z; Liu, HY; Wang, YT				Wang, Qian; Li, Qingli; Zhou, Mei; Sun, Zhen; Liu, Hongying; Wang, Yiting			A hyperspectral vessel image registration method for blood oxygenation mapping	PLOS ONE			English	Article							SATURATION; FLOW	Blood oxygenation mapping by the means of optical oximetry is of significant importance in clinical trials. This paper uses hyperspectral imaging technology to obtain in vivo images for blood oxygenation detection. The experiment involves dorsal skin fold window chamber preparation which was built on adult (8-10 weeks of age) female BALB/c nu/nu mice and in vivo image acquisition which was performed by hyperspectral imaging system. To get the accurate spatial and spectral information of targets, an automatic registration scheme is proposed. An adaptive feature detection method which combines the local threshold method and the level-set filter is presented to extract target vessels. A reliable feature matching algorithm with the correlative information inherent in hyperspectral images is used to kick out the outliers. Then, the registration images are used for blood oxygenation mapping. Registration evaluation results show that most of the false matches are removed and the smooth and concentrated spectra are obtained. This intensity invariant feature detection with outliers-removing feature matching proves to be effective in hyperspectral vessel image registration. Therefore, in vivo hyperspectral imaging system by the assistance of the proposed registration scheme provides a technique for blood oxygenation research.	[Wang, Qian; Li, Qingli; Zhou, Mei; Liu, Hongying; Wang, Yiting] East China Normal Univ, Shanghai Key Lab Multidimens Informat Proc, Shanghai, Peoples R China; [Sun, Zhen] Nanjing Univ, Sch Med, Jinling Hosp, Dept Tangshan Branch Sanat, Nanjing, Jiangsu, Peoples R China	East China Normal University; Nanjing University	Li, QL (corresponding author), East China Normal Univ, Shanghai Key Lab Multidimens Informat Proc, Shanghai, Peoples R China.	qlli@cs.ecnu.edu.cn	wang, yiting/GYU-5306-2022	Li, Qingli/0000-0001-5063-8801	National Natural Science Foundation of China [61377107]; Science and Technology Commission of Shanghai Municipality [14DZ2260800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported in part by the National Natural Science Foundation of China (grant no. 61377107, Qingli Li, http://www.nsfc.gov.cn) and the Science and Technology Commission of Shanghai Municipality (grant no. 14DZ2260800, Qingli Li, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have no relevant financial interests or conflicts of interest to disclose. This work is supported by the National Natural Science Foundation of China (Grant No. 61377107), the Science and Technology Commission of Shanghai Municipality (Grant No. 14DZ2260800).	Algire GH, 1943, J NATL CANCER I, V4, P1; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bazi Y, 2007, PATTERN RECOGN, V40, P619, DOI 10.1016/j.patcog.2006.05.006; Bioucas-Dias JM, 2013, IEEE GEOSC REM SEN M, V1, P6, DOI 10.1109/MGRS.2013.2244672; FANTINI S, 1995, OPT ENG, V34, P32, DOI 10.1117/12.183988; FISCHLER M, 1987, RANDOM SAMPLE CONSEN; Fontanelli D, 2007, AUT SCI ENG 2007 CAS; Freeman J., 1997, P 19 ANN INT C IEEE; Gatos B, 2006, PATTERN RECOGN, V39, P317, DOI 10.1016/j.patcog.2005.09.010; Gong MG, 2014, IEEE T GEOSCI REMOTE, V52, P4328, DOI 10.1109/TGRS.2013.2281391; Gutierreznavarro O, 2015, COMPUT METH PROG BIO, V124, P148; Han X, 2003, IEEE T PATTERN ANAL, V25, P755, DOI 10.1109/TPAMI.2003.1201824; Hanna G, 2013, AM J PHYSIOL-LUNG C, V304, pL86, DOI 10.1152/ajplung.00178.2012; Huang A, 2009, IEEE T BIO-MED ENG, V56, P1838, DOI 10.1109/TBME.2009.2017509; Koehl GE, 2009, CLIN EXP METASTAS, V26, P329, DOI 10.1007/s10585-008-9234-7; Li B, 2014, IEEE GEOSCI REMOTE S, V11, P1433, DOI 10.1109/LGRS.2013.2295115; LI H, 1995, IEEE T IMAGE PROCESS, V4, P320, DOI 10.1109/83.366480; Li HS, 2014, IEEE T PATTERN ANAL, V36, P2407, DOI 10.1109/TPAMI.2014.2324568; Li QL, 2010, IEEE T BIO-MED ENG, V57, P1699, DOI 10.1109/TBME.2010.2041663; Ma JY, 2015, IEEE T GEOSCI REMOTE, V53, P6469, DOI 10.1109/TGRS.2015.2441954; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Machado MJC, 2011, MICROCIRCULATION, V18, P183, DOI 10.1111/j.1549-8719.2010.00076.x; Maikala RV, 2010, INT J IND ERGONOM, V40, P125, DOI 10.1016/j.ergon.2009.02.011; MALLADI R, 1995, IEEE T PATTERN ANAL, V17, P158, DOI 10.1109/34.368173; Moroni M, 2012, SENSORS-BASEL, V12, P10228, DOI 10.3390/s120810228; Moy AJ, 2011, MICROVASC RES, V82, P199, DOI 10.1016/j.mvr.2011.07.004; Nordsmark M, 2000, RADIOTHER ONCOL, V57, P39, DOI 10.1016/S0167-8140(00)00223-1; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Oye KS, 2008, MICROVASC RES, V75, P179, DOI 10.1016/j.mvr.2007.06.009; Pike R, 2016, MINIMUM SPANNING FOR, P63; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Skala MC, 2009, OPT LETT, V34, P289, DOI 10.1364/OL.34.000289; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Subhash HM, 2011, IEEE T MED IMAGING, V30, P224, DOI 10.1109/TMI.2010.2072934; Wang YC, 2011, IEEE T MED IMAGING, V30, P2030, DOI 10.1109/TMI.2011.2160191; Willems G, 2008, EFFICIENT DENSE SCAL; Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	38	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178499	10.1371/journal.pone.0178499	http://dx.doi.org/10.1371/journal.pone.0178499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570589	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800066
J	Zhang, Y; Hu, JZ; Duan, CY; Hu, P; Lu, HB; Peng, XJ				Zhang, Yi; Hu, Jianzhong; Duan, Chunyue; Hu, Ping; Lu, Hongbin; Peng, Xianjing			Correlation study between facet joint cartilage and intervertebral discs in early lumbar vertebral degeneration using T2, T2*and T1 rho mapping	PLOS ONE			English	Article							PFIRRMANN GRADING SYSTEM; KNEE ARTICULAR-CARTILAGE; T-2 RELAXATION-TIMES; OSTEOARTHRITIS; MRI; T-1-RHO; T1RHO; 3T; GRADES; SPINE	Recent advancements in magnetic resonance imaging have allowed for the early detection of biochemical changes in intervertebral discs and articular cartilage. Here, we assessed the feasibility of axial T2, T2* and T1 rho mapping of the lumbar facet joints (LFJs) to determine correlations between cartilage and intervertebral discs (IVDs) in early lumbar vertebral degeneration. We recruited 22 volunteers and examined 202 LFJs and 101 IVDs with morphological (sagittal and axial FSE T2-weighted imaging) and axial biochemical (T2, T2* and T1 rho mapping) sequences using a 3.0T MRI scanner. IVDs were graded using the Pfirrmann system. Mapping values of LFJs were recorded according to the degeneration grades of IVDs at the same level. The feasibility of T2, T2* and T1 rho in IVDs and LFJs were analyzed by comparing these mapping values across subjects with different rates of degeneration using Kruskal-Wallis tests. A Pearson's correlation analysis was used to compare T2, T2* and T1 rho values of discs and LFJs. We found excellent reproducibility in the T2, T2* and T1 rho values for the nucleus pulposus (NP), anterior and posterior annulus fibrosus (PAF), and LFJ cartilage (intraclass correlation coefficients 0.806-0.955). T2, T2* and T1 rho mapping (all P < 0.01) had good Pfirrmann grade performances in the NP with IVD degeneration. LFJ T2* values were significantly different between grades I and IV (P-L = 0.032, P-R = 0.026), as were T1 rho values between grades II and III (P-L = 0.002, P-R = 0.006) and grades III and IV (P-L = 0.006, P-R = 0.001). Correlations were moderately negative for T1 rho values between LFJ cartilage and NP (r(L) = -0.574, r(R) = -0.551), and between LFJ cartilage and PAF (r(L) = -0.551, r(R) = -0.499). T1 rho values of LFJ cartilage was weakly correlated with T2 (r = 0.007) and T2* (r = -0.158) values. Overall, we show that axial T1 rho effectively assesses early LFJ cartilage degeneration. Using T1 rho analysis, we propose a link between LFJ degeneration and IVD NP or PAF changes.	[Zhang, Yi; Hu, Jianzhong; Duan, Chunyue] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha, Hunan, Peoples R China; [Hu, Ping; Peng, Xianjing] Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Dept Sports Med, Changsha, Hunan, Peoples R China; [Lu, Hongbin] Cent S Univ, Res Ctr Sports Med, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, XJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China.	pengxianjing@sina.cn			National Natural Science Foundation of China [81301522]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NO. 81301522).	Bittersohl B, 2012, OSTEOARTHR CARTILAGE, V20, P653, DOI 10.1016/j.joca.2012.03.011; Bittersohl B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006895; Bittersohl B, 2014, SKELETAL RADIOL, V43, P443, DOI 10.1007/s00256-013-1806-1; Blumenkrantz G, 2007, EUR CELLS MATER, V13, P75; Borthakur A, 2011, SPINE, V36, P2190, DOI 10.1097/BRS.0b013e31820287bf; Bumenkrantz G, 2010, MAGN RESON MED, V63, P1193, DOI 10.1002/mrm.22362; Cao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21838; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087856; Duan CY, 2011, OSTEOARTHR CARTILAGE, V19, P96, DOI 10.1016/j.joca.2010.10.015; Fujiwara A, 1999, EUR SPINE J, V8, P396, DOI 10.1007/s005860050193; Gellhorn AC, 2013, NAT REV RHEUMATOL, V9, P216, DOI 10.1038/nrrheum.2012.199; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hannila I, 2015, MAGN RESON MATER PHY, V28, P547, DOI 10.1007/s10334-015-0494-3; Hirose J, 2012, EUR J RADIOL, V81, P2776, DOI 10.1016/j.ejrad.2011.11.019; Hoppe S, 2012, EUR RADIOL, V22, P2013, DOI 10.1007/s00330-012-2448-8; Kalichman L, 2007, SEMIN ARTHRITIS RHEU, V37, P69, DOI 10.1016/j.semarthrit.2007.01.007; Kijowski R, 2014, MAGN RESON IMAGING C, V22, P649, DOI 10.1016/j.mric.2014.07.005; Kim HK, 2016, KOREAN J RADIOL, V17, P159, DOI 10.3348/kjr.2016.17.1.159; Kim T, 2014, SKELETAL RADIOL, V43, P947, DOI 10.1007/s00256-014-1872-z; Kumar D, 2014, J ORTHOP SPORT PHYS, V44, P964, DOI 10.2519/jospt.2014.5523; Manchikanti Laxmaiah, 2003, Pain Physician, V6, P399; Marinelli NL, 2010, AM J NEURORADIOL, V31, P1278, DOI 10.3174/ajnr.A2080; Newbould RD, 2012, J MAGN RESON IMAGING, V35, P1422, DOI 10.1002/jmri.23598; Prasad AP, 2013, OSTEOARTHR CARTILAGE, V21, P69, DOI 10.1016/j.joca.2012.09.011; Regatte RR, 2006, J MAGN RESON IMAGING, V23, P547, DOI 10.1002/jmri.20536; Rodrigues LMR, 2013, SPINE, V38, P1112, DOI 10.1097/BRS.0b013e3182894cf4; Rim Dae Cheol, 2016, Korean J Spine, V13, P1, DOI 10.14245/kjs.2016.13.1.1; Schooler J, 2014, OSTEOARTHR CARTILAGE, V22, P51, DOI 10.1016/j.joca.2013.10.014; Singh A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097486; Souza RB, 2014, OSTEOARTHR CARTILAGE, V22, P1367, DOI 10.1016/j.joca.2014.04.017; Stelzeneder D, 2011, EUR RADIOL, V21, P2388, DOI 10.1007/s00330-011-2198-z; Takashima H, 2014, MAGN RESON MED SCI, V13, P261, DOI 10.2463/mrms.2013-0099; Wang LG, 2014, ACAD RADIOL, V21, P463, DOI 10.1016/j.acra.2013.12.010; Wang LG, 2012, EUR J RADIOL, V81, P2329, DOI 10.1016/j.ejrad.2011.07.017; Wang YXJ, 2013, EUR RADIOL, V23, P228, DOI 10.1007/s00330-012-2591-2; Welsch GH, 2011, SKELETAL RADIOL, V40, P543, DOI 10.1007/s00256-010-1036-8; Zhang XJ, 2015, MED SCI MONITOR, V21, P1934, DOI 10.12659/MSM.894406; Zhou ZY, 2013, RADIOLOGY, V268, P492, DOI 10.1148/radiol.13120874	38	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178406	10.1371/journal.pone.0178406	http://dx.doi.org/10.1371/journal.pone.0178406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570641	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800050
J	Gudenas, BL; Srivastava, AK; Wang, LJ				Gudenas, Brian L.; Srivastava, Anand K.; Wang, Liangjiang			Integrative genomic analyses for identification and prioritization of long non-coding RNAs associated with autism	PLOS ONE			English	Article							EPIGENETIC MECHANISMS; SPECTRUM DISORDER; EXPRESSION; REVEALS; PATHOGENESIS; PLASTICITY; PATHWAYS; GENES; ROLES	Genetic studies have identified many risk loci for autism spectrum disorder (ASD) although causal factors in the majority of cases are still unknown. Currently, known ASD risk genes are all protein-coding genes; however, the vast majority of transcripts in humans are non-coding RNAs (ncRNAs) which do not encode proteins. Recently, long non-coding RNAs (lncRNAs) were shown to be highly expressed in the human brain and crucial for normal brain development. We have constructed a computational pipeline for the integration of various genomic datasets to identify lncRNAs associated with ASD. This pipeline utilizes differential gene expression patterns in affected tissues in conjunction with gene co-expression networks in tissue-matched non-affected samples. We analyzed RNA-seq data from the cortical brain tissues from ASD cases and controls to identify lncRNAs differentially expressed in ASD. We derived a gene co-expression network from an independent human brain developmental transcriptome and detected a convergence of the differentially expressed lncRNAs and known ASD risk genes into specific co-expression modules. Co-expression network analysis facilitates the discovery of associations between previously uncharacterized lncRNAs with known ASD risk genes, affected molecular pathways and at-risk developmental time points. In addition, we show that some of these lncRNAs have a high degree of overlap with major CNVs detected in ASD genetic studies. By utilizing this integrative approach comprised of differential expression analysis in affected tissues and connectivity metrics from a developmental co-expression network, we have prioritized a set of candidate ASD-associated lncRNAs. The identification of lncRNAs as novel ASD susceptibility genes could help explain the genetic pathogenesis of ASD.	[Gudenas, Brian L.; Wang, Liangjiang] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA	Clemson University; Greenwood Genetic Center	Wang, LJ (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	liangjw@clemson.edu			Self Regional Healthcare Foundation	Self Regional Healthcare Foundation	This work was supported by a grant from the Self Regional Healthcare Foundation.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Ander BP, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0029-9; Ayupe AC, 2015, RNA BIOL, V12, P877, DOI 10.1080/15476286.2015.1062960; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Clark BS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00164; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Iyengar BR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00047; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nardone S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.70; Nazeen S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1084-z; Nie L, 2012, AM J TRANSL RES, V4, P127; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Qiu SF, 2006, NEUROBIOL LEARN MEM, V85, P16, DOI 10.1016/j.nlm.2005.08.009; Schaukowitch K, 2014, NEUROSCIENCE, V264, P25, DOI 10.1016/j.neuroscience.2013.12.009; Shimamoto C, 2015, HUM MOL GENET, V24, P2409, DOI 10.1093/hmg/ddv011; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; van de Vondervoort IIGM, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00053; Voineagu I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00738; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.144; Warnes GR, 2009, GPLOTS VARIOUS R PRO, V2, P4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson B, 2013, INT REV NEUROBIOL, V113, P35, DOI 10.1016/B978-0-12-418700-9.00002-2; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wu P, 2013, BRAIN RES BULL, V97, P69, DOI 10.1016/j.brainresbull.2013.06.001; Yu L, 2015, SCI CHINA LIFE SCI, V58, P958, DOI 10.1007/s11427-015-4941-1; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207; Zhubi A, 2014, INT REV NEUROBIOL, V115, P203, DOI 10.1016/B978-0-12-801311-3.00006-8; Ziats MN, 2013, J MOL NEUROSCI, V49, P589, DOI 10.1007/s12031-012-9880-8	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178532	10.1371/journal.pone.0178532	http://dx.doi.org/10.1371/journal.pone.0178532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562671	gold, Green Submitted, Green Published			2022-12-26	WOS:000402608700068
J	Mercier-Delarue, S; Durier, C; de Verdlere, NC; Poveda, JD; Meiffredy, V; Garcia, MDF; Lastere, S; Cesaire, R; Manuggera, JC; Molina, JM; Amara, A; Simon, F				Mercier-Delarue, Severine; Durier, Christine; de Verdlere, Nathalie Colin; Poveda, Jean-Dominique; Meiffredy, Vincent; Garcia, Maria Dolores Fernandez; Lastere, Stephane; Cesaire, Raymond; Manuggera, Jean-Claude; Molina, Jean-Michel; Amara, Ali; Simon, Francois			Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype	PLOS ONE			English	Article							VACCINE; CHALLENGE	Given the possibility of yellow fever virus reintroduction in epidemiologically receptive geographic areas, the risk of vaccine supply disruption is a serious issue. New strategies to reduce the doses of injected vaccines should be evaluated very carefully in terms of immunogenicity. The plaque reduction test for the determination of neutralizing antibodies (PRNT) is particularly time-consuming and requires the use of a confinement laboratory. We have developed a new test based on the use of a non-infectious pseudovirus (WN/YF17D). The presence of a reporter gene allows sensitive determination of neutralizing antibodies by flow cytometry. This WNNF17D test was as sensitive as PRNT for the follow-up of yellow fever vaccinees. Both tests lacked specificity with sera from patients hospitalized for acute Dengue virus infection. Conversely, both assays were strictly negative in adults never exposed to flavivirus infection or vaccination, and in patients sampled some time after acute Dengue infection. This WNNF17D test will be particularly useful for large epidemiological studies and for screening for neutralizing antibodies against yellow fever virus.	[Mercier-Delarue, Severine; Simon, Francois] St Louis Univ Hosp, Dept Microbiol, Paris, France; [Durier, Christine] INSERM, SC10 US19, Villejuif, France; [de Verdlere, Nathalie Colin; Molina, Jean-Michel] St Louis Univ Hosp, Dept Infect Dis, Paris, France; [Poveda, Jean-Dominique] Lab CERBA St Ouen Laurnone France, St Ouen Laurnone, France; [Garcia, Maria Dolores Fernandez; Amara, Ali] St Louis Univ Hosp, INSERM, U944 UMR 7212, Paris, France; [Lastere, Stephane] Ctr Hosp Polynesie Francaise, Dept Med Biol, Tahiti, French Polynesi, France; [Cesaire, Raymond] Univ Hosp Ft France, Dept Viroimmunol, Fort De France, French West Ind, France; [Manuggera, Jean-Claude] Inst Pasteur, Lab Urgent Response Biol Threats, Environm & Infect Risks Res & Expertise Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Martinique; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Simon, F (corresponding author), St Louis Univ Hosp, Dept Microbiol, Paris, France.	francois.simon@aphp.fr	AMARA, Ali/ABX-9903-2022; Amara, Ali/E-8803-2017; Fernandez-Garcia, Maria Dolores/B-2029-2016	Fernandez-Garcia, Maria Dolores/0000-0003-0336-6596; AMARA, Ali/0000-0002-0283-1815	French "Agence Nationale de Recherches contre les hepatites et le SIDA" ANRS [ANRS EP46 NOVAA]; Cerba laboratories	French "Agence Nationale de Recherches contre les hepatites et le SIDA" ANRS; Cerba laboratories	This work was funded by the French "Agence Nationale de Recherches contre les hepatites et le SIDA" ANRS (http://www.anrs.fr/), Grant number: ANRS EP46 NOVAA; Funding: FS. Cerba laboratories just provide the financial support as Dr. Poveda's salaries and have no role in the study design and analysis or decision to publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, 57252 ISO; Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997; Camacho LAB, 2012, BIOL J INT ASS BIOL, V40, P399; Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15; Fisker AB, 2014, VACCINE, V32, P598, DOI 10.1016/j.vaccine.2013.11.074; Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77; Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264; Hepburn MJ, 2006, VACCINE, V24, P2843, DOI 10.1016/j.vaccine.2005.12.055; Jonker Emile F F, 2013, Ther Adv Vaccines, V1, P144, DOI 10.1177/2051013613498954; Julander JG, 2011, VACCINE, V29, P6008, DOI 10.1016/j.vaccine.2011.06.034; Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0; Martins RD, 2015, HUM VACC IMMUNOTHER, V11, P2183, DOI 10.1080/21645515.2015.1022700; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Mather S, 2013, FUTURE VIROL, V8, P745, DOI 10.2217/fvl.13.60; Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303; Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021; RICE C M, 1989, New Biologist, V1, P285; Salmona M, 2015, VACCINE, V33, P5432, DOI 10.1016/j.vaccine.2015.08.055; SPECTOR S, 1968, APPL MICROBIOL, V16, P1770, DOI 10.1128/AEM.16.11.1770-1775.1968; Tanizaki R, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw012; Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458; WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040	24	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177882	10.1371/journal.pone.0177882	http://dx.doi.org/10.1371/journal.pone.0177882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562615	Green Submitted, gold, Green Published			2022-12-26	WOS:000402608700033
J	Kumar, NP; Moideen, K; Dolla, C; Kumaran, P; Babu, S				Kumar, Nathella Pavan; Moideen, Kadar; Dolla, Chandrakumar; Kumaran, Paul; Babu, Subash			Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; T-CELL RESPONSES; DIABETES-MELLITUS; CD8(+) T; INDIVIDUALS; CYTOKINES; HUMANS; TH1	Type 2 diabetes mellitus (DM) is associated with the down modulation of Th1, Th2 and Th17 responses in latent Mycobacterium tuberculosis infection but the role of prediabetes (PDM) in this setting is not well understood. To examine the role of CD4(+) and CD8(+) T cell cytokines in latent tuberculosis (LTB) with coincident PDM, we studied the baseline, mycobacterial, control antigen and mitogen-stimulated T cell cytokine responses in LTB individuals with (LTB-PDM; n = 20) or without (LTB-NDM; n = 20) concomitant prediabetes. LTB-PDM is characterized by diminished frequencies of mono-and dual-functional CD4(+) Th1 and Th17 cells and mono-functional Th2 cells at baseline and/or following mycobacterial-antigen stimulation in comparison to LTB-NDM. LTB-PDM is also characterized by diminished frequencies of mono-functional CD8(+) Tc1, Tc2 and Tc17 cells at baseline and/or following mycobacterial-antigen stimulation in comparison to LTB-NDM. LTB-PDM is therefore characterized by diminished frequencies of antigen-specific Th1/Tc1 and Th17/Tc17 cells, indicating that PDM is associated with alterations of the immune response in latent TB associated with compromised CD4(+) and CD8(+) T cell function.	[Kumar, Nathella Pavan; Moideen, Kadar; Babu, Subash] Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India; [Dolla, Chandrakumar; Kumaran, Paul] Natl Inst Res TB, Madras, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Babu, S (corresponding author), Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Division of Intramural Research, NIAID, NIH. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Almeida JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153590; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hensel RL, 2016, INT J TUBERC LUNG D, V20, P71, DOI 10.5588/ijtld.15.0457; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumar NP, 2015, IMMUNOLOGY, V144, P677, DOI 10.1111/imm.12421; Kumar NP, 2016, J INFECT DIS, V213, P866, DOI 10.1093/infdis/jiv484; Kumar NP, 2016, EUR J IMMUNOL, V46, P390, DOI 10.1002/eji.201545973; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112108; Kumar NP, 2014, J INFECT DIS, V210, P1670, DOI 10.1093/infdis/jiu329; Lin PL, 2015, SEMIN IMMUNOPATHOL, V37, P239, DOI 10.1007/s00281-015-0490-8; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Rook GAW, 2007, CURR MOL MED, V7, P327; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	23	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178000	10.1371/journal.pone.0178000	http://dx.doi.org/10.1371/journal.pone.0178000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558065	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000402607000021
J	Schmidt, C; Tchouankoue, JP; Nemzoue, PNN; Ayaba, F; Nformidah-Ndah, SS; Chifu, EN				Schmidt, Christoph; Tchouankoue, Jean Pierre; Nemzoue, Peguy Noel Nkouamen; Ayaba, Felicite; Nformidah-Ndah, Siggy Signe; Chifu, Emmanuel Nformi			New thermoluminescence age estimates for the Nyos maar eruption (Cameroon Volcanic Line)	PLOS ONE			English	Article							LAKE NYOS; LUMINESCENCE METHODS; GERMANY; EIFEL; FIELD; SEDIMENTS; BASALTS; SAMPLES; SERIES; DAM	Nyos maar is located in the Cameroon Volcanic Line and generates a multitude of primary and secondary hazards to the local population. For risk assessment and hazard mitigation, the age of the Nyos maar eruption provides some vital information. Since previous dating efforts using a range of techniques resulted in vastly varying eruption ages, we applied thermoluminescence (TL) methods to obtain independent and direct chronological constraints for the time of maar formation. Target minerals were granitic quartz clasts contained in pyroclastic surge deposits. Thermoluminescence plateau results prove that heat and/or pressure during the phreatomagmatic eruption was sufficient to reset the inherited luminescence signal of granitic bedrock quartz. Parallel application of three TL measurement protocols to one of the two samples gave consistent equivalent doses for the quartz ultra-violet emission. Despite the robustness of our dose estimates, the assessment of the dose rate was accompanied by methodological challenges, such as estimation of the original size distribution of quartz grains in the pyroclastic deposits. Considering results from additional laboratory analyses to constrain these uncertainties, we calculate an average maximum TL age of 12.3 1.5 ka for the Nyos maar eruption. Based on these new data, a more solid risk assessment can be envisaged.	[Schmidt, Christoph] Univ Bayreuth, Chair Geomorphol, Bayreuth, Germany; [Schmidt, Christoph] Univ Bayreuth, BayCEER, Bayreuth, Germany; [Tchouankoue, Jean Pierre; Nemzoue, Peguy Noel Nkouamen; Ayaba, Felicite; Nformidah-Ndah, Siggy Signe; Chifu, Emmanuel Nformi] Univ Yaounde I, Dept Earth Sci, Yaounde, Cameroon	University of Bayreuth; University of Bayreuth; University of Yaounde I	Schmidt, C (corresponding author), Univ Bayreuth, Chair Geomorphol, Bayreuth, Germany.; Schmidt, C (corresponding author), Univ Bayreuth, BayCEER, Bayreuth, Germany.	christoph.schmidt@uni-bayreuth.de		Schmidt, Christoph/0000-0002-2309-3209; Tchouankoue, Jean Pierre/0000-0001-8864-2320	German Research Foundation (DFG); University of Bayreuth in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth in the funding programme Open Access Publishing	We would like to thank Manfred Fischer and the supporting student staff at the luminescence laboratory in Bayreuth for valuable help with sample preparation and discussions. The Editor and two anonymous reviewers provided detailed and helpful comments, from which this paper significantly benefitted. This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing.	Aitken MJ, 1985, THERMOLUMINESCENCE D; Aka FT, 2008, J VOLCANOL GEOTH RES, V176, P212, DOI 10.1016/j.jvolgeores.2008.04.009; [Anonymous], 1990, NAT HAZARDS, V3, P373; Auclair M, 2003, RADIAT MEAS, V37, P487, DOI 10.1016/S1350-4487(03)00018-0; Bulur E, 1996, RADIAT MEAS, V26, P701, DOI 10.1016/S1350-4487(97)82884-3; Fattahi M, 2003, EARTH-SCI REV, V62, P229, DOI 10.1016/S0012-8252(02)00159-9; Freeth SJ, 2000, J VOLCANOL GEOTH RES, V97, P261, DOI 10.1016/S0377-0273(99)00172-9; Fuhrmann U., 1986, N JB GEOL PALAONT AB, V172, P1; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Gaudru H, 2002, COGEOENVIRONMENT NEW, V18, P12; Guerin G, 2011, ANCIENT TL, V29, P5; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Guerin G, 2012, RADIAT MEAS, V47, P778, DOI 10.1016/j.radmeas.2012.04.004; Heineke C, 2016, QUAT GEOCHRONOL, V34, P81, DOI 10.1016/j.quageo.2016.04.004; Huntley DJ, 2001, CAN J EARTH SCI, V38, P1093, DOI 10.1139/e01-013; Jensen L, 2003, RADIAT MEAS, V37, P441; Jensen L, 1994, QUATERNARY SCI REV, V13, P551; Jensen L, 2010, RADIAT MEAS, V45, P253; Kreutzer S., 2016, LUMINESCENCE COMPREH; Kreutzer S., 2012, ANC TL, V30, P1, DOI DOI 10.1007/978-94-007-6326-5_121-2; Kulig G, 2005, THESIS TECHNISCHE U; Liu C-Z, CHEM GEOL; Lockwood J.P., 1988, EOS T AM GEOPHYS UN, V69, P776; LOCKWOOD JP, 1988, B VOLCANOL, V50, P340, DOI 10.1007/BF01073590; LOCKWOOD JP, 1989, J VOLCANOL GEOTH RES, V39, P117, DOI 10.1016/0377-0273(89)90052-8; Mauz B., 2006, ANCIENT TL, V24, P47; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mendoza-Rosas AT, 2008, J VOLCANOL GEOTH RES, V176, P277, DOI 10.1016/j.jvolgeores.2008.04.005; Mertz DF, 2015, J GEODYN, V88, P59, DOI 10.1016/j.jog.2015.04.002; Peyronne Y, 1968, DIRECTION MINES GEOL; Pinter Z, 2015, J AFR EARTH SCI, V111, P170, DOI 10.1016/j.jafrearsci.2015.07.006; Preusser F, 2011, GEOLOGY, V39, P1135, DOI 10.1130/G32345.1; R Development Core Team, 2016, R FDN STAT COMP; Richter D, 2013, GEOCHRONOMETRIA, V40, P220, DOI 10.2478/s13386-013-0110-0; Rufer D, 2012, GEOCHRONOMETRIA, V39, P48, DOI 10.2478/s13386-011-0049-y; Schmincke H-U, 2007, MANTLE PLUMES MULTID, P241, DOI DOI 10.1007/978-3-540-68046-8_8; Singarayer JS, 2003, RADIAT MEAS, V37, P451, DOI 10.1016/S1350-4487(03)00062-3; Singer BS, 2008, PHYS EARTH PLANET IN, V169, P28, DOI 10.1016/j.pepi.2008.05.001; Sirocko F, 2013, QUATERNARY SCI REV, V62, P56, DOI 10.1016/j.quascirev.2012.09.011; Tsukamoto S, 2008, RADIAT MEAS, V43, P721, DOI 10.1016/j.radmeas.2007.10.025; Tsukamoto S, 2011, QUAT GEOCHRONOL, V6, P61, DOI 10.1016/j.quageo.2010.04.002; Tsukamoto S, RAD MEAS; WINTLE AG, 1973, NATURE, V245, P143, DOI 10.1038/245143a0; Zogning A, 1997, J AFR EARTH SCI, V24, P285, DOI 10.1016/S0899-5362(97)00044-4; Zoller L., 1989, ANCIENT TL, V7, P11; Zoller L, 2009, ANCIENT TL, V27, P15	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178545	10.1371/journal.pone.0178545	http://dx.doi.org/10.1371/journal.pone.0178545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558057	gold, Green Published, Green Submitted			2022-12-26	WOS:000402607000054
J	Gzyl, KE; Wieden, HJ				Gzyl, Katherine E.; Wieden, Hans-Joachim			Tetracycline does not directly inhibit the function of bacterial elongation factor Tu	PLOS ONE			English	Article							FACTOR EF-TU; ESCHERICHIA-COLI; NUCLEOTIDE EXCHANGE; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; P-LOOP; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; RIBOSOMAL-SUBUNIT; STRUCTURAL BASIS	Understanding the molecular mechanism of antibiotics that are currently in use is important for the development of new antimicrobials. The tetracyclines, discovered in the 1940s, are a well-established class of antibiotics that still have a role in treating microbial infections in humans. It is generally accepted that the main target of their action is the ribosome. The estimated affinity for tetracycline binding to the ribosome is relatively low compared to the actual potency of the drug in vivo. Therefore, additional inhibitory effects of tetracycline on the translation machinery have been discussed. Structural evidence suggests that tetracycline inhibits the function of the essential bacterial GTPase Elongation Factor (EF)-Tu through interaction with the bound nucleotide. Based on this, tetracycline has been predicted to impede the nucleotide-binding properties of EF-Tu. However, detailed kinetic studies addressing the effect of tetracycline on nucleotide binding have been prevented by the fluorescence properties of the antibiotic. Here, we report a fluorescence-based kinetic assay that minimizes the effect of tetracycline autofluorescence, enabling the detailed kinetic analysis of the nucleotide-binding properties of Escherichia coli EF-Tu. Furthermore, using physiologically relevant conditions, we demonstrate that tetracycline does not affect EF-Tu's intrinsic or ribosome-stimulated GTPase activity, nor the stability of the EF-Tu .GTP.Phe-tRNA(Phe) complex. We therefore provide clear evidence that tetracycline does not directly impede the function of EF-Tu.	[Gzyl, Katherine E.; Wieden, Hans-Joachim] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada	University of Lethbridge	Wieden, HJ (corresponding author), Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB, Canada.	hj.wieden@uleth.ca		Wieden, Hans-Joachim/0000-0001-5181-6059	Canadian Institutes of Health Research [M0P246392]; Alberta Innovates Technology Futures [SC60-T2]; Canadian Foundation for Innovation [202588]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by funding from the Canadian Institutes of Health Research (H.J.W.; Operating Grants Program, M0P246392; www.cihr-irsc.gc.ca/e/193.html), Alberta Innovates Technology Futures (H.J.W.; Strategic Chairs Program, SC60-T2; http://www.albertatechfutures. cal), and the Canadian Foundation for Innovation (H.J.W.; John R. Evans Leaders Fund, 202588; https://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aevarsson A, 1995, J MOL EVOL, V41, P1096; Aleksandrov A, 2008, BIOCHEMISTRY-US, V47, P13594, DOI 10.1021/bi801726q; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; Burke MD, 2009, NAT CHEM BIOL, V5, P77, DOI 10.1038/nchembio0209-77; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clark RB, 2011, J MED CHEM, V54, P1511, DOI 10.1021/jm1015389; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; De Laurentiis EI, 2016, J BIOL CHEM, V291, P23136, DOI 10.1074/jbc.M116.740381; De Laurentiis EI, 2011, BBA-PROTEINS PROTEOM, V1814, P684, DOI 10.1016/j.bbapap.2011.02.007; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Donhofer A, 2012, P NATL ACAD SCI USA, V109, P16900, DOI 10.1073/pnas.1208037109; DONNER D, 1978, P NATL ACAD SCI USA, V75, P3192, DOI 10.1073/pnas.75.7.3192; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; GORDON J, 1969, J BIOL CHEM, V244, P5680; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Heffron SE, 2006, ACTA CRYSTALLOGR D, V62, P1392, DOI 10.1107/S0907444906035426; Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710; Huang Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00914; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Koonin EV, 2000, ADV PROTEIN CHEM, V54, P245, DOI 10.1016/S0065-3233(00)54008-X; Lamberti A, 2011, CHEM BIOL DRUG DES, V78, P260, DOI 10.1111/j.1747-0285.2011.01142.x; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Maracci C, 2014, P NATL ACAD SCI USA, V111, P14418, DOI 10.1073/pnas.1412676111; Mercier E, 2015, SCI REP-UK, V5, DOI 10.1038/srep07677; MESTERS JR, 1994, J MOL BIOL, V242, P644, DOI 10.1006/jmbi.1994.1614; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; PINGOUD A, 1983, J BIOL CHEM, V258, P4200; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Sakellari D, 2000, J CLIN PERIODONTOL, V27, P53, DOI 10.1034/j.1600-051x.2000.027001053.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEMENKOV YP, 1982, FEBS LETT, V144, P125, DOI 10.1016/0014-5793(82)80584-X; Solomkin JS, 2014, ANTIMICROB AGENTS CH, V58, P1847, DOI 10.1128/AAC.01614-13; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wieden HJ, 2010, BIOPHYS J, V99, P3735, DOI 10.1016/j.bpj.2010.10.013; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311	45	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178523	10.1371/journal.pone.0178523	http://dx.doi.org/10.1371/journal.pone.0178523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552981	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000049
J	Beheshti, R; Jones-Smith, JC; Igusa, T				Beheshti, Rahmatollah; Jones-Smith, Jessica C.; Igusa, Takeru			Taking dietary habits into account: A computational method for modeling food choices that goes beyond price	PLOS ONE			English	Article							AGENT-BASED SIMULATION; NUTRIENT DENSITY; COST; CONSUMPTION; CHILDREN; BEHAVIOR; HEALTH; IMPACT; OPTIMIZATION; QUALITY	Computational models have gained popularity as a predictive tool for assessing proposed policy changes affecting dietary choice. Specifically, they have been used for modeling dietary changes in response to economic interventions, such as price and income changes. Herein, we present a novel addition to this type of model by incorporating habitual behaviors that drive individuals to maintain or conform to prior eating patterns. We examine our method in a simulated case study of food choice behaviors of low-income adults in the US. We use data from several national datasets, including the National Health and Nutrition Examination Survey (NHANES), the US Bureau of Labor Statistics and the USDA, to parameterize our model and develop predictive capabilities in 1) quantifying the influence of prior diet preferences when food budgets are increased and 2) simulating the income elasticities of demand for four food categories. Food budgets can increase because of greater affordability (due to food aid and other nutritional assistance programs), or because of higher income. Our model predictions indicate that low-income adults consume unhealthy diets when they have highly constrained budgets, but that even after budget constraints are relaxed, these unhealthy eating behaviors are maintained. Specifically, diets in this population, before and after changes in food budgets, are characterized by relatively low consumption of fruits and vegetables and high consumption of fat. The model results for income elasticities also show almost no change in consumption of fruit and fat in response to changes in income, which is in agreement with data from the World Bank's International Comparison Program (ICP). Hence, the proposed method can be used in assessing the influences of habitual dietary patterns on the effectiveness of food policies.	[Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Global Obes Prevent Ctr, Baltimore, MD 21205 USA; [Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Whiting Sch Engn, Baltimore, MD 21218 USA; [Beheshti, Rahmatollah; Igusa, Takeru] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Jones-Smith, Jessica C.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle	Beheshti, R (corresponding author), Johns Hopkins Global Obes Prevent Ctr, Baltimore, MD 21205 USA.; Beheshti, R (corresponding author), Johns Hopkins Whiting Sch Engn, Baltimore, MD 21218 USA.; Beheshti, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	r.b@jhu.edu	Igusa, Takeru/A-3218-2010	Igusa, Takeru/0000-0002-3632-2867; Jones-Smith, Jessica/0000-0001-8962-1695; Beheshti, Rahmatollah/0000-0001-8912-3063	Global Obesity Prevention Center (GOPC) at Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of the Director, National Institutes of Health (OD) [U54HD070725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD070725, R00HD073327] Funding Source: NIH RePORTER	Global Obesity Prevention Center (GOPC) at Johns Hopkins University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Global Obesity Prevention Center (GOPC) at Johns Hopkins University, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of the Director, National Institutes of Health (OD) under award number U54HD070725. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], BR J NUTR; [Anonymous], 2008, DEV CNPP PRIC DAT; Atshin A, 2017, PLOS ONE, V12; Bartfeld J., 2015, SNAP MATTERS FOOD ST; Beheshti R, 2016, J NUTR; Bellisle F., 2005, EUFIC REV, V17, P1; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Brimblecombe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083587; Champagne F, 2001, Prog Brain Res, V133, P287; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2002, AM J CLIN NUTR, V75, P245, DOI 10.1093/ajcn/75.2.245; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Dibari F, 2012, J NUTR, V142, P955, DOI 10.3945/jn.111.156943; Dowler E, 2008, POVERTY FOOD NUTR WH, P34; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Dykstra H, 2016, J NUTR, V146, P630, DOI 10.3945/jn.115.225516; Falk LW, 1996, J NUTR EDUC, V28, P257; Ford ES, 2013, AM J CLIN NUTR, V97, P848, DOI 10.3945/ajcn.112.052662; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; HAINES PS, 1988, AM J AGR ECON, V70, P543, DOI 10.2307/1241492; Hall KD, 2014, AM J PUBLIC HEALTH, V104, P1169, DOI 10.2105/AJPH.2014.301931; Hammond RA, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00082; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Hlaing LM, 2015, BR J NUTR, P1; Huang KS, 1996, AM J AGR ECON, V78, P21, DOI 10.2307/1243775; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Langellier BA, 2016, SSM-POPUL HLTH, V2, P757, DOI 10.1016/j.ssmph.2016.10.006; Li Y, 2016, J URBAN HEALTH, V93, P244, DOI 10.1007/s11524-016-0028-y; Maillot M, 2011, J NUTR, V141, P333, DOI 10.3945/jn.110.131920; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; Nader PR, 2012, CHILD OBES, V8, P195, DOI 10.1089/chi.2012.0004; Pag?n, 2016, CURRENT NUTR REPORTS, V5, P245, DOI DOI 10.1007/s13668-016-0179-1; Rambeloson ZJ, 2008, PUBLIC HEALTH NUTR, V11, P395, DOI 10.1017/S1368980007000511; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Seale JL, 2006, REV INCOME WEALTH, P603; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Spruijt-Metz D, 2015, TRANSL BEHAV MED, V5, P335, DOI 10.1007/s13142-015-0324-1; De Carvalho IST, 2015, FOOD NUTR BULL, V36, P75, DOI 10.1177/156482651503600107; van Dooren C, 2015, SUSTAINABILITY-BASEL, V7, P12837, DOI 10.3390/su70912837; Wilensky U., 1999, CTR CONNECTED LEARNI; Wilson N, 2016, BMC NUTR, V2, P1; Zhang DL, 2014, AM J PUBLIC HEALTH, V104, P1217, DOI 10.2105/AJPH.2014.301934	46	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							0178348	10.1371/journal.pone.0178348	http://dx.doi.org/10.1371/journal.pone.0178348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542615	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800078
J	Metta, E; Bailey, A; Kessy, F; Geubbels, E; Haisma, H				Metta, Emmy; Bailey, Ajay; Kessy, Flora; Geubbels, Eveline; Haisma, Hinke			Illness experiences of diabetes in the context of malaria in settings experiencing double burden of disease in southeastern Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; QUALITY-OF-LIFE; FALCIPARUM-MALARIA; SELF-CARE; COMMUNITY; RISK; TUBERCULOSIS; MELLITUS; ADULTS; UNCERTAINTY	Background Tanzania is doubly burdened with both non-communicable and infectious diseases, but information on how Tanzanians experience the co-existence of these conditions is limited. Using Kleinman's eight prompting questions the study synthesizes explanatory models from patients to describe common illness experiences of diabetes in a rural setting where malaria is the predominant health threat. Methods We conducted 17 focus group discussions with adult members of the general community, diabetes patients, neighbours and relatives of diabetes patients to gain insight into shared experiences. To gain in-depth understanding of the individual illness experiences, we conducted 41 in-depth interviews with malaria or diabetes patients and family members of diabetes patients. The analysis followed grounded theory principles and the illness experiences were derived from the emerging themes. Results The illness experiences showed that malaria and diabetes are both perceived to be severe and fatal conditions, but over the years people have learned to live with malaria and the condition is relatively manageable compared with diabetes. In contrast, diabetes was perceived as a relatively new disease, with serious life-long consequences. Uncertainty, fear of those consequences, and the increased risk for severe malaria and other illnesses impacted diabetes patients and their families' illness experiences. Unpredictable ailments and loss of consciousness, memory, libido, and functional incapability were common problems reported by diabetes patients. These problems had an effect on their psychological and emotional health and limited their social life. Direct and indirect costs of illness pushed individuals and their families further into poverty and were more pronounced for diabetes patients. Conclusion The illness experiences revealed both malaria and diabetes as distressing conditions, however, diabetes showed a higher level of stress because of its chronicity. Strategies for supporting social, emotional, and psychological well-being that build on the patient accounts are likely to improve illness experiences and quality of life for the chronically ill patient.	[Metta, Emmy; Geubbels, Eveline] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Metta, Emmy; Bailey, Ajay; Haisma, Hinke] Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands; [Kessy, Flora] Mzumbe Univ, Dar Es Salaam, Tanzania	Ifakara Health Institute; University of Groningen	Metta, E (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.; Metta, E (corresponding author), Univ Groningen, Fac Spatial Sci, Populat Res Ctr, Groningen, Netherlands.	emetta@ihi.or.tz		Geubbels, Eveline/0000-0002-9702-5460; Bailey, Ajay/0000-0003-3163-6805	Netherlands Organization for International Cooperation in Higher Education (NUFFIC) [NICHE/TZA/005]; Ifakara Health and Demographic Surveillance System (HDSS)	Netherlands Organization for International Cooperation in Higher Education (NUFFIC); Ifakara Health and Demographic Surveillance System (HDSS)	This study is part of The Netherlands Initiative for Capacity building in Higher Education (NICHE/TZA/005) funded by the Netherlands Organization for International Cooperation in Higher Education (NUFFIC) to EM as part of her PhD studies. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We acknowledge the support received from the Ifakara Health and Demographic Surveillance System (HDSS) and the MZIMA project team members during the data collection processes. We are very grateful to the village leaders, the district diabetes clinic authorities and to the community members who participated in or otherwise contributed to these results.	Acquah S, 2014, EVIDENCE INSULIN RES, V2014; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Ahmad L.A., 2010, CLIN DIABETES, V28, P53, DOI DOI 10.2337/DIACLIN.28.2.53; Apostolo JLA, 2007, REV LAT-AM ENFERM, V15, P575, DOI 10.1590/S0104-11692007000400009; Andreassen S, 2007, INT J QUAL STUD HEAL, V2, P114, DOI DOI 10.1080/17482620701305589; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Aujoulat I, 2007, QUAL HEALTH RES, V17, P772, DOI 10.1177/1049732307302665; Bailey DE, 2009, PSYCHOSOMATICS, V50, P138, DOI 10.1176/appi.psy.50.2.138; Balogun E.A., 2013, BIOKEMISTRI, V24, P38; Brown WV, 2008, AM J CARDIOL, V102, p10L, DOI 10.1016/j.amjcard.2008.09.068; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Danquah I, 2010, EMERG INFECT DIS, V16, P1601, DOI 10.3201/eid1610.100399; Davis E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045980; De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284; de-Graft Aikins Ama, 2010, Global Health, V6, P6, DOI 10.1186/1744-8603-6-6; Debono Miguel, 2007, Psychol Health Med, V12, P545, DOI 10.1080/13548500701235740; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Faurholt-Jepsen D, 2013, TROP MED INT HEALTH, V18, P822, DOI 10.1111/tmi.12120; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; Gallagher EB, 1999, J NERV MENT DIS, V187, P648, DOI 10.1097/00005053-199910000-00013; Geubbels E, 2013, 12 IND SCI C 2013 28; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Habib T, 2010, ANTROCOM, V6, P79; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Haraka F, 2015, PLOS ONE, V10; Harchut K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-159; Helman C G, 1981, J R Coll Gen Pract, V31, P548; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Hofmann B, 2002, J MED PHILOS, V27, P651, DOI 10.1076/jmep.27.6.651.13793; Holmes MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000244; IDF, 2019, IDF DIABETES ATLAS; Ikekpeazu EJ, 2010, AS J MED SCI, V2, P214; Ishengoma DS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-338; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jezewski, 2002, MEXICAN AM EXPLANATO; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman A., 1988, ILLNESS NARRATIVES; Kleinman A., 1980, PATIENTS HEALERS CON; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x; Makundi EA, 2007, AM J TROP MED HYG, V77, P106, DOI 10.4269/ajtmh.2007.77.106; Mboera LEG, 2013, MALARIA WORLD J, V4, P1; Mboera LEG, 2007, AM J TROP MED HYG, V77, P112, DOI 10.4269/ajtmh.2007.77.112; Metta E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0768-5; Metta E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1504-0; Metta E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-249; Mfinanga S, 2012, TANZANIA J HLTH RES, V13; Mlozi MR, 2014, TANZANIA J HLTH RES, V17; Mohapatra KM., 2001, INT J DIABETES DEV C, V2, P156; MoHSW, MIDT AN REV PERF HLT; MoHSW, 2008, HLTH SECT STRAT PLAN; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mukeshimana MM, 2014, J CLIN NURS, V23, P541, DOI 10.1111/jocn.12199; Nombo C, 2007, AIDS MEETS POVERTY I; President's Malaria Initiative (PMI), MAL OP PLAN MOP TANZ; Royer A., 1998, LIFE CHRONIC ILLNESS; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Saydah SH, 2002, AM J EPIDEMIOL, V156, P714, DOI 10.1093/aje/kwf111; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SHALEV O, 1992, POSTGRAD MED J, V68, P281, DOI 10.1136/pgmj.68.798.281; Smithson P, 2009, IFAKARA HLTH I SPOTL, V2, P1; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; Thomsen RW, 2005, CLIN INFECT DIS, V40, P628, DOI 10.1086/427699; Thomsen RW, 2004, DIABETES CARE, V27, P1143, DOI 10.2337/diacare.27.5.1143; Thorne S, 2003, QUAL HEALTH RES, V13, P1337, DOI 10.1177/1049732303258039; Toombs S Kay, 1995, Second Opin, V21, P11; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123575; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHO, WORLD MAL REP GEN; WHO, TANZ STEPS SURV 2012; Yew VW, 2014, J SOCIAL SCI HUMANIT, V9, P116; Zimmet P, DIABETES EPIDEMIC FU	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178394	10.1371/journal.pone.0178394	http://dx.doi.org/10.1371/journal.pone.0178394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542578	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800085
J	Qin, ZY; Zhang, XG				Qin, Zhiyi; Zhang, Xuegong			The identification of switch-like alternative splicing exons among multiple samples with RNA-Seq data	PLOS ONE			English	Article							CELL-DIFFERENTIATION; ALU EXONS; PROTEOME; PROGRAM	Alternative splicing is an ubiquitous phenomenon in most human genes and has important functions. The switch-like exon is the type of exon that has a high level of usage in some tissues, but has a low level of usage in the other tissues. They usually undergo strong tissue-specific regulations. There is still a lack a systematic method to identify switch-like exons from multiple RNA-seq samples. We proposed a novel method called iterative Tertile Absolute Deviation around the mode (iTAD) to profile the distribution of exon relative usages among multiple samples and to identify switch-like exons and other types of exons using a robust statistic estimator. We validated the method with simulation data, and applied it on RNA-seq data of 16 human body tissues and detected 3,100 switch-like exons. We found that switch-like exons tend to be more associated with Alu elements in their flanking intron regions than other types of exons.	[Qin, Zhiyi; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, MOE Key Lab Bioinformat,Bioinformat Div, Beijing, Peoples R China; [Qin, Zhiyi; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing, Peoples R China; [Zhang, Xuegong] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, MOE Key Lab Bioinformat,Bioinformat Div, Beijing, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.	zhangxg@tsinghua.edu.cn		Zhang, Xuegong/0000-0002-9684-5643	National Natural Science Foundation of China [61673231]; TNLIST, Tsinghua University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); TNLIST, Tsinghua University	This work is supported by National Natural Science Foundation of China grant No. 61673231 and by internal funding of our institution TNLIST, Tsinghua University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar I, 2003, J BIOL CHEM, V278, P5802, DOI 10.1074/jbc.M207178200; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Donoho D.L., 1983, NOTION BREAKDOWN POI; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng HJ, 2013, CANCER LETT, V340, P179, DOI 10.1016/j.canlet.2012.11.010; Gao ZH, 2012, MOL CELL BIOL, V32, P2794, DOI 10.1128/MCB.00570-12; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lin L, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0876-5; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178320	10.1371/journal.pone.0178320	http://dx.doi.org/10.1371/journal.pone.0178320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542625	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800070
J	Chen, PX; Zhang, YL; Xu, JW; Yu, MH; Huang, JH; Zhao, L; Zhou, WL				Chen, Peng-Xiao; Zhang, Yi-Lin; Xu, Jia-Wen; Yu, Ming-Hao; Huang, Jie-Hong; Zhao, Lei; Zhou, Wen-Liang			Sodium tanshinone IIA sulfonate stimulated Cl- secretion in mouse trachea	PLOS ONE			English	Article							SURFACE LIQUID; CHLORIDE SECRETION; EPITHELIAL-CELLS; AIRWAY; MECHANISM; PATHOGENESIS; INHIBITION; ACTIVATION; PHYSIOLOGY; APOPTOSIS	Sodium tanshinone IIA sulfonate (STS) is a derivate of tanshinone IIA, a lipophilic compound in Salvia miltiorrhiza. This study aimed to investigate the effect of STS on ion transport in mouse tracheal epithelium and the mechanisms underlying it. Short-circuit current (Isc) was measured to evaluate the effect of STS on transepithelial ion transport. Intracellular Ca2+ imaging was performed to observe intracellular Ca2+ concentration ([Ca2+](i)) changes induced by STS in primary cultured mouse tracheal epithelial cells. Results showed that the apical application of STS at mouse trachea elicited an increase of Isc, which was abrogated by atropine, an antagonist of muscarinic acetylcholine receptor (mAChR). By removing ambient Cl-or applying blockers of Ca2+-activated Cl-channel (CaCC), the response of STS-induced Isc was suppressed. Moreover, STS elevated the [Ca2+] i in mouse tracheal epithelial cells. As a result, STS stimulated Cl-secretion in mouse tracheal epithelium via CaCC in an mAChR-dependent way. Due to the critical role of Cl-secretion in airway hydration, our findings suggested that STS may be used to ameliorate the airway dehydration symptom in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD).	[Chen, Peng-Xiao; Zhang, Yi-Lin; Xu, Jia-Wen; Yu, Ming-Hao; Huang, Jie-Hong; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhao, Lei] Guangzhou Med Univ, Sch Basic Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Zhou, WL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Zhao, L (corresponding author), Guangzhou Med Univ, Sch Basic Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China.	crystal-zl@163.com; lsszwl@aliyun.com	xu, jia/GSD-6347-2022	Zhang, Yi-Lin/0000-0001-5350-8279	National Natural Science Foundation of China [31271247, 81471445]; State Key Program of National Natural Science Foundation of China [31230034]; Natural Science Foundation of Guangdong Province [2016A030313301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by: 1. National Natural Science Foundation of China (No. 31271247, No. 81471445), www.nsfc.gov.cn/; 2. State Key Program of National Natural Science Foundation of China (No. 31230034), www.nsfc.gov.cn/; 3. The Natural Science Foundation of Guangdong Province (Grant 2016A030313301), http://gonggao.gdstc.goy.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 1999, J PHYSIOL-LONDON, V516, P631, DOI 10.1111/j.1469-7793.1999.0631u.x; Boucher Richard C, 2004, Proc Am Thorac Soc, V1, P66, DOI 10.1513/pats.2306018; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cuthbert AW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12398; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Feng Y, 2015, ASIAN PAC J TROP MED, V8, P957, DOI 10.1016/j.apjtm.2015.10.003; Fischer A, 1996, ANN NY ACAD SCI, V805, P717; Ghosh A, 2015, CELL MOL LIFE SCI, V72, P3637, DOI 10.1007/s00018-015-1946-7; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Krasteva G, 2012, HISTOCHEM CELL BIOL, V138, P365, DOI 10.1007/s00418-012-0993-5; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; LEE YH, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1039/C4CC06435F); Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Lin JC, 2015, EXP CELL RES, V334, P260, DOI 10.1016/j.yexcr.2015.02.026; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Ming JCK, 2011, J ETHNOPHARMACOL, V138, P201, DOI 10.1016/j.jep.2011.08.081; Qiu XL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/715790; Racke K, 2004, PULM PHARMACOL THER, V17, P181, DOI 10.1016/j.pupt.2004.03.001; Rehman R, 2013, INT IMMUNOPHARMACOL, V15, P597, DOI 10.1016/j.intimp.2013.02.010; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Sun DD, 2008, EUR J PHARMACOL, V590, P317, DOI 10.1016/j.ejphar.2008.06.005; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Tarran Robert, 2005, Journal of General Physiology, V127, P591; [王建荣 Wang Jianrong], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P1390; Wei F, 2015, WORLD J GASTROENTERO, V21, P1444, DOI 10.3748/wjg.v21.i5.1444; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wu DXY, 1998, AM J PHYSIOL-LUNG C, V274, pL388, DOI 10.1152/ajplung.1998.274.3.L388; Yang L, 2007, EXP MOL MED, V39, P65, DOI 10.1038/emm.2007.8; Yang RF, 2008, J CARDIOVASC PHARM, V51, P396, DOI 10.1097/FJC.0b013e3181671439; Yang Y, 2008, EUR J PHARMACOL, V598, P9, DOI 10.1016/j.ejphar.2008.09.013; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang Y, 2015, ALLERGY ASTHMA IMMUN, V7, P367, DOI 10.4168/aair.2015.7.4.367; Zheng LH, 2015, RESP PHYSIOL NEUROBI, V205, P120, DOI 10.1016/j.resp.2014.09.025; Zholos AV, 2015, CURR NEUROPHARMACOL, V13, P279, DOI 10.2174/1570159X13666150331223118	43	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178226	10.1371/journal.pone.0178226	http://dx.doi.org/10.1371/journal.pone.0178226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542554	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400071
J	Ohno, H; Takeda, K; Niwa, S; Tsujinaka, T; Hanazono, Y; Hirano, Y; Miki, K				Ohno, Hiraku; Takeda, Kazuki; Niwa, Satomi; Tsujinaka, Tomotaka; Hanazono, Yuya; Hirano, Yu; Miki, Kunio			Crystallographic characterization of the high-potential iron-sulfur protein in the oxidized state at 0.8 angstrom resolution	PLOS ONE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; THERMOCHROMATIUM-TEPIDUM; ELECTRON-TRANSFER; RHODOFERAX-FERMENTANS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; FE4S4 CLUSTERS; RADIATION; SITE; REFINEMENT	High-potential iron-sulfur protein (HiPIP) is a soluble electron carrier protein of photosynthetic bacteria with an Fe4S4 cluster. Although structural changes accompanying the electron transfer are important for understanding of the functional mechanism, the changes have not been clarified in sufficient detail. We previously reported the high-resolution crystal structures of HiPIP from a thermophilic purple bacterium Thermochromatium tepidum in the reduced state. In order to perform a detailed comparison between the structures in different redox states, the oxidized structure should also be revealed at high resolution. Therefore, in the present study we performed a crystallographic analysis of oxidized HiPIP and a structural comparison with the reduced form at a high resolution of 0.8 angstrom. The comparison highlighted small but significant contraction in the iron-sulfur cluster. The changes in Fe-S bond lengths were similar to that predicted by theoretical calculation, although some discrepancies were also found. Almost distances between the sulfur atoms of the iron-sulfur cluster and the protein environment are elongated upon the oxidation. Positional changes of hydrogen atoms in the protein environment, such as on the amide-hydrogen of Cys75 in the proximity of the iron-sulfur cluster, were also observed in the accurate analyses. None of the water molecules exhibited significant changes in position or anisotropy of atomic displacement parameter between the two states, while the orientations of some water molecules were different.	[Ohno, Hiraku; Takeda, Kazuki; Niwa, Satomi; Tsujinaka, Tomotaka; Hanazono, Yuya; Hirano, Yu; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan; [Hirano, Yu] Natl Inst Quantum & Radiol Sci & Technol, Tokai Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan	Kyoto University; National Institutes for Quantum Science & Technology	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto, Japan.	miki@kuchem.kyoto-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Niwa, Satomi/0000-0002-2648-8257; Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Culture, Sports, Science and Technology of Japan [23657073]; Grants-in-Aid for Scientific Research [15J02413] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (No. 23657073 to K.T.) and Photon and Quantum Basic Research Coordinated Development Program (to K.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Messrs. H. Jonotsuka, M. Kosugi, N. Hashimoto and H. Maeda for assistance in the crystallization and data collection, and to Mmes. Y. Nishikawa and E. Tsutsumi for assistance in the cultivation and purification. Thanks are also due to beamline staff for their help in data collection at SPring-8 (Proposal Nos. 2010A1237, 2010B1284, 2015B1037 and 2016A2737 to K.T.). This work was supported by Grant-in-Aid for Scientific Research (No. 23657073 to K.T.) and Photon and Quantum Basic Research Coordinated Development Program (to K.M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	[Anonymous], THE PYMOL MOLECULAR; BENNING MM, 1994, BIOCHEMISTRY-US, V33, P2476, DOI 10.1021/bi00175a016; BERTINI I, 1995, BIOCHEMISTRY-US, V34, P9851, DOI 10.1021/bi00031a005; BREITER DR, 1991, J BIOL CHEM, V266, P18660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter C. W., 2001, HDB METALLOPROTEINS, V1, P602; CARTER CW, 1974, J BIOL CHEM, V249, P6339; CARTER CW, 1974, J BIOL CHEM, V249, P4212; CARTER CW, 1972, P NATL ACAD SCI USA, V69, P3526, DOI 10.1073/pnas.69.12.3526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Dey A, 2005, INORG CHEM, V44, P8349, DOI 10.1021/ic050981m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gonzalez A, 2003, ACTA CRYSTALLOGR D, V59, P1582, DOI 10.1107/S0907444903014604; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Hirano Y, 2016, NATURE, V534, P281, DOI 10.1038/nature18001; Hochkoeppler A, 1996, P NATL ACAD SCI USA, V93, P6998, DOI 10.1073/pnas.93.14.6998; Improta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerfeld CA, 1998, BIOCHEMISTRY-US, V37, P13911, DOI 10.1021/bi9810252; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Nogi T, 2000, ACTA CRYSTALLOGR D, V56, P656, DOI 10.1107/S0907444900003127; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; RAYMENT I, 1992, J MOL BIOL, V228, P672, DOI 10.1016/0022-2836(92)90849-F; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sigfridsson E, 2001, INORG CHEM, V40, P2509, DOI 10.1021/ic000752u; Stelter M, 2010, J BIOL INORG CHEM, V15, P303, DOI 10.1007/s00775-009-0603-8; Takeda K, 2010, J STRUCT BIOL, V169, P135, DOI 10.1016/j.jsb.2009.09.012; Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104; Venturoli G, 2004, BIOCHEMISTRY-US, V43, P437, DOI 10.1021/bi035384v; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zanello P, 2017, COORDIN CHEM REV, V335, P172, DOI 10.1016/j.ccr.2016.10.003	36	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178183	10.1371/journal.pone.0178183	http://dx.doi.org/10.1371/journal.pone.0178183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542634	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400068
J	Leufgen, C; Gembruch, U; Stoffel-Wagner, B; Fimmers, R; Merz, WM				Leufgen, Christina; Gembruch, Ulrich; Stoffel-Wagner, Birgit; Fimmers, Rolf; Merz, Waltraut M.			N-terminal pro-B-type natriuretic peptide in amniotic fluid of fetuses with known or suspected cardiac load	PLOS ONE			English	Article							HEART-FAILURE MANAGEMENT; BNP MEASUREMENTS USEFUL; UMBILICAL ARTERY; FETAL ANEMIA; DIAGNOSIS; VOLUME; ECHOCARDIOGRAPHY; CIRCULATION; DISEASE; FLOW	Background Myocardial dysfunction occurs in a variety of fetal disorders. Findings from adult cardiology, where n-terminal pro-B-type natriuretic peptide (nt-proBNP) is an established biomarker of left ventricular dysfunction have been extended to fetal life. Since fetal blood sampling is technically challenging we investigated amniotic fluid nt-proBNP for its suitability to diagnose fetal myocardial dysfunction. Methods Ultrasound, Doppler examination and echocardiography was applied to classify cases and controls. Amniotic fluid nt-proBNP to amniotic fluid total protein ratio was calculated and compared to the gestational age-dependent reference intervals. In a subset of cases, fetal and maternal plasma nt-proBNP levels were determined. Results Specimen from 391 fetuses could be analyzed (171 cases, 220 controls). There was a high correlation between amniotic fluid and fetal blood nt-proBNP levels (r = 0.441 for cases; r = 0.515 for controls), whereas no correlation could be detected between maternal and fetal (blood and amniotic fluid) nt-proBNP concentrations. Specificity and positive likelihood ratio of amniotic fluid nt-proBNP to amniotic fluid total protein ratio were high (0.97 and 4.3, respectively). Conclusion Amniotic fluid nt-proBNP measurement allows diagnostic confirmation of fetal myocardial dysfunction. It may serve as a useful adjunct in addition and correlation to existing tests of myocardial function, particularly in the context of invasive fetal therapy, where access to the amniotic cavity is part of the procedure.	[Leufgen, Christina; Gembruch, Ulrich; Merz, Waltraut M.] Univ Bonn, Med Sch, Dept Obstet & Prenatal Med, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Med Sch, Inst Clin Chem & Pharmacol, Bonn, Germany; [Fimmers, Rolf] Univ Bonn, Med Sch, Inst Med Biometry Informat & Epidemiol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Merz, WM (corresponding author), Univ Bonn, Med Sch, Dept Obstet & Prenatal Med, Bonn, Germany.	waltraut.merz@ukb.uni-bonn.de	Gembruch, Ulrich/Q-8228-2017	Gembruch, Ulrich/0000-0001-8284-4669				Anderson DF, 2013, AM J PHYSIOL-REG I, V305, pR506, DOI 10.1152/ajpregu.00175.2013; Bahlmann F, 2011, J PERINAT MED, V39, P529, DOI [10.1515/JPM.2011.065, 10.1515/jpm.2011.065]; Brace RA, 2004, AM J OBSTET GYNECOL, V191, P837, DOI 10.1016/j.ajog.2004.01.048; Cantinotti M, 2015, CARDIOL YOUNG, V25, P424, DOI 10.1017/S1047951114002133; Clerico A, 2004, CLIN CHEM, V50, P33, DOI 10.1373/clinchem.2003.024760; Crispi F, 2012, FETAL DIAGN THER, V32, P47, DOI 10.1159/000338003; Cruz-Lemini M, 2012, FETAL DIAGN THER, V32, P116, DOI 10.1159/000333001; Davis L, 2005, J PHYSIOL-LONDON, V565, P35, DOI 10.1113/jphysiol.2004.082388; Delabaere A, 2010, ULTRASOUND OBST GYN, V35, P620, DOI 10.1002/uog.7579; Deprest JA, 2010, PRENATAL DIAG, V30, P653, DOI 10.1002/pd.2571; Desai AS, 2013, CIRCULATION, V127, P509, DOI 10.1161/CIRCULATIONAHA.112.120493; Diemert A, 2012, DTSCH ARZTEBL INT, V109, P603, DOI 10.3238/arztebl.2012.0603; Donofrio MT, 2014, CIRCULATION, V129, P2183, DOI 10.1161/01.cir.0000437597.44550.5d; Gardiner HM, 2014, CARDIOL YOUNG, V24, P26, DOI 10.1017/S1047951114001401; Girsen A, 2007, ULTRASOUND OBST GYN, V29, P296, DOI 10.1002/uog.3934; Godfrey ME, 2012, ULTRASOUND OBST GYN, V39, P131, DOI 10.1002/uog.9064; Habli M, 2010, AM J OBSTET GYNECOL, V203; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Kocylowski RD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.009; Lechner E, 2009, PEDIATR RES, V66, P466, DOI 10.1203/PDR.0b013e3181b3aee4; Luterek K, 2011, NEUROENDOCRINOL LETT, V32, P657; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Matsumoto LC, 2000, AM J OBSTET GYNECOL, V182, P699, DOI 10.1067/mob.2000.104226; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Merz WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114416; Merz WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063664; Merz WM, 2012, PEDIATR RES, V72, P174, DOI 10.1038/pr.2012.53; Merz WM, 2012, CLIN RES CARDIOL, V101, P73, DOI 10.1007/s00392-011-0366-4; Merz WM, 2010, CLIN BIOCHEM, V43, P519, DOI 10.1016/j.clinbiochem.2009.11.012; Moon-Grady AJ, 2014, AM J PERINAT, V31, pS31, DOI 10.1055/s-0034-1378146; Moriichi A, 2013, J PERINATOL, V33, P182, DOI 10.1038/jp.2012.94; Ogawa T, 2014, NATRIURETIC PEPTIDES, P1; Ross M G, 2001, J Matern Fetal Med, V10, P2, DOI 10.1080/714904292; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Schidlow DN, 2014, AM J PERINAT, V31, P629, DOI 10.1055/s-0034-1383884; Schmidt W, 1992, Adv Anat Embryol Cell Biol, V127, P1; Troughton RW, 2014, EUR HEART J, V35, P1559, DOI 10.1093/eurheartj/ehu090; Van Mieghem T, 2014, PRENATAL DIAG, V34, P23, DOI 10.1002/pd.4254; van Mieghem T, 2012, BEST PRACT RES CL OB, V26, P711, DOI 10.1016/j.bpobgyn.2012.03.005; Van Mieghem T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.013; Weber R, 2014, JACC-HEART FAIL, V2, P403, DOI 10.1016/j.jchf.2014.02.010; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yandle TG, 2015, CLIN CHIM ACTA, V448, P195, DOI 10.1016/j.cca.2015.07.004; Zanardini C, 2010, ULTRASOUND OBST GYN, V35, P332, DOI 10.1002/uog.7451	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177253	10.1371/journal.pone.0177253	http://dx.doi.org/10.1371/journal.pone.0177253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545116	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400031
J	Lim, W; Lee, J; Lim, Y; Bae, DH; Park, H; Kim, DS; Jung, K				Lim, Woosang; Lee, Jungsoo; Lim, Yongsub; Bae, Doo-Hwan; Park, Haesun; Kim, Dae-Shik; Jung, Kyomin			Hierarchical ordering with partial pairwise hierarchical relationships on the macaque brain data sets	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; ORGANIZATION; AREAS	Hierarchical organizations of information processing in the brain networks have been known to exist and widely studied. To find proper hierarchical structures in the macaque brain, the traditional methods need the entire pairwise hierarchical relationships between cortical areas. In this paper, we present a new method that discovers hierarchical structures of macaque brain networks by using partial information of pairwise hierarchical relationships. Our method uses a graph-based manifold learning to exploit inherent relationship, and computes pseudo distances of hierarchical levels for every pair of cortical areas. Then, we compute hierarchy levels of all cortical areas by minimizing the sum of squared hierarchical distance errors with the hierarchical information of few cortical areas. We evaluate our method on the macaque brain data sets whose true hierarchical levels are known as the FV91 model. The experimental results show that hierarchy levels computed by our method are similar to the FV91 model, and its errors are much smaller than the errors of hierarchical clustering approaches.	[Lim, Woosang; Bae, Doo-Hwan] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Lee, Jungsoo; Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Sch Elect Engn, Daejeon, South Korea; [Lim, Yongsub] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Park, Haesun] Georgia Tech, Sch Computat Sci & Engn, Atlanta, GA USA; [Jung, Kyomin] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); University System of Georgia; Georgia Institute of Technology; Seoul National University (SNU)	Jung, K (corresponding author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea.	kjung@snu.ac.kr	Kim, Dae-Shik/C-2071-2011	Lim, Woosang/0000-0002-6615-5801	KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund; Google Ph.D. Fellowship in machine learning; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016R1A2B2009759]; Brain Korea 21 Plus Project	KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund; Google Ph.D. Fellowship in machine learning(Google Incorporated); National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Brain Korea 21 Plus Project	W. Lim acknowledges support from the 2015 KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund and the 2016 Google Ph.D. Fellowship in machine learning. K. Jung was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (2016R1A2B2009759), and supported by the Brain Korea 21 Plus Project in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W. Lim acknowledges support from the 2015 KAIST Graduate Research Fellowship via Kim-Bo-Jung Fund and the 2016 Google Ph.D. Fellowship in machine learning. K. Jung was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (2016R1A2B2009759), and supported by the Brain Korea 21 Plus Project in 2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2000, J NEUROSCI, V20, P3263, DOI 10.1523/JNEUROSCI.20-09-03263.2000; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Belkin M, 2002, ADV NEUR IN, V14, P585; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Fogel F., 2014, ADV NEURAL INFORM PR, V27, P900; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Grant S, 2005, EUR J NEUROSCI, V22, P681, DOI 10.1111/j.1460-9568.2005.04232.x; Gupte Mangesh, 2011, P 20 INT C WORLD WID, P557, DOI DOI 10.1145/1963405.1963484; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hilgetag CC, 1996, SCIENCE, V271, P776, DOI 10.1126/science.271.5250.776; Hilgetag CC, 2000, PHILOS T R SOC B, V355, P71, DOI 10.1098/rstb.2000.0550; Krumnack A, 2010, FRONT NEUROINFORM, P4; Li J, 2007, J MACH LEARN RES, V8, P1687; Lind P, 2003, J CHEM INF COMP SCI, V43, P1855, DOI 10.1021/ci034107s; Mahadevan S., 2005, ADV NEURAL INFORM PR, P843; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Markov NT, 2014, J COMP NEUROL, V522, P225, DOI 10.1002/cne.23458; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; Meunier D, 2009, FRONT NEUROINFORM, P3; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Reid AT, 2009, NEUROIMAGE, V47, P611, DOI 10.1016/j.neuroimage.2009.04.061; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076315; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177373	10.1371/journal.pone.0177373	http://dx.doi.org/10.1371/journal.pone.0177373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545042	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672400039
J	Hohn, DP; Lucas, CH; Thatje, S				Hohn, Danja P.; Lucas, Cathy H.; Thatje, Sven			Respiratory response to temperature of three populations of Aurelia aurita polyps in northern Europe	PLOS ONE			English	Article							ASEXUAL REPRODUCTION; COMMON JELLYFISH; MARINE ZOOPLANKTON; RATES; LIFE; FOOD; STRATEGIES; SALINITY; DYNAMICS; CNIDARIA	The benthic life stage (polyp or scyphistoma) of the bloom-forming jellyfish, Aurelia aurita (Linnaeus, 1759), also known as the moon jellyfish, contributes to the seasonal occurrence and abundance of medusa blooms via asexual reproduction. A. aurita is widely distributed in coastal areas in northern Europe, and one of the most studied jellyfish species. While the physiology of the visible medusa is largely understood, understanding of the physiology of the perennial benthic life-stage is scarce. To measure the physiological tolerance of A. aurita, the scyphistoma's temperature sensitivity across its distributional range was investigated. Respiration rates of polyps from three northern European locations exposed to 11 temperatures between 2 and 22 degrees C were measured. There was a significant difference in respiration rate among the three polyp populations, which may reflect on differences in their thermal tolerance window. A critical temperature was reached at 14 degrees C with the metabolic rate decreasing below and above that temperature. This pattern was less pronounced in the Norwegian population but polyps were able to survive, at least temporarily, those temperatures exceeding their natural range. While polyps collected from northern Norway, with a narrow environmental thermal window, displayed a low baseline metabolism with a Q(10) value of 1.2, polyps from southern England and Scotland had Q(10) values of 1.6 and 2.5, respectively. Differences in polyps' respiration rates across their distributional range suggest that populations have evolved adaptations to local environmental thermal conditions.	[Hohn, Danja P.; Lucas, Cathy H.; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Hohn, DP (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England.	dph1g12@soton.ac.uk	Hoehn, Danja/AAX-6812-2021	Hoehn, Danja/0000-0002-3238-3283	NOCS PhD studentship	NOCS PhD studentship	This work was supported by NOCS PhD studentship award to DPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], MAR ECOL; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; CLARKE A, 1983, OCEANOGR MAR BIOL, V21, P341; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dawson MN, 2015, BIOL INVASIONS, V17, P851, DOI 10.1007/s10530-014-0732-z; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Fleming NEC, 2015, PEERJ, V3, DOI 10.7717/peerj.1110; Gambill M, 2014, J EXP MAR BIOL ECOL, V459, P17, DOI 10.1016/j.jembe.2014.05.005; Gatti S, 2002, MAR BIOL, V140, P1075, DOI 10.1007/s00227-002-0786-9; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; Graham WM, 2014, FRONT ECOL ENVIRON, V12, P515, DOI 10.1890/130298; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Hirst AG, 1998, MAR ECOL PROG SER, V165, P259, DOI 10.3354/meps165259; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; Kamiyama T, 2013, J EXP MAR BIOL ECOL, V445, P21, DOI 10.1016/j.jembe.2013.03.018; Lebrato M, 2011, LIMNOL OCEANOGR, V56, P1917, DOI 10.4319/lo.2011.56.5.1917; Lesniowski TJ, 2015, MAR BIOL, V162, P1371, DOI 10.1007/s00227-015-2660-6; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lucas CH, 1997, ESTUAR COAST SHELF S, V45, P209, DOI 10.1006/ecss.1996.0173; MANGUM CP, 1972, MAR BIOL, V15, P298, DOI 10.1007/BF00401389; Moller LF, 2007, MAR ECOL PROG SER, V330, P149, DOI 10.3354/meps330149; NEMAZIE DA, 1993, MAR BIOL, V116, P451, DOI 10.1007/BF00350062; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2008, CLIM RES, V37, P253, DOI 10.3354/cr00766; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Prieto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013793; Purcell JE, 2012, HYDROBIOLOGIA, V690, P169, DOI 10.1007/s10750-012-1047-7; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; Schneider G, 1998, OPHELIA, V48, P71, DOI 10.1080/00785236.1998.10428677; Sweetman AK, 2015, P ROY SOC B, V281; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Willcox S, 2007, J EXP MAR BIOL ECOL, V353, P107, DOI 10.1016/j.jembe.2007.09.006	39	6	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177913	10.1371/journal.pone.0177913	http://dx.doi.org/10.1371/journal.pone.0177913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545145	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000401487700094
J	Klepeis, NE; Bellettiere, J; Hughes, SC; Nguyen, B; Berardi, V; Liles, S; Obayashi, S; Hofstetter, CR; Blumberg, E; Hovell, MF				Klepeis, Neil E.; Bellettiere, John; Hughes, Suzanne C.; Nguyen, Benjamin; Berardi, Vincent; Liles, Sandy; Obayashi, Saori; Hofstetter, C. Richard; Blumberg, Elaine; Hovell, Melbourne F.			Fine particles in homes of predominantly low-income families with children and smokers: Key physical and behavioral determinants to inform indoor-air-quality interventions	PLOS ONE			English	Article							POLLUTANT CONCENTRATIONS; RESIDENTIAL EXPOSURE; ULTRAFINE PARTICLES; PARTICULATE MATTER; EMISSION FACTORS; PM2.5; SMOKING; HEALTH; MARIJUANA; MODELS	Children are at risk for adverse health outcomes from occupant-controllable indoor airborne contaminants in their homes. Data are needed to design residential interventions for reducing low-income children's pollutant exposure. Using customized air quality monitors, we continuously measured fine particle counts (0.5 to 2.5 microns) over a week in living areas of predominantly low-income households in San Diego, California, with at least one child (under age 14) and at least one cigarette smoker. We performed retrospective interviews on home characteristics, and particle source and ventilation activities occurring during the week of monitoring. We explored the relationship between weekly mean particle counts and interview responses using graphical visualization and multivariable linear regression (base sample n = 262; complete cases n = 193). We found associations of higher weekly mean particle counts with reports of indoor smoking of cigarettes or marijuana, as well as with frying food, using candles or incense, and house cleaning. Lower particle levels were associated with larger homes. We did not observe an association between lower mean particle counts and reports of opening windows, using kitchen exhaust fans, or other ventilation activities. Our findings about sources of fine airborne particles and their mitigation can inform future studies that investigate more effective feedback on residential indoor-air-quality and better strategies for reducing occupant exposures.	[Klepeis, Neil E.; Bellettiere, John; Hughes, Suzanne C.; Nguyen, Benjamin; Berardi, Vincent; Liles, Sandy; Obayashi, Saori; Hofstetter, C. Richard; Blumberg, Elaine; Hovell, Melbourne F.] San Diego State Univ, Grad Sch Publ Hlth, SDSURF, C BEACH, San Diego, CA 92182 USA; [Bellettiere, John] Univ Calif San Diego, San Diego State Univ Calif San Diego Joint Doctor, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Klepeis, NE (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, SDSURF, C BEACH, San Diego, CA 92182 USA.	pubs2@klepeis.net	Bellettiere, John/AAC-6092-2020	Bellettiere, John/0000-0002-7167-3048; Klepeis, Neil/0000-0002-6934-3242; Hughes, Suzanne/0000-0001-8279-1544; Blumberg, Elaine/0000-0002-1968-4495	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL103684]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103684] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported with a grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL103684 (http://www.nhlbi.nih.gov/) to San Diego State University Research Foundation (Dr. M. Hovell, principal investigator). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Bolton V, 2014, INDOOR AIR, V24, P199, DOI 10.1111/ina.12057; Adamkiewicz, 2011, J INFECTION, P238, DOI DOI 10.2105/AJPH.2011.300119; Apelberg BJ, 2013, TOB CONTROL, V22, P147, DOI 10.1136/tobaccocontrol-2011-050301; Baxter LK, 2007, J EXPO SCI ENV EPID, V17, P433, DOI 10.1038/sj.jes.7500532; Bellettiere John, 2014, Am J Public Health Res, V2, P232; Buonanno G, 2009, ATMOS ENVIRON, V43, P3235, DOI 10.1016/j.atmosenv.2009.03.044; Dacunto PJ, 2015, ENVIRON SCI-PROC IMP, V17, P1959, DOI [10.1039/c5em00365b, 10.1039/C5EM00365B]; Dacunto PJ, 2013, ENVIRON SCI-PROC IMP, V15, P1511, DOI 10.1039/c3em00209h; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; Ferro AR, 2009, ATMOS ENVIRON, V43, P706, DOI 10.1016/j.atmosenv.2008.09.032; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; He CR, 2004, ATMOS ENVIRON, V38, P3405, DOI 10.1016/j.atmosenv.2004.03.027; Henschen M, 1997, ENVIRON RES, V72, P65, DOI 10.1006/enrs.1996.3688; Hill T., 2006, STATISTICS METHODS A; Jacob P, 2017, CHEM RES TOXICOL, V30, P270, DOI 10.1021/acs.chemrestox.6b00343; Jiang RT, 2011, J EXPO SCI ENV EPID, V21, P31, DOI 10.1038/jes.2009.75; Jones LL, 2011, PLOS ONE, P9; Kearney J, 2014, ATMOS ENVIRON, V94, P793, DOI 10.1016/j.atmosenv.2014.05.020; Kim S., 2009, CRIT CARE, P81; Kim S., 2013, P SIGCHI C HUMAN FAC, P2745, DOI [DOI 10.1145/2470654.2481380, 10.1145/2470654.2481380]; Kim S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1861; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Klepeis NE, 1999, J EXPO ANAL ENV EPID, V9, P622, DOI 10.1038/sj.jea.7500065; Klepeis NE, 2013, PLOS ONE, P8; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4393, DOI 10.1016/j.atmosenv.2006.03.018; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4408, DOI 10.1016/j.atmosenv.2006.03.017; Knapp TR, 2001, J EXP EDUC, V70, P65, DOI 10.1080/00220970109599498; Koistinen KJ, 2001, ATMOS ENVIRON, V35, P2473, DOI 10.1016/S1352-2310(00)00446-5; Lai HK, 2006, ATMOS ENVIRON, V40, P1299, DOI 10.1016/j.atmosenv.2005.10.030; Lanki T, 2007, J EXPO SCI ENV EPID, V17, P124, DOI 10.1038/sj.jes.7500470; Lee K, 1997, COMMUN STAT-SIMUL C, V26, P559, DOI DOI 10.1080/03610919708813397; MacNeill M, 2014, INDOOR AIR, V24, P362, DOI 10.1111/ina.12084; Meng QY, 2009, ATMOS ENVIRON, V43, P5750, DOI 10.1016/j.atmosenv.2009.07.066; Miller MD, 2002, INT J TOXICOL, V21, P403, DOI 10.1080/10915810290096630; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; Nazaroff WW, 2004, INDOOR AIR, V14, P175, DOI 10.1111/j.1600-0668.2004.00286.x; Northcross AL, 2013, ENVIRON SCI-PROC IMP, V15, P433, DOI 10.1039/c2em30568b; Ott W, 2008, J EXPO SCI ENV EPID, V18, P312, DOI 10.1038/sj.jes.7500601; Ott WR, 1999, ENVIRON HEALTH PERSP, V107, P375, DOI 10.2307/3434430; Ott WR, 2003, J AIR WASTE MANAGE, V53, P918, DOI 10.1080/10473289.2003.10466248; Ozkaynak H, 1996, J EXPO ANAL ENV EPID, V6, P57; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2000, AEROSOL SCI TECH, V32, P4, DOI 10.1080/027868200303885; R. Core Team, 2015, R A LANGUAGE AND ENV; Rosen LJ, 2014, PEDIATRICS, V133, P698, DOI 10.1542/peds.2013-0958; Semple S, 2012, TOB CONTROL, P295; Semple S, 2013, TOB CONTROL; Semple S, 2015, TOB CONTROL, V24, pE205, DOI 10.1136/tobaccocontrol-2014-051635; Semple S, 2014, NICOTINE TOB RES, V16, P1365, DOI 10.1093/ntr/ntu089; Tukey JW., 1977, EXPLORATORY DATA ANA, DOI 10.1002/bimj.4710230408; Urso P, 2015, BUILD ENVIRON, V86, P61, DOI 10.1016/j.buildenv.2014.12.019; US Census Bureau, 2016, POVERTY; US Environmental Protection Agency, 2016, NATIONAL AMBIENT AIR; US Surgeon General, 2010, THE HEALTH CONSEQUEN, pL12; Wallace L, 1996, J AIR WASTE MANAGE, V46, P98, DOI 10.1080/10473289.1996.10467451; Wallace L, 2011, J EXPO SCI ENV EPID, V21, P20, DOI 10.1038/jes.2009.59; Wang GS, 2014, ANN EMERG MED, V63, P684, DOI 10.1016/j.annemergmed.2014.01.017; Wang GS, 2011, CHILD ABUSE NEGLECT, V35, P563, DOI 10.1016/j.chiabu.2011.03.012; Wang QG, 2008, COMMUN STAT-SIMUL C, V37, P62, DOI 10.1080/03610910701723625; Wang X. M., 2016, INT J CHEM ENG, V2016, P1, DOI DOI 10.3852/16-100; Wheeler AJ, 2011, AEROSOL SCI TECH, V45, P1078, DOI 10.1080/02786826.2011.580798; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilson I, 2012, TOB CONTROL, P1; Wooldridge J, 2006, INTRO ECONOMETRICS M; Zeileis A, 2004, J STAT SOFTW, P11	66	30	31	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177718	10.1371/journal.pone.0177718	http://dx.doi.org/10.1371/journal.pone.0177718			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545099	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700068
J	Noguchi, K; Dalton, AC; Howley, BV; McCall, BJ; Yoshida, A; Diehl, JA; Howe, PH				Noguchi, Ken; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Yoshida, Akihiro; Diehl, J. Alan; Howe, Philip H.			Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; MESENCHYMAL TRANSITION; TUMOR-CELLS; TGF-BETA; E-CADHERIN; METASTATIC MELANOMA; CANCER GENOMICS; RNA-SEQ; ILEI	ILEI (FAM3C) is a secreted factor that contributes to the epithelial-to-mesenchymal transition (EMT), a cell biological process that confers metastatic properties to a tumor cell. Initially, we found that ILEI mRNA is highly expressed in melanoma metastases but not in primary tumors, suggesting that ILEI contributes to the malignant properties of melanoma. While melanoma is not an epithelial cell-derived tumor and does not undergo a traditional EMT, melanoma undergoes a similar process known as phenotype switching in which high (micropthalmia-related transcription factor) MITF expressing (MITF-high) proliferative cells switch to a low expressing (MITF-low) invasive state. We observed that MITF-high proliferative cells express low levels of ILEI (ILEI-low) and MITF-low invasive cells express high levels of ILEI (ILEI-high). We found that inducing phenotype switching towards the MITF-low invasive state increases ILEI mRNA expression, whereas phenotype switching towards the MITF-high proliferative state decreases ILEI mRNA expression. Next, we used in vitro assays to show that knockdown of ILEI attenuates invasive potential but not MITF expression or chemoresistance. Finally, we used gene expression analysis to show that ILEI regulates several genes involved in the MITF-low invasive phenotype including JARID1B, HIF-2 alpha, and BDNF. Gene set enrichment analysis suggested that ILEI-regulated genes are enriched for JUN signaling, a known regulator of the MITF-low invasive phenotype. In conclusion, we demonstrate that phenotype switching regulates ILEI expression, and that ILEI regulates partial phenotype switching in MITF-low melanoma cell lines.	[Noguchi, Ken; Dalton, Annamarie C.; Howley, Breege V.; McCall, Buckley J.; Yoshida, Akihiro; Diehl, J. Alan; Howe, Philip H.] Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Diehl, J. Alan; Howe, Philip H.] Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina	Howe, PH (corresponding author), Med Univ South Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Howe, PH (corresponding author), Hollings Canc Ctr, Charleston, SC 29425 USA.	howep@musc.edu	McCall, Buckley/AAB-3828-2021	McCall, Buckley/0000-0002-0460-1124; Howe, Philip/0000-0002-1358-1313	National Cancer Institute [CA055536, CA154664, F30CA203269]; NATIONAL CANCER INSTITUTE [F30CA203269, T32CA193201, P30CA138313, R01CA154663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by CA055536 and CA154664 from the National Cancer Institute to PHH (www.cancer.gov) and F30CA203269 from the National Cancer Institute to KN (www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137696; Brown AS, 2016, NUCL ACIDS RES; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Csiszar A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0433-7; Eichhoff OM, 2011, PIGM CELL MELANOMA R, V24, P631, DOI 10.1111/j.1755-148X.2011.00871.x; Ennen M, 2015, ONCOGENE, V34, P3251, DOI 10.1038/onc.2014.262; Falletta P, 2017, GENE DEV, V31, P18, DOI 10.1101/gad.290940.116; Fischer KR, 2015, NATURE; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Gopal SK, 2015, ONCOTARGET, V6, P13718, DOI 10.18632/oncotarget.3764; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Howley BV, 2015, ONCOGENE; Hussey GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052624; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Jolly MK, 2016, ONCOTARGET, DOI 10.18632/oncotarget.8166; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Katahira T, 2010, BIOCHEM BIOPH RES CO, V392, P301, DOI 10.1016/j.bbrc.2009.12.180; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Koyanagi K, 2006, CLIN CANCER RES, V12, P1137, DOI 10.1158/1078-0432.CCR-05-1847; Kraya AA, 2015, AUTOPHAGY, V11, P60, DOI 10.4161/15548627.2014.984273; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Li WY, 2016, TRENDS CANCER, V2, P65, DOI 10.1016/j.trecan.2016.01.001; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Maguire LH, 2015, DEV DYNAM, V244, P311, DOI 10.1002/dvdy.24226; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Ramsdale R, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1111; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; Schlegel NC, 2015, EXP DERMATOL, V24, P22, DOI 10.1111/exd.12580; Shibahara S, 2000, PIGM CELL RES, V13, P98, DOI 10.1034/j.1600-0749.13.s8.18.x; Song Q, 2014, TUMOR BIOL, V35, P1377, DOI 10.1007/s13277-013-1188-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2016, IUBMB LIFE; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vandamme N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00352; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wellbrock C, 2015, PIGM CELL MELANOMA R, V28, P390, DOI 10.1111/pcmr.12370; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yasumoto K, 1997, J BIOL CHEM, V272, P503; Zheng X, 2015, NATURE; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816	87	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177830	10.1371/journal.pone.0177830	http://dx.doi.org/10.1371/journal.pone.0177830			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545079	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700086
J	Ma, CJ; Kwon, Y; Sung, P; Greene, EC				Ma, Chu Jian; Kwon, Youngho; Sung, Patrick; Greene, Eric C.			Human RAD52 interactions with replication protein A and the RAD51 presynaptic complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; SYNTHETICALLY LETHAL; MAMMALIAN RAD52; END RESECTION; REPAIR; EXCHANGE; GENE; INACTIVATION; MECHANISM	Rad52 is a highly conserved protein involved in the repair of DNA damage. Human RAD52 has been shown to mediate single-stranded DNA (ssDNA) and is synthetic lethal with mutations in other key recombination proteins. For this study, we used single-molecule imaging and ssDNA curtains to examine the binding interactions of human RAD52 with replication protein A (RPA)-coated ssDNA, and we monitored the fate of RAD52 during assembly of the presynaptic complex. We show that RAD52 binds tightly to the RPA-ssDNA complex and imparts an inhibitory effect on RPA turnover. We also found that during presynaptic complex assembly, most of the RPA and RAD52 was displaced from the ssDNA, but some RAD52-RPA-ssDNA complexes persisted as interspersed clusters surrounded by RAD51 filaments. Once assembled, the presence of RAD51 restricted formation of new RAD52-binding events, but additional RAD52 could bind once RAD51 dissociated from the ssDNA. Together, these results provide new insights into the behavior and dynamics of human RAD52 during presynaptic complex assembly and disassembly.	[Ma, Chu Jian; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kwon, Youngho; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Columbia University; Yale University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [R35GM118026, R01ES007061, P01CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM118026 (to E.C.G.) and R01ES007061 and P01CA92584 (to P.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; BENDIXEN C, 1994, GENOMICS, V23, P300, DOI 10.1006/geno.1994.1503; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Bhowmick R, 2016, MOL CELL, V64, P1117, DOI 10.1016/j.molcel.2016.10.037; Bianco P R, 1998, Front Biosci, V3, pD570; Brouwer I, 2017, CELL REP, V18, P2845, DOI 10.1016/j.celrep.2017.02.068; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Carr AM, 2013, J MOL BIOL, V425, P4733, DOI 10.1016/j.jmb.2013.04.023; Cejka P, 2015, J BIOL CHEM, V290, P22931, DOI 10.1074/jbc.R115.675942; Chandramouly G, 2015, CHEM BIOL, V22, P1491, DOI 10.1016/j.chembiol.2015.10.003; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Chun J, 2013, MOL CELL BIOL, V33, P387, DOI 10.1128/MCB.00465-12; Ciccia A, 2016, MOL CELL, V64, P1017, DOI 10.1016/j.molcel.2016.11.036; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cramer-Morales K, 2013, BLOOD, V122, P1293, DOI 10.1182/blood-2013-05-501072; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibb B, 2014, NAT STRUCT MOL BIOL, V21, P893, DOI 10.1038/nsmb.2886; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; Graham JS, 2011, NUCLEIC ACIDS RES, V39, P2249, DOI 10.1093/nar/gkq1140; Grimme JM, 2010, NUCLEIC ACIDS RES, V38, P2917, DOI 10.1093/nar/gkp1249; Hanamshet K, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090063; Heyer WD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016501; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Honda M, 2011, EMBO J, V30, P3368, DOI 10.1038/emboj.2011.238; Huang F, 2016, NUCLEIC ACIDS RES, V44, P4189, DOI 10.1093/nar/gkw087; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kass EM, 2016, MOL CELL, V62, P777, DOI 10.1016/j.molcel.2016.05.021; Kitao H, 2002, J BIOL CHEM, V277, P48944, DOI 10.1074/jbc.M208151200; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lam I, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016634; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lisby M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016535; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lok BH, 2013, ONCOGENE, V32, P3552, DOI 10.1038/onc.2012.391; Lok BH, 2012, CLIN CANCER RES, V18, P6400, DOI 10.1158/1078-0432.CCR-11-3150; Ma CJ, 2017, METHOD ENZYMOL, V582, P193, DOI 10.1016/bs.mie.2016.08.005; Ma CJ, 2017, NUCLEIC ACIDS RES, V45, P749, DOI 10.1093/nar/gkw1125; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURIS DFR, 1994, MUTAT RES-DNA REPAIR, V315, P295, DOI 10.1016/0921-8777(94)90040-X; Navadgi VM, 2003, BIOCHEMISTRY-US, V42, P15237, DOI 10.1021/bi0350452; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ohuchi T, 2008, DNA REPAIR, V7, P879, DOI 10.1016/j.dnarep.2008.02.005; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rothenberg E, 2008, P NATL ACAD SCI USA, V105, P20274, DOI 10.1073/pnas.0810317106; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Sotiriou SK, 2016, MOL CELL, V64, P1127, DOI 10.1016/j.molcel.2016.10.038; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sullivan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147230; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430	86	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11702	11713		10.1074/jbc.M117.794545	http://dx.doi.org/10.1074/jbc.M117.794545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28551686	Green Published, hybrid			2022-12-26	WOS:000405485600010
J	Azeem, W; Hellem, MR; Olsen, JR; Hua, YP; Marvyin, K; Qu, Y; Lin, BY; Ke, XS; Oyan, AM; Kalland, KH				Azeem, Waqas; Hellem, Margrete Reime; Olsen, Jan Roger; Hua, Yaping; Marvyin, Kristo; Qu, Yi; Lin, Biaoyang; Ke, Xisong; Oyan, Anne Margrete; Kalland, Karl-Henning			An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; INCREASED SURVIVAL; STRUCTURAL BASIS; CANCER; GENE; ACTIVATION; BINDING; ANTIGEN; PROGRESSION; ABIRATERONE	The androgen receptor (AR) transcription factor plays a key role in the development and progression of prostate cancer, as is evident from the efficacy of androgen-deprivation therapy, AR is also the most frequently mutated gene, in castration resistant prostate cancer (CRPC). AR has therefore become an even more attractive therapeutic target in aggressive and disseminated prostate cancer. To investigate mechanisms of AR and AR target gene activation in different subpopulations of prostate cancer cells, a toolkit of AR expressor and androgen response element (ARE) reporter vectors were developed. Three ARE reporter vectors were constructed with different ARE consensus sequences in promoters linked to either fluorescence or luciferase reporter genes in lentiviral vector backbones. Cell lines transduced with the different vectors expressed the reporters in an androgen-dependent way according to fluorescence microscopy, flow cytometry and multi-well fluorescent and luminescence assays. Interestingly, the background reporter activity in androgen-depleted medium was significantly higher in LNCaP cells compared to the prostate transit amplifying epithelial cell lines, EP156T-AR and 957E/hTERT-AR with exogenous AR. The androgen-induced signal to background was much higher in the latter benign prostate cells than in LNCaP cells. Androgen-independent nuclear localization of AR was seen in LNCaP cells and reduced ARE-signaling was seen following treatment with abiraterone, an androgen synthesis inhibitor. The ARE reporter activity was significantly stronger when stimulated by androgens than by beta-estradiol, progesterone and dexamethasone in all tested cell types. Finally, no androgen-induced ARE reporter activity was observed in tumorigenic mesenchymal progeny cells of EP156T cells following epithelial to mesenchymal transition. This underscores the observation that expression of the classical luminal differentiation transcriptome is restricted in mesenchymal type cells with or without AR expression, and presence of androgen.	[Azeem, Waqas; Hellem, Margrete Reime; Olsen, Jan Roger; Hua, Yaping; Marvyin, Kristo; Qu, Yi; Ke, Xisong; Oyan, Anne Margrete; Kalland, Karl-Henning] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Azeem, Waqas; Kalland, Karl-Henning] Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway; [Qu, Yi; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Lin, Biaoyang] Zhejiang California Int NanoSyst Inst, Hangzhou, Zhejiang, Peoples R China; [Lin, Biaoyang] Univ Washington, Dept Urol, Seattle, WA 98195 USA	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Washington; University of Washington Seattle	Azeem, W; Kalland, KH (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Azeem, W; Kalland, KH (corresponding author), Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway.; Kalland, KH (corresponding author), Haukeland Hosp, Dept Microbiol, Bergen, Norway.	waqas.azeem@uib.no; kalland@uib.no	Lin, Biaoyang/AAA-1258-2020; 花, 亚萍/AHE-6466-2022; Kalland, Karl-Henning/B-9445-2017	Lin, Biaoyang/0000-0002-2189-0407; Kalland, Karl-Henning/0000-0003-4486-2334; hua, yaping/0000-0002-5756-3563	Centre of Cancer Biomarkers; Research Council of Norway; University of Bergen; Helse Vest [911626, 911747, 911582, 911778, 912062]; Helse Vest Strategic Program; Bergen Stem Cell Consortium [502027]; Personalized Medicine/Liquid Biopsy [303484]; Bergen Research Foundation; Research Council of Norway (Centre of Cancer Biomarkers, CCBIO, a Centre of Excellence in Cancer Biomarkers)	Centre of Cancer Biomarkers; Research Council of Norway(Research Council of Norway); University of Bergen; Helse Vest; Helse Vest Strategic Program; Bergen Stem Cell Consortium; Personalized Medicine/Liquid Biopsy; Bergen Research Foundation; Research Council of Norway (Centre of Cancer Biomarkers, CCBIO, a Centre of Excellence in Cancer Biomarkers)	The study was funded by the following grants: Centre of Cancer Biomarkers, the Research Council of Norway and University of Bergen; Helse Vest (grants 911626, 911747, 911582, 911778, 912062); Helse Vest Strategic Program, Bergen Stem Cell Consortium (grant 502027); Helse Vest Strategic Program, Personalized Medicine/Liquid Biopsy (grant 303484); Bergen Research Foundation, Kare Rommetveit, Einar Galtung Dosvig, Espen Galtung Dosvig, Trond Mohn, Bjame Rieber, Herman Friele, Jan Einar Greve and Thorstein Selvik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Lisha Li for expert construction and sequence verification of AR expression vectors and Beth Johannessen and Hua My Hoang for technical assistance. We greatly acknowledge the private funding of this study by Einar Galtung Dosvig, Espen Galtung Dosvig, Bjarne Rieber, Trond Mohn, Herman Friele, Jan Einar Greve and the help by Bergen Research Foundation (BFS), Kare Rommetveit and Thorstein Selvik. This work received additional funding from Helse Vest (grant numbers 912062, 911626, 911747, 911582, 911778) and the Research Council of Norway (Centre of Cancer Biomarkers, CCBIO, a Centre of Excellence in Cancer Biomarkers authorized and funded by the Research Council of Norway).	Antony L, 2014, PROSTATE, V74, P1118, DOI 10.1002/pros.22828; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Berman BP, 2010, CELL CYCLE, V9, P2249, DOI 10.4161/cc.9.11.11621; BRINKMANN AO, 1989, UROL RES, V17, P87, DOI 10.1007/BF00262026; Brooke GN, 2008, ONCOGENE, V27, P2941, DOI 10.1038/sj.onc.1210955; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; CULIG Z, 1994, CANCER RES, V54, P5474; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Davis JN, 2002, MOL CARCINOGEN, V34, P91, DOI 10.1002/mc.10053; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DORSETT D, 1993, GENETICS, V134, P1135; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Gao WQ, 2005, CHEM REV, V105, P3352, DOI 10.1021/cr020456u; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Grist E, 2015, UROL ONCOL-SEMIN ORI, V33, P289, DOI 10.1016/j.urolonc.2015.03.021; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Holterhus PM, 2002, J STEROID BIOCHEM, V82, P269, DOI 10.1016/S0960-0760(02)00220-0; Horie-Inoue K, 2004, BIOCHEM BIOPH RES CO, V325, P1312, DOI 10.1016/j.bbrc.2004.10.174; Jin HJ, 2013, TRANSL ANDROL UROL, V2, P158, DOI 10.3978/j.issn.2223-4683.2013.09.01; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Ke XS, 2011, EXP CELL RES, V317, P234, DOI 10.1016/j.yexcr.2010.10.009; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Krasnov G S, 2015, Mol Biol (Mosk), V49, P716, DOI 10.7868/S0026898415050110; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Linja MJ, 2001, CANCER RES, V61, P3550; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nakhla AM, 1997, J BIOL CHEM, V272, P6838, DOI 10.1074/jbc.272.11.6838; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Olsen JR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2453-4; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Qu Y, 2013, CANCER RES, V73, P7090, DOI 10.1158/0008-5472.CAN-13-1560; Roy AK, 1999, VITAM HORM, V55, P309; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slupianek A, 2010, J CELL PHYSIOL, V224, P369, DOI 10.1002/jcp.22132; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tan M H Eileen, 2015, Acta Pharmacol Sin, V36, P3, DOI 10.1038/aps.2014.18; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; van Soest RJ, 2013, EUR J CANCER, V49, P3821, DOI 10.1016/j.ejca.2013.09.026; Vander Griend DJ, 2014, INT J BIOL SCI, V10, P627, DOI 10.7150/ijbs.8756; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2015, NAT REV CANC; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	59	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177861	10.1371/journal.pone.0177861	http://dx.doi.org/10.1371/journal.pone.0177861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570625	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800018
J	Bernier, MR; Vandenberg, LN				Bernier, Meghan R.; Vandenberg, Laura N.			Handling of thermal paper: Implications for dermal exposure to bisphenol A and its alternatives	PLOS ONE			English	Article							URINARY CONCENTRATIONS; DEVELOPMENTAL ORIGINS; ENDOCRINE DISRUPTORS; BPA GLUCURONIDE; RATS; HEALTH; TOXICOKINETICS; CHIMPANZEES; METABOLISM; STATEMENT	Bisphenol A (BPA) is an endocrine disrupting chemical used in a wide range of consumer products including photoactive dyes used in thermal paper. Recent studies have shown that dermal absorption of BPA can occur when handling these papers. Yet, regulatory agencies have largely dismissed thermal paper as a major source of BPA exposure. Exposure estimates provided by agencies such as the European Food Safety Authority (EFSA) are based on assumptions about how humans interact with this material, stating that 'typical' exposures for adults involve only one handling per day for short periods of time (<1 minute), with limited exposure surfaces (three fingertips). The objective of this study was to determine how individuals handle thermal paper in one common setting: a cafeteria providing short-order meals. We observed thermal paper handling in a college-aged population (n = 698 subjects) at the University of Massachusetts' dining facility. We find that in this setting, individuals handle receipts for an average of 11.5 min, that >30% of individuals hold thermal paper with more than three fingertips, and >60% allow the paper to touch their palm. Only 11% of the participants we observed were consistent with the EFSA model for time of contact and dermal surface area. Mathematical modeling based on handling times we measured and previously published transfer coefficients, concentrations of BPA in paper, and absorption factors indicate the most conservative estimated intake from handling thermal paper in this population is 51.1 ng/kg/day, similar to EFSA's estimates of 59 ng/kg/day from dermal exposures. Less conservative estimates, using published data on concentrations in thermal paper and transfer rates to skin, indicate that exposures are likely significantly higher. Based on our observational data, we propose that the current models for estimating dermal BPA exposures are not consistent with normal human behavior and should be reevaluated.	[Bernier, Meghan R.; Vandenberg, Laura N.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Environm Hlth Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Vandenberg, LN (corresponding author), Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Environm Hlth Sci, Amherst, MA 01003 USA.	lvandenberg@schoolph.umass.edu			University of Massachusetts; National Institute of Environmental Health Sciences of the National Institutes of Health [K22ES025811]	University of Massachusetts; National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors acknowledge support from the University of Massachusetts (start-up funds to LNV) and Award Number K22ES025811 from the National Institute of Environmental Health Sciences of the National Institutes of Health (to LNV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the University of Massachusetts.	Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bolognesi C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3978; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Castro B, 2015, ENVIRON RES, V142, P281, DOI 10.1016/j.envres.2015.07.001; Catanese MC, 2017, ENDOCRINOLOGY, V158, P516, DOI 10.1210/en.2016-1723; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Demierre AL, 2012, TOXICOL LETT, V213, P305, DOI 10.1016/j.toxlet.2012.07.001; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dodson RE, 2012, ENVIRON HEALTH PERSP, V120, P935, DOI 10.1289/ehp.1104052; Domoradzki JY, 2003, TOXICOL SCI, V76, P21, DOI 10.1093/toxsci/kfg206; Ehrlich S, 2014, JAMA-J AM MED ASSOC, V311, P859, DOI 10.1001/jama.2013.283735; EPA U, FINAL REPORT; Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059; Geens T, 2012, SCI TOTAL ENVIRON, V435, P30, DOI 10.1016/j.scitotenv.2012.07.001; Geens T, 2011, INT J HYG ENVIR HEAL, V214, P339, DOI 10.1016/j.ijheh.2011.04.005; Gerona RR, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0131-2; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Heindel JJ, 2015, ENDOCRINOLOGY, V156, P3416, DOI 10.1210/EN.2015-1394; Heindel JJ, 2015, CURR OPIN PEDIATR, V27, P248, DOI 10.1097/MOP.0000000000000191; Hill Corinne E, 2017, Cogent Med, V4; Hormann AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110509; Hwa C, 2011, DERMATOL THER, V24, P464, DOI 10.1111/j.1529-8019.2012.01460.x; Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015; Kim B, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0051-6; Lassen C, 2011, MIGRATION OF BISPHEN; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6860, DOI 10.1021/es301334j; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P6515, DOI 10.1021/es300876n; Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P9372, DOI 10.1021/es202507f; Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; Mendum T, 2011, GREEN CHEM LETT REV, V4, P81, DOI 10.1080/17518253.2010.502908; Mitragotri S, 2011, INT J PHARMACEUT, V418, P115, DOI 10.1016/j.ijpharm.2011.02.023; Negishi T, 2004, EXP ANIM TOKYO, V53, P391, DOI 10.1538/expanim.53.391; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Teeguarden JG, 2013, FOOD CHEM TOXICOL; Tominaga T, 2006, TOXICOLOGY, V226, P208, DOI 10.1016/j.tox.2006.07.004; Vandenberg L.N., 2013, ENDOCR DISRUPTORS, V1, DOI [DOI 10.4161/ENDO.26490, 10.4161/endo.26490]; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2017, J CLEAN PROD, V140, P373, DOI 10.1016/j.jclepro.2015.01.071; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Ye XY, 2015, ENVIRON SCI TECHNOL, V49, P11834, DOI 10.1021/acs.est.5b02135; Zalko D, 2003, ENVIRON HEALTH PERSP, V111, P309, DOI 10.1289/ehp.5603; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058	53	33	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178449	10.1371/journal.pone.0178449	http://dx.doi.org/10.1371/journal.pone.0178449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570582	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800057
J	Nagaya, N; Mizumoto, N; Abe, MS; Dobata, S; Sato, R; Fujisawa, R				Nagaya, Naohisa; Mizumoto, Nobuaki; Abe, Masato S.; Dobata, Shigeto; Sato, Ryota; Fujisawa, Ryusuke			Anomalous diffusion on the servosphere: A potential tool for detecting inherent organismal movement patterns	PLOS ONE			English	Article							VIRTUAL-REALITY; SEX-PHEROMONE; RANDOM-WALKS; LEVY WALK; BEHAVIOR; ORIENTATION; TRACKING; INSECTS; SEARCH; MOTION	Tracking animal movements such as walking is an essential task for understanding how and why animals move in an environment and respond to external stimuli. Different methods that implemented image analysis and a data logger such as GPS have been used in laboratory experiments and in field studies, respectively. Recently, animal movement patterns without stimuli have attracted an increasing attention in search for common innate characteristics underlying all of their movements. However, it is difficult to track the movements in a vast and homogeneous environment without stimuli because of space constraints in laboratories or environmental heterogeneity in the field, hindering our understanding of inherent movement patterns. Here, we applied an omnidirectional treadmill mechanism, or a servosphere, as a tool for tracking two-dimensional movements of small animals that can provide both a homogenous environment and a virtual infinite space for walking. To validate the use of our tracking system for assessment of the free-walking behavior, we compared walking patterns of individual pillbugs (Armadillidium vulgare) on the servosphere with that in two types of experimental flat arenas. Our results revealed that the walking patterns on the servosphere showed similar diffusive characteristics to those observed in the large arena simulating an open space, and we demonstrated that our mechanism provides more robust measurements of diffusive properties compared to a small arena with enclosure. Moreover, we showed that anomalous diffusion properties, including Levy walk, can be detected from the free-walking behavior on our tracking system. Thus, our novel tracking system is useful to measure inherent movement patterns, which will contribute to the studies of movement ecology, ethology, and behavioral sciences.	[Nagaya, Naohisa] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Kita Ku, Kyoto, Japan; [Mizumoto, Nobuaki; Dobata, Shigeto] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Sakyo Ku, Kyoto, Japan; [Abe, Masato S.] Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo, Japan; [Abe, Masato S.] Japan Sci & Technol Agcy, ERATO Kawarabayashi Large Graph Project, Chiyoda Ku, Hitotsubashi 2-1-2, Tokyo, Japan; [Sato, Ryota; Fujisawa, Ryusuke] Hachinohe Inst Technol, Dept Mech Engn, Hachinohe, Aomori, Japan	Kyoto Sangyo University; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Japan Science & Technology Agency (JST); Hachinohe Institute Technology	Nagaya, N (corresponding author), Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Kita Ku, Kyoto, Japan.; Fujisawa, R (corresponding author), Hachinohe Inst Technol, Dept Mech Engn, Hachinohe, Aomori, Japan.	nagaya@cc.kyoto-su.ac.jp; swarm.ant@gmail.com	Mizumoto, Nobuaki/M-9651-2017; Dobata, Shigeto/P-6749-2018	Mizumoto, Nobuaki/0000-0002-6731-8684; Dobata, Shigeto/0000-0003-1586-6758; Abe, Masato/0000-0002-0468-1179	Japan Society for the Promotion of Science [16K16107, 15J02767, 15H06830, 15K18609, 26891015]; Grants-in-Aid for Scientific Research [15K18609, 15H04425, 15H02652] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research 16K16107 (NN), 15J02767 (NM), 15H06830 (MSA), and 15K18609 and 26891015 (SD) from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html.	Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; BELL WJ, 1979, J INSECT PHYSIOL, V25, P631, DOI 10.1016/0022-1910(79)90112-4; BELL WJ, 1980, J CHEM ECOL, V6, P287, DOI 10.1007/BF01402908; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; CREED RP, 1990, EXPERIENTIA, V46, P758, DOI 10.1007/BF01939959; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Drahokoupilova T, 2012, ZOOKEYS, P145, DOI 10.3897/zookeys.176.2375; Fehlmann G, 2016, CURR BIOL, V26, pR830, DOI 10.1016/j.cub.2016.05.033; Humphries NE, 2013, METHODS ECOL EVOL; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Iwata K, 1957, ANNU ANIM PSYCHOL, V7, P53; Kanzaki R, 2013, J COMP PHYSIOL A, V199, P1037, DOI 10.1007/s00359-013-0832-8; Kolzsch A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0424; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Kumagai M, 2010, IEEE INT C INT ROBOT, P3352, DOI 10.1109/IROS.2010.5651007; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Miramontes O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111183; Moore RJD, 2014, J NEUROSCI METH, V225, P106, DOI 10.1016/j.jneumeth.2014.01.010; Noldus LPJJ, 2002, COMPUT ELECTRON AGR, V35, P201, DOI 10.1016/S0168-1699(02)00019-4; Otalora-Luna F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020990; Party V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052897; Peckmezian T, 2015, ANIM BEHAV, V107, P87, DOI 10.1016/j.anbehav.2015.06.018; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; R Core Team, 2013, R LANG ENV STAT COMP; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Reynolds AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03158; Sakuma M, 2002, COMPUT ELECTRON AGR, V35, P243, DOI 10.1016/S0168-1699(02)00021-2; Sims DW, 2014, P NATL ACAD SCI USA, V111, P11073, DOI 10.1073/pnas.1405966111; Suzuki T, 2013, J EXP BIOL, V216, P977, DOI 10.1242/jeb.079582; Takalo J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00324; Taylor GJ, 2015, J EXP BIOL, V218, P3118, DOI 10.1242/jeb.125617; Van Tilborg M, 2003, BEHAV RES METH INS C, V35, P478, DOI 10.3758/BF03195526; Viswanathan G. M., 2011, PHYS FORAGING; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668	37	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177480	10.1371/journal.pone.0177480	http://dx.doi.org/10.1371/journal.pone.0177480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570562	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800011
J	Osada, H; Okamoto, T; Kawashima, H; Toda, E; Miyake, S; Nagai, N; Kobayashi, S; Tsubota, K; Ozawa, Y				Osada, Hideto; Okamoto, Tomohiro; Kawashima, Hirohiko; Toda, Eriko; Miyake, Seiji; Nagai, Norihiro; Kobayashi, Saori; Tsubota, Kazuo; Ozawa, Yoko			Neuroprotective effect of bilberry extract in a murine model of photo-stressed retina	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PIGMENT EPITHELIUM; CELL-DEATH; LIGHT; DEGENERATION; DAMAGE; ANTHOCYANIN; EXPRESSION; BLUE; ACTIVATION	Excessive exposure to light promotes degenerative and blinding retinal diseases such as age-related macular degeneration and retinitis pigmentosa. However, the underlying mechanisms of photo-induced retinal degeneration are not fully understood, and a generalizable preventive intervention has not been proposed. Bilberry extract is an antioxidant-rich supplement that ameliorates ocular symptoms. However, its effects on photo-stressed retinas have not been clarified. In this study, we examined the neuroprotective effects of bilberry extract against photo-stress in murine retinas. Light-induced visual function impairment recorded by scotopic and phototopic electroretinograms showing respective rod and cone photoreceptor function was attenuated by oral administration of bilberry extract through a stomach tube in Balb/c mice (750 mg/kg body weight). Bilberry extract also suppressed photo-induced apoptosis in the photoreceptor cell layer and shortening of the outer segments of rod and cone photoreceptors. Levels of photo-induced reactive oxygen species (ROS), oxidative and endoplasmic reticulum (ER) stress markers, as measured by real-time reverse transcriptase polymerase chain reaction, were reduced by bilberry extract treatment. Reduction of ROS by N-acetyl-L-cysteine, a well-known antioxidant also suppressed ER stress. Immunohistochemical analysis of activating transcription factor 4 expression showed the presence of ER stress in the retina, and at least in part, in Muller glial cells. The photo-induced disruption of tight junctions in the retinal pigment epithelium was also attenuated by bilberry extract, repressing an oxidative stress marker, although ER stress markers were not repressed. Our results suggest that bilberry extract attenuates photo-induced apoptosis and visual dysfunction most likely, and at least in part, through ROS reduction, and subsequent ER stress attenuation in the retina. This study can help understand the mechanisms of photo-stress and contribute to developing a new, potentially useful therapeutic approach using bilberry extract for preventing retinal photo-damage.	[Osada, Hideto; Okamoto, Tomohiro; Kawashima, Hirohiko; Toda, Eriko; Miyake, Seiji; Nagai, Norihiro; Ozawa, Yoko] Keio Univ, Dept Ophthalmol, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan; [Okamoto, Tomohiro; Kawashima, Hirohiko; Nagai, Norihiro; Tsubota, Kazuo; Ozawa, Yoko] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Miyake, Seiji; Kobayashi, Saori] Wakasa Seikatsu Co Ltd, Kyoto, Japan	Keio University; Keio University	Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Lab Retinal Cell Biol, Sch Med, Tokyo, Japan.; Ozawa, Y (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.	ozawa@a5.keio.jp	Ozawa, Yoko/AAH-9888-2020; Kobayashi, Saori/GXV-3835-2022; Tsubota, Kazuo/M-1915-2013	Osada, Hideto/0000-0001-9971-8992; Tsubota, Kazuo/0000-0002-8874-7111	Wakasa Seikatsu Co., Ltd	Wakasa Seikatsu Co., Ltd	The study was supported by Wakasa Seikatsu Co., Ltd. SK is an employee of Wakasa Seikatsu Co., Ltd. and provided a resource. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salary to HO and in the grant to YO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors were articulated in the 'author contributions' section.	Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; APPLEGATE LA, 1991, CANCER RES, V51, P974; Armstrong Richard A, 2015, J Stem Cells, V10, P171; Brader Lea, 2013, Rev Diabet Stud, V10, P270, DOI 10.1900/RDS.2013.10.270; Burdulis D, 2007, MED LITH, V43, P971, DOI 10.3390/medicina43120127; Caballero-George C, 2002, PLANTA MED, V68, P1066, DOI 10.1055/s-2002-36344; Chen Y, 2016, EXP EYE RES, V144, P64, DOI 10.1016/j.exer.2015.08.021; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Fahim AT, 1993, GENEREVIEWS; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hoggard N, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.16; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Kamoshita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30226; Kamoshita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103013; Kerksick Chad, 2005, J Int Soc Sports Nutr, V2, P38, DOI 10.1186/1550-2783-2-2-38; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim J, 2015, INT J FOOD SCI NUTR, V66, P236, DOI 10.3109/09637486.2014.979319; Kishi S, 2010, JPN J OPHTHALMOL, V54, P514, DOI 10.1007/s10384-010-0849-2; Kubota S, 2010, AM J PATHOL, V177, P1725, DOI 10.2353/ajpath.2010.100098; Kurihara T, 2009, MOL VIS, V15; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Lei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043856; Li GF, 2014, ADV MECH ENG, DOI 10.1155/2014/792670; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Marquioni-Ramella MD, 2015, PHOTOCH PHOTOBIO SCI, V14, P1560, DOI 10.1039/c5pp00188a; McCarty CA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1455; Milbury PE, 2007, INVEST OPHTH VIS SCI, V48, P2343, DOI 10.1167/iovs.06-0452; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; Nag TC, 2012, MICRON, V43, P759, DOI 10.1016/j.micron.2012.01.011; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nakanishi T, 2013, J NEUROCHEM, V125, P111, DOI 10.1111/jnc.12116; Narimatsu T, 2015, EXP EYE RES, V132, P48, DOI 10.1016/j.exer.2015.01.003; Narimatsu T, 2014, CLIN EXP OPHTHALMOL, V42, P555, DOI 10.1111/ceo.12253; Narimatsu T, 2014, FREE RADICAL BIO MED, V71, P176, DOI 10.1016/j.freeradbiomed.2014.03.020; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Nguyen ATH, 2014, ADV EXP MED BIOL, V801, P471, DOI 10.1007/978-1-4614-3209-8_60; Ogawa K, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-120; Okamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146517; Ozawa Y, 2015, J NUTR HEALTH AGING, V19, P548, DOI 10.1007/s12603-014-0573-6; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sakakibara H, 2009, J AGR FOOD CHEM, V57, P7681, DOI 10.1021/jf901341b; Sasaki M, 2012, J NUTR BIOCHEM, V23, P423, DOI 10.1016/j.jnutbio.2011.01.006; Sozen E, 2015, FREE RADICAL BIO MED, V78, P30, DOI 10.1016/j.freeradbiomed.2014.09.031; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yoshida T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-45	55	33	34	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178627	10.1371/journal.pone.0178627	http://dx.doi.org/10.1371/journal.pone.0178627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570634	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800090
J	Silva-Hucha, S; Hernandez, RG; Benitez-Temino, B; Pastor, AM; de la Cruz, RR; Morcuende, S				Silva-Hucha, Silvia; Hernandez, Rosendo G.; Benitez-Temino, Beatriz; Pastor, Angel M.; de la Cruz, Rosa R.; Morcuende, Sara			Extraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; FACTOR VEGF; DIFFERENTIAL VULNERABILITY; SELECTIVE VULNERABILITY; PROLONGS SURVIVAL; AMPA RECEPTORS; MOUSE MODEL; BRAIN-STEM; EXPRESSION	Recent studies show a relationship between the deficit of vascular endothelial growth factor (VEGF) and motoneuronal degeneration, such as that occurring in amyotrophic lateral sclerosis (ALS). VEGF delivery protects motoneurons from cell death and delayed neurodegeneration in animal models of ALS. Strikingly, extraocular motoneurons show lesser vulnerability to neurodegeneration in ALS compared to other cranial or spinal motoneurons. Therefore, the present study investigates possible differences in VEGF and its main receptor VEGFR-2 or Flk-1 between extraocular and non-extraocular brainstem motoneurons. We performed immunohistochemistry and Western blot to determine the presence of VEGF and Flk-1 in rat motoneurons located in the three extraocular motor nuclei (abducens, trochlear and oculomotor) and to compare it to that observed in two other brainstem nuclei (hypoglossal and facial) that are vulnerable to degeneration. Extraocular motoneurons presented higher amounts of VEGF and its receptor Flk-1 than other brainstem motoneurons, and thus these molecules could be participating in their higher resistance to neurodegeneration. In conclusion, we hypothesize that differences in VEGF availability and signaling could be a contributing factor to the different susceptibility of extraocular motoneurons, when compared with other motoneurons, in neurodegenerative diseases.	[Silva-Hucha, Silvia; Hernandez, Rosendo G.; Benitez-Temino, Beatriz; Pastor, Angel M.; de la Cruz, Rosa R.; Morcuende, Sara] Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain	University of Sevilla	Morcuende, S (corresponding author), Univ Seville, Fac Biol, Dept Fisiol, Lab Fisiol & Plasticidad Neuronal, Seville, Spain.	smorcuende@us.es	Morcuende, Sara/G-8672-2015; Hernandez, Rosendo G./AAP-5946-2020; Pastor, Angel M. M/A-6385-2010	Morcuende, Sara/0000-0003-1471-7005; Hernandez, Rosendo G./0000-0001-7098-8630; Pastor, Angel M. M/0000-0002-6213-7454	Ministerio de lndustria y Competitividad (MINECO-FEDER) [BFU2015-64515-P, BFU2012-33975]; Junta de Andalucia [CVI-6053]	Ministerio de lndustria y Competitividad (MINECO-FEDER); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from Ministerio de lndustria y Competitividad (MINECO-FEDER) BFU2015-64515-P and BFU2012-33975 and Junta de Andalucia (CVI-6053) to AMP [http://www.mineco.gob.es/portal/site/mineco/, http://www.juntadeandalucia.es/temas/estudiar/investigacion/financiacion.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Benitez-Temino B, 2004, J COMP NEUROL, V473, P538, DOI 10.1002/cne.20095; Bogaert E, 2010, NEUROBIOL AGING, V31, P2185, DOI 10.1016/j.neurobiolaging.2008.12.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brockington A, 2006, J NEUROPATH EXP NEUR, V65, P26, DOI 10.1097/01.jnen.0000196134.51217.74; Brockington A, 2013, ACTA NEUROPATHOL, V125, P95, DOI 10.1007/s00401-012-1058-5; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Comley L, 2015, NEUROSCIENCE, V291, P216, DOI 10.1016/j.neuroscience.2015.02.013; Croll SD, 2004, ADV EXP MED BIOL, V548, P57; de Carrizosa MADL, 2010, J NEUROSCI, V30, P8308, DOI 10.1523/JNEUROSCI.0719-10.2010; de Almodovar CR, 2011, NEURON, V70, P966, DOI 10.1016/j.neuron.2011.04.014; de Almodovar CR, 2010, J NEUROSCI, V30, P15052, DOI 10.1523/JNEUROSCI.0477-10.2010; de la Cruz RR, 1998, J COMP NEUROL, V390, P377, DOI 10.1002/(SICI)1096-9861(19980119)390:3<377::AID-CNE6>3.0.CO;2-Z; Dekkers J, 2004, NEUROSCIENCE, V123, P459, DOI 10.1016/j.neuroscience.2003.07.013; DEPAUL R, 1988, NEUROLOGY, V38, P281, DOI 10.1212/WNL.38.2.281; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; ELLIOTT JL, 1995, NEUROREPORT, V6, P449, DOI 10.1097/00001756-199502000-00011; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gong CY, 2013, BIOSCI TRENDS, V7, P230, DOI 10.5582/bst.2013.v7.5.230; Gould TW, 2011, BRAIN RES REV, V67, P1, DOI 10.1016/j.brainresrev.2010.10.003; Haenggeli C, 2002, NEUROSCI LETT, V335, P39, DOI 10.1016/S0304-3940(02)01140-0; Hedlund E, 2010, BRAIN, V133, P2313, DOI 10.1093/brain/awq167; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; KOLIATSOS VE, 1991, BRAIN RES, V549, P297, DOI 10.1016/0006-8993(91)90471-7; Krakora D, 2013, MOL THER, V21, P1602, DOI 10.1038/mt.2013.108; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Laslo P, 2001, NEUROREPORT, V12, P1903, DOI 10.1097/00001756-200107030-00027; Laudenbach V, 2007, NEUROBIOL DIS, V26, P243, DOI 10.1016/j.nbd.2006.12.020; Li Y, 2008, 2008 PROCEEDINGS OF INFORMATION TECHNOLOGY AND ENVIRONMENTAL SYSTEM SCIENCES: ITESS 2008, VOL 4, P1; Marquez-Ruiz J, 2007, J COMP NEUROL, V503, P407, DOI 10.1002/cne.21397; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; McCloskey DP, 2008, BRAIN RES BULL, V76, P36, DOI 10.1016/j.brainresbull.2007.11.018; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; Medina L, 1996, EXP NEUROL, V142, P287, DOI 10.1006/exnr.1996.0198; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050; Morcuende S, 2011, J COMP NEUROL, V519, P2335, DOI 10.1002/cne.22630; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Nimchinsky EA, 2000, J COMP NEUROL, V416, P112, DOI 10.1002/(SICI)1096-9861(20000103)416:1<112::AID-CNE9>3.0.CO;2-K; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; PIEHL F, 1994, NEUROREPORT, V5, P697, DOI 10.1097/00001756-199402000-00009; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; Pronto-Laborinho AC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947513; Rao SD, 2004, TRENDS NEUROSCI, V27, P17, DOI 10.1016/j.tins.2003.11.001; REINER A, 1995, EXP NEUROL, V131, P239, DOI 10.1016/0014-4886(95)90046-2; Ringer C, 2012, NEUROBIOL DIS, V45, P547, DOI 10.1016/j.nbd.2011.09.011; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Sathasivam S, 2008, NEUROSCI RES, V62, P71, DOI 10.1016/j.neures.2008.06.008; Shiote M, 2005, NEUROSCIENCE, V132, P175, DOI 10.1016/j.neuroscience.2004.12.031; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Talaveron R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054519; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Tovar-Y-Romo LB, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-31; Van Damme P, 2002, J NEUROPHYSIOL, V88, P1279, DOI 10.1152/jn.2002.88.3.1279; Van Damme P, 2007, P NATL ACAD SCI USA, V104, P14825, DOI 10.1073/pnas.0705046104; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Wang Y, 2016, BRAIN RES, V1648, P1, DOI 10.1016/j.brainres.2016.06.043; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178616	10.1371/journal.pone.0178616	http://dx.doi.org/10.1371/journal.pone.0178616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570669	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800088
J	Wang, LX; Yang, X; Yue, Y; Fan, T; Hou, J; Chen, GX; Liang, MY; Wu, ZK				Wang, Le-Xun; Yang, Xiao; Yue, Yuan; Fan, Tian; Hou, Jian; Chen, Guang-Xian; Liang, Meng-Ya; Wu, Zhong-Kai			Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; REMODELING FOLLOWING INFARCTION; TYROSINE KINASE INHIBITORS; CONGESTIVE-HEART-FAILURE; MYOCARDIAL FIBROSIS; FIBROBLAST PROLIFERATION; SYSTEMIC FIBROSIS; TRANSGENIC MICE; ANGIOTENSIN-II; PDGF RECEPTOR	Cardiac fibrosis is a significant global health problem with limited treatment choices. Although previous studies have shown that imatinib (IMA) inhibited cardiac fibrosis, the anti-fibrotic mechanisms have not been clearly uncovered. The aim of this study is to evaluate whether IMA attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors (PDGFR) on isoproterenol (ISO)-induced mice. Adult male C57BL/6 mice were treated with vehicle or ISO +/- IMA for one week. After echocardiography examination, the hearts of mice were used for histopathologic, RT-qPCR, and western blot analyses. We found that the ventricular wall thickness, cardiac hypertrophy, and apoptosis were enhanced following ISO treatment. IMA decreased the left ventricular wall thickness, prevented hypertrophy, and inhibited apoptosis induced by ISO. In addition, IMA attenuated the accumulation of collagens and a-smooth muscle actin (alpha-SMA) (the markers of fibrosis) caused by ISO treatment. Moreover, the expression of fibrosis related genes, and the phosphorylation of PDGFRs in ISO-treated mice hearts were inhibited by IMA as well. However, IMA did not change the expression of the matrix metalloproteinase-9 (MMP-9) in ISO-treated hearts. Furthermore, IMA reduced the expressions of collagens as well as alpha-SMA caused by activation of PDGFR alpha in cardiac fibroblasts. Taken together, our data demonstrate that IMA attenuated the cardiac fibrosis by blocking the phosphorylation of PDGFRs in the ISO-induced mice model. This study indicates that IMA could be a potentially therapeutic option for cardiac fibrosis in clinical application.	[Wang, Le-Xun; Yang, Xiao; Yue, Yuan; Hou, Jian; Chen, Guang-Xian; Liang, Meng-Ya; Wu, Zhong-Kai] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiac Surg 2, Guangzhou, Guangdong, Peoples R China; [Wang, Le-Xun; Yang, Xiao; Yue, Yuan; Hou, Jian; Chen, Guang-Xian; Liang, Meng-Ya; Wu, Zhong-Kai] Sun Yat Sen Univ, Affiliated Hosp 1, Assisted Circulatory Lab, Hlth Minist, Guangzhou, Guangdong, Peoples R China; [Fan, Tian] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China; [Fan, Tian] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Wu, ZK (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiac Surg 2, Guangzhou, Guangdong, Peoples R China.; Wu, ZK (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Assisted Circulatory Lab, Hlth Minist, Guangzhou, Guangdong, Peoples R China.	wuzhk@mail.sysu.edu.cn	Hou, Jian/GLR-7074-2022	Wu, Zhongkai/0000-0003-1184-1182	National Natural Science Funds of China [81370215, 81570039]; China Postdoctoral Science Foundation [2016M590838]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Funds of China (Grant No.81370215 and 81570039; URL: http://www.nsfc.gov.cn/) and China Postdoctoral Science Foundation (Grant No.2016M590838; URL: http.//jj.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2008, FASEB J, V22, P2214, DOI 10.1096/fj.07-105627; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Balasubramanian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140273; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Belge C, 2014, CIRCULATION, V129, P451, DOI 10.1161/CIRCULATIONAHA.113.004940; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Ciuclan L, 2013, AM J RESP CRIT CARE, V187, P78, DOI 10.1164/rccm.201206-1028OC; Dang MQ, 2015, CELL PHYSIOL BIOCHEM, V35, P467, DOI 10.1159/000369712; Distler JHW, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/ken431; Douxfils J, 2016, JAMA ONCOL, V2, P625, DOI 10.1001/jamaoncol.2015.5932; Estabragh ZR, 2011, LEUKEMIA RES, V35, P49, DOI 10.1016/j.leukres.2010.08.020; Fan B, 2014, INT J CLIN EXP PATHO, V7, P16; Fan Zhaobo, 2016, Biomater Res, V20, P13, DOI 10.1186/s40824-016-0060-8; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gallini R, 2016, EXP CELL RES, V349, P282, DOI 10.1016/j.yexcr.2016.10.022; Gambacorti-Passerini C, 2014, AM J HEMATOL, V89, P947, DOI 10.1002/ajh.23788; Gaspard GJ, 2014, AM J PHYSIOL-CELL PH, V306, pC540, DOI 10.1152/ajpcell.00206.2013; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Grimminger F, 2010, ADV EXP MED BIOL, V661, P435, DOI 10.1007/978-1-60761-500-2_28; Grisanti LA, 2015, AM J PHYSIOL-HEART C, V308, pH316, DOI 10.1152/ajpheart.00635.2014; Hohimer AR, 2005, CAN J PHYSIOL PHARM, V83, P191, DOI 10.1139/y04-137; Hope TA, 2013, MAGN RESON IMAGING, V31, P139, DOI 10.1016/j.mri.2012.06.027; Iyer RP, 2016, AM J PHYSIOL-HEART C, V311, pH190, DOI 10.1152/ajpheart.00243.2016; Jang SW, 2014, HYPERTENSION, V63, P1228, DOI 10.1161/HYPERTENSIONAHA.113.01866; Kania G, 2009, TRENDS CARDIOVAS MED, V19, P247, DOI 10.1016/j.tcm.2010.02.005; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lin Y, 2016, CELL PHYSIOL BIOCHEM, V38, P1553, DOI 10.1159/000443096; Liu C, 2014, MOL CELL BIOCHEM, V397, P295, DOI 10.1007/s11010-014-2197-x; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; Marcolino MS, 2011, HEMATOL ONCOL, V29, P124, DOI 10.1002/hon.967; Milhem M, 2015, CURR CLIN PHARMACOL, V10, P311, DOI 10.2174/1574884710666151020100518; Molojavyi A, 2010, PHYSIOL GENOMICS, V41, P137, DOI 10.1152/physiolgenomics.90297.2008; NAGANO M, 1992, HYPERTENSION, V19, P708, DOI 10.1161/01.HYP.19.6.708; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; Qu K, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00300; Rai V, 2017, MOL CELL BIOCHEM, V424, P123, DOI 10.1007/s11010-016-2849-0; Samuel CS, 2014, HYPERTENSION, V64, P315, DOI 10.1161/HYPERTENSIONAHA.114.03594; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Soria A, 2008, DERMATOLOGY, V216, P109, DOI 10.1159/000111507; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stagno F, 2016, EXPERT REV ANTICANC, V16, P273, DOI 10.1586/14737140.2016.1151356; Sun M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18351; Tao H, 2016, INFLAMM RES, V65, P415, DOI 10.1007/s00011-016-0925-2; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Trent JC, 2010, CANCER-AM CANCER SOC, V116, P184, DOI 10.1002/cncr.24683; Turrisi G, 2010, INT J CARDIOL, V145, P148, DOI 10.1016/j.ijcard.2009.07.006; Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Zhang XY, 2014, CELL PHYSIOL BIOCHEM, V33, P557, DOI 10.1159/000358634; Zhao TQ, 2013, AM J PHYSIOL-HEART C, V304, pH1719, DOI 10.1152/ajpheart.00130.2013; Zhao WY, 2011, J MOL CELL CARDIOL, V51, P830, DOI 10.1016/j.yjmcc.2011.06.023	61	19	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178619	10.1371/journal.pone.0178619	http://dx.doi.org/10.1371/journal.pone.0178619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570599	Green Submitted, gold, Green Published			2022-12-26	WOS:000402611800089
J	Borzee, AEL; Kosch, TA; Kim, M; Jang, Y				Borzee, Amae E. L.; Kosch, Tiffany A.; Kim, Miyeon; Jang, Yikweon			Introduced bullfrogs are associated with increased Batrachochytrium dendrobatidis prevalence and reduced occurrence of Korean treefrogs	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; RANA-CATESBEIANA; EMERGING PATHOGEN; HYLA-SUWEONENSIS; TREE FROGS; CHYTRIDIOMYCOSIS; DISEASE; WIDESPREAD; INFECTION; POPULATIONS	Bullfrogs, Lithobates catesbeianus, have been described as major vectors of the amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd). Bd is widespread throughout the range of amphibians yet varies considerably within and among populations in prevalence and host impact. In our study, the presence of L. catesbeianus is correlated with a 2.5 increase in Bd prevalence in treefrogs, and the endangered Dryophytes suweonensis displays a significantly higher Bd prevalence than the more abundant D. japonicus for the 37 sites surveyed. In addition, the occurrence of L. catesbeianus was significantly correlated with a decrease in presence of D. suweonensis at sites. We could not determine if it is the presence of bullfrogs as competitors or predators that is limiting the distribution of D. suweonensis or whether this is caused by bullfrogs acting as a reservoir for Bd. However, L. catesbeianus can now be added to the list of factors responsible for the decline of D. suweonensis populations.	[Borzee, Amae E. L.] Seoul Natl Univ, Sch Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea; [Kosch, Tiffany A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Hlth Res Grp 1, Townsville, Qld, Australia; [Kim, Miyeon; Jang, Yikweon] Ewha Womans Univ, Div EcoSci, Seoul, South Korea	Seoul National University (SNU); James Cook University; Ewha Womans University	Jang, Y (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	jangy@ewha.ac.kr	Kosch, Tiffany A/A-3110-2017; Borzée, Amaël/P-6247-2018	Kosch, Tiffany A/0000-0001-5158-5748; Borzée, Amaël/0000-0003-1093-677X	Rotary Club Lectoure-Fleurance; National Research Foundation of Korea [2015R1A4A1041997]; Rural Development Administration [PJ012285]; Biodiversity Foundation	Rotary Club Lectoure-Fleurance; National Research Foundation of Korea(National Research Foundation of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Biodiversity Foundation	This work was financially supported by a grant from The Biodiversity Foundation and a grant from the Rotary Club Lectoure-Fleurance to AB and by a National Research Foundation of Korea grant (2015R1A4A1041997) and a Rural Development Administration grant (PJ012285) to YJ. The observations in this study comply with the current laws of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by a grant from The Biodiversity Foundation and a grant from the Rotary Club Lectoure-Fleurance to AB and by a National Research Foundation of Korea grant (2015R1A4A1041997) and a Rural Development Administration grant (PJ012285) to YJ. The observations in this study comply with the current laws of the Republic of Korea.	Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Berger L, 2004, AUST VET J, V82, P82; Borzee A, 2016, INTEGR ZOOL, V11, P375, DOI 10.1111/1749-4877.12200; Borzee A, 2015, ANIM CELLS SYST, V19, P216, DOI 10.1080/19768354.2015.1028442; Borzee A, 2013, ANIM CELLS SYST, V17, P348, DOI 10.1080/19768354.2013.842931; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Brannelly LA, 2016, ANIM CONSERV, V19, P153, DOI 10.1111/acv.12230; Cashins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056747; Chun S., 2012, KOREAN J HERPETOL, V4, P31, DOI DOI 10.1080/23802359.2017.1292475; Daszak P, 2004, HERPETOL J, V14, P201; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Dufresnes C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0814-x; Erismis UC, 2014, DIS AQUAT ORGAN, V111, P153, DOI 10.3354/dao02742; Ernst R, 2011, BIOL INVASIONS, V13, P1767, DOI 10.1007/s10530-010-9930-5; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fei L., 1999, ATLAS AMPHIBIANS CHI; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hobel G, 2014, BEHAVIOUR, V151, P741, DOI 10.1163/1568539X-00003167; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016063; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kiesecker JM, 2001, ECOLOGY, V82, P1964, DOI 10.1890/0012-9658(2001)082[1964:PMUTDO]2.0.CO;2; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kuzmin S, 2016, IUCN RED LIST THREAT; Leivas PT, 2012, ZOOLOGIA-CURITIBA, V29, P405, DOI 10.1590/S1984-46702012000500003; Li JT, 2015, MOL PHYLOGENET EVOL, V87, P80, DOI 10.1016/j.ympev.2015.02.018; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; Miaud C., 2016, BIOL INVASIONS, P1; Molur S, 2015, DIS AQUAT ORGAN, V112, P251, DOI 10.3354/dao02804; Moriguchi S, 2015, DIS AQUAT ORGAN, V113, P177, DOI 10.3354/dao02838; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Park D., 2014, CONSERVATION AMPHIBI; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pryor GS, 2014, ZOO BIOL, V33, P502, DOI 10.1002/zoo.21152; Ra NY, 2008, ZOOL SCI, V25, P894, DOI 10.2108/zsj.25.894; Reshetnikov AN, 2014, DIS AQUAT ORGAN, V110, P235, DOI 10.3354/dao02757; Retallick RWR, 2007, DIS AQUAT ORGAN, V75, P201, DOI 10.3354/dao075201; Richards-Zawacki CL, 2009, P ROY SOC LOND B BIO, V282; Roh G, 2014, ECOL INFORM, V24, P78, DOI 10.1016/j.ecoinf.2014.07.009; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Swei A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023179; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Yang H, 2010, THESIS SEOUL NATL U; Yang H, 2009, DIS AQUAT ORGAN, V86, P9, DOI 10.3354/dao02098; Yoo E, 2012, ANIM CELLS SYST, V16, P260, DOI 10.1080/19768354.2011.625043; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7; Zuur Alain F., 2009, P1	65	32	32	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177860	10.1371/journal.pone.0177860	http://dx.doi.org/10.1371/journal.pone.0177860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562628	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000402608700031
J	Li, FX; Guo, YN; Liu, JT; Zhang, RP				Li, Fangxuan; Guo, Yuenan; Liu, Juntian; Zhang, Rupeng			The significance of elevated plasma expression of microRNA 106b similar to 25 clusters in gastric cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; POTENTIAL BIOMARKERS; SERUM; PROLIFERATION; APOPTOSIS; DIAGNOSIS; MARKERS; CA72-4; CA19-9; CEA	Objective Concentrating on oncogenic role and increased plasma expression of microRNA(miR) 106b similar to 25 clusters (involving miR 106b, miR 93 and miR 25), we evaluated significance of the over-expression of plasma miR 106b similar to 25 in GC. Methods Based on 65 pairs matched GC patients and health controls, we explored clinical significance of miR 106b similar to 25 for GC and compared their diagnostic performance with conventional tumor biomarkers including CA724, CA242, CA199 and CEA. Results Both miR 106b similar to 25 cluster and conventional tumor biomarkers were significantly elevated in GC (All P<0.05). In ROC curves, miR 106b had the highest AUC (0.898) in diagnosing GC with optimal sensitivity of 86.2% and specificity of 92.3% at the cut-off value of 1.385. MiR 25 had moderate diagnostic efficacy (AUC = 0.817) with sensitivity of 87.6% and specificity of 76.9% at the threshold of 1.015. The AUC of miR 93 (0.756) was the lowest. The AUC, sensitivity, accuracy and Youden index of miR 106b were higher than all of four conventional biomarkers, while its specificity is higher than CA242 and CA724. The AUC of miR 25 was also higher than CA724, CA242 and CA199, while AUC of miR 93 was only higher than CA199 and CA724. Compared the diagnostic efficacy via ROC curves, miR 106b was significantly higher diagnostic efficacy than CA724, CA242 and CA199, the diagnostic efficacies of miR 93 and miR 25 were significantly higher than CA199(all P<0.05). Conclusions Plasma miR 106b similar to 25 cluster, especially miR 106b, were significantly increased in GC patients and may be hopeful diagnostic biomarkers.	[Li, Fangxuan; Liu, Juntian] Tianjin Med Univ Canc Inst & Hosp, Dept Canc Prevent Ctr, Tianjin, Peoples R China; [Li, Fangxuan; Guo, Yuenan; Liu, Juntian; Zhang, Rupeng] Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Fangxuan; Guo, Yuenan; Liu, Juntian; Zhang, Rupeng] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Li, Fangxuan; Guo, Yuenan; Liu, Juntian; Zhang, Rupeng] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Guo, Yuenan; Zhang, Rupeng] Tianjin Med Univ Canc Inst & Hosp, Dept Gastr Canc Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Liu, JT (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Canc Prevent Ctr, Tianjin, Peoples R China.; Liu, JT; Zhang, RP (corresponding author), Natl Clin Res Ctr Canc, Tianjin, Peoples R China.; Liu, JT; Zhang, RP (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.; Liu, JT; Zhang, RP (corresponding author), Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.; Zhang, RP (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Gastr Canc Surg, Tianjin, Peoples R China.	ljt641024@163.com; tijzhangrp@163.com			National Natural Science Fund of China [81502309]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Fund of China (81502309). There was no additional external funding received for this study.	Arabpour M, 2016, CURR MED CHEM; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen XZ, 2012, MOL BIOL REP, V39, P9031, DOI 10.1007/s11033-012-1774-x; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Ebert MR, 2006, EUR J GASTROEN HEPAT, V18, P847, DOI 10.1097/00042737-200608000-00007; Haendeler J, 2013, ARTERIOSCL THROM VAS, V33, P1639, DOI 10.1161/ATVBAHA.113.301428; He X, 2013, NEOPLASMA; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Li FX, 2013, BIOMARKERS, V18, P632, DOI 10.3109/1354750X.2013.840800; Li FX, 2013, SURG ONCOL, V22, pE7, DOI 10.1016/j.suronc.2013.01.003; Li L, 2015, MED SCI MONITOR, V21, P1155, DOI 10.12659/MSM.892940; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Lu YF, 2014, ASIAN PAC J CANCER P, V15, P1419, DOI 10.7314/APJCP.2014.15.3.1419; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; McGuire S, 2014, ADV NUTR, V5, P456, DOI 10.3945/an.114.006171; Menon U, 2014, BJOG-INT J OBSTET GY, V121, P35, DOI 10.1111/1471-0528.13211; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Spila A, 1996, ANTICANCER RES, V16, P2241; Tsai MM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060945; Wu JH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/435656; Wu JH, 2015, BIOMARKERS, V20, P58, DOI 10.3109/1354750X.2014.992812; Ychou M, 2000, DIS MARKERS, V16, P105, DOI 10.1155/2000/595492; Zhang RP, 2016, TUMOR BIOL, V37, P10507, DOI 10.1007/s13277-016-4937-x; Zhang RP, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0243-x; Zhu JH, 2015, MOL CLIN ONCOL, V3, P1315, DOI 10.3892/mco.2015.616	31	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178427	10.1371/journal.pone.0178427	http://dx.doi.org/10.1371/journal.pone.0178427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562634	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700059
J	Machnowska, P; Hauser, A; Meixenberger, K; Altmann, B; Bannert, N; Rempis, E; Schnack, A; Decker, S; Braun, V; Busingye, P; Rubaihayo, J; Harms, G; Theuring, S				Machnowska, Patrycja; Hauser, Andrea; Meixenberger, Karolin; Altmann, Britta; Bannert, Norbert; Rempis, Eva; Schnack, Alexandra; Decker, Sarah; Braun, Vera; Busingye, Priscilla; Rubaihayo, John; Harms, Gundel; Theuring, Stefanie			Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B plus for PMTCT	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; INHIBITOR-BASED THERAPY; SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY; TREATMENT FAILURE; VIROLOGICAL FAILURE; INFECTED UGANDANS; PREGNANT-WOMEN; PREVENTION	Background Since 2012, WHO guidelines for the prevention of mother-to-child transmission (PMTCT) of HIV-1 in resource-limited settings recommend the initiation of lifelong antiretroviral combination therapy (CART) for all pregnant HIV-1 positive women independent of CD4 count and WHO clinical stage (Option B+). However, long-term outcomes regarding development of drug resistance are lacking until now. Therefore, we analysed the emergence of drug resistance mutations (DRMs) in women initiating Option B+ in Fort Portal, Uganda, at 12 and 18 months postpartum (ppm). Methods and findings 124 HIV-1 positive pregnant women were enrolled within antenatal care services in Fort Portal, Uganda. Blood samples were collected at the first visit prior starting Option B+ and postpartum at week six, month six, 12 and 18. Viral load was determined by real-time RT-PCR. An RT-PCR covering resistance associated positions in the protease and reverse transcriptase HIV-1 genomic region was performed. PCR-positive samples at 12/18 ppm and respective baseline samples were analysed by next generation sequencing regarding HIV-1 drug resistant variants including low-frequency variants. Furthermore, vertical transmission of HIV-1 was analysed. 49/124 (39.5%) women were included into the DRM analysis. Viro-logical failure, defined as >1000 copies HIV-1 RNA/ml, was observed in three and seven women at 12 and 18 ppm, respectively. Sequences were obtained for three and six of these. In total, DRMs were detected in 3/49 (6.1%) women. Two women displayed dual-class resistance against all recommended first-line regimen drugs. Of 49 mother-infant-pairs no infant was HIV-1 positive at 12 or 18 ppm. Conclusion Our findings suggest that the WHO-recommended Option B+ for PMTCT is effective in a cohort of Ugandan HIV-1 positive pregnant women with regard to the low selection rate of DRMs and vertical transmission. Therefore, these results are encouraging for other countries considering the implementation of lifelong cART for all pregnant HIV-1 positive women.	[Machnowska, Patrycja; Rempis, Eva; Schnack, Alexandra; Decker, Sarah; Braun, Vera; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Machnowska, Patrycja; Hauser, Andrea; Meixenberger, Karolin; Altmann, Britta; Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Busingye, Priscilla] Holy Family Virika Hosp, Ft Portal, Uganda; [Rubaihayo, John] Mountains Moon Univ, Dept Publ Hlth, Ft Portal, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Machnowska, P (corresponding author), Charite, Inst Trop Med & Int Hlth, Berlin, Germany.; Machnowska, P (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.	MachnowskaP@rki.de	Rubaihayo, John/HDO-2747-2022	Rubaihayo, Prof. John/0000-0002-3421-2242; Klink, Patrycja/0000-0001-6139-9199	ESTHER Germany, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); H.W. & J. Hector Foundation, Germany	ESTHER Germany, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); H.W. & J. Hector Foundation, Germany	We would like to thank all participating women, midwives, laboratory staff and administration of both The Holy Family Virika Hospital and Fort Portal Regional Referral Hospital. The study was funded and supported by the H.W. & J. Hector Foundation, Germany. The sponsor had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. This research was based on a larger PMTCT study supported by ESTHER Germany, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ).	[Anonymous], 2012, INT SCHOLARLY RES NO, DOI DOI 10.5402/2012/589817; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boltz VF, 2014, J INFECT DIS, V209, P703, DOI 10.1093/infdis/jit635; Brooks K, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20798; Cleland A, 2001, VOX SANG, P81; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Cortez KJ, 2011, VIRUSES-BASEL, V3, P347, DOI 10.3390/v3040347; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Fisher RG, 2015, J CLIN VIROL, V62, P48, DOI 10.1016/j.jcv.2014.11.014; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Fox Z, 2008, AIDS, V22, P2279, DOI 10.1097/QAD.0b013e328311d16f; Galluzzo CM, 2007, AIDS RES HUM RETROV, V23, P1449, DOI 10.1089/aid.2007.0109; Geretti AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069266; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Hauser A, 2016, EURO SURVEILLANCE; Hauser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032055; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Kyeyune F, 2016, ANTIMICROB AGENTS CH, V60, P3380, DOI 10.1128/AAC.00038-16; Kyeyune F, 2013, AIDS, V27, P1899, DOI 10.1097/QAD.0b013e3283610ec7; Lee GQ, 2014, AIDS RES HUM RETROV, V30, P896, DOI [10.1089/aid.2014.0043, 10.1089/AID.2014.0043]; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Magoc T, BIOINFORMATICS BTR50; Mancinelli S, 2016, AIDS RES HUMAN RETRO; McIntyre J, 2005, BJOG-INT J OBSTET GY, V112, P1196, DOI 10.1111/j.1471-0528.2005.00716.x; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Nadembega WM, 2006, J MED VIROL, V78, P1385, DOI 10.1002/jmv.20709; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Palombi L, 2016, J ANTIMICROB CHEMOTH, V71, P1027, DOI 10.1093/jac/dkv435; Palombi L, 2015, J ANTIMICROB CHEMOTH, V70, P2881, DOI 10.1093/jac/dkv171; Paredes R, 2013, J INFECT DIS, V207, pS93, DOI 10.1093/infdis/jit110; Perno CF, 2004, J INFECT DIS, V189, P1983, DOI 10.1086/386307; Perno CF, 2001, J INFECT DIS, V184, P983, DOI 10.1086/323604; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013; Rhee SY, 2003, NUCLEIC ACIDS RES, P31; Samuel R, 2014, AIDS REV, V16, P187; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; UNAIDS, 2015, HIV AIDS UG PROGR RE; UNAIDS, 2014, GAP REP 2014; Vandamme AM, 1998, ANTIVIR CHEM CHEMOTH, V9, P187, DOI 10.1177/095632029800900301; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; WHO, 2012, WHO GLOB STRAT SURV; who, HIV AIDS FACT SHEET; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2016, CONS GUID US ANT DRU; Zoufaly A, 2015, J ANTIMICROB CHEMOTH, V70, P922, DOI 10.1093/jac/dku470	54	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178297	10.1371/journal.pone.0178297	http://dx.doi.org/10.1371/journal.pone.0178297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562612	Green Published, gold			2022-12-26	WOS:000402608700052
J	Ye, ZP; Vollhardt, IMG; Tomanovic, Z; Traugott, M				Ye, Zhengpei; Vollhardt, Ines M. G.; Tomanovic, Zeljko; Traugott, Michael			Evaluation of three molecular markers for identification of European primary parasitoids of cereal aphids and their hyperparasitoids	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BIOLOGICAL-CONTROL; PHYLOGENETIC-RELATIONSHIPS; COMPLEX HYMENOPTERA; APHIDIINAE; DNA; BRACONIDAE; PRIMERS; GENE; AMPLIFICATION	Aphids are major pests of cereal crops and a suite of hymenopteran primary parasitoids play an important role in regulating their populations. However, hyperparasitoids may disrupt the biocontrol services provided by primary parasitoids. As such, understanding cereal aphid-primary parasitoid-hyperparasitoid interactions is vital for a reliable parasitoid-based control of cereal aphids. For this, the ability to identify the different primary and hyperparasitoid species is necessary. Unfortunately, this is often difficult due to a lack of morphologically diagnostic features. DNA sequence-based species identification of parasitoids can overcome these hurdles. However, comprehensive DNA sequence information is lacking for many of these groups, particularly for hyperparasitoids. Here we evaluate three genes [cytochrome c oxidase subunit I (COI), 16S ribosomal RNA (16S) and 18S ribosomal RNA (18S)] for their suitability to identify 24 species of primary parasitoids and 16 species of hyperparasitoids associated with European cereal aphids. To identify aphelinid primary parasitoid species and hyperparasitoids, we found 16S to be more suitable compared to COI sequences. In contrast, the Aphidiinae are best identified using COI due to better species-level resolution and a more comprehensive DNA sequence database compared to 16S. The 18S gene was better suited for group-specific identification of parasitoids, but did not provide resolution at the species level. Our results provide a DNA sequence database for cereal aphid primary parasitoids and their associated hyperparasitoids in Central Europe, which will allow further improvement of our understanding of cereal aphid-primary parasitoid-hyperparasitoid interactions in relation to aphid biological control.	[Ye, Zhengpei; Traugott, Michael] Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, Innsbruck, Austria; [Vollhardt, Ines M. G.] Georg August Univ Gottingen, Dept Crop Sci, Agroecol, Gottingen, Germany; [Tomanovic, Zeljko] Univ Belgrade, Fac Biol, Inst Zool, Belgrade, Serbia	University of Innsbruck; University of Gottingen; University of Belgrade	Ye, ZP (corresponding author), Univ Innsbruck, Inst Ecol, Mt Agr Res Unit, Innsbruck, Austria.	Zhengpei.Ye@uibk.ac.at	; Ye, Zhengpei/D-1445-2016	Zeljko, Tomanovic/0000-0002-5063-5480; Ye, Zhengpei/0000-0003-4788-0386; Traugott, Michael/0000-0001-9719-5059	German Research Foundation (DFG) [V01673/2-1]; Mountain Agriculture Research Unit; government of Tyrol; University of Innsbruck; Serbian Ministry of Education, Science and Technological Development [11143001]	German Research Foundation (DFG)(German Research Foundation (DFG)); Mountain Agriculture Research Unit; government of Tyrol; University of Innsbruck; Serbian Ministry of Education, Science and Technological Development(Ministry of Education, Science & Technological Development, Serbia)	The work presented in this paper was funded by the DACH project "Agricultural intensification and aphid-parasitoid food webs" (Austrian Science Fund (FWF) I632 and German Research Foundation (DFG) V01673/2-1). We also acknowledged financial support through grants of the Mountain Agriculture Research Unit and the regional government of Tyrol as well as a PhD scholarship provided by the University of Innsbruck for ZY. Contribution of ZT was partially supported by grant Serbian Ministry of Education, Science and Technological Development (11143001).	Ballard JWO, 2000, J MOL EVOL, V51, P48, DOI 10.1007/s002390010066; Boivin G, 2012, CAN J PLANT SCI, V92, P1, DOI [10.4141/cjps2011-045, 10.4141/CJPS2011-045]; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Derocles SAP, 2014, MOL ECOL, V23, P3900, DOI 10.1111/mec.12701; Derocles SAP, 2012, MOL ECOL RESOUR, V12, P634, DOI 10.1111/j.1755-0998.2012.03131.x; Derocles SAP, 2012, MOL ECOL RESOUR, V12, P197, DOI 10.1111/j.1755-0998.2011.03083.x; Fergusson N.D.M., 1986, Handbooks for the Identification of British Insects, V8, P1; Fergusson N.D.M., 1980, Bulletin of the British Museum (Natural History) Entomology, V41, P255; Ferrer-Suay M., 2015, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V117, P23; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fulbright JL, 2007, P ENTOMOL SOC WASH, V109, P541; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Gariepy TD, 2014, MOL ECOL, V23, P3912, DOI 10.1111/mec.12515; Gariepy TD, 2012, BIOL CONTROL, V60, P26, DOI 10.1016/j.biocontrol.2011.06.011; Gariepy T, 2008, J APPL ECOL, V45, P708, DOI 10.1111/j.1365-2664.2007.01451.x; Gibson Gary A.P., 2001, Journal of Hymenoptera Research, V10, P29; Gibson Gary A.P., 1998, Journal of Hymenoptera Research, V7, P209; Gomez-Marco F, 2015, BIOL CONTROL, V81, P111, DOI 10.1016/j.biocontrol.2014.11.015; Graham MWRdV, 1969, B BRIT MUSEUM NA S16; Greenstone MH, 2006, B ENTOMOL RES, V96, P1, DOI 10.1079/BER2005402; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkins BA, 1994, PATTERN PROCESS HOST, pI; Hawro V, 2015, BIOCONTROL, V60, P451, DOI 10.1007/s10526-015-9660-9; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heraty JM, 2007, MOL PHYLOGENET EVOL, V45, P480, DOI 10.1016/j.ympev.2007.06.021; HOLLER C, 1993, J ANIM ECOL, V62, P12, DOI 10.2307/5478; Hoy AM, 2003, INSECT MOL GENETICS; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Japoshvili G, 2006, J NAT HIST, V40, P855, DOI 10.1080/00222930600790737; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Kambhampati S, 1995, INSECT MOL BIOL, V4, P233, DOI 10.1111/j.1365-2583.1995.tb00028.x; Kambhampati S, 2000, SYST ENTOMOL, V25, P437, DOI 10.1046/j.1365-3113.2000.00129.x; Kamijo K., 1973, Insecta Matsumurana, V2, P39; Kavallieratos NG, 2005, ZOOL ANZ, V243, P181, DOI 10.1016/j.jcz.2004.11.001; Lohaus K, 2013, OECOLOGIA, V171, P249, DOI 10.1007/s00442-012-2387-8; Luan YX, 2003, SCI CHINA SER C, V46, P67, DOI 10.1007/BF03182686; Luo AR, 2015, ECOL EVOL, V5, pS869, DOI 10.1002/ece3.1846; Macfadyen S, 2009, AGR ECOSYST ENVIRON, V133, P14, DOI 10.1016/j.agee.2009.04.012; Medvedev GS, 1988, KEYS INSECTS EUROP 3, pi; Mitrovski-Bogdanovic A, 2014, ZOOL ANZ, V253, P270, DOI 10.1016/j.jcz.2014.02.001; Mitrovski-Bogdanovic A, 2013, ANN ENTOMOL SOC AM, V106, P170, DOI 10.1603/AN12100; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; PENNACCHIO F, 1994, B ENTOMOL RES, V84, P57, DOI 10.1017/S0007485300032235; PENNACCHIO F, 1987, B LAB ENTOMOLOGIA AG, V43, P105; Pennacchio F., 1990, B LAB ENTOMOLOGIA AG, V46, P75; Polidori C, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev149; POWELL W, 1982, SYST ENTOMOL, V7, P465, DOI 10.1111/j.1365-3113.1982.tb00457.x; Powell W, 2007, APHIDS AS CROP PESTS, P469, DOI 10.1079/9780851998190.0469; Quicke DLJ, 2015, BRACONID AND ICHNEUMONID PARASITOID WASPS: BIOLOGY, SYSTEMATICS, EVOLUTION AND ECOLOGY, P1; Rakhshani E, 2005, J PEST SCI, V78, P193, DOI 10.1007/s10340-004-0080-3; Rakhshani E, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.14301; Rand TA, 2012, ECOGRAPHY, V35, P97, DOI 10.1111/j.1600-0587.2011.07016.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Schmidt MH, 2003, P ROY SOC B-BIOL SCI, V270, P1905, DOI 10.1098/rspb.2003.2469; Schooler SS, 2011, BIOL CONTROL, V58, P167, DOI 10.1016/j.biocontrol.2011.05.018; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; STARY P, 1981, ACTA ENTOMOL BOHEMOS, V78, P382; Stary P, 1966, APHID PARASITES CZEC; Takada H, 2002, APPL ENTOMOL ZOOL, V37, P237, DOI 10.1303/aez.2002.237; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Tomanovic Z., 2005, Acta Entomologica Serbica, V8, P15; Traugott M, 2008, MOL ECOL, V17, P3928, DOI 10.1111/j.1365-294X.2008.03878.x; Traugott M, 2008, B ENTOMOL RES, V98, P223, DOI 10.1017/S0007485308005968; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; WALTON MP, 1990, ENTOMOL EXP APPL, V54, P271, DOI 10.1007/BF00186796; Ye Z, 2017, SCI REPORTS IN PRESS	73	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5								10.1371/journal.pone.0177376	http://dx.doi.org/10.1371/journal.pone.0177376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562603	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700013
J	Rodriguez-Gonzalez, A; Sarabeev, V; Balbuena, JA				Rodriguez-Gonzalez, Abril; Sarabeev, Volodimir; Antonio Balbuena, Juan			Evolutionary morphology in shape and size of haptoral anchors in 14 Ligophorus spp. (Monogenea: Dactylogyridae)	PLOS ONE			English	Article							MULLET MUGIL-CEPHALUS; PHYLOGENETIC SIGNAL; HOST-SPECIFICITY; GEOMETRIC MORPHOMETRICS; TELEOSTEI MUGILIDAE; PARASITES; CONSERVATISM; INTEGRATION; MODULARITY; PATTERNS	The search for phylogenetic signal in morphological traits using geometric morphometrics represents a powerful approach to estimate the relative weights of convergence and shared evolutionary history in shaping organismal form. We assessed phylogenetic signal in the form of ventral and dorsal haptoral anchors of 14 species of Ligophorus occurring on grey mullets (Osteichthyes: Mugilidae) from the Mediterranean, the Black Sea and the Sea of Azov. The phylogenetic relationships among these species were mapped onto the morphospaces of shape and size of dorsal and ventral anchors and two different tests were applied to establish whether the spatial positions in the morphospace were dictated by chance. Overall significant phylogenetic signal was found in the data. Allometric effects on anchor shape were moderate or non-significant in the case of evolutionary allometry. Relatively phylogenetically distant species occurring on the same host differed markedly in anchor morphology indicating little influence of host species on anchor form. Our results suggest that common descent and shared evolutionary history play a major role in determining the shape and, to a lesser degree in the size of haptoral anchors in Ligophorus spp. The present approach allowed tracing paths of morphological evolution in anchor shape. Species with narrow anchors and long shafts were associated predominately with Liza saliens. This morphology was considered to be ancestral relative to anchors of species occurring on Liza haematocheila and M. cephalus possessing shorter shafts and longer roots. Evidence for phylogenetic signal was more compelling for the ventral anchors, than for the dorsal ones, which could reflect different functional roles in attachment to the gills. Although phylogeny and homoplasy may act differently in other monogeneans, the present study delivers a common framework to address effectively the relationships among morphology, phylogeny and other traits, such as host specificity or niche occupancy.	[Rodriguez-Gonzalez, Abril; Antonio Balbuena, Juan] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Sci Pk, Valencia, Spain; [Sarabeev, Volodimir] Zaporizhzhia Natl Univ, Dept Biol, Zhaporizhzhia, Ukraine	University of Valencia; Ministry of Education & Science of Ukraine; Zaporizhzhia National University	Rodriguez-Gonzalez, A (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Marine Zool Unit, Sci Pk, Valencia, Spain.	arogon5@uv.es	Sarabeev, Volodimir/H-9936-2018; Balbuena, Juan Antonio/O-6404-2014	Balbuena, Juan Antonio/0000-0003-4006-1353; Rodriguez Gonzalez, Abril/0000-0002-9940-5299; Sarabeev, Volodimir/0000-0003-4724-3141	Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government; Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Yucatan State, Mexico [204397]; National Plan for Scientific Research, Development and Technological Innovation of Spain [CGL2008-02701]; Generalitat Valenciana, Spain [2015/018]; Ministry of Economy and Competitivity, Spain [CGL2015-71146]; MINECO-FEDER, UE	Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government; Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Yucatan State, Mexico; National Plan for Scientific Research, Development and Technological Innovation of Spain; Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Ministry of Economy and Competitivity, Spain(Spanish Government); MINECO-FEDER, UE(Spanish Government)	A.R.G. benefited from a PhD student grant from the Consejo Nacional de Ciencia y Tecnologia (CONACYT-CONCYTEY) of the Mexican Government and Yucatan State, Mexico (Scholarship No. 204397) www.conacyt.mx, www.siies.yucatan.gob.mx. This study was funded by the National Plan for Scientific Research, Development and Technological Innovation of Spain (CGL2008-02701), http://www.idi.mineco.gob.es/ Generalitat Valenciana, Spain (Prometeo Project 2015/018), www.gva.es and Ministry of Economy and Competitivity, Spain (CGL2015-71146) MINECO-FEDER, UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; [Anonymous], 2014, MODERN PHYLOGENETIC; Armbruster JW, 2016, EVOL ECOL, V30, P435, DOI 10.1007/s10682-015-9811-6; Blasco-Costa I, 2012, PARASITOL INT, V61, P619, DOI 10.1016/j.parint.2012.06.004; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Desdevises Y, 2001, INT J PARASITOL, V31, P205, DOI 10.1016/S0020-7519(00)00163-6; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; EUZET L, 1983, ANN PARASIT HUM COMP, V58, P325, DOI 10.1051/parasite/1983584325; Diniz JAF, 2012, EVOLUTION, V66, P1079, DOI 10.1111/j.1558-5646.2011.01499.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, INFERRING PHYLOGENIE; Froese R, FISHBASE; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Huyse T, 2005, TRENDS PARASITOL, V21, P469, DOI 10.1016/j.pt.2005.08.009; Jarkovsky J, 2004, PARASITOL RES, V92, P95, DOI 10.1007/s00436-003-0993-4; Khang TF, 2016, PEERJ, V4, DOI 10.7717/peerj.1668; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2010, SYST BIOL, V59, P245, DOI 10.1093/sysbio/syp106; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Koehler AV, 2012, EVOL ECOL, V26, P1497, DOI 10.1007/s10682-012-9558-2; Krasnov BR, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P351; Krasnov BR, 2011, ECOGRAPHY, V34, P751, DOI 10.1111/j.1600-0587.2010.06597.x; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Lim LHS, 2009, SYST PARASITOL, V73, P13, DOI 10.1007/s11230-008-9167-1; Liu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12246; Llopis-Belenguer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142365; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; Mallet J, 2010, BIOL PHILOS, V25, P497, DOI 10.1007/s10539-010-9213-7; Mandeng FDM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1181-y; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Morand S, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P1; Mouillot D, 2005, OIKOS, V109, P447, DOI 10.1111/j.0030-1299.2005.13590.x; Mouillot D, 2006, ECOGRAPHY, V29, P596, DOI 10.1111/j.0906-7590.2006.04507.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Poisot T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026252; Pronkina NV, 2010, MORSKY ECOL ZH, V9, P53; R Development Core Team, 2014, R LANG ENV STAT COMP; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Richter S, 2014, J ZOOL SYST EVOL RES, V52, P338, DOI 10.1111/jzs.12061; Rodriguez-Gonzalez A, 2016, PARASITOL RES, V115, P3519, DOI 10.1007/s00436-016-5117-z; Rodriguez-Gonzalez A, 2015, ACTA PARASITOL, V60, P767, DOI 10.1515/ap-2015-0109; Rodriguez-Gonzalez A, 2015, INT J PARASITOL, V45, P295, DOI 10.1016/j.ijpara.2015.01.005; Rohlf FJ, TPS SERIES; Sanfilippo D., 1978, THESIS; Sarabeev V., 2013, Vestnik Zoologii Supplement, V28, P1; Sarabeev V, 2015, PARASITOL INT, V64, P6, DOI 10.1016/j.parint.2015.01.001; Sarabeev V, 2014, PARASITOL INT, V63, P9, DOI 10.1016/j.parint.2013.10.001; Sasal P, 1998, ECOGRAPHY, V21, P639, DOI 10.1111/j.1600-0587.1998.tb00557.x; Timi JT, 2003, J FISH BIOL, V63, P90, DOI 10.1046/j.1095-8649.2003.00131.x; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	58	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178367	10.1371/journal.pone.0178367	http://dx.doi.org/10.1371/journal.pone.0178367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542570	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500083
J	Hao, JX; Meng, TG; Fan, LH; Yao, YQ				Hao, Jian-Xiu; Meng, Tie-Gang; Fan, Li-Hua; Yao, Yuan-Qing			Rac1 is dispensable for oocyte maturation and female fertility in vivo	PLOS ONE			English	Article							MOUSE OOCYTES; MEIOTIC SPINDLE; FERTILIZATION; ORGANIZATION; CYTOKINESIS; SEGREGATION; REQUIRES; DELETION; FORMIN-2; POLARITY	Oocyte maturation, the important process to produce female haploid gamete, accompanies with polarity establishment and highly asymmetric cell division to emit minor polar body within little cytoplasm. Microfilaments play central roles in polarity establishment and asymmetric cell division. Several actin regulators like WASP protein family as well as small GTPases function in microfilament dynamics, involving the process. Rac1, one member of RhoGTPases, has been reported to regulate the polarity and asymmetric cell division in mouse oocytes in vitro. The physiological role of Rac1 in mouse oocyte remains unknown. By conditional knockout technology, we specifically deleted Rac1 gene in mouse oocyte, and found that Rac1 deletion exerted little effect on mouse oocyte maturation including polarity establishment and asymmetric division, and the mutant mice showed normal fertility.	[Hao, Jian-Xiu; Yao, Yuan-Qing] Chinese Peoples Liberat Army, Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Meng, Tie-Gang; Fan, Li-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Meng, Tie-Gang; Fan, Li-Hua] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yao, YQ (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.	yqyao@126.com		YAO, YUANQING/0000-0001-5942-4121	National High technology Research and Development Program(863 Program) of China [2015AA020402]; Key Projiects of Military Medical Research [BWS11J058]	National High technology Research and Development Program(863 Program) of China; Key Projiects of Military Medical Research	This work was supported by the grants of the National High technology Research and Development Program(863 Program) of China, No.2015AA020402 to YYQ, the Key Projiects of Military Medical Research, No.BWS11J058 to YYQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hoff M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001796; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Wang L, 2008, DEV BIOL, V313, P155, DOI 10.1016/j.ydbio.2007.10.009; Wang ZB, 2016, MOL HUM REPROD, V22, P613, DOI 10.1093/molehr/gaw046; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005; Zhong ZS, 2005, MOL REPROD DEV, V71, P256, DOI 10.1002/mrd.20253	19	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177202	10.1371/journal.pone.0177202	http://dx.doi.org/10.1371/journal.pone.0177202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545113	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400028
J	Li, YJ; Dungey, H; Yanchuk, A; Apiolaza, LA				Li, Yongjun; Dungey, Heidi; Yanchuk, Alvin; Apiolaza, Luis A.			Improvement of non-key traits in radiata pine breeding programme when long-term economic importance is uncertain	PLOS ONE			English	Article							GENOMIC SELECTION; WOOD-QUALITY; SILVICULTURAL REGIMES; OBJECTIVES; INDEXES; GROWTH; VALUES; PROFIT; ACCURACY; DIAMETER	Diameter at breast height (DBH), wood density (DEN) and predicted modulus of elasticity (PME) are considered as 'key traits' (KT) in the improvement in radiata pine breeding programmes in New Zealand. Any other traits which are also of interest to radiata pine breeders and forest growers are called 'non-key traits' (NKTs). External resin bleeding (ERB), internal checking (IC), number of heartwood rings (NHR) are three such non-key traits which affect wood quality of radiata pine timber. Economic importance of the KTs and NKTs is hard to define in radiata pine breeding programmes due to long rotation period. Desired-gain index (DGIs) and robust selection were proposed to incorporate NKTs into radiata pine breeding programme in order to deal with the uncertainty of economic importance. Four desired-gain indices A-D were proposed in this study. The desired-gain index A (DGI-A) emphasized growth and led to small decrease in ERB and small increase in IC and NHR. The expected genetic gains of all traits in the desired-gain index B (DGI-B) were in the favourable directions (positive genetic gains in the key traits and negative genetic gains in the non-key traits). The desired-gain index C (DGI-C) placed emphasis on wood density, leading to favourable genetic gain in the NKTs but reduced genetic gains for DBH and PME. The desired-gain index D (DGI-D) exerted a bit more emphasis on the non-key traits, leading large favourable reduction in the non-key traits and lower increase in the key traits compared with the other DGIs. When selecting both the key traits and the non-key traits, the average EBVs of six traits were all in the same directions as the expected genetic gains except for DBH in the DGI-D. When the key traits were measured and selected, internal checking always had a negative (favourable) genetic gain but ERB and NHR had unfavourable genetic gain in the most of time. After removing some individuals with high sensitivity to the change of economic weights, robust desired-gain selection made genetic gains of all the key and non-key traits to move a little bit toward unfavourable directions in the four indices. It is concluded that desired-gain index combined with robust selection concept is an efficient way for selecting the key and non-key traits in radiata pine breeding programmes.	[Li, Yongjun; Dungey, Heidi] Scion, New Zealand Forest Res Inst, Rotorua, New Zealand; [Yanchuk, Alvin] British Columbia Forest Serv, Tree Improvement Branch, Victoria, BC, Canada; [Apiolaza, Luis A.] Univ Canterbury, Coll Engn, Sch Forestry, Christchurch, New Zealand	Scion; University of Canterbury	Li, YJ (corresponding author), Scion, New Zealand Forest Res Inst, Rotorua, New Zealand.	Yongjun.Li@scionresearch.com		Apiolaza, Luis/0000-0003-0958-3540; Dungey, Heidi/0000-0003-2589-3928	Radiata Pine Breeding Company	Radiata Pine Breeding Company	The authors acknowledge the Radiata Pine Breeding Company for providing funding for this manuscript. The funder (the Radiata Pine Breeding Company) provided funding and data for this study and reviewed the manuscript.; The authors would like to acknowledge the Radiata Pine Breeding Company for providing fund and data for this study and reviewing the manuscript, Mari Suontama and Charlie Low for their valuable suggestions and comments.	Apiolaza LA, 2001, CAN J FOREST RES, V31, P654, DOI 10.1139/cjfr-31-4-654; Apiolaza LA, 2001, IUFRO S DEV EUC FUT; Bateson J, 2014, NEW ZEALAND TREE GRO, V2014, P15; Berlin M, 2012, SCAND J FOREST RES, V27, P681, DOI 10.1080/02827581.2012.672586; Berlin M, 2010, SILVA FENN, V44, P643, DOI 10.14214/sf.132; Cheng C, 2007, THE 3RD INTERNATIONA; COTTERILL PP, 1990, SUCCESSFUL TREE BREE; Cown Dave J., 2011, New Zealand Journal of Forestry Science, V41, P41; DEKKERS JCM, 1991, LIVEST PROD SCI, V29, P131, DOI 10.1016/0301-6226(91)90062-U; DEKKERS JCM, 1995, ANIM SCI, V61, P165, DOI 10.1017/S1357729800013667; Dubey M.K., 2010, THESIS; Evison DC, 2015, CAN J FOREST RES, V45, P135, DOI 10.1139/cjfr-2014-0363; Falconer DS, 1996, INTRODUCTION TO QUAN; Francis J. K., 1994, Tree Planters' Notes, V45, P10; GIBSON JP, 1990, THEOR APPL GENET, V80, P801, DOI 10.1007/BF00224195; Gilmour AR, 2009, ASREML USER GUIDE RE; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Greaves B. L., 1997, Forest Genetics, V4, P35; Greaves BL, 1997, FOREST SCI, V43, P465; Hazel LN, 1943, GENETICS, V28, P476; Hazel LN, 1942, J HERED, V33, P393, DOI 10.1093/oxfordjournals.jhered.a105102; Isik F., 2011, BMC P S7, V5, P18, DOI DOI 10.1186/1753-6561-5-S7-I8; Isik F, 2016, PLANT SCI, V242, P108, DOI 10.1016/j.plantsci.2015.08.006; ITOH Y, 1987, GENET SEL EVOL, V19, P69, DOI 10.1186/1297-9686-19-1-69; Ivkovic M, 2006, CAN J FOREST RES, V36, P2920, DOI 10.1139/X06-161; Ceron-Rojas JJ, 2008, J AGR BIOL ENVIR ST, V13, P440, DOI 10.1198/108571108X378911; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kennedy SG, 2014, NEW ZEAL J FOR SCI, V44, DOI 10.1186/s40490-014-0012-9; Kennedy SG, 2013, TREE GENET GENOMES, V9, P1313, DOI 10.1007/s11295-013-0639-3; Koots KR, 1998, CAN J ANIM SCI, V78, P29, DOI 10.4141/A97-038; Kumar S., 2008, New Zealand Journal of Forestry Science, V38, P88; Kumar S, 2008, CAN J FOREST RES, V38, P2372, DOI 10.1139/X08-086; Kumar S, 2004, CAN J FOREST RES, V34, P2601, DOI [10.1139/x04-128, 10.1139/X04-128]; Lee J, 2003, RPBC REPORT 141; Lexer C, 2012, NEW PHYTOL, V196, P652, DOI 10.1111/j.1469-8137.2012.04362.x; Maclaren P, 2002, NEW ZEALAND JOURNAL; Marchal A, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0423-1; Mason Euan, 2012, New Zealand Journal of Forestry, V57, P13; Munoz P., 2012, GENETICS; PONZONI RW, 1989, ANIM PROD, V49, P35, DOI 10.1017/S0003356100004232; PONZONI RW, 1986, J ANIM BREED GENET, V103, P342, DOI 10.1111/j.1439-0388.1986.tb00096.x; Price K, 1997, DR DOBBS J, V22, P18; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Resende M.F.R., 2011, BMC P, V5, pO14, DOI DOI 10.1186/1753-6561-5-S7-014; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; SCHNEEBERGER M, 1992, J ANIM BREED GENET, V109, P180, DOI 10.1111/j.1439-0388.1992.tb00395.x; Shelbourne CJA, 1997, IUFRO 97 GENETICS RA; VANDEPITTE WM, 1977, ANN GENET SEL ANIM, V9, P87, DOI 10.1051/1297-9686-9-1-87; Wu H. X., 2008, New Zealand Journal of Forestry Science, V38, P56; Xie C, 1997, GENET SEL EVOL, V29, P193, DOI 10.1051/gse:19970206; YAMADA Y, 1975, JPN J GENET, V50, P33, DOI 10.1266/jjg.50.33	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177806	10.1371/journal.pone.0177806	http://dx.doi.org/10.1371/journal.pone.0177806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542558	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672400086
J	Zhu, W; Ma, Q; Bian, YY; Zhuang, QY; Xia, ZN; Jin, J; Weng, XS				Zhu, Wei; Ma, Qi; Bian, Yanyan; Zhuang, Qianyu; Xia, Zenan; Jin, Jin; Weng, Xisheng			Total hip/knee arthroplasty in the treatment of tumor-induced osteomalacia patients: More than 1 year follow-up	PLOS ONE			English	Article							RECONSTRUCTION; OUTCOMES	Background Tumor-induced osteomalacia (TIO) may result in a better prognosis after complete resection of the causative neoplasm. However, tumors located proximal to the articular surface of the metaphysis remain largely uninvestigated. Methods A retrospective study of sixteen patients was undertaken to evaluate treatment of tumors with joint arthroplasty and tumor resection. The bone metabolism index, hip/knee joint function, arthroplasty complications and symptoms were followed up for at least 12 months in each patient. Results All patients presented with neoplasms situated in the articular surface of the metaphysis, with 13 cases undergoing hip arthroplasty and 3 undergoing knee arthroplasty. Treatment of the tumors with joint arthroplasty and tumor resection significantly and rapidly ameliorate bone metabolism indexes in patients with TIO (p<0.01), with no identified tumor recurrence. The joint function evaluation score was improved in 15 patients (93.75%). Complications in these patients included post-operative pain, joint squeaking and secondary hyperparathyroidism. Conclusions Joint arthroplasty that includes tumor-expanding resection appears to be a safe and appropriate method for the treatment of TIO patients with a neoplasm located in the metaphysis proximal to the articular surface.	[Jin, Jin; Weng, Xisheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, J; Weng, XS (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing, Peoples R China.	13520072281@163.com; xshweng@medmail.com.cn		Weng, Xisheng/0000-0002-6021-1462				Chong WH, 2011, ENDOCR-RELAT CANCER, V18, pR53, DOI 10.1530/ERC-11-0006; Dadoniene J, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-015-0763-7; Hautmann AH, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/729387; Hautmann AH, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0512-5; Houdek MT, 2016, KNEE, V23, P167, DOI 10.1016/j.knee.2015.08.010; Jiang Y, 2012, J BONE MINER RES, V27, P1967, DOI 10.1002/jbmr.1642; Liu C, 2016, OBES SURG, V26, P91, DOI 10.1007/s11695-015-1724-5; Lopresti M, 2015, CLINICS PRACT, V5, P99, DOI 10.4081/cp.2015.814; Meehan JP, 2011, J BONE JOINT SURG AM, V93A, P2203, DOI 10.2106/JBJS.J.01350; Mullan BP., 2015, TRANSL ENDOCRINOL ME, V7, P1871; Nwachukwu BU, 2015, J ARTHROPLASTY, V30, P1058, DOI 10.1016/j.arth.2015.01.015; Schaser KD, 2014, ORTHOPADE, V43, P92, DOI 10.1007/s00132-013-2133-x; Wang H, 2015, J BONE JOINT SURG AM, V97A, P1084, DOI 10.2106/JBJS.N.01299; Wilken F, 2016, ORTHOPADE, V45, P439, DOI 10.1007/s00132-016-3255-8; Zhang P, 2014, EXP THER MED, V8, P567, DOI 10.3892/etm.2014.1744	15	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177835	10.1371/journal.pone.0177835	http://dx.doi.org/10.1371/journal.pone.0177835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545150	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700088
J	Collins, SL; Welsh, AW; Impey, L; Noble, JA; Stevenson, GN				Collins, Sally L.; Welsh, Alec W.; Impey, Lawrence; Noble, J. Alison; Stevenson, Gordon N.			3D fractional moving blood volume (3D-FMBV) demonstrates decreased first trimester placental vascularity in pre-eclampsia but not the term, small for gestation age baby	PLOS ONE			English	Article							FETAL-GROWTH-RETARDATION; POWER DOPPLER; INDEXES; PREGNANCY	Objective To undertake an observational study to see whether first trimester placental vascularity, measured with a standardized power Doppler index: 3D-FMBV, is different in pregnancies which either develop pre-eclampsia or lead to term, normotensive small for gestational age (SGA) babies. Methods Women were scanned between 11 and 13(+6) weeks. The placental volume (sPlaV) was estimated using our previously validated semi-automated tool. Estimates of 3D-FMBV were generated from the raw power Doppler signal for the whole utero-placental interface, UPI (FMBV-UPI) and 5mm into the placenta (FMBV-IVS). Differences in the placental volume and FMBV for pregnancies developing pre-eclampsia and resulting in term, normotensive SGA babies were compared with term, normotensive, appropriate for gestational age (AGA), controls. Results Results were available for 143 women. The placental volume (sPlaV) was reduced in both pre-eclampsia (p = 0.007) and term, normotensive SGA (p = 0.001) when compared with term normotensive AGA controls. 3D-FMBV estimates were significantly lower for pregnancies developing pre-eclampsia (FMBV-UPI, p = 0.03, FMBV-IVS, p = 0.01) but not for the normotensive SGA pregnancies (FMBV-UPI, p = 0.16, FMBV-IVS, p = 0.27). Conclusion Pregnancies destined to develop pre-eclampsia are more likely to have small placentas with significantly reduced vascularity at 11-13 weeks. Those pregnancies which were normotensive throughout but resulted in an SGA baby delivered at term, had significantly smaller placentas but with similar vascularity to normotensive AGA pregnancies.	[Collins, Sally L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Collins, Sally L.; Impey, Lawrence] John Radcliffe Hosp, Fetal Med Unit, Oxford, England; [Welsh, Alec W.; Stevenson, Gordon N.] Univ New South Wales, Sch Womens & Childrens Hlth, Randwick, NSW, Australia; [Welsh, Alec W.] Royal Hosp Women, Dept Maternal Fetal Med, Randwick, NSW, Australia; [Noble, J. Alison] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford, England	University of Oxford; University of Oxford; University of New South Wales Sydney; University of Oxford	Collins, SL (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.; Collins, SL (corresponding author), John Radcliffe Hosp, Fetal Med Unit, Oxford, England.	sally.collins@obs-gyn.ox.ac.uk	Stevenson, Gordon/B-6352-2017	Stevenson, Gordon/0000-0002-2809-8084; Collins, Sally/0000-0002-0648-7433; Noble, Alison/0000-0002-3060-3772	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health [U01 HD 087209]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres funding scheme; UNSW, Sydney; NIH; NIHR; Lesley Stevens Fund	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); UNSW, Sydney; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR(National Institute for Health Research (NIHR)); Lesley Stevens Fund	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Human Placenta Project of the National Institutes of Health under award number U01 HD 087209, the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health NIHR Biomedical Research Centres funding scheme and the Lesley Stevens Fund, UNSW, Sydney. SC and GS are supported by NIH and NIHR funding. GS is supported by the Lesley Stevens Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar JL, 2008, ULTRASOUND OBST GYN, V32, P485, DOI 10.1002/uog.6144; Bayliss H, 2002, HYPERTENS PREGNANCY, V21, P161, DOI 10.1081/PRG-120013785; BROSENS I, 1977, BRIT J OBSTET GYNAEC, V84, P656; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Collins S, 2011, DEV PLACENTAL ULTRAS; Collins SL, 2012, ULTRASOUND OBST GYN, V40, P171, DOI 10.1002/uog.10149; Collins SL, 2012, ULTRASOUND OBST GYN, V40, P75, DOI 10.1002/uog.10122; Collins SL, 2013, ULTRASOUND MED BIOL, V39, P253, DOI 10.1016/j.ultrasmedbio.2012.09.003; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DEWOLF F, 1980, BRIT J OBSTET GYNAEC, V87, P678; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Figueras F, 2008, BJOG, V2008, P590; Figueras F, 2007, ARCH DIS CHILD-FETAL, V92, P277, DOI 10.1136/adc.2006.108621; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Gardosi J, 2009, AM J OBSTET GYNECOL, V201, pe1, DOI DOI 10.1016/J.AJ0G.2009.04.034; Gardosi J, 2011, PAEDIATR PERINAT EP, V25, P2, DOI 10.1111/j.1365-3016.2010.01166.x; Hernandez-Andrade E, 2004, ULTRASOUND OBST GYN, V23, P363, DOI 10.1002/uog.1002; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Loughna P, 2009, ULTRASOUND, V17, P160, DOI 10.1179/174313409X448543; Martins WP, 2010, ULTRASOUND OBST GYN, V36, P530, DOI 10.1002/uog.8836; McCowan LME, 2000, BRIT J OBSTET GYNAEC, V107, P916, DOI 10.1111/j.1471-0528.2000.tb11092.x; Mone F, 2016, CONT CLIN TRIALS; Moodley J, 2004, J Obstet Gynaecol, V24, P742; Narchi H, 2010, J MATERN-FETAL NEO M, V23, P48, DOI 10.3109/14767050903067352; O'Gorman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011801; Rubin JM, 1997, RADIOLOGY, V205, P757, DOI 10.1148/radiology.205.3.9393532; RUBIN JM, 1995, RADIOLOGY, V197, P183, DOI 10.1148/radiology.197.1.7568820; Severi FM, 2002, ULTRASOUND OBST GYN, V19, P225, DOI 10.1046/j.1469-0705.2002.00652.x; Stevenson GN, 2015, ULTRASOUND IN PRESS; Stevenson GN, 2015, RADIOLOGY, V274, P230, DOI 10.1148/radiol.14132363; Welsh AW, 2008, ULTRASOUND OBST GYN, V31, P111, DOI 10.1002/uog.5203; Welsh AW, 2013, ULTRASOUND OBST GYN, V41, P473, DOI 10.1002/uog.12441; Welsh AW., 2008, ULTRASOUND OBST GYN, V31, P2	36	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178675	10.1371/journal.pone.0178675	http://dx.doi.org/10.1371/journal.pone.0178675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570600	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800098
J	Lutfi, E; Babin, PJ; Gutierrez, J; Capilla, E; Navarro, I				Lutfi, Esmail; Babin, Patrick J.; Gutierrez, Joaquim; Capilla, Encarnacion; Navarro, Isabel			Caffeic acid and hydroxytyrosol have anti-obesogenic properties in zebrafish and rainbow trout models	PLOS ONE			English	Article							SUPPRESSES LIPID-ACCUMULATION; REGULATING EARLY ADIPOGENESIS; DIET-INDUCED OBESITY; CELL-CYCLE; ADIPOCYTE DIFFERENTIATION; ANTIOXIDANT ACTIVITY; ANATOMICAL FEATURES; INCREASED ADIPOSITY; ADEQUATE CHOICE; GENE-EXPRESSION	Some natural products, known sources of bioactive compounds with a wide range of properties, may have therapeutic values in human health and diseases, as well as agronomic applications. The effect of three compounds of plant origin with well-known dietary antioxidant properties, astaxanthin (ATX), caffeic acid (CA) and hydroxytyrosol (HT), on zebrafish (Danio rerio) larval adiposity and rainbow trout (Onchorynchus mykiss) adipocytes was assessed. The zebrafish obesogenic test (ZOT) demonstrated the anti-obesogenic activity of CA and HT. These compounds were able to counteract the obesogenic effect produced by the peroxisome proliferator-activated receptor gamma (PPAR.) agonist, rosiglitazone (RGZ). CA and HT suppressed RGZ-increased PPAR. protein expression and lipid accumulation in primary-cultured rainbow trout adipocytes. HT also significantly reduced plasma triacylglycerol concentrations, as well as mRNA levels of the fasn adipogenic gene in the adipose tissue of HT-injected rainbow trout. In conclusion, in vitro and in vivo approaches demonstrated the anti-obesogenic potential of CA and HT on teleost fish models that may be relevant for studying their molecular mode of action. Further studies are required to evaluate the effect of these bioactive components as food supplements for modulating adiposity in farmed fish.	[Lutfi, Esmail; Gutierrez, Joaquim; Capilla, Encarnacion; Navarro, Isabel] Univ Barcelona, Dept Cell Biol Physiol & Immunol, Fac Biol, Barcelona, Spain; [Babin, Patrick J.] Univ Bordeaux, INSERM, U12211, MRGM, Pessac, France	University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Navarro, I (corresponding author), Univ Barcelona, Dept Cell Biol Physiol & Immunol, Fac Biol, Barcelona, Spain.; Babin, PJ (corresponding author), Univ Bordeaux, INSERM, U12211, MRGM, Pessac, France.	p.babin@gpp.u-bordeaux1.fr; mnavarro@ub.edu	Gutierrez, Joaquim/H-2836-2015; Lutfi, Esmail/J-3529-2017; Capilla, Encarnación/L-6143-2014; NAVARRO ALVAREZ, ISABEL/L-9318-2014	Gutierrez, Joaquim/0000-0002-3126-2236; Lutfi, Esmail/0000-0002-0208-9075; Capilla, Encarnación/0000-0002-0863-9728; Babin, Patrick/0000-0002-7411-2297; NAVARRO ALVAREZ, ISABEL/0000-0002-2641-0361	Spanish Ministerio de Economia y Competitividad [AGL2011-24961, AGL2014-57974-R]; Government of Catalunya [2014SGR-01371]; Conseil Regional d'Aquitaine [200881301031]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Government of Catalunya; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (AGL2011-24961, AGL2014-57974-R) to I.N. and E.C.; the Government of Catalunya (2014SGR-01371) to J.G; and the Conseil Regional d'Aquitaine (200881301031/TOD project) to PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (AGL2011-24961, AGL2014-57974-R) and the Government of Catalunya (2014SGR-01371) to I.N. This work was supported by a Conseil Regional d'Aquitaine grant (200881301031/TOD project) to P.J.B.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Andrade-Oliveira V, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/681612; Arunkumar E, 2012, FOOD FUNCT, V3, P120, DOI 10.1039/c1fo10161g; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; BABIN PJ, 1989, J LIPID RES, V30, P467; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Bluher M, 2013, BEST PRACT RES CL EN, V27, P163, DOI 10.1016/j.beem.2013.02.005; Bou M, 2016, BBA-GEN SUBJECTS, V1860, P86, DOI 10.1016/j.bbagen.2015.10.022; Bou M, 2014, GEN COMP ENDOCR, V205, P218, DOI 10.1016/j.ygcen.2014.05.005; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Caro M, 2016, FOOD FUNCT, V7, P2615, DOI [10.1039/c6fo00046k, 10.1039/C6FO00046K]; Celi Francesco S, 2002, Curr Diab Rep, V2, P179, DOI 10.1007/s11892-002-0078-2; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Choi HS, 2015, MOL NUTR FOOD RES, V59, P1458, DOI 10.1002/mnfr.201500021; Choi HS, 2014, BIOCHIMIE, V104, P127, DOI 10.1016/j.biochi.2014.06.010; D'Angelo L, 2016, ANN ANAT, V205, P75, DOI 10.1016/j.aanat.2016.02.001; Den Broeder MJ, 2015, PPAR RES, V2015, DOI 10.1155/2015/358029; Drira R, 2014, EUR J NUTR, V53, P743, DOI 10.1007/s00394-013-0578-7; Drira R, 2013, BIOCHEM BIOPH RES CO, V440, P576, DOI 10.1016/j.bbrc.2013.09.106; Drira R, 2011, LIFE SCI, V89, P708, DOI 10.1016/j.lfs.2011.08.012; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; Gordon MH, 2001, J AGR FOOD CHEM, V49, P2480, DOI 10.1021/jf000537w; Grun F, 2006, ENDOCRINOLOGY, V147, pS50, DOI 10.1210/en.2005-1129; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Gulcin I, 2006, TOXICOLOGY, V217, P213, DOI 10.1016/j.tox.2005.09.011; Gutierrez VR, 2001, MOL CELL BIOCHEM, V217, P35, DOI 10.1023/A:1007219931090; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; Huang CC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1077-1; Hussein Z, 2004, MED J AUSTRALIA, V181, P536, DOI 10.5694/j.1326-5377.2004.tb06441.x; Ikeuchi M, 2007, BIOSCI BIOTECH BIOCH, V71, P893, DOI 10.1271/bbb.60521; Imrie D, 2010, DEV DYNAM, V239, P3013, DOI 10.1002/dvdy.22443; Inoue M, 2012, BIOCHEM PHARMACOL, V84, P692, DOI 10.1016/j.bcp.2012.05.021; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Jeon HJ, 2015, MOLECULES, V20, P21715, DOI 10.3390/molecules201219796; Johansson M, 2016, J COMP PHYSIOL B, V186, P759, DOI 10.1007/s00360-016-0988-y; Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163; Kim JH, 2016, BIOCHEM BIOPH RES CO, V469, P646, DOI 10.1016/j.bbrc.2015.12.049; Lee J-E, 2014, BIOMED CENTRAL, V4, P29; Lee YJ, 2015, FOOD FUNCT, V6, P2824, DOI 10.1039/c5fo00481k; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Liao CC, 2013, J AGR FOOD CHEM, V61, P11082, DOI 10.1021/jf4026647; Lossi L, 2016, ANN ANAT, V204, P11, DOI 10.1016/j.aanat.2015.10.002; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; McMenamin SK, 2013, ENDOCRINOLOGY, V154, P1476, DOI 10.1210/en.2012-1734; Meguro S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120142; Minchin JEN, 2015, P NATL ACAD SCI USA, V112, P4363, DOI 10.1073/pnas.1416412112; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Naguib YMA, 2000, J AGR FOOD CHEM, V48, P1150, DOI 10.1021/jf991106k; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Olesen KM, 2005, J NEUROENDOCRINOL, V17, P255, DOI 10.1111/j.1365-2826.2005.01302.x; Ouadah-Boussouf N, 2016, TOXICOL APPL PHARM, V294, P32, DOI 10.1016/j.taap.2016.01.014; Pandita A, 2016, DIABET METAB SYND OB, V9, P83, DOI 10.2147/DMSO.S90783; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pignatelli J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110920; Res PT, 2013, MED SCI SPORT EXER, V45, P1158, DOI 10.1249/MSS.0b013e31827fddc4; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sadowska-Bartosz I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404680; Salmeron C, 2015, COMP BIOCHEM PHYS A, V188, P40, DOI 10.1016/j.cbpa.2015.06.017; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Samdani P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12340; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Santoro MM, 2014, TRENDS ENDOCRIN MET, V25, P546, DOI 10.1016/j.tem.2014.06.003; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Seo MJ, 2014, FOOD CHEM TOXICOL, V67, P57, DOI 10.1016/j.fct.2014.02.009; Seth A, 2013, DIS MODEL MECH, V6, P1080, DOI 10.1242/dmm.011346; Siraj FM, 2015, J GINSENG RES, V39, P141, DOI 10.1016/j.jgr.2014.10.002; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Suh HJ, 2015, CHEM-BIOL INTERACT, V227, P53, DOI 10.1016/j.cbi.2014.12.027; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tingaud-Sequeira A, 2011, J LIPID RES, V52, P1765, DOI 10.1194/jlr.D017012; Tutino V, 2016, J CELL PHYSIOL, V231, P483, DOI 10.1002/jcp.25094; Vanella L, 2016, PPAR RES, V2016, DOI 10.1155/2016/7359521; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Velez EJ, 2017, AM J PHYSIOL-REG I, V312, pR643, DOI 10.1152/ajpregu.00308.2016; Velez EJ, 2014, GEN COMP ENDOCR, V205, P296, DOI 10.1016/j.ygcen.2014.05.024; Wang LM, 2014, BIOCHEM PHARMACOL, V92, P73, DOI 10.1016/j.bcp.2014.07.018; Woo MS, 2015, PHYTOTHER RES, V29, P398, DOI 10.1002/ptr.5264; Yada T, 2002, GEN COMP ENDOCR, V128, P36, DOI 10.1016/S0016-6480(02)00047-3	81	10	12	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178833	10.1371/journal.pone.0178833	http://dx.doi.org/10.1371/journal.pone.0178833			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570659	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800124
J	Mendonca, MA; Araujo, WMC; Borgo, LA; Alencar, ED				Mendonca, Marcio Antonio; Coelho Araujo, Wilma Maria; Borgo, Luiz Antonio; Alencar, Ernandes de Rodrigues			Lipid profile of different infant formulas for infants	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; HUMAN-MILK; PRETERM INFANTS; BREAST-MILK; OMEGA-3-FATTY-ACIDS; PASTEURIZATION; BRAIN; WOMEN; TERM	Situations including premature infants, or those in which there is a rejection to breastfeeding, require the use infant formulas for total or partial replacement of human milk. The objective of this study was to determine the lipid content and to identify the lipid profile of infant formulas. Samples were collected from ten different infant formulas, used as a substitute for breast milk at the Maternal and Child Hospital of Brasilia. The human milk sample consisted of a pool of samples from 10 mature milk donors at the milk bank of the University Hospital of Brasilia. The lipid content and lipid profile of the different infant formulas and human milk were analyzed. The experiment was conducted in a randomized block design, with eleven treatments and three replicates, in triplicate. The data obtained in this study indicated significant differences between infant formulas and human milk, and among the infant formulas analyzed in relation to the percentage of total lipids and the fatty acid profile, except for the fractions of linoleic acid and linolenic acid. Regarding the percentage of polyunsaturated fatty acids in relation to the total unsaturated fatty acids, only the Soy Protein Isolate-based Infant Formula (SPIIF) and Whey Protein Extensively Hydrolyzed Infant Formula (WPEHIF) resembled human milk. It was concluded that despite the observed differences, the use of infant formulas is a viable strategy for the development of infants subjected or not to specific physiological conditions.	[Mendonca, Marcio Antonio; Borgo, Luiz Antonio; Alencar, Ernandes de Rodrigues] Univ Brasilia, Fac Agron & Vet Med, Brasilia, DF, Brazil; [Coelho Araujo, Wilma Maria] Univ Brasilia, Coll Hlth Sci, Dept Nutr, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Mendonca, MA (corresponding author), Univ Brasilia, Fac Agron & Vet Med, Brasilia, DF, Brazil.	marcioamen@gmail.com	de Alencar, Ernandes Rodrigues/A-7483-2018; Alencar, Ernandes/T-4159-2019	de Alencar, Ernandes Rodrigues/0000-0003-4288-4097; Alencar, Ernandes/0000-0003-4288-4097; Coelho Araujo, Wilma Maria/0000-0001-5549-3568				Alan F, 1980, DETERMINACAO TEOR GO, P03; AOAC, 2005, AOAC OFFICIAL METHOD, V18th ed.; Tinoco SMB, 2007, CAD SAUDE PUBLICA, V23, P525, DOI 10.1590/S0102-311X2007000300011; BELDA M. C. R., 1991, CIENCIA TECNOLOGIA A, V11, P5; BITMAN J, 1983, AM J CLIN NUTR, V38, P300, DOI 10.1093/ajcn/38.2.300; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgo LA, 2015, NUTR HOSP, V31, P1386, DOI 10.3305/nh.2015.31.3.8120; Carlson SE, 1997, AM J CLIN NUTR, V66, P717; Carver JD, 2003, AM J CLIN NUTR, V77, p1550S, DOI 10.1093/ajcn/77.6.1550S; Christie W., 1989, GAS CHROMATOGRAPHY L; Christie WW, FATTY ACIDS METHYLEN; Costa CE, 1998, REV SAUDE PUBL, V32, P328, DOI 10.1590/S0034-89101998000400004; Magalhes MSF, 2008, ACTA CIR BRAS, V23, P262, DOI 10.1590/S0102-86502008000300009; Ferreira CEC., 1990, THESIS; Fidler N, 1998, J PEDIATR GASTR NUTR, V27, P317, DOI 10.1097/00005176-199809000-00009; GARTON GA, 1963, J LIPID RES, V4, P237; HALL B, 1979, AM J CLIN NUTR, V32, P304, DOI 10.1093/ajcn/32.2.304; HYLANDER MA, 1995, PEDIATR RES, V37, pA214; IAL, 2005, PHYS CHEM METH FOOD; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; JENSEN RG, 1990, J DAIRY SCI, V73, P223, DOI 10.3168/jds.S0022-0302(90)78666-3; Koletzko B, 2005, J PEDIATR GASTR NUTR, V41, P584, DOI 10.1097/01.mpg.0000187817.38836.42; Koletzko B, 2003, EUR J NUTR, V42, P243, DOI 10.1007/s00394-003-0418-2; Koletzko B, 2001, EARLY HUM DEV, V65, pS3, DOI 10.1016/S0378-3782(01)00204-3; Kus MMM, 2010, FUNCOES PLENAMENTE R; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lira BF., 2002, THESIS; Long A. C., 2013, Lipid Technology, V25, P127, DOI 10.1002/lite.201300279; Lopez-Lopez A, 2002, EUR J CLIN NUTR, V56, P1242, DOI 10.1038/sj.ejcn.1601470; Lopez-Lopez A, 2001, EARLY HUM DEV, V65, pS83, DOI 10.1016/S0378-3782(01)00210-9; Kus MMM, 2011, REV NUTR, V24, P209, DOI 10.1590/S1415-52732011000200002; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Oleynik A., 2013, The Open Nutrition Journal, V7, P26, DOI 10.2174/1874288220131127003; Rego C, 2013, ACTA PEDIAT PORT, V44, pS50; Riva E, 2007, J INT MED RES, V35, P20, DOI 10.1177/147323000703500102; Santos RD, 2012, ARQ BRAS CARDIOL, V99, P1, DOI [10.5935/abc.20120202, 10.1590/S0066-782X2013000900001]; Sarkar S, 2004, J NUTR FOOD SCI, V34, P151; Silva Deila Regina Bentes da, 2007, Rev. Bras. Saude Mater. Infant., V7, P123, DOI 10.1590/S1519-38292007000200002; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Sinclair R., 2000, Nutrition & Food Science, V30, P178, DOI 10.1108/00346650010330207; Straarup EM, 2006, J PEDIATR GASTR NUTR, V42, P293, DOI 10.1097/01.mpg.0000214155.51036.4f; Thompkinson DK, 2007, COMPR REV FOOD SCI F, V6, P79, DOI 10.1111/j.1541-4337.2007.00020.x; UAUY R, 1990, J PEDIATR GASTR NUTR, V11, P296, DOI 10.1097/00005176-199010000-00002; USDA-United States Department of Agriculture, 2009, FOOD NUTR SERV SPEC, P81; Costa AGV, 2010, REV NUTR, V23, P445, DOI 10.1590/S1415-52732010000300012; Villalpando S, 1995, ARCH MED RES, V26, pS139; von Schacky C, 2004, CURR OPIN CLIN NUTR, V7, P131, DOI 10.1097/00075197-200403000-00005; Yamawaki N, 2005, J TRACE ELEM MED BIO, V19, P171, DOI 10.1016/j.jtemb.2005.05.001; Zambiazi R. C., 2007, Boletim do Centro de Pesquisa e Processamento de Alimentos, V25, P111; Zunin P, 2015, FOOD CHEM, V173, P332, DOI 10.1016/j.foodchem.2014.10.014	50	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177812	10.1371/journal.pone.0177812	http://dx.doi.org/10.1371/journal.pone.0177812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570611	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800017
J	Michelsen, SW; Soborg, B; Diaz, LJ; Hoff, ST; Agger, EM; Koch, A; Rosenkrands, I; Wohlfahrt, J; Melbye, M				Michelsen, Sascha Wilk; Soborg, Bolette; Diaz, Lars Jorge; Hoff, Soren Tetens; Agger, Else Marie; Koch, Anders; Rosenkrands, Ida; Wohlfahrt, Jan; Melbye, Mads			The dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders	PLOS ONE			English	Article							T-CELL RESPONSES; INTERFERON-GAMMA; ANTIGENS; VACCINE; VIRULENCE; SYSTEM; INDIVIDUALS; PERSISTENCE; SECRETION; CANDIDATE	Objective Understanding human immunity to Mycobacterium tuberculosis (Mtb) during different stages of infection is important for development of an effective tuberculosis (TB) vaccine. We aimed to evaluate immunity to Mtb infection by measuring immune responses to selected Mtb antigens expressed during different stages of infection over time and to observe sustainability of immunity. Methods In a cohort study comprising East Greenlanders aged 17-22 years (2012 to 2014) who had either; undetectable Mtb infection, ongoing or prior Mtb infection at enrolment, we measured immunity to 15 antigens over a one-year period. Quantiferon-TB Gold testing (QFT) defined Mtb infection status (undetected/detected). The eligible study population of East Greenlanders aged 17-22 years was identified from the entire population using the Civil Registration System. From the source population 65 participants were selected by stratified random sampling according to information on Mtb infection stage. Retrospective and prospective information on notified TB (including treatment) was obtained through the mandatory TB notification system and was used to characterise Mtb infection stage (ongoing/prior). Immunity to 15 antigens including two QFT antigens, PPD and 12 non-QFT antigens (representing early, constitutive and latent Mtb infection) was assessed by measuring immune responses using whole-blood antigen stimulation and interferon gamma measurement. Results Of 65 participants, 54 were considered Mtb-infected. Immunity to Mtb infection fluctuated with high annual risk of conversion (range: 6-69%) and reversion (range: 5-95%). During follow-up, five (8%) participants were notified with TB; neither conversion nor reversion was associated with an increased risk of progressing to TB. Conclusions Our findings suggest that human immunity to natural Mtb infection over time is versatile with fluctuations, resulting in high levels of conversion and reversion of immunity, thus human immunity to Mtb is much more dynamic than anticipated. The study findings suggest future use of longitudinal assessment of immune responses when searching for TB vaccine candidate antigens.	[Michelsen, Sascha Wilk; Soborg, Bolette; Diaz, Lars Jorge; Koch, Anders; Wohlfahrt, Jan; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Michelsen, Sascha Wilk; Hoff, Soren Tetens; Agger, Else Marie; Rosenkrands, Ida] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA	Statens Serum Institut; Statens Serum Institut; University of Copenhagen; Stanford University	Michelsen, SW (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.; Michelsen, SW (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark.	swm@ssi.dk		Diaz, Lars/0000-0002-5853-721X; Koch, Anders/0000-0001-9205-1048; Michelsen, Sascha Wilk/0000-0002-6499-8581; melbye, mads/0000-0001-8264-6785	Commission for Scientific Research in Greenland; Danish research Council; Rosalie Petersen's Foundation; Ebba Celinders Legat; Aase og Ejnar Danielsens Foundation; Dagmar Marshalls Foundation; Christian X Foundation; A.P. Moeller Foundation for the Advancement of Medical Science; Danish Lung Association; Sundhedspuljen Greenland Self Government; Forskningspuljen Greenland Self-Government; European Commission [TBVAC2020, H2020-PHC2014-2015-643381]	Commission for Scientific Research in Greenland; Danish research Council(Det Frie Forskningsrad (DFF)); Rosalie Petersen's Foundation; Ebba Celinders Legat; Aase og Ejnar Danielsens Foundation; Dagmar Marshalls Foundation; Christian X Foundation; A.P. Moeller Foundation for the Advancement of Medical Science; Danish Lung Association; Sundhedspuljen Greenland Self Government; Forskningspuljen Greenland Self-Government; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the following funding sources: The Commission for Scientific Research in Greenland (SWM), http://ufm.dk/forskning-og-innovation/tilskud-til-forskning-og-innovation/hvem-har-modtaget-tilskud/2012/ph-d-stipendier-stottet-af- kvug-2011; The Danish research Council (SWM, MM), http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research; Rosalie Petersen's Foundation (BS), Ebba Celinders Legat (SWM), Aase og Ejnar Danielsens Foundation (SWM), www.danielsensfond.dk; Dagmar Marshalls Foundation (SWM); The 17.12.1981 Foundation (SWM), http://www.fondenaf17121981.dk/; Christian X Foundation (SWM), http://kongehuset.dk/node/5556; The A.P. Moeller Foundation for the Advancement of Medical Science (SWM), www.apmollerfonde.dk/; The Danish Lung Association (SWM), https://www.lunge.dk/: Sundhedspuljen Greenland Self Government (SWM), http://naalakkersuisut.gl/da/Naalakkersuisut/Departementer/Sundhed/Forskdingsstoette-Sunahedspuljen; Forskningspuljen Greenland Self-Government (SWM). Else Marie Agger was supported by a grant from the European Commission through the TBVAC2020 consortium contract H2020-PHC2014-2015-643381. The sponsors played no role in the study design; the collection, analysis or interpretation of data, the writing of the report; or in the decision to submit the manuscript for publication.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; Amor YB, 2005, SCAND J IMMUNOL, V61, P139, DOI 10.1111/j.0300-9475.2005.01557.x; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Belay M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124134; Benaglia T, 2009, J STAT SOFTW, V32, P1; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhat KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052601; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Cellestis a QIAGEN Company, 2013, QUANTIFERON TB GOLD, P1; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chen JM, 2012, J BACTERIOL, V194, P884, DOI 10.1128/JB.06417-11; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Demster A, 1977, J ROYAL STAT SOC B, V39, P1; Dillon DC, 1999, INFECT IMMUN, V67, P2941, DOI 10.1128/IAI.67.6.2941-2950.1999; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2015, IMMUNOL REV, V264, P60, DOI 10.1111/imr.12258; Geluk A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00256; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14; Huygen K, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00321; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kremer L, 2001, J BIOL CHEM, V276, P27967, DOI 10.1074/jbc.M103687200; Legesse M, 2013, SCAND J IMMUNOL, V78, P266, DOI 10.1111/sji.12080; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002; Michelsen SW, 2014, THORAX, V69, P851, DOI 10.1136/thoraxjnl-2014-205688; Michelsen SW, 2016, VACCINE, V34, P5975, DOI 10.1016/j.vaccine.2016.09.047; Millington KA, 2010, J INFECT DIS, V202, P1685, DOI 10.1086/656772; Modlin RL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007402; Mukherjee P, 2007, CLIN MICROBIOL INFEC, V13, P146, DOI 10.1111/j.1469-0691.2006.01660.x; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Owens CP., 2012, BIOCHEMISTRY-US, V29, P997; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pedersen CB, 2006, DAN MED BULL, V53, P441; Penn-Nicholson A, 2015, TUBERCULOSIS, P6; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Ravindran R, 2014, J MED PRIMATOL, V43, P59, DOI 10.1111/jmp.12097; The National Board of Health in Greenland, 2012, NAT TB STRAT 2012 20; Tiwari B, 2014, FEBS J, V281, P1556, DOI 10.1111/febs.12723; Torres M, 2015, EUR RESPIR J, V45, P473, DOI 10.1183/09031936.00123314; World Health Organization, 2014, GLOB TUB REP	51	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177906	10.1371/journal.pone.0177906	http://dx.doi.org/10.1371/journal.pone.0177906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570574	Green Published, gold			2022-12-26	WOS:000402611800021
J	Planton, M; Saint-Aubert, L; Raposo, N; Branchu, L; Lyoubi, A; Bonneville, F; Albucher, JF; Olivot, JM; Peran, P; Pariente, J				Planton, Melanie; Saint-Aubert, Laure; Raposo, Nicolas; Branchu, Laura; Lyoubi, Aicha; Bonneville, Fabrice; Albucher, Jean-Francois; Olivot, Jean-Marc; Peran, Patrice; Pariente, Jeremie			High prevalence of cognitive impairment after intracerebral hemorrhage	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; SMALL VESSEL DISEASE; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; ASSESSMENTS; DEMENTIA	Background Cognitive impairment seems to be frequent in intracerebral hemorrhage (ICH) survivors, but remains widely understudied. In this study, we investigated the frequency and patterns of vascular cognitive disorders (VCDs) in patients with cerebral amyloid angiopathy (CAA)-related and deep ICH compared to patients with mild cognitive impairment due to Alzheimer's disease (MCI-AD) and healthy controls. Methods We prospectively recruited 20 patients with CAA-related lobar ICH, 20 with deep ICH, 20 with MCI-AD and 17 healthy controls. Patients with cognitive decline pre-ICH were excluded from the analysis. Each participant underwent a comprehensive neuropsychological assessment and a structural brain MRI. Cognitive assessment was performed at a median delay of 4 months after the acute phase in ICH patients, and more than 6 months after the first complaint in MCI-AD patients. Cognitive profiles were compared between groups. The prevalence of VCDs in the ICH groups was estimated using the recent VASCOG criteria. Results "Mild" and "major VCDs" were respectively observed in 87.5% and 2.5% of all ICH patients. Every patient in the CAA group had mild VCDs. No significant difference was observed in cognitive functioning between CAA-related and deep ICH patients. The most impaired process in the CAA group was naming, with a mean (+/- standard deviation) z-score of -5.2 +/- 5.5, followed by processing speed (-4.1 +/- 3.3), executive functioning (-2.6 +/- 2.5), memory (-2.4 +/- 3.5) and attention (-0.9 +/- 1.3). This cognitive pattern was different from the MCI-AD patients, but the groups were only different in gestural praxis, and by construction, in memory processes. Conclusions VCDs are frequent after ICH. Cognitive patterns of patients with deep or CAA-related ICH did not differ, but there was impaired performance in specific domains distinct from the effects of Alzheimer's disease.	[Planton, Melanie; Raposo, Nicolas; Albucher, Jean-Francois; Olivot, Jean-Marc; Pariente, Jeremie] Toulouse Univ Hosp, Dept Neurol, Toulouse, France; [Planton, Melanie; Raposo, Nicolas; Branchu, Laura; Bonneville, Fabrice; Albucher, Jean-Francois; Olivot, Jean-Marc; Peran, Patrice; Pariente, Jeremie] Univ Toulouse, INSERM, UPS, Toulouse NeuroImaging Ctr, Toulouse, France; [Saint-Aubert, Laure] Karolinska Inst, Div Translat Alzheimer Neurobiol, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, Stockholm, Sweden; [Lyoubi, Aicha] Grp Hosp Lariboisiere Fernand Widal, AP HP, Dept Neurol, Paris, France; [Bonneville, Fabrice] Toulouse Univ Hosp, Dept Neuroradiol, Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Planton, M (corresponding author), Toulouse Univ Hosp, Dept Neurol, Toulouse, France.; Planton, M (corresponding author), Univ Toulouse, INSERM, UPS, Toulouse NeuroImaging Ctr, Toulouse, France.	melanie.planton@inserm.fr	Peran, Patrice/N-7561-2015	Peran, Patrice/0000-0001-7200-0139	Toulouse Teaching Hospital grant from the Agence Nationale de la Recherche [ANR-08-JCJC-0040]; "Institut des Sciences et du Cerveau de Toulouse"; CHU Toulouse	Toulouse Teaching Hospital grant from the Agence Nationale de la Recherche(French National Research Agency (ANR)); "Institut des Sciences et du Cerveau de Toulouse"; CHU Toulouse	This study was funded by Toulouse Teaching Hospital (local grant 2007, local grant 2011) a grant from the Agence Nationale de la Recherche (ANR-08-JCJC-0040), and the "Institut des Sciences et du Cerveau de Toulouse". This work was supported by CHU Toulouse for regulatory and ethical approval and compliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitakis Z, 2011, ANN NEUROL, V69, P320, DOI 10.1002/ana.22112; Baykara E, 2016, ANN NEUROL, V80, P581, DOI 10.1002/ana.24758; Biffi A, 2016, JAMA NEUROL, V73, P969, DOI 10.1001/jamaneurol.2016.0955; Case NF, 2016, STROKE, V47, P2010, DOI 10.1161/STROKEAHA.116.012999; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Crosson B, 2013, BRAIN LANG, V126, P73, DOI 10.1016/j.bandl.2012.06.011; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Danet L, 2015, NEUROLOGY, V85, P2107, DOI 10.1212/WNL.0000000000002226; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FUH JL, 1995, CLIN NEUROL NEUROSUR, V97, P296, DOI 10.1016/0303-8467(95)00059-S; Godefroy O, 2014, CORTEX, V54, P51, DOI 10.1016/j.cortex.2014.01.016; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Moulin S, 2016, LANCET NEUROL, V15, P820, DOI 10.1016/S1474-4422(16)00130-7; Planton M, 2011, EUROPEAN J NEUROLOGY, V19, P212; Reijmer YD, 2016, STROKE, V47, P2470, DOI 10.1161/STROKEAHA.116.014337; Reijmer YD, 2015, BRAIN, V138, P179, DOI 10.1093/brain/awu316; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Saint-Aubert L, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-43; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Xiong L, 2016, J ALZHEIMERS DIS, P1	25	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178886	10.1371/journal.pone.0178886	http://dx.doi.org/10.1371/journal.pone.0178886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570698	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800133
J	Schut, MH; Patassini, S; Kim, EH; Bullock, J; Waldvogel, HJ; Faull, RLM; Pepers, BA; den Dunnen, JT; van Ommen, GJB; van Roon-Mom, WMC				Schut, Menno H.; Patassini, Stefano; Kim, Eric H.; Bullock, Jocelyn; Waldvogel, Henry J.; Faull, Richard L. M.; Pepers, Barry A.; den Dunnen, Johan T.; van Ommen, Gert-Jan B.; van Roon-Mom, Willeke M. C.			Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates	PLOS ONE			English	Article							MUTANT HUNTINGTIN; MOUSE MODEL; REDUCES TOXICITY; CASPASE CLEAVAGE; CEREBRAL-CORTEX; PROTEOLYSIS; CALPAIN; EXON-1; TISSUE; TEMPERATURE	Huntington disease is associated with elongation of a CAG repeat in the HTT gene that results in a mutant huntingtin protein. Several studies have implicated N-terminal huntingtin protein fragments in Huntington disease pathogenesis. Ideally, these fragments are studied in human brain tissue. However, the use of human brain tissue comes with certain unavoidable variables such as post mortem delay, artefacts from freeze-thaw cycles and subject-to-subject variation. Knowledge on how these variables might affect N-terminal huntingtin protein fragments in post mortem human brain is important for a proper interpretation of study results. The effect of post mortem delay on protein in human brain is known to vary depending on the protein of interest. In the present study, we have assessed the effect of post mortem delay on N-terminal huntingtin protein fragments using western blot. We mimicked post mortem delay in one individual control case and one individual Huntington disease case with low initial post mortem delay. The influence of subject-to-subject variation on N-terminal huntingtin fragments was assessed in human cortex and human striatum using two cohorts of control and Huntington disease subjects. Our results show that effects of post mortem delay on N-terminal huntingtin protein fragments are minor in our individual subjects. Additionally, one freeze-thaw cycle decreases the huntingtin western blot signal intensity in the cortex control subject, but does not introduce additional N-terminal huntingtin fragments. Our results suggest that subject-to-subject variation contributes more to variability in N-terminal huntingtin fragments than post mortem delay.	[Schut, Menno H.; Pepers, Barry A.; den Dunnen, Johan T.; van Ommen, Gert-Jan B.; van Roon-Mom, Willeke M. C.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Patassini, Stefano; Kim, Eric H.; Bullock, Jocelyn; Waldvogel, Henry J.; Faull, Richard L. M.] Univ Auckland, Ctr Brain Res, Auckland, New Zealand; [Patassini, Stefano; Kim, Eric H.; Bullock, Jocelyn; Waldvogel, Henry J.; Faull, Richard L. M.] Univ Auckland, Dept Anat Radiol, Auckland, New Zealand; [den Dunnen, Johan T.] Leiden Univ, Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Auckland; University of Auckland; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Roon-Mom, WMC (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands.	w.vanroon@lumc.nl	dunnen, johan den/ABH-4228-2020; van Roon-Mom, Willeke/Y-3039-2018	dunnen, johan den/0000-0002-6304-1710; van Roon-Mom, Willeke/0000-0002-3035-0533; Schut, Menno/0000-0002-0550-2806	Princess Beatrix Spierfonds [WAR08-08]; Bontius stichting	Princess Beatrix Spierfonds; Bontius stichting	This study was funded by grant WAR08-08 from the Princess Beatrix Spierfonds (https://www.prinsesbeatrixspierfonds.nl) received by WMCRM. MHS received a travel and expenses grant by the Bontius stichting (https://lumc.nl/org/bontius-stichting) to perform part of this work in New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Barrachina M, 2012, CELL TISSUE BANK, V13, P597, DOI 10.1007/s10561-011-9278-9; Blair JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151615; Choudhury KR, 2015, BIOCHEM BIOPH RES CO, V456, P66, DOI 10.1016/j.bbrc.2014.11.035; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; El-Daher MT, 2015, EMBO J, V34, P2255, DOI 10.15252/embj.201490808; Evers MM, 2014, NUCLEIC ACID THER, V24, P4, DOI 10.1089/nat.2013.0452; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Fraser T, 2008, J NEUROSCI METH, V169, P135, DOI 10.1016/j.jneumeth.2007.12.001; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goni-Oliver P, 2009, J NEUROSCI RES, V87, P1156, DOI 10.1002/jnr.21932; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hilbig H, 2004, EXP TOXICOL PATHOL, V56, P159, DOI 10.1016/j.etp.2004.08.002; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; O'Brien R, 2015, J BIOL CHEM, V290, P19287, DOI 10.1074/jbc.M114.623561; PETIT TL, 1990, BRAIN RES, V517, P269, DOI 10.1016/0006-8993(90)91037-H; ROSS B, 1993, BRAIN RES, V629, P225, DOI 10.1016/0006-8993(93)91324-L; Schut MH, 2015, NEUROL SCI, V36, P429, DOI 10.1007/s10072-014-1971-6; Siew LK, 2004, J NEUROSCI METH, V139, P153, DOI 10.1016/j.jneumeth.2004.04.020; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Sorimachi Y, 1996, FORENSIC SCI INT, V81, P165, DOI 10.1016/S0379-0738(96)01981-0; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Waldvogel HJ, 2008, CELL TISSUE BANK, V9, P169, DOI 10.1007/s10561-008-9068-1; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178556	10.1371/journal.pone.0178556	http://dx.doi.org/10.1371/journal.pone.0178556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570578	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800076
J	Lindegaard, MR; Liebst, LS; Bernasco, W; Heinskou, MB; Philpot, R; Levine, M; Verbeek, P				Lindegaard, Marie Rosenkrantz; Liebst, Lasse Suonpera; Bernasco, Wim; Heinskou, Marie Bruvik; Philpot, Richard; Levine, Mark; Verbeek, Peter			Consolation in the aftermath of robberies resembles post-aggression consolation in chimpanzees	PLOS ONE			English	Article							BYSTANDER INTERVENTION; CONFLICT-RESOLUTION; CAPTIVE CHIMPANZEES; EMPATHY; GENDER; RECONCILIATION; AFFILIATION; EXPRESSION; 3RD-PARTY; BEHAVIOR	Post-aggression consolation is assumed to occur in humans as well as in chimpanzees. While consolation following peer aggression has been observed in children, systematic evidence of consolation in human adults is rare. We used surveillance camera footage of the immediate aftermath of nonfatal robberies to observe the behaviors and characteristics of victims and bystanders. Consistent with empathy explanations, we found that consolation was linked to social closeness rather than physical closeness. While females were more likely to console than males, males and females were equally likely to be consoled. Furthermore, we show that high levels of threat during the robbery increased the likelihood of receiving consolation afterwards. These patterns resemble post-aggression consolation in chimpanzees and suggest that emotions of empathic concern are involved in consolation across humans and chimpanzees.	[Lindegaard, Marie Rosenkrantz; Bernasco, Wim] Netherlands Inst Study Crime & Law Enforcement NS, Amsterdam, Netherlands; [Lindegaard, Marie Rosenkrantz; Liebst, Lasse Suonpera] Univ Copenhagen, Dept Sociol, Copenhagen, Denmark; [Bernasco, Wim] Vrije Univ Amsterdam, Dept Spatial Econ, Amsterdam, Netherlands; [Heinskou, Marie Bruvik] Aalborg Univ, Dept Sociol & Social Work, Aalborg, Denmark; [Philpot, Richard; Levine, Mark] Univ Exeter, Dept Psychol, Exeter, Devon, England; [Verbeek, Peter] Univ Alabama Birmingham, Dept Anthropol, Birmingham, AL USA	Vrije Universiteit Amsterdam; University of Copenhagen; Vrije Universiteit Amsterdam; Aalborg University; University of Exeter; University of Alabama System; University of Alabama Birmingham	Lindegaard, MR (corresponding author), Netherlands Inst Study Crime & Law Enforcement NS, Amsterdam, Netherlands.; Lindegaard, MR (corresponding author), Univ Copenhagen, Dept Sociol, Copenhagen, Denmark.	Mlindegaard@nscr.nl	Bernasco, Wim/B-3639-2012	Bernasco, Wim/0000-0002-3385-0883; Liebst, Lasse/0000-0003-1062-2447; Lindegaard, Marie Rosenkrantz/0000-0002-1630-774X; Levine, Mark/0000-0001-5696-6021; Philpot, Richard/0000-0002-0359-2123	Police and Science grant program of the Netherlands National Police [PW/OC/2014/07]	Police and Science grant program of the Netherlands National Police	Data collection was supported by the Police and Science grant program of the Netherlands National Police (grant no. PW/OC/2014/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; Belsley D. A., 1991, Computer Science in Economics and Management, V4, P33; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Butovskaya M.L., 2000, NATURAL CONFLICT RES, P243; CARO TM, 1979, BEHAVIOUR, V69, P303, DOI 10.1163/156853979X00520; Chaplin TM, 2005, EMOTION, V5, P80, DOI 10.1037/1528-3542.5.1.80; Clay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055206; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; De Waal F.B., 1999, PHILOS TOPICS, V27, P255, DOI 10.5840/philtopics199927122; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; De Waal Frans B. M., 1996, P80; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Dovidio J.F., 1991, REV PERSONALITY SOCI, P86; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Eisenberg N., 2014, HDB MORAL BEHAV DEV, VVol. 2, P63, DOI DOI 10.1017/9781316271698.007; FBM de Waal, 1989, PEACEKEEPING PRIMATE; FBM De Waal, 2015, OXFORD HDB PROSOCIAL, p[61, 61]; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Fischer P, 2006, EUR J SOC PSYCHOL, V36, P267, DOI 10.1002/ejsp.297; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Fraser ON, 2008, AM J PRIMATOL, V70, P1114, DOI 10.1002/ajp.20608; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Fraser Orlaith N, 2009, Commun Integr Biol, V2, P285; Fujisawa KK, 2006, J COMP PSYCHOL, V120, P48, DOI 10.1037/0735-7036.120.1.48; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Haynes K.E., 1984, GRAVITY SPATIAL INTE; Hertenstein MJ, 2011, SEX ROLES, V64, P70, DOI 10.1007/s11199-010-9842-y; Kaneko T, 2011, P ROY SOC B-BIOL SCI, V278, P3694, DOI 10.1098/rspb.2011.0611; Kano F, 2010, J COMP PSYCHOL, V124, P287, DOI 10.1037/a0019146; KASAKOFF AB, 1977, MAN, V12, P48, DOI 10.2307/2800993; Koski SE, 2007, ANIM BEHAV, V73, P133, DOI 10.1016/j.anbehav.2006.04.009; Koski SE, 2009, AM J PRIMATOL, V71, P409, DOI 10.1002/ajp.20668; KRACKHARDT D, 1988, SOC NETWORKS, V10, P359, DOI 10.1016/0378-8733(88)90004-4; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Levine M, 2002, J APPL SOC PSYCHOL, V32, P1452, DOI 10.1111/j.1559-1816.2002.tb01446.x; Levine M, 2011, PSYCHOL SCI, V22, P406, DOI 10.1177/0956797611398495; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Norscia I, 2016, ROYAL SOC OPEN SCI, V3; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P105, DOI 10.1002/ajpa.20242; Palagi E, 2014, EVOL HUM BEHAV, V35, P341, DOI 10.1016/j.evolhumbehav.2014.04.002; Palagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079290; Parr L., 2015, APA HDB NONVERBAL CO; Pavesich Vida, 2015, NATURALISM PHILOS AN, P66; Plotnik JM, 2014, PEERJ, V2, DOI 10.7717/peerj.278; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2013, PSYCHOL BULL, V139, P1305, DOI 10.1037/a0031755; Puga-Gonzalez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091262; Reich WT, 2012, THEOR MED BIOETH, V33, P25, DOI 10.1007/s11017-012-9212-6; Romero T., PEACE ETHOLOGY BEHAV; Romero T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022173; Romero T, 2010, J COMP PSYCHOL, V124, P278, DOI 10.1037/a0019144; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Saucier DA, 2005, PERS SOC PSYCHOL REV, V9, P2, DOI 10.1207/s15327957pspr0901_1; Shah KSV, 2014, EUR J PREV CARDIOL, V21, P619, DOI 10.1177/2047487312451815; Stanko E. A., 1990, EVERYDAY VIOLENCE WO; Sternglanz RW, 2004, J NONVERBAL BEHAV, V28, P245, DOI 10.1007/s10919-004-4158-7; Suddendorf T, 2013, TRENDS COGN SCI, V17, P121, DOI 10.1016/j.tics.2013.01.004; Suvilehto JT, 2015, P NATL ACAD SCI USA, V112, P13811, DOI 10.1073/pnas.1519231112; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; Udry JR, 2000, AM SOCIOL REV, V65, P443, DOI 10.2307/2657466; Verbeek P, 1997, INT J PRIMATOL, V18, P703, DOI 10.1023/A:1026391728909; Verbeek P, 2008, BEHAVIOUR, V145, P1497, DOI 10.1163/156853908786131270; Violence Collins R., 2008, MICROSOCIOLOGICAL TH; WATTS DP, 1995, ETHOLOGY, V100, P158; Wilson AG, 1985, MATH MODELS HUMAN GE; Wittig RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013995; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126; Zimmerman PH, 2009, BEHAV RES METHODS, V41, P731, DOI 10.3758/BRM.41.3.731	72	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177725	10.1371/journal.pone.0177725	http://dx.doi.org/10.1371/journal.pone.0177725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GY	28562686	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700023
J	Osumi, H; Shinozaki, E; Suenaga, M; Wakatsuki, T; Nakayama, I; Matsushima, T; Ogura, M; Ichimura, T; Takahari, D; Chin, K; Nagasaki, T; Konishi, T; Akiyoshi, T; Fujimoto, Y; Nagayama, S; Fukunaga, Y; Ueno, M; Yamaguchi, K				Osumi, Hiroki; Shinozaki, Eiji; Suenaga, Mitsukuni; Wakatsuki, Takeru; Nakayama, Izuma; Matsushima, Tomohiro; Ogura, Mariko; Ichimura, Takashi; Takahari, Daisuke; Chin, Keisho; Nagasaki, Toshiya; Konishi, Tsuyoshi; Akiyoshi, Takashi; Fujimoto, Yoshiya; Nagayama, Satoshi; Fukunaga, Yosuke; Ueno, Masashi; Yamaguchi, Kensei			Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer	PLOS ONE			English	Article							RANDOMIZED PHASE-III; COLON-CANCER; PLUS LEUCOVORIN; FLUOROURACIL; TRIAL; THERAPY; 5-FLUOROURACIL; CAPECITABINE; OXALIPLATIN; LEVAMISOLE	Background There are robust data supporting the contribution of oxaliplatin (L-OHP) regarding clinical outcomes for colorectal cancer (CRC) in an adjuvant setting in European and US trials; however, there is no Japanese clinical evidence although L-OHP has been approved since 2009. We examined the transition of adjuvant chemotherapy for stage III colorectal cancer in our institute. Methods A total of 642 patients with histopathologically confirmed stage III CRC underwent curative surgery from 2005 to 2010. We examined disease free survival (DFS), overall survival (OS) and prognostic factors for stage III CRC patients who underwent adjuvant chemotherapy. Results A total of 509 patients received adjuvant chemotherapy. 3-year DFS and 5-year OS rates were 74.5% and 87.5%, respectively. The frequency of inclusion of L-OHP as adjuvant chemotherapy was increased after 2008. A total of 189 patients received adjuvant chemotherapy from 2005 to 2007 increasing to 320 patients from 2008 to 2010; the 5-year OS rates were 82.4% and 91.5%, respectively, and the 3-year DFS rates were 69.2% and 76.6%, respectively (OS, P=0.007; DFS, P=0.023). In univariate analysis, adjuvant chemotherapy including L-OHP was no significant deference compared to FU monotherapy. (OS: HR 0.88, 95%Cl 0.4-1.91, p=0.75, DFS: HR 0.78, 95%Cl 0.21-2.3, p=0.29). In multivariate analysis, the OS was predicted by means of N stage (HR=2; 95%X1, 1.1-3.8; P=0.02) and pathology (HR=0.28; 95%X1, 0.13-0.59; P=0.0008). The DFS was predicted by means of N stage (HR=2.67; 95%Cl, 1.82-3.9; P< 0.05), T stage (HR=1.61; 95%X1, 1.1-2.3; P=0.01) pathology (HR=0.47; 95%X1, 0.29-0.75; P< 0.05) and venous invasion (HR=2.06; 95%Cl, 1.12-3.77; P=0.01). Conclusions Clinical outcomes of stage III CRC patients receiving adjuvant chemotherapy improved. The frequency of L-OHP usage was increasing annually, however it was no influence for clinical outcomes in this study. It will be necessary to reevaluate additional effect of L-OHP with more patients.	[Osumi, Hiroki; Shinozaki, Eiji; Suenaga, Mitsukuni; Wakatsuki, Takeru; Nakayama, Izuma; Matsushima, Tomohiro; Ogura, Mariko; Ichimura, Takashi; Takahari, Daisuke; Chin, Keisho; Yamaguchi, Kensei] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; [Nagasaki, Toshiya; Konishi, Tsuyoshi; Akiyoshi, Takashi; Fujimoto, Yoshiya; Nagayama, Satoshi; Fukunaga, Yosuke; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Shinozaki, E (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan.	eiji.shinozaki@jfcr.or.jp	nagasaki, toshiya/AAE-6844-2020; Fukunaga, Yosuke/AAR-8933-2021; Takahari, Daisuke/AAI-3955-2020	nagasaki, toshiya/0000-0001-5853-314X; Fukunaga, Yosuke/0000-0002-6397-0907; Takahari, Daisuke/0000-0002-2492-6014; Akiyoshi, Takashi/0000-0002-2321-1412				Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Arkenau HT, 2003, ANN ONCOL, V14, P395, DOI 10.1093/annonc/mdg100; de Gramont A, 2011, SEMIN ONCOL, V38, P521, DOI 10.1053/j.seminoncol.2011.05.006; FRANCINI G, 1994, GASTROENTEROLOGY, V106, P899, DOI 10.1016/0016-5085(94)90748-X; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Haller SG, 2010, J CLIN ONCOL, V28, p15s; Hugen N, 2015, INT J CANCER, V136, P333, DOI 10.1002/ijc.28981; Ishihara S, 2012, INT J COLORECTAL DIS, V27, P371, DOI 10.1007/s00384-011-1343-0; Kim SH, 2013, ANN SURG ONCOL, V20, P3407, DOI 10.1245/s10434-013-3169-1; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; LABIANCA R, 1995, LANCET, V345, P939; Meta Anal Grp Japanese Soc Canc, 2004, J CLIN ONCOL, V22, P484, DOI 10.1200/JCO.2004.04.065; OConnell MJ, 1997, J CLIN ONCOL, V15, P246, DOI 10.1200/JCO.1997.15.1.246; Schmoll HJ, 2007, J CLIN ONCOL, V25, P102, DOI 10.1200/JCO.2006.08.1075; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Snaebjornsson P, 2014, INT J CANCER, V135, P467, DOI 10.1002/ijc.28676; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Watanabe T, 2015, INT J CLIN ONCOL, V20, P207, DOI 10.1007/s10147-015-0801-z; WOLMARK N, 1993, J CLIN ONCOL, V11, P1879, DOI 10.1200/JCO.1993.11.10.1879; Wolmark N, 1999, J CLIN ONCOL, V17, P3553, DOI 10.1200/JCO.1999.17.11.3553; Yoshida M, 2014, ANN ONCOL, V25, P1743, DOI 10.1093/annonc/mdu232	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0176745	10.1371/journal.pone.0176745	http://dx.doi.org/10.1371/journal.pone.0176745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562679	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700005
J	Schultz, HS; Reedtz-Runge, SL; Backstrom, BT; Lamberth, K; Pedersen, CR; Kvarnhammar, AM				Schultz, Heidi S.; Reedtz-Runge, Stine Louise; Backstrom, B. Thomas; Lamberth, Kasper; Pedersen, Christian R.; Kvarnhammar, Anne M.		ABIRISK Consortium	Quantitative analysis of the CD4(+) T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLINICAL-RESPONSE; IN-VITRO; RITUXIMAB TREATMENT; PRECURSOR FREQUENCY; IFN-BETA; B-CELL; IMMUNOGENICITY; NAIVE; INFLIXIMAB	Many biopharmaceuticals (BPs) are known to be immunogenic in the clinic, which can result in modified pharmacokinetics, reduced efficacy, allergic reactions and anaphylaxis. During recent years, several technologies to predict immunogenicity have been introduced, but the predictive value is still considered low. Thus, there is an unmet medical need for optimization of such technologies. The generation of T cell dependent high affinity anti-drug antibodies plays a key role in clinical immunogenicity. This study aimed at developing and evaluating a novel in vitro T cell:PBMC assay for prediction of the immunogenicity potential of BPs. To this end, we assessed the ability of infliximab (anti-INF-alpha), rituximab (anti-CD20), adalimumab (anti-INF-alpha) and natalizumab (anti-alpha 4-integrin), all showing immunogenicity in the clinic, to induce a CD4(+) T cells response. Keyhole limpet hemocyanin (KLH) and cytomegalovirus pp65 protein (CMV) were included as neo-antigen and recall antigen positive controls, respectively. By analyzing 26 healthy donors having HLA-DRB1 alleles matching the European population, we calculated the frequency of responding donors, the magnitude of the response, and the frequency of BP specific T cells, as measured by (3)[H]-thymidine incorporation and ELISpot IL-2 secretion. KLH and CMV demonstrated a strong T cell response in all the donors analyzed. The frequency of responding donors to the BPs was 4% for infliximab, 8% for adalimumab, 19% for rituximab and 27% for natalizumab, which is compared to and discussed with their respective observed clinical immunogenicity. This study further complements predictive immunogenicity testing by quantifying the in vitro CD4(+) T cell responses to different BPs. Even though the data generated using this modified method does not directly translate to the clinical situation, a high sensitivity and immunogenic potential of most BPs is demonstrated.	[Schultz, Heidi S.; Backstrom, B. Thomas; Lamberth, Kasper; Kvarnhammar, Anne M.] Novo Nordisk AS, Immunogen Predict & Tolerance, Global Res, Malov, Denmark; [Reedtz-Runge, Stine Louise] Novo Nordisk AS, NCD Project Management, Global Res, Malov, Denmark; [Pedersen, Christian R.] Novo Nordisk AS, Immunogen Assessment, Global Res, Malov, Denmark; [Backstrom, B. Thomas] BTB Pharma AB, Malmo, Sweden	Novo Nordisk; Novo Nordisk; Novo Nordisk	Schultz, HS (corresponding author), Novo Nordisk AS, Immunogen Predict & Tolerance, Global Res, Malov, Denmark.	HSHZ@novonordisk.com	Maggi, Enrico/AAA-8045-2019; de Vries, Niek/J-9348-2013	Maggi, Enrico/0000-0002-1824-3583; Donnes, Pierre/0000-0002-4613-2952; Allez, Matthieu/0000-0002-2012-7522; Mauri, Claudia/0000-0001-9761-2625; de Vries, Niek/0000-0002-6257-8604	Innovative Medicines Initiative Joint Undertaking ABIRISK project [115303]; European Union's Seventh Framework Programme (FP7); EFPIA; ABIRISK project; Novo Nordisk A/S	Innovative Medicines Initiative Joint Undertaking ABIRISK project; European Union's Seventh Framework Programme (FP7); EFPIA; ABIRISK project; Novo Nordisk A/S(Novo Nordisk)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking ABIRISK project under grant agreement no [115303], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The ABIRISK project provided financial support in the form of authors' salaries [HSS], research materials and travel costs [HSS, AMK and CRP], as well as provided input for study design, data collection, analysis, approval of the manuscript and encouraged publication. The ABIRISK project provided the antibodies used in the study. Besides being funded by ABIRISK project, several of the authors are employed by the commercial company: Novo Nordisk A/S. Novo Nordisk A/S provided support in the form of salaries for authors [SRR, BTB, KL, CRP and AMK], as well as provided input for study design, data collection, analysis, and preparation of the manuscript.	Anthony Donald D, 2012, Cells, V1, P127, DOI 10.3390/cells1020127; Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Baker MP, 2010, CURR DRUG SAF, V5, P308, DOI 10.2174/157488610792246000; Baldwin HM, 2010, ANN RHEUM DIS, V69, P1200, DOI 10.1136/ard.2009.110502; Barbosa MDFS, 2006, CLIN IMMUNOL, V118, P42, DOI 10.1016/j.clim.2005.08.017; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bender NK, 2007, RHEUMATOL INT, V27, P269, DOI 10.1007/s00296-006-0183-7; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dahlen R, 2013, SCAND J IMMUNOL, V78, P275, DOI 10.1111/sji.12081; de Andres Clara, 2012, PLoS One, V7, pe34103, DOI 10.1371/journal.pone.0034103; de Vries MK, 2007, ANN RHEUM DIS, V66, P1252, DOI 10.1136/ard.2007.072397; Delluc S, 2011, FASEB J, V25, P2040, DOI 10.1096/fj.10-173872; Delluc S, 2010, BLOOD, V116, P4542, DOI 10.1182/blood-2010-04-280875; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; Eng GP, 2015, ARTHRITIS, DOI 10.1155/2015/784825; GEBEL HM, 1983, J IMMUNOL, V130, P29; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Holmen C, 2011, MULT SCLER J, V17, P708, DOI 10.1177/1352458510394701; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Jones TD, 2005, J THROMB HAEMOST, V3, P991, DOI 10.1111/j.1538-7836.2005.01309.x; Joubert MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159328; Karle A, 2016, MABS-AUSTIN, V8, P536, DOI 10.1080/19420862.2015.1136761; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kneepkens EL, 2015, ANN RHEUM DIS, V74, P396, DOI 10.1136/annrheumdis-2013-204185; Looney RJ, 2004, ARTHRITIS RHEUM, V50, P2580, DOI 10.1002/art.20430; Lundkvist M, 2013, MULT SCLER J, V19, P757, DOI 10.1177/1352458512462920; Maillere B, 2013, J IMMUNOL, V190, P1895, DOI 10.4049/jimmunol.1290079; Mannering SI, 2003, J IMMUNOL METHODS, V283, P173, DOI 10.1016/j.jim.2003.09.004; Mascarenhas RE, 2006, CLIN VACCINE IMMUNOL, V13, P547, DOI 10.1128/CVI.13.5.547-552.2006; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Miller RA, 2001, CURR PROTOC IMMUNOL; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Moss AC, 2013, ALIMENT PHARM THER, V38, P1188, DOI 10.1111/apt.12507; Pijpe J, 2005, ARTHRITIS RHEUM-US, V52, P2740, DOI 10.1002/art.21260; Piro LD, 1999, ANN ONCOL, V10, P655, DOI 10.1023/A:1008389119525; Pratt K, 2009, CLIN REV ALLERG IMMU, V37, P80, DOI 10.1007/s12016-009-8120-7; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Rup B, 2015, CLIN EXP IMMUNOL, V181, P385, DOI 10.1111/cei.12652; Schmidt E, 2009, CLIN IMMUNOL, V132, P334, DOI 10.1016/j.clim.2009.05.007; Singh SK, 2011, J PHARM SCI-US, V100, P354, DOI 10.1002/jps.22276; Smith KGC, 2006, ARTHRITIS RHEUM-US, V54, P2970, DOI 10.1002/art.22046; Stickler M, 2004, TOXICOL SCI, V77, P280, DOI 10.1093/toxsci/kfh021; Stickler M, 2004, GENES IMMUN, V5, P1, DOI 10.1038/sj.gene.6364027; Tanaka Yoshiya, 2007, Mod Rheumatol, V17, P191; Thurlings RM, 2010, ANN RHEUM DIS, V69, P409, DOI 10.1136/ard.2009.109041; Tovey Michael G, 2011, Expert Rev Clin Pharmacol, V4, P623, DOI 10.1586/ecp.11.39; van Schie KA, 2015, MABS-AUSTIN, V7, P662, DOI 10.1080/19420862.2015.1048411; Wang YMC, 2016, AAPS J, V18, P395, DOI 10.1208/s12248-015-9857-y; Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001; Wolfl M, 2014, NAT PROTOC, V9, P950, DOI 10.1038/nprot.2014.064; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671; Wullner D, 2010, CLIN IMMUNOL, V137, P5, DOI 10.1016/j.clim.2010.06.018; Yeung VP, 2004, J IMMUNOL, V172, P6658, DOI 10.4049/jimmunol.172.11.6658	58	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178544	10.1371/journal.pone.0178544	http://dx.doi.org/10.1371/journal.pone.0178544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562666	Green Published, Green Submitted, gold			2022-12-26	WOS:000402608700071
J	Peng, XL; Liu, Y; Liang, BS; Du, ZM				Peng, Xiaolong; Liu, Yong; Liang, Baosheng; Du, Zhimin			Interface condition for the Darcy velocity at the water-oil flood front in the porous medium	PLOS ONE			English	Article							MULTIPHASE FLOW; NUMERICAL-SIMULATION	Flood front is the jump interface where fluids distribute discontinuously, whose interface condition is the theoretical basis of a mathematical model of the multiphase flow in porous medium. The conventional interface condition at the jump interface is expressed as the continuous Darcy velocity and fluid pressure (named CVCM). Our study has inspected this conclusion. First, it is revealed that the principle of mass conservation has no direct relation to the velocity conservation, and the former is not the true foundation of the later, because the former only reflects the kinetic characteristic of the fluid particles at one position(the interface), but not the different two parts of fluid on the different side of the interface which required by the interface conditions. Then the reasonableness of CVCM is queried from the following three aspects:(1) Using Mukat's two phase seepage equation and the mathematical method of apagoge, we have disproved the continuity of each fluid velocity;(2) Since the analytical solution of the equation of Buckley-Leveret equations is acquirable, its velocity jumps at the flood front presents an appropriate example to disprove the CVCM;(3) The numerical simulation model gives impractical result that flood front would stop moving if CVCM were used to calculate the velocities at the interface between two gridcells. Subsequently, a new one, termed as Jump Velocity Condition Model (JVCM), is deduced from Muskat's two phase seepage equations and Darcy's law without taking account of the capillary force and compressibility of rocks and fluids. Finally, several cases are presented. And the comparisons of the velocity, pressure difference and the front position, which are given by JVCM, CVCM and SPU, have shown that the result of JVCM is the closest to the exact solution.	[Peng, Xiaolong; Liu, Yong; Du, Zhimin] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Liang, Baosheng] Chevron North Amer Explorat & Dev, Houston, TX USA	Southwest Petroleum University	Peng, XL (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	pengxl@swpu.edu.cn		Peng, Xiaolong/0000-0001-8163-4459	Ministry of Science and Technology of China [2011ZX05060-004, 2011ZX0514-004]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China 2011ZX05060-004 and 2011ZX0514-004 (http//www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz K., 1986, PETROLEUM RESERVOIR; Brenner K, 2013, COMPUTAT GEOSCI, V17, P573, DOI 10.1007/s10596-013-9345-3; Brooks RH, 1991, HYDRAULIC PROPERTIES; Buckley SE, 1942, T AM I MIN MET ENG, V146, P107, DOI 10.2118/942107-G; Chu J, 2013, SIAM J MULTISCALE MO, V10, P515; Costa VAF, 2004, NUMER HEAT TR A-APPL, V45, P675, DOI 10.1080/10407780490424839; DATTAGUPTA A, 1995, ADV WATER RESOUR, V18, P9, DOI 10.1016/0309-1708(94)00021-V; Doster F, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123030; Haggerty R, 2000, WATER RESOUR RES, V36, P3467, DOI 10.1029/2000WR900214; HASSANIZADEH SM, 1989, WATER RESOUR RES, V25, P1705, DOI 10.1029/WR025i007p01705; Huber R, 2000, COMPUTAT GEOSCI, V4, P141, DOI 10.1023/A:1011559916309; Hyman JM, 1983, PHYSICA D, V12, P396; Jenny P, 2005, MULTISCALE MODEL SIM, V3, P50, DOI 10.1137/030600795; LeVeque RJ, 2002, CAMBRIDGE TEXTS APPL, V31, DOI DOI 10.1017/CBO9780511791253; Lunati I, 2006, J COMPUT PHYS, V216, P616, DOI 10.1016/j.jcp.2006.01.001; Mozolevski I, 2013, J COMPUT APPL MATH, V242, P12, DOI 10.1016/j.cam.2012.09.045; Muskat M, 1937, FLOW HETEROGENEOUS F; Nataf F., 2002, INTERFACE CONNECTION, DOI DOI 10.1007/978-94-010-0510-4_9; Peng DL, 2007, MODELING 2 PHASE FLO; Reddy JN, 2000, FINITE ELEMENT METHO; Schweizer B, 2007, DISCRETE CONTINUOUS; Szymkiewicz A, 2013, GEOPLANET-EARTH PLAN, P1, DOI 10.1007/978-3-642-23559-7; Tveit S, 2012, COMPUTAT GEOSCI, V16, P809, DOI 10.1007/s10596-012-9289-z; Valdes-Parada FJ, 2005, J POROUS MEDIA, V8, P557, DOI 10.1615/JPorMedia.v8.i6.20; Wu YS, 2009, COMMUN COMPUT PHYS, V6, P85	25	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177187	10.1371/journal.pone.0177187	http://dx.doi.org/10.1371/journal.pone.0177187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542612	Green Published, gold			2022-12-26	WOS:000402058800010
J	Jamme, M; Raimbourg, Q; Chauveau, D; Seguin, A; Presne, C; Perez, P; Gobert, P; Wynckel, A; Provot, F; Delmas, Y; Mousson, C; Servais, A; Vrigneaud, L; Veyradier, A; Rondeau, E; Coppo, P; Thrombotic, F; Centre, MR				Jamme, Matthieu; Raimbourg, Quentin; Chauveau, Dominique; Seguin, Amelie; Presne, Claire; Perez, Pierre; Gobert, Pierre; Wynckel, Alain; Provot, Francois; Delmas, Yahsou; Mousson, Christiane; Servais, Aude; Vrigneaud, Laurence; Veyradier, Agnss; Rondeau, Eric; Coppo, Paul; Thrombotic, French; Centre, Microangiopathies Reference			Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome	PLOS ONE			English	Article							THROMBOTIC-THROMBOCYTOPENIC PURPURA; COMPLEMENT INHIBITOR ECULIZUMAB; PROGNOSTIC-FACTORS; MICROANGIOPATHIES; PATHOPHYSIOLOGY; MUTATIONS; IMPACT	Chronic kidney disease (CKD) is a frequent and serious complication of atypical haemolytic uremic syndrome (aHUS). We aimed to develop a simple accurate model to predict the risk of renal dysfunction in aHUS based on clinical and biological features available at hospital admission. Renal function at 1-year follow-up, based on an estimated glomerular filtration rate <60mL/min/1.73m(2) as assessed by the Modification of Diet in Renal Disease equation, was used as an indicator of significant CKD. Prospectively collected data from a cohort of 156 aHUS patients who did not receive eculizumab were used to identify predictors of CKD. Covariates associated with renal impairment were identified by multivariate analysis. The model performance was assessed and a scoring system for clinical practice was constructed from the regression coefficient. Multivariate analyses identified three predictors of CKD: a high serum creatinine level, a high mean arterial pressure and a mildly decreased platelet count. The prognostic model had a good discriminative ability (area under the curve=.84). The scoring system ranged from 0 to 5, with corresponding risks of CKD ranging from 18% to 100%. This model accurately predicts development of 1-year CKD in patients with aHUS using clinical and biological features available on admission. After further validation, this model may assist in clinical decision making.	[Jamme, Matthieu; Chauveau, Dominique; Seguin, Amelie; Presne, Claire; Perez, Pierre; Gobert, Pierre; Wynckel, Alain; Provot, Francois; Delmas, Yahsou; Mousson, Christiane; Servais, Aude; Vrigneaud, Laurence; Veyradier, Agnss; Rondeau, Eric; Coppo, Paul] Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France; [Jamme, Matthieu] Hop Tenon, AP HP, Urgences Nephrolog & Transplantat Renale, Paris, France; [Raimbourg, Quentin] Hop Bichat Claude Bernard, AP HP, Serv Nephrol, Paris, France; [Chauveau, Dominique] Hop Rangueil, Serv Nephrol Immunol Clin, Toulouse, France; [Seguin, Amelie] Ctr Hosp Univ Caen, Serv Reanimat Me dicale, Normandy, France; [Presne, Claire] Hop Sud, Serv Nephrol Med Interne, Amiens, France; CHU Brabois, Serv Nephrol Immunol, Serv Reanimat, Nancy, France; [Wynckel, Alain] Hop Gen Henri Duffaut, Serv Med Interne & Nephrol, Avignon, France; [Wynckel, Alain] Hop Albert Calmette, Serv Nephrol, Lille, France; [Delmas, Yahsou] CHU Bordeaux, Serv Nephrol Transplantat Dialyse, Bordeaux, France; [Vrigneaud, Laurence] Hop Necker Enfants Malad, AP HP, Serv Nephrol, Dijon, France; [Vrigneaud, Laurence] Ctr Hosp Valenciennes, Serv Med Interne, Nephrol & Med Vasc, Valenciennes, France; [Veyradier, Agnss; Rondeau, Eric] Hop Lariboisiere, AP HP, Serv Hematol Biol, Paris, France; [Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU de Caen NORMANDIE; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Nancy; Universite de Lille - ISITE; CHU Lille; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; CH de Valenciennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Coppo, P (corresponding author), Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France.	paul.coppo@aphp.fr		Servais, Aude/0000-0002-8165-8212	National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS))	National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS))	This work was supported by the National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Patients were recruited with the help of the members of the Reference Centre for Thrombotic Microangiopathies (CNR-MAT)(www,cnr-mat.fr). We thank S. Thouzeau, S. Savigny, S. Capdenat (Laboratoire d'Hematologie, Hopital Lariboisiere, Paris) and S. Malot (Centre de Reference des Microangiopathies Thrombotiques, HOpital Saint-Antoine, AP-HP, Paris) for technical assistance. This work was also supported by the National Plan for Rare Diseases of the French Ministry of Health (Direction Generale de l'Offre de Soin (DGOS)).	Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Coppo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010208; Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36; Dierkes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030886; Fakhouri F, 2016, AM J KIDNEY DIS OFF; Fakhouri F, 2013, EUR J INTERN MED, V24, P492, DOI 10.1016/j.ejim.2013.05.008; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hollenbeck M, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.1.76; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Licht C, 2015, KIDNEY INT; Mariotte E, 2016, LANCET HAEMATOL, V3, pE237, DOI [10.1016/s2352-3026(16)30018-7, 10.1016/S2352-3026(16)30018-7]; Nguyen L, 2009, TRANSFUSION, V49, P392, DOI 10.1111/j.1537-2995.2008.02030.x; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Pene F, 2005, INTENS CARE MED, V31, P71, DOI 10.1007/s00134-004-2505-0; Phillips EH, 2016, J THROMB HAEMOST, V14, P175, DOI 10.1111/jth.13189; SCHIEPPATI A, 1992, J AM SOC NEPHROL, V2, P1640; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tostivint I, 2002, NEPHROL DIAL TRANSPL, V17, P1228, DOI 10.1093/ndt/17.7.1228; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	25	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177894	10.1371/journal.pone.0177894	http://dx.doi.org/10.1371/journal.pone.0177894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542627	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400109
J	Emery, AC; Xu, WQ; Eiden, MV; Eiden, LE				Emery, Andrew C.; Xu, Wenqin; Eiden, Maribeth V.; Eiden, Lee E.			Guanine nucleotide exchange factor Epac2-dependent activation of the GTP-binding protein Rap2A mediates cAMP-dependent growth arrest in neuroendocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; RECEPTOR TYROSINE KINASE; MAP KINASE; CYCLIC-AMP; R-RAS; COCAINE ADDICTION; PC12 CELLS; P38 MAPK; SPECIFICITY; PATHWAY	First messenger-dependent activation of MAP kinases in neuronal and endocrine cells is critical for cell differentiation and function and requires guanine nucleotide exchange factor (GEF)-mediated activation of downstream Ras family small GTPases, which ultimately lead to ERK, JNK, and p38 phosphorylation. Because there are numerous GEFs and also a host of Ras family small GTPases, it is important to know which specific GEF-small GTPase dyad functions in a given cellular process. Here we investigated the upstream activators and downstream effectors of signaling via the GEF Epac2 in the neuroendocrine NS-1 cell line. Three cAMP sensors, Epac2, PKA, and neuritogenic cAMP sensor-Rapgef2, mediate distinct cellular outputs: p38-dependent growth arrest, cAMP response element-binding protein-dependent cell survival, and ERK-dependent neuritogenesis, respectively, in these cells. Previously, we found that cAMP-induced growth arrest of PC12 and NS-1 cells requires Epac2-dependent activation of p38 MAP kinase, which posed the important question of how Epac2 engages p38 without simultaneously activating other MAP kinases in neuronal and endocrine cells. We now show that the small GTP-binding protein Rap2A is the obligate effector for, and GEF substrate of, Epac2 in mediating growth arrest through p38 activation in NS-1 cells. This new pathway is distinctly parcellated from the G protein-coupled receptor -> G(s) -> adenylate cyclase -> cAMP -> PKA -> cAMP response element-binding protein pathway mediating cell survival and the G protein-coupled receptor -> G(s) -> adenylate cyclase -> cAMP -> neuritogenic cAMP sensor-Rapgef2 -> B-Raf -> MEK -> ERK pathway mediating neuritogenesis in NS-1 cells.	[Emery, Andrew C.; Xu, Wenqin; Eiden, Lee E.] NIMH, Sect Mol Neurosci, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA; [Eiden, Maribeth V.] NIMH, Off Sci Director, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Sect Mol Neurosci, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Emery, Andrew/0000-0002-6760-2570	National Institute of Mental Health Intramural Research Program [MH002386, MH002592]; Brain and Behavior Research Foundation NARSAD Young Investigator Grant [21356]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002386, Z01MH002592, Z01MH002386] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation NARSAD Young Investigator Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health Intramural Research Program Projects MH002386 (to L. E. E.) and MH002592 (to M. V. E.) and by Brain and Behavior Research Foundation NARSAD Young Investigator Grant 21356 (to A. C. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Ali D, 2004, MOL ENDOCRINOL, V18, P1721, DOI 10.1210/me.2003-0129; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Emery AC, 2016, PEPTIDES, V79, P39, DOI 10.1016/j.peptides.2016.03.003; Emery AC, 2014, J BIOL CHEM, V289, P10126, DOI 10.1074/jbc.M113.529321; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FARRELL FX, 1993, BIOCHEM J, V289, P349, DOI 10.1042/bj2890349; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kelley GG, 2009, ISLETS, V1, P260, DOI 10.4161/isl.1.3.9645; Knowles PJ, 2011, J NEUROENDOCRINOL, V23, P224, DOI 10.1111/j.1365-2826.2010.02100.x; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mor A, 2011, J INVEST DERMATOL, V131, P2040, DOI 10.1038/jid.2011.152; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; OVERBECK AF, 1995, MOL REPROD DEV, V42, P468, DOI 10.1002/mrd.1080420415; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tian XJ, 2001, J BIOL CHEM, V276, P47248, DOI 10.1074/jbc.M107407200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Xia ZG, 2012, LEARN MEMORY, V19, P369, DOI 10.1101/lm.027128.112; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12220	12231		10.1074/jbc.M117.790329	http://dx.doi.org/10.1074/jbc.M117.790329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28546426	Green Published, hybrid			2022-12-26	WOS:000406053300019
J	Balasubramaniam, SL; Gopalakrishnapillai, A; Petrelli, NJ; Barwe, SP				Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Petrelli, Nicholas J.; Barwe, Sonali P.			Knockdown of sodium-calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE UVOMORULIN; TIGHT JUNCTION FORMATION; NF-KAPPA-B; BETA-CATENIN; E-CADHERIN; PLASMA-MEMBRANE; GENE-EXPRESSION; OVARIAN-CANCER; ION CHANNELS; NA+-CA2+ EXCHANGER	Mesenchymal-to-epithelial transition (MET) and epithelialto- mesenchymal transition (EMT) are important processes in kidney development. Failure to undergo MET during development leads to the initiation of Wilms tumor, whereas EMT contributes to the development of renal cell carcinomas (RCC). The role of calcium regulators in governing these processes is becoming evident. We demonstrated earlier that Na+/Ca2+ exchanger 1 (NCX1), a major calcium exporter in renal epithelial cells, regulates epithelial cell motility. Here, we show for the first time that NCX1 mRNA and protein expression was downregulated in Wilms tumor and RCC. Knockdown of NCX1 in Madin-Darby canine kidney cells induced fibroblastic morphology, increased intercellular junctional distance, and induced paracellular permeability, loss of apico-basal polarity in 3D cultures, and anchorage-independent growth, accompanied by expression of mesenchymal markers. We also provide evidence that NCX1 interacts with and anchors E-cadherin to the cell surface independent of NCX1 ion transport activity. Consistent with destabilization of E-cadherin, NCX1 knockdown cells showed an increase in beta-catenin nuclear localization, enhanced transcriptional activity, and up-regulation of downstream targets of the beta-catenin signaling pathway. Taken together, knockdown of NCX1 in Madin-Darby canine kidney cells alters epithelial morphology and characteristics by destabilization of E-cadherin and induction of beta-catenin signaling.	[Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Barwe, Sonali P.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA; [Balasubramaniam, Sona Lakshme; Barwe, Sonali P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Petrelli, Nicholas J.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute	Barwe, SP (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA.	barwe@medsci.udel.edu	gopala, Anilkumar/AAG-2713-2021	Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X; Barwe, Sonali/0000-0003-4162-3004	Delaware-CTR ACCEL Grant [U54GM104941]; American Heart Association [10SDG260011]; DE INBRE Pilot Awards; Core Access Award [P20GM103446]; Biomolecular Core of the Center for Pediatric Research Grant [P30GM114736]; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104941, P30GM114736, P20GM103446] Funding Source: NIH RePORTER	Delaware-CTR ACCEL Grant; American Heart Association(American Heart Association); DE INBRE Pilot Awards; Core Access Award; Biomolecular Core of the Center for Pediatric Research Grant; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by Delaware-CTR ACCEL Grant U54GM104941, American Heart Association Grant 10SDG260011, DE INBRE Pilot Awards and a Core Access Award for use of the Delaware Bioimaging Center (Grant P20GM103446), Biomolecular Core of the Center for Pediatric Research Grant P30GM114736, and the Nemours Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Anilkumar G, 2003, CANCER RES, V63, P2645; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Aydar E, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-23; Balasubramaniam SL, 2015, AM J PHYSIOL-CELL PH, V309, pC437, DOI 10.1152/ajpcell.00140.2015; Balasubramaniam SL, 2015, J BIOL CHEM, V290, P12463, DOI 10.1074/jbc.M114.629519; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bolinger MT, 2016, MOL CELL BIOL, V36, P2051, DOI 10.1128/MCB.00053-16; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Campbell CE, 1998, INT J CANCER, V78, P182, DOI 10.1002/(SICI)1097-0215(19981005)78:2<182::AID-IJC11>3.3.CO;2-D; Carmosino M, 2010, MOL BIOL CELL, V21, P3985, DOI 10.1091/mbc.E10-05-0456; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Chou AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138856; Cutcliffe C, 2005, CLIN CANCER RES, V11, P7986, DOI 10.1158/1078-0432.CCR-05-1354; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Deliot N, 2015, BBA-BIOMEMBRANES, V1848, P2512, DOI 10.1016/j.bbamem.2015.06.009; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dumanskiy Y. V., 2013, Experimental Oncology, V35, P325; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hansson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046001; Harada K, 2012, BJU INT, V110, pE1131, DOI 10.1111/j.1464-410X.2012.11297.x; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hohenstein P, 2015, GENE DEV, V29, P467, DOI 10.1101/gad.256396.114; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Januchowski R, 2014, BIOMED PHARMACOTHER, V68, P447, DOI 10.1016/j.biopha.2014.02.002; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Lee BH, 2002, BIOCHEM BIOPH RES CO, V297, P1218, DOI 10.1016/S0006-291X(02)02356-2; Lee WJ, 2005, J BIOL CHEM, V280, P27076, DOI 10.1074/jbc.M414142200; LI ZP, 1994, J BIOL CHEM, V269, P17434; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Mahdi SHA, 2015, ARCH BIOCHEM BIOPHYS, V583, P18, DOI 10.1016/j.abb.2015.07.008; Marciano DK, 2011, DEVELOPMENT, V138, P2099, DOI 10.1242/dev.056564; Modla S, 2015, METHODS MOL BIOL, V1217, P121, DOI 10.1007/978-1-4939-1523-1_8; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Munoz JJ, 2015, J UROLOGY, V194, P245, DOI 10.1016/j.juro.2014.11.097; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Orsulic S, 1999, J CELL SCI, V112, P1237; Ozcan A, 2012, ARCH PATHOL LAB MED, V136, P1541, DOI 10.5858/arpa.2012-0072-OA; Pacini L, 2013, CAN J PHYSIOL PHARM, V91, P1135, DOI 10.1139/cjpp-2012-0419; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Phillips BE, 2008, INVEST OPHTH VIS SCI, V49, P2568, DOI 10.1167/iovs.07-1204; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Schweigert A, 2016, PEDIATR SURG INT, V32, P1141, DOI 10.1007/s00383-016-3970-6; Srigley JR, 2009, MODERN PATHOL, V22, pS2, DOI 10.1038/modpathol.2009.70; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stock C, 2015, BBA-BIOMEMBRANES, V1848, P2638, DOI 10.1016/j.bbamem.2014.11.012; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Sullivan LP, 1998, PHYSIOL REV, V78, P1165, DOI 10.1152/physrev.1998.78.4.1165; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; van der Hagen EAE, 2015, NEPHRON, V131, P145, DOI 10.1159/000440655; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Wang GH, 2009, J BIOL CHEM, V284, P14469, DOI 10.1074/jbc.M808909200; Wang J, 2014, BIOCHEM BIOPH RES CO, V454, P547, DOI 10.1016/j.bbrc.2014.10.118; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Yusenko MV, 2009, INT J BIOL SCI, V5, P517; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zhang XQ, 2017, ONCOTARGET, V8, P19566, DOI 10.18632/oncotarget.15361	80	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11388	11399		10.1074/jbc.M116.752352	http://dx.doi.org/10.1074/jbc.M116.752352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28550085	Green Published, hybrid			2022-12-26	WOS:000405119600022
J	McReynolds, MR; Wang, WQ; Holleran, LM; Hanna-Rose, W				McReynolds, Melanie R.; Wang, Wenqing; Holleran, Lauren M.; Hanna-Rose, Wendy			Uridine monophosphate synthetase enables eukaryotic de novo NAD(+) biosynthesis from quinolinic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; REPRODUCTIVE DEVELOPMENT; C-ELEGANS; METABOLISM; NICOTINAMIDE; VITAMINS; SALVAGE; PATHWAY	NAD(+) biosynthesis is an attractive and promising therapeutic target for influencing health span and obesity-related phenotypes as well as tumor growth. Full and effective use of this target for therapeutic benefit requires a complete understanding of NAD(+) biosynthetic pathways. Here, we report a previously unrecognized role for a conserved phosphoribosyltransferase in NAD(+) biosynthesis. Because a required quinolinic acid phosphoribosyltransferase (QPRTase) is not encoded in its genome, Caenorhabditis elegans are reported to lack a de novo NAD(+) biosynthetic pathway. However, all the genes of the kynurenine pathway required for quinolinic acid (QA) production from tryptophan are present. Thus, we investigated the presence of de novo NAD(+) biosynthesis in this organism. By combining isotope- tracing and genetic experiments, we have demonstrated the presence of an intact de novo biosynthesis pathway for NAD(+) from tryptophan via QA, highlighting the functional conservation of this important biosynthetic activity. Supplementation with kynurenine pathway intermediates also boosted NAD(+) levels and partially reversed NAD(+)-dependent phenotypes caused by mutation of pnc-1, which encodes a nicotinamidase required for NAD(+) salvage biosynthesis, demonstrating contribution of de novo synthesis to NAD(+) homeostasis. By investigating candidate phosphoribosyltransferase genes in the genome, we determined that the conserved uridine monophosphate phosphoribosyltransferase (UMPS), which acts in pyrimidine biosynthesis, is required for NAD(+) biosynthesis in place of the missing QPRTase. We suggest that similar underground metabolic activity of UMPS may function in other organisms. This mechanism for NAD(+) biosynthesis creates novel possibilities for manipulating NAD(+) biosynthetic pathways, which is key for the future of therapeutics.	[McReynolds, Melanie R.; Wang, Wenqing; Holleran, Lauren M.; Hanna-Rose, Wendy] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wang, Wenqing] ABLife Inc, Wuhan 430075, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hanna-Rose, W (corresponding author), 104D Life Sci Bldg, University Pk, PA 16802 USA.	wxh21@psu.edu		Hanna-Rose, Wendy/0000-0002-5566-4758	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086786] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Patterson and P. Smith and the Pennsylvania State Metabolomics Core Facility, Huck Institutes of the Life Sciences, for technical assistance and advice. tm alleles were provided by the Mitani Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. Other strains were provided by the Caenorhabditis Genetics Center, which is funded by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440.	Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Banyai L, 1998, BBA-PROTEIN STRUCT M, V1429, P259, DOI 10.1016/S0167-4838(98)00237-4; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; BRENNER S, 1974, GENETICS, V77, P71; C. elegans Consortium, 2012, G3 BETHESDA, V2, P1415; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang L, 2006, DEV BIOL, V300, P599, DOI 10.1016/j.ydbio.2006.08.024; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; Majewski M, 2016, J PHYSIOL PHARMACOL, V67, P3; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sas K, 2007, J NEUROL SCI, V257, P221, DOI 10.1016/j.jns.2007.01.033; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Vrablik TL, 2011, DEV BIOL, V349, P387, DOI 10.1016/j.ydbio.2010.11.014; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Wang WQ, 2015, J BIOL CHEM, V290, P26163, DOI 10.1074/jbc.M115.662916	21	10	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11147	11153		10.1074/jbc.C117.795344	http://dx.doi.org/10.1074/jbc.C117.795344			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28559281	Green Published, hybrid			2022-12-26	WOS:000405119600002
J	Cha, MG; Kim, HM; Kang, YL; Lee, M; Kang, H; Kim, J; Pham, XH; Kim, TH; Hahm, E; Lee, YS; Jeong, DH; Jun, BH				Cha, Myeong Geun; Kim, Hyung-Mo; Kang, Yoo-Lee; Lee, Minwoo; Kang, Homan; Kim, Jaehi; Pham, Xuan-Hung; Kim, Tae Han; Hahm, Eunil; Lee, Yoon-Sik; Jeong, Dae Hong; Jun, Bong-Hyun			Thin silica shell coated Ag assembled nanostructures for expanding generality of SERS analytes	PLOS ONE			English	Article							ENHANCED RAMAN-SCATTERING; MICROWAVE-POLYOL METHOD; SILVER NANOSTRUCTURES; SENSITIVE DETECTION; GOLD NANOPARTICLES; SPLENIC TOXICITY; SINGLE-MOLECULE; NANOPROBES; ANILINE; SPECTROSCOPY	Surface-enhanced Raman scattering (SERS) provides a unique non-destructive spectroscopic fingerprint for chemical detection. However, intrinsic differences in affinity of analyte molecules to metal surface hinder SERS as a universal quantitative detection tool for various analyte molecules simultaneously. This must be overcome while keeping close proximity of analyte molecules to the metal surface. Moreover, assembled metal nanoparticles (NPs) structures might be beneficial for sensitive and reliable detection of chemicals than single NP structures. For this purpose, here we introduce thin silica-coated and assembled Ag NPs (SiO2@Ag@SiO(2)NPs) for simultaneous and quantitative detection of chemicals that have different intrinsic affinities to silver metal. These SiO2@Ag@SiO(2)NPs could detect each SERS peak of aniline or 4-aminothiophenol (4-ATP) from the mixture with limits of detection (LOD) of 93 ppm and 54 ppb, respectively. E-field distribution based on interparticle distance was simulated using discrete dipole approximation (DDA) calculation to gain insight into enhanced scattering of these thin silica coated Ag NP assemblies. These NPs were successfully applied to detect aniline in river water and tap water. Results suggest that SiO2@Ag@SiO2 NP-based SERS detection systems can be used as a simple and universal detection tool for environment pollutants and food safety.	[Cha, Myeong Geun; Lee, Minwoo; Jeong, Dae Hong] Seoul Natl Univ, Dept Chem Educ, Seoul, South Korea; [Kim, Hyung-Mo; Kang, Yoo-Lee; Pham, Xuan-Hung; Kim, Tae Han; Hahm, Eunil; Jun, Bong-Hyun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Kang, Homan; Lee, Yoon-Sik] Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea; [Kim, Jaehi; Lee, Yoon-Sik] Seoul Natl Univ Seoul, Sch Chem & Biol Engn, Seoul, South Korea; [Kang, Homan] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Kang, Homan] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA USA	Seoul National University (SNU); Konkuk University; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Jeong, DH (corresponding author), Seoul Natl Univ, Dept Chem Educ, Seoul, South Korea.; Jun, BH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	jeongdh@snu.ac.kr; bjun@konkuk.ac.kr	Hahm, Eunil/GLU-1815-2022; Kang, Homan/I-1528-2013; Lee, Yoon-Sik/W-3770-2018; Jeong, Dae Hong/B-9973-2015; Pham, Xuan-Hung/M-2424-2013	Kang, Homan/0000-0002-0732-9779; Jeong, Dae Hong/0000-0001-7869-5648; Pham, Xuan-Hung/0000-0002-4927-7102; Kim, Hyung-Mo/0000-0001-8507-089X	National Research Foundation (NRF) - Korean government (MSIP MOHW) [2016-A423-0045]; Ministry of Health Welfare [HI17C1264]; National Research Foundation (NRF); Korean government (MSIP MOHW) [2016-A423-0045]	National Research Foundation (NRF) - Korean government (MSIP MOHW); Ministry of Health Welfare; National Research Foundation (NRF); Korean government (MSIP MOHW)	This work was supported by a grant (2016-A423-0045) of Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIP & MOHW), and grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI17C1264); This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) & funded by the Korean government (MSIP & MOHW) (2016-A423-0045), Korean Health Technology R&D Project, Ministry of Health & Welfare (HI17C1264). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, CHEMOSPHERE, V45, P487, DOI 10.1016/S0045-6535(01)00049-2; Alvarez-Puebla RA, 2012, CHEM SOC REV, V41, P43, DOI 10.1039/c1cs15155j; Avasthi DK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/12/125604; Costa CAR, 2003, J PHYS CHEM B, V107, P4747, DOI 10.1021/jp027525t; Di Girolamo F, 2009, ECOTOX ENVIRON SAFE, V72, P1601, DOI 10.1016/j.ecoenv.2008.09.006; DRAINE BT, 1994, J OPT SOC AM A, V11, P1491, DOI 10.1364/JOSAA.11.001491; Driskell JD, 2006, J PHYS CHEM B, V110, P17444, DOI 10.1021/jp0636930; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; Hahm E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26082; Hering K, 2008, ANAL BIOANAL CHEM, V390, P113, DOI 10.1007/s00216-007-1667-3; Hewage HS, 2009, J AM CHEM SOC, V131, P13099, DOI 10.1021/ja904045n; Im YB, 2011, J NANOSCI NANOTECHNO, V11, P5934, DOI 10.1166/jnn.2011.4386; Jeong Seung Hee, 2015, SCI REPORTS, V5; Jiang CF, 2011, NANOSCALE, V3, P3316, DOI 10.1039/c1nr10396b; Jiang XC, 2007, LANGMUIR, V23, P2218, DOI 10.1021/la062797z; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jun BH, 2015, B KOREAN CHEM SOC, V36, P963, DOI 10.1002/bkcs.10179; Jun BH, 2011, NANOMEDICINE-UK, V6, P1463, DOI [10.2217/NNM.11.123, 10.2217/nnm.11.123]; Jun BH, 2011, PHYS CHEM CHEM PHYS, V13, P7298, DOI 10.1039/c0cp02055a; Jun BH, 2010, SMALL, V6, P119, DOI 10.1002/smll.200901459; Kang H., 2015, SCI REPORTS, P5; Kang H, 2013, ACS APPL MATER INTER, V5, P12804, DOI 10.1021/am404435d; Khan MF, 2003, TOXICOLOGY, V194, P95, DOI 10.1016/j.tox.2003.08.008; Khan MF, 2000, J TOXICOL ENV HEAL A, V60, P263, DOI 10.1080/00984100050027815; Kim HM, 2016, J IND ENG CHEM, V33, P22, DOI 10.1016/j.jiec.2015.09.035; Kim HM, 2015, J IND ENG CHEM, V21, P158, DOI 10.1016/j.jiec.2014.06.010; Kneipp J, 2008, CHEM SOC REV, V37, P1052, DOI 10.1039/b708459p; Kudelski A, 2008, TALANTA, V76, P1, DOI 10.1016/j.talanta.2008.02.042; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Li GL, 2011, J HAZARD MATER, V192, P277, DOI 10.1016/j.jhazmat.2011.05.015; Li JF, 2010, NATURE, V464, P392, DOI 10.1038/nature08907; Liang HY, 2009, ADV MATER, V21, P4614, DOI 10.1002/adma.200901139; Mishra YK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345606; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mishra YK, 2013, PLASMONICS, V8, P811, DOI 10.1007/s11468-013-9477-2; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mohapatra S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2894187; Ngo HT, 2014, ANALYST, V139, P5655, DOI [10.1039/C4AN01077A, 10.1039/c4an01077a]; Noh MS, 2009, BIOMATERIALS, V30, P3915, DOI 10.1016/j.biomaterials.2009.03.059; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Park BK, 2007, J COLLOID INTERF SCI, V311, P417, DOI 10.1016/j.jcis.2007.03.039; Pauluhn J, 2004, TOXICOL SCI, V81, P198, DOI 10.1093/toxsci/kfh187; Polavarapu L, 2008, LANGMUIR, V24, P10608, DOI 10.1021/la802319c; Polavarapu L, 2014, J MATER CHEM C, V2, P7460, DOI 10.1039/c4tc01142b; Qian XM, 2008, CHEM SOC REV, V37, P912, DOI 10.1039/b708839f; Rossi LM, 2005, LANGMUIR, V21, P4277, DOI 10.1021/la0504098; Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Singhal R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2976674; Singhal R, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/15/155103; Tripathy SK, 2013, J MATER SCI-MATER EL, V24, P2082, DOI 10.1007/s10854-013-1062-0; Tripathy SK, 2013, ANAL METHODS-UK, V5, P1456, DOI 10.1039/c3ay26549h; Tsuji M, 2006, MATER LETT, V60, P834, DOI 10.1016/j.matlet.2005.10.027; Tsuji M, 2007, COLLOID SURFACE A, V293, P185, DOI 10.1016/j.colsurfa.2006.07.027; Vo-Dinh T, 2010, J BIOPHOTONICS, V3, P89, DOI 10.1002/jbio.200910015; Wachsmann-Hogiu S, 2009, CURR OPIN BIOTECH, V20, P63, DOI 10.1016/j.copbio.2009.02.006; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wahab R, 2013, CHEM ENG J, V226, P154, DOI 10.1016/j.cej.2013.02.128; Wahab R, 2011, CHEM ENG J, V168, P359, DOI 10.1016/j.cej.2011.01.038; Wang YQ, 2013, CHEM REV, V113, P1391, DOI 10.1021/cr300120g; Zhao B, 2008, CHEM J CHINESE U, V29, P2591	62	16	16	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178651	10.1371/journal.pone.0178651	http://dx.doi.org/10.1371/journal.pone.0178651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570633	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800094
J	Henares-Molina, A; Benzekry, S; Lara, PC; Garcia-Rojo, M; Perez-Garcia, VM; Martinez-Gonzalez, A				Henares-Molina, Araceli; Benzekry, Sebastien; Lara, Pedro C.; Garcia-Rojo, Marcial; Perez-Garcia, Victor M.; Martinez-Gonzalez, Alicia			Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas	PLOS ONE			English	Article							MATHEMATICAL-MODEL; BRAIN-TUMORS; STEREOTACTIC BRACHYTHERAPY; GLIOBLASTOMA GROWTH; RADIATION-THERAPY; I-125 SEEDS; IN-VIVO; SIMULATION; CHILDREN; DIFFUSION	Grade II gliomas are slowly growing primary brain tumors that affect mostly young patients. Cytotoxic therapies (radiotherapy and/or chemotherapy) are used initially only for patients having a bad prognosis. These therapies are planned following the "maximum dose in minimum time" principle, i. e. the same schedule used for high-grade brain tumors in spite of their very different behavior. These tumors transform after a variable time into high-grade gliomas, which significantly decreases the patient's life expectancy. In this paper we study mathematical models describing the growth of grade II gliomas in response to radiotherapy. We find that protracted metronomic fractionations, i. e. therapeutical schedules enlarging the time interval between low-dose radiotherapy fractions, may lead to a better tumor control without an increase in toxicity. Other non-standard fractionations such as protracted or hypoprotracted schemes may also be beneficial. The potential survival improvement depends on the tumor's proliferation rate and can be even of the order of years. A conservative metronomic scheme, still being a suboptimal treatment, delays the time to malignant progression by at least one year when compared to the standard scheme.	[Henares-Molina, Araceli; Perez-Garcia, Victor M.; Martinez-Gonzalez, Alicia] Univ Castilla La Mancha, Dept Math, Ciudad Real, Castilla La Man, Spain; [Benzekry, Sebastien] INRIA Bordeaux Sud Ouest, Team MONC, Inst Math Bordeaux, Bordeaux, Nouvelle Aquita, France; [Lara, Pedro C.] Negrin Las Palmas Univ Hosp, Dept Radiat Oncol, Los Palmas Gc, Canarias, Spain; [Garcia-Rojo, Marcial] Hosp Jerez Frontera, Dept Pathol, Cadiz, Spain	Universidad de Castilla-La Mancha	Henares-Molina, A (corresponding author), Univ Castilla La Mancha, Dept Math, Ciudad Real, Castilla La Man, Spain.	araceli.henares@alu.uclm.es	García-Rojo, Marcial/H-4688-2018; Pérez-García, Víctor M./C-8892-2011; Benzekry, Sébastien/AAG-5164-2020; Martínez-González, Alicia/Q-5117-2017	García-Rojo, Marcial/0000-0001-6272-9401; Pérez-García, Víctor M./0000-0002-6575-495X; Benzekry, Sébastien/0000-0002-3749-8637; Martínez-González, Alicia/0000-0002-6938-0932	Ministerio de Economa y Competitividad/FEDER, Spain [MTM2015-71200-R]; Consejera de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain [PEII-2014-031-P]; James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer [220020420, 220020450]	Ministerio de Economa y Competitividad/FEDER, Spain; Consejera de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain; James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer	This work has been supported by Ministerio de Economa y Competitividad/FEDER, Spain [grant number MTM2015-71200-R], Consejera de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain [grant number PEII-2014-031-P] and James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer [Special Initiative Collaborative, Planning Grant 220020420 and Collaborative award 220020450].	Badoual M, 2014, CELL PROLIFERAT, V47, P369, DOI 10.1111/cpr.12114; Barazzuol L, 2010, J THEOR BIOL, V262, P553, DOI 10.1016/j.jtbi.2009.10.021; Bogdanska MU, 2017, MATH BIOSCI, V288, P1, DOI 10.1016/j.mbs.2017.02.003; Bondiau PY, 2008, PHYS MED BIOL, V53, P879, DOI 10.1088/0031-9155/53/4/004; Bondiau PY, 2011, PHYS MEDICA, V27, P103, DOI 10.1016/j.ejmp.2010.05.002; Brat DJ, 2003, ANN INTERN MED, V138, P659, DOI 10.7326/0003-4819-138-8-200304150-00014; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Clatz O, 2005, IEEE T MED IMAGING, V24, P1334, DOI 10.1109/TMI.2005.857217; Eikenberry SE, 2009, CELL PROLIFERAT, V42, P511, DOI 10.1111/j.1365-2184.2009.00613.x; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Galochkina T, 2015, MATH BIOSCI, V267, P1, DOI 10.1016/j.mbs.2015.05.006; GARCIA DM, 1985, CANCER, V55, P919, DOI 10.1002/1097-0142(19850301)55:5<919::AID-CNCR2820550502>3.0.CO;2-4; Grier JT, 2006, ONCOLOGIST, V11, P681, DOI 10.1634/theoncologist.11-6-681; Gururangan S, 2014, NEURO-ONCOLOGY, V16, P310, DOI 10.1093/neuonc/not154; Hathout Leith, 2015, CNS Oncol, V4, P247, DOI 10.2217/cns.15.16; Heng MA, 2016, CANCER MED-US, V5, P1542, DOI 10.1002/cam4.699; Higuchi Y, 2004, NEUROLOGY, V63, P2384, DOI 10.1212/01.WNL.0000147243.02317.28; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; Joiner MC, 2009, BASIC CLIN RADIOBIOL, V4; Konukoglu E, 2010, MED IMAGE ANAL, V14, P111, DOI 10.1016/j.media.2009.11.005; Korinthenberg R, 2011, INT J RADIAT ONCOL, V79, P1131, DOI 10.1016/j.ijrobp.2009.12.040; Kucharzewska P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116740; Leder K, 2014, CELL, V156, P603, DOI 10.1016/j.cell.2013.12.029; Marcu LG, 2010, CANCER TREAT REV, V36, P606, DOI 10.1016/j.ctrv.2010.04.004; Martinez-Gonzalez A, 2016, ADV EXP MED BIOL, V936, P11, DOI 10.1007/978-3-319-42023-3_2; Martinez-Gonzalez A, 2015, MATH MED BIOL, V32, P239, DOI 10.1093/imammb/dqu002; Martinez-Gonzalez A, 2012, B MATH BIOL, V74, P2875, DOI 10.1007/s11538-012-9786-1; Molina D, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160242; Murray J D, 2007, MATH BIOL; Pallud J, 2012, NEUROSURGERY, V71, P729, DOI 10.1227/NEU.0b013e31826213de; Pallud J, 2012, NEURO-ONCOLOGY, V14, P496, DOI 10.1093/neuonc/nos069; Perez-Beteta J, 2017, EUR RADIOL, V27, P1096, DOI 10.1007/s00330-016-4453-9; Perez-Garcia VM, 2016, MATH MED BIOL, V33, P253, DOI 10.1093/imammb/dqv017; Perez-Garcia VM, 2015, MATH MED BIOL, V32, P307, DOI 10.1093/imammb/dqu009; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Powathil G, 2007, PHYS MED BIOL, V52, P3291, DOI 10.1088/0031-9155/52/11/023; Ribba B, 2012, CLIN CANCER RES, V18, P5071, DOI 10.1158/1078-0432.CCR-12-0084; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Ruge MI, 2013, NEURO-ONCOLOGY, V15, P1721, DOI 10.1093/neuonc/not126; Ruge MI, 2011, J CLIN ONCOL, V29, P4151, DOI 10.1200/JCO.2011.37.3381; Ruiz J, 2009, CURR TREAT OPTION ON, V10, P231, DOI 10.1007/s11864-009-0096-2; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stamatakos GS, 2006, IEEE T BIO-MED ENG, V53, P1467, DOI 10.1109/TBME.2006.873761; Suchorska B, 2011, NEURO-ONCOLOGY, V13, P1133, DOI 10.1093/neuonc/nor100; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tanaka ML, 2009, CELL PROLIFERAT, V42, P637, DOI 10.1111/j.1365-2184.2009.00631.x; The WHO, 2020, CLASSIFICATION TUMOU; Tyagi A, 2015, J MAXILLOFAC ORAL SU, V14, pS127, DOI [10.4103/0973-029X.164519, 10.1007/s12663-012-0366-6]; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178552	10.1371/journal.pone.0178552	http://dx.doi.org/10.1371/journal.pone.0178552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570587	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800075
J	Hong, JH; Sohn, SI; Kwak, J; Yoo, J; Ahn, SJ; Woo, SJ; Jung, C; Yum, KS; Bae, HJ; Chang, JY; Jung, JH; Lee, JS; Han, MK				Hong, Jeong-Ho; Sohn, Sung-Il; Kwak, Jaehyuk; Yoo, Joonsang; Ahn, Seong Joon; Woo, Se Joon; Jung, Cheolkyu; Yum, Kyu Sun; Bae, Hee-Joon; Chang, Jun Young; Jung, Jin-Heon; Lee, Ji Sung; Han, Moon-Ku			Retinal artery occlusion and associated recurrent vascular risk with underlying etiologies	PLOS ONE			English	Article							OPHTHALMIC ARTERY; AMAUROSIS FUGAX; ISCHEMIC-STROKE; POPULATION; SUBTYPE; DISEASE; EMBOLI	Background and purpose RAO is caused by various etiologies and subsequent vascular events may be associated with underlying etiologies. Our aim is to investigate the etiologies of RAO, the occurrence of subsequent vascular events and their association in patients with RAO. Methods We analyzed data from 151 consecutive patients presenting with acute non-arteritic RAO between 2003 and 2013 in a single tertiary-care hospital. The primary outcome was the occurrence of a vascular event defined as stroke, myocardial infarction, and vascular death within 365 days of the RAO onset. The Kaplan-Meier survival analysis and Cox proportional hazard model were used to estimate the hazard ratio of the vascular events. Results Large artery atherosclerosis (LAA) was the etiology more frequently associated with of RAO (41.1%, 62/151). During the one year follow-up, ischemic stroke and vascular events occurred in 8.6% and 9.9% of patients, respectively. Ten vascular events occurred in RAO patients attributed to LAA and 4 occurred in undetermined etiology. RAO patients with LAA had a nearly four times higher risk of vascular events compared to those without LAA (hazard ratio 3.94, 95% confidence interval 1.21-12.81). More than a half of all events occurred within one month and over three fourths of ischemic strokes occurred ipsilateral to the RAO. Conclusion After occurrence of RAO, there is a high risk of a subsequent vascular event, particularly ipsilateral stroke, within one month. LAA is an independent factor for the occurrence of a subsequent vascular event. Management for the prevention of secondary vascular events is necessary in patients with RAO especially with LAA. Large clinical trials are needed to confirm these findings.	[Hong, Jeong-Ho; Sohn, Sung-Il; Kwak, Jaehyuk; Yoo, Joonsang] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Ahn, Seong Joon] Hanyang Univ, Coll Med, Hanyang Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Seongnam, South Korea; [Jung, Cheolkyu] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Yum, Kyu Sun; Bae, Hee-Joon; Han, Moon-Ku] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Seoul, South Korea; [Chang, Jun Young] Gyengsang Natl Univ, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Jung, Jin-Heon] Dong A Univ Hosp, Dept Crit Care Med & Neurol, Busan, South Korea; [Lee, Ji Sung] Univ Ulsan, Clin Trial Ctr, Coll Med, Seoul, South Korea; [Lee, Ji Sung] Asan Med Ctr, Seoul, South Korea	Keimyung University; Hanyang University; Hanyang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Dong A University; University of Ulsan	Han, MK (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Neurol, Seoul, South Korea.	mkhan@snu.ac.kr	Hong, Jeong-Ho/T-8099-2018; JEONG, JIN-HEON/O-3734-2017; Hong, Jeong-Ho/AAE-1002-2022	Hong, Jeong-Ho/0000-0002-8235-9855; JEONG, JIN-HEON/0000-0002-5878-9206; Hong, Jeong-Ho/0000-0002-8235-9855; Chang, Jun Young/0000-0003-4880-9258; Sohn, Sung Il/0000-0002-6900-1242	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2014R1A5A2010008]	National Research Foundation of Korea (NRF) - Korean Government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (No. 2014R1A5A2010008).	ADAMS HP, 1983, STROKE, V14, P742, DOI 10.1161/01.STR.14.5.742; Ahn SJ, 2013, INVEST OPHTH VIS SCI, V54, P7746, DOI 10.1167/iovs.13-12952; Atkins EJ, 2009, AM J OPHTHALMOL, V148, P172, DOI 10.1016/j.ajo.2009.03.020; Babikian V, 2001, CEREBROVASC DIS, V12, P108, DOI 10.1159/000047689; BRUNO A, 1995, ANN INTERN MED, V122, P249, DOI 10.7326/0003-4819-122-4-199502150-00002; Callizo J, 2015, OPHTHALMOLOGY, V122, P1881, DOI 10.1016/j.ophtha.2015.05.044; Chang YS, 2012, AM J OPHTHALMOL, V154, P645, DOI 10.1016/j.ajo.2012.03.046; Hayreh SS, 2011, PROG RETIN EYE RES, V30, P359, DOI 10.1016/j.preteyeres.2011.05.001; Hayreh SS, 2009, OPHTHALMOLOGY, V116, P1928, DOI 10.1016/j.ophtha.2009.03.006; Helenius J, 2012, ANN NEUROL, V72, P286, DOI 10.1002/ana.23597; Hwang GJ, 2010, J NEURO-OPHTHALMOL, V30, P228, DOI 10.1097/WNO.0b013e3181dc2078; Kim BJ, 2015, J STROKE, V17, P38, DOI 10.5853/jos.2015.17.1.38; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1063; Ko Y, 2014, J STROKE, V16, P161, DOI 10.5853/jos.2014.16.3.161; Leisser C, 2015, GRAEF ARCH CLIN EXP, V253, P1227, DOI 10.1007/s00417-014-2804-2; Leisser C, 2014, SPEKTRUM AUGENHEILKD, V28, P118, DOI 10.1007/s00717-014-0218-5; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Park SJ, 2015, OPHTHALMOLOGY, V122, P2336, DOI 10.1016/j.ophtha.2015.07.018; SAVINO PJ, 1977, ARCH OPHTHALMOL-CHIC, V95, P1185, DOI 10.1001/archopht.1977.04450070083005; Schmidt D, 2007, EUR J MED RES, V12, P595; WEINBERGER J, 1980, STROKE, V11, P290, DOI 10.1161/01.STR.11.3.290; WILSON LA, 1979, LANCET, V1, P292	22	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177663	10.1371/journal.pone.0177663	http://dx.doi.org/10.1371/journal.pone.0177663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570629	Green Submitted, gold, Green Published			2022-12-26	WOS:000402611800016
J	Caliskaner, ZO; Cakar, T; Ozcelik, E; Ozdilik, A; Kim, AS; Dogan, O; Bosompem, A; Grosveld, G; Saka, B; Kandilci, A				Caliskaner, Zihni Onur; Cakar, Turkan; Ozcelik, Emrah; Ozdilik, Ahmet; Kim, Annette S.; Dogan, Oner; Bosompem, Amma; Grosveld, Gerard; Saka, Bulent; Kandilci, Ayten			DEK protein level is a biomarker of CD138(positive) normal and malignant plasma cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA; OVEREXPRESSION; EXPRESSION; GENE; PROTOONCOGENE; INHIBITOR	Overexpression of DEK oncogene is associated with increased proliferation of carcinoma cells and it is observed in several solid tumors due to the amplification of the 6p22.3 chromosomal region where DEK locates. Although the same chromosomal amplification occurs in multiple myeloma (MM), a plasma cell neoplasm, whether the expression and the copy number of the DEK gene are affected in MM remains elusive. We show that despite the increased copy number in CD138(positive) MM cells (4 out of 41 MM samples), DEK mRNA expression was down-regulated compared with that in CD138(negative) bone marrow (BM) cells of the same patients (P< 0.0001). DEK protein was not detectable by immunohistochemistry (IHC) in CD138(positive) normal plasma cells or in malignant plasma cells of MM patients (n = 56) whereas it was widely expressed in normal and neoplastic B-cells. Stable knockdown or overexpression of DEK in CD138(positive) MM cell lines did not affect the proliferation and viability of the cells profoundly in the presence or absence of chemotherapeutic agent melphalan whereas knockdown of DEK moderately but significantly increased the expression level of CD138 (p< 0.01). Decreased DEK expression in plasma cells suggests a potential role of this gene in plasma cell development and lack of detectable DEK protein by IHC could be used as a biomarker for normal and malignant plasma cells.	[Caliskaner, Zihni Onur; Cakar, Turkan; Ozcelik, Emrah; Ozdilik, Ahmet; Kandilci, Ayten] Gebze Tech Univ, Dept Mol Biol & Genet, Gebze, Kocaeli, Turkey; [Kim, Annette S.; Bosompem, Amma] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Dogan, Oner] Istanbul Univ, Dept Pathol, Istanbul Med Fac, Istanbul, Turkey; [Grosveld, Gerard] St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA; [Saka, Bulent] Istanbul Univ, Istanbul Med Fac, Dept Internal Med, Istanbul, Turkey	Gebze Technical University; Vanderbilt University; Istanbul University; St Jude Children's Research Hospital; Istanbul University	Kandilci, A (corresponding author), Gebze Tech Univ, Dept Mol Biol & Genet, Gebze, Kocaeli, Turkey.	akandilci@gtu.edu.tr	Özçelik, Emrah/AAL-3587-2021; Saka, Bulent/AAE-5588-2020; Çalışkaner, Onur/AAQ-6517-2021; Saka, Bulent/AGZ-8083-2022	CALISKANER, Zihni Onur/0000-0003-1385-1739	Scientific and Technological Research Council of Turkey (TUEBITAK) [KBAG212T108]; Gebze Technical University Research Fund [BAP-2015-A14]; NCI/NIH Cancer Center [2P30CA06848514]	Scientific and Technological Research Council of Turkey (TUEBITAK); Gebze Technical University Research Fund(Gebze Teknik University); NCI/NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Scientific and Technological Research Council of Turkey (TUEBITAK) Grant (KBAG212T108) and Gebze Technical University Research Fund (BAP-2015-A14). Samples were obtained from the Translational Pathology Shared Resource at Vanderbilt University Medical Center that is supported by NCI/NIH Cancer Center Support Grant 2P30CA06848514.	Ageberg M, 2006, HAEMATOL-HEMATOL J, V91, P268; Alexander DD, 2007, INT J CANCER, P40, DOI 10.1002/ijc.22718; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Broxmeyer HE, 2012, STEM CELLS DEV, V21, P1449, DOI 10.1089/scd.2011.0451; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; FORNEROD M, 1995, ONCOGENE, V10, P1739; Galson Deborah L, 2012, Bonekey Rep, V1, P135, DOI 10.1038/bonekey.2012.135; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Kandilci A, 2009, BLOOD, V114, P1596, DOI 10.1182/blood-2009-02-205443; Kappes F, 2001, J BIOL CHEM, V276, P26317, DOI 10.1074/jbc.M100162200; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Paino T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092378; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Rose-Zerilli MJ, 2009, CLIN CHEM, V55, P1680, DOI 10.1373/clinchem.2008.120105; Savli H, 2002, BRIT J HAEMATOL, V118, P1065, DOI 10.1046/j.1365-2141.2002.03734.x; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vogt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014249; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wu QO, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-16	28	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178025	10.1371/journal.pone.0178025	http://dx.doi.org/10.1371/journal.pone.0178025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558048	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000022
J	Katsu, N; Yamada, K; Nakamichi, M				Katsu, Noriko; Yamada, Kazunori; Nakamichi, Masayuki			Vocalizations during post -conflict affiliations from victims toward aggressors based on uncertainty in Japanese macaques	PLOS ONE			English	Article							LONG-TAILED MACAQUES; ADULT FEMALE BABOONS; MACACA-FUSCATA; RELATIONSHIP QUALITY; RECONCILIATION; PRIMATES; MONKEYS; ANXIETY; RHESUS; GRUNTS	We investigated the use of vocalizations called "grunts," "girneys," and "coos" accompanied by post-conflict affiliative interaction between former opponents (reconciliation) in Japanese macaques (Macaca fuscata). Although reconciliation functions to repair bonds, such interactions sometimes entail risks of receiving further aggression. Vocalizations can be used at a distance from the former opponent; thus, we predict that vocalizations are used particularly by victims of a conflict, and are frequently used in situations of uncertainty when it is difficult for them to estimate whether the former opponent will resume aggression. In addition, we predict that vocalizations are effective in preventing further aggression. To test these hypotheses, we conducted observations of post-conflict and matched-control situations in female Japanese macaques living in a free-ranging group. We found that former opponents tended to be attracted to each other within the first minute following a conflict, thus demonstrating reconciliation behavior. Vocalizations were more frequently used by the victims in post-conflict interactions than under control situations; however, this tendency was not found in aggressors. When affiliation with the former opponent occurred, victims were more likely to use vocalizations towards less familiar opponents. These findings suggest that Japanese macaques used vocalizations more often when interacting with less predictable former opponents. Victims were more likely to receive aggression from former aggressors when engaged in affiliations with them than under no such affiliations. No significant differences were found in the probability of the victims receiving aggression, regardless of whether they used vocalizations; thus, whether the victim benefits from using vocalizations in these contexts remains unclear. Japanese macaques form despotic societies and therefore, further aggression was inevitable, to some degree, after a conflict. The use of vocalizations by a victim was found to depend on the nature of their relationship with the aggressor; however, the effectiveness of this behavior requires further investigation.	[Katsu, Noriko] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Yamada, Kazunori; Nakamichi, Masayuki] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan	University of Tokyo; Osaka University	Katsu, N (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	katsuno0414@gmail.com		Katsu, Noriko/0000-0002-6056-8197; Yamada, Kazunori/0000-0001-5966-5080	JSPS KAKENHI [13J03612, 16H06928, 17J10994]; Grants-in-Aid for Scientific Research [17H02436] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support was provided by JSPS KAKENHI Grant Numbers 13J03612, 16H06928, and 17J10994 to N.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support provided by Mr. S. Asaba and the staff of the Iwatayama Monkey Park. Financial support was provided by JSPS KAKENHI Grant Numbers 13J03612, 16H06928, and 17J10994 to N. K.	[Anonymous], 2013, R LANG ENV STAT COMP; Asquith, 1991, MONKEYS ARASHIYAMA 3; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; AURELI F, 1991, ETHOLOGY, V89, P101; Bates D., 2013, LME4 LINEAR MIXED EF; Call J, 1999, ANIM BEHAV, V58, P165, DOI 10.1006/anbe.1999.1116; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Colmenares F, 2008, ETHOLOGY, V114, P1101, DOI 10.1111/j.1439-0310.2008.01559.x; CORDS M, 1993, ETHOLOGY, V93, P315; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Cords M., 2000, NATURAL CONFLICT RES, P177; Cords Marina, 1996, Evolutionary Anthropology, V5, P42, DOI 10.1002/(SICI)1520-6505(1996)5:2<42::AID-EVAN3>3.3.CO;2-R; Demaria C, 2001, BEHAVIOUR, V138, P397, DOI 10.1163/15685390152032514; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Hothorn T., 2015, EXACTRANKTESTS EXACT; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Katsu N, 2016, BEHAVIOUR, V153, P125, DOI 10.1163/1568539X-00003330; Katsu N, 2014, ETHOLOGY, V120, P1024, DOI 10.1111/eth.12275; Koski SE, 2007, AM J PRIMATOL, V69, P158, DOI 10.1002/ajp.20338; Koyama NF, 2001, ETHOLOGY, V107, P975, DOI 10.1046/j.1439-0310.2001.00731.x; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; MAESTRIPIERI D, 1994, FOLIA PRIMATOL, V63, P192, DOI 10.1159/000156819; Majolo B, 2009, ETHOLOGY, V115, P152, DOI 10.1111/j.1439-0310.2008.01591.x; Matsumura S, 1999, PRIMATES, V40, P23, DOI 10.1007/BF02557699; McFarland R, 2011, ETHOLOGY, V117, P928, DOI 10.1111/j.1439-0310.2011.01948.x; Patzelt A, 2009, ETHOLOGY, V115, P658, DOI 10.1111/j.1439-0310.2009.01649.x; Petit O, 1997, BEHAVIOUR, V134, P415, DOI 10.1163/156853997X00610; Schino G, 1998, BEHAVIOUR, V135, P897, DOI 10.1163/156853998792640314; Schino G, 2007, ETHOLOGY, V113, P1081, DOI 10.1111/j.1439-0310.2007.01407.x; Schino G, 2011, ANIM BEHAV, V81, P1009, DOI 10.1016/j.anbehav.2011.02.004; Silk JB, 2002, ANNU REV ANTHROPOL, V31, P21, DOI 10.1146/annurev.anthro.31.032902.101743; Silk JB, 1996, ANIM BEHAV, V52, P259, DOI 10.1006/anbe.1996.0171; Silk JB, 2000, ANIM BEHAV, V59, P423, DOI 10.1006/anbe.1999.1312; Silk JB, 2003, ETHOLOGY, V109, P627, DOI 10.1046/j.1439-0310.2003.00907.x; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Thierry Bernard, 2000, P106; Tokuyama N, 2014, BEHAVIOUR, V151, P1121, DOI 10.1163/1568539X-00003176; Whitham JC, 2007, ETHOLOGY, V113, P862, DOI 10.1111/j.1439-0310.2007.01381.x	44	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178655	10.1371/journal.pone.0178655	http://dx.doi.org/10.1371/journal.pone.0178655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GJ	28558070	gold, Green Submitted, Green Published			2022-12-26	WOS:000402607000060
J	Shuey, MM; Billings, FT; Wei, SZ; Milne, GL; Nian, H; Yu, C; Brown, NJ				Shuey, Megan M.; Billings, Frederic T.; Wei, Shouzou; Milne, Ginger L.; Nian, Hui; Yu, Chang; Brown, Nancy J.			Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ACUTE-RENAL-FAILURE; EPOXYEICOSATRIENOIC ACIDS EETS; BYPASS GRAFT-SURGERY; ENDOTHELIAL-CELLS; BLOOD-PRESSURE; HYPERPOLARIZING FACTORS; OUTCOMES; RISK; HYPERTENSION	Twenty to thirty percent of patients undergoing cardiac surgery develop acute kidney injury (AKI). In mice, inhibition of soluble epoxide hydrolase (sEH) attenuates renal injury following ischemia-reperfusion. We tested the hypothesis that functional variants of EPHX2, encoding sEH, are associated with AKI after cardiac surgery. We genotyped patients in two independent cardiac surgery cohorts for functional EPHX2 polymorphisms, Lys55Arg and Arg287Gln, and determined AKI using Acute Kidney Injury Network criteria. The 287Gln variant was not associated with AKI. In the discovery cohort, the gain-of-function 55Arg variant was associated with an increased incidence of AKI in univariate (p = 0.03) and multivariable (p = 0.04) analyses. In white patients without chronic kidney disease (CKD), the 55Arg variant was independently associated with AKI with an OR of 2.04 (95% CI 0.95-4.42) for 55Arg heterozygotes and 31.53 (1.57-633.19) for homozygotes (p = 0.02), after controlling for age, sex, body mass index, baseline estimated glomerular filtration rate, and use of cardiopulmonary bypass. These findings were replicated in the second cardiac surgery cohort. 12,13- and total-dihydroxyoctadecanoic acids (DiHOME): epoxyoctadecanoic acids (EpOME) ratios were increased in EPHX2 55Arg variant carriers, consistent with increased hydrolase activity. The EPHX2 Lys55Arg polymorphism is associated with AKI following cardiac surgery in patients without preexisting CKD. Pharmacological strategies to decrease sEH activity might decrease postoperative AKI.	[Shuey, Megan M.; Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Billings, Frederic T.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA; [Billings, Frederic T.; Wei, Shouzou; Milne, Ginger L.; Nian, Hui; Yu, Chang; Brown, Nancy J.] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA; [Billings, Frederic T.; Wei, Shouzou; Milne, Ginger L.; Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Nian, Hui; Yu, Chang] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, NJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.; Brown, NJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.; Brown, NJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	nancy.j.brown@vanderbilt.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; Billings, Josh/0000-0001-7135-7785	National Institutes of Health [K23 GM102676, R01 GM112871, P01 DK038226, UL1 RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM102676, R01GM112871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the National Institutes of Health (K23 GM102676 and R01 GM112871 awarded to FTB, P01 DK038226 awarded to NJB, and UL1 RR024975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Billings FT, 2016, JAMA-J AM MED ASSOC, V315, P877, DOI 10.1001/jama.2016.0548; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Body SC, 2009, CIRC-CARDIOVASC GENE, V2, P499, DOI 10.1161/CIRCGENETICS.109.849075; Brodsky SV, 2002, AM J PHYSIOL-RENAL, V282, pF1140, DOI 10.1152/ajprenal.00329.2001; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; CAPDEVILA JH, 1991, METHOD ENZYMOL, V206, P441; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Cardinal-Fernandez P, 2012, MED INTENSIVA, V36, P626, DOI 10.1016/j.medin.2012.02.002; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chen D, 2012, J CLIN PHARMACOL, V52, P319, DOI 10.1177/0091270010397049; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; Elmarakby AA, 2011, AM J PHYSIOL-REG I, V301, pR1307, DOI 10.1152/ajpregu.00759.2010; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF131, DOI 10.1152/ajprenal.00531.2014; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Landray MJ, 2004, AM J KIDNEY DIS, V43, P244, DOI 10.1053/j.ajkd.2003.10.037; Lazaar A. L., 2015, BR J CLIN PHARM; Lee CR, 2011, HYPERTENSION, V57, P116, DOI 10.1161/HYPERTENSIONAHA.110.161695; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; Medhora M, 2003, AM J PHYSIOL-HEART C, V284, pH215, DOI 10.1152/ajpheart.01118.2001; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Parrish AR, 2009, CELL BIOL TOXICOL, V25, P217, DOI 10.1007/s10565-008-9071-0; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Ramirez CE, 2014, PROSTAG OTH LIPID M, V113, P38, DOI 10.1016/j.prostaglandins.2014.08.001; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Rosolowsky M, 1996, BBA-LIPID LIPID MET, V1299, P267, DOI 10.1016/0005-2760(95)00216-2; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Shen HC, 2010, EXPERT OPIN THER PAT, V20, P941, DOI 10.1517/13543776.2010.484804; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Srivastava PK, 2004, ARCH BIOCHEM BIOPHYS, V427, P164, DOI 10.1016/j.abb.2004.05.003; Swaminathan M, 2007, CRIT CARE MED, V35, P2286, DOI 10.1097/01.CCM.0000282079.05994.57; TAYLOR KM, 1977, J THORAC CARDIOV SUR, V74, P840; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244; Zhu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145645	57	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0175292	10.1371/journal.pone.0175292	http://dx.doi.org/10.1371/journal.pone.0175292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552948	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000001
J	Nordenstedt, N; Marcenaro, D; Chilagane, D; Mwaipopo, B; Rajamaki, ML; Nchimbi-Msolla, S; Njau, PJR; Mbanzibwa, DR; Valkonen, JPT				Nordenstedt, Noora; Marcenaro, Delfia; Chilagane, Daudi; Mwaipopo, Beatrice; Rajamaki, Minna-Liisa; Nchimbi-Msolla, Susan; Njau, Paul J. R.; Mbanzibwa, Deusdedith R.; Valkonen, Jari P. T.			Pathogenic seedborne viruses are rare but Phaseolus vulgaris endornaviruses are common in bean varieties grown in Nicaragua and Tanzania	PLOS ONE			English	Article							MOSAIC-NECROSIS-VIRUS; CYTOPLASMIC MALE-STERILITY; BELL PEPPER ENDORNAVIRUS; SMALL INTERFERING RNAS; NUCLEOTIDE-SEQUENCE; DEGENERATE PRIMERS; GERMPLASM LINES; GENOME SEQUENCE; RESISTANCE; TRANSMISSION	Common bean (Phaseolus vulgaris) is an annual grain legume that was domesticated in Mesoamerica (Central America) and the Andes. It is currently grown widely also on other continents including Africa. We surveyed seedborne viruses in new common bean varieties introduced to Nicaragua (Central America) and in landraces and improved varieties grown in Tanzania (eastern Africa). Bean seeds, harvested from Nicaragua and Tanzania, were grown in insect-controlled greenhouse or screenhouse, respectively, to obtain leaf material for virus testing. Equal amounts of total RNA from different samples were pooled (30-36 samples per pool), and small RNAs were deep-sequenced (Illumina). Assembly of the reads (21-24 nt) to contiguous sequences and searches for homologous viral sequences in data-bases revealed Phaseolus vulgaris endornavirus 1 (PvEV-1) and PvEV-2 in the bean varieties in Nicaragua and Tanzania. These viruses are not known to cause symptoms in common bean and are considered non-pathogenic. The small-RNA reads from each pool of samples were mapped to the previously characterized complete PvEV-1 and PvEV-2 sequences (genome lengths ca. 14 kb and 15 kb, respectively). Coverage of the viral genomes was 87.9-99.9%, depending on the pool. Coverage per nucleotide ranged from 5 to 471, confirming virus identification. PvEV-1 and PvEV-2 are known to occur in Phaseolus spp. in Central America, but there is little previous information about their occurrence in Nicaragua, and no information about occurrence in Africa. Aside from Cowpea mild mosaic virus detected in bean plants grown from been seeds harvested from one region in Tanzania, no other pathogenic seedborne viruses were detected. The low incidence of infections caused by pathogenic viruses transmitted via bean seeds may be attributable to new, virus-resistant CB varieties released by breeding programs in Nicaragua and Tanzania.	[Nordenstedt, Noora; Marcenaro, Delfia; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Marcenaro, Delfia] Nicaraguan Inst Agr Technol CNIAB INTA, Managua, Nicaragua; [Chilagane, Daudi; Mwaipopo, Beatrice; Nchimbi-Msolla, Susan; Njau, Paul J. R.] Sokoine Univ Agr, Morogoro, Tanzania; [Chilagane, Daudi; Mwaipopo, Beatrice; Mbanzibwa, Deusdedith R.] Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania	University of Helsinki; Sokoine University of Agriculture	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.; Mbanzibwa, DR (corresponding author), Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania.	mbanzibwad@yahoo.co.uk; jari.valkonen@helsinki.fi	Rajamäki, Minna-Liisa/AAY-5758-2020; Mbanzibwa, Deusdedith/GZB-1649-2022	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Mbanzibwa, Deusdedith Rugaihukamu/0000-0002-1588-5150; Valkonen, Jari/0000-0002-3704-9911	Bill & Melinda Gates Foundation [OPP1112522, OPP1130216]; Ministry for Foreign Affairs of Finland [36419901, HEL67338-129, 36421515]; Ministry of Agriculture and Forestry, Finland [2221/03.01.02/2015]; European Cooperation in Science and Technology (FA COST Action) [FM407]; Program for Emerging Agricultural Research Leaders (PEARL) [OPP1112522]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry for Foreign Affairs of Finland; Ministry of Agriculture and Forestry, Finland; European Cooperation in Science and Technology (FA COST Action); Program for Emerging Agricultural Research Leaders (PEARL)	This work was supported financially by the Bill & Melinda Gates Foundation (PEARL grant OPP1112522 to D. Mbanzibwa and subproject of the NextGen Phytosanitation programme OPP1130216 to J. Valkonen), the Ministry for Foreign Affairs of Finland (grants 36419901, HEL67338-129 and 36421515 to J. Valkonen), Ministry of Agriculture and Forestry, Finland (grant 2221/03.01.02/2015 to J. Valkonen), and European Cooperation in Science and Technology (FA COST Action FM407), none of which had any role in data collection or analysis, decision to publish, or manuscript preparation. The Nicaraguan Institute of Agricultural Technology (INTA) and Mikocheni Agricultural Research Institute, Tanzania, financially supported the collection of research material but had no role in decision to publish or manuscript preparation.; We thank Dr. Aldo Rojas and Dr. Juan Carlos Rosas, Nicaragua, for collaboration and sharing valuable information. We also thank the personnel of La Compailia and the Nicaraguan Institute of Agricultural Technology (INTA), Nicaragua, Ms. Hilda Bachwenkizi and Mr. Deogratias Mark of Mikocheni Agricultural Research Institute, Tanzania, and Yaqi Bi, Katrin Artola, Milton Untiveros and Juha Kiveld, Finland, for assistance. The farmers all over Tanzania are thanked for collaboration and providing us with bean seeds. This study was part of the Nicaragua-Finland Agrobiotechnology and Human Capacity Building Program (NIFAPRO) carried out jointly by INTA and University of Helsinki. Participation of the Ministry of Agriculture, Livestock and Forestry (MAGFOR), National University of Agriculture (UNA), Ministry of Foreign Affairs of Nicaragua, and Ministry for Foreign Affairs of Finland in the Steering Committee of NIFAPRO is gratefully acknowledged. The study was also part of the Program for Emerging Agricultural Research Leaders (PEARL; OPP1112522) and linked to the NextGen Phytosanitation programme (OPP1130216) of the Bill & Melinda Gates Foundation.	Anjum F, 2016, CROP PROT, V88, P131, DOI 10.1016/j.cropro.2016.06.002; [Anonymous], 2016, GEN END; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Beaver JS, 2015, J PLANT REGIST, V9, P208, DOI 10.3198/jpr2014.09.0061crg; Bi YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042758; Blair MW, 2007, THEOR APPL GENET, V114, P261, DOI 10.1007/s00122-006-0428-6; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Candresse T, 2016, ARCH VIROL, V161, P741, DOI 10.1007/s00705-015-2709-3; Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Chacon MI, 2005, THEOR APPL GENET, V110, P432, DOI 10.1007/s00122-004-1842-2; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ferrufino A, 2013, CATALOGO SEMILLAS GR; Flores-Estevez N, 2003, PLANT DIS, V87, P21, DOI 10.1094/PDIS.2003.87.1.21; FRISCHMUTH T, 1990, VIROLOGY, V178, P461, DOI 10.1016/0042-6822(90)90343-P; FUENTES AL, 1990, PLANT DIS, V74, P938, DOI 10.1094/PD-74-0938B; Fukuhara T, 2006, ARCH VIROL, V151, P995, DOI 10.1007/s00705-005-0688-5; Gallitelli D, 2000, VIRUS RES, V71, P9, DOI 10.1016/S0168-1702(00)00184-2; Gamez R., 1973, VIRUS FRIJOL CTR AM; Garrido-Ramirez ER, 2000, PHYTOPATHOLOGY, V90, P1224, DOI 10.1094/PHYTO.2000.90.11.1224; GRILL LK, 1981, P NATL ACAD SCI-BIOL, V78, P7043, DOI 10.1073/pnas.78.11.7043; Hall R, 1991, COMPENDIUM BEAN DIS; Hillocks RJ, 2006, EUPHYTICA, V150, P215, DOI 10.1007/s10681-006-9112-9; Hord MJ, 2001, PLANT DIS, V85, P952, DOI 10.1094/PDIS.2001.85.9.952; Hull R., 2004, SO BEAN MOSAIC VIRUS; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jimenez OR, 2012, PLANT GENET RESOUR-C, V10, P108, DOI 10.1017/S1479262112000081; JOHANSEN E, 1994, ANNU REV PHYTOPATHOL, V32, P363, DOI 10.1146/annurev.py.32.090194.002051; Karkashian J, 2011, PLANT DIS, V95, P901, DOI 10.1094/PDIS-03-10-0165; Kashif M, 2012, PLANT DIS, V96, P1430, DOI 10.1094/PDIS-03-12-0268-RE; Khankhum S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01905; Khankhum S, 2015, ARCH VIROL, V160, P1131, DOI 10.1007/s00705-015-2335-0; Kontra L, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005935; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kutnjak D, 2015, J VIROL, V89, P4760, DOI 10.1128/JVI.03685-14; LEFEBVRE A, 1990, PLANT MOL BIOL, V14, P477, DOI 10.1007/BF00027494; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Marcenaro D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168662; Maule AJ, 1996, TRENDS MICROBIOL, V4, P153, DOI 10.1016/0966-842X(96)10016-0; Melgarejo TA, 2007, ARCH VIROL, V152, P1941, DOI 10.1007/s00705-007-1008-z; Melotto M, 1996, GENOME, V39, P1216, DOI 10.1139/g96-155; MINK GI, 1987, PLANT DIS, V71, P557, DOI 10.1094/PD-71-0557F; MORALES FJ, 1988, PLANT DIS, V72, P1020, DOI 10.1094/PD-72-1020; MORALES FJ, 1987, PLANT DIS, V71, P51, DOI 10.1094/PD-71-0051; Myers J.R., 2000, ANN REPORT BEAN IMPR, P13; Njau PJR, 2000, SEED SCI TECHNOL, V28, P85; Okada R, 2013, J GEN VIROL, V94, P220, DOI 10.1099/vir.0.044487-0; Okada R, 2011, J GEN VIROL, V92, P2664, DOI 10.1099/vir.0.034686-0; OTHMAN Y, 1995, VIROLOGY, V206, P287, DOI 10.1016/S0042-6822(95)80044-1; Palukaitis P., 2003, CUCUMBER MOSAIC VIRU; Prophete E, 2014, J PLANT REGIST, V8, P49, DOI 10.3198/jpr2013.08.0046crg; Rojas A, 2005, ARCH VIROL, V150, P1281, DOI 10.1007/s00705-005-0509-x; ROJAS MR, 1993, PLANT DIS, V77, P340, DOI 10.1094/PD-77-0340; Roossinck MJ, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00767; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santalla M., 1999, BASE: Biotechnologie, Agronomie, Societe et Environnement, V3, P225; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Seguin J, 2014, J VIROL METHODS, V195, P120, DOI 10.1016/j.jviromet.2013.10.013; Segundo E, 2008, EUR J PLANT PATHOL, V122, P579, DOI 10.1007/s10658-008-9328-8; Sela N, 2012, J VIROL, V86, P7721, DOI 10.1128/JVI.00983-12; Sengooba TN, 1997, PLANT PATHOL, V46, P95, DOI 10.1046/j.1365-3059.1997.d01-12.x; Shang HH, 2015, ARCH VIROL, V160, P1827, DOI 10.1007/s00705-015-2426-y; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Singh SP, 2000, CROP SCI, V40, P1565, DOI 10.2135/cropsci2000.4061565x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tryphone MT, 2013, PLANT BREEDING LAB F, P121, DOI [10.5772/52823, DOI 10.5772/52823]; Vallejos CE, 2006, GENETICS, V172, P1229, DOI 10.1534/genetics.105.050815; Valverde RA, 2007, VIRUS GENES, V35, P399, DOI 10.1007/s11262-007-0092-1; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]; Worrall EA, 2015, ADV VIRUS RES, V93, P1, DOI 10.1016/bs.aivir.2015.04.002; Wortmann CS, 2004, USITC PUBL, V297; Wyatt SD, 1996, PHYTOPATHOLOGY, V86, P1288, DOI 10.1094/Phyto-86-1288; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017	74	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178242	10.1371/journal.pone.0178242	http://dx.doi.org/10.1371/journal.pone.0178242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542624	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800059
J	Arora, K; Sequeira, JM; Hernandez, AI; Alarcon, JM; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Hernandez, Alejandro I.; Alarcon, Juan M.; Quadros, Edward V.			Behavioral alterations are associated with vitamin B-12 deficiency in the transcobalamin receptor/CD320 KO mouse	PLOS ONE			English	Article							ACTIVE PLACE AVOIDANCE; SYNAPTIC DYSFUNCTION; OXIDATIVE STRESS; COBALAMIN; HOMOCYSTEINE; MICE; INFORMATION; PLASTICITY; GLUTAMATE; MODEL	Vitamin B-12 (cobalamin) deficiency is prevalent worldwide and causes megaloblastic anemia and neurologic deficits. While the anemia can be treated, the neurologic deficits can become refractive to treatment as the disease progresses. Therefore, timely intervention is critical for a favorable outcome. Moreover, the metabolic basis for the neuro-pathologic changes and the role of cobalamin deficiency in the pathology still remains unexplained. Using a transcobalamin receptor/CD320 knockout mouse that lacks the receptor for cellular uptake of transcobalamin bound cobalamin, we aimed to determine whether cobalamin deficiency in the central nervous system produced functional neurologic deficits in the mouse that would parallel those observed in humans. Our behavioral analyses indicate elevated anxiety and deficits in learning, memory and set-shifting of a spatial memory task in the KO mouse. Consistent with the behavioral deficits, the knockout mouse shows impaired expression of the early phase of hippocampal long-term potentiation along with reduced expression of GluR1, decreased brain mass and a significant reduction in the size of nuclei of the hippocampal pyramidal neurons. Our study suggests that the CD320 knockout mouse develops behavioral deficits associated with cobalamin deficiency and therefore could provide a model to understand the metabolic and genetic basis of neuro-pathologic changes due to cobalamin deficiency.	[Arora, Kaveri] Suny Downstate Med Ctr, Grad Program Mol & Cellular Biol, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Hernandez, Alejandro I.; Alarcon, Juan M.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pathol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	Edward.quadros@downstate.edu		Quadros, Edward/0000-0002-7663-8014; Pohlman, Kaveri/0000-0002-1154-1406	US National Institutes of Health grant [R01DK064732, R21NS091830]	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by US National Institutes of Health grant R01DK064732 to EVQ and by R21NS091830 to JMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMANOLIS DP, 1978, J NEUROPATH EXP NEUR, V37, P273, DOI 10.1097/00005072-197805000-00006; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; ALLEN RH, 1993, FASEB J, V7, P1344, DOI 10.1096/fasebj.7.14.7901104; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anderson Shanna, 2016, Integr Med (Encinitas), V15, P48; Bailey KR, 2009, FRONT NEUROSCI, P77; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Berciano MT, 2007, J STRUCT BIOL, V158, P410, DOI 10.1016/j.jsb.2006.12.008; Biancheri R, 2001, NEUROPEDIATRICS, V32, P14, DOI 10.1055/s-2001-12217; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; CANNATA JJB, 1965, J BIOL CHEM, V240, P3249; CHANARIN I, 1985, BLOOD, V66, P479; CHRISTMAS AJ, 1970, NEUROPHARMACOLOGY, V9, P17, DOI 10.1016/0028-3908(70)90044-4; Cimadevilla JM, 2000, J NEUROSCI METH, V102, P155, DOI 10.1016/S0165-0270(00)00288-0; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; DASTUR DK, 1975, AM J CLIN NUTR, V28, P1255, DOI 10.1093/ajcn/28.11.1255; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; Faverzani JL, 2017, CELL MOL NEUROBIOL; Fenton AA, 2000, J GEN PHYSIOL, V116, P211, DOI 10.1085/jgp.116.2.211; Fernandez-Fernandez D, 2016, J NEUROSCI RES, V94, P266, DOI 10.1002/jnr.23701; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; GREEN R, 1995, BAILLIERE CLIN HAEM, V8, P533, DOI 10.1016/S0950-3536(05)80220-3; GREEN R, 1975, NATURE, V254, P148, DOI 10.1038/254148a0; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Guest J, 2015, NUTR NEUROSCI, V18, P355, DOI 10.1179/1476830515Y.0000000041; Gurkas E, 2015, GENET COUNSEL, V26, P425; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Head E, 2009, NEUROBIOL AGING, V30, P1125, DOI 10.1016/j.neurobiolaging.2007.10.001; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Hoffman DA, 2002, P NATL ACAD SCI USA, V99, P7740, DOI 10.1073/pnas.092157999; Kalita J, 2013, NUTR NEUROSCI, V16, P39, DOI 10.1179/1476830512Y.0000000028; Kamat PK, 2015, J CELL PHYSIOL, V230, P378, DOI 10.1002/jcp.24722; KNOWLES JF, 1976, J ANAT, V121, P461; Kumar S., 2021, FRONT PSYCHOL, V12, DOI DOI 10.3389/fpsyg.2021.577529; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu Hui, 2013, Shengli Xuebao, V65, P61; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Malek N, 2015, SCOT MED J, V60, P44, DOI 10.1177/0036933014561948; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Pawlak R, 2013, NUTR REV, V71, P110, DOI 10.1111/nure.12001; Per A., 2009, HIPPOCAMPUS BOOK; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Ramulu Surekha, 2013, J Oral Maxillofac Pathol, V17, P23, DOI 10.4103/0973-029X.110698; Reynolds E H, 2014, Handb Clin Neurol, V120, P927, DOI 10.1016/B978-0-7020-4087-0.00061-9; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rudy JW, 2008, PSYCHOLOGY, V4032, P5032; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; Sachdev PS, 2002, NEUROLOGY, V58, P1539, DOI 10.1212/WNL.58.10.1539; Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.3.CO;2-P; Scalabrino G, 1997, EXP NEUROL, V144, P258, DOI 10.1006/exnr.1996.6376; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Smith BT, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-30; Stuchlik A, 2009, BEHAV BRAIN RES, V200, P144, DOI 10.1016/j.bbr.2009.01.010; TAYLOR RT, 1967, J BIOL CHEM, V242, P1509; TREIT D, 1986, PHARMACOL BIOCHEM BE, V25, P561, DOI 10.1016/0091-3057(86)90141-3; TREIT D, 1987, BRAIN RES BULL, V19, P401, DOI 10.1016/0361-9230(87)90143-2; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yang M, 2004, PHYSIOL BEHAV, V81, P465, DOI 10.1016/j.physbeh.2004.02.010; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zinyuk L, 2000, P NATL ACAD SCI USA, V97, P3771, DOI 10.1073/pnas.050576397; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	75	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177156	10.1371/journal.pone.0177156	http://dx.doi.org/10.1371/journal.pone.0177156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545069	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400023
J	Keogh, K; Waters, SM; Cormican, P; Kelly, AK; O'Shea, E; Kenny, DA				Keogh, Kate; Waters, Sinead M.; Cormican, Paul; Kelly, Alan K.; O'Shea, Emma; Kenny, David A.			Effect of dietary restriction and subsequent re-alimentation on the transcriptional profile of bovine ruminal epithelium	PLOS ONE			English	Article							BELGIAN-BLUE BULLS; RESIDUAL FEED-INTAKE; COMPENSATORY GROWTH; BEEF HEIFERS; GASTROINTESTINAL-TRACT; ANIMAL PERFORMANCE; PLASMA METABOLITES; CONCENTRATE RATIO; DIFFERENT PERIODS; NITROGEN-BALANCE	Compensatory growth (CG) is utilised worldwide in beef production systems as a management approach to reduce feed costs. However the underlying biology regulating the expression of CG remains to be fully elucidated. The objective of this study was to examine the effect of dietary restriction and subsequent re-alimentation induced CG on the global gene expression profile of ruminal epithelial papillae. Holstein Friesian bulls (n = 60) were assigned to one of two groups: restricted feed allowance (RES; n = 30) for 125 days (Period 1) followed by ad libitum access to feed for 55 days (Period 2) or (ii) ad libitum access to feed throughout (ADLIB; n = 30). At the end of each period, 15 animals from each treatment were slaughtered and rumen papillae harvested. mRNA was isolated from all papillae samples collected. cDNA libraries were then prepared and sequenced. Resultant reads were subsequently analysed bioinformatically and differentially expressed genes (DEGs) are defined as having a Benjamini-Hochberg P value of <0.05. During re-alimentation in Period 2, RES animals displayed CG, growing at 1.8 times the rate of their ADLIB contemporary animals in Period 2 (P < 0.001). At the end of Period 1, 64 DEGs were identified between RES and ADLIB, with only one DEG identified at the end of Period 2. When analysed within RES treatment (RES, Period 2 v Period 1), 411 DEGs were evident. Genes identified as differentially expressed in response to both dietary restriction and subsequent CG included those involved in processes such as cellular interactions and transport, protein folding and gene expression, as well as immune response. This study provides an insight into the molecular mechanisms underlying the expression of CG in rumen papillae of cattle; however the results suggest that the role of the ruminal epithelium in supporting overall animal CG may have declined by day 55 of re-alimentation.	[Keogh, Kate; Waters, Sinead M.; Cormican, Paul; O'Shea, Emma; Kenny, David A.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, Co Meath, Ireland; [Kelly, Alan K.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland	Teagasc; University College Dublin	Kenny, DA (corresponding author), TEAGASC, Anim & Grassland Res & Innovat Ctr, Anim & Biosci Res Dept, Dunsany, Co Meath, Ireland.	david.kenny@teagasc.ie	Keogh, Kate/AAY-2455-2020	Keogh, Kate/0000-0001-8338-5177	Science Foundation Ireland (SFI) [09/RFP/GEN2447]	Science Foundation Ireland (SFI)(Science Foundation Ireland)	SMW received financial assistance from Science Foundation Ireland (SFI) contract no 09/RFP/GEN2447.	Ahmed T, 2009, J GERONTOL A-BIOL, V64, P1107, DOI 10.1093/gerona/glp101; Alexandre PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2292-8; Armistead J, 2009, AM J HUM GENET, V84, P728, DOI 10.1016/j.ajhg.2009.04.017; Ashfield A, 2014, J AGR SCI-CAMBRIDGE, V152, P805, DOI 10.1017/S0021859613000531; Baldwin RL, 1999, SMALL RUMINANT RES, V32, P261, DOI 10.1016/S0921-4488(98)00188-6; Barilli A, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-32; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cabaraux JF, 2003, ANIM SCI, V77, P205, DOI 10.1017/S135772980005894X; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Connor EE, 2010, FUNCT INTEGR GENOMIC, V10, P39, DOI 10.1007/s10142-009-0138-7; Demeyer D. I., 1991, Rumen microbial metabolism and ruminant digestion., P217; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Elsasser TH, 2000, BIOLOGY OF ANIMAL STRESS, P77, DOI 10.1079/9780851993591.0077; FIELD CJ, 1991, AM J CLIN NUTR, V54, P123, DOI 10.1093/ajcn/54.1.123; Finneran E., 2010, Journal of Farm Management, V14, P95; Fitzsimons C, 2013, J ANIM SCI, V91, P5789, DOI 10.2527/jas.2013-6956; FOX DG, 1974, J ANIM SCI, V38, P437, DOI 10.2527/jas1974.382437x; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Gabut M, 2008, CELL, V133, P192, DOI 10.1016/j.cell.2008.03.010; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Grimaud P, 1998, ANIM SCI, V67, P49, DOI 10.1017/S1357729800009784; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Hornick JL, 1998, J ANIM SCI, V76, P249; Hornick JL, 1998, J ANIM SCI, V76, P260; Istasse L., 2000, Domestic Animal Endocrinology, V19, P121, DOI 10.1016/S0739-7240(00)00072-2; JOHNSON DE, 1990, J NUTR, V120, P649, DOI 10.1093/jn/120.6.649; Keogh K, 2015, J ANIM SCI, V93, P3590, DOI 10.2527/jas.2014-8471; Keogh K, 2015, J ANIM SCI, V93, P3578, DOI 10.2527/jas.2014-8470; Keogh K, 2016, P EUR ASS AN PROD BE, P185; Keogh K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2578-5; Keogh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149373; Kern RJ, 2016, GENE, V586, P12, DOI 10.1016/j.gene.2016.03.034; Kong RSG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2935-4; Krehbiel C. R., 2014, Professional Animal Scientist, V30, P129; Lamas O, 2004, J NUTR BIOCHEM, V15, P418, DOI 10.1016/j.jnutbio.2004.02.003; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lesmeister KE, 2004, J DAIRY SCI, V87, P1336, DOI 10.3168/jds.S0022-0302(04)73283-X; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; McLeod KR, 2000, J ANIM SCI, V78, P760; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Notani D, 2010, METHODS MOL BIOL, V647, P317, DOI 10.1007/978-1-60761-738-9_20; O'Kiely P, 1997, COMPUT ELECTRON AGR, V19, P23, DOI 10.1016/S0168-1699(97)00019-7; Owens F. N., 2014, Professional Animal Scientist, V30, P150; Pahlavani M A, 2004, J Nutr Health Aging, V8, P38; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Phillips WA, 2001, J ANIM SCI, V79, P1370; Purbey PK, 2009, MOL CELL BIOL, V29, P1321, DOI 10.1128/MCB.00822-08; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Rattray AMJ, 2012, BIOCHEM SOC T, V40, P880, DOI 10.1042/BST20120065; REYNOLDS CK, 1991, J NUTR, V121, P994, DOI 10.1093/jn/121.7.994; Richardson EC, 2004, AUST J EXP AGR, V44, P431, DOI 10.1071/EA02221; Ryan W. J., 1990, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V60, P653; RYAN WJ, 1993, AUST J AGR RES, V44, P1623, DOI 10.1071/AR9931623; SAINZ RD, 1995, J ANIM SCI, V73, P2971; Sainz RD, 1997, J ANIM SCI, V75, P1229; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Skaar JR, 2015, CELL RES, V25, P288, DOI 10.1038/cr.2015.19; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Sun ZH, 2013, J ANIM SCI, V91, P4336, DOI 10.2527/jas.2011-4500; Tizioto PC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1464-x; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Uehata T, 2013, BBA-GENE REGUL MECH, V1829, P708, DOI 10.1016/j.bbagrm.2013.03.001; Vreugdenhil ACE, 2003, J IMMUNOL, V170, P1399, DOI 10.4049/jimmunol.170.3.1399; Wasinski F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/395672; WESTER TJ, 1995, J ANIM SCI, V73, P1674; Yambayamba ESK, 1996, LIVEST PROD SCI, V46, P19, DOI 10.1016/0301-6226(96)00014-0; Yambayamba ESK, 1996, J ANIM SCI, V74, P57	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177852	10.1371/journal.pone.0177852	http://dx.doi.org/10.1371/journal.pone.0177852			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545102	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700089
J	Liu, XX; Shen, BM; Du, P; Wang, N; Wang, JX; Li, JR; Sun, AH				Liu, Xiaoxiang; Shen, Bimiao; Du, Peng; Wang, Nan; Wang, Jiaxue; Li, Jianrong; Sun, Aihua			Transcriptomic analysis of the response of Pseudomonas fluorescens to epigallocatechin gallate by RNA-seq	PLOS ONE			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; ANTIGEN CHAIN-LENGTH; HYDROGEN-PEROXIDE; STRESS-RESPONSE; BIOFILM FORMATION; SIGMA FACTORS; UP-REGULATION; SOS RESPONSE; EFFLUX PUMPS; GENE	Epigallocatechin gallate (EGCG) is a main constituent of green tea polyphenols that are widely used as food preservatives and are considered to be safe for consumption. However, the underlying antimicrobial mechanism of EGCG and the bacterial response to EGCG are not clearly understood. In the present study, a genome-wide transcriptional analysis of a typical spoilage bacterium, Pseudomonas fluorescens that responded to EGCG was performed using RNA-seq technology. A total of 26,365,414 and 23,287,092 clean reads were generated from P. fluorescens treated with or without 1 mM EGCG and the clean reads were aligned to the reference genome. Differential expression analysis revealed 291 upregulated genes and 134 downregulated genes and the differentially expressed genes (DEGs) were verified using RT-qPCR. Most of the DGEs involved in iron uptake, antioxidation, DNA repair, efflux system, cell envelope and cell-surface component synthesis were significantly upregulated by EGCG treatment, while most genes associated with energy production were downregulated. These transcriptomic changes are likely to be adaptive responses of P. fluorescens to iron limitation and oxidative stress, as well as DNA and envelope damage caused by EGCG. The expression of specific genes encoding the extra-cytoplasmic function sigma factor (PvdS, RpoE and AlgU) and the two-component sensor histidine kinase (BaeS and RpfG) were markedly changed by EGCG treatment, which may play important roles in regulating the stress responses of P. fluorescens to EGCG. The present data provides important insights into the molecular action of EGCG and the possible cross-resistance mediated by EGCG on P. fluorescens, which may ultimately contribute to the optimal application of green tea polyphenols in food preservation.	[Liu, Xiaoxiang; Du, Peng; Sun, Aihua] Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China; [Shen, Bimiao; Wang, Jiaxue] Hangzhou Med Coll, Dept Lab Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Nan] Zhejiang Shuren Univ, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Li, Jianrong] Bohai Univ, Food Safety Key Lab Liaoning Prov, Jinzhou, Liaoning, Peoples R China	Hangzhou Medical College; Hangzhou Medical College; Zhejiang Shuren University; Bohai University	Sun, AH (corresponding author), Hangzhou Med Coll, Fac Basic Med, Hangzhou, Zhejiang, Peoples R China.	aihuasun@126.com	Wang, Nan/GRY-3150-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Sciences Foundation of China [31501581, 31471639, 31401500]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by Grants from the National Natural Sciences Foundation of China (31501581, http://www.nsfc.gov.cn) to XL, and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (http://325rc.zjwjw.gov.cn:8081/zjmedrc/html/index.htm) to XL and AS, and the National Natural Sciences Foundation of China (31471639 and 31401500, http://www.nsfc.gov.cn/) to JL and NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram V, 2013, FOOD CHEM, V139, P804, DOI 10.1016/j.foodchem.2013.01.100; Andreani NA, 2015, INT J FOOD MICROBIOL, V213, P88, DOI 10.1016/j.ijfoodmicro.2015.05.024; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Bikels-Goshen T, 2010, INT J FOOD MICROBIOL, V138, P26, DOI 10.1016/j.ijfoodmicro.2010.01.011; Borodina T, 2011, METHOD ENZYMOL, V500, P79, DOI 10.1016/B978-0-12-385118-5.00005-0; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Cai LY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00981; Caldera L, 2014, CURR MICROBIOL, V68, P133, DOI 10.1007/s00284-013-0430-6; Carraro L, 2014, MICROB BIOTECHNOL, V7, P265, DOI 10.1111/1751-7915.12119; Cho YS, 2007, CURR MICROBIOL, V55, P501, DOI 10.1007/s00284-007-9021-8; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; Dahlsten E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089958; Decimo M, 2014, J FOOD SCI, V79, pM2081, DOI 10.1111/1750-3841.12645; den Besten HMW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013746; Dreier J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00660; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dueholm MS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00898-14; Elhabiri M, 2007, INORG CHIM ACTA, V360, P353, DOI 10.1016/j.ica.2006.07.110; Tran ENH, 2014, MICROBIOL-SGM, V160, P589, DOI 10.1099/mic.0.074955-0; Fan WJ, 2008, FOOD CHEM, V108, P148, DOI 10.1016/j.foodchem.2007.10.057; Friedman M, 2007, MOL NUTR FOOD RES, V51, P116, DOI 10.1002/mnfr.200600173; Gradisar H, 2007, J MED CHEM, V50, P264, DOI 10.1021/jm060817o; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; He L, 2016, J FOOD SCI, V81, pM1466, DOI 10.1111/1750-3841.13312; Hesketh A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-226; Hider RC, 2001, METHOD ENZYMOL, V335, P190; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; IRINO N, 1986, MOL GEN GENET, V205, P298, DOI 10.1007/BF00430442; Kawaji S, 2010, VET MICROBIOL, V145, P252, DOI 10.1016/j.vetmic.2010.03.025; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kumar SR, 2013, J BACTERIOL, V195, P4569, DOI 10.1128/JB.00737-13; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Levinger O, 2012, APPL ENVIRON MICROB, V78, P7954, DOI 10.1128/AEM.02253-12; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Liang WD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760904; Liang W, 2016, FEBS J, V283, P446, DOI 10.1111/febs.13587; Lim CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039139; Liu XX, 2013, FOLIA MICROBIOL, V58, P211, DOI 10.1007/s12223-012-0198-2; Liu XX, 2012, WORLD J MICROB BIOT, V28, P3373, DOI 10.1007/s11274-012-1149-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nakayama M, 2015, BIOSCI BIOTECH BIOCH, V79, P845, DOI 10.1080/09168451.2014.993356; Osawa K, 2013, MICROBIOL IMMUNOL, V57, P616, DOI 10.1111/1348-0421.12084; Paget MS, 2015, BIOMOLECULES, V5, P1245, DOI 10.3390/biom5031245; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Medina CAP, 2016, INT J RADIAT BIOL, V92, P321, DOI 10.3109/09553002.2016.1152412; Qin TT, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.12.09; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Serra DO, 2016, MOL MICROBIOL, V101, P136, DOI 10.1111/mmi.13379; Shen Q, 2015, ANAL BIOANAL CHEM, V407, P1475, DOI 10.1007/s00216-014-8365-8; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Thode SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0342-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Vittal R, 2004, MOL CANCER THER, V3, P1091; Vuong QV, 2011, FOOD REV INT, V27, P227, DOI 10.1080/87559129.2011.563397; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang R, 2008, J FOOD ENG, V87, P505, DOI 10.1016/j.jfoodeng.2008.01.002; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; Yi SM, 2010, INT J FOOD MICROBIOL, V144, P111, DOI 10.1016/j.ijfoodmicro.2010.09.005; Yi SM, 2011, J SCI FOOD AGR, V91, P1591, DOI 10.1002/jsfa.4352; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang YJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00636; Zhang YM, 2004, J BIOL CHEM, V279, P30994, DOI 10.1074/jbc.M403697200; Zhou H, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0072-4; Zhu JL, 2015, J MICROBIOL, V53, P829, DOI 10.1007/s12275-015-5123-3; Zhu QY, 1997, J AGR FOOD CHEM, V45, P4624, DOI 10.1021/jf9706080	76	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177938	10.1371/journal.pone.0177938	http://dx.doi.org/10.1371/journal.pone.0177938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545064	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700097
J	Lerat, H; Imache, MR; Polyte, J; Gaudin, A; Mercey, M; Donati, F; Baudesson, C; Higgs, MR; Picard, A; Magnan, C; Foufelle, F; Pawlotsky, JM				Lerat, Herve; Imache, Mohamed Rabah; Polyte, Jacqueline; Gaudin, Aurore; Mercey, Marion; Donati, Flora; Baudesson, Camille; Higgs, Martin R.; Picard, Alexandre; Magnan, Christophe; Foufelle, Fabienne; Pawlotsky, Jean-Michel			Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose metabolism; hepatitis C virus (HCV); insulin resistance; transgenic mice; type 2 diabetes	INSULIN-RECEPTOR SUBSTRATE-1; SUSTAINED VIROLOGICAL RESPONSE; AMINO-ACID SUBSTITUTIONS; DIABETES-MELLITUS; DOWN-REGULATION; UP-REGULATION; CORE PROTEIN; TYROSINE PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; NONCIRRHOTIC PATIENTS	Virus-related type 2 diabetes is commonly observed in individuals infected with the hepatitis C virus (HCV); however, the underlying molecular mechanisms remain unknown. Our aim was to unravel these mechanisms using FL-N/35 transgenic mice expressing the full HCV ORF. We observed that these mice displayed glucose intolerance and insulin resistance. We also found that Glut-2 membrane expression was reduced in FL-N/35 mice and that hepatocyte glucose uptake was perturbed, partly accounting for the HCV-induced glucose intolerance in these mice. Early steps of the hepatic insulin signaling pathway, from IRS2 to PDK1 phosphorylation, were constitutively impaired in FL-N/35 primary hepatocytes via deregulation of TNF/SOCS3. Higher hepatic glucose production was observed in the HCV mice, despite higher fasting insulinemia, concomitant with decreased expression of hepatic gluconeogenic genes. Akt kinase activity was higher in HCV mice than in WT mice, but Akt-dependent phosphorylation of the forkhead transcription factor FoxO1 at serine 256, which triggers its nuclear exclusion, was lower in HCV mouse livers. These findings indicate an uncoupling of the canonical Akt/FoxO1 pathway in HCV protein-expressing hepatocytes. Thus, the expression of HCV proteins in the liver is sufficient to induce insulin resistance by impairing insulin signaling and glucose uptake. In conclusion, we observed a complete set of events leading to a prediabetic state in HCV-transgenic mice, providing a valuable mechanistic explanation for HCV-induced diabetes in humans.	[Lerat, Herve; Imache, Mohamed Rabah; Polyte, Jacqueline; Gaudin, Aurore; Mercey, Marion; Donati, Flora; Baudesson, Camille; Higgs, Martin R.; Pawlotsky, Jean-Michel] INSERM, U955, Team Pathophysiol & Therapy Chron Viral Hepatitis, F-94010 Creteil, France; [Lerat, Herve; Pawlotsky, Jean-Michel] Univ Paris Est Creteil Val de Marne, F-94010 Creteil, France; [Picard, Alexandre; Magnan, Christophe] Univ Paris Diderot, Unite Biol Fonct & Adaptat, Sorbonne Paris Cite, CNRS,UMR 8251, F-75013 Paris, France; [Foufelle, Fabienne] Ctr Rech Cordeliers, INSERM, UMRS 1138, F-75006 Paris, France; [Pawlotsky, Jean-Michel] Hop Henri Mondor, AP HP, Natl Reference Ctr Viral Hepatitis B C & Delta, Dept Virol, F-94010 Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Lerat, H (corresponding author), INSERM, U955, Team Pathophysiol & Therapy Chron Viral Hepatitis, F-94010 Creteil, France.; Lerat, H (corresponding author), Univ Paris Est Creteil Val de Marne, F-94010 Creteil, France.	herve.lerat@inserm.fr	Higgs, Martin/AAK-2108-2021; LERAT, Hervé/D-4331-2019; Pawlotsky, Jean-Michel/R-8159-2018; magnan, christophe/AAJ-7622-2021	Higgs, Martin/0000-0002-8218-0089; LERAT, Hervé/0000-0002-8505-378X; magnan, christophe/0000-0002-7044-2571; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Picard, Alexandre/0000-0003-2564-7428; FOUFELLE, Fabienne/0000-0002-0752-622X	National Agency for Research on AIDS and Viral Hepatitis; French Direction Departementale de la Protection des Populations [94-028-7]; French Ministry of Research	National Agency for Research on AIDS and Viral Hepatitis; French Direction Departementale de la Protection des Populations; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the National Agency for Research on AIDS and Viral Hepatitis. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an agreement to perform research using animals, delivered by the French Direction Departementale de la Protection des Populations (Agreement 94-028-7). To whom correspondence should be addressed. Tel.: 33-1-4981-4711; Fax: 33-1-4981-4844; E-mail: herve.lerat@inserm.fr.; Recipient of a fellowship from the French Ministry of Research.; Recipient of a postdoctoral fellowship from the National Agency for Research on AIDS and Viral Hepatitis.	Alexander GJM, 2000, ANN INTERN MED, V133, P650, DOI 10.7326/0003-4819-133-8-200010170-00018; ALLISON MED, 1994, J HEPATOL, V21, P1135, DOI 10.1016/S0168-8278(05)80631-2; Anty R, 2007, EUR J GASTROEN HEPAT, V19, P671, DOI 10.1097/MEG.0b013e3281532b9a; Arase Y, 2013, HEPATOLOGY, V57, P964, DOI 10.1002/hep.26087; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Aytug S, 2003, HEPATOLOGY, V38, P1384, DOI 10.1016/j.hep.2003.09.012; Banerjee A, 2010, J VIROL, V84, P5936, DOI 10.1128/JVI.02344-09; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bernsmeier C, 2014, J VIRAL HEPATITIS, V21, P9, DOI 10.1111/jvh.12208; Bernsmeier C, 2008, J HEPATOL, V49, P429, DOI 10.1016/j.jhep.2008.04.007; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12; Bugianesi E, 2012, J HEPATOL, V56, pS56, DOI 10.1016/S0168-8278(12)60007-5; Calzadilla-Bertot L, 2016, DIGEST LIVER DIS, V48, P283, DOI 10.1016/j.dld.2015.12.002; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Chen JZ, 2015, DIABETES, V64, P4088, DOI 10.2337/db15-0197; Chen LH, 2013, EUR J GASTROEN HEPAT, V25, P935, DOI 10.1097/MEG.0b013e32835fa988; Chouteau P, 2012, J HEPATOL, V57, P499, DOI 10.1016/j.jhep.2012.04.019; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; El-Saadany S, 2013, CAN J GASTROENTEROL, V27, pE13, DOI 10.1155/2013/562765; Eslam M, 2012, J CLIN GASTROENTEROL, V46, P228, DOI 10.1097/MCG.0b013e31822a2dc6; Foxton MR, 2006, AM J TRANSPLANT, V6, P1922, DOI 10.1111/j.1600-6143.2006.01408.x; Funaoka Y, 2011, J VIROL, V85, P5986, DOI 10.1128/JVI.02583-10; Furutani T, 2006, GASTROENTEROLOGY, V130, P2087, DOI 10.1053/j.gastro.2006.02.060; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Higgs MR, 2013, ONCOGENE, V32, P4683, DOI 10.1038/onc.2012.484; Higgs MR, 2014, J GEN VIROL, V95, P991, DOI 10.1099/vir.0.059485-0; Higgs MR, 2010, CANCER RES, V70, P4901, DOI 10.1158/0008-5472.CAN-09-4554; Hsu CS, 2008, LIVER INT, V28, P271, DOI 10.1111/j.1478-3231.2007.01626.x; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Hung CH, 2013, INTERVIROLOGY, V56, P166, DOI 10.1159/000343913; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Imazeki F, 2008, LIVER INT, V28, P355, DOI 10.1111/j.1478-3231.2007.01630.x; Kaddai V, 2011, EXPERT REV GASTROENT, V5, P503, DOI [10.1586/EGH.11.43, 10.1586/egh.11.43]; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; Kawaguchi T, 2007, AM J GASTROENTEROL, V102, P570, DOI 10.1111/j.1572-0241.2006.01038.x; Kawamura Y, 2010, AM J MED, V123, P951, DOI 10.1016/j.amjmed.2010.05.013; Kim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008649; Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021; Kondapaka SB, 2004, CLIN CANCER RES, V10, P7192, DOI 10.1158/1078-0432.CCR-04-0772; Kuo YC, 2014, LIVER INT, V34, P1358, DOI 10.1111/liv.12389; Lecube A, 2004, DIABETES CARE, V27, P1171, DOI 10.2337/diacare.27.5.1171; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Lubura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037026; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; Mehta SH, 2003, HEPATOLOGY, V38, P50, DOI 10.1053/jhep.2003.50291; Mitsuyoshi H, 2008, HEPATOL RES, V38, P348, DOI 10.1111/j.1872-034X.2007.00280.x; Miyamoto H, 2007, J VIROL, V81, P1727, DOI 10.1128/JVI.01683-06; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; Naing C, 2013, CURR DIABETES REP, V13, P428, DOI 10.1007/s11892-013-0370-3; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Negro F, 2011, CLIN RES HEPATOL GAS, V35, P358, DOI 10.1016/j.clinre.2011.01.011; Park SH, 2009, AM J GASTROENTEROL, V104, P1135, DOI 10.1038/ajg.2009.6; Parvaiz F, 2014, ARCH VIROL, V159, P1017, DOI 10.1007/s00705-013-1892-3; Pawlotsky JM, 2015, GASTROENTEROLOGY, V148, P468, DOI 10.1053/j.gastro.2015.01.002; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Romero-Gomez M, 2008, J HEPATOL, V48, P721, DOI 10.1016/j.jhep.2007.11.022; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Serfaty L, 2012, GUT, V61, P1473, DOI 10.1136/gutjnl-2011-300749; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sumida Y, 2011, J GASTROEN HEPATOL, V26, P836, DOI 10.1111/j.1440-1746.2010.06568.x; Thompson AJ, 2012, GUT, V61, P128, DOI 10.1136/gut.2010.236158; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Tsochatzis E, 2009, ALIMENT PHARM THER, V30, P947, DOI 10.1111/j.1365-2036.2009.04094.x; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Uraki S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131346; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674; Wang CC, 2015, J GASTROEN HEPATOL, V30, P14, DOI 10.1111/jgh.12700; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	87	16	16	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12860	12873		10.1074/jbc.M117.785030	http://dx.doi.org/10.1074/jbc.M117.785030			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28559285	Green Published, hybrid			2022-12-26	WOS:000407220100016
J	De Cock, AM; Fransen, E; Perkisas, S; Verhoeven, V; Beauchet, O; Remmen, R; Vandewoude, M				De Cock, Anne-Marie; Fransen, Erik; Perkisas, Stany; Verhoeven, Veronique; Beauchet, Olivier; Remmen, Roy; Vandewoude, Maurits			Gait characteristics under different walking conditions: Association with the presence of cognitive impairment in community-dwelling older people	PLOS ONE			English	Article							DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; GO TEST; DEMENTIA; DECLINE; RECOMMENDATIONS; RELIABILITY; WORKGROUPS; RISK	Background Gait characteristics measured at usual pace may allow profiling in patients with cognitive problems. The influence of age, gender, leg length, modified speed or dual tasking is unclear. Methods Cross-sectional analysis was performed on a data registry containing demographic, physical and spatial-temporal gait parameters recorded in five walking conditions with a GAI-TRite (R) electronic carpet in community-dwelling older persons with memory complaints. Four cognitive stages were studied: cognitively healthy individuals, mild cognitive impaired patients, mild dementia patients and advanced dementia patients. Results The association between spatial-temporal gait characteristics and cognitive stages was the most prominent: in the entire study population using gait speed, steps per meter ( translation for mean step length), swing time variability, normalised gait speed ( corrected for leg length) and normalised steps per meter at all five walking conditions; in the 50-to-70 years old participants applying step width at fast pace and steps per meter at usual pace; in the 70-to-80 years old persons using gait speed and normalised gait speed at usual pace, fast pace, animal walk and counting walk or steps per meter and normalised steps per meter at all five walking conditions; in over-80 years old participants using gait speed, normalised gait speed, steps per meter and normalised steps per meter at fast pace and animal dual-task walking. Multivariable logistic regression analysis adjusted for gender predicted in two compiled models the presence of dementia or cognitive impairment with acceptable accuracy in persons with memory complaints. Conclusion Gait parameters in multiple walking conditions adjusted for age, gender and leg length showed a significant association with cognitive impairment. This study suggested that multifactorial gait analysis could be more informative than using gait analysis with only one test or one variable. Using this type of gait analysis in clinical practice could facilitate screening for cognitive impairment.	[De Cock, Anne-Marie] Gen Hosp St Maarten, Dept Geriatr Med, Mechelen, Belgium; [De Cock, Anne-Marie; Perkisas, Stany; Verhoeven, Veronique; Remmen, Roy; Vandewoude, Maurits] Univ Antwerp, Dept Geriatr, Antwerp, Belgium; [De Cock, Anne-Marie; Perkisas, Stany; Verhoeven, Veronique; Remmen, Roy; Vandewoude, Maurits] Univ Antwerp, Dept Primary & Interdisciplinary Care ELIZA, Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, StatUa Ctr Stat, Antwerp, Belgium; [Beauchet, Olivier] McGill Univ, Ctr Excellence Aging & Chron Dis CEViMaC, Div Geriatr Med, Dept Med, Montreal, PQ, Canada	University of Antwerp; University of Antwerp; University of Antwerp; McGill University	De Cock, AM (corresponding author), Gen Hosp St Maarten, Dept Geriatr Med, Mechelen, Belgium.; De Cock, AM (corresponding author), Univ Antwerp, Dept Geriatr, Antwerp, Belgium.; De Cock, AM (corresponding author), Univ Antwerp, Dept Primary & Interdisciplinary Care ELIZA, Antwerp, Belgium.	annemarie.decock@emmaus.be	Fransen, Erik/C-4102-2015; Perkisas, Stany/AAZ-4532-2020; De Cock, Anne-Marie/W-2144-2019; Beauchet, Olivier/AAP-8108-2020; Verhoeven, Veronique/B-5915-2017	Fransen, Erik/0000-0001-7785-4790; Perkisas, Stany/0000-0002-4192-327X; De Cock, Anne-Marie/0000-0001-5505-0249; Verhoeven, Veronique/0000-0002-3708-6501				Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Allali G, 2016, EUR J NEUROL, V23, P527, DOI 10.1111/ene.12882; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P933, DOI 10.1007/s12603-011-0062-0; Beauchet O, 2016, J AM MED DIR ASSOC, V17, P482, DOI 10.1016/j.jamda.2015.12.092; Brach JS, 2008, ARCH PHYS MED REHAB, V89, P2293, DOI 10.1016/j.apmr.2008.06.010; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Cedervall Y, 2014, GAIT POSTURE, V39, P1022, DOI 10.1016/j.gaitpost.2013.12.026; Crawford S, 2012, INT J GERIATR PSYCH, V27, P659, DOI 10.1002/gps.2771; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Deshpande N, 2009, AGE AGEING, V38, P509, DOI 10.1093/ageing/afp093; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frimenko R, 2015, PHYSIOTHERAPY, V101, P266, DOI 10.1016/j.physio.2015.01.003; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hancock P, 2009, INT PSYCHOGERIATR, V21, P526, DOI 10.1017/S1041610209008941; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Jahn K, 2010, DTSCH ARZTEBL INT, V107, P306, DOI 10.3238/arztebl.2010.0306; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Kikkert LHJ, 2016, AGEING RES REV, V27, P1, DOI 10.1016/j.arr.2016.02.001; Kressig RW, 2006, AGING CLIN EXP RES, V18, P174, DOI 10.1007/BF03327437; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nordin E, 2006, PHYS THER, V86, P646, DOI 10.1093/ptj/86.5.646; Nordin E, 2010, GAIT POSTURE, V32, P92, DOI 10.1016/j.gaitpost.2010.03.012; Onen F, 2008, BRAIN RES, V1222, P79, DOI 10.1016/j.brainres.2008.05.027; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rosso AL, 2013, J GERONTOL A-BIOL, V68, P1379, DOI 10.1093/gerona/glt089; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Terpening Z, 2011, AUSTRALAS J AGEING, V30, P113, DOI 10.1111/j.1741-6612.2010.00446.x; Turner G, 2014, AGE AGEING, V43, P744, DOI 10.1093/ageing/afu138; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Kan GA, 2013, J CACHEXIA SARCOPENI, V4, P225, DOI 10.1007/s13539-013-0112-z; van Kan GA, 2013, AGE AGEING, V42, P196, DOI 10.1093/ageing/afs173; Verghese J, 2014, NEUROLOGY, V83, P718, DOI 10.1212/WNL.0000000000000717; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Whitney SL, 1998, AM J OCCUP THER, V52, P666, DOI 10.5014/ajot.52.8.666	44	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178566	10.1371/journal.pone.0178566	http://dx.doi.org/10.1371/journal.pone.0178566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6HZ	28570662	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800079
J	Liebsch, C; Graf, N; Appelt, K; Wilke, HJ				Liebsch, Christian; Graf, Nicolas; Appelt, Konrad; Wilke, Hans-Joachim			The rib cage stabilizes the human thoracic spine: An in vitro study using stepwise reduction of rib cage structures	PLOS ONE			English	Article							INTERVERTEBRAL DISC; BIOMECHANICAL ROLE; MOTION; LUMBAR; RANGE; STERNUM; VIVO	The stabilizing effect of the rib cage on the human thoracic spine is still not sufficiently analyzed. For a better understanding of this effect as well as the calibration and validation of numerical models of the thoracic spine, experimental biomechanics data is required. This study aimed to determine (1) the stabilizing effect of the single rib cage structures on the human thoracic spine as well as the effect of the rib cage on (2) the flexibility of the single motion segments and (3) coupled motion behavior of the thoracic spine. Six human thoracic spine specimens including the entire rib cage were loaded quasi-statically with pure moments of +/- 2 Nm in flexion/extension (FE), lateral bending (LB), and axial rotation (AR) using a custom-built spine tester. Motion analysis was performed using an optical motion tracking system during load application to determine range of motion (ROM) and neutral zone (NZ). Specimens were tested (1) in intact condition, (2) after removal of the intercostal muscles, (3) after median sternotomy, after removal of (4) the anterior rib cage up to the rib stumps, (5) the right sixth to eighth rib head, and (6) all rib heads. Significant (p < 0.05) increases of the ROM were found after dissecting the intercostal muscles (LB: + 22.4%, AR: + 22.6%), the anterior part of the rib cage (FE: + 21.1%, LB: + 10.9%, AR: + 72.5%), and all rib heads (AR: + 5.8%) relative to its previous condition. Compared to the intact condition, ROM and NZ increased significantly after removing the anterior part of the rib cage (FE: + 52.2%, + 45.6%; LB: + 42.0%, + 54.0%; AR: + 94.4%, + 187.8%). Median sternotomy (FE: + 11.9%, AR: + 21.9%) and partial costovertebral release (AR: + 11.7%) significantly increased the ROM relative to its previous condition. Removing the entire rib cage increased both monosegmental and coupled motion ROM, but did not alter the qualitative motion behavior. The rib cage has a strong effect on thoracic spine rigidity, especially in axial rotation by a factor of more than two, and should therefore be considered in clinical scenarios, in vitro, and in silico.	[Liebsch, Christian; Graf, Nicolas; Appelt, Konrad; Wilke, Hans-Joachim] Ulm Univ, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Graf, Nicolas] SpineServ GmbH & Co KG, Ulm, Germany; [Appelt, Konrad] Univ Hosp Basel, Basel, Switzerland	Ulm University; University of Basel	Wilke, HJ (corresponding author), Ulm Univ, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	hans-joachim.wilke@uni-ulm.de	Liebsch, Christian/AAY-9918-2020; Wilke, Hans-Joachim/M-6440-2014	Liebsch, Christian/0000-0003-1543-4728; Wilke, Hans-Joachim/0000-0001-6007-8844	German Research Foundation (DFG) [WI 1352/20-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported from the German Research Foundation (DFG), Project WI 1352/20-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1980, SPINE, V5, P245, DOI 10.1097/00007632-198005000-00007; ANDRIACCHI T, 1974, J BIOMECH, V7, P497, DOI 10.1016/0021-9290(74)90084-0; Brasiliense LBC, 2011, SPINE, V36, pE1686, DOI 10.1097/BRS.0b013e318219ce84; DALTON ML, 1992, ANN THORAC SURG, V53, P532, DOI 10.1016/0003-4975(92)90293-D; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FEIERTAG MA, 1995, SPINE, V20, P1604, DOI 10.1097/00007632-199507150-00009; Fujimori T, 2012, SPINE, V37, pE1318, DOI 10.1097/BRS.0b013e318267254b; Heuer F, 2007, J BIOMECH, V40, P271, DOI 10.1016/j.jbiomech.2006.01.007; Horton WC, 2005, SPINE, V30, P2014, DOI 10.1097/01.brs.0000180478.96494.88; KETTLER A, 2000, SPINE, V5, P543, DOI DOI 10.1097/BRS.0B013E318267254B; Li C, 2012, EUR SPINE J, V21, P498, DOI 10.1007/s00586-011-1972-6; Liebsch C, 2016, EUR SPINE J; Mannen EM, 2015, SPINE, V40, pE760, DOI 10.1097/BRS.0000000000000879; Morita D, 2014, EUR SPINE J, V23, P673, DOI 10.1007/s00586-013-3088-7; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oda I, 1996, SPINE, V21, P1423, DOI 10.1097/00007632-199606150-00005; Oda Itaru, 2002, Spine (Phila Pa 1976), V27, pE64, DOI 10.1097/00007632-200202010-00007; PANJABI MM, 1975, J BIOMECH, V8, P327, DOI 10.1016/0021-9290(75)90085-8; POSNER I, 1982, SPINE, V7, P374, DOI 10.1097/00007632-198207000-00008; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Sham ML, 2005, BIOMED TECH, V50, P361, DOI 10.1515/BMT.2005.051; SIS HL, 2016, J BIOMECH, DOI DOI 10.1093/BEHECO/ARH107; Takeuchi T, 1999, SPINE, V24, P1414, DOI 10.1097/00007632-199907150-00005; Watkins R, 2005, SPINE, V30, P1283, DOI 10.1097/01.brs.0000164257.69354.bb; White A.A., 1990, CLIN BIOMECH; WHITE AA, 1969, ACTA ORTHOP SCAND, VS, P7; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; Willems JM, 1996, CLIN BIOMECH, V11, P311, DOI 10.1016/0268-0033(96)00017-4	31	49	50	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178733	10.1371/journal.pone.0178733	http://dx.doi.org/10.1371/journal.pone.0178733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570671	gold, Green Submitted, Green Published			2022-12-26	WOS:000402611800114
J	Moreno, PS; Wagner, J; Mansfield, CS; Stevens, M; Gilkerson, JR; Kirkwood, CD				Moreno, Paloma S.; Wagner, Josef; Mansfield, Caroline S.; Stevens, Matthew; Gilkerson, James R.; Kirkwood, Carl D.			Characterisation of the canine faecal virome in healthy dogs and dogs with acute diarrhoea using shotgun metagenomics	PLOS ONE			English	Article							VIRAL FLORA; SAMPLES REVEALS; CROHNS-DISEASE; VIRUSES; ASTROVIRUS; FECES; DIVERSITY; SEQUENCE; PUPPIES; BACTERIOPHAGES	The virome has been increasingly investigated in numerous animal species and in different sites of the body, facilitating the identification and discovery of a variety of viruses. In spite of this, the faecal virome of healthy dogs has not been investigated. In this study we describe the faecal virome of healthy dogs and dogs with acute diarrhoea in Australia, using a shotgun metagenomic approach. Viral sequences from a range of different virus families, including both RNA and DNA families, and known pathogens implicated in enteric disease were documented. Twelve viral families were identified, of which four were bacteriophages. Eight eukaryotic viral families were detected: Astroviridae, Coronaviridae, Reoviridae, Picornaviridae, Caliciviridae, Parvoviridae, Adenoviridae and Papillomaviridae. Families Astroviridae, Picornaviridae and Caliciviridae were found only in dogs with acute diarrhoea, with Astroviridae being the most common family identified in this group. Due to its prevalence, characterisation the complete genome of a canine astrovirus was performed. These studies indicate that metagenomic analyses are useful for the investigation of viral populations in the faeces of dogs. Further studies to elucidate the epidemiological and biological relevance of these findings are warranted.	[Moreno, Paloma S.; Wagner, Josef; Kirkwood, Carl D.] Murdoch Childrens Res Inst, Enter Viruses Grp, Melbourne, Vic, Australia; [Moreno, Paloma S.; Mansfield, Caroline S.] Univ Melbourne, Fac Vet & Agr Sci, Translat Res & Anim Clin Trial Study TRACTS Grp, Melbourne, Vic, Australia; [Wagner, Josef; Kirkwood, Carl D.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Stevens, Matthew] Australian Genome Res Facil, Melbourne, Vic, Australia; [Gilkerson, James R.] Univ Melbourne, Fac Vet & Agr Sci, Ctr Equine Infect Dis, Melbourne, Vic, Australia; [Wagner, Josef] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England; [Kirkwood, Carl D.] Global Hlth Bill & Melinda Gates Fdn, Enter & Diarrheal Dis, Seattle, WA USA	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; Wellcome Trust Sanger Institute	Moreno, PS (corresponding author), Murdoch Childrens Res Inst, Enter Viruses Grp, Melbourne, Vic, Australia.; Moreno, PS (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Translat Res & Anim Clin Trial Study TRACTS Grp, Melbourne, Vic, Australia.	pmmoreno@student.unimelb.edu.au	Mansfield, Caroline/GZA-5920-2022	Moreno, Paloma/0000-0002-3500-6846; Gilkerson, James/0000-0003-1801-4817	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chilean government	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chilean government(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	PSM is supported by Becas Chile scholarship program, Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chilean government (http://www.conicyt.cl/becas-conicyt). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Blomstrom AL, 2011, VET QUART, V31, P107, DOI 10.1080/01652176.2011.604971; Bodewes R, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-89; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Caddy SL, 2015, VET MICROBIOL, V177, P206, DOI 10.1016/j.vetmic.2015.03.011; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Castro TX, 2013, VET REC, V172, P557, DOI 10.1136/vr.101566; Choi S, 2014, J VET MED SCI, V76, P1141, DOI 10.1292/jvms.13-0585; De Paepe M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00039; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; Decaro N, 2014, VACCINE, V32, P3850, DOI 10.1016/j.vaccine.2014.04.050; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Evermann JF, 2005, J VET DIAGN INVEST, V17, P610, DOI 10.1177/104063870501700618; Finkbeiner SR, 2008, PLOS PATHOG, V4, P1; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Greene CE, 2013, INFECT DIS DOG CAT, P67; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; Guard BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127259; Haynes M, 2011, METAGENOMICS OF THE HUMAN BODY, P63, DOI 10.1007/978-1-4419-7089-3_4; Holtz LR, 2014, VIROLOGY, V468, P556, DOI 10.1016/j.virol.2014.09.012; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lappin M., 2013, CANINE FELINE GASTRO, P651; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; MARSHALL JA, 1984, AUST VET J, V61, P33, DOI 10.1111/j.1751-0813.1984.tb07186.x; Martella V, 2012, J CLIN MICROBIOL, V50, P1066, DOI 10.1128/JCM.05018-11; Martella V, 2011, J GEN VIROL, V92, P1880, DOI 10.1099/vir.0.029025-0; Mendez E, 2013, FIELDS VIROLOGY, V1, P609; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Namiki Toshiaki, 2012, Nucleic Acids Res, V40, pe155, DOI 10.1093/nar/gks678; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Perez-Brocal V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.9; Pesavento PA, 2013, VET PATHOLOGY; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pratelli A, 2002, VET REC, V151, P758; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz BS, 2008, J SMALL ANIM PRACT, V49, P84, DOI 10.1111/j.1748-5827.2007.00470.x; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071595; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Takano T, 2015, ARCH VIROL, V160, P1549, DOI 10.1007/s00705-015-2405-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toffan A, 2009, VET MICROBIOL, V139, P147, DOI 10.1016/j.vetmic.2009.04.031; Phan TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072787; Tupler T, 2012, JAVMA-J AM VET MED A, V241, P338, DOI 10.2460/javma.241.3.338; van den Brand JMA, 2012, J VIROL, V86, P2360, DOI 10.1128/JVI.06373-11; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wagner J, 2013, INFLAMM BOWEL DIS, V19, P1598, DOI 10.1097/MIB.0b013e318292477c; WILLIAMS FP, 1980, ARCH VIROL, V66, P215, DOI 10.1007/BF01314735; Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020; Yesilbag K, 2007, VET REC, V161, P169, DOI 10.1136/vr.161.5.169; Zhang B, 2014, J GEN VIROL, V95, P1603, DOI 10.1099/vir.0.063743-0; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhang W, 2014, J GEN VIROL, V95, P2553, DOI 10.1099/vir.0.069674-0; Zhu AL, 2011, ARCH VIROL, V156, P1671, DOI 10.1007/s00705-011-1022-z	71	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178433	10.1371/journal.pone.0178433	http://dx.doi.org/10.1371/journal.pone.0178433			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570584	Green Submitted, gold, Green Published			2022-12-26	WOS:000402611800053
J	Siers, SR; Savidge, JA; Reed, RN				Siers, Shane R.; Savidge, Julie A.; Reed, Robert N.			Quantile regression of microgeographic variation in population characteristics of an invasive vertebrate predator	PLOS ONE			English	Article							TREESNAKES BOIGA-IRREGULARIS; SEXUAL SIZE DIMORPHISM; BROWN TREESNAKES; GEOGRAPHIC-VARIATION; BODY CONDITION; REPRODUCTIVE-BIOLOGY; MORELIA-SPILOTA; PYTHONS; SNAKES; GUAM	Localized ecological conditions have the potential to induce variation in population characteristics such as size distributions and body conditions. The ability to generalize the influence of ecological characteristics on such population traits may be particularly meaningful when those traits influence prospects for successful management interventions. To characterize variability in invasive Brown Treesnake population attributes within and among habitat types, we conducted systematic and seasonally-balanced surveys, collecting 100 snakes from each of 18 sites: three replicates within each of six major habitat types comprising 95% of Guam's geographic expanse. Our study constitutes one of the most comprehensive and controlled samplings of any published snake study. Quantile regression on snake size and body condition indicated significant ecological heterogeneity, with a general trend of relative consistency of size classes and body conditions within and among scrub and Leucaena forest habitat types and more heterogeneity among ravine forest, savanna, and urban residential sites. Larger and more robust snakes were found within some savanna and urban habitat replicates, likely due to relative availability of larger prey. Compared to more homogeneous samples in the wet season, variability in size distributions and body conditions was greater during the dry season. Although there is evidence of habitat influencing Brown Treesnake populations at localized scales (e.g., the higher prevalence of larger snakes- particularly males-in savanna and urban sites), the level of variability among sites within habitat types indicates little ability to make meaningful predictions about these traits at unsampled locations. Seasonal variability within sites and habitats indicates that localized population characterization should include sampling in both wet and dry seasons. Extreme values at single replicates occasionally influenced overall habitat patterns, while pooling replicates masked variability among sites. A full understanding of population characteristics should include an assessment of variability both at the site and habitat level.	[Siers, Shane R.; Savidge, Julie A.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Siers, Shane R.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Hilo, HI USA	Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Siers, SR (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.; Siers, SR (corresponding author), USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Hilo, HI USA.	shane.r.siers@aphis.usda.gov			U.S. Navy, Joint Region Marianas MIPR [N61128-10-MP-001GS]	U.S. Navy, Joint Region Marianas MIPR	This research was funded by the U.S. Navy, Joint Region Marianas, MIPR Number: N61128-10-MP-001GS, awarded to RNR. Apart from approval of the work plan and access to military lands, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin-Demers G, 2002, J ZOOL, V256, P1, DOI 10.1017/S0952836902000018; Bonnet X, 1998, OIKOS, V83, P333, DOI 10.2307/3546846; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Brown GP, 1997, CAN J ZOOL, V75, P424, DOI 10.1139/z97-052; Cade BS, 2008, N AM J FISH MANAGE, V28, P349, DOI 10.1577/M07-048.1; Cade BS, 2011, T AM FISH SOC, V140, P1657, DOI 10.1080/00028487.2011.641885; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; EHRLICH PR, 1975, SCIENCE, V188, P221, DOI 10.1126/science.1118723; Filippi E, 2005, COPEIA, P517; Fosberg FR., 2013, VEGETATION TROPICAL; Fritts TH, 1985, BROWN TREE SNAKE GUA; Gragg JE, 2007, J WILDLIFE MANAGE, V71, P2311, DOI 10.2193/2006-444; GREENE H W, 1989, Proceedings of the California Academy of Sciences, V46, P193; GREGORY P T, 1987, P366; GREGORY PT, 1993, COPEIA, P946; Henderson RW, 1998, AMPHIBIA-REPTILIA, V19, P203, DOI 10.1163/156853898X00485; Jenkins CL, 2009, COPEIA, P774, DOI 10.1643/CE-07-277; KEPHART DG, 1982, OECOLOGIA, V52, P287, DOI 10.1007/BF00363852; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Koenker R, 2016, PACKAGE QUANTREG INT; Lardner B, 2014, COPEIA, P428, DOI 10.1643/CE-14-050; Lardner B, 2013, WILDLIFE SOC B, V37, P664, DOI 10.1002/wsb.297; Lardner B, 2009, HERPETOL CONSERV BIO, V4, P313; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu Z., 2005, GUAM VEGETATION MAPP; Luiselli L, 2005, HERPETOL J, V15, P221; Madsen T, 2006, AUSTRAL ECOL, V31, P30, DOI 10.1111/j.1442-9993.2006.01540.x; Madsen T, 2002, AUSTRAL ECOL, V27, P672, DOI 10.1046/j.1442-9993.2002.01228.x; Madsen T, 1998, AUST J ECOL, V23, P340, DOI 10.1111/j.1442-9993.1998.tb00739.x; Mathies T, 2010, J HERPETOL, V44, P209, DOI 10.1670/06-069.1; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; Naulleau G, 1996, OECOLOGIA, V107, P301, DOI 10.1007/BF00328446; PARKER W S, 1987, P253; Pearson D, 2002, OECOLOGIA, V131, P418, DOI 10.1007/s00442-002-0917-5; Pearson D, 2002, BIOL J LINN SOC, V77, P113, DOI 10.1046/j.1095-8312.1999.00075.x; Plummer MV, 1997, HERPETOL MONOGR, P102; Reinert HK., 1987, SNAKES ECOLOGY EVOLU, P201; Rodda GH, 1999, PROBLEM SNAKE MANAGEMENT, P44; Rodda GH, 2007, MANAGING VERTEBRATE, p[7, 257]; Rodda GH, 2007, J WILDLIFE MANAGE, V71, P656, DOI 10.2193/2005-742; SAVIDGE JA, 1991, BIOTROPICA, V23, P294, DOI 10.2307/2388207; SAVIDGE JA, 1988, J HERPETOL, V22, P275, DOI 10.2307/1564150; Savidge JA, 2007, PAC SCI, V61, P191, DOI 10.2984/1534-6188(2007)61[191:RBOTBT]2.0.CO;2; SHINE R, 1991, COPEIA, P120, DOI 10.2307/1446254; SHINE R, 1987, J HERPETOL, V21, P165, DOI 10.2307/1564479; Siers SR, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1292; Siers SR, 2014, J HERPETOL, V48, P500, DOI 10.1670/13-037; Siers SR, 2015, THESIS; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Trembath DF, 2008, AUST J ZOOL, V56, P173, DOI 10.1071/ZO08008; Tyrrell CL, 2009, J APPL ECOL, V46, P128, DOI 10.1111/j.1365-2664.2008.01591.x; Ujvari B, 2011, ECOLOGY, V92, P777, DOI 10.1890/10-1471.1; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zuffi MAL, 2007, HERPETOL J, V17, P219; Zuffi MAL, 2009, BIOL J LINN SOC, V96, P383, DOI 10.1111/j.1095-8312.2008.01124.x	56	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177671	10.1371/journal.pone.0177671	http://dx.doi.org/10.1371/journal.pone.0177671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570632	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800015
J	Hsu, WY; Zanto, TP; van Schouwenburg, MR; Gazzaley, A				Hsu, Wan-Yu; Zanto, Theodore P.; van Schouwenburg, Martine R.; Gazzaley, Adam			Enhancement of multitasking performance and neural oscillations by transcranial alternating current stimulation	PLOS ONE			English	Article							BETA-BAND OSCILLATIONS; DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; ELECTRICAL-STIMULATION; THETA-OSCILLATIONS; FLUID INTELLIGENCE; BRAIN-STIMULATION; COGNITIVE CONTROL; MOTOR SYSTEM; OLDER-ADULTS	Multitasking is associated with the generation of stimulus-locked theta (4-7 Hz) oscillations arising from prefrontal cortex (PFC). Transcranial alternating current stimulation (tACS) is a non-invasive brain stimulation technique that influences endogenous brain oscillations. Here, we investigate whether applying alternating current stimulation within the theta frequency band would affect multitasking performance, and explore tACS effects on neurophysiological measures. Brief runs of bilateral PFC theta-tACS were applied while participants were engaged in a multitasking paradigm accompanied by electroencephalography (EEG) data collection. Unlike an active control group, a tACS stimulation group showed enhancement of multitasking performance after a 90-minute session (F-1,F-35 = 6.63, p = 0.01, eta p(2) = 0.16; effect size = 0.96), coupled with significant modulation of posterior beta (13-30 Hz) activities (F-1,F-32 =7.66, p = 0.009, eta p(2) = 0.19; effect size = 0.96). Across participant regression analyses indicated that those participants with greater increases in frontal theta, alpha and beta oscillations exhibited greater multitasking performance improvements. These results indicate frontal theta-tACS generates benefits on multitasking performance accompanied by widespread neuronal oscillatory changes, and suggests that future tACS studies with extended treatments are worth exploring as promising tools for cognitive enhancement.	[Hsu, Wan-Yu; Zanto, Theodore P.; van Schouwenburg, Martine R.; Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Hsu, Wan-Yu; Zanto, Theodore P.; Gazzaley, Adam] Univ Calif San Francisco, Neuroscape, San Francisco, CA 94143 USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zanto, TP; Gazzaley, A (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Zanto, TP; Gazzaley, A (corresponding author), Univ Calif San Francisco, Neuroscape, San Francisco, CA 94143 USA.; Gazzaley, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Gazzaley, A (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	theodore.zanto@ucsf.edu; adam.gazzaley@ucsf.edu			NIH Grant [R01MH096861]; Hart Center for Deep Rhythm	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hart Center for Deep Rhythm	This work was supported by the NIH Grant R01MH096861 and Hart Center for Deep Rhythm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseichuk I, 2016, CURR BIOL, V26, P1513, DOI 10.1016/j.cub.2016.04.035; Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Antal A, 2012, CLIN EEG NEUROSCI, V43, P175, DOI 10.1177/1550059412448030; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Brinkman L, 2016, J NEUROSCI, V36, P8726, DOI 10.1523/JNEUROSCI.0868-16.2016; Brittain JS, 2013, CURR BIOL, V23, P436, DOI 10.1016/j.cub.2013.01.068; Chander BS, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00120; Clapp WC, 2011, P NATL ACAD SCI USA, V108, P7212, DOI 10.1073/pnas.1015297108; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Feurra M, 2013, J NEUROSCI, V33, P17483, DOI 10.1523/JNEUROSCI.1414-13.2013; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Feurra M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00013; Filmer HL, 2013, CORTEX, V49, P2845, DOI 10.1016/j.cortex.2013.08.015; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hoppenbrouwers SS, 2013, CORTEX, V49, P1377, DOI 10.1016/j.cortex.2012.06.003; Hsu WY, 2015, CORTEX, V69, P175, DOI 10.1016/j.cortex.2015.05.014; Hsu WY, 2015, NEUROBIOL AGING, V36, P2348, DOI 10.1016/j.neurobiolaging.2015.04.016; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Jausovec N, 2014, ACTA PSYCHOL, V146, P1, DOI 10.1016/j.actpsy.2013.11.011; Jausovec N, 2014, BIOL PSYCHOL, V96, P42, DOI 10.1016/j.biopsycho.2013.11.006; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kaminski J, 2012, INT J PSYCHOPHYSIOL, V85, P125, DOI 10.1016/j.ijpsycho.2011.11.006; Kanai R, 2008, CURR BIOL, V18, P1839, DOI 10.1016/j.cub.2008.10.027; Kirov R, 2009, P NATL ACAD SCI USA, V106, P15460, DOI 10.1073/pnas.0904438106; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Knapp T. R., 2009, PRACTICAL ASSESSMENT, V14; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Lin CT, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-11; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marshall L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016905; Meiron O, 2014, CLIN NEUROPHYSIOL, V125, P77, DOI 10.1016/j.clinph.2013.06.013; Merlet I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057330; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pahor A, 2014, INT J PSYCHOPHYSIOL, V93, P322, DOI 10.1016/j.ijpsycho.2014.06.015; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Raco V, 2014, BRAIN STIMUL, V7, P823, DOI 10.1016/j.brs.2014.08.005; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Santarnecchi E, 2013, CURR BIOL, V23, P1449, DOI 10.1016/j.cub.2013.06.022; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Thut G, 2011, CURR BIOL, V21, P1176, DOI 10.1016/j.cub.2011.05.049; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Turi Z, 2013, RESTOR NEUROL NEUROS, V31, P275, DOI 10.3233/RNN-120297; van Schouwenburg MR, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00658; Vanderhasselt MA, 2006, EXP BRAIN RES, V169, P279, DOI 10.1007/s00221-005-0344-z; Voss U, 2014, NAT NEUROSCI, V17, P810, DOI 10.1038/nn.3719; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	62	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178579	10.1371/journal.pone.0178579	http://dx.doi.org/10.1371/journal.pone.0178579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562642	Green Published, gold			2022-12-26	WOS:000402608700076
J	Seith, F; Schmidt, H; Gatidis, S; Bezrukov, I; Schraml, C; Pfannenberg, C; la Fougere, C; Nikolaou, K; Schwenzer, N				Seith, Ferdinand; Schmidt, Holger; Gatidis, Sergios; Bezrukov, Ilja; Schraml, Christina; Pfannenberg, Christina; la Fougere, Christian; Nikolaou, Konstantin; Schwenzer, Nina			SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue	PLOS ONE			English	Article							ATTENUATION CORRECTION; QUANTITATIVE-EVALUATION; CT; MRI; ARTIFACT	Purpose The aim of the study was to investigate the influence of lung density changes as well as bone proximity on the attenuation correction of lung standardized uptake values (SUVs). Methods and materials 15 patients with mostly oncologic diseases were examined in 18F-FDG-PET/CT and subsequently in a fully integrated PET/MR scanner. From each PET dataset acquired in PET/MR, four different PET reconstructions were computed using different attenuation maps (mu-maps): i) CT-based mu-map (gold standard); ii) CT-based mu-map in which the linear attenuation coefficients (LAC) of the lung tissue was replaced by the lung LAC from the MR-based segmentation method; iii) based on reconstruction ii), the LAC of bone structures was additionally replaced with the LAC from the MR-based segmentation method; iv) the vendor-provided MR-based mu-map (segmentation-based method). Those steps were performed using MATLAB. CT Hounsfield units (HU) and SUVmean was acquired in different levels and regions of the lung. Relative differences between the differently corrected PETs were computed. Results Compared to the gold standard, reconstruction ii), iii) and iv) led to a relative underestimation of SUV in the posterior regions of -9.0%, -13.4% and -14.0%, respectively. Anterior and middle regions were less affected with an overestimation of about 6-8% in reconstructions ii) iv). Conclusion It could be shown that both, differences in lung density and the vicinity of bone tissue in the mu-map may have an influence on SUV, mostly affecting the posterior lung regions.	[Seith, Ferdinand; Schmidt, Holger; Gatidis, Sergios; Schraml, Christina; Pfannenberg, Christina; Nikolaou, Konstantin; Schwenzer, Nina] Eberhard Karls Univ Tubingen, Dept Radiol, Diagnost & Intervent Radiol, Hoppe Seyler Str 3, Tubingen, Germany; [Bezrukov, Ilja] Eberhard Karls Univ Tubingen, Dept Radiol, Lab Preclin Imaging, Preclin Imaging & Radiopharm, Hoppe Seyler Str 3, Tubingen, Germany; [Bezrukov, Ilja] Eberhard Karls Univ Tubingen, Dept Radiol, Imaging Technol Werner Siemens Fdn, Hoppe Seyler Str 3, Tubingen, Germany; [Bezrukov, Ilja] Max Planck Inst Intelligent Syst, Spemannstr 38, Tubingen, Germany; [la Fougere, Christian] Eberhard Karls Univ Tubingen, Dept Radiol, Nucl Med, Hoppe Seyler Str 3, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Siemens AG; Siemens Germany; Max Planck Society; Eberhard Karls University of Tubingen	Schmidt, H (corresponding author), Eberhard Karls Univ Tubingen, Dept Radiol, Diagnost & Intervent Radiol, Hoppe Seyler Str 3, Tubingen, Germany.	holger.schmidt@uni-tuebingen.de	Gatidis, Sergios/AAF-4858-2020; Seith, Ferdinand/AAF-9156-2020; la Fougère, Christian/AAN-2811-2021; la Fougere, Christian/G-6514-2012	Gatidis, Sergios/0000-0002-6928-4967; la Fougère, Christian/0000-0001-7519-0417; Bezrukov, Ilja/0000-0003-0420-4329				Antoch G, 2002, J NUCL MED, V43, P1339; Barrington SF, 2010, EUR J NUCL MED MOL I, V37, P1824, DOI 10.1007/s00259-010-1490-5; Bezrukov I, 2013, J NUCL MED, V54, P1768, DOI 10.2967/jnumed.112.113209; Bruegel M, 2007, J MAGN RESON IMAGING, V25, P73, DOI 10.1002/jmri.20824; Carney JPJ, 2006, MED PHYS, V33, P976, DOI 10.1118/1.2174132; Chandarana H, 2013, RADIOLOGY, V268, P874, DOI 10.1148/radiol.13130620; Fraioli F, 2015, EUR J NUCL MED MOL I, V42, P49, DOI 10.1007/s00259-014-2873-9; Gallamini A, 2014, CANCERS, V6, P1821, DOI 10.3390/cancers6041821; GATTINONI L, 1991, ANESTHESIOLOGY, V74, P15, DOI 10.1097/00000542-199101000-00004; HARTLEY PG, 1994, J APPL PHYSIOL, V76, P271, DOI 10.1152/jappl.1994.76.1.271; HEREMANS A, 1992, CHEST, V102, P805, DOI 10.1378/chest.102.3.805; Heusch P, 2014, J NUCL MED, V55, P373, DOI 10.2967/jnumed.113.129825; Hofmann M, 2011, J NUCL MED, V52, P1392, DOI 10.2967/jnumed.110.078949; Huellner MW, 2016, J NUCL MED, V57, P21, DOI 10.2967/jnumed.115.162040; Izquierdo-Garcia D, 2014, EUR J NUCL MED MOL I, V41, P1574, DOI 10.1007/s00259-014-2751-5; KALENDER WA, 1990, RADIOLOGY, V175, P265, DOI 10.1148/radiology.175.1.2315492; Kartmann R, 2013, MED PHYS, V40, DOI 10.1118/1.4812685; Keereman V, 2013, MAGN RESON MATER PHY, V26, P81, DOI 10.1007/s10334-012-0334-7; Keereman V, 2010, J NUCL MED, V51, DOI 10.2967/jnumed.109.065425; Keereman V, 2012, MOL IMAGING, V11, P155, DOI 10.2310/7290.2011.00036; Keereman V, 2011, MED PHYS, V38, P6010, DOI 10.1118/1.3651640; Kinahan PE, 2003, SEMIN NUCL MED, V33, P166, DOI 10.1053/snuc.2003.127307; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Marshall HR, 2012, J NUCL MED, V53, P977, DOI 10.2967/jnumed.111.098350; Mehranian A, 2015, PHYS MED BIOL, V60, P4813, DOI 10.1088/0031-9155/60/12/4813; Park KJ, 1999, RADIOLOGY, V211, P541, DOI 10.1148/radiology.211.2.r99ma52541; Paulus DH, 2013, PHYS MED BIOL, V58, P8021, DOI 10.1088/0031-9155/58/22/8021; Paulus DH, 2015, J NUCL MED, V56, P1061, DOI 10.2967/jnumed.115.156000; Paulus DH, 2012, MED PHYS, V39, P4306, DOI 10.1118/1.4729716; Samarin A, 2012, EUR J NUCL MED MOL I, V39, P1154, DOI 10.1007/s00259-012-2113-0; Schaarschmidt BM, 2016, EUROPEAN RADIOLOGY; Spicks C, 2016, J NUCL MED, V57, P420, DOI 10.2967/jnumed.115.158808; VERSCHAKELEN JA, 1993, AM J ROENTGENOL, V161, P713, DOI 10.2214/ajr.161.4.8372744; Vogel MN, 2007, ROFO-FORTSCHR RONTG, V179, P72, DOI 10.1055/s-2006-926978; Wagenknecht G, 2013, MAGN RESON MATER PHY, V26, P99, DOI 10.1007/s10334-012-0353-4; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; WATANUKI Y, 1994, CHEST, V106, P806, DOI 10.1378/chest.106.3.806; Zeimpekis K, 2014, J NUCL MED S1, V55, P2103	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0177856	10.1371/journal.pone.0177856	http://dx.doi.org/10.1371/journal.pone.0177856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562622	Green Submitted, Green Published, gold			2022-12-26	WOS:000402608700030
J	Fukushima, S; Endo, M; Matsumoto, Y; Fukushi, JI; Matsunobu, T; Kawaguchi, KI; Setsu, N; Iida, K; Yokoyama, N; Nakagawa, M; Yahiro, K; Oda, Y; Iwamoto, Y; Nakashima, Y				Fukushima, Suguru; Endo, Makoto; Matsumoto, Yoshihiro; Fukushi, Jun-ichi; Matsunobu, Tomoya; Kawaguchi, Ken-ichi; Setsu, Nokitaka; Iida, Keiichiro; Yokoyama, Nobuhiko; Nakagawa, Makoto; Yahiro, Kenichiro; Oda, Yoshinao; Iwamoto, Yukihide; Nakashima, Yasuharu			Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; FACTOR-I; CELL-PROLIFERATION; FACTOR 1-ALPHA; EXPRESSION; HIF-1-ALPHA; CARCINOMA; CANCER; OVEREXPRESSION; PATHWAY	Background Malignant peripheral nerve sheath tumor (MPNST) is a rare soft tissue sarcoma with poor prognosis. Hypoxia-inducible factor 1 (HIF-1) plays a crucial role in the cellular response to hypoxia and regulates the expression of multiple genes involved in tumor progression in various cancers. However, the importance of the expression of HIF-1 alpha in MPNSTs is unclear. Methods The expression of HIF-1 alpha was examined immunohistochemically in 82 MPNST specimens. Cell culture assays of human MPNST cells under normoxic and hypoxic conditions were used to evaluate the impact of anti-HIF-1 alpha-specific siRNA inhibition on cell survival. A screening kit was employed to identify small molecules that inhibited HIF-1 alpha. Results The nuclear expression of HIF-1 alpha was positive in 75.6% of MPNST samples (62/82 cases). Positivity for HIF-1a was a significant poor prognostic factor both in univariate (P = 0.048) and multivariate (P <= 0.0001) analyses. HIF-1 alpha knockdown abrogated MPNST cell growth, inducing apoptosis. Finally, chetomin, an inhibitor of HIF-1 alpha, effectively inhibited the growth of MPNST cells and induced their apoptosis. Conclusion Inhibition of HIF-1 alpha signaling is a potential treatment option for MPNSTs.	[Fukushima, Suguru; Endo, Makoto; Matsumoto, Yoshihiro; Fukushi, Jun-ichi; Matsunobu, Tomoya; Kawaguchi, Ken-ichi; Setsu, Nokitaka; Iida, Keiichiro; Yokoyama, Nobuhiko; Nakagawa, Makoto; Yahiro, Kenichiro; Iwamoto, Yukihide; Nakashima, Yasuharu] Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Fukuoka, Japan; [Endo, Makoto; Nakagawa, Makoto] Natl Canc Ctr, Div Orthopaed Surg, Tokyo, Japan; [Matsunobu, Tomoya] Kyushu Rosai Hosp, Dept Orthopaed Surg, Kitakyushu, Fukuoka, Japan; [Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Pathol Sci, Grad Sch Med Sci, Fukuoka, Japan; [Iwamoto, Yukihide] Kyushu Rosai Hosp, Kitakyushu, Fukuoka, Japan	Kyushu University; National Cancer Center - Japan; Kyushu University	Matsumoto, Y (corresponding author), Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Fukuoka, Japan.	ymfbb85586@gmail.com	Endo, Makoto/K-2896-2012	Endo, Makoto/0000-0002-7956-2190	 [23592192];  [25293325];  [26713046]; Grants-in-Aid for Scientific Research [26713046] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 23592192, https://kaken.nii.ac.jp/file/KAKENHI-PROJECT-2 3592192/23592192seika.pdf; 25293325, https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-2 5293325/; 26713046, https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26713046/, http://www.mhlw.go.jp/file/05-Shingikai10601000-DaijinkanboukouseikagakukaK ouseikagakuka/0000064008.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghileri M, 2006, CANCER-AM CANCER SOC, V107, P1065, DOI 10.1002/cncr.22098; Aoki M, 2006, INT J ONCOL, V29, P1421; Birner P, 2000, CANCER RES, V60, P4693; Brizel DM, 1996, CANCER RES, V56, P941; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Endo M, 2011, CLIN CANC RES OFFICI, P17; Endo M, 2013, CLIN CANCER RES, V19, P450, DOI 10.1158/1078-0432.CCR-12-1067; Fan Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001646; Farid M, 2014, ONCOLOGIST, V19, P193, DOI 10.1634/theoncologist.2013-0328; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Grobmyer SR, 2008, J SURG ONCOL, V97, P340, DOI 10.1002/jso.20971; Hakozaki M, 2009, VIRCHOWS ARCH, V455, P517, DOI 10.1007/s00428-009-0848-1; Harada H, 2011, J RADIAT RES, V52, P545, DOI 10.1269/jrr.11056; Hatano M, 2015, CLIN EXP METASTAS, V32, P579, DOI 10.1007/s10585-015-9729-y; Hemmerlein B, 2004, HISTOPATHOLOGY, V45, P603, DOI 10.1111/j.1365-2559.2004.02019.x; HRUBAN RH, 1990, CANCER-AM CANCER SOC, V66, P1253, DOI 10.1002/1097-0142(19900915)66:6<1253::AID-CNCR2820660627>3.0.CO;2-R; Iida K, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-21; Ji ZG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-158; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kobayashi C, 2006, CANCER GENET CYTOGEN, V165, P98, DOI 10.1016/j.cancergencyto.2005.07.006; Kroeger N, 2014, EUR J CANCER, V50, P1531, DOI 10.1016/j.ejca.2014.01.031; Kroep JR, 2011, ANN ONCOL, V22, P207, DOI 10.1093/annonc/mdq338; Kubo T, 2008, J BONE JOINT SURG BR, V90B, P364, DOI 10.1302/0301-620X.90B3.19806; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Li YJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3064-x; Luan YJ, 2013, PATHOL RES PRACT, V209, P184, DOI 10.1016/j.prp.2012.10.017; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Ng VY, 2013, ANTICANCER RES, V33, P2597; Oku Y, 2015, FEBS OPEN BIO, V5, P542, DOI 10.1016/j.fob.2015.06.007; Rad E, 2015, MOL CANCER RES, V13, P1149, DOI 10.1158/1541-7786.MCR-14-0182; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semba H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11635; Setsu N, 2012, CANCER-AM CANCER SOC, V118, P1637, DOI 10.1002/cncr.26448; Sivridis E, 2002, CANCER-AM CANCER SOC, V95, P1055, DOI 10.1002/cncr.10774; Song WB, 2015, ONCOTARGET, V6, P19290, DOI 10.18632/oncotarget.4478; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Q., 2014, MATH PROB ENG, V2014, P1, DOI DOI 10.1016/J.GENE.2014.03.025; Wasa J, 2008, CLIN EXP METASTAS, V25, P819, DOI 10.1007/s10585-008-9197-8; Wu J, 2005, ELECT J DIFFERENTIAL, V2005, P1, DOI DOI 10.1016/J.M0LCEL.2005.02.002; Zhang B, 2014, ASIAN PAC J CANCER P, V15, P8251, DOI 10.7314/APJCP.2014.15.19.8251; Zhong H, 1999, CANCER RES, V59, P5830	47	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178064	10.1371/journal.pone.0178064	http://dx.doi.org/10.1371/journal.pone.0178064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558056	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000025
J	Nissen, J; Jokelainen, P; Stensvold, CR; Trevisan, C; Fuchs, J; Burgdorf, KS; Nielsen, HV; Pires, SM				Nissen, Janna; Jokelainen, Pikka; Stensvold, Christen Rune; Trevisan, Chiara; Fuchs, Josefine; Burgdorf, Kristoffer Solvsten; Nielsen, Henrik Vedel; Pires, Sara M.			The disease burden of congenital toxoplasmosis in Denmark, 2014	PLOS ONE			English	Article							NEONATAL SCREENING-PROGRAM; ADJUSTED LIFE YEARS; GLOBAL BURDEN; DISABILITY; ANTIBODIES; HEALTH	Background Congenital toxoplasmosis (CT) causes a substantial disease burden worldwide. The aim of this study was to estimate the disease burden of CT in Denmark, a developed country with free public healthcare and nationwide data available. Methods Using data primarily from two public health surveillance programmes conducted between 1992 and 2007, we estimated the incidence, occurrence of sequelae, mortality and the burden of disease in terms of disability-adjusted life years (DALYs) of CT in Denmark in 2014. Findings We estimated that 14 children were born with CT in 2014, of which six will have developed sequelae by the age of 12. CT resulted in a total disease burden of 123 DALYs (95% uncertainty interval [UI], 100-148), of which 78 (95% UI, 64-94) were due to foetal loss and 2 (95% UI, 1-3) were due to neonatal death; the remaining burden was due to moderate to severe life-long sequelae. A comparison of the estimated incidence of CT with the number of reported CT cases in 2008-2014 indicated that for each reported CT case, at least five other CT cases could be expected to have occurred and gone unreported. Interpretation Early onset, severity, and life-long duration of sequelae have a major effect on the disease burden of CT. Our data suggest that CT is under-diagnosed or under-reported in Denmark. The estimated disease burden and public health impact in Denmark is lower than in other European countries, highlighting the need for country-specific studies.	[Nissen, Janna] Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, Lyngby, Denmark; [Jokelainen, Pikka; Stensvold, Christen Rune; Nielsen, Henrik Vedel] Statens Serum Inst, Lab Parasitol, Copenhagen, Denmark; [Jokelainen, Pikka] Univ Helsinki, Fac Vet Med, Helsinki, Finland; [Jokelainen, Pikka] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Dept Basic Vet Sci & Populat Med, Tartu, Estonia; [Trevisan, Chiara] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Fuchs, Josefine] Copenhagen Univ Hosp, Dept Ophthalmol, Glostrup, Denmark; [Burgdorf, Kristoffer Solvsten] Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark	Technical University of Denmark; Statens Serum Institut; University of Helsinki; Estonian University of Life Sciences; University of Copenhagen; University of Copenhagen; University of Copenhagen	Nissen, J (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, Lyngby, Denmark.	ioni@food.dtu.dk	Pires, Sara/M-2506-2019; Jokelainen, Pikka/U-7238-2019; Stensvold, Christen Rune/H-3718-2011	Pires, Sara/0000-0002-7751-1509; Jokelainen, Pikka/0000-0002-3035-5094; Nielsen, Henrik Vedel/0000-0002-6773-1874; Burgdorf, Kristoffer/0000-0001-5814-6844; Nissen, Janna/0000-0002-8891-8451; Trevisan, Chiara/0000-0002-4920-6750; Stensvold, Christen Rune/0000-0002-1417-7048	Metrix-project by the Danish Ministry for Environment and Food	Metrix-project by the Danish Ministry for Environment and Food	This work was partly funded through the Metrix-project by the Danish Ministry for Environment and Food. There was no additional funding received for this study.	[Anonymous], [No title captured]; [Anonymous], 2014, DANISH LIFE EXPECTAN; [Anonymous], 2009, ANN REP ZOON DENM 20; Counotte MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004831; COUVREUR J, 2001, TOXOPLASMOSIS COMPRE, P254; Derouin F, 2005, TOXOPLASMOSE ETAT CO; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, P56, DOI DOI 10.1371/J0URNAL.PNTD.0002634; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Gkogka E, 2011, EMERG INFECT DIS, V17, P1581, DOI 10.3201/eid1709.101766; Hammerum MS, 2002, LANDSPATIENTREGISTER; Havelaar AH, 2007, CLIN INFECT DIS, V44, P1467, DOI 10.1086/517511; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; KOPPE JG, 1986, LANCET, V1, P254; Kortbeek LM, 2009, MEM I OSWALDO CRUZ, V104, P370, DOI 10.1590/S0074-02762009000200034; LEBECH M, 1993, SCAND J INFECT DIS, V25, P751, DOI 10.3109/00365549309008574; Lebech M, 1999, LANCET, V353, P1834, DOI 10.1016/S0140-6736(98)11281-3; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; National Food Institute, 2014, BURD DIS FOODB PATH; Paul M, 2000, PEDIATR INFECT DIS J, V19, P30, DOI 10.1097/00006454-200001000-00007; Roser D, 2010, J INHERIT METAB DIS, V33, pS241, DOI 10.1007/s10545-010-9124-4; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Scallan E, 2015, EPIDEMIOL INFECT, V143, P2795, DOI 10.1017/S0950268814003185; Schmidt DR, 2006, ARCH DIS CHILD, V91, P661, DOI 10.1136/adc.2004.066514; Schmidt DR., 2005, NEONATAL SCREENING P; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; van Lier A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153106; World Health Organization (WHO), 2013, WHOHISHSIGHE20134, P81	32	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178282	10.1371/journal.pone.0178282	http://dx.doi.org/10.1371/journal.pone.0178282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558051	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000037
J	Patel, RR; Mena, L; Nunn, A; McBride, T; Harrison, LC; Oldenburg, CE; Liu, JX; Mayer, KH; Chan, PA				Patel, Rupa R.; Mena, Leandro; Nunn, Amy; McBride, Timothy; Harrison, Laura C.; Oldenburg, Catherine E.; Liu, Jingxia; Mayer, Kenneth H.; Chan, Philip A.			Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention	PLOS ONE			English	Article							MEDICAID; CARE; ACCESS	Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Mississippi; St. Louis, Missouri; Providence, Rhode Island) from 2014-2015. The outcome, PrEP utilization, was defined as patient PrEP use at three months. Multivariable logistic regression was performed to determine the association between insurance coverage and PrEP utilization. Of 201 patients (Jackson: 34%; St. Louis: 28%; Providence: 28%), 91% were male, 51% were White, median age was 29 years, and 21% were uninsured; 82% of patients reported taking PrEP at three months. Insurance coverage was significantly associated with PrEP utilization. After adjusting for Medicaid-expansion and individual socio-demographics, insured patients were four times as likely to use PrEP services compared to the uninsured (OR: 4.49, 95% CI: 1.68-12.01; p = 0.003). Disparities in insurance coverage are important considerations in implementation programs and may impede PrEP utilization.	[Patel, Rupa R.; Harrison, Laura C.] Washington Univ St Louis, Div Infect Dis, St Louis, MO 63130 USA; [Mena, Leandro] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA; [Nunn, Amy] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI USA; [McBride, Timothy] Washington Univ St Louis, Brown Sch, St Louis, MO USA; [McBride, Timothy] Washington Univ St Louis, Ctr Hlth Econ & Policy, St Louis, MO USA; [Oldenburg, Catherine E.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Liu, Jingxia] Washington Univ St Louis, Div Publ Hlth Sci, St Louis, MO USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Harvard Med Sch, Dept Med, Boston, MA USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Chan, Philip A.] Brown Univ, Div Infect Dis, Providence, RI 02912 USA	Washington University (WUSTL); University of Mississippi; University of Mississippi Medical Center; Brown University; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco; Washington University (WUSTL); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Fenway Health; Brown University	Patel, RR (corresponding author), Washington Univ St Louis, Div Infect Dis, St Louis, MO 63130 USA.	rupapatel@wustl.edu		Liu, Jingxia/0000-0002-9434-7907	Washington University Institute of Clinical and Translational Sciences [UL1TR000448]; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000450]; Washington University in St. Louis Institute; National Institute of Allergy And Infectious Diseases [1K23A1096923]; National Institute of Mental Health [1R34MH109371, 5R25MH083620-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Washington University Institute of Clinical and Translational Sciences; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Washington University in St. Louis Institute; National Institute of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RRP is supported by the Washington University Institute of Clinical and Translational Sciences grant UL1TR000448, sub-award KL2TR000450, from the National Center for Advancing Translational Sciences of the National Institutes of Health, and the Washington University in St. Louis Institute for Public Health Cubed Funding. PAC is supported by the National Institute of Allergy And Infectious Diseases (1K23A1096923). LM is supported by the National Institute of Mental Health (1R34MH109371). AN is supported by the National Institute of Mental Health (5R25MH083620-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NAT HIV AIDS STRAT U; Centers for Disease Control and Prevention, 2014, HIV SURVEILLANCE REP, V26; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Doblecki- Lewis S, 2016, J ACQUIR IMMUNE DEFI; Gilead, TRUV PREP MED ASS PR; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Goodman-Bacon AJ, 2017, NEW ENGL J MED, V376, P1005, DOI 10.1056/NEJMp1615696; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Kelley CF, 2015, CLIN INFECT DIS, V61, P1590, DOI 10.1093/cid/civ664; Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613; Long SK, 2005, HEALTH SERV RES, V40, P39, DOI 10.1111/j.1475-6773.2005.00341.x; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; Robin A, 2016, HLTH INSURANCE COVER; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4	15	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178737	10.1371/journal.pone.0178737	http://dx.doi.org/10.1371/journal.pone.0178737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558067	Green Published, gold, Green Submitted			2022-12-26	WOS:000402607000061
J	Reist, C; Mee, S; Fujimoto, K; Rajani, V; Bunney, WE; Bunney, BG				Reist, Christopher; Mee, Steven; Fujimoto, Ken; Rajani, Vivek; Bunney, William E.; Bunney, Blynn G.			Assessment of psychological pain in suicidal veterans	PLOS ONE			English	Article							SERVICEMEMBERS ARMY STARRS; PSYCHIATRIC-HOSPITALIZATION; MENTAL-HEALTH; RISK-FACTORS; IMPULSIVITY; DISCHARGE; HISTORY; SCALE; RESILIENCE; SEVERITY	Psychological pain is a relatively understudied and potentially important construct in the evaluation of suicidal risk. Psychological pain also referred to as 'mental pain' or 'psychache' can be defined as an adverse emotional reaction to a severe trauma (e.g., the loss of a child) or may be associated with an illness such as depression. When psychological pain levels reach intolerable levels, some individuals may view suicide as the only and final means of escape. To better understand psychological pain, we previously developed and validated a brief self-rating 10-item scale, Mee-Bunney Psychological Pain Assessment Scale [MBP] in depressed patients and non-psychiatric controls. Our results showed a significant increase in psychological pain in the depressed patients compared to controls. We also observed a significant linear correlation between psychological pain and suicidality in the depressed patient cohort. The current investigation extends our study of psychological pain to a diagnostically heterogeneous population of 57 US Veterans enrolled in a suicide prevention program. In addition to the MBP, we administered the Columbia Suicide Severity Rating Scale (C-SSRS), Beck Depression Inventory (BDI-II), Beck Hopelessness Scale (BHS), and the Barratt Impulsiveness Scale (BIS-11). Suicidal patients scoring above a predetermined threshold for high psychological pain also had significantly elevated scores on all the other assessments. Among all of the evaluations, psychological pain accounted for the most shared variance for suicidality (C-SSRS). Stepwise regression analyses showed that impulsiveness (BIS) and psychological pain (MBP) contributed more to suicidality than any of the other combined assessments. We followed patients for 15 months and identified a subgroup (24/57) with serious suicide events. Within this subgroup, 29% (7/24) had a serious suicidal event (determined by the lethality subscale of the C-SSRS), including one completed suicide. Our results build upon our earlier findi`ngs and recent literature supporting psychological pain as a potentially important construct. Systematically evaluating psychological pain along with additional measures of suicidality could improve risk assessment and more effectively guide clinical resource allocation toward prevention.	[Reist, Christopher; Rajani, Vivek] VA Long Beach Healthcare Syst, Long Beach, CA USA; [Reist, Christopher; Bunney, William E.; Bunney, Blynn G.] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; [Mee, Steven] Appl Innovat Psychiat, Los Alamitos, CA USA; [Fujimoto, Ken] Loyola Univ, Chicago, IL 60611 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; Loyola University Chicago	Bunney, BG (corresponding author), Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA.	bgbunney@uci.edu						[Anonymous], 2015, DEP DEFENSE SUICIDE, V3; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Beck AT, 1996, PSYCHOL ASSESS; Bolton JM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4978; Caceda R, 2014, PSYCHOSOM MED, V76, P445, DOI 10.1097/PSY.0000000000000075; CDC, 2015, FASTST CTR DIS CONTR; Doihara C, 2012, PSYCHIAT CLIN NEUROS, V66, P529, DOI 10.1111/j.1440-1819.2012.02379.x; Jones JE, 2005, J NEUROPSYCH CLIN N, V17, P172, DOI 10.1176/appi.neuropsych.17.2.172; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Large M, 2011, AUST NZ J PSYCHIAT, V45, P619, DOI 10.3109/00048674.2011.590465; Leenaars AA, 2010, SUICIDE LIFE-THREAT, V40, P476, DOI 10.1521/suli.2010.40.5.476; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Luxton DD, 2013, PSYCHIAT SERV, V64, P626, DOI 10.1176/appi.ps.201200413; Mee S, 2011, J PSYCHIATR RES, V45, P1504, DOI 10.1016/j.jpsychires.2011.06.011; Meehan J, 2006, BRIT J PSYCHIAT, V188, P129, DOI 10.1192/bjp.188.2.129; Meerwijk EL, 2015, BIOL PSYCHOL, V105, P106, DOI 10.1016/j.biopsycho.2015.01.003; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P245, DOI 10.1007/s11682-013-9234-3; Olfson M, 2016, JAMA PSYCHIAT, V73, P1119, DOI 10.1001/jamapsychiatry.2016.2035; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Rimkeviciene J, 2015, J AFFECT DISORDERS, V171, P93, DOI 10.1016/j.jad.2014.08.044; SHNEIDMAN ES, 1993, J NERV MENT DIS, V181, P145, DOI 10.1097/00005053-199303000-00001; Swann AC, 2005, AM J PSYCHIAT, V162, P1680, DOI 10.1176/appi.ajp.162.9.1680; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Trakhtenbrot R, 2016, J AFFECT DISORDERS, V199, P73, DOI 10.1016/j.jad.2016.03.054; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Verrocchio MC, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00108; WHO, 2017, WORLD HLTH ORG SUIC	28	6	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177974	10.1371/journal.pone.0177974	http://dx.doi.org/10.1371/journal.pone.0177974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6GJ	28558020	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000018
J	Biederman, L; Mortensen, B; Fay, P; Hagenah, N; Knops, J; La Pierre, K; Laungani, R; Lind, E; McCulley, R; Power, S; Seabloom, E; Tognetti, P				Biederman, Lori; Mortensen, Brent; Fay, Philip; Hagenah, Nicole; Knops, Johannes; La Pierre, Kimberly; Laungani, Ramesh; Lind, Eric; McCulley, Rebecca; Power, Sally; Seabloom, Eric; Tognetti, Pedro			Nutrient addition shifts plant community composition towards earlier flowering species in some prairie ecoregions in the US Central Plains	PLOS ONE			English	Article							TALLGRASS PRAIRIE; SOIL-MOISTURE; GRASSLAND; CLIMATE; PHENOLOGY; PRODUCTIVITY; SEASON; CONSTRAINTS; VARIABILITY; RESOURCES	The distribution of flowering across the growing season is governed by each species' evolutionary history and climatic variability. However, global change factors, such as eutrophication and invasion, can alter plant community composition and thus change the distribution of flowering across the growing season. We examined three ecoregions (tall-, mixed, and short-grass prairie) across the U.S. Central Plains to determine how nutrient (nitrogen (N), phosphorus, and potassium (+ micronutrient)) addition alters the temporal patterns of plant flowering traits. We calculated total community flowering potential (FP) by distributing peakseason plant cover values across the growing season, allocating each species' cover to only those months in which it typically flowers. We also generated separate FP profiles for exotic and native species and functional group. We compared the ability of the added nutrients to shift the distribution of these FP profiles (total and sub-groups) across the growing season. In all ecoregions, N increased the relative cover of both exotic species and C-3 graminoids that flower in May through August. The cover of C-4 graminoids decreased with added N, but the response varied by ecoregion and month. However, these functional changes only aggregated to shift the entire community's FP profile in the tall-grass prairie, where the relative cover of plants expected to flower in May and June increased and those that flower in September and October decreased with added N. The relatively low native cover in May and June may leave this ecoregion vulnerable to disturbance-induced invasion by exotic species that occupy this temporal niche. There was no change in the FP profile of the mixed and short-grass prairies with N addition as increased abundance of exotic species and C-3 graminoids replaced other species that flower at the same time. In these communities a disturbance other than nutrient addition may be required to disrupt phenological patterns.	[Biederman, Lori; Mortensen, Brent] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Fay, Philip] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Hagenah, Nicole] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Knops, Johannes] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [La Pierre, Kimberly] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Laungani, Ramesh] Doane Univ, Dept Biol, Crete, NE USA; [Lind, Eric; Seabloom, Eric] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [McCulley, Rebecca] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Power, Sally] Western Sydney Univ, Hawkesbury Inst Environm, Richmond, NSW, Australia; [Tognetti, Pedro] Univ Buenos Aires, IFEVA, CONICET, Fac Agron, Buenos Aires, DF, Argentina; [Hagenah, Nicole] SAEON Grasslands Forest Wetlands Node, Pietermaritzburg, South Africa; [La Pierre, Kimberly] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	Iowa State University; United States Department of Agriculture (USDA); University of Kwazulu Natal; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Kentucky; Western Sydney University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Research Foundation - South Africa; South African Environmental Observation Network (SAEON); Smithsonian Institution; Smithsonian Environmental Research Center	Biederman, L (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA.	lbied@iastate.edu	Knops, Johannes/AAA-8546-2020; Tognetti, Pedro Maximiliano/AAF-7018-2019; Mortensen, Brent/AAD-2092-2021; Power, Sally/I-2923-2012	Tognetti, Pedro Maximiliano/0000-0001-7358-1334; Mortensen, Brent/0000-0002-4873-6127; Biederman, Lori/0000-0003-2171-7898; Lind, Eric/0000-0003-3051-7724; Komatsu, Kimberly/0000-0001-7056-4547; Power, Sally/0000-0002-2723-8671	National Science Foundation Research Coordination Network program [NSF-DEB-1042132]; Long Term Ecological Research program [NSF-DEB1234162]; Institute on the Environment [DG-0001-13]; Division Of Environmental Biology [1234162, 1440484] Funding Source: National Science Foundation	National Science Foundation Research Coordination Network program; Long Term Ecological Research program; Institute on the Environment; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work used data from the Nutrient Network (http://www.nutnet.org) experiment, funded at the site-scale by individual researchers. Coordination and data management have been supported by funding to E. Borer and E. Seabloom from the National Science Foundation Research Coordination Network (NSF-DEB-1042132) and Long Term Ecological Research (NSF-DEB1234162 to Cedar Creek LTER) programs, and the Institute on the Environment (DG-0001-13). We also thank the Minnesota Supercomputer Institute for hosting project data and the Institute on the Environment for hosting Network meetings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge G, 2011, J ECOL, V99, P905, DOI 10.1111/j.1365-2745.2011.01826.x; [Anonymous], 2021, LANG ENV STAT COMP; Armstrong JB, 2016, ECOLOGY, V97, P1099, DOI 10.1890/15-0554.1; Biederman LA, 2017, PRAIRIE PLANT COVER; Biederman LA, PRAIRIE PLANT SPECIE; Borer ET, 2014, METHODS ECOL EVOL, V5, P65, DOI 10.1111/2041-210X.12125; BOWERS JE, 1994, B TORREY BOT CLUB, V121, P215, DOI 10.2307/2997177; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Britton N, 1970, ILLUSTRATED FLORA NO; Ceulemans T, 2014, GLOBAL CHANGE BIOL, V20, P3814, DOI 10.1111/gcb.12650; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Correll DS, 1996, MANUAL VASCULAR PLAN; Craine JM, 2012, ECOGRAPHY, V35, P1033, DOI 10.1111/j.1600-0587.2012.07625.x; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Fay PA, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.80, 10.1038/nplants.2015.80]; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO, V19; Gallinat AS, 2015, TRENDS ECOL EVOL, V30, P169, DOI 10.1016/j.tree.2015.01.004; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Great Plains Flora Association, 1986, FLORA GREAT PLAINS; Harpole WS, 2016, NATURE, V537, P93, DOI 10.1038/nature19324; HETRICK BAD, 1988, CAN J BOT, V66, P1376, DOI 10.1139/b88-193; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jurasinski G, 2013, FLUX FLUX RATE CALCU; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; La Pierre KJ, 2016, ECOSYSTEMS, V19, P521, DOI 10.1007/s10021-015-9949-7; La Pierre KJ, 2011, J ECOL, V99, P1250, DOI 10.1111/j.1365-2745.2011.01844.x; Larson DL, 2011, BIOL CONSERV, V144, P3127, DOI 10.1016/j.biocon.2011.10.018; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lind EM, 2013, ECOL LETT, V16, P513, DOI 10.1111/ele.12078; Maurer K, 2003, BASIC APPL ECOL, V4, P307, DOI 10.1078/1439-1791-00162; Morales MA, 2005, OECOLOGIA, V142, P83, DOI 10.1007/s00442-004-1694-0; Munson SM, 2017, NEW PHYTOL, V213, P1945, DOI 10.1111/nph.14327; Osborne CP, 2014, NEW PHYTOL, V204, P441, DOI 10.1111/nph.12942; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Pinheiro J., 2016, NLME LINEAR NONLINEA; Rafferty NE, J ECOL IN PRESS; Rafferty NE, 2015, OIKOS, V124, P14, DOI 10.1111/oik.01523; Russell FL, 2004, OECOLOGIA, V139, P525, DOI 10.1007/s00442-004-1543-1; Seabloom E, 2015, NATURE COMM, P6; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Stevens CJ, 2015, ECOLOGY, V96, P1459, DOI 10.1890/14-1902.1; Sun SC, 2011, J ECOL, V99, P991, DOI 10.1111/j.1365-2745.2011.01830.x; Wilsey BJ, 2015, NEW PHYTOL, V205, P928, DOI 10.1111/nph.13028; Wolkovich EM, 2014, AOB PLANTS, P6; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Zhang WP, 2016, FUNCTIONAL ECOL	53	10	10	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178440	10.1371/journal.pone.0178440	http://dx.doi.org/10.1371/journal.pone.0178440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552986	Green Published, gold			2022-12-26	WOS:000402063000047
J	Zhou, ZF; Zhang, FJ; Huo, YF; Yu, YX; Yu, LN; Sun, K; Sun, LH; Xing, XF; Yan, M				Zhou, Zhen-feng; Zhang, Feng-jiang; Huo, Yang-fan; Yu, Yun-xian; Yu, Li-na; Sun, Kai; Sun, Li-hong; Xing, Xiu-fang; Yan, Min			Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery	PLOS ONE			English	Article							BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; DOUBLE-BLIND; CONVULSIVE SEIZURES; RISK-FACTORS; BLOOD-LOSS; FIBRINOLYSIS; APROTININ; MORTALITY; INJURY	Background Stroke is a devastating and potentially preventable complication of cardiac surgery. Tranexamic acid (TXA) is a commonly antifibrinolytic agent in cardiac surgeries with cardiopulmonary bypass (CPB), however, there is concern that it might increase incidence of stroke after cardiac surgery. In this retrospective study, we investigated whether TXA usage could increase postoperative stroke in cardiac surgery. Methods A retrospective study was conducted from January 1, 2010, to December 31, 2015, in 2,016 patients undergoing cardiac surgery, 664 patients received intravenous TXA infusion and 1,352 patients did not receive any antifibrinolytic agent. Univariate and propensity-weighted multivariate regression analysis were applied for data analysis. Results Intraoperative TXA administration was associated with postoperative stroke (1.7% vs. 0.5%; adjusted OR, 4.11; 95% CI, 1.33 to 12.71; p = 0.014) and coma (adjusted OR, 2.77; 95% CI, 1.06 to 7.26; p = 0.038) in cardiac surgery. As subtype analysis was performed, TXA administration was still associated with postoperative stroke (1.7% vs. 0.3%; adjusted OR, 5.78; 95% CI, 1.34 to 27.89; p = 0.018) in patients undergoing valve surgery or multivalve surgery only, but was not associated with postoperative stroke (1.7% vs. 1.3%; adjusted OR, 5.21; 95% CI, 0.27 to 101.17; p = 0.276) in patients undergoing CABG surgery only. However, TXA administration was not associated with postoperative mortality (adjusted OR, 1.31; 95% CI, 0.56 to 3.71; p = 0.451), seizure (adjusted OR, 1.13; 95% CI, 0.42 to 3.04; p = 0.816), continuous renal replacement therapy (adjusted OR, 1.36; 95% CI, 0.56 to 3.28; p = 0.495) and resternotomy for postoperative bleeding (adjusted OR, 1.55; 95% CI, 0.55 to 4.30; p = 0.405). No difference was found in postoperative ventilation time (adjusted B, -1.45; SE, 2.33; p = 0.535), length of intensive care unit stay ( adjusted B, -0.12; SE, 0.25; p = 0.633) and length of hospital stay (adjusted B, 0.48; SE, 0.58; p = 0.408). Conclusions Based on the 5-year experience of TXA administration in cardiac surgery with CPB, we found that postoperative stroke was associated with intraoperative TXA administration in patients undergoing cardiac surgery, especially in those undergoing valve surgeries only. This study may suggest that TXA should be administrated according to clear indications after evaluating the bleeding risk in patients undergoing cardiac surgery, especially in those with high stroke risk.	[Zhou, Zhen-feng; Zhang, Feng-jiang; Yu, Li-na; Sun, Kai; Xing, Xiu-fang; Yan, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Huo, Yang-fan] Weifang Med Univ, Weifang, Peoples R China; [Yu, Yun-xian] Zhejiang Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hangzhou, Zhejiang, Peoples R China; [Sun, Li-hong] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China	Zhejiang University; Weifang Medical University; Zhejiang University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China.	zryanmin@zju.edu.cn						Baharoglu MI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001245.pub2; Bowles BJ, 2001, CHEST, V119, P25, DOI 10.1378/chest.119.1.25; Boyle EM, 1997, ANN THORAC SURG, V63, P277; Casati V, 2001, ANESTHESIOLOGY, V94, P8, DOI 10.1097/00000542-200101000-00007; CHANDLER WL, 1995, THROMB HAEMOSTASIS, V74, P1293; Fairbairn TA, 2012, HEART, V98, P18, DOI 10.1136/heartjnl-2011-300065; Gorlinger K, 2011, ANESTHESIOLOGY, V115, P1179, DOI 10.1097/ALN.0b013e31823497dd; Goldstone Andrew B, 2011, J Cardiothorac Vasc Anesth, V25, pe25, DOI 10.1053/j.jvca.2011.02.020; Gottesman RF, 2006, STROKE, V37, P2306, DOI 10.1161/01.STR.0000236024.68020.3a; HARKER LA, 1980, BLOOD, V56, P824; Hedberg M, 2013, SCAND CARDIOVASC J, V47, P136, DOI 10.3109/14017431.2012.737016; HOLLOWAY DS, 1988, THROMB HAEMOSTASIS, V59, P62; Jakobsen CJ, 2009, EUR J CARDIO-THORAC, V36, P863, DOI 10.1016/j.ejcts.2009.05.040; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Koo JR, 1999, NEPHROL DIAL TRANSPL, V14, P750, DOI 10.1093/ndt/14.3.750; Koster A, 2013, BRIT J ANAESTH, V110, P34, DOI 10.1093/bja/aes310; Lapar DJ, 2015, ANN THORAC SURG, V100, P1276, DOI 10.1016/j.athoracsur.2015.04.038; Later AFL, 2009, EUR J CARDIO-THORAC, V36, P322, DOI 10.1016/j.ejcts.2008.11.038; Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3; Manji RA, 2012, CAN J ANESTH, V59, P6, DOI 10.1007/s12630-011-9618-z; Marti-Carvajal AJ, 2012, COCHRANE DATABASE SY, V12; Merie C, 2012, STROKE, V43, P38, DOI 10.1161/STROKEAHA.111.620880; Min JJ, 2014, BRIT J ANAESTH, V113, P391, DOI 10.1093/bja/aeu099; Murkin JM, 2010, ANESTH ANALG, V110, P350, DOI 10.1213/ANE.0b013e3181c92b23; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Myles PS, 2016, N ENGL J MED; Ngaage DL, 2010, EUR J CARDIO-THORAC, V37, P1375, DOI 10.1016/j.ejcts.2009.11.055; Ortmann E, 2013, BRIT J ANAESTH, V111, P549, DOI 10.1093/bja/aet154; OVRUM E, 1993, J THORAC CARDIOV SUR, V105, P78; PARAMO JA, 1991, HAEMOSTASIS, V21, P58; Rifon J, 1997, BRIT J HAEMATOL, V99, P262, DOI 10.1046/j.1365-2141.1997.3913205.x; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; Sharma V, 2014, ANAESTHESIA, V69, P124, DOI 10.1111/anae.12516; Slaughter TF, 1997, ANESTH ANALG, V85, P1221, DOI 10.1097/00000539-199712000-00008; Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x; Sundstrom A, 2009, BJOG-INT J OBSTET GY, V116, P91, DOI 10.1111/j.1471-0528.2008.01926.x; Tanaka K, 1989, J Cardiothorac Anesth, V3, P181, DOI 10.1016/S0888-6296(89)92642-2; Vives M, 2014, INTERACT CARDIOV TH, V18, P637, DOI 10.1093/icvts/ivu014; Wang GY, 2012, ANESTH ANALG, V115, P239, DOI 10.1213/ANE.0b013e3182264a11	40	16	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0177011	10.1371/journal.pone.0177011	http://dx.doi.org/10.1371/journal.pone.0177011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552944	Green Submitted, gold, Green Published			2022-12-26	WOS:000402063000003
J	Choi, HM; Kim, HC; Kang, DR				Choi, Hayon Michelle; Kim, Hyeon Chang; Kang, Dae Ryong			Sex differences in hypertension prevalence and control: Analysis of the 2010-2014 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GENDER-DIFFERENCES	Although not fully understood, sex may affect both the prevalence and control rate of hypertension. The present study was designed to investigate factors associated with hypertension prevalence and control among Korean adults. We analyzed 27,887 individuals (12,089 males and 15,798 females) aged 30 years or older who participated in the fifth (2010-2012) and sixth (2013-2014) Korea National Health and Nutrition Examination Survey. Multiple logistic regression models were applied to delineate factors associated with the prevalence and control of hypertension separately for men and women. Overall, the prevalence of hypertension was higher in men (34.6%) than in women (30.8%). However, after the age of 60 years, hypertension was more prevalent in females than in males. Regardless of sex, the older the participants were, the more likely they were to have hypertension. Factors positively associated with hypertension prevalence were old age, low education, and high BMI in women (p< 0.001) and increasing age, low income, alcohol intake, and high BMI in men (p< 0.001). The overall control rate of hypertension was higher in women (51.3%) than in men (44.8%). However, after the age of 60 years, hypertension control rates were higher in men than in women. Factors decreasing hypertension control were white-collared women and young age, alcohol consumption in men. Sex differences in hypertension prevalence and control were discovered among Korean adults. After the age of 60, females were more likely to have hypertension and less likely to maintain hypertension control than males of the same age range. Accordingly, sex-specific approaches are recommended for effective blood pressure management.	[Choi, Hayon Michelle] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Dae Ryong] Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Ctr Biomed Data Sci, Wonju, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University	Kang, DR (corresponding author), Yonsei Univ, Wonju Coll Med, Inst Genom Cohort, Ctr Biomed Data Sci, Wonju, South Korea.	dr.kang@yonsei.ac.kr	; Kim, Hyeon Chang/F-8796-2019	Kang, Dae Ryong/0000-0002-8792-9730; Kim, Hyeon Chang/0000-0001-7867-1240; Choi, Hayon Michelle/0000-0002-0622-8554	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992).	Ann D, 2013, PREVALENCE HYPERTENS; Aram V., 2003, 7 REPORT JOINT NATL; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229; Chu Sang Hui, 2015, J Prev Med Public Health, V48, P38, DOI 10.3961/jpmph.14.043; Daugherty SL, 2011, J HYPERTENS, V29, P1005, DOI 10.1097/HJH.0b013e3283449512; Doumas M, 2013, CURR HYPERTENS REP, V15, P321, DOI 10.1007/s11906-013-0359-y; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Husain K, 2014, WORLD J CARDIOL, V6, P245, DOI 10.4330/wjc.v6.i5.245; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; McAlister FA1 WK, 2011, CHANGES RATES AWAREN, V183, P1007; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Nilsson PM1 CJ, 2011, TRENDS BLOOD PRESSUR, V20, P348; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Organization WH, 2000, GLOB STRAT PREV CONT; Organization WH, 2000, AS PAC PERSP RED OB; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Suh DC1 KB, 2009, TRENDS BLOOD PRESSUR, V27, P1908; Wang J1 GL, 2011, LONG TERM RECENT PRO, V34, P1579; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8	23	74	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178334	10.1371/journal.pone.0178334	http://dx.doi.org/10.1371/journal.pone.0178334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542557	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800074
J	Blystad, I; Warntjes, JBM; Smedby, O; Lundberg, P; Larsson, EM; Tisell, A				Blystad, Ida; Warntjes, J. B. Marcel; Smedby, Orjan; Lundberg, Peter; Larsson, Elna-Marie; Tisell, Anders			Quantitative MRI for analysis of peritumoral edema in malignant gliomas	PLOS ONE			English	Article							RECURRENT GLIOBLASTOMA; TUMOR PROGRESSION; PATTERN-ANALYSIS; PSEUDOPROGRESSION; DIFFUSION; BRAIN; DIFFERENTIATION; QUANTIFICATION; PERFUSION; RESECTION	Background and purpose Damage to the blood-brain barrier with subsequent contrast enhancement is a hallmark of glioblastoma. Non-enhancing tumor invasion into the peritumoral edema is, however, not usually visible on conventional magnetic resonance imaging. New quantitative techniques using relaxometry offer additional information about tissue properties. The aim of this study was to evaluate longitudinal relaxation R-1, transverse relaxation R-2, and proton density in the peritumoral edema in a group of patients with malignant glioma before surgery to assess whether relaxometry can detect changes not visible on conventional images. Methods In a prospective study, 24 patients with suspected malignant glioma were examined before surgery. A standard MRI protocol was used with the addition of a quantitative MR method (MAGIC), which measured R-1, R-2, and proton density. The diagnosis of malignant glioma was confirmed after biopsy/surgery. In 19 patients synthetic MR images were then created from the MAGIC scan, and ROIs were placed in the peritumoral edema to obtain the quantitative values. Dynamic susceptibility contrast perfusion was used to obtain cerebral blood volume (rCBV) data of the peritumoral edema. Voxel-based statistical analysis was performed using a mixed linear model. Results R-1, R-2, and rCBV decrease with increasing distance from the contrast-enhancing part of the tumor. There is a significant increase in R1 gradient after contrast agent injection (P<.0001). There is a heterogeneous pattern of relaxation values in the peritumoral edema adjacent to the contrast-enhancing part of the tumor. Conclusion Quantitative analysis with relaxometry of peritumoral edema in malignant gliomas detects tissue changes not visualized on conventional MR images. The finding of decreasing R-1 and R-2 means shorter relaxation times closer to the tumor, which could reflect tumor invasion into the peritumoral edema. However, these findings need to be validated in the future.	[Blystad, Ida; Smedby, Orjan] Linkoping Univ, Dept Radiol, Linkoping, Sweden; [Blystad, Ida; Smedby, Orjan] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Blystad, Ida; Warntjes, J. B. Marcel; Smedby, Orjan; Lundberg, Peter; Larsson, Elna-Marie; Tisell, Anders] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Warntjes, J. B. Marcel] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Smedby, Orjan] KTH Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Lundberg, Peter; Tisell, Anders] Linkoping Univ, Dept Radiat Phys, Linkoping, Sweden; [Lundberg, Peter; Tisell, Anders] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Royal Institute of Technology; Linkoping University; Linkoping University; Uppsala University	Blystad, I (corresponding author), Linkoping Univ, Dept Radiol, Linkoping, Sweden.; Blystad, I (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.; Blystad, I (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.	ida.blystad@regionostergotland.se		Blystad, Ida/0000-0002-8857-5698; Smedby, Orjan/0000-0002-7750-1917	Medical Research Council of Southeast Sweden [FORSS-234551]	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council of Southeast Sweden, grant number FORSS-234551 (http://www.fou.nu/is/forss/).	Akbari H, 2016, NEUROSURGERY, V78, P572, DOI 10.1227/NEU.0000000000001202; Akbari H, 2014, RADIOLOGY, V273, P502, DOI 10.1148/radiol.14132458; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Blasel S, 2010, ACTA NEUROCHIR, V152, P1893, DOI 10.1007/s00701-010-0774-7; Boxerman JL, 2014, AM J CLIN ONCOL; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Deoni SCL, QUANTITATIVE RELAXOM; Eisele SC, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0413-5; Ellingson BM, 2012, J NEURO-ONCOL, V106, P111, DOI 10.1007/s11060-011-0638-x; Grabowski MM, 2014, J NEUROSURG, V121, P1115, DOI 10.3171/2014.7.JNS132449; Hattingen E, 2013, NEURO-ONCOLOGY, V15, P1395, DOI 10.1093/neuonc/not105; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; Lemee JM, 2015, J NEURO-ONCOL, V122, P53, DOI 10.1007/s11060-014-1695-8; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Lescher S, 2014, NEURORADIOLOGY; Li YM, 2016, J NEUROSURG, V124, P977, DOI 10.3171/2015.5.JNS142087; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Prager AJ, 2015, AM J NEURORADIOL, V36, P877, DOI 10.3174/ajnr.A4218; Saitta L, 2011, EUR RADIOL, V21, P1068, DOI 10.1007/s00330-010-2004-3; Shiroishi MS, 2016, NEURO-ONCOLOGY, V18, P467, DOI 10.1093/neuonc/nov179; Wang S, 2016, AM J NEURORADIOL, V37, P28, DOI 10.3174/ajnr.A4474; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Yan JL, 2016, J NEUROSURG, P1; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016; Zetterling M, 2016, J NEUROSURG, V125, P1155, DOI 10.3171/2015.10.JNS15583; Zhang H, 2014, EUR J RADIOL, V83, P2181, DOI 10.1016/j.ejrad.2014.09.018	29	49	53	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177135	10.1371/journal.pone.0177135	http://dx.doi.org/10.1371/journal.pone.0177135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542553	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800007
J	Barlow, RS; McMillan, KE; Duffy, LL; Fegan, N; Jordan, D; Mellor, GE				Barlow, Robert S.; McMillan, Kate E.; Duffy, Lesley L.; Fegan, Narelle; Jordan, David; Mellor, Glen E.			Antimicrobial resistance status of Enterococcus from Australian cattle populations at slaughter	PLOS ONE			English	Article							ESCHERICHIA-COLI; FOOD; DAPTOMYCIN; TIGECYCLINE; FAECIUM; ANIMALS; HEALTH; SUSCEPTIBILITY; SALMONELLA; PREVALENCE	Antimicrobial agents are used in cattle production systems for the prevention and control of bacterial associated diseases. A consequence of their use is the potential development of antimicrobial resistance (AMR). Enterococcus faecium and Enterococcus faecalis that are resistant to antimicrobials are of increased concern to public health officials throughout the world as they may compromise the ability of various treatment regimens to control disease and infection in human medicine. Australia is a major exporter of beef; however it does not have an ongoing surveillance system for AMR in cattle or foods derived from these animals. This study examined 910 beef cattle, 290 dairy cattle and 300 veal calf faecal samples collected at slaughter for the presence of enterococci. Enterococcus were isolated from 805 (88.5%) beef cattle faeces, 244 (84.1%) dairy cattle faeces and 247 (82.3%) veal calf faeces with a total of 800 enterococci subsequently selected for AMR testing. The results of AMR testing identified high levels of resistance to antimicrobials that are not critically or highly important to human medicine with resistance to flavomycin (80.2%) and lincomycin (85.4-94.2%) routinely observed. Conversely, resistance to antibiotics considered critically or highly important to human medicine such as tigecycline, daptomycin, vancomycin and linezolid was not present in this study. There is minimal evidence that Australian cattle production practices are responsible for disproportionate contributions to AMR development and in general resistance to antimicrobials of critical and high importance in human medicine was low regardless of the isolate source. The low level of antimicrobial resistance in Enterococcus from Australian cattle is likely to result from comprehensive controls around the use of antimicrobials in food-production animals in Australia. Nevertheless, continued monitoring of the effects of all antimicrobial use is required to support Australia's reputation as a supplier of safe and healthy food.	[Barlow, Robert S.; McMillan, Kate E.; Duffy, Lesley L.; Mellor, Glen E.] CSIRO Agr & Food, Coopers Plains, Brisbane, Qld, Australia; [Fegan, Narelle] CSIRO Agr & Food, Werribee, Vic, Australia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries	Barlow, RS (corresponding author), CSIRO Agr & Food, Coopers Plains, Brisbane, Qld, Australia.	Robert.Barlow@csiro.au	Duffy, Lesley L/G-1667-2011; McMillan, Kate/T-5838-2019; Barlow, Robert/AFQ-3671-2022; Jordan, David/P-7281-2019; Fegan, Narelle/K-5316-2012; Barlow, Robert/H-6759-2013; Mellor, Glen/P-8717-2019	Duffy, Lesley L/0000-0001-6347-528X; McMillan, Kate/0000-0001-8179-2502; Barlow, Robert/0000-0001-8913-1178; Fegan, Narelle/0000-0002-1729-9630; Barlow, Robert/0000-0001-8913-1178; Mellor, Glen/0000-0003-2849-2687	Meat & Livestock Australia (MLA); Commonwealth Scientific and Industrial Research Organisation (CSIRO)	Meat & Livestock Australia (MLA)(Meat and Livestock Australia); Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	The authors received funding from Meat & Livestock Australia (MLA) and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) for this work.; The authors thank Dr Darren Trott, Dr Sam Abraham, Dr John Turnidge and Dr Stephen Page for their assistance with the design of the study and analysis of results. We gratefully acknowledge funding from Meat & Livestock Australia and the Commonwealth Scientific and Industrial Research Organisation (CSIRO). We also acknowledge the significant contribution of samples from processing establishments, without which this project would not have been possible.	Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; Abraham S, 2014, INT J ANTIMICROB AG, V43, P126, DOI 10.1016/j.ijantimicag.2013.10.014; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Barlow R., 2008, PILOT SURVEY ANTIMIC; Barlow RS, 2015, J FOOD PROTECT, V78, P912, DOI 10.4315/0362-028X.JFP-14-476; Barton M., 2003, COMMUNICABLE DIS I S, V27, P121; Butaye P, 1998, J CLIN MICROBIOL, V36, P1907, DOI 10.1128/JCM.36.7.1907-1911.1998; Cattoir V, 2015, ANTIMICROB AGENTS CH, V59, P239, DOI 10.1128/AAC.04174-14; Collignon P, 2006, J INFECT DIS, V194, P8, DOI 10.1086/504922; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Department of Agriculture Fisheries and Forestry, 2007, PILOT SURVEILLANCE P; Diaz L, 2014, ANTIMICROB AGENTS CH, V58, P4527, DOI 10.1128/AAC.02686-14; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Fiedler S, 2016, J ANTIMICROB CHEMOTH, V71, P871, DOI 10.1093/jac/dkv420; Hammerum AM, 2012, CLIN MICROBIOL INFEC, V18, P619, DOI 10.1111/j.1469-0691.2012.03829.x; Hao HH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01626; Heuer OE, 2006, CLIN INFECT DIS, V43, P911, DOI 10.1086/507534; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Jackson CR, 2011, LETT APPL MICROBIOL, V52, P41, DOI 10.1111/j.1472-765X.2010.02964.x; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Ke DB, 1999, J CLIN MICROBIOL, V37, P3497, DOI 10.1128/JCM.37.11.3497-3503.1999; Kelesidis T, 2011, CLIN INFECT DIS, V52, P228, DOI 10.1093/cid/ciq113; Meat & Livestock Australia, 2016, FAST FACTS 2016 AUST; Ramos S, 2012, ANN MICROBIOL, V62, P1485, DOI 10.1007/s13213-011-0402-7; Rathe M, 2010, APMIS, V118, P66, DOI 10.1111/j.1600-0463.2009.02559.x; Szmolka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00258; Walsh C, 2008, CURR DRUG TARGETS, V9, P808, DOI 10.2174/138945008785747761; World Health Organisation, 2011, CRIT IMP ANT HUM NED	29	14	16	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177728	10.1371/journal.pone.0177728	http://dx.doi.org/10.1371/journal.pone.0177728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542602	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400071
J	Rhee, EJ; Han, K; Ko, SH; Ko, KS; Lee, WY				Rhee, Eun-Jung; Han, Kyungdo; Ko, Seung-Hyun; Ko, Kyung-Soo; Lee, Won-Young			Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; INSULIN-SECRETION; MULTIFACTORIAL INTERVENTION; GLUCOSE FLUCTUATION; OXIDATIVE STRESS; CELL APOPTOSIS; BLOOD-PRESSURE; VARIABILITY; ASSOCIATION	Background Recent studies suggest a role for hyperlipidemia in the development of diabetes. The aim of this study is to analyze the relationship between variations of total cholesterol (TC) levels and the risk for type 2 diabetes development from a Korean nationwide population-based database. Materials and methods We examined the General Health Check-up sub-dataset of the Korean National Health Insurance Service (NHIS) of 2,827,950 participants who had at least three health checkups between 2002 and 2007, and were not reported to have diabetes during that time. The variations of TC levels between the examinations were calculated as follows: TC-SD = root{Sigma(x(i) - (x) over bar)(2)/(n - 1)}. The examinees were divided into 10 groups according to TC variation, and the hazard ratio for diabetes development from 2007 to 2013, were analyzed. Results During the follow-up period, 3.4% of the participants had developed diabetes. The hazard ratio (HR) for diabetes development relative to the overall risk in the whole study population started to be higher than 1.0 from eighth decile of TC variation. The highest decile group showed an increased HR for diabetes development after adjustment for confounding variables (1.139; 95% confidence interval 1.116 similar to 1.163). These results were similar regardless of the use of anti-hyperlipidemic medication and baseline TC levels. Conclusions The participants with a large variation in TC levels showed an increased risk for diabetes development, independent of the use of anti-hyperlipidemic medications. These results suggest a relationship between fluctuations in lipid levels and the development of type 2 diabetes.	[Rhee, Eun-Jung; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Ko, Seung-Hyun] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Ko, Kyung-Soo] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med,Cardiovasc & Metab Dis Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Catholic University of Korea; Inje University	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592				[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bacova Z, 2012, MED CHEM, V8, P65; Besseling J, 2015, JAMA-J AM MED ASSOC, V313, P1029, DOI 10.1001/jama.2015.1206; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273; Deshpande S, 2017, CURR MED RES OPIN, V33, P769, DOI 10.1080/03007995.2017.1281109; Dirkx R, 2012, J DIABETES INVEST, V3, P339, DOI 10.1111/j.2040-1124.2012.00200.x; Erion DM, 2016, BMB REP, V49, P139, DOI 10.5483/BMBRep.2016.49.3.268; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gosmanova EO, 2016, J AM COLL CARDIOL, V68, P1375, DOI 10.1016/j.jacc.2016.06.054; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hirakawa Y, 2014, DIABETES CARE, V37, P2359, DOI 10.2337/dc14-0199; Kim M, 2012, DIABETES RES CLIN PR, V98, P132, DOI 10.1016/j.diabres.2012.04.013; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lee J., 2016, INT J EPIDEMIOL; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Park S, 2016, J AM SOC HYPERTENS, V10, P799, DOI 10.1016/j.jash.2016.08.004; Rhee EJ, 2015, ENDOCRINOL METAB, V30, P263, DOI 10.3803/EnM.2015.30.3.263; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Souza JC, 2013, BBA-MOL CELL BIOL L, V1831, P769, DOI 10.1016/j.bbalip.2012.12.013; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Wada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149452; Wu N, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0427-0; Zou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093686	27	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176615	10.1371/journal.pone.0176615	http://dx.doi.org/10.1371/journal.pone.0176615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545051	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400011
J	Tian, Y; Yang, L; Chen, SF; Guo, DQ; Ding, ZC; Tam, KY; Yao, DZ				Tian, Yin; Yang, Li; Chen, Sifan; Guo, Daqing; Ding, Zechao; Tam, Kin Yip; Yao, Dezhong			Causal interactions in resting-state networks predict perceived loneliness	PLOS ONE			English	Article							SOCIAL-ISOLATION; ATTENTION; BELONG; BRAIN; NEED; CONNECTIVITY; CORTEX; MEMORY; CONSEQUENCES; DEPRESSION	Loneliness is broadly described as a negative emotional response resulting from the differences between the actual and desired social relations of an individual, which is related to the neural responses in connection with social and emotional stimuli. Prior research has discovered that some neural regions play a role in loneliness. However, little is known about the differences among individuals in loneliness and the relationship of those differences to differences in neural networks. The current study aimed to investigate individual differences in perceived loneliness related to the causal interactions between resting-state networks (RSNs), including the dorsal attentional network (DAN), the ventral attentional network (VAN), the affective network (AfN) and the visual network (VN). Using conditional granger causal analysis of resting-state fMRI data, we revealed that the weaker causal flow from DAN to VAN is related to higher loneliness scores, and the decreased causal flow from AfN to VN is also related to higher loneliness scores. Our results clearly support the hypothesis that there is a connection between loneliness and neural networks. It is envisaged that neural network features could play a key role in characterizing the loneliness of an individual.	[Tian, Yin; Yang, Li; Ding, Zechao] ChongQing Univ Posts & Telecommun, Biomed Engn Dept, Chongqing, Peoples R China; [Tian, Yin] Chongqing Key Lab Photoelect Informat Sensing & T, Chongqing, Peoples R China; [Tian, Yin] Chongqing High Sch Innovat Team Architecture & Co, Chongqing, Peoples R China; [Chen, Sifan; Guo, Daqing; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu, Peoples R China; [Tam, Kin Yip] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Chongqing University of Posts & Telecommunications; University of Electronic Science & Technology of China; University of Macau	Tian, Y (corresponding author), ChongQing Univ Posts & Telecommun, Biomed Engn Dept, Chongqing, Peoples R China.; Tian, Y (corresponding author), Chongqing Key Lab Photoelect Informat Sensing & T, Chongqing, Peoples R China.; Tian, Y (corresponding author), Chongqing High Sch Innovat Team Architecture & Co, Chongqing, Peoples R China.; Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu, Peoples R China.	tiany20032003@163.com; dyao@uestc.edu.cn	Tam, Kin/A-7812-2011; Guo, Daqing/G-5867-2010	Tam, Kin/0000-0001-5507-8524; Tian, Yin/0000-0002-4293-6830	National Nature Science Foundation of China [61671097, 91232725]; ChongQing advanced and applied basic research project [cstc2015jcyjA10024]; Science and Technology Development Fund (Macao) SAR (FDCT) [118/2013/A3]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); ChongQing advanced and applied basic research project; Science and Technology Development Fund (Macao) SAR (FDCT)	This research is supported by the National Nature Science Foundation of China (#61671097, #91232725), the ChongQing advanced and applied basic research project cstc2015jcyjA10024, and the Science and Technology Development Fund (Macao) SAR (FDCT, project reference no.118/2013/A3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the National Nature Science Foundation of China (#61671097, #91232725), the ChongQing advanced and applied basic research project cstc2015jcyjA10024 and the Science and Technology Development Fund (Macao) SAR (FDCT, project reference no. 118/2013/A3).	Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cacioppo John T, 2011, Cerebrum, V2011, P17; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Cacioppo JT, 2000, INT J PSYCHOPHYSIOL, V35, P143, DOI 10.1016/S0167-8760(99)00049-5; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Chica AB, 2014, FRONTIERS IN HUMAN N, V8, P34; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davis M.H., 1983, INTERPERSONAL REACTI; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Gardner WL, 2005, PERS SOC PSYCHOL B, V31, P1549, DOI 10.1177/0146167205277208; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Kanai R, 2012, CURR BIOL, V22, P1975, DOI 10.1016/j.cub.2012.08.045; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Lavigne GL, 2011, PERS SOC PSYCHOL B, V37, P1185, DOI 10.1177/0146167211405995; Leary M. R., 2004, HDB SELF REGULATION, P373; Lodder GMA, 2015, BRITISH JOURNAL OF P; Matykiewicz P., 2012, P BIONLP P 2012 WORK, P193; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Ortigue S, 2010, J SEX MED, V7, P3541, DOI 10.1111/j.1743-6109.2010.01999.x; Peplau LA, 1982, LONELINESS A SOURCEB, V36; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Powers KE, 2013, SOC COGN AFFECT NEUR, V8, P151, DOI 10.1093/scan/nsr079; Powers KE, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00046; Powers KE, 2013, PLOS ONE, P8; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Qualter P, 2013, J ADOLESCENCE, V36, P1283, DOI 10.1016/j.adolescence.2013.01.005; Qualter P, 2015, PERSPECT PSYCHOL SCI, V10, P250, DOI 10.1177/1745691615568999; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Spielberger CD, 1994, STATE TRAIT ANXIETY; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Tian Y, 2008, BIOL PSYCHOL, V79, P171, DOI 10.1016/j.biopsycho.2008.04.006; Tian Y, 2014, NEUROREPORT, V25, P843, DOI 10.1097/WNR.0000000000000197; Tian Y, 2014, NEUROSCI BULL, V30, P141, DOI 10.1007/s12264-013-1372-5; Tian Y, 2011, BRAIN RES, V1391, P81, DOI 10.1016/j.brainres.2011.03.062; Tian Y, 2011, BRAIN TOPOGR, V24, P164, DOI 10.1007/s10548-011-0172-3; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; Viviani R., 2012, FRONTIERS IN HUMAN N, V7, P526; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Vossel S, 2012, J NEUROSCI, V32, P10637, DOI 10.1523/JNEUROSCI.0414-12.2012; Waytz A, 2012, J EXP SOC PSYCHOL, V48, P70, DOI 10.1016/j.jesp.2011.07.012; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Wong NM, 2016, PSYCHOL MED, V1, P1; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yoshida K, 2015, IEEE INT C BIOINFORM, P1078, DOI 10.1109/BIBM.2015.7359831; Zhou ZY, 2009, HUM BRAIN MAPP, V30, P2197, DOI 10.1002/hbm.20661; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; Zysberg L, 2012, J PSYCHOL, V146, P37, DOI 10.1080/00223980.2011.574746	60	19	19	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177443	10.1371/journal.pone.0177443	http://dx.doi.org/10.1371/journal.pone.0177443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28545125	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400044
J	Guo, RR; Zhou, YQ; Lu, LJ; Cao, LF; Cao, JJ				Guo, Ruru; Zhou, Yanqing; Lu, Liangjing; Cao, Lanfang; Cao, Junjia			Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; AUTOIMMUNE; POPULATION; ARTHRITIS; ASTHMA; IL-17; INFLAMMATION; PREVALENCE; DISORDERS; PATHOGENESIS	The influence of co-existing atopy on the prognosis of juvenile systemic lupus erythematosus (JSLE) was assessed in this study. Patients diagnosed with JSLE between October 2005 and April 2016 were enrolled in a prospective study and followed up for 2 years. Management of patients was evaluated using the systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K) score and laboratory variables. Eighty JSLE patients were enrolled at diagnosis and divided into those with (n = 35) and without (n = 45) atopy. When compared with the non-atopic group, atopic patients showed higher SLEDAI-2K score at disease onset (16.09 vs. 11.18), higher erythrocyte sedimentation rate (52.89 vs. 38.27 mm/h), higher percentage of total B-cells (25.85 vs. 19.51%), lower percentage (7.26 vs. 9.03%) and cytotoxicity (9.92 vs. 11.32%) of natural killer cells, and lower complement C3 (0.51 vs. 0.69 g/L) (all p < 0.05). At 1, 3, 6, 12, 18, and 24 months, JSLE patients with atopy reached higher SLEDAI-2K score and lower. SLEDAI-2K improvement rate (at 1 month, 8.34 vs. 4.71 and 43.63 vs. 57.95%, respectively; at 3 months, 8.57 vs. 2.62 and 48.39 vs. 75.10%, respectively; at 6 months, 6.91 vs. 2.38 and 53.59 vs. 77.26%, respectively; at 12 months, 4.71 vs. 1.80 and 69.54 vs. 84.10%, respectively; at 18 months, 4.66 vs. 2.02 and 68.14 vs. 82.93%, respectively; at 24 months, 8.57 vs. 2.62 and 70.00 vs. 81.88%, respectively; all p < 0.05). During the 24 months of follow-up, the total number of disease flares was higher in JSLE patients with co-existing atopy (3.77 vs. 1.51, p < 0.05), and the atopic group needed much more time to reach the stable condition of the disease (6.88 vs. 4.65 months, p < 0.05). JSLE patients combined with co-existing atopy had more severe disease at diagnosis and poorer outcomes than JSLE patients without atopy.	[Guo, Ruru; Lu, Liangjing] Shanghai Jiao Tong Univ, Dept Rheumatol, Renji Hosp, Sch Med, Shanghai, Peoples R China; [Zhou, Yanqing] Cent Hosp Jiading, Dept Pediat, Shanghai, Peoples R China; [Cao, Lanfang; Cao, Junjia] Shanghai Jiao Tong Univ, Dept Pediat, Renji Hosp, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Dept Rheumatol, Renji Hosp, Sch Med, Shanghai, Peoples R China.; Cao, LF (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat, Renji Hosp, Sch Med, Shanghai, Peoples R China.	lu_liangjing@medmail.com.cn; proclf@163.com			Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152214]	Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support	The authors received Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20152214) for this work.; This work was supported by a grant from Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (project number 20152214).	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497, DOI 10.1590/S0100-879X2004001000008; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Borchers AT, 2010, AUTOIMMUN REV, V9, pA277, DOI 10.1016/j.autrev.2009.12.008; Brunner HI, 2011, NAT REV RHEUMATOL, V7, P225, DOI 10.1038/nrrheum.2011.15; Confino-Cohen R, 2012, J ALLERGY CLIN IMMUN, V129, P1307, DOI 10.1016/j.jaci.2012.01.043; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Custovic A, 2013, CURR OPIN ALLERGY CL, V13, P173, DOI 10.1097/ACI.0b013e32835e82b6; Dong GF, 2003, CHINESE MED J-PEKING, V116, P543; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; ELKAYAM O, 1995, ALLERGY, V50, P94; Flodstrom-Tullberg M, 2009, CURR OPIN IMMUNOL, V21, P634, DOI 10.1016/j.coi.2009.09.012; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Guo RR, 2015, EUR J PEDIATR, V174, P1441, DOI 10.1007/s00431-015-2553-1; Habibi S, 2011, INDIAN PEDIATR, V48, P879, DOI 10.1007/s13312-011-0143-5; Heinrich J, 1998, AM J PUBLIC HEALTH, V88, P1319, DOI 10.2105/AJPH.88.9.1319; Hemminki K, 2010, ANN EPIDEMIOL, V20, P217, DOI 10.1016/j.annepidem.2009.11.007; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hsiao YP, 2014, INT J ENV RES PUB HE, V11, P8112, DOI 10.3390/ijerph110808112; Huang C, 2013, CHINESE SCI BULL, V58, P4203, DOI 10.1007/s11434-013-5679-4; Huang JL, 2004, CLIN EXP RHEUMATOL, V22, P776; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Kitaba Shun, 2011, Allergology International, V60, P387, DOI 10.2332/allergolint.10-CR-0265; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kurahara DK, 2007, J RHEUMATOL, V34, P425; Ferriani MPL, 2015, INT ARCH ALLERGY IMM, V167, P186, DOI 10.1159/000438723; Leung R, 1997, J ALLERGY CLIN IMMUN, V99, P594, DOI 10.1016/S0091-6749(97)70018-6; Liphaus BL, 2012, CLINICS, V67, P1275, DOI 10.6061/clinics/2012(11)09; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; Liu W, 2013, CHINESE SCI BULL, V58, P4211, DOI 10.1007/s11434-013-5728-z; Maas T, 2014, PRIM CARE RESP J, V23, P14, DOI 10.4104/pcrj.2013.00108; Milovanovic M, 2010, J INVEST DERMATOL, V130, P2621, DOI 10.1038/jid.2010.175; Nalbandian A, 2009, CLIN EXP IMMUNOL, V157, P209, DOI 10.1111/j.1365-2249.2009.03944.x; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Parks CG, 2008, LUPUS, V17, P711, DOI 10.1177/0961203308089436; Parks CG, 2010, LUPUS, V19, P1614, DOI 10.1177/0961203310379870; Quan SH, 2012, ANN ALLERG ASTHMA IM, V108, P342, DOI 10.1016/j.anai.2012.02.014; Rabin RL, 2008, CLIN EXP IMMUNOL, V153, P19, DOI 10.1111/j.1365-2249.2008.03679.x; Rao V, 2014, CURR OPIN RHEUMATOL, V26, P510, DOI 10.1097/BOR.0000000000000085; REBHUN J, 1983, ANN ALLERGY, V50, P34; Rudwaleit M, 2002, ANN RHEUM DIS, V61, P968, DOI 10.1136/ard.61.11.968; Schuh C, 2015, RESP MED, V109, P308, DOI 10.1016/j.rmed.2015.01.014; Shah A, 2012, CURR ALLERGY ASTHM R, V12, P520, DOI 10.1007/s11882-012-0293-0; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; Spada R, 2015, J LEUKOCYTE BIOL, V98, P479, DOI 10.1189/jlb.4RU0315-081RR; Thomsen SF, 2015, EUR CLIN RESP J, V2; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134; Upham JW, 2005, CURR OPIN ALLERGY CL, V5, P167, DOI 10.1097/01.all.0000162310.79555.ed; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Wu LC, 2014, PEDIAT ALLERG IMM-UK, V25, P586, DOI 10.1111/pai.12274; Yap DYH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/365083	55	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177774	10.1371/journal.pone.0177774	http://dx.doi.org/10.1371/journal.pone.0177774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545118	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700072
J	Park, K; Kim, J; Lee, J				Park, Keunheung; Kim, Jinmi; Lee, Jiwoong			Measurement of macular structure-function relationships using spectral domain-optical coherence tomography (SD-OCT) and pattern electroretinograms (PERG)	PLOS ONE			English	Article							GANGLION-CELL FUNCTION; NERVE-FIBER THICKNESS; EARLY GLAUCOMA; INTRAOCULAR-PRESSURE; EYES; REPRODUCIBILITY; DYSFUNCTION; PROGRESSION	Background Retinal ganglion cell (RGC) death is a common cause of loss of vision during glaucoma. Pattern electroretinogram (PERG) is an objective measure of the central retinal function that correlates with macular GCL thickness. The aim of this study is to determine possible relationships between the N95 amplitude of pattern electroretinogram (PERG(amp)) and macular ganglion cell/inner plexiform layer thickness (GCIPLT). Methods and findings This was a retrospective and comparative study including 74 glaucoma patients (44 early stage and 30 advanced stage cases) and 66 normal control subjects. Macular GCIPLT was measured using Cirrus spectral domain-optical coherence tomography. Standard automated perimetry and pattern ERGs were used in all patient examinations. Three types of regression analysis (broken stick, linear regression, and quadratic regression) were used to evaluate possible relationships between PERG(amp) and GCIPLT. Correlations between visual field parameters and GCIPLT were evaluated according to glaucoma severity. The best fit model for the relationship between PERG(amp) and GCIPLT was the linear regression model (r(2) = 0.22; P < 0.001). The best-fit model for the relationship between visual field parameters and GCIPLT was the broken stick model. During early glaucoma, macular GCIPLT was positively correlated with PERGamp, but not with visual field loss. In advanced glaucoma, macular GCIPLT was positively correlated with both PERG(amp) and visual field loss. Conclusions PERGamp was significantly correlated with macular GCIPT in early glaucoma patients, while visual field performance showed no correlation with GCIPLT. PERG(amp) can therefore assist clinicians in making an early decision regarding the most suitable treatment plan, especially when GCIPLT is thinning with no change in visual field performance.	[Park, Keunheung; Lee, Jiwoong] Pusan Natl Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Kim, Jinmi] Pusan Natl Univ Hosp, Biomed Res Inst, Clin Trial Ctr, Dept Biostat, Busan, South Korea; [Lee, Jiwoong] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, J (corresponding author), Pusan Natl Univ, Coll Med, Dept Ophthalmol, Busan, South Korea.; Lee, J (corresponding author), Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea.	alertlee@naver.com	Kim, Jinmi/GLT-0246-2022	kim, jinmi/0000-0002-6715-0447; Lee, Jiwoong/0000-0002-1053-612X				ARDEN GB, 1982, ANN NY ACAD SCI, V388, P580, DOI 10.1111/j.1749-6632.1982.tb50818.x; Bach M, 1997, DOC OPHTHALMOL, V94, P253, DOI 10.1007/BF02582983; Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Banitt MR, 2013, INVEST OPHTH VIS SCI, V54, P2346, DOI 10.1167/iovs.12-11026; BOBAK P, 1983, AM J OPHTHALMOL, V96, P72, DOI 10.1016/0002-9394(83)90457-9; Budenz DL, 2008, OPHTHALMOLOGY, V115, P661, DOI 10.1016/j.ophtha.2007.05.035; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DAVIES RB, 1987, BIOMETRIKA, V74, P33, DOI 10.1093/biomet/74.1.33; FALSINI B, 1991, CLIN VISION SCI, V6, P423; Fredette MJ, 2008, OPHTHALMOLOGY, V115, P957, DOI 10.1016/j.ophtha.2007.08.023; GLOVINSKY Y, 1993, INVEST OPHTH VIS SCI, V34, P395; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; HOLDER GE, 1987, BRIT J OPHTHALMOL, V71, P166, DOI 10.1136/bjo.71.3.166; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; JONAS JB, 1990, INVEST OPHTH VIS SCI, V31, P736; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Kotera Y, 2011, INVEST OPHTH VIS SCI, V52, P1412, DOI 10.1167/iovs.10-5572; Luo XD, 2011, INVEST OPHTH VIS SCI, V52, P8571, DOI 10.1167/iovs.11-8376; MARX MS, 1987, DOC OPHTHALMOL, V67, P281, DOI 10.1007/BF00144282; Nagaraju M, 2007, INVEST OPHTH VIS SCI, V48, P4573, DOI 10.1167/iovs.07-0582; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Porciatti V, 2012, J NEURO-OPHTHALMOL, V32, P354, DOI 10.1097/WNO.0b013e3182745600; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; SILIPRANDI R, 1988, INVEST OPHTH VIS SCI, V29, P558; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Ventura LM, 2005, OPHTHALMOLOGY, V112, P20, DOI 10.1016/j.ophtha.2004.09.002; Ventura LM, 2006, INVEST OPHTH VIS SCI, V47, P3904, DOI 10.1167/iovs.06-0161; VM M, 2008, R PACKAGE FIT REGRES	30	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0178004	10.1371/journal.pone.0178004	http://dx.doi.org/10.1371/journal.pone.0178004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545121	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700103
J	van Neck, JW; Tuk, B; Fijneman, EMG; Redeker, JJ; Talahatu, EM; Tong, M				van Neck, Johan W.; Tuk, Bastiaan; Fijneman, Esther M. G.; Redeker, Jonathan J.; Talahatu, Edwin M.; Tong, Miao			Hyperbaric oxygen therapy for wound healing in diabetic rats: Varying efficacy after a clinically-based protocol	PLOS ONE			English	Article							FOOT ULCERS; ANGIOGENESIS; INFLAMMATION; MECHANISMS; COLLAGEN	Hyperbaric oxygen therapy (HBOT) is a clinical treatment in which a patient breathes pure oxygen for a limited period of time at an increased pressure. Although this therapy has been used for decades to assist wound healing, its efficacy for many conditions is unproven and its mechanism of action is not yet fully clarified. This study investigated the effects of HBOT on wound healing using a diabetes-impaired pressure ulcer rat model. Seven weeks after streptozotocin-induced diabetes in rats (n = 55), a pressure ulcer was created on dorsal skin. Subsequently, animals received HBOT during 6 weeks following a standard clinical protocol (HBOT group with varying endpoints up to 42 days post-wounding) versus controls without HBOT. Capillary venous oxygen saturation (SO2) showed a significant increase in the HBOT group on day 24; however, this increase was significant at this time point only. The quantity of hemoglobin in the micro-blood vessels (rHB) showed a significant decrease in the HBOT group on days 21 and 42, and showed a trend to decrease on day 31. Blood flow in the microcirculation showed a significant increase on days 17, 21 and 31 but a significant decrease on days 24 and 28. Inflammation scoring showed significantly decreased CD68 counts in the HBOT group on day 42, but not in the early stages of wound healing. Animals in the HBOT group showed a trend for an increase in mean wound breaking strength on day 42.	[van Neck, Johan W.; Tuk, Bastiaan; Fijneman, Esther M. G.; Redeker, Jonathan J.; Talahatu, Edwin M.; Tong, Miao] Erasmus MC Univ Med Ctr, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Neck, JW (corresponding author), Erasmus MC Univ Med Ctr, Dept Plast & Reconstruct Surg, Rotterdam, Netherlands.	j.vanneck@erasmusmc.nl			Nuts Ohra Foundation (the Netherlands) [1103-055]	Nuts Ohra Foundation (the Netherlands)(Netherlands Government)	This research was supported by grant 1103-055 from the Nuts Ohra Foundation (the Netherlands). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidia A, 2003, EUR J VASC ENDOVASC, V25, P513, DOI 10.1053/ejvs.2002.1911; BOEREMA I, 1960, Ned Tijdschr Geneeskd, V104, P949; Broussard Craig L, 2004, J Vasc Nurs, V22, P42, DOI 10.1016/j.jvn.2004.03.001; Camporesi EM, 2014, UNDERSEA HYPERBAR M, V41, P247; Djasim UM, 2012, INT J ORAL MAX SURG, V41, P271, DOI 10.1016/j.ijom.2011.10.007; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; HARTMANN M, 1992, EUR J SURG, V158, P521; Kalani M, 2002, J DIABETES COMPLICAT, V16, P153, DOI 10.1016/S1056-8727(01)00182-9; Kranke P, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004123.pub3, 10.1002/14651858.CD004123.pub4]; LEA Medizintechnik Giessen Germany, MEAS PRINC O2C APPL; Lioupis C, 2005, J Wound Care, V14, P84; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Londahl M, 2015, INT WOUND J, V12, P232, DOI 10.1111/iwj.12093; Londahl M, 2013, MED CLIN N AM, V97, P957, DOI 10.1016/j.mcna.2013.04.004; Londahl M, 2010, DIABETES CARE, V33, P998, DOI 10.2337/dc09-1754; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; O'Reilly D, 2013, INT J TECHNOL ASSESS, V29, P269, DOI 10.1017/S0266462313000263; Rosen Anders, 2013, Lakartidningen, V110, P1609; Sander AL, 2009, WOUND REPAIR REGEN, V17, P179, DOI 10.1111/j.1524-475X.2009.00455.x; Stoekenbroek RM, 2014, EUR J VASC ENDOVASC, V47, P647, DOI 10.1016/j.ejvs.2014.03.005; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Tong M, 2008, WOUND REPAIR REGEN, V16, P294, DOI 10.1111/j.1524-475X.2008.00368.x; Tong M, 2012, DIABETES, V61, P2633, DOI 10.2337/db11-1329; Tong M, 2011, WOUND REPAIR REGEN, V19, P505, DOI 10.1111/j.1524-475X.2011.00704.x; Tong M, 2009, WOUND REPAIR REGEN, V17, P840, DOI 10.1111/j.1524-475X.2009.00548.x; Tuk B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108533; Widgerow AD, 2011, WOUND REPAIR REGEN, V19, P117, DOI 10.1111/j.1524-475X.2010.00662.x	31	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177766	10.1371/journal.pone.0177766	http://dx.doi.org/10.1371/journal.pone.0177766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28545109	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700071
J	Mompean, M; Romano, V; Pantoja-Uceda, D; Stuani, C; Baralle, FE; Buratti, E; Laurents, DV				Mompean, Miguel; Romano, Valentina; Pantoja-Uceda, David; Stuani, Cristiana; Baralle, Francisco E.; Buratti, Emanuele; Laurents, Douglas V.			Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); microscopic imaging; nuclear magnetic resonance (NMR); protein aggregation; site-directed mutagenesis; structure-function; subcellular fractionation	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOIDOGENIC CORE REGION; NUCLEIC-ACID BINDING; IN-VIVO; STRUCTURAL DETERMINANTS; INCLUSION FORMATION; PHASE-SEPARATION; RNA RECOGNITION; NMR RELAXATION	Transactive response DNA-binding protein 43 (TDP-43) performs multiple tasks in mRNA processing, transport, and translational regulation, but it also forms aggregates implicated in amyotrophic lateral sclerosis. TDP-43's N-terminal domain (NTD) is important for these activities and dysfunctions; however, there is an open debate about whether or not it adopts a specifically folded, stable structure. Here, we studied NTD mutations designed to destabilize its structure utilizing NMR and fluorescence spectroscopies, analytical ultracentrifugation, splicing assays, and cell microscopy. The substitutions V31R and T32R abolished TDP-43 activity in splicing and aggregation processes, and even the rather mild L28A mutation severely destabilized the NTD, drastically reducing TDP-43's in vitro splicing activity and inducing aberrant localization and aggregation in cells. These findings strongly support the idea that a stably folded NTD is essential for correct TDP-43 function. The stably folded NTD also promotes dimerization, which is pertinent to the protein's activities and pathological aggregation, and we present an atomic-level structural model for the TDP-43 dimer based on NMR data. Leu-27 is evolutionarily well conserved even though it is exposed in the monomeric NTD. We found here that Leu-27 is buried in the dimer and that the L27A mutation promotes monomerization. In conclusion, our study sheds light on the structural and biological properties of the TDP-43 NTD, indicating that the NTD must be stably folded for TDP-43's physiological functions, and has implications for understanding the mechanisms promoting the pathological aggregation of this protein.	[Mompean, Miguel; Pantoja-Uceda, David; Laurents, Douglas V.] CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain; [Romano, Valentina; Stuani, Cristiana; Baralle, Francisco E.; Buratti, Emanuele] ICGEB, Padriciano 99, I-34149 Trieste, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); International Center for Genetic Engineering & Biotechnology (ICGEB)	Laurents, DV (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.; Buratti, E (corresponding author), ICGEB, Padriciano 99, I-34149 Trieste, Italy.	buratti@icgeb.org; dlaurents@iqfr.csic.es	Buratti, Emanuele/K-4691-2016; Pantoja-Uceda, David/J-8097-2014; Mompeán, Miguel/A-4909-2016; Laurents, Douglas/E-7527-2015	Buratti, Emanuele/0000-0002-1356-9074; Mompeán, Miguel/0000-0002-5608-3648; Pantoja-Uceda, David/0000-0003-4390-6972; Laurents, Douglas/0000-0002-4187-165X; Baralle, Francisco/0000-0002-4645-2809	European Union [JPND AC14/00037]; European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR; Thierry Latran Foundation REHNPALS;  [SAF2013-49179-C2-2-R];  [SAF2016-76678-C2-2-R]	European Union(European Commission); European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR; Thierry Latran Foundation REHNPALS; ; 	This work was supported by Grants SAF2013-49179-C2-2-R and SAF2016-76678-C2-2-R, European Union Grant JPND AC14/00037 (to D. V. L.), European Union Grant JPND RiMOdFTD, Italy, Ministero della Sanita/MIUR (to E. B.), and the Thierry Latran Foundation REHNPALS (to E. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Budini M, 2015, HUM MOL GENET, V24, P9, DOI 10.1093/hmg/ddu415; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Chang CK, 2016, FEBS J, V283, P1239, DOI 10.1111/febs.13676; Chang CK, 2013, FEBS LETT, V587, P575, DOI 10.1016/j.febslet.2013.01.038; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chong PA, 2016, CURR OPIN STRUC BIOL, V41, P180, DOI 10.1016/j.sbi.2016.08.001; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Goddard D., 2008, SPARKY 3; Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Mihevc SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33996; Mompean M, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00125; Mompean M, 2016, J PHYS CHEM LETT, V7, P1859, DOI 10.1021/acs.jpclett.6b00699; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Mompean M, 2015, J PHYS CHEM LETT, V6, P2608, DOI 10.1021/acs.jpclett.5b00918; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ortega A, 2005, J AM CHEM SOC, V127, P12764, DOI 10.1021/ja053080l; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pawley NH, 2001, J BIOMOL NMR, V20, P149, DOI 10.1023/A:1011249816560; Qin HN, 2014, P NATL ACAD SCI USA, V111, P18619, DOI 10.1073/pnas.1413994112; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; Romano V, 2015, PRION, V9, P1, DOI 10.1080/19336896.2015.1011885; Sasaguri H, 2016, BRAIN RES, V1647, P57, DOI 10.1016/j.brainres.2016.04.069; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Wei YY, 2016, BIOCHEM BIOPH RES CO, V473, P614, DOI 10.1016/j.bbrc.2016.03.158; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	61	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11992	12006		10.1074/jbc.M117.775965	http://dx.doi.org/10.1074/jbc.M117.775965			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28566288	Green Published, hybrid			2022-12-26	WOS:000405485600034
J	Ho, SW; Yeh, CB; Yang, SF; Yeh, HW; Huang, JY; Teng, YH				Ho, Sai-Wai; Yeh, Chao-Bin; Yang, Shun-Fa; Yeh, Han-Wei; Huang, Jing-Yang; Teng, Ying-Hock			Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study	PLOS ONE			English	Article							KLEBSIELLA; NATIONWIDE; MORTALITY; INFECTION	Background Bacteremic pneumonia is considered a potential cause of distal organ abscess formation. Therefore, we hypothesize that pneumonia is a risk factor for pyogenic liver abscess (PLA). The aim of this study is to explore the association between pneumonia and PLA. Methodology/Principal findings A nationwide, population-based, nested, case-control study was conducted using data from the Taiwan National Health Insurance Research Database. In total, 494 patients with PLA and 1,976 propensity score matched controls were enrolled. Conditional logistic regression was used to estimate adjusted odds ratios (aORs) in patients with exposure to pneumonia before PLA. After matched and adjusted for confounding factors including age, sex, urbanization, income, chronic liver disease, alcohol-related disease, biliary stone, chronic kidney disease, diabetes mellitus, chronic liver disease, and cancer, hospitalization for pneumonia remained an independent risk factor for PLA with an aORs of 2.104 [95% confidence interval (CI) = 1.309-3.379, p = 0.0021]. Moreover, the aORs were significantly higher among patients hospitalized for pneumonia within 30 days (aORs = 10.73, 95% CI = 3.381-34.054), 30-90 days (aORs = 4.698, 95% CI = 1.541-14.327) and 90-180 (aORs = 4.000, 95% CI = 1.158-13.817) days before PLA diagnosis. Conclusion Pneumonia is an independent risk factor for subsequent PLA. Moreover, hospitalization for pneumonia within 180 days before PLA diagnosis was associated with an increased risk of PLA.	[Ho, Sai-Wai; Yeh, Chao-Bin; Teng, Ying-Hock] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Ho, Sai-Wai; Yeh, Chao-Bin; Teng, Ying-Hock] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Ho, Sai-Wai; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa; Huang, Jing-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yeh, Han-Wei] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Teng, YH (corresponding author), Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan.; Teng, YH (corresponding author), Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan.	cshy392@csh.org.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576				Ali AH, 2014, INT J GEN MED, V7, P37, DOI 10.2147/IJGM.S54448; Bordon J, 2013, INT J INFECT DIS, V17, pE76, DOI 10.1016/j.ijid.2012.06.006; Cannizzaro MA, 2008, SURG TODAY, V38, P1036, DOI 10.1007/s00595-008-3761-3; CHAKRAVARTY A, 1995, CHEST, V107, P1752, DOI 10.1378/chest.107.6.1752; Chang Feng-Yee, 1995, Journal of the Formosan Medical Association, V94, P232; Drahos J, 2013, ANN EPIDEMIOL, V23, P291, DOI 10.1016/j.annepidem.2013.02.005; Gonzalez-Juarbe N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005337; Izumikawa K, 2006, JPN J INFECT DIS, V59, P320; Jepsen P, 2005, ALIMENT PHARM THER, V21, P1185, DOI 10.1111/j.1365-2036.2005.02487.x; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Koo KKY, 2009, CAN J CARDIOL, V25, P233, DOI 10.1016/S0828-282X(09)70074-1; Lai SW, 2015, J EPIDEMIOL, V25, P561, DOI 10.2188/jea.JE20140267; Lardiere-Deguelte S, 2015, J VISC SURG, V152, P231, DOI 10.1016/j.jviscsurg.2015.01.013; Lee SSJ, 2008, CLIN INFECT DIS, V47, P642, DOI 10.1086/590932; Lee YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142254; Lee YT, 2013, J INFECT DEV COUNTR, V7, P116, DOI 10.3855/jidc.2834; Liao KF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001302; Lin JN, 2015, LANCET ONCOL, V16, P1335, DOI 10.1016/S1470-2045(15)00060-1; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033978; Lin YT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-13; Lin YT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-307; Liu K, 2016, J CRANIOFACIAL SURG; Marcos PJ, 2015, NEW ENGL J MED, V373, P2380, DOI 10.1056/NEJMc1511751; Meddings L, 2010, AM J GASTROENTEROL, V105, P117, DOI 10.1038/ajg.2009.614; Molle I, 2001, GUT, V48, P260, DOI 10.1136/gut.48.2.260; MOORADIAN AD, 1986, DIABETOLOGIA, V29, P221, DOI 10.1007/BF00454879; Ou SM, 2015, ANN INTERN MED, V163, P663, DOI 10.7326/M15-0308; Pang TCY, 2011, WORLD J GASTROENTERO, V17, P1622, DOI [10.3748/wjg.v17.i12. 1622, 10.3748/wjg.v17.i12.1622]; Piton G, 2013, CRIT CARE MED, V41, P2169, DOI 10.1097/CCM.0b013e31828c26b5; Shah SV, 2016, J ASSOC PHYSICIAN I, V64, P114; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tian LT, 2012, CLIN MICROBIOL INFEC, V18, pE314, DOI 10.1111/j.1469-0691.2012.03912.x; Wang YP, 2015, ALIMENT PHARM THER, V41, P1175, DOI 10.1111/apt.13203; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yu VL, 2007, EMERG INFECT DIS, V13, P986, DOI 10.3201/eid1307.070187	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178571	10.1371/journal.pone.0178571	http://dx.doi.org/10.1371/journal.pone.0178571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570670	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800080
J	Torres-Carvajal, O; Koch, C; Venegas, PJ; Poe, S				Torres-Carvajal, Omar; Koch, Claudia; Venegas, Pablo J.; Poe, Steve			Phylogeny and diversity of neotropical monkey lizards (Iguanidae: Polychrus Cuvier, 1817)	PLOS ONE			English	Article							SPECIES DELIMITATION; MITOCHONDRIAL GENOME; SQUAMATA; EVOLUTION; DIVERSIFICATION; MORPHOLOGY; REPTILIA; GENES; POLYCHROTIDAE; SYSTEMATICS	Neotropical monkey lizards (Polychrus) are arboreal lizards with compressed bodies, partially fused eyelids and strikingly long, whip-like tails. The eight currently recognized species occur in the lowlands of South and Central America. Based on the largest taxon and character sampling to date, we analyze three mitochondrial and one nuclear gene using Bayesian methods to (1) infer the phylogeny of Polychrus under both concatenated-tree and species-tree methods; (2) identify lineages that could represent putative undescribed species; and (3) estimate divergence times. Our species tree places P. acutirostris as the sister taxon to all other species of Polychrus. While the phylogenetic position of P. gutturosus and P. peruvianus is poorly resolved, P. marmoratus and P. femoralis are strongly supported as sister to P. liogaster and P. jacquelinae, respectively. Recognition of P. auduboni and P. marmoratus sensu stricto as distinct species indicates that the populations of "P. marmoratus" from the Amazon and the Atlantic coast in Brazil represent separate species. Similarly, populations of P. femoralis from the Tumbes region might belong to a cryptic undescribed species. Relative divergence times and published age estimates suggest that the orogeny of the Andes did not play a significant role in the early evolution of Polychrus.	[Torres-Carvajal, Omar] Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Quito, Ecuador; [Koch, Claudia] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Venegas, Pablo J.] Ctr Ornitol & Biodiversidad CORBIDI, Lima, Peru; [Poe, Steve] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Poe, Steve] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA	Pontificia Universidad Catolica del Ecuador; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of New Mexico; University of New Mexico	Torres-Carvajal, O (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Ciencias Biol, Museo Zool, Quito, Ecuador.	omartorcar@gmail.com	Koch, Claudia/AAM-1463-2020; Torres-Carvajal, Omar/I-1977-2019	Koch, Claudia/0000-0002-7115-2816; Torres-Carvajal, Omar/0000-0003-0041-9250; venegas, pablo/0000-0002-6501-4492	Deutscher Akademischer Austauschdienst (DAAD); Alexander Koenig Stiftung (AKS); Alexander Koenig Gesellschaft (AKG); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT); Pontificia Universidad Catolica del Ecuador; Systematics Association's Systematics Research Fund	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander Koenig Stiftung (AKS); Alexander Koenig Gesellschaft (AKG); Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT); Pontificia Universidad Catolica del Ecuador; Systematics Association's Systematics Research Fund	CK received funds from the Deutscher Akademischer Austauschdienst (DAAD), the Alexander Koenig Stiftung (AKS) and the Alexander Koenig Gesellschaft (AKG). OTC received funds from Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador (SENESCYT), Pontificia Universidad Catolica del Ecuador, and The Systematics Association's Systematics Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Blankers T, 2013, BIOL J LINN SOC, V108, P127, DOI 10.1111/j.1095-8312.2012.01988.x; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2007, J PALEONTOL, V81, P1365, DOI 10.1666/06-005R.1; D'Angiolella Annelise B., 2011, Bulletin of the Museum of Comparative Zoology, V160, P35; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Estes R., 1988, P119; Etheridge R., 1988, P283; Foster MS, 2012, REPTILE BIODIVERSITY: STANDARD METHODS FOR INVENTORY AND MONITORING, P95; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; FROST D R, 1989, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Frost Darrel R., 2001, American Museum Novitates, V3343, P1, DOI 10.1206/0003-0082(2001)343<0001:TESAEO>2.0.CO;2; Funk WC, 2011, P ROYAL SOC LONDON B; Garda AA, 2012, J HERPETOL, V46, P2, DOI 10.1670/10-288; Gomez-Hoyos Diego A., 2015, Herpetology Notes, V8, P297; GORMAN G C, 1969, Breviora, P1; Harris DJ, 1998, P ROY SOC B-BIOL SCI, V265, P1939, DOI 10.1098/rspb.1998.0524; Hoogmoed M., 1973, NOTES HERPETOFAUNA S, V4; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koch C, 2011, ZOOKEYS, P79, DOI 10.3897/zookeys.141.1678; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Macey JR, 1997, J MOL EVOL, V44, P660, DOI 10.1007/PL00006190; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; MILLER M., 2010, GAT COMP ENV 1101 WO; Murphy JC, 2017, AMPHIB REPTILE CONSE, V11, P1; Noonan BP, 2010, AM NAT, V175, P61, DOI 10.1086/648607; Okajima Y, 2009, GENE, V441, P28, DOI 10.1016/j.gene.2008.06.011; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Poe S, 2004, HERPETOL MONOGR, V18, P37, DOI 10.1655/0733-1347(2004)018[0037:POA]2.0.CO;2; Poe S, 2013, ZOOTAXA, V3626, P295, DOI 10.11646/zootaxa.3626.2.7; Prates I, 2015, MOL PHYLOGENET EVOL, V82, P258, DOI 10.1016/j.ympev.2014.10.005; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2016, SYST BIOL IN PRESS; Rambaut A., 2016, FIGTREE V1 3 1 I EVO; Rambaut A, 2014, FIGTREE; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Nunes PMS, 2012, ZOOL J LINN SOC-LOND, V166, P361, DOI 10.1111/j.1096-3642.2012.00846.x; Schulte JA, 2003, HERPETOLOGICA, V59, P399, DOI 10.1655/02-48; Schulte JA, 2009, MOL PHYLOGENET EVOL, V50, P391, DOI 10.1016/j.ympev.2008.10.018; Torres-Carvajal O, 2009, MOL PHYLOGENET EVOL, V50, P31, DOI 10.1016/j.ympev.2008.10.002; Townsend TM, 2011, MOL PHYLOGENET EVOL, V61, P363, DOI 10.1016/j.ympev.2011.07.008; Townsend TM, 2011, P ROY SOC B-BIOL SCI, V278, P2568, DOI 10.1098/rspb.2010.2598; Vanzolini P.E., 1983, P118; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Yang Z, 2014, Molecular Evolution: A Statistical Approach, P1, DOI 10.1093/acprof:oso/9780199602605.001.0001; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	54	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178139	10.1371/journal.pone.0178139	http://dx.doi.org/10.1371/journal.pone.0178139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570575	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800031
J	Wu, KJ; Huang, JM; Zhong, HJ; Dong, ZZ; Vellaisamy, K; Lu, JJ; Chen, XP; Chiu, P; Kwong, DWJ; Han, QB; Ma, DL; Leung, CH				Wu, Ke-Jia; Huang, Jie-Min; Zhong, Hai-Jing; Dong, Zhen-Zhen; Vellaisamy, Kasipandi; Lu, Jin-Jian; Chen, Xiu-Ping; Chiu, Pauline; Kwong, Daniel W. J.; Han, Quan-Bin; Ma, Dik-Lung; Leung, Chung-Hang			A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells	PLOS ONE			English	Article							CANCER-CELLS; METASTATIC MELANOMA; MULTIDRUG-RESISTANCE; PROTEOMIMETIC INHIBITORS; SIGNALING PATHWAY; CHINESE MEDICINE; STAT3 ACTIVATION; MARINE SPONGE; GROWTH-FACTOR; IN-VITRO	The JAK2/STAT3 signaling pathway plays a critical role in tumorigenesis, and has been suggested as a potential molecular target for anti-melanoma therapeutics. However, few JAK2 inhibitors were being tested for melanoma therapy. In this study, eight amentoflavone analogues were evaluated for their activity against human malignant melanoma cells. The most potent analogue, compound 1, inhibited the phosphorylation of JAK2 and STAT3 in human melanoma cells, but had no discernible effect on total JAK2 and STAT3 levels. A cellular thermal shift assay was performed to identify that JAK2 is engaged by 1 in cell lysates. Moreover, compound 1 showed higher antiproliferative activity against human melanoma A375 cells compared to a panel of cancer and normal cell lines. Compound 1 also activated caspase-3 and cleaved PARP, which are markers of apoptosis, and suppressed the antiapoptotic Bcl-2 level. Finally, compound 1 induced apoptosis in 80% of treated melanoma cells. To our knowledge, compound 1 is the first amentoflavone-based JAK2 inhibitor to be investigated for use as an anti-melanoma agent.	[Wu, Ke-Jia; Huang, Jie-Min; Zhong, Hai-Jing; Lu, Jin-Jian; Chen, Xiu-Ping; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Dong, Zhen-Zhen; Vellaisamy, Kasipandi; Kwong, Daniel W. J.; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Chiu, Pauline] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Chiu, Pauline] Univ Hong Kong, State Key Lab Synthet Chem, Hong Kong, Hong Kong, Peoples R China; [Han, Quan-Bin] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China	University of Macau; Hong Kong Baptist University; University of Hong Kong; University of Hong Kong; Hong Kong Baptist University	Leung, CH (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.; Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk; duncanleung@umac.mo	Chen, Xiuping/AAG-3086-2020; Chiu, Pauline/D-3063-2009; WU, KE JIA/GLU-5609-2022; Kasipandi, Vellaisamy/AAF-5899-2019; Lu, Jinjian/X-2083-2019; Lu, Jinjian/R-6207-2019	Chiu, Pauline/0000-0001-5081-4756; WU, KE JIA/0000-0002-0809-5628; Lu, Jinjian/0000-0001-6703-3120; Zhong, Hai-Jing/0000-0002-1247-3150; Han, Quanbin/0000-0001-9051-1485	Hong Kong Baptist University [FRG2/15-16/002]; Health and Medical Research Fund [HMRF/14130522]; Research Grants Council [HKBU/12301115, HKBU/204612, HKBU/201913]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12-Oligoswitch]; National Natural Science Foundation of China [21575121, 21628502]; Guangdong Province Natural Science Foundation [2015A030313816]; Hong Kong Baptist University Century Club Sponsorship Scheme; Interdisciplinary Research Matching Scheme [RC-IRMS/15-16/03]; Science and Technology Development Fund; Macao SAR [098/2014/A2]; University of Macau [MYRG2015-0 0137-ICMS-QRCM, MYRG2016-00151-ICMS-Q QRCM, MRG044/LCH/2015/ICMS]	Hong Kong Baptist University; Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Hong Kong Baptist University Century Club Sponsorship Scheme; Interdisciplinary Research Matching Scheme; Science and Technology Development Fund(Science and Technology Development Fund (STDF)); Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/15-16/002), the Health and Medical Research Fund (HMRF/14130522), the Research Grants Council (HKBU/12301115, HKBU/204612 and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12-Oligoswitch), National Natural Science Foundation of China (21575121), Guangdong Province Natural Science Foundation (2015A030313816), Hong Kong Baptist University Century Club Sponsorship Scheme 2016, Interdisciplinary Research Matching Scheme (RC-IRMS/15-16/03), the Science and Technology Development Fund, Macao SAR(098/2014/A2), the University of Macau (MYRG2015-0 0137-ICMS-QRCM, MYRG2016-00151-ICMS-Q QRCM and MRG044/LCH/2015/ICMS) to CHL, and National Natural Science Foundation of China (21628502).	Abraham I, 2010, BIOCHEM PHARMACOL, V80, P1497, DOI 10.1016/j.bcp.2010.08.001; Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; Ahn KS, 2008, CANCER RES, V68, P4406, DOI 10.1158/0008-5472.CAN-07-6696; Andraos R, 2012, CANCER DISCOV, V2, P512, DOI 10.1158/2159-8290.CD-11-0324; [Anonymous], 2016, ANGEW CHEM, V128, P11262; [Anonymous], 2015, CANC FACTS; Anreddy N, 2014, MOLECULES, V19, P13848, DOI 10.3390/molecules190913848; Aoki S, 1998, TETRAHEDRON LETT, V39, P6303, DOI 10.1016/S0040-4039(98)01336-7; Banerjee T, 2002, PROSTAG LEUKOTR ESS, V66, P485, DOI 10.1054/plef.2002.0387; Barnard A, 2015, ANGEW CHEM INT EDIT, V54, P2960, DOI 10.1002/anie.201410810; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; Blaskovich MA, 2003, CANCER RES, V63, P1270; Boykin C, 2011, BRIT J CANCER, V104, P781, DOI 10.1038/bjc.2011.10; Burslem GM, 2014, CHEMBIOCHEM, V15, P1083, DOI 10.1002/cbic.201400009; Chen JY, 2010, ACS MED CHEM LETT, V1, P85, DOI 10.1021/ml100010j; Chen Q, 2010, CANCER LETT, V291, P246, DOI 10.1016/j.canlet.2009.10.019; De Nicolo A, 2009, CANCER RES, V69, P7030, DOI 10.1158/0008-5472.CAN-09-1440; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Gomez C, 2009, BIOORG MED CHEM LETT, V19, P1733, DOI 10.1016/j.bmcl.2009.01.091; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoffman-Luca CG, 2015, CLIN CANCER RES, V21, P2558, DOI 10.1158/1078-0432.CCR-14-2506; 김정옥, 2008, [Modern English Education, 현대영어교육], V9, P71; Kim MK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/573734; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Leung P-C, ANN TRADITIONAL CHIN, V6; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li F, 2010, CANCER LETT, V292, P197, DOI 10.1016/j.canlet.2009.12.003; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Ma DL, 2014, CHEM COMMUN, V50, P13885, DOI 10.1039/c4cc04498c; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Mosesso P, 2012, TOXICOL LETT, V213, P361, DOI 10.1016/j.toxlet.2012.07.021; Nam S, 2012, MOL ONCOL, V6, P484, DOI 10.1016/j.molonc.2012.05.002; Nielsen M, 1999, LEUKEMIA, V13, P735, DOI 10.1038/sj.leu.2401415; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Petrella T, 2007, CANCER TREAT REV, V33, P484, DOI 10.1016/j.ctrv.2007.04.003; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Selvendiran K, 2008, CELL CYCLE, V7, P81, DOI 10.4161/cc.7.1.5103; Sen R, 2012, MOL CANCER THER, V11, P2033, DOI 10.1158/1535-7163.MCT-12-0302; Sutendra G, 2013, ONCOGENE, V32, P1638, DOI 10.1038/onc.2012.198; Swinson DEB, 2004, INT J CANCER, V111, P43, DOI 10.1002/ijc.20052; Trinh VA, 2008, AM J HEALTH-SYST PH, V65, pS3, DOI 10.2146/ajhp080460; Tu SP, 2012, CANCER PREV RES, V5, P205, DOI 10.1158/1940-6207.CAPR-11-0247; Uzuner H, 2012, J ETHNOPHARMACOL, V140, P458, DOI 10.1016/j.jep.2012.02.028; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Wang DS, 2014, ONCOTARGET, V5, P4529, DOI 10.18632/oncotarget.2102; Yang C., 2012, SCI REP, V3, P1, DOI DOI 10.1021/ML200301W; Yang C, 2016, CHEM COMMUN, V52, P12837, DOI 10.1039/c6cc04938a; Yang D, 2012, BREAST CANCER RES TR, V133, P189, DOI 10.1007/s10549-011-1752-3; Ye DY, 2012, BIOORGAN MED CHEM, V20, P4489, DOI 10.1016/j.bmc.2012.05.030; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang Dingfei, 2012, TECHNIQUE APPL, V1, P23, DOI DOI 10.1021/MP300249S; Zhong HJ, 2017, J MED CHEM, V60, P497, DOI 10.1021/acs.jmedchem.6b00250; Zhong HJ, 2015, METHODS, V71, P21, DOI 10.1016/j.ymeth.2014.07.003; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	60	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177123	10.1371/journal.pone.0177123	http://dx.doi.org/10.1371/journal.pone.0177123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570563	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800006
J	Bag, A; Chattopadhyay, RR				Bag, Anwesa; Chattopadhyay, Rabi Ranjan			Synergistic antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-beta-D-glucopyranose from Terminalia chebula fruit in combination with gentamicin and trimethoprim against multidrug resistant uropathogenic Escherichia coli biofilms	PLOS ONE			English	Article							CANDIDA-ALBICANS BIOFILMS; BACTERIAL BIOFILMS; IN-VITRO; SURVIVAL; ASSAY; MECHANISMS; GROWTH	In recent years the emergence of multiple drug resistance microbes has become a global public health problem. The aim of the present investigation was to evaluate possible antibiofilm efficacy of a gallotannin 1,2,6-tri-O-galloyl-beta-D-glucopyranose from Terminalia chebula fruits alone and in combination with gentamicin and trimethoprim against preformed biofilms of multidrug-resistant (MDR) uropathogenic E. coli isolates using microbroth dilution, checkerboard titration and kill kinetics methods. Test gallotannin showed > 50% antibiofilm efficacy after 24 h when administered alone whereas gentamicin and trimethoprim failed to do so. But in combination, test gallotannin/gentamicin and test gallotannin/trimethoprim showed 71.24 +/- 6.75% and 93.4 +/- 8.46% antibiofilm activity respectively. On the basis of FICI values, test gallotannin/gentamicin showed synergistic interactions against 71.42% and test gallotannin/trimethoprim against 85.71% biofilm forming test bacterial isolates. Kill-kinetics study confirmed their synergistic interactions. Thus, gentamicin and trimethoprim in combination with test gallotannin may have potential for treatment of urinary tract infections caused by biofilm forming MDR uropathogenic E. coli.	[Bag, Anwesa; Chattopadhyay, Rabi Ranjan] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Bag, A (corresponding author), Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, India.	anwesa.bag@gmail.com			University Grants Commission, NEW Delhi, India [F.15-1/2012-13/PDFWM-2012-13-GW-WES-18557(SA-II)]	University Grants Commission, NEW Delhi, India(University Grants Commission, India)	This work was supported by the University Grants Commission, NEW Delhi, India provided Post Doctoral Fellowship [F.15-1/2012-13/PDFWM-2012-13-GW-WES-18557(SA-II)] to AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bag A, 2013, J APPL MICROBIOL, V115, P390, DOI 10.1111/jam.12256; Barapatre A., 2016, BIORESOUR BIOPROCESS, V3, P1, DOI [10.1186/s40643-016-0083-y, DOI 10.1186/S40643-016-0083-Y]; *CLIN LAB STAN I, 2005, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2012, M02A11 CLSI; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dineshbabu J, 2015, INDOAMERICAN J PHARM, V5, P2598; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dosler S, 2016, J CHEMOTHERAPY, V28, P95, DOI 10.1179/1973947815Y.0000000004; Foxman B, 2002, AM J MED, V113, p5S; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Khan MSA, 2012, J ANTIMICROB CHEMOTH, V67, P618, DOI 10.1093/jac/dkr512; LECLERCQ R, 1991, ANTIMICROB AGENTS CH, V35, P92, DOI 10.1128/AAC.35.1.92; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Messick CR, 1999, J ANTIMICROB CHEMOTH, V44, P831, DOI 10.1093/jac/44.6.831; Miquel S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00592; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Musk DJ, 2006, CURR MED CHEM, V13, P2163, DOI 10.2174/092986706777935212; Pramodhini S, 2012, AUSTRALAS MED J, V5, P344, DOI 10.4066/AMJ.2012.1193; Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Rogers SA, 2008, ANGEW CHEM INT EDIT, V47, P5229, DOI 10.1002/anie.200800862; Sherry L, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-182; SIEUWERTS AM, 1995, EUR J CLIN CHEM CLIN, V33, P813	22	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5							e0178712	10.1371/journal.pone.0178712	http://dx.doi.org/10.1371/journal.pone.0178712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562631	Green Published, gold, Green Submitted			2022-12-26	WOS:000402608700084
J	Woodruff, DC; Foster, JR				Woodruff, D. Cary; Foster, John R.			The first specimen of Camarasaurus (Dinosauria: Sauropoda) from Montana: The northernmost occurrence of the genus	PLOS ONE			English	Article							JURASSIC MORRISON FORMATION; NEURAL SPINE BIFURCATION; LARGE-SAMPLE; OSTEOLOGY; DIPLODOCOIDEA; HISTORY; AGE	A partial skeleton from the Little Snowy Mountains of central Montana is the first referable specimen of the Morrison Formation macronarian sauropod Camarasaurus. This specimen also represents the northernmost occurrence of a sauropod in the Morrison. Histological study indicates that, although the specimen is relatively small statured, it is skeletally mature; this further emphasizes that size is not a undeviating proxy to maturity in dinosaurs, and that morphologies associated with an individual's age and stature may be more nebulous in sauropods.	[Woodruff, D. Cary] Great Plains Dinosaur Museum & Field Stn, Malta, MT 59538 USA; [Woodruff, D. Cary] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Woodruff, D. Cary] Royal Ontario Museum, Toronto, ON, Canada; [Foster, John R.] Museum Moab, Moab, UT USA	University of Toronto; Royal Ontario Museum	Woodruff, DC (corresponding author), Great Plains Dinosaur Museum & Field Stn, Malta, MT 59538 USA.; Woodruff, DC (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.; Woodruff, DC (corresponding author), Royal Ontario Museum, Toronto, ON, Canada.	sauropod4@gmail.com						Ayer J., 1999, SAURIERMUSEUM AATHAL; Britt BB, 1993, THESIS; BUBENIK AB, 1965, J EXP ZOOL, V159, P289, DOI 10.1002/jez.1401590302; Canudo JI, 2012, GEOL MAG, V149, P252, DOI 10.1017/S0016756811000732; Carballido JL, 2014, J SYSTEMATIC PALAEON, V12, P1; Carballido JL, 2011, ZOOL J LINN SOC-LOND, V163, P605, DOI 10.1111/j.1096-3642.2011.00723.x; Christopher M., 2006, ANTERIOR AXIAL ANATO; Cope E.D., 1877, P AM PHILOS SOC, V17, P233, DOI [10.1038/ nature22065, DOI 10.1038/NATURE22065]; Cubo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131131; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; Foster J. R., 2000, NEW MEXICO MUSEUM NA, V17, P47; Foster JR, 1994, WYOM GEOL ASS 44 ANN, P115; Foster JR., 2003, NEW MEXICO MUSEUM NA, V23, P1; Foster JR, 2015, APATOSAURUS; Foster JR, 1996, U WYOMING CONTRIBUTI, V31, P1; Fowler DW, 2012, J VERTEBR PALEONTOL, V32, P96; Fowler EAF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141304; Frederickson JA, 2014, PEERJ, V2, DOI 10.7717/peerj.252; Goodwin MB, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1078343; Harris JD, 2006, J VERTEBR PALEONTOL, V26, P88, DOI 10.1671/0272-4634(2006)26[88:COOSES]2.0.CO;2; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Hunt Adrian P., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V2, P71; Ikejiri T, 2005, LIFE O PAST, P154; Ikejiri T., 2005, GEOLOGY CHAMA BASIN, P367; Ikejiri T., 2008, FORT HAYS SPECIAL ST, P31; Ikejiri T, 2015, BIOL J LINN SOC, V116, P649, DOI 10.1111/bij.12607; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Janensch W., 1929, PALAEONTOGRAPHICA S7, V2, P3; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Madsen JH, 1995, SKULL ATLAS AXIS COM; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Marsh O.C., 1879, AM J SCI, V3, P501; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; McIntosh J. S., 1981, BULL CARNEG MUS NAT, V18, P1; McIntosh John S., 1996, Brigham Young University Geology Studies, V41, P73; McIntosh John S., 1996, Bulletin of Gunma Museum of Natural History, V1, P1; Moser M, 2006, PALAEONTOL Z, V80, P34, DOI 10.1007/BF02988396; Otero A, 2012, HIST BIOL, V24, P243, DOI 10.1080/08912963.2011.618269; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Rigby Jr JK, 1982, 33 FIELD C, P271; Royo-Torres R., 2009, ACT 4 JORN INT PAL D, P139; Royo-Torres R, 2009, PALAEONTOLOGY, V52, P1009, DOI 10.1111/j.1475-4983.2009.00898.x; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Stein K., 2009, METHODS FOSSIL PREPA, P69; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Trujillo K.C., 2006, NEW MEXICO MUSEUM NA, V36, P17; Trujillo K.C., 2015, W INTERIOR US GEOLOG, V2, P1, DOI DOI 10.31711/GIW.V2.PP1-8; Trujillo Kelli C., 2014, Volumina Jurassica, V12, P107, DOI 10.5604/17313708.1130132; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Turner CE., 1999, VERTEBRATE PALEONTOL, P77; Upchurch P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125819; Waskow K, 2014, J VERTEBR PALEONTOL, V34, P852, DOI 10.1080/02724634.2014.840645; Wedel Mathew J., 2013, PalArch's Journal of Vertebrate Palaeontology, V10, P1; WHITE TE, 1958, J PALEONTOL, V32, P477; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wolff EDS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007288; Woodruff DC, 2012, J MORPHOL, V273, P754, DOI 10.1002/jmor.20021; Woods D. C., 2016, HDB UNCERTAINTY QUAN, P1; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19	64	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2017	12	5								10.1371/journal.pone.0177423	http://dx.doi.org/10.1371/journal.pone.0177423			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GY	28562606	Green Published, gold			2022-12-26	WOS:000402608700015
J	Cavaiuolo, M; Cocetta, G; Spadafora, ND; Muller, CT; Rogers, HJ; Ferrante, A				Cavaiuolo, Marina; Cocetta, Giacomo; Spadafora, Natasha Damiana; Muller, Carsten T.; Rogers, Hilary J.; Ferrante, Antonio			Gene expression analysis of rocket salad under pre-harvest and postharvest stresses: A transcriptomic resource for Diplotaxis tenuifolia	PLOS ONE			English	Article							ABIOTIC STRESS; RNA-SEQ; ARABIDOPSIS-THALIANA; REGULATORY NETWORK; RESPONSIVE GENES; LEAF SENESCENCE; DROUGHT STRESS; ASCORBIC-ACID; CELL-DEATH; QUALITY	Diplotaxis tenuifolia L. is of important economic value in the fresh-cut industry for its nutraceutical and sensorial properties. However, information on the molecular mechanisms conferring tolerance of harvested leaves to pre-and postharvest stresses during processing and shelflife have never been investigated. Here, we provide the first transcriptomic resource of rocket by de novo RNA sequencing assembly, functional annotation and stress-induced expression analysis of 33874 transcripts. Transcriptomic changes in leaves subjected to commerciallyrelevant pre-harvest (salinity, heat and nitrogen starvation) and postharvest stresses (cold, dehydration, dark, wounding) known to affect quality and shelf-life were analysed 24h after stress treatment, a timing relevant to subsequent processing of salad leaves. Transcription factors and genes involved in plant growth regulator signaling, autophagy, senescence and glucosinolate metabolism were the most affected by the stresses. Hundreds of genes with unknown function but uniquely expressed under stress were identified, providing candidates to investigate stress responses in rocket. Dehydration and wounding had the greatest effect on the transcriptome and different stresses elicited changes in the expression of genes related to overlapping groups of hormones. These data will allow development of approaches targeted at improving stress tolerance, quality and shelf-life of rocket with direct applications in the fresh-cut industries.	[Cavaiuolo, Marina; Cocetta, Giacomo; Ferrante, Antonio] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Spadafora, Natasha Damiana; Muller, Carsten T.; Rogers, Hilary J.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Cavaiuolo, Marina] Inst Biol Phys Chim, Paris, France	University of Milan; Cardiff University	Ferrante, A (corresponding author), Univ Milan, Dept Agr & Environm Sci, Milan, Italy.	antonio.ferrante@unimi.it	Spadafora, Natasha Damiana/AAN-1056-2020; cavaiuolo, marina/ABF-7831-2020; Ferrante, Antonio/B-1927-2008; Müller, Carsten T/A-7114-2010; Rogers, Hilary/A-4516-2010	cavaiuolo, marina/0000-0002-8580-6462; Ferrante, Antonio/0000-0001-7781-9784; Müller, Carsten T/0000-0003-0455-7132; Rogers, Hilary/0000-0003-3830-5857; Spadafora, Natasha, Damiana/0000-0001-7273-6322; Cocetta, Giacomo/0000-0002-8796-4245	EU Seventh Framework Programme (FP7) [289719]	EU Seventh Framework Programme (FP7)	Research was funded by the EU Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 289719 (Project QUAFETY).	Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Baldassarre V, 2015, J EXP BOT, V66, P1511, DOI 10.1093/jxb/eru516; Bell L, 2014, J AGR FOOD CHEM, V62, P4481, DOI 10.1021/jf501096x; Beneventi MA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-322; Bhardwaj AR, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0405-1; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Bottino A, 2009, J AGR FOOD CHEM, V57, P2925, DOI 10.1021/jf803740q; Cavaiuolo M, 2015, FOOD CHEM, V188, P225, DOI 10.1016/j.foodchem.2015.04.143; Cavaiuolo M, 2014, NUTRIENTS, V6, P1519, DOI 10.3390/nu6041519; Chen CNN, 2009, PLANT PHYSIOL, V149, P1679, DOI 10.1104/pp.108.131490; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Choura M., 2015, NETW BIOL, V5, P55; Cocetta G, 2014, POSTHARVEST BIOL TEC, V88, P8, DOI 10.1016/j.postharvbio.2013.09.001; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Martinez-Ballesta MD, 2013, INT J MOL SCI, V14, P11607, DOI 10.3390/ijms140611607; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Hall M. K. D., 2012, Vegetable Crops Research Bulletin, V76, P21, DOI 10.2478/v10032-012-0002-5; Hickman R, 2013, PLANT J, V75, P26, DOI 10.1111/tpj.12194; Hodges DM, 2008, POSTHARVEST BIOL TEC, V48, P155, DOI 10.1016/j.postharvbio.2007.10.016; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Kader AA, 2002, POSTHARVEST TECHNOLO, V545, P39; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kohli A, 2013, PLANT CELL REP, V32, P945, DOI 10.1007/s00299-013-1461-y; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lee S, 2014, PLANT SCI, V227, P76, DOI 10.1016/j.plantsci.2014.07.003; Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv Q, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-180; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Martinez-Ballesta M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00524; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Oono Youko, 2006, Functional & Integrative Genomics, V6, P212, DOI 10.1007/s10142-005-0014-z; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Rasmussen S, 2013, PLANT PHYSIOL, V161, P1783, DOI 10.1104/pp.112.210773; Rico D, 2007, TRENDS FOOD SCI TECH, V18, P373, DOI 10.1016/j.tifs.2007.03.011; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouphael Y, 2012, J FOOD AGRIC ENVIRON, V10, P680; Sasaki Y, 2001, DNA RES, V8, P153, DOI 10.1093/dnares/8.4.153; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Suzuki N, 2014, NEW PHYTOL, V203, P32, DOI 10.1111/nph.12797; Tuberosa R, 2006, TRENDS PLANT SCI, V11, P405, DOI 10.1016/j.tplants.2006.06.003; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Vermeirssen V, 2014, PLANT CELL, V26, P4656, DOI 10.1105/tpc.114.131417; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Wagstaff C, 2007, POSTHARVEST BIOL TEC, V46, P150, DOI 10.1016/j.postharvbio.2007.04.013; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wehner GG, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0524-3; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Zhang SS, 2009, PLANT SIGNAL BEHAV, V4, P1117, DOI 10.4161/psb.4.12.9903; Zhang T, 2016, J EXP BOT, V67, P2107, DOI 10.1093/jxb/erv521; Zheng ZY, 2013, NAT CHEM BIOL, V9, P244, DOI [10.1038/nchembio.1178, 10.1038/NCHEMBIO.1178]; Zhou J, 2014, J EXP BOT, V65, P4371, DOI 10.1093/jxb/eru217	70	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178119	10.1371/journal.pone.0178119	http://dx.doi.org/10.1371/journal.pone.0178119			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558066	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000029
J	Ryabov, VV; Kirgizova, MA; Suslova, TE; Karas, SI; Markov, VA; Karpov, RS				Ryabov, Vyacheslav V.; Kirgizova, Marina A.; Suslova, Tatiana E.; Karas, Sergei I.; Markov, Valentin A.; Karpov, Rostislav S.			Relationships of growth factors, proinflammatory cytokines, and antiinflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMI	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; INTRACORONARY; THERAPY; INJURY; INFLAMMATION; REPERFUSION; MECHANISMS; BIOLOGY; REPAIR	The aim of the study was to test the hypothesis suggesting that the pre-interventionlevels of proinflammatory cytokines, anti-inflammatory cytokines, and angiogenic growth factors predict the long-term clinical results of autologous bone marrow-derived mononuclear cell (ABMMC) transplantation in patients with primary ST elevation myocardial infarction (STEMI).	[Ryabov, Vyacheslav V.; Kirgizova, Marina A.; Suslova, Tatiana E.; Markov, Valentin A.; Karpov, Rostislav S.] Tomsk Natl Res Med Ctr, Cardiol Res Inst, Tomsk, Russia; [Ryabov, Vyacheslav V.; Karas, Sergei I.; Markov, Valentin A.; Karpov, Rostislav S.] Siberian State Med Univ, Fac Continuous Med Educ, Dept Cardiol, Tomsk, Russia; [Ryabov, Vyacheslav V.; Suslova, Tatiana E.] Natl Res Tomsk State Univ, Lab Translat Cellular & Mol Biomed, Tomsk, Russia	Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; Siberian State Medical University; Tomsk State University	Ryabov, VV (corresponding author), Tomsk Natl Res Med Ctr, Cardiol Res Inst, Tomsk, Russia.; Ryabov, VV (corresponding author), Siberian State Med Univ, Fac Continuous Med Educ, Dept Cardiol, Tomsk, Russia.; Ryabov, VV (corresponding author), Natl Res Tomsk State Univ, Lab Translat Cellular & Mol Biomed, Tomsk, Russia.	rvvt@cardio-tomsk.ru	Karpov, Rostislav S./F-5406-2014; Markov, Valentin A/O-4459-2016; Suslova, Tatiana/M-4339-2016; Karas, Sergey I./O-3671-2016; Ryabov, V V/F-2153-2014; Dragunova, Marina/F-4418-2018	Karpov, Rostislav S./0000-0002-7011-4316; Markov, Valentin A/0000-0002-5959-2771; Suslova, Tatiana/0000-0001-9645-6720; Karas, Sergey I./0000-0001-6716-856X; Ryabov, V V/0000-0002-4358-7329; Dragunova, Marina/0000-0002-7264-9904; Karpov, Rostislav S./0000-0001-8578-6636	Russian Academy of Sciences; National Research Tomsk State University; Tomsk State University; Siberian State Medical University	Russian Academy of Sciences(Russian Academy of Sciences); National Research Tomsk State University; Tomsk State University; Siberian State Medical University	This work was supported by the Russian Academy of Sciences, National Research Tomsk State University, Tomsk State University, Siberian State Medical University.	Assmus B, 2014, EUR HEART J, V35, P1275, DOI 10.1093/eurheartj/ehu062; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Chen XH, 2007, J CARD FAIL, V13, P874, DOI 10.1016/j.cardfail.2007.07.004; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Clifford MD, PLOS ONE, V4; CUEVAS P, 1991, SCIENCE, V254, P1208, DOI 10.1126/science.1957172; Cuevas P, 1997, GROWTH FACTORS, V15, P29, DOI 10.3109/08977199709002110; ENTMAN ML, 1994, CARDIOVASC RES, V28, P1301, DOI 10.1093/cvr/28.9.1301; Fernandes JL, 2008, ATHEROSCLEROSIS, V196, P434, DOI 10.1016/j.atherosclerosis.2006.11.032; FRANCO WP, 1980, ANN INTERN MED, V93, P637, DOI 10.7326/0003-4819-93-4-637; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Karpov RS, 2005, B EXP BIOL MED+, V140, P640, DOI 10.1007/s10517-006-0043-1; KLUGE A, 1995, CARDIOVASC RES, V29, P407, DOI 10.1016/S0008-6363(96)88599-3; Madonna R, 2016, EUR HEART J, V37, P1789, DOI 10.1093/eurheartj/ehw113; Ndrepepa G, 2009, JAMA-J AM MED ASSOC, V301, P487, DOI 10.1001/jama.2009.32; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Ridker P, 2000, CIRCULATION, V101, P329; Rybov VV, 2006, THERAPEUTIC ARCH, V78, P47; Sato K, 2000, ANN THORAC SURG, V70, P2113, DOI 10.1016/S0003-4975(00)02018-X; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Suslova TE, Pat., Patent No. 2292895; UCHIDA Y, 1995, AM HEART J, V130, P1182, DOI 10.1016/0002-8703(95)90140-X; UNGER EF, 1994, AM J PHYSIOL, V266, pH1588, DOI 10.1152/ajpheart.1994.266.4.H1588; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Yousef M, 2009, J AM COLL CARDIOL, V53, P2262, DOI 10.1016/j.jacc.2009.02.051	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0176900	10.1371/Journal.pone.0176900	http://dx.doi.org/10.1371/Journal.pone.0176900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558042	Green Submitted, gold, Green Published			2022-12-26	WOS:000402607000005
J	Khatua, S; Dutta, AK; Chandra, S; Paloi, S; Das, K; Acharya, K				Khatua, Somanjana; Dutta, Arun Kumar; Chandra, Swarnendu; Paloi, Soumitra; Das, Kanad; Acharya, Krishnendu			Introducing a novel mushroom from mycophagy community with emphasis on biomedical potency	PLOS ONE			English	Article							WATER-SOLUBLE POLYSACCHARIDES; CHEMICAL-CHARACTERIZATION; IMMUNOMODULATING ACTIVITY; ANTIOXIDATIVE ACTIVITIES; ANTIMICROBIAL ACTIVITY; PLEUROTUS-OSTREATUS; EASTERN HIMALAYA; EXTRACTION; RUSSULA; PURIFICATION	Mushrooms have been prized by humankind as medicine and culinary wonder since antiquity. Though several species are ethnically valued; many prospective species are still being discovered. One such wild macrofungus has recently been discovered during subsequent field surveys in West Bengal, India which in turn exposed as a traditionally consumed popular myco-food. The collected taxon was found to be unique with regard to its morphological as well as genetical features. After detailed characterizations, the fungus was identified as a novel taxon belonging to the genus Russula (Russulaceae, Basidiomycota). Besides, the investigation was further extended in search of new functional ingredients and in this context, a water soluble crude polysaccharide rich extract (Rusalan) was isolated from dried basidiocarps. Accumulating evidences from GC-MS, HPTLC, FT-IR along with several spectrophotometric methods postulated that the fraction consisted mainly of carbohydrate in triple helical conformation, where glucose was the major monosaccharide mostly with ss-type glycosidic linkage. Conversely, Rusalan showed pronounced antioxidant activity in six in vitro assay systems with EC50 value ranging from 190-1328 mu g/ml concentration. The crude polysaccharide was also evaluated against six bacterial strains using microdilution method and the growth of Staphylococcus aureus and Bacillus subtilis were found to be inhibited effectively. In addition, immune-stimulatory assays demonstrated that Rusalan could evidently promote proliferation, induce phagocytosis, release NO, produce intracellular ROS and upregulate mRNA expression of iNOS, TNF-alpha, COX-2, as well as IL-6 genes in in mouse macrophage cells. Therefore, aim of the present study was not only to describe a new taxon to the world mycoflora but also to introduce a potent therapeutic agent that could be explored for food and pharmaceutical purposes. However, isolation of active component and in vivo studies need to be designed further.	[Khatua, Somanjana; Dutta, Arun Kumar; Chandra, Swarnendu; Paloi, Soumitra; Acharya, Krishnendu] Univ Calcutta, Ctr Adv Study, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India; [Das, Kanad] Bot Survey India, Cryptogam Unit, Howrah, India	University of Calcutta; Botanical Survey of India (BSI)	Acharya, K (corresponding author), Univ Calcutta, Ctr Adv Study, Dept Bot, Mol & Appl Mycol & Plant Pathol Lab, Kolkata, W Bengal, India.	krish_paper@yahoo.com	Dutta, Arun Kumar/AAH-2797-2020; Acharya, Krishnendu/G-2317-2012; Khatua, Somanjana/AAR-9068-2021; Paloi, Soumitra/R-1519-2019	Dutta, Arun Kumar/0000-0001-5234-3441; Acharya, Krishnendu/0000-0003-1193-1823; Khatua, Somanjana/0000-0003-1752-5754; PALOI, SOUMITRA/0000-0003-3980-9168				Alves MJ, 2012, J APPL MICROBIOL, V113, P466, DOI 10.1111/j.1365-2672.2012.05347.x; Alves MJ, 2012, PLANTA MED, V78, P1707, DOI 10.1055/s-0032-1315370; [Anonymous], 2007, MEDICINA, V43, P597; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bayar N, 2016, INT J BIOL MACROMOL, V92, P441, DOI 10.1016/j.ijbiomac.2016.07.042; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buyck B, 2008, FUNGAL DIVERS, V28, P15; Buyck B., 1989, BULL SOC MYCOL FR, V105, P1; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Chatterjee A, 2013, GLYCOCONJUGATE J, V30, P759, DOI 10.1007/s10719-013-9479-5; Das K., 2005, RUSSULACEAE KUMAON H; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Dong HM, 2016, INT J BIOL MACROMOL, V93, P179, DOI 10.1016/j.ijbiomac.2016.08.074; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Dutta AK, 2015, TURK J BOT, V39, P850, DOI 10.3906/bot-1407-1; Ekanayake PM, 2005, J FOOD LIPIDS, V12, P34, DOI 10.1111/j.1745-4522.2005.00004.x; El Enshasy HA, 2013, TRENDS BIOTECHNOL, V31, P668, DOI 10.1016/j.tibtech.2013.09.003; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; GEYER CJ, 1991, COMPUTING SCIENCE AND STATISTICS, P156; Guan Di, 2011, International Journal of Biology, V3, P3; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; He JZ, 2012, MOLECULES, V17, P4373, DOI 10.3390/molecules17044373; He JZ, 2010, CHINESE J ANAL CHEM, V38, P372, DOI 10.3724/SP.J.1096.2010.00372; Hou Y, 2013, INDIAN J PHARM SCI, V75, P393, DOI 10.4103/0250-474X.119809; Hrudayanath Thatoi, 2014, African Journal of Biotechnology, V13, P523; Hsieh PW, 2013, BIOMEDICINE-TAIWAN, V3, P106, DOI 10.1016/j.biomed.2013.01.002; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jayakumar T, 2011, FOOD RES INT, V44, P851, DOI 10.1016/j.foodres.2011.03.015; Khatua S., 2013, RES J PHARM TECHNOLO, V6, P496; Khatua S, 2016, J FOOD SCI TECH MYS, V53, P1878, DOI 10.1007/s13197-015-2145-0; Kim EJ, 2015, KOREAN J PHYSIOL PHA, V19, P211, DOI 10.4196/kjpp.2015.19.3.211; Klaus A, 2011, LWT-FOOD SCI TECHNOL, V44, P2005, DOI 10.1016/j.lwt.2011.05.010; KORNERUP A., 1967, Methuen handbook of colour.; Kozarski M, 2012, J FOOD COMPOS ANAL, V26, P144, DOI 10.1016/j.jfca.2012.02.004; Lee JS, 2013, INT IMMUNOPHARMACOL, V17, P858, DOI 10.1016/j.intimp.2013.09.019; Lima CUJO, 2016, REV BRAS FARMACOGN, V26, P780, DOI 10.1016/j.bjp.2016.05.013; Martinez CA, 2001, PLANT SCI, V160, P505, DOI 10.1016/S0168-9452(00)00418-0; Menaga D, 2012, INT J CHEM PHARM SCI, V3, P1; Mitra P., 2013, ASIAN J PHARM CLIN R, V6, P67; Nandi AK, 2014, CARBOHYD POLYM, V99, P774, DOI 10.1016/j.carbpol.2013.09.016; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Palacios I, 2012, CARBOHYD RES, V358, P72, DOI 10.1016/j.carres.2012.06.016; Paloi S, 2016, PHYTOTAXA, V252, P123, DOI 10.11646/phytotaxa.252.2.4; Paloi S, 2015, PHYTOTAXA, V234, P255, DOI 10.11646/phytotaxa.234.3.6; Paterson R Russell M, 2014, Biomed J, V37, P357, DOI 10.4103/2319-4170.143502; Preethi S, 2016, INT J BIOL MACROMOL, V92, P347, DOI 10.1016/j.ijbiomac.2016.07.036; Prieto P, 1999, ANAL BIOCHEM, V269, P337, DOI 10.1006/abio.1999.4019; Qiu T, 2013, CARBOHYD POLYM, V98, P922, DOI 10.1016/j.carbpol.2013.07.014; Razali FN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108988; Romagnesi H., 1967, LES RUSSULES DEUROPE; Ruthes AC, 2015, CARBOHYD POLYM, V117, P753, DOI 10.1016/j.carbpol.2014.10.051; Saini SS, 1989, INDIAN J MYCOL PL PA, V19, P44; Sarnari M., 1994, BOLLETTINO DELLASSOC, V33, P3; Sarnari M, 1998, MONOGRAFIA ILLUSTRAT; Sarnari M, 2005, MONOGRAFI ILLUSTRATA, V2; Shi JJ, 2016, INT J BIOL MACROMOL, V91, P23, DOI 10.1016/j.ijbiomac.2016.05.082; Stojkovic D, 2013, FOOD RES INT, V53, P56, DOI 10.1016/j.foodres.2013.03.046; Subarna Saha, 2013, International Journal of Green Pharmacy, V7, P182; Sun H, 2017, RES VET SCI, V110, P22, DOI 10.1016/j.rvsc.2016.10.015; Sun ZW, 2010, FOOD CHEM, V118, P675, DOI 10.1016/j.foodchem.2009.05.036; Synytsya A, 2009, CARBOHYD POLYM, V76, P548, DOI 10.1016/j.carbpol.2008.11.021; Tabarsa M, 2013, INT J BIOL MACROMOL, V59, P1, DOI 10.1016/j.ijbiomac.2013.04.022; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096786; Vlatka P, 2010, CONSPEC SCI, V75, P149; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wang M, 2017, CARBOHYD POLYM, V156, P390, DOI 10.1016/j.carbpol.2016.09.033; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yayeh T, 2012, J NAT MED-TOKYO, V66, P49, DOI 10.1007/s11418-011-0552-8; Zhang QH, 2016, INT J BIOL MACROMOL, V93, P459, DOI 10.1016/j.ijbiomac.2016.08.052	72	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178050	10.1371/journal.pone.0178050	http://dx.doi.org/10.1371/journal.pone.0178050			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552988	gold, Green Published, Green Submitted			2022-12-26	WOS:000402063000019
J	Paulsen, O; Laird, B; Aass, N; Lea, T; Fayers, P; Kaasa, S; Klepstad, P				Paulsen, Ornulf; Laird, Barry; Aass, Nina; Lea, Tor; Fayers, Peter; Kaasa, Stein; Klepstad, Pal			The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DOUBLE-BLIND; SYMPTOM CLUSTERS; CHEMORADIATION THERAPY; PANCREATIC-CANCER; CASTLEMAN-DISEASE; NEUROPATHIC PAIN; CONTROLLED-TRIAL; CLINICAL-TRIALS	Background Systemic inflammation is associated with reduced quality of life and increased symptoms in patients with advanced cancer. The aims of this study were to examine the relationships between inflammatory biomarkers and the Patient Reported Outcome Measures (PROMs) of pain, appetite and fatigue; and to explore whether levels of baseline biomarkers were associated with changes in these PROMs following treatment with corticosteroids. Material and methods An exploratory analysis was done on a trial examining the analgesic properties of corticosteroids in patients with advanced cancer. Inclusion criteria were: > 18 years, taking opioids for moderate or severe cancer pain; pain >= 4 (numerical rating scale 0-10). Serum was extracted and levels of inflammatory biomarkers were assessed. PROMs of pain, appetite and fatigue were assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30). The relationships between PROMs and inflammatory biomarkers were examined using Spearman Rho-Rank and multiple regression analysis. Results Data were available on 49 patients. Levels of sTNF-r1, IL-6, IL-18, MIF, MCP-1, TGF-beta 1, IL-1ra, and C-reactive protein (CRP) and Erythrocyte sedimentation rate (ESR) were elevated; IL-1 beta, IL-2, IL-4, IL-8, IL-10, IL-12(p70), interferon-gamma, MIP-1 alpha, and TNF-alpha were below the level of detection. The following correlations were observed: appetite and IL-6 and CRP; fatigue and IL-1ra (r(s): 0.38-0.41, p<.01). There was no association between pretreatment biomarkers and effect from corticosteroid treatment. Conclusion In patients with advanced cancer and pain, some pro-inflammatory cytokines were related to appetite and fatigue. Inflammatory biomarkers were not associated with pain or with the efficacy of corticosteroid therapy. Further research examining the attenuation of the systemic inflammatory response and possible effects on symptoms would be of interest.	[Paulsen, Ornulf; Laird, Barry; Fayers, Peter; Kaasa, Stein; Klepstad, Pal] Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr, Dept Canc Res & Mol Med, Trondheim, Norway; [Paulsen, Ornulf] Telemark Hosp Trust, Palliat Care Unit, Skien, Norway; [Laird, Barry] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Aass, Nina; Kaasa, Stein] Univ Oslo, Fac Med, Oslo, Norway; [Aass, Nina; Kaasa, Stein] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Lea, Tor] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Fayers, Peter] Univ Aberdeen, Dept Publ Hlth, Aberdeen, Scotland; [Klepstad, Pal] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Klepstad, Pal] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Anesthesiol & Intens Care Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Telemark Hospital Trust; University of Edinburgh; University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Aberdeen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Paulsen, O (corresponding author), Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr, Dept Canc Res & Mol Med, Trondheim, Norway.; Paulsen, O (corresponding author), Telemark Hosp Trust, Palliat Care Unit, Skien, Norway.	ornulf.paulsen@sthf.no		Fayers, Peter/0000-0003-4778-1513; Paulsen, Ornulf/0000-0002-2508-9289	Telemark Hospital Trust; South-Eastern Norway Regional Health Authority	Telemark Hospital Trust; South-Eastern Norway Regional Health Authority	This work was funded by unrestricted grants from the Telemark Hospital Trust and the South-Eastern Norway Regional Health Authority, and is a part of Ornulf Paulsen's PhD project.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Al-Hashimi M, 2013, BRIT J ANAESTH, V111, P80, DOI 10.1093/bja/aet153; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Barnes PJ, 2006, EUR RESPIR J, V27, P413, DOI 10.1183/09031936.06.00125404; Boland JW, 2014, BRIT J CANCER, V111, P866, DOI 10.1038/bjc.2014.384; Breitbart W, 2014, PSYCHO-ONCOLOGY, V23, P339, DOI 10.1002/pon.3422; BRUERA E, 1985, CANCER TREAT REP, V69, P751; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Cleeland CS, 2003, CANCER-AM CANCER SOC, V97, P2919, DOI 10.1002/cncr.11382; Davis MP, 2004, J CLIN ONCOL, V22, P1510, DOI 10.1200/JCO.2004.03.103; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; de Raaf PJ, 2013, J CLIN ONCOL, V31, P3056, DOI 10.1200/JCO.2013.49.3403; de Raaf PJ, 2012, J PAIN SYMPTOM MANAG, V44, P823, DOI 10.1016/j.jpainsymman.2011.12.279; de Raaf PJ, 2012, CANCER-AM CANCER SOC, V118, P6005, DOI 10.1002/cncr.27613; Dong ST, 2016, J PAIN SYMPTOM MANAG, V51, P88, DOI 10.1016/j.jpainsymman.2015.07.013; Dong ST, 2014, J PAIN SYMPTOM MANAG, V48, P411, DOI 10.1016/j.jpainsymman.2013.10.027; Du YJ, 2013, PROG NEURO-PSYCHOPH, V47, P69, DOI 10.1016/j.pnpbp.2013.08.004; El-Osta H, 2010, MOL CANCER THER, V9, P1485, DOI 10.1158/1535-7163.MCT-10-0156; Fayers PM, EORTC QLQ C30 SCORIN; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Haywood A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010756.pub2; Heitzer E, 2012, PAIN PHYSICIAN, V15, P499; Hu JH, 2012, NEUROSCI LETT, V517, P60, DOI 10.1016/j.neulet.2012.04.026; Hurwitz HI, 2015, J CLIN ONCOL, V33, P4039, DOI 10.1200/JCO.2015.61.4578; Inagaki M, 2008, J PAIN SYMPTOM MANAG, V35, P153, DOI 10.1016/j.jpainsymman.2007.03.009; Jatoi Aminah, 2007, J Support Oncol, V5, P41; Jatoi A, 2010, SUPPORT CARE CANCER, V18, P1299, DOI 10.1007/s00520-009-0748-6; Kaasa S, 1995, EUR J CANCER, V31A, P2260, DOI 10.1016/0959-8049(95)00296-0; Knobel H, 2003, PALLIATIVE MED, V17, P664, DOI 10.1191/0269216303pm841oa; Kurzrock R, 2013, CLIN CANCER RES, V19, P3659, DOI 10.1158/1078-0432.CCR-12-3349; Laird BJ, 2013, ONCOLOGIST, V18, P1050, DOI 10.1634/theoncologist.2013-0120; Laird BJA, 2011, J PAIN SYMPTOM MANAG, V42, P1, DOI 10.1016/j.jpainsymman.2010.10.261; Laird BJA, 2011, PAIN, V152, P460, DOI 10.1016/j.pain.2010.10.035; Laird BJ, 2016, J CLIN ONCOLOGY OFFI; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Lundstrom SH, 2006, ACTA ONCOL, V45, P430, DOI 10.1080/02841860500401167; Makimura C, 2011, ANTICANCER RES, V31, P4561; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Miller AH, 2008, J CLIN ONCOL, V26, P971, DOI 10.1200/JCO.2007.10.7805; Miller S, 2014, J PALLIAT MED, V17, P482, DOI 10.1089/jpm.2013.0324; Minton O, 2012, J PAIN SYMPTOM MANAG, V43, P226, DOI 10.1016/j.jpainsymman.2011.03.025; NCCN, 2016, CANC REL FAT; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Norheim KB, 2012, PLOS ONE, V7, P429, DOI 10.1371/journal.pone.0030123; Omdal R, 2005, RHEUMATOL INT, V25, P481, DOI 10.1007/s00296-004-0463-z; Paiva CE, 2013, SUPPORT CARE CANCER, V21, P1053, DOI 10.1007/s00520-012-1625-2; Paulsen O, 2014, J CLIN ONCOL, V32, P3221, DOI 10.1200/JCO.2013.54.3926; Pevida M, 2014, CELL MOL NEUROBIOL, V34, P143, DOI 10.1007/s10571-013-9995-7; Rausch SM, 2010, CANCER-AM CANCER SOC, V116, P4103, DOI 10.1002/cncr.25255; Reyes-Gibby CC, 2013, J PAIN SYMPTOM MANAG, V46, P161, DOI 10.1016/j.jpainsymman.2012.07.019; Roerink ME, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0971-z; Roxburgh CSD, 2014, BRIT J CANCER, V110, P1409, DOI 10.1038/bjc.2014.90; Saligan LN, 2012, BRAIN BEHAV IMMUN, V26, P830, DOI 10.1016/j.bbi.2012.05.004; Saligan LN, 2015, SUPPORT CARE CANCER, V23, P2461, DOI 10.1007/s00520-015-2763-0; Scheede-Bergdahl C, 2012, CLIN NUTR, V31, P85, DOI 10.1016/j.clnu.2011.07.010; Schimmer BP, 2011, GOODMAN GILMANS PHAR, V12th; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Slotkin JR, 2016, SPINE, V41, pE441, DOI 10.1097/BRS.0000000000001309; Tanaka T, 2004, NEUROSCI RES, V48, P463, DOI 10.1016/j.neures.2004.01.004; Wang XS, 2012, BRAIN BEHAV IMMUN, V26, P699, DOI 10.1016/j.bbi.2011.12.007; Wang XS, 2010, BRAIN BEHAV IMMUN, V24, P968, DOI 10.1016/j.bbi.2010.03.009; Yennurajalingam S, 2016, ONCOLOGIST, V21, P384, DOI 10.1634/theoncologist.2014-0260; Yennurajalingam S, 2013, J CLIN ONCOL, V31, P3076, DOI 10.1200/JCO.2012.44.4661	66	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177620	10.1371/journal.pone.0177620	http://dx.doi.org/10.1371/journal.pone.0177620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542626	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000402062800019
J	Clarke, B; Mahapatra, M; Friedgut, O; Bumbarov, V; Parida, S				Clarke, Brian; Mahapatra, Mana; Friedgut, Orly; Bumbarov, Velizar; Parida, Satya			Persistence of Lineage IV Peste-des-petits ruminants virus within Israel since 1993: An evolutionary perspective	PLOS ONE			English	Article							LUMPY SKIN-DISEASE; GENETIC-CHARACTERIZATION; GOATS; EPIDEMIOLOGY; DYNAMICS; SEQUENCE; SHEEP; RINDERPEST; INFECTION; SULTANATE	Peste-des-petits ruminants (PPR) is one of the most important infectious diseases of domesticated small ruminants. From the initial identification in 1942 in West Africa, PPR virus (PPRV) has spread throughout much of the developing world. PPRV is now considered endemic throughout Africa, with the notable exception of South Africa, the Middle-East and Israel, as well as South-, East-, and Central Asia. Despite this widespread dispersal, the evolution and transmission of PPRV in endemic populations is not well understood. This understanding will be critical in the planning of rational measures to eradicate PPRV by the planned time as defined by the FAO and OIE. To further advance the understanding of the evolution of PPRV the full genome sequence of 18 viruses isolated from Israel from consecutive years between 1997-2014 were generated. This data set is unique and crucial for the understanding of the evolution of PPRV, as it represents the first set of full-length sequence data available from consecutive years from a single geographic location. Analysis of these full genome sequences shows 96.2-99.9% nucleotide conservation across the Israel isolates and further demonstrates the strong purifying selection pressures on PPRV within Israel and globally. Four amino acid substitutions indicative of putative positive selection were additionally identified within the Israel isolates. The mean substitution rate per site per year was estimated to be 9.22 x 10(-4) (95% HPD 6.206 x 10-4-1.26 x 10(-3)). Using Bayesian and phylogenetic analyses we further demonstrate that the PPRV isolates from Israel belongs to linage IV and form a single strong regional cluster within all other lineage IV viruses circulating worldwide implying a single incursion into Israel.	[Clarke, Brian; Mahapatra, Mana; Parida, Satya] Pirbright Inst, Woking, Surrey, England; [Friedgut, Orly; Bumbarov, Velizar] Kimron Vet Inst, Rishon Leziyyon, Israel	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Kimron Veterinary Institute	Parida, S (corresponding author), Pirbright Inst, Woking, Surrey, England.	satya.parida@pirbright.ac.uk	Parida, Satya/E-5463-2015	Parida, Satya/0000-0001-8253-9461; Mahapatra, Mana/0000-0002-3977-1465; Clarke, Brian/0000-0001-8447-0381	Biotechnology and Biological Sciences Research Council; European Commission ANIHWA ERA first call fund [BB/L013657/1]; DBT-BBSRC FADH [BB/L004801/1]; BBSRC [BB/L013657/1, BB/L004801/1, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007035, BBS/E/I/00007036] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L013657/1, BBS/E/I/00007035, BBS/E/I/00007037, BBS/E/I/00007036, BB/L004801/1, BBS/E/I/00007031] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission ANIHWA ERA first call fund; DBT-BBSRC FADH(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Biotechnology and Biological Sciences Research Council, and the European Commission ANIHWA ERA first call fund for providing support for PPRV research under the IUEPPR project led by the Pirbright Institute (BB/L013657/1) as well as the DBT-BBSRC FADH grant (BB/L004801/1). Funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Biotechnology and Biological Sciences Research Council, and the European Commission ANIHWA ERA first call fund for providing support for PPRV research under the IUEPPR project led by the Pirbright Institute (BB/L013657/1) as well as the DBT-BBSRC FADH grant (BB/L004801/1).	Abd El-Rahim IHAA, 2010, REV SCI TECH OIE, V29, P655, DOI 10.20506/rst.29.3.2004; Abubakar M, 2011, TRANSBOUND EMERG DIS, V58, P152, DOI 10.1111/j.1865-1682.2010.01193.x; Adombi CM, 2011, J VIROL METHODS, V173, P306, DOI 10.1016/j.jviromet.2011.02.024; al-Mughrabi N, UNDERGROUND CATTLE T; Alkhamis MA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00019; Balamurugan V, 2012, J VET SCI, V13, P203, DOI 10.4142/jvs.2012.13.2.203; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2012, J VIROL, V86, P10885, DOI 10.1128/JVI.01503-12; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Ben-Gera J, 2015, VACCINE, V33, P4837, DOI 10.1016/j.vaccine.2015.07.071; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Bouslikhare M., 2015, CROSS BORDER MOVEMEN; BUNDZA A, 1988, CAN J VET RES, V52, P46; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fakri F, 2016, VET MICROBIOL, V197, P137, DOI 10.1016/j.vetmic.2016.11.006; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; Friedgut O, 2011, ISR J VET MED, V66, P65; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; Galon N, 2017, PROMED MAIL     0110; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; HEDGER RS, 1980, TROP ANIM HEALTH PRO, V12, P107, DOI 10.1007/BF02242618; Kahle D, 2013, R J, V5; Kgotlele T, 2014, TRANSBOUND EMERG DIS, V61, P56, DOI 10.1111/tbed.12229; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kock RA, 2015, TRANSBOUND EMERG DIS, V62, P470, DOI 10.1111/tbed.12398; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Leibovich H, 2015, SHEEP GOAT IND ISRAE; Lembo T, 2013, EMERG INFECT DIS, V19, P2037, DOI 10.3201/eid1912.130973; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Maganga GD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-82; Mahapatra M, 2003, VIRUS RES, V96, P85, DOI 10.1016/S0168-1702(03)00176-X; Mahapatra M, 2015, EMERG INFECT DIS, V21, P2230, DOI 10.3201/eid2112.150223; Mariner JC, 2016, J IMMUNOL, V196, P3499, DOI 10.4049/jimmunol.1502625; MORNET P., 1956, Revue de l'Elevage. Productions animales - Productions fourrageres, V9, P313; Muniraju M, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01023-14; Muniraju M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00096-13; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Ozkul A, 2002, EMERG INFECT DIS, V8, P708; Padhi A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07040; Parida S, 2015, VET MICROBIOL, V181, P90, DOI 10.1016/j.vetmic.2015.08.009; Parida S, 2016, SMALL RUMIN IN PRESS; Perl S., 1994, Israel Journal of Veterinary Medicine, V49, P59; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR WP, 1990, VET MICROBIOL, V22, P341, DOI 10.1016/0378-1135(90)90021-M; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817; Wertheim JO, 2011, MOL BIOL EVOL, V28, P3355, DOI 10.1093/molbev/msr170	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177028	10.1371/journal.pone.0177028	http://dx.doi.org/10.1371/journal.pone.0177028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545149	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400020
J	Giebeler, N; Schonefuss, A; Landsberg, J; Tuting, T; Mauch, C; Zigrino, P				Giebeler, N.; Schoenefuss, A.; Landsberg, J.; Tuting, T.; Mauch, C.; Zigrino, P.			Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; INCREASED EXPRESSION; CELL-MIGRATION; CANCER-CELL; IN-VITRO; TUMOR; INVASION; METALLOPROTEINASES; PROLIFERATION; ABNORMALITIES	ADAM-9 is a metalloproteinase expressed in peritumoral areas by invading melanoma cells and by adjacent peritumoral stromal cells; however, its function in stromal and melanoma cells is not fully understood. To address this question in vivo in a spontaneous melanoma model, we deleted ADAM-9 in mice carrying the hepatocyte growth factor (Hgf) transgene and knock-in mutation Cdk4(R24C/R24C), demonstrated to spontaneously develop melanoma. Spontaneous melanoma arose less frequently in ADAM-9-deleted mice than in controls. Similarly reduced tumor numbers (although with faster growth kinetics) were detected upon induction of melanoma with 7,12-dimethylbenz[a]anthracene (DMBA). However, more lesions were induced at early time points in the absence of ADAM-9. Increased initial and decreased late tumor numbers were paralleled by altered tumor cell proliferation, but not apoptosis or inflammation. Importantly, significantly reduced lung metastases were detected upon ADAM-9 deletion. Using in vitro assays to address this effect mechanistically, we detected reduced adhesion and transmigration of ADAM-9-silenced melanoma cells to/through the endothelium. This implies that ADAM-9 functionally and cell autonomously mediates extravasation of melanoma cells. In vitro and in vivo we demonstrated that the basement membrane (BM) component laminin beta 3-chain is a direct substrate of ADAM-9, thus contributing to destabilization and disruption of the BM barrier during invasion. In in vitro invasion assays using human melanoma cells and skin equivalents, depletion of ADAM-9 resulted in decreased invasion of the BM, which remained almost completely intact, as shown by continuous staining for laminin beta 3-chain. Importantly, supplying soluble ADAM-9 to the system reversed this effect. Taken together, our data show that melanoma derived ADAM-9 autonomously contributes to melanoma progression by modulating cell adhesion to the endothelium and altering BM integrity by proteolytically processing the laminin-beta 3 chain. This newly described process and ADAM-9 itself may represent potential targets for anti-tumor therapies.	[Giebeler, N.; Schoenefuss, A.; Mauch, C.; Zigrino, P.] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany; [Landsberg, J.] Univ Bonn, Dept Dermatol & Allergol, Bonn, Germany; [Tuting, T.] Univ Magdeburg, Dept Dermatol, Magdeburg, Germany	University of Cologne; University of Bonn; Otto von Guericke University	Zigrino, P (corresponding author), Univ Cologne, Dept Dermatol, NRW, Kerpener Str 62, D-50937 Cologne, Germany.	paola.zigrino@uni-koeln.de	Landsberg, Jennifer/AAF-5113-2019; Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Zigrino, Paola/0000-0002-7470-0064	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund); Deutsche Forschungsgemeinschaft [SFB829]; Koln Fortune Program of the University of Cologne	Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune Program of the University of Cologne	We thank Prof Manuel Koch, Department of Biochemistry, University of Cologne for kindly providing the laminin beta 3 antibody and recombinant laminin beta 3-chain. We thank Jan Zamek, Claudia Coerper-Ochsman and Nina Ruers for excellent technical assistance. This work was supported by the Melanoma Research Network of the Deutsche Krebshilfe (Melanoma Verbund), by the Deutsche Forschungsgemeinschaft through the SFB829 (B4) and by Koln Fortune Program of the University of Cologne.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Abety AN, 2012, J INVEST DERMATOL, V132, P2451, DOI 10.1038/jid.2012.153; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Chen CM, 2015, TUMOR BIOL, V36, P3407, DOI 10.1007/s13277-014-2975-9; Dennhofer R, 2003, INT J CANCER, V106, P316, DOI 10.1002/ijc.11255; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Landsberg J, 2010, PIGM CELL MELANOMA R, V23, P649, DOI 10.1111/j.1755-148X.2010.00744.x; Leiter U, 2004, J SURG ONCOL, V86, P172, DOI 10.1002/jso.20079; Lin CY, 2014, CANCER RES, V74, P5229, DOI 10.1158/0008-5472.CAN-13-2995; Mammadova-Bach E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88245; McAteer MA, 2008, ARTERIOSCL THROM VAS, V28, P77, DOI 10.1161/ATVBAHA.107.145466; Micocci KC, 2016, BIOCHIMIE, V128, P174, DOI 10.1016/j.biochi.2016.08.006; Mongaret C, 2011, INT J CANCER, V129, P791, DOI 10.1002/ijc.25746; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nath D, 2000, J CELL SCI, V113, P2319; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; Rocks N, 2008, BIOCHIMIE, V90, P369, DOI 10.1016/j.biochi.2007.08.008; Sarkar S, 2015, NEURO-ONCOLOGY, V17, P1095, DOI 10.1093/neuonc/nou362; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076; Tao KS, 2010, JPN J CLIN ONCOL, V40, P645, DOI 10.1093/jjco/hyq030; Tormo D, 2006, AM J PATHOL, V169, P665, DOI 10.2353/ajpath.2006.060017; Tsuruta D, 2008, CURR MED CHEM, V15, P1968, DOI 10.2174/092986708785132834; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Udayakumar TS, 2003, CANCER RES, V63, P2292; Wan DW, 2016, ANTI-CANCER AGENT ME, V16, P414, DOI 10.2174/1871520615666150716105955; Wang CZ, 2015, INT J CLIN EXP PATHO, V8, P6547; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; WILLIAMS RL, 1988, CELL, V52, P121; Xu Q, 2010, TUMOR BIOL, V31, P217, DOI 10.1007/s13277-010-0034-8; Yamada D, 2007, ANTICANCER RES, V27, P793; Zhang CZ, 2015, INVEST NEW DRUG, V33, P1, DOI 10.1007/s10637-014-0156-8; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087; Zigrino P, 2011, J BIOL CHEM, V286, P6801, DOI 10.1074/jbc.M110.168617	41	9	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 31	2017	36	35					5058	5067		10.1038/onc.2017.162	http://dx.doi.org/10.1038/onc.2017.162			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FF3AV	28553955				2022-12-26	WOS:000408768800010
J	Moffett, AS; Bender, KW; Huber, SC; Shukla, D				Moffett, Alexander S.; Bender, Kyle W.; Huber, Steven C.; Shukla, Diwakar			Molecular dynamics simulations reveal the conformational dynamics of Arabidopsis thaliana BRI1 and BAK1 receptor-like kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; molecular dynamics; plant molecular biology; protein kinase; signal transduction; BAK1; BRI1; Markov state models	BRASSINOSTEROID SIGNALING NETWORK; ALPHA-C HELIX; PROTEIN-KINASES; TYROSINE PHOSPHORYLATION; COMPUTATIONAL MICROSCOPE; STRUCTURAL-ANALYSIS; INTRINSIC DISORDER; EGF RECEPTOR; FORCE-FIELDS; ACTIVATION	The structural motifs responsible for activation and regulation of eukaryotic protein kinases in animals have been studied extensively in recent years, and a coherent picture of their activation mechanisms has begun to emerge. In contrast, non-animal eukaryotic protein kinases are not as well understood from a structural perspective, representing a large knowledge gap. To this end, we investigated the conformational dynamics of two key Arabidopsis thaliana receptor-like kinases, brassinosteroid-insensitive 1 (BRI1) and BRI1-associated kinase 1 (BAK1), through extensive molecular dynamics simulations of their fully phosphorylated kinase domains. Molecular dynamics simulations calculate the motion of each atom in a protein based on classical approximations of interatomic forces, giving researchers insight into protein function at unparalleled spatial and temporal resolutions. We found that in an otherwise active BAK1 the C helix is highly disordered, a hallmark of deactivation, whereas the BRI1 C helix is moderately disordered and displays swinging behavior similar to numerous animal kinases. An analysis of all known sequences in the A. thaliana kinome found that C helix disorder may be a common feature of plant kinases.	[Moffett, Alexander S.; Shukla, Diwakar] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Bender, Kyle W.; Huber, Steven C.; Shukla, Diwakar] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Huber, Steven C.] ARS, USDA, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Shukla, D (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.; Shukla, D (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	diwakar@illinois.edu	Shukla, Diwakar/GRY-2518-2022; Bender, Kyle W/V-4678-2017; Bender, Kyle/AAJ-5993-2020; Huber, Steven/O-1664-2013	Shukla, Diwakar/0000-0003-4079-5381; Bender, Kyle W/0000-0002-1805-8097; Bender, Kyle/0000-0002-1805-8097; Huber, Steven/0000-0002-8562-0043; Moffett, Alexander/0000-0003-1631-2722	National Science Foundation [OCI-0725070, ACI-1238993]	National Science Foundation(National Science Foundation (NSF))	We thank the Blue Waters sustained petascale computing project, which is supported by National Science Foundation Awards OCI-0725070 and ACI-1238993, and the state of Illinois for providing computing time for this study.	Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Case D., 2015, AMBER, V14; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Endres NF, 2014, TRENDS BIOCHEM SCI, V39, P437, DOI 10.1016/j.tibs.2014.08.001; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Huang H, 2012, J PHYS CHEM B, V116, P4465, DOI 10.1021/jp301628r; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kathiriya JJ, 2014, MOL BIOSYST, V10, P2876, DOI 10.1039/c4mb00224e; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035; McGibbon RT, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916292; Metzner P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021106; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang WF, 2014, CURR OPIN PLANT BIOL, V21, P147, DOI 10.1016/j.pbi.2014.07.012; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wereszczynski J, 2012, METHODS MOL BIOL, V819, P515, DOI 10.1007/978-1-61779-465-0_30; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yan LM, 2012, CELL RES, V22, P1304, DOI 10.1038/cr.2012.74; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	66	29	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12643	12652		10.1074/jbc.M117.792762	http://dx.doi.org/10.1074/jbc.M117.792762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28559283	Green Published, hybrid			2022-12-26	WOS:000406636900028
J	Wagner, AL; Mubarak, MY; Johnson, LE; Porth, JM; Yousif, JE; Boulton, ML				Wagner, Abram L.; Mubarak, Mohammad Y.; Johnson, Laura E.; Porth, Julia M.; Yousif, Jenna E.; Boulton, Matthew L.			Trends of vaccine-preventable diseases in Afghanistan from the Disease Early Warning System, 2009-2015	PLOS ONE			English	Article							DIARRHEA; EPIDEMIOLOGY; KABUL; AREA	Background Afghanistan's public health system was neglected during decades of military and civil conflict, and trends in infectious disease occurrence remain poorly characterized. This study examines cyclical and long-term trends of six vaccine-preventable diseases: pneumonia, diarrhea, meningitis, typhoid, measles, and acute viral hepatitis. Methods Using weekly data collected between 2009 and 2015 through Afghanistan's Disease Early Warning System, we calculated monthly case counts, and fit a Poisson regression with a Fourier transformation for seasonal cycles and dummy variables for year. Results We found the greatest incidence of diarrhea and typhoid in the summer, pneumonia in the winter, and measles in the late spring. Meningitis and acute viral hepatitis did not demonstrate substantial seasonality. Rates of pneumonia and diarrhea were constant across years whereas rates of meningitis, typhoid, and acute viral hepatitis decreased. Measles incidence increased in 2015. Conclusions Communicable disease reporting systems can guide public health operations-such as the implementation of new vaccines, and permit evaluation of health interventions. For example, measles supplementary immunization activities in Afghanistan have not slowed long-term transmission of the disease, but decreases in typhoid fever and acute viral hepatitis are probably tied to improvements in sanitation in the country.	[Wagner, Abram L.; Johnson, Laura E.; Porth, Julia M.; Yousif, Jenna E.; Boulton, Matthew L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1415 Washington Hts, Ann Arbor, MI 48109 USA; [Mubarak, Mohammad Y.] Kabul Med Univ, Dept Microbiol, Kabul, Afghanistan; [Johnson, Laura E.; Boulton, Matthew L.] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Johnson, Laura E.; Boulton, Matthew L.] Univ Michigan, Sch Med, 1500 East Med Ctr Dr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1415 Washington Hts, Ann Arbor, MI 48109 USA.	awag@umich.edu	Mubarak, Mohammad Yousuf/GNW-6383-2022; Wagner, Abram/X-6379-2019; Mubarak, Mohammad Yousuf/AAM-2525-2021	Mubarak, Mohammad Yousuf/0000-0002-6983-6047; Wagner, Abram/0000-0003-4691-7802; Mubarak, Mohammad Yousuf/0000-0002-6983-6047; Boulton, Matthew/0000-0002-0565-9010; Porth, Julia/0000-0001-6407-5579	PhRMA Foundation; U.S. government Cooperative Biological Engagement Program; CRDF Global	PhRMA Foundation; U.S. government Cooperative Biological Engagement Program; CRDF Global	We are grateful to the health care workers who diligently submit reports of disease into the Disease Early Warning System in Afghanistan. ALW's salary was supported through a Health Outcomes Post Doctoral Fellowship from the PhRMA Foundation.; Publication of this study was funded through the U.S. government Cooperative Biological Engagement Program with support from CRDF Global [http://www.crdfglobal.org]. The content of the information does not necessarily reflect the position or the policy of the federal government, and no official endorsement should be inferred. ALW's salary was supported through a Health Outcomes Post Doctoral Fellowship from the PhRMA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P185; [Anonymous], 2012, Wkly Epidemiol Rec, V87; BHUTTA Z, 2007, BACKGROUND PAPER VAC; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Eick A, 2010, J INFECT DIS, V202, P1302, DOI 10.1086/656598; Elyan D, 2014, T ROY SOC TROP MED H, V108, P461, DOI 10.1093/trstmh/tru096; Fayaz N, 2013, CRISIS POPULATION GR; Hemat S, 2009, VACCINE, V27, P2823, DOI 10.1016/j.vaccine.2009.02.097; Ikram MS, 2014, GLOB PUBLIC HEALTH, V9, pS43, DOI 10.1080/17441692.2013.826708; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; MAJIDI NASSIM, 2014, J INTERNAL DISPLACEM, V4, P78; Ministry of Public Health, 2015, DIS EARL WARN SYST P; Ministry of Public Health, 2012, COMPR MULT PLAN NAT; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Mubarak MY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1789-3; Norwegian Refugee Council, 2012, AFGH CONFL DISPL DIS; Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514; Paireau J, 2016, LANCET GLOB HEALTH, V4, pE370, DOI 10.1016/S2214-109X(16)30064-X; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Riddle MS, 2005, MIL MED, V170, P492, DOI 10.7205/MILMED.170.6.492; Sanders JW, 2005, CURR OPIN GASTROEN, V21, P9; Thomas K, 2013, J CLIN EPIDEMIOL, V66, P36, DOI 10.1016/j.jclinepi.2012.04.006; United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD URB PROSP 2014; Varkey S, 2015, LANCET GLOB HEALTH, V3, pE13, DOI 10.1016/S2214-109X(14)70362-6; Wagner AL, 2016, INT J INFECT DIS, V45, P103, DOI 10.1016/j.ijid.2016.03.005; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; World Health Organization, 2016, WHO VACC PREV DIS MO; Zhang XY, 2016, INT J INFECT DIS, V48, P7, DOI 10.1016/j.ijid.2016.04.010	30	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178677	10.1371/journal.pone.0178677	http://dx.doi.org/10.1371/journal.pone.0178677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570694	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800099
J	Yang, XL; Li, HD; Sun, ZK				Yang, XiaoLi; Li, HuiDan; Sun, ZhongKui			Partial coupling delay induced multiple spatiotemporal orders in a modular neuronal network	PLOS ONE			English	Article							INDUCED REGIME SHIFTS; COHERENCE RESONANCE; CORRELATED NOISE; TIME DELAYS; SYNCHRONIZATION; CONNECTIVITY; ORGANIZATION; DYNAMICS; IMPACT	The influence of partial coupling delay on the spatiotemporal spiking dynamics is explored in a modular neuronal network. The modular neuronal network is composed of two subnetworks which present the small-world property and scale-free property, respectively. Numerical results show that spatiotemporal order that the modular network is most coherent in time and nearly synchronized in space can emerge intermittently when the coupling delays among neurons are appropriately tuned. The appropriately tuned delays are further detected to be integer multiples of the intrinsic spiking period of the modular neuronal network, which implies that the phenomenon of multiple spatiotemporal orders could be the result of a locking between the length of coupling delay and the intrinsic spiking period of the modular neuronal network. Moreover, the multiple spatiotemporal orders are verified to be robust against variations of the fraction of delayed connection as well as the key parameters of network architecture such as the rewiring probability, the average degree of small-world subnetwork, the initial nodes of scale-free subnetwork and the total size of the modular network.	[Yang, XiaoLi; Li, HuiDan] Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China; [Sun, ZhongKui] Northwestern Polytech Univ, Dept Appl Math, Xian, Peoples R China	Shaanxi Normal University; Northwestern Polytechnical University	Yang, XL (corresponding author), Shaanxi Normal Univ, Coll Math & Informat Sci, Xian, Peoples R China.	yangxiaoli@snnu.edu.cn			National Natural Science Foundation of China [11572180]; Fundamental Funds Research for the Central Universities [GK201602009, GK201701001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Funds Research for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is partially supported by the National Natural Science Foundation of China (Grant No. 11572180), the Fundamental Funds Research for the Central Universities (Grant No. GK201602009, GK201701001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partially supported by the National Natural Science Foundation of China (Grant No. 11572180), the Fundamental Funds Research for the Central Universities (Grant No. GK201602009, GK201701001).	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batista CAS, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.016211; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; Fusi S, 1999, NEURAL COMPUT, V11, P633, DOI 10.1162/089976699300016601; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Haken H., 1985, ADV SYNERGETICS; Han QL, 2014, PHYSICA A, V408, P96, DOI 10.1016/j.physa.2014.04.015; Hao YH, 2011, NEUROCOMPUTING, V74, P1748, DOI 10.1016/j.neucom.2011.02.005; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Jia YB, 2014, CHAOS, V24, DOI 10.1063/1.4904101; Kreuz T, 2007, NEUROCOMPUTING, V70, P1970, DOI 10.1016/j.neucom.2006.10.129; Kwon O, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066121; Li YY, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415501047; Liu C, 2013, CHAOS, V23, DOI 10.1063/1.4817607; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Nicolis G, 1977, SELF ORG NONEQUILIBR; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Rappel WJ, 1996, PHYS REV LETT, V77, P3256, DOI 10.1103/PhysRevLett.77.3256; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Sun XJ, 2016, ACTA PHYS SIN-CH ED, V65, DOI 10.7498/aps.65.120502; Sun XJ, 2011, CHAOS, V21, DOI 10.1063/1.3559136; Sun ZK, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061125; Tang Z, 2012, COMMUN THEOR PHYS, V57, P61, DOI 10.1088/0253-6102/57/1/10; Wang Q, 2015, NONLINEAR DYNAM, V81, P1689, DOI 10.1007/s11071-015-2099-9; Wang QY, 2012, COMMUN NONLINEAR SCI, V17, P3979, DOI 10.1016/j.cnsns.2012.02.019; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang XL, 2012, CHAOS, V22, DOI 10.1063/1.4772999; Yang XL, 2011, CHAOS, V21, DOI 10.1063/1.3629984; Yang XL, 2016, NONLINEAR DYNAM, V86, P1797, DOI 10.1007/s11071-016-2993-9; Yu HT, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052917; Yu HT, 2011, CHAOS, V21, DOI 10.1063/1.3620401; Zeng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19591; Zeng CH, 2015, ECOL COMPLEX, V22, P102, DOI 10.1016/j.ecocom.2015.02.005; Zeng CH, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/10/P10017; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025; Zeng JK, 2016, PHYSICA A, V462, P1273, DOI 10.1016/j.physa.2016.06.115; Zhou CS, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.098101	43	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0177918	10.1371/journal.pone.0177918	http://dx.doi.org/10.1371/journal.pone.0177918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570577	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800022
J	Hartz, A; Pagel, J; Humberg, A; Preuss, M; Schreiter, L; Rupp, J; Figge, J; Karsten, CM; Nurnberg, P; Herting, E; Gopel, W; Hartel, C				Hartz, Annika; Pagel, Julia; Humberg, Alexander; Preuss, Michael; Schreiter, Lena; Rupp, Jan; Figge, Julia; Karsten, Christian M.; Nuernberg, Peter; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph		German Neonatal Network GNN	The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants	PLOS ONE			English	Article							COMPLEMENT; PATHWAY; MBL; INFECTION; NEWBORNS; CHILDREN; FICOLIN; SEPSIS; GENE	Objectives Studies on the influence of mannose-binding lectin (MBL) deficiency on infection susceptibility in preterm infants have yielded controversial results. We investigated the association of genotype-based MBL levels with outcome in very-low-birth weight infants (VLBWI). Methods We genotyped 3 genetic variants of MBL2 (rs1800450, rs1800451, rs5030737) in 6878 VLBWI. MBL plasma levels were categorized as normal (wild type, A/A), low (heterozygotes, A/O) or undetectable (homozygotes, O/O). Primary outcome was the effect of genotype-based MBL2 levels on blood-culture proven and clinical sepsis during primary stay in hospital. We also evaluated burden of infection within 24 months after discharge. Results We found no association between MBL levels and sepsis risk in the whole cohort. Infants without measurable MBL levels born between 32 0/7 to 36 6/7 weeks of gestation, however, had a higher rate of Gram-negative sepsis than infants with normal or reduced MBL levels. In a follow-up investigation at 24 months (n = 1070 infants), infants without measurable MBL levels suffered more frequently from stomatitis and urinary tract infection. Conclusions In a large cohort of VLBWI MBL2 deficiency had no major impact on infection risk unless children were born between 32 0/7 and 36 6/7 weeks of gestation.	[Hartz, Annika; Pagel, Julia; Humberg, Alexander; Preuss, Michael; Schreiter, Lena; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph] Univ Hosp Lubeck, Dept Pediat, Lubeck, Germany; [Hartz, Annika; Schreiter, Lena; Figge, Julia; Karsten, Christian M.] Univ Hosp Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Pagel, Julia; Rupp, Jan] Univ Hosp Lubeck, Dept Infect Dis & Microbiol, Lubeck, Germany; [Preuss, Michael] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany; [Nuernberg, Peter] Cologne Ctr Genom, Cologne, Germany	University of Lubeck; University of Lubeck; University of Lubeck; University of Lubeck; University of Cologne	Hartz, A (corresponding author), Univ Hosp Lubeck, Dept Pediat, Lubeck, Germany.; Hartz, A (corresponding author), Univ Hosp Lubeck, Inst Syst Inflammat Res, Lubeck, Germany.	Annika.Hartz@uksh.de	Rupp, Jan/C-8794-2011; Härtel, Christoph/ABD-8841-2020	Rupp, Jan/0000-0001-8722-1233; Preuss, Michael/0000-0001-5266-8465	Deutsche Forschungsgemeinschaft [IRTG1911]; Bundesministerium fur Bildung und Forschung (German Ministry of Education and Research) [BMBF01ER0805, BMBF01ER1501]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	Deutsche Forschungsgemeinschaft http://www.dfg.de/ Grant for international research collaboration (IRTG1911, project MD/PhD2): AH, CH. Bundesministerium fur Bildung und Forschung (German Ministry of Education and Research) https://www.bmbf.de/ grant no. BMBF01ER0805 and BMBF01ER1501: WG, EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Frakking FNJ, 2006, CLIN EXP IMMUNOL, V145, P5, DOI 10.1111/j.1365-2249.2006.03093.x; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, J INFECT DIS, V188, P1394, DOI 10.1086/379044; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Israels J, 2010, ARCH DIS CHILD-FETAL, V95, pF452, DOI 10.1136/adc.2009.172122; McGreal EP, 2012, IMMUNOBIOLOGY, V217, P176, DOI 10.1016/j.imbio.2011.07.027; Neth O, 2001, LANCET, V358, P614, DOI 10.1016/S0140-6736(01)05776-2; Sallenbach S, 2011, PEDIAT ALLERG IMM-UK, V22, P424, DOI 10.1111/j.1399-3038.2010.01104.x; Schlapbach LJ, 2010, CLIN INFECT DIS, V51, P153, DOI 10.1086/653531; Schmitz R, 2011, DTSCH ARZTEBL INT, V108, P99, DOI 10.3238/arztebl.2011.0099; Seppanen M, 2009, HUM IMMUNOL, V70, P218, DOI 10.1016/j.humimm.2009.01.022; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Swierzko AS, 2009, MOL IMMUNOL, V46, P551, DOI 10.1016/j.molimm.2008.07.025; Takahashi K, 2011, EXPERT REV ANTI-INFE, V9, P1179, DOI [10.1586/ERI.11.136, 10.1586/eri.11.136]; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005	15	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178032	10.1371/journal.pone.0178032	http://dx.doi.org/10.1371/journal.pone.0178032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558032	gold, Green Published, Green Submitted			2022-12-26	WOS:000402607000024
J	Lehsten, V; Wiik, L; Hannukkala, A; Andreasson, E; Chen, DL; Ou, TH; Liljeroth, E; Lankinen, A; Grenville-Briggs, L				Lehsten, Veiko; Wiik, Lars; Hannukkala, Asko; Andreasson, Erik; Chen, Deliang; Ou, Tinghai; Liljeroth, Erland; Lankinen, Asa; Grenville-Briggs, Laura			Earlier occurrence and increased explanatory power of climate for the first incidence of potato late blight caused by Phytophthora infestans in Fennoscandia	PLOS ONE			English	Article							MULTIVARIATE DATA-ANALYSIS; HOST-RESISTANCE; FIELD TRIALS; MATING-TYPE; FINLAND; FAMINE; TEMPERATURE; FORECASTS; NORWAY; MODEL	Background Late blight (caused by Phytophthora infestans) is a devastating potato disease that has been found to occur earlier in the season over the last decades in Fennoscandia. Up until now the reasons for this change have not been investigated. Possible explanations for this change are climate alterations, changes in potato production or changes in pathogen biology, such as increased fitness or changes in gene flow within P. infestans populations. The first incidence of late blight is of high economic importance since fungicidal applications should be typically applied two weeks before the first signs of late blight and are repeated on average once a week. Methods We use field observations of first incidence of late blight in experimental potato fields from five sites in Sweden and Finland covering a total of 30 years and investigate whether the earlier incidence of late blight can be related to the climate. Results We linked the field data to meteorological data and found that the previous assumption, used in common late blight models, that the disease only develops at relative humidity levels above 90% had to be rejected. Rather than the typically assumed threshold relationship between late blight disease development and relative humidity we found a linear relationship. Our model furthermore showed two distinct responses of late blight to climate. At the beginning of the observation time (in Sweden until the early 90s and in Finland until the 2000s) the link between climate and first incidence was very weak. However, for the remainder of the time period the link was highly significant, indicating a change in the biological properties of the pathogen which could for example be a change in the dominating reproduction mode or a physiological change in the response of the pathogen to climate. Conclusions The study shows that models used in decision support systems need to be checked and re parametrized regularly to be able to capture changes in pathogen biology. While this study was performed with data from Fennoscandia this new pathogen biology and late blight might spread to (or already be present at) other parts of the world as well. The strong link between climate and first incidence together with the presented model offers a tool to assess late blight incidence in future climates.	[Lehsten, Veiko] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Lehsten, Veiko] Swiss Fed Inst Forest Snow & Landscape Res WSL, Dynam Macroecol Landscape dynam, Birmensdorf, Switzerland; [Wiik, Lars] Rural Econ & Agr Soc Scania, Dept Res & Dev, Kalmar, Sweden; [Hannukkala, Asko] Luke, Nat Resources Inst Finland, Management & Prod Renewable Resources, Jokioinen, Finland; [Andreasson, Erik; Liljeroth, Erland; Lankinen, Asa; Grenville-Briggs, Laura] Swedish Univ Agr Sci SLU, Dept Plant Protect Biol, Alnarp, Sweden; [Chen, Deliang; Ou, Tinghai] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden	Lund University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences; University of Gothenburg	Lehsten, V (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.; Lehsten, V (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Dynam Macroecol Landscape dynam, Birmensdorf, Switzerland.	veiko.lehsten@nateko.lu.se	Chen, Deliang/A-5107-2013; Ou, Tinghai/A-5068-2013; Grenville-Briggs, Laura J/C-3419-2014	Chen, Deliang/0000-0003-0288-5618; Grenville-Briggs, Laura J/0000-0001-5910-3651; Andreasson, Erik/0000-0003-0666-7204; Ou, Tinghai/0000-0002-6847-4099; Lehsten, Veiko/0000-0002-0649-0042; Liljeroth, Erland/0000-0002-6950-2434	SSF (FEL5 Future Research Leaders grant); FORMAS; FORMAS via the BIODIVERSA project CONNECT	SSF (FEL5 Future Research Leaders grant); FORMAS(Swedish Research Council Formas); FORMAS via the BIODIVERSA project CONNECT	This work was funded by SSF (FEL5 Future Research Leaders grant to LGB), FORMAS to LGB, and FORMAS to VL via the BIODIVERSA project CONNECT.	Bradburn MJ, 2003, BRIT J CANCER, V89, P431, DOI 10.1038/sj.bjc.6601119; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Brurberg MB, 2011, FUNGAL BIOL-UK, V115, P335, DOI 10.1016/j.funbio.2011.01.003; Brurberg MB, 1999, MYCOL RES, V103, P1609, DOI 10.1017/S0953756299008771; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Clement JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037838; DOSTER MA, 1989, AM POTATO J, V66, P227, DOI 10.1007/BF02853445; EPPO, EPPO STAND, P6; European and Mediterranean Plant Protection Organization, 1999, EPPO STAND CERT SCHE; Ewers BE, 2000, TREE PHYSIOL, V20, P579; Forbes G. A., 2008, V3, P161, DOI 10.1007/978-1-4020-8571-0_8; FRY WE, 1983, PHYTOPATHOLOGY, V73, P1054, DOI 10.1094/Phyto-73-1054; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Grenville-Briggs LJ, 2005, ADV APPL MICROBIOL, V57, P217, DOI 10.1016/S0065-2164(05)57007-2; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Grunwald NJ, 2000, PLANT DIS, V84, P410, DOI 10.1094/PDIS.2000.84.4.410; Grunwald NJ, 2002, PLANT DIS, V86, P1163, DOI 10.1094/PDIS.2002.86.10.1163; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hannukkala AO, 2007, PLANT PATHOL, V56, P167, DOI 10.1111/j.1365-3059.2006.01451.x; HARRISON JG, 1989, PLANT PATHOL, V38, P585, DOI 10.1111/j.1365-3059.1989.tb01455.x; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hermansen A, 2000, PLANT PATHOL, V49, P11, DOI 10.1046/j.1365-3059.2000.00426.x; Hijmans RJ, 2000, PLANT PATHOL, V49, P697, DOI 10.1046/j.1365-3059.2000.00511.x; Hurley P, 2009, AIR QUAL CLIM CHANG, V43, P19; Jordbruksverket, 2015, FOR AND STAT JORDBR; Kadir S, 1987, 10 TRIENN C EAPR AAL, P223; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KRAUSE RA, 1975, PLANT DIS REP, V59, P95; Lee E, 1980, STAT METHODS SURVIVA; Lehtinen A, 2004, AGR FOOD SCI, V13, P399, DOI 10.2137/1239099043633332; Liljeroth E, 2016, CROP PROT, V86, P42, DOI 10.1016/j.cropro.2016.04.003; Mariette N, 2016, PLANT PATHOL, V65, P577, DOI 10.1111/ppa.12441; MINOGUE KP, 1981, PHYTOPATHOLOGY, V71, P1181, DOI 10.1094/Phyto-71-1181; Niederhauser J.S., 1991, PHYTOPHTHORA, P25; Organization E and MPP, 2004, EPPO STAND EFF EV PL, V2; Pulatov B, 2015, AGR FOREST METEOROL, V214, P281, DOI 10.1016/j.agrformet.2015.08.266; SCHERM H, 1993, AGR FOREST METEOROL, V66, P229, DOI 10.1016/0168-1923(93)90073-Q; SCHERM H, 1994, PHYTOPATHOLOGY, V84, P1380; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shakya SK, 2015, PHYTOPATHOLOGY, V105, P230, DOI 10.1094/PHYTO-05-14-0132-R; Sjoholm L, 2013, FUNGAL BIOL-UK, V117, P722, DOI 10.1016/j.funbio.2013.08.002; Sparks AH, 2014, GLOBAL CHANGE BIOL, V20, P3621, DOI 10.1111/gcb.12587; Tang L, 2009, BOREAL ENVIRON RES, V14, P338; Turner RS, 2005, HIST STUD PHYS BIOL, V35, P341, DOI 10.1525/hsps.2005.35.2.341; WALLIN J. R., 1962, American Potato Journal, V39, P306, DOI 10.1007/BF02862155; Wang EL, 1998, AGR SYST, V58, P1, DOI 10.1016/S0308-521X(98)00028-6; Wiik L, 2014, POTATO RES, V57, P77, DOI 10.1007/s11540-014-9256-2; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x; Zadoks JC, 2008, POTATO RES, V51, P5, DOI 10.1007/s11540-008-9091-4	50	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0177580	10.1371/journal.pone.0177580	http://dx.doi.org/10.1371/journal.pone.0177580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558041	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000012
J	Lin, SH; Wang, TC; Lai, CF; Tsai, RY; Yang, CP; Wong, CS				Lin, Sheng-Hsiung; Wang, Ting-Chuan; Lai, Chun-Fu; Tsai, Ru-Yin; Yang, Chih-Ping; Wong, Chih-Shung			Association of anterior cruciate ligament injury with knee osteoarthritis and total knee replacement: A retrospective cohort study from the Taiwan National Health Insurance Database	PLOS ONE			English	Article							ACL RECONSTRUCTION; INTRAARTICULAR INJECTION; RISK-FACTORS; PREVALENCE; JOINT; REHABILITATION; ARTHROPLASTY; PROGRESSION; MENISCUS; DISEASE	Objective This study aimed to support the potential protective role of anterior cruciate ligament (ACL) reconstruction against the development of osteoarthritis (OA). Methods In this retrospective cohort study, the long-term results of ACL reconstruction in Taiwan were evaluated based on data from the National Health Insurance Research Database (NHIRD). In total, 8,769 eligible cases were included from 11,921 ACL-injured patients. The cumulative incidence rates of OA and total knee replacement (TKR) were analyzed using the Kaplan-Meier estimator. Cox proportional hazards models were applied to estimate the hazard ratios (HRs) and 95% confidence intervals (Cis) of OA. Results There was a lower cumulative incidence of OA among ACL-reconstructed patients (271, 33.1%) than among non-reconstructed patients (1,874, 40.3%; p < 0.001). Patients who underwent ACL reconstruction had a lower cumulative incidence of TKR during the follow-up period (0.6%) than the non-reconstructed patients (4.6%, p < 0.001). After adjusting for covariates, ACL-injured patients who underwent reconstruction within one month after ACL injury showed a significantly lower risk of OA than those who never underwent reconstruction (adjusted HR = 0.83, 95% CI = 0.69-0.99). Conclusions These results indicate that ACL reconstruction might not provide complete protection from OA development after traumatic knee injury but does yield a lower cumulative incidence of OA development and TKR. Moreover, based on the present study, ACL-injured patients should undergo reconstruction as early as possible (within one month) to lower the risk of OA.	[Lin, Sheng-Hsiung; Wong, Chih-Shung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Ting-Chuan] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lai, Chun-Fu] Triserv Gen Hosp, Div Occupat Med, Dept Family & Community Med, Natl Def Med Ctr, Taipei, Taiwan; [Lai, Chun-Fu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Family Med, Songshan Branch, Taipei, Taiwan; [Tsai, Ru-Yin] Da Yeh Univ, Dept Nursing, Changhua, Taiwan; [Yang, Chih-Ping] Armed Forces Taoyuan Gen Hosp, Div Anesthesiol, Taoyuan, Taiwan; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wong, Chih-Shung] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan	National Defense Medical Center; Cathay General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Da Yeh University; Cathay General Hospital; Fu Jen Catholic University	Wong, CS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wong, CS (corresponding author), Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.; Wong, CS (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.	w82556@gmail.com	ycp810, ycp810/GYI-9629-2022	LAI, CHUN-FU/0000-0003-2109-1522; Wang, Ting-Chuan/0000-0001-8928-9565	Cathay General Hospital, Taipei, Taiwan [CGH-MR-A10307]	Cathay General Hospital, Taipei, Taiwan	This study was funded through a grant from the Cathay General Hospital, Taipei, Taiwan (CGH-MR-A10307).	Brophy RH, 2014, J BONE JOINT SURG AM, V96A, P801, DOI 10.2106/JBJS.M.00105; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; CHOU CT, 1994, J RHEUMATOL, V21, P302; Culvenor AG, 2014, BRIT J SPORT MED, V48, P435, DOI 10.1136/bjsports-2013-092975; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Dunn WR, 2004, AM J SPORT MED, V32, P1906, DOI 10.1177/0363546504265006; Kim Ha Sung, 2013, Knee Surg Relat Res, V25, P165, DOI 10.5792/ksrr.2013.25.4.165; Englund M, 2015, NAT REV RHEUMATOL, V11, P448, DOI 10.1038/nrrheum.2015.87; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Garstang SV, 2006, AM J PHYS MED REHAB, V85, pS2, DOI 10.1097/01.phm.0000245568.69434.1a; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Hasegawa A, 2012, ARTHRITIS RHEUM-US, V64, P696, DOI 10.1002/art.33417; Hunter DJ, 2009, J ANAT, V214, P197, DOI 10.1111/j.1469-7580.2008.01013.x; Jean YH, 2007, OSTEOARTHR CARTILAGE, V15, P638, DOI 10.1016/j.joca.2006.11.008; Jomha NM, 1999, CLIN ORTHOP RELAT R, P188; Kessler MA, 2008, KNEE SURG SPORT TR A, V16, P442, DOI 10.1007/s00167-008-0498-x; Kiapour AM, 2014, BONE JOINT RES, V3, P20, DOI 10.1302/2046-3758.32.2000241; Leroux T, 2014, J BONE JOINT SURG AM, V96A, P2, DOI 10.2106/JBJS.M.00393; Liao CD, 2015, ARTHRIT CARE RES, V67, P799, DOI 10.1002/acr.22474; Lin I. S., 2010, TAIWAN J FAMILY MED, V20, P53; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Ferrandiz ML, 2014, EXP GERONTOL, V55, P44, DOI 10.1016/j.exger.2014.03.010; Magnussen RA, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115573706; Magnussen RA, 2012, KNEE, V19, P275, DOI 10.1016/j.knee.2011.05.001; Malempati C, 2015, ORTHOPEDICS, V38, P689, DOI 10.3928/01477447-20151016-07; Mihelic R, 2011, INT ORTHOP, V35, P1093, DOI 10.1007/s00264-011-1206-x; Negus JJ, 2015, CONTEMP CLIN TRIALS, V40, P47, DOI 10.1016/j.cct.2014.11.007; Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770; Norris Rory, 2012, Open Orthop J, V6, P506, DOI 10.2174/1874325001206010506; O'Brien EJO, 2013, J ORTHOP RES, V31, P35, DOI 10.1002/jor.22187; Oiestad BE, 2010, AM J SPORT MED, V38, P2201, DOI 10.1177/0363546510373876; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Petersen W, 2012, ARTHROSCOPY, V28, P448, DOI 10.1016/j.arthro.2012.02.011; Price AJ, 2010, KNEE, V17, P196, DOI 10.1016/j.knee.2009.09.003; Simon D, 2015, ADV ORTHOP, V2015, DOI 10.1155/2015/928301; Spindler KP, 2008, NEW ENGL J MED, V359, P2135, DOI 10.1056/NEJMcp0804745; Suri P, 2012, PM&R, V4, pS10, DOI 10.1016/j.pmrj.2012.01.007; Tien WC, 2009, INT ORTHOP, V33, P949, DOI 10.1007/s00264-008-0612-1; Tsai WY, 2016, J ORTHOP RES, V34, P650, DOI 10.1002/jor.23069; Tsai WY, 2013, CONNECT TISSUE RES, V54, P49, DOI 10.3109/03008207.2012.734877; Wen CW, 2014, NAT REV RHEUMATOL, V10, P577, DOI 10.1038/nrrheum.2014.120; Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001; Xie Xiaobo, 2015, Eur J Orthop Surg Traumatol, V25, P149, DOI 10.1007/s00590-014-1459-3; Zoran Z, 2015, INJURY, V46, pS91, DOI 10.1016/j.injury.2015.10.056	47	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178292	10.1371/journal.pone.0178292	http://dx.doi.org/10.1371/journal.pone.0178292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558029	Green Submitted, Green Published, gold			2022-12-26	WOS:000402607000038
J	Matter, ML; Shvetsov, YB; Dugay, C; Haiman, CA; Le Marchand, L; Wilkens, LR; Maskarinec, G				Matter, Michelle L.; Shvetsov, Yurii B.; Dugay, Chase; Haiman, Christopher A.; Le Marchand, Loic; Wilkens, Lynne R.; Maskarinec, Gertraud			High mortality due to sepsis in Native Hawaiians and African Americans: The Multiethnic Cohort	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; UNITED-STATES; CLINICAL-CRITERIA; SEPTIC SHOCK; EPIDEMIOLOGY; AUSTRALIA; BURDEN; COSTS; RISK	Background/Objectives Sepsis is a severe systemic response to infection with a high mortality rate. A higher incidence has been reported for older people, in persons with a compromised immune system including cancer patients, and in ethnic minorities. We analyzed sepsis mortality and its predictors by ethnicity in the Multiethnic Cohort (MEC). Subjects/Methods Among 191,561 white, African American, Native Hawaiian, Japanese American, and Latino cohort members, 49,347 deaths due to all causes and 345 deaths due to sepsis were recorded during follow-up from 1993-96 until 2010. Cox proportional hazard ratios (HRs) and 95% confidence intervals (Cis) were calculated and adjusted for relevant confounders. In addition, national death rates were analyzed to compare mortality by state. Results Age-adjusted rates of sepsis death were 5-times higher for Hawaii than Los Angeles (14.4 vs. 2.7 per 100,000). By ethnicity, Native Hawaiians had the highest rate in Hawaii (29.0 per 100,000) and African Americans in Los Angeles (5.2 per 100,000). In fully adjusted models, place of residence was the most important predictor of sepsis mortality (HR = 7.18; 95%Cl: 4.37-11.81 Hawaii vs. Los Angeles). African Americans showed the highest risk (HR = 2.08; 95% CI: 1.16-3.75) followed by Native Hawaiians (HR = 1.88; 95% CI: 1.34-2.65) as compared to whites. Among cohort members with cancer (N = 49,794), the 2-fold higher sepsis mortality remained significant in Native Hawaiians only. The geographic and ethnic differences in the MEC agreed with results for national death data. Conclusions The finding that African Americans and Native Hawaiians experience a higher mortality risk due to sepsis than other ethnic groups suggest ethnicity-related biological factors in the predisposition of cancer patients and other immune-compromising conditions to develop sepsis, but regional differences in health care access and death coding may also be important.	[Matter, Michelle L.; Dugay, Chase] Univ Hawaii, Canc Ctr, Canc Biol Program, Honolulu, HI 96822 USA; [Shvetsov, Yurii B.; Le Marchand, Loic; Wilkens, Lynne R.; Maskarinec, Gertraud] Univ Hawaii, Epidemiol Program, Canc Ctr, Honolulu, HI 96822 USA; [Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Haiman, Christopher A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	Cancer Research Center of Hawaii; University of Hawaii System; Cancer Research Center of Hawaii; University of Hawaii System; University of Southern California; University of Southern California	Matter, ML (corresponding author), Univ Hawaii, Canc Ctr, Canc Biol Program, Honolulu, HI 96822 USA.; Maskarinec, G (corresponding author), Univ Hawaii, Epidemiol Program, Canc Ctr, Honolulu, HI 96822 USA.	matter@hawaii.edu; gertraud@cc.hawaii.edu	Matter, Michelle/GSN-9703-2022; Shvetsov, Yurii/ABA-3196-2020	Matter, Michelle/0000-0002-5988-9663	National Institutes of Health [RO1GM104984]; National Cancer Institute [U01CA164973]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health RO1GM104984 to MLM. The Multiethnic Cohort was funded by grant U01CA164973 from the National Cancer Institute (PIs: LLM, LRW, CAH).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Cheek JE, 2014, AM J PUBLIC HEALTH, V104, pS446, DOI 10.2105/AJPH.2013.301721; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; Davis JS, 2011, MED J AUSTRALIA, V194, P519, DOI 10.5694/j.1326-5377.2011.tb03088.x; Einsiedel LJ, 2010, MED J AUSTRALIA, V192, P567, DOI 10.5694/j.1326-5377.2010.tb03638.x; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hernandez BY, 2015, CANCER MED-US, V4, P354, DOI 10.1002/cam4.375; Kempker JA, 2016, CLIN CHEST MED, V37, P165, DOI 10.1016/j.ccm.2016.01.002; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Maskarinec G, 2016, EUR J CLIN NUTR, V70, P1022, DOI 10.1038/ejcn.2016.32; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Statistics NCfH, 2017, VIT STAT DAT; Wang HE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-9; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893	22	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2017	12	5							e0178374	10.1371/journal.pone.0178374	http://dx.doi.org/10.1371/journal.pone.0178374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6GJ	28558016	Green Published, Green Submitted, gold			2022-12-26	WOS:000402607000040
J	Wei, YY; Xu, YC; Lu, P; Wang, XX; Li, ZQ; Cai, XY; Zhou, ZL; Wang, YH; Zhang, ZM; Lin, ZX; Liu, F; Wang, KB				Wei, Yangyang; Xu, Yanchao; Lu, Pu; Wang, Xingxing; Li, Zhenqing; Cai, Xiaoyan; Zhou, Zhongli; Wang, Yuhong; Zhang, Zhenmei; Lin, Zhongxu; Liu, Fang; Wang, Kunbo			Salt stress responsiveness of a wild cotton species (Gossypium klotzschianum) based on transcriptomic analysis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; GENOME-WIDE IDENTIFICATION; CALCIUM SENSOR CBL10; PROTEIN-KINASE SOS2; ABSCISIC-ACID; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; PROVIDES INSIGHTS; ION HOMEOSTASIS; OSMOTIC-STRESS	Cotton is a pioneer of saline land crop, while salt stress still causes its growth inhibition and fiber production decrease. Phenotype identification showed better salt tolerance of a wild diploid cotton species Gossypium klotzschianum. To elucidate the salt-tolerant mechanisms in G. klotzschianum, we firstly detected the changes in hormones, H2O2 and glutathione (GSSH and GSH), then investigated the gene expression pattern of roots and leaves treated with 300 mM NaCl for 0, 3, 12, 48 h, and each time control by RNA-seq on the Illumina-Solexa platform. Physiological determination proved that the significant increase in hormone ABA at 48 h, while that in H2O2 was at 12 h, likewise, the GSH content decrease at 48 h and the GSSH content increase at 48 h, under salt stress. In total, 37,278 unigenes were identified from the transcriptome data, 8,312 and 6,732 differentially expressed genes (DEGs) were discovered to be involved in salt stress tolerance in roots and leaves, respectively. Gene function annotation and expression analysis elucidated hormone biosynthesis and signal transduction, reactive oxygen species (ROS), and salt overly sensitive (SOS) signal transduction related genes revealed the important roles of them in signal transmission, oxidation balance and ion homeostasis in response to salinity stress. This is a report which focuses on primary response to highly salty stress (upto 300 mM NaCl) in cotton using a wild diploid Gossypium species, broadening our understanding of the salt tolerance mechanism in cotton and laying a solid foundation of salt resistant for the genetic improvement of upland cotton with the resistance to salt stress.	[Wei, Yangyang; Xu, Yanchao; Lu, Pu; Wang, Xingxing; Li, Zhenqing; Cai, Xiaoyan; Zhou, Zhongli; Wang, Yuhong; Zhang, Zhenmei; Liu, Fang; Wang, Kunbo] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Wei, Yangyang; Lin, Zhongxu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Huazhong Agricultural University	Liu, F; Wang, KB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.; Lin, ZX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement Wuhan, Wuhan, Hunan, Peoples R China.	linzhongxu@mail.hzau.edu.cn; liufcri@163.com; wkbcri@163.com			National Natural Science Foundation of China [31530053, 31401424]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This program was financially sponsored by the National Natural Science Foundation of China (31530053), the National Natural Science Foundation of China for Young Scholars (31401424), and the Innovation Scientists and Technicians Troop Construction Projects of Henan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bello B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112269; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Brosche A M, 2009, STRESS SIGNALING, P91; Chater CCC, 2014, NEW PHYTOL, V202, P376, DOI 10.1111/nph.12713; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Chinnusamy Viswanathan, 2006, Genet Eng (N Y), V27, P141, DOI 10.1007/0-387-25856-6_9; Cui JX, 2011, PLANT CELL ENVIRON, V34, P347, DOI 10.1111/j.1365-3040.2010.02248.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; de la Torre F, 2013, PLANT CELL, V25, P2748, DOI 10.1105/tpc.113.113530; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Elzahab AAA, 1971, SALT TOLERANCE 8 EGY; Fahad S, 2015, CROP PLANT HORMONES; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Griffiths J.W.R., 1983, ABSTR APPL ANAL, V130, P3, DOI DOI 10.1371/J0URNAL.P0NE.0054002; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; He CX, 2005, PLANT CELL PHYSIOL, V46, P1848, DOI 10.1093/pcp/pci201; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Huang JG, 2009, PLANT CELL ENVIRON, V32, P1132, DOI 10.1111/j.1365-3040.2009.01995.x; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Julkowska MM, 2015, TRENDS PLANT SCI, V20, P586, DOI 10.1016/j.tplants.2015.06.008; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kaya C, 2009, ROLE PLANT HORMONES; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kurusu T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00427; Lake JA, 2002, J EXP BOT, V53, P183, DOI 10.1093/jexbot/53.367.183; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00732; Lin HX, 2009, PLANT CELL, V21, P1607, DOI 10.1105/tpc.109.066217; Liu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086895; Liu Y, 2013, INT J MOL SCI, V14; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Ma JC, 2015, EVOL BIOINFORM, V11, P47, DOI 10.4137/EBO.S22067; Ma LY, 2012, J EXP BOT, V63, P305, DOI 10.1093/jxb/err280; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Matakiadis T, 2009, PLANT PHYSIOL, V149, P949, DOI 10.1104/pp.108.126938; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; North HM, 2007, PLANT J, V50, P810, DOI 10.1111/j.1365-313X.2007.03094.x; Pang Cai-Hong, 2008, V69, P231, DOI 10.1007/978-3-540-72954-9_9; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Park W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-90; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Peng Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-760; Petrov V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00069; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; Rodriguez-Uribe L, 2011, PLANT SCI, V180, P461, DOI 10.1016/j.plantsci.2010.10.009; Ryu H, 2015, J PLANT BIOL, V58, P147, DOI 10.1007/s12374-015-0103-z; Shi WN, 2014, PLANT CELL REP, V33, P483, DOI 10.1007/s00299-013-1548-5; Steffens B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00179; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; VAADIA Y, 1976, PHILOS T ROY SOC B, V273, P513, DOI 10.1098/rstb.1976.0028; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Ye NH, 2012, RICE, V5, DOI 10.1186/1939-8433-5-1; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Yokoi S, 2010, PLANT J, V1, P495, DOI [10.1111/j.1365-313X.2009.04073.x, DOI 10.1111/J.1365-313X.2009.04073.X]; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20582; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang JL, 2013, PHOTOSYNTH RES, V115, P1, DOI 10.1007/s11120-013-9813-6; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]; Zheng LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00678; ZHONG HL, 1993, J EXP BOT, V44, P763, DOI 10.1093/jxb/44.4.763; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zhu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080218	92	38	41	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2017	12	5							e0178313	10.1371/journal.pone.0178313	http://dx.doi.org/10.1371/journal.pone.0178313			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VT	28552980	Green Published, Green Submitted, gold			2022-12-26	WOS:000402063000034
J	Mishra, AK; Parish, CR; Wong, ML; Licinio, J; Blackburn, AC				Mishra, Ameet K.; Parish, Christopher R.; Wong, Ma-Li; Licinio, Julio; Blackburn, Anneke C.			Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BODY-MASS INDEX; TUMOR-STROMAL INTERACTIONS; GROWTH-FACTOR; ANTAGONIST PEPTIDE; BETA-CATENIN; RISK-FACTORS; FEMALE MICE; CELLS; METFORMIN	Epidemiological studies have shown obesity to be linked with poorer outcomes in breast cancer patients. The molecular mechanisms responsible for the increased risk of invasive/ metastatic disease with obesity are complex, but may include elevated levels of adipokines such as leptin. Using physiological levels of leptin found in obesity in a novel chronic in vitro treatment model (<= 200 ng/ml for 14 days), we confirmed the occurrence of leptin-mediated changes in growth, apoptosis and metastatic behavior, and gene expression changes representing epithelial-to-mesenchymal transition (EMT) and a cancer stem cell (CSC) like phenotype in breast epithelial and cancer cell lines (MCF10A, MCF10AT1, MCF7 and MDAMB-231). Further, we have discovered that these effects were accompanied by increased expression of TGFB1, and could be significantly reduced by co-treatment with neutralizing antibody against TGFB1, indicating that the induction of these characteristics was mediated via TGFB1. Occurring in both MCF7 and MCF10AT1 cells, it suggests these actions of leptin to be independent of estrogen receptor status. By linking leptin signalling to the established TGFB1 pathway of metastasis / EMT, this study gives a direct mechanism by which leptin can contribute to the poorer outcomes of obese cancer patients. Inhibitors of TGFB1 are in currently in phase III clinical trials in other malignancies, thus identifying the connection between leptin and TGFB1 will open new therapeutic opportunities for improving outcomes for obese breast cancer patients.	[Mishra, Ameet K.; Parish, Christopher R.; Blackburn, Anneke C.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Wong, Ma-Li; Licinio, Julio] South Australian Hlth & Med Res Inst, Mind & Brain Theme, Adelaide, SA, Australia; [Wong, Ma-Li; Licinio, Julio] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia	Australian National University; John Curtin School of Medical Research; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia	Blackburn, AC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia.	anneke.blackburn@anu.edu.au	Blackburn, Anneke C/B-3670-2011; Licinio, Julio/L-4244-2013; Wong, Ma-Li/ABD-5525-2020; Wong, Ma-Li/D-7903-2011	Blackburn, Anneke C/0000-0002-6589-0142; Licinio, Julio/0000-0001-6905-5884; Parish, Christopher/0000-0001-7740-0430; Mishra, Ameet/0000-0002-6491-7278; Wong, Ma-Li/0000-0003-1512-3073	Cancer Council ACT [585409]; National Health and Medical Research Council of Australia [366787]	Cancer Council ACT(Cancer Council Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	ACB was supported by Cancer Council ACT #585409 and the National Health and Medical Research Council of Australia #366787 during this time.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ando S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00340; Barone I, 2012, CANCER RES, V72, P1416, DOI 10.1158/0008-5472.CAN-11-2558; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Binai NA, 2010, INT J CANCER, V127, P55, DOI 10.1002/ijc.25010; Boterberg I, 2001, METASTASIS RES PROTO, P58; Briffa JF, 2015, MOL CELL ENDOCRINOL, V401, P25, DOI 10.1016/j.mce.2014.11.024; Catalano S, 2003, J BIOL CHEM, V278, P28668, DOI 10.1074/jbc.M301695200; Catalano S, 2015, J CELL MOL MED, V19, P1122, DOI 10.1111/jcmm.12517; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Dignam JJ, 2004, ANN ONCOL, V15, P850, DOI 10.1093/annonc/mdh241; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Feng HL, 2013, ONCOL RES, V21, P165, DOI 10.3727/096504014X13887748696662; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; Frankenberry KA, 2004, AM J SURG, V188, P560, DOI 10.1016/j.amjsurg.2004.07.031; Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Ghiasvand R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-414; Giordano C, 2016, ONCOTARGET, V7, P1262, DOI 10.18632/oncotarget.6014; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Haakinson DJ, 2012, ANN SURG ONCOL, V19, P3012, DOI 10.1245/s10434-012-2320-8; Han CZ, 2005, ENDOCRINE, V26, P19, DOI 10.1385/ENDO:26:1:019; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalinsky K, 2014, CANCER INVEST, V32, P150, DOI 10.3109/07357907.2014.889706; Karaduman M, 2010, J BUON, V15, P369; Kawai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-149; Kotiyal S, 2014, BIOCHEM BIOPH RES CO, V453, P112, DOI 10.1016/j.bbrc.2014.09.069; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maor G, 2002, J BONE MINER RES, V17, P1034, DOI 10.1359/jbmr.2002.17.6.1034; MCNEE RK, 1987, BREAST CANCER RES TR, V9, P145, DOI 10.1007/BF01807367; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Morin-Papunen LC, 1998, J CLIN ENDOCR METAB, V83, P2566, DOI 10.1210/jc.83.7.2566; Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067349; Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018; Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163; Paz-Filho G, 2013, ADIPOKINES SOLUBLE F, P71; Reddy BY, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/721659; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Wada N, 2014, J CHEM NEUROANAT, V61-62, P191, DOI 10.1016/j.jchemneu.2014.09.002; Weichhaus M, 2014, ONCOL LETT, V8, P374, DOI 10.3892/ol.2014.2085; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Wu MH, 2009, BRIT J CANCER, V100, P578, DOI 10.1038/sj.bjc.6604913; Xiao H, 2010, CARDIOVASC RES, V87, P504, DOI 10.1093/cvr/cvq066; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zheng Q, 2013, ENDOCR-RELAT CANCER, V20, P797, DOI 10.1530/ERC-13-0329; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	66	36	37	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178454	10.1371/journal.pone.0178454	http://dx.doi.org/10.1371/journal.pone.0178454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542577	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800092
J	Liu, L; Jiang, YD; Steinle, JJ				Liu, Li; Jiang, Youde; Steinle, Jena J.			Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; INJURY; INFLAMMATION; RECEPTOR; GLYCYRRHIZIN; BRAIN; MICE	The role of inflammation in diabetic retinal amage is well accepted. While a number of cytokines and inflammatory mediators are responsible for these changes, upstream regulators are less well studied. Additionally, the role for these upstream mediators in retinal health is unclear. In this study, we hypothesized that inhibition of high mobility group box 1 (HMGB1) could restore normal insulin signaling in retinal endothelial cells (REC) grown in high glucose, as well as protect the retina against ischemia/reperfusion (I/R)-induced retinal damage. REC were grown in normal (5mM) or high glucose (25mM) and treated with Box A or glycyrrhizin, two different HMGB1 inhibitors. Western blotting was done for HMGB1, toll-like receptor 4 (TLR4), insulin receptor, insulin receptor substrate-1 (IRS-1), and Akt. ELISA analyses were done for tumor necrosis factor alpha (TNFa) and cleaved caspase 3. In addition, C57/B6 mice were treated with glycyrrhizin, both before and after ocular I/R. Two days following I/R, retinal sections were processed for neuronal changes, while vascular damage was measured at 10 days post-I/R. Results demonstrate that both Box A and glycyrrhizin reduced HMGB1, TLR4, and TNFa levels in REC grown in high glucose. This led to reduced cleavage of caspase 3 and IRS-1 Ser307 phosphorylation, and increased insulin receptor and Akt phosphorylation. Glycyrrhizin treatment significantly reduced loss of retinal thickness and degenerate capillary numbers in mice exposed to I/R. Taken together, these results suggest that inhibition of HMGB1 can reduce retinal insulin resistance, as well as protect the retina against I/R-induced damage.	[Liu, Li; Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Steinle, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Steinle, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA.	jsteinle@med.wayne.edu	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680; Steinle, Jena/0000-0002-7539-2892	 [R01EY022330];  [P30EY04068]; NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01EY022330 and P30EY04068. No funders had any influence on this study.	Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Abu El-Asrar AM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/746415; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Berger E.A., 2016, IMMUNOL CELL BIOL; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Dvoriantchikova G, 2011, INVEST OPHTH VIS SCI, V52, P7187, DOI 10.1167/iovs.11-7793; Guzman-Ruiz R, 2014, INT J OBESITY, V38, P1545, DOI 10.1038/ijo.2014.36; Huang Y, 2007, AM J TRANSPLANT, V7, P799, DOI 10.1111/j.1600-6143.2007.01734.x; Jiang Y.-Y., 2015, SHOCK VIB, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0130400; Jiang YD, 2014, J BIOL CHEM, V289, P26395, DOI 10.1074/jbc.M114.583880; Jiang YD, 2014, MOL VIS, V20, P872; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159532; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Montes VN, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.11; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Veenstra Alexander, 2015, Curr Protoc Mouse Biol, V5, P247, DOI 10.1002/9780470942390.mo140190; Wang Y., 2016, J ASIAN CONCR FED, V2, P1, DOI DOI 10.1155/2016/2543268; Wang YL, 2015, GRAEF ARCH CLIN EXP, V253, P389, DOI 10.1007/s00417-014-2832-y; Zhang JC, 2014, BRAIN RES, V1582, P176, DOI 10.1016/j.brainres.2014.07.002; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	28	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178236	10.1371/journal.pone.0178236	http://dx.doi.org/10.1371/journal.pone.0178236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542588	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058800049
J	Kennedy, ITR; Van Hoek, AJ; Ribeiro, S; Christensen, H; Edmunds, J; Ramsay, ME; Ladhani, SN				Kennedy, Iain T. R.; van Hoek, Albert J.; Ribeiro, Sonia; Christensen, Hannah; Edmunds, John; Ramsay, Mary E.; Ladhani, Shamez N.			Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study	PLOS ONE			English	Article								Objectives The short-term impact of childhood invasive meningococcal disease (IMD) on quality-of-life (QoL) remains largely unquantified. This study aimed to quantify QoL loss at the point when illness was at its worst, and assess health state recovery in the months following illness. Methods Parents of children aged < 16 years with laboratory-confirmed meningococcal group B (MenB) disease in England, with onset dates from November 2012 to May 2013 were asked to complete a short questionnaire, which included EQ-5DY, a version of EQ-5D for 8-15 year-olds. The parents, or child if able, were asked to complete the questionnaires while considering the child's health on the worst day of illness and on the date the questionnaires were completed. Results The overall response rate was 43% (109/254 children), with no significant differences between respondents and non-respondents. The median time from disease onset to questionnaire completion was 134 days (interquartile range (IQR), 92 to 156 days). After imputation, the median health index was -0.056 (IQR, -0.073 to 0.102) on the worst day of illness, and 1 (IQR 0.866 to 1.000) on the date of questionnaire completion. The respective Visual Analogue Scores (VAS) were 6.5/100.0 (IQR, 0.0 to 20.0) and 95.0/100.0 (IQR, 90.0 to 100.0). The health state of cases with long-term sequelae (n = 41) was significantly worse at follow-up than those who recovered uneventfully (n = 64; 90.0 vs. 98.0; p< 0.001), although there was no significant difference on the worst day of illness (5.0 vs. 10.0; p = 0.671). Conclusions This work has provided, for the first time, a quantitative estimate of QoL loss at the peak of illness and in the months after MenB disease in children. The magnitude of QoL loss is staggering, with the reported health state being at, or close to, the worst possible outcome imaginable. This study highlights the difficulties in measuring the impact of illness in young children, who often have the highest burden of potentially preventable infectious diseases.	[Kennedy, Iain T. R.; van Hoek, Albert J.; Ribeiro, Sonia; Ramsay, Mary E.; Ladhani, Shamez N.] Publ Hlth England, Immunisat Dept, London, England; [van Hoek, Albert J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Christensen, Hannah] Univ Bristol, Sch Social & Community Med, Bristol, England; [Edmunds, John] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; St Georges University London	Ladhani, SN (corresponding author), Publ Hlth England, Immunisat Dept, London, England.; Ladhani, SN (corresponding author), St Georges Univ London, Paediat Infect Dis Res Grp, London, England.	shamez.ladhani@phe.gov.uk	Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; Christensen, Hannah/0000-0002-2388-9733	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); National Institute for Health Research [PDF-2012-05-245] Funding Source: researchfish	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England (PHE); National Institute for Health Research(National Institute for Health Research (NIHR))	The study is supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at the University of Bristol and the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine, in partnership with Public Health England (PHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi H, 2015, HLTH EC; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; JCVI, 2014, JCVI POS STAT US BEX; Joint Committee on Vaccination and Immunisation (JCVI), 2014, MIN JCVI MEN SUBC; Khandaker GM, 2015, ANN EPIDEMIOL, V25, P236, DOI 10.1016/j.annepidem.2014.11.013; Ladhani SN, 2016, ARCH DIS CHILD, V101, P91, DOI 10.1136/archdischild-2015-308928; Ladhani SN, 2012, VACCINE, V30, P3710, DOI 10.1016/j.vaccine.2012.03.011; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Public Health England, 2015, HLTH PROTECTION REPO, V9, P14; Tarride JE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-12; Thorrington D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105153; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	14	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177082	10.1371/journal.pone.0177082	http://dx.doi.org/10.1371/journal.pone.0177082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545152	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000401672400021
J	Khan, NA; McAlister, FA; Pilote, L; Palepu, A; Quan, HD; Hill, MD; Fang, JM; Kapral, MK				Khan, Nadia A.; McAlister, Finlay A.; Pilote, Louise; Palepu, Anita; Quan, Hude; Hill, Michael D.; Fang, Jiming; Kapral, Moira K.			Temporal trends in stroke incidence in South Asian, Chinese and white patients: A population based analysis	PLOS ONE			English	Article							ETHNICITY; MORTALITY; PREVALENCE; ONTARIO; SEX	Background Little is known about potential ethnic differences in stroke incidence. We compared incidence and time trends of ischemic stroke and primary intracerebral hemorrhage in South Asian, Chinese and white persons in a population-based study. Methods Population based census and administrative data analysis in the provinces of Ontario and British Columbia, Canada using validated ICD 9/ICD 10 coding for acute ischemic and hemorrhagic stroke (1997-2010). Results There were 3290 South Asians, 4444 Chinese and 160944 white patients with acute ischemic stroke and 535 South Asian, 1376 Chinese and 21842 white patients with intracerebral hemorrhage. South Asians were younger than whites at onset of stroke (70 vs. 74 years for ischemic and 67 vs. 71 years for hemorrhagic stroke). Age and sex adjusted ischemic stroke incidence in 2010 was 43% lower in Chinese and 63% lower in South Asian than in White patients. Age and sex adjusted intracerebral hemorrhage incidence was 18% higher in Chinese patients, and 66% lower in South Asian relative to white patients. Stroke incidence declined in all ethnic groups (relative reduction 69% in South Asians, 25% in Chinese, and 34% in white patients for ischemic stroke and for intracerebral hemorrhage, 79% for South Asians, 51% for Chinese and 30% in white patients). Conclusion Although stroke rates declined across all ethnic groups, these rates differed significantly by ethnicity. Further study is needed to understand mechanisms underlying the higher ischemic stroke incidence in white patients and intracerebral hemorrhage in Chinese patients.	[Khan, Nadia A.; Palepu, Anita] Univ British Columbia, Div Gen Internal Med, Vancouver, BC, Canada; [Khan, Nadia A.; Palepu, Anita] Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Patient Hlth Outcomes Res & Clin Effectiveness Un, Edmonton, AB, Canada; [Pilote, Louise] McGill Univ, Res Inst, Hlth Ctr, Dept Med,Div Clin Epidemiol, Montreal, PQ, Canada; [Pilote, Louise] McGill Univ, Dept Med, Div Gen Internal Med, Montreal, PQ, Canada; [Quan, Hude; Hill, Michael D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Fang, Jiming; Kapral, Moira K.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kapral, Moira K.] Univ Toronto, Div Gen Internal Med, Dept Med, Toronto, ON, Canada	University of British Columbia; University of Alberta; University of Alberta; McGill University; McGill University; University of Calgary; University of Calgary; University of Toronto; University of Toronto	Khan, NA (corresponding author), Univ British Columbia, Div Gen Internal Med, Vancouver, BC, Canada.; Khan, NA (corresponding author), Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC, Canada.	nakhanubc@gmail.com	Hill, Michael D/C-9073-2012; McAlister, Finlay/C-4151-2013	Hill, Michael D/0000-0002-6269-1543; McAlister, Finlay/0000-0001-7435-3341; Pilote, Louise/0000-0002-6159-0628; Quan, Hude/0000-0002-7848-7256	Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research; Alberta-Innovates-Health Solution; Career Investigator Award from the Heart and Stroke Foundation of Canada; Alberta Innovates [201300690] Funding Source: researchfish	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Alberta-Innovates-Health Solution; Career Investigator Award from the Heart and Stroke Foundation of Canada; Alberta Innovates	This study was funded by Heart and Stroke Foundation of Canada. NAK receives salary support from the Michael Smith Foundation for Health Research. HQ's and FAM's salaries are supported by Alberta-Innovates-Health Solution. MKK was supported by a Career Investigator Award from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BC Ministry of Health Data Stewardship Committee, 2012, DISCH ABSTR DAT HOSP; Bhopal RS, 2012, EUR J PREV CARDIOL, V19, P1503, DOI 10.1177/1741826711423217; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gunarathne A, 2009, STROKE, V40, pE415, DOI 10.1161/STROKEAHA.108.535724; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Khan NA, 2011, DIABETES CARE, V34, P96, DOI 10.2337/dc10-0865; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Leenen FHH, 2008, CAN MED ASSOC J, V178, P1441, DOI 10.1503/cmaj.071340; Li B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139461; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu Richard, 2010, Open Med, V4, pe143; Mok V, 2014, INT J STROKE, V9, P36, DOI 10.1111/ijs.12270; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nguyen-Huynh MN, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-21; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Quan H, 2006, MED CARE, V44, P328, DOI 10.1097/01.mlr.0000204010.81331.a9; Quan HD, 2013, HEART, V99, P715, DOI 10.1136/heartjnl-2012-303152; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Sheth T, 1999, CAN MED ASSOC J, V161, P132; Tu JV, 2015, CIRCULATION, V132, P1549, DOI 10.1161/CIRCULATIONAHA.115.015345; Wasay M, 2014, NAT REV NEUROL, V10, P135, DOI 10.1038/nrneurol.2014.13; Williams G R, 2001, BMC Neurol, V1, P2, DOI 10.1186/1471-2377-1-2; Wu ZS, 2001, CIRCULATION, V103, P462; Yadav S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057305; Zhou ZQ, 2008, J EPIDEMIOL, V18, P209, DOI 10.2188/jea.JE2008021	29	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0175556	10.1371/journal.pone.0175556	http://dx.doi.org/10.1371/journal.pone.0175556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545076	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400002
J	Li, G; Niu, H; Zhang, YH; Li, YL; Xie, F; Langford, PR; Liu, S; Wang, CL				Li, Gang; Niu, Hui; Zhang, Yanhe; Li, Yanling; Xie, Fang; Langford, Paul R.; Liu, Siguo; Wang, Chunlai			Haemophilus parasuis cytolethal distending toxin induces cell cycle arrest and p53-dependent apoptosis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HELICOBACTER-HEPATICUS; BACTERIAL GENOTOXIN; HISTONE H2AX; DNA-DAMAGE; DUCREYI; CDT; PROGRESSION; PREVALENCE	Haemophilus parasuis is the causative agent of Glasser's disease in pigs. Cytolethal distending toxin (CDT) is an important virulence factor of H. parasuis. It is composed of three subunits: CdtA, CdtB and CdtC and all were successfully expressed in soluble form in Escherichia coli when the signal peptides were removed. Purified CdtB had DNase activity, i.e. caused DNA double strand damage, in vitro and in vivo prior to cell arrest and apoptosis. Flow cytometry analysis showed CdtB alone could induce cell cycle arrest and apoptosis in PK-15 porcine kidney and pulmonary alveolar macrophage (PAM) cells, which could be enhanced by CdtA or/and CdtC. CDT holotoxin could lead to significant cell distension, G(2) arrest and apoptotic death in PK-15 and PAM cells. The apoptosis induced by CDT holotoxin was significantly inhibited by pifithrin-a, which indicates that it is p53-dependent. The results suggest that H. parasuis CDT holotoxin is a major virulence factor.	[Li, Gang; Niu, Hui; Zhang, Yanhe; Li, Yanling; Xie, Fang; Liu, Siguo; Wang, Chunlai] Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Langford, Paul R.] Imperial Coll London, Dept Med, Paediat Sect, St Marys Campus, London, England	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Imperial College London	Wang, CL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Div Bacterial Dis, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	chunlai.w@hvri.ac.cn	li, yan/GTI-4638-2022; niu, hui/GQP-6490-2022		Natural Science Foundation of Heilongjiang Province of China [C2016067]; Special Fund for Agro-scientific Research in the Public Interest [201303034]; National Natural Science Foundation of China [31302091]; project of Harbin Science and Technology innovative talents [2015RQQYJ073]; State's Key Project of Research and Development Plan [2016YFD0500700]; BBSRC [BB/K020765/1, BB/G018553/1, BB/M023052/1]; Biotechnology and Biological Sciences Research Council [BB/M023052/1, BB/K020765/1, BB/G018553/1] Funding Source: researchfish	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of Harbin Science and Technology innovative talents; State's Key Project of Research and Development Plan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from Natural Science Foundation of Heilongjiang Province of China (C2016067), Special Fund for Agro-scientific Research in the Public Interest (201303034), National Natural Science Foundation of China (31302091), the project of Harbin Science and Technology innovative talents (2015RQQYJ073), and the State's Key Project of Research and Development Plan (2016YFD0500700). PRL is supported by the BBSRC (BB/K020765/1, BB/G018553/1, BB/M023052/1).	Akifusa S, 2001, INFECT IMMUN, V69, P5925, DOI 10.1128/IAI.69.9.5925-5930.2001; Bello-Orti B, 2014, VET MICROBIOL, V170, P430, DOI 10.1016/j.vetmic.2014.01.011; Bezine E, 2014, CELLS-BASEL, V3, P592, DOI 10.3390/cells3020592; Bielaszewska M, 2005, INFECT IMMUN, V73, P552, DOI 10.1128/IAI.73.1.552-562.2005; Blackall PJ, 1996, AUST VET J, V73, P93, DOI 10.1111/j.1751-0813.1996.tb09984.x; Cortes-Bratti X, 1999, J CLIN INVEST, V103, P107, DOI 10.1172/JCI3831; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Costa-Hurtado M, 2013, INFECT IMMUN, V81, P2327, DOI 10.1128/IAI.00056-13; Deng KP, 2001, BIOCHEM BIOPH RES CO, V285, P609, DOI 10.1006/bbrc.2001.5223; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Elwell CADL, 2000, MOL MICROBIOL, V37, P12; Fahrer JHJ, 2014, DNA REPAIR AMST, V18, P13; Fedor Y, 2013, CELL MICROBIOL, V15, P1, DOI 10.1111/cmi.12028; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Hu MM, 2013, CLIN VACCINE IMMUNOL, V20, P795, DOI 10.1128/CVI.00676-12; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Kitagawa T, 2007, INFECT IMMUN, V75, P1393, DOI 10.1128/IAI.01321-06; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lara-Tejero MGJ, 2002, TRENDS MICROBIOL, V10, P6; Liyanage NPM, 2010, HELICOBACTER, V15, P98, DOI 10.1111/j.1523-5378.2010.00749.x; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; OKUDA J, 1995, MICROB PATHOGENESIS, V18, P167, DOI 10.1016/S0882-4010(95)90022-5; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pickett CL, 1996, INFECT IMMUN, V64, P2070, DOI 10.1128/IAI.64.6.2070-2078.1996; Pickett CLCD, 1994, INFECT IMMUN, V62, P6; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Saiki K, 2001, MICROBIOL IMMUNOL, V45, P497, DOI 10.1111/j.1348-0421.2001.tb02650.x; Sert V, 1999, ONCOGENE, V18, P6296, DOI 10.1038/sj.onc.1203007; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Tadjine A, 2004, J CLIN MICROBIOL, V42, P839, DOI 10.1128/JCM.42.2.839-840.2004; Taieb F, 2015, ACTA VET HUNG, V63, P1, DOI 10.1556/AVet.2015.001; Young VB, 2000, INFECT IMMUN, V68, P184, DOI 10.1128/IAI.68.1.184-191.2000; Zhang B, 2014, VET MICROBIOL, V168, P1, DOI 10.1016/j.vetmic.2013.07.027; Zhang B, 2012, VET MICROBIOL, V157, P237, DOI 10.1016/j.vetmic.2011.12.002; Zhang JM, 2012, CAN J VET RES, V76, P224; Zhou MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032580	42	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177199	10.1371/journal.pone.0177199	http://dx.doi.org/10.1371/journal.pone.0177199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545143	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400027
J	Marangi, L; Mirinaviciute, G; Flem, E; Tomba, GS; Guzzetta, G; de Blasio, BF; Manfredi, P				Marangi, Luigi; Mirinaviciute, Grazina; Flem, Elmira; Tomba, Gianpaolo Scalia; Guzzetta, Giorgio; de Blasio, Birgitte Freiesleben; Manfredi, Piero			The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster	PLOS ONE			English	Article							SOCIAL CONTACTS; UNITED-STATES; COST-EFFECTIVENESS; VACCINATION; IMPACT; EPIDEMIOLOGY; EXPOSURE; HYPOTHESIS; PROTECTION; PARAMETERS	We use age-structured models for VZV transmission and reactivation to reconstruct the natural history of VZV in Norway based on available pre-vaccination serological data, contact matrices, and herpes zoster incidence data. Depending on the hypotheses on contact and transmission patterns, the basic reproduction number of varicella in Norway ranges between 3.7 and 5.0, implying a vaccine coverage between 73 and 80% to effectively interrupt transmission with a 100% vaccine efficacy against infection. The varicella force of infection peaks during early childhood (3-5 yrs) and shows a prolonged phase of higher risk during the child-bearing period, though quantitative variations can occur depending on contact patterns. By expressing the magnitude of exogenous boosting as a proportion of the force of infection, it is shown that reactivation is well described by a progressive immunity mechanism sustained by a large, though possibly below 100%, degree of exogenous boosting, in agreement with findings from other Nordic countries, implying large reproduction numbers of boosting. Moreover, magnitudes of exogenous boosting below 40% are robustly discon-firmed by data. These results bring further insight on the magnitude of immunity boosting and its relationship with reactivation.	[Marangi, Luigi; Manfredi, Piero] Univ Pisa, Dept Econ & Management, Pisa, Italy; [Mirinaviciute, Grazina; Flem, Elmira; de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modeling Infect Contr, Oslo, Norway; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy; [Guzzetta, Giorgio] Kessler Fdn, Trento, Italy; [de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo Ctr Biostat & Epidemiol, Oslo, Norway	University of Pisa; Norwegian Institute of Public Health (NIPH); University of Rome Tor Vergata; Fondazione Bruno Kessler; University of Oslo	Marangi, L (corresponding author), Univ Pisa, Dept Econ & Management, Pisa, Italy.	marangighen@gmail.com	Flem, Elmira/AFS-7695-2022; Flem, Elmira/GOG-9451-2022	Flem, Elmira/0000-0002-5099-1960; Flem, Elmira/0000-0002-5099-1960; Guzzetta, Giorgio/0000-0002-9296-9470	Norwegian Institute of Public Health; NIPH	Norwegian Institute of Public Health; NIPH	The study was funded by the Norwegian Institute of Public Health.; Luigi Marangi was funded by NIPH within collaborative agreement "Burden of VZV infection in Norway". We would like to acknowledge Arild Osen, Department of Health Data Management and Analysis, the Norwegian Institute of Public Health, for assistance during extraction and management of data on primary healthcare consultations. We warmly thank an Editor and two anonymous referees of the Journal for a number of deep and helpful suggestions which allowed to sharply improve the manuscript.	ANDERSON R M, 1991; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Del Fava E, PLOS ONE IN PRESS; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P635, DOI 10.1017/S0950268800004672; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gaillat J, 2011, CLIN INFECT DIS, V53, P405, DOI 10.1093/cid/cir436; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050; Guzzetta G, AMERICAN JOURNAL OF; Guzzetta G, 2013, AM J EPIDEMIOL, V177, P1134, DOI 10.1093/aje/kws370; Hales CM, 2013, ANN INTERN MED, V159, P739, DOI 10.7326/0003-4819-159-11-201312030-00006; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Horn J, HUM VACCIN IMMUNOT; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Kawai K, CLIN INFEC DIS, DOI 10.1093/cid/ciw296; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; Marinelli I, 2016, EPIDEMICS; Marziano V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2509; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Ogunjimi B, 2015, ELIFE, V4, DOI 10.7554/eLife.07116; Ogunjimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066485; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; Pinquier D, 2011, HUM VACCINES, V7, P534, DOI 10.4161/hv.7.5.14820; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Prymula R, 2014, LANCET, V383, P1313, DOI 10.1016/S0140-6736(12)61461-5; Rimseliene G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1581-4; Santermans E, 2015, EPIDEMICS-NETH, V11, P14, DOI 10.1016/j.epidem.2014.12.005; Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; SEILER HE, 1949, J HYG-CAMBRIDGE, V47, P253, DOI 10.1017/S002217240001456X; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; van Lier A, 2015, EBIOMEDICINE, V2, P1494, DOI 10.1016/j.ebiom.2015.08.017; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0176845	10.1371/journal.pone.0176845	http://dx.doi.org/10.1371/journal.pone.0176845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545047	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000401672400014
J	Munoz-Esquerre, M; Aliagas, E; LopPez-Sanchez, M; Escobar, I; Huertas, D; Penin, R; Dorca, J; Santos, S				Munoz-Esquerre, Mariana; Aliagas, Elisabet; LopPez-Sanchez, Marta; Escobar, Ignacio; Huertas, Daniel; Penin, Rosa; Dorca, Jordi; Santos, Salud			Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)	PLOS ONE			English	Article							HUMAN CC-CHEMOKINE; ATHEROSCLEROSIS; PROTEIN-1; SMOKERS; CCL18; SERUM	Introduction The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not fully understood. The aim of the present study is to analyze the expression of PARC in lung tissue and its relationship with the vascular remodeling of the systemic and pulmonary arteries of COPD subjects. Methods To achieve this objective, protein and gene expression experiments, together with ELISA assays, were performed on the lung tissue, intercostal arteries and serum samples from COPD patients, non-obstructed smokers (NOS) and never-smokers (NS). Results A total of 57 subjects were included in the analysis (23 COPD, 18 NOS and 16 NS). In the comparisons between groups, a significantly increased lung protein expression of PARC was observed in the COPD group compared to the NOS group (1.96 +/- 0.22 vs. 1.29 +/- 0.27, P-adjusted = 0.038). PARC was located predominantly in the smooth muscle cells of the remodeled pulmonary muscular arteries and the macrophage-rich area of the alveolar parenchyma. No differences were detected in PARC gene expression analyses. The protein content of PARC in the intercostal arteries were similar between groups, though little remodeling was observed in these arteries. Circulating levels of PARC were numerically higher in patients with COPD compared to NOS and NS. Conclusion The results of the present study suggest an increased lung protein expression of PARC in COPD subjects. This protein was mainly localized in the smooth muscle cells of the pulmonary muscular arteries and was associated with the severity of intimal thickening, indicating its possible role in this remodeling process.	[Munoz-Esquerre, Mariana; Aliagas, Elisabet; LopPez-Sanchez, Marta; Huertas, Daniel; Dorca, Jordi; Santos, Salud] Univ Barcelona, Bellvitge Univ Hosp, IDIBELL, Dept Pulm Med, Barcelona, Spain; [Escobar, Ignacio] Univ Barcelona, Bellvitge Univ Hosp, IDIBELL, Dept Thorac Surg, Barcelona, Spain; [Penin, Rosa] Univ Barcelona, Bellvitge Univ Hosp, IDIBELL, Dept Pathol, Barcelona, Spain; [Santos, Salud] Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Santos, S (corresponding author), Univ Barcelona, Bellvitge Univ Hosp, IDIBELL, Dept Pulm Med, Barcelona, Spain.; Santos, S (corresponding author), Biomed Res Networking Ctr Consortium Resp Dis CIB, Barcelona, Spain.	saludsantos@bellvitgehospital.cat	Munoz-Esquerre, Mariana/F-7386-2012; Dorca, Jordi/Q-3617-2016	Dorca, Jordi/0000-0002-8137-878X; Santos, Salud/0000-0002-5835-1028; Aliagas Marin, Elisabeth/0000-0001-5606-3252	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR [081/2011]; Fundacio Catalana de Pneumologia FUCAP [URIACH 2011]; Institut d'Investigacio Biomedica de Bellvitge, IDIBELL; Fondo de Investigacion en Salud ISCIII [PI16/00193]	Comite de Recerca de l'Hospital Universitari de Bellvitge; Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR; Fundacio Catalana de Pneumologia FUCAP; Institut d'Investigacio Biomedica de Bellvitge, IDIBELL; Fondo de Investigacion en Salud ISCIII	This study was funded by Comite de Recerca de l'Hospital Universitari de Bellvitge (2012), Sociedad Espanola de Neumologia y Cirugia Toracica SEPAR (No 081/2011); Fundacio Catalana de Pneumologia FUCAP (URIACH 2011); Institut d'Investigacio Biomedica de Bellvitge, IDIBELL (Predoctoral fellowship 2012) and Fondo de Investigacion en Salud ISCIII (PI16/00193). The study sponsors did not have any role in the study design, collection, analysis and interpretation of data, or in writing the report.	Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Berkhout TA, 1997, J BIOL CHEM, V272, P16404, DOI 10.1074/jbc.272.26.16404; Cai MT, 2013, RESP MED, V107, P1444, DOI 10.1016/j.rmed.2013.06.004; Courtois A, 2014, MOL MED, V20, P697, DOI 10.2119/molmed.2014.00065; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fimognari Filippo Luca, 2008, Int J Chron Obstruct Pulmon Dis, V3, P89; Gao YS, 2016, AM J RESP CELL MOL, V54, P451, DOI 10.1165/rcmb.2015-0323TR; Guan P, 1999, GENOMICS, V56, P296, DOI 10.1006/geno.1998.5635; Hagg Daniel A, 2009, Atherosclerosis, V204, pe15, DOI 10.1016/j.atherosclerosis.2008.10.010; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Lahousse L, 2013, AM J RESP CRIT CARE, V187, P58, DOI 10.1164/rccm.201206-1046OC; Moss JWE, 2016, FUTURE MED CHEM, V8, P1317, DOI 10.4155/fmc-2016-0072; Munoz-Esquerre M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152987; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Pardo A, 2001, J LEUKOCYTE BIOL, V70, P610; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Shchelkunova TA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P463, DOI 10.1134/S0006297913050040; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Stenmark KR, 1985, J APPL PHYSIOL, P119; Tabara Y, 2014, ATHEROSCLEROSIS, V232, P59, DOI 10.1016/j.atherosclerosis.2013.10.020; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Ye C, 2016, QJM	35	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177218	10.1371/journal.pone.0177218	http://dx.doi.org/10.1371/journal.pone.0177218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545096	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400029
J	Tunc-Ozdemir, M; Jones, AM				Tunc-Ozdemir, Meral; Jones, Alan M.			BRL3 and AtRGS1 cooperate to fine tune growth inhibition and ROS activation	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ARABIDOPSIS; GLUCOSE; REGULATOR; KINASES; ROLES	Plasma membrane-localized leucine-rich repeat receptor-like kinases directly activates G protein complex via interaction with seven transmembrane domain Regulator of G-protein Signaling 1 (AtRGS1) protein. Brassinosteroid insensitive 1 (BRI1) LIKE3 (BRL3) phosphorylates AtRGS1 in vitro. FRET analysis showed that BRL3 and AtRGS1 interaction dynamics change in response to glucose and flg22. Both BRL3 and AtRGS1 function in glucose sensing and brl3 and rgs1-2 single mutants are hyposensitive to high glucose as well as the brl3/rgs1 double mutant. BRL3 and AtRGS1 function in the same pathway linked to high glucose sensing. Hypocotyl elongation, another sugar-mediated pathway, is also implicated to be partially mediated by BRL3 and AtRGS1 because rgs1-2, brl3-2 and brl3-2/ rgs1-2 mutants share the long hypocotyl phenotype. BRL3 and AtRGS1 modulate the flg22-induced ROS burst and block one or more components positively regulating ROS production because the brl3/ rgs1 double mutant has similar to 60% more ROS production than wild type while rgs1-2 has a partial ROS burst impairment and brl3 has slightly more ROS production. Here, we proposed a simple model where both BRL3 and AtRGS1 are part of a fine-tuning mechanism sensing glucose and flg22 to prevent excess ROS burst and control growth inhibition.	[Tunc-Ozdemir, Meral; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.; Jones, AM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Jones, Alan/K-7433-2012	Jones, Alan/0000-0002-2365-6462	NIGMS [R01GM065989]; NSF [MCB-0718202]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF))	This work was supported by grants from the NIGMS (R01GM065989) and NSF (MCB-0718202) to A.M.J.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Chung EH, 2014, CELL HOST MICROBE, V16, P484, DOI 10.1016/j.chom.2014.09.004; Colaneri AC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-129; Coll-Garcia D, 2004, FEBS LETT, V563, P82, DOI 10.1016/S0014-5793(04)00255-8; Fabregas N, 2013, PLANT CELL, V25, P3377, DOI 10.1105/tpc.113.114462; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Gao YJ, 2008, PLANT CELL PHYSIOL, V49, P1013, DOI 10.1093/pcp/pcn078; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Gupta A, 2015, PLANT PHYSIOL, V168, P1091, DOI 10.1104/pp.15.00495; Huang J, 2015, POLYSACCHARIDE-BASED NANOCRYSTALS: CHEMISTRY AND APPLICATIONS, P1; Kang YH, 2017, DEVELOPMENT, V144, P272, DOI 10.1242/dev.145623; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liao KL, 2017, J THEOR BIOL, V414, P231, DOI 10.1016/j.jtbi.2016.11.027; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Salazar-Henao JE, 2016, J EXP BOT, V67, P4951, DOI 10.1093/jxb/erw258; Schroder F, 2011, PLANT PHYSIOL, V156, P1620, DOI 10.1104/pp.111.177204; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Singh M, 2014, J EXP BOT, V65, P2981, DOI 10.1093/jxb/eru146; ten Hove CA, 2011, PLANT MOL BIOL, V76, P69, DOI 10.1007/s11103-011-9769-x; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Torres MA, 2013, MOL PLANT MICROBE IN; Tunc- Ozdemir M, 2016, METHODS IN MOLECULAR; Tunc-Ozdemir M, 2016, J BIOL CHEM; Tunc-Ozdemir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171854; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf9558; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	38	16	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177400	10.1371/journal.pone.0177400	http://dx.doi.org/10.1371/journal.pone.0177400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28545052	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400041
J	Hong, M; Jung, J; Park, HS; Lee, SM; Jeong, NJ; Kim, SH; Lee, KW; Lee, JA; Kim, MS				Hong, Moonju; Jung, Jeeyoun; Park, Hee-Sook; Lee, So Min; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Lee, Ju-A; Kim, Myung-Sunny			Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; ACTIVE FRACTION; BLOOD-STASIS; TNF-ALPHA; MEDICINE; RATS; IDENTIFICATION	Shaofu Zhuyu decoction (SFZYD, also known as Sobokchugeo-tang), a classical prescription drug in traditional East Asian medicine, has been used to treat blood stasis syndrome (BSS). Hepatic steatosis is the result of excess caloric intake, and its pathogenesis involves internal retention of phlegm and dampness, blood stasis, and liver Qi stagnation. To evaluate the effects of treatment with SFZYD on obesity-induced inflammation and hepatic steatosis, we fed male C57BL/6N mice a high fat diet (HFD) for 8 weeks and then treated them with SFZYD by oral gavage for an additional 4 weeks. The results of histological and biochemical examinations indicated that SFZYD treatment ameliorates systemic inflammation and hepatic steatosis. A partial least squares-discriminant analysis (PLS-DA) scores plot of serum metabolites showed that HFD mice began to produce metabolites similar to those of normal chow (NC) mice after SFZYD administration. We noted significant alterations in the levels of twenty-seven metabolites, alterations indicating that SFZYD regulates the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism. Increases in the levels of TCA cycle intermediate metabolites, such as 2-oxoglutaric acid, isocitric acid, and malic acid, in the serum of obese mice were significantly reversed after SFZYD treatment. In addition to inducing changes in the above metabolites, treatment with SFZYD also recovered the expression of genes related to hepatic mitochondrial dysfunction, including Ucp2, Cpt1 alpha, and Ppargc1 alpha, as well as the expression of genes involved in lipid metabolism and inflammation, without affecting glucose uptake or insulin signaling. Taken together, these findings suggest that treatment with SFZYD ameliorated obesity-induced systemic inflammation and hepatic steatosis by regulating inflammatory cytokine and adipokine levels in the circulation and various tissues. Moreover, treatment with SFZYD also reversed alterations in the levels of metabolites of the TCA cycle, the pentose phosphate pathway and aromatic amino acid metabolism.	[Hong, Moonju; Park, Hee-Sook; Jeong, Nam-Joo; Kim, Soon-Hee; Lee, Kyoung-Won; Kim, Myung-Sunny] Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea; [Hong, Moonju; Kim, Myung-Sunny] Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea; [Jung, Jeeyoun; Lee, So Min; Lee, Ju-A] Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea	Korea Food Research Institute (KFRI); Korea Institute of Oriental Medicine (KIOM)	Kim, MS (corresponding author), Korea Food Res Inst, Div Metab & Nutr, Gyeonggi Do, South Korea.; Kim, MS (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Gyeonggi Do, South Korea.	truka@kfri.re.kr	Jung, Jeeyoun/G-8438-2018	Hong, Moonju/0000-0001-7688-6803	Korea Institute of Oriental Medicine [K15113, K15114]; Korea Food Research Institute [E0150302-2]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024748] Funding Source: NIH RePORTER	Korea Institute of Oriental Medicine; Korea Food Research Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Korea Institute of Oriental Medicine (K15113 and K15114) and the Korea Food Research Institute (E0150302-2). We thank Drs. K.S. Sung and C.E. Lee for providing technical support for the animal experiments.	Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Dietrich P, 2014, BEST PRACT RES CL GA, V28, P637, DOI 10.1016/j.bpg.2014.07.008; Dong H, 2012, CHIN J INTEGR MED, V18, P152, DOI 10.1007/s11655-012-0993-2; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Fan M., 2011, BEIJING J TRADIT CHI, V30, P455; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Guo N, 2014, J CHROMATOGR A, V1362, P89, DOI 10.1016/j.chroma.2014.08.028; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Huang XC, 2016, J ETHNOPHARMACOL, V186, P234, DOI 10.1016/j.jep.2016.03.067; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Jia W, 2006, PHYTOTHER RES, V20, P819, DOI 10.1002/ptr.1905; Kim M, 2002, J COMMUN HEALTH, V27, P109, DOI 10.1023/A:1014509200352; Kim MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082847; Kim SH, 2016, J ETHNOPHARMACOL, V192, P201, DOI 10.1016/j.jep.2016.07.023; KUNJARA S, 1993, BIOCHEM MED METAB B, V49, P217, DOI 10.1006/bmmb.1993.1024; Lan K, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/819147; Li SM, 2014, CHIN J INTEGR MED, V20, P483, DOI 10.1007/s11655-014-1803-9; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; Liu CG, 2013, BIOL PHARM BULL, V36, P1700; Liu L, 2010, MOLECULES, V15, P5066, DOI 10.3390/molecules15085066; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Park HS, 2016, MOL NUTR FOOD RES, V60, P1944, DOI 10.1002/mnfr.201500689; Rodriguez-Gallego E, 2015, INT J OBESITY, V39, P279, DOI 10.1038/ijo.2014.53; Su SL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/901943; Su SL, 2010, AM J CHINESE MED, V38, P777, DOI 10.1142/S0192415X10008238; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Yonghe CMY, 2007, J TRADITIONAL CHINES, V27, P115; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19288; Zhao XJ, 2008, J CHROMATOGR B, V873, P151, DOI 10.1016/j.jchromb.2008.08.010	39	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178514	10.1371/journal.pone.0178514	http://dx.doi.org/10.1371/journal.pone.0178514			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28441416	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800069
